On branch master

2 files changed, 2 insertions, 3901 deletions

diff --git a/wqflask/maintenance/dataset/bxdphenotypes.txt b/wqflask/maintenance/dataset/bxdphenotypes.txt
deleted file mode 100644
index 39277747..00000000
--- a/wqflask/maintenance/dataset/bxdphenotypes.txt
+++ /dev/null
@@ -1,3899 +0,0 @@
-id	Original_description	Pre_publication_description	Post_publication_description	D2B6F1	B6D2F1	C57BL/6J	DBA/2J	BXD1	BXD2	BXD5	BXD6	BXD8	BXD9	BXD11	BXD12	BXD13	BXD14	BXD15	BXD16	BXD18	BXD19	BXD20	BXD21	BXD22	BXD23	BXD24A	BXD24	BXD25	BXD27	BXD28	BXD29	BXD30	BXD31	BXD32	BXD33	BXD34	BXD35	BXD36	BXD37	BXD38	BXD39	BXD40	BXD41	BXD42	BXD43	BXD44	BXD45	BXD46	BXD47	BXD48	BXD49	BXD50	BXD51	BXD52	BXD53	BXD54	BXD55	BXD56	BXD57	BXD58	BXD59	BXD60	BXD61	BXD62	BXD63	BXD64	BXD65	BXD66	BXD67	BXD68	BXD69	BXD70	BXD71	BXD72	BXD73	BXD74	BXD75	BXD76	BXD77	BXD78	BXD79	BXD80	BXD81	BXD82	BXD83	BXD84	BXD85	BXD86	BXD87	BXD88	BXD89	BXD90	BXD91	BXD92	BXD93	BXD94	BXD95	BXD96	BXD97	BXD98	BXD99	BXD100	BXD101	BXD102	BXD103
-10001	Original post publication description: Cerebellum weight [mg]	None	Central nervous system, morphology: Cerebellum weight [mg]	x	x	x	x	61.4	49.0	62.5	53.1	59.1	53.9	53.1	45.9	48.4	49.4	47.4	56.3	53.6	50.1	48.2	50.6	53.8	48.6	x	54.9	49.6	47.4	51.5	50.2	53.6	49.7	56.0	52.1	53.7	49.7	44.5	x	51.1	54.9	49.9	x	59.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10002	Original post publication description: Central nervous system, morphology: Cerebellum weight after adjustment for covariance with brain size [mg]	None	Central nervous system, morphology: Cerebellum weight after adjustment for covariance with brain size [mg]	x	x	x	x	54.1	50.1	53.3	55.1	57.3	51.2	53.6	46.8	50.6	49.3	45.7	52.5	52.0	51.1	52.4	49.0	51.6	50.7	x	55.5	52.6	53.1	53.5	53.2	58.7	50.8	53.3	51.9	54.1	52.3	46.1	x	51.8	57.0	48.6	x	56.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10003	Original post publication description: Central nervous system, morphology: Brain weight, male and female adult average, unadjusted for body weight, age, sex [mg]	None	Central nervous system, morphology: Brain weight, male and female adult average, unadjusted for body weight, age, sex [mg]	x	x	x	x	483.0	403.0	501.0	403.0	438.0	448.0	408.0	405.0	392.0	414.0	437.0	450.0	429.0	409.0	374.0	437.0	435.0	394.0	x	408.0	385.0	359.0	394.0	385.0	365.0	403.0	439.0	445.0	439.0	417.0	427.0	x	436.0	423.0	455.0	x	469.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10004	Original post publication description: Central nervous system, morphology: Cerebellum volume [mm^3]	None	Central nervous system, morphology: Cerebellum volume [mm^3]	x	x	x	x	49.8	45.5	62.9	x	55.1	47.3	50.6	43.8	47.9	47.1	44.5	x	47.5	46.4	43.2	x	50.4	43.1	x	50.7	45.1	43.5	47.7	40.9	47.9	46.0	55.1	48.2	50.4	46.9	40.9	x	45.5	50.6	44.9	x	53.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10005	Original post publication description: Central nervous system, morphology: Cerebellum volume, adjusted for covariance with brain size [mm^3]	None	Central nervous system, morphology: Cerebellum volume, adjusted for covariance with brain size [mm^3]	x	x	x	x	46.0	44.9	52.5	x	54.3	45.8	49.0	42.6	48.3	45.0	41.6	x	47.8	45.8	45.8	x	48.0	43.9	x	52.2	46.6	49.3	49.3	46.0	52.6	46.8	51.5	47.7	51.0	48.2	42.5	x	45.8	52.6	44.2	x	51.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10006	Original post publication description: Central nervous system, morphology: Cerebellum internal granule layer (IGL) volume without adjustment [mm^3]	None	Central nervous system, morphology: Cerebellum internal granule layer (IGL) volume without adjustment [mm^3]	x	x	x	x	20.3	15.0	23.0	x	22.7	18.8	19.5	16.4	18.6	15.8	15.2	x	18.6	18.5	14.5	x	21.6	16.4	x	21.1	17.3	16.9	18.9	14.9	17.8	16.5	21.2	19.5	18.7	17.6	14.6	x	16.8	18.9	18.1	x	21.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10007	Original post publication description: Central nervous system, morphology: Internal granule layer (IGL) of the cerebellum volume, adjusted for sex, age, body and brain weight [mm3]	None	Central nervous system, morphology: Internal granule layer (IGL) of the cerebellum volume, adjusted for sex, age, body and brain weight [mm3]	x	x	x	x	18.7	14.8	18.7	x	22.4	18.1	18.9	16.0	18.8	14.9	14.0	x	18.8	18.3	15.9	x	20.6	16.8	x	21.8	17.9	19.3	19.5	17.0	19.8	16.9	19.7	19.3	18.9	18.2	15.3	x	16.9	19.8	17.8	x	20.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10008	Original post publication description: Phencyclidine response (7.5 mg/kg ip), locomotor response, difference in activity (PCP minus saline) between 1 hr test periods [cm]	None	Phencyclidine response (7.5 mg/kg ip), locomotor response, difference in activity (PCP minus saline) between 1 hr test periods [cm]	x	x	5525.0	5062.0	4897.0	4616.0	612.0	4695.0	982.0	441.0	10276.0	10420.0	8905.0	2267.0	2620.0	3237.0	2999.0	6160.0	12184.0	688.0	4218.0	8182.0	x	1165.0	6391.0	1159.0	245.0	2633.0	2805.0	5463.0	3298.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10009	Original post publication description: Phencyclidine response (7.5 mg/kg ip), locomotor activity from 0-60 min after PCP injection [cm]	None	Phencyclidine response (7.5 mg/kg ip), locomotor activity from 0-60 min after PCP injection [cm]	x	x	6180.0	5274.0	6307.0	5459.0	1487.0	5691.0	3709.0	1499.0	10922.0	12818.0	2999.0	2743.0	3011.0	4322.0	3763.0	6456.0	11556.0	1873.0	4541.0	7795.0	x	1426.0	7287.0	2635.0	684.0	4337.0	3938.0	6035.0	4701.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10010	Original post publication description: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of phencyclidine) [cm]	None	Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of phencyclidine) [cm]	x	x	605.0	273.0	2029.0	957.0	361.0	1062.0	1980.0	1184.0	718.0	2416.0	245.0	560.0	532.0	1123.0	751.0	209.0	659.0	1294.0	609.0	1615.0	x	284.0	988.0	443.0	442.0	1847.0	1037.0	663.0	1598.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10011	Original post publication description: Amphetamine response (5 mg/kg ip), locomotor response, difference in activity (amphetamine minus saline) between 1 hr test periods [cm]	None	Amphetamine response (5 mg/kg ip), locomotor response, difference in activity (amphetamine minus saline) between 1 hr test periods [cm]	x	x	4844.0	7801.0	13196.0	4389.0	6627.0	8699.0	2973.0	8065.0	2881.0	2461.0	5670.0	4267.0	9238.0	414.0	4438.0	8887.0	4821.0	9263.0	6573.0	5800.0	x	10645.0	8489.0	15450.0	4772.0	4507.0	4413.0	5166.0	6022.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10012	Original post publication description: Amphetamine response (5 mg/kg ip), locomotor activity from 0-60 min after injection [cm]	None	Central nervous system, pharmacology, behavior: Amphetamine response (5 mg/kg ip), locomotor activity from 0-60 min after injection [cm]	x	x	6251.0	7137.0	14117.0	4990.0	6820.0	10392.0	4061.0	9382.0	3238.0	3389.0	6222.0	5243.0	9746.0	1756.0	5539.0	9105.0	5021.0	10467.0	6910.0	6730.0	x	10844.0	10070.0	15944.0	5005.0	5479.0	5925.0	5533.0	6867.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10013	Original post publication description: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of 5 mg/kg amphetamine) [cm]	None	Central nervous system, pharmacology, behavior: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of 5 mg/kg amphetamine) [cm]	x	x	841.0	431.0	996.0	911.0	423.0	1795.0	798.0	1465.0	413.0	1090.0	582.0	592.0	645.0	1565.0	1195.0	201.0	314.0	1370.0	642.0	688.0	x	202.0	1789.0	586.2	277.0	1074.0	1143.0	460.0	1003.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10014	Original post publication description: Ca2+ stimulated ecto-ATPase activity [umolPi /mg protein/hr]	None	Central nervous system, pharmacology, behavior: Calcium (Ca2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes (monogenic trait mapping to Chr 2 at 25 Mb at Entpd8) [umolPi /mg protein/hr]	x	x	8.15	4.13	4.13	6.55	4.03	7.03	4.73	4.03	7.15	4.32	4.11	4.52	6.54	7.84	7.86	7.74	x	4.02	4.24	x	x	4.43	3.83	7.32	8.07	7.32	4.61	4.33	3.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10015	Original post publication description: Mg2+ stimulated ecto-ATPase activity [umolPi /mg protein/hr]	None	Central nervous system, pharmacology, behavior: Magnesium (Mg2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes (monogenic trait mapping to Chr 2 at 25 Mb at Entpd8) [umolPi /mg protein/hr]	x	x	10.12	4.61	4.81	8.41	4.61	8.31	5.11	4.7	8.39	4.71	4.43	4.83	8.33	9.72	9.64	10.51	x	4.2	5.14	x	x	5.02	4.63	9.03	9.72	9.52	4.92	4.84	3.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10016	Original post publication description: Morphine response (dose ip), hypothermia [slope of drug response curve]	None	Central nervous system, pharmacology, metabolism: Morphine response (variable doses, ip), hypothermia [slope of drug-response curve]	x	-7.65	-4.58	-7.01	-7.06	-5.75	-6.33	-4.88	-7.36	-2.93	x	-2.02	-3.43	-3.75	-1.88	-1.31	-4.53	x	x	-2.73	-2.12	-5.29	x	-3.54	-6.06	-5.82	-7.5	-6.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10017	Original post publication description: Morphine response (dose ip), analgesia, slope of the drug response curve (DRC) [units]	None	Central nervous system, behavior, pharmacology: Morphine response (dose ip), analgesia, slope of the drug response curve (DRC) [units]	x	42.9	26.8	59.7	50.1	63.4	30.0	30.5	62.7	27.6	x	33.9	25.8	31.2	25.5	36.7	39.1	x	x	15.2	10.9	44.3	x	59.8	35.4	46.3	34.7	24.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10018	Original post publication description: Morphine response (dose mg/kg ip), Straub tail test, slope of the drug response curve DRC [units]	None	Morphine response (dose mg/kg ip), Straub tail test, slope of the drug response curve DRC [units]	x	0.78	0.94	0.25	1.37	1.04	1.07	0.94	0.42	0.75	x	0.81	0.94	1.37	0.91	0.73	0.98	x	x	0.48	0.61	1.2	x	0.35	0.75	1.16	1.24	0.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10019	Original post publication description: Body temperature following control saline injection [degree C]	None	Central nervous system, pharmacology, metabolism: Body temperature following saline injection, control for morphine response [degree C]	x	38.2	37.5	37.7	38.1	37.0	37.2	38.3	37.4	37.3	x	38.4	37.8	37.6	36.6	37.0	38.4	x	x	36.8	37.3	37.5	x	37.5	37.9	38.5	37.8	38.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10020	Original post publication description: Pain response, morphine, amphetamine, and saline responses, hot plate latency after saline control injection [seconds]	None	Pain response, morphine, amphetamine, and saline responses, hot plate latency after saline control injection [seconds]	x	19.1	20.2	21.3	22.0	19.5	11.8	8.8	31.0	18.0	x	14.1	11.6	12.8	13.0	11.9	20.0	x	x	13.8	16.1	12.2	x	13.5	15.0	15.5	22.9	9.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10021	Original post publication description: Saline control response (vehicle ip), open field activity after (unpublished means from same series of studies as reported in Belknap & Crabbe, 1992 ANYAS 654:311-323) [units]	None	Central nervous system, behavior: Saline control response (vehicle ip), open field activity after injection (unpublished data from same series of studies as reported in Belknap and Crabbe, 1992 ANYAS 654:311-323) [units]	x	x	15.44	6.39	9.34	12.15	9.24	15.25	8.4	8.675	x	14.49	6.43	11.84	7.315	10.25	12.72	x	x	7.95	8.3	5.925	x	6.945	8.26	8.58	5.25	12.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10022	Original post publication description: Central nervous system, gustatory system: Saccharin sweet taste response, saccharin preference versus water ratio [%]	None	Central nervous system, gustatory system: Saccharin sweet taste response, saccharin preference versus water ratio [%]	x	x	96.0	59.0	74.0	82.0	90.0	91.0	57.0	60.0	x	77.0	57.0	85.0	82.0	86.0	77.0	x	x	61.0	61.0	79.0	x	91.0	64.0	76.0	87.0	83.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10023	Original post publication description: Central nervous system, gustatory system: Saccharin sweet taste water consumption (BXD5 value of 1228 units winsorized to 700 units) [mg/kg/day]	None	Central nervous system, gustatory system: Saccharin sweet taste water consumption (BXD5 value of 1228 units winsorized to 700 units) [mg/kg/day]	x	x	677.0	294.0	333.0	473.0	700.0	519.0	267.0	286.0	x	475.0	253.0	601.0	457.0	458.0	436.0	x	x	354.0	264.0	380.0	x	500.0	477.0	358.0	469.0	450.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10024	Original post publication description: Handling-induced convulsions (HIC) baseline scores [units]	None	Central nervous system, pharmacology, behavior: Handling-induced convulsions (HIC) baseline scores [units]	x	x	0.6995	0.3415	1.6835	2.0565	1.17045	0.3985	1.146	1.8895	x	0.6495	1.581	1.928	0.1625	0.4835	0.4165	x	x	0.7105	0.6315	x	x	0.091	0.125	1.5725	0.625	0.0985	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10025	Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC) area under the curve [units]	None	Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC) area under the curve [units]	x	x	5.68	13.24	6.85	1.17	15.6	4.57	5.35	20.0	x	2.2	10.15	2.55	1.0	1.33	3.8	x	x	8.87	3.36	x	x	6.5	6.67	9.0	6.94	5.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10026	Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC), corrected peak level [units]	None	Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC), corrected peak level [units]	x	x	1.4	2.94	1.41	0.44	3.4	1.28	1.31	4.17	x	0.62	2.2	0.88	0.3	0.39	0.73	x	x	2.09	0.79	x	x	1.71	1.56	2.0	1.35	1.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10027	Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion (HIC) score, difference between treated and baseline untreated [units]	None	Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion (HIC) score, difference between treated and baseline untreated [units]	x	x	6.067	12.635	9.533	0.333	14.131	4.252	7.821	15.977	x	0.807	8.35	2.4717	0.55	1.0467	3.55	x	x	9.337	4.243	x	x	6.727	6.447	7.213	9.137	5.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10028	Original post publication description: Ethanol response, acute withdrawal severity measured as the difference in handling-induced convulsion (HIC) from the saline control group (unpublished values from the same series of studies reported in Belknap et al. 1993 Behav Genetics 23:213-222) [	None	Ethanol response, acute withdrawal severity measured as the difference in handling-induced convulsion (HIC) from the saline control group (unpublished values from the same series of studies reported in Belknap et al. 1993 Behav Genetics 23:213-222) [	x	x	5.227	14.08	8.6	9.303	7.9	1.91	3.05	6.27	x	1.78	5.07	5.6	3.11	6.3	4.06	x	x	8.47	5.707	x	x	2.21	6.047	6.696	5.5	1.49	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10029	Original post publication description: Morphine response (16 mg/kg), analgesia relative to maximum possible effect [%]	None	Central nervous system, pharmacology, nociception: Morphine response (16 mg/kg), analgesia relative to maximum possible effect [%]	x	x	13.0	82.0	63.0	73.0	45.0	16.0	72.0	50.0	x	10.0	20.0	23.0	32.0	25.0	33.0	x	x	18.0	12.0	60.0	x	80.0	30.0	55.0	45.0	18.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10030	Original post publication description: Naloxone ([3H]-naloxone) Bmax concentration (binding maximum) [pM]	None	Central nervous system, pharmacology, nociception: Naloxone ([3H]-naloxone) Bmax concentration (binding maximum) [pM/mg]	x	x	84.0	95.0	x	104.0	90.0	92.0	95.0	100.0	x	90.0	90.0	83.0	x	76.0	84.0	x	x	83.0	74.0	88.0	x	86.0	92.0	90.0	103.0	86.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10031	Original post publication description: Morphology, metabolism: Body weight of adult males [g]	None	Morphology, metabolism: Body weight of adult males [g]	x	x	25.5	25.5	27.6	28.4	26.1	25.0	26.4	27.1	x	25.2	29.3	30.4	27.8	26.75	29.0	x	x	28.4	25.1	24.3	x	25.0	24.7	25.2	26.3	24.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10032	Original post publication description: Central nervous system, morphology: Brain weight in young adult males [mg]	None	Central nervous system, morphology: Brain weight in young adult males [mg]	x	x	465.0	339.0	450.0	390.0	477.0	361.0	421.0	419.0	x	412.0	403.0	439.0	429.0	436.0	427.0	x	x	409.0	431.0	432.0	x	380.0	394.0	381.0	389.0	375.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10033	Original post publication description: Central nervous system, morphology: Brain to body weight ratio [ratio]	None	Central nervous system, morphology: Brain to body weight ratio [ratio]	x	x	0.0183	0.0134	0.0163	0.0138	0.0183	0.145	0.016	0.0154	x	0.0164	0.0138	0.0145	0.0155	0.0163	0.0149	x	x	0.0145	0.0172	0.0179	x	0.0153	0.0161	0.0152	0.0148	0.0153	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10034	Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU]	None	Infectious disease, immune system: Salmonella typhimurium bacterial strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3, filled circles) [log10 CFU]	x	x	4.92	5.55	4.14	5.29	6.79	4.12	4.69	4.95	4.89	4.57	5.42	5.17	x	3.04	5.61	x	x	x	x	3.78	x	5.52	x	x	4.82	3.06	4.69	x	3.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10035	Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU]	None	Infectious disease, immune system: Salmonella typhimurium bacterial strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3 open circles) [log10 CFU]	x	x	6.67	5.04	4.29	7.74	7.64	3.96	4.69	6.75	7.84	6.61	5.27	8.16	x	3.69	7.78	x	x	x	x	4.08	x	6.46	x	x	4.86	3.86	5.16	x	3.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10036	Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain SR-11 from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU]	None	Infectious disease, immune system: Salmonella typhimurium bacterial strain SR-11, net growth in livers and spleens 6 days after inoculation with 10^2 CFU (figure 5, triangles, Itk/Nramp1/Slc11a1-associated) [log10 CFU]	x	x	8.01	6.23	5.28	7.35	7.81	5.58	4.86	7.92	7.46	7.54	5.38	x	x	7.27	8.04	x	x	x	x	5.27	x	8.05	x	x	6.31	5.62	5.57	x	5.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10037	Original post publication description: Central nervous system, behavior: Activity level, total distance travelled day 1 of novel environment [cm]	None	Central nervous system, behavior: Activity level, total distance travelled day 1 of novel environment [cm]	x	x	1405.0	1530.0	2132.0	1416.0	946.0	1882.0	954.0	1740.0	1090.0	1703.0	x	1325.0	x	1542.0	1716.0	1543.0	x	1273.0	855.0	x	x	914.0	1155.0	1004.0	925.0	x	1422.0	x	1817.0	1138.0	1364.0	1367.0	x	x	1084.0	859.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10038	Original post publication description: Central nervous system, behavior: Activity level, distance travelled (day 1 total distance-day 3 total distance) [cm]	None	Central nervous system, behavior: Activity level, distance travelled (day 1 total distance-day 3 total distance) [cm]	x	x	310.0	-92.0	398.0	269.0	385.0	394.0	53.1	-347.0	355.0	388.0	x	-74.7	x	293.0	-362.0	95.0	x	-236.0	-21.0	x	x	70.0	195.0	-262.0	-84.0	x	-12.0	x	405.0	-165.0	-13.0	459.0	x	x	-280.0	322.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10040	Original post publication description: Ethanol response, blood ethanol concentration (BEC) at recovery of righting reflex (retro-orbital sinus sample) [mg/ml]	None	Central nervous system, pharmacology, behavior: Ethanol response, blood ethanol concentration (BEC) at recovery of righting reflex (retro-orbital sinus sample) [mg/ml]	x	x	3.915	3.58	3.788	3.46	3.966	3.453	3.971	x	3.894	3.406	3.837	3.846	3.899	3.446	3.547	3.266	x	3.581	3.406	4.084	x	3.813	3.651	4.121	4.002	3.757	4.129	3.634	3.843	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10041	Original post publication description: Ethanol response (2.5 g/kg ip), duration of loss of righting reflex [minutes]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), duration of loss of righting reflex [minutes]	x	x	88.222	87.254	130.45	172.442	114.3	131.204	93.668	x	82.472	176.828	148.655	94.72	122.329	124.98	182.56	194.169	x	132.467	155.08	111.9	x	138.067	113.967	161.538	118.362	122.59	56.071	124.086	178.463	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10042	Original post publication description: Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as the latency to fall, saline response minus ethanol response [seconds]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as the latency to fall, saline response minus ethanol response [seconds]	x	x	45.155	16.107	43.169	43.434	27.264	33.383	42.943	35.512	16.804	41.471	36.536	36.324	36.524	46.496	40.204	30.813	x	35.676	27.141	25.203	x	21.797	32.526	28.99	39.616	49.821	24.452	46.511	40.265	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10043	Original post publication description: Infectious disease, immune function: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]	None	Infectious disease, immune system: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]	x	3.0	3.0	1.0	2.0	3.0	1.0	3.0	3.0	1.0	2.0	3.0	2.0	2.0	3.0	2.0	3.0	3.0	x	3.0	2.0	3.0	x	1.0	2.0	3.0	3.0	3.0	3.0	2.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10044	Original post publication description: Infectious disease, immune function: Ectromelia virus-induced mortality [3 = resistant, 1 = both intermediate and susceptible, major gene model, ordinal scale]	None	Infectious disease, immune system: Ectromelia virus-induced mortality [3 = resistant, 1 = both intermediate and susceptible, ordinal scale]	x	3.0	3.0	1.0	3.0	3.0	1.0	3.0	3.0	1.0	3.0	3.0	3.0	3.0	3.0	3.0	3.0	3.0	x	3.0	3.0	3.0	x	1.0	3.0	3.0	3.0	3.0	3.0	3.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10045	Original post publication description: Body temperature (baseline control for quinpirole study) [degrees C]	None	Metabolism: Body temperature (baseline control for quinpirole study) [degrees C]	x	x	38.711	38.687	x	38.851	38.724	38.69	39.37	38.721	39.227	38.958	38.581	38.645	38.565	38.369	38.192	38.247	x	39.009	39.074	38.79	x	38.453	39.183	38.67	38.7	39.449	38.46	38.168	39.068	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10046	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia 60 min after injection on day 1 measured as change from baseline temperature [degrees C]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia 60 min after injection on day 1 measured as change from baseline temperature [degrees C]	x	x	-1.622	-5.043	x	-3.847	-1.144	-3.634	-4.746	-4.374	-1.224	-2.074	-0.874	-2.673	-1.127	-2.798	-1.573	-6.465	x	-3.295	-1.781	-3.488	x	-2.557	-2.4	-3.615	-6.767	-2.089	-3.831	-1.115	-3.967	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10047	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 2 compared to day 1 [degrees C]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 2 compared to day 1 [degrees C]	x	x	-0.242	-0.735	x	-0.918	-0.18	-1.153	-1.407	-1.184	-0.34	-0.056	-0.202	-0.386	0.03	-0.768	-0.636	-2.019	x	-0.754	-0.542	-1.215	x	-0.457	-0.692	-0.688	-2.167	-0.461	-1.024	-0.226	-1.718	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10048	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 3 compared to day 1 [degrees C]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 3 compared to day 1 [degrees C]	x	x	-0.758	-1.652	x	-1.472	-0.262	-2.213	-2.151	-1.412	-0.636	-0.234	-0.139	-0.978	-0.296	-1.374	-1.015	-3.181	x	-1.102	-0.936	-1.321	x	-1.038	-0.575	-0.528	-2.867	-1.222	-0.569	-0.39	-2.197	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10049	Original post publication description: Saline baseline response (ip, for quinpirole study), locomotion after injection [cm]	None	Central nervous system, pharmacology, behavior: Saline baseline response (ip, for quinpirole study), locomotion after injection [cm]	x	x	4856.45	3130.0	x	3465.56	2872.5	4197.17	3103.19	3973.81	1348.96	4790.5	2741.05	4112.67	4431.0	2289.59	4913.86	3254.37	x	3430.68	2475.78	2849.41	x	1952.25	4462.47	2008.57	2237.4	6160.66	3338.65	3182.64	4400.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10050	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), locomotion change relative to baseline [cm]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), locomotion change relative to baseline [cm]	x	x	-2878.27	-843.33	x	-1327.56	-1165.64	-2840.87	-1098.64	-1016.06	-735.08	-3267.53	-1597.27	-956.22	-1714.36	-999.5	-2063.09	-1038.57	x	-1214.11	-1095.88	-902.82	x	-848.6	-1845.5	-459.14	-786.2	-2773.6	-914.67	-1319.57	-1696.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10051	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), locomotion change relative to baseline [cm]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), locomotion change relative to baseline [cm]	x	x	-2963.64	-1541.71	x	-1777.94	-1658.43	-2678.6	-1934.9	-1839.38	-808.92	-3388.47	-1582.0	-2256.11	-2761.92	-1368.38	-2667.27	-2029.77	x	-1945.8	-1501.44	-1162.07	x	-1158.05	-1969.09	-717.06	-1669.6	-3768.1	-1573.64	-1691.86	-2403.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10052	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]	x	-216.857	-184.5	-180.286	x	x	-66.56	-79.571	-137.2	-168.2	-120.875	-74.833	-201.2	-104.545	-120.333	-120.167	-115.38	-83.273	x	-148.308	-179.4	-77.625	x	-78.267	-29.1	-162.909	-20.25	-89.2	-123.714	-157.27	-107.714	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10053	Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]	None	Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]	x	x	-124.267	-77.33	x	-27.375	-57.286	-164.4	-101.636	-86.125	-54.615	-150.53	-105.091	-23.333	-52.182	-64.0	-20.364	-88.571	x	-62.667	-31.875	-72.706	x	-33.1	-126.25	9.571	-32.0	-102.1	-49.5	-55.333	-153.273	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10054	Original post publication description: Saline baseline response (ip, for quinpirole study), vertical activity (rears) after injection [n beam breaks]	None	Central nervous system, behavior: Saline baseline response (ip, control for quinpirole study), vertical activity (rears, beam breaks) after injection [n]	x	x	277.448	356.462	x	173.882	167.357	263.933	330.952	357.313	114.48	273.0	195.545	214.556	220.783	184.235	249.455	272.741	x	296.737	99.813	214.813	x	84.85	299.158	118.467	136.8	282.0	335.217	210.048	380.095	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10055	Original post publication description: Ethanol withdrawal handling induced convulsions, 2-12 hours after 4 g/kg 20% v/v EtOH, Area Under Curve	None	Ethanol withdrawal handling induced convulsions, 2-12 hours after 4 g/kg 20% v/v EtOH, Area Under Curve	x	x	6.8	15.5	14.5	13.0	14.2	2.7	7.9	18.7	x	5.0	16.4	10.4	4.3	7.0	4.5	x	x	9.3	9.8	x	x	2.5	6.4	11.1	6.7	1.5	x	0.0	6.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10056	Original post publication description: Hematopoietic stem cell pool size [cobblestone area-forming cells per 10e5 bone marrow cells]	None	Immune system, development: Hematopoietic stem cell pool size [cobblestone area-forming cells per 10e5 bone marrow cells]	x	x	x	x	3.1	11.1	3.2	4.3	3.11	9.1	10.9	1.01	x	6.0	10.0	3.97	6.9	x	x	3.25	9.5	x	x	x	7.3	9.2	2.86	6.2	x	2.34	4.42	6.19	9.6	x	x	x	2.2	x	6.8	x	3.02	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10057	Original post publication description: Infectious disease, immune function: BCG-induced anergy (delayed type hypersensitivity) in footpad increments [mm]	None	Immune system: BCG-induced anergy (delayed type hypersensitivity) in footpad increments [mm]	x	x	x	x	x	0.22	x	x	0.14	x	x	0.79	0.79	0.15	0.48	x	x	0.15	0.86	x	x	0.3	x	x	x	x	x	0.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10058	Original post publication description: Immune system, blood: Peripheral blood lymphocytes, percentage of B cells [B220 %]	None	Immune system, blood: Peripheral blood lymphocytes, percentage of B cells [B220 %]	x	63.7	67.0	46.1	60.0	64.0	49.0	38.0	58.0	61.0	44.0	61.0	55.0	67.0	53.0	34.0	44.0	60.0	9.0	48.0	58.0	39.0	x	44.0	69.0	53.0	56.0	52.0	49.0	61.0	46.0	58.0	46.0	42.0	54.0	44.0	43.0	49.0	63.0	x	50.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10059	Original post publication description: Immune function, blood: Peripheral blood lymphocytes, percentage of CD4+ T cells [%]	None	Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD4+ T cells [%]	x	14.9	13.3	18.3	20.0	9.0	25.0	18.0	14.0	14.0	18.0	16.0	12.0	6.0	16.0	19.0	11.0	10.0	25.0	13.0	19.0	15.0	x	20.0	11.0	11.0	10.0	15.0	16.0	7.0	12.0	12.0	20.0	18.0	16.0	21.0	18.0	19.0	11.0	x	12.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10060	Original post publication description: Immune function, blood: Peripheral blood lymphocytes, percentage of CD8+ T cells [%]	None	Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD8+ T cells [%]	x	8.9	7.7	5.9	7.7	6.1	11.5	9.0	6.4	11.7	7.1	7.1	5.6	2.5	7.5	14.6	7.1	6.4	25.4	6.9	10.0	9.0	x	8.0	4.5	13.5	6.9	11.7	11.7	6.7	5.4	8.4	7.3	15.7	9.6	14.9	15.7	9.0	7.3	x	7.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10061	Original post publication description: Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)]	None	Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)]	x	x	132.5	425.0	260.9	405.0	78.3	413.7	311.3	213.5	224.2	195.0	304.2	199.1	301.7	764.5	204.3	64.3	890.0	273.9	399.1	x	x	126.1	250.0	153.0	265.2	x	307.0	250.0	202.6	264.3	140.0	x	302.6	x	286.1	304.3	223.9	x	320.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10062	Original post publication description: Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml]	None	Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml]	x	x	508.6	1462.9	1671.4	454.3	1722.9	750.0	980.0	634.3	368.3	1520.0	397.1	876.3	374.3	1000.0	1182.9	1305.7	2035.7	1807.1	1668.6	x	x	182.9	1128.6	1157.1	1829.4	x	1860.1	434.3	868.6	828.6	1634.3	x	1505.7	x	474.3	300.3	400.0	x	1036.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10063	Original post publication description: Ethanol response, withdrawal-associated handling-induced convulsions (HIC) after a 72 hr exposure to ethanol vapor (with Pyrazole injections to inhibit EtOH metabolism) [seizure severity area under the 25-hr curve]	None	Central nervous system, pharmacology, behavior: Ethanol response, withdrawal-associated handling-induced convulsions (HIC) after a 72 hr exposure to ethanol vapor (with Pyrazole injections to inhibit EtOH metabolism) [seizure severity area under the 25-hr curve]	x	x	42.65	77.11	58.0	83.25	72.21	33.65	54.75	74.69	65.24	48.41	66.86	49.03	29.78	36.19	30.38	7.19	x	56.1	58.57	78.33	x	68.42	59.71	58.86	46.93	14.77	70.25	5.5	57.88	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10064	Original post publication description: Ethanol response, area under the 25-hr curve for withdrawal following 72 hr exposure to air. Pyrazole injections were given daily to inhibit EtOH metabolism. Handling-induced convulsions (HIC) were scored hourly for 10 hr and again at hrs 24 and 25 [seizure severity]	None	Ethanol response, area under the 25-hr curve for withdrawal following 72 hr exposure to air. Pyrazole injections were given daily to inhibit EtOH metabolism. Handling-induced convulsions (HIC) were scored hourly for 10 hr and again at hrs 24 and 25 [seizure severity]	x	x	9.9	15.54	29.19	7.72	39.0	1.71	38.58	24.0	6.06	24.33	35.38	4.28	2.21	2.67	3.5	0.0	x	10.85	13.57	4.83	x	3.19	0.67	8.31	5.33	0.08	31.22	0.22	0.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10065	Original post publication description: Ethanol response (1.5 g/kg ip loading dose and 68.1 mg/kg pyrazole), chronic withdrawal, handling-induced convulsion score (HIC) corrected for response to pyrazole alone (difference between strain mean values for AREA25 and PYRAREA25) [seizure severity]	None	Ethanol response (1.5 g/kg ip loading dose and 68.1 mg/kg pyrazole), chronic withdrawal, handling-induced convulsion score (HIC) corrected for response to pyrazole alone (difference between strain mean values for AREA25 and PYRAREA25) [seizure severity]	x	x	32.75	61.57	29.01	75.53	33.21	31.94	16.17	50.69	59.17	24.08	31.48	44.76	27.56	33.52	26.88	7.19	x	45.25	45.0	73.5	x	65.24	59.05	50.56	41.6	14.69	39.03	5.28	57.58	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10066	Original post publication description: Ethanol response (1.5 g/kg), blood ethanol concentration (BEC) normalization data set (BEC was stabilized to ~1.5 mg EtOH/ml blood using daily pyrazole injections) [mg/ml]	None	Ethanol response (1.5 g/kg), blood ethanol concentration (BEC) normalization data set (BEC was stabilized to ~1.5 mg EtOH/ml blood using daily pyrazole injections) [mg/ml]	x	x	1.51	1.5	1.51	1.53	1.48	1.47	1.49	1.52	1.5	1.51	1.54	1.5	1.53	1.49	1.49	1.49	x	1.5	1.48	1.34	x	1.49	1.59	1.51	1.5	1.49	1.54	1.51	1.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10067	Original post publication description: Ethanol response (2 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	None	Ethanol response (2 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	x	x	2.0	1.63	1.15	1.34	2.37	2.26	1.23	2.64	x	1.27	1.3	1.62	0.88	0.85	1.44	x	x	1.39	1.63	x	x	1.33	1.86	0.88	1.1	1.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10068	Original post publication description: Ethanol response (3 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	None	Ethanol response (3 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	x	x	3.1	1.6	2.08	2.47	3.17	2.9	1.8	3.33	x	2.92	2.58	1.73	2.53	1.91	2.23	x	x	1.79	3.17	x	x	1.86	2.39	3.15	2.19	2.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10069	Original post publication description: Ethanol response (4 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	None	Ethanol response (4 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]	x	x	3.4	2.93	2.33	2.53	3.65	3.48	2.11	3.47	x	2.98	3.73	3.9	3.23	1.83	2.71	x	x	2.74	2.77	x	x	2.4	2.07	4.29	2.31	2.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10070	Original post publication description: Ethanol response (2 g/kg ip), hypothermia after injection [degrees C]	None	Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg ip), hypothermia after injection [degrees C]	x	x	0.5	0.56	0.01	0.23	0.04	0.69	0.1	0.41	x	0.22	0.25	0.6	0.02	-0.05	-0.19	x	x	0.07	-0.5	x	x	-0.16	0.3	-0.11	-0.42	0.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10071	Original post publication description: Ethanol response (3 g/kg ip), hypothermia after injection [degrees C]	None	Central nervous system, pharmacology, behavior: Ethanol response (3 g/kg ip), hypothermia after injection [degrees C]	x	x	0.91	-0.06	0.32	0.57	-0.02	0.44	0.18	0.69	x	0.7	0.16	-0.1	0.99	0.34	0.37	x	x	-0.73	0.18	x	x	-1.12	0.51	0.49	0.51	0.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10072	Original post publication description: Ethanol response (4 g/kg ip), hypothermia after injection [degrees C]	None	Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia after injection [degrees C]	x	x	0.78	0.92	-0.1	0.35	0.68	0.86	-0.14	0.03	x	0.36	0.67	1.28	1.14	-0.11	0.47	x	x	0.5	0.34	x	x	-0.44	0.6	-0.72	0.57	0.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10073	Original post publication description: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake relative to previous water intake in 20-24 week-old males [ratio]	None	Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake relative to previous water intake in 20-24 week-old males [ratio]	x	x	0.75	0.29	0.44	x	1.09	0.07	0.53	x	0.67	0.67	x	0.34	0.49	0.73	x	0.66	x	0.5	x	0.82	x	0.44	0.08	x	0.04	0.63	0.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10074	Original post publication description: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake in 20-24 week-old males [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake in 20-24 week-old males [g/kg]	x	x	12.6	3.36	3.52	x	9.95	1.32	10.89	x	13.34	8.9	x	8.29	7.65	9.34	x	10.21	x	12.66	x	10.78	x	2.43	1.03	x	0.68	4.81	2.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10075	Original post publication description: Saline response (saline injection ip), open field activity in 20-24 week-old males (control for ethanol trait 10077) [beam crossings]	None	Central nervous system, pharmacology, behavior: Saline response (saline injection ip), open field activity in 20-24 week-old males (control for ethanol trait 10077) [beam crossings]	x	x	155.0	132.0	175.0	182.0	240.0	152.0	113.0	x	79.0	141.0	127.0	152.0	104.0	158.0	131.0	166.0	x	171.0	x	159.0	x	125.0	x	134.0	89.0	171.0	95.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10076	Original post publication description: Ethanol response (2.5 g/kg ip), distance run in the grid test, 10-12 min after injection in 20-24 week-old males [n beam crossings]	None	Ethanol response (2.5 g/kg ip), distance run in the grid test, 10-12 min after injection in 20-24 week-old males [n beam crossings]	x	x	83.0	335.0	264.0	155.0	178.0	144.0	171.0	x	133.0	317.0	121.0	245.0	117.0	252.0	150.0	268.0	x	251.0	x	204.0	x	154.0	x	187.0	170.0	226.0	233.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10077	Original post publication description: Ethanol response (1.33 g/kg ip), open field activity in 20-24 week-old males tested under dim light, 10-13 min after injection of saline (day 1) and ethanol (day 2), difference in number of beam crossings relative to saline control injection [n]	None	Ethanol response (1.33 g/kg ip), open field activity in 20-24 week-old males tested under dim light, 10-13 min after injection of saline (day 1) and ethanol (day 2), difference in number of beam crossings relative to saline control injection [n]	x	x	-72.0	203.0	89.0	-27.0	-62.0	-8.0	58.0	x	54.0	176.0	-6.0	93.0	13.0	94.0	19.0	102.0	x	80.0	x	45.0	x	29.0	x	53.0	81.0	55.0	138.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10078	Original post publication description: Ethanol response (2.5 g/kg ip), ataxia on grid test, 10 to 12 min after injection in 24-28 week-old males, foot fall errors/distance run in the apparatus [n/distance]	None	Ethanol response (2.5 g/kg ip), ataxia on grid test, 10 to 12 min after injection in 24-28 week-old males, foot fall errors/distance run in the apparatus [n/distance]	x	x	2.58	1.84	1.66	2.4	x	2.28	5.43	x	x	x	x	x	x	x	x	3.18	x	x	x	x	x	2.25	x	x	1.84	x	2.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10079	Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, first experimental replication (Table 4) [area under curve]	None	Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, first experimental replication (Table 4) [area under curve]	x	x	14.5	29.0	x	34.5	x	x	x	x	23.75	21.13	x	22.83	16.0	x	x	x	x	7.5	x	x	x	x	x	32.5	x	x	25.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10080	Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, second experimental replication (Table 4) [area under curve]	None	Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, second experimental replication (Table 4) [area under curve]	x	x	x	x	28.3	29.83	x	11.83	x	x	41.3	x	x	25.88	11.75	x	x	x	x	x	x	15.0	x	28.17	x	35.3	x	5.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10081	Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, third experimental replication (Table 4) [area under curve]	None	Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day), withdrawal severity score (15x 1 hour measurements) handling-induced convulsion (HIC) in 24-28 week-old males, third experimental replication (Table 4) [area under curve]	x	x	11.83	28.0	19.43	x	x	13.64	x	x	x	x	x	x	x	x	8.0	x	x	x	x	x	x	22.75	x	7.5	9.83	4.0	23.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10082	Original post publication description: Ethanol response (4 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), difference between day 3 and day 1 [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (4 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]	x	x	0.78	0.922	-0.097	0.354	0.679	0.863	-0.136	0.025	0.356	0.363	0.667	1.278	1.139	-0.108	0.465	0.559	x	0.5	0.343	x	x	-0.444	0.6	-0.722	0.573	0.381	1.031	x	0.972	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10083	Original post publication description: Ethanol response (3 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), difference between day 3 and day 1 [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (3 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]	x	x	0.907	-0.058	0.316	0.569	-0.023	0.439	0.181	0.687	-0.003	0.697	0.164	-0.1	0.991	0.338	0.366	0.759	x	-0.727	0.178	x	x	-1.122	0.505	0.492	5.13	0.179	0.464	x	0.229	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10084	Original post publication description: Ethanol response (2 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1 [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (2 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]	x	x	0.495	0.564	0.014	0.225	0.035	0.692	0.103	0.408	0.008	2.17	0.252	0.597	0.019	-0.053	-0.189	0.153	x	0.066	-0.503	x	x	-0.161	0.295	-0.108	-0.424	0.752	0.019	x	0.444	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10085	Original post publication description: Ethanol response, hypothermia (4 g/kg ip) [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (4 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]	x	x	3.96	2.934	2.233	2.528	3.651	3.479	2.109	3.467	1.514	2.979	3.73	3.9	3.323	1.826	2.71	2.549	x	2.742	2.769	x	x	2.403	2.067	4.285	2.312	2.922	2.101	x	3.086	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10086	Original post publication description: Ethanol response (3 g/kg), hypothermia [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (3 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]	x	x	3.1	1.601	2.083	2.467	3.174	2.904	1.797	3.331	1.008	2.921	2.583	1.733	2.528	1.909	2.225	2.654	x	1.793	3.167	x	x	1.856	2.386	3.146	2.192	2.449	1.595	x	2.363	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10087	Original post publication description: Ethanol response (2 g/kg), hypothermia [degrees C]	None	Central nervous system, behavior, pharmacology: Ethanol response (2 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]	x	x	2.0	1.628	1.153	1.344	2.374	2.255	1.231	2.642	0.594	1.27	1.296	1.617	0.875	0.853	1.439	1.038	x	1.394	1.631	x	x	1.328	1.861	0.877	1.096	1.908	0.602	x	1.492	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10088	Original post publication description: Ethanol response (2 mg/kg ip), acute difference in locomotion between experimental ethanol-condidtioned and saline control group of males [activity counts/min]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute difference in locomotion between experimental ethanol-condidtioned and saline control group of males [activity counts/min]	x	x	28.869	75.2	42.207	20.144	36.412	15.49	85.832	49.069	52.4	2.147	43.093	58.071	18.172	15.048	44.434	x	x	50.538	33.052	x	x	28.221	68.007	38.566	23.353	31.488	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10089	Original post publication description: Ethanol response (2 mg/kg ip), locomotor tolerance or sensitization in males [difference between activity after fourth ethanol trial and first trial]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males [difference between activity after fourth ethanol trial and first trial]	x	x	-59.094	26.921	-44.237	-26.048	-22.375	-47.387	-10.206	15.869	-37.031	-23.027	-19.28	-30.107	-15.159	-29.042	-1.931	x	x	10.117	-2.704	x	x	7.3	-34.855	34.772	-15.973	-4.218	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10090	Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [percentage time on ethanol-paired floor during 30 min test]	None	Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [percentage time on ethanol-paired floor during 30 min test]	x	x	58.316	59.618	65.087	62.43	54.588	63.214	59.001	60.163	78.344	57.973	59.701	55.239	64.039	61.564	57.696	x	x	49.491	65.529	x	x	74.6	49.865	66.859	54.526	53.349	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10091	Original post publication description: Saline control response (vehicle ip) of ethanol-treated (2 mg/kg ip) males, locomotion 1-5 min after saline injection, trial 4 (experimental group, prior ethanol exposure) [activity counts per min]	None	Saline control response (vehicle ip) of ethanol-treated (2 mg/kg ip) males, locomotion 1-5 min after saline injection, trial 4 (experimental group, prior ethanol exposure) [activity counts per min]	x	x	39.9	53.5	54.6	36.9	27.3	40.4	29.7	52.8	24.1	33.8	23.8	42.7	37.6	28.2	68.8	x	x	47.6	35.7	x	x	32.4	49.8	34.0	37.8	124.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10092	Original post publication description: Ethanol response (2 mg/kg ip), locomotion from 1-5 min after injection, conditioning trial 1 in males [activity counts per min]	None	Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 1 in males [activity counts per min]	x	x	116.7	138.9	134.6	93.7	76.8	97.8	134.0	122.6	98.1	68.1	89.4	124.6	64.1	60.7	128.0	x	x	104.2	80.0	x	x	67.0	150.7	98.6	75.3	175.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10093	Original post publication description: Floor preference baseline, time on grid textured floor for experimental group of males [sec/min]	None	Floor preference baseline, time on grid textured floor for experimental group of males [sec/min]	x	x	38.5	42.8	31.0	37.8	27.9	31.4	33.5	47.3	25.8	37.1	26.8	40.2	30.1	21.2	52.2	x	x	39.9	26.0	x	x	22.9	36.2	42.3	32.7	88.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10094	Original post publication description: Locomotion from 1-5 min after a single saline i.p. injection for the control group of males [activity/min]	None	Locomotion from 1-5 min after a single saline i.p. injection for the control group of males [activity/min]	x	x	132.9	66.0	101.1	77.5	57.0	117.9	52.1	85.7	50.2	87.0	68.1	80.6	47.4	44.8	93.1	x	x	56.3	46.1	x	x	46.9	81.8	54.3	49.0	141.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10095	Original post publication description: Saline control response (vehicle, ip), locomotion of control group from 1-5 min after injection on trial 1 [activity/min]	None	Saline control response (vehicle, ip), locomotion of control group from 1-5 min after injection on trial 1 [activity/min]	x	x	75.9	48.0	74.4	58.5	35.2	81.0	50.6	67.5	37.2	60.4	37.1	52.2	44.5	37.8	75.9	x	x	57.2	45.0	x	x	35.4	62.8	58.3	41.2	135.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10096	Original post publication description: Locomotion from 1-5 min after a saline injection for the control group of males on trial 4 [activity/min]	None	Central nervous system, pharmacology, behavior: Locomotion from 1-5 min after a saline injection for the control group of males on trial 4 [activity/min]	x	x	37.8	39.3	41.9	26.4	22.9	38.7	28.6	41.2	14.9	35.9	15.4	33.9	33.6	25.5	58.2	x	x	41.6	30.2	x	x	20.5	36.8	22.1	30.2	97.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10097	Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [s/min]	None	Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [s/min]	x	x	35.6	36.0	43.7	40.9	32.1	38.6	36.2	36.1	50.5	35.7	33.7	35.7	36.1	40.5	34.5	x	x	31.0	36.3	x	x	45.7	33.8	43.5	31.2	34.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10098	Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired hole floor in experimental group males [s/min]	None	Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired hole floor in experimental group males [s/min]	x	x	25.6	24.4	26.0	25.8	26.6	22.8	22.5	24.0	16.0	26.1	22.1	29.4	19.4	26.4	253.0	x	x	31.5	17.4	x	x	16.2	33.7	23.0	25.7	30.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10099	Original post publication description: Saline control response (vehicle ip), habituation, locomotion from 1-5 min after a single saline injection for the experimental group of males [activity/min]	None	Central nervous system, behavior: Saline control response (vehicle ip), habituation, locomotion from 1-5 min after a single saline injection for the experimental group of males [activity/min]	x	x	116.2	65.1	116.0	83.7	54.9	106.7	47.4	76.6	50.4	91.5	60.0	97.6	53.0	48.3	87.1	x	x	52.1	48.4	x	x	47.3	85.8	49.9	44.5	146.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10100	Original post publication description: Locomotion from 1-5 min after a single saline ip injection of saline vehicle for the experimental group on trial 1 [activity counts per min]	None	Locomotion from 1-5 min after a single saline ip injection of saline vehicle for the experimental group on trial 1 [activity counts per min]	x	x	87.8	63.7	92.4	73.5	40.4	82.3	48.1	73.6	45.7	66.0	46.3	66.6	45.9	45.7	83.5	x	x	53.6	47.0	x	x	38.8	8.7	60.1	51.9	143.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10101	Original post publication description: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]	None	Central nervous system, behavior: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]	x	x	29.6	33.4	31.3	35.2	26.9	33.7	28.6	32.4	30.7	26.5	24.7	29.7	25.6	27.3	31.3	x	x	28.8	23.2	x	x	38.0	31.5	31.6	32.1	31.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10102	Original post publication description: Ethanol response (2 mg/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min]	None	Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min]	x	x	57.6	165.8	90.4	67.6	54.4	50.4	123.7	138.5	61.0	45.1	70.1	94.5	49.0	31.7	126.0	x	x	114.3	77.3	x	x	74.3	115.8	133.4	59.3	170.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10103	Original post publication description: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]	None	Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]	x	x	41.5	40.2	29.4	30.1	29.3	31.4	33.4	43.8	29.0	40.0	30.6	40.7	29.5	24.1	48.0	x	x	37.9	26.6	x	x	20.9	34.8	38.3	31.7	66.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10104	Original post publication description: Ethanol response (2 mg/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control group on fourth conditioning day [activity counts/min]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control group on fourth conditioning day [activity counts/min]	x	x	17.954	112.444	36.212	30.788	27.695	10.331	94.338	85.444	37.384	11.907	46.397	52.106	11.656	3.311	57.404	x	x	67.04	41.583	x	x	41.868	66.298	99.001	21.788	46.616	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10105	Original post publication description: Saline control response (0.9% ip), activity habituation in males [4th saline injection trial activity minus first saline activity trial activity]	None	Saline control response (0.9% ip), activity habituation in males [4th saline injection trial activity minus first saline activity trial activity]	x	x	-47.925	-10.243	-37.8	-36.568	-13.088	-41.865	-18.465	-20.793	-21.569	-32.167	-22.473	-23.9	-8.386	-17.503	-14.676	x	x	-6.034	-11.252	x	x	-6.357	-32.848	-26.041	-14.067	-18.888	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10106	Original post publication description: Central nervous system, morphology: Striatum cholinergic neurons, section 11 [number/section]	None	Central nervous system, morphology: Striatum cholinergic neurons, section 11 [number/section]	x	x	60.0	86.0	72.0	75.0	80.0	69.0	92.0	80.0	73.0	52.0	74.0	66.0	70.0	64.0	68.0	93.0	86.0	71.0	85.0	68.0	x	99.0	96.0	x	80.0	62.0	72.0	75.0	95.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10107	Original post publication description: Striatum cholinergic neurons section 14 [number of neurons]	None	Striatum cholinergic neurons section 14 [number of neurons]	x	x	91.0	116.0	104.0	103.0	103.0	117.0	122.0	124.0	115.0	89.0	101.0	94.0	93.0	86.0	132.0	129.0	139.0	110.0	111.0	93.0	x	111.0	139.0	x	130.0	97.0	97.0	109.0	145.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10108	Original post publication description: Striatum cholinergic neurons section 17 [number of neurons]	None	Central nervous system, morphology: Striatum cholinergic neurons section 17 [n neurons/section]	x	x	110.0	135.0	133.0	117.0	124.0	130.0	174.0	142.0	138.0	125.0	127.0	131.0	117.0	127.0	174.0	161.0	159.0	127.0	129.0	130.0	x	156.0	166.0	x	140.0	148.0	137.0	139.0	152.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10109	Original post publication description: Striatum cholinergic neurons section 20 [number of neurons]	None	Striatum cholinergic neurons section 20 [number of neurons]	x	x	105.0	134.0	109.0	106.0	115.0	125.0	135.0	132.0	125.0	117.0	123.0	136.0	116.0	133.0	134.0	153.0	143.0	122.0	135.0	120.0	x	138.0	156.0	x	116.0	142.0	117.0	124.0	137.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10110	Original post publication description: Striatum cholinergic neurons section 22 [number of neurons]	None	Central nervous system, morphology: Striatum cholinergic neurons section 22 [n neurons/section]	x	x	70.0	89.0	76.0	67.0	62.0	75.0	97.0	82.0	95.0	72.0	60.0	72.0	65.0	70.0	75.0	71.0	76.0	66.0	82.0	76.0	x	83.0	85.0	x	70.0	102.0	74.0	87.0	85.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10111	Original post publication description: Striatum cholinergic neurons section 24 [number of neurons]	None	Striatum cholinergic neurons section 24 [number of neurons]	x	x	47.0	67.0	40.0	52.0	51.0	49.0	48.0	44.0	52.0	46.0	47.0	44.0	42.0	48.0	46.0	62.0	46.0	47.0	53.0	44.0	x	52.0	51.0	x	44.0	61.0	45.0	58.0	54.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10112	Original post publication description: Life span, longevity [days] (RWW winsorized outliers BXD2, BXD14, and DBA2J from 400, 500, and 175 days, respectively)	None	Life span, longevity [days] (RWW winsorized outliers BXD2, BXD14, and DBA2J from 400, 500, and 175 days, respectively)	x	x	675.0	365.0	600.0	450.0	525.0	690.0	660.0	825.0	750.0	740.0	x	500.0	800.0	650.0	740.0	900.0	x	x	740.0	760.0	x	840.0	x	715.0	760.0	700.0	740.0	580.0	420.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10113	Original post publication description: Quiescent stem cells in old mice-cobblestone area forming cells (CAFC) day 35 frequency in bone marrow [105 BM cells]	None	Immune system, aging: Quiescent stem cells in aged mice, cobblestone area forming cells (CAFC) at day 35 in culture, frequency in bone marrow [10^5 BM cells]	x	x	1.5	3.0	1.5	x	x	2.0	x	3.5	8.0	2.0	x	3.0	2.0	2.5	2.5	2.0	2.0	x	x	2.0	x	2.0	1.0	2.0	3.0	0.5	3.0	3.3	3.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10114	Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells]	None	Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells]	x	x	4.0	1.0	1.0	x	x	12.0	x	11.5	2.0	4.5	x	7.0	21.0	3.3	6.0	3.3	4.0	x	x	2.5	x	2.5	6.0	4.0	4.0	0.1	6.5	2.0	3.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10115	Original post publication description: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC]	None	Immune system, aging: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC]	x	x	110.0	100.0	125.0	x	x	110.0	x	102.0	98.0	105.0	x	125.0	75.0	110.0	110.0	102.0	104.0	x	x	103.0	x	120.0	100.0	104.0	105.0	90.0	120.0	85.0	80.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10116	Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change, [% CAFC]	None	Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change, [% CAFC]	x	x	180.0	82.0	90.0	x	x	200.0	x	120.0	80.0	125.0	x	130.0	340.0	108.0	130.0	92.0	130.0	x	x	115.0	x	70.0	110.0	110.0	108.0	60.0	125.0	75.0	108.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10117	Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC]	None	Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC]	x	x	190.0	75.0	103.0	x	x	420.0	x	190.0	50.0	130.0	x	130.0	800.0	108.0	130.0	110.0	125.0	x	x	110.0	x	108.0	240.0	125.0	110.0	20.0	135.0	80.0	102.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10118	Original post publication description: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 100000 cells]	None	Immune system, development: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 100000 cells]	x	x	1.2	3.3	1.0	3.4	2.9	1.6	2.1	3.5	8.22	1.6	0.9	2.6	2.1	2.4	2.3	2.1	1.9	2.2	2.2	1.8	x	1.8	1.2	1.8	2.5	0.5	2.5	2.8	2.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10119	Original post publication description: Hemopoietic stem cell cycling day 7 [% CAFC]	None	Immune system, aging: Hemopoietic stem cell cycling day 7 in culture [% CAFC]	x	x	8.0	20.0	36.0	12.6	31.0	31.0	13.0	2.0	29.0	16.0	26.0	18.0	22.0	34.0	13.0	2.0	0.8	32.0	6.0	12.6	x	7.8	0.8	12.8	24.0	19.0	0.8	56.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10120	Original post publication description: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 0-5 min time interval [cm]	None	Central nervous system, pharmacology, behavior: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 0-5 min time interval [cm]	x	x	-696.0	-81.0	-716.0	x	-40.0	-9.0	-284.0	197.0	919.0	112.0	-509.0	-594.0	216.0	7.0	668.0	335.0	744.0	76.0	787.0	-113.0	x	739.0	-39.0	-413.0	387.0	742.0	204.0	328.0	299.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10121	Original post publication description: Chlordiazepoxide response (10 mg/kg), induced locomotor response distance traveled, 5-10 min time interval [cm]	None	Chlordiazepoxide response (10 mg/kg), induced locomotor response distance traveled, 5-10 min time interval [cm]	x	x	-459.0	863.0	-248.0	x	-487.0	-36.0	-18.0	-1623.0	1166.0	1306.0	-451.0	132.0	-1104.0	1377.0	10.0	-39.0	510.0	-246.0	-448.0	256.0	x	174.0	-86.0	-497.0	409.0	1909.0	-590.0	527.0	500.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10122	Original post publication description: Chlordiazepoxide locomotor response, 10-15 min after injection (10 mg/kg) [cm/5 min]	None	Chlordiazepoxide locomotor response, 10-15 min after injection (10 mg/kg) [cm/5 min]	x	x	-69.0	875.0	-462.0	x	-846.0	-137.0	-285.0	-2600.0	518.0	477.0	-642.0	443.0	-1036.0	1013.0	266.0	-403.0	453.0	-520.0	-743.0	104.0	x	-390.0	-110.0	-555.0	9.0	903.0	-28.0	774.0	419.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10123	Original post publication description: Chlordiazepoxide response (10 mg/kg ip), locomotion from 15-20 min after injection [cm]	None	Chlordiazepoxide response (10 mg/kg ip), locomotion from 15-20 min after injection [cm]	x	x	297.0	857.0	-817.0	x	-705.0	-358.0	-425.0	-2564.0	319.0	-383.0	-888.0	268.0	-835.0	814.0	367.0	-828.0	-40.0	-354.0	-622.0	825.0	x	-351.0	-132.0	-1058.0	-340.0	1059.0	-312.0	233.0	504.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10124	Original post publication description: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 5-20 min time interval [cm]	None	Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 5-20 min time interval [cm]	x	x	-231.0	2595.0	-1526.0	x	-2039.0	-531.0	-727.0	-6786.0	2002.0	1401.0	-1981.0	843.0	-2974.0	3204.0	643.0	-1270.0	923.0	-1119.0	-1812.0	1185.0	x	-567.0	-327.0	-2110.0	78.0	3870.0	-930.0	1534.0	1423.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10125	Original post publication description: Ethanol induced locomotor response distance traveled, 0-5 min time interval [cm]	None	Central nervous system, pharmacology, behavior: Ethanol induced locomotor response distance traveled, 0-5 min time interval [cm]	x	x	208.0	2284.0	1274.0	x	323.0	-208.0	1182.0	289.0	308.0	1819.0	925.0	146.0	943.0	1845.0	2042.0	1786.0	1423.0	1228.0	481.0	109.0	x	683.0	698.0	447.0	486.0	155.0	983.0	414.0	1073.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10126	Original post publication description: Ethanol induced locomotor response distance traveled, 5-10 min time interval [cm]	None	Ethanol induced locomotor response distance traveled, 5-10 min time interval [cm]	x	x	536.0	1689.0	533.0	x	-144.0	-504.0	1387.0	-2024.0	459.0	2298.0	392.0	288.0	-119.0	1884.0	2243.0	264.0	2291.0	1904.0	-1116.0	-138.0	x	-281.0	-378.0	1689.0	566.0	1038.0	902.0	671.0	515.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10127	Original post publication description: Ethanol induced locomotor response distance traveled, 10-15 min time interval [cm]	None	Ethanol induced locomotor response distance traveled, 10-15 min time interval [cm]	x	x	356.0	1094.0	182.0	x	-824.0	-1115.0	1344.0	-2458.0	599.0	1244.0	282.0	-354.0	-324.0	1555.0	2235.0	-357.0	1742.0	1693.0	-591.0	-450.0	x	-319.0	-634.0	800.0	749.0	799.0	758.0	908.0	766.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10128	Original post publication description: Ethanol induced locomotor response distance traveled, 15-20 min time interval [cm]	None	Central nervous system, pharmacology, behavior: Ethanol induced locomotor response distance traveled, 15-20 min time interval [cm]	x	x	215.0	739.0	639.0	x	-936.0	-1376.0	1147.0	-2107.0	578.0	1495.0	-308.0	-857.0	-420.0	1416.0	1799.0	-606.0	1234.0	1406.0	-528.0	-173.0	x	-380.0	-711.0	319.0	515.0	142.0	1065.0	1225.0	851.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10129	Original post publication description: Ethanol induced locomotor response distance traveled, 5-20 min time interval [cm]	None	Ethanol induced locomotor response distance traveled, 5-20 min time interval [cm]	x	x	1107.0	3522.0	1354.0	x	-1905.0	-2995.0	3879.0	-6588.0	1636.0	5037.0	366.0	-923.0	-864.0	4855.0	6277.0	-717.0	5267.0	5003.0	-2235.0	-761.0	x	-979.0	-1722.0	2808.0	1829.0	1980.0	2725.0	2805.0	2132.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10130	Original post publication description: Saline control locomotor response, distance traveled, 0-5 min time interval [cm]	None	Saline control locomotor response, distance traveled, 0-5 min time interval [cm]	x	x	5131.0	2170.0	4018.0	x	1876.0	2893.0	1784.0	3817.0	1647.0	3998.0	2876.0	3481.0	1086.0	1603.0	3117.0	2888.0	2713.0	1929.0	1926.0	2511.0	x	2317.0	2391.0	2194.0	1449.0	4543.0	2128.0	2099.0	1559.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10131	Original post publication description: Activity level, locomotion after a saline injection, distance traveled, 5-10 min time interval [cm]	None	Activity level, locomotion after a saline injection, distance traveled, 5-10 min time interval [cm]	x	x	3595.0	1894.0	2908.0	x	1767.0	2469.0	1807.0	3533.0	1333.0	2730.0	2356.0	2640.0	892.0	1752.0	3032.0	2900.0	2367.0	2200.0	1859.0	1864.0	x	1854.0	2316.0	1925.0	1645.0	4018.0	2143.0	2266.0	1789.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10132	Original post publication description: Saline control response (dose ip), locomotion from 10-15 min after injection [cm]	None	Saline control response (dose ip), locomotion from 10-15 min after injection [cm]	x	x	2783.0	1582.0	2391.0	x	1442.0	2302.0	1753.0	2865.0	1166.0	2391.0	1806.0	2433.0	865.0	1612.0	2775.0	2625.0	1868.0	1852.0	1430.0	1573.0	x	1418.0	1752.0	1691.0	1476.0	3395.0	1850.0	2013.0	1657.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10133	Original post publication description: Saline-induced locomotor response distance traveled, 15-20 min time interval [cm]	None	Saline-induced locomotor response distance traveled, 15-20 min time interval [cm]	x	x	2580.0	1317.0	1964.0	x	1420.0	2272.0	1656.0	2531.0	1268.0	2084.0	2148.0	2658.0	954.0	1383.0	2642.0	2442.0	1794.0	1781.0	1347.0	1351.0	x	1340.0	1594.0	1797.0	1519.0	3083.0	1598.0	1775.0	1770.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10134	Original post publication description: Saline induced locomotor response, distance traveled, 5-20 min time interval [cm]	None	Saline induced locomotor response, distance traveled, 5-20 min time interval [cm]	x	x	8958.0	4793.0	7263.0	x	4629.0	7043.0	5216.0	8929.0	3767.0	7204.0	6311.0	7731.0	2710.0	4747.0	8449.0	7966.0	6029.0	5833.0	4636.0	4787.0	x	4612.0	5663.0	5413.0	4640.0	10496.0	5590.0	6055.0	5215.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10135	Original post publication description: Ethanol acceptance-male raw mean consumption (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation), raw mean consumption of adult males (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	16.1	14.96	15.26	13.48	11.28	9.47	16.78	14.75	10.03	10.4	x	14.77	7.08	10.92	x	16.47	14.66	x	x	4.85	13.25	12.06	11.73	15.57	9.38	15.58	11.02	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10136	Original post publication description: Ethanol response (X% po), acceptance by females, raw mean consumption (same data as in Rodriguez et al., 1994 with outliers removed and two strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), acceptance by females (74-91 days of age), consumption after 24 hr of water deprivation (same data as in Rodriguez et al., 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	15.99	15.76	18.53	17.07	12.59	12.75	18.78	16.25	14.75	18.84	x	21.47	13.51	15.41	x	18.35	15.7	x	x	10.1	13.48	10.88	9.63	17.43	12.82	18.18	11.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10137	Original post publication description: Ethanol response, acceptance, male residual (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), voluntary consumption after 24 hr water deprivation, acceptance, male residual values (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	2.97	1.98	0.46	-0.36	0.39	-1.53	1.82	1.44	-2.28	-4.46	x	-1.97	-4.42	-1.83	x	1.78	1.72	x	x	-4.4	1.77	2.29	2.79	1.49	-1.67	1.0	1.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10138	Original post publication description: Ethanol response, acceptance level, female residual (same data as in Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), acceptance by 74-91 day old females after 24 hr water deprivation, residuals (same data as in Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	-1.54	-1.0	1.56	1.29	-1.72	-0.34	0.79	-0.37	1.28	5.12	x	4.83	2.02	1.35	x	0.58	-0.87	x	x	0.09	-2.14	-3.95	-4.98	0.26	-0.21	1.0	-3.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10139	Original post publication description: Ethanol preference, male raw mean consumption (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), preference, young male (53-67 days) consumption using two-bottle choice (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	3.31	3.6	3.68	4.66	3.82	2.68	5.75	4.82	1.97	2.27	x	4.09	2.22	4.43	x	4.46	3.68	x	x	2.22	6.54	5.64	5.53	5.04	3.01	8.01	2.37	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10140	Original post publication description: Ethanol preference-female raw mean consumption (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), consumption preference using two bottle choice in young adult females (53-67 days) (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	5.36	6.48	4.09	6.73	4.91	2.96	5.02	4.82	2.25	3.49	x	11.03	4.05	4.98	x	4.62	4.19	x	x	3.18	6.9	8.38	6.59	3.84	4.78	10.44	2.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10141	Original post publication description: Ethanol response, preference of males, residual mean (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), preference of young males (53-67 days) using two-bottle choice, residuals (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	-0.81	-1.05	0.16	-0.1	-0.09	-0.31	1.79	0.96	-0.68	-0.97	x	-1.18	0.49	0.69	x	0.69	0.11	x	x	-0.88	1.7	0.1	0.83	1.64	-0.83	1.5	-0.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10142	Original post publication description: Ethanol preference-female residual mean (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption in females using two-bottle choice, residual mean over a two week test period (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]	x	x	x	x	0.88	1.7	-0.77	0.85	-0.1	-0.87	-1.98	-1.22	-0.85	0.09	x	5.75	0.7	-0.66	x	-1.05	-0.67	x	x	-0.17	-0.92	1.49	-0.18	-2.43	0.61	1.09	-1.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10143	Original post publication description: Sleep need, slow wave sleep delta EEG power after 6 hrs sleep deprivation [%]	None	Central nervous system, physiology: Sleep need, slow wave sleep delta EEG power after 6 hrs sleep deprivation [%]	x	x	223.133	179.452	168.304	148.551	223.583	197.68	198.379	155.447	161.296	156.793	166.24	130.001	166.624	179.251	x	189.507	133.289	147.317	172.023	169.368	x	165.23	187.284	168.229	144.83	153.054	149.713	138.458	132.991	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10144	Original post publication description: Ethanol response (dose ip), ethanol-induced ataxia following first of five injections (initial sensitivity), onset threshold [mg/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (variable dose ip), ethanol-induced ataxia following first of five injections (initial sensitivity), onset threshold [mg/kg]	x	x	1.44	0.4	1.21	1.09	0.8	1.03	0.77	1.16	0.88	0.94	0.71	0.8	0.41	1.22	1.28	0.98	x	1.07	0.49	0.9	x	0.72	1.07	0.8	0.69	1.37	1.03	1.15	0.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10145	Original post publication description: Ethanol response (dose route), maximal threshold to ethanol induced ataxia [mg/ml]	None	Ethanol response (dose route), maximal threshold to ethanol induced ataxia [mg/ml]	x	x	2.62	3.47	3.75	2.94	2.75	2.21	3.13	3.63	3.24	2.63	3.27	2.65	2.66	2.88	2.86	2.81	x	2.93	3.28	3.12	x	3.26	3.17	2.67	3.21	2.91	3.52	2.57	3.49	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10146	Original post publication description: Ethanol response (dose route), tolerance, difference between ethanol induced ataxia (maximal threshold) minus onset threshold	None	Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), tolerance, difference between ethanol induced ataxia (maximal threshold blood ethanol concentration BEC) minus onset threshold [mg/ml]	x	x	1.18	3.07	2.54	1.85	1.95	1.19	2.36	2.47	2.36	1.69	2.56	1.85	2.25	1.66	1.58	1.83	x	1.86	2.79	2.22	x	2.54	2.1	1.87	2.52	1.54	2.49	1.42	3.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10147	Original post publication description: Ethanol response (dose route), tolerance measured as the fold-increase to ethanol-induced ataxia [ratio of maximal threshold divided by onset threshold]	None	Central nervous system, pharmacology, behavior: Ethanol response (iv?), tolerance measured as the fold-increase of blood ethanol concentration (BEC) to ethanol-induced ataxia [ratio of tolerance BEC level over initial BEC ataxia level]	x	x	1.82	8.68	3.1	2.7	3.44	2.16	4.06	3.13	3.68	2.8	4.61	3.31	6.49	2.36	2.23	2.87	x	2.74	6.69	3.47	x	4.53	2.96	3.34	4.65	2.12	3.42	2.23	7.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10148	Original post publication description: Life history, aging: Life span, longevity [days]	None	Life history, aging: Life span, longevity (authors excluded BXD13 (176 days) due to seizures, and BXD31 (577 days), and BXD32 (440 days) due to poor marker coverage. RWW reinstated all strains and winsorized BXD13 to 439 days) [days]	x	x	x	x	594.0	479.0	528.0	687.0	617.0	816.0	750.0	738.0	439.0	493.0	798.0	642.0	742.0	904.0	x	x	743.0	763.0	x	835.0	x	711.0	765.0	703.0	737.0	577.0	440.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10149	Original post publication description: Hepatic lipid peroxidation (LPO) levels [malondialdehyde (MDA)/mg]	None	Liver, metabolism, aging: Hepatic lipid peroxidation (LPO) levels in 2-month-old males [malondialdehyde (MDA)/mg]	x	x	21.7	30.1	30.2	43.2	26.9	40.1	34.6	44.3	37.3	51.0	x	44.4	x	32.7	22.3	40.1	x	33.1	36.3	x	x	42.8	24.7	26.3	57.0	x	28.4	x	24.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10150	Original post publication description: Immune function: Thymic T-cell response to anti-CD3-induced proliferation	None	Immune system: Thymic T-cell response to anti-CD3-induced proliferation	x	x	x	x	17.99	29.53	2.84	34.51	43.11	4.2	27.22	2.66	33.2	7.65	2.37	4.86	17.19	3.07	1.83	3.29	5.07	40.15	x	22.96	17.36	27.61	5.54	5.04	31.48	47.96	8.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10151	Original post publication description: Ethanol response (10% in water po), total fluid intake during 4-day forced 10% ethanol exposure period [total mls/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), total fluid intake during 4-day forced 10% ethanol exposure period [total mls/day]	x	x	5.23	4.96	6.39	x	x	4.65	6.07	x	4.38	x	x	x	x	5.39	x	x	x	x	x	x	x	x	x	x	5.09	x	x	x	6.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10152	Original post publication description: Fluid intake (total) during free choice ethanol period [ml/day]	None	Central nervous system, pharmacology, behavior: Fluid intake (total) during free choice ethanol period [ml/day]	x	x	6.06	6.64	2.5	x	x	5.26	7.04	x	6.02	x	x	x	x	6.35	x	x	x	x	x	x	x	x	x	x	5.89	x	x	x	7.19	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10153	Original post publication description: Ethanol response (10% in water, po), preference during 3-week free choice period using two bottle choice test for males [mls 10% ethanol/mls total fluid]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), preference during 3-week free choice period using two bottle choice test for males [mls 10% ethanol/mls total fluid]	x	x	0.83	0.16	0.27	x	x	0.83	0.24	x	0.43	x	x	x	x	0.79	x	x	x	x	x	x	x	x	x	x	0.24	x	x	x	0.16	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10154	Original post publication description: Ethanol response (10% in water po), preference during free choice period for females using two bottle choice [mls 10 % ethanol/mls total fluid]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference during free choice period for females using two bottle choice [mls 10 % ethanol/mls total fluid]	x	x	0.81	0.14	0.48	x	x	0.71	0.46	x	0.29	x	x	x	x	0.63	x	x	x	x	x	x	x	x	x	x	0.45	x	x	x	0.19	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10155	Original post publication description: Ethanol response (10% in water, po), consumption during 3-week free choice period using two bottle choice test for males [gm ethanol/kg body weight/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during 3-week free choice period using two bottle choice test for males [gm ethanol/kg body weight/day]	x	x	14.8	3.8	5.2	x	x	12.9	4.4	x	9.5	x	x	x	x	13.3	x	x	x	x	x	x	x	x	x	x	4.5	x	x	x	7.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10156	Original post publication description: Ethanol response (10% in water, po), consumption during free choice period for females using two-bottle choice [gms ethanol/kg body weight/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during free choice period for females using two-bottle choice [gms ethanol/kg body weight/day]	x	x	20.5	3.7	12.2	x	x	17.5	9.1	x	7.2	x	x	x	x	17.1	x	x	x	x	x	x	x	x	x	x	9.2	x	x	x	4.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10157	Original post publication description: Morphology: Body weight [g]	None	Morphology: Body weight [g]	x	x	23.5	22.9	22.6	x	x	21.4	23.9	x	20.5	x	x	x	x	23.5	x	x	x	x	x	x	x	x	x	x	23.3	x	x	x	22.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10158	Original post publication description: Ethanol response (10% in water po), ethanol preference ratio using a two bottle choice test [ratio of 10% ethanol/total fluid]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), ethanol preference ratio using a two bottle choice test [ratio of 10% ethanol/total fluid]	x	x	0.82	0.15	0.35	x	x	0.76	0.38	x	0.37	x	x	x	x	0.71	x	x	x	x	x	x	x	x	x	x	0.37	x	x	x	0.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10159	Original post publication description: Ethanol response (10% in water po), voluntary consumption ratio using a two bottle choice test [gms ethanol/kg body weight]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), voluntary consumption ratio using a two bottle choice test [gms ethanol/kg body weight]	x	x	17.4	3.7	8.0	x	x	15.1	8.7	x	8.5	x	x	x	x	15.2	x	x	x	x	x	x	x	x	x	x	7.4	x	x	x	5.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10160	Original post publication description: Catalase activity in liver [uMol]	None	Liver, pharmacology, protein expression: Catalase activity in liver [uMol]	x	x	68.4	115.9	71.1	x	x	76.2	0.0	x	130.9	x	x	x	x	106.8	x	x	x	x	x	x	x	x	x	x	121.6	x	x	x	136.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10161	Original post publication description: Catalase activity in brain [nMol]	None	Central nervous system, pharmacology, protein expression: Catalase activity in brain [nMol]	x	x	517.0	750.1	785.8	x	x	627.3	0.0	x	660.0	x	x	x	x	636.7	x	x	x	x	x	x	x	x	x	x	615.1	x	x	x	795.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10162	Original post publication description: Pharmacology, metabolism: Aldehyde dehydrogenase (ALDH) activity in liver [nMol NADH produced/minute/milligram of protein]	None	Liver, pharmacology, metabolism, protein expression: Aldehyde dehydrogenase (ALDH) activity in liver [nMol NADH produced/minute/milligram of protein]	x	x	23.6	21.6	14.1	x	x	15.3	15.0	x	12.4	x	x	x	x	15.7	x	x	x	x	x	x	x	x	x	x	21.3	x	x	x	13.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10163	Original post publication description: Aldehyde dehydrogenase (ALDH) activity in brain [nMol NADH produced/minute/milligram of protein]	None	Central nervous system, pharmacology, protein expression: Aldehyde dehydrogenase (ALDH) activity in brain [nMol NADH/min/mg protein]	x	x	1.89	2.02	0.57	x	x	1.47	0.59	x	0.95	x	x	x	x	1.43	x	x	x	x	x	x	x	x	x	x	3.1	x	x	x	1.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10164	Original post publication description: Home cage activity after saline injection	None	Central nervous system, behavior: Home cage activity level 10-14 week old males after saline injection [n quadrant crossings/1 min]	x	x	13.25	8.375	11.75	8.625	10.75	15.5	11.25	11.375	8.375	7.88889	6.0	10.75	8.0	11.875	10.5	12.0	x	7.5	11.375	15.75	x	1.77778	17.125	11.5	7.5	13.5	9.125	8.625	20.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10165	Original post publication description: Methamphetamine response (4 mg/kg ip), locomotor activity difference from saline [quadrant crossings/min]	None	Central nervous system, behavior, pharmacology: Methamphetamine response (4 mg/kg i.p.), locomotor activity difference from saline in 10-14 week males [n quadrant crossings/min]	x	x	21.625	18.7679	47.25	35.9306	41.5	19.25	7.0	33.125	8.5	31.8986	19.875	13.125	35.75	18.125	21.875	31.5	x	34.375	9.5	10.125	x	13.8472	15.5	22.0	25.5	33.75	10.375	30.0	14.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10166	Original post publication description: Activity difference from saline for 8 mg/kg methamphetamine [quadrant crossings/min]	None	Central nervous system, behavior, pharmacology: Methamphetamine response (8 mg/kg i.p.), activity difference from saline in 10-14 week males [n quadrant crossings/min]	x	x	11.375	17.0	49.875	24.4861	43.125	1.7	7.25	14.25	6.125	27.4861	31.5	15.25	16.25	4.375	16.5	26.125	x	28.7857	5.5	-0.875	x	25.3472	9.375	40.625	11.5	12.125	23.4306	37.375	7.375	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10167	Original post publication description: Methamphetamine response, difference in locomotion between methamphetamine (16 mg/kg) and saline [quadrant crossings/min]	None	Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg i.p.), difference in locomotion relative saline in 10-14 week males [quadrant crossings/min]	x	x	-8.75	3.79167	6.625	-0.875	8.25	-12.75	-9.13889	-2.0	-5.75	-2.88889	6.875	3.625	-7.14286	-2.0	4.875	-6.85714	x	-1.75	-4.125	-7.25	x	25.4444	-13.3472	8.0	-1.75	-7.7	11.25	4.25	-4.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10168	Original post publication description: Methamphetamine response (16 mg/kg ip), frequency of sterotyped chewing events [n/min]	None	Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg i.p.), frequency of sterotyped chewing events 33 min after injection in 10-14 week males [n/min]	x	x	2.25	8.375	0.0	1.88889	1.375	7.3	8.25	5.75	4.875	5.04167	0.125	2.22222	9.625	0.875	4.5	7.375	x	1.44643	2.875	3.375	x	1.40278	0.0	3.875	2.275	2.125	0.0833333	2.125	-0.125	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10169	Original post publication description: Methamphetamine response (4 mg/kg ip), body temperature change after after injection [degree C]	None	Central nervous system, metabolism, pharmacology: Methamphetamine response (4 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C]	x	x	0.0125	-1.00357	0.832143	-0.461111	0.2375	-3.725	-2.05	0.425	0.0625	0.588889	-0.180357	-1.5625	0.55	-1.2125	0.3625	-0.1375	x	-1.4375	-0.4875	-1.8375	x	-1.35278	-0.275	-0.7375	-1.5375	-0.5375	-0.279167	0.125	-0.7625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10170	Original post publication description: Methamphetamine response (8 mg/kg ip), body temperature change after after injection [degree C]	None	Central nervous system, metabolism, pharmacology: Methamphetamine response (8 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C]	x	x	-0.3375	-0.0875	1.3	0.294444	0.675	-2.3	-0.7625	1.1875	0.225	1.02639	0.357143	0.8	1.775	-1.1125	1.2375	0.425	x	0.253571	0.0125	-0.6375	x	-0.0652778	-0.125	0.525	-0.85	1.3	-1.26806	0.825	-0.3625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10171	Original post publication description: Methamphetamine response (16 mg/kg ip), body temperature change after after injection [degree C]	None	Central nervous system, metabolism, pharmacology: Methamphetamine response (16 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C]	x	x	0.1625	0.258333	1.05	1.5375	1.095	-0.15	0.680556	1.4	0.75	1.05139	0.432143	0.8875	1.13036	1.1875	1.2625	1.39821	x	1.05	0.325	1.1375	x	0.377778	0.791667	0.725	1.2	2.3525	-0.1	1.2375	1.0125	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10172	Original post publication description: Brain methamphetamine levels after 8 mg/kg methamphetamine [micrograms/gm]	None	Central nervous system, pharmacology: Brain methamphetamine levels after 8 mg/kg methamphetamine in 10-14 week males [micrograms/gm]	x	x	2.0	2.5	3.8	1.5	2.1	1.9	2.9	2.5	2.7	2.7	2.7	3.8	2.8	1.8	2.1	2.9	x	2.1	1.8	2.3	x	1.9	0.8	2.0	2.7	2.0	2.5	2.8	2.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10173	Original post publication description: Climbing scores after 16 mg/kg i.p. methamphetamine injection [quadrant crossings/min]	None	Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg, i.p.), climbing scores of 10-14 week females 1 hr period after injection [ordinal scale 0=on floor, 1=two paws up; 3=climbing]	x	x	2.3	0.6	0.1	-0.8	1.5	-0.8	0.3	x	-0.1	0.7	2.6	-1.0	-0.7	2.0	-0.3	0.4	x	0.1	3.3	0.7	x	0.8	0.6	0.6	1.0	-1.4	2.6	-0.8	1.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10174	Original post publication description: Methamphetamine response (4 mg/kg ip), brain concentration after injection [micrograms/gm]	None	Central nervous system, pharmacology: Methamphetamine response (4 mg/kg ip), brain concentration after injection in 10-14 week males [micrograms/gm]	x	x	0.5	0.8	1.1	0.5	0.7	0.7	0.9	0.5	0.5	0.8	0.8	1.1	0.9	0.5	0.2	0.8	x	0.6	0.6	0.7	x	0.5	0.5	0.8	0.5	0.4	0.4	1.4	0.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10175	Original post publication description: Ethanol response (2 g/kg ip): metabolism rate of ethanol [mg/ml/hr]	None	Metabolism, pharmacology: Ethanol response (2 g/kg i.p.), metabolism rate of ethanol [mg/ml/hr]	x	x	-0.72	-0.92	-0.79	-0.8	-0.68	-0.64	-0.82	-0.8	-0.87	-0.64	-0.83	-0.95	-0.97	-0.76	-0.73	-0.82	x	-0.84	-0.84	-0.97	x	-0.92	-0.77	-0.96	-0.77	-1.0	-0.63	-0.68	-0.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10176	Original post publication description: Ethanol response (3 g/kg ip), rate of metabolism, beta [mg/ml/hr]	None	Metabolism, pharmacology: Ethanol response (3 g/kg i.p.), rate of metabolism, beta [mg/ml/hr]	x	x	-0.69	-0.83	-0.71	-0.72	-0.71	-0.69	-0.88	-0.85	-0.8	-0.51	-0.74	-0.85	-0.83	-0.67	-0.72	-0.73	x	-0.85	-0.75	-0.88	x	-0.86	-0.74	-0.92	-0.76	-0.83	-0.59	-0.62	-0.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10177	Original post publication description: Ethanol response (2 g/kg ip), blood ethanol concentration (BEC) 60 min after injection [mg/ml]	None	Pharmacology: Ethanol response (2 g/kg i.p.), blood ethanol concentration (BEC) 60 min after injection [mg/ml]	x	x	1.93	2.249	1.859	1.861	1.848	1.654	2.113	2.228	1.907	1.447	2.002	2.01	1.927	2.089	1.767	1.749	x	1.833	1.861	1.969	x	2.337	1.794	1.996	1.935	1.864	1.627	1.56	1.615	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10178	Original post publication description: Ethanol response (3 g/kg ip), blood ethanol concentration (BEC) 60 minutes after injection [mg/ml]	None	Pharmacology: Ethanol response (3 g/kg i.p.), blood ethanol concentration (BEC) 60 min after injection [mg/ml]	x	x	3.145	3.464	2.434	2.847	2.951	2.895	3.284	3.562	2.894	2.606	3.57	3.076	2.951	3.326	2.903	3.185	x	3.084	2.702	2.975	x	3.652	3.826	3.544	3.198	2.956	2.828	2.395	2.325	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10179	Original post publication description: Cancer biology: Metastasis of implanted breast tumor in lymph node [number of mice with tumor metastasis]	None	Cancer biology: Metastasis of implanted breast tumor in lymph node [number of mice with tumor metastasis]	x	x	0.0	0.0	0.0	x	0.0	x	x	0.0	0.0	0.0	x	x	x	0.0	x	x	x	0.0	x	x	x	5.0	3.0	0.0	4.0	x	5.0	3.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10180	Original post publication description: Cancer biology: Metastasis of implanted breast tumor in pancreas [number of mice with tumor metastasis]	None	Cancer biology: Metastasis of implanted breast tumor in pancreas [number of mice with tumor metastasis]	x	x	0.0	0.0	0.0	x	0.0	x	x	0.0	0.0	0.0	x	x	x	0.0	x	x	x	0.0	x	x	x	3.0	2.0	0.0	3.0	x	2.0	3.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10181	Original post publication description: Cancer biology: Necrosis of implanted breast tumor [number of mice with tumor metastasis]	None	Cancer biology: Necrosis of implanted breast tumor [number of mice with tumor metastasis]	x	x	0.0	1.0	0.0	x	0.0	x	x	0.0	0.0	0.0	x	x	x	0.0	x	x	x	0.0	x	x	x	5.0	5.0	0.0	5.0	x	5.0	5.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10182	Original post publication description: Cancer biology: Syngeneic breast tumor growth, number of mice with tumor metastasis [n]	None	Cancer biology: Syngeneic breast tumor growth, number of mice with tumor metastasis [n]	x	x	4.0	2.0	4.0	x	4.0	x	x	3.0	2.0	3.0	x	x	x	2.0	x	x	x	4.0	x	x	x	1.0	1.0	3.0	1.0	x	1.0	1.0	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10183	Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm^3]	None	Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm^3]	x	x	20.6	33.3	18.9	x	14.7	x	x	40.2	27.5	38.7	x	x	x	33.7	x	x	x	22.7	x	x	x	52.6	32.0	37.4	58.7	x	47.1	57.2	25.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10184	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3]	x	x	42.5	35.0	34.1	x	41.3	x	x	54.3	45.3	73.1	x	x	x	44.7	x	x	x	40.7	x	x	x	119.6	84.2	53.2	106.0	x	87.3	131.1	50.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10185	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3]	x	x	89.3	70.8	72.2	x	81.4	x	x	73.4	67.0	96.3	x	x	x	76.2	x	x	x	83.0	x	x	x	157.5	164.7	78.1	187.9	x	185.0	201.3	75.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10186	Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm^3]	None	Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm^3]	x	x	41.4	106.3	52.8	x	43.2	x	x	139.3	112.5	149.7	x	x	x	119.6	x	x	x	52.2	x	x	x	279.2	263.1	170.0	198.3	x	266.7	279.2	127.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10187	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3]	x	x	17.2	187.0	35.1	x	37.3	x	x	177.9	162.6	189.3	x	x	x	179.2	x	x	x	15.8	x	x	x	283.3	279.0	214.7	326.0	x	355.0	328.1	182.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10188	Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm^3]	None	Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm^3]	x	x	x	212.9	14.4	x	19.2	x	x	224.9	188.3	252.3	x	x	x	173.0	x	x	x	x	x	x	x	358.4	369.6	231.3	388.5	x	504.3	460.5	222.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10189	Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm^3]	None	Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm^3]	x	x	x	254.2	x	x	x	x	x	185.1	275.8	301.7	x	x	x	279.2	x	x	x	x	x	x	x	502.6	468.3	190.8	500.5	x	662.1	724.6	262.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10190	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3]	x	x	x	315.6	x	x	x	x	x	70.2	335.5	135.3	x	x	x	303.6	x	x	x	x	x	x	x	x	x	112.6	x	x	x	x	329.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10191	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3]	x	x	x	530.0	x	x	x	x	x	31.9	457.0	42.8	x	x	x	417.2	x	x	x	x	x	x	x	x	x	49.6	x	x	x	x	448.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10192	Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3]	None	Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3]	x	x	x	672.5	x	x	x	x	x	1.3	537.1	14.3	x	x	x	504.3	x	x	x	x	x	x	x	x	x	20.9	x	x	x	x	623.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10193	Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 5 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 5 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	2.07	0.91	2.52	x	2.64	x	x	0.49	0.25	x	x	x	x	1.51	x	x	x	1.92	x	x	x	x	x	x	x	x	x	x	0.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10194	Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 12 [ordinal scale: 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 12 [ordinal scale: 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	3.63	0.81	3.34	x	3.28	x	x	2.73	1.0	1.97	x	x	x	0.78	x	x	x	3.32	x	x	x	0.3	x	1.82	x	x	x	0.62	1.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10195	Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 30 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 30 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	2.12	x	2.37	x	2.71	x	x	3.55	x	3.34	x	x	x	x	x	x	x	2.84	x	x	x	x	x	3.39	x	x	x	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10196	Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 5 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 5 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	0.86	x	2.02	x	1.93	x	x	x	x	x	x	x	x	x	x	x	x	1.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10197	Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 1 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 1 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	3.64	1.13	3.33	x	3.28	x	x	1.72	1.52	1.46	x	x	x	1.27	x	x	x	3.85	x	x	x	x	x	1.82	x	x	x	0.47	1.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10198	Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 30 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 30 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	1.62	x	2.37	x	2.73	x	x	3.52	0.18	3.69	x	x	x	0.29	x	x	x	2.34	x	x	x	x	x	3.38	x	x	x	x	0.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10199	Original post publication description: Cancer biology: Apoptosis of breast tumor cells at day 12 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology: Apoptosis of breast tumor cells at day 12 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	3.5	0.3	3.31	x	3.26	x	x	0.1	0.82	0.83	x	x	x	0.61	x	x	x	3.37	x	x	x	x	x	1.09	x	x	x	x	0.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10200	Original post publication description: Cancer biology: Apoptosis of breast tumor cells, day 30 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe]	None	Cancer biology: Apoptosis of breast tumor cells, day 30 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe]	x	x	1.11	x	2.35	x	2.21	x	x	2.85	0.46	2.4	x	x	x	x	x	x	x	1.81	x	x	x	x	x	3.09	x	x	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10201	Original post publication description: Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated]	None	Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated]	x	x	x	x	1.59	x	1.79	x	55.0	1.33	1.4	1.67	x	x	x	x	x	43.62	x	2.44	x	x	x	x	x	2.25	x	x	7.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10202	Original post publication description: Cocaine response (variable, iv), dosage required to induce tonic seizure infused via tail vein [mg/kg]	None	Central nervous system, pharmacology, behavior: Cocaine response (variable, iv), dosage required to induce tonic seizure infused via tail vein [mg/kg]	x	x	36.5093	45.8624	42.9704	46.3609	43.496	48.0771	44.6149	38.973	48.6678	39.5212	39.4037	39.9768	37.3012	43.33	39.4038	45.4332	x	35.9428	49.5509	x	x	38.7928	46.6209	38.7701	38.7467	44.3891	42.0057	34.0522	44.0018	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10203	Original post publication description: Cocaine response (variable mg/kg, i.v. via tail vein), dose required to induce clonic seizure to induce clonic seizure [mg/kg]	None	Central nervous system, pharmacology, behavior: Cocaine response (variable mg/kg, i.v. via tail vein), dose required to induce clonic seizure to induce clonic seizure [mg/kg]	x	x	21.1276	21.9037	24.3794	21.8333	21.6786	20.1582	23.9731	21.8606	24.8676	17.5034	21.769	21.8179	17.4457	20.1132	24.3516	23.4872	x	20.3501	23.5815	x	x	20.7145	22.1648	22.8863	19.643	20.8624	22.8057	20.1509	20.737	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10204	Original post publication description: Immune function: TRBV4+ T cell levels among CD8+ T cells in spleen [%]	None	Immune system, hematology: TRBV4+ T cell levels among CD8+ T cells in spleen [%]	x	x	36.6	11.5	24.5	37.1	28.3	18.4	13.2	30.8	20.6	11.7	12.9	27.4	36.6	7.6	11.6	28.0	x	37.8	17.5	20.2	x	27.0	18.4	17.0	14.1	40.0	10.0	24.3	34.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10205	Original post publication description: Immune function: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%]	None	Immune system, hematology: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%]	x	x	44.5	11.4	29.3	27.8	32.4	27.9	18.4	24.7	18.9	15.5	10.9	15.6	33.4	34.3	11.2	32.5	x	17.6	21.5	23.0	x	32.0	21.6	19.6	8.5	30.2	12.2	26.3	39.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10206	Original post publication description: Immune function: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul]	None	Immune system: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul]	x	x	x	x	0.6	0.5	0.5	1.0	0.6	6.8	0.7	0.6	0.9	3.6	2.1	4.0	2.0	1.4	3.1	1.2	1.0	6.7	x	5.2	1.4	2.5	1.6	2.8	1.0	2.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10207	Original post publication description: Proliferative capacity in vitro of bone marrow stem and progenitor cells from young mice - proliferation of lin-Sca1++ cells from 8-week-old mice in response to KL, flt3L and TPO (# of cells per 50 input cells after 5 days of culture) [cell number]	None	Immune system, hematopoesis, aging: Hematopoietic stem cell and progenitor cell proliferative capacity (Lin-Sca1++ cells from femur bone marrow), in vitro assay of cells from 2-3 month old females in response to KL, flt3L, and TPO (Figure 3A of paper) [n cells]	x	x	x	x	168.0	970.0	4368.0	124.0	543.0	276.0	795.0	738.0	2329.0	1234.0	2500.0	3046.0	2628.0	1469.0	x	400.0	3180.0	870.0	x	207.0	800.0	450.0	4337.0	1757.0	x	1107.0	334.0	1751.0	x	2197.0	217.0	x	1635.0	x	312.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10208	Original post publication description: Immune function: Hematopoietic stem cells and progenitor cells, numbers of lin-Sca1++ cells at 8 weeks [n]		Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells, numbers of Lin-Sca1++ cells at 2 months of age in females (Figure 3B of paper) [n]	x	x	x	x	3872.0	1399.0	5475.0	721.0	2647.0	2566.0	1260.0	3130.0	3833.0	5058.0	3500.0	3562.0	6694.0	1750.0	x	1355.0	3558.0	1510.0	x	830.0	783.0	2611.0	6472.0	1150.0	x	1917.0	3927.0	3067.0	x	2195.0	1491.0	x	4633.0	x	2469.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10209	Original post publication description: Relative fraction of lin-Sca1++ cells [%]	None	Immune system, hematopoesis, aging: Relative fraction of hematopoietic stem cells and progenitor cells (Lin-Sca1++) from bone marrow in 2-3 month old females (Figure 3C of paper) [%]	x	x	x	x	0.376	0.149	0.747	0.128	0.438	0.277	0.201	0.352	0.579	0.46	0.316	0.495	0.6	0.201	x	0.189	0.606	0.297	x	0.165	0.201	0.27	0.652	0.18	x	0.379	0.738	0.579	x	0.264	0.229	x	x	x	0.338	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10210	Original post publication description: C-kit+ cells among lin-Sca1++ cells [%]	None	Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells in femur bone marrow, percentage of c-kit-postiive cells to c-kit-ngative cells among Lin-Sca1++ cells in 2-month old femaies (Figure 3d of paper) [%]	x	x	x	x	x	x	22.1	x	x	25.0	0.6	19.9	20.8	x	17.0	x	x	16.0	x	24.2	11.5	29.0	x	20.4	29.6	x	30.5	x	x	37.6	27.3	19.7	x	1.74	10.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10211	Original post publication description: Immune system and blood, hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells, LSK) from femur [n]	None	Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (Fig 2A of paper) [n per well]	x	x	x	x	287.0	321.0	x	314.0	x	40.0	274.0	120.0	x	731.0	254.0	x	760.0	33.0	102.0	48.0	230.0	296.0	x	96.0	295.0	99.0	292.0	81.0	183.0	285.0	124.0	170.0	231.0	70.0	63.0	x	196.0	x	183.0	x	540.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10212	Original post publication description: Hematopoietic stem and progenitor cells in the bone marrow (lin-Sca1++ c-kit+) [%]	None	Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells in femur bone marrow (lin-Sca1++ c-kit+) at 18 months of age (Figure 2B of paper) [%]	x	x	x	x	0.029	x	0.2	0.053	x	0.007	0.057	0.035	x	0.062	0.031	x	0.1	0.006	0.025	0.01	0.061	0.019	x	0.04	0.032	0.026	0.041	0.013	0.043	0.071	0.016	0.008	0.011	0.017	0.014	x	0.027	x	0.016	x	0.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10213	Original post publication description: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) in response to KL, flt3L and TPO [number of cells]	None	Immune system, aging: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age in response to KL, flt3L and TPO (figure 2C of paper) [n cells]	x	x	x	x	494.0	x	x	2153.0	x	1928.0	363.0	1141.0	x	3105.0	697.0	x	2400.0	843.0	552.0	1867.0	x	1062.0	x	1742.0	1008.0	434.0	4372.0	1268.0	3667.0	2000.0	2845.0	667.0	265.0	1176.0	6569.0	x	805.0	x	2633.0	x	4400.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10214	Original post publication description: Bone marrow stem and progenitor cells (lin-Sca1++ cells, data not included in paper) [number of cells]	None	Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (additional data not included in paper) [n cells total]	x	x	x	x	15970.0	11397.0	x	8793.0	x	5067.0	16367.0	9284.0	x	19682.0	4545.0	x	18476.0	5007.0	4585.0	3754.0	9201.0	7480.0	x	5323.0	7628.0	3535.0	22082.0	10551.0	24834.0	9964.0	10964.0	10017.0	7655.0	7796.0	7440.0	x	11347.0	x	x	x	10113.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10215	Original post publication description: Lin-Sca1++ c-kit+ cells in the bone marrow [number of cells]- unpublished	Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow	Immune system, aging: Hematopoietic stem cell and progenitor cell number (lin-Sca1++ c-kit+ cells) from femur bone marrow of females a 18 months (confirm) (unpublished additional data) [n cells]	x	x	x	x	15693.0	11075.0	22000.0	7662.0	7000.0	5027.0	15723.0	9154.0	x	20333.0	5897.0	x	17716.0	4212.0	3710.0	3706.0	8436.0	7223.0	x	5217.0	7333.0	3435.0	22511.0	10471.0	24650.0	9145.0	10874.0	9963.0	7616.0	7726.0	6141.0	x	11151.0	x	x	x	9573.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10216	Original post publication description: Effect of TGF-beta2 (0.01 ng/ml) on the proliferation of lin-Sca1++ c-kit+ cells [%]-unpublished	None	Immune system, aging: Proliferative capacity, number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.01 ng/ml) at 18 months of age (confirm) (unpublished additional data) [% increase]	x	x	x	x	43.0	x	x	69.0	x	x	101.0	128.0	x	38.0	195.0	x	94.0	80.0	90.0	71.0	x	149.0	x	94.0	118.0	112.0	100.0	x	57.0	87.0	151.0	x	x	72.0	57.0	x	62.0	x	94.0	x	81.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10217	Original post publication description: Effect of TGF-beta2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells [%]-unpublished	None	Immune system, aging: Proliferative capacity, effect of TGF-beta2 stimulation (0.1 ng/ml) on numbers of lin-Sca1++ c-kit+ cells (unpublished additional data) [% increase]	x	x	x	x	46.0	x	x	68.0	x	x	95.0	x	x	21.0	116.0	x	58.0	68.0	83.0	51.0	x	92.0	x	43.0	47.0	78.0	88.0	x	31.0	53.0	84.0	x	x	47.0	23.0	x	71.0	x	83.0	x	47.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10218	Original post publication description: Difference between old and young mice on the effect of TGF-beta2 (0.1 nl/ml) on the proliferation of lin-Sca1++c-kit+ cells-unpublished	None	Immune system, aging: Proliferative capacity change, difference between old (18 months) and young (2 months) on number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.1 nl/ml) (unpublished additional data) [cells per well]	x	x	x	x	5.0	x	x	-55.0	x	x	-63.0	x	x	35.0	-68.0	x	-1.0	-53.0	x	7.0	x	-43.0	x	-8.0	-11.0	-47.0	-47.0	x	x	2.0	-57.0	x	x	8.0	16.0	x	-45.0	x	-38.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10219	Original post publication description: Lin-Sca1++c-kit- cells in the bone marrow [%]-unpublished	None	Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow [%]	x	x	x	x	1.138	x	0.91	0.688	x	0.598	1.75	0.95	x	1.88	0.39	x	1.35	0.247	0.395	0.397	0.7	0.44	x	0.97	0.75	0.436	1.946	0.67	1.39	1.145	1.03	0.73	0.89	0.72	0.708	x	0.647	x	0.93	x	1.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10220	Original post publication description: Central nervous system, neuropharmacology: Caudate putamen Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg]	None	Central nervous system, neuropharmacology: Striatum (caudate putamen) Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg]	x	x	311.0	304.0	x	x	x	278.0	295.0	253.0	250.0	x	263.0	261.0	240.0	213.0	267.0	268.0	235.0	175.0	235.0	263.0	x	238.0	167.0	269.0	264.0	218.0	295.0	281.0	199.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10221	Original post publication description: Nucleus accumbens core Drd2/3 receptor density binding of [125I] epidepride [fmol/mg]	None	Central nervous system, neuropharmacology: Nucleus accumbens core Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg]	x	x	238.0	228.0	x	x	x	253.0	214.0	184.0	196.0	x	213.0	228.0	222.0	174.0	212.0	202.0	210.0	143.0	208.0	237.0	x	190.0	127.0	197.0	198.0	168.0	193.0	194.0	163.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10222	Original post publication description: Central nervous system, neuropharmacology: Nucleus accumbens shell Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg]	None	Central nervous system, neuropharmacology: Nucleus accumbens shell Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg]	x	x	268.0	242.0	x	x	x	264.0	223.0	181.0	195.0	x	206.0	213.0	216.0	171.0	203.0	196.0	212.0	144.0	210.0	239.0	x	179.0	128.0	189.0	181.0	173.0	186.0	187.0	161.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10223	Original post publication description: Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in ventral tegmental area [mean cells/section]	None	Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in ventral tegmental area [mean cells/section]	x	x	94.0	110.0	78.0	93.0	93.0	94.0	95.0	81.0	91.0	89.0	98.0	92.0	92.0	102.0	105.0	101.0	89.0	86.0	91.0	93.0	x	100.0	99.0	74.0	85.0	86.0	78.0	82.0	78.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10224	Original post publication description: Central nervous system, morphology, extrapyramidal motor system: Tyrosine hydroxylase dopaminergic neurons in substantia nigra compacta [mean cells/section]	None	Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in substantia nigra compacta [mean cells/section]	x	x	142.0	173.0	125.0	132.0	117.0	135.0	124.0	129.0	136.0	127.0	140.0	148.0	141.0	142.0	147.0	142.0	135.0	136.0	142.0	136.0	x	136.0	130.0	129.0	132.0	127.0	118.0	129.0	118.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10225	Original post publication description: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4)	None	Immune system, aging: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4)[unit]	x	x	9933.0	5404.0	x	x	x	x	x	2782.0	218.0	0.0	x	x	9115.0	x	6777.0	911.0	x	x	1298.0	175.0	x	5033.0	8719.0	11363.0	47862.0	24487.0	x	x	135191.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10226	Original post publication description: Immune function, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells [%]	None	Immune system, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells in thymus [%]	x	x	3.8	11.4	x	x	x	x	x	3.7	16.0	44.4	x	x	8.7	x	5.8	11.5	x	x	8.8	5.9	x	33.5	5.4	5.3	8.0	6.1	x	x	2.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10227	Original post publication description: Immune function, age-related T-cell decline, percent of CD4-CD8 double positive cells [%]	None	Immune system, aging: Age-related T-cell decline, percent of CD4-CD8 double positive cells in thymus [%]	x	x	84.6	68.4	x	x	x	x	x	86.9	64.2	43.7	x	x	80.5	x	64.7	70.1	x	x	73.0	76.4	x	43.6	87.3	82.1	77.1	81.5	x	x	90.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10228	Original post publication description: Immune function and thymus, T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells at 22 months [%]	None	Immune system, aging: T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells in thymus at 22 months [%]	x	x	41.2	20.0	x	x	x	x	x	21.5	45.2	55.5	x	x	40.0	x	22.0	37.3	x	x	41.8	17.1	x	15.0	16.8	32.4	43.9	39.4	x	x	20.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10229	Original post publication description: Immune function, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells [%]	None	Immune system, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells in thymus [%]	x	x	13.2	2.1	x	x	x	x	x	32.9	12.0	2.4	x	x	28.2	x	6.3	20.4	x	x	19.8	25.8	x	1.5	12.9	18.6	16.6	15.3	x	x	22.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10230	Original post publication description: Immune and thymus function, age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%]	None	Immune system, aging: Age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%]	x	x	43.6	78.2	x	x	x	x	x	44.5	40.5	42.7	x	x	28.9	x	71.9	37.6	x	x	36.8	66.7	x	82.3	71.8	46.0	36.6	44.2	x	x	56.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10231	Original post publication description: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4)	None	Immune system, aging: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4)	x	39.0	41.0	49.0	37.0	x	x	35.0	132.0	30.0	45.0	50.0	x	59.0	37.0	52.0	62.0	26.0	x	x	52.0	x	x	65.0	x	36.0	52.0	34.0	x	66.0	56.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10232	Original post publication description: Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0]	None	Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0]	x	25.5	23.3	10.4	28.4	x	x	26.5	32.6	17.3	24.6	15.2	x	37.2	36.4	21.5	26.7	22.0	x	x	33.2	x	x	30.0	x	39.7	16.4	35.2	x	33.3	14.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10233	Original post publication description: Thymocyte count, projected at 60 days [units]	None	immune system, aging: Thymocyte count, projected at 60 days [units]	x	24.9	23.1	10.8	29.2	x	x	24.9	39.1	16.4	25.1	20.4	x	37.3	37.5	25.0	27.9	22.2	x	x	29.8	x	x	32.6	x	40.8	18.9	40.4	x	34.9	16.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10234	Original post publication description: Dopamine transporter (DAT, SLC6A3) protein density in the dorsal striatum (caudate putamen) [Bmax, pmol/mg]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (DAT, SLC6A3) protein density in the dorsal striatum (caudate putamen) [Bmax, pmol/mg]	x	x	2.28	3.37	2.15	1.96	x	3.95	5.26	3.22	3.86	2.52	x	1.68	3.33	5.29	2.32	1.65	x	3.22	x	x	x	4.85	2.91	4.2	2.45	3.11	3.38	2.83	1.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10235	Original post publication description: Immune system: Proliferation of JTL-G12 (Tcell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	None	Cancer biology, immune system: Proliferation of JTL-G12 (Tcell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	x	x	410.0	10040.0	190.0	980.0	14010.0	120.0	10360.0	6050.0	7460.0	140.0	180.0	270.0	290.0	170.0	240.0	180.0	x	220.0	2260.0	140.0	x	6200.0	6750.0	8240.0	9110.0	6330.0	9920.0	290.0	6400.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10236	Original post publication description: Proliferation of JTL-G12 cells (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	None	Immune system: Proliferation of JTL-G12 cells (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	x	x	270.0	11340.0	9420.0	2380.0	15850.0	12450.0	10080.0	10210.0	10480.0	14080.0	250.0	330.0	370.0	14690.0	17530.0	170.0	x	6330.0	6120.0	280.0	x	9820.0	11460.0	11810.0	13760.0	5480.0	14000.0	8150.0	7970.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10237	Original post publication description: Immune system: Proliferation of JTL-G12.8 (T cell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	None	Cancer biology, immune system: Proliferation of JTL-G12.8 (T cell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	x	x	160.0	4940.0	170.0	980.0	7470.0	160.0	7080.0	7000.0	5220.0	140.0	230.0	350.0	320.0	340.0	570.0	120.0	x	190.0	3290.0	140.0	x	4100.0	4240.0	5770.0	5310.0	2920.0	5590.0	590.0	4920.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10238	Original post publication description: Proliferation of JTL-G12.8 (Tcell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	None	Immune system: Proliferation of JTL-G12.8 (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]	x	x	210.0	7310.0	6580.0	1020.0	9040.0	9870.0	7000.0	9170.0	7120.0	8000.0	300.0	280.0	430.0	9150.0	9690.0	210.0	x	2600.0	4640.0	180.0	x	6240.0	7680.0	9580.0	7290.0	2560.0	8260.0	6410.0	5760.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10239	Original post publication description: Iron level in medial prefrontal cortex of males [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in medial prefrontal cortex of males [ug/g]	x	x	x	x	x	22.9	x	33.2	12.7	x	19.8	18.0	24.6	18.7	x	19.3	x	x	x	x	19.8	x	x	24.3	x	21.3	19.9	14.9	x	20.2	15.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10240	Original post publication description: Iron level in medial prefrontal cortex of females [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in medial prefrontal cortex of females [ug/g]	x	x	x	x	x	25.8	x	15.4	27.4	x	19.9	17.9	15.3	22.0	x	21.3	x	x	x	x	19.8	x	x	23.7	x	21.2	24.8	19.3	x	20.3	13.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10241	Original post publication description: Iron level in dorsal striatum (caudate putamen) of males [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in dorsal striatum (caudate putamen) of males [ug/g]	x	x	x	x	x	13.9	x	16.5	15.7	x	21.9	13.7	16.5	12.1	x	18.5	x	x	x	x	22.6	x	x	19.8	x	20.9	26.2	18.7	x	18.7	17.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10242	Original post publication description: Iron level in dorsal striatum (caudate putamen) of females [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in dorsal striatum (caudate putamen) of females [ug/g]	x	x	x	x	x	15.9	x	19.2	15.3	x	21.6	14.8	13.7	23.7	x	18.7	x	x	x	x	19.8	x	x	21.0	x	17.0	21.9	17.6	x	18.2	14.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10243	Original post publication description: Iron level in nucleus accumbens of males [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in nucleus accumbens of males [ug/g]	x	x	x	x	x	20.1	x	24.8	15.5	x	26.8	19.8	25.6	19.6	x	26.0	x	x	x	x	25.9	x	x	22.8	x	22.9	22.0	22.0	x	19.9	20.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10244	Original post publication description: Iron level in nucleus accumbens of females [ug/g]	None	Central nervous system, pharmacology, metabolism: Iron level in nucleus accumbens of females [ug/g]	x	x	x	x	x	18.8	x	26.1	19.1	x	32.4	22.2	14.7	27.1	x	24.3	x	x	x	x	23.4	x	x	24.6	x	20.7	30.1	24.0	x	22.8	20.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10245	Original post publication description: Iron level in ventral midbrain of males [ug/g]	None	Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of males [ug/g]	x	x	x	x	x	15.1	x	17.2	19.1	x	29.4	15.6	20.7	17.5	x	29.3	x	x	x	x	35.1	x	x	36.8	x	33.6	29.9	15.5	x	17.9	16.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10246	Original post publication description: Iron level in ventral midbrain of females [ug/g]	None	Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of females [ug/g]	x	x	x	x	x	14.2	x	18.3	17.1	x	38.4	14.4	15.7	16.4	x	29.3	x	x	x	x	33.2	x	x	35.9	x	29.6	36.0	17.5	x	20.7	17.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10247	Original post publication description: Iron level in liver of males [ug/g]	None	Metabolism, liver, nutrition: Iron level in liver of males [ug/g]	x	x	x	x	x	94.7	x	105.2	116.6	x	145.2	121.8	126.9	92.8	x	99.3	x	x	x	x	114.4	x	x	112.2	x	103.0	105.0	172.3	x	132.7	205.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10248	Original post publication description: Iron level in liver of females [ug/g]	None	Metabolism, liver, nutrition: Iron level in liver of females [ug/g]	x	x	x	x	x	142.1	x	187.4	135.0	x	138.7	204.9	201.5	154.9	x	181.8	x	x	x	x	116.4	x	x	154.4	x	159.0	134.2	143.0	x	214.7	233.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10249	Original post publication description: Dopamine receptor 1 (DRD1) protein density in nucleus accumbens of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	1146.09	1218.17	1551.25	1431.13	1660.89	1385.05	724.54	1428.62	1437.34	x	x	807.0	x	x	x	x	1334.39	x	x	1747.8	858.06	1234.18	x	788.02	x	1345.13	1258.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10250	Original post publication description: Dopamine receptor 1 (DRD1) protein density in nucleus accumbens of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	1165.17	898.7	1236.23	1319.21	1548.25	1407.51	693.2	1662.47	1112.43	x	x	1069.25	x	x	x	x	1415.07	x	x	1527.46	850.74	1108.99	x	559.63	x	1133.14	944.71	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10251	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the nucleus accumbens of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	1127.0	1537.64	1866.27	1543.04	1773.52	1362.6	755.89	1194.78	1762.26	x	x	544.75	x	x	x	x	1253.71	x	x	1968.13	865.37	1359.38	x	1016.41	x	1557.12	1571.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10252	Original post publication description: Dopamine receptor 1 (DRD1) density in dorsal striatum (caudate putamen) of males [fM Schering Compound 3H-23390]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	1042.12	1502.01	1181.74	1238.93	2496.82	1913.99	637.83	2071.32	2041.24	x	x	1124.94	x	x	x	x	2497.22	x	x	844.1	1433.32	1718.09	x	947.62	x	2229.84	1091.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10253	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the dorsal striatum (caudate putamen) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	678.67	1267.17	500.06	1001.61	2038.68	1812.29	892.36	1420.57	2169.59	x	x	579.79	x	x	x	x	1941.54	x	x	1983.04	1704.15	1780.39	x	1282.96	x	2015.38	1582.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10254	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the dorsal striatum (caudate putamen) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	860.395	1384.59	840.9	1120.27	2267.75	1863.14	765.095	1745.94	2105.42	x	x	852.365	x	x	x	x	2219.38	x	x	1413.57	1568.73	1749.24	x	1115.29	x	2122.61	1336.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10255	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	356.0	500.52	417.91	652.6	484.91	745.82	368.18	427.94	499.4	x	x	327.51	x	x	x	x	614.29	x	x	633.2	390.88	347.02	x	330.04	x	501.81	321.84	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10256	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	222.5	673.62	1786.29	305.52	472.75	588.41	482.63	487.41	751.59	x	x	112.91	x	x	x	x	520.06	x	x	548.29	347.19	463.85	x	228.38	x	757.84	383.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10257	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	289.25	587.07	1102.1	479.06	478.83	667.115	425.405	457.675	625.495	x	x	220.21	x	x	x	x	567.175	x	x	590.745	369.035	405.435	x	279.21	x	629.825	352.88	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10258	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	112.98	182.53	143.66	302.51	249.05	403.05	317.52	319.56	330.16	x	x	190.04	x	x	x	x	301.39	x	x	354.6	218.67	184.15	x	229.03	x	221.24	167.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10259	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	227.5	345.06	271.11	180.47	255.11	404.21	325.62	312.17	515.21	x	x	250.44	x	x	x	x	358.99	x	x	128.85	144.63	128.43	x	128.72	x	267.44	215.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10260	Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]	x	x	x	x	170.24	263.795	207.385	241.49	252.08	403.63	321.57	315.865	422.685	x	x	220.24	x	x	x	x	330.19	x	x	241.725	181.65	156.29	x	178.875	x	244.34	191.545	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10261	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	115.64	231.23	224.3	87.03	215.2	228.65	111.9	203.2	254.42	x	x	136.06	x	x	x	x	227.81	x	x	195.84	141.91	252.69	161.82	82.15	x	244.89	151.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10262	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	x	308.7	321.67	101.75	200.61	212.38	81.26	222.68	210.88	x	x	130.91	x	x	x	x	171.23	x	x	151.59	x	159.22	186.64	72.13	x	228.88	175.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10263	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males and females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	115.64	269.965	272.985	94.39	207.905	220.515	96.58	212.94	232.65	x	x	133.485	x	x	x	x	199.52	x	x	173.715	141.91	205.955	174.23	77.14	x	236.885	163.615	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10264	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	67.47	286.9	256.8	128.17	353.21	343.32	129.5	263.71	268.08	x	x	97.49	x	x	x	x	331.8	x	x	58.35	49.42	340.32	390.09	132.43	x	322.32	136.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10265	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	x	362.04	68.75	146.81	378.43	270.03	92.48	167.0	245.4	x	x	129.03	x	x	x	x	320.61	x	x	175.18	x	288.78	298.0	163.73	x	400.11	271.82	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10266	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	67.47	324.47	162.775	137.49	365.82	306.675	110.99	215.355	256.74	x	x	113.26	x	x	x	x	326.205	x	x	116.765	49.42	314.55	344.045	148.08	x	361.215	204.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10267	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the prefrontal cortex of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	50.59	36.56	38.41	59.81	50.9	64.47	44.77	47.49	62.96	x	x	28.51	x	x	x	x	57.87	x	x	42.6	25.91	63.01	66.75	44.71	x	83.44	23.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10268	Original post publication description: Dopamine receptor 2 (DRD2) protein density level in frontal cortex of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	x	58.3	377.59	57.29	32.58	68.1	28.45	47.08	59.79	x	x	10.81	x	x	x	x	55.94	x	x	39.29	x	49.15	76.42	62.11	x	72.48	32.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10269	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the prefrontal cortex of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	50.59	47.43	208.0	58.55	41.74	66.285	36.61	47.285	61.375	x	x	19.66	x	x	x	x	56.905	x	x	40.945	25.91	56.08	71.585	53.41	x	77.96	28.235	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10270	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	49.61	0.95	53.95	24.64	58.46	62.65	48.91	41.17	58.22	x	x	32.54	x	x	x	x	61.37	x	x	47.44	42.6	46.8	74.43	39.58	x	44.64	45.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10271	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	x	60.23	60.42	27.86	49.09	59.08	49.41	35.56	68.84	x	x	15.55	x	x	x	x	54.8	x	x	43.12	x	43.83	62.18	34.95	x	78.16	52.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10272	Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (125I-epidepride ligand) [fmol/mg wet weight]	x	x	x	x	49.61	30.59	57.185	26.25	53.775	60.865	49.16	38.365	63.53	x	x	24.045	x	x	x	x	58.085	x	x	45.28	42.6	45.315	68.305	37.265	x	61.4	49.335	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10273	Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	496.35	4820.0	2936.87	2956.52	3350.8	3311.0	1382.24	3887.1	3787.66	x	x	3367.63	x	x	x	x	4630.0	x	x	2679.06	4503.83	4407.5	5570.0	1485.2	x	4348.0	2008.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10274	Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	x	4930.0	3283.0	4445.33	2548.0	2776.44	2480.13	2734.35	4749.0	x	x	1286.33	x	x	x	x	3560.0	x	x	4371.0	3269.0	3660.97	5320.0	278.63	x	6356.38	2748.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10275	Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	496.35	4875.0	3109.94	3700.93	2949.4	3043.72	1931.19	3310.73	4268.33	x	x	2326.98	x	x	x	x	4095.0	x	x	3525.03	3886.42	4034.24	5445.0	881.915	x	5352.19	2378.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10276	Original post publication description: Dopamine transporter (SLC6A3) protein density in dorsal striatum (caudate putamen) of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	709.36	90.0	2787.62	2666.34	4228.58	7985.0	4698.77	3294.14	4768.66	x	x	1495.5	x	x	x	x	6940.0	x	x	6453.62	6741.93	6109.09	8323.33	1967.76	x	8400.96	4286.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10277	Original post publication description: Dopamine transporter (SLC6A3) protein density in the dorsal striatum (caudate putamen) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	x	6540.0	7311.0	3667.55	6359.0	5249.45	4108.66	2649.03	7018.0	x	x	937.83	x	x	x	x	7050.0	x	x	5979.0	7065.5	5028.35	7356.67	2541.46	x	7281.01	4465.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10278	Original post publication description: Dopamine transporter (SLC6A3) protein density in the dorsal striatum (caudate putamen) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	709.36	3315.0	5049.31	3166.95	5293.79	6617.23	4403.71	2971.58	5893.33	x	x	1216.67	x	x	x	x	6995.0	x	x	6216.31	6903.71	5568.72	7840.0	2254.61	x	7840.98	4375.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10279	Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	659.89	380.72	395.51	629.01	549.63	1093.0	721.69	730.29	1400.65	x	x	226.96	x	x	x	x	658.0	x	x	1639.37	1084.06	981.23	640.5	121.98	x	1351.14	793.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10280	Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	x	533.09	954.9	403.68	97.31	1232.51	472.13	1348.58	606.1	x	x	399.67	x	x	x	x	264.0	x	x	117.0	1211.12	659.24	440.0	400.29	x	1332.19	343.12	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10281	Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	659.89	456.905	675.205	516.345	323.47	1162.76	596.91	1039.44	1003.38	x	x	313.315	x	x	x	x	461.0	x	x	878.185	1147.59	820.235	540.25	261.135	x	1341.67	568.11	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10282	Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	47.51	376.11	250.61	422.72	346.32	172.3	198.34	124.21	1024.01	x	x	834.55	x	x	x	x	852.0	x	x	390.0	1083.4	900.86	304.0	185.13	x	824.58	324.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10283	Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmenal area and substantia nigra) of females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	x	290.49	411.3	737.98	231.1	674.25	492.02	674.14	625.7	x	x	419.03	x	x	x	x	811.0	x	x	84.49	1745.31	350.21	645.33	113.77	x	942.05	466.97	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10284	Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units]	None	Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]	x	x	x	x	47.51	333.3	330.955	580.35	288.71	423.275	345.18	399.175	824.855	x	x	626.79	x	x	x	x	831.5	x	x	237.245	1414.35	625.535	474.665	149.45	x	883.315	395.835	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10285	Original post publication description: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males and females [cm]	None	Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males and females [cm]	x	x	x	x	3602.0	7970.0	2689.0	9260.0	7485.0	5825.0	7816.0	4720.0	7377.0	6725.0	x	4464.0	6348.0	5098.0	x	5746.0	5518.0	x	x	5811.0	3865.0	9888.0	10600.0	4914.0	5392.0	7645.0	9783.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10286	Original post publication description: Cocaine stereotypy-number of repeated movements 5 mg/kg cocaine ip (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males [n difference]	x	x	x	x	23.9	-12.0909	-0.4545	-3.6364	28.4	25.0	19.8182	-5.5455	32.1	8.4	x	5.3333	8.625	16.0	x	27.8	20.1	x	x	18.2222	28.0	29.3333	31.3	10.8	35.5	12.1818	16.2727	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10287	Original post publication description: Cocaine stereotypy-number of repeated movements 5 mg/kg cocaine ip (difference from saline)-females	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in females [n difference]	x	x	x	x	-6.8	-11.9	12.3	18.0	15.3636	34.75	22.4545	0.7	8.5	12.5	x	13.5	x	37.5	x	21.8333	18.6	x	x	15.0	34.0	52.3	30.0	17.8	x	-1.5	19.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10288	Original post publication description: Cocaine stereotypy - number of repeated movements 5 mg/kg cocaine ip (difference from saline) - male and female mean	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males and females [n difference]	x	x	x	x	13.6667	-12.0	5.619	7.6522	21.5714	30.5714	21.1364	-2.5714	20.3	10.45	x	9.4167	8.625	26.75	x	25.5625	19.35	x	x	16.45	30.6667	39.7727	30.6842	14.3	35.5	5.6667	17.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10289	Original post publication description: Cocaine open field activity-total distance 5 mg/kg cocaine (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males [cm difference]	x	x	x	x	2194.6	1093.73	653.27	255.13	2711.7	3715.22	1177.6	759.91	1904.4	2046.7	x	179.83	1372.88	2233.75	x	1512.5	1201.3	x	x	2041.89	1101.89	2742.33	2597.11	1795.0	2155.0	1690.27	1310.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10290	Original post publication description: Cocaine open field locomotor response, difference in distance between cocaine injection (5 mg/kg) and saline control injection for females [cm/test]	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion measured as difference from saline control in females [cm difference]	x	x	x	x	1835.8	2194.5	588.7	1351.08	1839.36	4055.36	2005.82	1197.0	1000.4	1543.22	x	1182.33	x	3846.25	x	2829.67	2100.9	x	x	2051.18	2692.25	3533.5	3915.33	2787.8	x	1762.7	1210.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10291	Original post publication description: Cocaine response, open field activity, difference in locomotion between cocaine (5 mg/kg ip) and saline in males and females	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males and females [cm difference]	x	x	x	x	2075.0	1617.9	622.52	912.7	2254.76	3902.3	1611.43	968.05	1452.4	1808.21	x	681.08	1372.88	3040.0	x	2006.44	1651.1	x	x	2047.0	1850.29	3101.95	3256.22	2291.4	2155.0	1724.76	1263.19	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10292	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 5 mg/kg cocaine ip (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males [n]	x	x	x	x	-2.0	1.4545	1.6	2.0	-0.3333	-2.375	5.0	-5.7273	-7.5	-8.4	x	-1.0	-14.0	-7.5	x	-0.4	-4.4	x	x	0.4444	-3.1	-1.1667	0.5	-6.6	11.3333	-5.0909	10.5455	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10293	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 5 mg/kg cocaine ip (difference from saline)-females	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in females [n difference	x	x	x	x	10.0	7.4	-14.1	6.0	11.0	1.5455	0.8182	-4.0	-5.7	-1.0	x	-2.8333	x	-14.0	x	-8.0	7.1	x	x	-3.2727	-7.2857	-1.4	1.5	-8.6	x	-7.2	4.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10294	Original post publication description: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline level (mean of males and females) [n difference/test]	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males and females [n difference]	x	x	x	x	2.2857	4.2857	-6.25	4.087	5.9	-0.1053	2.901	-4.9048	-6.6	-4.7	x	-1.9167	-14.0	-10.75	x	-3.5294	1.35	x	x	-1.6	-4.8235	-1.2727	1.0	-7.6	11.3333	-6.0952	7.6667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10295	Original post publication description: Cocaine response (15 mg/kg ip), cocaine stereotypy, number of movements as difference from saline control injection in males [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), cocaine stereotypy, number of movements as difference from saline control injection in males [n]	x	x	x	x	19.4545	3.6667	14.7	-0.7273	42.6	61.7	45.6364	7.3636	47.6154	16.9	x	10.5	19.0	25.5	x	70.7	62.9	x	x	68.4545	50.0	41.3	33.6364	2.0	77.333	86.8182	44.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10296	Original post publication description: Cocaine stereotypy-number of movements 15 mg/kg cocaine ip (difference from saline)-females	None	Cocaine stereotypy-number of movements 15 mg/kg cocaine ip (difference from saline)-females	x	x	x	x	x	-7.44	26.545	40.917	1000.42	86.1	79.5	-1.909	46.3	38.2	x	25.0	x	60.25	x	53.4	80.7	x	x	35.545	39.333	52.273	74.364	18.0	x	39.182	61.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10297	Original post publication description: Cocaine response (15 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female average [n]	None	Cocaine response (15 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female average [n]	x	x	x	x	19.4545	-1.8889	20.9048	21.0	74.1364	73.9	61.7619	2.7273	47.0435	27.55	x	17.0909	19.0	42.875	x	64.9333	71.8	x	x	52.0	44.6667	47.0476	54.0	8.4	77.333	63.0	52.381	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10298	Original post publication description: Cocaine open field activity-total distance 15 mg/kg cocaine (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), locomotion in an open field, total distance measured as difference from saline control in males [cm]	x	x	x	x	3579.18	6650.91	1774.6	3500.6	5088.82	7017.6	4368.64	5007.0	6213.31	4561.3	x	3574.83	5452.83	5496.25	x	6155.3	4326.5	x	x	5827.64	4063.4	11211.0	4230.36	4538.0	4457.0	5598.09	4223.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10299	Original post publication description: Cocaine response (15 mg/kg ip), open field activity, total distance, difference from saline control in females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field activity, total distance, difference from saline control in females [cm]	x	x	x	x	x	3512.2	3032.18	7606.27	8513.17	9589.56	6710.8	5271.17	4328.0	5476.0	x	3917.2	x	6116.5	x	3859.0	4828.8	x	x	5737.82	6150.22	9452.0	7746.27	1128.25	x	4944.0	4797.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10300	Original post publication description: Cocaine open field locomotor response, difference in total distance after 15 mg/kg injection compared to saline, males and females [cm]	None	Cocaine open field locomotor response, difference in total distance after 15 mg/kg injection compared to saline, males and females [cm]	x	x	x	x	3579.18	5156.29	2433.33	5651.19	6875.43	8235.89	5483.95	5144.83	5393.61	5018.65	x	3730.45	5452.83	5806.38	x	5389.87	4577.65	x	x	5782.73	5051.89	10285.2	5988.32	3174.1	4457.0	5271.05	4497.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10301	Original post publication description: Cocaine response (15 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for males [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]	x	x	x	x	-3.3	-6.5455	-11.3333	-0.3636	-3.5455	-19.125	-7.3636	-4.6364	-11.1538	-4.1	x	1.5	-2.5714	-6.75	x	-5.0	-7.0	x	x	-6.0909	-8.4	-3.7	-0.4	-8.3333	-18.8	-6.3636	-2.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10302	Original post publication description: Cocaine response (15 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for females [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]	x	x	x	x	x	-1.4444	-9.2	-7.0909	-7.0833	-11.4	-7.9	-3.0833	-15.875	-4.5	x	-3.4	x	-7.0	x	-7.0	-14.1111	x	x	-5.5455	-8.6667	-1.2727	-9.0	-0.5	x	-9.6364	-8.4444	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10303	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 15 mg/kg cocaine ip (difference from saline)-mean males and females	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]	x	x	x	x	2.2857	-4.25	-10.2105	-3.7273	-5.3913	-14.8333	-7.619	-3.8261	-12.9524	-4.3	x	-0.7273	-2.5714	-6.875	x	-5.6667	-10.3684	x	x	-5.8182	-8.5263	-2.4286	-4.9048	-5.2	-18.8	-8.0	-5.1053	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10304	Original post publication description: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection for males [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection for males [n]	x	x	x	x	15.5566	3.8	20.0	39.6	54.818	71.667	47.5	36.909	81.75	33.778	x	3.25	41.333	32.25	x	37.571	59.818	x	x	51.385	69.0	68.727	68.222	18.833	82.2	50.5	109.091	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10305	Original post publication description: Cocaine stereotypy-number of movements 30 mg/kg cocaine ip (difference from saline)-females	None	Cocaine stereotypy-number of movements 30 mg/kg cocaine ip (difference from saline)-females	x	x	x	x	32.75	14.0	22.545	24.0	63.545	93.364	76.083	9.636	70.0	0.556	x	21.667	x	70.25	x	97.4	101.364	x	x	77.222	31.2	73.444	120.091	x	x	40.455	63.182	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10306	Original post publication description: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to from saline control injection, male and female mean [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female combined [n]	x	x	x	x	20.8462	8.9	21.333	31.8	59.1818	83.6	63.0909	23.2727	76.4091	17.1667	x	11.1429	41.3333	51.25	x	80.0	80.5909	x	x	61.9545	51.0	70.85	96.75	18.8333	82.2	45.2381	86.1364	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10307	Original post publication description: Cocaine response (30 mg/kg ip), open field activity, total distance (difference from saline control) in males [units]	None	Cocaine response (30 mg/kg ip), open field activity, total distance (difference from saline control) in males [units]	x	x	x	x	5138.78	7692.3	2523.3	9445.14	8038.09	6483.44	8598.8	4809.09	7829.0	6242.56	x	3394.13	6141.17	6317.75	x	5389.86	5089.25	x	x	6155.62	5855.36	11323.9	9137.43	6353.67	6395.2	7609.4	7896.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10308	Original post publication description: Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)- females	None	Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)- females	x	x	x	x	4406.25	8029.9	2724.55	6993.56	7777.18	9570.0	6825.09	3844.36	3277.8	8067.14	x	4819.0	x	7586.5	x	7748.2	6778.27	x	x	6744.3	3145.89	9256.78	13633.0	x	x	7764.27	10213.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10309	Original post publication description: Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)-male and female mean	None	Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)-male and female mean	x	x	x	x	4913.38	7861.1	2628.71	8066.13	7907.64	8181.05	7669.71	4326.73	7123.91	7040.81	x	4004.79	6141.17	6952.13	x	6372.5	5897.04	x	x	6411.57	4636.1	10393.7	11884.7	6353.67	6395.2	7690.52	9109.81	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10310	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 30 mg/kg cocaine ip (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]	x	x	x	x	-9.25	-7.1111	-22.375	-4.4	1.4	-11.4444	-7.8	-3.4545	-15.1667	-10.6667	x	-1.875	-6.8333	-10.0	x	-4.8571	-15.4545	x	x	-1.6923	-11.8182	-3.2727	-3.1	-9.1667	-7.25	-8.1	-8.8182	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10311	Original post publication description: Cocaine response, exploratory activity, difference holeboard nose pokes between cocaine (30 mg/kg ip) and saline in females [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]	x	x	x	x	-11.75	-10.1111	-10.8182	-12.0	1.81818	-13.5455	-9.16667	-0.72727	-10.6	-5.125	x	-2.66667	-8.0	-10.25	x	-2.0	-14.0	x	x	-6.3	-10.3	-12.2222	-11.7273	-12.3333	-27.0	-5.72727	-14.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10312	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 30 mg/kg cocaine ip (difference from saline)-male and female mean	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]	x	x	x	x	-10.0833	-8.6111	-15.6842	-8.0	1.619	-12.6	-8.5455	-2.0909	-13.0909	-13.2222	x	-2.2143	-6.8333	-10.125	x	-3.6667	-15.0952	x	x	-3.6957	-11.5	-7.3	-7.619	-9.1667	-7.25	-6.8571	-11.4762	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10313	Original post publication description: Cocaine response, stereotypy, difference in number of movements after cocaine (45 mg/kg ip) compared to saline control in males	None	Cocaine response, stereotypy, difference in number of movements after cocaine (45 mg/kg ip) compared to saline control in males	x	x	x	x	31.125	40.2727	12.0833	14.3636	83.2727	47.2727	30.9	14.7273	89.0833	16.9	x	1.5	28.375	45.25	x	36.5714	39.5455	x	x	18.2	51.3	79.0	55.6	16.8333	76.5	5.4	51.1111	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10314	Original post publication description: Cocaine response (45 mg/kg cocaine ip), stereotypy, number of movements relative to saline control injection in females [n]	None	Cocaine response (45 mg/kg cocaine ip), stereotypy, number of movements relative to saline control injection in females [n]	x	x	x	x	51.6	5.8	0.8182	31.2	50.75	58.5556	53.0	0.2222	74.7273	38.4	x	10.8	x	20.75	x	43.2	66.2	x	x	19.333	41.2	57.8	77.4	15.333	x	33.1818	46.4167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10315	Original post publication description: Cocaine response, stereotypy, difference in number of movements between cocaine (45 mg/kg ip) and saline in males and females	None	Cocaine response, stereotypy, difference in number of movements between cocaine (45 mg/kg ip) and saline in males and females	x	x	x	x	39.0	23.8571	6.6957	22.381	69.5789	52.35	42.4762	8.2	82.2174	27.65	x	5.7273	28.375	33.0	x	39.3333	52.2381	x	x	18.8182	46.25	68.4	66.5	16.3333	76.5	19.9524	48.4286	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10316	Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males	None	Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males	x	x	x	x	5167.88	8081.18	3118.17	7006.45	7651.0	9608.18	5561.9	5277.55	7793.67	5834.1	x	5273.83	4397.75	6007.75	x	4820.57	4210.73	x	x	4037.9	4716.67	9595.73	5946.67	5099.67	5787.0	6691.9	7125.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10317	Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-females	None	Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-females	x	x	x	x	6258.8	6524.8	3339.09	7076.55	7885.44	7719.89	7430.18	3791.22	7100.36	7641.1	x	4305.6	x	5703.0	x	5240.0	5918.6	x	x	5297.77	4288.89	7085.9	9051.2	5508.67	x	7988.18	5792.83	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10318	Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males and females	None	Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males and females	x	x	x	x	5587.46	7340.05	3223.83	7041.5	7756.5	8758.45	6540.52	4608.7	7462.09	6737.6	x	4833.73	4397.75	5855.38	x	4995.33	5024.0	x	x	4750.0	4502.78	8400.57	7580.63	5236.0	5787.0	7370.9	6325.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10319	Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 45 mg/kg cocaine ip (difference from saline)-males	None	Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]	x	x	x	x	-4.0	-10.2727	-12.6	-11.7273	-6.1818	-7.7273	-10.5	-4.0	-8.1667	-10.25	x	-4.6667	-13.5	-7.75	x	0.5714	-5.9	x	x	-2.7778	-11.5	-0.6364	-6.4	-3.0	-19.0	-8.1818	-9.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10320	Original post publication description: Cocaine response (45 mg/kg ip), exploratory activity assayed by nose pokes in holeboard minus saline control in females [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]	x	x	x	x	-5.5	-12.3	-27.0	-12.1667	0.375	-22.625	-7.4545	-12.2222	-19.6364	-11.3333	x	-4.0	x	-7.75	x	-0.4	-7.0	x	x	-8.0	-16.2	-10.3	-16.4	-11.3333	x	-16.9	-12.9167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10321	Original post publication description: Cocaine response (45 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for males and females [n]	None	Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]	x	x	x	x	-4.5455	-11.2381	-19.8	-11.9565	-3.4211	-14.0	-8.9048	-7.7	-13.6522	-10.8235	x	-4.3636	-13.5	-7.75	x	0.1667	-6.45	x	x	-5.8636	-13.85	-5.2381	-11.4	-5.7778	-19.0	-11.8571	-11.55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10322	Original post publication description: Cocaine open field behavior-total distance area under curve, 5 mg/kg cocaine, saline covariate	None	Central nervous system, behavior, pharmacology: Cocaine open field behavior-total distance area under curve, 5 mg/kg cocaine, saline covariate	x	x	x	x	6344.1	5600.6	3904.9	5340.5	5714.2	7861.3	5091.8	4983.1	4877.1	5963.5	x	4240.7	6514.6	7005.2	x	5962.8	4785.9	x	x	5435.1	5873.0	6522.6	6735.3	6477.4	6479.8	5332.6	5263.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10323	Original post publication description: Cocaine response, open field behavior, total distance area under curve, 15 mg/kg ip, with saline covariate [cm]	None	Cocaine response, open field behavior, total distance area under curve, 15 mg/kg ip, with saline covariate [cm]	x	x	x	x	8070.2	8952.4	6378.8	9327.2	10735.2	12173.5	9471.2	8978.4	9227.5	8828.8	x	7701.2	9170.7	9655.7	x	8873.1	8577.0	x	x	9751.9	8952.6	14268.4	9888.3	6628.1	8682.7	9204.5	8352.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10324	Original post publication description: Cocaine open field behavior-total distance area under curve, 30 mg/kg cocaine, saline covariate	None	Central nervous system, behavior: Cocaine open field behavior-total distance area under curve, 30 mg/kg cocaine, saline covariate	x	x	x	x	8966.9	11803.8	6140.4	12347.2	11570.5	11909.3	11419.9	8272.3	10733.8	11381.1	x	7682.1	9567.0	11022.5	x	10457.0	9480.2	x	x	10020.9	8494.0	13953.4	15114.6	10095.9	9632.3	11379.2	13001.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10325	Original post publication description: Cocaine response, open field behavior, total distance area under curve (45 mg/kg ip) with saline covariate [cm]	None	Central nervous system, behavior, pharmacology: Cocaine response, open field behavior, total distance area under curve (45 mg/kg ip) with saline covariate [cm]	x	x	x	x	10619.6	11321.9	6331.1	11605.6	11243.0	12728.1	9879.0	8835.7	10837.6	11773.3	x	8156.1	10098.4	10310.8	x	8823.8	8130.9	x	x	7990.5	8542.5	11679.6	11098.3	9591.9	10106.3	10914.4	10489.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10326	Original post publication description: Cocaine response (15 mg/kg ip), open field behavior, difference in time spent in the field center relative saline injection for females [sec]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, difference in time spent in the field center relative saline injection for females [sec]	x	x	x	x	-52.3333	-69.2	67.1	-30.0833	-8.66667	-45.3333	-20.4	-37.8182	-12.4	-6.0	x	53.75	-42.0	-29.0	x	-42.2	38.9	x	x	-43.1111	-49.5556	4.9	-47.1818	12.75	26.3333	-80.2	-12.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10327	Original post publication description: Cocaine response (30 mg/kg), open field behavior, center time (difference from saline) in males [sec]	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg), open field behavior, center time (difference from saline) in males [sec]	x	x	x	x	-11.1111	-64.1	1.11111	-7.5	1.09091	-41.4444	1.7	19.0909	6.75	-44.8889	x	25.7143	-4.16667	-37.0	x	-9.42857	11.5455	x	x	-26.9231	-47.9091	-1.0	-71.7778	-17.5	-15.6	-18.5	-45.3636	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10328	Original post publication description: Cocaine open field behavior-center time (difference from saline) 30 mg/kg cocaine-females	None	Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), open field behavior, center time difference from saline control in females [sec]	x	x	x	x	-58.25	-55.3	21.4444	-23.8889	32.6364	-92.4546	37.4167	-44.0909	-3.0	-37.8889	x	2.16667	8.0	-14.75	x	25.4	30.1818	x	x	-39.7	-73.6	-40.375	-74.5	0.0	44.0	-43.9	-63.2727	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10329	Original post publication description: Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-males	None	Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-males	x	x	x	x	-17.2857	-67.8182	63.4	-20.0	-5.0	-69.4546	-10.3	-30.6364	-4.08333	-31.7	x	-9.5	-16.75	-17.5	x	6.71429	55.1818	x	x	-53.5	-12.6	41.6	-32.9	20.3333	-8.5	0.09091	-61.5556	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10330	Original post publication description: Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-females	None	Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-females	x	x	x	x	-33.6	11.3	17.1	1.5	67.8889	-38.3333	36.6364	-26.4444	-10.0	-55.4	x	-12.0	-62.5	92.5	x	22.0	62.1	x	x	3.33333	-38.2222	-6.5	-47.7	-12.0	9.0	-2.2	-49.6667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10331	Original post publication description: Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males [cm]	None	Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males [cm]	x	x	x	x	3703.0	8768.0	2398.0	11354.0	6675.0	3863.0	9278.0	5540.0	7742.0	5381.0	x	4402.0	6348.0	5393.0	x	5415.0	5138.0	x	x	5527.0	6118.0	11639.0	7952.0	5848.0	5392.0	7660.0	8248.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10332	Original post publication description: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for females [cm]	None	Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for females [cm]	x	x	x	x	3303.0	7068.0	2961.0	7784.0	8209.0	7369.0	6527.0	3869.0	6799.0	8371.0	x	4770.0	x	4781.0	x	5942.0	5984.0	x	x	7237.0	1189.0	7814.0	12083.0	-3478.0	x	7618.0	11201.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10333	Original post publication description: Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-males	None	Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-males	x	x	x	x	-53.5	-64.1818	-75.6	-35.9091	-26.2222	-39.1111	-36.2727	-58.2727	-45.6	-30.0	x	-65.6667	-54.75	-91.6667	x	-30.5	0.2	x	x	-33.0	-12.5	-2.25	-0.14286	-12.8	26.4	-55.5454	-31.0909	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10334	Original post publication description: Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-females	None	Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg), anxiety assay, center time in an open field test, difference from saline control in females [sec]	x	x	x	x	-33.4	-56.5	-32.875	-16.4167	-60.0	-43.5833	-17.6364	-15.0	-33.9	-34.5556	x	10.3333	-17.3333	-25.0	x	-22.3333	44.375	x	x	-53.6	-50.5	-10.3	-1.8	-41.6	-30.5	-60.0	-44.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10335	Original post publication description: Cocaine response (15 mg/kg ip), open field behavior, time in the field center (difference from saline control) in males [sec]	None	Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, time in the field center (difference from saline control) in males [sec]	x	x	x	x	-37.7273	-35.1818	-36.2222	-37.1818	-6.0	-22.2	-11.0	-24.5455	-23.7692	-25.8	x	-53.8333	-17.8571	-18.0	x	-20.6	39.8	x	x	-1.8	-48.2222	-13.6667	-66.6364	3.33333	19.5	-42.5	-57.0909	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10336	Original post publication description: Haloperidol response, induced catalepsy at ED50 [mg/kg]	None	Central nervous system, pharmacology: Haloperidol response, induced catalepsy at ED50 [mg/kg]	x	x	3.8	0.4	1.17	7.9	1.23	3.25	1.48	1.73	2.47	2.94	1.53	2.31	1.17	4.18	4.43	2.39	2.8	0.98	0.61	5.89	x	0.93	3.62	1.35	2.73	6.67	0.55	0.96	3.81	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10337	Original post publication description: Central nervous system, morphology: Hippocampus granule cell number [n total per side]	None	Central nervous system, morphology: Hippocampus granule cell number [n total per side]	x	x	344252.0	298849.0	x	281933.0	386307.0	435866.0	343767.0	x	x	303769.0	x	x	x	x	308851.0	335002.0	x	x	x	x	x	x	292057.0	x	309037.0	348995.0	284144.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10338	Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, day 1 after last BrdU injection [n cells]	None	Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, day 1 after last BrdU injection [n cells]	x	x	5416.0	2014.0	x	2961.0	x	5389.0	7001.0	x	x	x	x	x	x	x	4047.0	2968.0	x	x	x	x	x	x	6131.0	x	3515.0	2254.0	4227.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10339	Original post publication description: Central nervous system, adult neurogenesis: Survival of BrdU-labelled cells in the hippocampal dentate gyrus subgranular zone 4 weeks after last injection [n cells]	None	Central nervous system, adult neurogenesis: Survival of BrdU-labelled cells in the hippocampal dentate gyrus subgranular zone 4 weeks after last injection [n cells]	x	x	2184.0	864.0	x	403.0	1157.0	2709.0	3745.0	x	x	1052.0	x	x	x	x	1085.0	1072.0	x	x	x	x	x	x	1283.0	x	1215.0	679.0	883.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10340	Original post publication description: Central nervous system, adult neurogenesis: fraction of new neurons in hippocampal dendate gyrus 4 weeks after last BrdU injection [%]	None	Central nervous system, adult neurogenesis: fraction of new neurons in hippocampal dentate gyrus 4 weeks after last BrdU injection [%]	x	x	78.3	51.8	x	27.9	63.7	67.6	78.6	x	x	44.4	x	x	x	x	57.7	68.7	x	x	x	x	x	x	79.2	x	68.8	50.5	56.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10341	Original post publication description: Central nervous system, learning and memory, adult neurogenesis: Astrocyte cell number percentage, 4 weeks after last BrdU injection [%]	None	Central nervous system, learning and memory, adult neurogenesis: Astrocyte cell number percentage, 4 weeks after last BrdU injection [%]	x	x	85.3	80.4	x	64.9	81.8	81.1	87.7	x	x	69.3	x	x	x	x	80.0	91.8	x	x	x	x	x	x	93.8	x	85.6	77.1	89.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10342	Original post publication description: Central nervous systems, adult neurogenesis: Newly generated neurons in the dentate gyrus 4 weeks after last BrdU injection [n BrdU cells X ratio of NeuN / BrdU labeled cells]	None	Central nervous systems, adult neurogenesis: Newly generated neurons in the dentate gyrus 4 weeks after last BrdU injection [n BrdU cells X ratio of NeuN / BrdU labeled cells]	x	x	1695.0	433.0	x	110.0	732.0	1816.0	2891.0	x	x	462.0	x	x	x	x	621.0	731.0	x	x	x	x	x	x	1007.0	x	872.0	365.0	493.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10343	Original post publication description: Central nervous system, adult neurogenesis: New astrocytes, 4 weeks after last BrdU injection [n BrdU cells X ratio of S100 beta / BrdU labelled cells]	None	Central nervous system, adult neurogenesis: New astrocytes, 4 weeks after last BrdU injection [n BrdU cells X ratio of S100 beta / BrdU labelled cells]	x	x	136.0	245.0	x	142.0	243.0	404.0	326.0	x	x	255.0	x	x	x	x	235.0	245.0	x	x	x	x	x	x	179.0	x	165.0	183.0	290.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10344	Original post publication description: Central nervous system, behavior, learning and memory: Learning measured by the time spent in target quadrant on day 5 (probe trial) using the Morris water maze [%]	None	Central nervous system, behavior, learning and memory: Learning measured by the time spent in target quadrant on day 5 (probe trial) using the Morris water maze [%]	x	x	31.7	23.1	x	34.2	x	37.7	28.6	x	x	34.4	x	x	x	x	28.1	31.4	x	x	x	x	x	x	35.1	x	30.5	24.9	32.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10345	Original post publication description: Central nervous system, behavior: Learning and memory function, probe trial water maze time spent in swim path, day 5 [%]	None	Central nervous system, behavior: Learning and memory function, probe trial water maze time spent in swim path, day 5 [%]	x	x	33.6	20.7	x	33.9	x	38.5	30.6	x	x	35.7	x	x	x	x	28.4	37.9	x	x	x	x	x	x	33.6	x	28.0	24.8	31.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10819	Original post publication description: Central nervous system, behavior: Open field behavior, locomotion from 0-45 min [n beam breaks]	None	Central nervous system, behavior: Open field behavior, locomotion from 0-45 min [n beam breaks]	x	x	212.6	207.4	x	211.25	x	216.2	220.0	x	x	180.0	x	x	x	x	154.6	228.2	x	x	x	x	x	x	212.0	x	x	296.6	206.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10347	Original post publication description: Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a dowel test (BEC time 0) [mg % ethanol]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a dowel test (BEC time 0) [mg % ethanol]	x	x	195.33	205.91	197.28	128.9	201.4	152.49	169.13	190.51	207.85	209.95	202.57	221.38	153.89	152.64	192.77	201.79	176.98	169.36	231.42	x	x	231.88	169.98	x	168.04	186.86	195.65	190.36	160.71	160.26	x	185.8	x	x	215.79	213.37	194.48	x	188.26	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10348	Original post publication description: Ethanol response (1.75 g/kg ip then 2 g/kg ip), acute functional tolerance (AFT) measured as the difference in blood alcohol concentration (BEC, retrobulbar bleed) following the second recovery of balance and the first recovery of balance using a dowel test (BEC2 minus BEC1) [mg %]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), acute functional tolerance (AFT) measured as the difference in blood alcohol concentration (BEC, retrobulbar bleed) following the second recovery of balance and the first recovery of balance using a dowel test (BEC2 minus BEC1) [mg %]	x	x	65.2	94.1	96.8	71.0	112.9	96.5	81.1	103.7	107.0	119.3	116.0	110.6	58.4	65.7	56.2	91.3	76.7	79.1	109.5	x	x	81.2	128.3	x	79.2	85.0	92.3	49.3	64.4	98.3	x	63.5	x	x	47.2	87.0	96.9	x	106.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10349	Original post publication description: Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of balance using a dowel test (Loss corresponds to BEC time 0) [min]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of balance using a dowel test (Loss corresponds to BEC time 0) [min]	x	x	2.09	2.33	1.75	1.03	2.3	1.47	2.11	1.55	1.82	2.19	2.2	1.81	1.83	1.2	1.38	2.47	2.32	1.41	3.47	x	x	3.22	1.64	x	1.56	2.25	1.71	2.28	1.44	1.6	x	1.44	x	x	1.57	1.56	2.02	x	1.63	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10350	Original post publication description: Ethanol response (1.75 mg/kg ip), duration of ataxia following the first ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1) [min]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), duration of ataxia following the first ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1) [min]	x	x	10.53	9.61	16.36	27.99	14.12	10.75	14.07	9.7	11.98	14.21	24.58	17.73	10.7	34.74	32.7	15.12	11.38	32.69	15.11	x	x	13.39	14.39	x	16.12	9.24	7.99	18.67	56.55	24.92	x	26.7	x	x	24.18	20.31	9.39	x	9.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10351	Original post publication description: Ethanol response (1.75 g/kg ip then 2 g/kg ip), duration of ataxia following the second ethanol injection using a dowel test (Regain Test 2 corresponds to BEC2) [min]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), duration of ataxia following the second ethanol injection using a dowel test (Regain Test 2 corresponds to BEC2) [min]	x	x	162.53	133.15	139.07	181.94	128.1	141.62	144.5	126.94	131.42	140.1	142.0	129.97	164.01	175.99	183.48	132.35	127.23	175.02	149.64	x	x	141.95	133.14	x	144.59	125.47	118.8	173.19	220.28	152.77	x	189.91	x	x	198.64	162.91	137.19	x	109.16	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10352	Original post publication description: cyclic AMP accumulation in cerebellum, basal level measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	None	Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, basal level measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	x	x	0.608	1.48	1.23	1.1	1.15	1.26	1.14	1.04	1.04	1.26	0.688	0.994	1.87	1.15	0.972	1.38	0.85	1.31	0.885	x	x	0.819	1.34	x	1.18	1.04	1.37	0.866	0.866	1.43	x	1.11	x	x	0.85	1.06	0.868	x	1.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10353	Original post publication description: cyclic AMP accumulation in cerebellum, stimuated with forskolin (10 uM) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	None	Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimuated with forskolin (10 uM) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	x	x	18.5	22.8	18.6	22.3	18.9	18.3	18.6	24.5	21.7	26.2	17.4	29.0	25.2	20.9	18.4	27.7	17.1	18.9	19.4	x	x	18.7	20.9	x	21.6	21.7	20.1	18.5	17.0	18.6	x	21.3	x	x	19.2	22.8	18.8	x	22.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10354	Original post publication description: cyclic AMP accumulation in cerebellum, stimuated with isoproterenol (1 um) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	None	Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimulated with isoproterenol (1 um) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]	x	x	3.37	6.0	4.77	3.68	4.23	4.24	4.31	6.37	5.05	5.17	4.29	5.15	9.38	5.19	4.27	5.14	4.83	5.63	4.81	x	x	5.88	5.41	x	4.34	4.62	5.51	3.81	4.1	4.85	x	4.8	x	x	5.15	5.23	4.27	x	5.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10355	Original post publication description: Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3]	None	Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3]	x	x	10.0	2.0	2.0	4.0	x	x	2.0	1.0	13.0	2.0	x	x	x	1.0	x	x	x	15.0	x	x	x	3.0	2.0	23.0	1.0	1.0	2.0	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10356	Original post publication description: Immune function, environmental toxicology: Airway inflammatory response to ozon (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3]	None	Immune system, pulmonary system, environmental toxicology: Airway inflammatory response to ozone (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3]	x	x	10.0	2.0	14.0	16.0	x	x	14.0	1.0	23.0	1.0	x	x	x	4.0	x	x	x	2.0	x	x	x	2.0	2.0	14.0	1.0	2.0	2.0	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10357	Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) measured by DXA in 12-week-old females for whole body [mg/cm2]	None	Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) measured by DXA in 12-week-old females for whole body [mg/cm2]	x	x	63.5	55.5	55.3	60.6	57.4	57.8	59.4	64.2	57.7	55.4	59.2	65.0	67.8	57.2	62.7	58.3	x	57.8	65.0	x	x	59.3	56.1	54.0	57.5	57.2	53.3	63.9	57.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10358	Original post publication description: Musculoskeletal system, morphology: Body weight [g]	None	Musculoskeletal system, morphology: Body weight [g]	x	x	19.6	20.3	15.8	20.5	19.1	18.0	17.6	24.9	17.3	16.9	20.4	22.2	20.7	22.0	21.0	17.6	x	19.1	17.5	x	x	19.4	16.1	17.0	19.1	18.9	14.2	18.0	19.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10359	Original post publication description: Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in males [mm^2]	None	Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in males [mm^2]	x	x	1.906	1.273	2.26	1.64	x	1.69	1.89	x	1.91	2.18	x	1.89	x	1.95	2.08	1.78	x	1.76	x	1.62	x	1.38	x	1.82	2.12	1.85	x	1.85	1.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10360	Original post publication description: Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in females [mm^2]	None	Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in females [mm^2]	x	x	1.663	1.14	1.82	1.5	x	1.54	1.7	x	1.44	1.55	x	1.62	x	1.62	1.61	1.64	x	1.49	x	1.55	x	1.15	x	1.5	1.49	1.7	x	1.52	1.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10361	Original post publication description: Progenitor cell proliferation in young mice-effect of TGF-beta2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells [% of ctrl without TGF-beta2]	None	Immune system, aging: Progenitor cell proliferation in young mice (2 months of age), effect of TGFB2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells relative to control without TGFB2 [%]	x	x	x	x	51.0	24.0	42.0	13.0	42.0	27.0	32.0	42.0	32.0	56.0	48.0	68.0	57.0	15.0	x	58.0	24.0	49.0	x	35.0	36.0	31.0	41.0	43.0	x	55.0	27.0	57.0	28.0	55.0	39.0	x	26.0	x	45.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10362	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total [units]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total [units]	x	x	201035.0	170534.0	235457.0	183237.0	176552.0	204155.0	241324.0	183084.0	167761.0	168565.0	182073.0	208777.0	181884.0	166098.0	166098.0	195597.0	183097.0	195597.0	167891.0	169252.0	x	159822.0	169252.0	159888.0	195822.0	183649.0	172789.0	206713.0	159736.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10363	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, CA4 (dentate gyrus) component [volume units]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, CA4 (dentate gyrus) component [volume units]	x	x	95604.0	73495.0	108113.0	79558.0	69461.0	98145.0	102257.0	82676.0	76052.0	71343.0	80200.0	85196.0	91529.0	84975.0	72329.0	78205.0	80195.0	82715.0	77941.0	79350.0	x	69893.0	72158.0	67393.0	86697.0	81027.0	73771.0	89044.0	70752.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10364	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal component (SPMF) [units]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal component (SPMF) [units]	x	x	78388.0	93765.0	101833.0	83695.0	82143.0	92057.0	105625.0	84840.0	76814.0	75664.0	84697.0	98555.0	118355.0	77463.0	72642.0	93293.0	77409.0	92860.0	90151.0	79737.0	x	77537.0	75635.0	74170.0	85185.0	83292.0	83211.0	98742.0	74437.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10365	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, intra- and infrapyramidal component (IIPMF) [units]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, intra- and infrapyramidal component (IIPMF) [units]	x	x	27042.0	12275.0	25512.0	19984.0	24948.0	13953.0	33443.0	15568.0	14895.0	21558.0	17176.0	25025.0	14859.0	19446.0	21127.0	12645.0	7688.0	20021.0	15005.0	26597.0	x	20462.0	21460.0	18326.0	24939.0	19329.0	15807.0	18926.0	14546.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10366	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway, ratio of volume of CA4 to total MF [%]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway, ratio of volume of CA4 to total MF [%]	x	x	47.56	40.88	45.42	43.33	39.48	48.17	42.3	45.26	45.36	42.32	44.08	40.6	40.6	46.77	43.53	42.64	48.55	42.21	42.57	42.66	x	41.82	42.65	42.2	43.74	44.11	42.72	42.64	44.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10367	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of suprapyramidal component relative to total volume [%]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of suprapyramidal component relative to total volume [%]	x	x	39.03	52.37	43.77	45.94	46.47	45.06	43.77	46.39	45.85	44.97	46.61	47.62	52.8	42.62	43.77	50.57	46.88	47.69	49.27	43.05	x	46.2	44.73	46.5	43.68	45.41	48.17	48.16	46.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10368	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of IIPMT relative to total volume [%]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of IIPMT relative to total volume [%]	x	x	13.41	6.76	10.81	10.73	14.05	6.77	13.93	8.34	8.79	12.71	9.31	11.78	6.6	10.61	12.7	6.78	4.57	10.1	8.16	14.29	x	11.97	12.62	11.31	12.58	10.48	9.11	9.0	9.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10369	Original post publication description: Genetics, epigenetics, imprinting: egg modifier phenotype [% androgenetic blastocyts]	None	Genetics, epigenetics, imprinting: egg modifier phenotype [% androgenetic blastocyts]	x	x	50.0	6.0	41.0	56.0	23.0	52.0	41.0	50.0	57.0	8.0	x	46.0	39.0	62.0	71.0	32.0	27.0	10.0	61.0	51.0	x	46.0	64.0	61.0	44.0	20.0	64.0	49.0	63.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10370	Original post publication description: Cancer: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n]	None	Cancer: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n]	x	x	1.6	31.0	2.7	14.0	22.0	1.3	18.0	x	63.0	1.7	8.2	x	0.06	22.0	16.0	43.0	x	14.0	x	5.8	x	15.0	12.0	14.0	5.6	2.3	3.5	8.6	8.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10371	Original post publication description: Cytosolic aryl-hydrocarbon receptor (AHR) protein levels in liver (fmol/mg cytosolic protein)	None	Cytosolic aryl-hydrocarbon receptor (AHR) protein levels in liver (fmol/mg cytosolic protein)	x	x	38.0	0.5	57.0	0.5	9.0	50.0	46.0	1.0	39.0	1.0	43.0	66.0	1.0	12.0	65.0	1.0	2.0	0.5	1.0	1.0	x	0.5	60.0	1.0	2.0	42.0	41.0	0.5	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10372	Original post publication description: Immune function: tumor necrosis factor (TNF)-induced hypothermia [degree C]	None	Immune system: Tumor necrosis factor (TNF)-induced hypothermia [degree C]	x	35.7	26.3	35.1	30.1	26.2	x	35.4	35.5	31.9	35.6	x	x	31.3	33.3	34.5	x	x	23.6	31.6	30.4	30.2	x	35.6	35.4	31.2	31.6	x	27.2	26.0	34.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10373	Original post publication description: Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml]	None	Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml]	x	2.2	5.0	2.45	4.0	5.3	x	2.5	3.0	2.9	2.5	x	x	5.5	2.95	2.55	x	x	4.4	4.25	4.8	5.0	x	1.8	2.5	2.8	3.0	x	4.3	4.9	1.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10374	Original post publication description: Immune function: Lethality due to tumor necrosis factor (TNF) injection [%]	None	Immune system: Lethality due to tumor necrosis factor (TNF) injection [%]	x	x	100.0	0.0	79.0	100.0	66.0	0.0	0.0	12.0	0.0	x	0.0	89.0	0.0	20.0	56.0	75.0	100.0	100.0	89.0	100.0	x	10.0	0.0	10.0	20.0	x	100.0	83.0	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10375	Original post publication description: Central nervous system, morphology: Hippocampus weight, bilateral, fixed and hand-dissected tissue, unadjusted for differences in age, sex, or body weight [mg]	None	Central nervous system, morphology: Hippocampus weight, bilateral, fixed and hand-dissected tissue, unadjusted for differences in age, sex, or body weight [mg]	x	x	x	x	27.1	25.3	26.8	26.3	26.2	25.4	25.5	26.4	24.7	26.0	27.9	28.3	26.2	28.3	24.3	26.5	25.3	24.3	x	23.9	24.5	23.3	23.1	22.1	21.1	23.6	25.3	26.3	23.8	26.1	25.7	24.5	27.3	24.7	30.5	x	27.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10376	Original post publication description: Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment only for age and sex (no adjustment for brain weight).	None	Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment only for age and sex (no adjustment for brain weight).	x	x	28.4	23.0	27.6	24.9	29.9	26.7	28.7	25.7	25.2	26.7	23.5	26.4	26.2	28.1	26.0	28.0	24.3	25.6	24.5	24.5	x	21.6	23.7	22.9	24.1	23.3	21.3	23.7	24.1	26.7	24.4	26.4	26.4	23.6	28.3	25.3	30.8	x	27.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10377	Original post publication description: Central nervous system, morphology: Hippocampus granule cell density [n x10^3]	None	Central nervous system, morphology: Hippocampus granule cell density [n x10^3]	x	x	857.0	871.0	1040.0	849.0	859.0	x	974.0	936.0	756.0	985.0	850.0	880.0	907.0	892.0	1010.0	954.0	921.0	x	928.0	828.0	x	1053.0	782.0	837.0	932.0	900.0	905.0	860.0	970.0	822.0	850.0	897.0	837.0	x	793.0	793.0	853.0	x	748.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10378	Original post publication description: Central nervous system, morphology: Hippocampus granule cell number, unilateral [n x10^3]	None	Central nervous system, morphology: Hippocampus granule cell number, unilateral [n x10^3]	x	x	886.0	697.0	1067.0	639.0	835.0	x	1155.0	708.0	793.0	887.0	864.0	1019.0	766.0	x	800.0	1002.0	709.0	x	960.0	725.0	x	766.0	966.0	684.0	742.0	645.0	734.0	700.0	809.0	760.0	533.0	772.0	664.0	x	718.0	776.0	995.0	x	794.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10379	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	496.0	415.0	433.0	417.0	544.0	386.0	477.0	448.0	415.0	453.0	384.0	412.0	447.0	455.0	435.0	436.0	399.0	429.0	441.0	435.0	x	388.0	412.0	373.0	415.0	403.0	367.0	409.0	444.0	427.0	420.0	413.0	405.0	411.0	418.0	405.0	438.0	x	443.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10380	Original post publication description: B-mannosidase activity in liver of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C]	None	Biochemistry, protein activity, liver: B-mannosidase activity in liver of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C]	x	x	2.187	1.734	1.676	1.536	2.741	1.633	1.051	1.813	1.439	1.466	x	1.956	2.548	2.717	1.524	1.46	x	1.608	1.829	x	x	1.658	1.732	2.529	1.636	2.567	x	2.275	1.304	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10381	Original post publication description: B-mannosidase activity in kidney of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C]	None	Biochemistry, protein activity, kidney: B-mannosidase activity in kidney of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C]	x	x	2.71	1.505	3.341	2.011	3.473	3.29	0.03	3.558	1.68	2.027	x	2.643	3.093	1.42	2.097	0.299	x	2.062	3.789	x	x	2.808	1.679	4.234	2.001	3.614	x	3.252	1.479	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10382	Original post publication description: Raffinose bitter taste response (raffinose undecaacetate 0.4 mM in water), consumption [%]	None	Raffinose bitter taste response (raffinose undecaacetate 0.4 mM in water), consumption [%]	x	x	x	x	x	42.0	x	40.0	x	7.0	x	44.0	x	x	x	43.0	43.0	5.0	x	x	49.0	x	x	x	x	48.0	49.0	16.0	44.0	37.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10383	Original post publication description: Lactose sweet taste response (0.3 mM beta-lactose acetate in water), consumption [%]	None	Central nervous system, behavior, gustation: Lactose sweet taste response (0.3 mM beta-lactose acetate in water), consumption [%]	x	x	x	x	x	6.0	x	18.0	x	30.0	x	7.0	x	x	x	11.0	3.0	34.0	x	x	16.0	x	x	x	x	19.0	17.0	36.0	6.0	15.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10384	Original post publication description: Saccharin sweet taste response (3.2 mM in water), consumption [%]	None	Central nervous system, behavior, gustation: Saccharin sweet taste response (3.2 mM in water), consumption [%]	x	x	x	x	62.0	66.0	95.0	88.0	57.0	x	92.0	65.0	x	x	80.0	68.0	64.0	86.0	x	x	64.0	x	x	84.0	81.0	62.0	55.0	93.0	55.0	84.0	55.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10385	Original post publication description: Acesulfame sweet taste response (3.2 mM in water), consumption [%]	None	Central nervous system, behavior, gustation: Acesulfame sweet taste response (3.2 mM in water), consumption [%]	x	x	x	x	53.0	57.0	93.0	82.0	58.0	x	89.0	57.0	x	x	81.0	57.0	60.0	77.0	x	x	56.0	x	x	79.0	77.0	54.0	51.0	85.0	53.0	88.0	52.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10386	Original post publication description: Glycine (sweet) taste response (10 mM in water), consumption [%]	None	Glycine (sweet) taste response (10 mM in water), consumption [%]	x	x	x	x	6.0	32.0	8.0	34.0	13.0	x	7.0	31.0	x	x	4.0	33.0	45.0	7.0	x	x	42.0	x	x	4.0	9.0	35.0	36.0	4.0	35.0	39.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10387	Original post publication description: Seizure threshold pressure at compression rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) [atm]	None	Central nervous system, behavior: Seizure threshold pressure at compression rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) [atm]	x	x	89.1	69.9	89.7	89.0	71.5	x	81.8	82.9	74.5	77.0	x	83.0	81.7	72.0	88.9	85.8	84.9	89.0	x	82.0	x	72.9	76.7	74.5	84.3	89.9	73.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10388	Original post publication description: Seizure threshold pressure at compression rate of 1000 atm hr-1 (1000iPc) (also see McCall, 2011, 21384758) [atm]	None	Central nervous system, behavior: Seizure threshold pressure at compression rate of 1000 atm hr-1 (1000iPc) (also see McCall, 2011, 21384758) [atm]	x	x	79.8	62.6	65.9	80.6	67.6	x	77.4	66.7	66.1	67.3	x	68.8	79.9	67.6	71.4	80.0	77.9	77.2	x	80.5	x	65.3	63.4	67.4	71.1	78.7	64.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10389	Original post publication description: Central nervous system, auditory system, behavior: High frequency hearing loss, acoustic startle response to 5 kHz white-noise bursts at 100 dB SPL [g]	None	Central nervous system, auditory system, behavior: High frequency hearing loss, acoustic startle response to 5 kHz white-noise bursts at 100 dB SPL [g]	x	x	0.3	1.1	0.4	x	0.4	5.3	2.8	0.1	1.5	2.7	0.8	-0.1	1.8	4.9	0.1	6.4	x	-0.5	0.8	0.8	x	1.7	-0.4	8.8	-1.0	0.6	0.1	0.5	1.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10390	Original post publication description: High frequency hearing loss and cochlear pathology, acoustic startle response to 10 kHz white noise bursts at 100 dB [g]	None	Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology, acoustic startle response to 10 kHz white noise bursts at 100 dB [g]	x	x	14.7	10.2	6.7	x	5.2	19.4	6.2	2.1	6.0	11.5	6.4	4.9	11.0	13.9	2.5	9.4	x	1.8	3.4	1.3	x	10.8	3.8	42.2	10.0	4.0	11.7	7.6	4.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10391	Original post publication description: High frequency hearing loss and cochlear pathology; acoustic startle response to 15 kHz white-noise bursts at 100 dB SPL [g]	None	Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology; acoustic startle response to 15 kHz white-noise bursts at 100 dB SPL [g]	x	x	21.4	7.3	9.9	x	5.1	14.8	2.0	2.4	8.8	10.0	5.2	10.4	7.6	18.1	4.6	7.8	x	3.6	5.0	1.0	x	15.4	5.2	39.5	7.4	3.4	24.9	9.9	3.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10392	Original post publication description: High frequency hearing loss and cochlear pathology; acoustic startle response to 20 kHz white-noise bursts at 100 dB [g]	None	Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology; acoustic startle response to 20 kHz white-noise bursts at 100 dB [g]	x	x	9.1	6.3	6.4	x	3.4	13.0	2.1	2.2	6.4	10.6	5.2	8.5	8.6	14.7	2.0	4.7	x	5.5	4.1	1.2	x	11.0	3.6	31.6	7.4	3.6	17.4	7.8	2.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10393	Original post publication description: Audition and hearing, high frequency hearing loss and cochlear pathology, acoustic startle response to 25 kHz white-noise bursts at 100 dB SPL [g]	None	Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology, acoustic startle response to 25 kHz white noise bursts at 100 dB SPL [g]	x	x	2.9	1.8	2.4	x	2.0	3.4	-0.4	1.4	2.1	4.1	2.2	1.0	4.6	10.4	0.9	1.4	x	-0.2	0.6	-0.5	x	-0.2	1.2	16.0	0.2	1.4	4.4	2.5	-0.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10394	Original post publication description: Acoustic startle response to a 110 dB SPL, 10 kHz tone without prepulse stimulus[g]	None	Central nervous system, behavior: Acoustic startle response to a 110 dB SPL, 10 kHz tone without prepulse stimulus[g]	x	x	23.6	14.1	23.5	x	10.7	30.7	10.3	5.6	17.2	14.2	16.3	18.3	14.4	26.2	6.7	18.9	x	7.9	7.9	2.1	x	26.4	14.2	57.3	10.6	24.7	15.1	20.7	18.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10395	Original post publication description: Central nervous system, auditory system: High frequency hearing loss and cochlear pathology, acoustic startle response to white-noise bursts at 110 dB SPL [force]	None	Central nervous system, auditory system: High frequency hearing loss and cochlear pathology, acoustic startle response to white-noise bursts at 110 dB SPL [force]	x	x	24.3	7.4	14.5	x	11.7	23.5	12.1	7.5	15.9	x	10.9	12.4	13.2	21.1	2.6	17.1	x	2.1	5.5	3.6	x	20.2	11.3	47.1	12.1	10.1	21.3	16.4	20.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10396	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 5 kHz, 80 dB prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 5 kHz, 80 dB prepulse stimulus [%]	x	x	50.8	24.4	31.6	x	34.8	17.5	36.3	40.7	9.9	x	35.3	-6.7	14.2	12.3	x	34.1	x	x	16.0	39.5	x	-14.6	19.0	11.6	19.0	31.5	-9.9	14.9	-10.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10397	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 10 kHz, 80 dB prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 10 kHz, 80 dB prepulse stimulus [%]	x	x	62.9	42.2	46.6	x	40.2	15.8	45.9	49.3	38.0	x	37.8	12.5	17.4	6.2	x	43.1	x	x	16.7	24.8	x	-2.7	27.4	20.6	39.1	37.5	-1.0	19.8	4.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10398	Original post publication description: Central nervous system, behavior: Prepulse inhibiition of the acoustic startle response to 110 dB SPL white-noise bursts, 15 kHz, 80 dB prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibiition of the acoustic startle response to 110 dB SPL white-noise bursts, 15 kHz, 80 dB prepulse stimulus [%]	x	x	46.0	45.9	40.8	x	54.7	25.5	27.0	37.5	33.3	x	25.6	-1.9	-10.6	6.6	x	22.4	x	x	15.6	59.4	x	17.1	41.0	4.5	29.8	46.2	14.8	18.8	-6.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10399	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 20 kHz, 80 dB prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 20 kHz, 80 dB prepulse stimulus [%]	x	x	40.6	9.2	31.6	x	23.0	15.3	13.6	21.7	25.7	x	11.8	-9.7	8.8	-7.3	x	7.1	x	x	9.6	31.9	x	-6.3	0.2	2.7	13.2	32.2	-2.6	13.1	-3.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10400	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 56 db SPL white-noise prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 56 db SPL white-noise prepulse stimulus [%]	x	x	26.8	2.1	44.0	x	25.9	13.4	60.1	35.7	13.3	35.4	30.4	27.9	13.7	9.8	59.5	8.4	x	44.7	36.2	x	x	15.1	39.1	4.9	25.1	3.4	35.8	15.2	17.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10401	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL 10 kHz tone, following a 68 db SPL white noise prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL 10 kHz tone, following a 68 db SPL white noise prepulse stimulus [%]	x	x	32.8	15.5	53.0	x	30.5	15.2	65.3	31.5	14.2	21.4	35.2	33.8	18.1	12.9	57.9	28.4	x	40.6	51.0	x	x	24.2	39.8	13.0	38.0	18.3	38.6	28.5	25.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10402	Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 80 db SPL white-noise prepulse stimulus [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 80 db SPL white-noise prepulse stimulus [%]	x	x	42.9	22.6	62.4	x	29.4	30.1	75.1	33.4	35.9	32.8	46.2	37.5	25.6	21.8	58.5	34.4	x	7.9	48.7	x	x	36.4	50.6	21.7	55.6	14.2	37.5	42.3	42.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10403	Original post publication description: Infectious disease, immune function: Theiler's murine encephalomyelitis virus (TMEV) susceptibility [% affected]	None	Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV) susceptibility [% affected]	x	x	x	x	56.0	11.0	73.0	x	11.0	63.0	84.0	100.0	0.0	0.0	0.0	x	53.0	10.0	x	0.0	10.0	0.0	x	93.0	10.0	88.0	0.0	0.0	67.0	89.0	20.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10404	Original post publication description: Infectious disease, immune function: Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease correlating with TMEV-specific DTH responsiveness [change in ear swelling (x10-4 in.)]	None	Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease correlating with TMEV-specific DTH responsiveness [change in ear swelling (x10-4 in.)]	x	x	4.2	16.9	12.4	4.3	16.1	x	10.0	19.2	x	x	x	4.9	7.7	x	22.1	0.2	x	x	x	0.9	x	32.8	3.5	x	2.4	6.5	x	17.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10405	Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm]	x	x	x	x	412.0	x	x	17161.0	795.0	38026.0	x	281.0	x	337.0	x	x	292.0	x	x	x	765.0	x	x	x	22049.0	29821.0	29808.0	x	15452.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10406	Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm]	x	x	x	x	260.0	x	x	11245.0	205.0	4758.0	x	194.0	x	220.0	x	x	156.0	x	x	x	432.0	x	x	x	11748.0	4883.0	15283.0	x	8478.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10407	Original post publication description: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [Thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [thymidine uptake cpm]	x	x	x	x	318.0	x	x	7345.0	336.0	12950.0	x	328.0	x	251.0	x	x	139.0	x	x	x	299.0	x	x	x	6293.0	4343.0	4662.0	x	5170.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10408	Original post publication description: Immune function, graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm]	None	Immune system: Graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm]	x	x	x	x	221.0	x	x	145.0	161.0	173.0	x	25194.0	x	x	x	x	17405.0	x	x	x	457.0	x	x	x	304.0	6760.0	8570.0	x	8299.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10409	Original post publication description: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [Thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [thymidine uptake cpm]	x	x	x	x	13801.0	x	x	463.0	235.0	407.0	x	387.0	x	359.0	x	x	424.0	x	x	x	38485.0	x	x	x	12698.0	134.0	158.0	x	47300.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10410	Original post publication description: Immune function: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake in cpm]	None	Immune system: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake in cpm]	x	x	x	x	21536.0	x	x	656.0	575.0	201.0	x	249.0	x	335.0	x	x	465.0	x	x	x	32232.0	x	x	x	20878.0	425.0	169.0	x	18342.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10411	Original post publication description: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm]	x	x	x	x	5234.0	x	x	3138.0	340.0	3766.0	x	5407.0	x	289.0	x	x	2580.0	x	x	x	5023.0	x	x	x	4804.0	2413.0	2244.0	x	4130.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10412	Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10 [thymidine uptake cpm]	None	Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10 [thymidine uptake cpm]	x	x	x	x	266.0	x	x	259.0	12535.0	7934.0	x	109.0	x	x	x	x	261.0	x	x	x	6819.0	x	x	x	14339.0	9057.0	18358.0	x	18635.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10413	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1) [log sec]	None	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Llat1 Table 1), males and females combined [log sec]	x	x	1.466	1.273	1.814	1.432	1.254	1.646	1.463	1.277	1.357	1.674	1.636	1.43	1.854	1.571	1.64	1.578	1.746	1.803	1.352	1.365	x	1.51	1.346	1.657	1.67	1.795	1.59	1.597	1.371	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10414	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2) [log sec]	None	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Llat2 Table 1), males and females combined [log sec]	x	x	1.169	1.179	1.483	1.244	1.094	1.405	1.444	1.257	1.176	1.427	1.505	1.395	1.603	1.414	1.463	1.565	1.51	1.551	1.176	1.341	x	1.204	1.169	1.337	1.392	1.587	1.26	1.513	1.219	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10415	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 3) [log sec]	None	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Llat3 Table 1), males and females combined [log sec]	x	x	1.147	1.198	1.425	1.195	1.051	1.134	1.282	1.002	1.037	1.249	1.33	1.141	1.422	1.344	1.336	1.401	1.298	1.325	1.079	1.314	x	1.397	1.041	1.137	1.264	1.393	1.202	1.505	1.009	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10416	Original post publication description: Locomotion, distance traveled in 30 min in open field, baseline [cm]	None	Locomotion, distance traveled in 30 min in open field, baseline [cm]	x	x	7281.6	8898.1	11964.4	x	8103.6	14430.4	x	6556.6	4687.7	8899.7	x	x	8686.1	5096.9	10100.3	x	x	x	x	x	x	x	x	6022.7	x	x	x	6449.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10417	Original post publication description: Cocaine response (dose), locomotion after injection, distance in 30 min [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (dose), locomotion after injection, distance in 30 min [cm]	x	x	7767.0	10920.7	13071.2	x	7896.4	14561.5	x	10946.6	8200.6	14453.1	x	x	12119.7	3038.8	10679.6	x	x	x	x	x	x	x	x	4284.8	x	x	x	5728.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10418	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for males and females [sec]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for males and females [sec]	x	x	19.1	24.3	22.6	19.4	18.3	19.8	28.6	19.8	18.1	24.5	23.9	24.6	18.3	15.1	25.9	16.1	x	20.9	24.6	15.9	x	x	24.2	20.4	18.3	17.9	18.9	13.0	13.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10419	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for females [sec]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for females [sec]	x	x	20.5	22.2	21.4	20.0	17.1	19.9	27.3	16.3	14.9	26.0	21.3	18.7	16.5	15.9	23.6	15.2	x	20.7	17.3	13.5	x	x	19.5	21.3	17.4	16.9	18.0	12.6	12.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10420	Original post publication description: Pain response, 54 degree C hot plate latencies baseline (before 3 min forced swim in 15 degree C water), male [seconds]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies baseline (before 3 min forced swim in 15 degree C water), male [seconds]	x	x	17.5	26.1	23.7	18.9	19.8	19.7	30.5	26.6	22.1	23.0	26.6	29.7	20.3	14.1	27.4	17.0	x	21.0	28.2	18.2	x	x	27.9	19.5	19.2	18.8	19.9	13.3	14.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10421	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latencies post-swim, male and female average [sec]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, 54 degree C hot plate latencies post-swim, male and female average [sec]	x	x	46.5	42.5	58.2	32.5	48.2	50.6	52.1	55.5	52.5	55.1	60.0	35.8	43.9	49.6	51.5	33.1	x	56.4	44.2	37.0	x	x	54.9	54.5	50.7	33.4	34.2	24.6	41.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10422	Original post publication description: Pain response, 54 degree C hot plate latencies post-swim in female [seconds]	None	Central nervous system, peripheral nervous system, behavior: Pain response, 54 degree C hot plate latencies post-swim in female [seconds]	x	x	46.7	39.1	58.1	29.6	51.6	51.3	54.2	53.2	54.5	55.4	60.0	30.0	39.4	50.2	47.7	34.0	x	60.0	31.7	31.5	x	x	57.1	60.0	47.1	33.4	28.0	14.7	44.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10423	Original post publication description: Pain response, 54 degree C hot plate latencies post-swim in male [sec]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies post-swim in male [sec]	x	x	46.2	45.6	58.3	35.1	44.2	49.9	49.1	60.0	49.8	54.7	60.0	40.9	48.8	48.8	53.9	32.1	x	52.7	50.5	42.6	x	x	53.2	48.9	54.3	33.5	40.1	32.3	38.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10424	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males and females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males and females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	x	x	68.7	52.2	95.0	34.3	74.3	78.6	79.5	90.4	83.6	82.9	100.0	41.6	64.3	77.0	77.2	40.1	x	x	6.28	50.3	x	x	86.5	87.2	79.2	39.8	41.9	25.5	59.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10425	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	x	x	67.8	47.2	95.3	26.2	81.5	80.0	83.8	86.2	88.2	82.3	99.7	33.8	55.2	77.7	68.7	43.9	x	x	40.3	41.2	x	x	94.0	99.7	71.4	38.5	28.3	5.6	65.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10426	Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]	x	x	71.0	58.3	96.5	43.2	66.9	77.6	76.4	60.1	79.3	84.6	102.0	50.0	74.6	78.7	84.3	37.7	x	x	75.5	60.4	x	x	81.8	76.5	88.4	41.5	57.8	45.0	54.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10427	Original post publication description: Infectious disease, immune function: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells [mean flourescence value=sum of products of each channel number times n cells in that channel divided by n cells counted]	None	Infectious disease, immune system: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells [mean flourescence value=sum of products of each channel number times n cells in that channel divided by n cells counted]	x	x	80.0	160.0	111.0	67.0	96.0	118.0	95.0	74.0	62.0	114.0	216.0	328.0	109.0	227.0	131.0	80.0	71.0	101.0	63.0	70.0	x	62.0	133.0	126.0	160.0	65.0	146.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10428	Original post publication description: Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level [mean fluorescence value=sum of products of each channel number times the number of spleen cells in that channel divided by the number of cells counted]	None	Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level [mean fluorescence value=sum of products of each channel number times the number of spleen cells in that channel divided by the number of cells counted]	x	x	120.0	464.0	261.0	104.0	156.0	189.0	180.0	151.0	126.0	291.0	430.0	493.0	250.0	345.0	340.0	107.0	143.0	215.0	110.0	194.0	x	120.0	308.0	208.0	405.0	110.0	451.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10429	Original post publication description: Metabolism, genetics, blood chemistry: Serum amyloid P component (APCS protein, endogenous SAP) level [ug/ml]	None	Metabolism, genetics, blood chemistry: Serum amyloid P component (APCS protein, endogenous SAP) level [ug/ml]	x	x	38.8	230.8	31.5	137.1	195.2	39.8	204.7	176.0	106.6	19.0	47.2	76.2	30.9	36.3	43.6	37.1	x	63.5	249.0	65.7	x	188.1	144.3	135.9	137.7	41.3	244.3	26.6	233.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10430	Original post publication description: Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm^3]	None	Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm^3]	x	x	x	x	x	x	15.2	x	x	32.3	17.6	100.1	x	x	x	x	x	x	x	x	x	x	x	52.4	29.9	x	41.1	x	x	145.8	33.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10431	Original post publication description: Cancer biology: Tumor growth 3 weeks post-implantation [mm3]	None	Cancer biology: Tumor growth 3 weeks post-implantation [mm3]	x	x	x	x	x	x	11.6	x	x	11.7	2.7	62.7	x	x	x	x	x	x	x	x	x	x	x	37.7	18.2	x	30.6	x	x	175.5	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10432	Original post publication description: Cancer biology: Tumor growth 7 weeks post-implantation [mm3]	None	Cancer biology: Tumor growth 7 weeks post-implantation [mm3]	x	x	x	x	x	x	92.3	x	x	0.0	3.3	62.1	x	x	x	x	x	x	x	x	x	x	x	26.9	0.0	x	26.9	x	x	856.7	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10433	Original post publication description: Immune function: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits]	None	Immune system, urogenital system: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits]	x	x	0.0	3.0	0.0	3.0	2.0	0.0	x	2.0	3.0	0.0	0.0	4.0	0.0	0.0	0.0	x	x	0.0	1.0	x	x	0.0	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10434	Original post publication description: Audiogenic seizure [% occurrence]	None	Audiogenic seizure [% occurrence]	x	x	2.0	91.0	0.0	92.0	68.0	0.0	23.0	93.0	21.0	0.0	0.0	8.0	94.0	0.0	0.0	35.0	x	92.0	x	40.0	x	22.0	0.0	29.0	22.0	0.0	0.0	x	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10435	Original post publication description: Audiogenic seizure severity, mean [ordinal scale]	None	Audiogenic seizure severity, mean [ordinal scale]	x	x	0.07	1.88	0.2	1.92	1.64	0.14	0.57	1.85	1.04	0.3	0.1	0.33	1.94	0.21	0.07	0.73	x	1.92	x	1.16	x	1.09	0.36	1.29	1.0	0.09	0.0	x	1.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10436	Original post publication description: Central nervous system, morphology: Cerebellum fissure number (vermis, midsagittal section, intraculminate fissure variation) [n]	None	Central nervous system, morphology: Cerebellum fissure number (vermis, midsagittal section, intraculminate fissure variation) [n]	x	x	10.0	9.0	9.95	6.19	8.41	10.27	9.1	9.89	8.83	7.33	9.5	9.1	9.13	8.57	10.25	8.4	9.2	8.83	9.0	10.13	x	9.4	8.06	8.96	10.07	9.0	9.0	7.25	8.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10437	Original post publication description: Audiogenic seizure-mean severity score in response to pure tone [severity of seizure]	None	Audiogenic seizure-mean severity score in response to pure tone [severity of seizure]	x	x	0.07	1.88	0.2	1.92	1.64	0.14	0.57	1.85	1.04	0.3	0.1	0.33	1.94	0.21	0.07	0.73	x	1.92	x	1.16	x	1.09	0.36	1.29	1.0	0.09	0.0	x	1.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10438	Original post publication description: Audiogeneic seizure-relative frequency of seizures [%]	None	Audiogeneic seizure-relative frequency of seizures [%]	x	x	2.0	91.0	0.0	92.0	68.0	0.0	23.0	93.0	21.0	0.0	0.0	8.0	94.0	0.0	0.0	35.0	x	92.0	x	40.0	x	22.0	0.0	29.0	22.0	0.0	0.0	x	94.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10439	Original post publication description: Lung, pulmonary function, immune function: Airway bronchial constrictor response after exposure to atracurium [airway pressure time index, cmH2O/s]	None	Pulmonary system, immune system: Airway bronchial constrictor response after exposure to atracurium, airway pressure time index [cmH2O/s]	x	x	86.0	404.0	109.0	142.0	65.0	169.0	247.0	273.0	107.0	408.0	281.0	53.0	462.0	521.0	164.0	84.0	x	317.0	54.0	x	x	83.0	984.0	570.0	291.0	102.0	346.0	304.0	142.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10440	Original post publication description: Cardiovascular system, blood chemistry: Red blood cell osmotic fragility [% lysis of red cells at 0.425% NaCl]	None	Cardiovascular system, blood chemistry: Red blood cell osmotic fragility [% lysis of red cells at 0.425% NaCl]	x	x	59.8	16.1	51.8	43.7	30.8	40.0	35.9	23.9	42.9	17.9	x	34.1	16.0	50.8	32.9	48.0	x	27.0	40.0	22.1	x	30.7	33.1	57.6	37.0	36.0	30.0	8.0	32.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10441	Original post publication description: Anti-F antigen (liver protein) titer, experiment 1 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen]	None	Anti-F antigen (liver protein) titer, experiment 1 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen]	x	x	x	x	x	0.83	2.4	x	1.27	x	x	3.25	x	x	x	3.49	2.96	x	x	x	3.4	x	x	3.39	3.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10442	Original post publication description: Anti-F antigen (liver protein) titer, experiment 2 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen]	None	Anti-F antigen (liver protein) titer, experiment 2 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen]	x	x	x	x	x	1.07	x	x	1.03	x	2.36	1.76	1.65	x	x	1.81	1.92	0.76	x	x	2.41	x	x	2.11	2.31	x	x	x	2.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10443	Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in males corrected for whole body weight [mg/cm2]	None	Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in males corrected for whole body weight [mg/cm2]	x	x	65.8	65.6	62.2	59.5	x	66.8	x	x	56.9	63.5	x	58.2	x	60.4	57.4	57.2	x	59.1	x	x	x	59.7	60.5	56.6	59.9	57.2	56.7	60.6	65.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10444	Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in females corrected for whole body weight [mg/cm2]	None	Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in females corrected for whole body weight [mg/cm2]	x	x	65.5	67.8	59.7	61.3	x	60.1	x	x	60.4	58.8	x	64.0	x	56.4	61.8	61.2	x	59.7	x	x	x	60.2	60.0	56.7	58.5	58.8	58.5	66.2	58.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10445	Original post publication description: Central nervous system, behavior: Fear response control (unconditioned auditory stimulus stimulus, US) in a contextualized fear conditioning paradigm [% freezing]	None	Central nervous system, behavior: Fear response control (unconditioned auditory stimulus stimulus, US) in a contextualized fear conditioning paradigm [% freezing]	x	x	70.0	60.0	62.0	45.0	x	20.0	51.0	60.0	100.0	40.0	64.0	32.0	x	18.0	x	20.0	x	67.0	61.0	64.0	x	41.0	50.0	53.0	61.0	64.0	62.0	x	65.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10446	Original post publication description: Central nervous system, behavior: Fear response to context [% freezing]	None	Central nervous system, behavior: Fear response to context [% freezing]	x	x	38.0	15.0	23.0	23.0	x	10.0	29.0	10.0	38.0	10.0	38.0	10.0	x	23.0	x	11.0	x	23.0	35.0	50.0	x	20.0	15.0	40.0	38.0	5.0	23.0	x	45.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10447	Original post publication description: Central nervous system, behavior: Fear response to preconditioned (altered) context stimulus [% freezing]	None	Central nervous system, behavior: Fear response to preconditioned (altered) context stimulus [% freezing]	x	x	32.0	10.0	5.0	11.0	x	5.0	30.0	15.0	22.0	7.0	20.0	6.0	x	17.0	x	6.0	x	27.0	35.0	35.0	x	15.0	10.0	32.0	32.0	0.0	5.0	x	40.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10448	Original post publication description: ATPase activity (total activity) for whole brain homogenate [umol Pi/h/mg protein]	None	ATPase activity (total activity) for whole brain homogenate [umol Pi/h/mg protein]	x	x	7.94	6.71	7.29	6.52	7.07	7.1	x	7.69	7.45	6.42	6.32	x	6.81	9.03	x	x	x	x	x	7.31	x	x	x	x	8.61	6.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10449	Original post publication description: ATPase activity (Mg2+ ATPase, magnesium ATPase, Mg-ATPase) for whole brain homogenate [umol Pi/h/mg protein]	None	Central nervous system, biochemistry: ATPase activity (Mg2+ ATPase, magnesium ATPase, Mg-ATPase) for whole brain homogenate [umol Pi/h/mg protein]	x	x	4.66	3.34	3.78	3.72	4.01	3.9	x	3.58	4.31	3.64	3.66	x	3.71	5.02	x	x	x	x	x	4.16	x	x	x	x	4.6	4.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10450	Original post publication description: ATPase activity (Na+/K+-ATPase, sodium-potassium ATPase, sodium-potassium pump) for whole brain homogenate [umol Pi/h/mg protein]	None	ATPase activity (Na+/K+-ATPase, sodium-potassium ATPase, sodium-potassium pump) for whole brain homogenate [umol Pi/h/mg protein]	x	x	3.28	3.37	3.51	2.92	3.06	3.2	x	4.11	3.14	2.79	2.66	x	3.1	4.01	x	x	x	x	x	3.15	x	x	x	x	4.01	2.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10451	Original post publication description: Seizure susceptibility, audiogenic seizure severity [scale]	None	Seizure susceptibility, audiogenic seizure severity [scale]	x	x	0.07	1.89	0.2	1.92	1.64	0.14	x	1.85	1.04	0.3	0.09	x	1.78	0.21	x	x	x	x	x	1.16	x	x	x	x	1.0	0.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10452	Original post publication description: Seizure susceptibility, Clonic-tonic audiogenic seizure [%]	None	Seizure susceptibility, Clonic-tonic audiogenic seizure [%]	x	x	1.8	91.4	0.0	92.0	68.0	0.0	x	93.0	21.0	0.0	0.0	x	82.2	0.0	x	x	x	x	x	40.0	x	x	x	x	22.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10453	Original post publication description: Control vehicle response ( 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion using Accuscan activity monitors between day 3 (third vehicle injection) and day 2 (vehicle baseline) [cm/30 min test]	None	Control vehicle response ( 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion using Accuscan activity monitors between day 3 (third vehicle injection) and day 2 (vehicle baseline) [cm/30 min test]	x	x	-88.0476	-640.6	-321.125	-1170.3	-1008.17	-1589.12	-174.154	-816.0	-483.929	-923.833	-25.8182	-1479.08	-1180.15	-207.917	-535.615	276.067	x	-408.769	-408.692	x	x	-204.5	-1464.23	285.214	-521.462	-1958.2	-312.615	-524.462	-620.227	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10454	Original post publication description: Allopregnanolone response (10 mg/kg 3a-hydroxy-5a-pregnan-20-one, THP, in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitors between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test]	None	Central nervous system, behavior, pharmacology: Allopregnanolone response (10 mg/kg 3a-hydroxy-5a-pregnan-20-one, THP, in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitors between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test]	x	x	3477.6	3019.9	598.467	2017.67	846.308	1093.14	1020.0	1203.59	674.0	1166.06	1419.27	1484.75	1831.77	3109.76	1081.69	2940.64	x	994.917	1652.58	x	x	337.091	523.692	801.714	1036.23	1559.0	11.0	393.667	694.458	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10455	Original post publication description: Allopregnanolone response (17 mg/kg 3a-hydroxy-5a-pregnan-20-one in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitor between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test]	None	Allopregnanolone response (17 mg/kg 3a-hydroxy-5a-pregnan-20-one in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitor between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test]	x	x	2414.73	5722.41	2639.67	4524.91	2317.92	3171.17	3867.77	3759.94	4051.0	3099.88	2904.92	2294.17	3454.23	4645.22	5758.31	5285.5	x	4636.69	3529.08	x	x	3781.0	4282.14	6489.57	428.167	5010.5	6124.31	2913.08	4020.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10456	Original post publication description: Central nervous system, morphology: Hippocampus volume, total [mm^3]	None	Central nervous system, morphology: Hippocampus volume, total [mm^3]	x	x	28.0	24.3	28.4	22.4	26.7	x	28.0	22.5	25.7	25.3	23.7	24.6	27.0	22.7	24.5	27.4	21.7	x	26.8	23.6	x	23.6	22.5	20.4	21.3	20.4	18.9	23.7	26.6	21.6	20.5	23.0	23.6	x	24.1	22.2	27.4	x	25.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10457	Original post publication description: Central nervous system, morphology: Hippocampus proper volume [mm^3]	None	Central nervous system, morphology: Hippocampus proper volume [mm^3]	x	x	22.4	19.7	23.0	18.7	21.4	x	22.3	18.1	21.3	20.5	19.2	19.7	21.9	18.9	19.6	22.2	17.6	x	21.3	19.2	x	19.3	18.2	16.7	17.1	16.3	15.2	19.3	21.6	17.5	16.8	18.5	19.3	x	19.8	17.9	22.2	x	20.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10458	Original post publication description: Central nervous system, morphology: Hippocampus pyramidal cell layer volume, unilateral [mm^3]	None	Central nervous system, morphology: Hippocampus pyramidal cell layer volume, unilateral [mm^3]	x	x	1.41	1.18	1.68	1.42	1.6	x	1.69	1.38	1.6	1.58	1.46	1.61	1.58	1.37	1.55	1.74	1.16	x	1.49	1.44	x	1.47	1.43	1.336	1.33	1.15	1.24	1.43	1.48	1.39	1.38	1.38	1.46	x	1.64	1.23	1.65	x	1.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10459	Original post publication description: Central nervous system, morphology: Hippocampus dentate gyrus granule cell layer volume, unilateral [mm^3]	None	Central nervous system, morphology: Hippocampus dentate gyrus granule cell layer volume, unilateral [mm^3]	x	x	1.09	0.75	1.06	0.75	0.99	x	1.13	0.85	1.0	0.87	0.95	1.1	0.85	0.5	0.87	0.97	0.75	x	1.01	0.8	x	0.84	0.94	0.75	0.84	0.69	0.79	0.78	0.91	0.74	0.66	0.85	0.76	x	0.84	0.96	1.04	x	1.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10460	Original post publication description: Central nervous system, morphology: Hippocampus dentate gyrus volume [mm^3]	None	Central nervous system, morphology: Hippocampus dentate gyrus volume [mm^3]	x	x	5.63	4.55	5.44	3.74	5.31	x	5.71	4.39	4.45	4.72	4.52	4.95	5.17	3.86	4.86	5.25	4.05	x	5.47	4.35	x	4.39	4.3	3.7	4.21	4.07	3.74	4.37	4.94	4.13	3.69	4.55	4.3	x	4.38	4.23	5.19	x	5.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10461	Original post publication description: Metabolism, morphology: Body weight, average males and females [g]	None	Metabolism, morphology: Body weight, average males and females [g]	x	x	28.6	25.9	20.7	21.9	28.3	x	24.3	23.9	19.1	23.2	23.1	23.2	28.7	23.5	22.0	21.2	21.7	x	25.5	18.3	x	25.8	15.7	23.5	21.3	16.9	18.2	22.0	25.3	20.5	23.5	19.9	19.7	x	20.2	18.5	18.5	x	21.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10462	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	477.4	401.4	458.0	426.6	544.9	x	424.8	434.9	429.0	438.4	417.7	444.4	453.1	435.6	418.0	425.4	392.2	x	458.2	414.1	x	408.1	391.9	358.0	395.4	371.7	361.2	402.2	446.0	429.2	413.5	410.0	409.3	x	415.6	396.6	429.7	x	454.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10463	Original post publication description: Morphology, immune system: Thymus to body size ratio [x10^3]	None	Morphology, immune system: Thymus to body size ratio [x10^3]	x	x	x	x	1.8	0.82	1.1	1.72	0.91	1.7	1.14	1.11	1.72	0.95	x	1.1	0.9	2.17	x	1.05	1.2	x	x	1.12	x	x	x	1.25	1.16	1.82	1.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10464	Original post publication description: Immune function: T cell receptor expression, V-gamma-1 positive, V-gamma-4 positive, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%]	None	Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 positive T cells) [%]	x	8.0	3.0	6.0	14.75	1.5	3.25	4.75	4.25	6.25	2.25	10.75	8.75	7.5	2.25	2.75	8.75	1.5	x	2.75	3.75	10.75	x	3.25	19.25	1.5	2.25	8.75	9.0	4.25	4.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10465	Original post publication description: Immune function: T cell receptor expression, V-gamma-7 positive and V-gamma-4] positive percentage of total gamma-delta intestinal intraepithelial lymphocytes [%]	None	Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 positive T cells) [%]	x	6.5	21.5	8.5	26.5	6.0	13.0	5.0	7.5	9.0	9.0	8.5	13.0	3.5	8.5	9.5	7.5	9.0	x	12.0	22.5	20.5	x	19.5	15.0	16.5	30.5	6.0	21.5	7.5	8.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10466	Original post publication description: Immune function: T cell receptor expression, V-gamma-7 positive, Vgamma-4 negative, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%]	None	Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 negative T cells) from Fig 4 y-axis [%]	x	31.0	40.5	31.0	24.0	49.5	21.0	17.5	57.0	27.5	36.5	27.5	43.0	38.0	52.5	34.0	26.0	58.5	x	22.0	26.0	41.0	x	34.0	24.0	29.5	31.5	43.0	27.5	31.5	22.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10467	Original post publication description: Immune function: T cell receptor expression, V-gamma-1 positive, V-gamma-4 negative, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%]	None	Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 negative T cells) from Fig 4 x-axis [%]	x	47.0	26.0	45.0	36.5	34.5	55.5	67.5	39.0	55.5	49.0	49.0	31.0	41.5	33.5	61.5	51.0	33.5	x	57.5	41.5	35.5	x	34.0	35.5	44.0	40.0	32.0	36.5	51.0	54.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10469	Original post publication description: Morphine response (0.3 to 0.7 mg/ml p.o.), consumption using two-bottle choice test [ml/test period]	None	Central nervous system, pharmacology, behavior: Morphine response (0.3 to 0.7 mg/ml p.o.), consumption using two-bottle choice test [ml/test period]	x	x	157.0	16.0	16.0	42.0	84.0	50.0	27.0	27.0	x	97.0	29.0	23.0	148.0	16.0	17.0	x	x	19.0	96.0	19.0	x	99.0	52.0	71.0	49.0	97.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10470	Original post publication description: Quinine response, consumption using two-bottle choice test (quinine at 0.1 to 0.4 mg/ml) [ml/test period]	None	Central nervous system, gustatory system, behavior: Quinine response, consumption using two-bottle choice test (quinine at 0.1 to 0.4 mg/ml) [ml/test period]	x	x	36.0	24.0	32.0	12.0	135.0	20.0	13.0	10.0	x	11.0	17.0	17.0	62.0	5.0	27.0	x	x	11.0	9.0	19.0	x	58.0	85.0	25.0	39.0	88.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10471	Original post publication description: Saccharin response, consumption using two-bottle choice test (concentration) [ml/test period]	None	Saccharin response, consumption using two-bottle choice test (concentration) [ml/test period]	x	x	806.5	383.0	352.0	459.5	1178.5	544.5	342.0	343.0	x	410.5	258.5	528.0	484.0	353.5	410.0	x	x	332.5	261.5	417.5	x	442.5	453.5	365.0	472.0	536.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10472	Original post publication description: Saccharin response, preference using two-bottle choice test [ratio relative tap water]	None	Saccharin response, preference using two-bottle choice test [ratio relative tap water]	x	x	0.95	0.715	0.79	0.765	0.915	0.9	0.715	0.695	x	0.765	0.6675	0.805	0.86	0.77	0.765	x	x	0.615	0.641	0.84	x	0.8965	0.717	0.7255	0.873	0.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10473	Original post publication description: Saccharin response, consumption using a two-bottle choice test (0.2%, mg/kg) vs. tap water, mean of day 2 and day 4 over a 4-day 24-hr access period [g/kg/day]	None	Central nervous system, gustatory system, behavior: Saccharin response, consumption using a two-bottle choice test (0.2%, mg/kg) vs. tap water, mean of day 2 and day 4 over a 4-day 24-hr access period [g/kg/day]	x	x	853.935	471.707	x	250.743	748.408	787.394	x	330.42	x	343.077	420.033	537.171	652.835	415.414	412.785	639.584	x	533.912	x	438.621	x	674.217	807.822	534.837	x	1071.04	x	591.661	572.167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10474	Original post publication description: Ethanol response (3%, g/kg in tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (3%, g/kg in tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	x	x	3.538	0.279	x	2.052	1.669	2.086	x	0.981	x	2.765	0.438	0.906	3.578	2.218	0.951	2.975	x	0.967	x	1.64	x	0.614	1.741	2.159	x	2.795	x	2.658	0.819	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10475	Original post publication description: Ethanol response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	None	Ethanol response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	x	x	10.965	2.0	x	6.135	11.207	7.023	x	2.924	x	4.828	6.245	6.159	7.236	5.58	3.274	5.534	x	5.473	x	11.658	x	6.992	8.083	6.646	x	10.266	x	7.308	4.638	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10476	Original post publication description: Ethanol response (10%, g/kg in tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	x	x	10.562	1.306	x	6.084	5.506	4.425	x	0.601	x	2.759	0.687	1.741	5.836	4.849	0.364	2.477	x	2.589	x	2.203	x	2.417	2.024	6.658	x	2.466	x	8.096	1.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10477	Original post publication description: Ethanol response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	None	Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]	x	x	18.194	1.05	x	11.378	13.58	12.161	x	1.98	x	6.256	6.588	5.727	14.376	11.1	3.678	6.692	x	8.083	x	15.58	x	10.256	10.05	12.975	x	13.02	x	12.737	4.135	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10478	Original post publication description: Ethanol response, withdrawal severity, handling-induced convulsion (HIC) score [corrected area under the HIC curve after voluntary ethanol consumption]	None	Central nervous system, pharmacology, behavior: Ethanol response, withdrawal severity, handling-induced convulsion (HIC) score [corrected area under the HIC curve after voluntary ethanol consumption]	x	x	5.66	2.61	x	0.52	2.18	5.69	x	0.6	x	1.64	1.05	1.17	3.21	4.68	0.48	0.0	x	4.82	x	1.26	x	1.75	2.33	3.3	x	3.42	x	0.31	1.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10479	Original post publication description: Ethanol response (10%, g/kg in tap water), preference using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [ratio of consumption]	None	Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), preference using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [ratio of consumption]	x	x	0.554	0.086	x	0.32	0.35	0.251	x	0.051	x	0.168	0.045	0.061	0.356	0.302	0.024	0.167	x	0.146	x	0.127	x	0.265	0.171	0.428	x	0.14	x	0.488	0.112	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10480	Original post publication description: Water response, consumption using a two-bottle choice test offered vs. 10% ethanol [ml]	None	Water response, consumption using a two-bottle choice test offered vs. 10% ethanol [ml]	x	x	4.82	2.25	x	4.65	3.54	3.75	x	4.23	x	3.06	4.64	6.82	3.55	4.13	4.95	4.65	x	4.45	x	4.54	x	2.35	3.63	3.05	x	5.55	x	2.36	5.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10481	Original post publication description: Water response, consumption using a two-bottle choice test offered vs. 0.2% saccharin [ml]	None	Water response, consumption using a two-bottle choice test offered vs. 0.2% saccharin [ml]	x	x	1.4	0.38	x	4.75	1.86	0.11	x	0.73	x	1.1	0.49	1.79	0.79	1.51	0.7	1.08	x	0.39	x	2.6	x	0.09	0.2	0.6	x	0.49	x	1.41	0.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10482	Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion in saline control group between day 11 (first and only ethanol injection) and day 3 (saline treatment) 1- 5 min after injection [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injections, difference between day 2 saline control and day 11 ethanol injection (first and only ethanol injection) in young adult control saline (CS) females (ACCS) [cm]	x	x	546.0	973.0	-241.0	725.0	-208.0	-493.0	1185.0	358.0	921.0	387.0	662.0	813.0	-266.0	38.0	726.0	x	x	1074.0	454.0	996.0	x	194.0	1242.0	837.0	529.0	309.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10483	Original post publication description: Ethanol response (2 g/kg ip), locomotor sensitization measured as difference between groups treated over 10 days with ip ethanol or saline to final acute ethanol test on day 11, 1-5 min after injection [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol, difference in locomotor activity between saline control group (CS) and ethanol treated group (CD) to final acute ethanol test on day 11 (deltaBG) [cm]	x	x	-694.0	-134.0	-468.0	507.0	435.0	395.0	-558.0	663.0	456.0	-372.0	1226.0	275.0	176.0	1026.0	1065.0	x	x	696.0	-62.0	758.0	x	935.0	430.0	388.0	677.0	356.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10484	Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion (sensitization or habituation) in chronic ethanol group between day 11 (fifth treatment) and day 3 (saline treatment), 1 to 5 min after injection [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol (CD group), difference in locomotor activity between fifth ethanol treatment (day 11) and first ethanol treatment (day 3), 1- 5 min after injections in young adult females (Figure 2 of paper, deltaCD) [cm]	x	x	-318.0	-725.0	-866.0	260.0	279.0	-51.0	-1013.0	1060.0	726.0	-297.0	644.0	-46.0	365.0	433.0	1119.0	x	x	682.0	39.0	1125.0	x	899.0	252.0	402.0	586.0	192.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10485	Original post publication description: Ethanol response (2 g/kg ip), difference in acute locomotion, 1-5 min after injection in chronic ethanol-sensitized group [cm/test period]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injection, difference between day 2 saline injection response and day 3 ethanol injection in young adult females (Figure 1 of paper, ACCD) [cm]	x	x	84.0	1521.0	268.0	843.0	-174.0	-36.0	1587.0	-162.0	924.0	504.0	976.0	1157.0	-204.0	649.0	675.0	x	x	1026.0	163.0	644.0	x	45.0	1445.0	891.0	747.0	382.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10486	Original post publication description: Saline response (baseline), locomotor activity on day 2, 1 to 5 min after injection [cm]	None	Central nervous system, behavior: Acute locomotor baseline activity response (horizontal distance), 1-5 min after saline injection on day 2 in young adult females (BASACT in the CD group) [cm]	x	x	1447.0	1362.0	1661.0	1528.0	1086.0	1162.0	886.0	1845.0	573.0	1643.0	1175.0	1729.0	1171.0	1035.0	2014.0	x	x	1411.0	949.0	1264.0	x	823.0	1360.0	1074.0	899.0	2146.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10487	Original post publication description: Saline response (vehicle ip), locomotion (baseline) on day 2 using Accuscan activity monitors, mean of all mice regardless of subsequent treatment [cm/15 min test]	None	Central nervous system, behavior: Saline control response (vehicle ip), locomotion (baseline) on day 2 using Accuscan activity monitors, mean all cases [cm/15 min test]	x	x	2826.82	2799.72	3664.41	2743.58	2678.95	2617.88	2099.21	4694.2	1362.02	3449.32	2847.36	3622.44	3085.52	1983.13	4519.18	3043.59	x	2886.95	2093.05	2820.62	x	1630.07	2906.81	2545.33	1674.5	5521.39	3115.33	2654.05	3486.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10488	Original post publication description: Cocaine response (10 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	None	Cocaine response (10 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	x	x	2961.25	3386.93	8506.82	4132.17	3241.0	3306.25	3463.42	5637.17	1755.69	7339.0	3957.9	3418.67	3078.09	99.667	5716.33	7159.5	x	5805.08	5342.25	5091.12	x	1101.55	4192.42	4569.42	2988.67	3540.61	5187.23	4367.27	5093.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10489	Original post publication description: Cocaine response (40 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	None	Cocaine response (40 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	x	x	12932.8	12608.9	15426.9	14007.7	4837.0	12578.4	8107.42	13238.8	7105.69	10082.5	7614.1	8616.09	6817.5	5307.42	12385.7	14297.8	x	10363.3	12060.9	13099.3	x	2832.9	7053.0	14651.7	10958.5	11884.2	8294.15	15252.9	10339.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10490	Original post publication description: Cocaine response (10 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	None	Cocaine response (10 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	x	x	3823.0	4570.71	6091.36	2503.73	3704.73	6180.0	2812.92	4479.33	1517.23	1760.83	4708.0	3883.5	3864.5	893.083	3789.0	8423.75	x	5866.08	4600.0	2285.5	x	2925.82	4008.58	5286.58	4198.75	-1518.92	2158.0	3725.27	4234.82	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10491	Original post publication description: Cocaine response (40 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	None	Cocaine response (40 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	x	x	-1069.33	1470.4	5966.54	-2287.75	4268.08	1017.15	3505.17	2721.33	872.615	-4245.61	7010.8	993.364	471.5	3670.33	3281.25	5300.33	x	3580.83	-2874.44	2053.14	x	4624.7	-2123.3	-3130.7	2830.69	-283.833	4110.54	2393.42	3420.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10492	Original post publication description: Cocaine response (5 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	None	Cocaine response (5 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]	x	x	3395.42	3456.86	3015.25	1590.0	1287.44	1901.92	1616.5	3988.67	1729.25	1232.5	2971.5	1963.64	644.25	1597.23	630.455	3115.23	x	1851.83	1931.12	3096.71	x	1753.18	2246.25	4200.31	3825.54	1217.45	3591.33	1692.82	4256.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10493	Original post publication description: Cocaine response (5 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	None	Cocaine response (5 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]	x	x	1297.67	2004.0	2726.25	2301.0	412.6	4.692	1229.42	3147.42	-468.417	1689.25	1944.4	2009.08	916.25	52.385	3776.46	2880.23	x	2212.25	745.5	1521.43	x	-139.818	1853.67	141.385	1411.23	571.364	1223.25	1440.36	317.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10494	Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) following ethanol injection, day 3 (first treatment) minus day 2 (saline baseline) in the chronic ethanol group [beam breaks/10 min test]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) following ethanol injection, day 3 (first treatment) minus day 2 (saline baseline) in the chronic ethanol group [beam breaks/10 min test]	x	x	-18.0	151.0	96.0	350.0	-227.0	-401.0	88.0	x	188.0	-128.0	353.0	79.0	78.0	-67.0	269.0	541.0	x	562.0	-117.0	-37.0	x	-44.0	241.0	608.0	-23.0	58.0	947.0	-142.0	-345.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10495	Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n beam breaks/10 min test]	None	Ethanol response (2 g/kg ip), difference in locomotion between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n beam breaks/10 min test]	x	x	-105.0	272.0	68.0	304.0	-426.0	-443.0	170.0	x	262.0	33.0	524.0	-68.0	3.0	-214.0	213.0	780.0	x	428.0	8.0	-23.0	x	79.0	247.0	687.0	-30.0	538.0	979.0	-13.0	-379.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10496	Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [beam breaks/10 min test]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [beam breaks/10 min test]	x	x	20.0	265.0	164.0	-238.0	254.0	214.0	121.0	x	395.0	201.0	516.0	119.0	210.0	386.0	482.0	234.0	x	136.0	234.0	360.0	x	98.0	548.0	-140.0	428.0	982.0	261.0	205.0	466.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10497	Original post publication description: Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic drug group [n grid test errors/10 min test]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic drug group [n grid test errors/10 min test]	x	x	114.0	123.0	135.0	187.0	86.0	103.0	143.0	x	129.0	154.0	191.0	165.0	138.0	227.0	320.0	289.0	x	186.0	108.0	165.0	x	132.0	151.0	185.0	152.0	298.0	159.0	164.0	109.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10498	Original post publication description: Ethanol response (2 g/kg ip), acute ataxia measured using using grid test (Accuscan activity monitor), difference between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n errors/activity counts/10 min test]	None	Ethanol response (2 g/kg ip), acute ataxia measured using using grid test (Accuscan activity monitor), difference between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n errors/activity counts/10 min test]	x	x	116.0	168.0	150.0	199.0	91.0	111.0	201.0	x	153.0	140.0	230.0	210.0	129.0	195.0	287.0	351.0	x	175.0	110.0	185.0	x	106.0	172.0	256.0	130.0	337.0	212.0	171.0	107.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10499	Original post publication description: Ethanol response (2 g/kg ip), difference in missteps using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [n/10 min test]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), intoxication and adaptation measured as difference in missteps using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [n/10 min test]	x	x	-33.0	-40.0	33.0	-83.0	-13.0	-14.0	-18.0	x	-43.0	-40.0	64.0	-5.0	-13.0	-30.0	83.0	-34.0	x	-33.0	-10.0	-8.0	x	-69.0	-7.0	4.0	66.0	-63.0	-57.0	-24.0	47.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10500	Original post publication description: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between acute ethanol on day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic ethanol group [n errors/activity counts/10 min test]	None	Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between acute ethanol on day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic ethanol group [n errors/activity counts/10 min test]	x	x	17.6	11.4	14.8	20.8	18.1	25.2	18.5	x	14.9	17.6	18.0	19.7	17.7	47.6	26.4	22.9	x	14.5	19.8	26.3	x	33.7	14.0	14.3	24.4	16.9	9.0	29.9	24.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10501	Original post publication description: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between injection on day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [errors/activity counts/10 min test]	None	Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between injection on day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [errors/activity counts/10 min test]	x	x	15.9	14.7	14.3	19.9	26.0	27.5	22.7	x	18.2	15.1	18.1	26.0	17.5	47.5	24.5	24.5	x	16.1	17.4	27.3	x	27.1	17.9	18.5	22.1	17.6	11.1	32.7	22.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10502	Original post publication description: Ethanol response, change in ataxic effects of 2 g/kg (ip) after repeated treatment, difference between day 11 (fifth treatment) minus day 3 (first treatment) in the chronic drug (CD) group, 10 min test [grid test inside accuscan activity monitors]	None	Ethanol response, change in ataxic effects of 2 g/kg (ip) after repeated treatment, difference between day 11 (fifth treatment) minus day 3 (first treatment) in the chronic drug (CD) group, 10 min test [grid test inside accuscan activity monitors]	x	x	-6.9	-5.1	0.3	-8.0	-6.8	-11.2	-2.8	x	-8.0	-8.2	-1.3	-5.4	-5.3	-23.5	-0.6	-5.3	x	-3.8	-8.4	-10.2	x	-22.3	-5.8	0.8	-2.7	-8.6	-4.6	-12.4	-7.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10503	Original post publication description: Saline response (vehicle ip control), baseline locomotor activity using grid test on day 2 after injection [n beam breaks/10 min test]	None	Saline response (vehicle ip control), baseline locomotor activity using grid test on day 2 after injection [n beam breaks/10 min test]	x	x	825.0	877.0	975.0	795.0	756.0	873.0	705.0	x	641.0	1040.0	725.0	971.0	766.0	621.0	967.0	762.0	x	721.0	700.0	790.0	x	510.0	813.0	762.0	645.0	1596.0	814.0	693.0	887.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10504	Original post publication description: Audiogenic seizure susceptibility at 21 days [severity of seizure]	None	Audiogenic seizure susceptibility at 21 days [severity of seizure]	x	x	0.25	2.75	0.25	2.25	2.25	0.25	1.75	2.75	1.25	0.25	0.25	0.25	2.75	0.25	x	1.25	x	2.75	x	1.25	x	1.25	0.25	1.75	1.25	0.25	0.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10505	Original post publication description: Open-field activity following saline injection [number of crossings during 3 min]	None	Central nervous system, behavior: Open-field activity following saline injection [number of crossings during 3 min]	x	x	160.0	140.0	180.0	180.0	190.0	160.0	120.0	x	80.0	140.0	120.0	160.0	100.0	160.0	140.0	160.0	x	180.0	x	160.0	x	120.0	x	140.0	80.0	180.0	100.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10506	Original post publication description: Seizure susceptibility to high atmospheric pressure at 100 atmospheres [measured at atm which seizure occurred]	None	Central nervous system, behavior: Seizure susceptibility to high atmospheric pressure at 100 atmospheres [atm of seizure initiation]	x	x	89.0	71.0	89.0	89.0	71.0	x	83.0	83.0	74.0	77.0	x	83.0	83.0	71.0	89.0	86.0	83.0	89.0	x	83.0	x	74.0	77.0	74.0	83.0	89.0	74.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10507	Original post publication description: Seizure susceptibility to high atmospheric pressure at 1000 atmospheres [measured at atm which seizure occurred]	None	Central nervous system, behavior: Seizure susceptibility to high atmospheric pressure at 1000 atmospheres [measured at atm which seizure occurred]	x	x	78.0	63.0	66.0	81.0	66.0	x	78.0	66.0	66.0	66.0	x	69.0	78.0	66.0	72.0	78.0	78.0	78.0	x	81.0	x	66.0	63.0	66.0	72.0	78.0	66.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10508	Original post publication description: Immune function: V beta 3+ T cells in lymph nodes [%]	None	Immune system: V beta 3+ T cells in lymph nodes [%]	x	x	3.3	0.1	1.5	2.7	1.9	4.9	1.0	1.8	0.1	0.6	4.0	2.7	1.3	0.3	1.3	1.4	x	1.4	1.4	1.0	x	0.1	0.2	0.1	1.6	0.7	0.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10509	Original post publication description: Antinociceptive responsive, nitrous oxide antinociception in the acetic acid writhing (abdominal constriction) test [%]	None	Central and peripheral nervous system, behavior: Antinociceptive responsive (pain analgesia), nitrous oxide antinociception in the acetic acid writhing (abdominal constriction) test [%]	x	x	77.0	27.0	87.0	70.0	94.0	x	37.0	80.0	40.0	85.0	60.0	100.0	80.0	74.0	x	30.0	x	31.0	96.0	x	x	89.0	100.0	10.0	90.0	70.0	24.0	90.0	70.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10510	Original post publication description: Body temperature postinjection (120 min) with 4 g/kg of ethanol in males [degrees C]	None	Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in males [degrees C]	x	x	34.7	33.5	x	33.8	x	33.9	34.8	34.8	35.4	33.6	34.2	33.2	34.2	34.8	34.4	34.1	x	34.4	x	34.0	x	x	x	x	x	35.1	x	34.5	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10511	Original post publication description: Blood glucose levels preinjection with 4g/kg of ethanol in females [mg/dl]	None	Central nervous system, pharmacology, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in females [mg/dl]	x	x	103.8	88.3	x	88.0	x	99.0	100.3	x	102.0	80.0	100.0	95.3	85.8	77.9	86.1	85.3	x	104.2	x	x	x	x	x	100.6	x	100.1	87.2	x	89.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10512	Original post publication description: Blood glucose levels preinjection with 4g/kg of ethanol in males [mg/dl]	None	Central nervous system, pharmacology, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in males [mg/dl]	x	x	122.7	98.3	x	87.8	x	112.1	108.5	113.2	109.5	86.0	106.2	111.6	81.3	89.7	84.3	89.6	x	121.5	x	95.0	x	x	x	x	x	105.2	x	112.7	87.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10513	Original post publication description: Blood glucose levels postinjection (120 min) with 4g/kg of ethanol in females [mg/dl]	None	Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in females [mg/dl]	x	x	163.0	117.8	x	127.7	x	137.0	138.6	x	105.2	125.9	113.0	120.3	76.2	109.3	106.7	111.3	x	127.7	x	x	x	x	x	113.0	x	132.0	95.2	x	110.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10514	Original post publication description: Blood glucose levels postinjection (120 min) with 4g/kg of ethanol in males [mg/dl]	None	Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in males [mg/dl]	x	x	234.2	152.5	x	166.6	x	155.0	187.0	184.7	138.2	118.4	130.2	138.3	119.0	137.0	111.1	151.4	x	231.9	x	149.0	x	x	x	x	x	188.6	x	182.2	140.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10515	Original post publication description: Blood glucose levels preinjection with saline in females [mg/dl]	None	Central nervous system, pharmacology, metabolism: Blood glucose levels before saline ip control injection in females [mg/dl]	x	x	105.4	90.0	x	93.4	x	94.2	102.7	x	100.0	87.1	87.7	70.3	81.6	77.8	83.5	82.2	x	98.4	x	x	x	x	x	95.8	x	102.1	x	x	86.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10516	Original post publication description: Blood glucose levels preinjection with saline in males [mg/dl]	None	Central nervous system, pharmacology, metabolism: Blood glucose levels before saline ip control injection in males [mg/dl]	x	x	117.8	104.0	x	95.6	x	113.2	120.0	107.5	102.2	87.5	114.0	109.6	77.7	92.6	86.0	90.2	x	125.6	x	101.7	x	x	x	x	x	105.5	x	x	86.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10517	Original post publication description: Blood glucose levels postinjection (120 min) with saline in females [mg/dl]	None	Central nervous system, pharmacology, metabolism: Saline control response (saline ip), blood glucose levels 120 min after injection in females [mg/dl]	x	x	119.6	99.3	x	102.4	x	103.9	114.7	x	109.3	101.8	109.3	106.3	71.6	82.1	92.6	99.2	x	112.6	x	x	x	x	x	114.6	x	104.0	x	x	93.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10518	Original post publication description: Blood glucose levels postinjection (120 min) with saline in males [mg/dl]	None	Central nervous system, pharmacology, metabolism: Saline control response (saline ip), blood glucose levels 120 min after injection in males [mg/dl]	x	x	140.8	117.2	x	121.6	x	130.4	145.0	120.7	130.0	103.4	118.0	104.3	86.1	90.3	90.0	108.5	x	154.0	x	143.0	x	x	x	x	x	111.2	x	x	101.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10519	Original post publication description: Body temperature, baseline level before injection with 4 g/kg of ethanol in females [degrees C]	None	Central nervous system, pharmacology, metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in females [degrees C]	x	x	37.4	37.7	x	37.7	x	37.4	37.4	x	37.5	37.8	37.4	37.4	37.1	36.9	37.3	37.2	x	37.8	x	x	x	x	x	37.9	x	37.7	37.2	37.3	37.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10520	Original post publication description: Metabolism: Body temperature, control baseline before injection with 4 g/kg of ethanol in males [degrees C]	None	Central nervous system, pharmacology, metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in males [degrees C]	x	x	37.3	37.4	x	37.4	x	36.9	36.9	37.6	37.7	37.1	37.0	37.0	36.0	36.9	36.7	37.0	x	37.5	x	36.9	x	x	x	x	x	37.8	x	37.5	37.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10521	Original post publication description: Ethanol response (4 g/kg), body temperature 120 min after injection in females [degrees C]	None	Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in females [degrees C]	x	x	34.4	33.8	x	34.1	x	34.1	35.1	x	36.1	33.1	35.4	34.1	34.1	35.2	34.7	34.2	x	34.9	x	x	x	x	x	35.6	x	34.9	35.4	34.9	33.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10522	Original post publication description: Body temperature preinjection with saline in females [degrees C]	None	Central nervous system, pharmacology, metabolism: Body temperature baseline control before saline injection in females [degrees C]	x	x	37.4	37.7	x	37.7	x	37.1	37.3	x	37.9	37.9	37.5	37.4	37.0	36.9	37.3	37.1	x	37.4	x	x	x	x	x	37.8	x	37.5	37.0	37.5	37.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10563	Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 16-20 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 16-20 min after injection [activity counts/min]	x	x	17.6	3.8	10.7	29.7	4.9	25.7	18.6	x	10.6	15.6	2.5	21.1	7.6	6.8	20.9	8.4	x	10.9	x	x	x	0.8	17.2	16.5	6.4	15.0	21.1	3.7	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10564	Original post publication description: Locomotor activity after 10 ml/kg of oil from 16-20 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 16-20 min after injection [activity counts/min]	x	x	42.7	42.8	53.2	22.4	19.4	36.4	31.7	x	29.6	33.6	29.3	37.6	26.7	18.9	29.3	33.8	x	36.4	x	x	x	17.5	32.5	29.4	20.9	42.5	23.3	30.9	36.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10565	Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 21-25 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 21-25 min after injection [activity counts/min]	x	x	12.9	3.8	4.2	37.6	6.2	25.3	15.2	x	8.1	13.1	2.5	15.2	4.3	10.1	13.0	9.8	x	8.7	x	x	x	1.7	12.2	16.3	4.4	16.3	13.3	2.9	1.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10566	Original post publication description: Locomotor activity after 10 ml/kg of oil from 21-25 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 21-25 min after injection [activity counts/min]	x	x	36.7	41.4	37.6	26.2	19.0	37.5	31.2	x	31.8	30.4	20.8	38.7	19.1	27.6	24.0	32.6	x	33.8	x	x	x	26.0	35.1	24.8	15.7	38.7	25.4	31.0	35.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10567	Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 26-30 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 26-30 min after injection [activity counts/min]	x	x	16.2	3.2	2.6	30.6	5.3	27.0	16.4	x	8.4	5.6	0.7	17.2	5.0	7.7	24.0	6.6	x	6.9	x	x	x	3.5	13.1	19.1	6.9	17.9	12.1	3.6	2.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10568	Original post publication description: Locomotor activity after 10 ml/kg of oil from 26-30 min [activity counts/min]	None	Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 26-30 min after injection [activity counts/min]	x	x	38.3	34.8	38.2	30.6	29.8	36.6	32.1	x	27.6	29.1	17.0	41.2	25.6	17.7	23.6	40.4	x	27.2	x	x	x	11.0	28.4	21.2	17.4	33.8	23.5	25.8	33.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10569	Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon in first 15 min of 30 min activity test [activity counts/min]	None	Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 0-15 min after injection [activity counts/min]	x	x	43.1	25.3	48.1	52.8	23.6	53.0	32.6	x	21.8	29.3	21.7	50.8	28.6	22.4	43.7	37.6	x	25.1	x	x	x	18.2	35.7	36.8	19.5	57.9	34.7	27.3	22.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10570	Original post publication description: Locomotor activity after 10 ml/kg of oil in first 15 min of 30 min activity test [activity counts/min]	None	Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 0-15 min after injection [activity counts/min]	x	x	54.1	53.8	26.3	40.4	31.4	68.7	41.6	x	32.2	49.9	41.8	60.0	39.6	42.5	52.7	53.9	x	49.8	x	x	x	32.2	50.6	41.5	30.4	73.7	38.6	44.3	48.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10571	Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon in last 15 min of 30 min activity test [activity counts/min]	None	Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 15-30 min after injection [activity counts/min]	x	x	16.3	4.3	6.3	33.5	5.7	26.0	17.6	x	9.5	11.4	2.5	18.9	6.3	8.5	19.5	8.4	x	9.4	x	x	x	2.5	14.5	17.3	6.2	16.4	15.5	3.7	2.26	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10572	Original post publication description: Locomotor activity after after 10 ml/kg of oil in last 15 min of 30 min activity test [activity counts/min]	None	Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 15-30 min after injection [activity counts/min]	x	x	40.0	40.8	43.6	26.0	23.7	37.4	32.4	x	30.4	31.0	22.3	39.5	24.7	21.4	26.4	26.1	x	32.9	x	x	x	18.2	32.7	25.3	18.3	38.4	24.6	29.7	35.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10573	Original post publication description: Ethanol response (4/g/kg ip), plasma corticosterone concentration 1 hr after injection [ug/dl]	None	Ethanol response (4/g/kg ip), plasma corticosterone concentration 1 hr after injection [ug/dl]	x	x	16.21	20.29	17.42	16.89	22.63	12.53	13.97	28.12	x	24.68	17.17	23.09	16.11	27.64	20.39	x	x	16.41	20.13	x	x	22.82	15.07	24.24	24.03	16.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10574	Original post publication description: Corticosterone plasma concentration 1 hr after saline injection [ug/dl]	None	Corticosterone plasma concentration 1 hr after saline injection [ug/dl]	x	x	4.36	4.07	4.35	8.28	3.99	8.59	15.19	5.07	x	5.64	2.47	6.14	6.04	7.54	1.09	x	x	5.66	4.22	x	x	6.95	11.34	11.86	7.77	2.88	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10575	Original post publication description: Ethanol response (4 g/kg ip), plasma corticosterone concentration 6 hr after injection [ug/dl]	None	Endocrinology, hematology, pharmacology: Ethanol response (4 g/kg ip), plasma corticosterone concentration 6 hr after injection [ug/dl]	x	x	7.0	10.5	7.5	x	10.0	10.0	6.0	12.0	3.5	10.5	x	7.5	8.0	7.5	7.5	5.0	x	6.0	x	x	x	10.5	3.0	4.5	7.5	10.0	7.5	4.0	4.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10576	Original post publication description: Saline response (vehicle ip), plasma corticosterone concentration 6 hr after injection [ug/dl]	None	Endocrinology, pharmacology: Plasma corticosterone concentration 6 hr after saline control injection (ip) [ug/dl]	x	x	1.0	7.5	1.0	x	6.0	2.5	2.0	3.5	3.0	2.0	x	5.5	4.5	3.5	6.0	2.0	x	2.5	x	x	x	3.5	2.5	4.0	3.0	1.5	5.0	4.0	4.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10577	Original post publication description: Ethanol response (4 g/kg ip), corticosterone plasma level 7 hr after injection [ug/dl]	None	Central nervous system, pharmacology, endocrinology: Ethanol response (4 g/kg ip), corticosterone plasma level 7 hr after injection [ug/dl]	x	x	7.0	12.0	4.0	10.0	12.0	12.5	5.0	13.0	10.0	9.5	6.0	6.0	9.0	7.0	5.5	4.0	x	8.0	9.5	x	x	15.0	x	24.5	8.0	15.5	16.0	8.5	13.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10578	Original post publication description: Ethanol response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection	None	Central nervous system, pharmacology, behavior: Ethanol response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection	x	x	0.2	3.0	0.8	2.4	0.9	0.0	0.9	2.0	0.7	0.4	1.8	1.4	0.9	0.4	0.3	0.0	x	0.9	0.8	x	x	0.0	x	1.2	0.8	0.1	2.3	0.0	1.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10579	Original post publication description: Ethanol response (4 g/kg ip), corticosterone plasma level 6 hr after injection in females (unpublished means from Roberts et al. 1995, Behav Neurosci 109:1199) [ug/dl]	None	Ethanol response (4 g/kg ip), corticosterone plasma level 6 hr after injection in females (unpublished means from Roberts et al. 1995, Behav Neurosci 109:1199) [ug/dl]	x	x	5.0	9.0	4.0	9.0	14.0	8.0	4.0	10.0	5.0	22.0	18.0	12.0	17.0	7.0	20.0	13.0	x	13.0	9.0	16.0	x	12.0	8.0	21.0	16.0	12.0	18.0	10.0	16.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10580	Original post publication description: Ethanol response [4/g/kg ip], plasma corticosterone concentration 6 hr after injection in males (unpublished data from Roberts, Phillips, Belknap, Finn, Keith 1995, Behavioral Neurosci 109:1199-1208) [ug/dl]	None	Central nervous system, pharmacology, endocrinology: Ethanol response [4/g/kg ip], plasma corticosterone concentration 6 hr after injection in males (unpublished data from Roberts, Phillips, Belknap, Finn, Keith 1995, Behavioral Neurosci 109:1199-1208) [ug/dl]	x	x	x	x	x	16.4	15.3	13.9	4.5	x	4.7	21.9	17.7	16.5	17.7	15.3	20.0	x	x	13.3	12.8	16.1	x	14.8	8.6	21.5	16.3	11.8	18.1	9.5	15.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10581	Original post publication description: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg]	x	x	20.21	9.18	15.99	15.76	19.37	17.07	12.32	11.03	18.78	16.25	14.88	18.6	x	21.47	13.51	x	x	21.97	15.52	x	x	10.85	12.45	10.88	9.63	15.71	x	18.19	10.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10582	Original post publication description: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for males [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for males [g/kg]	x	x	16.84	10.22	16.1	14.96	15.26	13.48	11.46	7.73	16.78	14.43	10.03	10.35	x	14.77	7.08	x	x	16.47	14.66	x	x	5.12	11.71	12.06	11.73	15.57	x	15.58	12.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10583	Original post publication description: Ethanol response (10% in water po), preference for alcohol for females [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference for alcohol for females [g/kg]	x	x	16.92	2.64	5.56	6.51	4.59	8.03	4.28	3.33	4.98	4.81	2.4	3.2	x	9.61	4.06	x	x	4.7	4.29	x	x	3.15	7.95	8.39	6.63	3.91	x	10.49	2.19	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10584	Original post publication description: Ethanol response (10% v/v in water), preference of females using 2-bottle choice [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), preference of females using 2-bottle choice [g/kg]	x	x	12.84	2.07	3.32	3.65	3.68	4.69	4.98	2.64	5.05	5.2	2.03	2.15	x	4.08	2.18	x	x	4.57	3.73	x	x	2.34	7.25	6.37	6.84	5.06	x	8.04	2.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10585	Original post publication description: Ethanol response (dose ip), hypnotic dose sensitivity (HDS), sleep time for females [min]	None	Ethanol response (dose ip), hypnotic dose sensitivity (HDS), sleep time for females [min]	x	x	103.83	116.46	109.89	121.93	17.96	112.66	125.27	97.84	107.41	159.76	91.98	119.62	x	104.52	x	x	x	100.89	132.81	x	x	110.6	115.38	111.68	116.27	119.97	x	146.8	141.16	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10586	Original post publication description: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex of males [min]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex of males [min]	x	x	118.43	108.61	116.96	142.79	150.8	136.34	126.14	109.79	109.32	157.56	125.0	105.96	x	140.48	x	x	x	103.54	153.76	x	x	129.67	145.67	128.02	109.74	128.2	x	141.96	154.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10587	Original post publication description: Ethanol response (10% in water po), acceptance and consumption of 10% ethanol in 24 hours after 24 hours of water deprivation [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake [g/kg]	x	x	18.48	9.71	16.05	15.41	17.43	15.37	11.86	9.38	17.67	15.34	12.45	14.48	x	18.12	10.3	x	x	19.08	15.11	x	x	7.98	12.1	11.47	10.68	15.64	x	16.88	11.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10588	Original post publication description: Ethanol response (10% in water po), preference and consumption of 10% ethanol vs. water over 15 days [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference and consumption of 10% ethanol vs. water over 15 days [g/kg]	x	x	14.83	2.35	4.44	5.08	4.13	6.36	4.67	2.98	5.02	5.0	2.22	2.7	x	6.54	3.07	x	x	4.64	4.01	x	x	2.72	7.6	7.83	6.73	4.49	x	9.27	2.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10589	Original post publication description: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex [min]	None	Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex [min]	x	x	112.1	112.41	113.21	132.36	139.98	124.5	125.7	103.5	108.37	158.71	110.55	112.39	x	118.9	x	x	x	102.21	144.6	x	x	120.13	127.85	119.85	113.0	124.08	x	144.54	148.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10590	Original post publication description: Vascular endothelial growth factor (VEGF)-induced angiogenesis	None	Cardiovascular system: Vascular endothelial growth factor (VEGF)-induced angiogenesis measured using corneal micropocket neovascularization assay [mm2]	x	1.1	0.8	1.4	0.87	x	0.92	0.94	0.62	0.86	1.29	0.71	1.04	0.91	0.96	2.22	x	1.04	0.77	1.35	0.65	x	x	1.34	0.96	x	1.35	1.07	1.06	0.67	0.98	0.32	1.28	0.82	x	1.48	1.01	1.07	0.85	x	1.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10591	Original post publication description: Infectious disease, immune function: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU [log10]	None	Infectious disease, immune system: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU (KLRA complex) [log10]	x	x	2.1	4.6	4.25	x	4.64	1.3	5.2	4.72	4.91	1.66	5.42	x	5.2	1.3	1.31	5.48	1.31	1.66	1.3	1.29	x	4.65	x	2.23	1.3	5.26	1.49	1.74	4.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10592	Original post publication description: Infectious disease, immune function: Anergy measured by footpad thickness resulting from BCG injection [mm]	None	Infectious disease, immune system: Anergy measured by footpad thickness resulting from BCG injection [mm]	x	x	x	x	0.68	0.22	0.25	0.67	0.14	0.63	0.64	0.79	x	0.15	0.48	0.92	0.92	0.15	0.86	1.0	0.31	0.3	x	0.6	x	0.74	0.8	x	0.99	0.46	0.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10593	Original post publication description: Amphetamine response (20 mg/kg ip d amphetamine), core temperature change after injection [degrees C]	None	Central nervous system, pharmacology, metabolism: Amphetamine response (20 mg/kg ip d amphetamine), core body temperature change after injection [degree C]	x	x	0.42	1.66	x	x	x	x	x	1.26	x	0.52	x	x	0.42	x	x	1.77	0.41	0.21	x	1.56	x	x	x	1.78	1.46	x	1.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10594	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	478.0	393.0	441.0	424.0	540.0	x	428.0	431.0	434.0	438.0	415.0	444.0	453.0	431.0	419.0	432.0	392.0	x	446.0	414.0	x	407.0	401.0	352.0	394.0	376.0	369.0	414.0	443.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10595	Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) volume, unilateral [mm^3]	None	Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) volume, unilateral, corrected for shrinkage [mm^3]	x	0.32	0.3	0.26	0.3	0.25	0.36	x	0.23	0.29	0.32	0.23	0.26	0.26	0.29	0.26	0.25	0.31	0.25	x	0.33	0.35	x	0.25	0.26	0.25	0.23	0.24	0.23	0.28	0.27	0.25	0.28	0.28	0.27	x	0.27	0.32	0.35	x	0.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10596	Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) total cell number, unilateral [n x10^3]	None	Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) total cell number, unilateral [n x10^3]	x	43.1	46.7	37.0	36.9	34.6	45.6	x	32.9	39.4	46.1	36.3	39.7	37.3	41.4	48.2	38.7	35.7	41.0	x	50.4	40.7	x	38.6	35.0	31.5	35.5	40.7	37.3	43.8	34.2	38.4	40.6	39.3	40.0	x	36.0	36.3	43.0	x	39.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10597	Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) neuron number, unilateral [n x10^3]	None	Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) neuron number, unilateral [n x10^3]	x	18.8	19.9	16.2	14.9	13.7	18.1	x	15.1	15.5	18.5	15.5	17.7	14.7	18.2	20.0	15.8	14.5	14.8	x	18.4	17.6	x	15.3	16.1	14.8	15.7	17.4	15.7	18.3	13.2	18.4	19.4	16.5	17.4	x	15.1	15.1	16.1	x	16.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10598	Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) glial cell number, unilateral [n x10^3]	None	Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) glial cell number, unilateral [n x10^3]	x	14.7	15.1	13.2	10.8	11.2	15.9	x	10.2	12.4	12.5	12.4	12.9	13.1	11.5	16.3	13.3	12.6	13.8	x	17.1	15.2	x	11.0	10.9	9.6	11.7	13.6	12.4	14.0	12.3	11.2	12.3	13.2	13.0	x	11.4	13.1	13.0	x	12.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10599	Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) endothelial cell number, unilateral [n x10^3]	None	Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) endothelial cell number, unilateral [n x10^3]	x	9.6	11.7	7.5	11.3	9.6	11.6	x	7.6	11.5	15.0	8.4	9.2	9.6	11.7	11.9	9.6	8.7	12.3	x	14.8	7.9	x	12.3	8.1	7.1	8.1	9.6	9.2	11.5	8.7	8.7	8.9	9.7	9.6	x	9.5	8.1	13.9	x	10.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10600	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x 1000]	None	Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x 1000]	x	x	54.6	63.4	59.5	65.9	73.4	62.7	57.1	64.0	60.9	53.3	54.3	63.6	62.5	64.3	53.7	63.8	61.6	60.0	63.1	52.6	x	61.4	52.6	50.9	55.2	61.2	67.4	64.2	74.5	57.4	58.6	60.7	63.3	x	59.7	67.5	67.4	x	63.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10601	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cells (RGC) to lateral geniculate nucleus (LGN) principal neuron number ratio [ratio]	None	Central nervous system, morphology, eye, visual system: Retinal ganglion cells (RGC) to lateral geniculate nucleus (LGN) principal neuron number ratio [ratio]	x	x	2.74	3.91	3.99	4.81	4.06	x	3.78	4.13	3.29	3.44	3.07	4.33	3.43	3.22	3.4	4.4	4.16	x	3.43	2.99	x	4.01	3.27	3.44	3.52	3.52	4.29	3.51	5.64	3.12	3.02	3.68	3.64	x	3.95	4.47	4.19	x	3.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10602	Original post publication description: Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml]	None	Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml]	x	x	6.7	10.3	x	10.2	x	6.0	x	6.2	x	8.6	x	x	x	8.7	x	7.3	x	x	x	x	x	x	x	x	x	9.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10603	Original post publication description: Serum thyroxine (T4) content (free) [ug/100ml]	None	Endocrinology, metabolism: Serum thyroxine (T4) content (free) [ug/100ml]	x	x	2.2	3.2	x	2.4	x	2.1	x	1.6	x	3.0	x	x	x	2.5	x	2.6	x	x	x	x	x	x	x	x	x	3.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10604	Original post publication description: Central nervous system, behavior: Seizure susceptibility (audiogenic), severity [score]	None	Central nervous system, behavior: Seizure susceptibility (audiogenic), severity [score]	x	x	0.07	1.89	x	1.92	x	0.14	x	1.85	x	0.3	x	x	x	0.21	x	0.73	x	x	x	x	x	x	x	x	x	0.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10605	Original post publication description: Central nervous system, behavior: Seizure susceptibility (audiogenic), clonic tonic percentage [%]	None	Central nervous system, behavior: Seizure susceptibility (audiogenic), clonic tonic percentage [%]	x	x	1.8	91.4	x	92.0	x	0.0	x	93.0	x	0.0	x	x	x	0.0	x	35.0	x	x	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10606	Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in frontal cortex [pmole/4min/mg protein]	None	Central nervous system, pharmacology: High affinity choline uptake (concentration of 0.5 10xE-6 M) in frontal cortex [pmole/4min/mg protein]	x	x	17.2	13.1	18.5	17.3	13.7	15.4	25.0	22.1	12.8	17.8	25.5	19.0	24.4	17.3	18.2	24.9	x	23.4	16.4	26.8	x	19.3	23.7	17.3	21.2	20.5	18.7	12.5	25.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10607	Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in hippocampus [pmole/4min/mg protein]	None	High affinity choline uptake (concentration of 0.5*10^-6M) in hippocampus [pmole/4min/mg protein]	x	x	17.5	14.2	17.6	18.9	22.4	18.9	20.8	25.9	21.2	19.9	27.7	22.2	23.3	17.4	19.1	28.5	x	25.2	21.6	26.2	x	17.9	36.0	21.0	22.4	30.3	22.8	17.7	23.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10608	Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in striatum [pmole/4min/mg protein]	None	Central nervous system, pharmacology: High affinity choline uptake (concentration of 0.5*10^-6M) in striatum [pmole/4min/mg protein]	x	x	80.1	64.8	52.4	62.8	43.5	55.5	112.1	94.2	59.4	54.7	92.3	90.4	112.8	62.7	55.2	107.1	x	89.3	59.5	107.9	x	51.7	128.9	76.2	78.1	79.2	51.6	52.5	87.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10609	Original post publication description: Cocaine response (32 mg/kg ip), locomotion from 0-60 min after injections in an activity chamber [n beam breaks]	None	Cocaine response (32 mg/kg ip), locomotion from 0-60 min after injections in an activity chamber [n beam breaks]	x	x	1481.0	2470.0	x	x	1814.0	x	2574.0	x	1557.0	x	1622.0	1333.0	1995.0	1787.0	x	x	x	2345.0	1702.0	1383.0	x	x	2158.0	1539.0	1494.0	x	1771.0	1597.0	1909.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10610	Original post publication description: Cocaine response (32 mg/kg ip), sensitization of locomotor response [% initial response]	None	Cocaine response (32 mg/kg ip), sensitization of locomotor response [% initial response]	x	x	81.4	28.2	x	x	92.5	x	71.7	x	111.4	x	128.7	97.1	53.1	115.0	x	x	x	59.0	81.3	100.0	x	x	87.4	86.4	102.0	x	102.0	88.6	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10611	Original post publication description: Cocaine response (32 mg/kg ip, daily), stereotypical behavior frequency after consecutive daily injections on day 8 [units]	None	Central nervous system, pharmacology, behavior: Cocaine response (32 mg/kg ip, daily), stereotypical behavior frequency after consecutive daily injections on day 8 [units]	x	x	0.75	17.21	x	x	3.67	x	1.33	x	0.33	x	0.67	1.33	4.0	0.0	x	x	x	4.68	3.33	1.0	x	x	0.0	5.0	0.0	x	0.0	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10612	Original post publication description: Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, primiparous lactating female [% total RNA]	None	Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, primiparous lactating female [% total RNA]	x	x	0.0265	0.016	0.0216	0.0062	0.023	0.0192	0.0138	0.0064	0.0141	0.012	0.0149	0.0	0.0134	0.0067	0.0118	0.0198	x	0.0062	0.003	0.016	x	0.0107	0.0268	x	0.0077	0.0198	0.019	0.0267	0.024	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10613	Original post publication description: Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, multiparous lactating female [% total RNA]	None	Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, multiparous lactating female [% total RNA]	x	x	0.024	x	0.032	0.0077	0.028	0.0212	0.0161	x	0.0213	0.0213	0.024	0.0034	x	0.0252	0.0161	0.0214	x	0.0064	0.016	0.0133	x	0.024	x	x	0.0184	0.023	0.016	0.016	0.031	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10614	Original post publication description: Pentylenetetrazol (PTZ) induced seizure thresholds [mg/kg]	None	Central nervous system, pharmacology, behavior: Pentylenetetrazol (PTZ, a GABA antagonists) response, dosage level (threshold) required to induce seizure [mg/kg]	x	x	35.0	23.0	30.0	41.0	28.0	40.0	x	25.0	37.0	32.0	28.0	27.0	x	33.0	31.0	30.0	x	29.0	29.0	29.0	x	28.0	29.0	x	32.0	34.0	38.0	33.0	27.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10615	Original post publication description: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 1 [cpm]	None	Immune system: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 1 [cpm]	x	x	1107.0	925.0	2021.0	158.0	x	2267.0	108.0	x	x	1757.0	x	x	x	x	x	x	x	x	x	x	x	127.0	x	x	x	158.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10616	Original post publication description: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 1, 5X105 stimulator cells [cpm]	None	Immune system: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 1, 5X105 stimulator cells [cpm]	x	x	3457.0	3736.0	4568.0	209.0	x	5070.0	148.0	x	x	3990.0	x	x	x	x	x	x	x	x	x	x	x	381.0	x	x	x	86.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10617	Original post publication description: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 2 [cpm]	None	Immune system: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 2 [cpm]	x	x	3765.0	x	4902.0	511.0	x	4413.0	593.0	x	x	2941.0	x	x	x	x	x	x	x	x	x	x	x	158.0	x	x	x	248.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10618	Original post publication description: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 2, 1X106 stimulator cells [cpm]	None	Immune system: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 2, 1X106 stimulator cells [cpm]	x	x	10955.0	x	11742.0	781.0	x	7541.0	378.0	x	x	10521.0	x	x	x	x	x	x	x	x	x	x	x	150.0	x	x	x	421.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10619	Original post publication description: Learning and memory performance, site preference, number of crosses over the trained site minus the mean of crosses over alternative sites, using Morris water maze [n]	None	Learning and memory performance, site preference, number of crosses over the trained site minus the mean of crosses over alternative sites, using Morris water maze [n]	x	x	x	x	1.12	5.85	x	x	x	1.89	x	x	x	x	2.06	2.74	x	x	x	2.21	x	2.0	x	3.0	3.82	2.34	3.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10620	Original post publication description: Morris water maze search-time preference, amount of time spent in the trained quadrant of the pool minus mean time in the alternative quadrants [seconds]	None	Central nervous system, behavior, learning and memory: Morris water maze search-time preference, amount of time spent in the trained quadrant of the pool minus mean time in the alternative quadrants [seconds]	x	x	x	x	8.43	19.45	x	x	x	6.11	x	x	x	x	11.61	10.47	x	x	x	7.59	x	12.37	x	10.84	13.35	6.23	11.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10621	Original post publication description: Protein kinase C (PKC) activity in hippocampus [pmol/min/mg protein total hippocampus]	None	Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity in hippocampus [pmol/min/mg protein total hippocampus]	x	x	x	x	416.0	1347.0	x	x	x	568.0	x	x	x	x	398.0	901.0	x	x	x	856.0	x	844.0	x	1122.0	931.0	843.0	902.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10622	Original post publication description: Protein kinase C (PKC) activity for particulate hippocampus [pmol/min/mg protein]	None	Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity for particulate hippocampus [pmol/min/mg protein]	x	x	x	x	95.0	349.0	x	x	x	195.0	x	x	x	x	140.0	353.0	x	x	x	142.0	x	296.0	x	213.0	375.0	209.0	437.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10623	Original post publication description: Protein kinase C (PKC) activity for cytosolic hippocampus [pmol/min/mg protein]	None	Central nervous system, protein expression, behavior, learning and memory: Protein kinase C (PKC) activity for cytosolic hippocampus [pmol/min/mg protein]	x	x	x	x	438.0	992.0	x	x	x	374.0	x	x	x	x	257.0	544.0	x	x	x	715.0	x	57.4	x	906.0	449.0	636.0	457.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10624	Original post publication description: Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex (total sample) [pmol/min/mg protein]	None	Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex (total sample) [pmol/min/mg protein]	x	x	x	x	391.0	619.0	x	x	x	279.0	x	x	x	x	494.0	419.0	x	x	x	1018.0	x	273.0	x	503.0	356.0	495.0	540.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10625	Original post publication description: Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex sample (particulate fraction) [pmol/min/mg protein]	None	Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity for neocortex sample (particulate fraction) [pmol/min/mg protein]	x	x	x	x	184.0	177.0	x	x	x	113.0	x	x	x	x	295.0	142.0	x	x	x	560.0	x	154.0	x	137.0	67.0	259.0	194.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10626	Original post publication description: Protein kinase C (PKC) activity for cytosolic cortex [pmol/min/mg protein]	None	Protein kinase C (PKC) activity for cytosolic cortex [pmol/min/mg protein]	x	x	x	x	302.0	512.0	x	x	x	169.0	x	x	x	x	261.0	276.0	x	x	x	461.0	x	229.0	x	361.0	285.0	345.0	451.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10627	Original post publication description: Mean 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean]	None	Immune system: Mean 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean]	x	x	x	45.0	x	x	x	59.0	x	x	55.0	55.0	x	x	x	38.0	x	x	x	51.0	x	x	x	51.0	x	46.0	78.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10628	Original post publication description: Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean]	None	Immune system: Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean]	x	x	x	39.0	x	x	x	42.0	x	x	40.0	45.0	x	x	x	29.0	x	x	x	37.0	x	x	x	33.0	x	29.0	42.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10629	Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean]	None	Immune system: T-cell response, antibody-dependent cell-mediated cytotoxicity, 51Cr release at 5:1 E:T after spleen cells primed and boosted in mixed lymphocyte culture (MLC) in pool of five responders [mean]	x	x	x	30.0	x	x	x	29.0	x	x	37.0	32.0	x	x	x	17.0	x	x	x	28.0	x	x	x	26.0	x	17.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10630	Original post publication description: Immune system: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]	None	Immune system: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]	x	x	x	x	x	x	x	63.0	x	x	3.0	0.0	x	x	x	14.0	x	x	x	32.0	x	x	x	2.0	x	27.0	33.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10631	Original post publication description: Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]	None	Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]	x	x	x	x	x	x	x	40.0	x	x	2.0	0.0	x	x	x	10.0	x	x	x	16.0	x	x	x	0.0	x	18.0	17.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10632	Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [mean]	None	Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [mean]	x	x	x	x	x	x	x	16.0	x	x	1.0	0.0	x	x	x	3.0	x	x	x	8.0	x	x	x	0.0	x	12.0	16.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10633	Original post publication description: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2	None	Immune sytstem: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2	x	x	x	x	x	x	x	100.0	x	x	6.0	0.0	x	x	x	48.0	x	x	x	66.0	x	x	x	11.0	x	72.0	68.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10634	Original post publication description: Immune function: 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units]	None	Immune sytstem: 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units]	x	x	x	x	x	x	x	100.0	x	x	5.0	0.0	x	x	x	36.0	x	x	x	47.0	x	x	x	7.0	x	46.0	72.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10635	Original post publication description: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2	None	Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2	x	x	x	x	x	x	x	67.0	x	x	3.0	0.0	x	x	x	23.0	x	x	x	32.0	x	x	x	6.0	x	40.0	29.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10636	Original post publication description: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3	None	Immune sytstem: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3	x	x	x	x	x	x	x	47.0	x	x	4.0	0.0	x	x	x	15.0	x	x	x	32.0	x	x	x	0.0	x	27.0	49.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10637	Original post publication description: 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3	None	Immune sytstem: 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3	x	x	x	x	x	x	x	32.0	x	x	2.0	0.0	x	x	x	10.0	x	x	x	22.0	x	x	x	3.0	x	18.0	35.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10638	Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [mean]	None	Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [mean]	x	x	x	x	x	x	x	22.0	x	x	2.0	0.0	x	x	x	7.0	x	x	x	12.0	x	x	x	0.0	x	7.0	29.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10639	Original post publication description: Hindbrain medulla weight (unadjusted) [mg]	None	Hindbrain medulla weight (unadjusted) [mg]	x	x	x	x	x	x	x	5.5	8.2	8.6	x	x	x	x	6.8	x	x	5.7	x	7.3	x	x	x	x	x	x	x	x	x	x	x	6.3	6.3	5.9	5.7	x	6.4	6.4	7.2	x	7.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10640	Original post publication description: Hindbrain weight, unadjusted [mg]	None	Central nervous system, morphology: Hindbrain weight, unadjusted [mg]	x	x	x	x	x	x	x	x	x	x	42.5	46.5	42.0	43.4	39.1	44.1	44.7	43.1	34.3	36.2	42.6	41.8	x	46.3	39.2	30.8	44.4	41.5	38.6	43.6	50.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10642	Original post publication description: Olfactory bulb weight, bilateral and unadjusted for age, sex, or body weight [mg]	None	Central nervous system, morphology: Olfactory bulb weight, bilateral, without any statistical corrections (raw) [mg]	x	x	x	x	20.9	23.1	22.3	21.2	20.2	22.0	17.7	20.3	18.0	18.7	18.8	21.5	21.1	18.7	18.2	18.9	21.0	x	x	16.9	17.6	17.9	19.1	19.1	17.8	20.4	21.7	20.3	23.0	24.0	17.5	23.0	22.4	19.5	22.0	x	20.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10643	Original post publication description: Central nervous system, morphology: Olfactory bulb weight, adjusted [mg] by age, sex, body weight, and brain minus olfactory bulb weight.	None	Central nervous system, morphology: Olfactory bulb weight, adjusted by age, sex, body weight, and brain minus olfactory bulb weight (Hager et al. 2012) [mg]	x	x	21.9	21.6	20.7	21.1	18.3	22.0	19.3	20.0	18.7	20.0	19.4	19.9	18.0	19.7	21.0	18.6	20.9	17.3	19.8	18.7	x	18.6	18.3	20.3	19.7	20.1	20.7	21.4	20.1	20.3	23.2	23.6	18.1	21.2	22.5	20.4	20.3	x	19.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10645	Original post publication description: Olfactory bulb weight, bilateral, fixed tissue, hand-dissected, unadjusted [mg]	None	Central nervous system, morphology, olfaction: Olfactory bulb weight, bilateral, fixed tissue, hand-dissected, unadjusted [mg]	x	x	22.7	19.8	21.6	21.2	21.2	20.3	22.6	21.7	18.6	20.4	18.5	20.9	19.0	21.7	22.2	18.6	18.8	17.9	20.8	18.1	x	17.3	17.4	17.7	19.2	19.1	18.6	21.0	19.8	21.0	23.8	24.4	18.2	19.9	23.1	20.4	21.7	x	21.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10646	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	495.0	415.0	456.0	440.0	502.0	391.0	498.0	469.0	420.0	447.0	402.0	439.0	449.0	467.0	445.0	432.0	382.0	442.0	444.0	420.0	x	394.0	410.0	375.0	413.0	403.0	382.0	415.0	432.0	445.0	439.0	449.0	427.0	428.0	437.0	423.0	464.0	x	469.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10647	Original post publication description: Body weight [g]	None	Metabolism, morphology: Body weight, adult sex average [g]	x	x	24.7	19.3	18.8	28.9	22.2	19.9	22.9	23.6	18.8	21.2	19.5	21.7	24.3	23.9	21.3	21.2	19.0	21.8	20.3	20.0	x	20.7	19.2	20.2	23.1	22.3	18.2	20.8	26.0	17.7	21.1	25.8	17.2	22.5	19.4	20.2	20.2	x	21.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10648	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	475.0	412.0	465.0	432.0	526.0	388.0	412.0	422.0	437.0	434.0	427.0	442.0	443.0	469.0	427.0	431.0	398.0	443.0	457.0	434.0	x	391.0	431.0	393.0	407.0	413.0	399.0	426.0	434.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10649	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [n x10^3]	None	Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [n x10^3]	x	x	55.4	63.4	60.3	65.9	75.5	62.7	62.8	65.6	61.0	56.8	54.7	64.0	63.8	64.0	55.1	67.1	59.9	60.0	64.5	53.0	x	62.4	53.8	50.8	52.4	63.6	66.0	66.6	75.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10650	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number residuals, unilateral, corrected for variation in brain and body size, sex, and age [residual n x10^3]	None	Central nervous system, morphology, eye, visual system: Retinal ganglion cell number residuals, unilateral, corrected for variation in brain and body size, sex, and age [residual n x10^3]	x	x	-4.5	4.5	-4.67	3.88	5.09	4.6	2.56	4.47	-1.47	-5.4	-6.88	1.08	0.79	-1.33	-6.48	5.16	0.91	-3.0	0.25	-9.2	x	4.03	-8.14	-7.75	-7.4	3.27	6.92	5.11	13.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10651	Original post publication description: Central nervous system, morphology, auditory system: Spiral ganglion cell density hook [cells per 10000 um2]	None	Central nervous system, morphology, auditory system: Spiral ganglion cell density hook [cells per 10000 um2]	x	x	17.0	8.0	17.0	4.0	9.0	8.0	4.0	8.0	8.0	7.0	x	10.0	7.0	3.0	8.0	x	5.0	6.0	7.0	9.0	x	6.0	18.0	3.0	12.0	12.0	9.0	12.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10652	Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid base [cells per 10000 um2]	None	Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid base [cells per 10000 um2]	x	x	43.0	11.0	15.0	5.0	17.0	22.0	6.0	12.0	13.0	8.0	x	25.0	17.0	3.0	21.0	x	9.0	23.0	13.0	22.0	x	5.0	23.0	11.0	19.0	17.0	25.0	31.0	19.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10653	Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-apical [cells per 10000 um2]	None	Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-apical [cells per 10000 um2]	x	x	46.0	25.0	40.0	15.0	16.0	25.0	11.0	33.0	28.0	12.0	x	26.0	21.0	4.0	22.0	x	26.0	23.0	21.0	25.0	x	20.0	27.0	10.0	29.0	23.0	24.0	35.0	32.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10654	Original post publication description: Central nervous system, morphology, auditory system: Spiral ganglion cell density apical [cells per 10000 um2]	None	Central nervous system, morphology, auditory system: Spiral ganglion cell density apical [cells per 10000 um2]	x	x	47.0	24.0	27.0	25.0	20.0	30.0	35.0	26.0	18.0	21.0	x	20.0	19.0	12.0	16.0	x	16.0	32.0	18.0	22.0	x	32.0	30.0	11.0	14.0	10.0	4.0	19.0	33.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10655	Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density total [cells per 10000 um2]	None	Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density total [cells per 10000 um2]	x	x	168.0	68.0	100.0	49.0	62.0	85.0	56.0	79.0	67.0	48.0	x	81.0	64.0	22.0	67.0	x	56.0	84.0	59.0	78.0	x	53.0	98.0	35.0	74.0	62.0	62.0	97.0	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10656	Original post publication description: Infectious disease, immune function: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	None	Infectious disease, immune system: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	x	x	1.82	1.92	2.08	2.19	2.23	1.84	1.96	1.77	2.29	1.93	x	x	1.81	2.0	2.0	1.78	x	x	2.15	2.31	x	1.89	x	2.03	2.04	x	2.09	2.0	2.26	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10657	Original post publication description: Infectious disease, immune function: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	None	Infectious disease, immune system: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	x	x	0.295	0.392	0.474	1.75	0.18	0.104	0.451	0.107	1.12	0.105	x	x	0.234	0.861	0.128	0.113	x	x	0.127	1.45	x	0.172	x	0.121	0.18	x	0.187	0.242	0.305	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10658	Original post publication description: Infectious disease, immune function: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	None	Infectious disease, immune system: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	x	x	0.195	0.359	0.112	1.45	0.082	0.086	0.201	0.098	0.78	0.082	x	x	0.15	0.565	0.115	0.083	x	x	0.103	1.51	x	0.097	x	0.102	0.148	x	0.112	0.14	0.205	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10659	Original post publication description: Infectious disease, immune function: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	None	Infectious disease, immune system: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]	x	x	0.029	0.084	0.053	1.15	0.057	0.022	0.109	0.054	0.39	0.037	x	x	0.066	0.199	0.049	0.042	x	x	0.057	0.956	x	0.076	x	0.037	0.091	x	0.043	0.043	0.031	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10660	Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%]	None	Infectious disease, immune system: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%]	x	x	18.5	18.5	18.1	7.7	15.4	11.7	19.1	11.5	11.7	18.7	x	x	18.1	7.13	18.4	18.1	x	x	18.6	5.4	x	18.5	x	18.4	18.5	x	18.5	15.1	17.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10661	Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%]	None	Infectious disease, immune system: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%]	x	x	72.7	73.6	73.1	47.3	72.4	72.6	64.5	73.2	62.3	73.4	x	x	70.0	25.9	73.4	73.1	x	x	72.5	11.0	x	73.0	x	73.3	64.0	x	70.7	73.3	73.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10662	Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%]	None	Infectious disease, immune system: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%]	x	x	101.0	103.0	102.0	64.5	102.0	102.0	80.3	103.0	76.0	73.1	x	x	101.0	76.6	96.0	95.1	x	x	101.0	24.1	x	85.4	x	95.0	67.3	x	92.2	91.3	103.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10663	Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%]	None	Infectious disease, immune system: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%]	x	x	99.2	102.0	103.0	58.3	101.0	101.0	71.0	102.0	43.1	104.0	x	x	96.6	59.9	88.7	89.0	x	x	92.6	8.9	x	76.1	x	88.4	36.6	x	85.5	84.2	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10664	Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/]	None	Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/]	x	x	80.8	7.71	0.943	0.812	6.5	3.83	x	12.1	18.9	16.0	x	13.0	13.0	20.9	x	16.5	x	42.4	27.3	36.5	x	43.2	58.4	65.4	51.9	47.8	x	74.1	52.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10665	Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml]	None	Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml]	x	x	49.5	3.07	2.77	49.9	2.49	17.3	x	6.96	13.3	12.1	x	25.9	27.5	11.6	x	30.8	x	14.0	15.9	39.9	x	26.5	28.0	23.1	29.9	27.8	x	56.3	35.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10666	Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml]	None	Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml]	x	x	38.9	4.16	0.279	41.5	1.81	18.8	x	3.5	5.68	16.5	x	18.6	18.0	8.29	x	24.0	x	11.3	11.2	31.0	x	14.6	18.0	23.3	27.6	16.5	x	32.0	23.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10667	Original post publication description: Eye, morphology, visual system: Eye weight corrected for age, sex, body and brain weight (BXD38 added) [mg]	None	Eye, morphology, visual system: Eye weight corrected for age, sex, body and brain weight (BXD38 added) [mg]	x	x	18.9	20.2	20.1	20.1	19.6	19.7	18.7	19.4	20.3	18.9	18.2	18.3	19.1	19.3	17.3	20.1	19.4	15.6	19.3	18.4	x	16.3	16.8	19.2	17.5	19.4	17.8	20.0	20.0	x	x	x	x	x	19.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10668	Original post publication description: Eye, morphology, visual system: Lens weight [mg]	None	Eye, morphology, visual system: Lens weight [mg]	x	x	5.9	6.7	6.2	6.1	5.7	5.9	5.8	6.0	6.0	5.3	5.3	5.7	5.7	6.1	5.2	6.5	5.5	4.8	6.0	5.5	x	5.3	5.3	5.6	5.0	5.9	5.5	6.0	6.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10669	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal area, adults of both sexes [mm2]	None	Central nervous system, morphology, eye, visual system: Retinal area, adults of both sexes [mm2]	x	x	18.5	20.1	19.8	20.2	19.1	19.8	18.6	19.3	20.2	18.9	19.3	18.7	19.3	19.0	18.1	19.7	18.8	16.2	19.5	18.2	x	17.0	17.6	18.9	17.8	19.3	18.4	19.2	19.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10670	Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x1000]	None	Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x1000]	x	x	55.4	63.4	60.3	65.9	75.5	62.7	62.8	65.6	61.0	56.8	54.7	64.0	63.8	64.0	55.1	67.1	59.9	60.0	64.5	53.0	x	62.4	53.8	50.8	52.4	63.6	66.0	66.6	75.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10671	Original post publication description: Eye, morphology, visual system: Eye weight, regression corrected for age, sex, body and brain weight [mg]	None	Eye, morphology, visual system: Eye weight, regression corrected for age, sex, body and brain weight [mg]	x	x	18.9	20.2	20.1	20.1	19.6	19.7	18.7	19.4	20.3	18.9	18.2	18.3	19.1	19.3	17.3	20.1	19.4	15.6	19.3	18.4	x	16.3	16.8	19.2	17.5	19.4	17.8	20.0	20.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10672	Original post publication description: Central nervous system, morphology: Brain weight [mg]	None	Central nervous system, morphology: Brain weight [mg]	x	x	475.0	412.0	465.0	432.0	526.0	388.0	412.0	422.0	437.0	434.0	427.0	442.0	443.0	469.0	427.0	431.0	398.0	443.0	457.0	434.0	x	391.0	431.0	393.0	407.0	413.0	399.0	426.0	434.0	427.3	417.3	415.4	406.6	410.6	418.1	401.8	431.7	x	448.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10673	Original post publication description: Testis weight [g]	None	Morphology, urogenital system: Testis weight [g]	x	x	0.16	0.22	0.16	0.22	0.22	0.23	0.17	x	0.21	0.16	0.13	0.16	0.24	0.24	0.15	0.14	x	0.2	0.25	0.14	x	0.24	0.16	0.16	0.21	0.17	0.16	0.16	0.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10674	Original post publication description: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral, shrinkage corrected from serial histological sections [mm^3]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral, shrinkage corrected from serial histological sections [mm^3]	x	1.87	1.628	1.55	1.566	1.434	1.596	1.221	1.51	1.515	1.478	1.469	1.387	1.489	1.424	1.55	1.481	1.797	1.517	1.455	1.573	1.476	x	1.517	1.402	1.429	1.374	1.067	1.145	1.522	1.61	1.324	1.536	1.467	1.44	1.4	1.426	1.34	1.497	x	1.442	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10675	Original post publication description: Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral shrinkage corrected and adjusted for variation in body weight and plane of section from serial histological sections [mm^3]	None	Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral shrinkage corrected and adjusted for variation in body weight and plane of section from serial histological sections [mm^3]	x	1.77	1.62	1.549	1.565	1.37	1.59	1.255	1.49	1.55	1.55	1.457	1.371	1.435	1.38	1.529	1.466	1.793	1.52	1.439	1.569	1.44	x	1.494	1.46	1.432	1.393	1.096	1.2	1.51	1.73	1.337	1.51	1.469	1.488	1.32	1.446	1.37	1.53	x	1.46	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10676	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral [n/mm^3]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral [n/mm^3]	x	x	118630.0	122192.0	145976.0	131359.0	128675.0	88555.0	134500.0	144911.0	158513.0	169263.0	145143.0	134307.0	152039.0	129656.0	134624.0	150659.0	140469.0	128420.0	113606.0	102254.0	x	139895.0	111356.0	127519.0	117092.0	115391.0	120955.0	169290.0	131745.0	140445.0	147905.0	113316.0	150588.0	x	111140.0	97207.0	117230.0	x	105948.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10677	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral without adjustment [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral without adjustment [n]	x	49515.0	17346.0	13806.0	25188.0	16368.0	15903.0	7126.0	10085.0	6991.0	26372.0	18533.0	19532.0	17495.0	3740.0	13739.0	9159.0	14141.0	8861.0	10742.0	15322.0	15338.0	x	9074.0	10652.0	10636.0	16779.0	7337.0	8966.0	14446.0	15896.0	15057.0	16763.0	16137.0	17002.0	25434.0	9028.0	12216.0	19195.0	x	7626.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10678	Original post publication description: Coat color (version 1, ordinal test case, black=4, brown=3, grey=2, dba dilute=1)	None	Skin, pigmentation: Hair coat color, ordinal scale version 1 black=4, brown=3, grey=2, dba dilute=1 [color intensity]	4.0	4.0	4.0	1.0	1.0	4.0	2.0	2.0	2.0	1.0	4.0	2.0	3.0	4.0	3.0	2.0	2.0	2.0	4.0	1.0	2.0	4.0	3.0	3.0	3.0	3.0	3.0	2.0	1.0	4.0	4.0	2.0	4.0	4.0	3.0	x	2.0	2.0	2.0	x	4.0	4.0	1.0	1.0	x	x	4.0	2.0	4.0	4.0	3.0	3.0	x	3.0	4.0	x	x	3.0	3.0	1.0	3.0	1.0	1.0	3.0	3.0	1.0	3.0	1.0	1.0	1.0	3.0	1.0	3.0	1.0	2.0	1.0	3.0	2.0	1.0	1.0	x	1.0	1.0	1.0	4.0	4.0	3.0	1.0	1.0	1.0	1.0	1.0	2.0	1.0	4.0	3.0	1.0	1.0	4.0	2.0	3.0	1.0	
-10679	Original post publication description: Central nervous system, adult neurogenesis: New neurons in dentate gyrus [density index]	None	Central nervous system, adult neurogenesis: New neurons in dentate gyrus [density index]	x	x	648.5	135.9	177.2	63.2	363.9	511.3	x	248.9	40.9	143.2	x	462.2	236.3	166.6	225.0	307.8	x	519.2	180.3	x	x	312.0	396.4	322.1	158.2	133.0	200.4	244.0	52.8	281.5	146.0	567.0	x	x	626.4	145.6	374.9	x	395.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10680	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral, adjusted for data-collector as a predictor [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral, adjusted for data-collector as a predictor [n]	x	27284.0	17084.0	19532.0	24926.0	16106.0	21133.0	12357.0	9823.0	12222.0	17872.0	18271.0	15609.0	17233.0	8971.0	13478.0	8897.0	13880.0	14092.0	10481.0	15060.0	15076.0	x	14305.0	10390.0	15866.0	22010.0	12567.0	14197.0	19676.0	11973.0	14795.0	12840.0	15876.0	15368.0	x	14259.0	11954.0	18934.0	x	12857.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10681	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral without adjustment [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral without adjustment [n]	x	221979.0	155155.0	160320.0	193887.0	161465.0	162937.0	110008.0	154854.0	166398.0	191778.0	202550.0	173271.0	165921.0	168307.0	154853.0	157273.0	179804.0	168306.0	154443.0	158289.0	130278.0	x	161921.0	142848.0	163329.0	157318.0	147945.0	146161.0	207417.0	169074.0	177990.0	186523.0	153340.0	178442.0	x	135235.0	127721.0	158536.0	x	136131.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10682	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]	x	204790.0	154952.0	157287.0	193684.0	161263.0	166982.0	114052.0	154652.0	170442.0	185206.0	202348.0	170237.0	165719.0	172352.0	154650.0	157070.0	179602.0	172351.0	154241.0	158087.0	130075.0	x	165966.0	142646.0	167374.0	161363.0	151989.0	150205.0	211461.0	166041.0	177788.0	183490.0	153138.0	177179.0	x	139279.0	127518.0	158334.0	x	140176.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10683	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral [n]	x	79883.0	36379.0	38193.0	47982.0	30304.0	34269.0	21890.0	20676.0	21600.0	33449.0	33386.0	28294.0	31755.0	16245.0	25181.0	22502.0	29198.0	27772.0	26036.0	31855.0	28051.0	x	22118.0	31578.0	35878.0	40513.0	32483.0	25261.0	38420.0	37409.0	37578.0	38704.0	39941.0	28237.0	x	24280.0	30583.0	41119.0	x	30189.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10684	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]	x	58250.0	36124.0	34376.0	47727.0	30049.0	39359.0	26980.0	20422.0	26690.0	25177.0	33132.0	24476.0	31500.0	21335.0	24926.0	22247.0	28944.0	32862.0	25782.0	31600.0	27796.0	x	27209.0	31323.0	40969.0	45603.0	37573.0	30351.0	43510.0	33592.0	37324.0	34887.0	39687.0	26647.0	x	29370.0	30328.0	40865.0	x	35279.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10685	Original post publication description: Central nervous system, morphology, aging: Polyglucosan bodies in the hippocampus of 18-month-old females [density]	None	Central nervous system, morphology, aging: Polyglucosan bodies in the hippocampus of 18-month-old females [density]	x	x	406.8	5.8	18.9	45.4	9.5	4.2	x	34.4	160.8	9.8	x	22.5	17.8	8.0	133.0	22.6	646.0	43.2	150.0	11.8	x	4.1	2.6	28.4	4.6	5.2	25.4	19.9	1.5	x	194.5	x	40.5	x	68.0	3.25	75.7	x	8.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10686	Original post publication description: Central nervous system, morphology, aging: Polyglucosan bodies in 18-month-old females (also see AXB/BXA data) [log number]	None	Central nervous system, morphology, aging: Polyglucosan bodies in 18-month-old females (also see AXB/BXA data) [log number]	x	x	2.609	0.763	1.276	1.657	0.978	0.623	x	1.537	2.206	0.991	x	1.352	1.25	0.903	2.124	1.354	2.81	1.635	2.176	1.072	x	0.613	0.415	1.453	0.663	0.716	1.405	1.299	0.176	1.602	2.289	2.301	1.607	x	1.833	0.512	1.879	x	0.916	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10687	Original post publication description: Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days after infection [ratio, death incidence]	None	Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days after infection [ratio, death incidence]	x	0.0	0.0	0.2	0.17	0.2	0.13	0.0	0.11	0.0	0.0	0.1	0.2	0.2	0.0	0.22	0.2	0.0	x	0.13	0.4	0.3	x	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10688	Original post publication description: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions	None	Immune system, infectious disease: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions [burden]	x	0.1	0.11	0.55	0.83	0.6	0.5	0.5	0.56	0.4	0.11	0.2	0.8	0.6	0.11	0.33	0.6	0.56	x	0.13	0.88	0.6	x	0.44	0.3	0.6	0.86	0.5	0.5	0.3	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10689	Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate	None	Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate	x	x	0.07	0.36	0.57	0.44	0.37	0.38	0.45	0.3	0.08	0.13	0.71	0.43	0.11	0.24	0.37	0.44	x	0.14	0.78	0.45	x	0.31	0.29	0.56	0.79	0.36	0.35	0.28	0.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10690	Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia	None	Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia	x	x	0.05	0.21	0.43	0.25	0.06	0.24	0.25	0.23	0.07	0.05	0.45	0.24	0.12	0.11	0.2	0.34	x	0.0	0.12	0.2	x	0.32	0.22	0.16	0.7	0.25	0.33	0.16	0.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10691	Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia	None	Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia	x	x	0.08	0.32	0.49	0.39	0.24	0.31	0.4	0.31	0.15	0.09	0.63	0.51	0.15	0.14	0.04	0.46	x	0.08	0.46	0.23	x	0.39	0.43	0.24	0.75	0.41	0.4	0.24	0.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10692	Original post publication description: Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units]	None	Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units]	x	x	0.05	0.28	0.23	0.33	0.18	0.2	0.25	0.29	0.05	0.12	0.41	0.38	0.06	0.19	0.28	0.36	x	0.03	0.48	0.4	x	0.2	0.16	0.32	0.59	0.25	0.35	0.19	0.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10693	Original post publication description: Morphine metabolism, morphine UDP-glucuronyltransferase activity [units]	None	Morphine metabolism, morphine UDP-glucuronyltransferase activity [units]	x	x	x	x	x	x	x	x	x	x	6.391	3.591	x	3.807	1.013	x	4.576	0.899	x	3.31	0.36	x	x	3.037	1.653	x	x	x	x	x	x	x	3.591	0.244	x	x	x	x	x	x	3.591	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.393	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10694	Original post publication description: Morphine UDP-glucouronytransferease activity [units]	None	Central nervous system, protein expression: Morphine UDP-glucouronytransferease activity (B3GAT genes) [units]	x	x	x	x	6.391	3.807	4.576	3.31	3.037	x	x	3.591	x	2.268	2.009	x	5.6	x	x	4.246	x	x	x	3.525	x	x	x	4.263	x	x	3.991	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10695	Original post publication description: Infectious disease, immune function: Lung inflammatory response, pulmonary granulomatous inflammation induced by BCG [units]	None	Infectious disease, immune system, pulmonary system: Lung inflammatory response, pulmonary granulomatous inflammation induced by BCG [units]	x	x	22.64	9.099	14.695	16.536	14.607	10.647	12.069	9.949	10.0	14.353	14.099	14.797	11.701	7.718	x	12.259	x	x	18.541	7.779	x	9.67	16.624	11.865	7.652	18.579	22.348	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10696	Original post publication description: Spleen weight, splenomegaly induced by BCG [units]	None	Spleen weight, splenomegaly induced by BCG [units]	x	x	33.745	5.443	33.284	23.358	14.483	5.304	15.277	8.284	9.133	11.882	17.989	21.679	4.096	6.476	x	9.723	x	x	35.627	5.055	x	4.557	13.911	11.624	6.642	14.852	19.502	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10697	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0 set to 0]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0 set to 0]	x	x	3.912	3.689	6.174	8.856	x	7.405	x	5.628	4.19	5.67	x	0.0	3.689	0.0	5.659	0.0	6.328	x	0.0	x	x	3.912	5.687	2.996	0.0	4.094	5.521	x	5.606	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10698	Original post publication description: Infectious disease, immune function: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4)	None	Infectious disease, immune system: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4)	x	x	8.745	6.771	6.917	9.13	x	7.243	x	7.095	7.941	6.924	x	6.399	7.175	6.223	6.672	6.033	6.565	x	6.586	x	x	7.466	6.599	6.702	5.595	7.17	6.601	x	7.037	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10702	Original post publication description: Cocaine and amphetamine-regulated transcript (CART) expression in hypothalamus [cycles]	None	Central nervous system, gene expression: Cocaine and amphetamine-regulated transcript (CART) expression in hypothalamus [rtPCR cycles]	x	x	27.143	27.862	x	x	25.832	26.54	26.923	x	26.607	26.79	x	25.388	x	25.795	25.515	26.998	x	24.702	24.515	23.168	x	24.782	27.948	27.396	25.89	25.555	x	25.538	25.075	24.713	28.695	x	24.193	x	25.962	25.655	24.0	x	24.625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10817	Original post publication description: Iron level in plasma of males [ug/dL]	None	Blood chemistry: Iron level in plasma of males [ug/dL]	x	x	133.99	185.47	204.86	150.66	x	170.13	231.86	202.81	183.33	139.13	170.15	180.51	198.0	175.42	180.97	186.07	145.2	174.44	x	180.55	x	190.1	x	201.64	173.95	190.06	x	162.19	172.04	165.4	165.3	x	176.21	x	145.66	197.27	185.21	x	174.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10818	Original post publication description: Iron level in spleen of males [ug/g]	None	Metabolism, physiology, nutrition: Iron level in spleen of males [ug/g]	x	x	385.82	811.1	423.06	318.64	x	311.34	683.85	783.24	1030.55	671.97	565.97	444.43	1033.67	377.62	715.0	289.37	1595.53	567.83	x	874.93	x	573.01	x	415.31	767.53	1165.92	x	615.58	584.82	793.1	539.07	x	443.64	x	609.76	758.64	530.73	x	226.63	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10815	Original post publication description: Central nervous system, learning and memory: Learning performance measured as the difference in swim path to reach the platform between days 1 and 4 of training using Morris water maze [cm]	None	Central nervous system, learning and memory: Learning performance measured as the difference in swim path to reach the platform between days 1 and 4 of training using Morris water maze [cm]	x	x	310.68	45.72	x	277.14	x	346.78	247.07	x	x	-63.8	x	x	x	x	-104.11	-55.06	x	x	x	x	x	x	353.97	x	407.09	135.78	32.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10816	Original post publication description: Central nervous system, learning and memory: Learning measured by the difference in time (latency) to reach the platform between day 1 and day 4 of training using Morris water maze [s]	None	Central nervous system, learning and memory: Learning measured by the difference in time (latency) to reach the platform between day 1 and day 4 of training using Morris water maze [s]	x	x	16.49	7.12	x	18.86	x	19.6	17.12	x	x	-0.16	x	x	x	x	2.43	8.74	x	x	x	x	x	x	21.73	x	21.19	11.78	13.02	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10812	Original post publication description: Iron level in liver of males [ug/g]	None	Metabolism, biochemistry: Iron level in liver of males [ug/g]	x	x	69.82	111.22	77.53	74.37	x	96.36	83.95	75.04	93.44	117.78	71.52	88.16	72.39	79.52	63.21	70.95	147.81	68.94	x	90.22	x	74.16	x	90.39	73.15	85.93	x	102.04	99.63	122.39	113.22	x	95.57	x	61.37	68.06	72.12	x	60.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10813	Original post publication description: Iron level in spleen of females [ug/g]	None	Metabolism, physiology, nutrition: Iron level in spleen of females [ug/g]	x	x	860.54	995.27	542.28	494.1	x	784.22	1181.4	1311.17	1426.57	759.04	1088.49	774.11	1220.66	711.74	1205.27	574.18	x	754.29	x	1848.53	x	1120.68	x	846.75	921.91	1189.27	x	1162.38	836.93	927.8	747.57	x	773.9	x	1095.0	1282.41	973.58	x	296.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10810	Original post publication description: Central nervous system, behavior, learning and memory: Average path length to reach the platform during acquisition of task using Morris water maze [cm]	None	Central nervous system, behavior, learning and memory: Average path length to reach the platform during acquisition of task using Morris water maze [cm]	x	x	511.9	667.87	x	448.8	x	545.87	431.97	x	x	523.36	x	x	x	x	702.46	649.13	x	x	x	x	x	x	514.95	x	606.24	642.95	626.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10808	Original post publication description: Central nervous system, behavior, learning and memory: Learning performance measured as the latency to reach the platform during acquisition of Morris water maze task [s]	None	Central nervous system, behavior, learning and memory: Learning performance measured as the latency to reach the platform during acquisition of Morris water maze task [s]	x	x	21.39	25.42	x	19.4	x	29.27	22.51	x	x	27.53	x	x	x	x	37.81	29.27	x	x	x	x	x	x	20.93	x	25.25	29.27	30.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10709	Original post publication description: Central nervous system, adult neurogenesis: New astrocytes in the dentate gyrus [n per gyrus]	None	Central nervous system, adult neurogenesis: New astrocytes in the dentate gyrus [n per gyrus]	x	x	33.0	79.0	39.0	53.0	21.0	86.0	x	72.0	51.0	33.0	x	65.0	36.0	30.0	29.0	86.0	x	36.0	46.0	x	x	32.0	86.0	36.0	61.0	54.0	53.0	51.0	33.0	34.0	59.0	32.0	x	x	41.0	108.0	19.0	x	73.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10710	Original post publication description: Striatum volume, dorsal striatum, bilateral and shrinkage corrected [mm^3]	None	Central nervous system, morphology: Striatum volume, dorsal striatum of young adults, bilateral and shrinkage corrected [mm^3]	x	x	23.0	21.39	25.505	20.197	27.27	18.768	21.44	23.974	24.309	20.669	18.857	21.035	21.35	20.869	20.812	22.859	19.768	23.424	25.43	18.924	x	22.433	19.59	19.938	20.123	18.741	19.16	20.33	25.748	23.531	22.67	20.276	21.417	x	19.805	21.827	23.241	x	24.039	21.778	26.3	22.73	x	x	x	x	x	24.827	x	x	x	x	x	x	x	x	24.055	x	25.336	22.865	x	x	x	x	x	22.643	x	x	x	23.606	x	22.097	x	24.02	x	x	x	x	x	23.811	x	22.137	26.518	21.136	x	20.182	22.48	x	21.836	x	x	x	x	21.949	x	x	x	x	x	x	
-10711	Original post publication description: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype)	None	Immune system: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype)[units]	x	x	1364.69	57.701	27.576	1335.46	x	682.708	1983.83	58.501	95.828	149.365	494.757	1424.11	135.619	55.259	34.918	1056.04	67.055	747.63	1972.85	942.434	x	47.254	1993.3	2339.99	65.649	1462.76	154.432	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10712	Original post publication description: Cancer susceptibility, skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [n/animal]	None	Toxicology, cancer biology: Skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [n per case]	x	x	0.2	1.7	1.89	x	0.0	2.88	4.0	0.0	0.09	0.5	x	0.0	0.0	0.86	1.5	3.56	x	0.1	1.2	0.22	x	0.13	0.17	0.88	0.0	1.38	0.1	x	0.63	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10713	Original post publication description: Development, urogenital system, environmental toxicology: Hydronephrosis induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]	None	Development, urogenital system, environmental toxicology: Hydronephrosis induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]	x	x	x	x	x	17.0	68.0	39.0	31.0	x	53.0	22.0	x	39.0	0.0	47.0	x	0.0	x	4.0	6.0	x	x	0.0	x	x	x	50.0	x	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10714	Original post publication description: Musculoskeletal system, development, environmental toxicology: Cleft palate frequency induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]	None	Musculoskeletal system, development, environmental toxicology: Cleft palate frequency induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]	x	x	x	x	x	0.0	100.0	89.0	91.0	x	88.0	71.0	x	100.0	0.0	88.0	x	0.0	x	0.0	0.0	x	x	0.0	x	x	x	100.0	x	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10715	Original post publication description: Infectious disease, immune function: Sendai virus lethality with 1.0 TCID50 [% mortality]	None	Infectious disease, immune system: Sendai virus lethality with 1.0 TCID50 [% mortality]	x	0.0	3.0	89.0	0.0	0.0	100.0	33.3	0.0	0.0	0.0	0.0	33.3	33.3	0.0	0.0	100.0	0.0	0.0	66.6	0.0	100.0	x	0.0	0.0	100.0	66.6	100.0	33.3	0.0	33.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10716	Original post publication description: Immune function, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%]	None	Immune system, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%]	x	x	100.0	0.0	65.0	x	21.0	100.0	x	79.0	78.0	x	x	x	x	87.0	71.0	x	x	79.0	61.0	x	x	70.0	54.0	61.0	35.0	x	76.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10717	Original post publication description: Epidermal ornithine decarboxylase (ODC) activity induced by topical TPA administration	None	Epidermal ornithine decarboxylase (ODC) activity induced by topical TPA administration	x	x	36.065	18.652	x	x	23.087	x	20.739	x	x	20.739	x	x	48.261	32.641	x	51.489	x	24.033	11.087	24.978	x	x	x	x	x	x	34.5	x	28.141	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10718	Original post publication description: Infectious disease, immune function: Leishmania L. mexicana lesion diameter in males	None	Infectious disease, immune system: Leishmania L. mexicana lesion diameter after subcutaneous injection in males (this entry is missing data) [mm]	x	x	4.139	0.0	x	x	1.39	4.284	0.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10719	Original post publication description: Infectious disease, immune function: Leishmania L. mexicana skin lesion diameter in females [mm]	None	Infectious disease, immune system: Leishmania L. mexicana skin lesion diameter in females [mm]	x	x	3.892	0.0	x	9.438	1.97	4.332	1.447	x	1.988	4.161	x	x	x	x	x	x	x	x	x	x	x	0.418	0.765	3.307	5.929	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10720	Original post publication description: Zinc level in ventral midbrain of males [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of males [ug/g]	x	x	x	x	x	149.52	x	133.91	177.94	x	172.94	150.62	161.37	156.81	x	195.85	x	x	x	x	182.55	x	x	180.42	x	190.9	166.7	186.46	x	164.04	186.84	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10721	Original post publication description: Zinc level in ventral midbrain of females [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of females [ug/g]	x	x	x	x	x	170.59	x	144.32	154.43	x	202.17	147.75	184.7	152.93	x	160.81	x	x	x	x	177.96	x	x	168.37	x	162.66	192.69	165.58	x	152.53	164.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10722	Original post publication description: Zinc levels in nucleus accumbens of males [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc levels in nucleus accumbens of males [ug/g]	x	x	x	x	x	153.68	x	170.7	150.03	x	208.74	173.65	180.31	145.47	x	226.41	x	x	x	x	204.03	x	x	204.73	x	239.0	206.68	177.51	x	168.61	193.68	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10723	Original post publication description: Zinc level in nucleus accumbens of females [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in nucleus accumbens of females [ug/g]	x	x	x	x	x	147.18	x	178.7	135.98	x	240.55	167.41	238.01	127.37	x	199.38	x	x	x	x	212.23	x	x	212.73	x	182.21	179.17	150.38	x	184.77	205.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10724	Original post publication description: Zinc level in medial prefrontal cortex of males [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of males [ug/g]	x	x	x	x	x	199.68	x	244.13	205.22	x	249.67	201.61	216.4	212.34	x	241.08	x	x	x	x	253.03	x	x	245.68	x	247.56	217.94	201.92	x	222.9	223.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10725	Original post publication description: Zinc level in medial prefrontal cortex of females [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of females [ug/g]	x	x	x	x	x	179.96	x	198.21	211.45	x	238.6	202.93	276.27	189.87	x	186.31	x	x	x	x	244.43	x	x	260.38	x	277.28	234.49	256.44	x	216.3	201.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10726	Original post publication description: Zinc level in dorsal striatum (caudate putamen) of males [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of males [ug/g]	x	x	x	x	x	182.98	x	202.7	217.13	x	243.42	182.11	196.95	173.83	x	221.24	x	x	x	x	223.38	x	x	193.24	x	203.63	219.95	320.0	x	196.99	255.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10727	Original post publication description: Zinc level in dorsal striatum (caudate putamen) of females [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of females [ug/g]	x	x	x	x	x	212.84	x	231.07	183.34	x	233.53	209.86	291.67	162.54	x	199.81	x	x	x	x	217.49	x	x	185.85	x	212.26	191.16	223.03	x	197.97	245.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10728	Original post publication description: Copper level in ventral midbrain of males [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of males [ug/g]	x	x	x	x	x	61.2	x	70.79	76.38	x	58.5	61.36	71.8	58.51	x	69.64	x	x	x	x	70.9	x	x	71.75	x	58.91	49.5	64.74	x	63.46	60.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10729	Original post publication description: Copper level in ventral midbrain of females [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of females [ug/g]	x	x	x	x	x	57.73	x	74.25	63.01	x	78.55	46.63	72.34	58.24	x	68.71	x	x	x	x	74.13	x	x	75.22	x	53.1	63.44	84.25	x	70.42	56.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10730	Original post publication description: Copper level in nucleus accumbens of males [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of males [ug/g]	x	x	x	x	x	29.88	x	74.49	40.044	x	35.56	24.45	46.61	40.37	x	47.98	x	x	x	x	50.63	x	x	28.05	x	103.61	57.09	81.26	x	89.34	51.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10731	Original post publication description: Copper level in nucleus accumbens of females [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of females [ug/g]	x	x	x	x	x	34.7	x	86.77	45.14	x	58.89	35.4	62.1	33.52	x	45.26	x	x	x	x	50.67	x	x	41.84	x	35.86	44.25	75.93	x	42.02	42.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10732	Original post publication description: Copper level in medial prefrontal cortex of males [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of males [ug/g]	x	x	x	x	x	45.62	x	73.08	35.43	x	84.01	43.51	65.37	49.51	x	83.37	x	x	x	x	72.03	x	x	82.4	x	48.89	69.58	31.48	x	67.82	60.49	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10733	Original post publication description: Copper level in medial prefrontal cortex of females [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of females [ug/g]	x	x	x	x	x	38.55	x	45.03	49.33	x	93.36	46.13	62.34	93.94	x	79.53	x	x	x	x	71.04	x	x	64.64	x	74.37	61.39	85.1	x	53.04	46.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10734	Original post publication description: Copper level in dorsal striatum (caudate putamen) of males [ug/g]	None	Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of males [ug/g]	x	x	x	x	x	41.1	x	54.34	70.97	x	55.04	52.73	50.95	36.14	x	61.24	x	x	x	x	51.67	x	x	62.49	x	49.71	45.91	71.26	x	48.42	66.58	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10735	Original post publication description: Copper level in dorsal striatum (caudate putamen) of females [ug/mg]	None	Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of females [ug/mg]	x	x	x	x	x	43.04	x	57.17	50.24	x	57.15	51.49	77.19	37.75	x	62.28	x	x	x	x	49.54	x	x	57.52	x	44.98	71.22	72.06	x	40.31	38.58	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10736	Original post publication description: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [% mice]	None	Toxicology, cancer biology: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [% mice]	x	x	20.0	95.0	78.0	x	0.0	75.0	100.0	0.0	9.0	50.0	x	0.0	0.0	57.0	100.0	100.0	x	10.0	90.0	22.0	x	13.0	8.0	75.0	0.0	88.0	10.0	x	63.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10738	Original post publication description: Dorsal thalamus volume, shrinkage corrected [mm^3]	None	Central nervous system, morphology: Dorsal thalamus volume of young adults, shrinkage corrected [mm^3]	x	x	19.194	16.097	20.507	14.104	22.032	14.353	17.757	20.111	18.285	18.78	16.781	19.045	18.192	17.993	15.932	17.498	15.826	16.783	19.291	20.157	x	16.229	16.804	16.723	16.401	15.967	14.11	16.832	18.686	16.419	15.61	17.648	16.733	x	16.157	16.111	19.959	x	19.137	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10737	Original post publication description: Cerebral cortex grey matter volume residuals after adjustment for age [mm^3 residuals]	None	Central nervous system, morphology: Cerebral cortex grey matter volume residuals after adjustment for age [mm^3 residuals]	x	x	x	x	2.619	-0.538	21.425	-15.268	-7.566	25.875	-4.135	1.498	-2.068	9.026	24.222	13.021	3.022	-1.797	-4.767	x	12.923	3.102	x	-4.391	-1.041	-16.278	-6.036	-12.216	-24.019	-4.962	-8.868	-7.719	0.553	-6.175	2.427	x	-6.443	-2.833	-0.18	x	-7.763	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10739	Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight of ~ 200-day-old males [mg]	None	Musculoskeletal system, morphology: Soleus muscle weight of ~ 200-day-old males [mg]	x	x	x	x	x	9.48	x	10.0	10.52	x	9.213	7.147	9.213	9.747	x	8.44	x	9.467	x	x	6.067	x	x	8.427	x	9.373	8.987	11.227	8.0	8.12	6.667	12.653	8.0	x	x	x	10.04	10.507	6.733	x	8.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10740	Original post publication description: Musculoskeletal system, morphology: Soleus weight in 200-day-old females [mg]	None	Musculoskeletal system, morphology: Soleus weight in 200-day-old females [mg]	x	x	x	x	x	7.133	x	8.8	8.867	x	7.467	6.853	7.64	7.48	x	6.933	x	7.267	x	x	4.507	x	x	6.267	x	7.88	8.147	7.813	6.8	6.667	5.733	9.947	6.133	x	x	x	7.227	7.8	5.76	x	6.907	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10741	Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight in 200-day-old males [mg]	None	Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight in 200-day-old males [mg]	x	x	x	x	x	9.707	x	10.787	11.133	x	12.067	8.987	9.48	9.4	x	8.893	x	9.813	x	x	8.4	x	x	10.213	x	11.0	9.013	12.773	8.547	10.347	8.747	13.467	9.44	x	x	x	11.627	11.707	8.0	x	9.253	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10742	Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 200-day-old females [mg]	None	Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 200-day-old females [mg]	x	x	x	x	x	8.133	x	9.707	9.267	x	8.947	7.92	8.053	7.6	x	8.267	x	8.133	x	x	7.067	x	x	8.133	x	8.8	7.387	9.773	7.387	8.427	7.733	10.333	7.6	x	x	x	9.267	9.093	6.413	x	7.427	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10743	Original post publication description: Musculoskeletal system, morphology: Tibialis anterior (TA) muscle mass in 200-day-old males [mg]	None	Musculoskeletal system, morphology: Tibialis anterior (TA) muscle mass in 200-day-old males [mg]	x	x	x	x	x	49.152	x	49.03	55.394	x	52.485	53.333	51.333	52.182	x	52.485	x	49.273	x	x	38.727	x	x	44.545	x	48.121	48.606	52.424	39.636	44.424	37.758	56.121	48.061	x	x	x	51.091	51.091	41.333	x	44.848	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10744	Original post publication description: Musculoskeletal system, morphology: Tibialis anterior (TA) weight in 200-day-old females [mg]	None	Musculoskeletal system, morphology: Tibialis anterior (TA) weight in 200-day-old females [mg]	x	x	x	x	x	37.212	x	44.485	50.303	x	42.636	46.667	42.424	40.909	x	46.909	x	40.242	x	x	32.061	x	x	33.394	x	40.667	38.545	42.909	33.939	38.606	37.758	45.576	39.515	x	x	x	42.667	41.212	34.061	x	40.727	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10745	Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass of 200-day-old males [mg]	None	Musculoskeletal system, morphology: Gastrocnemius muscle mass of 200-day-old males [mg]	x	x	x	x	x	137.444	x	133.333	142.667	x	131.0	131.0	128.333	138.111	x	142.111	x	142.111	x	x	110.0	x	x	122.222	x	110.0	123.889	135.111	120.111	128.0	102.889	156.667	129.889	x	x	x	141.0	150.444	114.222	x	120.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10746	Original post publication description: Musculoskeletal system, morphology: Gastrocnemius weight in 200-day-old females [mg]	None	Musculoskeletal system, morphology: Gastrocnemius muscle weight in 200-day-old females [mg]	x	x	x	x	x	105.333	x	113.333	125.0	x	101.778	115.556	105.333	106.667	x	126.667	x	112.444	x	x	92.889	x	x	91.444	x	91.778	105.556	111.333	96.333	110.556	94.333	120.444	105.556	x	x	x	109.0	123.889	90.0	x	107.556	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10747	Original post publication description: Polydipsia, drinking slope (contact G Mittleman, g.mittleman@mail.psyc.memphis.edu)	None	Polydipsia, drinking slope (contact G Mittleman, g.mittleman@mail.psyc.memphis.edu)	x	x	0.161	0.041	x	x	0.8	0.663	x	0.738	0.8	0.714	1.7	1.667	x	x	x	x	x	0.6	x	x	x	0.657	x	1.018	x	0.873	x	0.967	0.722	0.9	1.122	x	1.683	x	0.714	0.933	1.0	x	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10748	Original post publication description: Aortic atherosclerotic lesions following 16-week atherogenic diet in 16-month females [average lesions/strain]	None	Aortic atherosclerotic lesions following 16-week atherogenic diet in 16-month females [average lesions/strain]	x	x	x	x	11.364	x	x	38.848	2.242	4.909	55.212	2.121	x	3.939	x	2.242	2.121	8.485	x	x	3.182	26.818	x	39.394	6.424	21.939	7.939	0.758	30.515	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10749	Original post publication description: Blood chemistry, metabolism: High-density lipoprotein (HDL) cholesterol level following 16-week high-fat diet [mg/dL]	None	Blood chemistry, metabolism: High-density lipoprotein (HDL) cholesterol level following 16-week high-fat diet [mg/dL]	x	x	x	x	53.908	x	x	55.692	40.862	33.169	42.154	38.892	x	98.462	x	54.215	52.308	32.615	x	x	43.815	26.092	x	54.462	78.585	100.308	39.938	38.892	47.631	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10750	Original post publication description: HDL cholesterol levels following 16-week chow diet (control group) [mg/dL]	None	Blood chemistry, metabolism: HDL cholesterol levels following 16-week chow diet (control group) [mg/dL]	x	x	x	x	53.347	x	x	70.248	54.628	74.339	67.479	51.446	x	73.223	x	45.537	42.769	53.347	x	x	56.24	62.479	x	68.182	54.711	76.281	48.43	62.644	43.471	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10751	Original post publication description: LDL cholesterol levels following 16-week chow diet (control group) [mg/dL]	None	LDL cholesterol levels following 16-week chow diet (control group) [mg/dL]	x	x	x	x	6.098	x	x	20.031	18.14	9.085	15.163	16.124	x	17.096	x	5.096	8.217	11.214	x	x	6.15	16.155	x	16.155	4.041	18.129	15.09	8.145	15.101	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10752	Original post publication description: Metabolism, cardiovascular system: Cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]	None	Metabolism, cardiovascular system: Cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]	x	x	x	x	5.0	x	x	5.687	5.305	5.432	5.926	7.358	x	5.63	x	5.424	5.309	5.156	x	x	5.848	5.778	x	5.737	5.556	6.053	6.136	7.086	5.185	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10753	Original post publication description: Metabolism, cardiovascular system: LDL cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]	None	Metabolism, cardiovascular system: LDL cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]	x	x	x	x	4.558	x	x	5.479	5.062	5.281	5.835	7.393	x	5.248	x	5.149	5.041	4.959	x	x	5.723	5.686	x	5.521	5.281	5.814	6.07	7.124	4.847	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10754	Original post publication description: Cortical grey matter volume (residual mm3 after adjusting for volume of thalamus, coronal plane, from MBL images)	None	Central nervous system, morphology: Cortical grey matter volume (residual mm3 after adjusting for volume of thalamus, coronal plane, from MBL images)	x	x	14.714	-11.664	-8.595	13.231	4.261	-2.471	-8.05	16.206	-6.68	-2.978	1.256	3.516	22.04	11.616	9.659	-1.27	2.283	x	6.454	-6.746	x	1.087	2.193	-12.728	-1.229	-5.712	-10.281	-1.837	-12.973	-2.983	8.446	-6.234	5.938	x	-0.684	3.105	-9.26	x	-13.631	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10755	Original post publication description: Central nervous system, morphology: Hippocampus, dorsal hippocampus volume, age-adjusted residuals [mm^3]	None	Central nervous system, morphology: Hippocampus, dorsal hippocampus volume, age-adjusted residuals [mm^3]	x	x	2.05	-0.006	1.666	-1.157	1.292	0.315	-1.458	0.862	2.679	-1.457	-1.097	-0.344	2.303	0.542	-4.256	2.744	-0.282	x	1.256	0.174	x	-0.775	-0.927	-1.738	0.299	-2.522	-1.782	-0.816	0.611	0.722	-0.005	-0.514	-0.537	x	-0.416	-0.379	2.876	x	1.108	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10756	Original post publication description: Central nervous system, morphology: Hippocampus, ventral hippocampus volume, age-adjusted residuals (V2 Table 2A) [mm^3]	None	Central nervous system, morphology: Hippocampus, ventral hippocampus volume, age-adjusted residuals (V2 Table 2A) [mm^3]	x	x	0.8	0.3	4.8	-0.5	1.0	-2.5	0.4	-0.1	0.5	-1.6	-0.8	-0.9	1.5	-0.4	-1.2	3.6	-0.6	x	3.6	0.1	x	0.1	-1.0	-3.4	-1.7	-0.8	-1.0	-0.6	3.3	-2.0	-0.6	-1.3	-0.1	x	0.6	-0.9	2.0	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10757	Original post publication description: Central nervous system, morphology: Hippocampus, ventral hippocampus volume residuals, adjusted for differences in age and brain weight (from V3 Table 2A) [mm^3]	None	Central nervous system, morphology: Hippocampus, ventral hippocampus volume residuals, adjusted for differences in age and brain weight (from V3 Table 2A) [mm^3]	x	x	0.9	0.3	4.8	-2.4	1.1	-2.6	0.4	0.1	0.6	-1.5	-0.8	-0.9	1.6	-0.4	-1.2	3.5	-0.6	x	3.6	0.1	x	0.1	-1.1	-3.5	-1.7	-0.9	-1.1	-0.6	3.3	-1.9	-0.7	-1.3	-0.1	x	0.5	-1.0	2.0	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10758	Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight in males at 500 days [mg]	None	Musculoskeletal system, morphology: Soleus muscle weight in males at 500 days [mg]	x	x	10.725	8.626	x	9.791	x	11.033	11.835	x	9.022	6.989	x	12.121	x	8.67	x	9.593	x	x	5.352	x	x	8.022	x	11.352	9.44	12.121	9.374	6.824	7.143	11.407	9.308	x	x	x	8.769	11.011	8.418	x	9.374	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10759	Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight at ~ 500-days-of-age for females [mg]	None	Musculoskeletal system, morphology: Soleus muscle weight at ~ 500-days-of-age for females [mg]	x	x	8.626	7.407	x	6.758	x	9.374	9.418	x	8.89	6.857	x	8.813	x	7.176	x	9.297	x	x	4.176	x	x	6.352	x	9.791	8.253	8.769	8.121	6.824	5.088	8.725	7.879	x	x	x	8.945	8.264	6.44	x	8.319	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10760	Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 500-day-old males [mg]	None	Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 500-day-old males [mg]	x	x	12.286	10.703	x	11.022	x	11.978	12.813	x	12.033	10.341	x	11.374	x	9.451	x	12.44	x	x	9.451	x	x	10.209	x	14.637	9.297	14.088	10.593	12.165	9.451	13.088	11.352	x	x	x	10.934	12.11	9.264	x	11.374	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10761	Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 500-day-old females [mg]	None	Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 500-day-old females [mg]	x	x	9.187	8.495	x	7.791	x	10.593	11.758	x	11.176	8.176	x	8.736	x	8.714	x	10.659	x	x	7.89	x	x	8.714	x	11.396	8.011	10.165	9.143	9.363	8.374	11.011	9.824	x	x	x	9.253	11.033	7.868	x	8.242	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10762	Original post publication description: Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old males [mg]	None	Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old males [mg]	x	x	56.063	44.528	x	47.953	x	50.433	55.472	x	50.669	50.669	x	56.614	x	51.102	x	50.669	x	x	38.398	x	x	45.0	x	51.102	43.031	53.858	39.291	49.567	40.354	49.173	51.52	x	x	x	45.118	51.26	43.819	x	48.622	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10763	Original post publication description: Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old females [mg]	None	Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old females [mg]	x	x	46.299	40.157	x	35.315	x	41.732	49.685	x	47.835	42.913	x	45.63	x	44.567	x	46.378	x	x	31.299	x	x	34.685	x	44.016	37.323	41.22	35.63	41.181	34.094	42.874	43.228	x	x	x	40.472	45.984	34.606	x	40.276	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10764	Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass of 500-day-old males [mg]	None	Musculoskeletal system, morphology: Gastrocnemius muscle mass of 500-day-old males [mg]	x	x	141.604	112.736	x	123.868	x	123.868	141.132	x	116.509	117.358	x	143.113	x	128.491	x	142.453	x	x	112.736	x	x	114.528	x	112.736	104.623	143.113	110.755	128.491	111.509	126.887	138.679	x	x	x	118.208	136.321	105.566	x	118.774	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10765	Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass in 500-day-old females (mg)	None	Musculoskeletal system, morphology: Gastrocnemius muscle mass in 500-day-old females [mg]	x	x	120.755	96.321	x	92.547	x	100.283	122.075	x	108.019	105.66	x	122.83	x	118.113	x	124.906	x	x	89.245	x	x	88.491	x	104.057	96.887	112.547	98.585	112.925	91.038	120.377	114.623	x	x	x	101.321	125.943	91.792	x	105.566	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10766	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	x	x	30.968	983.226	x	0.0	x	0.0	19.355	38.71	x	0.0	0.0	0.0	0.0	0.0	34.839	x	0.0	x	x	34.839	0.0	34.839	0.0	27.097	0.0	x	46.452	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10767	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	13.333	41.111	44.444	861.111	x	288.889	x	288.889	30.0	30.0	x	0.0	52.222	0.0	295.556	0.0	32.222	x	0.0	x	x	0.0	0.0	0.0	13.333	13.333	38.889	x	20.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10768	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	62.326	0.0	416.744	3823.26	x	0.0	x	0.0	19.535	27.907	x	0.0	0.0	0.0	0.0	0.0	84.651	x	0.0	x	x	46.512	50.233	0.0	0.0	50.233	55.814	x	23.256	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10769	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	0.0	0.0	28.0	691.0	x	675.0	x	12.0	34.0	111.0	x	0.0	0.0	44.0	0.0	0.0	226.0	x	50.0	x	x	0.0	136.0	0.0	44.0	22.0	101.0	x	116.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10770	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	204.706	465.882	308.824	1235.29	x	451.765	x	494.118	425.294	245.294	x	317.647	532.941	335.294	432.353	285.882	114.706	x	337.059	x	x	287.647	51.177	377.647	102.353	266.471	460.588	x	536.471	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10771	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	126.667	114.0	26.667	231.333	x	160.667	x	115.333	120.0	310.667	x	104.0	426.667	30.0	106.667	62.667	108.667	x	36.0	x	x	412.0	16.667	106.667	96.667	15.333	33.333	x	186.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10772	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	1586.67	366.67	593.333	5386.67	x	253.333	x	200.0	580.0	360.0	x	220.0	360.0	160.0	206.667	120.0	306.667	x	240.0	x	x	433.333	700.0	266.667	120.0	700.0	213.333	x	366.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10773	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]	x	x	2523.08	92.308	134.615	2211.54	x	553.846	x	500.0	1676.92	157.692	x	0.0	80.769	123.077	123.077	107.692	250.0	x	207.692	x	x	657.692	138.462	211.538	119.231	430.769	169.231	x	200.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10774	Original post publication description: Infectious disease, immune function: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450]	None	Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450]	x	x	0.073	0.055	x	0.046	x	0.051	0.49	0.049	0.096	0.063	x	x	x	x	x	0.058	x	0.17	0.053	0.054	x	x	0.064	x	0.031	x	x	0.048	0.041	0.04	x	x	x	x	0.06	x	0.037	x	0.038	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10775	Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450]	None	Immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450]	x	x	0.235	0.192	x	0.154	x	0.192	0.231	0.204	0.144	0.129	x	x	x	x	x	0.187	x	0.438	0.272	0.225	x	x	0.305	x	0.108	x	x	0.133	0.077	0.11	x	x	x	x	0.085	x	0.045	x	0.175	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10776	Original post publication description: Infectious disease, immune function: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450]	None	Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450]	x	x	0.348	0.213	x	0.145	x	0.278	0.214	0.191	0.185	0.106	x	x	x	x	x	0.248	x	0.538	0.346	0.251	x	x	0.369	x	0.147	x	x	0.258	0.129	0.166	x	x	x	x	0.219	x	0.069	x	0.275	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10777	Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450]	None	IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450]	x	x	0.369	0.166	x	0.139	x	0.25	0.243	0.201	0.154	0.078	x	x	x	x	x	0.25	x	0.381	0.253	0.151	x	x	0.321	x	0.13	x	x	0.258	0.113	0.147	x	x	x	x	0.18	x	0.057	x	0.187	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10778	Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450]	None	IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450]	x	x	0.339	0.166	x	0.231	x	0.229	0.136	0.163	0.115	0.058	x	x	x	x	x	0.202	x	0.325	0.244	0.12	x	x	0.288	x	0.121	x	x	0.216	0.125	0.14	x	x	x	x	0.18	x	0.081	x	0.154	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10779	Original post publication description: Infectious disease, immune function: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)]	None	Infectious disease, immune system: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)]	x	x	x	x	x	173.326	x	482.721	156.048	192.765	133.909	363.931	x	x	x	x	x	105.832	x	126.89	65.335	452.484	x	x	74.514	x	362.851	x	x	105.292	400.108	516.739	x	x	x	x	184.125	x	36.177	x	272.678	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10780	Original post publication description: Coagulation Factor IX (cF.IX) levels following injection of 3e11 vg/mouse AAV2-cF.IX [ng/ml]	None	Immune function: Antibody IgG1 response following iv injection of canine coagulation factor IX (cF.IX, 3E11 vg/mouse) [ng/ml]	x	x	x	x	x	48.596	x	471.382	176.026	271.058	207.883	677.106	x	x	x	x	x	123.11	x	115.551	160.367	166.847	x	x	141.469	x	381.749	x	x	77.214	136.069	118.79	x	x	x	x	118.79	x	63.175	x	126.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10781	Original post publication description: Central nervous system, behavior: Preference for cinnamon-flavored food with pre-exposure to only plain-flavored food [percentage of total diet]	None	Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to only plain-flavored food [percentage of total diet]	x	x	41.769	25.462	36.769	30.769	18.231	37.538	40.462	27.308	17.077	46.538	x	35.846	x	62.692	24.769	38.077	x	39.231	38.077	x	x	28.769	26.538	49.231	18.231	x	18.769	x	5.846	53.692	22.077	49.231	x	x	56.154	29.231	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10782	Original post publication description: Preference for cinnamon-flavored food with pre-exposure to cinnamon-flavored food [percentage of total diet]	None	Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to cinnamon-flavored food [percentage of total diet]	x	x	19.522	45.578	38.566	49.562	28.526	22.869	25.976	15.936	40.876	40.717	x	65.976	x	28.446	30.677	35.06	x	37.052	25.657	x	x	14.661	16.733	22.47	54.024	x	27.41	x	23.586	67.57	18.167	35.857	x	x	51.793	20.319	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10783	Original post publication description: Novel food preference for cinnamon-flavored food [difference score, percentage total diet without pre-exposure minus percentage total diet with pre-exposure to cinnamon]	None	Novel food preference for cinnamon-flavored food [difference score, percentage total diet without pre-exposure minus percentage total diet with pre-exposure to cinnamon]	x	x	21.059	-20.249	-2.118	-19.252	-10.779	14.891	14.704	11.34	-23.863	5.421	x	-30.218	x	x	-6.231	3.115	x	5.358	12.71	x	x	14.081	10.031	26.231	-36.76	x	-8.411	x	-17.695	-14.704	4.237	12.648	x	x	4.486	9.221	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10784	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)]	x	x	3.9	3.733	6.175	14.167	x	7.433	x	x	4.2	5.708	x	0.0	3.733	0.0	5.708	0.0	6.375	x	0.0	x	x	3.9	5.708	3.05	0.0	4.125	5.55	x	5.658	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10785	Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)]	None	Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)]	x	x	8.377	6.785	6.919	9.13	x	7.247	x	7.103	7.955	6.919	x	6.408	7.179	6.238	6.682	6.04	6.57	x	6.605	x	x	7.471	6.605	6.695	5.601	7.179	6.605	x	7.031	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10786	Original post publication description: Corticotropin-releasing factor (CRF) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	None	Central nervous system, gene expression: Corticotropin-releasing factor (CRF) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	x	x	31.032	30.143	31.841	x	30.81	30.94	31.107	x	30.687	30.361	x	31.187	30.194	30.611	30.274	30.81	x	30.778	30.115	31.143	x	30.31	29.817	29.23	30.496	29.437	29.02	28.639	29.325	29.941	30.48	30.345	x	x	x	29.905	30.044	x	30.56	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10787	Original post publication description: Crf-R1 transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	None	Central nervous system, pharmacology, genetics: Corticotropin releasing factor receptor 1 (Crf-R1, CRF1, CRHR1) mRNA transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	x	x	35.373	34.468	x	x	34.969	34.468	35.46	x	34.468	34.579	x	33.881	x	35.778	33.365	36.476	x	32.96	33.873	31.595	x	34.095	36.198	34.135	34.969	31.056	x	34.714	31.389	32.079	38.571	x	32.27	x	33.246	34.302	31.794	x	33.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10788	Original post publication description: Corticotropin-releasing factor binding protein (Crf-BP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	None	Central nervous system, gene expression: Corticotropin-releasing factor binding protein (CRFBP, CRHBP) mRNA expression level in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	x	x	32.293	22.973	x	x	36.147	31.467	32.813	x	33.347	33.52	x	35.453	x	35.053	35.6	36.6	x	32.973	36.6	35.827	x	35.88	27.693	32.973	19.613	28.8	x	21.867	30.587	29.64	33.907	x	25.44	x	32.253	30.587	28.973	x	26.427	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10789	Original post publication description: Arginine vasopressin (AVP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	None	Central nervous system, gene expression: Arginine vasopressin (AVP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]	x	x	24.046	23.377	x	x	22.766	24.023	22.766	x	23.914	23.183	x	23.114	x	21.983	22.08	24.709	x	22.28	21.463	21.326	x	23.28	25.543	23.846	22.926	23.034	x	20.943	21.406	21.903	24.686	x	21.743	x	24.017	22.029	21.983	x	22.526	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10790	Original post publication description: Ethanol response, locomotion during 0 to 5 min interval (updated data PMID 9880575) [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 0 to 5 min interval (updated data PMID 9880575) [cm]	x	2220.13	229.56	2286.16	1069.18	x	273.585	220.126	1160.38	301.887	323.899	704.403	864.78	279.874	820.755	1411.95	2251.57	1805.03	1477.99	1358.49	405.66	528.302	x	172.956	452.83	588.05	544.025	261.006	996.855	471.698	1207.55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10791	Original post publication description: Ethanol response, locomotion during 5 to 10 min interval (updated data PMID 9880575) [cm]	None	Ethanol response, locomotion during 5 to 10 min interval (updated data PMID 9880575) [cm]	x	754.63	560.185	1703.7	458.333	x	-342.593	-518.519	1384.26	-2018.52	453.704	1310.19	324.074	356.481	-273.148	1652.78	2129.63	458.333	2245.37	1851.85	-1134.26	185.185	x	-435.185	-435.185	1810.19	495.37	689.815	888.889	634.259	680.556	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10792	Original post publication description: Ethanol response, locomotion during 10 to 15 min interval (updated data PMID 9880575) [cm]	None	Ethanol response, locomotion during 10 to 15 min interval (updated data PMID 9880575) [cm]	x	310.185	365.741	1115.74	231.481	x	-879.63	-1111.11	1324.07	-2425.93	578.704	578.704	305.556	-134.259	-462.963	1356.48	2254.63	-134.259	1625.0	1675.93	-657.407	-125.0	x	-435.185	-680.556	972.222	935.185	490.741	717.593	912.037	912.037	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10793	Original post publication description: Ethanol response, locomotion during 15 to 20 min interval (updated data PMID 9880575) [cm]	None	Ethanol response, locomotion during 15 to 20 min interval (updated data PMID 9880575) [cm]	x	138.889	240.741	763.889	601.852	x	-847.222	-1365.74	1120.37	-2078.7	583.333	694.444	-250.0	-625.0	-490.741	1189.81	1828.7	-347.222	1050.93	1578.7	-555.556	-69.444	x	-416.667	-671.296	435.185	717.593	69.444	875.0	1152.78	1046.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10794	Original post publication description: Ethanol response, adaptation to ethanol defined as 15-20 min interval locomotion minus 0-5 min interval locomotion [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response, adaptation to ethanol defined as 15-20 min interval locomotion minus 0-5 min interval locomotion [cm]	x	2133.84	30.303	1560.61	482.323	x	1156.57	11811.8	55.556	2401.51	-287.879	-37.879	1146.46	931.818	1338.38	232.323	535.354	2212.12	449.495	-232.323	957.071	560.606	x	593.434	1136.36	159.091	-222.222	-333.333	133.838	-719.697	191.919	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10795	Original post publication description: Central nervous system, adult neurogenesis: Cell proliferation in the adult dentate gyrus, Ki67-positive cells [residuals]	None	Central nervous system, adult neurogenesis: Cell proliferation in the adult dentate gyrus, Ki67-positive cells [residuals]	x	x	x	x	-1.6	-6.24	-3.37	2.61	x	2.25	-6.45	-3.21	x	5.78	-1.78	0.37	0.54	-0.33	x	-1.07	0.59	x	x	-2.67	6.11	1.96	0.7	2.6	-1.6	-2.47	-2.49	1.72	-4.37	3.46	x	x	5.12	-0.82	-1.35	x	2.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10796	Original post publication description: Central nervous system, adult neurogenesis: Survival of new cells in the adult dentate gyrus, BrdU-positive cells [residual n]	None	Central nervous system, adult neurogenesis: Survival of new cells in the adult dentate gyrus, BrdU-positive cells [residual n]	x	x	0.62	-0.34	-0.66	-0.83	-0.13	0.75	x	0.05	-1.15	-0.36	x	0.83	-0.26	-0.4	-0.25	0.13	x	-0.01	-0.14	x	x	-0.38	0.03	0.05	-0.33	-0.39	-0.25	-0.18	-0.4	0.0	-0.41	0.39	x	x	0.63	-0.23	0.35	x	0.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10797	Original post publication description: Central nervous system, adult neurogenesis: New neurons in the adult dentate gyrus [BrdU/NeuN; residuals]	None	Central nervous system, adult neurogenesis: New neurons in the adult dentate gyrus [BrdU/NeuN; residuals]	x	x	1.03	-0.51	-0.81	-1.57	0.24	0.8	x	0.08	-1.97	-0.46	x	0.69	-0.17	-0.53	-0.27	0.05	x	0.05	-0.43	x	x	-0.28	0.2	0.23	-0.4	-0.54	-0.4	-0.23	-0.85	0.04	-0.64	0.62	x	x	0.91	-0.76	0.5	x	0.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10798	Original post publication description: Central nervous system, adult neurogenesis: New astrocyte production level based on ratio of total BrdU cells to S100b+BrdU labeled cells [residuals of the ratio]	None	Central nervous system, adult neurogenesis: New astrocyte production level based on ratio of total BrdU cells to S100b+BrdU labeled cells [residuals of the ratio]	x	x	-0.32	0.52	0.0	0.16	-0.28	0.64	x	0.29	0.17	-0.3	x	0.31	-0.2	-0.64	-0.43	0.41	x	-0.25	-0.09	x	x	-0.52	0.64	-0.47	0.13	0.0	0.16	0.43	-0.02	-0.71	0.28	-0.25	x	x	-0.11	0.91	-0.88	x	0.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10799	Original post publication description: Eye weight, fresh unfixed, corrected for age [mg]	None	Eye, visual system: Eye weight, fresh unfixed, corrected for age [mg]	x	22.438	20.723	21.891	22.96	22.575	20.14	24.059	22.161	19.647	23.296	21.767	18.47	21.509	23.06	x	21.97	21.2	22.563	18.201	20.862	21.266	x	18.683	19.753	22.421	17.692	22.383	18.64	21.702	22.052	21.076	18.87	20.29	23.709	18.28	22.832	24.534	21.32	x	x	23.004	20.975	21.847	x	x	23.844	20.75	21.377	21.073	21.64	19.32	26.408	23.082	17.51	x	x	x	21.868	22.109	21.954	22.842	22.026	22.454	22.271	21.324	23.686	21.929	15.583	23.27	19.32	22.824	19.311	22.243	23.439	24.864	21.936	23.22	23.686	21.06	x	21.477	22.774	22.795	21.603	21.854	24.232	18.572	23.357	23.303	22.798	23.761	x	21.39	21.925	22.878	22.188	23.473	x	x	x	x	
-10801	Original post publication description: Infectious disease, immune function: Streptococcus pyogenes disease severity, residuals after correction for multiple cofactors [severity scale]	None	Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (Fig 1A, residuals after correction for age, sex, body weight and log inoculum, with added strains BXD76 and BXD80) [-1 = high susceptible, +1 is resistant]	x	x	-0.047	-0.5	x	x	x	x	x	-0.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.39	x	x	x	x	x	x	x	x	x	-0.32	-0.065	x	x	0.91	x	x	0.22	x	x	x	x	x	x	x	x	-0.36	-0.39	0.26	x	-0.19	x	-0.29	x	0.24	0.57	-0.01	0.46	x	0.62	-0.3	-0.42	-0.49	-0.55	x	-0.15	-0.355	x	x	x	x	0.47	x	1.08	x	0.44	-0.5	x	1.09	x	-0.64	x	x	-0.49	-0.02	x	-0.47	x	x	x	
-10803	Original post publication description: Cardiovascular system, morphology: Heart weight without statistical adjustment [mg]	None	Cardiovascular system, morphology: Heart weight without statistical adjustment (C57BL/6J data looks anomalous) [mg]	118.9	x	122.3	192.4	149.7	165.7	x	131.4	151.5	130.2	156.7	x	x	126.3	x	x	x	101.4	x	169.2	142.5	141.8	x	150.4	x	132.3	x	124.6	x	125.8	122.1	156.5	x	x	142.5	x	157.2	150.1	x	x	x	126.5	122.7	119.1	x	x	134.6	x	160.2	140.2	x	181.9	168.4	155.6	x	x	x	x	145.4	129.5	128.6	146.7	147.0	151.1	156.3	125.7	140.8	145.7	148.0	176.7	x	149.3	124.0	132.1	138.4	184.9	125.3	161.3	144.4	x	x	135.4	141.0	132.8	180.0	162.3	x	142.9	164.6	142.9	154.6	x	x	148.9	137.1	151.2	150.7	148.7	x	x	x	x	
-12487	Original post publication description: Iron level in ventral midbrain of 120-day-old in females fed 3 ppm Fe diet [µg/g]	None	Central nervous system, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 3 ppm Fe diet [µg/g]	x	x	14.1	12.3	16.3	10.7	x	17.0	10.8	16.4	13.4	12.2	13.8	14.2	x	12.0	13.2	13.2	x	12.0	x	x	x	x	x	x	15.2	13.3	x	18.4	12.5	12.3	15.5	x	x	x	10.1	13.0	10.3	x	13.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12488	Original post publication description: Spleen weight of 120-day-old females fed 3 ppm Fe diet [g]	None	Spleen weight of 120-day-old females fed 3 ppm Fe diet [g]	x	x	0.115	0.183	0.068	0.562	x	0.114	0.158	0.241	0.088	0.16	0.209	0.244	x	0.216	0.156	0.352	x	0.466	x	x	x	x	x	x	0.149	0.144	x	0.041	0.227	0.198	0.071	x	x	x	0.135	0.113	0.096	x	0.235	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12489	Original post publication description: Iron level in spleen of 120-day-old females fed 3 ppm Fe diet [µg/g]	None	Iron level in spleen of 120-day-old females fed 3 ppm Fe diet [µg/g]	x	x	111.3	61.0	195.9	77.6	x	77.8	51.3	86.2	76.5	141.5	57.4	54.8	x	59.2	167.6	28.7	x	37.2	x	x	x	x	x	x	79.6	64.3	x	268.2	84.9	76.2	164.5	x	x	x	68.0	99.5	105.9	x	44.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12490	Original post publication description: Iron level of liver of 120-day-old females fed 3 ppm Fe diet [µg/g]	None	Iron level of liver of 120-day-old females fed 3 ppm Fe diet [µg/g]	x	x	29.1	31.5	31.2	47.4	x	28.7	29.1	27.7	27.5	28.8	27.0	20.5	x	29.8	57.5	23.0	x	29.3	x	x	x	x	x	x	29.1	26.2	x	42.4	35.3	26.7	113.3	x	x	x	28.7	24.0	25.5	x	20.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10805	Original post publication description: Central nervous system, adult neurogenesis: Rostral migratory stream (RMS) BrdU-labeled cells in adults [number per mm]	None	Central nervous system, adult neurogenesis: Rostral migratory stream (RMS) BrdU-labeled cells in adults [number per mm]	x	x	76.0	131.0	x	101.0	x	x	x	96.0	x	x	x	x	x	x	83.0	x	x	x	x	x	x	x	x	x	x	x	x	x	91.0	x	x	x	89.0	x	x	114.0	x	x	x	108.0	88.0	94.0	x	x	78.0	x	83.0	54.0	x	x	x	x	x	x	x	x	85.0	99.0	97.0	x	x	94.0	x	129.0	96.0	126.0	90.0	x	x	96.0	104.0	126.0	x	78.0	x	x	100.0	x	x	x	x	96.0	92.0	115.0	x	92.0	74.0	94.0	119.0	141.0	x	x	103.0	98.0	x	x	x	x	x	x	
-10806	Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival]	None	Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival]	x	x	0.0	3.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.0	x	x	x	0.0	3.0	0.0	x	x	x	x	0.0	3.0	x	x	x	x	3.0	x	x	x	0.0	3.0	0.5	x	1.0	x	3.0	x	x	0.0	x	x	x	3.0	x	3.0	x	3.0	x	x	3.0	x	x	3.0	3.0	3.0	0.0	x	x	3.0	x	x	3.0	x	3.0	x	3.0	x	x	x	x	x	x	x	
-10811	Original post publication description: Iron level in spleen of males and females [ug/g]	None	Metabolism, physiology, nutrition: Iron level in spleen of males and females [ug/g]	x	x	607.35	899.77	474.15	403.54	x	591.56	958.36	1066.06	1228.56	713.76	922.23	583.91	1108.47	566.96	943.79	426.87	x	657.33	x	1445.66	x	864.32	x	617.55	844.72	1179.65	x	878.05	706.53	860.45	639.46	x	621.47	x	828.9	1028.97	752.16	x	256.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10814	Original post publication description: Central nervous system, behavior: average swim speed during acquisition of task using Morris water maze [cm/s]	None	Central nervous system, behavior: Swimming speed during acquisition of task using Morris water maze [cm/s]	x	x	24.69	26.03	x	23.96	x	19.36	19.91	x	x	18.13	x	x	x	x	18.32	18.55	x	x	x	x	x	x	26.43	x	25.13	20.27	21.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10809	Original post publication description: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of males and females [ug/dL]	None	Blood chemistry: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of males and females [ug/dL]	x	x	405.86	499.9	494.61	571.99	x	447.98	535.23	430.96	384.65	451.14	485.46	530.98	588.62	476.69	509.86	392.74	x	516.44	x	511.89	x	526.13	x	520.23	440.44	477.62	x	523.38	383.28	500.41	443.78	x	379.25	x	433.27	441.1	442.84	x	441.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10807	Original post publication description: Central nervous system, learning and memory, adult neurogenesis: percentage of swim path spent in target quadrant [%]	None	Central nervous system, learning and memory, adult neurogenesis: percentage of swim path spent in target quadrant [%]	x	x	31.68	23.14	x	34.18	x	37.46	28.65	x	x	34.2	x	x	x	x	28.08	37.46	x	x	x	x	x	x	35.05	x	30.48	37.46	32.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10820	Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in males and females [%]	None	Blood chemistry: Hematocrit (packed cell volume, erythrocyte volume fraction) in males and females [%]	x	x	41.53	39.3	46.86	40.94	x	37.02	39.61	42.24	39.52	39.04	46.19	40.72	41.0	43.06	40.0	38.87	x	40.04	x	45.68	x	45.11	x	40.45	44.24	41.59	x	38.46	38.72	40.5	40.14	x	40.66	x	36.03	42.58	34.93	x	41.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10821	Original post publication description: Iron level in liver of males and females [ug/g]	None	Iron level in liver of males and females [ug/g]	x	x	82.28	136.53	85.89	89.34	x	117.26	117.25	84.85	108.4	131.24	97.3	97.59	79.97	132.04	80.28	92.54	x	88.83	x	95.41	x	100.97	x	107.66	93.55	94.2	x	116.85	134.11	134.32	139.9	x	107.34	x	77.34	86.54	88.94	x	65.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10822	Original post publication description: Transferrin saturation of males [%]	None	Blood chemistry, metabolism: Transferrin saturation of males [%]	x	x	31.91	42.59	42.41	28.61	x	39.4	41.16	46.55	45.48	27.95	26.45	34.77	30.1	37.9	37.93	51.23	31.8	32.03	x	37.72	x	36.48	x	43.13	39.72	41.77	x	34.31	43.29	36.95	38.0	x	46.87	x	32.32	41.63	43.83	x	39.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10823	Original post publication description: Transferrin saturation of males and females [%]	None	Blood chemistry, metabolism: Transferrin saturation of males and females [%]	x	x	34.87	39.8	42.47	27.9	x	38.0	40.29	46.88	48.46	30.01	35.17	32.76	28.22	36.87	38.27	42.46	x	31.69	x	36.28	x	33.94	x	42.46	39.16	38.99	x	31.77	44.51	33.19	41.19	x	44.26	x	32.19	41.85	40.24	x	39.98	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10824	Original post publication description: Central nervous system, behavior: Locomotor performance, duration on an accelerating rotarod, mean of three trials [s]	None	Central nervous system, behavior: Locomotor performance, duration on an accelerating rotarod, mean of three trials [s]	x	x	77.8	32.4	x	48.94	x	45.15	52.75	x	x	70.75	x	x	x	x	45.45	50.2	x	x	x	x	x	x	91.56	x	36.31	66.0	69.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10825	Original post publication description: Hemoglobin in males [g/dL]	None	Blood chemistry: Hemoglobin in males [g/dL]	x	x	13.63	14.34	13.7	14.15	x	13.62	14.02	13.47	13.0	13.69	10.75	14.04	14.57	15.11	13.46	13.72	14.1	13.47	x	14.79	x	14.91	x	13.66	14.81	15.16	x	14.89	12.21	13.28	14.59	x	13.33	x	12.97	13.43	12.49	x	13.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10826	Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin in males and females [g/dL]	None	Blood chemistry, cardiovascular system: Hemoglobin in males and females [g/dL]	x	x	13.28	13.5	13.91	13.84	x	13.21	13.46	13.83	12.64	13.38	15.76	14.62	14.94	14.78	13.48	12.91	x	13.41	x	14.79	x	14.53	x	13.76	15.33	14.65	x	14.64	12.59	13.71	14.69	x	13.31	x	12.3	13.26	11.6	x	13.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10827	Original post publication description: Blood chemistry, metabolism: Iron binding capacity (systemic, total iron-binding capacity, TIBC, transferrin level) of males [ug/dL]	None	Blood chemistry, metabolism: Iron binding capacity (systemic, total iron-binding capacity, TIBC, transferrin level) of males [ug/dL]	x	x	427.91	418.69	507.52	540.17	x	452.83	568.56	412.65	424.63	512.82	655.2	545.96	649.53	467.31	482.24	373.37	460.93	537.41	x	506.46	x	517.26	x	481.24	437.83	475.98	x	501.26	381.27	472.93	421.39	x	377.46	x	458.63	464.6	428.13	x	462.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10828	Original post publication description: Iron level in plasma of females [g/dL]	None	Blood chemistry: Iron level in plasma of females [g/dL]	x	x	133.96	213.66	191.86	163.39	x	142.49	195.61	183.71	181.07	127.25	163.88	138.06	127.8	178.12	190.96	141.17	x	145.98	x	180.83	x	161.31	x	207.75	177.56	164.6	x	147.04	166.63	153.13	190.61	x	159.51	x	134.29	163.68	152.65	x	166.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10829	Original post publication description: Iron level in plasma of males and females [ug/dL]	None	Blood chemistry: Iron level in plasma of males and females [ug/dL]	x	x	133.97	198.0	199.77	157.24	x	154.77	212.53	192.62	181.07	133.43	165.55	165.08	169.92	176.95	186.13	163.62	x	160.83	x	180.72	x	175.37	x	204.42	175.76	175.4	x	155.52	169.62	159.26	177.11	x	167.57	x	140.16	179.93	170.09	x	171.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10830	Original post publication description: Transferrin saturation of females [%]	None	Blood chemistry, metabolism: Transferrin saturation of females [%]	x	x	38.03	36.71	42.58	27.19	x	36.89	39.73	47.15	51.71	32.45	38.7	29.24	25.4	36.09	38.62	33.07	x	31.34	x	35.16	x	31.64	x	41.65	38.63	37.19	x	28.55	45.83	29.43	44.59	x	41.66	x	32.04	42.04	36.08	x	40.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10831	Original post publication description: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of females [ug/dL]	None	Blood chemistry: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of females [ug/dL]	x	x	380.87	587.28	474.53	605.93	x	444.1	512.32	446.05	336.68	372.64	417.56	507.68	497.25	483.99	537.48	413.51	x	495.48	x	515.89	x	534.23	x	561.66	442.92	478.83	x	551.52	385.6	527.9	469.37	x	380.81	x	404.29	418.97	459.81	x	413.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10832	Original post publication description: Hemoglobin in females [g/dL]	None	Blood chemistry, hematology: Hemoglobin in females [g/dL]	x	x	12.91	12.63	14.22	13.51	x	13.09	13.0	14.18	12.28	13.0	16.26	15.46	15.5	14.54	13.5	12.04	x	13.34	x	14.93	x	14.15	x	13.88	15.81	14.29	x	14.32	13.02	13.71	14.79	x	13.3	x	11.55	13.11	10.59	x	13.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10833	Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in males [%]	None	Blood chemistry: Hematocrit (packed cell volume, erythrocyte volume fraction) in males [%]	x	x	40.93	36.43	47.69	43.06	x	38.91	41.64	42.2	38.92	40.21	32.0	39.64	39.67	42.79	39.06	42.75	40.0	39.31	x	45.53	x	47.96	x	38.94	42.76	45.29	x	38.86	39.47	44.25	38.6	x	41.29	x	36.94	42.0	37.44	x	42.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10834	Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in females [%]	None	Blood chemistry, cardiovascular system: Hematocrit (packed cell volume, erythrocyte volume fraction) in females [%]	x	x	42.13	42.58	42.22	38.67	x	36.56	37.94	42.29	40.18	37.67	47.5	42.09	41.0	43.26	40.94	34.73	x	40.91	x	45.79	x	42.14	x	42.06	45.74	39.0	x	38.0	37.93	36.75	41.79	x	40.07	x	35.0	43.13	32.07	x	41.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10835	Original post publication description: Iron level in liver of females [ug/g]	None	Iron level in liver of females [ug/g]	x	x	96.4	169.68	98.89	104.32	x	133.98	144.67	94.02	124.73	146.94	116.92	113.58	91.35	167.98	98.49	112.69	x	112.35	x	99.73	x	124.43	x	127.24	110.89	100.29	x	134.13	171.05	146.25	170.13	x	118.33	x	94.38	105.02	108.35	x	74.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10836	Original post publication description: Infectious disease susceptibility: Streptococcus pyogenes disease index [ordinal scale]	None	Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (differs from Fig 1A slightly, residuals after correction for age, sex, body weight and log inoculum, with added strain BXD80) [-1 = high susceptible, +1 is resistant]	x	x	1.779	1.415	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.093	1.078	1.815	x	x	2.027	x	x	1.386	x	x	x	x	x	x	x	x	1.224	1.298	1.751	x	1.306	x	0.957	x	2.017	2.5	1.427	2.142	x	2.411	1.481	1.289	x	x	x	2.076	1.714	x	x	x	x	2.144	x	2.818	x	2.297	1.276	x	2.58	x	1.454	x	x	0.997	2.5	x	x	x	x	x	
-12492	Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 120-day-old females fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells]	None	Blood chemistry, cardiovascular system: Hematocrit of 120-day-old females fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells]	x	x	38.4	37.0	38.0	34.2	x	36.6	22.8	33.2	38.6	32.1	35.8	41.5	x	32.8	42.3	24.0	x	22.5	x	x	x	x	x	x	36.7	34.5	x	39.3	38.2	37.0	44.0	x	x	x	35.6	32.1	34.7	x	25.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12493	Original post publication description: Body weight of 120-day-old females fed 3 ppm Fe diet [g]	None	Morphology, nutrition: Body weight of 120-day-old females fed 3 ppm Fe diet [g]	x	x	21.1	23.6	19.8	24.9	x	24.8	20.8	25.1	22.5	19.5	24.5	24.9	x	28.6	33.5	24.0	x	20.2	x	x	x	x	x	x	22.9	22.2	x	23.6	24.9	19.5	25.3	x	x	x	22.1	23.1	22.1	x	22.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12491	Original post publication description: Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 3 ppm iron (Fe) diet [ug/dl]	None	Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 3 ppm iron (Fe) diet [ug/dl]	x	x	8.9	8.9	9.2	8.2	x	8.3	4.5	8.3	9.5	7.0	12.0	9.5	x	7.1	12.6	4.8	x	4.5	x	x	x	x	x	x	8.5	7.2	x	13.6	9.1	8.6	10.8	x	x	x	8.5	8.9	8.7	x	5.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12640	Original post publication description: Anxiety assay (S5_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %].	x	x	9.08	11.848	7.496	8.1	1.041	4.996	12.762	11.181	0.639	15.7	x	5.194	8.213	23.29	3.348	6.389	7.424	19.824	10.448	6.257	x	x	x	1.7	0.944	x	x	8.496	8.025	7.354	7.244	x	4.815	x	7.586	0.958	x	x	10.559	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10984	Original post publication description: Anxiety assay (E10_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [n cm].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E10_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [cm]	x	x	2538.23	3539.62	4208.19	3025.98	1114.16	3942.18	2829.21	2799.54	2457.24	3444.01	x	3353.31	3119.24	3055.16	4828.09	3165.43	3371.16	2966.15	1845.94	2921.62	x	x	x	2447.56	1943.92	x	x	2981.95	3794.69	2435.22	2972.78	x	3479.25	x	3333.48	1668.42	x	x	4491.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10982	Original post publication description: Anxiety assay (E10_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %].	None	Central nervous system, behavior, pharmacology: Anxiety assay (E10_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [%]	x	x	41.393	32.543	51.612	54.307	42.156	47.588	37.965	29.171	30.413	60.671	x	41.866	43.132	51.213	54.276	34.034	41.365	44.076	26.278	44.246	x	x	x	27.206	24.952	x	x	34.305	31.229	54.844	43.86	x	21.746	x	33.285	30.388	x	x	47.312	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12623	Original post publication description: Ethanol response (10% EtOH in tap water) average daily consumption, two bottle choice [g/kg], males	None	Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water) average daily consumption, two bottle choice [g/kg], males	x	x	x	x	3.76	x	x	5.1	x	x	2.62	x	1.15	4.71	x	4.67	x	2.28	x	x	0.4	x	3.28	3.99	x	4.79	x	x	x	4.88	x	x	2.16	x	2.37	x	3.42	x	3.23	x	3.06	8.38	7.42	x	x	x	x	x	x	4.5	x	x	x	3.86	4.91	x	x	x	7.11	x	x	x	x	x	1.93	x	3.7	4.52	6.34	1.66	x	2.8	x	2.82	x	2.73	x	8.17	6.24	x	x	1.31	5.96	3.67	1.97	3.75	x	3.82	4.81	x	3.16	x	x	x	x	x	x	x	5.97	x	x	x	
-10979	Original post publication description: Anxiety assay (S10_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S10_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks].	x	x	23.933	34.875	11.333	10.714	2.0	21.75	36.143	30.0	1.0	35.5	x	9.0	20.125	28.571	11.286	19.556	12.429	39.429	4.0	11.286	x	x	x	3.714	x	x	x	12.875	21.125	11.375	17.667	x	6.111	x	14.714	2.0	x	x	40.111	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12634	Original post publication description: Anxiety assay (E5_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E5_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [sec]	x	x	144.8	116.331	187.325	212.325	140.1	172.45	133.662	87.717	113.117	194.157	x	155.914	143.988	200.55	219.875	122.05	163.986	182.757	115.65	143.767	x	x	x	89.55	89.25	x	x	136.629	84.263	180.475	158.7	x	84.583	x	127.338	96.633	x	x	174.988	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10978	Original post publication description: Anxiety assay (S10_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 10 min session [n entries].	None	Central nervous system, pharmacology, behavior: Anxiety assay (S10_NT), entries into light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during a 10 min test [n]	x	x	20.733	33.063	24.556	24.286	8.889	20.625	22.286	30.714	3.333	21.375	11.75	22.167	28.375	21.0	x	34.111	13.0	37.0	18.0	14.143	x	x	x	7.429	3.667	x	x	17.625	17.875	12.125	20.333	x	16.333	x	19.714	5.75	x	x	37.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12643	Original post publication description: Anxiety assay (S5_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S5_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec].	x	x	75.173	78.369	68.222	79.357	8.433	39.538	81.986	68.757	5.867	110.0	x	46.117	50.487	127.243	34.371	46.678	49.843	116.814	60.871	41.529	x	x	x	12.443	7.011	x	x	54.025	50.438	52.788	55.1	x	39.356	x	53.886	7.862	x	x	100.033	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10975	Original post publication description: Anxiety assay (S10_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [n cm].	None	Central nervous system, pharmacology, behavior: Anxiety assay (S10_TLA), restraint stress (15 min) and saline treated (0.018 ml/g ip), distance traveled in light-dark box, 8-12 week-old males during a 10 min session [cm]	x	x	2257.13	2248.7	2499.44	2141.28	879.617	2348.46	1462.39	1806.77	583.32	2661.98	x	1893.22	2169.0	1620.3	2080.8	2006.74	1149.83	2277.4	1371.43	1332.59	x	x	x	676.619	661.988	x	x	1550.01	1900.54	1263.98	1885.71	x	2095.34	x	1833.82	794.588	x	x	3148.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10973	Original post publication description: Anxiety assay (S10_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S10_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %].	x	x	27.759	27.025	19.83	30.325	6.859	23.304	34.103	28.758	7.199	35.379	x	16.975	25.969	35.477	18.288	24.102	22.176	37.981	21.512	20.338	x	x	x	12.369	4.405	x	x	24.061	19.774	27.251	24.165	x	13.984	x	24.446	7.098	x	x	32.963	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12712	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	5.922	100.0	11.175	x	x	x	x	x	x	7.87	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.584	1.245	4.312	69.422	x	x	x	32.543	65.329	x	x	x	x	5.91	6.172	x	x	x	8.861	38.63	216.377	x	x	x	x	x	x	96.705	1.081	x	x	x	23.349	x	x	4.084	x	x	32.295	x	x	6.431	x	x	x	x	x	3.24	x	x	x	x	x	x	49.312	x	x	x	x	x	x	x	
-12631	Original post publication description: Anxiety assay (E5_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %].	None	Central nervous system, behavior, pharmacology: Anxiety assay (E5_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %].	x	x	19.219	15.192	16.721	31.371	30.138	21.104	15.625	11.556	16.728	25.252	x	16.914	19.158	27.183	23.25	17.062	20.757	26.362	19.129	19.639	x	x	x	12.7	12.996	x	x	19.552	10.046	24.825	23.021	x	8.5	x	15.433	14.283	x	x	17.579	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12632	Original post publication description: Anxiety assay (E5_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E5_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [%]	x	x	48.267	38.777	62.442	70.775	46.7	57.483	44.554	29.239	37.706	64.719	x	51.971	47.996	66.85	73.292	40.683	54.662	60.919	38.55	47.922	x	x	x	29.85	29.75	x	x	45.543	28.087	60.158	52.9	x	28.194	x	42.446	32.211	x	x	58.329	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10970	Original post publication description: Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]	None	Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]	x	x	9.75	18.769	14.625	11.125	3.143	12.25	13.375	11.333	6.833	35.143	x	18.429	7.625	13.0	15.0	8.625	19.857	15.0	6.75	7.5	x	x	x	6.5	2.375	x	x	6.0	10.25	14.75	13.25	x	8.833	x	1.75	8.667	x	x	33.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12638	Original post publication description: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec].	Central nervous system, pharmacology, behavior: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]	Central nervous system, pharmacology, behavior: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]	x	x	99.987	73.246	73.975	163.05	171.686	98.412	61.575	64.317	75.4	22.629	x	84.8	100.35	152.113	105.775	88.237	58.014	108.357	81.912	90.15	x	x	x	59.612	44.112	x	x	100.614	62.337	161.512	122.025	x	34.65	x	61.55	69.567	x	x	91.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12639	Original post publication description: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %].	Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %]	Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %]	x	x	33.329	24.415	24.658	54.35	57.229	32.804	20.525	21.439	25.133	7.543	x	28.267	33.45	50.704	35.258	29.413	19.338	36.119	27.304	30.05	x	x	x	19.871	14.704	x	x	33.538	20.779	53.837	40.675	x	11.55	x	20.517	23.189	x	x	30.533	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10969	Original post publication description: Anxiety assay (E5_NT) , restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries].	None	Central nervous system, pharmacology, behavior: Anxiety level following restraint stress (15 min) and ethanol treatment (1.8 g/kg i.p., E5 NT group) measured as the number of entries into light side of light-dark box in 8-12 week-old males (5 min session) [n]	x	x	15.5	19.077	21.125	12.5	7.429	22.0	21.125	14.0	11.167	9.857	x	17.429	15.125	12.125	12.0	12.0	14.0	14.143	11.375	14.667	x	x	x	12.375	13.375	x	x	9.286	18.125	13.625	11.25	x	12.667	x	16.25	11.5	x	x	21.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10966	Original post publication description: Anxiety assay (E5_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm].	None	Anxiety assay (E5_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm].	x	x	1562.29	1894.02	2293.85	1610.76	864.433	2005.05	1796.43	1404.06	1370.9	1764.78	x	1952.68	1609.46	1542.4	2519.68	1618.42	1836.63	1575.04	959.035	1685.44	x	x	x	1383.49	1284.67	x	x	1576.17	1906.79	1483.2	1594.09	x	1985.53	x	1769.5	1101.41	x	x	2438.62	x	x	x	x	x	2346.97	x	2287.76	x	x	x	x	x	x	x	x	x	x	x	x	964.198	x	x	1564.71	1214.91	x	x	1495.34	x	x	x	x	1382.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2631.01	x	x	x	x	x	x	x	2511.43	x	x	x	x	x	
-10964	Original post publication description: Anxiety assay (E5_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %].	Central nervous system, pharmacology, behavior: Anxiety assay (E5_PDT), after restraint stress (15 min) with ethanol treatment (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [%]	Central nervous system, pharmacology, behavior: Anxiety assay (E5_PDT), after restraint stress (15 min) with ethanol treatment (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [%]	x	x	45.784	37.126	63.005	64.8	49.976	56.924	45.156	30.137	36.471	64.762	x	48.449	46.517	58.562	68.62	37.274	48.779	56.771	33.143	48.495	x	x	x	29.73	32.681	x	x	42.209	29.919	57.416	50.539	x	29.627	x	43.82	33.13	x	x	55.564	x	x	x	x	x	38.536	x	36.1	x	x	x	x	x	x	x	x	x	x	x	x	27.962	x	x	35.01	18.174	x	x	48.489	x	x	x	x	26.263	x	x	x	x	x	x	x	x	x	x	x	x	x	x	49.749	x	x	x	x	x	x	x	42.78	x	x	x	x	x	
-12641	Original post publication description: Anxiety assay (S5_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %].	x	x	25.058	26.123	22.741	26.452	2.811	13.179	27.329	22.919	1.956	36.667	x	15.372	16.829	42.414	11.457	15.559	16.614	38.938	20.29	13.843	x	x	x	4.148	2.337	x	x	18.008	16.812	17.596	18.367	x	13.119	x	17.962	2.621	x	x	33.344	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10960	Original post publication description: Anxiety assay (S5_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries]	None	Anxiety assay (S5_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries]	x	x	11.6	17.875	16.222	14.571	3.889	8.25	11.429	11.571	2.667	11.5	x	14.667	12.75	10.286	9.714	15.0	11.143	18.857	10.429	8.286	x	x	x	4.714	3.0	x	x	7.5	9.125	6.125	11.222	x	11.333	x	9.571	3.125	x	x	19.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10961	Original post publication description: Anxiety assay (S5_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks].	None	Anxiety assay (S5_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks].	x	x	13.8	14.25	8.444	7.429	0.556	7.875	15.571	12.571	0.833	17.875	x	6.333	3.375	12.429	6.0	5.222	10.143	15.857	2.286	4.714	x	x	x	x	x	x	x	4.75	9.75	5.625	8.778	x	5.0	x	5.143	1.0	x	x	22.444	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12633	Original post publication description: Anxiety assay (E5_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec].	None	Central nervous system, behavior, pharmacology: Anxiety assay (E5_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec].	x	x	57.656	45.577	50.163	94.112	90.414	63.312	46.875	34.667	50.183	75.757	x	50.743	57.475	81.55	69.75	51.188	62.271	79.086	57.388	58.917	x	x	x	38.1	38.987	x	x	58.657	30.137	74.475	69.062	x	25.5	x	46.3	42.85	x	x	52.737	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10855	Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio]	None	Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio]	x	x	1.0	0.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.065	0.768	1.078	x	x	x	x	x	0.792	x	x	x	x	x	x	x	x	0.998	0.826	0.866	x	1.01	x	x	x	x	1.061	x	x	x	0.799	x	0.92	x	0.791	x	x	0.826	x	x	0.789	0.867	0.771	x	x	x	0.8	x	x	0.949	x	0.866	x	x	x	x	x	x	x	x	x	
-10856	Original post publication description: Kidney weight, males and females (unilateral, uncorrected, 2006) [mg]	None	Urogenital system, kidney, morphology: Kidney weight, males and females (unilateral, uncorrected, 2006) [mg]	x	x	145.606	270.55	187.45	216.55	x	143.088	221.625	164.025	172.275	126.35	x	149.985	x	x	x	151.267	x	253.633	167.2	145.277	x	199.235	x	142.462	x	174.5	x	153.713	171.961	144.0	x	x	173.982	x	199.013	141.056	x	x	x	144.399	151.833	172.024	x	x	157.463	x	171.458	209.064	x	274.35	211.35	209.722	x	x	x	x	185.52	179.969	179.91	141.2	183.463	183.585	219.989	172.281	190.638	221.318	206.082	231.39	x	165.882	169.575	200.732	155.82	292.702	191.014	226.09	162.03	x	x	176.2	216.021	145.465	166.538	162.842	300.35	196.438	203.683	183.683	196.775	x	x	199.694	175.005	182.109	220.757	170.811	x	x	x	x	
-10858	Original post publication description: Kidney weight (unilateral, regressed to eliminate variance due to age, body weight, and sex in 2006) [mg]	None	Urogenital system, kidney, morphology: Kidney weight (unilateral, regressed to eliminate variance due to age, body weight, and sex in 2006) [mg]	x	x	160.302	248.716	195.054	216.096	x	173.805	205.424	160.032	170.277	179.388	x	165.871	x	x	x	127.126	x	225.016	156.464	162.615	x	176.723	x	162.575	x	162.222	x	161.436	193.208	163.863	x	x	176.489	x	212.577	169.393	x	x	x	155.03	159.074	204.2	x	x	155.162	x	171.14	206.747	x	206.42	184.106	202.612	x	x	x	x	158.987	186.115	183.108	161.031	152.0	170.446	218.927	173.647	184.101	218.163	204.682	183.115	x	180.648	183.043	204.719	168.835	254.595	195.797	182.673	161.99	x	x	173.937	203.098	146.312	161.186	157.216	115.01	200.015	202.309	208.604	180.893	x	x	161.39	167.595	179.197	207.365	170.742	x	x	x	x	
-10859	Original post publication description: Urogenital system, morphology: Kidney weight of adult females, unilateral, without any adjustments [mg]	None	Urogenital system, kidney, morphology: Kidney weight of adult females, unilateral, without any adjustments [mg]	x	x	146.607	214.31	160.95	231.55	x	136.592	222.375	145.56	154.4	126.35	x	133.84	x	x	x	131.675	x	x	201.1	112.12	x	168.671	x	122.036	x	x	x	135.264	145.403	131.817	x	x	128.06	x	185.038	136.15	x	x	x	131.994	130.447	148.027	x	x	148.373	x	173.67	191.003	x	274.35	211.35	201.867	x	x	x	x	154.714	144.4	139.315	130.95	183.367	177.967	170.78	173.438	174.513	181.503	166.713	153.375	x	138.956	151.575	181.6	153.6	290.395	170.79	211.683	165.6	x	x	155.5	195.667	134.111	138.155	149.541	x	173.531	190.289	160.95	167.797	x	x	186.557	161.911	173.15	201.56	162.442	x	x	x	x	
-10861	Original post publication description: Kidney weight of females (unilateral, corrected for age and body weight)[mg]	None	Urogenital system, kidney, morphology: Kidney weight of females (unilateral, corrected for age and body weight)[mg]	x	x	149.614	203.459	173.53	233.396	x	153.291	205.087	147.163	148.028	152.649	x	146.156	x	x	x	115.627	x	x	185.232	141.853	x	157.42	x	131.798	x	x	x	148.291	159.66	137.435	x	x	143.219	x	196.898	159.379	x	x	x	136.423	136.623	172.44	x	x	149.131	x	156.345	193.801	x	201.819	163.679	193.083	x	x	x	x	138.794	153.511	146.038	140.338	129.688	151.809	170.837	159.757	168.833	180.444	164.677	123.317	x	155.365	163.358	176.808	157.689	249.396	176.063	158.13	146.601	x	x	152.475	184.854	133.447	133.099	140.349	x	171.187	183.591	178.114	156.081	x	x	145.403	149.806	170.285	180.041	152.242	x	x	x	x	
-10862	Original post publication description: Kidney weight of males (unilateral) [mg]	None	Urogenital system, kidney, morphology: Kidney weight of males (unilateral) [mg]	x	x	144.203	364.283	213.95	201.55	x	162.575	220.875	182.49	225.9	x	x	170.167	x	x	x	190.45	x	253.633	133.3	166.0	x	270.55	x	179.908	x	174.5	x	166.397	217.11	150.092	x	x	199.494	x	212.988	145.963	x	x	x	165.331	188.495	231.096	x	x	165.673	x	160.4	222.61	x	x	x	213.65	x	x	x	x	205.864	219.095	220.505	164.262	183.75	196.225	281.5	171.125	206.763	254.496	228.579	283.4	x	185.465	178.575	219.864	159.15	295.01	241.575	247.7	161.138	x	x	196.9	231.287	163.128	207.086	183.743	300.35	219.344	222.435	229.15	228.972	x	x	245.675	184.825	193.629	268.75	187.55	x	x	x	x	
-10863	Original post publication description: Urogenital system, renal system, morphology: Kidney weight of males (unilateral, adjusted for age and body size) [mg]	None	Urogenital system, kidney, morphology: Kidney weight of males (unilateral, adjusted for age and body size) [mg]	x	x	172.0	327.439	217.683	200.212	x	185.718	208.151	174.213	194.833	x	x	187.654	x	x	x	130.047	x	249.599	131.801	186.345	x	188.575	x	202.577	x	189.365	x	180.41	234.066	196.828	x	x	208.001	x	230.947	182.928	x	x	x	172.941	181.847	244.243	x	x	164.911	x	167.489	224.027	x	x	x	223.003	x	x	x	x	181.56	220.421	221.701	180.807	184.799	189.836	274.082	192.622	201.25	255.718	241.609	228.725	x	208.063	209.506	236.947	177.814	263.663	206.952	214.419	190.784	x	x	197.541	225.396	155.507	192.297	172.478	109.885	232.413	222.378	246.043	207.672	x	x	177.982	190.784	181.574	244.909	191.05	x	x	x	x	
-13408	Original post publication description: Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid122.	Musculoskeletal system, morphology: VDavid122.	Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm]	x	1125.18	x	x	1126.86	x	x	x	x	x	x	1109.47	x	1095.64	x	x	x	x	x	x	x	x	x	1148.74	x	1105.37	x	1091.85	x	1146.07	x	x	1151.72	x	x	x	x	1135.98	x	x	x	x	1148.68	x	x	x	1086.46	1117.78	x	x	x	x	x	x	1162.25	x	x	x	1081.2	x	1172.09	x	x	1152.19	x	x	1146.35	1141.01	x	1149.01	x	1140.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1131.98	x	1116.59	
-13419	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid133.	Musculoskeletal system, morphology: VDavid133.	Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.191	x	x	0.238	x	x	x	x	x	x	0.202	x	0.179	x	x	x	x	x	x	x	x	x	0.186	x	0.145	x	0.18	x	0.171	x	x	0.182	x	x	x	x	0.177	x	x	x	x	0.166	x	x	x	0.21	0.311	x	x	x	x	x	x	0.151	x	x	x	0.157	x	0.208	x	x	0.157	x	x	0.152	0.149	x	0.139	x	0.167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.13	x	0.148	
-13410	Original post publication description: Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid124	Musculoskeletal system, morphology: VDavid124	Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.738	x	x	0.774	x	x	x	x	x	x	0.7	x	0.611	x	x	x	x	x	x	x	x	x	0.765	x	0.567	x	0.696	x	0.697	x	x	0.662	x	x	x	x	0.635	x	x	x	x	0.661	x	x	x	0.744	0.922	x	x	x	x	x	x	0.614	x	x	x	0.61	x	0.791	x	x	0.607	x	x	0.66	0.615	x	0.603	x	0.677	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.508	x	0.579	
-13417	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid131	Musculoskeletal system, morphology: VDavid131	Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.113	x	x	0.155	x	x	x	x	x	x	0.131	x	0.11	x	x	x	x	x	x	x	x	x	0.123	x	0.08	x	0.11	x	0.1	x	x	0.107	x	x	x	x	0.108	0.107	x	0.127	x	0.093	x	x	x	0.132	0.232	x	x	x	x	x	x	0.086	x	x	x	0.093	x	0.127	x	x	0.095	x	x	0.092	0.082	x	0.076	x	0.096	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.072	x	0.086	
-13409	Original post publication description: Musculoskeletal system, morphology: Femur cortical cross-sectional volume (F.Ct.CSV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid123	Musculoskeletal system, morphology: VDavid123	Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3]	x	1.944	x	x	2.186	x	x	x	x	x	x	2.246	x	1.987	x	x	x	x	x	x	x	x	x	2.377	x	1.735	x	1.921	x	2.178	1.73	x	1.94	x	x	x	x	2.128	x	x	x	x	1.924	x	x	x	2.221	2.946	x	x	x	x	x	x	2.151	x	x	x	2.123	x	2.338	x	x	1.722	x	x	2.145	1.976	x	1.89	x	2.462	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.74	x	1.629	
-13411	Original post publication description: Musculoskeletal system, morphology: Femur cortical marrow volume (F.Ct.MaV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid125.	Musculoskeletal system, morphology: VDavid125.	Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3]	x	1.206	x	x	1.412	x	x	x	x	x	x	1.546	x	1.376	x	x	x	x	x	x	x	x	x	1.612	x	1.168	x	1.224	x	1.48	x	x	1.278	x	x	x	x	1.493	x	x	x	x	1.263	x	x	x	1.477	2.024	x	x	x	x	x	x	1.537	x	x	x	1.513	x	1.547	x	x	1.114	x	x	1.485	1.361	x	1.287	x	1.785	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.232	x	1.05	
-13407	Original post publication description: Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid121.	Musculoskeletal system, morphology: VDavid121.	Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm]	x	1058.55	x	x	1060.0	x	x	x	x	x	x	1037.49	x	1017.67	x	x	x	x	x	x	x	x	x	1064.42	x	1026.68	x	1015.17	x	1074.17	x	x	1075.48	x	x	x	x	1057.4	x	x	x	x	1079.21	x	x	x	1022.05	1044.05	x	x	x	x	x	x	1081.96	x	x	x	1004.64	x	1101.34	x	x	1079.85	x	x	1073.67	1066.19	x	1071.53	x	1068.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1044.59	x	1043.12	
-13418	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid132	Musculoskeletal system, morphology: VDavid132	Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.28	x	x	0.303	x	x	x	x	x	x	0.277	x	0.237	x	x	x	x	x	x	x	x	x	0.244	x	0.21	x	0.283	x	0.253	x	x	0.258	x	x	x	x	0.246	x	x	x	x	0.223	x	x	x	0.297	0.426	x	x	x	x	x	x	0.22	x	x	x	0.23	x	0.32	x	x	0.19	x	x	0.219	0.215	x	0.207	x	0.256	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.178	x	0.192	
-13416	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid130	Musculoskeletal system, morphology: VDavid130	Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.263	x	x	0.299	x	x	x	x	x	x	0.25	x	0.216	x	x	x	x	x	x	x	x	x	0.252	x	0.189	x	0.268	x	0.263	x	x	0.239	x	x	x	x	0.234	x	x	x	x	0.199	x	x	x	0.298	0.47	x	x	x	x	x	x	0.197	x	x	x	0.212	x	0.347	x	x	0.147	x	x	0.219	0.19	x	0.184	x	0.247	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.148	x	0.164	
-13395	Original post publication description: Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid101.	Musculoskeletal system, morphology: VDavid101.	Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3]	1051.24	1049.39	1041.72	1072.6	1032.56	x	x	x	x	x	1033.94	1027.9	x	1029.09	x	x	x	x	x	x	x	x	x	x	x	x	x	1014.41	x	1044.11	1045.3	x	1065.49	x	x	x	1058.73	1069.4	x	x	x	x	1061.51	x	x	x	1023.37	1025.36	x	x	x	x	x	x	1069.03	x	x	x	1012.59	x	1077.46	x	x	1063.73	x	x	1046.13	1047.05	1016.6	1048.7	x	1044.6	x	1061.88	x	x	x	1080.76	1023.48	x	x	1062.04	x	x	x	1057.84	x	1043.8	1064.68	x	x	x	x	x	x	x	1037.83	x	1030.75	x	1029.29	x	
-13412	Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid126	Musculoskeletal system, morphology: VDavid126	Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2]	x	2.479	x	x	2.788	x	x	x	x	x	x	2.865	x	2.534	x	x	x	x	x	x	x	x	x	3.031	x	2.213	x	2.45	x	2.777	x	x	2.475	x	x	x	x	2.714	x	x	x	x	2.454	x	x	x	2.833	3.758	x	x	x	x	x	x	2.744	x	x	x	2.707	x	2.982	x	x	2.196	x	x	2.736	2.521	x	2.41	x	3.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.219	x	2.078	
-13414	Original post publication description: Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid128	Musculoskeletal system, morphology: VDavid128	Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2]	x	1.538	x	x	1.801	x	x	x	x	x	x	1.972	x	1.755	x	x	x	x	x	x	x	x	x	2.056	x	1.49	x	1.562	x	1.888	x	x	1.63	x	x	x	x	1.904	x	x	x	x	1.611	x	x	x	1.884	2.581	x	x	x	x	x	x	1.961	x	x	x	1.929	x	1.973	x	x	1.421	x	x	1.894	1.736	x	1.642	x	2.277	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.572	x	1.34	
-13965	Original post publication description: Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Original pre publication description: Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	x	1493.0	1365.0	x	x	1760.0	1462.0	1433.0	x	1361.0	1347.0	1501.0	x	1467.0	x	x	1421.0	x	1536.0	x	1461.0	x	x	x	x	x	1497.0	x	x	1369.0	x	x	1456.0	x	x	x	x	1529.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13415	Original post publication description: Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid129	Musculoskeletal system, morphology: VDavid129	Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.376	x	x	0.454	x	x	x	x	x	x	0.382	x	0.325	x	x	x	x	x	x	x	x	x	0.375	x	0.269	x	0.377	x	0.363	x	x	0.346	x	x	x	x	0.342	x	x	x	x	0.292	x	x	x	0.429	0.703	x	x	x	x	x	x	0.283	x	x	x	0.305	x	0.474	x	x	0.242	x	x	0.31	0.271	x	0.259	x	0.343	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.22	x	0.25	
-13420	Original post publication description: Central nervous system, morphology; Neocortical Neuron Number, corrected for age, sex, plane of section, and epoch. Original pre publication description: Central nervous system, morphology; CX Neur Resid Epoch	Central nervous system, morphology: CX neur resid epoch	Central nervous system, morphology: Neocortex total neuron number in adults (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million]	x	x	11830800.0	11157100.0	10601600.0	11163400.0	13334600.0	11109200.0	11990700.0	11132200.0	12209600.0	11521900.0	11265000.0	11495800.0	12114200.0	11177800.0	12085700.0	11620500.0	11263900.0	10483900.0	12840200.0	10715500.0	x	11331800.0	11303000.0	11028200.0	11331300.0	10437800.0	10095300.0	12014600.0	11759000.0	10762400.0	11859700.0	12469000.0	11108400.0	x	10347300.0	11323000.0	10732600.0	x	10218500.0	11152900.0	x	10307600.0	x	x	12237000.0	x	12149400.0	10632700.0	x	x	x	11260100.0	11501900.0	x	x	x	x	11141100.0	x	11049800.0	10282500.0	11083500.0	11665400.0	10327700.0	10396700.0	11758800.0	11135800.0	10761600.0	x	11565100.0	11159500.0	10463700.0	11687700.0	10196000.0	x	11794400.0	12256400.0	x	x	11226000.0	12464100.0	10303100.0	11803200.0	11738200.0	x	10119300.0	12368900.0	x	10835800.0	12668900.0	x	x	11098400.0	11870500.0	x	x	x	x	x	x	
-13421	Original post publication description: Central nervous system, morphology; Neocortical non-neuron number, corrected for age, sex, plane of section, brain weight, and epoch. Original pre publication description: Central nervous system, morphology; NN Resid Epoch	Central nervous system, morphology: NN Resid Epoch	Central nervous system, morphology: Neocortex total non-neuron number (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million]	x	x	8190010.0	6923150.0	6652630.0	7052070.0	8048980.0	7476330.0	7163880.0	7100610.0	8002900.0	8035020.0	7530320.0	7538210.0	8094700.0	7242550.0	7126570.0	7136640.0	7288940.0	7044620.0	7999740.0	7279960.0	x	6785060.0	6967760.0	6941780.0	7888920.0	6362900.0	6667770.0	8256570.0	6965960.0	6796330.0	7059900.0	7838800.0	6529180.0	x	6340740.0	6899080.0	7034380.0	x	6664930.0	8148550.0	x	7085650.0	x	x	6470000.0	x	5906590.0	7234430.0	x	x	x	8142930.0	7697750.0	x	x	x	x	7247230.0	x	7263900.0	6951120.0	7260540.0	7355060.0	6760940.0	7668470.0	7356350.0	7338400.0	8079740.0	x	7992770.0	6408160.0	7275730.0	5803020.0	7332970.0	x	6212290.0	7795820.0	x	x	7114380.0	6938030.0	7011400.0	6977880.0	7983970.0	x	6532480.0	7256050.0	x	7024570.0	6503720.0	x	x	4922660.0	7944690.0	x	x	x	x	x	x	
-13413	Original post publication description: Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid127	Musculoskeletal system, morphology: VDavid127	Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2]	x	0.941	x	x	0.987	x	x	x	x	x	x	0.893	x	0.78	x	x	x	x	x	x	x	x	x	0.976	x	0.723	x	0.888	x	0.889	x	x	0.845	x	x	x	x	0.81	x	x	x	x	0.843	x	x	x	0.949	1.176	x	x	x	x	x	x	0.783	x	x	x	0.778	x	1.009	x	x	0.775	x	x	0.841	0.784	x	0.769	x	0.863	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.648	x	0.739	
-10865	Original post publication description: Infectious disease, immune function: H5N1 influenza A virus mortality rate 30 days after infection (Boon-Webby Trait 1) [% death]	None	Infectious disease, immune system: H5N1 influenza A virus mortality rate 30 days after infection (10^4 EID-50 of HK213 virus in 30 microliters saline) [% death]	x	0.0	0.0	100.0	66.7	0.0	100.0	50.0	0.0	100.0	0.0	28.6	100.0	100.0	66.7	33.3	100.0	100.0	100.0	100.0	100.0	66.7	x	x	x	83.3	100.0	0.0	x	0.0	100.0	100.0	100.0	x	100.0	x	62.5	0.0	75.0	x	100.0	0.0	83.3	50.0	x	x	28.6	x	100.0	50.0	x	x	x	100.0	100.0	x	x	x	22.2	71.4	66.7	0.0	x	100.0	75.0	100.0	0.0	83.3	57.1	0.0	x	90.0	x	81.8	x	88.9	x	x	75.0	x	x	100.0	100.0	0.0	85.7	66.7	x	85.7	80.0	x	100.0	x	x	x	0.0	100.0	12.5	100.0	11.1	x	x	x	
-10866	Original post publication description: Infectious disease, immune function: H5N1 influenza A virus survival time (Trait 2) [days, max to 30]	None	Infectious disease, immune system: H5N1 influenza A virus survival time (10^4 EID-50 of HK213 virus in 30 microliters saline) [days, max to 30]	x	30.0	30.0	8.0	16.0	30.0	11.0	22.0	30.0	11.0	30.0	24.0	8.0	12.0	19.0	23.0	10.0	12.0	12.0	11.0	8.0	20.0	x	x	x	16.0	9.0	30.0	x	30.0	9.0	11.0	8.0	x	9.0	x	19.0	30.0	18.0	x	9.0	30.0	15.0	21.0	x	x	26.0	x	11.0	20.0	x	x	x	12.0	11.0	x	x	x	27.0	18.0	17.0	30.0	x	11.0	19.0	10.0	30.0	15.0	21.0	30.0	x	12.0	x	15.0	x	15.0	x	x	15.0	x	x	11.0	10.0	30.0	15.0	19.0	x	13.0	14.0	x	11.0	x	x	x	30.0	9.0	28.0	11.0	29.0	x	x	x	
-10867	Original post publication description: Infection disease, immune function: Cox-Hasty trait 1	None	Infection disease, immune function: Cox-Hasty trait 1	x	15474.0	4345.0	24993.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14177.0	x	x	x	x	x	x	x	16427.0	9416.0	x	x	x	x	8735.0	11947.0	17931.0	x	x	x	x	x	20306.0	x	x	x	21675.0	x	26393.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10870	Original post publication description: Corticosterone in plasma, level after a 10 min forced swim test (blood taken 30 min after stressor) [ng/ml]	None	Endocrinology, metabolism, pharmacology, central nervous system: Corticosterone in plasma, level after a 10 min forced Porsolt swim test (blood taken 30 min after stressor) [ng/ml]	x	x	180.282	167.389	x	x	x	x	280.992	x	302.05	108.79	x	x	x	150.224	x	x	x	294.586	210.1	256.259	x	x	x	x	x	x	x	x	x	x	x	x	x	x	323.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12985	Original post publication description: Liver distress test fold change in females (serum alanine aminotransferase activity fold change at 24hr post-gavage relative to averaged saline control activity) [ratio]	None	Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity fold change at 24 hr post-gavage in adult females relative to averaged saline control activity) [ratio]	x	x	1.65	1.56	x	x	x	x	x	x	x	x	x	x	x	1.49	x	0.97	x	x	x	x	1.32	x	x	x	x	x	x	x	1.25	x	1.33	x	x	x	0.95	1.04	1.0	x	1.5	1.06	1.35	1.1	x	x	1.13	x	1.26	1.0	x	x	x	0.92	1.31	x	x	x	1.01	1.42	1.05	x	x	x	1.04	x	0.77	1.61	0.88	0.87	x	0.89	x	1.04	x	0.88	x	x	x	x	x	1.21	0.97	x	0.85	1.35	x	1.01	0.97	x	x	x	x	x	1.17	x	0.97	x	1.67	0.78	1.38	1.62	
-13010	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 6 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 6 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%]	x	83.6	85.9	75.0	87.4	82.8	86.25	x	87.85	100.0	87.7	76.4	92.65	76.5	75.0	81.2	75.0	81.5	87.7	84.95	x	91.2	x	x	x	x	75.0	x	x	77.5	82.0	x	75.2	x	75.0	x	75.0	89.5	77.7	x	86.2	95.7	77.19	x	x	x	x	x	x	75.0	x	x	x	83.6	77.03	x	x	x	81.33	84.25	75.0	x	x	86.26	x	84.62	x	83.88	75.02	84.55	x	78.1	79.71	86.16	x	x	x	90.78	75.22	x	x	x	83.04	x	x	86.67	x	77.89	x	x	89.61	x	x	x	87.3	99.0	95.35	x	79.57	x	78.94	75.0	
-10957	Original post publication description: Central nervous system, behavior: Anxiety assay (S5_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm].	None	Central nervous system, behavior: Anxiety assay (S5_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm].	x	x	1350.63	1168.65	1583.18	1344.02	501.837	1264.05	844.097	841.759	358.64	1442.16	x	1170.17	1013.29	974.677	1299.97	1063.92	809.81	1162.45	778.19	808.136	x	x	x	361.024	469.222	x	x	767.665	1072.95	857.003	1098.72	x	1374.07	x	939.474	437.724	x	x	1754.67	x	x	x	x	x	1496.21	x	1347.73	x	x	x	x	x	x	x	x	x	x	x	x	430.348	x	x	835.454	494.76	x	x	1091.98	x	x	x	x	842.195	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1529.77	x	x	x	x	x	x	x	1216.5	x	x	x	x	x	
-10873	Original post publication description: Corticosterone in plasma, baseline control level [ng/ml]	None	Endocrinology, metabolism, pharmacology: Corticosterone in plasma, baseline control level [ng/ml]	x	x	19.572	63.643	x	x	x	x	48.046	x	16.76	9.61	x	x	x	42.994	x	x	x	33.048	x	45.808	x	x	x	x	x	x	x	x	x	x	x	x	x	x	66.803	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12716	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	17.598	100.0	102.367	x	x	x	x	x	x	1333.47	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3906.73	2286.04	1108.91	199.614	x	x	x	296.821	69.278	x	x	x	x	504.909	17.634	x	x	x	126.807	1772.56	357.497	x	x	x	x	x	x	8.794	84.718	x	x	x	9.822	x	x	220.352	x	x	248.021	x	x	1912.9	x	x	x	x	x	836.166	x	x	x	x	x	x	1680.49	x	x	x	x	x	x	x	
-10955	Original post publication description: Central nervous system, behavior: Anxiety assay (S5_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %].	None	Central nervous system, behavior: Anxiety assay (S5_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %].	x	x	27.477	25.55	24.462	36.169	6.198	15.932	34.124	21.273	7.226	35.495	x	19.588	15.663	34.683	15.39	17.709	25.045	37.856	23.462	18.899	x	x	x	6.982	4.88	x	x	21.75	17.493	23.355	22.891	x	15.207	x	22.688	5.087	x	x	36.745	x	x	x	x	x	13.927	x	16.425	x	x	x	x	x	x	x	x	x	x	x	x	16.298	x	x	21.808	12.588	x	x	34.589	x	x	x	x	17.812	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.526	x	x	x	x	x	x	x	17.197	x	x	x	x	x	
-10877	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral without adjustment (revised) [n]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral without adjustment (revised) [n]	x	142096.0	118776.0	115640.0	145905.0	131162.0	128669.0	88118.3	134178.0	144798.0	158329.0	169164.0	144977.0	134166.0	152062.0	129672.0	134771.0	150606.0	140534.0	128407.0	126434.0	102227.0	x	139803.0	111270.0	127451.0	116805.0	115461.0	120899.0	168997.0	131665.0	140412.0	147819.0	113399.0	150205.0	117114.0	110955.0	97137.7	117417.0	x	105942.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10878	Original post publication description: Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron cell density [n/mm^3]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron cell density [n/mm^3]	x	195332.0	194029.0	191757.0	224537.0	233111.0	216619.0	193513.0	211763.0	236667.0	268387.0	277313.0	262789.0	228693.0	247519.0	226246.0	240694.0	226049.0	252630.0	246571.0	186919.0	205137.0	x	221443.0	207733.0	222699.0	208493.0	249199.0	249590.0	259808.0	216680.0	256055.0	263028.0	214974.0	257486.0	260372.0	216735.0	192564.0	211243.0	x	202496.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10879	Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell density [n/mm^3]	None	Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell density [n/mm^3]	x	67549.0	28476.0	21240.0	38917.0	31885.0	27324.0	14627.0	16736.0	11461.0	44827.0	33476.0	39408.0	29326.0	5881.0	23344.0	15903.0	21626.0	17393.0	17351.0	12012.0	29319.0	x	14468.0	18041.0	18387.0	29748.0	15832.0	18953.0	22418.0	26687.0	26513.0	29121.0	31479.0	27871.0	47965.0	17975.0	23602.0	33304.0	x	14832.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10919	Original post publication description: Primary somatosensory cortex, posterior medial barrel subfield, statistically adjusted for variation in brain weight [mm2]	None	Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield, statistically adjusted for variation in brain weight [mm2]	x	2.45	1.96	2.14	1.68	1.822	x	x	x	1.928	x	1.866	x	x	x	x	x	x	x	x	x	x	x	2.031	2.0	x	x	x	x	1.78	1.825	1.942	x	x	x	x	x	1.771	1.955	x	x	2.353	1.761	x	x	x	x	x	x	2.095	x	x	x	2.163	1.914	x	x	x	1.929	1.942	1.577	1.876	1.86	x	1.979	x	1.871	1.942	1.903	2.014	2.041	1.693	x	1.692	x	1.982	x	x	1.95	x	x	1.746	2.079	x	1.885	x	2.065	2.093	2.093	x	1.954	2.246	x	x	1.564	2.105	1.724	x	x	x	x	x	
-10887	Original post publication description: Primary somatosensory cortex, posterior medial barrel subfield area [mm2, no adjustments]	None	Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield area [mm2, no adjustments]	x	2.5	2.0	2.08	1.7	1.81	x	x	x	1.96	x	1.89	x	x	x	x	x	x	x	x	x	x	x	2.0	1.97	x	x	x	x	1.76	1.82	1.9	x	x	x	x	x	1.73	2.02	x	x	2.38	1.82	x	x	x	x	x	x	2.15	x	x	x	2.25	1.92	x	x	x	1.96	2.0	x	1.87	1.8	x	1.88	x	1.9	1.99	1.86	2.11	2.05	1.76	x	1.71	x	2.03	x	x	1.95	x	x	1.8	2.06	x	1.97	x	2.07	2.05	2.09	x	2.05	2.25	x	x	1.69	2.15	1.71	x	x	x	x	x	
-10888	Original post publication description: Central nervous system, morphology: Brain weight, fixed tissue without corrections [mg]	None	Central nervous system, morphology: Brain weight, fixed tissue without corrections [mg]	x	423.62	415.57	345.83	394.0	375.45	x	x	x	403.9	x	397.5	x	x	x	x	x	x	x	x	x	x	x	357.5	361.0	x	x	x	x	363.21	380.48	350.9	x	x	x	x	x	352.3	428.4	x	x	399.55	422.85	x	x	x	x	x	x	420.6	x	x	x	445.85	388.6	x	x	x	405.85	421.35	388.2	375.9	336.17	x	311.73	x	400.65	415.3	349.65	455.9	385.8	432.7	x	394.6	x	413.97	x	x	380.38	x	x	421.55	370.4	x	446.45	x	389.03	346.35	382.03	x	450.55	388.4	x	x	474.55	417.05	368.45	x	x	x	x	x	
-10890	Original post publication description: Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published)	None	Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published)	x	x	346.5	553.0	260.0	831.0	618.0	292.0	373.0	724.0	921.0	555.0	195.0	510.0	359.0	545.0	461.0	449.0	371.0	515.0	515.0	287.0	x	335.0	249.0	320.0	597.0	144.0	478.0	554.0	468.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10891	Original post publication description: Central nervous system, morphology, visual system: Photoreceptor density (rods and cones) [cells/mm^3]	None	Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD32 excluded due to retinal degeneration, 201980+/-30851) [cells/mm^3]	532285.0	496127.0	454220.0	476438.0	457599.0	x	430738.0	446377.0	495641.0	420529.0	430495.0	450736.0	466350.0	414452.0	446296.0	x	x	x	x	x	x	433777.0	x	x	x	440170.0	x	x	x	412741.0	x	417369.0	459468.0	x	453167.0	x	483159.0	444788.0	425391.0	x	x	447714.0	391359.0	476600.0	x	x	429863.0	x	464332.0	463797.0	x	x	x	424639.0	481688.0	x	x	x	430323.0	438309.0	487072.0	435697.0	465094.0	484666.0	470057.0	417661.0	x	438878.0	439927.0	514277.0	x	454852.0	483608.0	472325.0	x	507147.0	x	x	475595.0	489766.0	x	x	426039.0	466512.0	465377.0	409347.0	x	471576.0	447365.0	x	506701.0	x	x	x	421453.0	459746.0	451449.0	x	x	x	x	x	
-12719	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) KC from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), chemokine (C-X-C motif) ligand 1 level (CXCL1, KC, Chr 5 at 91 Mb) from draining lymph node 3 weeks post infection in females [% of C57BL/6 control]	x	43.682	100.0	84.903	x	x	x	x	x	x	196.495	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	412.083	211.6	416.608	146.014	x	x	x	74.957	211.98	x	x	x	x	703.704	16.132	x	x	x	44.87	240.669	92.471	x	x	x	x	x	x	89.935	52.013	x	x	x	69.647	x	x	47.703	x	x	81.268	x	x	145.258	x	x	x	x	x	120.342	x	x	x	x	x	x	237.246	x	x	x	x	x	x	x	
-10893	Original post publication description: Septal nuclei volume, in situ postmortem from high field MRI [bilateral, mm^3]	None	Central nervous system, morphology: Septal nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	2.764	2.186	2.834	x	x	3.254	x	x	x	x	x	x	2.557	2.564	x	x	x	x	x	x	x	2.805	x	2.136	2.506	2.665	x	x	x	x	2.437	x	x	x	x	x	2.397	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10894	Original post publication description: Striatum (caudate-putamen), bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Striatum (caudate-putamen), bilateral, in situ postmortem from high field MRI [mm^3]	x	x	22.228	17.108	20.532	x	x	17.816	x	x	x	x	x	x	24.143	20.484	x	x	x	x	x	x	x	20.261	x	20.086	20.311	18.547	x	x	x	x	22.331	x	x	x	x	x	21.044	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10895	Original post publication description: Hippocampus volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Hippocampus volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	29.905	21.497	23.571	x	x	20.215	x	x	x	x	x	x	26.703	23.468	x	x	x	x	x	x	x	21.193	x	21.532	21.124	23.303	x	x	x	x	21.921	x	x	x	x	x	26.575	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10896	Original post publication description: Anxiety assay, closed arm entries in an elevated plus maze test [n]	None	Central nervous system, behavior: Anxiety assay, closed arm entries in an elevated plus maze test [n]	x	x	16.33	24.58	x	x	x	x	12.42	x	6.38	16.18	16.33	x	x	17.42	x	18.17	x	18.8	20.69	16.17	x	x	x	x	11.2	x	x	11.89	23.83	x	19.58	x	x	x	17.33	17.182	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10897	Original post publication description: Pain response, thermal nociception, latency to paw withdrawal and licking response using a hot plate test [sec]	None	Central nervous system, behavior: Pain response, thermal nociception, latency to paw withdrawal and licking response using a hot plate test [sec]	x	x	7.136	6.709	x	x	x	x	11.95	x	7.829	7.355	8.0	x	x	7.225	x	5.433	x	5.533	8.07	6.027	x	x	x	x	8.36	x	x	3.3	2.955	x	6.842	x	x	x	6.518	6.012	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10898	Original post publication description: Anxiety assay, open arm entries in an elevated plus maze test [n]	None	Central nervous system, behavior: Anxiety assay, open arm entries in an elevated plus maze test [n]	x	x	3.25	4.5	x	x	x	x	4.92	x	1.69	5.91	4.83	x	x	3.5	x	2.75	x	3.1	4.31	5.33	x	x	x	x	5.4	x	x	8.44	6.5	x	4.0	x	x	x	2.83	2.182	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10899	Original post publication description: Fear conditioning, baseline preconditioning freezing during a 2 min acclimation period prior to first pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]	None	Central nervous system, behavior, learning and memory: Fear conditioning, baseline preconditioning freezing during a 2 min acclimation period prior to first pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]	x	x	5.556	4.041	x	x	x	x	6.061	x	x	1.768	4.17	x	x	4.63	x	3.935	x	0.347	3.536	3.472	x	x	x	x	13.332	x	x	1.19	5.324	x	7.871	x	x	x	7.717	10.353	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10900	Original post publication description: Fear conditioning, freezing during consolidation period after final pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing during consolidation period after final pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]	x	x	70.075	73.485	x	x	x	x	69.419	x	80.952	65.405	87.502	x	x	84.027	x	52.777	x	57.812	87.247	66.436	x	x	x	x	27.778	x	x	55.16	59.029	x	82.638	x	x	x	81.635	78.031	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10901	Original post publication description: Fear conditioning, freezing in response to context exposure 48 hr after conditioning [%]	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing in response to context exposure 48 hr after conditioning [%]	x	x	41.97	28.166	x	x	x	x	32.273	x	41.429	47.879	51.67	x	x	41.946	x	37.223	x	50.625	23.167	33.889	x	x	x	x	22.0	x	x	17.143	40.973	x	40.555	x	x	x	40.557	66.515	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10902	Original post publication description: Fear conditioning, freezing during conditioned stimulus exposure, 24 hr after conditioning [%]	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing during conditioned stimulus exposure, 24 hr after conditioning [%]	x	x	72.474	49.242	x	x	x	x	41.161	x	81.482	82.501	97.22	x	x	63.889	x	65.046	x	61.806	44.723	50.463	x	x	x	x	72.776	x	x	48.015	60.649	x	79.398	x	x	x	79.012	88.131	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10903	Original post publication description: Depression assay, immobility from 2-10 min in a 10 min Porsolt forced swim test [%]	None	Central nervous system, behavior: Depression assay, immobility from 2-10 min in a 10 min Porsolt forced swim test [%]	x	x	70.694	41.806	x	x	x	x	61.333	x	49.667	61.296	71.667	x	x	19.0	x	64.097	x	59.722	20.0	54.722	x	x	x	x	64.0	x	x	60.741	57.197	x	71.809	x	x	x	74.0	38.106	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10904	Original post publication description: Anxiety assay, locomotion in the light compartment relative to total in a light-dark test [%]	None	Central nervous system, behavior: Anxiety assay, locomotion in the light compartment relative to total in a light-dark test [%]	x	x	29.99	34.14	x	x	x	x	36.82	x	18.76	33.93	35.33	x	x	34.89	x	28.86	x	34.63	36.09	28.67	x	x	x	x	35.21	x	x	41.47	29.09	x	30.43	x	x	x	30.89	23.145	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10905	Original post publication description: Anxiety assay, time in the center of an elevated plus maze [sec]	None	Central nervous system, behavior: Anxiety assay, time in the center of an elevated plus maze [sec]	x	x	30.27	31.27	x	x	x	x	24.64	x	13.63	26.85	28.63	x	x	29.2	x	36.85	x	32.57	35.16	31.39	x	x	x	x	19.25	x	x	28.9	31.68	x	35.19	x	x	x	21.73	24.217	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10906	Original post publication description: Novel open field behavior, time in the field center [sec]	None	Central nervous system, behavior: Novel open field behavior, time in the field center [sec]	x	x	10.86	7.2	x	x	x	x	10.44	x	7.8	6.87	6.48	x	x	9.5	x	10.85	x	12.76	4.82	7.93	x	x	x	x	3.53	x	x	6.11	6.39	x	10.05	x	x	x	9.76	4.608	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10907	Original post publication description: Anxiety assay, percentage of time in light compartment of a light-dark test [%]	None	Central nervous system, behavior: Anxiety assay, percentage of time in light compartment of a light-dark test [%]	x	x	34.08	36.25	x	x	x	x	33.99	x	10.0	34.95	34.87	x	x	38.09	x	31.9	x	33.86	38.45	29.45	x	x	x	x	28.72	x	x	41.54	32.18	x	28.84	x	x	x	32.09	21.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10908	Original post publication description: Anxiety assay, percentage of time in open arms of an elevated plus maze [%]	None	Central nervous system, behavior: Anxiety assay, percentage of time in open arms of an elevated plus maze [%]	x	x	7.51	6.99	x	x	x	x	11.56	x	1.95	8.37	17.21	x	x	9.32	x	7.12	x	6.96	7.97	11.23	x	x	x	x	24.28	x	x	19.89	9.1	x	9.63	x	x	x	4.08	4.086	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10909	Original post publication description: Anxiety assay, arm entries (total) in an elevated plus maze [n]	None	Central nervous system, behavior: Anxiety assay, arm entries (total) in an elevated plus maze [n]	x	x	19.58	29.08	x	x	x	x	17.33	x	8.08	22.09	21.17	x	x	20.92	x	20.92	x	21.9	25.0	21.5	x	x	x	x	16.6	x	x	20.33	30.33	x	23.58	x	x	x	20.17	19.364	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10910	Original post publication description: Novel open field behavior, locomotion from 0-30 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 0-30 min [cm]	x	x	11211.0	9755.0	x	x	x	x	9116.0	x	7605.0	10608.0	7778.0	x	x	10351.0	x	10140.0	x	10047.0	8595.0	10773.0	x	x	x	x	5882.0	x	x	8850.0	10270.0	x	9116.0	x	x	x	9832.0	7260.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10911	Original post publication description: Novel open field behavior, locomotion from 0-5 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 0-5 min [cm]	x	x	2355.0	1725.0	x	x	x	x	1395.0	x	1228.0	1865.0	1889.0	x	x	2221.0	x	1434.0	x	1762.0	1408.0	1628.0	x	x	x	x	985.0	x	x	1740.0	1947.0	x	1268.0	x	x	x	1806.0	1179.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10912	Original post publication description: Novel open field behavior, locomotion from 10-15 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 10-15 min [cm]	x	x	1712.7	1682.7	x	x	x	x	1563.9	x	1370.9	1807.2	1348.2	x	x	1774.4	x	1939.7	x	1777.2	1452.7	1770.1	x	x	x	x	1090.4	x	x	1522.7	1766.8	x	1630.2	x	x	x	1665.0	1328.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10913	Original post publication description: Novel open field behavior, locomotion from 15-20 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 15-20 min [cm]	x	x	1873.4	1610.6	x	x	x	x	1548.7	x	1200.4	1784.8	1128.6	x	x	1598.4	x	1762.1	x	1562.4	1471.2	1843.6	x	x	x	x	874.8	x	x	1318.2	1609.0	x	1689.2	x	x	x	1640.7	1206.87	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10914	Original post publication description: Novel open field behavior, locomotion from 20-25 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 20-25 min [cm]	x	x	1658.0	1443.0	x	x	x	x	1522.0	x	1135.0	1704.0	980.0	x	x	1452.0	x	1599.0	x	1660.0	1435.0	1739.0	x	x	x	x	936.0	x	x	1345.0	1508.0	x	1497.0	x	x	x	1444.0	1148.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10915	Original post publication description: Novel open field behavior, locomotion from 25-30 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 25-30 min [cm]	x	x	1600.0	1305.0	x	x	x	x	1531.0	x	1333.0	1412.0	930.0	x	x	1389.0	x	1520.0	x	1543.0	1270.0	1930.0	x	x	x	x	801.0	x	x	1262.0	1423.0	x	1381.0	x	x	x	1407.0	1137.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10916	Original post publication description: Novel open field behavior, locomotion from 5-10 min [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion from 5-10 min [cm]	x	x	2012.0	1989.0	x	x	x	x	1556.0	x	1337.0	2036.0	1502.0	x	x	1917.0	x	1885.0	x	1742.0	1557.0	1862.0	x	x	x	x	1196.0	x	x	1662.0	2015.0	x	1651.0	x	x	x	1870.0	1259.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10917	Original post publication description: Anxiety assay, transitions between light and dark compartments in light/dark test [n]	None	Central nervous system, behavior: Anxiety assay, transitions between light and dark compartments in light/dark test [n]	x	x	31.91	39.17	x	x	x	x	32.17	x	11.33	41.73	74.5	x	x	67.25	x	33.58	x	27.0	52.83	36.08	x	x	x	x	23.8	x	x	38.33	44.75	x	29.83	x	x	x	32.8	22.818	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10918	Original post publication description: Pain response, chemical nociception, acetic acid writhing test [writhes]	None	Central nervous system, peripheral nervous system, behavior: Pain response, chemical nociception, acetic acid writhing test [writhes]	x	x	x	x	5.4	3.2	10.0	x	10.4	9.8	10.5	8.8	4.2	2.1	10.6	5.6	x	3.4	x	3.6	5.0	x	x	5.2	5.5	6.6	6.2	7.4	6.1	3.8	4.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10921	Original post publication description: Cerebellum volume, in situ postmortem from high field MRI [bilateral mm^3]	None	Central nervous system, morphology: Cerebellum volume, in situ postmortem from high field MRI [bilateral mm^3]	x	x	55.932	49.206	60.504	x	x	52.416	x	x	x	x	x	x	53.59	55.511	x	x	x	x	x	x	x	53.948	x	48.535	56.904	51.988	x	x	x	x	57.433	x	x	x	x	x	52.078	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10922	Original post publication description: Cerebral cortex volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Cerebral cortex volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	169.46	137.31	158.04	x	x	135.0	x	x	x	x	x	x	162.71	151.62	x	x	x	x	x	x	x	132.5	x	131.85	137.52	137.69	x	x	x	x	150.8	x	x	x	x	x	163.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10923	Original post publication description: Olfactory bulb volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Olfactory bulb volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	29.593	24.825	27.679	x	x	25.692	x	x	x	x	x	x	26.91	28.273	x	x	x	x	x	x	x	23.255	x	24.114	28.882	24.234	x	x	x	x	30.472	x	x	x	x	x	29.007	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10924	Original post publication description: Amygdala volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Amygdala volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	13.608	10.193	9.8351	x	x	11.072	x	x	x	x	x	x	13.368	12.25	x	x	x	x	x	x	x	10.489	x	8.7893	10.426	10.813	x	x	x	x	9.8895	x	x	x	x	x	11.579	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10925	Original post publication description: Hypothalamus volume, bliateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Hypothalamus volume, bliateral, in situ postmortem from high field MRI [mm^3]	x	x	11.555	9.0017	10.099	x	x	8.4256	x	x	x	x	x	x	8.0882	8.7409	x	x	x	x	x	x	x	9.2559	x	8.2462	8.8628	9.0166	x	x	x	x	9.3621	x	x	x	x	x	11.005	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10926	Original post publication description: Superior colliculus volume (bilateral, in situ postmortem from high field MRI) [mm^3]	None	Central nervous system, morphology: Superior colliculus volume, bilateral, from in situ postmortem high field MRI) [mm^3]	x	x	10.774	9.6975	9.8349	x	x	8.5317	x	x	x	x	x	x	9.7906	9.5366	x	x	x	x	x	x	x	7.7724	x	7.7987	8.903	8.9374	x	x	x	x	9.1159	x	x	x	x	x	11.099	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10927	Original post publication description: Inferior colliculus volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Inferior colliculus volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	7.1723	7.169	6.5132	x	x	4.1923	x	x	x	x	x	x	5.5034	5.7329	x	x	x	x	x	x	x	4.3586	x	4.992	5.7999	7.0282	x	x	x	x	5.0296	x	x	x	x	x	7.4207	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10928	Original post publication description: Brain volume, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Brain volume, in situ postmortem from high field MRI [mm^3]	x	x	511.52	417.02	470.42	x	x	406.01	x	x	x	x	x	x	477.8	469.44	x	x	x	x	x	x	x	416.77	x	408.42	436.15	425.63	x	x	x	x	457.15	x	x	x	x	x	488.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10929	Original post publication description: Central nervous system, morphology: Brain ventricle volume (bilateral, all ventricles, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Brain ventricle volume (bilateral, all ventricles, in situ postmortem from high field MRI [mm^3]	x	x	3.7047	2.8433	3.894	x	x	1.383	x	x	x	x	x	x	4.7483	3.7351	x	x	x	x	x	x	x	3.481	x	2.9628	3.2284	3.157	x	x	x	x	3.1359	x	x	x	x	x	3.4616	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10930	Original post publication description: Corpus callosum volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Corpus callosum volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	17.695	10.552	13.771	x	x	8.5138	x	x	x	x	x	x	17.093	16.573	x	x	x	x	x	x	x	15.106	x	14.091	13.486	12.828	x	x	x	x	15.978	x	x	x	x	x	15.758	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10931	Original post publication description: Trigeminal tract volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Trigeminal tract volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	0.88817	0.6365	0.69115	x	x	0.46133	x	x	x	x	x	x	0.68897	0.65331	x	x	x	x	x	x	x	0.68245	x	0.65593	0.61025	0.64763	x	x	x	x	0.55575	x	x	x	x	x	0.76971	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10932	Original post publication description: Central nervous system, morphology, visual system: Optic tract volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology, visual system: Optic tract volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	0.94459	0.98109	0.94789	x	x	0.73174	x	x	x	x	x	x	1.0707	0.93661	x	x	x	x	x	x	x	0.80663	x	0.7715	0.81479	0.88221	x	x	x	x	0.85537	x	x	x	x	x	0.99481	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10933	Original post publication description: Anterior pretectal nucleus volume (mm^3, bilateral, in situ postmortem from high field MRI)	None	Central nervous system, morphology, visual system: Anterior pretectal nucleus volume, bilateral, from in situ postmortem high field MRI [mm^3]	x	x	0.43291	0.43137	0.49657	x	x	0.57245	x	x	x	x	x	x	0.51919	0.48662	x	x	x	x	x	x	x	0.42544	x	0.38366	0.47032	0.45375	x	x	x	x	0.45056	x	x	x	x	x	0.4702	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10934	Original post publication description: Central nervous system, morphology, visual system: Geniculate nuclei volume of thalamus (MGN and LGN combined, bilateral, in situ postmortem from high field MRI) [mm^3]	None	Central nervous system, morphology, visual system: Geniculate nuclei volume of thalamus (MGN and LGN combined, bilateral, in situ postmortem from high field MRI) [mm^3]	x	x	0.86027	0.82465	0.86523	x	x	0.70881	x	x	x	x	x	x	0.79404	0.7827	x	x	x	x	x	x	x	0.67259	x	0.73023	0.74228	0.7482	x	x	x	x	0.72674	x	x	x	x	x	0.86543	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10935	Original post publication description: Laterodorsal nucleus of thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Laterodorsal nucleus of thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	0.49179	0.29095	0.39077	x	x	0.22377	x	x	x	x	x	x	0.32876	0.28492	x	x	x	x	x	x	x	0.27616	x	0.32741	0.31123	0.38831	x	x	x	x	0.25955	x	x	x	x	x	0.42306	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10936	Original post publication description: Central nervous system, morphology: Deep mesencephalic nuclei (MRN, RN, right and left combined) volume in situ from high field MRI [mm3]	None	Central nervous system, morphology: Deep mesencephalic nuclei (MRN, RN, right and left combined) volume in situ from high field MRI [mm3]	x	x	1.673	2.2957	2.4213	x	x	2.5477	x	x	x	x	x	x	2.8222	3.212	x	x	x	x	x	x	x	2.1445	x	2.0063	2.4112	2.2786	x	x	x	x	2.395	x	x	x	x	x	2.0998	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10937	Original post publication description: Central nervous system, morphology: Globus pallidus volume, in situ postmortem from high field MRI [bilateral mm^3]	None	Central nervous system, morphology: Globus pallidus volume, in situ postmortem from high field MRI [bilateral mm^3]	x	x	1.9809	2.0181	2.2347	x	x	3.3573	x	x	x	x	x	x	2.4806	2.9966	x	x	x	x	x	x	x	2.7641	x	1.6496	1.9099	1.9249	x	x	x	x	2.8704	x	x	x	x	x	2.5875	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10938	Original post publication description: Central nervous system, morphology, auditory system: Cochlear nuclei volume (right and left combined), in situ postmortem from high field MRI [mm3]	None	Central nervous system, morphology, auditory system: Cochlear nuclei volume (right and left combined), in situ postmortem from high field MRI [mm3]	x	x	1.1315	0.95081	1.0622	x	x	1.1166	x	x	x	x	x	x	1.0104	0.88682	x	x	x	x	x	x	x	0.88893	x	0.9288	0.89346	0.86857	x	x	x	x	0.8225	x	x	x	x	x	0.85235	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10939	Original post publication description: Central nervous system, morphology: Interpeduncular nucleus volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Interpeduncular nucleus volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	0.49974	0.46607	0.33802	x	x	0.26313	x	x	x	x	x	x	0.27776	0.29767	x	x	x	x	x	x	x	0.31107	x	0.26428	0.34566	0.27009	x	x	x	x	0.31477	x	x	x	x	x	0.30431	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10940	Original post publication description: Cerebral peduncle [mm^3, bilateral, in situ postmortem from high field MRI]	None	Central nervous system, morphology: Cerebral peduncle volume, bilateral, from in situ postmortem high field MRI [mm^3]	x	x	1.3838	1.3645	1.451	x	x	1.2481	x	x	x	x	x	x	1.8868	1.9148	x	x	x	x	x	x	x	1.4964	x	1.2776	1.3409	1.2222	x	x	x	x	1.4708	x	x	x	x	x	1.3318	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10941	Original post publication description: Substantia nigra, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Substantia nigra, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	2.1758	1.912	1.8285	x	x	1.4542	x	x	x	x	x	x	2.1749	1.9676	x	x	x	x	x	x	x	1.6528	x	2.0067	1.7809	1.6619	x	x	x	x	1.6621	x	x	x	x	x	1.9314	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10942	Original post publication description: Pontine nuclei (right and left combined, mm3, in situ postmortem from high field MRI)	None	Central nervous system, morphology: Pontine nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	1.3106	1.1556	1.4789	x	x	1.3895	x	x	x	x	x	x	1.0291	1.223	x	x	x	x	x	x	x	1.0631	x	1.044	1.4227	1.1487	x	x	x	x	1.1814	x	x	x	x	x	1.3357	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10943	Original post publication description: Central nervous system, morphology: Nucleus accumbens volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Nucleus accumbens volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	5.332	3.872	4.73	x	x	2.012	x	x	x	x	x	x	5.042	5.03	x	x	x	x	x	x	x	4.178	x	3.754	4.145	4.457	x	x	x	x	4.402	x	x	x	x	x	4.854	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10944	Original post publication description: Anterior commissure volume (mm^3, bilateral, in situ postmortem from high field MRI)	None	Central nervous system, morphology: Anterior commissure volume, bilateral, from in situ postmortem high field MRI [mm^3]	x	x	1.1293	0.84488	0.93965	x	x	0.58283	x	x	x	x	x	x	0.95953	0.99522	x	x	x	x	x	x	x	0.9742	x	1.0384	0.94673	0.75862	x	x	x	x	1.0667	x	x	x	x	x	0.81662	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10945	Original post publication description: Ventral thalamic nuclei volume, bilateral in situ postmortem from high field MRI (includes the VPL, VPM, VP, and VA) [mm^3]	None	Central nervous system, morphology: Ventral thalamic nuclei volume, bilateral from in situ postmortem from high field MRI (includes the VPL, VPM, VP, and VA) [mm^3]	x	x	7.3049	5.9318	7.2004	x	x	5.743	x	x	x	x	x	x	6.4884	6.7828	x	x	x	x	x	x	x	5.9832	x	6.0655	6.3021	6.5992	x	x	x	x	6.3731	x	x	x	x	x	7.3819	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10946	Original post publication description: Central nervous system, morphology: Fimbria volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Fimbria volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	3.798	3.0328	3.5032	x	x	2.3604	x	x	x	x	x	x	3.3433	3.1391	x	x	x	x	x	x	x	2.92	x	2.8428	3.0176	3.2634	x	x	x	x	2.9108	x	x	x	x	x	3.5745	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10948	Original post publication description: Periaqueductal gray volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Periaqueductal gray volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	3.3285	2.448	2.9656	x	x	2.3007	x	x	x	x	x	x	2.8502	2.9693	x	x	x	x	x	x	x	2.8233	x	2.1587	2.692	2.5896	x	x	x	x	2.7973	x	x	x	x	x	3.3016	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10949	Original post publication description: Central nervous system, morphology: Lateral lemniscus (right and left combined), in situ postmortem from high field MRI [mm3]	None	Central nervous system, morphology: Lateral lemniscus (right and left combined), in situ postmortem from high field MRI [mm3]	x	x	0.75496	0.69287	0.89787	x	x	0.48535	x	x	x	x	x	x	0.84182	0.87076	x	x	x	x	x	x	x	0.70196	x	0.70487	0.76359	0.78525	x	x	x	x	0.73377	x	x	x	x	x	0.77269	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10950	Original post publication description: Thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]	x	x	30.287	24.2364	27.9764	x	x	23.0626	x	x	x	x	x	x	27.0562	29.3124	x	x	x	x	x	x	x	24.6	x	24.7371	25.5856	25.4117	x	x	x	x	25.7364	x	x	x	x	x	29.8854	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10951	Original post publication description: Midbrain partial volume, bilateral (excludes individually segmented nuclei) in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Midbrain partial volume, bilateral (excludes individually segmented nuclei) in situ postmortem from high field MRI [mm^3]	x	x	78.105	66.058	67.047	x	x	63.562	x	x	x	x	x	x	66.036	70.574	x	x	x	x	x	x	x	61.228	x	65.248	67.036	64.875	x	x	x	x	66.091	x	x	x	x	x	75.189	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10952	Original post publication description: Brainstem partial volume, bilateral including DpMe, APT, pons, but excluding other individually segmented nuclei, in situ postmortem from high field MRI [mm^3]	None	Central nervous system, morphology: Brainstem partial volume, bilateral including DpMe, APT, pons, but excluding other individually segmented nuclei, in situ postmortem from high field MRI [mm^3]	x	x	81.5215	69.9407	71.4438	x	x	68.0716	x	x	x	x	x	x	70.4065	75.4956	x	x	x	x	x	x	x	64.861	x	68.682	71.3402	68.7561	x	x	x	x	70.118	x	x	x	x	x	79.0947	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10953	Original post publication description: Brain volume minus cerebellum volume, in situ postmortem value from high field MRI [mm^3]	None	Central nervous system, morphology: Brain volume minus cerebellum volume, in situ postmortem value from high field MRI [mm^3]	x	x	455.589	367.815	409.921	x	x	353.597	x	x	x	x	x	x	424.205	413.929	x	x	x	x	x	x	x	362.819	x	359.885	379.241	373.645	x	x	x	x	399.712	x	x	x	x	x	436.246	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10954	Original post publication description: Cancer: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n]	None	Cancer: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n]	x	x	0.204	1.491	0.431	1.146	1.342	0.114	1.255	x	1.799	0.23	0.914	x	0.1	1.342	1.204	1.633	x	1.146	x	0.763	x	1.176	1.079	1.146	0.748	0.362	0.544	0.934	0.909	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10987	Original post publication description: Anxiety assay (E10_NT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 10 min session [n entries].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E10_NT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during a 10 min session [n]	x	x	23.938	37.0	42.625	32.0	11.0	47.375	35.25	27.0	21.143	17.571	x	30.429	30.25	34.125	27.875	28.375	27.286	27.429	24.875	27.333	x	x	x	24.25	16.125	x	x	18.714	41.875	24.875	25.375	x	21.167	x	27.75	17.5	x	x	49.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10988	Original post publication description: Anxiety assay (E10_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks].	None	Anxiety assay (E10_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks].	x	x	13.625	30.846	21.125	15.625	3.857	18.5	17.625	20.667	12.0	61.429	x	24.857	16.375	22.75	23.625	17.375	25.857	21.429	10.75	14.5	x	x	x	10.125	2.375	x	x	9.857	23.125	19.75	20.25	x	11.167	x	2.75	11.333	x	x	50.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12642	Original post publication description: Anxiety assay (S5_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec].	None	Central nervous system, behavior, pharmacology: Anxiety assay (S5_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec].	x	x	27.24	35.544	22.489	24.3	3.122	14.988	38.286	33.543	1.917	47.1	x	15.583	24.637	69.871	10.043	19.167	22.271	59.471	31.343	18.771	x	x	x	5.1	2.833	x	x	25.488	24.075	22.062	21.733	x	14.444	x	22.757	2.875	x	x	31.678	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10991	Original post publication description: Morphology, urogenital system: Kidney weight, adult, males and females combined, without statistical adjustments [mg, unilateral	None	Urogenital system, kidney, morphology: Kidney weight, adult, males and females combined, without statistical adjustments [mg, unilateral	206.036	208.343	154.796	242.522	215.584	231.699	x	153.21	259.422	172.926	187.124	207.174	x	174.994	x	x	x	x	x	x	x	158.439	x	x	137.233	167.318	x	x	x	159.482	198.233	154.039	255.015	x	168.08	x	205.354	174.533	178.691	x	x	159.89	157.841	198.561	x	x	170.394	x	195.803	220.951	x	x	x	243.686	x	x	x	x	196.208	195.099	193.092	149.055	x	185.471	178.309	x	205.272	218.602	200.456	183.994	x	174.756	x	215.45	x	330.417	x	x	185.967	x	x	176.052	208.7	150.448	185.637	162.539	x	200.247	217.565	x	206.734	x	x	x	195.211	227.181	230.637	x	201.049	x	x	x	
-10992	Original post publication description: Central nervous system, morphology: Cerebral cortex volume, shrinkage corrected [mm^3]	None	Central nervous system, morphology: Cerebral cortex volume, shrinkage corrected [mm^3]	x	x	115.59	91.92	118.47	99.58	125.11	90.41	101.54	107.47	108.96	105.06	103.77	103.47	119.99	115.06	103.33	90.66	97.1	111.76	108.19	100.65	x	99.81	99.65	93.83	89.0	84.53	77.29	95.4	99.07	102.47	101.59	105.73	102.7	x	98.36	101.14	100.47	x	101.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10993	Original post publication description: Central nervous system, morphology: Cerebral cortex volume, regression adjusted for age and body weight, shrinkage corrected [mm^3]	None	Central nervous system, morphology: Cerebral cortex volume, regression adjusted for age and body weight, shrinkage corrected [mm^3]	x	x	123.27	104.63	126.78	106.36	136.07	103.1	111.48	117.53	121.34	114.15	110.28	111.53	128.03	121.32	112.84	101.64	107.85	122.58	116.05	112.47	x	108.36	113.57	105.01	97.9	96.48	90.87	103.1	106.77	110.98	106.29	115.86	113.49	x	108.29	108.94	111.04	x	108.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-10994	Original post publication description: Kidney weight (unilateral, corrected for age, sex, and body weight) [mg]	None	Urogenital system, kidney, morphology: Kidney weight (unilateral, corrected for age, sex, and body weight) [mg]	197.12	205.47	169.6	248.94	210.54	219.19	x	181.55	210.14	169.25	176.27	193.75	x	183.23	x	x	x	x	x	x	x	167.2	x	x	146.58	183.05	x	x	x	156.82	209.91	168.4	240.8	x	179.6	x	224.36	164.63	188.03	x	x	163.02	169.03	220.83	x	x	166.09	x	169.67	217.19	x	x	x	233.38	x	x	x	x	173.7	201.7	197.34	166.88	x	180.45	186.0	x	190.81	224.54	198.81	183.32	x	188.48	x	218.59	x	301.44	x	x	181.25	x	x	187.51	215.94	156.19	172.32	164.25	x	198.37	210.33	x	198.54	x	x	x	185.04	203.14	218.73	x	184.47	x	x	x	
-10995	Original post publication description: Central nervous system, morphology: Cerebral cortex volume, bilateral, shrinkage corrected [mm^3]	None	Central nervous system, morphology: Cerebral cortex volume, bilateral, shrinkage corrected [mm^3]	x	x	123.563	93.862	113.139	95.57	126.88	81.562	110.893	114.859	111.874	99.199	104.929	101.035	113.142	103.924	98.437	106.412	98.6	105.3	109.703	112.605	x	103.229	103.204	94.034	100.526	91.096	73.369	90.36	111.133	102.823	106.734	100.681	103.46	x	100.524	109.516	111.505	x	104.596	98.165	106.542	102.34	x	x	83.274	x	x	109.854	x	x	x	x	x	x	x	x	95.695	x	106.982	101.595	x	x	x	x	x	95.922	x	x	x	102.449	x	95.231	x	99.144	x	x	x	x	x	108.515	x	98.494	114.585	90.128	x	110.516	101.768	x	89.329	x	x	x	x	96.0	x	x	x	x	x	x	
-10997	Original post publication description: Central nervous system, morphology: Cerebral cortex volume, adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch) [mm^3]	None	Central nervous system, morphology: Cerebral cortex volume, adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch) [mm^3]	x	x	121.04	97.136	110.459	91.536	118.767	83.153	112.074	113.193	110.146	95.825	104.765	100.252	110.164	100.834	97.469	104.747	99.759	100.109	106.489	111.304	x	103.274	105.887	99.129	101.904	92.584	76.449	90.07	109.221	101.749	105.698	100.219	103.054	x	99.699	110.878	110.318	x	100.201	102.686	109.326	102.919	x	x	85.193	x	x	111.005	x	x	x	x	x	x	x	x	94.973	x	109.502	106.294	x	x	x	x	x	96.21	x	x	x	105.911	x	101.145	x	101.082	x	x	x	x	x	112.395	x	100.124	111.287	93.809	x	113.985	104.414	x	91.931	x	x	x	x	98.883	x	x	x	x	x	x	
-10998	Original post publication description: Central nervous system, morphology: Striatum volume, dorsal striatum, bilateral and adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch (mm^3)	None	Central nervous system, morphology: Striatum volume, dorsal striatum, bilateral and adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch (mm^3)	x	x	20.52	22.63	24.769	19.942	23.64	20.931	22.367	23.869	24.345	20.062	19.567	20.996	20.435	19.761	21.732	23.454	21.391	22.656	24.507	19.015	x	23.566	21.565	23.475	21.512	21.496	22.203	21.455	25.35	23.918	23.216	21.135	22.314	x	20.622	23.005	23.339	x	23.025	21.439	25.427	21.545	x	x	x	x	x	23.451	x	x	x	x	x	x	x	x	21.816	x	24.288	22.725	x	x	x	x	x	21.01	x	x	x	22.655	x	22.659	x	22.669	x	x	x	x	x	23.067	x	20.905	23.337	20.927	x	18.925	21.361	x	21.347	x	x	x	x	20.785	x	x	x	x	x	x	
-11001	Original post publication description: Infectious disease, immune function: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml]	None	Infectious disease, immune system: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml]	x	x	136.47	411.05	255.52	396.35	67.36	402.06	301.65	204.94	218.88	188.94	293.77	192.72	285.4	745.33	199.56	53.76	878.4	265.66	389.71	x	x	116.58	235.39	139.4	251.05	0.51	294.21	240.49	193.41	249.21	135.26	x	291.83	x	271.8	289.51	212.65	x	308.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11002	Original post publication description: Ethanol response (3 g/kg ip), hypothermia (supplementary data to Brigman et al.) [deg C]	None	Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia (supplementary data to Brigman et al.) [deg C]	x	1.615	2.225	-5.99	x	x	x	x	-9.206	-8.235	x	x	x	1.994	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.744	x	x	x	x	x	x	x	x	x	x	x	x	-5.742	x	x	x	x	x	1.788	x	x	x	2.844	x	x	x	x	2.145	3.138	x	x	x	1.875	-8.119	x	x	-5.338	-8.539	x	x	x	x	2.078	x	x	x	x	x	-6.256	x	x	x	x	-6.81	1.094	x	x	1.312	x	x	x	x	-7.166	2.292	-4.474	x	-6.407	-6.964	x	x	x	
-11003	Original post publication description: Ethanol response (3 g/kg ip), loss of righting reflex (LORR) sleep time (supplementary data to Brigman et al.) [min]	None	Central nervous system, pharmacology, behavior: Ethanol response (3 g/kg ip), loss of righting reflex (LORR) sleep time (supplementary data to Brigman et al.) [min]	x	40.5	58.333	43.6	x	x	x	x	53.0	x	x	x	x	50.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	75.375	x	x	x	x	x	x	x	x	x	x	x	x	44.333	x	x	x	x	x	96.167	x	x	x	76.0	x	x	x	x	66.2	89.0	x	x	x	68.75	31.0	x	x	43.75	48.75	x	x	x	x	100.0	x	x	x	x	x	x	x	x	x	x	69.667	x	x	x	71.0	x	x	x	x	x	76.0	x	x	48.5	x	x	x	x	
-11004	Original post publication description: Rotarod performance, baseline control (supplementary data to Brigman et al.) [sec]	None	Central nervous system, behavior: Rotarod performance, baseline control (supplementary data to Brigman et al.) [sec]	x	15.8	27.0	21.75	x	x	x	x	10.75	11.0	x	x	x	17.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.0	x	x	x	x	x	x	x	x	x	x	x	x	20.25	x	x	x	x	x	25.0	x	x	x	55.875	x	x	x	x	57.8	35.0	x	x	x	49.0	24.75	x	x	11.0	20.25	x	x	x	x	20.364	x	x	x	x	x	11.25	x	x	x	x	9.333	15.25	x	x	31.0	x	x	x	x	15.333	37.833	29.333	x	19.25	15.75	x	x	x	
-11005	Original post publication description: Motor performance, improvement in rotarod training measured as change in time on rod [sec]	None	Central nervous system, behavior: Motor performance, improvement in rotarod training measured as change in time on rod [sec]	x	86.4	63.667	52.5	x	x	x	x	80.75	34.0	x	x	x	44.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	57.222	x	x	x	x	x	x	x	x	x	x	x	x	34.0	x	x	x	x	x	26.833	x	x	x	18.125	x	x	x	x	29.2	9.4	x	x	x	60.0	58.0	x	x	73.0	28.75	x	x	x	x	13.364	x	x	x	x	x	46.75	x	x	x	x	71.0	52.75	x	x	54.25	x	x	x	x	25.0	34.667	31.667	x	30.5	64.5	x	x	x	
-11006	Original post publication description: Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance, difference from saline baseline (supplementary data to Brigman et al.)	None	Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance, difference from saline baseline (supplementary data to Brigman et al.)	x	26.8	58.167	42.125	x	x	x	x	58.0	32.667	x	x	x	33.625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.278	x	x	x	x	x	x	x	x	x	x	x	x	30.125	x	x	x	x	x	19.333	x	x	x	21.75	x	x	x	x	17.4	12.8	x	x	x	45.375	21.5	x	x	49.0	53.625	x	x	x	x	18.455	x	x	x	x	x	21.125	x	x	x	x	21.167	43.0	x	x	41.125	x	x	x	x	28.0	37.5	37.333	x	39.625	48.0	x	x	x	
-11007	Original post publication description: Central nervous system, behavior: Startle response to loud acoustic stimulus [amplitude]	None	Central nervous system, behavior: Startle response to loud acoustic stimulus [amplitude]	x	46.48	223.733	55.34	x	x	x	x	81.35	46.65	x	x	x	46.475	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	156.037	x	x	x	x	x	x	x	x	x	x	x	x	119.5	x	x	x	x	x	213.617	x	x	x	47.9	x	x	x	x	404.067	140.12	x	x	x	157.375	97.1	x	x	56.875	126.175	x	x	x	x	100.427	x	x	x	x	x	90.3	x	x	x	x	52.567	294.425	x	x	42.2	x	x	x	x	x	140.117	179.3	x	125.525	141.9	x	x	x	
-11008	Original post publication description: Prepulse inhibition of the acoustic startle response [%]	None	Central nervous system, behavior: Prepulse inhibition of the acoustic startle response [%]	x	10.92	65.567	26.64	x	x	x	x	45.925	11.925	x	x	x	33.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	79.062	x	x	x	x	x	x	x	x	x	x	x	x	34.7	x	x	x	x	x	15.367	x	x	x	12.0	x	x	x	x	65.067	34.66	x	x	x	26.525	14.625	x	x	21.875	53.325	x	x	x	x	33.418	x	x	x	x	x	32.525	x	x	x	x	14.4	18.575	x	x	12.175	x	x	x	x	x	66.2	22.367	x	49.425	45.15	x	x	x	
-11009	Original post publication description: Fear conditioning, freezing response to conditioned cue after 48 hours (%)	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 48 hours [%]	x	84.0	93.333	45.0	x	x	x	x	60.0	40.0	x	x	x	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	45.0	x	x	x	x	x	x	x	x	x	x	x	x	25.0	x	x	x	x	x	70.0	x	x	x	40.0	x	x	x	x	80.0	60.0	x	x	x	90.0	80.0	x	x	65.0	10.0	x	x	x	x	47.273	x	x	x	x	x	85.0	x	x	x	x	73.333	60.0	x	x	50.0	x	x	x	x	x	70.0	26.667	x	65.0	60.0	x	x	x	
-11010	Original post publication description: Fear conditioning, freezing response to conditioned cue after 24 hours (%)	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 24 hours [%]	x	90.56	69.433	24.3	x	x	x	x	38.9	23.167	x	x	x	50.025	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.212	x	x	x	x	x	x	x	x	x	x	x	x	49.3	x	x	x	x	x	49.533	x	x	x	17.7	x	x	x	x	51.867	49.98	x	x	x	36.125	73.625	x	x	50.0	40.275	x	x	x	x	19.691	x	x	x	x	x	65.3	x	x	x	x	91.633	68.05	x	x	45.85	x	x	x	x	x	64.35	68.5	x	55.55	25.675	x	x	x	
-11011	Original post publication description: Fear conditioning, freezing response to context after 48 hours (%)	None	Central nervous system, behavior, learning and memory: Fear conditioning, freezing response to context after 48 hours (%)	x	27.68	40.567	9.175	x	x	x	x	26.25	5.0	x	x	x	2.075	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.962	x	x	x	x	x	x	x	x	x	x	x	x	7.9	x	x	x	x	x	7.217	x	x	x	0.625	x	x	x	x	2.233	0.0	x	x	x	2.925	10.825	x	x	15.825	5.85	x	x	x	x	1.355	x	x	x	x	x	20.825	x	x	x	x	28.867	17.9	x	x	1.25	x	x	x	x	x	19.15	6.1	x	6.65	23.35	x	x	x	
-11012	Original post publication description: Anxiety assay, time in open arm of elevated plus maze [sec]	None	Central nervous system, behavior: Anxiety assay, time in open arm of elevated plus maze [sec]	x	20.036	35.503	5.9	x	x	x	x	20.625	15.46	x	x	x	36.165	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	43.63	x	x	x	x	x	x	x	x	x	x	x	x	31.29	x	x	x	x	x	74.0	x	x	x	34.521	x	x	x	x	82.0	68.4	x	x	x	48.75	29.707	x	x	25.585	78.832	x	x	x	x	79.015	x	x	x	x	x	41.292	x	x	x	x	8.943	30.625	x	x	24.497	x	x	x	x	22.223	48.252	17.723	x	19.168	19.207	x	x	x	
-11013	Original post publication description: Anxiety assay, number of closed arm entries using elevated plus maze [n]	None	Central nervous system, behavior: Anxiety assay, number of closed arm entries using elevated plus maze [n]	x	16.4	18.667	7.8	x	x	x	x	11.5	20.0	x	x	x	26.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.111	x	x	x	x	x	x	x	x	x	x	x	x	30.0	x	x	x	x	x	19.167	x	x	x	20.0	x	x	x	x	24.0	30.0	x	x	x	20.75	13.75	x	x	25.0	13.25	x	x	x	x	21.364	x	x	x	x	x	17.5	x	x	x	x	13.667	9.5	x	x	16.25	x	x	x	x	15.333	15.833	17.333	x	15.5	11.25	x	x	x	
-11014	Original post publication description: Open field behavior, locomotion [cm]	None	Central nervous system, behavior: Locomotor activity, distance, open field behavior [cm]	x	10601.8	10821.3	10518.1	x	x	x	x	9499.72	10368.3	x	x	x	10583.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11049.2	x	x	x	x	x	x	x	x	x	x	x	x	12942.8	x	x	x	x	x	11472.2	x	x	x	12825.3	x	x	x	x	9435.16	9833.92	x	x	x	11667.4	9093.5	x	x	11010.6	12170.7	x	x	x	x	9654.04	x	x	x	x	x	8137.39	x	x	x	x	10352.2	7851.91	x	x	9467.93	x	x	x	x	10164.0	9560.43	10063.2	x	11573.5	8946.62	x	x	x	
-11015	Original post publication description: Anxiety assay, open field behavior, duration in center of field [sec]	None	Central nervous system, behavior: Anxiety assay, open field behavior, duration in center of field [sec]	x	180.1	296.223	214.708	x	x	x	x	174.125	256.045	x	x	x	142.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	289.408	x	x	x	x	x	x	x	x	x	x	x	x	299.915	x	x	x	x	x	192.167	x	x	x	136.396	x	x	x	x	262.868	157.166	x	x	x	292.5	191.625	x	x	243.0	216.667	x	x	x	x	224.123	x	x	x	x	x	150.915	x	x	x	x	219.333	90.457	x	x	218.04	x	x	x	x	126.0	232.805	112.223	x	120.665	171.25	x	x	x	
-11016	Original post publication description: Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, litter size, and parity [mg]	None	Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, litter size, and parity [mg]	x	x	487.0	424.7	465.7	424.3	527.6	419.7	460.7	432.2	442.2	436.2	406.1	442.5	436.0	462.5	421.6	434.1	407.4	457.6	450.4	439.8	x	399.7	433.9	382.6	408.9	398.7	392.8	417.4	432.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11018	Original post publication description: Central nervous system, morphology: Forebrain weight, adjusted by age, sex, body weight and BXD epoch [mg]	None	Central nervous system, morphology: Forebrain weight, adjusted by age, sex, body weight and BXD epoch [mg]	325.587	326.8	334.116	291.154	313.532	290.277	349.953	273.138	330.311	319.497	302.973	322.222	286.387	308.654	320.855	320.94	316.608	309.071	281.454	311.144	326.695	306.994	x	291.113	301.926	271.017	288.777	283.585	268.43	295.677	296.499	311.882	293.02	294.723	306.222	298.413	309.376	284.5	326.097	x	312.554	306.31	315.326	303.153	x	x	291.201	313.382	282.75	306.125	x	x	x	342.428	295.637	x	x	x	316.175	335.036	308.256	311.741	299.177	295.429	294.365	296.548	315.903	312.96	304.496	304.495	x	311.459	289.053	294.282	300.713	301.672	313.807	x	321.572	295.2	x	313.099	321.888	302.895	325.998	296.464	x	308.345	302.208	357.403	290.207	301.46	x	x	276.676	299.298	317.23	305.397	293.22	x	x	x	
-12558	Original post publication description: Musculoskeletal system, morphology: diaphysis bone density of females at 4 months [mg/cc]	None	Musculoskeletal system, morphology: Diaphysis bone density of tibia of females at 4 months measured by micro computed tomography (microCT) (ImTek MicroCAT II, 2005) [mg/cc]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2706.0	x	3091.0	x	x	x	x	3780.0	x	x	x	x	3916.0	x	x	x	x	x	3440.0	x	4174.0	x	x	3248.0	3087.0	3953.0	x	x	4003.0	x	x	3367.0	x	3947.0	x	3664.0	4220.0	3622.0	x	x	3459.0	3475.0	3765.0	3630.0	3386.0	x	3542.0	3120.0	x	x	3433.0	x	x	x	x	3346.0	x	x	x	x	x	
-11020	Original post publication description: Kidney morphology, Wilms tumor 1 homolog negative cells per glomerular cross section in males (8 - 20 weeks of age) [n/section]	None	Urogenital system, kidney, morphology: Wilms tumor 1 negative (WT1-neg) cells per glomerular cross section in males (8 - 20 weeks of age) [n/section]	x	x	28.939	35.643	x	x	x	x	x	33.741	x	x	x	54.781	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	46.631	39.633	x	33.7	x	x	x	x	x	x	x	34.06	27.6	39.722	30.083	x	x	x	x	x	27.694	x	x	x	x	x	x	x	x	41.073	x	27.379	x	x	38.667	x	x	27.929	35.367	37.594	x	x	28.6	x	29.65	x	36.263	x	x	32.95	x	x	27.955	37.689	32.984	39.031	34.117	x	28.994	33.586	x	40.35	x	29.065	x	x	x	x	x	x	x	x	x	
-11021	Original post publication description: Group A Streptococcal sepsis, bacterial dissemination to spleens	None	Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) dissemination to spleens, 24 h post-infection (Fig 1C) [CFU/ml]	x	x	-1.123	1.445	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.52	-0.003	-0.209	x	x	-0.617	x	x	-0.615	x	x	x	x	x	x	x	x	0.92	0.43	-0.402	x	0.053	x	0.828	x	-0.254	-0.053	0.332	-1.112	x	-0.933	0.483	0.579	x	x	x	0.81	x	x	x	x	x	0.389	x	-2.186	x	-1.087	1.215	x	-1.491	x	0.311	x	x	0.658	1.112	x	x	x	x	x	
-11022	Original post publication description: Infectious disease, immune function: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection [units]	None	Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection corrected for age, sex, body weight, log inoculum (Fig 1B) [corrected log CFU/ml]	x	x	0.166	0.054	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.646	x	x	x	x	x	x	x	x	-0.544	0.032	-0.099	x	x	0.291	x	x	-0.284	x	x	x	x	x	x	x	x	0.847	0.632	-0.006	x	0.158	x	1.073	x	-0.306	-1.277	0.036	-1.048	x	-0.42	0.973	0.725	x	0.404	x	0.683	x	x	x	x	x	-0.139	x	-0.359	x	-0.379	0.389	x	-0.214	x	0.561	x	x	0.741	-1.045	x	x	x	x	x	
-11023	Original post publication description: CxEct_Rosen_Mar2011	CxEct_Rosen_Mar2011	Central nervous system, morphology, development: ectopias in neocortex (cerebral cortex) of adults (celloidin material from the Mouse Brain Library) [2x arcsine % affected animals]	x	x	1.231	0.522	0.0	0.881	0.0	0.982	1.047	1.159	0.0	0.0	0.0	0.613	0.0	0.562	0.586	0.0	1.682	0.0	1.318	1.571	x	0.0	0.0	1.662	1.571	0.0	1.128	1.318	0.0	0.0	1.047	0.68	0.0	x	0.881	1.176	0.644	x	0.586	0.0	0.841	0.586	x	x	0.927	x	0.0	0.0	x	x	x	0.841	1.128	x	x	x	0.0	0.586	0.0	1.099	1.159	0.0	1.338	1.047	1.459	1.231	0.541	1.7	x	0.0	0.0	0.841	1.231	1.403	1.7	0.0	0.0	x	x	1.002	0.0	0.0	0.0	0.0	x	0.0	1.176	0.0	0.841	0.0	x	x	1.427	0.0	0.0	1.369	x	x	x	x	
-11024	Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina [n x10^6]	None	Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD32 excluded due to retinal degeneration (3.46+/-0.096 million) [n x10^6]	8.2	8.2	7.85	9.0	8.17	x	7.03	7.54	7.84	6.14	7.92	7.14	x	6.29	8.18	x	x	x	x	x	x	7.9	x	x	x	6.97	x	x	x	7.07	x	6.07	7.38	x	8.76	x	7.78	7.5	6.64	x	x	7.87	5.78	7.21	x	x	6.53	x	x	7.22	x	x	x	6.77	8.71	x	x	x	7.3	8.19	7.43	7.28	7.69	7.8	7.07	6.99	x	6.98	5.95	8.23	x	7.24	7.04	6.98	x	8.05	x	x	7.74	7.7	x	x	6.64	7.23	6.95	6.25	x	7.38	7.2	x	8.14	x	x	x	6.66	7.49	6.56	x	x	x	x	x	
-11025	Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males [log nanogram Cp DNA, -1.301 is technical minimum] (subset of animals described in Miyiari et al.)	None	Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males [log nanogram Cp DNA, -1.301 is technical minimum] (subset of animals described in Miyiari et al.)	x	x	-0.91	x	x	x	x	x	x	-1.301	x	x	x	x	x	x	-1.301	x	x	x	-1.301	x	x	x	-1.301	x	x	x	x	-1.301	x	x	x	x	x	x	x	x	-1.301	x	x	0.969	x	-0.081	x	x	x	x	x	x	x	x	x	0.074	x	x	x	x	1.238	0.162	-1.301	x	x	0.691	x	x	x	-1.301	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.202	x	x	x	x	x	x	x	x	1.13	x	-0.268	x	x	0.387	x	x	x	
-11026	Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm]	None	Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm]	x	x	0.143	x	x	x	x	x	x	0.09	x	x	x	x	x	x	0.105	x	x	x	0.09	x	x	x	0.09	x	x	x	x	x	x	x	x	x	x	x	x	x	0.08	x	x	0.21	x	0.175	x	x	x	x	x	x	x	x	x	0.245	x	x	x	x	0.27	0.25	0.08	x	x	0.155	x	x	x	0.077	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.187	x	x	x	x	x	x	x	x	0.41	x	0.185	x	x	0.3	x	x	x	
-11027	Original post publication description: Iron level in hippocampus of males [ug/g]	None	Central nervous system, metabolism, nutrition: Iron level in hippocampus of males [ug/g]	x	x	13.2	15.3	19.3	14.9	x	11.5	14.4	13.4	14.1	13.9	19.3	13.8	15.6	15.6	11.0	12.0	x	13.6	x	16.0	x	15.4	x	14.4	15.2	16.4	x	14.7	11.1	16.0	14.5	x	13.5	x	11.2	15.3	11.4	x	12.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11028	Original post publication description: Iron level in hippocampus of females [ug/g]	None	Central nervous system, metabolism, nutrition: Iron level in hippocampus of females [ug/g]	x	x	13.0	16.4	15.9	14.6	x	14.4	12.1	11.3	12.6	14.8	18.5	15.2	16.7	16.3	12.8	12.8	x	13.8	x	15.8	x	17.8	x	13.4	16.9	15.5	x	14.5	11.4	16.4	13.9	x	13.4	x	12.3	13.0	13.1	x	11.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11029	Original post publication description: Copper level in hippocampus of males [ug/g wet tissue]	None	Central nervous system, metabolism, nutrition: Copper level in hippocampus of males [ug/g wet tissue]	x	x	4.0	4.5	8.3	3.6	x	3.3	4.8	3.5	4.0	3.5	10.3	3.9	9.4	5.5	3.1	4.4	x	4.4	x	6.7	x	5.6	x	4.5	6.1	6.2	x	6.5	2.8	9.4	3.5	x	4.7	x	4.0	4.3	3.0	x	3.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11030	Original post publication description: Copper level in hippocampus of females [ug/g wet weight]	None	Central nervous system, metabolism, nutrition: Copper level in hippocampus of females [ug/g wet weight]	x	x	4.3	7.3	6.5	4.0	x	3.9	3.5	3.1	4.0	4.6	8.8	4.7	7.4	6.3	4.7	4.5	x	4.3	x	7.7	x	6.4	x	5.3	6.2	4.1	x	5.5	3.8	6.9	3.5	x	5.2	x	4.5	3.5	3.8	x	3.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11031	Original post publication description: Zinc level in hippocampus of males [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in hippocampus of males [ug/g]	x	x	20.4	19.0	24.6	19.0	x	16.4	18.8	19.6	17.7	17.6	23.9	18.1	21.3	19.5	15.1	18.4	x	16.7	x	20.0	x	18.0	x	20.0	21.2	20.9	x	22.1	15.4	24.9	15.3	x	17.2	x	16.5	19.2	16.8	x	17.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11032	Original post publication description: Zinc level in hippocampus of females [ug/g]	None	Central nervous system, metabolism, nutrition: Zinc level in hippocampus of females [ug/g]	x	x	15.6	21.8	19.2	18.9	x	19.2	16.2	16.1	15.8	19.4	23.2	21.0	21.6	20.0	18.0	19.0	x	17.0	x	20.8	x	22.9	x	18.0	21.4	21.1	x	24.6	15.7	23.8	17.3	x	16.5	x	18.4	16.0	20.3	x	18.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11033	Original post publication description: Muscloskeletal system, morphology: Soleus-femoral muscle attachment anomaly [frequency]	None	Musculoskeletal system, morphology: Soleus-femoral muscle attachment anomaly [frequency]	x	x	0.038	0.018	0.889	0.057	x	0.0	0.0	0.0	0.102	0.5	0.174	0.015	x	0.239	0.05	0.022	x	0.0	0.018	0.037	x	0.0	x	0.01	0.154	0.08	0.053	0.044	0.215	0.031	0.095	x	0.0	x	0.596	0.0	0.039	x	0.0	0.586	0.043	0.0	x	x	0.474	x	x	0.29	x	x	0.643	x	0.708	x	x	x	0.04	0.091	0.0	0.0	x	x	0.0	x	x	0.15	0.0	x	x	0.0	x	0.0	x	0.0	x	x	x	x	x	x	0.059	0.0	0.0	0.0	x	0.0	0.0	x	x	x	x	x	0.25	0.0	x	0.0	x	x	x	x	
-11348	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [cm]	x	x	x	x	2121.41	602.646	x	2799.09	3240.75	2360.0	1285.65	1926.51	596.408	2017.6	1176.77	1610.98	1769.79	1775.29	1514.65	1879.29	x	x	x	1511.53	x	1058.02	1045.45	4236.82	x	811.324	1401.65	2420.32	1216.22	x	308.978	x	2368.24	1268.56	3170.28	x	2091.71	1991.72	699.052	2774.02	x	x	3245.98	x	3551.25	1785.52	x	x	x	899.964	375.223	x	x	x	1209.5	2900.82	194.827	2142.52	x	2006.05	1993.68	993.315	2529.45	2099.72	2328.67	3514.14	x	1118.88	x	1738.32	x	x	x	x	920.815	x	x	1781.65	2060.6	440.964	2032.4	2046.94	x	2975.1	847.468	x	2517.47	x	x	x	1062.08	1005.89	3091.89	3790.18	1797.6	x	x	x	
-11347	Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [cm]	x	x	x	x	3219.92	1226.13	x	3197.81	3771.38	3383.74	1681.62	2224.0	1232.43	2177.07	1674.51	2396.22	2355.45	2243.17	1362.84	2685.57	x	x	x	2168.92	x	2159.34	1621.6	5207.74	x	1668.84	2015.48	3564.41	1836.11	x	269.855	x	2707.18	1319.7	3881.05	x	2460.13	2331.39	1245.07	3870.8	x	x	3953.36	x	4050.12	2457.68	x	x	x	1439.83	334.627	x	x	x	2613.81	3261.2	227.466	2780.77	x	2990.32	2191.82	1532.55	3064.85	2120.79	2495.99	3081.19	x	1524.15	x	1945.75	x	x	x	x	1283.45	x	x	2170.1	2872.95	1273.11	3415.08	2437.34	x	3009.97	1760.11	x	3057.65	x	x	x	1361.55	2911.42	3203.04	4249.46	2130.7	x	x	x	
-11346	Original post publication description: Novel open field behavior, locomotion locomotion in the periphery from 15-30 min for males in the morphine test battery [cm]	None	Novel open field behavior, locomotion locomotion in the periphery from 15-30 min for males in the morphine test battery [cm]	x	x	x	x	3483.77	1969.1	x	4560.43	3115.58	4196.29	2346.33	3769.99	2391.5	2415.9	2091.57	2651.26	3725.4	2732.79	2740.77	2790.24	x	x	x	2312.39	x	3616.5	2542.89	6893.53	x	2762.83	2583.98	3412.49	2700.01	x	471.79	x	2964.66	2030.45	3940.42	x	3671.13	2871.21	1803.23	3789.61	x	x	4008.11	x	3979.21	2691.58	x	x	x	2222.48	679.956	x	x	x	3553.55	4005.44	936.0	2830.38	x	3357.29	2399.99	1750.06	3736.74	2222.54	2783.0	3343.06	x	2188.23	x	2258.36	x	x	x	x	1780.5	x	x	2002.2	3180.55	2587.2	3585.09	2623.25	x	3309.14	2389.92	x	3219.23	x	x	x	1690.26	3357.64	3901.66	4214.82	2025.3	x	x	x	
-11345	Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [cm]	x	x	x	x	3701.48	3277.99	x	5929.09	2528.98	4609.18	1934.72	5025.12	3057.36	3427.83	2030.74	3010.38	6244.45	2440.83	3455.8	3074.54	x	x	x	2439.5	x	3028.59	2703.75	6755.32	x	3666.51	3640.67	2953.67	3510.76	x	2448.3	x	4566.45	2261.2	4961.05	x	5173.58	2798.85	2892.69	4139.66	x	x	4553.54	x	3957.96	3222.05	x	x	x	3287.71	1600.45	x	x	x	4816.91	4519.15	1504.22	2256.73	x	3564.85	3092.41	2035.92	3947.63	3188.63	3548.57	3861.37	x	2484.01	x	2826.58	x	x	x	x	2250.33	x	x	2618.6	3717.48	3463.43	4142.86	2971.97	x	3761.78	3689.12	x	4181.3	x	x	x	3221.2	4756.29	5087.2	4627.59	2164.0	x	x	x	
-11344	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [n beam breaks]	x	x	x	x	542.5	145.0	x	775.5	998.667	714.4	283.0	507.0	130.0	464.0	275.667	452.75	540.5	459.75	434.5	534.0	x	x	x	329.8	x	288.0	220.0	1306.4	x	198.333	342.0	665.375	287.667	x	64.5	x	573.5	274.333	886.833	x	574.667	525.167	178.6	787.0	x	x	887.0	x	1116.0	448.571	x	x	x	234.333	80.4	x	x	x	385.0	833.25	40.1667	561.333	x	590.833	474.667	251.5	633.0	586.0	524.333	815.0	x	293.8	x	396.833	x	x	x	x	231.4	x	x	398.0	523.5	97.5	584.25	635.8	x	820.333	155.667	x	616.333	x	x	x	216.833	201.0	941.5	1180.0	454.5	x	x	x	
-11343	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [n beam breaks]	x	x	x	x	875.667	315.5	x	906.167	1164.33	1103.8	365.0	583.5	295.75	526.25	379.0	695.0	693.0	575.25	403.5	745.667	x	x	x	467.8	x	632.714	361.167	1667.6	x	400.167	497.0	1020.62	468.333	x	63.75	x	682.333	285.167	1088.5	x	693.833	600.667	314.8	1128.0	x	x	1227.0	x	1300.83	631.714	x	x	x	344.167	66.2	x	x	x	790.571	976.5	44.8333	769.333	x	867.0	509.0	372.667	761.0	572.333	596.833	805.0	x	379.8	x	446.5	x	x	x	x	304.0	x	x	474.167	780.0	293.5	995.5	784.2	x	832.0	336.667	x	785.0	x	x	x	296.0	712.0	967.5	1342.4	524.833	x	x	x	
-11342	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the morphine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the morphine test battery [n beam breaks]	x	x	x	x	999.833	529.167	x	1413.17	874.0	1309.2	584.0	1138.5	629.75	589.25	473.0	756.25	1212.0	706.5	759.5	763.667	x	x	x	493.8	x	1108.57	629.0	2357.2	x	711.167	690.0	936.5	720.833	x	121.25	x	716.833	447.5	1102.5	x	1070.67	773.0	457.4	1062.25	x	x	1257.0	x	1268.67	694.429	x	x	x	536.0	109.6	x	x	x	1055.57	1165.25	222.333	717.667	x	948.833	581.833	407.167	1056.0	623.333	709.333	889.0	x	552.5	x	536.667	x	x	x	x	435.4	x	x	431.5	867.167	645.167	1001.25	800.4	x	927.667	537.333	x	851.667	x	x	x	389.833	862.5	1190.0	1312.0	472.333	x	x	x	
-11341	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [n beam breaks]	x	x	x	x	1106.17	974.5	x	1921.5	622.333	1417.4	442.0	1637.5	829.0	944.25	408.5	880.5	2111.5	612.5	1003.5	850.833	x	x	x	482.2	x	790.571	652.833	2207.4	x	958.0	1053.25	767.375	973.167	x	626.25	x	1362.0	498.0	1517.67	x	1652.83	747.0	747.4	1101.5	x	x	1399.0	x	1243.5	907.714	x	x	x	836.0	317.8	x	x	x	1441.29	1386.75	357.5	490.333	x	961.833	827.333	471.167	1107.4	996.0	992.333	935.0	x	608.6	x	725.0	x	x	x	x	602.2	x	x	573.833	1039.17	909.5	1173.0	794.8	x	1086.67	977.0	x	1191.0	x	x	x	926.333	1431.5	1661.0	1461.2	479.167	x	x	x	
-11340	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min after injection (total vertical activity over 3 hour test) for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min after injection (total vertical activity over 3 hour test) for males [n beam breaks]	x	x	x	x	6367.33	3621.83	x	6149.0	1444.0	5888.2	1338.0	4580.5	2125.25	9106.75	500.333	7446.75	3061.25	659.5	6843.5	3365.0	x	x	x	3192.0	x	5477.29	1148.83	4255.4	x	3934.67	131.5	1902.25	765.167	x	3174.75	x	4016.0	3870.83	8673.83	x	991.833	684.833	1316.4	4764.75	x	x	1237.0	x	2300.33	6505.0	x	x	x	35.3333	723.8	x	x	x	96.5714	1550.0	1392.67	4229.33	x	1773.5	1651.17	1327.5	3862.4	631.0	7762.33	8024.0	x	4034.3	x	2090.5	x	x	x	x	3841.0	x	x	931.167	424.333	6025.67	4442.25	61.4	x	451.167	3845.33	x	972.0	x	x	x	3947.33	868.5	4330.75	156.6	5138.0	x	x	x	
-11339	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	x	x	x	x	2858.52	5108.5	x	4090.99	-558.311	1748.44	108.3	1562.34	593.559	4314.78	-330.011	440.465	-817.29	-28.2453	0.511655	1599.49	x	x	x	-69.7091	x	3073.71	253.908	58.3685	x	1150.46	-646.261	1532.3	-679.56	x	272.892	x	1920.77	2247.3	2594.33	x	2309.58	-1557.85	-767.58	3894.03	x	x	22.4665	x	-307.208	4932.6	x	x	x	-110.669	-865.643	x	x	x	-670.085	238.863	154.365	6176.85	x	-307.477	1019.76	430.233	492.038	338.439	7061.51	5094.06	x	4506.33	x	-47.6348	x	x	x	x	2884.11	x	x	36.1002	1890.64	2611.44	9028.44	-841.978	x	-633.193	2228.88	x	-316.514	x	x	x	-552.735	50.6484	-1135.16	-1499.08	1644.65	x	x	x	
-11338	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males [cm]	x	x	x	x	106890.0	55191.8	x	104096.0	34085.4	107510.0	62022.9	140106.0	52545.9	105990.0	28199.6	110832.0	41161.0	15655.1	138678.0	75400.3	x	x	x	73582.9	x	102086.0	25236.9	87067.5	x	120264.0	3521.49	36081.4	25753.0	x	76096.7	x	65290.6	92380.8	161647.0	x	17164.2	9521.27	24839.2	74815.4	x	x	54982.7	x	56932.0	171021.0	x	x	x	4841.61	21625.6	x	x	x	2103.62	19740.3	43234.4	94614.0	x	32315.7	33293.1	35266.1	67879.2	15423.8	105450.0	128651.0	x	46551.5	x	43330.4	x	x	x	x	90755.1	x	x	13026.5	10387.6	110243.0	111015.0	1426.82	x	5413.09	75976.0	x	35314.9	x	x	x	20191.4	14997.8	74538.7	3595.24	56186.5	x	x	x	
-11337	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min after injection (total open field activity over 3 hour test) for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min after injection (total open field activity over 3 hour test) for males [n beam breaks]	x	x	x	x	35796.7	18362.2	x	33446.2	10491.0	34967.8	19751.0	51288.0	14241.8	37651.5	6785.33	41466.5	12435.0	4206.25	48140.5	24349.5	x	x	x	23112.8	x	33555.7	7226.67	28767.8	x	43895.8	974.5	10135.4	6740.5	x	26988.0	x	18438.8	28921.0	61351.5	x	4672.83	2719.17	7615.2	22506.5	x	x	16431.0	x	19188.2	61234.6	x	x	x	1131.0	3211.2	x	x	x	605.571	5964.5	13660.7	24674.3	x	9254.67	10466.5	8548.83	21805.0	4523.83	30201.7	42840.0	x	13304.0	x	13715.5	x	x	x	x	31638.8	x	x	3730.0	2547.5	36532.0	40198.5	380.8	x	1501.33	21542.7	x	10487.7	x	x	x	5993.5	3883.0	26143.8	1074.6	16903.3	x	x	x	
-11336	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males [n/15 min test]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males [n/15 min test]	x	x	x	x	0.0	0.0	x	1.66667	0.0	0.4	0.0	0.5	6.5	0.0	0.0	0.0	6.0	0.0	5.25	7.33333	x	x	x	0.0	x	3.42857	6.33333	0.0	x	0.0	0.0	0.0	3.33333	x	0.0	x	0.666667	3.0	0.833333	x	4.5	3.83333	0.0	4.5	x	x	1.5	x	0.0	3.0	x	x	x	0.0	7.2	x	x	x	0.142857	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.5	0.0	x	0.3	x	0.0	x	x	x	x	3.6	x	x	0.0	2.66667	1.33333	1.0	0.0	x	0.0	0.0	x	1.66667	x	x	x	1.5	0.0	6.75	0.0	6.33333	x	x	x	
-11335	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males [n fecal boli]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males [n fecal boli]	x	x	x	x	2.0	3.33333	x	3.0	1.0	0.6	2.0	4.0	0.75	1.75	1.83333	0.25	1.25	3.0	2.0	1.5	x	x	x	1.0	x	1.14286	0.0	2.4	x	1.83333	1.75	0.625	2.83333	x	2.75	x	0.0	1.5	1.33333	x	2.66667	3.33333	2.8	2.75	x	x	0.5	x	1.66667	2.85714	x	x	x	2.0	1.2	x	x	x	3.85714	4.0	1.66667	0.666667	x	2.83333	1.66667	4.16667	1.2	1.66667	0.5	3.0	x	2.0	x	3.66667	x	x	x	x	3.0	x	x	2.0	2.83333	0.5	2.75	1.8	x	1.33333	2.0	x	1.33333	x	x	x	2.0	3.5	2.0	2.2	0.666667	x	x	x	
-11334	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.0	0.333333	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	x	x	0.0	x	0.142857	0.0	0.2	x	0.0	0.0	0.0	0.166667	x	0.0	x	0.0	0.0	0.0	x	0.0	0.0	0.0	0.25	x	x	0.0	x	0.0	0.0	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	x	0.0	x	x	x	x	0.0	x	x	0.0	0.0	0.0	0.25	0.0	x	0.0	0.0	x	0.0	x	x	x	0.0	0.0	0.0	0.0	0.0	x	x	x	
-11333	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males [cm]	x	x	x	x	12298.8	4579.62	x	12542.8	8243.59	14680.2	11290.1	17666.2	7009.53	12641.7	3687.13	17045.5	4684.07	455.723	17217.6	10804.1	x	x	x	10221.2	x	13925.4	2157.55	11098.9	x	10927.4	267.956	3002.51	3903.8	x	10194.4	x	7407.62	11763.1	21464.2	x	497.94	1264.92	4004.96	9665.69	x	x	6895.36	x	7407.69	19634.0	x	x	x	144.874	2487.82	x	x	x	25.7629	1406.09	5751.83	9412.8	x	6103.21	5136.6	6027.54	9982.21	1700.5	9949.54	6525.46	x	4250.73	x	4791.84	x	x	x	x	13266.3	x	x	1758.06	116.522	12302.8	12234.9	39.2653	x	17.3776	8336.78	x	4510.36	x	x	x	3122.08	1643.21	9958.22	342.95	5999.12	x	x	x	
-11332	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males [cm]	x	x	x	x	11333.2	3604.59	x	12835.8	5396.71	15328.1	10915.7	17941.3	6400.25	11230.3	3583.35	17684.8	5617.39	158.578	16448.6	10095.7	x	x	x	9510.55	x	12961.8	1598.82	10395.2	x	16451.2	235.985	2785.13	3193.75	x	13772.9	x	7586.75	11643.9	20527.6	x	273.546	957.739	4505.8	8491.82	x	x	6742.33	x	10118.7	18368.1	x	x	x	70.3153	1997.65	x	x	x	112.304	904.603	6054.29	9087.17	x	5749.14	4005.67	4005.48	11547.5	1348.43	9182.32	10540.8	x	3314.01	x	3735.26	x	x	x	x	11772.2	x	x	1630.15	20.1998	13551.9	8596.89	95.8489	x	0.0	7132.8	x	5415.76	x	x	x	2524.57	1422.24	10621.6	255.075	4976.95	x	x	x	
-11331	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males [cm]	x	x	x	x	9653.85	2160.45	x	11531.9	2024.51	12496.3	8785.21	16972.9	4954.4	8056.44	2790.86	17121.3	5235.33	27.3364	15220.3	7909.12	x	x	x	8868.73	x	10767.9	1192.79	8937.76	x	19825.2	67.1376	2562.71	2278.48	x	14764.9	x	6289.32	8929.75	17134.2	x	177.83	726.556	3703.7	6248.65	x	x	5822.06	x	11987.2	16991.9	x	x	x	37.0836	1819.62	x	x	x	9.17922	328.053	6042.11	7927.91	x	4150.54	2569.76	2111.91	11766.2	879.605	8050.25	17669.4	x	2130.4	x	2580.1	x	x	x	x	9143.26	x	x	1104.0	6.35	12944.0	7616.05	127.983	x	13.4203	5650.03	x	4870.99	x	x	x	1833.57	1217.75	11181.9	109.27	3977.23	x	x	x	
-11330	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males [cm]	x	x	x	x	7296.9	1577.45	x	9924.63	796.667	8077.75	6309.71	15981.4	3594.25	5847.4	2433.82	14323.9	4473.3	40.0034	12902.5	5431.33	x	x	x	7031.66	x	7593.73	517.033	6155.81	x	20621.7	48.3042	2124.79	1477.29	x	11708.4	x	5174.99	7192.77	13420.3	x	176.072	451.236	3379.42	4466.76	x	x	5407.34	x	9978.39	13691.9	x	x	x	12.7419	1323.37	x	x	x	114.788	284.696	5356.25	6432.72	x	2914.15	1372.16	866.106	9499.62	706.794	6152.44	25510.3	x	1244.33	x	1670.23	x	x	x	x	4892.38	x	x	604.893	9.525	10545.0	4363.51	100.833	x	22.079	4464.8	x	3432.84	x	x	x	1071.26	173.499	9712.89	20.32	3252.17	x	x	x	
-11329	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males [cm]	x	x	x	x	5902.69	978.639	x	7288.48	145.304	5127.8	2273.06	13870.5	1689.58	4467.96	1905.09	9376.68	4059.25	8.255	11126.4	2589.27	x	x	x	4147.98	x	5188.22	456.184	5852.66	x	15830.6	61.2789	2145.22	1296.94	x	4471.54	x	3204.43	6228.33	9899.72	x	174.612	473.335	1925.83	3705.12	x	x	3806.47	x	5037.28	12009.0	x	x	x	61.2174	933.445	x	x	x	159.749	294.461	2884.97	5898.97	x	1859.1	1518.61	382.164	5665.6	354.214	5614.81	27903.4	x	1349.92	x	1207.19	x	x	x	x	2765.85	x	x	207.673	25.1377	7648.04	1883.95	33.5857	x	52.4089	4598.61	x	1856.11	x	x	x	508.398	97.5167	9305.91	16.51	2682.68	x	x	x	
-11328	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males [cm]	x	x	x	x	3877.12	6491.5	x	4825.85	687.474	2653.6	889.155	2670.07	1675.58	4999.2	359.685	1249.38	922.18	1284.57	1777.9	3475.57	x	x	x	900.548	x	4490.5	1870.61	1194.85	x	2262.29	570.576	3088.16	732.083	x	950.666	x	3296.51	3306.69	3908.74	x	4393.71	216.093	319.399	5285.23	x	x	1293.34	x	676.626	6115.71	x	x	x	1046.98	1121.54	x	x	x	539.041	1385.18	923.776	6685.86	x	261.989	1629.48	913.455	1548.29	1554.74	7944.1	5716.18	x	5210.47	x	814.721	x	x	x	x	3936.73	x	x	839.43	2960.28	3743.28	10864.5	232.477	x	1067.66	2877.97	x	737.117	x	x	x	808.058	1294.02	434.736	578.471	3427.75	x	x	x	
-11327	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for males [cm]	x	x	x	x	5484.31	7382.02	x	5638.55	603.367	4406.49	984.389	4057.5	2437.82	8909.02	437.839	2453.17	612.901	3510.13	3763.35	3797.04	x	x	x	1512.5	x	4763.6	3280.08	2736.45	x	4016.82	622.395	3079.71	697.885	x	715.231	x	4236.08	4317.17	6194.03	x	4054.82	31.9992	575.645	4916.32	x	x	2092.9	x	843.122	10053.6	x	x	x	472.121	1780.24	x	x	x	172.389	2356.22	1013.64	7858.5	x	122.663	2353.07	1747.19	520.141	1412.23	9086.62	5301.81	x	5224.16	x	2201.25	x	x	x	x	5531.12	x	x	889.204	2291.1	5416.44	12363.0	83.8599	x	919.353	5713.19	x	1463.14	x	x	x	1323.87	1692.35	226.498	290.506	4023.41	x	x	x	
-11326	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males [cm]	x	x	x	x	5531.1	1679.31	x	3711.77	798.939	4682.05	1064.29	5523.89	760.109	2722.34	1968.46	4956.09	4039.4	351.563	6708.64	1548.3	x	x	x	2409.23	x	2739.43	683.537	5460.99	x	5616.66	428.127	2689.98	1398.59	x	1992.33	x	3271.05	3735.41	8408.84	x	907.922	1123.11	1853.35	2729.71	x	x	3143.9	x	1829.07	6672.25	x	x	x	847.238	979.74	x	x	x	540.575	750.773	1462.57	3363.47	x	1114.34	2755.96	778.209	2890.09	1048.98	8312.93	10202.0	x	2141.57	x	1437.28	x	x	x	x	1860.99	x	x	469.456	611.606	2895.68	623.537	314.22	x	1788.4	4073.89	x	965.344	x	x	x	568.889	783.451	6080.76	696.505	2452.71	x	x	x	
-11325	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males [cm]	x	x	x	x	10567.0	7142.52	x	7456.86	1795.04	9044.45	3538.33	9077.16	5516.6	11509.6	1941.83	3833.05	2421.97	3692.31	12020.8	6750.9	x	x	x	6423.33	x	8412.58	3618.58	8955.91	x	5704.36	274.611	3780.12	2318.16	x	2640.7	x	5968.67	7336.61	13559.2	x	1775.32	1350.37	720.18	6437.58	x	x	4664.02	x	1538.29	15861.5	x	x	x	695.513	2252.64	x	x	x	181.968	3690.58	2811.95	9591.27	x	1258.81	2552.99	4197.78	1341.13	1351.41	10322.5	4534.55	x	5645.41	x	6330.1	x	x	x	x	8563.54	x	x	1212.31	1348.25	10121.9	13130.8	130.98	x	686.281	8217.86	x	2726.17	x	x	x	1732.76	1635.51	4283.34	263.598	6511.41	x	x	x	
-11324	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males	None	Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males	x	x	x	x	13121.5	6624.62	x	10243.5	5246.08	11530.5	5668.87	13225.8	7081.87	12487.7	3621.08	7437.69	3191.87	2429.94	15546.1	8102.43	x	x	x	9421.57	x	11869.7	3332.87	10401.8	x	6177.15	278.674	3560.26	3393.78	x	4261.92	x	6700.42	10292.6	16929.6	x	1266.4	1355.33	1134.2	8029.88	x	x	5650.4	x	2496.65	18894.7	x	x	x	535.187	2392.06	x	x	x	43.91	2913.32	4637.68	9589.29	x	3400.27	3116.71	5262.94	4201.93	2101.29	10244.9	4446.06	x	5032.15	x	6825.0	x	x	x	x	9487.22	x	x	1398.7	822.332	11122.0	13508.9	28.2443	x	168.495	8979.7	x	2971.06	x	x	x	2564.57	1436.44	5185.56	379.73	7008.81	x	x	x	
-11323	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males [cm]	x	x	x	x	13319.8	5660.21	x	12297.0	7889.28	13647.6	8358.18	16791.0	7474.66	13429.0	4334.51	12817.9	3582.17	654.305	17295.2	10180.3	x	x	x	10419.5	x	13541.5	2768.06	11010.7	x	7880.29	267.315	3616.86	3664.3	x	8425.49	x	7202.13	11548.5	20438.0	x	815.083	1313.5	2230.91	8991.11	x	x	6628.82	x	3808.96	20089.5	x	x	x	372.333	2462.74	x	x	x	36.1343	2658.36	4575.47	9624.99	x	5027.26	4695.63	6131.91	8530.58	1713.1	10777.7	5281.6	x	4792.44	x	6659.99	x	x	x	x	11953.3	x	x	1800.22	364.467	12018.9	12217.1	47.2227	x	31.7829	8754.49	x	3797.97	x	x	x	2996.69	1668.97	6602.65	330.893	6414.85	x	x	x	
-11322	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	4177.5	1374.33	x	4196.67	2696.33	5249.2	3763.67	6696.0	1999.5	4455.25	961.167	6777.5	1417.0	52.25	6379.25	3689.5	x	x	x	3396.6	x	4794.14	553.0	3740.0	x	3906.33	65.0	812.5	1127.83	x	3623.25	x	2126.17	3872.0	8902.83	x	67.3333	373.667	1266.4	3365.5	x	x	2110.0	x	2520.83	7254.29	x	x	x	11.0	273.4	x	x	x	7.85714	364.75	1807.83	2498.67	x	1974.5	1700.0	1485.5	3421.8	507.833	3003.33	1283.0	x	1155.6	x	1523.5	x	x	x	x	4957.4	x	x	513.333	9.33333	4187.0	4602.0	10.8	x	1.66667	2361.67	x	1383.67	x	x	x	935.5	454.5	3450.75	103.0	1846.17	x	x	x	
-11321	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	3811.0	988.833	x	4326.83	1453.33	5599.4	3561.67	6914.0	1710.5	3844.75	987.5	7137.25	1766.5	12.25	5983.0	3439.0	x	x	x	3126.6	x	4378.86	413.667	3454.6	x	6320.0	47.75	732.875	839.667	x	5026.25	x	2288.83	3795.67	8454.5	x	28.3333	267.167	1382.2	2752.25	x	x	1983.0	x	3493.17	6805.14	x	x	x	3.66667	160.4	x	x	x	28.8571	176.75	1970.5	2354.33	x	1747.33	1304.33	834.0	3953.4	389.167	2633.0	3312.0	x	812.5	x	1109.5	x	x	x	x	4309.8	x	x	454.0	2.33333	4744.33	2995.25	20.6	x	0.0	1895.0	x	1652.67	x	x	x	729.333	325.5	3764.5	67.6	1476.5	x	x	x	
-11320	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	3125.33	540.167	x	3773.0	495.0	4147.4	2702.0	6586.5	1178.25	2780.25	551.667	6767.25	1642.75	2.25	5355.5	2646.33	x	x	x	2899.8	x	3512.57	248.5	2853.6	x	8016.33	9.0	685.5	526.167	x	5289.5	x	1832.17	2614.0	6657.5	x	15.5	195.0	1119.8	1812.75	x	x	1731.0	x	4245.17	6346.86	x	x	x	1.83333	132.4	x	x	x	0.142857	48.75	2056.83	1857.67	x	1029.17	768.833	275.667	3941.8	243.167	2126.83	6476.0	x	447.2	x	703.167	x	x	x	x	3250.2	x	x	293.167	0.333333	4554.0	2495.5	24.0	x	1.5	1351.0	x	1434.0	x	x	x	526.5	303.0	3977.25	21.4	1074.67	x	x	x	
-11319	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	2338.67	365.833	x	3178.0	188.333	2313.8	1868.67	5844.5	680.25	2093.0	404.0	5236.25	1407.0	2.75	4297.5	1604.33	x	x	x	2097.4	x	2314.71	63.6667	1851.8	x	8400.5	4.5	571.0	266.833	x	4140.5	x	1413.0	2045.67	4813.33	x	15.5	105.0	1022.2	1073.25	x	x	1600.0	x	3429.33	4953.29	x	x	x	0.666667	99.8	x	x	x	27.4286	40.0	1853.0	1343.0	x	628.5	326.167	78.8333	2990.6	201.833	1278.33	10782.0	x	203.7	x	424.333	x	x	x	x	1552.2	x	x	157.5	0.5	3625.33	1270.5	18.4	x	2.0	975.0	x	961.0	x	x	x	305.333	40.0	3400.0	2.6	852.667	x	x	x	
-11318	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	1826.67	199.0	x	2275.33	25.3333	1296.0	651.667	4914.5	263.75	1565.0	222.667	2989.0	1278.5	1.0	3572.25	657.0	x	x	x	989.2	x	1514.14	48.0	1860.4	x	6081.17	7.5	634.5	206.0	x	1612.25	x	905.667	1829.5	3523.67	x	31.1667	101.0	581.2	802.25	x	x	1106.5	x	1542.67	4201.0	x	x	x	6.66667	79.6	x	x	x	41.5714	55.75	820.667	1275.0	x	368.333	365.333	30.1667	1529.4	103.333	1159.83	12059.0	x	289.7	x	333.0	x	x	x	x	819.2	x	x	50.8333	4.16667	2449.33	459.75	3.0	x	9.5	1111.0	x	476.333	x	x	x	149.167	17.0	3277.0	1.0	722.333	x	x	x	
-11317	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	1208.5	2241.83	x	1517.0	190.333	703.6	285.333	835.0	462.25	1740.75	81.5	357.25	249.5	362.75	538.5	1082.83	x	x	x	257.8	x	1521.57	584.833	364.4	x	681.5	159.5	852.125	209.5	x	323.75	x	945.833	980.333	1178.17	x	1403.17	51.1667	96.6	1516.0	x	x	373.0	x	225.0	1940.43	x	x	x	287.833	279.2	x	x	x	163.571	448.75	247.0	1741.67	x	78.3333	560.0	258.0	426.8	460.5	2155.83	1381.0	x	1603.1	x	243.5	x	x	x	x	1321.0	x	x	228.0	824.0	1117.33	3909.25	59.4	x	309.833	840.667	x	191.0	x	x	x	225.0	333.5	135.75	182.6	1009.83	x	x	x	
-11316	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	1772.67	2612.17	x	1713.17	161.667	1216.2	325.667	1300.0	669.0	3177.25	65.8333	740.5	126.75	1037.0	1205.25	1147.17	x	x	x	421.0	x	1448.43	1074.5	883.8	x	1204.17	190.0	852.75	207.333	x	224.75	x	1214.33	1260.33	1917.17	x	1255.67	1.5	159.0	1410.0	x	x	605.5	x	278.5	3401.0	x	x	x	125.5	426.4	x	x	x	49.4286	750.0	246.5	2131.0	x	34.1667	811.167	483.667	151.8	380.333	2588.33	1094.0	x	1629.5	x	703.5	x	x	x	x	1868.2	x	x	258.0	592.333	1688.5	4582.75	27.4	x	267.0	1755.67	x	416.667	x	x	x	376.167	451.0	72.5	89.0	1190.83	x	x	x	
-11307	Original post publication description: Pain response, thermal nociception using Hargreaves' test for males [units]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception using Hargreaves' test for males [units]	x	x	x	x	x	x	x	10.5148	13.8	x	8.56691	16.5295	14.3669	10.2102	13.7917	9.74463	13.7313	9.50583	10.3367	16.7707	x	x	x	15.12	x	11.3156	11.5027	13.236	x	9.93312	10.9415	15.0217	13.407	x	14.5357	x	15.3733	10.7323	12.2503	x	9.9575	17.6442	11.6169	9.893	x	x	10.969	x	10.2867	10.8322	x	x	x	12.0997	12.3933	x	x	x	10.8968	15.1283	10.9194	16.4203	x	14.608	16.475	19.9303	14.4356	11.9458	23.7783	14.7875	x	14.407	x	15.6732	x	13.441	x	x	10.7275	x	x	17.484	12.7757	20.18	8.48271	11.0256	x	16.1733	x	x	16.3293	x	x	x	12.707	13.2608	15.5398	19.0475	20.2953	x	x	x	
-11304	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males [sec]	x	x	x	x	159.0	x	x	9.5	x	x	118.571	18.5	3.75	4.66667	x	4.5	2.85714	45.6	x	2.2	x	x	x	x	x	25.2	0.0	17.0	x	3.42857	10.3636	12.3333	6.2	x	13.8	x	0.0	33.0	13.8	x	14.8	34.0	74.3333	6.4	x	x	60.0	x	13.4	10.6	x	x	x	4.2	6.0	x	x	x	9.5	4.33333	223.2	42.0	x	5.6	14.75	4.8	11.6	8.6	3.5	5.0	x	14.1667	x	27.8	x	x	x	x	3.625	x	x	x	19.0	x	10.0	6.0	x	5.33333	x	x	x	x	x	x	6.5	7.0	9.0	x	14.0	x	x	x	
-11262	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for females [um]	x	x	402.226	523.907	450.785	490.49	x	601.115	449.645	581.748	414.77	404.61	445.335	412.065	568.498	428.64	461.643	435.34	622.83	528.365	x	x	x	521.165	x	541.238	461.57	x	x	489.12	516.865	458.63	500.303	x	564.64	x	534.47	441.085	431.635	x	348.738	602.81	416.12	633.32	x	x	615.518	x	634.253	582.92	x	x	x	548.745	516.257	x	x	x	538.163	536.015	338.857	646.415	x	453.62	509.543	413.488	471.13	475.643	522.077	500.737	x	527.333	x	483.71	x	390.2	x	x	530.51	x	x	501.56	517.29	517.88	534.32	486.16	x	457.99	551.22	x	485.913	x	x	x	556.897	429.613	605.425	533.785	601.36	x	x	x	
-11263	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for males [um]	x	x	426.34	434.136	579.675	497.753	x	511.878	526.28	580.493	x	471.985	529.285	457.245	657.665	514.583	593.267	443.765	509.843	x	x	x	x	587.04	x	599.963	633.815	483.573	x	597.365	565.12	650.39	596.103	x	552.727	x	542.623	485.41	488.157	x	462.205	554.213	458.587	383.755	x	x	664.306	x	605.425	576.775	x	x	x	560.378	490.595	x	x	x	570.082	567.2	531.377	712.67	x	476.243	534.083	516.67	547.203	469.353	518.645	592.017	x	593.765	x	482.713	x	510.183	x	x	538.105	x	x	565.905	533.747	539.44	548.805	599.59	x	667.32	632.015	x	528.195	x	x	x	518.855	490.337	634.35	640.205	580.97	x	x	x	
-11266	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for males [um]	x	x	1065.04	906.118	1131.54	1029.55	x	1210.67	1064.63	1131.33	x	962.84	1019.47	960.715	1130.33	1249.22	1122.56	996.24	1204.9	x	x	x	x	1170.92	x	1157.2	1157.93	964.037	x	1074.44	1060.65	1210.14	1194.71	x	1084.26	x	1156.26	1037.65	958.603	x	1101.15	1059.56	981.133	1026.11	x	x	1262.81	x	1063.93	1271.21	x	x	x	1084.97	1057.65	x	x	x	1150.09	1091.13	1128.02	1249.06	x	1038.56	1101.78	1104.05	1102.79	1111.58	969.45	1149.26	x	1083.49	x	1022.65	x	1020.94	x	x	1022.99	x	x	1002.44	1111.89	1112.88	1041.82	1175.94	x	1115.32	1165.52	x	1061.99	x	x	x	1093.56	1033.61	1169.91	1162.54	1330.42	x	x	x	
-11267	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for females [um]	x	x	1178.02	1185.5	1135.51	1253.38	x	1461.82	1064.81	1271.12	1306.77	1067.68	1279.95	1037.69	1214.73	1409.33	1325.71	1076.3	1395.26	1245.78	x	x	x	1247.53	x	1271.53	1449.89	x	x	1235.49	1411.22	1217.19	1203.64	x	1289.41	x	1330.0	1303.38	1137.89	x	1116.28	1287.82	1037.93	1396.88	x	x	1344.69	x	1406.93	1514.21	x	x	x	1193.36	1348.0	x	x	x	1337.82	1262.56	1436.28	1408.98	x	1209.61	1305.66	1118.29	1236.96	1286.81	1230.03	1067.72	x	1233.93	x	1185.86	x	1024.55	x	x	1130.1	x	x	1199.17	1272.53	1215.21	1078.08	1248.08	x	1177.55	1285.69	x	1264.53	x	x	x	1269.19	1189.6	1286.06	1239.37	1350.56	x	x	x	
-11268	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for males [um]	x	x	46.556	45.552	39.74	40.657	x	53.423	42.765	43.795	x	32.108	36.988	33.0	43.31	44.66	46.826	39.255	48.108	x	x	x	x	50.044	x	39.44	35.48	41.165	x	36.59	36.11	49.865	45.065	x	42.637	x	40.91	43.295	39.113	x	51.123	39.254	43.188	45.325	x	x	47.328	x	41.395	61.518	x	x	x	42.569	50.258	x	x	x	49.17	41.382	39.29	50.803	x	42.542	38.973	47.998	39.66	42.613	35.783	46.085	x	46.94	x	44.035	x	43.315	x	x	41.263	x	x	37.215	39.393	43.474	40.223	39.913	x	38.53	43.711	x	41.838	x	x	x	38.513	42.297	42.423	38.808	45.568	x	x	x	
-11269	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for females [um]	x	x	41.181	38.095	44.028	46.978	x	46.555	38.608	41.95	38.55	31.413	45.888	32.013	45.048	49.253	42.849	41.127	38.743	45.475	x	x	x	41.043	x	47.889	39.273	x	x	50.775	33.42	33.585	46.018	x	40.327	x	44.51	50.293	39.312	x	46.389	40.286	46.438	51.898	x	x	41.491	x	46.912	55.374	x	x	x	43.653	49.995	x	x	x	48.664	43.032	54.27	47.183	x	42.036	39.36	49.168	49.75	40.317	46.153	43.77	x	47.219	x	44.699	x	48.383	x	x	35.532	x	x	42.102	45.355	44.42	42.495	39.863	x	38.4	50.189	x	42.041	x	x	x	46.277	42.865	39.565	41.816	34.317	x	x	x	
-11270	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width in young adult males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width in young adult males [um]	x	x	143.661	110.983	144.29	137.802	x	168.833	143.043	113.957	x	117.235	116.838	125.473	99.86	189.717	107.054	150.653	178.804	x	x	x	x	142.653	x	140.071	132.65	109.183	x	113.015	129.925	123.068	143.8	x	115.698	x	131.993	121.932	108.823	x	136.706	122.646	120.145	143.783	x	x	135.825	x	97.393	154.478	x	x	x	121.086	128.77	x	x	x	128.304	117.66	134.057	134.858	x	125.613	128.033	137.158	132.928	164.698	108.38	109.328	x	109.578	x	119.445	x	107.222	x	x	107.76	x	x	100.418	124.467	127.223	114.48	135.8	x	109.478	116.346	x	115.568	x	x	x	134.49	127.74	121.407	116.573	148.21	x	x	x	
-11271	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width for females [um]	x	x	190.799	114.783	136.563	182.118	x	228.625	142.955	153.214	192.095	150.615	201.718	142.485	164.184	221.848	122.774	154.223	147.14	153.648	x	x	x	184.065	x	143.865	133.215	x	x	173.49	102.86	195.993	179.93	x	127.681	x	171.698	224.443	202.105	x	155.734	163.203	155.08	189.82	x	x	184.469	x	156.525	232.236	x	x	x	145.49	214.718	x	x	x	181.467	174.325	259.647	212.683	x	175.089	195.732	185.485	178.443	172.478	138.397	149.028	x	162.344	x	148.823	x	136.4	x	x	132.493	x	x	164.467	184.065	156.943	130.532	157.143	x	120.338	141.634	x	173.931	x	x	x	166.875	165.24	179.257	156.44	203.055	x	x	x	
-11272	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for males [um]	x	x	0.0	0.0	0.0	0.0	x	0.0	0.0	0.0	x	0.0	0.0	0.0	19.25	38.52	11.223	0.0	0.0	x	x	x	x	0.0	x	0.0	0.0	0.0	x	0.0	0.0	7.3	0.0	x	27.892	x	36.83	0.0	0.0	x	0.0	0.0	0.0	0.0	x	x	0.0	x	0.0	14.148	x	x	x	0.0	20.99	x	x	x	0.0	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	x	0.0	x	0.0	x	x	0.0	x	x	0.0	0.0	0.0	0.0	0.0	x	0.0	0.0	x	0.0	x	x	x	0.0	0.0	0.0	0.0	0.0	x	x	x	
-11273	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for females [um]	x	x	36.523	47.136	37.885	66.465	x	52.876	50.103	42.921	109.35	58.865	74.81	51.448	40.746	66.28	78.404	43.97	65.747	47.285	x	x	x	54.343	x	61.791	39.665	x	x	57.715	40.903	57.445	58.905	x	63.556	x	57.615	64.723	47.01	x	57.071	48.404	36.67	57.945	x	x	44.26	x	60.232	66.824	x	x	x	53.933	51.742	x	x	x	49.251	47.962	74.492	43.605	x	71.183	69.267	27.418	53.578	86.36	74.662	28.355	x	37.744	x	65.528	x	56.488	x	x	51.843	x	x	57.118	54.343	70.81	36.315	80.77	x	34.318	53.14	x	70.659	x	x	x	58.248	78.33	40.185	64.744	51.243	x	x	x	
-11280	Original post publication description: Coat color (version 2, ordinal test case, black=4, grey=3, brown=2, dba dilute=1)	None	Skin, pigmentation: Hair coat color, ordinal scale version 2 where black=4, grey=3, brown=2, dba dilute=1 [color intensity]	4.0	4.0	4.0	1.0	1.0	4.0	3.0	3.0	3.0	1.0	4.0	3.0	2.0	4.0	2.0	3.0	3.0	3.0	4.0	1.0	3.0	4.0	2.0	2.0	2.0	2.0	2.0	3.0	1.0	4.0	4.0	3.0	4.0	4.0	2.0	x	3.0	3.0	3.0	x	4.0	4.0	1.0	1.0	x	x	4.0	3.0	4.0	4.0	2.0	2.0	x	2.0	4.0	x	x	2.0	2.0	1.0	2.0	1.0	1.0	2.0	2.0	1.0	2.0	1.0	1.0	1.0	2.0	1.0	2.0	1.0	3.0	1.0	2.0	3.0	1.0	1.0	x	1.0	1.0	1.0	4.0	4.0	2.0	1.0	1.0	1.0	1.0	1.0	3.0	1.0	4.0	2.0	1.0	1.0	4.0	3.0	2.0	1.0	
-11281	Original post publication description: Central nervous system, visual system: Ocular dominance index (imaged ocular dominance index of undeprived mice at P35 given by (control_OD_contra - control_OD_ipsi) / (control_OD_contra+control_OD_ipsi) [ratio]	None	Central nervous system, visual system: Ocular dominance index (imaged ocular dominance index of undeprived mice at P35 given by (control_OD_contra - control_OD_ipsi) / (control_OD_contra+control_OD_ipsi) [ratio]	x	x	0.409	0.474	0.368	0.571	x	0.384	x	0.74	0.408	x	x	0.48	x	0.645	x	0.404	x	0.518	x	x	x	x	x	0.43	0.347	0.374	x	0.365	0.405	0.373	0.426	x	0.43	x	x	0.473	0.422	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11282	Original post publication description: Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of contralateral eye [intensity]	None	Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of contralateral eye [intensity]	x	x	0.325	0.146	0.26	0.301	x	0.273	x	0.131	0.265	x	x	0.303	x	0.295	x	0.518	x	0.197	x	x	x	x	x	0.189	0.257	0.409	x	0.328	0.317	0.211	0.275	x	0.286	x	x	0.295	0.235	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11283	Original post publication description: Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of ipsilateral eye [intensity]	None	Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of ipsilateral eye [intensity]	x	x	0.14	0.059	0.119	0.085	x	0.128	x	0.021	0.124	x	x	0.111	x	0.076	x	0.217	x	0.062	x	x	x	x	x	0.078	0.12	0.18	x	0.157	0.137	0.095	0.114	x	0.11	x	x	0.104	0.096	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11284	Original post publication description: Central nervous system, visual system: Ocular dominance index shift after monocular deprivation of the contralateral eye from P28 to P35	None	Central nervous system, visual system: Ocular dominance index shift after monocular deprivation of the contralateral eye from P28 to P35	x	x	-0.408	-0.304	-0.322	0.133	x	-0.349	x	x	x	x	x	-0.257	x	-0.606	x	x	x	-0.337	x	x	x	x	x	x	0.057	-0.23	x	-0.276	x	-0.364	-0.242	x	x	x	x	-0.336	-0.195	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11285	Original post publication description: Central nervous system, visual system: Contralateral visual cortex (V1) shift in intrinsic response to contralateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35	None	Central nervous system, visual system: Contralateral visual cortex (V1) shift in intrinsic response to contralateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35	x	x	-0.073	-0.023	-0.092	0.047	x	-0.072	x	x	x	x	x	-0.013	x	x	x	x	x	-0.069	x	x	x	x	x	x	-0.056	x	x	-0.088	x	-0.041	0.006	x	x	x	x	-0.06	0.015	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11286	Original post publication description: Central nervous system, visual system: Visual cortex (V1) activity, ipsilateral shift in intrinsic response to ipsilateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35	None	Central nervous system, visual system: Visual cortex (V1) activity, ipsilateral shift in intrinsic response to ipsilateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35	x	x	0.104	0.033	0.045	-0.015	x	0.055	x	x	x	x	x	0.083	x	x	x	x	x	0.036	x	x	x	x	x	x	-0.037	x	x	0.048	x	0.064	0.079	x	x	x	x	0.068	0.062	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11308	Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for males [sec]	None	Central nervous system, behavior: Pain response, thermal nociception, hot plate test, average of two trials for males [sec]	x	x	x	x	x	x	x	8.429	12.175	x	7.69429	8.35286	4.795	6.459	9.7925	5.11444	9.879	5.583	6.2875	5.455	x	x	x	12.24	x	10.0006	7.53909	7.48938	x	5.81563	5.79833	8.914	7.282	x	6.572	x	9.14	7.2185	9.819	x	5.70563	12.475	8.09444	14.265	x	x	16.526	x	10.866	7.75778	x	x	x	11.0225	6.12	x	x	x	8.99542	8.65667	8.4975	15.683	x	8.46875	7.23214	8.49071	6.72083	6.71417	8.675	11.87	x	12.191	x	10.32	x	6.41222	x	x	8.254	x	x	7.72214	12.0783	9.29	10.1344	4.6575	x	9.331	x	x	10.1412	x	x	x	13.026	9.7	7.78889	5.6775	9.62	x	x	x	
-11309	Original post publication description: Pain response, mechanical nociception, tail clip latency for males [sec]	None	Central nervous system, behavior: Pain response, mechanical nociception, tail clip latency for males [sec]	x	x	x	x	x	x	x	10.073	27.525	x	19.5257	8.97571	18.3988	11.23	30.025	17.9378	14.444	8.665	31.96	6.134	x	x	x	15.484	x	21.3687	47.7682	37.4412	x	29.1775	29.045	19.754	47.54	x	16.204	x	8.364	29.006	25.027	x	9.32	16.14	17.8989	27.289	x	x	39.695	x	28.453	18.25	x	x	x	12.315	60.0	x	x	x	16.5742	23.5067	37.462	25.188	x	16.584	9.56714	22.6329	41.7108	21.8008	3.77	29.565	x	20.554	x	32.251	x	38.572	x	x	23.046	x	x	14.7571	5.907	12.18	11.7963	10.02	x	15.988	x	x	14.834	x	x	x	46.598	36.015	24.27	16.555	8.3	x	x	x	
-11310	Original post publication description: Pain response, thermal nociception, tail withdrawal latency for males [sec]	None	Pain response, thermal nociception, tail withdrawal latency for males [sec]	x	x	x	x	x	x	x	8.756	10.845	x	14.1876	11.7452	9.29917	6.84933	19.0733	9.95111	11.8793	14.5993	8.48667	7.21267	x	x	x	18.0547	x	12.7392	14.9267	21.0554	x	10.0842	12.015	11.68	13.7673	x	13.9807	x	12.7407	12.5237	21.616	x	13.7592	9.66333	12.597	22.7887	x	x	13.082	x	18.0887	12.167	x	x	x	9.988	28.13	x	x	x	11.9231	12.8433	13.1127	10.8133	x	8.88933	11.5671	21.0171	10.7622	13.6206	14.235	10.7933	x	18.9863	x	14.2343	x	17.9141	x	x	12.701	x	x	10.3314	13.745	5.64667	20.5637	11.4021	x	15.3253	x	x	7.93933	x	x	x	12.8227	13.9633	9.157	9.56833	15.436	x	x	x	
-11311	Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males [Force in mg]	None	Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males [Force in mg]	x	x	x	x	x	x	x	4.07095	3.96175	x	4.33079	4.30861	4.475	4.41765	4.37725	4.16708	4.37985	4.1105	4.23112	4.2374	x	x	x	4.23845	x	4.15503	4.35966	4.21844	x	4.27931	4.07069	4.0338	4.1918	x	3.9919	x	4.10945	4.03083	4.13415	x	4.37741	3.69375	4.42419	4.26197	x	x	4.1711	x	4.1815	4.37061	x	x	x	4.40882	4.22	x	x	x	4.19504	4.15158	4.19117	4.24515	x	4.01775	4.19268	4.11783	4.30873	3.98298	4.246	3.95263	x	4.15525	x	4.03135	x	4.15495	x	x	4.39307	x	x	4.17318	3.78443	4.11475	4.23116	4.07288	x	3.94595	x	x	4.06385	x	x	x	4.1174	3.99612	4.1125	4.07363	4.17915	x	x	x	
-11312	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	4631.5	1888.67	x	4062.33	2638.67	4797.6	2744.0	6312.5	2173.5	4901.5	1312.83	4929.0	1039.25	78.25	6324.75	3434.67	x	x	x	3479.0	x	4678.86	793.333	3745.2	x	2541.0	81.5	1020.5	1046.0	x	3026.0	x	1985.83	3784.5	8330.83	x	136.0	411.5	711.6	3018.75	x	x	2039.5	x	1192.83	7378.86	x	x	x	54.3333	353.4	x	x	x	11.4286	807.0	1438.0	2625.33	x	1607.33	1540.0	1598.5	2882.2	527.833	3364.67	628.0	x	1389.8	x	2175.67	x	x	x	x	4335.8	x	x	537.0	60.0	3970.17	4603.25	12.4	x	4.33333	2591.67	x	1195.33	x	x	x	929.833	460.5	2290.75	96.6	2037.17	x	x	x	
-11313	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	4541.67	2355.5	x	3266.0	1710.67	3854.4	1818.67	4935.0	2092.0	4604.75	1051.83	2815.0	921.25	608.0	5484.5	2637.83	x	x	x	3112.0	x	4089.14	984.0	3557.8	x	1801.83	85.25	1021.62	955.333	x	1482.5	x	1824.17	3384.67	6521.83	x	269.667	439.833	358.6	2502.0	x	x	1760.5	x	786.667	6778.43	x	x	x	131.5	374.6	x	x	x	11.7143	928.0	1492.83	2715.33	x	1047.83	974.167	1482.33	1367.0	653.667	3114.17	507.0	x	1482.2	x	2246.0	x	x	x	x	3210.6	x	x	422.333	144.167	3618.67	5092.25	6.6	x	18.6667	2773.0	x	914.667	x	x	x	794.833	361.5	1807.75	115.2	2282.67	x	x	x	
-11314	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	3691.0	2605.17	x	2249.17	537.333	2832.4	1137.0	3087.5	1675.0	4207.25	480.0	1338.0	616.25	1051.5	4037.75	2169.5	x	x	x	2028.2	x	2764.43	1091.0	3041.0	x	1641.67	87.5	1066.75	635.0	x	887.0	x	1566.5	2348.5	4821.17	x	431.5	412.333	217.2	1872.0	x	x	1398.0	x	491.167	5601.14	x	x	x	169.333	408.6	x	x	x	53.2857	1200.75	873.333	2703.33	x	363.167	778.833	1148.83	373.6	402.167	3185.67	627.0	x	1716.1	x	2151.83	x	x	x	x	2904.0	x	x	353.0	293.167	3292.0	4879.0	40.2	x	177.833	2578.33	x	818.0	x	x	x	524.5	398.5	1496.5	77.8	2000.5	x	x	x	
-11315	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	1820.5	514.333	x	1194.0	279.0	1342.0	297.333	1836.0	178.5	818.5	405.5	1589.75	1354.0	113.5	2086.25	393.333	x	x	x	514.4	x	778.286	189.0	1811.6	x	1813.0	113.25	837.0	340.5	x	629.5	x	994.0	1152.17	3003.17	x	270.833	307.667	562.6	731.5	x	x	908.5	x	579.833	2226.29	x	x	x	201.833	178.4	x	x	x	159.857	219.5	371.167	870.333	x	279.833	864.333	123.667	664.8	321.5	2657.0	3822.0	x	636.0	x	419.667	x	x	x	x	595.2	x	x	128.333	180.0	726.0	184.0	90.0	x	531.0	1130.33	x	305.0	x	x	x	155.833	243.5	2143.5	224.6	748.667	x	x	x	
-11305	Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for males [sec]	None	Motor coordination, time on dowel over a 2 min baseline test period for males [sec]	x	x	x	x	75.5	x	x	85.5	x	x	120.0	120.0	95.0	120.0	x	82.0	59.1429	120.0	x	108.4	x	x	x	x	x	117.0	104.0	120.0	x	105.714	117.818	120.0	120.0	x	102.2	x	120.0	116.0	120.0	x	120.0	120.0	120.0	101.6	x	x	120.0	x	120.0	120.0	x	x	x	120.0	60.0	x	x	x	109.0	120.0	120.0	120.0	x	102.2	120.0	120.0	105.0	120.0	120.0	75.0	x	120.0	x	120.0	x	x	x	x	91.375	x	x	x	120.0	x	51.8	100.0	x	120.0	x	x	x	x	x	x	120.0	69.0	85.0	x	120.0	x	x	x	
-11306	Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for males [sec]	None	Depression assay, Porsolt behavioral despair test, time immobile for males [sec]	x	x	x	x	7.5	x	x	96.3333	x	x	52.9286	86.75	98.75	102.0	x	0.0	98.8571	137.4	x	41.5	x	x	x	x	x	36.3	125.6	168.8	x	84.3571	57.7273	74.3333	174.75	x	30.0	x	188.667	28.8	166.0	x	99.2	100.333	61.7778	172.8	x	x	121.75	x	84.7	26.7	x	x	x	187.4	223.5	x	x	x	119.75	134.333	59.8	70.5	x	78.8	165.5	183.2	105.2	81.5	129.0	17.75	x	46.5	x	122.6	x	x	x	x	7.25	x	x	x	179.5	x	80.4	84.375	x	78.3333	x	x	x	x	x	x	131.0	12.0	68.0	x	136.0	x	x	x	
-11302	Original post publication description: Pain sensitivity, vocalization threshold to mild foot shock for males [mA]	None	Central nervous system, behavior, somatosensory system: Pain sensitivity, vocalization threshold to mild foot shock for males [mA]	x	x	x	x	0.21	0.54	0.34	0.25	0.3	0.25	0.34	0.24	0.31	0.24	0.4125	0.375	0.45	0.3	x	0.29	x	0.508333	x	0.42	x	0.32	0.23	0.34	x	0.34	0.35	0.26	0.43	x	0.341667	x	0.3	0.31	0.36	x	0.3	0.31875	0.33	0.375	x	x	0.3	0.3625	0.33	0.37	x	x	x	x	x	x	x	x	0.3625	0.37	0.4	0.45	0.31	0.32	0.2	0.3	0.283333	0.36	0.4	0.266667	x	0.29	0.36	0.33	x	0.328571	0.36	0.45	0.27	0.27	x	0.392857	0.29	0.355556	0.34	0.35	x	0.24	0.31	0.35	0.29	0.35	x	x	0.27	x	x	x	x	x	x	x	
-11303	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males [sec]	x	x	x	x	210.0	x	x	45.0	x	x	142.143	9.0	73.25	103.0	x	42.5	19.4286	111.2	x	13.2	x	x	x	x	x	95.2	46.4	88.6	x	72.7143	62.7273	68.6667	72.6	x	139.0	x	63.6667	138.4	115.2	x	118.0	119.0	90.5556	110.4	x	x	72.0	x	89.2	69.0	x	x	x	86.6	39.5	x	x	x	50.75	133.667	88.4	114.5	x	56.2	118.75	75.8	61.6	90.2	52.5	78.1667	x	88.8333	x	82.0	x	x	x	x	87.375	x	x	x	90.2	x	29.4	81.25	x	48.3333	x	x	x	x	x	x	57.5	5.0	94.0	x	185.5	x	x	x	
-11288	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for females [um]	x	x	17.922	13.538	14.27	15.91	x	14.934	15.66	14.271	14.625	10.515	14.968	11.938	13.818	17.498	15.369	13.675	15.338	16.813	x	x	x	12.508	x	14.999	12.158	x	x	12.37	8.778	11.295	16.592	x	14.339	x	14.18	20.188	12.553	x	16.867	15.571	14.318	11.14	x	x	14.741	x	14.215	14.981	x	x	x	12.555	14.373	x	x	x	18.562	13.865	15.702	14.165	x	14.478	14.137	13.939	15.583	14.21	13.048	15.298	x	16.041	x	15.644	x	13.063	x	x	12.02	x	x	13.583	16.412	15.005	13.102	14.88	x	11.045	14.766	x	14.919	x	x	x	15.232	14.62	13.018	16.051	13.905	x	x	x	
-11291	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for females [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for females [um]	x	x	52.486	70.501	68.45	76.213	x	53.148	46.853	54.23	69.125	68.4	66.92	67.89	42.958	86.39	92.872	53.863	73.843	64.73	x	x	x	63.84	x	63.858	75.79	x	x	54.475	62.708	71.29	61.757	x	81.446	x	80.073	72.338	48.38	x	71.764	45.598	46.248	58.128	x	x	48.044	x	76.015	71.63	x	x	x	54.16	68.625	x	x	x	64.057	64.642	96.248	47.735	x	71.495	74.408	44.241	51.09	86.117	69.703	38.432	x	43.229	x	67.219	x	54.758	x	x	51.587	x	x	58.165	59.087	59.193	36.69	72.735	x	51.99	61.533	x	75.918	x	x	x	55.372	66.603	54.367	66.481	61.518	x	x	x	
-11293	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for males [um]	x	x	19.583	14.612	14.463	12.303	x	20.754	13.25	15.413	x	10.478	11.535	13.17	12.878	14.505	16.773	10.973	19.379	x	x	x	x	15.388	x	19.481	14.375	13.355	x	12.605	12.583	16.86	14.668	x	12.043	x	13.719	13.103	11.848	x	14.626	12.006	14.853	17.253	x	x	13.993	x	12.734	12.978	x	x	x	12.513	11.153	x	x	x	17.706	12.875	13.232	14.685	x	13.183	14.827	16.996	13.685	13.695	12.909	14.208	x	18.089	x	14.67	x	14.302	x	x	15.295	x	x	10.05	12.69	14.573	14.668	14.408	x	15.293	14.061	x	14.21	x	x	x	13.655	14.372	13.733	14.135	13.865	x	x	x	
-11295	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for males [um]	x	x	65.385	44.882	70.66	61.038	x	67.733	59.855	69.408	x	70.323	66.98	70.288	44.54	69.567	49.492	49.845	60.133	x	x	x	x	60.298	x	55.286	47.605	64.715	x	51.198	64.68	59.298	85.428	x	54.647	x	57.87	75.217	64.257	x	74.423	60.99	72.888	66.94	x	x	76.554	x	59.435	48.075	x	x	x	57.435	49.483	x	x	x	65.479	78.823	101.203	45.67	x	82.208	83.257	55.975	81.123	83.477	58.024	72.81	x	46.761	x	85.392	x	78.947	x	x	71.19	x	x	59.845	98.782	79.995	67.235	90.003	x	38.128	60.433	x	81.588	x	x	x	81.168	76.52	72.792	69.6	108.243	x	x	x	
-11296	Original post publication description: Mechanical sensitivity, Von Frey threshold [units]	None	Central and peripheral nervous system, integumentary system: mechanical sensitivity, Von Frey hair test threshold [units]	x	x	x	x	0.71	0.746	0.888	0.72	1.088	0.959	0.863	0.636	1.169	1.19	1.692	0.864	1.354	0.695	1.313	1.282	1.051	1.133	x	1.348	1.146	1.12	1.256	0.716	1.423	1.234	0.989	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11297	Original post publication description: Ethanol response (10% w/v in water), consumption using a two-bottle choice for males and females, average between days 5-11, new BXD strains only [g/kg consumed in 24 h] (loaded by M Miles 2009)	None	Central nervous system, pharmacology, behavior: Ethanol response (10% w/v in water), consumption using a two-bottle choice for males and females, average between days 5-11, new BXD strains only [g/kg/24h]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.44	1.44	x	x	x	5.21	x	x	2.7	x	x	x	x	x	x	x	x	9.84	x	13.32	x	x	x	x	x	x	2.67	1.79	x	x	3.78	x	1.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11298	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal total weight for females [mg]	None	Endocrinology, neuroendocrine system, morphology: Adrenal total weight for females [mg]	x	x	2.18	2.3	2.013	2.5	x	2.788	2.3	2.388	3.1	2.263	2.563	2.213	2.438	3.063	2.843	1.863	2.525	2.238	x	x	x	2.2	x	2.3	3.433	2.15	x	2.3	3.525	2.65	2.8	x	2.325	x	2.9	2.575	2.0	x	2.456	2.3	1.563	2.388	x	x	2.663	x	2.55	2.75	x	x	x	1.95	2.738	x	x	x	2.433	2.25	3.113	2.538	x	2.488	2.7	2.35	2.763	3.1	2.338	1.688	x	2.108	x	2.263	x	2.025	x	x	1.825	x	x	2.4	2.638	2.5	1.9	2.688	x	2.238	2.125	x	2.863	x	x	x	2.313	2.563	2.55	2.4	2.488	x	x	x	
-11299	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal total weight for males [mg]	None	Endocrinology, neuroendocrine system, morphology: Adrenal total weight for males [mg]	x	x	1.388	1.91	1.725	1.475	x	2.125	1.788	1.5	1.95	2.113	1.613	1.913	1.85	2.363	1.814	1.525	1.875	1.975	x	x	x	1.725	x	1.771	2.317	1.625	x	1.95	1.788	1.688	2.163	x	1.713	x	1.775	2.063	1.575	x	1.519	1.663	1.45	1.513	x	x	1.869	x	1.5	1.8	x	x	x	1.2	1.588	x	x	x	1.78	1.617	1.983	1.625	x	1.575	1.575	1.488	1.813	1.717	1.463	1.4	x	1.55	x	1.55	x	1.59	x	x	1.538	x	x	1.675	1.713	1.663	1.463	1.688	x	1.75	1.538	x	1.513	x	x	x	2.038	1.55	1.663	1.738	1.95	x	x	x	
-11300	Original post publication description: Genetics: Mitochondrial strain origin (-1 = C57BL/6J and 1 = DBA/2J) [strain]	None	Metabolism, genetics: Mitochondrial strain origin (-1 = C57BL/6J and 1 = DBA/2J) [genotype]	1.0	-1.0	-1.0	1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	x	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	x	x	-1.0	-1.0	1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	-1.0	1.0	-1.0	-1.0	-1.0	-1.0	-1.0	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	-1.0	-1.0	-1.0	1.0	-1.0	-1.0	-1.0	1.0	-1.0	x	x	x	
-11349	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 0-15 min for males [n beam breaks]	x	x	x	x	205.167	215.167	x	315.333	197.0	328.4	136.667	310.5	166.0	276.75	145.0	274.5	342.25	298.25	273.75	244.833	x	x	x	68.4	x	114.429	146.667	358.8	x	269.333	207.5	302.625	281.5	x	196.5	x	279.333	137.333	345.167	x	327.333	428.0	220.0	220.5	x	x	461.5	x	326.667	279.571	x	x	x	181.667	120.6	x	x	x	366.857	373.25	153.667	158.333	x	166.833	243.5	181.333	387.2	220.333	291.333	289.0	x	300.2	x	274.833	x	x	x	x	259.0	x	x	161.667	305.167	315.667	263.0	190.2	x	322.333	177.333	x	228.333	x	x	x	395.5	255.5	315.0	420.4	230.5	x	x	x	
-11350	Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males [n beam breaks]	x	x	x	x	248.167	191.5	x	365.5	350.0	413.0	156.333	314.5	195.5	264.25	184.167	299.5	319.5	309.75	312.5	264.0	x	x	x	115.8	x	204.857	238.833	475.6	x	315.167	232.25	426.625	254.5	x	75.25	x	337.667	173.833	422.833	x	381.5	505.0	198.6	297.5	x	x	462.0	x	375.0	293.857	x	x	x	174.167	90.4	x	x	x	336.429	405.25	137.333	258.0	x	248.833	255.0	253.5	387.0	242.833	331.0	361.0	x	347.6	x	292.5	x	x	x	x	291.0	x	x	224.833	389.0	363.667	286.75	211.8	x	348.667	192.0	x	219.667	x	x	x	424.333	260.5	343.0	428.6	288.333	x	x	x	
-11351	Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for males [n beam breaks]	x	x	x	x	225.167	151.667	x	351.667	462.0	368.0	154.667	210.5	121.5	252.0	170.167	318.0	283.5	287.0	214.25	241.5	x	x	x	165.4	x	172.286	181.833	484.0	x	302.833	223.25	435.5	190.167	x	57.75	x	327.333	158.0	478.5	x	291.167	418.167	157.0	250.25	x	x	521.5	x	412.667	286.571	x	x	x	152.5	47.4	x	x	x	284.857	457.75	51.3333	221.333	x	229.5	203.667	262.667	285.6	221.333	362.5	291.0	x	316.6	x	283.333	x	x	x	x	256.4	x	x	237.667	400.333	222.0	243.25	208.0	x	357.5	146.333	x	266.0	x	x	x	376.167	261.5	238.25	409.8	304.5	x	x	x	
-11352	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males [n beam breaks]	x	x	x	x	188.0	77.3333	x	306.833	407.667	350.4	118.333	179.0	75.25	260.75	154.667	323.0	266.0	198.5	212.5	205.0	x	x	x	131.0	x	105.0	138.5	451.0	x	232.167	197.5	327.875	148.5	x	79.0	x	345.333	110.5	469.5	x	254.333	384.5	99.2	226.0	x	x	454.0	x	414.833	217.143	x	x	x	97.8333	51.6	x	x	x	150.143	473.25	33.3333	203.333	x	173.833	196.0	223.0	287.6	268.833	322.833	463.0	x	235.5	x	260.0	x	x	x	x	210.8	x	x	227.5	323.5	127.667	144.25	208.4	x	383.833	108.333	x	204.0	x	x	x	303.0	218.5	330.0	403.8	275.333	x	x	x	
-11353	Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]	x	x	x	x	3524.17	1964.17	x	5016.33	3659.33	4544.8	1674.0	3866.5	1884.5	2523.75	1536.17	2784.5	4557.0	2354.0	2601.0	2894.17	x	x	x	1773.6	x	2819.86	1863.0	7538.6	x	2267.67	2582.25	3389.88	2450.0	x	875.75	x	3334.67	1505.0	4595.5	x	3992.0	2645.83	1698.2	4078.75	x	x	4770.0	x	4929.0	2682.43	x	x	x	1950.5	574.0	x	x	x	3672.43	4361.75	664.833	2538.67	x	3368.5	2392.83	1502.5	3557.4	2777.67	2822.83	3444.0	x	1834.7	x	2105.0	x	x	x	x	1573.0	x	x	1877.5	3209.83	1945.67	3754.0	3015.2	x	3666.67	2006.67	x	3444.0	x	x	x	1829.0	3207.0	4760.0	5295.6	1930.83	x	x	x	
-11354	Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm]	x	x	x	x	12526.6	7075.87	x	16486.4	12656.7	14549.2	7248.32	12945.6	7277.7	10038.4	6973.6	9668.84	14095.1	9192.09	9074.06	10429.6	x	x	x	8432.33	x	9862.43	7913.69	23093.4	x	8909.5	9641.77	12350.9	9263.1	x	3498.92	x	12606.5	6879.91	15952.8	x	13396.5	9993.17	6640.04	14574.1	x	x	15761.0	x	15538.5	10156.8	x	x	x	7849.98	2990.26	x	x	x	12193.8	14686.6	2862.51	10010.4	x	11918.5	9677.89	6311.84	13278.7	9631.68	11156.2	13799.8	x	7315.26	x	8769.0	x	x	x	x	6235.1	x	x	8572.56	11831.6	7764.69	13175.4	10079.5	x	13056.0	8686.63	x	12975.7	x	x	x	7335.1	12031.2	15283.8	16882.0	8117.59	x	x	x	
-11355	Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males [n beam breaks]	x	x	x	x	866.5	635.667	x	1339.33	1416.67	1459.8	566.0	1014.5	558.25	1053.75	654.0	1215.0	1211.25	1093.5	1013.0	955.333	x	x	x	480.6	x	596.571	705.833	1769.4	x	1119.5	860.5	1492.62	874.667	x	408.5	x	1289.67	579.667	1716.0	x	1254.33	1735.67	674.8	994.25	x	x	1899.0	x	1529.17	1077.14	x	x	x	606.167	310.0	x	x	x	1138.29	1709.5	375.667	841.0	x	819.0	898.167	920.5	1347.4	953.333	1307.67	1404.0	x	1199.9	x	1110.67	x	x	x	x	1017.2	x	x	851.667	1418.0	1029.0	937.25	818.4	x	1412.33	624.0	x	918.0	x	x	x	1499.0	996.0	1226.25	1662.6	1098.67	x	x	x	
-11356	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males [n beam breaks]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males [n beam breaks]	x	x	x	x	292.667	435.333	x	207.667	365.333	275.8	214.0	366.5	318.0	178.0	160.333	250.25	624.0	412.25	575.5	613.667	x	x	x	209.4	x	452.286	531.167	380.4	x	301.333	394.75	487.25	446.333	x	207.0	x	435.5	331.667	395.5	x	588.333	572.833	345.2	425.25	x	x	425.5	x	320.667	405.571	x	x	x	311.667	615.6	x	x	x	389.857	386.5	226.167	129.333	x	150.0	195.333	122.0	311.0	384.833	252.5	187.0	x	202.0	x	235.167	x	x	x	x	341.0	x	x	189.333	356.667	310.0	643.0	345.4	x	531.5	179.0	x	290.333	x	x	x	452.667	286.5	476.5	710.2	572.667	x	x	x	
-11357	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males [cm]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males [cm]	x	x	x	x	1018.6	1383.0	x	734.861	1245.78	905.154	780.855	1107.73	1082.02	684.42	689.696	808.914	1739.47	1312.81	1777.39	1876.08	x	x	x	970.258	x	1416.79	1616.7	1136.48	x	1111.83	1216.84	1555.85	1411.64	x	677.775	x	1375.74	1059.38	1314.41	x	2084.13	1773.95	1086.98	1391.2	x	x	1270.88	x	983.834	1183.11	x	x	x	1157.65	1987.18	x	x	x	1209.13	1146.32	769.411	509.013	x	569.466	609.715	483.222	1056.26	1216.3	882.597	622.12	x	704.141	x	862.356	x	x	x	x	1052.62	x	x	803.33	1069.64	1131.84	1836.04	1074.46	x	1700.86	649.093	x	1053.63	x	x	x	1360.79	1243.37	1569.89	2077.55	1783.1	x	x	x	
-11358	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip) and naloxone response (30 mg/kg ip), naloxone-induced withdrawal after morphine, vertical activity (rears) from 0-15 min for males [n beam breaks]	x	x	x	x	75.3333	138.667	x	97.1667	61.0	55.2	30.6667	51.5	109.25	95.0	50.0	71.5	87.5	115.25	160.5	151.167	x	x	x	92.4	x	74.4286	60.0	61.8	x	119.0	76.25	31.25	95.5	x	53.25	x	191.0	75.5	110.333	x	206.667	147.167	110.4	119.75	x	x	44.5	x	83.8333	143.571	x	x	x	126.333	210.8	x	x	x	59.7143	135.75	56.6667	34.6667	x	32.6667	98.5	125.667	68.4	48.8333	106.5	43.0	x	126.1	x	136.833	x	x	x	x	75.2	x	x	120.0	75.0	140.167	37.0	75.6	x	157.667	62.6667	x	115.0	x	x	x	159.167	57.0	140.5	80.8	208.0	x	x	x	
-11359	Original post publication description: Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.166667	0.333333	x	0.0	0.0	0.4	0.333333	0.5	0.25	1.25	0.166667	0.0	0.25	0.25	0.0	0.166667	x	x	x	0.2	x	0.428571	0.0	0.0	x	0.0	0.0	0.0	0.0	x	0.0	x	0.166667	0.333333	0.0	x	0.166667	0.333333	0.0	0.5	x	x	0.5	x	0.0	0.285714	x	x	x	0.166667	0.0	x	x	x	0.285714	0.0	0.166667	0.0	x	0.166667	0.166667	0.666667	0.2	0.166667	0.5	0.0	x	0.1	x	0.166667	x	x	x	x	0.2	x	x	0.0	0.166667	0.333333	0.5	0.2	x	0.0	0.333333	x	0.666667	x	x	x	0.333333	0.5	0.0	0.0	0.333333	x	x	x	
-11360	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males [ordinal scale, 0=no effect, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males [ordinal scale, 0=no effect, 3=max]	x	x	x	x	1.5	0.0	x	0.333333	1.33333	0.0	0.0	0.5	0.0	0.0	2.66667	1.5	0.0	0.0	0.0	0.0	x	x	x	0.4	x	0.285714	1.16667	0.8	x	0.0	0.75	0.125	0.5	x	0.25	x	0.0	1.33333	0.0	x	0.0	0.166667	0.0	0.0	x	x	0.0	x	0.166667	0.142857	x	x	x	0.5	0.0	x	x	x	0.857143	0.5	0.833333	0.0	x	1.5	0.666667	0.5	0.0	0.333333	1.5	0.0	x	0.0	x	0.333333	x	x	x	x	0.2	x	x	0.166667	0.0	0.333333	0.0	0.2	x	0.0	0.666667	x	1.66667	x	x	x	0.833333	0.0	0.25	0.0	0.0	x	x	x	
-11361	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males [ordinal scale, 0=control level, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males [ordinal scale, 0=control level, 3=max]	x	x	x	x	0.166667	0.5	x	0.333333	0.333333	0.0	0.0	0.0	0.25	0.75	0.0	0.5	0.0	0.0	0.0	0.5	x	x	x	0.0	x	0.0	0.0	0.6	x	0.666667	0.0	0.0	0.0	x	0.75	x	1.83333	0.166667	0.0	x	0.0	0.166667	0.2	0.5	x	x	0.0	x	0.0	0.285714	x	x	x	0.666667	0.4	x	x	x	0.428571	0.5	0.333333	0.666667	x	0.333333	0.5	0.0	0.4	0.0	0.0	0.0	x	0.8	x	0.5	x	x	x	x	0.8	x	x	0.0	0.0	0.333333	0.0	0.4	x	0.333333	0.333333	x	0.333333	x	x	x	0.833333	0.0	0.25	0.0	0.0	x	x	x	
-11362	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.0	1.33333	x	1.16667	0.0	0.0	0.0	0.0	2.0	1.25	0.5	0.25	0.5	0.25	0.25	0.666667	x	x	x	0.6	x	0.571429	0.166667	0.6	x	0.5	0.0	0.625	0.333333	x	0.0	x	3.0	1.16667	0.166667	x	1.33333	1.83333	0.6	0.25	x	x	0.5	x	0.5	1.57143	x	x	x	1.0	3.0	x	x	x	0.142857	2.5	0.5	0.0	x	0.5	0.833333	0.833333	0.2	1.16667	0.166667	0.0	x	1.8	x	1.16667	x	x	x	x	0.0	x	x	1.66667	0.333333	0.666667	0.0	1.2	x	1.83333	0.666667	x	1.33333	x	x	x	1.0	1.5	1.5	0.2	0.666667	x	x	x	
-11363	Original post publication description: Novel open field behavior, urinations for males [n/test period]	None	Novel open field behavior, urinations for males [n/test period]	x	x	x	x	1.66667	2.83333	x	2.33333	1.33333	1.0	1.33333	1.5	2.75	1.5	1.83333	1.5	2.0	2.0	1.5	2.16667	x	x	x	0.6	x	1.57143	1.33333	1.8	x	1.0	0.5	1.375	2.0	x	1.25	x	1.83333	2.16667	1.5	x	1.66667	0.833333	0.2	2.0	x	x	0.5	x	0.666667	1.71429	x	x	x	2.5	1.4	x	x	x	0.857143	2.0	2.0	2.33333	x	1.66667	1.66667	3.0	0.8	0.5	2.83333	0.0	x	1.4	x	1.83333	x	x	x	x	0.8	x	x	1.33333	1.5	1.66667	2.0	1.6	x	1.83333	1.0	x	1.66667	x	x	x	1.33333	1.5	1.0	1.6	1.66667	x	x	x	
-11364	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	784.5	384.667	x	683.167	258.667	850.4	133.667	516.0	291.5	1124.0	51.3333	808.0	278.5	58.0	772.0	403.333	x	x	x	369.6	x	674.857	137.0	448.2	x	300.0	5.75	184.375	91.8333	x	352.5	x	512.833	473.667	1003.17	x	76.1667	71.0	100.2	506.25	x	x	64.0	x	154.333	714.857	x	x	x	5.16667	59.2	x	x	x	1.0	150.0	153.333	420.0	x	218.833	167.167	216.333	492.4	54.3333	741.0	660.0	x	419.6	x	291.0	x	x	x	x	471.6	x	x	131.167	36.0	616.167	539.0	0.0	x	13.6667	372.0	x	94.6667	x	x	x	564.667	70.5	434.75	5.2	457.833	x	x	x	
-11365	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	748.833	435.333	x	627.5	179.0	725.4	94.0	419.5	219.75	1057.25	32.8333	580.0	293.75	119.0	677.5	338.833	x	x	x	338.6	x	606.429	150.167	405.0	x	292.5	6.5	178.125	81.1667	x	220.25	x	490.5	379.833	859.333	x	102.167	61.0	44.8	478.75	x	x	102.5	x	95.3333	671.0	x	x	x	2.33333	56.4	x	x	x	3.14286	137.25	158.833	410.0	x	115.833	139.0	142.0	225.6	57.5	718.0	492.0	x	449.8	x	310.0	x	x	x	x	463.2	x	x	92.3333	61.0	552.167	565.5	0.0	x	34.0	369.333	x	69.0	x	x	x	479.0	96.0	393.75	5.2	540.833	x	x	x	
-11366	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	634.667	453.167	x	587.833	74.3333	503.0	73.6667	364.5	160.0	916.5	5.33333	358.75	231.5	147.25	579.25	279.333	x	x	x	210.8	x	453.143	148.667	354.6	x	266.333	2.5	175.0	45.6667	x	159.5	x	408.5	268.167	677.0	x	126.5	56.0	48.4	387.5	x	x	166.5	x	84.0	584.0	x	x	x	5.33333	48.4	x	x	x	2.85714	236.75	128.5	397.667	x	36.0	157.833	102.0	78.8	46.6667	711.833	395.0	x	494.5	x	249.333	x	x	x	x	397.0	x	x	77.6667	73.1667	488.167	544.5	1.8	x	46.1667	340.333	x	81.3333	x	x	x	374.833	150.5	335.0	7.4	576.0	x	x	x	
-11367	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	259.333	66.1667	x	169.833	11.3333	184.0	27.0	86.5	7.75	114.5	41.8333	237.25	134.75	11.75	292.0	40.1667	x	x	x	98.4	x	124.0	21.6667	249.2	x	166.833	14.0	83.0	29.0	x	54.75	x	107.833	136.333	335.167	x	24.1667	70.0	65.6	103.0	x	x	62.5	x	80.3333	208.286	x	x	x	9.66667	36.0	x	x	x	22.7143	50.75	42.1667	92.0	x	48.1667	129.833	19.6667	91.4	9.5	474.667	484.0	x	111.0	x	46.0	x	x	x	x	65.0	x	x	20.6667	14.6667	214.333	10.25	4.6	x	69.6667	240.0	x	4.66667	x	x	x	51.0	7.5	224.25	13.8	133.667	x	x	x	
-11368	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	358.167	466.5	x	415.0	45.3333	153.8	18.0	155.5	86.25	758.5	10.0	404.0	199.5	117.0	207.75	215.0	x	x	x	76.6	x	347.286	107.5	162.2	x	240.333	30.25	150.875	18.8333	x	56.5	x	264.667	134.5	371.667	x	166.333	14.8333	50.0	308.75	x	x	236.0	x	74.3333	400.0	x	x	x	1.5	32.6	x	x	x	17.8571	245.75	83.8333	300.0	x	11.3333	109.667	36.0	63.8	95.0	594.833	428.0	x	451.6	x	107.667	x	x	x	x	224.2	x	x	36.3333	70.5	302.833	398.25	2.4	x	65.1667	244.333	x	37.0	x	x	x	261.333	119.5	124.5	25.8	458.5	x	x	x	
-11369	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	272.5	401.0	x	281.667	58.0	76.4	37.0	155.5	58.5	448.5	3.5	218.25	226.75	42.0	113.5	204.167	x	x	x	72.0	x	282.286	53.8333	94.4	x	150.5	29.75	136.875	26.0	x	50.75	x	198.667	87.6667	217.0	x	191.0	25.1667	27.4	294.75	x	x	178.0	x	51.6667	263.143	x	x	x	6.0	39.0	x	x	x	32.8571	176.25	78.6667	227.333	x	13.1667	88.6667	43.1667	89.6	91.3333	596.833	475.0	x	423.7	x	118.5	x	x	x	x	142.6	x	x	38.3333	84.8333	200.833	353.0	16.0	x	118.667	98.3333	x	26.6667	x	x	x	224.0	73.5	91.0	52.8	277.833	x	x	x	
-11370	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	368.167	86.1667	x	403.5	12.0	291.2	63.6667	311.5	102.5	260.25	75.3333	610.5	182.75	1.0	579.75	122.167	x	x	x	253.2	x	366.571	43.1667	386.0	x	441.333	4.25	123.375	62.6667	x	158.5	x	179.333	313.5	585.333	x	22.1667	96.3333	106.2	287.75	x	x	28.0	x	243.833	493.429	x	x	x	0.166667	70.4	x	x	x	0.857143	45.25	97.1667	308.0	x	133.667	134.833	42.1667	376.6	9.16667	587.833	919.0	x	150.3	x	74.5	x	x	x	x	164.6	x	x	16.0	0.166667	466.5	31.75	4.6	x	6.33333	297.333	x	117.667	x	x	x	56.3333	0.0	431.75	0.0	300.667	x	x	x	
-11371	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	412.833	124.167	x	549.167	84.0	458.6	179.0	544.0	235.75	490.75	71.6667	838.5	256.25	4.25	691.5	241.333	x	x	x	376.8	x	409.714	50.6667	435.8	x	564.167	2.0	153.5	74.6667	x	452.5	x	292.833	376.833	877.333	x	27.1667	45.1667	192.0	392.5	x	x	38.0	x	383.167	567.571	x	x	x	1.33333	72.4	x	x	x	2.57143	51.75	120.667	424.667	x	217.833	124.167	74.6667	563.4	31.8333	605.167	961.0	x	136.6	x	100.5	x	x	x	x	232.0	x	x	49.8333	0.0	586.333	163.5	11.0	x	31.3333	311.0	x	137.0	x	x	x	170.833	4.5	543.25	25.2	377.833	x	x	x	
-11372	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	603.833	163.833	x	623.0	132.667	719.4	236.333	647.5	263.0	758.0	64.8333	1009.25	296.75	2.5	812.75	356.333	x	x	x	442.4	x	516.286	81.8333	519.4	x	522.833	13.0	166.75	89.0	x	562.75	x	391.333	465.5	1012.67	x	25.5	69.8333	222.4	465.25	x	x	22.0	x	454.0	658.714	x	x	x	0.166667	98.8	x	x	x	0.0	41.0	121.5	401.667	x	307.0	134.0	146.0	625.2	38.8333	653.5	925.0	x	233.5	x	160.333	x	x	x	x	355.0	x	x	101.333	0.166667	755.333	337.25	7.8	x	7.33333	411.333	x	114.667	x	x	x	355.333	65.0	570.25	1.6	465.167	x	x	x	
-11373	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	683.333	250.167	x	659.333	256.667	834.2	226.667	584.5	281.5	1149.5	65.1667	1026.75	343.75	27.75	846.0	430.5	x	x	x	409.4	x	632.571	88.6667	501.0	x	415.333	8.25	189.75	108.833	x	530.25	x	424.5	522.333	1092.83	x	43.3333	77.5	240.6	578.25	x	x	47.0	x	342.667	746.429	x	x	x	0.5	82.8	x	x	x	2.28571	91.25	138.833	420.333	x	330.833	154.0	202.667	617.2	56.6667	712.0	906.0	x	285.4	x	203.333	x	x	x	x	487.2	x	x	146.667	0.666667	784.0	443.75	5.8	x	0.666667	444.667	x	127.0	x	x	x	548.333	70.5	571.0	2.4	490.667	x	x	x	
-11374	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males [n beam breaks]	x	x	x	x	759.5	319.0	x	673.167	303.333	826.2	204.0	576.5	286.0	1177.75	76.0	992.0	335.75	46.0	845.25	464.5	x	x	x	419.2	x	681.286	122.167	486.0	x	322.667	6.5	178.875	113.333	x	490.75	x	458.833	488.5	1102.17	x	51.6667	86.3333	163.0	564.25	x	x	77.5	x	262.667	739.0	x	x	x	1.5	85.2	x	x	x	0.857143	101.25	161.5	434.0	x	327.167	198.0	234.833	580.6	66.1667	722.0	947.0	x	362.4	x	226.333	x	x	x	x	493.6	x	x	160.833	10.3333	669.833	540.25	3.0	x	10.5	414.667	x	95.0	x	x	x	605.667	86.5	491.75	3.4	549.667	x	x	x	
-11375	Original post publication description: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males [cm/90 min test]	None	Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males [cm/90 min test]	x	x	x	x	x	x	x	812.5	x	x	x	4105.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1384.0	x	x	x	x	x	x	x	490.333	x	x	1235.0	5446.25	x	12099.0	x	364.5	x	x	x	x	x	x	x	x	x	x	530.5	x	x	x	x	x	1584.5	x	x	x	16648.0	3004.75	x	x	x	x	x	x	x	x	x	x	2974.5	x	x	x	x	x	x	5317.5	x	x	x	x	x	x	x	1622.0	x	x	x	2365.33	x	765.5	x	x	x	x	x	
-11376	Original post publication description: Locomotor activity after first saline injection (day 1) for males (MDMA control) [cm/ test period]	None	Central nervous system, behavior: Locomotor activity after first saline injection (day 1) for males (MDMA control) [cm/ test period]	x	x	x	x	x	x	x	6961.0	x	x	2111.0	5727.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4800.0	x	x	x	x	x	x	x	1492.0	x	x	818.0	10970.0	x	5158.0	x	4096.5	x	x	x	x	x	x	x	x	x	x	7717.5	x	x	x	x	x	5058.0	x	x	x	3744.0	7132.0	x	x	x	x	x	x	x	x	x	x	2867.5	x	x	x	x	x	x	5534.0	x	x	x	x	x	x	x	4383.5	x	x	x	6561.33	x	6559.5	x	x	x	x	x	
-11377	Original post publication description: Saline control response, locomotor activity after second injection for males (control for MDMA response experiment) [cm/test period]	None	Central nervous system, behavior: Saline control response, locomotor activity after second injection for males (control for MDMA response experiment) [cm/test period]	x	x	x	x	x	x	x	832.5	x	x	3311.0	780.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	888.0	x	x	x	x	x	x	x	352.667	x	x	638.5	2590.75	x	802.75	x	2013.5	x	x	x	x	x	x	x	x	x	x	2260.5	x	x	x	x	x	166.0	x	x	x	1258.5	967.0	x	x	x	x	x	x	x	x	x	x	814.0	x	x	x	x	x	x	527.0	x	x	x	x	x	x	x	965.0	x	x	x	2219.67	x	580.0	x	x	x	x	x	
-11378	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males [explain the score]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males [explain the score]	x	x	x	x	x	x	1.33333	x	x	x	x	x	0.0	0.0	0.0	x	x	x	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.1	x	0.0	x	x	x	x	0.222222	0.909091	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.25	x	0.8	x	x	0.0	x	x	x	0.0	0.0	0.0	x	0.0	0.0	0.0	x	0.1	0.0	x	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	x	0.142857	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	
-11379	Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males [units]	None	Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males [units]	x	x	x	x	x	x	0.0	x	x	x	x	x	1.0	4.0	0.0	x	x	x	x	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.8	x	0.0	x	x	x	x	1.11111	1.63636	x	x	x	0.5	x	x	0.0	x	x	x	x	x	x	x	x	1.125	x	2.2	x	x	2.5	x	x	x	1.7	0.0	1.44444	x	0.6	0.0	1.6	x	0.2	0.0	x	1.0	0.5	x	5.0	0.142857	0.0	3.0	0.272727	x	0.142857	x	x	0.2	x	x	x	x	x	x	x	x	x	x	x	
-11380	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males [units]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males [units]	x	x	x	x	x	x	1.0	x	x	x	x	x	4.0	4.0	0.0	x	x	x	x	3.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.9	x	0.0	x	x	x	x	0.777778	1.18182	x	x	x	0.1	x	x	0.888889	x	x	x	x	x	x	x	x	0.375	x	2.6	x	x	2.0	x	x	x	2.5	0.0	0.777778	x	0.2	0.333333	0.2	x	0.7	0.0	x	0.2	0.0	x	4.5	0.285714	0.2	2.5	0.090909	x	0.857143	x	x	0.1	x	x	x	x	x	x	x	x	x	x	x	
-11381	Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males [score]	None	Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males [score]	x	x	x	x	x	x	0.333333	x	x	x	x	x	0.0	1.0	0.0	x	x	x	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.2	x	0.0	x	x	x	x	0.222222	0.727273	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.125	x	1.0	x	x	0.0	x	x	x	0.3	0.0	0.0	x	0.0	0.0	0.0	x	0.0	0.0	x	0.1	0.0	x	0.75	0.0	0.0	0.5	0.090909	x	0.142857	x	x	0.2	x	x	x	x	x	x	x	x	x	x	x	
-11382	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males [explain the score]	None	Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males [explain the score]	x	x	x	x	x	x	1.33333	x	x	x	x	x	5.0	6.0	0.0	x	x	x	x	4.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.7	x	0.0	x	x	x	x	x	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.5	x	x	x	3.6	0.0	0.777778	x	0.7	0.333333	1.8	x	0.9	0.0	x	1.1	0.5	x	8.0	0.428571	0.2	5.0	0.181818	x	1.0	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	
-11383	Original post publication description: Pain response, thermal nociception, hot plate latency for males [sec]	None	Pain response, thermal nociception, hot plate latency for males [sec]	x	x	x	x	8.115	6.81714	x	6.175	10.3617	x	7.47667	12.332	7.81111	7.425	7.15286	8.76571	8.83143	8.772	x	10.0192	x	x	x	8.83818	x	8.68222	7.24917	5.75833	x	7.3175	6.67167	9.08111	8.85875	x	8.315	x	9.39769	6.73667	9.26333	x	6.544	6.59	10.8494	9.12714	x	x	10.15	x	7.53667	7.23417	x	x	x	9.05	7.35833	x	x	x	6.56667	11.59	8.14929	x	x	7.875	11.4433	8.18222	9.42	8.97905	10.1367	8.69	x	8.661	x	9.58667	x	10.7433	x	x	5.71625	x	x	12.5267	7.7325	8.183	10.8975	8.21286	x	8.044	x	x	12.3	x	x	x	9.76917	6.472	6.535	4.715	5.9625	x	x	x	
-11384	Original post publication description: Locomotion in dark compartment of a light-dark box for males [cm]	None	Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for males [cm]	x	x	x	x	1713.5	757.143	x	970.083	489.167	x	225.667	688.2	413.444	828.875	408.429	616.429	836.857	471.1	x	765.5	x	x	x	351.091	x	333.111	269.5	894.875	x	693.375	948.833	521.222	571.75	x	727.0	x	486.0	471.444	832.333	x	843.6	666.714	652.941	752.429	x	x	827.875	x	663.833	507.667	x	x	x	1013.29	245.167	x	x	x	631.0	606.4	409.286	x	x	535.458	526.667	512.333	659.75	784.048	647.167	943.0	x	658.4	x	692.0	x	595.667	x	x	699.125	x	x	506.667	769.0	676.8	626.375	606.0	x	542.444	x	x	435.8	x	x	x	736.5	409.0	910.5	1107.0	514.833	x	x	x	
-11385	Original post publication description: Anxiety assay, time in dark side of a light-dark box for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males [sec]	x	x	x	x	486.65	520.829	x	371.25	406.233	x	305.267	404.42	392.122	393.062	405.357	335.614	291.029	348.26	x	374.258	x	x	x	161.545	x	343.044	291.192	373.531	x	358.875	471.05	335.233	328.575	x	409.467	x	347.908	440.744	345.95	x	398.95	412.929	378.159	418.214	x	x	422.225	x	376.017	413.2	x	x	x	412.271	377.883	x	x	x	394.467	421.94	390.593	x	x	469.346	311.6	460.667	388.756	370.59	328.7	418.75	x	402.5	x	396.65	x	396.878	x	x	448.0	x	x	446.9	404.9	383.37	433.15	446.5	x	342.689	x	x	316.22	x	x	x	447.183	398.58	475.45	434.5	396.45	x	x	x	
-11386	Original post publication description: Locomotion in both compartments of a light-dark box for males [cm]	None	Central nervous system, behavior: Locomotion in both compartments of a light-dark box for males [cm]	x	x	x	x	2285.5	956.714	x	1504.83	823.5	x	394.556	1043.8	631.444	1296.25	616.714	1009.57	1468.57	726.9	x	1244.83	x	x	x	840.818	x	436.0	413.667	1381.81	x	1153.0	1253.83	883.556	964.375	x	1069.0	x	755.077	645.889	1352.67	x	1371.2	1015.57	1022.59	1121.0	x	x	1199.75	x	1000.5	768.583	x	x	x	1502.71	397.333	x	x	x	930.5	917.4	556.429	x	x	694.458	840.444	664.111	969.5	1306.48	1159.17	1276.0	x	1009.3	x	1053.5	x	840.111	x	x	1016.38	x	x	681.333	1150.29	1002.7	867.375	877.714	x	969.889	x	x	674.8	x	x	x	1008.0	654.4	1139.33	1502.5	793.5	x	x	x	
-11387	Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for males [cm]	None	Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males [cm]	x	x	x	x	572.0	199.571	x	534.75	334.333	x	168.889	355.6	218.0	467.375	208.286	393.143	631.714	255.8	x	479.333	x	x	x	489.727	x	102.889	144.167	486.938	x	459.625	305.0	362.333	392.625	x	342.0	x	269.077	174.444	520.333	x	527.6	348.857	369.647	368.571	x	x	371.875	x	336.667	260.917	x	x	x	489.429	152.167	x	x	x	299.5	311.0	147.143	x	x	159.0	313.778	151.778	309.75	522.429	512.0	333.0	x	350.9	x	361.5	x	244.444	x	x	317.25	x	x	174.667	381.286	325.9	241.0	271.714	x	427.444	x	x	239.0	x	x	x	271.5	245.4	228.833	395.5	278.667	x	x	x	
-11388	Original post publication description: Anxiety assay, time in light side of a light-dark box for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males [sec]	x	x	x	x	113.35	79.1714	x	228.75	193.767	x	294.733	195.58	207.878	206.938	194.643	264.386	308.971	251.74	x	225.742	x	x	x	438.455	x	256.956	308.808	226.469	x	241.125	128.95	264.767	271.425	x	190.533	x	252.092	159.256	254.05	x	201.05	187.071	221.841	181.786	x	x	177.775	x	223.983	186.8	x	x	x	187.729	222.117	x	x	x	205.533	178.06	209.407	x	x	130.654	288.4	139.333	211.244	229.41	271.3	181.25	x	197.5	x	203.35	x	203.122	x	x	152.0	x	x	153.1	195.1	216.63	166.85	153.5	x	257.311	x	x	283.78	x	x	x	152.817	201.42	124.55	165.5	203.55	x	x	x	
-11389	Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for males [%]	None	Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males [%]	x	x	x	x	22.8574	19.7366	x	34.4899	39.7584	x	43.546	33.4199	36.5076	36.0706	28.5682	37.641	47.3982	35.7052	x	38.458	x	x	x	58.4355	x	32.9443	39.3891	33.172	x	39.5441	24.0786	40.7766	40.3427	x	31.9881	x	38.4997	27.0011	39.0076	x	37.9187	33.536	35.9875	31.7741	x	x	30.9179	x	33.6973	33.9002	x	x	x	32.2701	36.7659	x	x	x	35.5928	32.7514	29.5102	x	x	24.1288	42.6192	22.904	29.5736	39.7661	44.3447	26.312	x	32.9553	x	34.1568	x	29.3749	x	x	31.9719	x	x	26.0803	31.9611	31.5351	25.2644	29.6179	x	42.2581	x	x	36.7648	x	x	x	26.0058	35.6119	20.0612	26.3724	34.7742	x	x	x	
-11390	Original post publication description: Anxiety assay, percentage of time in light side of a light-dark box for males [%]	None	Central nervous system, behavior: Anxiety assay, percentage of time in light side of a light-dark box for males [%]	x	x	x	x	18.8917	13.1214	x	38.6944	31.7861	x	50.3259	31.9733	34.6463	34.1583	32.4405	44.2405	51.4952	42.615	x	37.6236	x	x	x	73.0758	x	42.8259	51.4681	38.1188	x	39.6688	21.2861	44.1278	44.0	x	31.7556	x	40.9859	26.5426	42.3472	x	32.7933	32.0	36.9804	30.2976	x	x	29.6292	x	37.3306	32.4653	x	x	x	31.2881	37.0194	x	x	x	33.7389	29.6767	34.3333	x	x	21.5417	48.0667	23.1907	35.8125	37.7635	44.1417	29.9167	x	32.9617	x	33.8917	x	33.8537	x	x	25.3333	x	x	26.3667	32.5167	37.2183	28.1979	25.5524	x	42.8852	x	x	47.2967	x	x	x	25.3681	33.57	20.7583	27.5833	33.8056	x	x	x	
-11391	Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for males [n]	None	Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males [n]	x	x	x	x	64.5	26.7143	x	46.4167	25.5	x	11.0	24.4	22.3333	47.125	17.0	35.8571	47.8571	21.9	x	40.4167	x	x	x	24.1818	x	8.77778	11.1667	41.875	x	41.375	35.6667	34.1111	31.25	x	32.8333	x	22.4615	17.5556	62.3333	x	50.2	32.1429	34.1176	46.2857	x	x	40.5	x	29.3333	23.0	x	x	x	44.8571	10.0	x	x	x	21.8333	40.2	17.5	x	x	13.7083	24.4444	16.2222	40.3125	61.8095	49.5	38.0	x	35.1	x	50.1667	x	25.8889	x	x	39.875	x	x	19.5	42.5714	30.8	27.875	29.4286	x	32.6667	x	x	17.2	x	x	x	32.0	14.4	26.0	59.5	32.6667	x	x	x	
-11392	Original post publication description: Fear conditioning response, activity in altered context for males [units]	None	Central nervous system, behavior: Fear conditioning response, activity in altered context for males [units]	x	x	x	x	52.0	34.8095	x	39.4861	32.5278	x	23.8889	24.6	32.1111	44.3542	30.7857	22.8333	37.4048	35.6	x	38.6111	x	x	x	30.2424	x	26.6852	26.0694	53.3021	x	28.4167	36.6667	25.8519	26.5	x	41.3056	x	42.7821	24.1852	45.3889	x	36.4667	34.8333	34.8333	48.7857	x	x	39.6042	x	29.6667	34.5417	x	x	x	54.0	18.6389	x	x	x	36.25	34.0333	16.5952	x	x	37.8194	36.3889	37.4444	28.5104	33.127	38.0833	34.1667	x	35.2833	x	30.4444	x	39.9259	x	x	38.9167	x	x	44.1667	46.0714	33.6	31.5	36.0238	x	39.6667	x	x	39.7333	x	x	x	34.4861	40.5667	39.0278	39.5833	35.4167	x	x	x	
-11393	Original post publication description: Fear conditioning behavior, baseline activity in apparatus for males [units]	None	Central nervous system, behavior: Fear conditioning behavior, baseline activity in apparatus for males [units]	x	x	x	x	65.125	23.0357	x	35.625	38.6667	x	16.0278	33.5	26.4167	36.625	23.4643	30.5714	41.1786	20.85	x	34.7292	x	x	x	28.3864	x	18.5556	17.5833	42.0938	x	30.7188	34.7917	31.6944	28.5	x	37.125	x	30.1538	22.6389	39.9583	x	39.725	34.5357	29.1471	43.6786	x	x	33.0938	x	27.8333	26.1042	x	x	x	35.3214	17.3333	x	x	x	25.8333	39.45	14.5357	x	x	25.1771	37.5556	22.3611	20.4062	40.0357	35.25	45.25	x	28.2	x	35.7917	x	34.1389	x	x	33.9375	x	x	28.75	27.25	25.65	24.0625	32.6429	x	32.3333	x	x	29.9	x	x	x	28.6875	25.0	34.1667	17.125	31.2083	x	x	x	
-11394	Original post publication description: Fear conditioning response, contextual activity for males [units]	None	Central nervous system, behavior: Fear conditioning response, contextual activity for males [units]	x	x	x	x	39.55	14.4429	x	7.31667	14.0167	x	8.53333	16.68	21.8444	16.3125	25.6357	9.77143	19.0071	15.77	x	20.7583	x	x	x	13.4364	x	9.26667	10.0167	27.3531	x	9.4625	24.825	13.4444	14.4875	x	10.6333	x	17.0231	7.98889	31.975	x	26.48	18.2143	26.9559	27.7571	x	x	13.175	x	14.75	17.0542	x	x	x	29.4071	4.40833	x	x	x	16.4833	32.7	4.96786	x	x	14.4333	11.0556	21.3167	11.4969	9.85238	23.9	35.4	x	11.73	x	17.0333	x	23.4722	x	x	10.0875	x	x	23.7833	15.6714	15.5	10.375	11.7857	x	24.7111	x	x	13.88	x	x	x	10.3667	5.08	27.1917	23.95	15.2708	x	x	x	
-11395	Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for males [n beam breaks]	None	Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for males [n beam breaks]	x	x	x	x	9.33333	17.8333	x	18.1944	6.58333	x	3.31482	5.33333	5.75926	9.9375	3.19048	11.5	9.28571	10.25	x	6.625	x	x	x	6.57576	x	5.87037	4.05556	23.6146	x	5.04167	7.97222	3.77778	2.10417	x	9.08333	x	7.41026	4.01852	12.2778	x	18.95	11.2857	12.402	27.2143	x	x	19.1667	x	6.63889	3.75	x	x	x	24.9286	1.69444	x	x	x	7.75	12.5	5.15476	x	x	5.57639	4.05556	11.3148	7.05208	6.4127	7.63889	25.25	x	8.51667	x	8.69444	x	9.68519	x	x	9.91667	x	x	13.7778	15.2381	12.6667	4.97917	3.83333	x	12.1481	x	x	5.26667	x	x	x	8.97222	6.8	10.7778	11.0	6.56944	x	x	x	
-11396	Original post publication description: Fear conditioning response, suppression of activity in altered context for males [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males [units]	x	x	x	x	x	0.414803	x	0.463535	0.199834	x	0.109772	0.301065	0.184636	0.226953	0.129261	0.515883	0.298875	0.368716	x	0.154434	x	x	x	0.220592	x	0.087649	0.142541	0.420912	x	0.174951	0.221084	0.189514	0.079494	x	0.215163	x	0.175516	0.157428	0.218831	x	0.526718	0.313888	0.371388	0.556997	x	x	0.486757	x	0.220518	0.119127	x	x	x	0.467703	0.083163	x	x	x	0.214411	0.363145	0.377714	x	x	0.141914	0.124455	0.25937	0.300014	0.181168	0.225024	0.778944	x	0.251601	x	0.309739	x	0.213147	x	x	0.254054	x	x	0.289408	0.322909	0.387818	0.172283	0.105362	x	0.318321	x	x	0.136962	x	x	x	0.2529	0.157916	0.281453	0.291383	0.176164	x	x	x	
-11397	Original post publication description: Fear conditioning response, activity during first tone-shock pairing for males [units]	None	Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males [units]	x	x	x	x	73.0	27.5714	x	36.3333	35.0	x	19.1111	22.6	17.0	26.75	21.0	26.2857	27.2857	24.9	x	38.5	x	x	x	33.8182	x	21.7778	22.5	41.125	x	33.25	39.5	22.1111	23.0	x	34.0	x	30.0	22.6667	37.8333	x	35.2	37.8571	32.1765	42.4286	x	x	34.0	x	32.1667	29.1667	x	x	x	46.1429	16.5	x	x	x	35.0	28.4	22.1429	x	x	27.5	22.3333	24.0	23.6875	45.1429	31.3333	53.0	x	20.6	x	28.1667	x	42.3333	x	x	28.375	x	x	22.8333	25.2857	20.1	24.5	33.7143	x	30.2222	x	x	33.8	x	x	x	27.9167	33.2	36.3333	19.5	29.9167	x	x	x	
-11398	Original post publication description: Fear conditioning response, activity during second tone-shock pairing for males [units]	None	Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males [units]	x	x	x	x	38.0	20.1429	x	20.4167	25.3333	x	15.4444	19.0	12.8889	21.375	16.2857	13.2857	21.5714	19.9	x	28.4167	x	x	x	28.8182	x	23.1111	19.0833	28.5	x	28.125	31.3333	24.2222	20.625	x	23.3333	x	18.3846	15.2222	34.3333	x	24.1	25.7143	27.7647	26.8571	x	x	33.125	x	24.0	20.0	x	x	x	37.1429	10.3333	x	x	x	31.8333	27.6	14.0714	x	x	21.3333	18.1111	22.3333	21.1875	28.6667	26.1667	48.0	x	22.1	x	25.6667	x	27.6667	x	x	21.5	x	x	29.3333	24.1429	19.6	23.375	22.2857	x	20.8889	x	x	18.4	x	x	x	20.9167	19.6	26.3333	25.5	23.75	x	x	x	
-11399	Original post publication description: Fear conditioning response, activity during third tone-shock pairing for males [units]	None	Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males [units]	x	x	x	x	29.0	16.4286	x	18.5833	17.5	x	11.2222	31.6	10.8889	17.0	9.85714	8.85714	17.0	18.3	x	15.1667	x	x	x	17.7273	x	20.1111	24.3333	21.9375	x	20.875	21.6667	27.1111	14.625	x	18.1667	x	15.7692	14.5556	25.3333	x	28.9	25.5714	22.2353	26.8571	x	x	19.625	x	18.1667	14.25	x	x	x	26.0	8.5	x	x	x	37.6667	23.2	14.3571	x	x	20.0	16.1111	18.0	14.75	25.5238	19.3333	28.0	x	13.9	x	21.5	x	29.8889	x	x	27.125	x	x	24.5	26.7143	18.8	26.625	11.5714	x	16.2222	x	x	17.8	x	x	x	17.6667	19.4	24.1667	35.0	18.8333	x	x	x	
-11400	Original post publication description: Fear conditioning response, activity after first tone shock pairing for males [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after first tone shock pairing for males [n beam breaks/30 sec test]	x	x	x	x	27.125	23.6786	x	6.1875	13.125	x	2.83333	10.5	9.44444	15.2188	8.17857	6.89286	19.7143	10.125	x	12.9167	x	x	x	20.7045	x	13.0556	9.77083	19.3594	x	17.625	14.4167	7.72222	13.8438	x	12.875	x	6.86539	4.55556	23.0	x	19.475	17.75	17.9559	29.1429	x	x	16.2812	x	18.625	12.6458	x	x	x	28.2143	7.41667	x	x	x	23.0417	22.25	5.28571	x	x	9.70833	13.0833	10.1389	11.4688	17.0119	11.5417	31.5	x	15.625	x	18.5	x	14.8333	x	x	14.8438	x	x	22.9167	15.75	25.725	8.1875	6.75	x	16.1389	x	x	9.6	x	x	x	16.5208	8.85	18.0833	4.375	18.125	x	x	x	
-11401	Original post publication description: Fear conditioning response, activity after second tone-shock pairing for males [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males [n beam breaks/30 sec test]	x	x	x	x	19.25	18.9286	x	6.22917	6.16667	x	1.77778	15.05	4.47222	9.78125	7.78571	3.28571	14.6786	8.575	x	11.875	x	x	x	14.6364	x	11.8333	11.875	21.2656	x	12.375	12.5417	5.05556	3.8125	x	7.66667	x	7.44231	2.86111	16.4583	x	21.65	11.8214	12.7206	31.1429	x	x	11.5625	x	12.0833	8.04167	x	x	x	26.0714	5.04167	x	x	x	12.2083	18.8	5.35714	x	x	8.70833	8.5	9.77778	7.26562	12.7976	15.25	25.5	x	11.45	x	12.4167	x	16.0278	x	x	16.7812	x	x	13.6667	12.3929	24.45	5.71875	4.89286	x	16.3611	x	x	7.65	x	x	x	12.1458	4.3	16.8333	5.0	15.2083	x	x	x	
-11402	Original post publication description: Fear conditioning response, activity after third tone-shock pairing for males [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males [n beam breaks/30 sec test]	x	x	x	x	28.0	14.0	x	3.66667	11.3333	x	3.88889	9.8	6.0	13.5	16.1429	3.14286	15.4286	8.5	x	10.25	x	x	x	8.72727	x	6.88889	12.5833	18.0625	x	9.0	6.0	4.88889	5.625	x	12.6667	x	12.8462	6.66667	11.1667	x	17.1	19.1429	10.9412	28.0	x	x	11.875	x	8.33333	7.66667	x	x	x	11.7143	8.66667	x	x	x	8.5	14.4	6.42857	x	x	6.45833	4.11111	8.77778	12.6875	8.7619	17.0	32.5	x	20.2	x	9.33333	x	17.1111	x	x	10.75	x	x	8.0	15.7143	12.5	4.0	7.14286	x	14.1111	x	x	3.6	x	x	x	11.25	10.8	16.6667	13.5	14.0833	x	x	x	
-11403	Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males [units]	x	x	x	x	0.419859	0.665349	x	0.122732	0.328108	x	0.46698	0.284072	0.234885	0.344792	0.743	0.129462	0.374429	0.421149	x	0.304483	x	x	x	0.318892	x	0.968435	0.947446	0.457793	x	0.307081	0.166029	0.234521	0.231704	x	0.343743	x	0.437798	0.350382	0.290283	x	0.425398	0.527256	0.447024	0.640386	x	x	0.362502	x	0.276434	0.329456	x	x	x	0.331328	0.516575	x	x	x	0.33114	0.361762	0.683253	x	x	0.265066	0.106937	0.446903	0.669669	0.222403	0.537659	0.718025	x	0.759078	x	0.26084	x	0.399955	x	x	0.419724	x	x	0.274695	0.602081	0.581566	0.157413	0.225362	x	0.45933	x	x	0.144092	x	x	x	0.414964	0.70695	0.535839	0.907018	0.427185	x	x	x	
-11404	Original post publication description: Open field behavior, percentage of distance in the center for males [%]	None	Central nervous system, behavior: Open field behavior, percentage of distance in the center for males [%]	x	x	x	x	47.5922	22.2511	x	33.7074	33.8505	x	26.9011	27.3044	30.0451	32.7967	26.4645	39.5517	38.1148	23.8	x	33.4322	x	x	x	47.2721	x	12.389	17.7159	19.5317	x	34.3412	26.5988	35.5744	25.7129	x	24.6892	x	29.5805	26.4911	37.4642	x	33.6939	32.4145	23.6561	30.6265	x	x	25.0747	x	26.5675	21.0835	x	x	x	28.614	22.6917	x	x	x	19.9243	23.834	22.3253	x	x	22.2828	30.7544	28.4501	28.5905	35.9184	39.0805	28.4942	x	24.7029	x	23.8406	x	33.9456	x	x	26.4213	x	x	35.3407	14.3226	21.5318	32.0908	20.065	x	33.9087	x	x	22.6105	x	x	x	32.1542	26.3169	19.1432	28.5559	38.1785	x	x	x	
-11405	Original post publication description: Open field behavior, percentage of time in center for males [%]	None	Open field behavior, percentage of time in center for males [%]	x	x	x	x	43.8875	11.9893	x	24.5	18.6653	x	15.1769	12.2983	17.0778	22.925	18.8393	32.9548	23.7321	13.4775	x	18.6125	x	x	x	28.6455	x	4.975	11.9868	10.9661	x	28.2479	12.9625	25.6602	17.2313	x	9.96111	x	15.9833	14.1657	21.8069	x	20.8975	16.006	13.1779	16.2536	x	x	13.7969	x	12.6208	10.2451	x	x	x	17.7202	17.4347	x	x	x	10.8194	9.90333	12.2411	x	x	11.591	19.7463	20.5074	20.8078	23.069	24.4625	16.1875	x	12.9183	x	12.2889	x	31.7657	x	x	14.2615	x	x	20.0986	7.15625	12.0992	22.1365	9.53929	x	19.9565	x	x	10.7817	x	x	x	24.2146	16.6117	6.70694	16.875	21.1556	x	x	x	
-11406	Original post publication description: Open field behavior, time in corners for males [min]	None	Central nervous system, behavior: Open field behavior, time in corners for males [min]	x	x	x	x	41.7125	33.9583	x	42.3264	42.2667	x	28.9333	43.5	45.2389	43.6937	39.5655	41.0381	49.3179	45.5158	x	38.9799	x	x	x	40.9258	x	28.0574	36.3063	45.3089	x	47.0844	43.6444	43.8204	44.8854	x	35.9278	x	43.2545	42.963	43.025	x	43.0108	38.3976	43.5382	47.4976	x	x	46.6813	x	40.2778	44.2757	x	x	x	45.6667	51.4375	x	x	x	37.0306	42.575	37.703	x	x	39.4559	40.2574	47.2907	42.8714	46.3317	45.9861	47.2625	x	37.8625	x	40.4736	x	47.1222	x	x	39.5469	x	x	45.225	54.0354	43.5192	47.7031	41.3595	x	45.4861	x	x	39.2	x	x	x	44.9833	48.525	34.5153	41.8208	43.75	x	x	x	
-11407	Original post publication description: Open field behavior, locomotion from 0-5 min for males [cm]	None	Open field behavior, locomotion from 0-5 min for males [cm]	x	x	x	x	1337.5	418.571	x	859.25	359.167	x	223.444	525.6	346.222	703.125	229.143	641.0	834.857	310.0	x	648.083	x	x	x	475.364	x	162.778	114.083	743.5	x	403.25	389.833	562.889	417.75	x	556.667	x	379.538	287.444	848.5	x	677.7	426.143	467.0	675.143	x	x	560.625	x	478.167	470.083	x	x	x	812.286	195.333	x	x	x	360.167	530.8	152.357	x	x	262.0	470.889	308.889	479.125	543.429	588.167	635.5	x	541.9	x	528.167	x	382.556	x	x	471.125	x	x	407.667	406.0	366.3	503.625	404.143	x	506.0	x	x	344.6	x	x	x	543.333	390.4	418.333	706.0	430.0	x	x	x	
-11408	Original post publication description: Open field behavior, locomotion from 10-15 min for males [cm]	None	Open field behavior, locomotion from 10-15 min for males [cm]	x	x	x	x	1304.5	256.571	x	865.25	392.833	x	257.111	413.0	270.222	440.125	386.429	492.0	679.714	402.7	x	429.667	x	x	x	525.545	x	193.111	253.917	794.938	x	554.25	467.667	429.111	415.25	x	380.5	x	347.0	269.0	709.167	x	493.7	334.143	437.647	563.571	x	x	457.875	x	490.0	336.667	x	x	x	773.0	289.833	x	x	x	406.833	574.4	267.429	x	x	410.917	403.889	489.222	471.0	582.238	578.667	668.5	x	490.2	x	425.5	x	655.556	x	x	482.0	x	x	411.167	454.0	502.3	494.5	326.0	x	496.778	x	x	524.4	x	x	x	364.167	464.6	465.167	650.0	342.917	x	x	x	
-11409	Original post publication description: Open field behavior, locomotion from 15-20 min for males [cm]	None	Open field behavior, locomotion from 15-20 min for males [cm]	x	x	x	x	1002.0	258.143	x	829.833	363.333	x	219.333	314.8	247.778	409.125	319.143	455.286	615.0	388.5	x	400.917	x	x	x	465.636	x	205.111	240.417	677.062	x	505.25	406.667	436.556	407.25	x	275.833	x	318.692	241.444	625.333	x	450.8	340.714	367.824	524.714	x	x	462.0	x	524.167	348.0	x	x	x	680.286	329.167	x	x	x	384.0	551.6	232.429	x	x	397.167	400.889	480.333	524.188	535.619	600.833	504.0	x	492.2	x	398.5	x	834.556	x	x	479.75	x	x	377.167	415.0	527.9	473.875	314.0	x	481.667	x	x	454.4	x	x	x	344.083	485.4	423.5	636.0	283.833	x	x	x	
-11410	Original post publication description: Open field behavior, locomotion from 5-10 min for males [cm]	None	Central nervous system, behavior: Open field behavior, locomotion from 5-10 min for males [cm]	x	x	x	x	1392.5	395.714	x	896.167	356.5	x	220.222	411.8	315.111	528.875	411.714	570.286	809.286	415.1	x	515.917	x	x	x	637.909	x	204.556	252.25	849.375	x	540.5	589.0	498.667	472.125	x	476.667	x	424.0	262.889	753.5	x	599.4	360.286	504.588	649.143	x	x	506.75	x	562.0	399.75	x	x	x	851.286	291.833	x	x	x	543.167	627.6	201.286	x	x	422.417	417.222	440.778	503.75	594.19	566.833	645.0	x	510.3	x	496.833	x	560.222	x	x	510.25	x	x	490.833	459.25	563.6	547.0	358.857	x	485.0	x	x	504.6	x	x	x	477.5	424.2	455.667	633.0	353.5	x	x	x	
-11411	Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for males (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	None	Central nervous system, behavior: Open field activity, habituation ratio for males (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	x	x	x	x	0.412021	0.386808	x	0.499355	0.584485	x	0.533762	0.379177	0.416883	0.361718	0.596545	0.415634	0.436824	0.59747	x	0.374387	x	x	x	0.497585	x	0.519478	0.70453	0.504739	x	0.57488	0.536579	0.450558	0.495266	x	0.318976	x	0.48649	0.428878	0.416796	x	0.40512	0.408928	0.452213	0.447193	x	x	0.453089	x	0.516075	0.42822	x	x	x	0.460135	0.653781	x	x	x	0.536256	0.504888	0.545367	x	x	0.619402	0.478405	0.609318	0.545735	0.504068	0.504275	0.442927	x	0.475019	x	0.418838	x	0.629927	x	x	0.533803	x	x	0.510124	0.543208	0.612408	0.497692	0.434068	x	0.507922	x	x	0.55968	x	x	x	0.413164	0.566834	0.541323	0.476828	0.405243	x	x	x	
-11412	Original post publication description: Open field behavior, percentage time in perimeter minus time in corners for males [%]	None	Open field behavior, percentage time in perimeter minus time in corners for males [%]	x	x	x	x	14.4	54.0524	x	33.1736	39.0681	x	55.8898	44.2017	37.6833	33.3812	41.5952	26.0071	26.95	41.0067	x	42.4076	x	x	x	30.4288	x	66.9676	51.7069	43.725	x	24.6677	43.3931	30.5194	37.8833	x	54.1111	x	40.7622	42.8713	35.1681	x	36.0917	45.5964	43.2838	36.2488	x	x	39.5219	x	47.1014	45.4792	x	x	x	36.6131	31.1278	x	x	x	52.15	47.5217	50.056	x	x	48.9531	39.9963	32.2019	36.3208	30.5992	29.5514	36.55	x	49.2192	x	47.2375	x	21.112	x	x	46.1917	x	x	34.6764	38.8083	44.3817	30.1604	49.1012	x	34.5574	x	x	50.0183	x	x	x	30.8021	34.8633	58.7778	41.3042	35.0944	x	x	x	
-11413	Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for males [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-20 min for males [n beam breaks]	x	x	x	x	88.5	52.7143	x	148.833	90.3333	x	51.0	135.4	65.5556	127.5	79.4286	98.7143	162.0	99.4	x	180.667	x	x	x	96.5455	x	38.4444	35.3333	101.0	x	156.0	81.8333	125.889	103.5	x	101.333	x	60.0769	51.8889	162.667	x	125.2	136.857	99.5294	149.857	x	x	145.0	x	162.333	135.5	x	x	x	125.143	32.6667	x	x	x	103.167	135.8	39.6429	x	x	85.9167	140.667	128.778	129.625	141.571	146.0	132.0	x	199.5	x	186.833	x	34.0	x	x	103.0	x	x	69.1667	91.25	120.0	163.0	90.8571	x	164.222	x	x	102.0	x	x	x	127.167	149.8	78.0	168.5	126.417	x	x	x	
-11414	Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for males [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-5 min for males [n beam breaks]	x	x	x	x	8.5	13.7143	x	26.0833	10.8333	x	10.4444	23.0	12.0	26.75	5.0	18.2857	32.4286	12.8	x	41.5833	x	x	x	9.81818	x	1.77778	2.5	14.25	x	17.875	11.1667	29.4444	18.5	x	28.1667	x	7.15385	9.11111	36.0	x	24.9	21.5714	18.4706	36.7143	x	x	29.25	x	31.6667	35.9167	x	x	x	25.8571	4.66667	x	x	x	17.6667	23.6	2.85714	x	x	7.83333	28.1111	6.88889	16.875	20.4286	26.5	26.0	x	41.1	x	41.0	x	2.88889	x	x	12.25	x	x	8.0	9.25	17.7	27.25	22.1429	x	15.3333	x	x	11.2	x	x	x	25.1667	16.2	13.6667	36.5	22.1667	x	x	x	
-11415	Original post publication description: Open field behavior, vertical activity (rears) 10-15 min for males [n beam breaks]	None	Open field behavior, vertical activity (rears) 10-15 min for males [n beam breaks]	x	x	x	x	27.5	10.2857	x	41.75	29.1667	x	15.5556	42.0	17.7778	31.375	29.2857	25.8571	42.4286	29.6	x	45.25	x	x	x	30.2727	x	13.2222	11.5	29.6875	x	47.375	23.1667	28.5556	29.375	x	22.6667	x	16.3077	14.7778	45.8333	x	31.5	41.0	26.5294	33.1429	x	x	42.125	x	43.0	28.75	x	x	x	31.5714	8.0	x	x	x	27.8333	35.4	14.9286	x	x	26.75	37.8889	44.5556	35.5	39.8095	42.1667	39.0	x	51.3	x	49.3333	x	11.5556	x	x	33.125	x	x	20.5	28.0	32.3	45.875	23.8571	x	53.0	x	x	30.8	x	x	x	34.1667	46.0	22.1667	52.5	39.1667	x	x	x	
-11416	Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for males [n beam breaks]	None	Open field behavior, vertical activity (rears) from 15-20 min for males [n beam breaks]	x	x	x	x	22.0	12.0	x	43.0	29.8333	x	13.2222	35.8	17.5556	33.75	23.1429	28.4286	43.4286	28.3	x	41.25	x	x	x	27.5455	x	14.4444	14.9167	29.375	x	50.5	20.0	35.5556	26.125	x	15.6667	x	20.5385	15.2222	33.5	x	31.2	36.5714	27.1765	35.2857	x	x	34.75	x	44.8333	34.4167	x	x	x	29.4286	10.5	x	x	x	25.1667	36.6	12.9286	x	x	28.4167	33.8889	44.7778	44.75	44.3333	41.5	31.5	x	54.4	x	47.3333	x	9.33333	x	x	30.75	x	x	26.0	35.75	36.9	40.25	23.0	x	59.2222	x	x	34.6	x	x	x	29.5	50.0	20.8333	42.0	30.75	x	x	x	
-11417	Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for males [n beam breaks]	None	Open field behavior, vertical activity (rears) from 5-10 min for males [n beam breaks]	x	x	x	x	30.5	16.7143	x	38.0	20.5	x	11.7778	34.6	18.2222	35.625	22.0	26.1429	43.7143	28.7	x	52.5833	x	x	x	28.9091	x	9.0	6.41667	27.6875	x	40.25	27.5	32.3333	29.5	x	34.8333	x	16.0769	12.7778	47.3333	x	37.6	37.7143	27.3529	44.7143	x	x	38.875	x	42.8333	36.4167	x	x	x	38.2857	9.5	x	x	x	32.5	40.2	8.92857	x	x	22.9167	40.7778	32.5556	32.5	37.0	35.8333	35.5	x	52.7	x	49.1667	x	10.2222	x	x	26.875	x	x	14.6667	18.25	33.1	49.625	21.8571	x	36.6667	x	x	25.4	x	x	x	38.3333	37.6	21.3333	37.5	34.3333	x	x	x	
-11418	Original post publication description: Open field behavior, locomotion for entire test period for males [cm]	None	Open field behavior, locomotion for entire test period for males [cm]	x	x	x	x	5036.5	1329.0	x	3450.5	1471.83	x	920.111	1665.2	1179.33	2081.25	1346.43	2158.57	2938.86	1516.3	x	1994.58	x	x	x	2104.45	x	765.556	860.667	3064.88	x	2003.25	1853.17	1927.22	1712.38	x	1689.67	x	1469.23	1060.78	2936.5	x	2221.6	1461.29	1777.06	2412.57	x	x	1987.25	x	2054.33	1554.5	x	x	x	3116.86	1106.17	x	x	x	1694.17	2284.4	853.5	x	x	1492.5	1692.89	1719.22	1978.06	2255.48	2334.5	2453.0	x	2034.6	x	1849.0	x	2432.89	x	x	1943.12	x	x	1686.83	1734.25	1960.1	2019.0	1403.0	x	1969.44	x	x	1828.0	x	x	x	1729.08	1764.6	1762.67	2625.0	1410.25	x	x	x	
-11419	Original post publication description: Open field behavior, percentage of distance in the perimeter for males [%]	None	Central nervous system, behavior: Open field behavior, percentage of distance in the perimeter for males [%]	x	x	x	x	52.4078	77.7489	x	66.2926	66.1495	x	73.0989	72.6956	69.9549	67.2033	73.5355	60.4483	61.8852	76.2	x	66.5678	x	x	x	52.7279	x	87.611	82.2841	80.4683	x	65.6588	73.4012	64.4256	74.2871	x	75.3108	x	70.4195	73.5089	62.5358	x	66.3061	67.5854	76.3439	69.3735	x	x	74.9253	x	73.4325	78.9165	x	x	x	71.386	77.3083	x	x	x	80.0757	76.166	77.6747	x	x	77.7172	69.2456	71.5499	71.4095	64.0816	60.9195	71.5058	x	75.2971	x	76.1594	x	66.0544	x	x	73.5787	x	x	64.6593	85.6774	78.4682	67.9092	79.935	x	66.0913	x	x	77.3895	x	x	x	67.8458	73.6831	80.8568	71.4441	61.8215	x	x	x	
-11420	Original post publication description: Open field behavior, percentage of time in perimeter for males [%]	None	Open field behavior, percentage of time in perimeter for males [%]	x	x	x	x	56.1125	88.0107	x	75.5	81.3347	x	84.8232	87.7017	82.9222	77.075	81.1607	67.0452	76.2679	86.5225	x	81.3875	x	x	x	71.3545	x	95.025	88.0132	89.0339	x	71.7521	87.0375	74.3398	82.7688	x	90.0389	x	84.0167	85.8343	78.1931	x	79.1025	83.994	86.8221	83.7464	x	x	86.2031	x	87.3792	89.7549	x	x	x	82.2798	82.5653	x	x	x	89.1806	90.0967	87.7589	x	x	88.409	80.2537	79.4926	79.1922	76.931	75.5375	83.8125	x	87.0817	x	87.7111	x	68.2343	x	x	85.7385	x	x	79.9014	92.8438	87.9008	77.8635	90.4607	x	80.0435	x	x	89.2183	x	x	x	75.7854	83.3883	93.2931	83.125	78.8444	x	x	x	
-11421	Original post publication description: Startle response, baseline level for males [units]	None	Startle response, baseline level for males [units]	x	x	x	x	0.076	0.115987	x	0.143808	0.09897	x	0.079076	0.064236	0.070584	0.122803	0.12074	0.154312	0.103532	0.094691	x	0.109371	x	x	x	0.127636	x	0.159375	0.123644	0.195176	x	0.108011	0.096197	0.061779	0.074227	x	0.079409	x	0.119669	0.071828	0.078727	x	0.147784	0.119922	0.078898	0.081221	x	x	0.080318	x	0.127636	0.118227	x	x	x	0.045758	0.148424	x	x	x	x	0.0538	0.096344	x	x	0.104794	0.063515	0.101475	0.123517	0.093036	0.086652	0.269864	x	0.090736	x	0.047432	x	0.129055	x	x	0.119102	x	x	0.089606	0.111922	0.121545	0.08625	0.071247	x	0.141195	x	x	0.740636	x	x	x	0.154955	0.090855	0.140545	0.077273	0.1225	x	x	x	
-11422	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	3.53121	0.814163	x	1.63367	0.713345	x	1.93318	1.12877	1.99244	2.10435	1.31396	1.06357	1.24712	0.728007	x	0.130107	x	x	x	0.968325	x	4.33644	1.39854	1.47392	x	3.38005	0.644536	1.26275	0.330518	x	0.551607	x	0.735623	1.37984	0.35919	x	0.357286	2.11628	1.97644	1.29952	x	x	2.54731	x	1.84281	1.38295	x	x	x	0.582905	1.66363	x	x	x	x	0.780786	0.778969	x	x	1.5648	1.61298	0.408056	0.865509	0.483886	3.14271	1.19079	x	0.270664	x	0.267714	x	0.981457	x	x	1.33399	x	x	2.16787	1.45764	0.260829	0.369455	0.4215	x	0.760184	x	x	1.33662	x	x	x	1.60635	4.78576	0.88056	1.73575	1.8588	x	x	x	
-11423	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	2.3465	0.883171	x	1.20969	0.478517	x	0.9686	0.87046	1.43746	2.26213	0.953614	1.24443	0.786229	0.54933	x	0.1175	x	x	x	0.9436	x	3.94691	1.50698	1.24832	x	2.77924	0.5803	0.875514	0.380625	x	0.42675	x	0.538127	1.02516	0.237217	x	0.285863	1.62179	1.20051	0.975871	x	x	2.53536	x	1.0816	0.88667	x	x	x	0.3013	1.5086	x	x	x	x	0.58342	0.661343	x	x	1.00751	1.28526	0.268167	0.479125	0.48608	2.75788	0.70165	x	0.26389	x	0.1836	x	0.73984	x	x	1.20673	x	x	1.48017	1.52229	0.24436	0.345212	0.272243	x	0.666357	x	x	0.766133	x	x	x	1.33795	3.74856	0.707583	1.27735	1.46641	x	x	x	
-11424	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	0.8255	0.534357	x	0.935467	0.291067	x	0.8181	0.75868	1.03677	1.7023	0.6986	0.9971	0.287614	0.31577	x	0.102483	x	x	x	0.589218	x	2.78904	0.901267	0.702493	x	2.47108	0.357717	0.558214	0.285762	x	0.472325	x	0.398864	0.585744	0.22745	x	0.190475	1.10197	0.629753	0.600529	x	x	1.98193	x	0.296283	0.48387	x	x	x	0.173567	1.22143	x	x	x	x	0.41534	0.461443	x	x	0.470667	1.056	0.209956	0.224131	0.26068	2.25518	0.27915	x	0.1789	x	0.133075	x	0.41274	x	x	0.63155	x	x	1.35165	0.921357	0.20077	0.180787	0.206614	x	0.475414	x	x	0.496467	x	x	x	0.62255	2.5629	0.417717	0.8686	0.766075	x	x	x	
-11425	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	0.5462	0.381714	x	0.782889	0.200783	x	0.753567	0.75316	0.8357	1.42097	0.621014	0.964714	0.318343	0.34496	x	0.099725	x	x	x	0.507136	x	1.8589	0.8293	0.63078	x	2.08421	0.35445	0.509257	0.241487	x	0.3552	x	0.370736	0.472556	0.21545	x	0.21235	0.7155	0.601241	0.516114	x	x	1.79414	x	0.327467	0.56776	x	x	x	0.114033	0.973067	x	x	x	x	0.35896	0.303393	x	x	0.444267	0.889178	0.200689	0.215475	0.21418	2.15558	0.25345	x	0.15422	x	0.09635	x	0.3927	x	x	0.5411	x	x	1.36758	0.863671	0.21761	0.190238	0.228157	x	0.448443	x	x	0.767533	x	x	x	0.445583	2.72254	0.4179	0.73045	0.751917	x	x	x	
-11426	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	31.8625	-14.3781	x	24.9191	29.4952	x	55.4663	23.0248	23.1485	-10.1356	29.2715	-8.26697	34.6269	25.1284	x	11.9009	x	x	x	-1.07855	x	8.99673	-9.74715	13.4676	x	16.9234	11.0487	29.5496	-25.0252	x	18.5433	x	24.1566	19.6035	25.7913	x	23.7481	24.2318	35.5166	22.5302	x	x	2.42607	x	40.4802	27.4653	x	x	x	45.0653	6.40973	x	x	x	x	27.2168	17.1704	x	x	33.8511	19.002	27.0098	43.8189	3.27372	13.2832	47.7629	x	0.047551	x	29.6153	x	24.9174	x	x	9.11357	x	x	28.2087	-4.39566	-0.653405	-1.46868	31.8903	x	12.4346	x	x	39.347	x	x	x	15.1432	20.071	17.3323	22.712	22.5925	x	x	x	
-11427	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	76.2695	34.109	x	41.6348	54.8681	x	62.8654	33.0929	42.4165	17.7501	43.9674	14.5913	74.5509	57.4607	x	19.371	x	x	x	38.4973	x	36.3844	33.2503	52.2326	x	27.4109	41.2723	51.875	4.66378	x	19.3895	x	43.8726	48.9323	20.6776	x	44.0033	46.849	65.7721	52.1974	x	x	24.56	x	82.9681	60.9206	x	x	x	68.4616	25.8014	x	x	x	x	48.5845	44.4443	x	x	68.8393	33.0552	42.4598	69.1468	40.2674	28.4318	78.3847	x	28.3099	x	48.3603	x	55.9221	x	x	49.9424	x	x	43.1714	42.1036	17.3611	45.4302	48.4745	x	33.9249	x	x	58.7508	x	x	x	59.5097	43.9016	51.0839	49.1563	61.0722	x	x	x	
-11428	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	84.3712	52.977	x	52.3002	69.0214	x	65.6511	33.9538	54.4029	31.3187	48.8105	15.2388	71.8177	57.1195	x	23.8991	x	x	x	45.6469	x	57.4984	38.719	57.432	x	40.0873	40.4909	60.0198	22.2605	x	31.458	x	46.6422	59.9091	23.3277	x	40.0314	65.0361	68.1653	57.2601	x	x	31.2547	x	81.685	56.0712	x	x	x	79.4247	37.9335	x	x	x	x	55.6974	62.4519	x	x	69.2557	42.3827	42.2874	73.1479	46.3172	31.578	78.208	x	36.0629	x	55.0784	x	56.3105	x	x	57.3531	x	x	46.0892	46.1734	11.7799	40.7199	48.2078	x	39.5847	x	x	40.5684	x	x	x	71.7857	40.8072	51.4907	49.939	60.7701	x	x	x	
-13035	Original post publication description: Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible]	None	Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus Cdm (Slc39a8) [-1= resistant, 1 = susceptible]	x	1.0	-1.0	1.0	x	1.0	-1.0	-1.0	1.0	x	1.0	1.0	1.0	1.0	x	-1.0	0.5	-0.5	1.0	1.0	0.0	0.0	x	-0.5	x	-1.0	1.0	-1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13036	Original post publication description: Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible]	None	Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible]	x	x	-1.0	1.0	-1.0	1.0	-1.0	-1.0	1.0	-1.0	1.0	1.0	1.0	1.0	-1.0	-1.0	1.0	1.0	1.0	1.0	-1.0	1.0	x	-1.0	1.0	-1.0	1.0	-1.0	-1.0	-1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11432	Original post publication description: Time below threshold for males	None	Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males [sec below threshold movement level]	x	x	x	x	x	x	x	x	x	x	x	47.25	205.0	x	x	x	94.5	x	x	192.0	x	x	x	x	x	x	217.0	x	x	x	141.5	196.0	238.75	x	103.5	x	180.0	280.0	119.25	x	x	x	206.333	x	x	x	x	x	x	116.0	x	x	x	x	x	x	x	x	x	168.5	182.5	x	x	73.0	x	x	29.0	x	78.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	210.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11433	Original post publication description: Locomotion in zero maze for males [n beam breaks]	None	Central nervous system, behavior: Locomotion in zero maze for males [n beam breaks]	x	x	x	x	885.5	575.429	x	710.9	460.667	x	327.0	634.0	444.6	637.5	556.0	526.857	573.857	513.429	x	556.7	x	x	x	505.444	x	490.5	336.111	711.267	x	507.0	575.167	510.286	557.667	x	656.333	x	513.231	408.667	616.5	x	612.8	302.857	538.059	730.286	x	x	538.75	x	380.167	485.0	x	x	x	583.429	582.333	x	x	x	533.333	602.6	364.714	x	x	613.417	406.889	479.357	536.312	653.286	563.5	564.0	x	605.8	x	525.75	x	412.889	x	x	581.375	x	x	514.5	524.714	637.1	564.5	506.571	x	444.0	x	x	549.2	x	x	x	574.833	799.6	618.5	383.5	426.857	x	x	x	
-11434	Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for males [n]	None	Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males [n]	x	x	x	x	128.5	61.5714	x	139.7	37.1667	x	38.625	104.25	16.4	69.1667	46.7143	48.2857	60.7143	42.4286	x	74.7	x	x	x	57.2222	x	55.0	30.5556	93.4	x	69.625	98.5	52.0	69.5	x	70.6667	x	28.6154	40.5556	62.0	x	100.7	92.4286	59.5294	72.5714	x	x	104.25	x	113.5	69.75	x	x	x	71.5714	67.5	x	x	x	102.833	111.4	55.0	x	x	74.5	69.7778	36.7857	103.375	116.143	67.6667	87.5	x	95.2	x	66.0	x	41.7778	x	x	102.875	x	x	66.5	87.4286	92.3	70.875	112.429	x	85.8889	x	x	78.0	x	x	x	120.667	94.4	94.1667	131.0	57.0	x	x	x	
-11435	Original post publication description: Anxiety assay, entries in open quadrants of a zero maze for males [n]	None	Central nervous system, behavior: Anxiety assay, entries in open quadrants of a zero maze for males [n]	x	x	x	x	128.0	61.7143	x	138.9	37.1667	x	38.875	104.5	16.6	69.1667	46.8571	48.4286	61.1429	42.7143	x	74.8	x	x	x	57.3333	x	54.8333	30.6667	93.0667	x	69.875	98.6667	52.0	69.5	x	70.6667	x	28.6154	40.5556	62.3333	x	100.5	92.7143	59.5294	72.7143	x	x	103.875	x	113.333	69.5833	x	x	x	71.4286	67.3333	x	x	x	102.5	110.6	55.0	x	x	74.4583	69.8889	36.7143	102.562	116.19	68.0	86.5	x	95.0	x	65.75	x	41.6667	x	x	102.5	x	x	66.5	87.4286	91.8	71.0	112.571	x	86.5556	x	x	77.6	x	x	x	120.833	94.4	94.0	132.0	57.1429	x	x	x	
-11436	Original post publication description: Zero maze, latency to enter an open quadrant for males [sec]	None	Zero maze, latency to enter an open quadrant for males [sec]	x	x	x	x	0.45	14.8286	x	12.47	84.3167	x	30.4625	1.975	48.88	14.3667	58.7571	23.6714	47.5333	64.9167	x	35.7	x	x	x	8.8	x	46.34	35.6667	21.56	x	14.1875	15.4	40.8857	23.1167	x	19.7333	x	76.6333	82.3375	42.05	x	18.23	17.8286	21.8824	21.6714	x	x	23.75	x	11.15	20.9583	x	x	x	20.1571	23.5833	x	x	x	10.6833	13.66	31.8154	x	x	31.2333	18.4	49.0167	15.8	14.72	24.4833	36.7	x	15.82	x	24.875	x	91.125	x	x	9.8875	x	x	37.0	25.2714	11.15	41.3375	12.3286	x	30.3556	x	x	23.3	x	x	x	9.425	12.08	26.9167	16.1	24.9143	x	x	x	
-11437	Original post publication description: Anxiety assay, percentage of time in open quadrants of a zero maze for males [%]	None	Central nervous system, behavior: Anxiety assay, percentage of time in open quadrants of a zero maze for males [%]	x	x	x	x	16.4833	8.70952	x	23.54	9.62778	x	6.0375	17.2417	1.98	8.76111	11.8143	5.30476	12.9952	9.48571	x	11.2067	x	x	x	18.7407	x	10.9556	22.2815	26.06	x	14.1667	21.1	7.58571	19.3722	x	11.1056	x	2.23077	11.1926	21.45	x	24.92	43.8238	13.4549	10.9429	x	x	22.7042	x	44.4667	21.5639	x	x	x	14.2476	8.68333	x	x	x	29.5611	31.0	23.0214	x	x	11.4431	20.6519	9.22857	32.8417	18.7746	15.6111	23.8	x	13.8733	x	24.1167	x	22.5	x	x	20.7542	x	x	10.5	15.6762	17.7	16.8625	27.6619	x	21.1815	x	x	13.1267	x	x	x	17.425	8.38667	20.3	43.7	12.1571	x	x	x	
-11438	Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males [sec]	x	x	x	x	250.55	273.871	x	221.38	271.117	x	281.888	248.275	294.06	273.717	264.557	284.086	261.014	266.014	x	262.16	x	x	x	243.778	x	267.133	257.078	233.527	x	257.5	236.7	277.243	241.883	x	266.683	x	293.308	266.422	235.65	x	225.24	168.529	259.635	267.171	x	x	207.988	x	166.6	235.308	x	x	x	257.257	273.95	x	x	x	211.317	207.0	230.936	x	x	265.671	238.044	272.314	201.475	243.676	253.167	228.6	x	258.38	x	227.65	x	232.5	x	x	237.738	x	x	268.5	241.243	246.9	249.413	217.014	x	218.3	x	x	260.62	x	x	x	235.067	274.84	239.1	168.9	252.086	x	x	x	
-11439	Original post publication description: Anxiety assay, time in open quadrants of a zero maze for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males [sec]	x	x	x	x	49.45	26.1286	x	78.62	28.8833	x	18.1125	51.725	5.94	26.2833	35.4429	15.9143	38.9857	33.9857	x	37.84	x	x	x	56.2222	x	32.8667	42.9222	66.4733	x	42.5	63.3	22.7571	58.1167	x	33.3167	x	6.69231	33.5778	64.35	x	74.76	131.471	40.3647	32.8286	x	x	92.0125	x	133.4	64.6917	x	x	x	42.7429	26.05	x	x	x	88.6833	93.0	69.0643	x	x	34.3292	61.9556	27.6857	98.525	56.3238	46.8333	71.4	x	41.62	x	72.35	x	67.5	x	x	62.2625	x	x	31.5	58.7571	53.1	50.5875	82.9857	x	81.7	x	x	39.38	x	x	x	64.9333	25.16	60.9	131.1	47.9143	x	x	x	
-11440	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males [cm]	x	x	x	x	1089.36	1194.46	x	509.389	x	280.75	893.872	1602.59	751.134	554.335	242.882	935.877	1768.28	1165.3	x	1325.21	x	x	x	190.395	x	1117.21	354.432	1356.16	x	1345.51	868.182	880.992	1151.55	x	1233.95	x	415.818	833.95	1127.67	x	1384.34	583.177	728.755	1827.55	x	x	1093.69	x	1372.14	1355.83	x	x	x	358.945	306.5	x	x	x	1021.57	849.047	376.438	406.07	x	846.483	1599.09	838.47	1013.58	245.562	1612.04	674.003	x	1012.5	x	216.34	x	x	x	x	445.253	x	x	1008.47	630.272	267.925	406.778	437.578	x	368.643	639.35	x	941.27	x	x	x	396.473	603.73	561.43	1532.58	343.25	x	x	x	
-11441	Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males [cm]	None	Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males [cm]	x	x	x	x	722.237	376.0	x	777.314	x	583.535	657.202	1055.82	443.454	731.032	202.682	622.262	1173.07	785.747	x	945.685	x	x	x	436.597	x	772.753	269.565	1183.16	x	717.953	570.972	531.93	553.505	x	507.212	x	575.443	522.768	833.353	x	1041.7	648.69	1056.32	1162.76	x	x	878.742	x	761.02	463.682	x	x	x	701.615	282.0	x	x	x	1179.09	625.465	300.53	220.075	x	707.477	471.125	548.578	611.723	685.023	1263.15	534.123	x	667.296	x	455.828	x	x	x	x	690.945	x	x	669.103	964.06	446.923	582.368	549.002	x	877.685	714.27	x	949.92	x	x	x	762.425	868.585	747.32	1253.52	622.07	x	x	x	
-11442	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males [cm]	x	x	x	x	675.84	1388.19	x	364.508	x	333.53	787.73	1365.86	552.992	217.13	175.937	934.86	1567.04	785.8	x	912.605	x	x	x	176.312	x	961.797	440.825	1278.51	x	1178.89	858.093	534.963	1004.94	x	822.07	x	312.12	177.148	1054.41	x	1346.55	212.492	610.503	1608.82	x	x	904.32	x	1341.14	973.162	x	x	x	0.9925	112.495	x	x	x	848.305	969.805	231.758	121.24	x	716.078	1060.02	897.185	681.013	245.523	1390.45	730.727	x	907.286	x	167.492	x	x	x	x	348.902	x	x	1053.74	631.59	255.708	250.417	392.683	x	256.127	677.992	x	686.128	x	x	x	320.938	345.15	133.395	754.125	296.478	x	x	x	
-11443	Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males [cm]	None	Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males [cm]	x	x	x	x	372.858	205.965	x	438.27	x	381.522	622.225	665.943	278.684	372.138	127.742	255.777	603.46	518.068	x	624.575	x	x	x	187.637	x	568.575	101.082	952.24	x	397.957	289.393	433.358	483.545	x	75.56	x	418.328	330.592	571.218	x	516.278	263.03	562.458	582.35	x	x	626.095	x	449.395	353.185	x	x	x	635.43	87.73	x	x	x	693.715	377.508	140.77	55.535	x	491.155	164.977	397.172	441.65	367.908	1265.02	321.83	x	325.334	x	216.065	x	x	x	x	379.337	x	x	400.72	366.478	360.287	378.248	361.328	x	545.675	241.02	x	444.693	x	x	x	483.062	505.505	371.978	1030.55	364.12	x	x	x	
-11444	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males [cm]	x	x	x	x	528.835	775.265	x	254.164	x	400.59	659.277	909.055	459.586	213.097	163.713	898.477	1326.74	772.615	x	636.18	x	x	x	297.853	x	703.775	286.98	1137.71	x	1024.93	892.422	334.405	838.81	x	696.828	x	385.378	212.395	1007.45	x	1246.02	124.085	505.205	1397.1	x	x	989.333	x	1069.73	893.545	x	x	x	157.2	420.79	x	x	x	615.88	798.648	148.435	296.285	x	637.492	849.513	1094.09	828.66	138.117	1392.57	826.11	x	723.022	x	771.42	x	x	x	x	637.855	x	x	1246.34	740.322	294.942	173.288	357.742	x	461.175	1057.49	x	991.633	x	x	x	314.685	453.47	377.617	870.595	284.02	x	x	x	
-11445	Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males [cm]	x	x	x	x	245.363	174.69	x	414.807	x	436.332	578.503	483.61	239.862	300.483	62.1333	194.492	421.908	300.185	x	431.925	x	x	x	124.333	x	589.182	168.54	767.635	x	324.365	300.515	432.335	313.56	x	206.28	x	378.555	369.925	445.522	x	485.58	445.578	392.883	632.76	x	x	533.013	x	512.89	461.783	x	x	x	498.33	89.625	x	x	x	669.095	335.087	211.965	43.345	x	324.615	159.712	515.345	479.08	381.203	1364.19	306.607	x	256.376	x	151.497	x	x	x	x	373.26	x	x	241.125	259.91	277.023	352.513	319.298	x	453.792	149.042	x	380.672	x	x	x	270.985	639.655	367.33	924.115	321.08	x	x	x	
-11446	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males [cm]	x	x	x	x	269.975	682.56	x	226.792	x	303.275	761.02	719.3	497.494	308.502	147.387	692.128	886.665	698.42	x	661.347	x	x	x	277.888	x	542.188	190.97	802.948	x	736.177	745.652	366.195	895.177	x	573.122	x	348.39	181.137	983.723	x	975.292	527.395	556.19	1197.58	x	x	894.165	x	917.53	688.965	x	x	x	17.3875	236.395	x	x	x	555.025	820.523	132.122	254.58	x	635.325	786.708	894.917	634.907	273.212	1002.78	761.753	x	567.664	x	1124.87	x	x	x	x	674.713	x	x	1201.28	514.348	274.89	282.245	271.012	x	649.71	1163.92	x	835.335	x	x	x	628.45	621.53	477.622	878.75	281.475	x	x	x	
-11447	Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males [cm]	x	x	x	x	410.943	169.355	x	322.239	x	558.747	419.408	431.817	278.642	267.432	61.1183	143.485	412.652	245.215	x	345.48	x	x	x	119.52	x	427.802	127.72	802.432	x	276.515	246.743	413.83	263.848	x	162.482	x	284.948	268.69	616.975	x	448.095	222.678	130.122	198.835	x	x	517.838	x	363.177	484.633	x	x	x	237.5	87.15	x	x	x	580.295	283.52	126.455	72.855	x	307.14	141.765	496.017	605.563	406.698	1231.46	488.423	x	323.592	x	152.265	x	x	x	x	272.905	x	x	236.51	164.645	278.3	279.523	350.228	x	552.73	97.7775	x	314.495	x	x	x	208.387	535.525	395.64	1000.72	467.71	x	x	x	
-11448	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males [cm]	x	x	x	x	812.607	3114.47	x	-597.778	x	-641.992	824.56	2618.91	1020.56	-1103.52	276.243	2245.33	2937.64	1572.92	x	1187.68	x	x	x	74.3617	x	966.662	606.3	869.86	x	2568.71	1956.72	305.103	2276.02	x	2374.44	x	-195.568	-87.345	1706.19	x	2460.55	-132.825	258.872	3454.36	x	x	1325.82	x	2614.06	2148.22	x	x	x	-1538.35	529.675	x	x	x	-81.42	1816.44	109.033	686.365	x	1004.99	3357.75	1767.55	1020.14	-938.415	-4732.0	1341.61	x	1364.9	x	1304.46	x	x	x	x	390.275	x	x	2962.37	761.438	-269.068	-479.925	-120.842	x	-694.226	2336.64	x	1364.58	x	x	x	-64.315	-525.39	-332.203	-172.845	-569.758	x	x	x	
-11449	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males [cm]	x	x	x	x	2564.01	4040.48	x	1354.85	x	1318.15	3101.9	4596.81	2261.21	1293.06	729.918	3461.34	5548.72	3422.13	x	3535.35	x	x	x	942.448	x	3324.98	1273.21	4575.33	x	4285.5	3364.35	2116.55	3890.48	x	3325.97	x	1461.7	1404.63	4173.26	x	4952.2	1447.15	2400.65	6031.06	x	x	3881.51	x	4700.54	3911.5	x	x	x	534.525	1076.18	x	x	x	3040.78	3438.02	888.753	1078.18	x	2835.38	4295.33	3724.66	3158.16	902.415	391.81	2992.59	x	2675.4	x	2280.12	x	x	x	x	2106.72	x	x	4509.83	2516.53	1093.46	1112.73	1459.02	x	1735.66	3538.75	x	3454.36	x	x	x	1660.55	2023.88	1550.06	4036.05	1205.22	x	x	x	
-11450	Original post publication description: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males [cm]	x	x	x	x	1751.4	926.01	x	1952.63	x	1960.14	2277.34	2637.19	1240.64	2396.58	453.675	1216.02	2611.09	1849.21	x	2347.67	x	x	x	868.087	x	2358.31	666.907	3705.47	x	1716.79	1407.62	1811.45	1614.46	x	951.535	x	1657.27	1491.97	2467.07	x	2491.65	1579.97	2141.78	2576.7	x	x	2555.69	x	2086.48	1763.28	x	x	x	2072.88	546.505	x	x	x	3122.2	1621.58	779.72	391.81	x	1830.39	937.58	1957.11	2138.02	1840.83	5123.81	1650.98	x	1310.5	x	975.655	x	x	x	x	1716.45	x	x	1547.46	1755.09	1362.53	1592.65	1579.86	x	2429.88	1202.11	x	2089.78	x	x	x	1724.86	2549.27	1882.27	4208.9	1774.98	x	x	x	
-11451	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males [cm]	x	x	x	x	367.12	818.465	x	-267.925	x	-302.785	236.67	810.72	307.68	-176.697	40.2	313.615	595.215	379.547	x	379.53	x	x	x	-246.202	x	344.462	84.8675	173.0	x	627.555	297.21	349.062	598.047	x	726.737	x	-159.625	311.182	294.32	x	342.645	-65.5125	-327.562	664.795	x	x	214.947	x	611.117	892.148	x	x	x	-342.67	24.5	x	x	x	-157.525	223.583	75.9075	185.995	x	139.007	1127.97	289.892	401.857	-439.46	348.885	139.88	x	287.672	x	-239.488	x	x	x	x	-245.693	x	x	339.362	-333.788	-178.998	-175.59	-111.423	x	-509.041	-74.92	x	-8.65	x	x	x	-365.953	-264.855	-185.89	279.065	-278.82	x	x	x	
-11452	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males [cm]	x	x	x	x	-140.967	513.205	x	-95.4463	x	-255.473	341.612	395.438	218.852	41.07	86.2683	548.643	474.013	453.205	x	315.867	x	x	x	158.368	x	114.385	63.25	0.515	x	459.663	498.908	-47.635	631.33	x	410.64	x	63.4425	-87.5525	366.748	x	527.198	304.717	426.068	998.745	x	x	376.328	x	554.352	204.333	x	x	x	-220.113	149.245	x	x	x	-25.27	537.003	5.6675	181.725	x	328.185	644.943	398.9	29.3433	-133.485	-228.685	273.33	x	203.393	x	972.602	x	x	x	x	401.807	x	x	964.773	349.703	-3.41	2.72167	-79.2167	x	96.98	1066.14	x	520.84	x	x	x	420.062	86.005	81.9825	-121.97	-186.235	x	x	x	
-11453	Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males [mg/dl XX min after injection]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males [mg/dl XX min after injection]	x	x	x	x	268.8	221.9	x	296.717	x	311.1	209.133	217.525	276.167	263.483	248.3	250.9	216.96	202.575	x	233.8	x	x	x	243.92	x	206.1	223.5	249.45	x	231.75	229.633	248.1	212.3	x	244.4	x	279.2	220.9	245.7	x	238.95	231.65	301.375	259.3	x	x	198.55	x	231.15	223.85	x	x	x	213.85	291.0	x	x	x	313.9	283.85	257.75	191.35	x	313.32	239.95	259.45	248.6	326.85	171.85	280.267	x	281.5	x	282.25	x	x	x	x	297.0	x	x	219.0	263.967	291.933	217.15	284.433	x	251.867	265.55	x	237.45	x	x	x	273.5	265.8	238.475	145.15	202.1	x	x	x	
-11454	Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males [n]	x	x	x	x	54.75	51.5	x	90.6667	x	42.25	45.25	40.0	47.5	49.5	41.1667	37.3333	76.5	49.0	x	55.5	x	x	x	45.5	x	65.0	56.0	46.0	x	55.25	29.3333	50.75	49.5	x	41.75	x	42.25	37.75	57.1667	x	37.325	39.0	69.25	58.0	x	x	56.5	x	59.5	57.0	x	x	x	53.5	38.0	x	x	x	44.0	50.75	79.5	37.0	x	51.0	19.5	51.0	82.3333	53.5	25.0	44.3333	x	67.0	x	90.0	x	x	x	x	60.25	x	x	34.5	57.1667	56.3333	37.6667	46.0	x	31.6667	60.0	x	58.25	x	x	x	40.0	55.5	39.0	31.0	37.25	x	x	x	
-11455	Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males [n]	x	x	x	x	39.25	32.5	x	77.0	x	65.25	71.25	78.5	30.5	65.5	12.5	37.0	48.5	49.0	x	55.75	x	x	x	25.25	x	47.5	41.25	73.75	x	67.5	18.6667	48.0	79.5	x	74.25	x	49.25	38.25	38.8333	x	68.25	27.5	43.75	18.0	x	x	61.5	x	57.0	59.5	x	x	x	26.75	17.5	x	x	x	47.0	25.75	45.5	25.0	x	39.8333	35.75	41.0	41.6667	24.5	51.0	26.6667	x	40.2	x	91.3333	x	x	x	x	48.75	x	x	26.6667	54.6667	24.8333	31.0	47.3333	x	53.8333	49.5	x	51.5	x	x	x	23.5	22.5	19.75	57.5	30.5	x	x	x	
-11456	Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males [%]	x	x	x	x	33.0073	44.11	x	66.3	x	27.0902	41.385	34.3279	69.3321	41.7664	68.4564	53.1287	60.292	48.7675	x	45.255	x	x	x	38.1542	x	55.93	54.2975	29.6825	x	37.3525	36.1288	45.94	33.445	x	35.75	x	44.015	38.475	47.1784	x	31.8797	62.3684	65.4551	86.045	x	x	33.65	x	49.6728	46.8315	x	x	x	41.2825	40.45	x	x	x	45.3	57.8558	64.1947	62.2	x	46.8314	22.15	40.3052	68.5667	60.3541	41.075	63.8519	x	57.1204	x	20.1248	x	x	x	x	60.1758	x	x	45.3477	49.2395	50.9287	48.588	41.6159	x	36.826	53.9889	x	49.8003	x	x	x	75.95	54.1032	57.3739	33.565	46.6112	x	x	x	
-11457	Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males [%]	x	x	x	x	66.9927	55.89	x	33.7	x	47.9098	58.615	65.6721	30.6679	58.2336	14.8769	46.8713	39.708	51.2325	x	54.745	x	x	x	61.8458	x	44.07	45.7025	70.3175	x	62.6475	30.5379	54.085	66.555	x	64.25	x	55.985	61.525	36.155	x	68.1203	37.6316	34.5449	13.955	x	x	66.35	x	50.3272	53.1685	x	x	x	50.9725	59.55	x	x	x	54.7	42.1442	35.8053	37.8	x	53.1686	77.85	59.6948	31.4333	39.6459	58.925	36.1481	x	42.8796	x	46.5418	x	x	x	x	39.8242	x	x	54.6523	50.7605	32.4046	51.412	58.3841	x	63.174	46.0111	x	50.1997	x	x	x	24.075	45.8968	42.6261	66.435	53.3888	x	x	x	
-11458	Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males [%]	x	x	x	x	37.1033	37.605	x	45.3678	x	28.5717	26.8525	29.5842	79.4267	32.525	74.835	62.2233	65.72	39.43	x	35.6625	x	x	x	25.235	x	43.98	60.8025	32.5225	x	42.92	28.7894	46.8325	31.965	x	40.6083	x	61.5775	32.5375	39.8572	x	45.2892	68.6467	68.9133	85.695	x	x	36.55	x	42.4083	46.7417	x	x	x	59.95	49.3383	x	x	x	58.885	60.0442	54.395	41.2583	x	52.4406	10.75	37.7867	51.2211	44.8358	26.085	65.9289	x	52.752	x	26.0344	x	x	x	x	61.7175	x	x	36.7656	42.6583	51.3456	58.6033	34.0594	x	36.0194	45.1858	x	53.665	x	x	x	58.1217	60.7233	59.3167	26.77	50.9417	x	x	x	
-11459	Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for males [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for males [%]	x	x	x	x	57.1125	57.055	x	49.5033	x	36.8533	64.5325	58.8925	17.63	53.1025	4.18556	31.4928	21.1192	46.3225	x	51.6225	x	x	x	55.3075	x	39.675	33.62	59.24	x	51.2575	26.3483	42.175	53.56	x	54.6083	x	33.795	61.51	31.5789	x	47.175	26.1467	23.4092	5.225	x	x	60.855	x	45.1642	45.1083	x	x	x	31.4525	50.4133	x	x	x	33.325	19.45	23.3433	25.6117	x	42.7317	37.175	39.3825	14.2333	46.1833	45.31	17.2944	x	37.41	x	37.3622	x	x	x	x	34.9033	x	x	41.4556	49.2956	16.0672	37.4406	56.5356	x	58.4117	41.9508	x	41.2525	x	x	x	35.3833	34.005	25.6383	57.835	45.0083	x	x	x	
-11460	Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec]	x	x	x	x	21.7917	5.3	x	15.3938	x	19.55	11.4217	-15.6083	1.57333	12.0722	8.21111	10.8278	12.7833	-2.86667	x	-0.9	x	x	x	9.33889	x	1.825	15.425	22.8417	x	8.43333	12.4	-1.71667	21.85	x	-4.44167	x	13.975	27.9	8.60556	x	-1.85	-1.15833	10.0833	-12.7667	x	x	7.475	x	-9.825	11.7075	x	x	x	12.85	4.48333	x	x	x	25.7667	-1.49167	15.1083	4.66667	x	0.838889	1.66667	-2.15	-0.355556	16.35	4.68333	6.06667	x	24.8333	x	-0.35	x	x	x	x	28.7583	x	x	-16.7833	8.55	7.51667	3.17222	17.4111	x	18.55	28.6	x	0.483333	x	x	x	-8.125	-9.61667	1.9	5.18333	12.3633	x	x	x	
-11461	Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males [sec]	x	x	x	x	21.7817	41.35	x	44.3222	x	21.9167	56.7117	49.3417	17.9778	27.1556	14.9717	35.3989	19.1889	43.135	x	31.24	x	x	x	16.7172	x	25.2758	27.26	31.43	x	31.0975	33.6489	42.5425	44.235	x	47.2975	x	13.645	33.5075	30.11	x	33.1908	24.4083	28.2508	40.085	x	x	32.44	x	68.7992	27.3608	x	x	x	15.235	11.55	x	x	x	25.065	31.5083	41.8092	28.25	x	27.2222	37.4917	16.8342	52.6222	24.5675	23.8833	26.8222	x	46.5993	x	25.7667	x	x	x	x	25.5333	x	x	43.4444	24.6556	19.0056	25.85	18.8278	x	18.1778	29.075	x	31.7167	x	x	x	34.2492	30.6833	30.8167	35.4167	38.595	x	x	x	
-11462	Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec]	x	x	x	x	-13.2083	-10.8333	x	13.3604	x	-6.80833	5.95611	16.5917	5.71333	-7.82222	2.49444	-4.64444	-4.9	12.7167	x	-4.08333	x	x	x	-3.08889	x	-1.20833	-14.6833	-17.0833	x	-3.69167	-5.41667	1.375	0.375	x	4.48333	x	-4.4	-24.375	-14.8944	x	3.86667	5.50833	-8.19167	7.95	x	x	-9.075	x	7.50917	4.69167	x	x	x	1.00833	-2.6	x	x	x	-14.3	-0.758333	-20.8	-2.91667	x	-2.28889	-13.725	-5.33333	-10.4889	-0.008333	-2.56667	11.8889	x	-22.7267	x	-1.625	x	x	x	x	-5.58333	x	x	5.07222	5.31667	-2.3	-4.51111	9.2	x	-7.36667	-13.5167	x	11.15	x	x	x	6.89167	24.15	-10.325	-0.7	-8.32267	x	x	x	
-11463	Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males [sec]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males [sec]	x	x	x	x	43.5825	46.65	x	55.5824	x	41.4667	68.1322	33.7317	15.45	39.2283	23.1833	46.23	31.9711	40.27	x	30.345	x	x	x	26.0556	x	27.0992	42.685	54.2725	x	39.5325	46.05	40.8225	58.6233	x	42.8575	x	27.6175	61.4075	38.7156	x	31.3417	23.25	38.3342	27.32	x	x	39.9158	x	58.975	39.0683	x	x	x	28.085	16.035	x	x	x	50.835	30.0167	56.9175	32.9167	x	28.0617	39.1567	14.6825	52.2667	40.9175	28.5667	32.8889	x	71.4327	x	25.4167	x	x	x	x	54.2917	x	x	26.6611	33.2056	26.5222	29.0222	43.4867	x	36.7278	57.675	x	32.2	x	x	x	34.8333	21.0667	32.7167	40.6	50.9583	x	x	x	
-11464	Original post publication description: Saline response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males [sec]	None	Central nervous system, behavior: Motor coordination effect of saline control injection (ip), difference in time on rotarod between training session and saline for males [sec]	x	x	x	x	8.58333	-5.53333	x	28.7542	x	12.7417	17.3778	0.983333	7.28667	4.25	10.7056	6.18333	7.88333	9.85	x	-4.98333	x	x	x	6.25	x	0.616667	0.741667	5.75833	x	4.74167	6.98333	-0.341667	22.225	x	0.041667	x	9.575	3.525	-6.28889	x	2.01667	4.35	1.89167	-4.81667	x	x	-1.6	x	-2.31583	16.3992	x	x	x	13.8583	1.88333	x	x	x	11.4667	-2.25	-5.69167	1.75	x	-1.45	-12.0583	-7.48333	-10.8444	16.3417	2.11667	17.9556	x	2.10667	x	-1.975	x	x	x	x	23.175	x	x	-11.7111	13.8667	5.21667	-1.33889	26.6111	x	11.1833	15.0833	x	11.6333	x	x	x	-1.23333	14.5333	-8.425	4.48333	4.04067	x	x	x	
-11465	Original post publication description: Motor coordination, rotarod performance, untreated training trial for males [sec]	None	Motor coordination, rotarod performance, untreated training trial for males [sec]	x	x	x	x	30.365	35.815	x	61.9958	x	34.6583	74.0883	50.3233	18.0733	31.4044	25.6783	41.5833	27.0717	52.985	x	26.2575	x	x	x	22.9661	x	25.8925	28.0	37.1925	x	35.8425	40.6333	42.2	44.34	x	47.34	x	23.2175	37.035	23.8211	x	35.2075	28.7583	30.1408	35.265	x	x	30.8433	x	66.4842	43.7583	x	x	x	29.09	13.43	x	x	x	36.535	29.2575	36.1175	30.0	x	25.7728	25.4325	9.34833	41.7778	40.9083	26.0	44.7778	x	48.706	x	23.7917	x	x	x	x	48.7083	x	x	31.7333	38.5222	24.2222	24.5111	45.4389	x	29.3611	44.1583	x	43.35	x	x	x	33.0175	45.2167	22.3917	39.9	42.6357	x	x	x	
-11466	Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males [sec]	x	x	x	x	111.308	112.815	x	136.06	x	85.715	80.58	88.74	238.28	97.5925	224.498	186.672	197.163	118.283	x	106.945	x	x	x	75.705	x	131.93	182.405	97.565	x	128.765	86.3683	140.45	95.895	x	121.85	x	184.705	97.6175	119.572	x	135.867	205.94	206.735	257.085	x	x	109.66	x	127.223	140.227	x	x	x	179.852	148.015	x	x	x	176.655	180.133	163.185	123.775	x	157.322	32.22	113.363	153.663	134.523	78.25	197.787	x	158.246	x	78.1033	x	x	x	x	185.152	x	x	110.295	127.975	154.037	175.807	102.198	x	108.058	135.557	x	160.995	x	x	x	174.4	182.17	177.95	80.3	152.827	x	x	x	
-11467	Original post publication description: Anxiety assay, time in middle of an elevated plus maze for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males [sec]	x	x	x	x	17.36	16.01	x	15.4733	x	103.725	25.8425	34.5675	8.83	43.1225	62.96	18.85	39.48	42.73	x	38.185	x	x	x	58.375	x	49.04	16.735	24.695	x	17.465	134.587	33.0	43.42	x	14.34	x	13.9625	17.8525	85.6917	x	22.6125	15.62	23.035	27.24	x	x	7.78	x	37.28	24.4425	x	x	x	25.7875	0.745	x	x	x	23.37	61.5175	66.785	99.39	x	14.4833	156.295	68.4525	103.637	26.9575	85.825	50.33	x	29.538	x	109.81	x	x	x	x	10.1375	x	x	65.3367	24.1383	97.7617	11.87	28.1817	x	16.7067	38.59	x	15.2475	x	x	x	19.5	15.815	45.135	46.2	12.145	x	x	x	
-11468	Original post publication description: Anxiety assay, time in open arms of a plus maze for males [sec]	None	Central nervous system, behavior: Anxiety assay, time in open arms of a plus maze for males [sec]	x	x	x	x	171.333	171.175	x	148.467	x	110.56	193.598	176.69	52.89	159.295	12.5417	94.4783	63.3425	138.958	x	154.87	x	x	x	165.92	x	119.03	100.86	177.74	x	153.77	79.045	126.545	160.685	x	163.825	x	101.33	184.53	94.7367	x	141.52	78.44	70.23	15.675	x	x	182.56	x	135.497	135.33	x	x	x	94.36	151.24	x	x	x	99.975	58.35	70.03	76.835	x	128.195	111.485	118.185	42.7	138.52	135.925	51.8833	x	112.216	x	112.087	x	x	x	x	104.71	x	x	124.368	147.887	48.2017	112.323	169.62	x	175.235	125.853	x	123.757	x	x	x	106.1	102.015	76.915	173.5	135.027	x	x	x	
-11469	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [n beam breaks]	x	x	x	x	2391.71	1403.9	x	993.692	955.4	2715.6	1072.36	2018.8	1063.07	2567.73	1020.25	817.385	2905.53	1720.69	957.0	2637.55	x	x	x	2387.62	x	1772.5	1222.27	2050.08	x	1903.75	892.333	3703.23	1456.94	x	583.111	x	1888.92	1576.31	4417.88	x	2316.64	3037.87	1434.05	1712.89	x	x	1771.92	x	1730.56	1156.12	x	x	x	1135.0	1004.56	x	x	x	1854.5	1297.86	870.438	1901.31	x	1733.86	617.692	1072.71	1974.92	3103.6	2375.68	3183.24	x	1290.06	x	1496.55	x	4048.42	x	x	1383.35	x	x	1256.8	2308.4	860.882	1820.42	1862.29	x	2346.27	x	x	1621.5	x	x	x	2165.25	2914.8	2551.83	2567.29	2017.18	x	x	x	
-11470	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [n beam breaks]	x	x	x	x	2314.79	815.9	x	869.923	634.6	2571.6	1135.55	1765.9	1097.0	2028.0	906.5	958.462	1873.35	1968.15	1227.0	2175.0	x	x	x	1818.88	x	1269.5	1002.0	1898.62	x	2137.88	1396.33	3062.38	1230.76	x	473.444	x	2033.75	1488.85	4278.69	x	2105.64	2785.8	1244.29	1222.89	x	x	1483.75	x	1845.0	1348.12	x	x	x	1299.5	1074.61	x	x	x	1965.57	1389.77	895.0	1892.92	x	1717.07	764.846	1317.07	1917.31	3316.87	2494.58	3300.88	x	1139.41	x	1508.82	x	3181.92	x	x	1190.59	x	x	1131.6	2292.5	926.824	1896.08	1889.29	x	2217.36	x	x	1822.36	x	x	x	1770.25	2330.6	2026.83	2897.41	1912.09	x	x	x	
-11471	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [n beam breaks]	x	x	x	x	1558.43	686.7	x	666.231	702.6	2005.2	1257.09	1306.3	962.714	1614.4	696.25	874.385	1192.0	1470.69	1337.0	1749.82	x	x	x	1399.38	x	968.7	795.364	1474.23	x	1413.88	1410.0	2298.0	866.529	x	365.778	x	1579.75	1175.15	3198.25	x	1433.5	1821.2	935.286	962.889	x	x	1589.17	x	1536.67	1197.65	x	x	x	1144.0	663.278	x	x	x	1728.71	1264.32	472.438	1205.31	x	1238.71	607.077	1177.43	1647.15	2827.8	2003.42	2421.47	x	892.824	x	1356.27	x	2183.08	x	x	1028.82	x	x	968.267	1954.7	521.353	1597.75	1554.06	x	1762.73	x	x	1449.14	x	x	x	1157.75	1820.2	1100.75	2661.82	1468.36	x	x	x	
-11472	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [n beam breaks]	x	x	x	x	1174.21	396.2	x	462.385	469.4	1711.4	853.909	1234.1	780.857	1077.33	477.0	836.846	1140.82	806.154	794.0	1401.36	x	x	x	1185.38	x	575.2	532.364	1110.54	x	1278.75	1240.33	1683.62	447.647	x	207.222	x	1159.83	950.154	2473.38	x	1021.71	1418.73	656.143	667.667	x	x	1260.25	x	1132.89	1050.65	x	x	x	856.333	232.0	x	x	x	1307.71	922.273	322.188	705.462	x	1050.86	492.769	1010.93	1278.38	2327.4	1676.53	1930.29	x	690.824	x	1082.0	x	1532.17	x	x	630.706	x	x	798.467	1352.5	323.176	1162.0	1047.12	x	1580.55	x	x	1044.43	x	x	x	1844.38	1447.0	908.833	2274.12	1072.09	x	x	x	
-11473	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [cm]	x	x	x	x	6803.54	4170.04	x	2966.53	2997.62	7522.03	3062.7	5763.18	3326.14	7425.7	3051.77	2574.53	7993.21	5587.93	2933.3	7378.28	x	x	x	6788.72	x	5109.82	3648.73	6001.78	x	5756.39	2617.81	9993.69	4417.63	x	1908.84	x	5738.72	4515.74	11584.9	x	6895.67	8422.96	4412.16	5395.51	x	x	5192.93	x	5329.35	3815.92	x	x	x	3753.56	3375.18	x	x	x	5389.7	3901.29	2683.48	5801.81	x	5188.4	2046.31	3572.57	6125.98	8829.99	6897.64	8911.82	x	3986.5	x	4697.63	x	10593.4	x	x	4107.25	x	x	4226.47	6867.35	2955.96	5315.73	5651.85	x	6992.84	x	x	4914.25	x	x	x	6375.15	8159.97	6944.12	7519.05	5997.08	x	x	x	
-11474	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [cm]	x	x	x	x	6492.58	2621.3	x	2666.18	2139.1	7025.14	3358.91	5310.67	3592.64	6021.15	2759.84	2955.02	5446.17	6479.86	3541.36	6310.98	x	x	x	5337.0	x	3849.83	3231.92	5679.19	x	6262.1	4037.63	8317.7	3788.06	x	1552.16	x	6062.3	4247.41	11056.7	x	6174.98	7887.0	3759.9	4105.16	x	x	4552.86	x	5603.98	4351.81	x	x	x	4197.84	3639.58	x	x	x	5749.7	4191.79	2791.48	5665.06	x	5137.49	2582.83	4137.11	5987.15	9324.98	7144.64	9083.56	x	3592.49	x	4713.82	x	8670.18	x	x	3664.71	x	x	3805.13	6709.07	3082.5	5518.4	5586.59	x	6628.93	x	x	5599.99	x	x	x	5401.41	6700.13	5642.13	8312.44	5770.9	x	x	x	
-11475	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [cm]	x	x	x	x	4556.32	2257.54	x	2108.0	2451.51	5733.6	3731.9	4179.94	3204.39	4883.41	2321.13	2754.0	3517.55	4972.7	3934.44	5293.79	x	x	x	4349.03	x	3114.86	2620.16	4691.75	x	4247.65	4126.46	6630.44	2827.03	x	1263.31	x	4931.91	3509.85	8631.64	x	4362.01	5512.87	2924.96	3353.88	x	x	4901.57	x	4737.19	3939.2	x	x	x	3732.71	2267.92	x	x	x	5123.4	3869.89	1608.61	3652.77	x	3841.13	2037.43	3729.7	5146.89	8174.96	5965.88	6803.18	x	2887.97	x	4314.86	x	6287.98	x	x	3156.85	x	x	3272.73	5964.73	1841.26	4768.39	4627.43	x	5344.69	x	x	4555.9	x	x	x	3880.97	5200.0	3141.68	7630.34	4636.75	x	x	x	
-11476	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [cm]	x	x	x	x	3579.86	1423.81	x	1557.87	1682.89	5028.89	2589.47	3993.26	2670.62	3366.78	1664.48	2593.68	3528.1	2852.32	2430.52	4389.21	x	x	x	3875.99	x	2033.36	1935.2	3654.29	x	3982.53	3670.71	5206.57	1527.72	x	736.09	x	3835.61	2902.21	7008.9	x	3231.94	4610.76	2098.67	2364.34	x	x	3944.4	x	3624.35	3541.97	x	x	x	2856.11	802.259	x	x	x	3930.53	2952.88	1181.43	2164.62	x	3254.93	1720.02	3212.25	3998.09	6916.79	5146.18	5551.64	x	2195.02	x	3496.1	x	4671.85	x	x	2008.16	x	x	2698.29	4356.84	1146.43	3564.41	3212.09	x	4896.0	x	x	3296.96	x	x	x	5230.67	4135.58	2689.71	6694.73	3565.08	x	x	x	
-11477	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males [n beam breaks]	x	x	x	x	283.714	314.9	x	277.923	156.4	303.6	118.909	248.5	227.929	560.533	143.75	299.077	255.765	418.077	156.5	355.0	x	x	x	236.75	x	278.1	182.818	448.385	x	301.25	190.583	267.077	305.0	x	142.778	x	327.833	135.462	514.312	x	601.929	568.8	356.476	323.556	x	x	468.25	x	459.444	299.824	x	x	x	278.083	194.611	x	x	x	332.786	291.955	321.062	246.692	x	270.214	172.308	387.357	444.308	680.2	360.579	478.235	x	304.647	x	385.364	x	509.5	x	x	360.176	x	x	354.6	443.3	222.941	315.667	404.412	x	487.818	x	x	277.714	x	x	x	510.375	292.6	332.917	478.294	430.182	x	x	x	
-11478	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males [n beam breaks]	x	x	x	x	375.857	282.8	x	301.231	212.8	376.4	175.636	369.5	319.786	587.2	202.625	375.462	269.824	548.769	185.0	436.182	x	x	x	249.125	x	276.5	251.182	444.385	x	382.875	340.75	379.231	306.412	x	173.556	x	420.333	196.231	623.875	x	522.071	688.2	344.619	338.889	x	x	477.583	x	460.778	327.059	x	x	x	313.5	272.389	x	x	x	385.357	381.455	376.25	348.923	x	294.571	283.231	458.929	470.077	806.0	429.105	547.235	x	327.824	x	475.636	x	595.417	x	x	422.294	x	x	408.6	483.7	290.176	345.5	415.471	x	558.909	x	x	375.786	x	x	x	596.5	322.8	390.75	528.353	512.909	x	x	x	
-11479	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males [n beam breaks]	x	x	x	x	332.429	268.9	x	241.231	289.8	389.8	224.0	339.7	316.786	504.8	181.0	335.769	260.588	460.154	189.5	424.636	x	x	x	278.0	x	252.0	185.455	402.769	x	318.375	336.25	418.538	246.059	x	132.444	x	396.0	197.462	605.75	x	433.5	571.333	315.381	332.0	x	x	525.083	x	464.889	314.588	x	x	x	277.75	184.333	x	x	x	347.786	395.136	341.25	248.692	x	239.571	212.769	438.0	414.308	753.867	426.368	481.765	x	300.529	x	478.273	x	558.25	x	x	348.294	x	x	349.267	508.8	231.294	308.333	371.235	x	475.273	x	x	332.786	x	x	x	499.5	263.4	269.167	522.118	497.727	x	x	x	
-11480	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males [n beam breaks]	x	x	x	x	344.071	220.6	x	177.385	251.0	428.2	191.727	368.4	276.214	392.467	146.375	326.462	255.294	315.154	160.0	389.727	x	x	x	274.375	x	205.2	208.0	383.923	x	331.0	314.583	396.385	163.235	x	99.8889	x	407.083	203.0	616.312	x	355.929	582.267	221.905	254.333	x	x	477.583	x	405.0	278.529	x	x	x	219.917	67.8889	x	x	x	288.929	361.182	275.688	187.0	x	226.286	187.385	420.571	315.923	706.867	412.263	440.588	x	264.235	x	397.273	x	527.5	x	x	264.529	x	x	348.8	469.5	141.882	263.333	291.059	x	481.091	x	x	259.071	x	x	x	488.75	287.8	268.25	526.882	446.273	x	x	x	
-11481	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	4968.43	1944.4	x	1990.54	2265.0	5345.2	1234.27	3347.0	2227.14	3970.07	1307.0	1661.38	3952.59	3135.31	1628.0	4486.55	x	x	x	3071.5	x	3081.4	3022.36	2893.0	x	2805.0	1980.58	6078.85	2036.59	x	703.111	x	2838.33	2394.62	6471.44	x	3861.86	3610.67	2337.48	1820.78	x	x	2539.42	x	2002.0	2269.65	x	x	x	1786.58	1688.94	x	x	x	3233.21	2033.05	1130.56	2815.0	x	2192.0	1391.0	1594.57	2982.54	4170.73	3711.89	4045.41	x	2152.59	x	2617.1	x	5222.5	x	x	2390.06	x	x	2332.33	3980.0	1485.94	4165.8	2742.94	x	3157.55	x	x	2401.64	x	x	x	3084.62	4029.4	4383.42	3411.06	2427.64	x	x	x	
-11482	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	3475.86	683.6	x	1347.92	845.8	4717.0	1375.55	2268.9	1914.93	2846.07	1429.0	1527.08	2974.12	2460.92	1780.0	2909.64	x	x	x	1760.75	x	2098.8	1978.73	2155.0	x	2750.75	1810.0	4624.0	1552.71	x	416.333	x	2432.33	1852.62	5368.06	x	3048.79	2699.93	1856.33	1298.11	x	x	1903.25	x	1770.56	2027.65	x	x	x	2068.58	1509.44	x	x	x	2987.29	1705.27	841.312	2034.38	x	2070.21	1208.92	1588.14	2194.62	3667.33	3412.78	3684.0	x	1371.47	x	1855.1	x	3536.0	x	x	1569.65	x	x	1824.53	3289.3	1232.18	3591.6	2179.18	x	2443.82	x	x	1958.07	x	x	x	1911.25	3342.0	2566.5	2951.56	1954.91	x	x	x	
-11483	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, behavior, pharmacology: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	2468.57	441.7	x	1109.31	875.0	3031.6	1204.09	1415.1	1156.71	1879.67	1175.62	1236.54	2011.41	1545.69	2121.5	2111.91	x	x	x	1429.12	x	1210.9	1269.09	1730.54	x	2014.75	1508.33	2847.31	1043.18	x	338.889	x	1804.75	1361.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11484	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	1720.86	345.6	x	709.385	691.0	2149.4	1023.0	1072.5	931.929	1315.2	633.75	957.769	1732.59	725.538	1659.5	1709.27	x	x	x	1006.38	x	768.0	898.636	1140.69	x	1562.38	1246.0	1946.46	548.412	x	121.333	x	1431.0	958.923	2782.12	x	1518.86	1276.0	837.19	556.222	x	x	1216.08	x	1212.33	1053.82	x	x	x	1502.75	466.5	x	x	x	1680.21	1066.55	288.875	826.462	x	1287.93	692.385	1119.86	1142.38	2641.13	2030.11	1953.53	x	701.412	x	1010.3	x	1809.67	x	x	851.471	x	x	972.0	1704.3	489.059	1764.3	1248.65	x	1560.27	x	x	1112.79	x	x	x	1181.5	1635.4	1025.75	2442.31	1150.09	x	x	x	
-11485	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males [cm]	x	x	x	x	12562.3	5479.07	x	5677.66	6293.29	13889.9	3531.52	8658.28	6482.38	10817.9	3640.22	4685.5	10292.2	9289.86	4615.12	11709.6	x	x	x	8325.97	x	8135.02	8277.83	8220.84	x	7868.79	5561.35	15202.7	5856.35	x	2114.4	x	8202.51	6670.79	15959.8	x	10752.5	9796.95	6736.89	5638.43	x	x	7220.15	x	5925.78	6697.08	x	x	x	5601.17	5167.12	x	x	x	9009.37	5833.23	3217.16	8054.34	x	6323.28	4032.56	4967.24	8847.29	11564.9	10031.5	10830.3	x	6178.8	x	7902.37	x	13130.4	x	x	6448.32	x	x	6892.33	10460.0	4676.38	11076.7	7747.26	x	8737.48	x	x	6867.45	x	x	x	8450.12	10666.5	11664.0	9374.63	7102.49	x	x	x	
-11486	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males [cm]	x	x	x	x	8874.27	2191.54	x	4000.53	2879.05	11898.2	4079.55	6341.59	5649.16	7985.99	4056.28	4471.69	7856.15	7573.91	5100.98	8182.21	x	x	x	5136.35	x	5880.64	6134.62	6278.68	x	7489.06	5102.89	11786.1	4574.18	x	1405.07	x	7113.89	5244.09	13187.3	x	8551.73	7568.28	5384.13	4251.88	x	x	5733.48	x	5377.26	6123.37	x	x	x	6553.23	4908.25	x	x	x	8230.51	4937.91	2472.42	5845.12	x	5924.33	3649.87	4972.35	6634.43	10274.2	9365.51	9872.84	x	4076.65	x	5794.69	x	9583.41	x	x	4602.61	x	x	5529.31	8961.31	4070.8	9775.23	6210.6	x	7035.01	x	x	5730.93	x	x	x	5611.92	8853.12	7098.01	8229.84	5905.41	x	x	x	
-11487	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males [cm]	x	x	x	x	6600.85	1532.71	x	3406.92	3048.58	7780.75	3650.4	4368.77	3750.33	5503.89	3611.9	3749.59	5588.23	4962.57	6157.44	6258.18	x	x	x	4445.44	x	3759.98	4274.04	5234.54	x	5575.72	4390.01	7812.64	3345.7	x	1116.24	x	5592.88	4084.49	10133.7	x	6470.16	5708.47	3986.99	4449.02	x	x	5041.06	x	4184.9	4841.53	x	x	x	5644.63	2814.96	x	x	x	6793.55	4165.04	1497.95	4033.3	x	4478.93	3537.86	4250.43	5252.65	8893.29	7663.03	7687.5	x	3112.88	x	4741.01	x	7099.6	x	x	3315.13	x	x	4013.49	7515.72	2641.16	6925.35	4642.22	x	5925.29	x	x	4508.03	x	x	x	4112.31	6898.26	4523.08	7633.9	4731.85	x	x	x	
-11488	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males [cm]	x	x	x	x	4921.85	1240.0	x	2187.32	2269.95	5925.85	3165.64	3390.76	3149.13	4021.32	2200.4	2927.76	4839.67	2463.73	4461.73	5378.12	x	x	x	3448.56	x	2594.86	3203.34	3611.69	x	4538.74	3771.37	5770.14	1854.38	x	424.242	x	4608.55	3109.84	7706.21	x	4499.09	4137.59	2651.38	1895.78	x	x	3928.34	x	3880.91	3636.56	x	x	x	4824.66	1658.06	x	x	x	4803.02	3340.94	1001.39	2493.5	x	3883.91	2264.5	3589.42	3693.62	7637.64	6000.1	5423.29	x	2217.81	x	3404.52	x	5455.41	x	x	2579.15	x	x	3255.51	5272.92	1691.64	5184.15	3629.88	x	4768.83	x	x	3563.62	x	x	x	3861.99	4857.69	3070.12	7049.01	3873.11	x	x	x	
-11489	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	309.857	353.2	x	425.615	183.6	443.6	146.545	259.7	333.143	695.667	143.875	327.231	379.0	607.462	222.5	529.818	x	x	x	281.375	x	365.3	343.818	580.769	x	400.375	356.25	324.692	394.235	x	145.0	x	441.833	223.615	645.625	x	757.786	592.467	462.333	339.0	x	x	522.333	x	397.556	418.353	x	x	x	331.25	238.611	x	x	x	529.571	374.318	304.625	278.154	x	258.643	244.846	486.714	546.462	829.2	461.667	522.647	x	300.412	x	644.8	x	612.833	x	x	384.471	x	x	426.6	484.9	300.882	482.4	449.588	x	511.364	x	x	341.786	x	x	x	602.375	356.4	554.333	483.938	558.636	x	x	x	
-11490	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	414.571	225.7	x	436.923	256.8	527.2	229.364	317.2	412.571	696.4	219.125	396.462	415.294	600.385	238.0	574.364	x	x	x	252.25	x	383.4	467.182	515.462	x	460.125	418.583	408.923	351.765	x	180.333	x	459.917	261.308	668.75	x	656.643	628.533	434.095	335.556	x	x	565.5	x	458.333	416.118	x	x	x	458.083	320.222	x	x	x	537.286	436.136	378.875	297.0	x	303.286	332.308	584.357	497.769	902.8	555.333	557.588	x	295.471	x	590.1	x	689.333	x	x	431.882	x	x	477.133	587.1	350.765	525.2	467.118	x	528.0	x	x	355.929	x	x	x	616.125	380.8	432.917	524.875	639.364	x	x	x	
-11491	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	400.214	193.5	x	375.615	320.6	470.4	225.273	284.3	319.786	559.2	234.75	334.308	342.647	434.846	302.0	527.545	x	x	x	301.125	x	318.2	422.273	473.0	x	397.625	387.167	385.077	305.706	x	147.333	x	455.167	280.538	710.5	x	548.429	639.4	354.381	323.889	x	x	505.167	x	407.556	361.471	x	x	x	415.667	215.667	x	x	x	452.214	459.591	346.062	243.0	x	248.429	310.462	544.857	412.308	834.6	509.167	514.706	x	292.412	x	584.9	x	642.75	x	x	349.176	x	x	424.4	548.5	269.529	450.7	408.118	x	526.273	x	x	318.429	x	x	x	543.75	355.4	355.25	564.125	579.909	x	x	x	
-11492	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males [n beam breaks]	None	Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males [n beam breaks]	x	x	x	x	362.143	161.3	x	286.385	306.8	483.6	221.818	269.8	315.857	470.2	192.875	338.538	316.353	247.385	241.0	485.909	x	x	x	265.125	x	260.7	332.636	360.538	x	364.375	362.583	375.0	203.941	x	91.6667	x	436.25	245.692	668.875	x	430.929	548.8	263.667	182.222	x	x	484.167	x	417.0	314.882	x	x	x	374.417	151.833	x	x	x	352.571	413.864	250.062	189.462	x	234.571	257.154	511.357	351.846	753.6	479.778	405.824	x	259.941	x	470.9	x	570.333	x	x	296.765	x	x	371.933	493.9	211.529	410.0	326.647	x	457.909	x	x	291.929	x	x	x	570.25	270.6	325.583	573.188	531.818	x	x	x	
-11493	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males [sec]	None	Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males [sec]	x	x	x	x	395.143	387.358	x	326.72	374.16	x	380.867	373.067	318.833	405.836	276.062	418.621	395.87	388.869	492.45	408.117	x	x	x	501.71	x	391.664	406.64	408.288	x	513.138	449.943	384.519	430.683	x	301.5	x	325.47	384.756	299.636	x	345.456	384.05	370.475	301.967	x	x	442.615	x	325.0	367.527	x	x	x	348.05	350.05	x	x	x	397.718	421.571	394.868	319.48	x	399.156	317.669	364.017	389.038	385.506	420.468	351.117	x	368.327	x	444.079	x	427.557	x	x	403.292	x	x	448.495	335.05	382.818	414.95	463.346	x	444.567	x	x	418.63	x	x	x	412.967	496.45	356.336	368.441	499.35	x	x	x	
-11494	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males [sec]	None	Central nervous system, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males [sec]	x	x	x	x	428.614	569.35	x	557.67	425.32	x	570.058	538.467	376.583	452.668	504.875	404.464	496.68	426.175	394.4	470.167	x	x	x	385.5	x	459.407	448.96	476.1	x	379.575	454.529	505.169	451.358	x	461.725	x	450.36	442.306	502.268	x	569.844	458.369	460.969	406.939	x	x	484.16	x	501.55	518.659	x	x	x	461.693	465.777	x	x	x	518.445	504.918	415.936	452.805	x	495.556	473.612	515.844	419.619	479.811	457.032	423.206	x	443.795	x	532.35	x	434.564	x	x	440.413	x	x	448.075	535.88	466.832	375.658	441.154	x	439.642	x	x	436.245	x	x	x	490.108	459.95	501.414	519.359	419.264	x	x	x	
-11495	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males [sec]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males [sec]	x	x	x	x	407.929	513.45	x	562.68	478.83	x	363.025	573.983	349.872	547.941	465.025	467.536	456.58	453.294	647.7	448.808	x	x	x	529.0	x	416.783	514.39	388.337	x	639.25	251.807	373.25	541.432	x	223.613	x	427.99	395.65	433.495	x	452.017	537.606	456.153	548.761	x	x	447.37	x	198.4	497.232	x	x	x	500.814	437.096	x	x	x	394.432	471.9	363.941	406.61	x	497.5	425.419	459.328	413.644	447.244	420.836	436.667	x	402.377	x	425.907	x	492.036	x	x	449.246	x	x	461.995	443.44	433.191	334.4	496.071	x	462.108	x	x	490.21	x	x	x	490.242	427.4	423.064	452.641	470.7	x	x	x	
-11496	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males [sec]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males [sec]	x	x	x	x	378.736	454.03	x	393.65	438.9	x	499.317	334.833	521.667	383.845	372.712	280.764	448.883	382.312	206.75	417.117	x	x	x	396.41	x	420.942	382.24	423.388	x	329.25	503.121	412.95	359.205	x	597.2	x	442.035	477.825	344.336	x	381.667	372.394	421.831	286.839	x	x	423.735	x	263.15	435.414	x	x	x	455.893	354.562	x	x	x	539.182	461.986	479.195	411.85	x	358.961	371.25	458.478	403.375	454.294	420.596	375.989	x	323.236	x	516.657	x	366.914	x	x	434.871	x	x	439.805	393.47	402.755	310.82	390.317	x	401.775	x	x	435.115	x	x	x	410.942	614.65	498.8	464.555	439.5	x	x	x	
-11497	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males [%]	None	Central nervous system, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males [%]	x	x	x	x	48.0201	40.6905	x	37.2979	45.9591	x	40.8245	40.9748	45.6397	47.5682	35.7702	51.1679	44.5186	47.0787	55.53	46.3339	x	x	x	56.444	x	45.8195	47.435	46.1859	x	57.0022	49.7091	43.1618	48.8683	x	39.0825	x	41.9992	46.861	37.3041	x	38.0661	45.961	44.3834	42.8554	x	x	47.6412	x	40.3954	41.5969	x	x	x	43.2473	43.0294	x	x	x	43.4548	45.4694	47.462	41.3834	x	44.7692	40.3299	41.141	47.6404	44.6826	47.9584	45.2392	x	45.4835	x	45.4544	x	49.2207	x	x	47.8909	x	x	50.1474	37.5538	44.9649	52.0053	51.2096	x	50.0377	x	x	48.5662	x	x	x	45.4994	51.9082	41.8	41.4163	54.0023	x	x	x	
-11498	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [sec]	None	Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [sec]	x	x	x	x	12.7857	122.33	x	235.96	104.67	x	-17.8417	200.917	31.0389	142.105	188.962	48.9143	60.71	64.425	155.25	40.6917	x	x	x	27.29	x	31.475	107.75	-19.95	x	126.113	-198.136	-11.2688	108.55	x	-77.8875	x	102.52	10.8938	133.859	x	106.561	153.556	85.6781	246.794	x	x	4.755	x	-24.55	129.705	x	x	x	152.764	87.0462	x	x	x	-3.28636	50.3286	-30.9273	87.13	x	98.3444	107.75	95.3111	24.6063	53.3312	0.367857	85.55	x	34.05	x	-18.1714	x	64.4786	x	x	45.9542	x	x	13.5	108.39	50.3727	-91.24	32.725	x	17.5417	x	x	71.58	x	x	x	77.275	-69.05	66.7286	84.2	-28.65	x	x	x	
-11499	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage of time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [% change]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage of time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [% change]	x	x	x	x	4.23632	12.0691	x	21.2289	6.19673	x	2.63913	22.5418	-4.92952	11.0764	19.823	10.7777	6.00674	7.65657	20.28	5.61447	x	x	x	0.560599	x	5.36613	9.81094	2.23497	x	8.82496	-15.2886	3.97439	11.2671	x	-12.135	x	7.78289	-1.70634	18.0516	x	13.8899	13.0031	8.33092	22.0361	x	x	3.64808	x	19.51	11.7157	x	x	x	9.16607	11.7	x	x	x	-1.28769	4.9747	-2.17557	9.16594	x	13.3941	13.0059	8.98967	3.37691	4.0679	2.07174	8.28169	x	7.80626	x	-0.086746	x	8.26846	x	x	3.21906	x	x	1.25471	15.1553	6.41567	0.701178	4.65644	x	3.59936	x	x	4.22577	x	x	x	9.08239	-10.8929	3.87671	8.51196	-2.45831	x	x	x	
-11500	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]	None	Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]	x	x	x	x	1887.0	1919.82	x	3204.92	2566.2	3768.2	2139.73	3719.4	1247.29	2698.73	694.125	1734.15	2601.71	1187.08	1478.0	2228.73	x	x	x	1851.5	x	506.533	712.636	2932.23	x	1196.62	2689.92	2592.23	1358.0	x	394.333	x	2158.08	1022.23	3025.06	x	2064.07	1568.31	900.571	1488.22	x	x	2465.92	x	2421.77	1581.59	x	x	x	2393.58	324.389	x	x	x	2531.0	1824.36	520.062	1171.77	x	2352.57	1480.62	1487.21	1776.31	3039.07	3134.2	2399.0	x	952.706	x	2430.58	x	2707.42	x	x	2083.12	x	x	1049.0	1394.0	579.176	2192.42	1945.59	x	2824.91	x	x	2404.14	x	x	x	1309.12	2084.6	3491.25	3626.18	1453.91	x	x	x	
-11501	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males [cm]	None	Novel open field behavior, locomotion in the center from 0-60 min for males [cm]	x	x	x	x	6067.31	5577.63	x	8515.68	7339.61	10234.1	5983.62	9733.47	4158.64	7853.81	2393.62	5171.64	6994.83	4038.3	4297.36	6303.63	x	x	x	6262.12	x	1626.86	2660.96	7529.19	x	4035.47	7468.52	7912.39	4150.92	x	1337.15	x	6410.6	3273.29	8570.74	x	6068.23	4816.85	2647.3	4786.0	x	x	7552.74	x	6576.38	5037.34	x	x	x	6860.24	1231.41	x	x	x	7147.63	5496.47	1983.27	3742.9	x	6778.17	4664.75	4832.93	5787.55	8411.19	9354.54	6909.45	x	2952.47	x	6885.36	x	7275.32	x	x	6017.77	x	x	3487.54	4380.35	1981.92	6289.71	5269.18	x	8414.48	x	x	7184.04	x	x	x	4300.89	6194.98	9016.19	9654.83	4615.94	x	x	x	
-11502	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males [n beam breaks]	x	x	x	x	330.643	424.909	x	495.308	396.0	536.4	270.091	597.2	271.571	710.0	94.5	323.154	262.0	255.769	167.5	220.455	x	x	x	271.5	x	71.0667	137.182	266.615	x	173.0	369.083	632.538	224.765	x	60.6667	x	365.083	126.615	658.5	x	376.071	492.5	112.81	181.778	x	x	626.167	x	384.846	240.824	x	x	x	216.25	36.7222	x	x	x	433.571	321.5	280.438	179.923	x	303.571	227.154	333.786	402.0	772.133	741.0	444.294	x	211.941	x	436.167	x	251.833	x	x	502.824	x	x	182.933	368.5	159.059	318.583	301.176	x	586.273	x	x	334.286	x	x	x	666.125	277.4	329.833	532.294	465.455	x	x	x	
-11503	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males [n beam breaks]	x	x	x	x	7439.14	3302.7	x	2992.23	2762.0	9003.8	4318.91	6325.1	3903.64	7287.47	3100.0	3487.08	7111.71	5965.69	4315.0	7963.73	x	x	x	6791.25	x	4585.9	3552.0	6533.46	x	6734.25	4939.0	10747.2	4001.88	x	1629.56	x	6662.25	5190.46	14368.2	x	6877.5	9063.6	4269.76	4566.33	x	x	6105.08	x	6245.11	4752.53	x	x	x	4434.83	2974.44	x	x	x	6856.5	4874.23	2560.06	5705.0	x	5740.5	2482.38	4578.14	6817.77	11575.7	8550.21	10835.9	x	4013.12	x	5443.64	x	10945.6	x	x	4233.47	x	x	4155.13	7908.1	2632.24	6476.25	6352.76	x	7906.91	x	x	5937.43	x	x	x	6937.62	8512.6	6588.25	10400.6	6469.73	x	x	x	
-11504	Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males [cm]	x	x	x	x	21432.3	10472.7	x	9298.57	9271.12	25309.7	12743.0	19247.1	12793.8	21697.0	9797.23	10877.2	20485.0	19892.8	12839.6	23372.3	x	x	x	20350.7	x	14107.9	11436.0	20027.0	x	20248.7	14452.6	30148.4	12560.4	x	5460.4	x	20568.5	15175.2	38282.2	x	20664.6	26433.6	13195.7	15218.9	x	x	18591.8	x	19294.9	15648.9	x	x	x	14540.2	10084.9	x	x	x	20193.3	14915.9	8264.99	17284.3	x	17422.0	8386.6	14651.6	21258.1	33246.7	25154.3	30350.2	x	12662.0	x	17222.4	x	30223.4	x	x	12937.0	x	x	14002.6	23898.0	9026.15	19166.9	19078.0	x	23862.5	x	x	18367.1	x	x	x	20888.2	24195.7	18417.6	30156.6	19969.8	x	x	x	
-11505	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for males [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for males [n beam breaks]	x	x	x	x	1336.07	1087.2	x	997.769	910.0	1498.0	710.273	1326.1	1140.71	2045.0	673.75	1336.77	1041.47	1742.15	691.0	1605.55	x	x	x	1038.25	x	1011.8	827.455	1679.46	x	1333.5	1182.17	1461.23	1020.71	x	548.667	x	1551.25	732.154	2360.25	x	1913.43	2410.6	1238.38	1248.78	x	x	1948.5	x	1790.11	1220.0	x	x	x	1089.25	719.222	x	x	x	1354.86	1429.73	1314.25	1031.31	x	1030.64	855.692	1704.86	1644.62	2946.93	1628.32	1947.82	x	1197.24	x	1736.55	x	2190.67	x	x	1395.29	x	x	1461.27	1905.3	886.294	1232.83	1482.18	x	2003.09	x	x	1245.36	x	x	x	2095.12	1166.6	1261.08	2055.65	1887.09	x	x	x	
-11506	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [n beam breaks]	x	x	x	x	562.357	708.909	x	1131.92	473.8	1127.6	278.364	874.2	360.357	973.667	219.875	361.231	1035.12	271.846	471.0	681.273	x	x	x	478.625	x	233.2	131.545	802.538	x	392.625	805.417	601.0	548.647	x	275.444	x	636.667	279.308	853.625	x	912.357	430.5	418.857	385.889	x	x	771.083	x	542.385	418.706	x	x	x	639.917	148.111	x	x	x	862.5	584.455	201.438	171.154	x	655.429	491.538	365.571	326.846	840.067	795.2	623.353	x	315.647	x	647.583	x	1017.92	x	x	552.0	x	x	319.2	441.8	195.529	763.917	515.235	x	826.182	x	x	714.0	x	x	x	520.375	723.4	1041.58	894.235	368.455	x	x	x	
-11507	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males [n beam breaks]	None	Novel open field behavior, locomotion in the center from 15-30 min for males [n beam breaks]	x	x	x	x	505.214	523.273	x	1004.31	618.6	1069.8	660.909	1103.0	398.857	766.667	214.25	430.154	727.706	426.385	497.0	646.182	x	x	x	607.125	x	174.2	215.0	842.923	x	307.375	768.083	711.0	444.882	x	90.1111	x	581.833	304.538	752.25	x	550.571	381.938	278.857	488.333	x	x	686.5	x	614.692	393.882	x	x	x	821.25	114.278	x	x	x	776.5	506.273	142.75	386.0	x	752.857	435.538	492.786	511.154	860.2	767.3	658.588	x	283.059	x	678.25	x	793.167	x	x	606.824	x	x	308.6	409.5	182.412	674.25	540.647	x	816.455	x	x	733.0	x	x	x	330.125	697.0	1005.17	985.941	474.182	x	x	x	
-11508	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males [n beam breaks]	None	Novel open field behavior, locomotion in the center from 30-45 min for males [n beam breaks]	x	x	x	x	483.357	409.364	x	654.692	693.2	1005.0	607.818	898.5	305.643	530.8	164.375	480.769	522.941	266.538	391.0	522.364	x	x	x	442.25	x	81.4	257.0	710.846	x	278.625	674.5	708.462	260.941	x	15.8889	x	512.083	272.538	695.625	x	374.571	415.062	136.81	346.444	x	x	552.25	x	641.923	413.647	x	x	x	568.75	48.0556	x	x	x	618.429	419.5	112.188	346.538	x	637.143	353.154	400.214	535.231	723.533	834.95	568.824	x	240.235	x	619.5	x	536.25	x	x	476.882	x	x	247.267	309.9	133.588	449.333	468.824	x	644.273	x	x	622.714	x	x	x	237.125	341.6	821.583	910.0	367.545	x	x	x	
-11509	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [n beam breaks]	x	x	x	x	336.071	278.273	x	414.0	780.6	565.8	592.636	843.7	182.429	427.6	95.625	462.0	315.941	222.308	119.0	378.909	x	x	x	323.5	x	17.7333	109.091	575.923	x	218.0	441.917	571.769	103.529	x	12.8889	x	427.5	165.846	723.562	x	226.571	340.812	66.0476	267.556	x	x	456.083	x	622.769	355.353	x	x	x	363.667	13.9444	x	x	x	273.571	314.136	63.6875	268.077	x	307.143	200.385	228.643	403.077	615.267	736.75	548.235	x	113.765	x	485.25	x	360.083	x	x	447.412	x	x	173.933	232.8	67.6471	304.917	420.882	x	538.0	x	x	334.429	x	x	x	221.5	322.6	622.917	836.0	243.727	x	x	x	
-11510	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [cm]	x	x	x	x	1732.73	2000.23	x	2903.28	1387.73	3081.89	835.364	2291.14	1242.22	2714.79	714.343	1141.93	2702.82	943.662	1340.02	1903.38	x	x	x	1582.26	x	741.65	520.076	2042.27	x	1468.62	2196.6	1925.84	1621.14	x	908.036	x	1849.33	947.112	2428.55	x	2532.21	1305.97	1185.33	1268.49	x	x	2259.37	x	1482.15	1330.08	x	x	x	1911.38	550.435	x	x	x	2415.77	1744.46	728.361	657.172	x	1921.03	1538.76	1306.71	1056.99	2262.9	2349.09	1865.45	x	994.189	x	1817.83	x	2647.61	x	x	1566.61	x	x	1094.67	1353.16	676.896	2237.77	1427.08	x	2451.77	x	x	2110.88	x	x	x	1556.17	2140.38	2664.5	2422.25	1181.81	x	x	x	
-11511	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males [cm]	None	Novel open field behavior, locomotion in the center from 15-30 min for males [cm]	x	x	x	x	1622.3	1517.33	x	2621.68	1822.58	2904.87	1828.91	2862.95	1304.66	2188.38	739.551	1265.07	1966.39	1386.57	1452.35	1812.1	x	x	x	1930.57	x	554.914	832.95	2121.2	x	1028.34	2088.91	2138.95	1380.81	x	313.111	x	1725.57	965.402	2189.43	x	1675.28	1179.66	823.812	1523.48	x	x	2103.88	x	1655.07	1239.66	x	x	x	2332.19	444.399	x	x	x	2233.59	1511.63	560.636	1239.58	x	2138.33	1402.45	1532.03	1664.43	2310.85	2294.33	1868.0	x	875.36	x	1906.32	x	2141.52	x	x	1697.94	x	x	1040.45	1280.18	612.636	1930.64	1453.81	x	2369.66	x	x	2188.68	x	x	x	1119.78	1988.41	2563.73	2606.42	1444.72	x	x	x	
-11512	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males [cm]	None	Novel open field behavior, locomotion in the center from 30-45 min for males [cm]	x	x	x	x	1587.9	1216.12	x	1801.2	1997.94	2718.95	1661.8	2338.38	1006.75	1629.49	603.443	1396.88	1423.82	937.408	1193.92	1456.68	x	x	x	1538.33	x	264.061	893.175	1818.42	x	862.594	1919.21	2135.11	825.151	x	58.6671	x	1529.19	833.668	1968.49	x	1136.01	1276.71	429.993	1130.71	x	x	1707.86	x	1747.24	1322.83	x	x	x	1598.64	182.425	x	x	x	1708.1	1286.35	416.877	1020.47	x	1824.79	1095.81	1249.99	1727.36	2081.71	2469.13	1622.24	x	728.971	x	1778.9	x	1446.27	x	x	1398.8	x	x	785.872	969.276	440.901	1268.56	1273.92	x	1974.57	x	x	1875.04	x	x	x	840.877	1071.91	2139.72	2404.84	1178.78	x	x	x	
-11513	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [cm]	x	x	x	x	1124.38	843.955	x	1189.53	2131.37	1528.39	1657.55	2241.0	605.006	1321.15	336.285	1367.77	901.806	770.662	311.062	1131.47	x	x	x	1210.97	x	66.2312	414.758	1547.3	x	675.929	1263.8	1712.49	323.814	x	57.3372	x	1306.51	527.106	1984.27	x	724.731	1054.5	208.164	863.317	x	x	1481.63	x	1691.92	1144.77	x	x	x	1018.03	54.1519	x	x	x	790.171	954.031	277.392	825.677	x	894.02	627.734	744.206	1338.77	1755.73	2241.99	1553.76	x	353.945	x	1382.31	x	1039.92	x	x	1354.42	x	x	566.549	777.732	251.489	852.739	1114.37	x	1618.49	x	x	1009.44	x	x	x	784.061	994.281	1648.24	2221.32	810.641	x	x	x	
-11514	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males [n beam breaks]	x	x	x	x	66.7857	134.182	x	127.231	45.6	130.4	28.0	91.4	52.7143	188.267	18.0	36.7692	78.1176	45.6154	45.0	53.0	x	x	x	51.5	x	28.8667	23.4545	39.6923	x	54.25	77.0833	140.308	83.4706	x	39.4444	x	58.9167	32.0	136.125	x	108.357	101.125	40.381	28.3333	x	x	147.917	x	57.4615	62.6471	x	x	x	55.5833	12.4444	x	x	x	140.071	91.0909	67.6875	23.3846	x	84.3571	74.0	73.0714	54.0	133.933	121.65	93.2353	x	49.5294	x	71.25	x	67.6667	x	x	74.5294	x	x	44.9333	60.6	36.4706	120.0	59.4706	x	118.273	x	x	77.2857	x	x	x	151.125	78.2	100.167	136.353	85.3636	x	x	x	
-11515	Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males [n beam breaks]	x	x	x	x	97.0714	127.364	x	159.462	100.2	156.0	87.5455	183.9	82.3571	211.333	34.25	89.0	80.1765	76.4615	60.0	64.5455	x	x	x	83.75	x	25.6	33.5455	73.4615	x	59.625	100.667	184.0	81.5882	x	14.4444	x	98.3333	40.6154	173.125	x	115.214	122.5	41.5238	73.7778	x	x	181.417	x	100.769	68.7059	x	x	x	74.5	14.9444	x	x	x	145.286	99.1818	80.625	59.4615	x	97.6429	65.0769	94.7143	114.538	220.933	178.2	115.824	x	63.5882	x	116.833	x	72.9167	x	x	132.765	x	x	58.8	109.8	50.5294	96.4167	83.9412	x	164.182	x	x	95.0	x	x	x	197.75	65.6	87.3333	136.176	141.273	x	x	x	
-11516	Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males [n beam breaks]	x	x	x	x	96.7857	95.1818	x	116.308	113.2	164.0	76.9091	163.0	69.5714	163.867	23.0	91.4615	56.6471	78.8462	58.0	58.2727	x	x	x	74.375	x	13.7333	54.1818	75.9231	x	38.25	104.083	166.923	43.1765	x	1.33333	x	88.5833	33.0	168.375	x	83.4286	149.625	22.4762	46.8889	x	x	159.25	x	108.385	58.0588	x	x	x	55.25	7.72222	x	x	x	98.2857	79.0	82.375	50.0	x	83.7143	57.0	98.2143	118.538	232.733	223.65	117.0	x	62.7647	x	138.833	x	56.0	x	x	141.529	x	x	42.8667	104.8	45.6471	61.0	80.3529	x	157.909	x	x	104.286	x	x	x	183.375	68.6	81.5	141.765	129.909	x	x	x	
-11517	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males [n beam breaks]	x	x	x	x	70.0	68.1818	x	92.3077	137.0	86.0	77.6364	158.9	41.9286	146.533	19.25	105.923	47.0588	54.8462	4.5	44.6364	x	x	x	61.875	x	2.86667	26.0	77.5385	x	20.875	87.25	141.308	16.5294	x	5.44444	x	119.25	21.0	180.875	x	69.0714	119.25	8.42857	32.7778	x	x	137.583	x	118.231	51.4118	x	x	x	30.9167	1.61111	x	x	x	49.9286	52.2273	49.75	47.0769	x	37.8571	31.0769	67.7857	114.923	184.533	217.5	118.235	x	36.0588	x	109.25	x	55.25	x	x	154.0	x	x	36.3333	93.3	26.4118	41.1667	77.4118	x	145.909	x	x	57.7143	x	x	x	133.875	65.0	60.8333	118.0	108.909	x	x	x	
-11518	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	482.643	398.0	x	1118.38	622.6	698.8	360.455	848.0	462.571	528.4	328.0	464.0	825.941	561.0	617.0	575.545	x	x	x	297.5	x	434.133	329.636	1405.92	x	426.5	677.333	460.538	414.235	x	382.0	x	510.25	398.538	765.688	x	765.071	362.312	688.524	639.556	x	x	436.667	x	630.923	455.529	x	x	x	783.333	291.556	x	x	x	938.714	603.545	331.625	345.154	x	495.286	414.615	377.5	512.077	748.0	471.1	536.647	x	445.882	x	526.25	x	679.0	x	x	559.353	x	x	309.8	593.1	433.529	626.5	535.588	x	543.455	x	x	482.0	x	x	x	285.75	552.6	846.833	830.647	258.182	x	x	x	
-11519	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the cocaine test battery [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	342.143	266.636	x	637.846	397.8	699.6	328.273	690.1	316.071	324.067	332.5	317.538	494.706	537.923	365.5	444.636	x	x	x	214.75	x	281.333	353.273	1089.62	x	380.375	471.083	426.615	271.647	x	170.0	x	381.167	292.308	537.312	x	511.857	308.375	391.714	551.889	x	x	295.167	x	585.0	385.824	x	x	x	698.333	138.389	x	x	x	540.143	432.182	217.875	336.615	x	390.714	309.385	381.286	460.769	627.333	403.65	516.824	x	296.882	x	345.5	x	547.75	x	x	377.765	x	x	216.6	385.4	309.941	554.5	403.235	x	547.455	x	x	388.5	x	x	x	214.75	380.8	646.75	808.294	199.182	x	x	x	
-11520	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the cocaine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 30-45 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	282.929	231.273	x	460.462	362.6	613.0	316.364	614.0	235.0	231.267	240.875	321.462	361.765	421.077	203.5	402.909	x	x	x	186.75	x	144.2	258.455	847.846	x	204.625	386.75	363.769	197.0	x	50.0	x	297.083	245.385	493.188	x	343.929	278.125	221.619	424.0	x	x	271.0	x	650.538	350.235	x	x	x	483.917	40.3889	x	x	x	483.429	357.5	144.812	219.615	x	376.143	264.154	304.0	437.231	505.533	383.95	438.824	x	202.353	x	266.417	x	368.083	x	x	305.235	x	x	176.467	321.6	220.0	426.083	304.471	x	387.182	x	x	310.714	x	x	x	167.625	170.2	519.917	697.765	155.273	x	x	x	
-11521	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the cocaine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	210.357	178.364	x	277.846	292.4	382.8	292.364	538.2	156.357	203.0	99.375	239.769	247.529	300.538	114.5	323.364	x	x	x	169.375	x	44.9333	141.182	619.385	x	138.875	288.417	294.154	100.118	x	10.6667	x	255.167	143.077	456.062	x	199.571	256.5	111.238	341.0	x	x	220.583	x	584.308	295.706	x	x	x	307.167	17.2222	x	x	x	265.143	264.727	70.9375	151.462	x	220.214	165.0	175.429	322.077	413.667	350.65	363.176	x	90.1176	x	224.917	x	266.917	x	x	242.765	x	x	130.4	184.7	95.3529	307.75	262.118	x	342.636	x	x	172.929	x	x	x	117.375	206.8	332.417	622.353	126.182	x	x	x	
-11522	Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for males in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males in the cocaine test battery [cm]	x	x	x	x	1881.73	1675.07	x	3727.68	2389.72	2576.67	1483.43	3030.68	1893.43	2021.88	1441.02	1820.83	2962.63	2243.89	2295.9	2186.84	x	x	x	1488.4	x	1754.99	1620.78	4674.17	x	1893.82	2505.81	1990.21	1730.26	x	1651.24	x	2080.6	1820.83	2882.71	x	2747.84	1616.67	2676.59	2522.4	x	x	1884.31	x	2465.99	1837.84	x	x	x	2902.77	1388.64	x	x	x	3394.05	2401.29	1450.42	1600.18	x	2046.9	1744.32	1626.18	2059.02	2789.76	1965.03	2182.66	x	1873.5	x	2152.44	x	2436.38	x	x	2154.91	x	x	1460.67	2485.38	1897.78	2495.46	2151.17	x	2180.96	x	x	1997.6	x	x	x	1296.62	2255.49	2960.29	3095.35	1341.76	x	x	x	
-11523	Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for males in the cocaine test battery [cm]	None	Novel open field behavior, locomotion from 15-30 min in the periphery for males in the cocaine test battery [cm]	x	x	x	x	1431.2	1129.64	x	2273.53	1637.7	2548.46	1419.57	2476.25	1419.09	1346.67	1378.7	1306.03	1916.53	2171.01	1526.27	1787.41	x	x	x	1158.99	x	1112.39	1499.54	3705.13	x	1537.61	1815.89	1768.23	1188.73	x	771.356	x	1615.89	1260.91	2197.77	x	1959.09	1425.56	1542.52	2151.8	x	x	1356.51	x	2279.76	1586.59	x	x	x	2560.01	674.225	x	x	x	2031.73	1786.42	982.717	1351.31	x	1630.74	1391.66	1576.14	1847.98	2436.48	1749.15	1935.34	x	1317.23	x	1484.31	x	1913.77	x	x	1531.23	x	x	1095.7	1813.71	1395.51	2154.82	1620.72	x	2147.06	x	x	1613.46	x	x	x	998.131	1653.93	2303.15	2971.52	1082.54	x	x	x	
-11524	Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for males in the cocaine test battery [cm]	None	Novel open field behavior, locomotion from 30-45 min in the periphery for males in the cocaine test battery [cm]	x	x	x	x	1245.29	1014.41	x	1672.45	1586.23	2261.0	1293.63	2232.18	1079.51	1025.07	1066.14	1297.37	1452.46	1719.99	821.121	1642.78	x	x	x	1052.81	x	549.112	1198.42	3008.45	x	822.041	1499.3	1565.52	881.711	x	218.73	x	1327.98	1045.82	2035.65	x	1323.8	1342.43	895.472	1726.88	x	x	1262.27	x	2526.63	1509.0	x	x	x	1786.35	211.166	x	x	x	1785.18	1480.34	686.841	858.359	x	1505.59	1169.3	1283.4	1748.97	2005.23	1707.23	1606.1	x	876.902	x	1189.56	x	1413.42	x	x	1271.51	x	x	880.816	1515.11	987.45	1561.01	1212.94	x	1680.45	x	x	1264.08	x	x	x	838.159	780.886	1862.83	2627.65	853.45	x	x	x	
-11525	Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for males in the cocaine test battery [cm]	None	Novel open field behavior, locomotion from 45-60 min in the periphery for males in the cocaine test battery [cm]	x	x	x	x	958.664	787.706	x	1088.49	1252.15	1487.81	1227.48	1996.42	716.636	878.287	441.643	982.0	1012.71	1243.69	379.745	1297.23	x	x	x	886.147	x	175.224	649.405	2301.13	x	527.445	1152.57	1264.92	437.205	x	56.4759	x	1173.43	615.311	1886.56	x	759.251	1226.81	447.755	1407.61	x	x	1008.43	x	2262.67	1277.39	x	x	x	1132.75	82.4967	x	x	x	977.655	1083.04	365.019	582.37	x	888.122	694.568	755.789	1298.93	1690.59	1562.17	1370.4	x	444.697	x	1025.6	x	1036.46	x	x	1019.32	x	x	654.736	923.195	441.126	1190.47	1011.05	x	1463.45	x	x	707.224	x	x	x	659.944	866.017	1255.28	2378.41	701.525	x	x	x	
-11526	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males [n beam breaks]	x	x	x	x	155.071	213.455	x	263.308	235.4	242.0	120.909	285.0	152.714	228.267	142.625	164.615	207.471	222.077	249.5	211.182	x	x	x	109.75	x	176.533	118.455	238.308	x	196.375	226.583	238.0	204.941	x	184.444	x	242.167	163.308	267.188	x	264.643	273.688	247.714	178.556	x	x	257.417	x	283.538	224.059	x	x	x	242.417	123.667	x	x	x	307.286	276.455	219.25	118.231	x	203.429	211.615	184.214	262.538	332.6	244.15	218.765	x	278.706	x	243.333	x	184.417	x	x	246.882	x	x	185.4	298.9	236.118	276.083	257.471	x	254.273	x	x	171.5	x	x	x	267.0	177.6	232.25	339.529	190.636	x	x	x	
-11527	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males [n beam breaks]	None	Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males [n beam breaks]	x	x	x	x	177.714	185.182	x	258.231	225.8	260.6	135.909	352.9	213.5	212.6	156.875	174.385	189.706	263.692	213.5	219.727	x	x	x	115.125	x	168.067	139.0	323.077	x	208.375	223.0	256.462	169.647	x	122.444	x	265.333	185.923	318.75	x	259.571	297.188	194.048	209.889	x	x	243.583	x	331.615	214.882	x	x	x	246.5	90.1667	x	x	x	211.214	293.5	234.0	139.231	x	191.071	215.077	230.714	258.231	382.867	264.45	241.235	x	282.882	x	258.167	x	278.333	x	x	281.353	x	x	210.667	286.3	269.353	277.167	239.765	x	291.364	x	x	168.357	x	x	x	261.375	158.8	249.417	366.765	219.636	x	x	x	
-11528	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males [n beam breaks]	x	x	x	x	174.5	169.455	x	255.846	264.2	279.6	130.545	322.6	194.786	185.2	207.875	217.0	190.059	235.308	226.0	218.273	x	x	x	110.625	x	81.6667	143.0	326.769	x	192.625	211.667	243.846	143.824	x	52.4444	x	250.5	172.077	347.25	x	208.786	316.0	130.714	185.778	x	x	236.5	x	356.0	199.941	x	x	x	215.333	37.5556	x	x	x	188.929	280.273	187.625	103.385	x	160.643	194.615	234.0	226.385	328.533	262.95	237.294	x	226.176	x	261.583	x	322.0	x	x	289.647	x	x	169.0	307.5	214.118	219.833	189.588	x	289.364	x	x	157.0	x	x	x	235.5	135.2	234.917	331.412	216.182	x	x	x	
-11529	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males [n beam breaks]	x	x	x	x	171.143	148.0	x	228.846	202.8	267.8	134.091	319.3	153.071	183.2	121.0	187.923	140.706	180.615	96.5	166.182	x	x	x	84.25	x	36.1333	108.091	284.231	x	141.25	194.75	238.308	82.5294	x	17.2222	x	217.75	161.846	338.438	x	159.929	308.5	71.8571	153.444	x	x	229.5	x	349.0	175.706	x	x	x	161.333	14.3889	x	x	x	136.429	278.364	140.75	85.9231	x	157.714	119.615	203.929	207.154	277.8	259.0	216.588	x	182.706	x	249.667	x	277.083	x	x	274.059	x	x	159.533	212.2	107.471	204.5	179.882	x	256.727	x	x	132.429	x	x	x	260.625	123.0	224.25	287.235	162.182	x	x	x	
-11530	Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for males [%]	None	Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males [%]	x	x	x	x	49.1384	45.8614	x	51.2534	49.3777	46.9238	49.1581	51.118	56.2152	40.5034	74.5913	52.7356	52.7583	65.8704	56.0976	53.0332	x	x	x	42.9603	x	73.6323	66.663	64.8537	x	62.9237	48.9316	45.6892	51.5184	x	69.1825	x	50.6749	59.6384	52.0169	x	52.9091	54.1653	69.4147	63.7567	x	x	42.9271	x	60.8577	55.9267	x	x	x	56.0033	71.0932	x	x	x	54.1916	55.8427	65.2336	61.4206	x	51.1564	54.4535	56.0035	57.5834	51.8573	43.8237	55.8662	x	63.3591	x	48.0646	x	49.886	x	x	51.6778	x	x	55.2163	62.0839	73.0474	55.2489	57.7165	x	46.5019	x	x	46.5025	x	x	x	46.6379	49.8812	51.3999	53.5997	47.0433	x	x	x	
-11531	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 0-60 min for males [n beam breaks]	x	x	x	x	1318.07	1074.27	x	2494.54	1675.4	2394.2	1297.45	2690.3	1170.0	1286.73	1000.75	1342.77	1929.94	1820.54	1300.5	1746.45	x	x	x	868.375	x	904.6	1082.55	3962.77	x	1150.38	1823.58	1545.08	983.0	x	612.667	x	1443.67	1079.31	2252.25	x	1820.43	1205.31	1413.1	1956.44	x	x	1223.42	x	2450.77	1487.29	x	x	x	2272.75	487.556	x	x	x	2227.43	1657.95	765.25	1052.85	x	1482.36	1153.15	1238.21	1732.15	2294.53	1609.35	1855.47	x	1035.24	x	1363.08	x	1861.75	x	x	1485.12	x	x	833.267	1484.8	1058.82	1914.83	1505.41	x	1820.73	x	x	1354.14	x	x	x	785.5	1310.4	2345.92	2959.06	738.818	x	x	x	
-11532	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males [cm]	None	Novel open field behavior, locomotion in the periphery from 0-60 min for males [cm]	x	x	x	x	5516.89	4606.83	x	8762.15	6865.8	8873.95	5424.11	9735.53	5108.67	5271.91	4327.49	5406.23	7344.33	7378.58	5023.04	6914.25	x	x	x	4586.35	x	3591.72	4968.15	13688.9	x	4780.92	6973.58	6588.88	4237.9	x	2697.8	x	6197.9	4742.88	9002.68	x	6789.98	5611.47	5562.34	7808.68	x	x	5511.53	x	9535.05	6210.83	x	x	x	8381.88	2356.53	x	x	x	8188.61	6751.1	3485.0	4392.22	x	6071.35	4999.85	5241.51	6954.89	8922.06	6983.59	7094.5	x	4512.33	x	5851.91	x	6800.03	x	x	5976.97	x	x	4091.92	6737.4	4721.86	7401.77	5995.88	x	7471.93	x	x	5582.37	x	x	x	3792.86	5556.32	8381.55	11072.9	3979.28	x	x	x	
-11533	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males [n beam breaks]	x	x	x	x	678.429	716.091	x	1006.23	928.2	1050.0	521.455	1279.8	666.929	809.267	628.375	743.923	727.941	901.692	785.5	815.364	x	x	x	419.75	x	462.4	508.545	1172.38	x	738.625	856.0	976.615	600.941	x	376.556	x	975.75	683.154	1271.62	x	892.929	1195.38	644.333	727.667	x	x	967.0	x	1320.15	814.588	x	x	x	865.583	265.778	x	x	x	843.857	1128.59	781.625	446.769	x	712.857	740.923	852.857	954.308	1321.8	1030.55	913.882	x	970.471	x	1012.75	x	1061.83	x	x	1091.94	x	x	724.6	1104.9	827.059	977.583	866.706	x	1091.73	x	x	629.286	x	x	x	1024.5	594.6	940.833	1324.94	788.636	x	x	x	
-11534	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [n beam breaks]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [n beam breaks]	x	x	x	x	1484.43	1063.64	x	2589.0	2057.6	4393.6	2793.64	3067.8	1803.57	2407.53	1205.0	2220.38	2061.0	1728.31	1148.5	2978.82	x	x	x	2150.62	x	620.571	889.455	4668.85	x	2120.38	2570.58	3363.62	1583.76	x	344.778	x	2680.75	1934.85	4243.44	x	2495.43	2235.94	1240.9	1528.56	x	x	2341.33	x	2414.0	2178.88	x	x	x	3162.08	728.333	x	x	x	4327.36	2134.36	740.25	1187.46	x	2110.57	855.615	2021.86	2650.31	4863.53	2915.3	3119.24	x	611.059	x	1749.25	x	2989.67	x	x	2775.24	x	x	1560.33	2099.1	917.176	3050.92	1659.53	x	4230.64	x	x	2254.5	x	x	x	1865.62	1400.6	2776.08	3736.29	1608.55	x	x	x	
-11535	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [cm]	x	x	x	x	5710.92	3822.87	x	8206.88	7602.84	13827.0	9015.84	10501.4	6841.0	8245.4	4515.61	7450.6	6986.87	6491.06	3953.66	10063.7	x	x	x	8283.64	x	2476.17	3588.25	15397.9	x	7234.47	8331.64	11763.1	5642.41	x	1306.99	x	9845.61	6617.08	14179.3	x	8236.67	8266.23	4385.73	5805.77	x	x	8332.14	x	8307.88	8427.33	x	x	x	10442.2	2884.64	x	x	x	13587.7	7390.72	2938.13	4137.07	x	7157.33	3210.99	7430.97	9456.49	15887.0	10304.0	10255.2	x	2405.85	x	6197.68	x	10033.3	x	x	9207.92	x	x	6094.86	8276.5	3790.79	10233.8	5784.3	x	14290.4	x	x	8004.53	x	x	x	7098.29	5317.69	8361.1	11965.8	6008.98	x	x	x	
-11536	Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males [n beam breaks/60 min]	None	Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males [n beam breaks/60 min]	x	x	x	x	710.714	460.273	x	1095.38	959.8	1257.8	701.182	1196.8	859.643	1187.27	478.875	1178.46	706.706	838.769	390.5	942.818	x	x	x	602.625	x	285.643	472.909	1382.31	x	842.75	834.583	1236.08	662.529	x	157.556	x	1380.75	685.308	1634.94	x	1013.21	1309.5	519.238	625.778	x	x	1406.08	x	1046.5	938.353	x	x	x	882.417	265.667	x	x	x	1101.29	1369.0	856.562	316.077	x	659.929	498.154	1199.93	1193.08	2005.47	1106.15	1181.94	x	535.706	x	901.417	x	1318.92	x	x	1394.06	x	x	915.333	1223.8	686.824	1063.0	760.118	x	1675.09	x	x	665.857	x	x	x	1595.12	535.0	767.0	1090.71	836.909	x	x	x	
-11537	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males [difference in cm/1 hr test, positive values indicate sensitization]	None	Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males [difference in cm/1 hr test, positive values indicate sensitization]	x	x	x	x	11526.9	-29.3762	x	5973.82	5219.75	14185.0	1684.13	3512.42	6237.2	6632.06	3711.58	4957.3	8091.25	4397.21	7495.78	8155.8	x	x	x	1005.61	x	5693.29	10453.8	3318.69	x	5223.58	4373.0	10423.1	3070.14	x	-400.361	x	4949.31	3933.95	8704.88	x	9608.91	777.753	5563.7	1016.21	x	x	3331.23	x	74.0201	5649.64	x	x	x	8083.48	4463.45	x	x	x	8643.12	3361.27	-76.1015	3141.93	x	3188.43	5098.23	3127.81	3169.8	5123.27	6573.86	3463.7	x	2924.21	x	2918.64	x	5045.43	x	x	4008.25	x	x	5688.01	8311.99	4053.82	12698.9	3151.97	x	2604.15	x	x	2302.95	x	x	x	1148.16	7079.87	7937.6	3253.31	1643.06	x	x	x	
-11538	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [n beam breaks, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [n beam breaks, positive values indicate sensitization]	x	x	x	x	12633.7	3415.3	x	5157.15	4676.8	15243.2	4836.91	8103.5	6230.71	10011.0	4545.38	5382.77	10670.7	7867.46	7189.0	11217.4	x	x	x	7267.75	x	6508.27	7168.82	7919.23	x	9132.88	6544.92	15496.6	5180.88	x	1579.67	x	8506.42	6567.38	18519.4	x	10675.6	9442.53	6346.05	5027.33	x	x	7291.0	x	6324.11	6845.65	x	x	x	7151.08	4499.22	x	x	x	10337.8	6169.77	2710.31	7029.92	x	7048.93	4499.46	5632.71	8017.15	13601.9	11879.4	12490.2	x	5237.29	x	6935.5	x	12987.8	x	x	5918.35	x	x	6375.67	11610.4	3979.82	11950.0	7731.59	x	9124.55	x	x	6910.43	x	x	x	7497.0	11464.4	9514.5	11477.3	7032.27	x	x	x	
-11539	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [cm, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [cm, positive values indicate sensitization]	x	x	x	x	32959.2	10443.3	x	15272.4	14490.9	39494.7	14427.1	22759.4	19031.0	28329.1	13508.8	15834.5	28576.3	24290.1	20335.3	31528.1	x	x	x	21356.3	x	18518.6	21889.8	23345.8	x	25472.3	18825.6	40571.5	15630.6	x	5059.96	x	25517.8	19109.2	46987.1	x	30273.5	27211.3	18759.4	16235.1	x	x	21923.0	x	19368.9	21298.5	x	x	x	22623.7	14548.4	x	x	x	28836.4	18277.1	8188.92	20426.3	x	20610.5	13484.8	17779.4	24428.0	38370.0	33060.1	33813.9	x	15586.1	x	21842.6	x	35268.8	x	x	16945.2	x	x	19690.6	32210.0	13080.0	32961.4	22230.0	x	26466.6	x	x	20670.0	x	x	x	22036.3	31275.5	26355.3	32287.4	21612.9	x	x	x	
-11540	Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	None	Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	x	x	x	x	1486.79	933.7	x	1524.54	1067.8	1924.8	823.0	1131.0	1381.36	2421.47	790.625	1396.54	1453.29	1890.08	1003.5	2117.64	x	x	x	1099.88	x	1206.91	1565.91	1929.77	x	1622.5	1524.58	1493.69	1255.65	x	564.333	x	1793.17	1011.15	2693.75	x	2393.79	2409.2	1514.48	1180.67	x	x	2077.17	x	1680.44	1510.82	x	x	x	1579.42	926.333	x	x	x	1871.64	1683.91	1279.62	1007.62	x	1044.93	1144.77	2127.29	1808.38	3320.2	2005.94	2000.76	x	1148.24	x	2290.7	x	2515.25	x	x	1462.29	x	x	1700.07	2114.4	1132.71	1868.3	1651.47	x	2023.55	x	x	1308.07	x	x	x	2332.5	1363.2	1668.08	2146.12	2309.73	x	x	x	
-11541	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [n beam breaks/15 min]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [n beam breaks/15 min]	x	x	x	x	581.857	453.909	x	661.923	582.4	1272.0	492.818	798.5	612.929	895.467	331.625	433.923	896.176	511.462	462.0	779.273	x	x	x	732.625	x	249.929	298.455	1509.0	x	516.875	603.0	815.538	575.647	x	261.556	x	664.833	515.231	1051.75	x	975.929	557.75	718.381	597.889	x	x	596.5	x	504.0	453.412	x	x	x	955.0	388.778	x	x	x	1356.57	641.091	243.688	395.077	x	754.143	389.538	527.357	660.923	1362.0	815.4	954.706	x	322.118	x	721.333	x	1073.08	x	x	758.0	x	x	537.867	752.4	302.588	1061.83	521.294	x	1219.64	x	x	692.357	x	x	x	649.875	589.0	1089.25	875.647	416.182	x	x	x	
-11542	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [n beam breaks/15 min]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [n beam breaks/15 min]	x	x	x	x	439.643	202.0	x	613.077	422.0	1238.6	678.909	695.7	489.571	567.267	416.0	454.769	535.353	474.0	403.5	699.0	x	x	x	614.5	x	166.429	266.636	1180.69	x	592.125	608.167	738.154	444.176	x	59.8889	x	619.083	547.231	1050.75	x	615.857	548.125	291.524	483.667	x	x	565.417	x	632.8	544.824	x	x	x	1067.83	186.278	x	x	x	1143.64	617.136	174.812	294.538	x	692.571	243.385	569.5	742.615	1272.67	681.15	787.765	x	187.882	x	402.167	x	790.833	x	x	730.647	x	x	435.267	502.7	253.0	763.583	494.412	x	1168.73	x	x	762.214	x	x	x	409.75	236.6	693.5	949.588	435.818	x	x	x	
-11543	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [n beam breaks/15 min]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [n beam breaks/15 min]	x	x	x	x	277.0	176.455	x	710.308	555.0	939.0	783.182	670.1	406.286	505.2	279.125	578.231	353.0	392.615	182.5	784.364	x	x	x	400.375	x	131.857	124.727	992.385	x	511.875	715.5	894.231	323.059	x	20.0	x	690.583	422.769	1020.81	x	495.214	584.125	125.143	270.556	x	x	592.333	x	637.1	570.353	x	x	x	746.917	111.222	x	x	x	993.643	503.818	190.0	241.308	x	414.571	151.769	508.786	672.769	1224.07	682.6	782.588	x	57.0	x	330.25	x	623.0	x	x	629.412	x	x	330.333	405.2	203.941	686.583	391.588	x	978.636	x	x	453.643	x	x	x	415.0	296.4	506.333	966.235	389.364	x	x	x	
-11544	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [n beam breaks/15 min]	x	x	x	x	185.929	231.273	x	603.692	498.2	944.0	838.727	903.5	294.786	439.6	178.25	753.462	276.471	350.231	100.5	716.182	x	x	x	403.125	x	72.3571	199.636	986.769	x	499.5	643.917	915.692	240.882	x	3.33333	x	706.25	449.615	1120.12	x	408.429	545.938	105.857	176.444	x	x	587.083	x	640.1	610.294	x	x	x	392.333	42.0556	x	x	x	833.5	372.318	131.75	256.538	x	249.286	70.9231	416.214	574.0	1004.8	736.15	594.176	x	44.0588	x	295.5	x	502.75	x	x	657.176	x	x	256.867	438.8	157.647	538.917	252.235	x	863.636	x	x	346.286	x	x	x	391.0	278.6	487.0	944.824	367.182	x	x	x	
-11545	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [cm]	x	x	x	x	2231.95	1551.31	x	2092.7	2161.96	3958.65	1668.23	2781.25	2254.26	2916.85	1280.93	1593.72	2955.45	1970.93	1601.23	2792.85	x	x	x	2787.42	x	949.768	1236.0	4774.6	x	1978.59	1974.63	2934.95	2028.92	x	963.437	x	2495.78	1813.58	3612.47	x	3212.74	2026.31	2471.05	2247.26	x	x	2061.01	x	1779.8	1807.32	x	x	x	3339.92	1601.76	x	x	x	4204.39	2232.47	958.391	1507.04	x	2551.07	1442.45	2032.99	2393.21	4402.46	2785.45	3176.84	x	1262.89	x	2378.26	x	3491.85	x	x	2528.93	x	x	2104.11	2800.84	1278.73	3495.23	1884.5	x	4010.82	x	x	2485.81	x	x	x	2368.04	2134.4	3252.16	2815.02	1574.97	x	x	x	
-11546	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [cm]	x	x	x	x	1709.54	762.187	x	1986.17	1649.75	3787.72	2230.54	2455.53	1905.53	1985.68	1547.22	1586.59	1854.76	1809.74	1413.64	2495.96	x	x	x	2368.64	x	683.334	1063.0	3903.04	x	2023.81	2039.43	2647.9	1590.62	x	243.222	x	2289.45	1844.43	3539.16	x	2038.82	2030.76	1081.59	1855.11	x	x	2029.24	x	2178.41	2155.48	x	x	x	3507.05	726.858	x	x	x	3599.77	2126.77	720.752	1037.65	x	2374.29	930.325	2119.72	2692.59	4099.84	2401.16	2604.17	x	750.939	x	1416.65	x	2668.65	x	x	2462.88	x	x	1692.78	2067.27	1060.31	2547.0	1681.48	x	3907.92	x	x	2677.36	x	x	x	1615.06	992.026	2119.2	3082.5	1629.67	x	x	x	
-11547	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [cm]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [cm]	x	x	x	x	1054.65	691.296	x	2219.78	2029.41	3079.09	2481.71	2269.39	1584.05	1784.25	1022.99	1903.72	1238.33	1430.59	620.282	2556.74	x	x	x	1588.94	x	554.001	511.402	3344.28	x	1624.03	2303.91	3098.14	1162.56	x	82.9381	x	2503.91	1420.7	3361.76	x	1660.71	2181.26	470.248	1053.77	x	x	2115.75	x	2184.35	2221.94	x	x	x	2357.31	405.728	x	x	x	3137.65	1726.92	729.606	770.31	x	1403.42	559.536	1787.84	2360.11	4058.43	2446.15	2564.79	x	220.127	x	1260.85	x	2110.17	x	x	2063.6	x	x	1290.09	1696.35	818.444	2373.45	1361.78	x	3366.44	x	x	1635.31	x	x	x	1557.06	1173.68	1487.2	3058.77	1440.4	x	x	x	
-11548	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [cm]	x	x	x	x	714.777	818.075	x	1908.23	1761.72	3001.5	2635.36	2995.22	1097.16	1558.61	664.468	2366.56	938.328	1279.8	318.51	2218.14	x	x	x	1538.64	x	289.068	777.854	3375.98	x	1608.05	2013.68	3082.05	860.322	x	17.3864	x	2556.47	1538.37	3665.87	x	1324.41	2027.9	362.841	649.633	x	x	2126.14	x	2165.32	2242.59	x	x	x	1237.9	150.3	x	x	x	2645.86	1304.56	529.379	822.067	x	828.555	278.683	1490.43	2010.57	3326.29	2671.22	1909.35	x	171.898	x	1141.93	x	1762.67	x	x	2152.51	x	x	1007.87	1712.05	633.301	1818.16	856.544	x	3005.23	x	x	1206.06	x	x	x	1558.12	1017.58	1502.54	3009.55	1363.95	x	x	x	
-11549	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males [n beam breaks/15 min]	None	Central nervous system, pharmacology, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males [n beam breaks/15 min]	x	x	x	x	176.0	138.818	x	251.462	181.8	307.6	116.727	225.8	192.929	301.333	109.75	225.231	188.529	215.462	121.0	199.455	x	x	x	167.0	x	91.4286	90.5455	317.385	x	188.125	165.583	253.154	210.824	x	88.5556	x	289.75	141.077	331.062	x	321.286	242.188	229.095	192.667	x	x	271.333	x	199.1	211.235	x	x	x	271.417	119.5	x	x	x	317.0	333.682	204.625	79.3846	x	192.286	194.462	278.786	321.385	469.733	226.8	273.765	x	230.353	x	231.0	x	313.0	x	x	302.706	x	x	228.867	297.8	203.824	289.083	194.118	x	358.455	x	x	177.5	x	x	x	387.625	130.2	213.75	244.412	166.636	x	x	x	
-11550	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males [n beam breaks/15 min]	x	x	x	x	232.0	104.455	x	305.769	267.2	343.0	181.273	290.1	254.786	309.467	141.125	306.385	204.118	247.462	166.5	263.273	x	x	x	187.75	x	83.9286	143.182	369.846	x	247.375	227.333	322.846	201.235	x	41.2222	x	367.667	202.077	427.375	x	262.714	354.875	146.667	214.222	x	x	384.5	x	282.3	248.471	x	x	x	287.0	81.5556	x	x	x	298.357	382.409	247.0	86.4615	x	214.857	157.308	343.357	339.923	512.133	274.65	315.471	x	175.765	x	261.417	x	364.5	x	x	386.235	x	x	258.2	322.2	216.706	276.083	230.059	x	459.182	x	x	228.071	x	x	x	418.25	133.8	210.667	279.588	230.182	x	x	x	
-11551	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males [n beam breaks/15 min]	x	x	x	x	161.786	92.6364	x	299.462	261.2	296.6	184.0	304.9	239.786	310.133	119.375	317.923	175.706	194.462	93.5	245.0	x	x	x	129.375	x	68.6429	121.545	350.308	x	213.25	232.167	339.846	137.882	x	17.3333	x	359.917	183.231	407.625	x	242.714	376.812	86.8095	136.222	x	x	382.667	x	289.3	238.824	x	x	x	217.917	43.5556	x	x	x	253.857	356.409	222.25	75.6923	x	141.786	92.4615	309.357	286.923	556.6	287.35	333.412	x	81.0	x	206.5	x	321.0	x	x	351.353	x	x	245.133	309.9	160.0	258.833	196.647	x	438.091	x	x	142.857	x	x	x	420.5	156.4	193.083	283.118	216.0	x	x	x	
-11552	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males [n beam breaks/15 min]	x	x	x	x	140.929	124.364	x	238.692	249.6	310.6	219.182	376.0	172.143	266.333	108.625	328.923	138.353	181.385	9.5	235.091	x	x	x	118.5	x	41.6429	117.636	344.769	x	194.0	209.5	320.231	112.588	x	10.4444	x	363.417	158.923	468.875	x	186.5	335.625	56.6667	82.6667	x	x	367.583	x	275.8	239.824	x	x	x	106.083	21.0556	x	x	x	232.071	296.5	182.688	74.5385	x	111.0	53.9231	268.429	244.846	467.0	317.35	259.294	x	48.5882	x	202.5	x	320.417	x	x	353.765	x	x	183.133	293.9	106.294	239.0	139.294	x	419.364	x	x	117.429	x	x	x	368.75	114.6	149.5	283.588	224.091	x	x	x	
-11553	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	3205.07	2994.09	x	5699.46	4241.6	6162.4	3437.18	6409.7	2417.29	3985.47	1694.88	3076.92	4531.65	3007.62	2778.5	3975.18	x	x	x	2719.88	x	1411.13	1795.18	6895.0	x	2347.0	4513.5	4137.31	2341.0	x	1007.0	x	3601.75	2101.54	5277.31	x	3884.5	2773.62	2313.67	3444.67	x	x	3689.33	x	4872.54	3068.88	x	x	x	4666.33	811.944	x	x	x	4758.43	3482.32	1285.31	2224.62	x	3834.93	2633.77	2725.43	3508.46	5333.6	4743.55	4254.47	x	1987.94	x	3793.67	x	4569.17	x	x	3568.24	x	x	1882.27	2878.8	1638.0	4107.25	3451.0	x	4645.64	x	x	3758.29	x	x	x	2094.62	3395.0	5837.17	6585.24	2192.73	x	x	x	
-11554	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [cm]	None	Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [cm]	x	x	x	x	11584.2	10184.5	x	17277.9	14205.4	19108.1	11407.7	19468.9	9267.31	13125.7	6721.12	10577.9	14339.2	11416.9	9320.55	13217.9	x	x	x	10848.5	x	5218.6	7629.08	21218.2	x	8816.4	14442.0	14501.3	8388.82	x	4034.94	x	12608.5	8016.2	17573.4	x	12858.2	10428.4	8209.71	12594.7	x	x	13064.2	x	16111.4	11248.1	x	x	x	15242.1	3587.94	x	x	x	15336.2	12247.5	5468.24	8135.13	x	12849.5	9664.6	10074.4	12742.4	17333.2	16338.1	14004.0	x	7464.77	x	12737.2	x	14075.4	x	x	11994.7	x	x	7579.45	11117.7	6703.78	13691.5	11265.1	x	15886.4	x	x	12766.5	x	x	x	8093.75	11751.3	17397.7	20727.8	8595.21	x	x	x	
-11555	Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]	None	Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]	x	x	x	x	1009.07	1141.0	x	1501.54	1324.2	1586.4	791.545	1877.0	938.5	1519.27	722.875	1067.08	989.941	1157.46	953.0	1035.82	x	x	x	691.25	x	533.467	645.727	1439.0	x	911.625	1225.08	1609.15	825.706	x	437.222	x	1340.83	809.769	1930.12	x	1269.0	1687.88	757.143	909.444	x	x	1593.17	x	1705.0	1055.41	x	x	x	1081.83	302.5	x	x	x	1277.43	1450.09	1062.06	626.692	x	1016.43	968.077	1186.64	1356.31	2093.93	1771.55	1358.18	x	1182.41	x	1448.92	x	1313.67	x	x	1594.76	x	x	907.533	1473.4	986.118	1296.17	1167.88	x	1678.0	x	x	963.571	x	x	x	1690.62	872.0	1270.67	1857.24	1254.09	x	x	x	
-11556	Original post publication description: Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males [density]	None	Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males [density]	x	x	x	x	x	100.0	x	76.0	x	98.5	x	x	x	69.0	108.0	x	77.5	x	x	x	x	x	x	x	x	63.0	x	x	x	x	87.0	x	x	x	85.8	x	x	132.5	x	x	x	108.75	79.0	84.6667	x	x	x	x	82.75	x	x	x	x	x	x	x	x	x	67.0	100.333	83.25	x	79.5	101.5	72.5	142.0	122.0	128.0	95.5	x	x	81.0	100.333	97.0	x	76.0	x	x	102.0	x	x	x	x	79.0	94.5	104.0	x	97.5	74.25	90.6667	121.5	98.6667	x	x	87.5	85.0	74.0	x	x	x	x	x	
-11557	Original post publication description: Adrenal weight (left) of males [mg]	None	Endocrinology, morphology: Adrenal weight (left) of males [mg]	x	x	x	x	1.75	1.6	x	2.1125	1.775	1.5	2.1	2.025	1.675	2.1	1.9	2.475	1.95	1.525	1.825	1.975	x	x	x	1.8	x	1.8	2.325	1.7	x	2.0	1.9	1.7	2.125	x	1.675	x	1.775	2.025	1.5	x	1.6375	1.65	1.4	1.65	x	x	1.875	x	1.45	1.9	x	x	x	1.275	1.675	x	x	x	1.775	1.65	2.175	1.675	x	1.725	1.6	1.575	1.875	1.75	1.55	1.43333	x	1.55	x	1.65	x	1.58333	x	x	1.625	x	x	1.675	1.7	1.7	1.475	1.75	x	1.575	1.6	x	1.725	x	x	x	2.05	1.65	1.8	1.625	2.05	x	x	x	
-11558	Original post publication description: Adrenal weight (right) of males [mg]	None	Endocrinology, morphology: Adrenal weight (right) of males [mg]	x	x	x	x	1.7	1.35	x	2.1375	1.8	1.5	1.925	2.2	1.55	1.725	1.8	2.25	1.46667	1.525	1.925	2.0	x	x	x	1.65	x	1.8625	2.25	1.55	x	1.9	1.675	1.675	2.2	x	1.75	x	1.775	2.1	1.65	x	1.4	1.675	1.5	1.375	x	x	1.8625	x	1.55	1.7	x	x	x	1.125	1.5	x	x	x	1.6375	1.65	1.75	1.575	x	1.425	1.55	1.4	1.75	1.725	1.375	1.23333	x	1.4875	x	1.45	x	1.53333	x	x	1.45	x	x	1.675	1.725	1.625	1.45	1.625	x	1.575	1.475	x	1.3	x	x	x	2.025	1.45	1.525	1.85	1.85	x	x	x	
-11559	Original post publication description: Pain sensitivity, vocalization threshold to mild foot shock for females [mA]	None	Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for females [mA]	x	x	x	x	0.27	0.316667	0.37	0.26	0.3	0.28	0.34	0.23	0.2875	0.22	0.26	0.3125	0.34	0.35	x	0.26	x	0.35	x	0.39	x	0.38	0.23	0.32	x	0.32	0.43	0.25	0.29	x	0.3	x	0.26	0.3	0.32	x	0.24	0.3875	0.32	0.1625	x	x	0.33125	0.25	0.29	0.33	x	x	x	x	x	x	x	x	0.36	0.39	0.37	0.38	0.3625	0.36	0.27	x	0.33	0.31875	0.33	0.25	x	0.32	0.34	0.43	x	0.32	0.39	0.5	0.41	0.283333	x	0.28	0.32	0.31	0.3	0.35	0.65	0.26	0.24	x	0.29	0.2	x	x	0.31	x	x	x	x	x	x	x	
-11560	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for females [sec]	x	x	x	x	120.5	39.6667	x	x	x	x	89.0	143.333	112.0	x	x	84.3333	31.0	101.5	x	163.0	x	x	x	x	x	142.286	77.3333	80.6	x	112.0	87.8	122.333	64.2	x	89.5	x	54.0	114.167	74.1667	x	103.4	95.0	85.0	67.6667	x	x	123.0	x	100.0	73.8	x	x	x	97.8	x	x	x	x	51.5	54.6	84.4	x	x	123.667	113.4	x	157.0	87.4	76.75	x	x	116.167	x	122.75	x	x	x	x	x	x	x	75.6667	163.333	x	x	83.0	x	x	x	x	71.3333	x	x	x	x	x	74.0	x	x	x	x	x	
-11561	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for females [sec]	x	x	x	x	23.5	9.0	x	x	x	x	14.5	11.3333	5.0	x	x	10.3333	7.5	98.0	x	75.0	x	x	x	x	x	122.429	4.16667	8.6	x	16.0	20.8	6.66667	1.8	x	6.0	x	1.6	93.8333	106.5	x	140.6	188.5	45.0	19.3333	x	x	46.5	x	62.4	30.6	x	x	x	79.2	x	x	x	x	12.5	4.6	185.2	x	x	24.3333	30.6	x	11.0	24.6	11.25	x	x	59.8333	x	41.0	x	x	x	x	x	x	x	111.667	176.0	x	x	10.3333	x	x	x	x	12.6667	x	x	x	x	x	6.66667	x	x	x	x	x	
-11562	Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for females [sec]	None	Central nervous system, behavior: Motor coordination, time on dowel over a 2 min baseline test period for females [sec]	x	x	x	x	120.0	120.0	x	x	x	x	120.0	120.0	120.0	x	x	120.0	120.0	120.0	x	120.0	x	x	x	x	x	120.0	103.667	120.0	x	120.0	120.0	120.0	107.0	x	120.0	x	114.4	120.0	120.0	x	120.0	120.0	86.5	83.0	x	x	120.0	x	120.0	120.0	x	x	x	120.0	x	x	x	x	120.0	113.0	120.0	x	x	120.0	120.0	x	120.0	120.0	120.0	x	x	120.0	x	120.0	x	x	x	x	x	x	x	83.3333	120.0	x	x	120.0	x	x	x	x	89.6667	x	x	x	x	x	87.3333	x	x	x	x	x	
-11563	Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for females [sec]	None	Central nervous system, behavior: Depression assay, Porsolt behavioral despair test, time immobile for females [sec]	x	x	x	x	0.25	41.8333	x	x	x	x	98.5	18.6667	20.0	x	x	16.3333	138.0	89.0	x	161.75	x	x	x	x	x	25.4286	150.333	108.4	x	49.0	31.9	48.0	149.0	x	27.5	x	148.3	31.6	98.0833	x	53.9	75.25	61.1667	152.0	x	x	98.5	x	85.4	15.5	x	x	x	123.7	x	x	x	x	159.0	166.8	65.6	x	x	109.0	174.8	x	8.0	95.9	139.5	x	x	30.9167	x	105.875	x	x	x	x	x	x	x	102.5	93.0	x	x	150.5	x	x	x	x	59.6667	x	x	x	x	x	85.3333	x	x	x	x	x	
-11564	Original post publication description: Pain response, thermal nociception, Hargreaves' test for females [units]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, Hargreaves' test for females [units]	x	x	x	x	20.9517	x	x	8.602	10.1283	x	7.39	19.9239	13.807	9.03611	x	6.39167	13.364	10.1483	x	14.2025	x	x	x	10.1675	x	11.0133	10.4803	13.8645	x	15.1867	10.579	8.70813	10.0198	x	12.1297	x	14.157	16.0387	8.94014	x	11.5657	9.55375	8.72074	12.3953	x	x	10.1448	x	10.8205	6.84111	x	x	x	9.19352	x	x	x	x	13.6783	8.92648	13.0527	12.7197	x	13.8387	13.4446	11.1142	11.3353	14.0602	12.6843	x	x	14.3312	x	11.3888	x	10.6592	x	x	7.81667	x	x	10.4375	14.9417	x	9.071	8.6925	x	14.0667	x	x	15.5675	x	x	x	11.0558	x	13.6533	x	12.5727	x	x	x	
-11565	Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for females [sec]	None	Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate test, average of two trials for females [sec]	x	x	x	x	8.5075	x	x	6.8005	11.485	x	9.22	10.0562	5.073	6.78889	x	4.89	9.239	4.3075	x	7.0885	x	x	x	9.605	x	9.51357	10.966	7.04857	x	5.637	6.798	10.0233	9.52429	x	6.07	x	10.9389	13.309	14.0985	x	6.914	9.745	8.985	14.355	x	x	16.825	x	18.0537	7.05167	x	x	x	5.40357	x	x	x	x	9.245	6.73556	11.923	16.472	x	5.586	7.679	5.935	7.07	5.29714	11.1625	x	x	8.94714	x	17.9007	x	9.745	x	x	6.525	x	x	9.51429	7.8125	x	9.202	8.27571	x	7.827	x	x	5.19583	x	x	x	10.7605	x	8.45063	x	11.2987	x	x	x	
-11566	Original post publication description: Pain response, mechanical nociception, tail clip latency for females [sec]	None	Central nervous system, peripheral nervous system, behavior: Pain response, mechanical nociception, tail clip latency for females [sec]	x	x	x	x	33.835	x	x	23.807	24.74	x	34.185	9.23667	33.24	12.9567	x	17.74	21.59	4.95	x	8.167	x	x	x	59.125	x	19.3729	39.592	22.0557	x	47.518	43.52	19.9167	41.8114	x	21.87	x	5.46778	25.57	20.335	x	23.178	23.942	22.5367	36.962	x	x	30.8778	x	21.334	9.555	x	x	x	10.6711	x	x	x	x	5.276	17.3778	51.464	28.708	x	28.266	22.71	21.91	41.0583	12.9357	20.11	x	x	28.8743	x	40.4987	x	23.014	x	x	17.19	x	x	25.1786	7.835	x	22.038	10.4657	x	12.966	x	x	18.5917	x	x	x	23.798	x	29.868	x	11.56	x	x	x	
-11567	Original post publication description: Pain response, thermal nociception, tail withdrawal latency for females [sec]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, tail withdrawal latency for females [sec]	x	x	x	x	8.28333	x	x	12.1093	13.5867	x	18.1683	8.6425	7.70867	9.71667	x	10.3267	8.87133	10.825	x	9.34133	x	x	x	13.4517	x	10.9748	9.83933	13.7867	x	10.6333	12.004	13.3696	11.1086	x	13.708	x	10.7637	11.424	21.7508	x	9.40933	10.7347	10.603	16.8787	x	x	9.74963	x	9.944	11.0467	x	x	x	11.3048	x	x	x	x	7.64267	9.91667	8.83267	9.572	x	7.95533	12.3587	10.4233	10.005	13.6105	9.50458	x	x	12.479	x	12.4329	x	10.9933	x	x	9.56444	x	x	12.5295	18.3633	x	13.9277	8.45905	x	8.28067	x	x	7.74056	x	x	x	9.89767	x	8.89433	x	11.276	x	x	x	
-11568	Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for females [Force in mg]	None	Central nervous system, peripheral nervous system, somatosensory system: Mechanical sensitivity using Von Frey test, threshold for females [force in mg]	x	x	x	x	4.38912	x	x	3.96575	3.97475	x	4.2685	3.97069	4.3442	4.35722	x	4.44767	4.2621	4.14525	x	4.11555	x	x	x	4.18925	x	4.17504	4.2432	4.06868	x	4.063	4.03625	4.15914	4.37232	x	4.0235	x	4.14119	4.08505	4.0025	x	4.10835	4.1567	4.335	4.027	x	x	3.96939	x	3.99605	4.25925	x	x	x	4.37758	x	x	x	x	3.9029	4.22761	4.3283	4.06905	x	4.1605	4.15625	4.19425	4.16129	3.98496	4.24087	x	x	3.88375	x	3.97894	x	4.1465	x	x	4.34458	x	x	4.20311	3.77325	x	4.17462	4.06539	x	4.2096	x	x	4.016	x	x	x	4.09027	x	4.17847	x	3.9719	x	x	x	
-11569	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	3364.29	322.6	x	3241.83	0.0	2658.83	3617.5	6188.0	2081.0	2613.75	1333.33	4054.25	5083.17	543.25	3468.8	4297.33	x	x	x	3612.5	x	6389.83	601.875	2468.0	x	3104.38	310.0	1727.0	541.143	x	2776.33	x	2396.67	3386.22	4475.36	x	511.091	191.0	1704.62	4220.5	x	x	2082.25	x	652.143	4947.73	x	x	x	337.286	671.0	x	x	x	1.33333	44.5	2563.0	3298.0	x	2501.0	1089.67	2740.17	162.25	937.125	4880.0	2678.67	x	3677.17	x	1825.33	x	37.25	x	x	2429.8	x	x	1027.83	202.6	2729.5	5512.5	118.5	x	331.6	1725.17	x	2803.33	x	x	x	768.167	2569.0	1816.83	61.5	3152.0	x	x	x	
-11570	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	3122.43	439.8	x	3214.33	0.0	2181.17	2579.75	4887.4	1963.4	2326.0	1299.67	2676.75	4711.0	1290.0	2668.0	3370.5	x	x	x	2668.5	x	5245.5	738.25	1722.33	x	1957.75	313.25	1853.2	502.143	x	2114.0	x	2320.33	3487.89	3413.27	x	728.182	385.0	1577.38	4254.0	x	x	1799.25	x	606.857	3943.91	x	x	x	578.0	567.8	x	x	x	2.83333	46.5	2040.17	2681.5	x	2344.0	1304.67	2272.33	43.25	692.625	4011.0	2211.67	x	3277.83	x	1352.33	x	16.0	x	x	1666.4	x	x	923.167	396.8	3162.5	5022.67	124.333	x	512.4	1824.83	x	2342.0	x	x	x	583.5	3527.5	1466.83	262.333	2777.62	x	x	x	
-11571	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	2742.57	573.8	x	2760.33	6.0	1754.0	1429.25	2830.4	2039.4	1268.5	1002.83	2128.25	3857.0	1094.25	2116.8	2433.67	x	x	x	1652.0	x	3716.33	898.375	765.833	x	1587.0	336.0	1481.6	331.0	x	1844.67	x	2148.0	3402.22	2666.73	x	1171.18	510.5	1324.0	4229.25	x	x	1045.25	x	522.429	3339.36	x	x	x	815.143	395.8	x	x	x	64.3333	75.75	1688.67	1797.5	x	2036.62	901.167	1750.83	49.5	616.125	3636.12	2213.0	x	2850.83	x	682.833	x	70.25	x	x	1172.0	x	x	857.667	550.8	3368.0	4612.5	118.0	x	1175.6	1752.67	x	1653.67	x	x	x	429.5	4430.5	1088.17	353.667	2108.25	x	x	x	
-11572	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	2734.14	404.6	x	517.0	134.0	1167.33	2768.0	2196.8	230.2	1611.75	334.667	2443.75	1486.17	158.25	1121.0	1112.33	x	x	x	989.25	x	1370.83	217.375	1041.5	x	2239.25	165.0	801.2	216.429	x	1764.0	x	1200.5	766.889	2686.55	x	736.818	298.833	1121.62	897.75	x	x	868.0	x	265.857	693.545	x	x	x	409.571	568.4	x	x	x	95.1667	216.75	309.5	946.25	x	471.125	487.0	448.667	321.5	413.75	2811.12	4925.33	x	529.833	x	951.667	x	494.0	x	x	1126.4	x	x	287.167	258.2	1013.67	1377.17	156.667	x	713.8	1222.33	x	784.333	x	x	x	412.5	562.0	2155.17	375.667	933.875	x	x	x	
-11573	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	1372.71	615.8	x	1430.17	62.0	1257.17	401.5	1039.4	1511.6	686.25	620.667	485.0	1945.67	415.75	573.0	1238.17	x	x	x	456.5	x	1719.83	859.75	24.5	x	865.375	186.5	1383.6	59.5714	x	1761.67	x	1505.83	2156.78	1531.55	x	1988.18	248.833	497.0	3199.5	x	x	349.0	x	217.0	1919.91	x	x	x	533.714	163.2	x	x	x	54.1667	230.75	781.667	1427.25	x	1086.88	243.0	1007.67	5.25	256.0	2787.5	2109.17	x	2374.0	x	398.333	x	182.75	x	x	532.0	x	x	442.0	887.0	3094.0	2703.0	65.5	x	1257.6	992.5	x	838.333	x	x	x	217.5	3370.5	280.333	262.5	1409.62	x	x	x	
-11574	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	1003.86	659.2	x	808.333	21.0	1028.17	250.25	675.0	622.2	577.0	623.833	432.25	1348.33	371.25	406.8	815.5	x	x	x	420.5	x	758.833	818.5	58.1667	x	356.5	129.75	1387.6	156.0	x	718.0	x	1340.17	1665.33	1098.18	x	2038.73	93.6667	250.0	1938.75	x	x	563.5	x	95.2857	1452.64	x	x	x	302.857	150.4	x	x	x	28.3333	301.25	489.5	1143.5	x	751.375	180.0	419.667	26.25	260.0	2563.88	1595.0	x	1425.17	x	379.167	x	283.5	x	x	446.0	x	x	307.333	1188.0	2526.0	2085.33	42.5	x	939.2	516.667	x	646.667	x	x	x	144.667	2109.0	118.667	168.0	1427.12	x	x	x	
-11575	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	3040.14	85.4	x	530.5	0.0	1290.17	4455.25	5287.6	230.6	905.0	331.333	3906.25	1655.67	35.5	2113.2	1961.33	x	x	x	1192.25	x	2581.33	24.125	2115.33	x	5518.5	4.25	704.6	85.4286	x	3671.0	x	1477.0	934.222	3951.0	x	193.091	100.333	1222.25	1176.75	x	x	988.75	x	505.0	974.364	x	x	x	41.2857	356.2	x	x	x	1.5	43.75	780.0	1300.5	x	442.375	197.333	296.0	1545.5	173.875	1874.62	9722.5	x	853.5	x	1014.83	x	137.25	x	x	1835.2	x	x	136.667	0.2	2220.33	2113.17	6.66667	x	103.0	1010.33	x	782.667	x	x	x	347.0	351.5	3334.33	9.66667	1123.0	x	x	x	
-11576	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	3497.57	105.4	x	1029.17	3.0	3132.83	6202.5	6581.6	631.4	1225.5	488.0	5278.0	2690.83	139.0	2808.0	3312.0	x	x	x	2458.5	x	3588.83	65.625	3234.33	x	8352.25	9.0	616.6	126.429	x	4844.33	x	1890.67	1225.11	4115.55	x	112.0	30.6667	981.75	1365.75	x	x	1217.75	x	1023.29	1566.45	x	x	x	16.8571	554.6	x	x	x	1.0	12.0	1444.0	1667.25	x	681.125	271.167	794.333	2848.75	217.875	2260.0	8441.17	x	1537.67	x	1449.0	x	27.75	x	x	2266.4	x	x	306.5	0.6	2926.5	2527.33	22.1667	x	40.2	962.333	x	1251.67	x	x	x	409.167	288.0	4096.67	4.5	1535.62	x	x	x	
-11577	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	4121.71	135.2	x	2244.67	0.0	3678.67	6916.5	6892.8	1186.4	1675.75	609.833	6174.0	3155.67	297.5	3307.4	3773.67	x	x	x	3137.0	x	5006.5	145.125	3899.0	x	8703.5	31.75	820.6	207.714	x	4711.33	x	2114.5	1978.44	4751.36	x	173.0	37.5	1379.75	1890.5	x	x	1912.5	x	1100.29	2711.18	x	x	x	23.0	1025.8	x	x	x	0.833333	27.25	2163.0	2317.0	x	1063.38	394.5	1289.5	3099.0	398.25	3354.0	6591.83	x	1974.67	x	2279.33	x	7.5	x	x	3059.2	x	x	569.667	3.4	2996.0	3755.67	48.6667	x	24.8	1282.5	x	2003.33	x	x	x	548.5	395.5	4365.0	47.1667	2090.12	x	x	x	
-11578	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	4406.57	179.2	x	3072.5	0.0	3186.0	6298.75	7363.0	1581.8	2028.75	705.0	6364.0	4396.33	173.5	3744.6	4463.5	x	x	x	3898.0	x	6027.33	276.625	4040.17	x	7421.38	122.0	1112.6	364.286	x	3840.67	x	2421.33	2609.89	4792.0	x	307.818	77.8333	1843.88	2626.5	x	x	2192.75	x	950.0	3827.45	x	x	x	54.0	1059.6	x	x	x	0.666667	36.5	2227.83	3232.75	x	1567.5	660.5	1671.5	2283.5	654.25	3909.0	4918.67	x	2570.67	x	2656.5	x	24.25	x	x	3729.0	x	x	827.333	41.8	2921.17	4897.33	75.0	x	46.8	1688.5	x	2261.0	x	x	x	675.667	806.0	3832.83	175.167	2546.88	x	x	x	
-11579	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	3783.71	250.0	x	3355.0	0.0	2807.83	4414.0	6976.6	1897.2	2349.25	951.667	5486.0	5069.5	263.0	3506.4	4781.67	x	x	x	4167.25	x	6632.5	454.0	3373.33	x	5396.0	234.25	1545.6	464.429	x	3531.0	x	2440.5	3028.78	4835.09	x	409.273	143.0	1928.12	3341.5	x	x	2337.5	x	654.571	4716.18	x	x	x	184.571	744.0	x	x	x	1.33333	58.0	2498.17	3400.25	x	2141.0	878.5	2535.17	833.75	1060.12	4618.12	3647.17	x	3275.83	x	2611.0	x	51.25	x	x	3552.0	x	x	916.0	167.8	2823.83	5538.5	107.0	x	156.0	2011.0	x	2648.33	x	x	x	775.667	1599.5	2450.33	143.833	3104.88	x	x	x	
-11580	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for females [cm]	x	x	x	x	10990.1	1583.24	x	10144.8	0.0	8794.66	11004.6	16057.9	6787.78	8770.84	5338.25	11285.6	13853.3	2147.59	10851.3	11895.8	x	x	x	10856.4	x	17620.0	2516.43	7177.84	x	9371.44	970.655	5643.35	1995.27	x	8323.78	x	8609.84	10454.7	12924.5	x	1946.83	776.32	5131.9	11888.4	x	x	6619.84	x	1910.1	13964.7	x	x	x	1379.72	2159.31	x	x	x	21.1667	201.93	7133.43	10368.1	x	8929.46	3805.6	8714.57	654.226	3035.42	13945.9	9122.61	x	11252.5	x	5459.82	x	301.657	x	x	7514.69	x	x	3264.29	1387.01	9013.92	14104.3	389.566	x	1493.79	6434.7	x	9618.27	x	x	x	2421.18	9375.98	5587.52	286.57	9841.19	x	x	x	
-11581	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for females [cm]	x	x	x	x	10367.4	1982.87	x	10051.9	0.0	7429.45	8112.42	12949.1	6584.52	7834.62	4952.79	7683.29	12902.4	4215.74	8525.27	9731.66	x	x	x	8006.48	x	15125.3	2921.52	5024.49	x	6812.19	968.735	5990.13	1794.88	x	6480.52	x	8385.76	10594.2	10661.4	x	2608.32	1375.47	4563.34	12324.1	x	x	5688.48	x	1877.97	11348.7	x	x	x	2180.91	1806.06	x	x	x	12.9117	197.803	5761.59	8988.65	x	8338.1	4424.34	7148.16	170.488	2206.43	12073.2	8259.5	x	9833.49	x	4132.14	x	175.259	x	x	5608.11	x	x	2967.67	2217.69	10031.2	13164.9	399.518	x	2257.93	6651.0	x	8492.49	x	x	x	1869.26	11580.5	4570.3	1002.53	8986.93	x	x	x	
-11582	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for females [cm]	x	x	x	x	9161.34	2246.01	x	8651.85	25.4	6148.35	4677.48	8065.81	6702.81	5067.92	4087.61	6428.17	10823.4	3469.28	6959.6	7404.54	x	x	x	5302.35	x	11268.4	3311.2	2356.8	x	5611.4	1026.37	4920.64	1281.96	x	5642.6	x	7995.85	10169.4	8845.87	x	3778.18	1711.5	3256.09	12329.0	x	x	3387.07	x	1631.29	9832.09	x	x	x	2799.43	1227.95	x	x	x	198.357	278.464	4941.48	6803.47	x	7332.8	3007.62	5464.93	214.813	1982.21	11063.3	8334.33	x	8467.92	x	2104.43	x	412.085	x	x	4073.26	x	x	2719.68	2858.02	10589.6	12282.6	370.184	x	4271.2	6132.1	x	6525.11	x	x	x	1400.75	13139.7	3471.23	1202.41	7179.61	x	x	x	
-11583	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for females [cm]	x	x	x	x	7978.38	1417.43	x	1676.99	470.626	3971.86	7549.68	6263.29	1038.24	4857.87	1831.26	7171.8	4661.19	560.811	3816.95	3843.24	x	x	x	3662.31	x	4457.54	828.748	3285.77	x	6257.07	541.2	2649.11	974.193	x	5697.42	x	3880.0	2566.04	7827.27	x	2329.61	977.534	3509.92	3097.61	x	x	2862.74	x	944.525	2734.62	x	x	x	1540.03	2052.73	x	x	x	331.315	801.113	1258.97	3608.93	x	1794.65	1713.69	1887.33	1238.83	1437.95	8535.84	12905.2	x	1651.14	x	3005.39	x	1684.44	x	x	3393.57	x	x	988.388	738.64	3692.99	4467.85	458.032	x	2911.57	4419.01	x	3236.84	x	x	x	1510.24	1885.94	6344.16	1158.49	3285.97	x	x	x	
-11584	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for females [cm]	x	x	x	x	4773.9	2414.98	x	4637.04	212.178	4117.37	1191.82	3297.2	5003.65	3050.28	2636.3	1761.99	5976.51	1400.94	2065.15	4178.54	x	x	x	1576.75	x	5611.23	3016.83	100.877	x	2647.88	595.198	4694.92	270.124	x	5303.99	x	6367.5	6949.24	5202.65	x	5870.2	961.407	1174.11	9319.43	x	x	1162.08	x	739.497	6090.24	x	x	x	1906.63	520.257	x	x	x	164.911	719.964	2450.61	5760.27	x	4247.73	877.721	3204.97	16.8275	901.811	8919.33	7727.14	x	7489.11	x	1278.33	x	829.62	x	x	1933.93	x	x	1424.01	3432.81	9832.4	7753.43	205.895	x	4489.45	3412.87	x	4181.88	x	x	x	790.144	10525.1	889.813	869.665	5013.17	x	x	x	
-11585	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for females [cm]	x	x	x	x	3428.39	2476.51	x	2563.53	86.0564	3205.75	805.078	2120.11	2396.26	2610.25	2559.72	1687.86	4003.8	1302.61	1495.61	2832.27	x	x	x	1466.85	x	2610.13	2793.34	213.094	x	1205.7	408.981	4486.88	556.772	x	2174.74	x	5755.71	5643.55	3686.09	x	5960.67	379.952	659.513	6344.52	x	x	1859.01	x	315.283	4965.51	x	x	x	1152.74	549.452	x	x	x	88.447	923.301	1533.32	4577.64	x	3017.45	648.57	1310.29	97.8364	888.807	8411.83	6047.09	x	4659.98	x	1197.65	x	1064.1	x	x	1692.04	x	x	1073.82	3987.72	8132.76	6163.7	139.917	x	3461.52	1804.36	x	3514.02	x	x	x	602.423	7259.9	374.175	589.732	4963.2	x	x	x	
-11586	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for females [cm]	x	x	x	x	9498.16	577.499	x	2148.57	0.0	4755.71	11774.8	13786.4	1220.27	3382.54	1902.2	12050.2	5497.8	251.492	6820.35	6594.49	x	x	x	4784.58	x	8068.89	226.626	6478.3	x	14396.5	24.258	2663.44	639.847	x	11581.5	x	5257.01	3680.46	11292.7	x	917.866	491.303	4552.79	3923.6	x	x	3589.62	x	1808.18	3898.06	x	x	x	353.035	1701.49	x	x	x	26.3434	248.413	2833.52	5971.56	x	2556.7	895.924	1957.35	5197.36	927.362	7341.41	23696.8	x	2856.1	x	3304.16	x	757.578	x	x	5337.15	x	x	556.858	1.29515	7942.03	6704.66	65.7439	x	932.267	4536.06	x	3981.93	x	x	x	1347.21	1549.19	9727.54	51.3296	4370.05	x	x	x	
-11587	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for females [cm]	x	x	x	x	11134.2	663.505	x	3945.56	26.67	8978.56	15778.0	16881.9	2905.79	4371.05	2806.02	14780.4	8026.99	654.196	8486.65	9699.08	x	x	x	8339.68	x	10822.0	690.039	9384.43	x	20707.3	94.6164	2506.34	886.393	x	14121.4	x	6680.26	5146.33	12176.7	x	731.258	228.215	3989.62	4244.23	x	x	4390.85	x	3384.92	5704.0	x	x	x	210.109	2378.63	x	x	x	26.5608	84.1375	4659.42	7506.9	x	4030.91	1355.62	3669.74	8583.62	1049.17	8541.38	21221.5	x	5347.44	x	4739.33	x	221.912	x	x	6632.16	x	x	1149.52	8.89	9736.57	7782.08	156.765	x	505.329	4470.37	x	5878.62	x	x	x	1622.08	2036.58	11644.5	47.2512	5768.57	x	x	x	
-11588	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for females [cm]	x	x	x	x	12679.6	907.419	x	7449.59	0.0	10548.2	17393.2	17759.5	5035.0	5751.53	3705.6	16412.3	9431.09	1381.04	10162.4	10690.5	x	x	x	10169.9	x	14302.0	1148.04	10963.9	x	21348.4	157.29	3169.99	1195.2	x	13736.5	x	7490.47	7301.84	13691.6	x	960.739	254.989	4947.9	5462.22	x	x	6444.78	x	3493.8	8741.28	x	x	x	235.263	3439.56	x	x	x	18.0732	182.449	6564.34	9120.37	x	5428.74	1859.6	5391.09	9287.42	1793.77	11019.6	17825.0	x	7193.62	x	7039.26	x	73.9509	x	x	8597.46	x	x	2079.27	42.033	9468.66	10471.6	278.407	x	304.196	5493.71	x	7981.31	x	x	x	1978.08	2862.1	12445.5	288.449	7362.81	x	x	x	
-11589	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for females [cm]	x	x	x	x	13322.8	1046.88	x	9609.08	0.0	9718.23	16583.6	18683.8	6049.03	6872.41	4144.57	16879.9	12134.7	995.369	11363.6	12165.6	x	x	x	11919.4	x	16868.2	1522.75	11226.1	x	18935.8	460.226	4005.41	1673.84	x	11420.2	x	8416.28	8944.93	13714.8	x	1346.87	443.431	6176.04	7764.76	x	x	7119.37	x	2911.19	11535.6	x	x	x	411.752	3404.48	x	x	x	20.1083	193.962	6655.99	10564.1	x	6807.8	2719.36	6612.37	7248.88	2590.69	12122.6	14357.3	x	8811.02	x	7951.71	x	204.98	x	x	10328.4	x	x	2861.06	339.162	9492.21	12799.4	367.161	x	524.606	6521.81	x	8735.46	x	x	x	2263.59	4606.02	11003.1	727.852	8571.85	x	x	x	
-11590	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for females [cm]	x	x	x	x	12026.9	1303.54	x	10320.3	0.0	9189.87	12993.2	17846.3	6533.18	8129.21	4531.33	14967.2	13610.3	1384.29	10577.9	12899.0	x	x	x	12425.5	x	18174.2	2074.94	9451.71	x	14314.9	796.344	5147.75	1926.0	x	10518.7	x	8486.53	9829.37	13758.6	x	1663.49	599.331	5979.84	9600.81	x	x	7453.85	x	1982.16	13607.2	x	x	x	1020.16	2339.84	x	x	x	33.8667	299.207	7152.64	10747.3	x	8207.36	3169.46	8550.39	2991.71	3561.08	13485.6	11368.3	x	10491.4	x	7757.22	x	405.169	x	x	9919.35	x	x	3009.01	1184.76	9054.62	14101.1	421.975	x	939.853	7271.67	x	9513.55	x	x	x	2492.95	7189.92	7251.44	570.093	9880.12	x	x	x	
-11591	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for females [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.166667	0.0	0.0	0.166667	x	x	x	0.0	x	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	x	0.0	x	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	x	x	0.0	x	0.0	0.181818	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	x	0.0	x	0.0	x	x	0.0	x	x	0.0	0.0	0.0	0.0	0.333333	x	0.0	0.333333	x	0.0	x	x	x	0.0	0.0	0.0	0.0	0.0	x	x	x	
-11592	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for females [n fecal boli]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for females [n fecal boli]	x	x	x	x	1.71429	3.0	x	3.16667	6.0	0.833333	1.0	2.0	1.0	2.25	2.0	0.75	1.83333	4.25	1.8	1.5	x	x	x	2.75	x	1.5	0.875	1.0	x	1.375	3.0	0.0	2.85714	x	1.0	x	0.166667	1.44444	1.45455	x	1.36364	2.0	1.125	1.75	x	x	2.5	x	3.28571	2.0	x	x	x	3.14286	4.6	x	x	x	4.0	2.5	3.16667	1.5	x	1.0	1.5	2.66667	2.75	1.375	1.125	4.5	x	0.833333	x	3.0	x	2.33333	x	x	3.0	x	x	3.66667	2.0	0.166667	2.5	1.83333	x	1.4	1.83333	x	0.833333	x	x	x	1.66667	1.0	3.0	1.66667	0.25	x	x	x	
-11593	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for females [n/15 min test]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for females [n/15 min test]	x	x	x	x	0.0	0.0	x	0.0	0.0	3.16667	0.0	0.0	3.4	0.0	0.0	0.0	5.83333	0.0	2.2	0.0	x	x	x	0.0	x	3.33333	2.0	0.0	x	0.0	0.0	0.0	3.14286	x	0.0	x	0.166667	1.77778	0.0	x	4.72727	0.0	0.25	5.25	x	x	2.75	x	1.0	1.72727	x	x	x	0.0	0.0	x	x	x	4.0	0.0	1.83333	0.0	x	4.75	0.0	0.0	0.0	0.0	2.25	0.0	x	0.333333	x	0.0	x	0.0	x	x	0.4	x	x	0.0	2.6	0.0	1.33333	0.0	x	0.0	5.5	x	1.16667	x	x	x	14.1667	7.5	0.0	29.0	2.625	x	x	x	
-11594	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]	x	x	x	x	35226.0	4324.8	x	23897.5	277.0	25523.5	39929.0	52637.4	15618.8	18436.2	9100.33	40522.8	38608.3	5348.0	26875.8	33282.0	x	x	x	25500.0	x	45569.2	6095.25	22860.7	x	46711.8	2103.25	14855.0	3214.29	x	33271.0	x	23065.0	27490.1	40442.1	x	9969.45	2754.17	14699.4	33390.8	x	x	16031.0	x	7053.57	32707.1	x	x	x	4052.71	6534.6	x	x	x	314.5	1178.0	18041.7	24965.8	x	16697.1	7178.5	16722.8	11259.8	6065.5	39929.2	51408.3	x	27324.3	x	16112.8	x	1483.25	x	x	22536.4	x	x	7330.33	4396.8	33097.2	43870.0	952.333	x	6824.6	16449.3	x	19091.5	x	x	x	5691.33	24758.0	25545.3	2203.5	23880.5	x	x	x	
-11595	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [cm]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [cm]	x	x	x	x	112361.0	18800.9	x	76738.3	1033.67	81555.5	109847.0	138907.0	55605.1	65327.0	41925.2	114564.0	110098.0	19641.4	84562.1	97570.3	x	x	x	81354.8	x	133034.0	24561.4	66084.2	x	125456.0	6859.04	50697.0	13854.9	x	100256.0	x	84625.0	90000.7	121144.0	x	33076.4	10219.6	45955.3	98128.1	x	x	52801.7	x	22495.3	100393.0	x	x	x	15790.7	22519.8	x	x	x	1140.56	4431.0	54265.9	90744.4	x	66656.4	26390.0	58450.5	35858.8	21662.3	125391.0	149418.0	x	86770.3	x	49575.1	x	6854.36	x	x	67630.3	x	x	24374.9	19289.2	107403.0	120190.0	3461.98	x	27369.0	62211.4	x	76484.4	x	x	x	19653.9	85547.4	75016.0	7897.98	81048.4	x	x	x	
-11596	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	x	x	x	x	2387.97	1284.13	x	1788.86	-780.056	2094.71	-71.4445	693.94	1460.92	2041.37	1875.24	761.829	2318.57	381.424	-65.6929	1949.95	x	x	x	272.73	x	636.661	474.457	-847.413	x	416.711	-1585.04	3259.62	-1139.42	x	1635.04	x	5061.62	4793.9	2630.84	x	4302.47	-1436.5	-51.3446	4451.72	x	x	535.394	x	-844.552	3955.01	x	x	x	-75.3665	-387.7	x	x	x	-1163.57	204.566	394.132	3793.42	x	2118.45	-89.0678	693.25	-555.598	-318.608	7186.49	5239.1	x	3767.58	x	287.104	x	333.953	x	x	788.712	x	x	148.014	2453.78	7183.01	4137.8	-845.303	x	2054.06	914.574	x	2627.34	x	x	x	-820.319	6441.29	-1316.12	-2763.77	3674.15	x	x	x	
-11597	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]	x	x	x	x	4977.14	1023.8	x	6453.33	123.0	3693.0	2767.25	4718.4	2910.2	5001.25	348.5	8838.25	5945.67	676.5	3675.6	3920.17	x	x	x	2955.25	x	5896.5	1149.0	2601.17	x	4050.62	228.0	1606.8	341.714	x	3229.0	x	4974.83	4083.78	6819.36	x	1646.64	399.667	1718.38	2306.75	x	x	2516.0	x	833.714	4389.91	x	x	x	284.0	490.0	x	x	x	161.0	300.5	1688.83	3713.75	x	2107.5	2431.83	2614.17	933.0	1130.75	4576.25	7217.5	x	5083.5	x	3511.83	x	438.75	x	x	3581.0	x	x	977.0	670.6	5104.33	6101.5	154.833	x	1891.6	5259.5	x	4559.17	x	x	x	3005.17	6597.5	3786.83	401.333	5508.25	x	x	x	
-11598	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [n beam breaks]	x	x	x	x	1533.86	902.8	x	1433.5	639.0	845.167	991.0	1529.6	651.2	1167.5	162.0	771.25	2158.33	1097.75	857.2	1143.67	x	x	x	589.5	x	670.333	338.0	2029.33	x	945.0	865.25	1131.0	980.143	x	686.333	x	536.0	516.333	1493.55	x	1391.36	775.667	713.25	1542.75	x	x	795.75	x	1394.29	1175.18	x	x	x	1619.71	505.8	x	x	x	1650.0	1026.0	580.667	307.25	x	776.625	548.167	391.333	741.75	1199.5	1233.25	1297.83	x	881.5	x	842.5	x	1397.5	x	x	1029.8	x	x	503.333	677.2	755.667	1275.67	1072.17	x	1059.6	1033.17	x	1233.0	x	x	x	1010.67	1252.5	1306.0	1860.67	471.25	x	x	x	
-11599	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [n beam breaks]	x	x	x	x	1082.57	666.8	x	1038.67	989.0	949.833	802.0	1206.2	635.4	805.25	168.667	493.75	1520.0	1092.25	554.2	755.5	x	x	x	582.75	x	314.167	416.625	1785.67	x	641.375	620.75	1118.4	592.143	x	267.0	x	596.667	605.778	1320.82	x	944.545	689.5	370.625	1360.5	x	x	711.75	x	1319.57	916.0	x	x	x	1250.57	249.8	x	x	x	991.167	931.25	436.167	607.25	x	814.5	397.167	523.5	830.0	1140.12	1252.25	1363.0	x	748.333	x	725.833	x	1364.5	x	x	570.6	x	x	449.5	726.4	653.0	1039.67	769.667	x	1288.8	491.333	x	1000.33	x	x	x	528.833	661.0	1409.83	1581.0	450.875	x	x	x	
-11600	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [n beam breaks]	x	x	x	x	928.0	329.8	x	840.667	1149.0	756.5	996.75	1103.0	469.0	564.75	316.167	324.0	1159.67	973.5	282.0	579.667	x	x	x	436.0	x	109.0	296.75	1197.0	x	434.375	577.75	1128.6	411.429	x	109.667	x	551.167	458.889	1185.09	x	734.727	717.667	260.25	779.25	x	x	571.5	x	1353.29	869.091	x	x	x	983.429	179.0	x	x	x	661.0	837.5	417.667	687.75	x	610.5	381.833	526.5	718.5	1200.5	1214.75	1370.83	x	612.333	x	569.0	x	1081.0	x	x	488.6	x	x	402.167	705.2	564.833	746.833	623.167	x	1303.4	448.667	x	868.333	x	x	x	364.5	549.5	1400.33	1215.17	432.375	x	x	x	
-11601	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [n beam breaks]	x	x	x	x	814.286	278.2	x	767.0	993.0	536.5	669.5	907.8	225.8	434.25	219.5	438.0	978.0	618.5	172.6	439.167	x	x	x	308.75	x	28.5	208.5	1050.5	x	205.0	310.25	965.8	291.286	x	69.0	x	454.167	351.667	909.182	x	617.727	616.0	154.875	268.0	x	x	552.5	x	1175.14	566.818	x	x	x	684.714	41.4	x	x	x	527.0	814.0	232.333	586.75	x	516.875	291.5	458.333	495.75	964.0	1046.75	1037.83	x	549.833	x	562.5	x	1007.0	x	x	263.8	x	x	343.833	586.4	379.5	489.667	418.833	x	1122.2	294.833	x	760.833	x	x	x	275.833	389.0	1291.33	1051.5	370.375	x	x	x	
-11602	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [cm]	x	x	x	x	4837.79	3227.47	x	4596.56	2491.75	2904.89	3278.89	4770.0	2569.63	4047.58	986.159	2737.7	6404.02	3654.42	3062.19	3754.7	x	x	x	2559.49	x	2655.7	1615.82	6320.83	x	3486.55	3065.0	3883.22	3483.53	x	2723.26	x	2353.98	2156.95	4827.42	x	4577.67	2702.97	2617.77	5001.44	x	x	2803.29	x	4397.01	3872.31	x	x	x	5349.2	2030.04	x	x	x	5136.08	3667.0	1994.64	1580.28	x	3050.59	2162.78	1883.22	2847.86	4083.4	4151.92	4449.81	x	3208.97	x	3020.5	x	4367.48	x	x	3656.91	x	x	2073.61	2727.66	2883.99	4203.35	3466.27	x	3781.48	3769.16	x	4271.84	x	x	x	3407.98	3966.97	4231.38	5748.61	2037.6	x	x	x	
-11603	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [cm]	x	x	x	x	3776.94	2296.65	x	3421.78	3516.0	3153.53	2685.87	3980.13	2677.89	2878.27	1021.1	1897.67	4713.03	3950.22	2053.25	2652.73	x	x	x	2474.7	x	1250.32	1911.39	5452.64	x	2506.79	2290.22	3961.97	2334.19	x	1158.95	x	2588.13	2329.17	4379.19	x	3353.5	2558.17	1377.51	4368.28	x	x	2427.9	x	4169.91	3300.48	x	x	x	4122.67	1275.36	x	x	x	3290.51	3342.88	1780.98	2553.73	x	2993.51	1679.01	2214.16	3204.22	3831.19	4136.24	4465.81	x	2719.07	x	2697.56	x	4247.02	x	x	2310.71	x	x	1920.8	2869.36	2486.22	3441.52	2587.32	x	4294.59	2239.86	x	3635.67	x	x	x	1970.84	2505.43	4428.46	4981.89	1894.47	x	x	x	
-11604	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [cm]	x	x	x	x	3159.82	1226.38	x	2855.83	3500.01	2668.91	3108.21	3683.35	2063.84	2036.4	1618.72	1369.0	3679.01	3498.39	1091.33	1908.81	x	x	x	1989.13	x	412.642	1448.3	3764.05	x	1716.48	2033.89	3867.09	1591.62	x	475.633	x	2322.48	1870.17	3936.7	x	2629.74	2677.74	970.682	2716.09	x	x	2132.84	x	4270.95	3137.46	x	x	x	3426.34	861.135	x	x	x	2239.64	3084.71	1608.93	2788.35	x	2189.54	1485.06	2188.67	2951.68	4081.04	4080.72	4410.47	x	2315.72	x	2225.27	x	3494.36	x	x	1895.83	x	x	1672.62	2705.45	2063.04	2476.86	2119.28	x	4285.03	2015.1	x	3149.9	x	x	x	1454.32	1986.18	4462.45	3993.77	1687.39	x	x	x	
-11605	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [cm]	x	x	x	x	2769.91	976.646	x	2671.16	3299.83	1821.36	2280.32	3127.07	1128.71	1723.43	1148.85	1654.91	3113.26	2203.18	617.629	1384.07	x	x	x	1412.72	x	114.537	992.6	3348.52	x	781.016	1065.86	3324.2	1094.37	x	291.152	x	2028.39	1507.52	3114.38	x	2191.66	2351.07	560.053	1055.43	x	x	2047.71	x	3695.3	2130.65	x	x	x	2415.29	229.685	x	x	x	1668.45	2967.01	1035.05	2331.56	x	1853.43	1160.43	1933.5	2105.35	3377.42	3580.18	3419.65	x	2098.55	x	2107.11	x	3242.21	x	x	1102.94	x	x	1427.72	2345.33	1408.6	1649.14	1414.11	x	3779.39	1510.14	x	2634.58	x	x	x	1083.4	1410.4	4117.85	3456.0	1481.58	x	x	x	
-11606	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 for females [n beam breaks]	x	x	x	x	211.0	210.0	x	269.167	234.0	227.0	165.75	208.4	74.8	276.5	29.0	219.5	284.5	284.5	259.4	266.5	x	x	x	82.25	x	178.5	78.125	287.5	x	228.0	144.25	273.6	299.857	x	129.0	x	196.667	110.111	357.636	x	291.909	354.833	108.875	312.5	x	x	216.5	x	355.143	265.364	x	x	x	287.143	46.4	x	x	x	347.0	261.0	142.167	56.75	x	160.875	219.5	166.167	274.0	284.75	251.875	279.167	x	320.167	x	243.0	x	239.0	x	x	317.4	x	x	106.0	258.6	306.667	305.0	233.833	x	341.2	253.667	x	185.333	x	x	x	378.333	260.5	192.0	404.333	123.5	x	x	x	
-11607	Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for females [n beam breaks]	x	x	x	x	268.0	210.4	x	315.167	331.0	283.167	173.25	242.0	170.8	281.25	51.6667	302.0	347.667	396.5	211.2	245.333	x	x	x	91.5	x	116.833	142.5	409.833	x	263.5	178.5	364.0	236.0	x	117.667	x	316.167	177.556	422.909	x	310.0	461.333	100.75	292.0	x	x	289.0	x	408.429	265.909	x	x	x	309.429	47.0	x	x	x	276.5	326.25	219.667	141.5	x	260.125	260.167	306.5	340.75	400.375	348.0	362.333	x	420.0	x	276.833	x	337.25	x	x	332.4	x	x	172.833	354.4	330.667	314.0	224.333	x	455.4	252.0	x	243.5	x	x	x	417.833	239.0	237.0	386.5	208.875	x	x	x	
-11608	Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for females [n beam breaks]	x	x	x	x	210.857	204.6	x	299.667	393.0	299.833	158.0	280.6	166.8	249.75	47.3333	314.0	313.667	421.0	156.8	203.0	x	x	x	70.75	x	65.1667	127.625	382.667	x	234.875	158.25	391.8	170.429	x	61.0	x	370.833	152.778	392.909	x	286.636	477.167	79.625	164.75	x	x	256.5	x	454.714	242.636	x	x	x	301.571	42.4	x	x	x	239.0	369.0	221.167	191.75	x	186.75	201.333	323.5	299.75	415.375	401.5	384.833	x	384.0	x	248.167	x	363.75	x	x	355.2	x	x	160.5	386.2	327.167	227.0	201.667	x	461.0	219.0	x	238.0	x	x	x	367.0	278.5	283.0	302.5	207.0	x	x	x	
-11609	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for females [n beam breaks]	x	x	x	x	231.286	121.6	x	332.333	338.0	268.667	111.75	240.6	102.0	232.0	55.0	306.25	290.333	311.0	84.6	136.5	x	x	x	46.25	x	45.0	108.125	409.0	x	160.25	122.75	405.2	123.286	x	41.6667	x	386.333	195.444	358.091	x	279.727	474.333	54.25	81.75	x	x	285.0	x	405.286	199.545	x	x	x	224.857	18.4	x	x	x	150.5	314.0	185.167	170.25	x	202.375	198.167	309.833	257.5	410.625	384.75	348.333	x	365.0	x	267.667	x	336.25	x	x	265.2	x	x	169.833	357.2	260.0	177.333	176.667	x	458.2	195.167	x	171.5	x	x	x	349.167	181.0	289.5	316.667	203.375	x	x	x	
-11610	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]	None	Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]	x	x	x	x	4358.71	2177.6	x	4079.83	3770.0	3088.0	3459.25	4746.6	1981.4	2971.75	866.333	2027.0	5816.0	3782.0	1866.0	2918.0	x	x	x	1917.0	x	1122.0	1259.88	6062.5	x	2225.75	2374.0	4343.8	2275.0	x	1132.0	x	2138.0	1932.67	4908.64	x	3688.36	2798.83	1499.0	3950.5	x	x	2631.5	x	5242.29	3527.09	x	x	x	4538.43	976.0	x	x	x	3829.17	3608.75	1666.83	2189.0	x	2718.5	1618.67	1899.67	2786.0	4504.12	4747.0	5069.5	x	2792.0	x	2699.83	x	4850.0	x	x	2352.8	x	x	1698.83	2695.2	2353.0	3551.83	2883.83	x	4774.0	2268.0	x	3862.5	x	x	x	2179.83	2852.0	5407.5	5708.33	1724.88	x	x	x	
-11611	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [cm]	None	Novel open field behavior, locomotion in the center from 0-60 min for females [cm]	x	x	x	x	14544.5	7727.15	x	13545.3	12807.6	10548.7	11353.3	15560.5	8440.08	10685.7	4774.83	7659.28	17909.3	13306.2	6824.4	9700.3	x	x	x	8436.05	x	4433.2	5968.11	18886.0	x	8490.84	8454.98	15036.5	8503.71	x	4648.99	x	9292.98	7863.81	16257.7	x	12752.6	10290.0	5526.02	13141.2	x	x	9411.74	x	16533.2	12440.9	x	x	x	15313.5	4396.22	x	x	x	12334.7	13061.6	6419.6	9253.93	x	10087.1	6487.29	8219.56	11109.1	15373.1	15949.0	16745.7	x	10342.3	x	10050.4	x	15351.1	x	x	8966.4	x	x	7094.75	10647.8	8841.86	11770.9	9586.98	x	16140.5	9534.26	x	13692.0	x	x	x	7916.54	9868.99	17240.1	18180.3	7101.04	x	x	x	
-11612	Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for females [n beam breaks]	x	x	x	x	921.143	746.6	x	1216.33	1296.0	1078.67	608.75	971.6	514.4	1039.5	183.0	1141.75	1236.17	1413.0	712.0	851.333	x	x	x	290.75	x	405.5	456.375	1489.0	x	886.625	603.75	1434.6	829.571	x	349.333	x	1270.0	635.889	1531.55	x	1168.27	1767.67	343.5	851.0	x	x	1047.0	x	1623.57	973.455	x	x	x	1123.0	154.2	x	x	x	1013.0	1270.25	768.167	560.25	x	810.125	879.167	1106.0	1172.0	1511.12	1386.12	1374.67	x	1489.17	x	1035.67	x	1276.25	x	x	1270.2	x	x	609.167	1356.4	1224.5	1023.33	836.5	x	1715.8	919.833	x	838.333	x	x	x	1512.33	959.0	1001.5	1410.0	742.75	x	x	x	
-11613	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for females [n beam breaks]	x	x	x	x	283.571	351.2	x	224.333	272.0	315.0	241.5	414.4	259.6	148.0	154.833	271.75	554.5	260.5	424.2	229.333	x	x	x	304.5	x	578.0	685.125	342.167	x	213.5	673.5	397.6	570.571	x	142.333	x	184.0	243.556	317.727	x	482.545	594.333	205.75	605.5	x	x	455.5	x	329.571	338.636	x	x	x	353.143	228.2	x	x	x	394.5	218.0	384.333	202.75	x	250.125	233.0	172.5	168.75	367.5	384.125	229.333	x	270.333	x	271.667	x	278.667	x	x	266.0	x	x	241.5	505.4	259.5	659.5	305.167	x	413.2	255.333	x	231.5	x	x	x	448.333	236.5	485.833	1136.83	407.125	x	x	x	
-11614	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for females [cm]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for females [cm]	x	x	x	x	1040.41	1192.38	x	774.669	866.112	1111.03	876.523	1426.17	935.343	568.881	684.475	926.03	1685.23	921.181	1561.3	882.322	x	x	x	1194.13	x	1973.47	2318.88	1060.51	x	788.99	1994.02	1227.26	1696.19	x	539.691	x	694.091	849.65	1055.25	x	1658.2	1816.45	710.858	1892.8	x	x	1323.61	x	1159.83	1010.5	x	x	x	1228.1	937.153	x	x	x	1252.02	718.735	1139.19	784.218	x	899.002	737.637	617.037	653.434	1207.42	1225.34	807.984	x	892.401	x	910.542	x	1084.85	x	x	903.33	x	x	925.804	1533.95	949.745	2025.9	985.22	x	1407.46	889.788	x	886.683	x	x	x	1422.74	818.619	1690.29	3353.51	1289.05	x	x	x	
-11615	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for females [n beam breaks]	x	x	x	x	82.2857	72.2	x	98.8333	42.0	73.5	47.5	80.2	88.8	52.75	41.6667	72.75	111.5	95.25	161.4	116.833	x	x	x	56.75	x	166.833	91.25	88.8333	x	62.5	94.25	25.4	101.714	x	32.3333	x	118.333	73.2222	53.1818	x	145.727	153.333	57.25	151.0	x	x	130.25	x	135.429	101.091	x	x	x	118.571	24.0	x	x	x	103.667	74.0	44.8333	64.0	x	92.5	121.5	117.833	46.25	46.25	133.75	64.8333	x	108.333	x	136.667	x	68.3333	x	x	111.2	x	x	101.5	70.4	148.833	63.5	37.6667	x	151.2	65.6667	x	98.5	x	x	x	201.0	109.5	92.3333	196.5	81.75	x	x	x	
-11616	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for females [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.0	0.0	x	0.0	0.0	0.0	0.75	0.2	0.6	0.25	0.333333	0.0	1.16667	0.0	0.0	0.166667	x	x	x	0.0	x	0.166667	0.125	0.666667	x	0.125	0.0	0.0	0.142857	x	0.0	x	0.5	0.222222	0.090909	x	0.0	0.0	0.125	0.75	x	x	0.0	x	0.857143	0.636364	x	x	x	0.285714	0.0	x	x	x	0.333333	0.5	0.0	0.0	x	0.125	0.166667	0.166667	0.0	0.125	0.125	0.333333	x	0.166667	x	0.166667	x	0.333333	x	x	0.2	x	x	0.0	0.0	0.0	0.666667	0.0	x	0.0	0.166667	x	0.333333	x	x	x	0.166667	0.0	0.333333	0.0	0.0	x	x	x	
-11617	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for females [ordinal scale, 0=no effect, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	1.57143	0.0	x	0.166667	2.0	0.0	0.0	0.0	0.0	0.25	1.66667	1.25	0.666667	0.25	0.0	0.0	x	x	x	0.25	x	0.333333	0.125	0.833333	x	0.0	0.25	0.4	0.0	x	0.333333	x	0.0	0.0	0.272727	x	0.090909	0.0	0.0	0.0	x	x	0.5	x	0.285714	0.454545	x	x	x	0.714286	0.0	x	x	x	0.666667	0.0	0.833333	0.0	x	0.0	0.833333	0.166667	0.0	0.0	1.5	0.333333	x	0.333333	x	0.0	x	1.0	x	x	0.6	x	x	0.166667	0.0	0.0	0.166667	0.0	x	0.0	0.0	x	0.333333	x	x	x	0.333333	0.0	0.0	0.0	0.0	x	x	x	
-11618	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for females [ordinal scale, 0=control level, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for females [ordinal scale, 0=control level, 3=max]	x	x	x	x	0.285714	0.0	x	0.166667	0.0	0.0	0.25	0.2	0.2	0.25	0.0	0.25	0.333333	0.0	0.0	0.333333	x	x	x	0.5	x	0.166667	0.0	0.666667	x	0.375	0.25	0.0	0.0	x	0.333333	x	2.16667	0.222222	0.090909	x	0.545455	0.166667	0.0	0.75	x	x	0.25	x	0.0	0.181818	x	x	x	0.857143	0.2	x	x	x	0.0	0.25	0.166667	0.0	x	0.125	0.0	0.0	0.5	0.5	0.125	0.166667	x	0.5	x	0.5	x	0.0	x	x	0.0	x	x	0.0	0.6	0.5	0.0	0.166667	x	0.0	0.0	x	0.0	x	x	x	1.16667	0.0	0.0	0.166667	0.0	x	x	x	
-11619	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for females [ordinal scale, 0=no effect, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.285714	2.2	x	0.5	0.0	0.0	0.5	0.0	2.4	0.5	0.0	0.5	0.833333	0.75	1.2	1.0	x	x	x	0.25	x	2.5	1.0	0.666667	x	0.25	0.0	0.4	0.142857	x	0.0	x	2.66667	0.777778	0.181818	x	1.45455	1.83333	0.375	1.5	x	x	1.5	x	0.285714	1.36364	x	x	x	1.28571	1.6	x	x	x	0.166667	1.5	0.0	0.0	x	1.5	1.33333	0.5	0.0	1.375	0.5	0.166667	x	1.0	x	1.5	x	2.33333	x	x	0.0	x	x	0.666667	0.6	0.666667	0.166667	0.166667	x	0.6	0.666667	x	1.5	x	x	x	1.5	0.5	2.16667	1.5	0.5	x	x	x	
-11620	Original post publication description: Novel open field behavior, urinations for females [n/test period]	None	Central nervous system, behavior: Novel open field behavior, urinations for females [n/test period]	x	x	x	x	1.0	1.4	x	1.16667	1.0	1.33333	1.75	1.2	1.8	1.5	0.833333	1.0	1.16667	1.5	1.8	1.5	x	x	x	1.5	x	1.83333	0.875	1.5	x	1.0	1.0	1.0	1.0	x	0.333333	x	1.5	1.0	0.454545	x	1.45455	0.833333	0.75	0.75	x	x	1.5	x	1.28571	1.36364	x	x	x	1.14286	1.2	x	x	x	1.66667	1.5	1.16667	1.0	x	1.375	1.83333	1.5	0.75	0.875	2.125	1.0	x	0.833333	x	0.833333	x	1.0	x	x	1.0	x	x	0.5	1.0	1.0	1.66667	0.5	x	1.2	1.16667	x	1.0	x	x	x	1.5	2.0	1.5	1.33333	1.0	x	x	x	
-11621	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	438.429	92.2	x	792.0	1.0	385.0	246.25	530.2	298.8	454.75	41.3333	835.75	687.0	46.75	415.2	417.167	x	x	x	342.5	x	742.0	129.75	254.5	x	479.625	40.75	159.8	36.7143	x	268.333	x	551.0	457.111	728.545	x	133.455	33.3333	170.0	256.75	x	x	237.5	x	61.5714	610.0	x	x	x	30.2857	32.0	x	x	x	1.16667	18.5	223.667	372.75	x	291.875	440.167	309.5	52.0	124.75	377.0	525.5	x	627.833	x	408.0	x	30.25	x	x	431.6	x	x	122.333	55.8	389.0	765.167	19.3333	x	119.2	509.0	x	443.0	x	x	x	325.333	730.0	221.167	17.6667	617.625	x	x	x	
-11622	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	422.286	98.8	x	763.5	1.0	304.0	173.5	463.8	311.6	497.75	31.1667	683.25	700.833	101.75	314.8	373.667	x	x	x	246.25	x	642.5	134.5	197.5	x	359.5	32.0	145.2	26.1429	x	209.0	x	497.667	461.0	703.818	x	150.091	45.0	154.0	180.0	x	x	196.5	x	150.571	515.0	x	x	x	34.1429	15.4	x	x	x	6.66667	23.0	172.667	364.0	x	285.25	447.5	254.167	48.25	85.125	334.0	471.5	x	601.833	x	280.0	x	28.0	x	x	301.4	x	x	116.833	102.2	439.5	681.333	12.6667	x	169.2	486.333	x	427.167	x	x	x	247.5	917.0	141.167	36.6667	580.625	x	x	x	
-11623	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	451.857	118.8	x	686.833	9.0	259.667	93.75	237.2	341.6	465.25	23.0	704.75	648.833	131.0	253.2	290.667	x	x	x	151.75	x	523.5	137.625	109.167	x	223.875	25.25	150.0	18.4286	x	206.333	x	409.667	436.0	660.091	x	200.545	56.3333	91.75	133.25	x	x	118.5	x	162.857	396.091	x	x	x	20.2857	6.4	x	x	x	12.0	16.25	132.5	300.75	x	254.75	224.167	223.0	52.0	66.375	286.0	452.167	x	489.333	x	124.333	x	26.0	x	x	175.0	x	x	114.167	109.8	448.667	513.5	11.5	x	241.4	442.333	x	352.167	x	x	x	181.5	1173.0	109.833	34.5	491.875	x	x	x	
-11624	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	408.143	52.4	x	121.5	7.0	160.0	169.75	155.2	35.2	272.0	41.6667	341.0	116.667	17.75	133.6	103.5	x	x	x	62.0	x	199.5	38.125	134.333	x	137.875	10.0	63.0	31.8571	x	111.0	x	153.833	103.556	336.091	x	61.6364	40.6667	112.125	86.5	x	x	74.75	x	36.1429	87.0	x	x	x	30.8571	34.6	x	x	x	15.1667	45.25	9.83333	73.0	x	67.125	80.1667	85.1667	21.25	37.5	462.0	535.167	x	32.3333	x	119.5	x	69.25	x	x	109.4	x	x	38.5	22.4	203.333	114.0	6.5	x	188.6	308.167	x	206.833	x	x	x	135.0	20.5	295.5	38.3333	127.375	x	x	x	
-11625	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) 150-165 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) 150-165 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	298.429	109.2	x	491.5	22.0	179.167	27.5	129.4	248.0	390.25	11.0	335.5	370.167	46.25	75.0	236.5	x	x	x	45.25	x	285.0	102.0	48.3333	x	96.125	7.75	153.6	10.4286	x	175.333	x	296.5	381.778	332.636	x	219.727	17.3333	33.375	321.0	x	x	66.75	x	89.8571	270.909	x	x	x	15.5714	3.6	x	x	x	17.3333	37.25	64.3333	268.25	x	80.25	41.3333	99.0	57.25	88.125	317.125	415.0	x	438.333	x	85.6667	x	8.75	x	x	93.2	x	x	43.6667	93.2	510.333	329.167	6.5	x	266.8	235.833	x	262.5	x	x	x	139.333	765.5	75.1667	16.1667	324.25	x	x	x	
-11626	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	258.714	116.8	x	222.167	28.0	144.833	38.75	129.8	106.8	326.0	6.66667	325.25	236.167	60.75	99.2	181.5	x	x	x	47.25	x	174.0	78.125	54.6667	x	67.125	10.0	140.6	30.4286	x	69.6667	x	302.0	294.667	185.636	x	203.818	15.0	15.875	297.25	x	x	110.75	x	32.4286	204.455	x	x	x	27.2857	3.6	x	x	x	4.66667	28.25	49.8333	248.5	x	38.625	33.1667	85.6667	33.25	68.5	291.75	323.667	x	267.0	x	117.333	x	3.25	x	x	92.8	x	x	37.3333	126.2	356.833	290.667	3.16667	x	185.0	86.3333	x	201.667	x	x	x	127.167	500.0	53.0	13.0	296.625	x	x	x	
-11627	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	556.429	50.2	x	264.333	0.0	228.333	349.75	411.0	103.8	384.75	47.1667	915.5	319.667	24.25	347.4	259.0	x	x	x	199.75	x	358.5	24.75	252.833	x	367.5	4.5	106.4	24.2857	x	362.333	x	385.667	205.556	613.091	x	68.2727	51.3333	229.625	162.5	x	x	328.75	x	12.1429	192.727	x	x	x	43.1429	66.2	x	x	x	3.5	33.25	40.1667	254.75	x	91.875	55.1667	213.5	50.5	67.5	543.0	1168.67	x	128.167	x	248.0	x	79.75	x	x	285.2	x	x	26.5	0.0	404.0	360.167	3.33333	x	139.0	524.167	x	400.667	x	x	x	230.333	42.5	576.667	101.5	288.75	x	x	x	
-11628	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	383.714	50.6	x	402.667	18.0	392.833	427.75	626.6	217.8	410.0	34.5	1065.0	446.667	39.25	438.0	398.0	x	x	x	404.25	x	505.5	56.0	375.5	x	510.0	8.5	115.4	32.1429	x	451.333	x	485.833	261.111	612.364	x	61.0909	21.6667	205.125	60.0	x	x	339.25	x	36.0	283.0	x	x	x	19.4286	89.6	x	x	x	9.0	14.0	174.0	375.75	x	142.25	112.5	239.0	165.25	71.625	415.75	854.667	x	322.167	x	366.333	x	33.0	x	x	391.0	x	x	51.1667	0.8	446.0	455.0	12.8333	x	77.0	502.667	x	473.667	x	x	x	286.833	139.5	645.5	11.1667	466.75	x	x	x	
-11629	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	433.571	66.4	x	546.5	0.0	470.167	433.5	659.8	294.6	405.25	33.5	1115.25	516.833	59.75	531.4	469.167	x	x	x	440.75	x	616.667	87.5	428.167	x	533.125	11.75	130.4	41.0	x	433.0	x	493.667	291.111	699.818	x	84.1818	16.1667	199.75	121.5	x	x	327.0	x	25.5714	420.818	x	x	x	12.8571	109.0	x	x	x	31.5	21.25	256.0	391.75	x	196.5	197.0	263.833	226.0	116.125	441.75	702.0	x	474.5	x	515.333	x	16.75	x	x	481.8	x	x	98.6667	15.8	481.5	614.0	19.0	x	53.0	568.167	x	502.333	x	x	x	363.0	222.0	688.667	29.8333	577.0	x	x	x	
-11630	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	500.571	64.6	x	705.167	0.0	500.0	412.0	610.8	352.2	431.75	29.0	1101.25	647.5	29.75	525.8	498.333	x	x	x	533.0	x	719.5	111.75	406.5	x	520.0	23.0	143.0	39.5714	x	411.667	x	548.167	365.0	693.182	x	108.727	33.3333	236.625	221.5	x	x	314.5	x	31.1429	493.091	x	x	x	13.4286	80.8	x	x	x	41.6667	17.5	247.0	401.75	x	245.25	296.0	310.0	116.75	156.5	403.375	686.0	x	569.333	x	577.833	x	47.0	x	x	591.8	x	x	114.0	21.4	470.667	773.833	28.0	x	80.4	609.167	x	499.167	x	x	x	381.167	393.0	603.0	46.0	681.125	x	x	x	
-11631	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for females [n beam breaks]	x	x	x	x	485.571	89.4	x	818.167	3.0	477.333	349.0	574.6	324.6	480.0	37.1667	965.75	681.0	41.5	434.4	457.833	x	x	x	429.5	x	708.667	129.25	302.5	x	598.75	32.0	154.6	43.2857	x	333.667	x	538.833	440.222	721.545	x	110.818	23.8333	214.625	220.5	x	x	306.75	x	40.2857	566.091	x	x	x	28.0	40.8	x	x	x	3.33333	27.25	246.333	386.25	x	238.625	382.5	389.833	40.0	176.125	388.875	634.0	x	640.333	x	566.0	x	68.0	x	x	508.0	x	x	120.333	45.8	475.167	801.667	24.1667	x	92.2	635.167	x	493.5	x	x	x	395.667	554.5	331.167	28.8333	651.875	x	x	x	
-11632	Original post publication description: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for females [cm/90 min test]	None	Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for females [cm/90 min test]	x	x	x	x	x	x	x	x	x	x	x	2392.0	x	x	x	735.5	x	x	x	x	x	x	x	x	x	x	1219.0	x	x	x	x	x	x	x	217.5	x	x	2288.5	x	x	x	1463.5	538.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4339.0	x	27235.0	x	x	x	x	x	x	19276.0	x	x	x	22764.0	x	2664.0	x	x	x	x	x	x	x	x	x	x	36001.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11633	Original post publication description: Locomotor activity after first saline injection (day 1) for females (MDMA control) [cm/ test period]	None	Locomotor activity after first saline injection (day 1) for females (MDMA control) [cm/ test period]	x	x	x	x	x	x	x	x	x	x	2766.0	7316.5	x	x	x	5692.0	x	x	x	x	x	x	x	x	x	x	3966.0	x	x	x	x	x	x	x	1678.0	x	x	5494.5	x	x	x	3902.0	1717.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4637.0	x	5353.5	x	x	x	x	x	x	16310.0	x	x	x	3506.5	x	5529.0	x	x	x	x	x	x	x	x	x	x	5212.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11634	Original post publication description: Saline control response, locomotor activity after second injection for females (control for MDMA response experiment) [cm/test period]	None	Saline control response, locomotor activity after second injection for females (control for MDMA response experiment) [cm/test period]	x	x	x	x	x	x	x	x	x	x	2147.0	875.0	x	x	x	1220.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	208.0	x	x	1156.5	x	x	x	1544.0	592.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	137.5	x	544.5	x	x	x	x	x	x	7598.5	x	x	x	1611.0	x	1072.0	x	x	x	x	x	x	x	x	x	x	635.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11635	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for females [explain the score]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for females [explain the score]	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.142857	x	0.0	x	x	x	x	0.333333	1.125	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.125	x	0.4	x	x	0.0	x	x	x	0.125	0.0	0.0	x	0.1	0.0	0.0	x	0.071429	0.0	x	0.0	x	x	0.0	0.0	0.1	0.0	0.0	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	
-11636	Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for females [units]	None	Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for females [units]	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.14286	x	0.0	x	x	x	x	0.666667	3.375	x	x	x	0.0	x	x	1.33333	x	x	x	x	x	x	x	x	1.375	x	1.6	x	x	0.333333	x	x	x	1.375	0.0	0.5	x	0.9	0.2	0.2	x	1.07143	2.0	x	1.0	x	x	1.66667	0.0	0.8	0.6	0.833333	x	1.25	x	x	0.4	x	x	x	x	x	x	x	x	x	x	x	
-11637	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for females [units]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for females [units]	x	x	x	x	x	x	x	x	x	x	x	x	0.6	1.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.85714	x	0.0	x	x	x	x	0.666667	1.75	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.25	x	1.3	x	x	0.333333	x	x	x	1.625	0.0	0.5	x	0.7	0.0	0.0	x	1.0	0.0	x	0.0	x	x	1.0	0.5	0.0	1.3	0.5	x	0.625	x	x	0.2	x	x	x	x	x	x	x	x	x	x	x	
-11638	Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for females [score]	None	Seizure susceptibility, handling-induced convulsion (HIC) baseline for females [score]	x	x	x	x	x	x	x	x	x	x	x	x	0.0	1.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.142857	x	0.0	x	x	x	x	1.0	0.375	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.5	x	0.6	x	x	0.0	x	x	x	0.375	0.0	0.5	x	0.0	0.0	0.0	x	0.0	1.66667	x	0.0	x	x	0.0	0.0	0.0	0.2	0.166667	x	0.375	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	
-11639	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for females [explain the score]	None	Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for females [explain the score]	x	x	x	x	x	x	x	x	x	x	x	x	0.6	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.71429	x	0.0	x	x	x	x	x	5.125	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.666667	x	x	x	2.25	0.0	0.5	x	1.6	0.2	0.2	x	2.14286	0.333333	x	1.0	x	x	2.66667	0.5	0.9	1.6	1.16667	x	1.25	x	x	0.6	x	x	x	x	x	x	x	x	x	x	x	
-11640	Original post publication description: Pain response, thermal nociception, hot plate latency for females [sec]	None	Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, hot plate latency for females [sec]	x	x	x	x	x	6.19889	x	7.795	11.23	x	7.68333	10.7457	7.088	7.61	6.07667	9.76333	8.66714	7.42454	x	9.77231	x	x	x	7.46875	x	8.72429	10.13	7.12308	x	5.73714	6.467	11.0837	11.6175	x	6.97857	x	8.20111	6.99091	5.84273	x	8.58286	7.386	9.4625	10.894	x	x	9.5425	x	5.6975	8.28625	x	x	x	7.94889	7.122	x	x	x	8.00636	8.88208	6.53833	x	x	9.46	9.38	6.87625	6.87909	8.40481	10.275	8.715	x	8.72143	x	11.056	x	7.26	x	x	6.001	x	x	12.0983	7.2625	x	12.8183	8.268	x	9.3725	x	x	6.70167	x	x	x	10.43	8.3475	5.978	x	7.41286	x	x	x	
-11641	Original post publication description: Locomotion in dark compartment of a light-dark box for females [cm]	None	Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for females [cm]	x	x	x	x	x	777.222	x	966.375	564.0	x	270.667	1013.14	422.556	831.0	260.0	668.5	924.714	422.636	x	775.692	x	x	x	338.875	x	469.714	362.286	813.308	x	765.556	911.1	439.625	664.143	x	590.857	x	579.444	329.636	782.0	x	745.143	738.2	506.5	748.4	x	x	724.75	x	640.25	507.125	x	x	x	914.556	334.2	x	x	x	800.727	598.958	402.833	x	x	756.375	696.25	537.25	679.182	757.37	705.375	524.5	x	733.222	x	437.8	x	622.75	x	x	583.25	x	x	561.5	640.125	x	645.5	531.8	x	745.75	x	x	634.5	x	x	x	808.833	652.25	903.6	x	535.857	x	x	x	
-11642	Original post publication description: Anxiety assay, time in dark side of a light-dark box for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for females [sec]	x	x	x	x	x	462.822	x	413.212	477.5	x	356.35	472.871	395.789	445.4	304.9	328.45	354.129	350.882	x	368.108	x	x	x	219.637	x	446.471	415.014	392.515	x	433.433	438.07	403.625	405.786	x	461.829	x	501.211	441.2	350.427	x	356.686	394.22	402.942	390.14	x	x	412.962	x	372.275	452.237	x	x	x	411.833	490.14	x	x	x	396.5	388.617	462.15	x	x	396.587	437.525	415.65	386.036	367.467	350.55	385.85	x	463.567	x	315.76	x	447.325	x	x	480.938	x	x	466.95	366.837	x	461.967	455.88	x	370.575	x	x	473.1	x	x	x	469.05	459.425	495.04	x	440.243	x	x	x	
-11643	Original post publication description: Locomotion in both compartments of a light-dark box for females [cm]	None	Locomotion in both compartments of a light-dark box for females [cm]	x	x	x	x	x	1048.67	x	1447.12	810.5	x	396.0	1319.14	665.222	1169.5	427.0	1062.5	1538.0	613.455	x	1231.54	x	x	x	715.375	x	604.429	478.143	1181.77	x	1059.78	1210.3	713.125	985.571	x	832.143	x	734.222	445.0	1318.0	x	1246.86	1123.4	772.25	1155.1	x	x	1076.0	x	956.25	730.625	x	x	x	1366.78	451.8	x	x	x	1130.09	941.125	535.167	x	x	1151.0	991.75	723.75	996.455	1263.48	1188.5	765.833	x	1014.44	x	738.8	x	919.25	x	x	810.375	x	x	750.833	982.875	x	863.667	756.4	x	1205.0	x	x	830.167	x	x	x	1096.33	863.25	1135.4	x	778.714	x	x	x	
-11644	Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for females [cm]	None	Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for females [cm]	x	x	x	x	x	271.444	x	480.75	246.5	x	125.333	306.0	242.667	338.5	167.0	394.0	613.286	190.818	x	455.846	x	x	x	376.5	x	134.714	115.857	368.462	x	294.222	299.2	273.5	321.429	x	241.286	x	154.778	115.364	536.0	x	501.714	385.2	265.75	406.7	x	x	351.25	x	316.0	223.5	x	x	x	452.222	117.6	x	x	x	329.364	342.167	132.333	x	x	394.625	295.5	186.5	317.273	506.111	483.125	241.333	x	281.222	x	301.0	x	296.5	x	x	227.125	x	x	189.333	342.75	x	218.167	224.6	x	459.25	x	x	195.667	x	x	x	287.5	211.0	231.8	x	242.857	x	x	x	
-11645	Original post publication description: Anxiety assay, time in light side of a light-dark box for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for females [sec]	x	x	x	x	x	137.178	x	186.788	122.5	x	243.65	127.129	204.211	154.6	295.1	271.55	245.871	249.118	x	231.892	x	x	x	380.362	x	153.529	184.986	207.485	x	166.567	161.93	196.375	194.214	x	138.171	x	98.7889	158.8	249.573	x	243.314	205.78	197.058	209.86	x	x	187.038	x	227.725	147.762	x	x	x	188.167	109.86	x	x	x	203.5	211.383	137.85	x	x	203.413	162.475	184.35	213.964	232.533	249.45	214.15	x	136.433	x	284.24	x	152.675	x	x	119.062	x	x	133.05	233.163	x	138.033	144.12	x	229.425	x	x	126.9	x	x	x	130.95	140.575	104.96	x	159.757	x	x	x	
-11646	Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for females [%]	None	Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for females [%]	x	x	x	x	x	24.7038	x	32.6783	30.1223	x	32.7031	23.8904	36.5268	28.6394	39.9012	42.8887	39.6247	33.6851	x	36.6407	x	x	x	52.5716	x	21.2905	25.7806	28.106	x	26.6908	24.3065	38.1161	32.5301	x	28.3624	x	20.2575	26.6187	39.9989	x	40.1834	34.4316	34.7788	35.327	x	x	31.8272	x	32.9554	29.6804	x	x	x	33.6636	25.3322	x	x	x	28.4731	35.6058	24.1541	x	x	32.908	29.6984	27.3512	31.0239	39.4541	40.1693	28.0115	x	26.9657	x	45.4204	x	30.308	x	x	27.0662	x	x	22.6999	34.1281	x	22.7131	28.3803	x	37.5026	x	x	22.9114	x	x	x	25.718	20.4027	17.7425	x	30.2221	x	x	x	
-11647	Original post publication description: Anxiety assay, percentage of time in the light side of a light-dark box for females [%]	None	Central nervous system, behavior: Anxiety assay, percentage of time in the light side of a light-dark box for females [%]	x	x	x	x	x	22.863	x	31.1313	20.4167	x	40.6083	21.1881	34.5611	25.7667	50.4056	45.2083	40.9786	41.3227	x	37.8192	x	x	x	63.3937	x	25.7857	30.831	34.6192	x	27.537	26.6467	32.9313	32.181	x	23.0286	x	17.2444	25.4591	41.2121	x	40.5524	34.9533	32.6833	34.9767	x	x	31.1729	x	37.9542	25.4958	x	x	x	31.6722	18.31	x	x	x	33.7727	35.6799	23.5139	x	x	33.8729	28.8208	30.725	35.6606	38.4562	41.4896	35.6917	x	22.1463	x	47.3733	x	25.4458	x	x	20.0167	x	x	22.2	40.3583	x	23.0056	24.02	x	38.8583	x	x	21.15	x	x	x	21.825	23.4292	17.4933	x	26.6262	x	x	x	
-11648	Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for females [n]	None	Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for females [n]	x	x	x	x	x	30.5556	x	49.625	28.5	x	8.5	35.0	25.8889	41.0	11.6667	38.3333	60.4286	21.2727	x	38.5385	x	x	x	27.375	x	16.1429	9.42857	36.6154	x	34.5556	38.3	25.5	34.0	x	24.5714	x	17.4444	12.1818	53.5455	x	50.4286	42.8	26.5833	47.1	x	x	42.375	x	27.25	25.0	x	x	x	45.4444	15.0	x	x	x	36.0	40.7083	14.1667	x	x	37.0	34.5	16.375	39.0	61.6667	49.875	31.1667	x	35.1111	x	31.2	x	31.75	x	x	27.875	x	x	21.8333	36.75	x	26.0	23.0	x	42.0	x	x	19.6667	x	x	x	35.6667	16.75	33.4	x	29.1429	x	x	x	
-11649	Original post publication description: Fear conditioning response, activity in altered context for females [units]	None	Central nervous system, behavior: Fear conditioning response, activity in altered context for females [units]	x	x	x	x	x	31.7222	x	40.625	43.8333	x	23.6667	36.619	35.4259	41.4167	15.0556	34.8333	41.119	36.3333	x	40.7821	x	x	x	26.75	x	30.9048	33.3095	51.8333	x	39.537	30.1167	27.3958	29.4524	x	38.7381	x	36.6296	23.7424	42.9545	x	36.7143	32.7667	33.5556	44.0	x	x	39.7083	x	29.2917	42.7708	x	x	x	41.7222	36.0333	x	x	x	36.7121	40.5	11.4444	x	x	42.7708	37.3333	37.2708	29.6667	34.8025	40.5833	38.0556	x	37.8889	x	32.0333	x	41.0	x	x	37.2292	x	x	49.6944	39.5	x	29.6111	32.5667	x	41.0417	x	x	42.0556	x	x	x	36.7222	42.4583	39.6667	x	32.5952	x	x	x	
-11650	Original post publication description: Fear conditioning response, baseline activity in apparatus for females [units]	None	Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for females [units]	x	x	x	x	x	35.9722	x	38.5	41.0	x	13.375	39.9643	26.75	34.125	18.0833	36.875	42.1429	20.4773	x	34.3846	x	x	x	31.125	x	18.2143	24.2857	40.6154	x	23.9722	25.45	21.4375	23.7143	x	38.3214	x	25.0556	13.6591	36.2045	x	42.1429	33.05	29.875	44.325	x	x	37.4375	x	23.4375	27.625	x	x	x	34.8889	15.3	x	x	x	28.9545	38.0312	21.0	x	x	35.3438	34.9375	29.75	22.2727	37.2315	36.8438	29.2917	x	35.9444	x	32.9	x	26.8125	x	x	24.25	x	x	36.75	33.875	x	27.5	29.35	x	40.375	x	x	29.5833	x	x	x	28.625	27.0	36.25	x	35.3571	x	x	x	
-11651	Original post publication description: Fear conditioning response, contextual activity for females [units]	None	Central nervous system, behavior: Fear conditioning response, contextual activity for females [units]	x	x	x	x	x	26.0222	x	11.9625	32.0	x	15.5833	16.4143	9.66667	16.25	5.93333	15.7917	35.9857	11.3727	x	19.3846	x	x	x	12.1625	x	14.9214	20.8571	24.1769	x	11.5	10.24	9.85625	16.3286	x	11.6	x	10.3444	5.15454	25.2545	x	25.3286	19.46	23.2458	29.34	x	x	16.3375	x	18.225	13.825	x	x	x	32.3889	5.56	x	x	x	22.4091	18.1187	2.86667	x	x	19.275	17.25	18.2625	10.2773	11.2648	28.6688	16.65	x	19.6167	x	15.06	x	19.275	x	x	19.65	x	x	28.3167	30.075	x	7.88333	11.06	x	25.425	x	x	6.7	x	x	x	13.95	6.4	20.06	x	15.2286	x	x	x	
-11652	Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for females [units]	None	Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for females [units]	x	x	x	x	x	12.8333	x	17.5625	3.08333	x	2.5	8.61905	4.16667	6.75	1.33333	8.30556	2.52381	8.34848	x	9.33333	x	x	x	1.72917	x	4.54762	6.73809	16.5897	x	8.40741	6.0	5.02083	5.02381	x	6.92857	x	9.62963	3.0303	10.1061	x	16.5952	9.23333	10.25	11.7	x	x	14.3333	x	7.125	12.7292	x	x	x	16.9815	1.9	x	x	x	7.4697	8.15278	4.55556	x	x	5.1875	3.125	10.2083	5.77273	5.05556	5.77083	12.9722	x	10.4815	x	7.53333	x	13.75	x	x	8.41667	x	x	16.1944	14.8958	x	4.27778	4.83333	x	8.91667	x	x	3.94444	x	x	x	10.8611	5.29167	9.96667	x	7.19048	x	x	x	
-11653	Original post publication description: Fear conditioning response, suppression of activity in altered context for females [units]	None	Central nervous system, behavior: Fear conditioning response, suppression of activity in altered context for females [units]	x	x	x	x	x	0.264403	x	0.303767	0.070847	x	0.064849	0.326699	0.117863	0.157382	0.091292	0.131842	0.013102	0.21245	x	0.211793	x	x	x	0.040411	x	0.156877	0.210121	0.331952	x	0.235225	0.312653	0.096904	0.159818	x	0.170742	x	0.256616	0.141369	0.248604	x	0.47071	0.305785	0.311311	0.272351	x	x	0.374913	x	0.271834	0.298039	x	x	x	0.405976	0.053272	x	x	x	0.201244	0.212319	0.464686	x	x	0.116615	0.081265	0.228567	0.227731	0.139697	0.1401	0.304711	x	0.281419	x	0.255427	x	0.331464	x	x	0.197971	x	x	0.323489	0.523537	x	0.135619	0.142611	x	0.202627	x	x	0.093116	x	x	x	0.303276	0.123186	0.266635	x	0.219737	x	x	x	
-11654	Original post publication description: Fear conditioning response, activity during first tone-shock pairing for females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for females [units]	x	x	x	x	x	31.7778	x	42.875	42.0	x	30.3333	35.8571	15.8889	19.5	21.0	31.3333	26.4286	22.0	x	34.2308	x	x	x	31.875	x	20.5714	29.5714	43.3846	x	25.7778	26.7	28.625	22.2857	x	27.5714	x	27.5556	24.2727	29.8182	x	30.1429	37.6	34.3333	30.4	x	x	42.0	x	25.25	34.375	x	x	x	38.7778	13.2	x	x	x	33.5455	25.625	21.0	x	x	36.25	26.75	33.0	29.2727	46.6667	32.875	43.5	x	27.6667	x	24.2	x	30.25	x	x	26.625	x	x	31.5	28.75	x	31.1667	21.4	x	34.25	x	x	30.3333	x	x	x	32.1667	35.25	40.2	x	24.7143	x	x	x	
-11655	Original post publication description: Fear conditioning response, activity during second tone-shock pairing for females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for females [units]	x	x	x	x	x	31.3333	x	20.0	23.5	x	17.0	26.4286	10.8889	23.5	12.3333	14.6667	26.7143	22.8182	x	26.9231	x	x	x	21.625	x	19.2857	26.5714	30.5385	x	24.8889	24.0	25.75	15.2857	x	16.2857	x	17.1111	17.6364	25.0909	x	26.0	30.2	31.4167	30.0	x	x	26.5	x	28.25	23.75	x	x	x	28.4444	10.4	x	x	x	22.8182	19.5833	16.6667	x	x	20.25	17.75	22.125	20.4545	29.9259	23.5	26.3333	x	23.4444	x	22.4	x	20.0	x	x	23.625	x	x	24.5	25.75	x	28.3333	16.6	x	14.25	x	x	23.0	x	x	x	24.6667	19.25	33.8	x	17.2857	x	x	x	
-11656	Original post publication description: Fear conditioning response, activity during third tone-shock pairing for females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for females [units]	x	x	x	x	x	14.8889	x	17.125	13.0	x	14.5	21.8571	7.77778	12.5	9.0	10.1667	27.0	15.0909	x	15.0	x	x	x	13.75	x	15.0	25.5714	23.3077	x	15.2222	18.9	24.25	13.7143	x	11.0	x	17.6667	20.0	20.2727	x	25.8571	30.6	18.9167	27.4	x	x	18.375	x	20.0	14.25	x	x	x	21.7778	6.2	x	x	x	22.6364	16.3333	16.0	x	x	17.125	12.5	15.25	16.6364	27.9259	22.25	24.3333	x	16.7778	x	22.4	x	23.25	x	x	18.5	x	x	21.6667	27.125	x	21.6667	12.2	x	18.25	x	x	24.5	x	x	x	19.8333	15.5	23.6	x	18.0	x	x	x	
-11657	Original post publication description: Fear conditioning response, activity after first tone-shock pairing for females [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after first tone-shock pairing for females [n beam breaks/30 sec test]	x	x	x	x	x	19.5556	x	4.40625	8.5	x	2.66667	17.25	5.55556	6.125	7.91667	7.66667	19.4286	16.0682	x	17.4038	x	x	x	12.6562	x	7.14286	11.3571	19.5385	x	14.0278	6.075	8.875	13.0714	x	9.10714	x	5.61111	1.90909	13.5455	x	14.9286	24.25	14.6458	23.1	x	x	19.125	x	13.4375	15.375	x	x	x	21.9167	3.6	x	x	x	16.0	17.2188	0.583333	x	x	9.53125	14.0625	11.1562	12.8636	10.9815	10.5938	19.5	x	14.3611	x	15.85	x	13.3125	x	x	12.0	x	x	21.4583	10.6875	x	7.70833	8.5	x	20.4375	x	x	10.1667	x	x	x	14.4583	11.3125	21.5	x	13.9643	x	x	x	
-11658	Original post publication description: Fear conditioning response, activity after second tone-shock pairing for females [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for females [n beam breaks/30 sec test]	x	x	x	x	x	12.7222	x	5.5625	4.875	x	2.875	13.3214	2.30556	4.25	4.58333	2.875	12.7857	8.84091	x	8.53846	x	x	x	4.34375	x	3.64286	12.8929	21.4231	x	7.41667	6.45	5.75	4.5	x	3.92857	x	5.16667	2.61364	7.84091	x	17.0	16.2	6.4375	20.75	x	x	7.625	x	14.125	5.875	x	x	x	18.4722	2.25	x	x	x	8.72727	13.4688	1.33333	x	x	5.625	9.1875	11.0	6.52273	8.65741	9.65625	16.4167	x	14.6944	x	11.2	x	12.3125	x	x	9.96875	x	x	12.75	8.90625	x	5.75	3.65	x	20.0	x	x	2.625	x	x	x	6.58333	4.8125	13.95	x	8.57143	x	x	x	
-11659	Original post publication description: Fear conditioning response, activity after third tone-shock pairing for females [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for females [n beam breaks/30 sec test]	x	x	x	x	x	8.44444	x	7.25	6.5	x	1.33333	19.5714	4.33333	10.5	14.0	4.5	8.57143	9.0	x	6.84615	x	x	x	9.0	x	6.57143	12.7143	14.8462	x	10.1111	8.7	7.125	4.71429	x	12.1429	x	6.0	1.81818	9.63636	x	14.8571	7.0	5.66667	21.9	x	x	6.5	x	3.5	6.5	x	x	x	10.6667	5.6	x	x	x	9.54545	7.95833	7.16667	x	x	10.875	4.0	7.5	9.09091	8.37037	13.0	18.8333	x	9.88889	x	13.0	x	7.75	x	x	5.625	x	x	7.16667	12.125	x	5.33333	2.8	x	12.5	x	x	3.66667	x	x	x	11.1667	6.0	9.6	x	8.42857	x	x	x	
-11660	Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for females [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for females [units]	x	x	x	x	x	0.263736	x	0.181384	0.167742	x	0.099437	0.483816	0.160755	0.306116	0.820547	0.118258	0.192899	0.450263	x	0.196751	x	x	x	0.317297	x	0.533989	0.632072	0.358838	x	0.43865	0.426535	0.302025	0.222676	x	0.315176	x	0.248715	0.143086	0.248572	x	0.35656	0.225752	0.19039	0.496873	x	x	0.219516	x	0.146025	0.251705	x	x	x	0.333014	0.630337	x	x	x	0.414747	0.216205	0.364532	x	x	0.295333	0.113991	0.286884	0.425944	0.22916	0.408989	0.743509	x	0.302854	x	0.453191	x	0.314854	x	x	0.23172	x	x	0.189251	0.378583	x	0.272224	0.089136	x	0.325465	x	x	0.123532	x	x	x	0.396497	0.188587	0.276833	x	0.228242	x	x	x	
-11661	Original post publication description: Open field behavior, percentage of distance in the center for females [%]	None	Open field behavior, percentage of distance in the center for females [%]	x	x	x	x	x	21.5691	x	29.1432	31.7203	x	25.1966	27.4659	17.4721	30.9176	18.4053	31.9107	28.7318	20.3419	x	33.368	x	x	x	40.9781	x	10.7646	15.6218	18.2967	x	23.3482	20.181	35.2807	27.5504	x	19.8347	x	31.4954	16.482	32.6517	x	31.2346	29.8493	24.807	23.463	x	x	30.4582	x	17.6804	17.8149	x	x	x	24.4075	14.5337	x	x	x	25.9094	25.9028	18.9444	x	x	26.8235	23.1917	24.4348	24.9442	35.5874	39.85	23.5273	x	19.7433	x	13.5595	x	34.9244	x	x	28.228	x	x	28.7228	17.9572	x	29.0621	21.1673	x	32.8822	x	x	29.6979	x	x	x	21.8183	21.5721	20.0511	x	35.0575	x	x	x	
-11662	Original post publication description: Open field behavior, percentage of time in center for females [%]	None	Open field behavior, percentage of time in center for females [%]	x	x	x	x	x	8.94167	x	19.3771	15.1667	x	5.45556	12.9821	6.54537	16.7667	8.13333	20.2903	17.4988	12.0417	x	17.3019	x	x	x	22.5917	x	7.04405	7.42143	9.63333	x	15.5954	9.37083	20.5802	16.6167	x	6.48333	x	14.6389	6.92348	18.4462	x	16.944	12.6683	13.0097	11.6833	x	x	16.7052	x	11.9438	7.46667	x	x	x	12.9583	7.13	x	x	x	16.0205	11.4017	10.9389	x	x	14.3188	10.5208	16.1656	18.0129	21.4667	24.8083	12.1056	x	9.31296	x	4.95833	x	22.6187	x	x	15.4083	x	x	13.525	9.44479	x	18.6111	10.7417	x	17.025	x	x	19.6125	x	x	x	9.22917	13.9667	7.76667	x	20.0036	x	x	x	
-11663	Original post publication description: Open field behavior, time in corners for females [min]	None	Open field behavior, time in corners for females [min]	x	x	x	x	x	39.1935	x	43.024	43.0062	x	25.0861	40.0643	38.975	38.4875	41.9917	46.1958	40.25	45.7212	x	40.7346	x	x	x	42.8417	x	24.0071	47.2726	44.4013	x	44.3639	35.87	44.3688	43.0226	x	28.75	x	44.163	36.3652	39.0689	x	39.6833	39.2117	43.6326	45.8625	x	x	45.124	x	34.9938	43.6698	x	x	x	42.4713	43.2967	x	x	x	40.8545	35.8247	34.6514	x	x	41.8063	43.8417	47.2938	45.4447	45.1769	45.0198	46.1889	x	34.6667	x	36.5617	x	51.2458	x	x	44.8258	x	x	40.6653	46.2042	x	45.2347	42.0133	x	41.6708	x	x	43.3014	x	x	x	39.0931	41.4625	37.6317	x	50.8119	x	x	x	
-11664	Original post publication description: Open field behavior, locomotion from 0-5 min for females [cm]	None	Open field behavior, locomotion from 0-5 min for females [cm]	x	x	x	x	x	451.556	x	804.625	496.75	x	108.333	815.286	227.333	795.0	360.333	594.5	766.0	300.727	x	632.077	x	x	x	458.5	x	136.143	213.714	819.846	x	402.889	440.6	406.875	329.143	x	436.286	x	334.667	118.091	750.182	x	832.571	527.2	385.0	601.4	x	x	554.125	x	586.75	400.625	x	x	x	717.778	170.6	x	x	x	503.909	490.042	298.0	x	x	543.875	702.25	368.375	475.182	597.963	768.875	262.167	x	365.667	x	366.0	x	511.25	x	x	595.9	x	x	385.0	393.5	x	490.667	361.6	x	765.0	x	x	599.667	x	x	x	404.833	460.5	478.8	x	451.429	x	x	x	
-11665	Original post publication description: Open field behavior, locomotion from 10-15 min for females [cm]	None	Open field behavior, locomotion from 10-15 min for females [cm]	x	x	x	x	x	272.444	x	731.125	302.25	x	228.667	496.429	308.556	677.5	175.0	401.167	524.857	366.0	x	441.923	x	x	x	428.5	x	284.143	286.571	820.769	x	351.444	412.3	388.25	292.429	x	176.286	x	281.667	205.091	613.455	x	460.714	318.6	422.667	477.5	x	x	382.375	x	560.25	389.875	x	x	x	636.0	175.8	x	x	x	514.182	381.333	231.0	x	x	630.75	349.75	468.875	550.273	599.926	677.125	488.167	x	427.0	x	437.2	x	576.5	x	x	510.7	x	x	365.0	342.25	x	495.833	377.8	x	520.5	x	x	503.667	x	x	x	413.333	572.25	607.8	x	396.143	x	x	x	
-11666	Original post publication description: Open field behavior, locomotion from 15-20 min for females [cm]	None	Open field behavior, locomotion from 15-20 min for females [cm]	x	x	x	x	x	277.222	x	686.125	322.5	x	238.667	519.571	256.0	673.5	271.667	438.5	612.714	380.545	x	431.615	x	x	x	430.875	x	203.286	270.857	713.231	x	378.111	360.7	327.0	307.143	x	169.429	x	293.444	163.818	573.455	x	400.429	356.8	367.0	454.8	x	x	359.75	x	565.0	380.5	x	x	x	652.222	166.4	x	x	x	490.091	358.042	215.167	x	x	592.75	322.5	488.0	570.0	598.667	613.375	589.667	x	394.444	x	340.2	x	517.5	x	x	537.8	x	x	370.333	314.375	x	492.333	373.2	x	573.0	x	x	498.667	x	x	x	272.167	534.0	607.8	x	321.429	x	x	x	
-11667	Original post publication description: Open field behavior locomotion from 5-10 min for females [cm]	None	Open field behavior locomotion from 5-10 min for females [cm]	x	x	x	x	x	348.556	x	747.75	517.0	x	227.167	578.429	292.667	569.5	331.333	468.0	600.429	376.364	x	521.615	x	x	x	453.125	x	255.0	254.429	951.0	x	408.778	502.4	377.375	297.143	x	301.286	x	350.889	125.818	625.818	x	574.286	344.0	454.417	590.3	x	x	430.625	x	591.0	428.75	x	x	x	647.222	211.2	x	x	x	582.455	409.25	239.333	x	x	641.375	412.25	459.625	520.182	604.593	683.875	414.833	x	395.556	x	453.8	x	650.75	x	x	534.6	x	x	378.5	381.0	x	484.5	344.4	x	556.75	x	x	474.167	x	x	x	398.167	524.5	560.8	x	430.143	x	x	x	
-11668	Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	None	Central nervous system, behavior: Open field activity, habituation ratio for females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	x	x	x	x	x	0.386532	x	0.469993	0.389388	x	0.739229	0.381068	0.555799	0.438077	0.430148	0.41748	0.491322	0.587473	x	0.401464	x	x	x	0.493233	x	0.582527	0.580669	0.471252	x	0.498233	0.476317	0.44661	0.480782	x	0.237611	x	0.489065	0.561503	0.429596	x	0.316014	0.393092	0.483296	0.408015	x	x	0.402197	x	0.488186	0.491483	x	x	x	0.478306	0.49765	x	x	x	0.49027	0.420176	0.416883	x	x	0.541481	0.317282	0.561927	0.555268	0.505668	0.443641	0.724383	x	0.535821	x	0.49765	x	0.530742	x	x	0.477231	x	x	0.536112	0.450469	x	0.4899	0.488498	x	0.428443	x	x	0.453708	x	x	x	0.387096	0.539348	0.551586	x	0.4194	x	x	x	
-11669	Original post publication description: Open field behavior, percentage time in perimeter minus time in corners for females [%]	None	Open field behavior, percentage time in perimeter minus time in corners for females [%]	x	x	x	x	x	51.8648	x	37.599	41.8271	x	69.4583	46.9536	54.4796	44.7458	49.875	33.5139	42.2512	42.2371	x	41.9635	x	x	x	34.5667	x	68.9488	45.306	45.9654	x	40.0407	54.7592	35.051	40.3607	x	64.7667	x	41.1981	56.7114	42.4848	x	43.3726	48.12	43.3576	42.4542	x	x	38.1708	x	53.0625	48.8635	x	x	x	44.5704	49.5733	x	x	x	43.125	52.7736	54.4097	x	x	43.875	45.6375	36.5406	36.5424	33.3565	30.1719	41.7056	x	56.0204	x	58.48	x	26.1354	x	x	39.7658	x	x	45.8097	44.351	x	36.1542	47.245	x	41.3042	x	x	37.0861	x	x	x	51.6778	44.5708	54.6017	x	29.1845	x	x	x	
-11670	Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-20 min for females [n beam breaks]	x	x	x	x	x	76.5556	x	99.0	95.0	x	33.6667	190.286	72.1111	88.5	39.3333	68.3333	138.429	70.7273	x	171.692	x	x	x	111.375	x	46.2857	59.4286	91.2308	x	95.1111	67.9	110.625	78.8571	x	59.4286	x	69.0	23.4545	151.0	x	131.429	139.6	110.833	128.4	x	x	118.0	x	171.75	143.125	x	x	x	129.667	22.2	x	x	x	126.455	97.9583	71.5	x	x	160.0	133.5	128.75	163.364	167.481	179.125	67.1667	x	138.889	x	126.2	x	114.75	x	x	124.9	x	x	57.6667	112.625	x	145.167	84.6	x	198.5	x	x	136.333	x	x	x	144.833	151.5	93.4	x	133.857	x	x	x	
-11671	Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-5 min for females [n beam breaks]	x	x	x	x	x	17.8889	x	22.375	20.75	x	3.16667	50.4286	5.88889	32.0	7.0	13.3333	28.2857	5.27273	x	40.4615	x	x	x	12.25	x	4.14286	5.57143	14.8462	x	15.5556	11.2	17.375	15.0	x	25.4286	x	12.4444	2.54545	37.1818	x	34.0	23.4	22.4167	32.7	x	x	29.5	x	36.25	32.125	x	x	x	32.3333	0.6	x	x	x	27.7273	21.2083	14.5	x	x	25.5	36.5	11.125	25.7273	29.8148	37.5	6.16667	x	28.1111	x	24.2	x	17.0	x	x	25.7	x	x	8.33333	17.5	x	26.0	18.2	x	37.75	x	x	25.1667	x	x	x	25.3333	15.75	10.0	x	18.4286	x	x	x	
-11672	Original post publication description: Open field behavior, vertical activity (rears) from 10-15 min for females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 10-15 min for females [n beam breaks]	x	x	x	x	x	18.0	x	23.75	20.0	x	10.6667	46.0	23.3333	16.5	9.33333	16.3333	35.2857	21.0909	x	41.2308	x	x	x	32.5	x	15.1429	17.5714	25.9231	x	25.6667	19.0	33.75	21.4286	x	7.57143	x	17.5556	9.72727	38.0	x	29.7143	44.0	30.5833	29.3	x	x	28.375	x	44.5	35.25	x	x	x	32.1111	9.6	x	x	x	31.5455	24.8333	18.6667	x	x	46.75	30.75	39.625	45.5455	45.3704	48.0	21.0	x	36.8889	x	33.8	x	30.75	x	x	30.6	x	x	13.8333	32.25	x	35.5	24.6	x	52.75	x	x	37.0	x	x	x	44.0	44.5	29.8	x	41.1429	x	x	x	
-11673	Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 15-20 min for females [n beam breaks]	x	x	x	x	x	17.8889	x	26.625	22.25	x	9.16667	44.1429	23.8889	18.0	13.0	22.8333	40.0	26.0	x	44.9231	x	x	x	37.25	x	13.5714	20.5714	24.6154	x	26.0	17.8	30.25	25.1429	x	9.0	x	18.6667	7.63636	35.9091	x	31.4286	36.8	31.5833	30.8	x	x	25.0	x	48.5	36.75	x	x	x	31.6667	9.4	x	x	x	29.1818	28.6667	18.0	x	x	46.0	27.75	47.0	53.4545	52.963	45.5	26.1667	x	38.6667	x	31.6	x	30.75	x	x	34.6	x	x	21.3333	31.375	x	42.1667	25.2	x	56.5	x	x	40.1667	x	x	x	35.0	50.5	32.0	x	35.7143	x	x	x	
-11674	Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 5-10 min for females [n beam breaks]	x	x	x	x	x	22.7778	x	26.25	32.0	x	10.6667	49.7143	19.0	22.0	10.0	15.8333	34.8571	18.3636	x	45.0769	x	x	x	29.375	x	13.4286	15.7143	25.8462	x	27.8889	19.9	29.25	17.2857	x	17.4286	x	20.3333	3.54545	39.9091	x	36.2857	35.4	26.25	35.6	x	x	35.125	x	42.5	39.0	x	x	x	33.5556	2.6	x	x	x	38.0	23.25	20.3333	x	x	41.75	38.5	31.0	38.6364	39.3333	48.125	13.8333	x	35.2222	x	36.6	x	36.25	x	x	34.0	x	x	14.1667	31.5	x	41.5	16.6	x	51.5	x	x	34.0	x	x	x	40.5	40.75	21.6	x	38.5714	x	x	x	
-11675	Original post publication description: Open field behavior, locomotion for entire test period for females [cm]	None	Open field behavior, locomotion for entire test period for females [cm]	x	x	x	x	x	1349.78	x	2969.62	1638.5	x	802.833	2409.71	1084.56	2715.5	1138.33	1902.17	2504.0	1423.64	x	2027.23	x	x	x	1771.0	x	878.571	1025.57	3304.85	x	1541.22	1716.0	1499.5	1225.86	x	1083.29	x	1260.67	612.818	2562.91	x	2268.0	1546.6	1629.08	2124.0	x	x	1726.88	x	2303.0	1599.75	x	x	x	2653.22	724.0	x	x	x	2090.64	1638.67	983.5	x	x	2408.75	1786.75	1784.88	2115.64	2401.15	2743.25	1754.83	x	1582.67	x	1597.2	x	2256.0	x	x	2179.0	x	x	1498.83	1431.12	x	1963.33	1457.0	x	2415.25	x	x	2076.17	x	x	x	1488.5	2091.25	2255.2	x	1599.14	x	x	x	
-11676	Original post publication description: Open field behavior, percentage distance in the perimeter for females [%]	None	Open field behavior, percentage distance in the perimeter for females [%]	x	x	x	x	x	78.4309	x	70.8568	68.2797	x	74.8034	72.5341	82.5279	69.0824	81.5947	68.0893	71.2682	79.6581	x	66.632	x	x	x	59.0219	x	89.2354	84.3782	81.7033	x	76.6517	79.819	64.7193	72.4496	x	80.1653	x	68.5046	83.518	67.3483	x	68.7654	70.1507	75.193	76.537	x	x	69.5418	x	82.3196	82.1851	x	x	x	75.5925	85.4663	x	x	x	74.0906	74.0972	81.0556	x	x	73.1765	76.8083	75.5652	75.0558	64.4126	60.15	76.4727	x	80.2567	x	86.4405	x	65.0756	x	x	71.772	x	x	71.2772	82.0428	x	70.9379	78.8327	x	67.1178	x	x	70.3021	x	x	x	78.1817	78.4279	79.9489	x	64.9425	x	x	x	
-11677	Original post publication description: Open field behavior, percentage of time in perimeter for females [%]	None	Open field behavior, percentage of time in perimeter for females [%]	x	x	x	x	x	91.0583	x	80.6229	84.8333	x	94.5444	87.0179	93.4546	83.2333	91.8667	79.7097	82.5012	87.9583	x	82.6981	x	x	x	77.4083	x	92.956	92.5786	90.3667	x	84.4046	90.6292	79.4198	83.3833	x	93.5167	x	85.3611	93.0765	81.5538	x	83.056	87.3317	86.9903	88.3167	x	x	83.2948	x	88.0563	92.5333	x	x	x	87.0417	92.87	x	x	x	83.9795	88.5983	89.0611	x	x	85.6813	89.4792	83.8344	81.9871	78.5333	75.1917	87.8944	x	90.687	x	95.0417	x	77.3812	x	x	84.5917	x	x	86.475	90.5552	x	81.3889	89.2583	x	82.975	x	x	80.3875	x	x	x	90.7708	86.0333	92.2333	x	79.9964	x	x	x	
-11678	Original post publication description: Startle response, baseline level for females [units]	None	Central nervous system, behavior: Startle response, baseline level for females [amplitude]	x	x	x	x	x	0.124323	x	0.136205	0.102045	x	0.064636	0.173	0.054325	0.086409	x	0.094591	0.055675	0.131773	x	0.112322	x	x	x	0.112216	x	0.142532	0.084	0.130661	x	0.10003	0.081055	0.065455	0.062662	x	0.069709	x	0.12102	0.071331	0.09619	x	0.076442	0.099636	0.095985	0.102709	x	x	0.115291	x	0.113477	0.115803	x	x	x	0.137291	0.098218	x	x	x	0.108657	0.091273	0.054273	x	x	0.066623	0.025545	0.133784	0.103831	0.121512	0.115398	0.114545	x	0.079899	x	0.02197	x	0.114636	x	x	0.086682	x	x	0.085455	0.141159	x	0.086955	0.077455	x	0.069273	x	x	0.089477	x	x	x	0.028545	0.121	0.221291	x	0.108974	x	x	x	
-11679	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	x	0.719746	x	1.02988	0.81925	x	0.948357	0.590459	1.5707	1.92696	x	0.490357	1.27387	0.737518	x	0.119291	x	x	x	1.01301	x	3.27919	0.657571	1.06245	x	2.62263	0.522357	0.75108	0.757439	x	0.756843	x	0.534397	0.829058	0.485922	x	0.139745	1.31336	1.44901	1.68587	x	x	3.47681	x	0.895536	0.634214	x	x	x	1.41053	1.22033	x	x	x	1.22902	0.781807	0.376071	x	x	0.821898	0.614143	0.247723	0.619102	0.847737	2.01863	1.29191	x	0.409905	x	0.623024	x	0.775786	x	x	0.666125	x	x	1.88755	0.677955	x	0.426393	0.875667	x	0.297214	x	x	1.59095	x	x	x	0.615536	3.6765	0.764329	x	1.00142	x	x	x	
-11680	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	x	0.770622	x	1.24983	0.5135	x	0.543833	0.479086	1.28033	1.9151	x	0.449833	0.496329	0.536637	x	0.105338	x	x	x	0.909325	x	3.01327	0.7769	0.887509	x	2.2065	0.48441	0.644038	0.645571	x	0.4715	x	0.524967	0.619245	0.360645	x	0.093086	0.8699	1.06858	1.24572	x	x	3.28074	x	0.6521	0.5315	x	x	x	1.00498	1.22906	x	x	x	1.16174	0.530112	0.3913	x	x	0.477129	0.53295	0.229587	0.361186	0.7909	1.5532	1.14833	x	0.443022	x	0.438033	x	0.85455	x	x	0.503463	x	x	1.22685	0.600612	x	0.3768	0.3559	x	0.2426	x	x	1.07973	x	x	x	0.537	2.6009	0.78366	x	0.694857	x	x	x	
-11681	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	x	0.542133	x	0.711712	0.32615	x	0.427617	0.358486	1.0839	1.4623	x	0.280617	0.198729	0.370588	x	0.094954	x	x	x	0.671612	x	1.94926	0.53014	0.568391	x	1.59179	0.28895	0.446937	0.499257	x	0.36174	x	0.426344	0.417182	0.286482	x	0.100443	0.39426	0.5018	0.9682	x	x	2.73232	x	0.30255	0.2667	x	x	x	0.56612	1.00876	x	x	x	1.07818	0.339471	0.27735	x	x	0.295629	0.41425	0.158675	0.172171	0.481386	1.12269	0.654567	x	0.297078	x	0.345867	x	0.50495	x	x	0.387587	x	x	1.07275	0.319487	x	0.205925	0.320533	x	0.3373	x	x	0.6159	x	x	x	0.384	1.92265	0.41982	x	0.277886	x	x	x	
-11682	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	x	0.375022	x	0.489488	0.23175	x	0.390217	0.374114	1.04821	1.43695	x	0.270033	0.175014	0.289637	x	0.097692	x	x	x	0.6346	x	1.57317	0.53262	0.476064	x	1.53428	0.28609	0.4276	0.369929	x	0.31276	x	0.440767	0.334518	0.295773	x	0.103457	0.3987	0.461183	0.59858	x	x	2.3735	x	0.21865	0.229017	x	x	x	0.47344	0.9048	x	x	x	0.976722	0.296025	0.22665	x	x	0.1962	0.3652	0.17575	0.188286	0.378336	0.963187	0.556067	x	0.241756	x	0.292733	x	0.46745	x	x	0.351388	x	x	1.03628	0.264288	x	0.19625	0.358667	x	0.2498	x	x	0.534575	x	x	x	0.29255	1.74185	0.36166	x	0.259	x	x	x	
-11683	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	x	-8.13248	x	-13.2447	37.9026	x	36.6549	16.8212	21.337	-0.949543	x	11.0234	62.3644	26.302	x	6.9075	x	x	x	16.8608	x	7.74532	-26.1948	15.9232	x	16.689	10.4971	8.37587	20.9267	x	36.6992	x	3.29247	19.3839	24.1118	x	31.6543	32.0111	25.3548	28.0579	x	x	6.89739	x	24.4176	15.5423	x	x	x	30.4637	1.16016	x	x	x	3.71022	32.9654	-8.15699	x	x	38.529	11.8917	6.46058	40.0655	5.28535	23.9094	13.1757	x	-7.94903	x	29.7377	x	-11.6459	x	x	27.1552	x	x	32.9707	6.33238	x	9.8158	59.4721	x	-4.90555	x	x	38.7742	x	x	x	11.0716	28.9691	-0.633259	x	34.7869	x	x	x	
-11684	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	x	28.4922	x	33.4127	61.3543	x	57.1939	35.0656	33.1596	23.1737	x	41.4743	83.4132	49.6382	x	16.136	x	x	x	37.2079	x	41.7908	13.5818	42.3663	x	38.9885	45.9525	31.5367	42.2912	x	50.1825	x	20.9774	44.69	35.3982	x	26.4771	69.0956	67.2802	44.0292	x	x	23.3257	x	65.1737	58.8972	x	x	x	60.54	20.6991	x	x	x	19.7518	56.0682	23.5079	x	x	61.7838	30.1002	34.0477	68.9413	44.4875	43.3394	50.593	x	25.8722	x	48.219	x	34.7349	x	x	42.6033	x	x	43.5956	50.9835	x	31.6007	64.2471	x	-16.2871	x	x	65.3809	x	x	x	38.4715	47.9003	43.5226	x	70.9693	x	x	x	
-11685	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	x	50.6708	x	51.1225	72.2281	x	61.8176	35.4641	35.5502	24.7378	x	36.9222	85.1805	61.2886	x	14.7205	x	x	x	45.3885	x	54.3546	16.2628	51.6874	x	42.4509	47.7412	35.3039	56.2488	x	59.264	x	19.0205	54.3475	34.3259	x	27.7858	70.3468	67.7301	64.8971	x	x	33.7379	x	75.2925	63.5255	x	x	x	66.4764	28.4193	x	x	x	29.0539	61.618	38.3069	x	x	69.1859	36.4804	24.2115	65.6362	52.4535	52.9066	57.6334	x	40.3651	x	59.296	x	39.9124	x	x	48.3482	x	x	45.9483	57.7309	x	35.8101	60.5934	x	9.53289	x	x	67.4968	x	x	x	51.578	52.5113	51.22	x	73.2082	x	x	x	
-11689	Original post publication description: Depression assay, immobility using a tail suspension test for females [sec below threshold movement level]	None	Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for females [sec below threshold movement level]	x	x	x	x	x	x	x	x	x	x	x	143.2	196.0	x	x	60.5	144.0	x	x	204.0	x	x	x	x	x	x	83.0	x	x	x	147.6	x	165.5	x	112.0	x	x	x	16.0	x	128.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	51.0	161.0	x	x	170.4	x	x	x	x	x	x	x	178.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11690	Original post publication description: Activity level, locomotion in zero maze for females [n beam breaks]	None	Central nervous system, behavior: Activity level, locomotion in zero maze for females [n beam breaks]	x	x	x	x	x	538.857	x	698.5	478.0	x	425.0	662.4	453.286	705.5	538.0	499.667	576.571	457.0	x	624.182	x	x	x	462.25	x	497.429	407.333	718.875	x	507.625	602.1	412.375	516.2	x	655.0	x	445.889	393.909	560.909	x	629.143	417.4	449.091	603.75	x	x	470.0	x	350.75	494.875	x	x	x	588.556	495.2	x	x	x	519.091	586.208	462.25	x	x	672.6	516.0	590.375	476.222	553.0	560.5	601.833	x	649.857	x	375.667	x	485.75	x	x	547.8	x	x	472.5	521.875	x	544.333	511.0	x	571.25	x	x	625.333	x	x	x	552.5	834.0	592.2	x	467.286	x	x	x	
-11691	Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for females [n]	None	Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for females [n]	x	x	x	x	x	92.4286	x	133.25	82.25	x	35.75	137.0	24.8571	33.5	50.3333	35.6667	42.2857	74.8889	x	51.0909	x	x	x	66.625	x	46.2857	53.3333	90.0	x	87.5	114.2	67.75	108.8	x	71.4286	x	29.1111	42.9091	89.8182	x	100.714	90.8	67.5455	62.625	x	x	130.375	x	109.5	78.125	x	x	x	61.5556	57.2	x	x	x	109.818	99.2917	86.25	x	x	51.2	85.0	45.125	100.444	88.3333	85.0	90.1667	x	79.8571	x	40.3333	x	31.5	x	x	110.7	x	x	100.5	71.375	x	62.1667	107.6	x	118.5	x	x	117.167	x	x	x	125.5	92.75	102.8	x	90.0	x	x	x	
-11692	Original post publication description: Anxiety assay, entries into open quadrants of a zero maze for females [n]	None	Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for females [n]	x	x	x	x	x	92.1429	x	132.5	82.5	x	35.75	136.8	25.0	33.5	50.3333	35.5	42.4286	74.8889	x	51.3636	x	x	x	67.0	x	46.4286	53.3333	89.875	x	87.625	113.8	68.125	108.4	x	71.4286	x	29.1111	42.9091	89.6364	x	100.714	91.0	67.5455	62.75	x	x	130.625	x	109.75	78.0	x	x	x	61.5556	57.2	x	x	x	109.727	98.9167	86.0	x	x	51.2	85.25	45.125	100.111	88.2963	85.375	90.3333	x	80.1429	x	40.3333	x	31.25	x	x	110.3	x	x	100.0	71.5	x	62.1667	107.4	x	118.75	x	x	117.333	x	x	x	125.167	93.0	103.0	x	90.0	x	x	x	
-11693	Original post publication description: Zero maze, latency to enter an open quadrant for females [sec]	None	Zero maze, latency to enter an open quadrant for females [sec]	x	x	x	x	x	22.7429	x	25.9125	36.025	x	13.15	4.02	12.9429	24.6	67.7667	17.1833	10.1286	40.2889	x	52.0273	x	x	x	18.2125	x	126.3	63.7833	11.2714	x	22.1625	10.86	74.275	23.62	x	21.2429	x	48.4	20.36	19.1909	x	11.6571	30.02	11.2	26.325	x	x	6.8375	x	24.175	19.475	x	x	x	13.1778	54.02	x	x	x	14.0	21.125	27.8	x	x	38.1	22.75	34.3875	21.4778	26.4852	35.4	45.4167	x	16.4429	x	66.3667	x	108.25	x	x	8.73	x	x	22.55	42.4625	x	62.2	37.8	x	30.475	x	x	16.3333	x	x	x	17.2833	39.75	16.94	x	16.3286	x	x	x	
-11694	Original post publication description: Anxiety assay, percentage time in open quadrants of a zero maze for females [%]	None	Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for females [%]	x	x	x	x	x	13.5524	x	24.3625	18.2167	x	5.15	20.14	7.37143	2.86667	10.2222	3.66667	9.75238	11.6556	x	5.25151	x	x	x	19.2083	x	6.87619	16.7333	14.6667	x	12.4667	22.0933	17.4125	25.2667	x	10.2905	x	5.4037	7.57879	32.6879	x	18.6095	35.6	19.3485	15.3542	x	x	35.375	x	33.125	17.1458	x	x	x	9.94815	5.6	x	x	x	36.1303	22.1431	21.4917	x	x	5.72667	28.15	9.8625	29.0259	21.1556	16.4917	24.7056	x	11.781	x	8.54444	x	7.475	x	x	22.9567	x	x	25.0167	18.3375	x	15.5833	19.7733	x	24.1333	x	x	15.1778	x	x	x	28.3167	11.875	24.72	x	26.2048	x	x	x	
-11695	Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for females [sec]	x	x	x	x	x	259.343	x	226.913	245.35	x	284.55	239.58	278.771	291.4	269.333	289.0	270.743	251.178	x	284.245	x	x	x	242.375	x	279.371	249.8	256.0	x	251.65	233.72	247.762	217.84	x	269.129	x	283.789	277.264	201.936	x	244.171	193.2	241.955	271.663	x	x	193.875	x	176.15	248.562	x	x	x	270.156	283.2	x	x	x	191.609	233.571	235.525	x	x	282.82	215.55	270.413	212.922	236.533	250.525	225.883	x	264.657	x	274.367	x	277.575	x	x	231.13	x	x	224.95	244.988	x	253.25	240.68	x	227.6	x	x	254.467	x	x	x	215.05	264.375	225.84	x	221.386	x	x	x	
-11696	Original post publication description: Anxiety assay, time in open quadrants of a zero maze for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for females [sec]	x	x	x	x	x	40.6571	x	73.0875	54.65	x	15.45	60.42	21.2286	8.6	30.6667	11.0	29.2571	48.8222	x	15.7545	x	x	x	57.625	x	20.6286	50.2	44.0	x	48.35	66.28	52.2375	82.16	x	30.8714	x	16.2111	22.7364	98.0636	x	55.8286	106.8	58.0455	28.3375	x	x	106.125	x	123.85	51.4375	x	x	x	29.8444	16.8	x	x	x	108.391	66.4292	64.475	x	x	17.18	84.45	29.5875	87.0778	63.4667	49.475	74.1167	x	35.3429	x	25.6333	x	22.425	x	x	68.87	x	x	75.05	55.0125	x	46.75	59.32	x	72.4	x	x	45.5333	x	x	x	84.95	35.625	74.16	x	78.6143	x	x	x	
-11697	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for females [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for females [cm]	x	x	x	x	1488.92	795.097	x	892.64	x	1047.02	1004.0	2256.69	826.64	597.89	724.77	1338.81	1700.62	908.006	341.965	1904.56	x	x	x	16.92	x	491.775	240.615	1693.09	x	1687.33	1197.03	1341.23	1151.42	x	x	x	216.995	1371.01	882.955	x	1943.99	400.653	488.478	1780.76	x	x	859.605	x	1431.69	1800.52	x	x	x	1456.8	1795.94	x	x	x	333.238	823.662	289.205	453.958	x	1893.02	1434.44	393.812	936.62	670.463	1087.06	1899.48	x	1947.83	x	942.505	x	x	x	x	1123.33	x	x	836.475	322.58	394.32	688.307	490.702	x	636.275	1036.06	x	1124.14	x	x	x	808.472	x	1053.44	1198.48	1361.54	x	x	x	
-11698	Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for females [cm]	x	x	x	x	818.265	758.173	x	891.8	x	829.242	677.933	914.05	428.703	767.198	194.048	461.41	865.725	362.376	795.815	859.11	x	x	x	59.56	x	375.35	365.935	987.64	x	1080.93	626.86	589.604	695.612	x	x	x	449.335	450.677	806.885	x	915.302	506.568	516.227	1215.42	x	x	668.72	x	666.835	690.133	x	x	x	1124.3	919.935	x	x	x	692.2	549.875	348.305	204.545	x	1233.99	474.812	269.415	800.16	1024.65	682.156	767.45	x	532.82	x	670.667	x	x	x	x	593.278	x	x	399.085	801.18	779.552	606.148	503.428	x	833.343	555.475	x	894.703	x	x	x	826.975	x	1060.88	694.272	524.905	x	x	x	
-11699	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for females [cm]	x	x	x	x	1017.22	656.217	x	689.995	x	453.135	724.477	2143.48	336.4	394.772	512.278	1478.57	1454.1	783.756	281.2	1685.88	x	x	x	118.18	x	870.095	245.223	1639.06	x	1054.26	788.43	1125.76	1123.34	x	x	x	236.17	1339.54	730.545	x	1745.91	106.767	509.293	1814.48	x	x	762.245	x	1119.15	1351.69	x	x	x	787.345	994.407	x	x	x	351.482	884.612	286.997	245.363	x	1692.03	959.19	354.538	726.52	216.297	1097.81	1643.75	x	1764.99	x	1078.07	x	x	x	x	926.927	x	x	926.04	306.957	842.6	588.662	554.237	x	948.42	972.725	x	903.373	x	x	x	692.315	x	636.812	1091.71	767.765	x	x	x	
-11700	Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for females [cm]	x	x	x	x	271.948	316.332	x	528.568	x	468.707	331.04	692.73	359.357	587.7	85.0225	312.685	342.388	298.232	241.975	540.196	x	x	x	186.63	x	307.677	111.54	544.707	x	951.037	322.12	366.7	268.798	x	x	x	277.83	232.4	529.958	x	384.64	234.615	225.895	756.72	x	x	635.63	x	455.155	477.807	x	x	x	721.715	684.175	x	x	x	389.562	203.852	104.308	174.005	x	944.795	179.87	406.065	538.245	755.663	442.238	481.733	x	296.413	x	464.163	x	x	x	x	310.698	x	x	324.28	279.44	491.302	518.828	254.185	x	485.897	335.335	x	380.59	x	x	x	335.188	x	410.47	599.855	193.685	x	x	x	
-11701	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for females [cm]	x	x	x	x	1465.15	640.078	x	534.438	x	643.795	464.77	1540.44	493.763	281.508	360.065	1489.96	1318.63	651.04	441.77	1388.55	x	x	x	27.08	x	496.122	338.885	1844.69	x	1240.71	986.98	946.026	851.818	x	x	x	417.8	1106.03	941.622	x	1527.42	591.393	583.508	1310.02	x	x	913.505	x	863.41	1215.89	x	x	x	682.79	572.7	x	x	x	342.412	889.715	269.155	267.638	x	1766.11	902.992	623.403	704.94	225.51	1517.39	1442.27	x	1353.01	x	1344.68	x	x	x	x	1108.1	x	x	1069.29	280.17	849.208	460.592	694.455	x	1016.98	1133.39	x	1079.33	x	x	x	556.487	x	748.872	1194.94	660.39	x	x	x	
-11702	Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for females [cm]	None	Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for females [cm]	x	x	x	x	333.908	191.868	x	456.77	x	356.98	219.543	470.74	384.103	523.115	80.735	137.24	246.423	202.88	288.75	438.674	x	x	x	152.98	x	330.9	134.055	503.095	x	731.438	141.71	395.712	378.915	x	x	x	299.64	264.22	337.783	x	289.665	273.823	145.617	387.57	x	x	382.485	x	360.147	544.073	x	x	x	565.795	500.138	x	x	x	201.208	224.163	203.745	178.877	x	705.97	121.72	329.323	433.758	660.607	341.394	384.193	x	254.035	x	232.19	x	x	x	x	306.188	x	x	217.755	192.688	371.615	531.148	190.672	x	464.43	175.72	x	365.937	x	x	x	228.225	x	313.457	539.685	157.97	x	x	x	
-11703	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for females [cm]	x	x	x	x	967.182	529.783	x	440.638	x	558.833	289.51	1540.78	242.197	239.923	341.025	1192.86	1268.19	478.558	306.24	1072.85	x	x	x	0.0	x	365.255	346.122	1584.52	x	1049.93	924.245	731.646	835.568	x	x	x	377.925	908.18	1354.2	x	1029.37	237.443	694.475	1332.85	x	x	762.905	x	416.743	1012.51	x	x	x	457.075	515.017	x	x	x	325.103	935.422	196.34	384.003	x	1319.94	572.275	753.263	537.157	278.737	1210.88	1243.04	x	1097.67	x	1132.71	x	x	x	x	1003.5	x	x	1049.9	268.108	602.105	495.772	744.615	x	622.932	960.23	x	958.667	x	x	x	483.55	x	868.91	1153.69	515.98	x	x	x	
-11704	Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for females [cm]	None	Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for females [cm]	x	x	x	x	338.592	172.565	x	300.0	x	368.13	421.227	522.565	194.333	391.165	158.135	155.645	301.342	230.466	327.345	458.128	x	x	x	40.0	x	216.863	146.55	479.025	x	611.073	114.54	407.65	457.455	x	x	x	224.64	264.927	460.408	x	267.802	356.79	84.035	559.35	x	x	262.025	x	213.857	569.057	x	x	x	714.835	206.315	x	x	x	342.007	306.43	106.387	136.92	x	633.515	105.577	367.922	693.155	711.397	334.328	231.113	x	252.828	x	216.852	x	x	x	x	247.653	x	x	213.185	215.935	362.823	423.312	230.81	x	426.655	138.29	x	447.81	x	x	x	244.88	x	244.727	674.563	289.42	x	x	x	
-11705	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for females [cm]	x	x	x	x	3175.75	1182.24	x	380.573	x	679.725	833.017	4881.29	-1522.22	-755.085	1420.2	4433.23	3985.67	1727.41	-282.71	3755.72	x	x	x	-276.99	x	992.458	412.765	4246.9	x	1657.75	2691.46	2385.0	2161.37	x	x	x	-2.555	3512.53	1774.3	x	4389.29	-369.603	1303.98	3319.05	x	x	1349.4	x	1177.26	1754.38	x	x	x	257.36	597.987	x	x	x	-279.892	2249.09	278.953	656.617	x	3152.81	2986.92	752.29	439.92	-1761.31	3113.02	4364.06	x	2223.32	x	2567.28	x	x	x	x	2481.17	x	x	2727.39	-311.427	682.94	153.9	1304.91	x	1014.28	2897.59	x	1976.47	x	x	x	905.557	x	1278.5	2130.45	2139.69	x	x	x	
-11706	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for females [cm]	x	x	x	x	4938.46	2621.18	x	2557.71	x	2702.78	2482.76	7481.38	1899.0	1514.09	1938.14	5500.21	5741.55	2821.36	1371.18	6051.83	x	x	x	162.18	x	2223.25	1170.84	6761.37	x	5032.23	3896.69	4144.67	3962.15	x	x	x	1248.89	4724.76	3909.33	x	6246.69	1002.19	2275.75	6238.1	x	x	3298.26	x	2873.25	4035.45	x	x	x	3384.0	2908.55	x	x	x	1345.08	3533.41	1041.7	1350.96	x	6671.09	3868.9	2125.01	2905.24	1391.01	4913.14	6228.55	x	3559.42	x	4151.16	x	x	x	x	3938.99	x	x	3881.7	1177.81	2688.23	2233.33	2484.01	x	3224.61	4102.41	x	4065.51	x	x	x	2540.82	x	3308.03	4638.83	3305.67	x	x	x	
-11707	Original post publication description: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for females [cm]	None	Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for females [cm]	x	x	x	x	1762.71	1438.94	x	2177.14	x	2023.06	1649.74	2600.08	3421.22	2269.18	517.94	1066.98	1755.88	1093.95	1653.89	2296.11	x	x	x	439.17	x	1230.79	758.08	2514.47	x	3374.48	1205.23	1759.67	1800.78	x	x	x	1251.44	1212.22	2135.03	x	1857.41	1371.8	971.775	2919.05	x	x	1948.86	x	1695.99	2281.07	x	x	x	3126.65	2310.56	x	x	x	1624.98	1284.32	762.745	694.347	x	3518.27	881.98	1372.72	2465.32	3152.31	1800.12	1864.49	x	1336.1	x	1583.87	x	x	x	x	1457.82	x	x	1154.31	1489.24	2005.29	2079.44	1179.09	x	2210.32	1204.82	x	2089.04	x	x	x	1635.27	x	2029.53	2508.38	1165.98	x	x	x	
-11708	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for females [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for females [cm]	x	x	x	x	670.653	36.9233	x	0.84	x	217.78	326.07	1342.64	397.937	-169.307	530.722	877.395	834.9	545.63	-453.85	1045.45	x	x	x	-42.64	x	116.425	-125.32	705.453	x	606.4	570.17	751.628	455.81	x	x	x	-232.34	920.333	76.07	x	1028.69	-206.077	-27.75	565.34	x	x	190.885	x	406.935	660.255	x	x	x	332.495	427.022	x	x	x	-358.962	273.788	-59.1	249.413	x	659.02	959.633	124.397	136.46	-354.183	404.9	1132.03	x	1090.37	x	271.837	x	x	x	x	530.052	x	x	437.39	-478.6	-385.233	82.16	-12.7267	x	-197.068	480.59	x	229.437	x	x	x	-18.5025	x	-7.4375	504.21	836.63	x	x	x	
-11709	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for females [cm]	x	x	x	x	628.59	357.218	x	140.637	x	190.702	-131.717	1018.21	47.8633	-151.242	182.89	1037.21	966.85	248.092	-21.105	614.72	x	x	x	-40.0	x	148.393	199.572	1105.5	x	438.858	809.705	323.996	378.113	x	x	x	153.285	643.253	893.797	x	761.568	-178.708	610.44	773.505	x	x	500.88	x	98.7	190.322	x	x	x	-257.76	179.947	x	x	x	-16.9033	628.992	89.9525	247.083	x	686.425	466.698	385.34	-155.997	-432.66	876.554	1011.93	x	661.898	x	915.862	x	x	x	x	755.85	x	x	836.71	52.1725	239.283	72.46	513.805	x	196.277	821.94	x	510.857	x	x	x	238.67	x	624.182	479.13	226.56	x	x	x	
-11710	Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for females [mg/dl XX min after injection]	None	Pharmacology, metabolism: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for females [mg/dl XX min after injection]	x	x	x	x	288.625	258.4	x	172.05	x	263.425	223.933	249.1	251.167	255.9	272.65	x	293.1	142.58	330.5	232.08	x	x	x	x	x	268.75	271.9	216.6	x	274.2	260.1	259.2	236.867	x	x	x	276.4	227.8	236.467	x	212.7	282.1	367.3	208.7	x	x	237.4	x	219.6	246.35	x	x	x	297.1	259.75	x	x	x	319.5	254.55	259.7	284.267	x	299.6	271.05	297.5	282.25	269.3	281.48	269.933	x	190.52	x	194.0	x	x	x	x	254.883	x	x	246.2	307.3	300.1	274.45	188.55	x	291.2	212.8	x	342.067	x	x	x	178.425	x	281.6	270.75	229.9	x	x	x	
-11711	Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for females [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for females [n]	x	x	x	x	67.75	56.6	x	65.5	x	47.0	72.0	78.0	27.0	54.5	72.25	x	36.5	x	56.0	51.0	x	x	x	x	x	37.6667	40.5	124.0	x	45.5	72.0	80.75	46.1667	x	x	x	32.5	69.3333	x	x	43.5	65.0	94.25	122.0	x	x	83.0	x	44.6667	58.75	x	x	x	150.5	65.75	x	x	x	66.8333	52.75	43.5	48.6667	x	97.0	54.0	44.75	70.0	53.3333	53.0	59.0	x	78.5	x	93.3333	x	x	x	x	74.4	x	x	72.5	47.25	52.0	41.0	39.1667	x	42.25	68.0	x	36.3333	x	x	x	39.75	x	70.5	47.4	65.5	x	x	x	
-11712	Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for females [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for females [n]	x	x	x	x	66.0	27.2	x	87.5	x	49.0	52.0	94.0	21.0	41.5	43.75	x	48.75	x	48.5	67.5	x	x	x	x	x	34.0	9.75	44.3333	x	22.0	47.0	67.75	56.1667	x	x	x	26.0	47.6667	x	x	41.0	36.5	9.25	52.0	x	x	103.0	x	46.6667	87.25	x	x	x	76.5	63.25	x	x	x	34.6667	36.75	43.75	4.66667	x	34.0	42.0	41.25	15.75	44.6667	46.2	43.6667	x	91.0	x	18.0	x	x	x	x	54.4	x	x	29.75	20.0	34.25	28.0	22.1667	x	28.75	51.0	x	13.0	x	x	x	69.75	x	47.25	52.4	78.0	x	x	x	
-11713	Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for females [%]	x	x	x	x	43.1448	59.4847	x	43.94	x	42.9938	63.0687	43.85	56.25	49.9185	61.7221	x	24.6827	x	38.0952	37.6284	x	x	x	x	x	38.5518	66.4775	73.6705	x	69.4	60.0082	37.3007	43.0348	x	x	x	27.7778	61.7177	x	x	45.9399	48.075	91.3726	70.11	x	x	46.23	x	47.3567	42.475	x	x	x	66.3	64.5	x	x	x	71.55	43.388	50.0896	94.6667	x	74.25	55.3413	44.0608	37.2768	53.1	51.2655	39.3649	x	52.6613	x	84.525	x	x	x	x	59.237	x	x	66.466	64.769	66.5944	32.0	50.3466	x	55.4658	58.7779	x	88.9667	x	x	x	30.3809	x	57.4239	50.51	45.9438	x	x	x	
-11714	Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for females [%]	x	x	x	x	56.8552	40.5153	x	56.06	x	57.0062	36.9313	56.15	43.75	50.0815	38.2779	x	50.3173	x	61.9048	62.3716	x	x	x	x	x	61.4482	33.5225	26.3295	x	30.6	39.9918	62.6993	56.9652	x	x	x	22.2222	38.2823	x	x	54.0601	51.925	8.62738	29.89	x	x	53.77	x	52.6433	57.525	x	x	x	33.7	35.5	x	x	x	28.45	56.612	49.9104	5.33325	x	25.75	44.6587	55.9392	37.7232	46.9	48.7345	27.3018	x	47.3387	x	15.475	x	x	x	x	40.763	x	x	33.534	35.231	33.4056	68.0	49.6534	x	44.5342	41.2221	x	11.0333	x	x	x	69.6191	x	42.5761	49.49	54.0562	x	x	x	
-11715	Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for females [%]	x	x	x	x	28.6033	47.9953	x	10.735	x	37.9608	46.9311	44.27	23.135	33.1842	66.7125	x	20.82	x	33.5467	31.8733	x	x	x	x	x	34.1044	52.3675	68.3011	x	52.6575	48.1183	35.7142	33.7494	x	x	x	25.7317	62.2708	36.86	x	37.0817	40.4492	90.9608	68.305	x	x	44.22	x	49.755	40.0642	x	x	x	71.6	65.235	x	x	x	73.5694	45.3108	56.4317	96.9367	x	68.9	43.465	44.0458	36.5292	46.92	39.9147	28.79	x	46.3917	x	78.1556	x	x	x	x	58.686	x	x	64.6325	32.7292	56.2975	29.5975	40.7867	x	55.7758	73.5617	x	85.7956	x	x	x	31.0842	x	40.3392	43.414	51.63	x	x	x	
-11716	Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for females [%]	x	x	x	x	53.1958	39.566	x	78.235	x	52.0783	44.1811	50.1283	17.325	43.31	26.8325	x	30.9242	x	60.7967	44.7767	x	x	x	x	x	47.0744	29.8375	25.0044	x	33.9875	42.5783	58.92	41.415	x	x	x	16.4933	31.4783	12.405	x	40.1267	24.2517	4.30167	28.01	x	x	46.09	x	46.5958	48.6017	x	x	x	24.8	25.1333	x	x	x	16.5894	29.21	35.115	1.87889	x	19.2	24.9292	51.675	31.1475	16.2789	45.5087	28.6211	x	44.1617	x	7.08222	x	x	x	x	31.1193	x	x	22.7125	24.0442	34.1983	57.0542	42.0389	x	39.4583	21.33	x	7.86667	x	x	x	58.895	x	30.4917	42.9773	40.215	x	x	x	
-11717	Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for females [sec]	x	x	x	x	16.95	5.57778	x	17.5833	x	16.6667	11.1667	3.05	-1.3	26.9583	3.68333	29.4333	23.675	-2.84667	15.4	-7.43333	x	x	x	7.7	x	-16.3333	-6.1	10.8056	x	9.95	20.2667	7.78667	55.9833	x	x	x	-1.76667	21.7667	-15.4333	x	9.76667	2.26667	11.7583	-2.15	x	x	3.46667	x	7.85	11.4667	x	x	x	-0.6	-4.7	x	x	x	19.5778	6.21667	3.03333	-1.37778	x	0.633333	-0.25	1.18333	12.35	15.5556	8.32667	2.81111	x	24.8389	x	-13.5583	x	x	x	x	16.1111	x	x	-11.2417	-0.466667	1.64167	0.955833	23.6222	x	10.6075	-0.55	x	-19.8778	x	x	x	2.05833	x	-16.575	0.677778	-9.93333	x	x	x	
-11718	Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for females [sec]	None	Ethanol response (2.25 g/kg ip), duration on rotarod following injection for females [sec]	x	x	x	x	27.1258	37.2994	x	37.5	x	28.9167	39.3311	26.3167	23.9678	21.2675	26.7167	x	30.4325	40.16	12.4667	42.0933	x	x	x	17.3667	x	40.3417	57.8925	27.1672	x	32.89	36.5167	42.4267	35.1267	x	x	x	10.0667	43.275	34.5842	x	21.8917	24.115	20.525	37.35	x	x	22.965	x	49.2075	34.9	x	x	x	33.6	21.38	x	x	x	25.8156	33.7167	39.875	27.9544	x	40.53	35.3767	14.0333	45.8667	46.6222	25.0267	33.7667	x	53.38	x	54.05	x	x	x	x	35.7556	x	x	31.625	30.9758	42.9833	42.9617	19.6111	x	10.7258	56.0167	x	40.5756	x	x	x	29.4333	x	35.7758	43.2222	43.6	x	x	x	
-11719	Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for females [sec]	x	x	x	x	-2.7	-6.96667	x	0.016667	x	-13.15	10.5667	9.35	-3.43333	-17.4417	-5.30833	21.55	-23.7917	-2.06667	-11.25	0.026667	x	x	x	5.83333	x	2.575	-18.775	-0.088889	x	4.525	-3.21667	-3.57333	-46.0978	x	x	x	14.5667	-17.1333	2.18333	x	9.225	1.43333	-6.825	-13.0	x	x	1.81667	x	-16.925	-20.9083	x	x	x	5.75	-0.658333	x	x	x	-2.98889	-4.45	-8.51667	0.45	x	-4.85	-0.875	-3.575	-19.4917	-6.66667	-7.16667	3.28889	x	-21.2167	x	-3.16667	x	x	x	x	-3.98889	x	x	0.991667	3.29167	-5.925	-3.25	-9.83333	x	2.1	-7.51667	x	11.5667	x	x	x	-4.75	x	10.7583	-0.211111	-11.3	x	x	x	
-11720	Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for females [sec]	None	Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for females [sec]	x	x	x	x	44.075	42.8789	x	55.0825	x	45.5833	50.4989	29.3667	22.6667	48.225	30.4008	58.8667	54.1067	37.3133	27.8667	34.66	x	x	x	25.0667	x	24.0075	51.79	37.9722	x	42.84	56.7833	50.2133	91.1117	x	x	x	8.3	65.0417	19.1508	x	31.6583	26.3825	32.2833	35.2	x	x	26.435	x	57.0575	46.3675	x	x	x	33.0	16.685	x	x	x	45.3939	39.9333	42.9075	26.5833	x	41.17	35.1233	15.2158	58.2167	62.1778	33.3533	36.5778	x	69.3222	x	40.4917	x	x	x	x	51.8667	x	x	20.3833	30.5092	44.625	43.9167	43.2333	x	21.3333	55.4667	x	31.0483	x	x	x	31.4917	x	25.6	43.8933	33.6667	x	x	x	
-11721	Original post publication description: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for females [sec]	None	Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for females [sec]	x	x	x	x	14.25	-1.38889	x	17.6	x	3.51667	21.7333	12.4	-4.73333	9.51667	-1.625	50.9833	-0.116667	-4.91333	4.15	-7.40667	x	x	x	13.5333	x	-13.7583	-24.875	10.7167	x	14.475	17.05	4.21333	9.88556	x	x	x	12.8	4.63333	-13.25	x	18.9917	3.7	4.93333	-15.15	x	x	5.28333	x	-9.075	-9.44167	x	x	x	5.15	-5.35833	x	x	x	16.5889	1.76667	-5.48333	-0.927778	x	-4.21667	-1.125	-2.39167	-7.14167	8.88889	1.16	6.1	x	3.62222	x	-16.725	x	x	x	x	12.1222	x	x	-10.25	2.825	-4.28333	-2.29417	13.7889	x	12.7075	-8.06667	x	-8.31111	x	x	x	-2.69167	x	-5.81667	0.466667	-21.2333	x	x	x	
-11722	Original post publication description: Motor coordination, rotarod performance, untreated training trial for females [sec]	None	Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for females [sec]	x	x	x	x	41.3733	35.9117	x	55.1	x	32.4333	61.0667	38.7167	19.2333	30.7842	25.09	50.9833	30.3175	35.2467	16.6167	34.6867	x	x	x	30.9	x	26.585	33.0175	37.8833	x	47.3675	53.5667	46.64	45.0122	x	x	x	22.8667	47.91	21.3333	x	40.8833	27.8175	25.4583	22.2	x	x	28.25	x	40.1325	25.4575	x	x	x	38.75	16.025	x	x	x	42.4056	35.4833	34.3908	27.0278	x	36.315	34.2492	11.6408	38.725	55.5111	26.1867	39.8667	x	48.1056	x	37.325	x	x	x	x	47.8778	x	x	21.375	33.8	38.7008	40.6675	33.4	x	23.4333	47.95	x	32.2689	x	x	x	26.7417	x	29.9583	43.6883	22.3667	x	x	x	
-11723	Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for females [sec]	None	Central nervous system, behavior: Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for females [sec]	x	x	x	x	85.8125	143.982	x	32.2	x	113.882	140.8	132.81	69.4	99.55	200.122	x	62.4375	x	100.64	95.62	x	x	x	x	x	102.313	157.092	204.9	x	157.913	144.355	107.143	101.25	x	x	x	77.195	186.807	110.57	x	111.245	121.348	272.883	204.92	x	x	132.66	x	149.262	120.192	x	x	x	214.77	195.705	x	x	x	220.708	135.932	169.295	290.81	x	206.7	130.395	132.143	109.588	140.76	119.744	86.37	x	139.172	x	234.47	x	x	x	x	176.058	x	x	193.898	98.1925	168.893	88.7725	122.358	x	167.327	220.685	x	257.357	x	x	x	93.255	x	121.022	130.238	154.89	x	x	x	
-11724	Original post publication description: Anxiety assay, time in middle of an elevated plus maze for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for females [sec]	x	x	x	x	54.5975	37.324	x	33.09	x	29.8825	26.6633	16.805	178.62	70.52	19.4075	x	144.785	x	16.97	70.05	x	x	x	x	x	56.4633	53.425	20.0883	x	40.0975	27.91	16.0975	74.5083	x	x	x	173.325	18.7525	56.345	x	68.375	105.897	14.2125	11.05	x	x	29.07	x	10.9525	34.0025	x	x	x	10.825	28.895	x	x	x	29.5217	76.4375	25.36	3.55	x	35.695	94.8175	12.82	96.97	110.403	43.73	127.767	x	28.3467	x	44.2867	x	x	x	x	30.582	x	x	37.965	129.673	28.515	40.06	51.5267	x	14.2975	15.325	x	19.0133	x	x	x	30.0575	x	87.505	40.83	24.465	x	x	x	
-11725	Original post publication description: Anxiety assay, time in open arms of an elevated plus maze for females [sec]	None	Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for females [sec]	x	x	x	x	159.59	118.694	x	234.7	x	156.235	132.563	150.385	52.0	129.93	80.47	x	92.7775	x	182.39	134.33	x	x	x	x	x	141.223	89.4825	75.0117	x	101.99	127.735	176.76	124.242	x	x	x	49.48	94.44	133.085	x	120.38	72.755	12.905	84.03	x	x	138.27	x	139.785	145.805	x	x	x	74.405	75.4	x	x	x	49.77	87.63	105.345	5.64	x	57.65	74.7875	155.038	93.4425	48.8367	136.526	85.8633	x	132.482	x	21.2433	x	x	x	x	93.36	x	x	68.1375	72.135	102.592	171.167	126.115	x	118.375	63.99	x	23.63	x	x	x	176.688	x	91.4725	128.932	120.645	x	x	x	
-11726	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [n beam breaks]	None	Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [n beam breaks]	x	x	x	x	1409.0	1360.1	x	868.455	1060.86	3039.8	530.9	1698.09	1062.5	2995.0	659.5	979.5	2923.86	1853.6	934.5	3013.55	x	x	x	2374.88	x	1324.57	1440.0	3010.11	x	2021.9	1423.09	3022.17	1105.71	x	578.625	x	2506.36	1423.29	3805.43	x	2376.67	2427.56	1032.44	1905.0	x	x	1636.11	x	1524.0	1110.47	x	x	x	1767.2	592.316	x	x	x	2907.67	1316.5	949.4	1939.18	x	2537.08	907.375	1297.38	1828.36	3257.71	2012.93	3791.5	x	1307.18	x	1685.09	x	3293.57	x	x	1734.0	x	x	1396.27	3716.88	1227.47	1948.92	1463.0	x	3112.0	778.0	x	1818.18	x	x	x	2222.67	2983.17	2876.81	2868.18	848.321	x	x	x	
-11727	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [n beam breaks]	x	x	x	x	1267.33	723.6	x	783.455	524.571	2521.4	838.6	1150.09	829.0	1794.14	306.167	890.625	2374.14	1398.0	1420.5	2772.09	x	x	x	1525.88	x	894.429	718.5	2113.89	x	1976.5	1479.64	2525.58	1007.57	x	271.25	x	2137.64	937.643	3292.07	x	2002.07	1888.44	740.188	1545.38	x	x	1637.89	x	1648.43	1013.2	x	x	x	1542.5	373.947	x	x	x	2721.87	1251.78	840.8	1565.36	x	2105.42	875.5	1303.08	1942.64	3101.24	2147.47	3562.58	x	1086.94	x	1240.45	x	2194.86	x	x	1332.56	x	x	1060.2	2289.19	1560.0	1392.69	1137.1	x	2251.75	380.2	x	1743.55	x	x	x	1780.93	2270.83	1323.52	3182.91	786.179	x	x	x	
-11728	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [n beam breaks]	x	x	x	x	1110.67	477.2	x	928.364	513.286	2078.0	902.3	979.727	774.167	1248.29	313.667	739.375	1522.29	454.6	1803.25	1997.82	x	x	x	1301.25	x	626.214	670.5	1336.33	x	1390.3	1383.36	1475.25	816.857	x	91.125	x	1605.73	782.357	2242.64	x	1206.67	1545.0	576.938	1852.25	x	x	1539.78	x	1271.29	769.333	x	x	x	1436.7	220.316	x	x	x	1926.0	983.722	670.933	1226.73	x	1468.0	798.875	1007.92	1481.86	2501.05	1478.87	2785.75	x	836.882	x	734.727	x	1467.0	x	x	938.444	x	x	822.667	1199.12	1122.4	1055.31	678.4	x	1791.5	222.2	x	1287.18	x	x	x	1226.67	1421.67	660.524	2675.27	647.964	x	x	x	
-11729	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [n beam breaks]	x	x	x	x	793.333	251.5	x	536.0	503.286	1425.8	783.4	809.182	490.583	1009.57	144.0	898.125	780.857	178.8	1109.0	1617.27	x	x	x	1009.5	x	400.857	741.75	785.444	x	928.8	1008.27	1289.0	545.357	x	32.25	x	1190.36	710.643	1829.57	x	1022.2	1087.44	450.375	1500.38	x	x	1310.22	x	1250.57	610.267	x	x	x	1117.6	92.7368	x	x	x	1481.93	837.556	379.333	855.0	x	1132.42	613.0	925.0	1049.21	2036.62	1195.2	2053.92	x	552.0	x	497.636	x	1169.57	x	x	728.889	x	x	781.733	939.438	680.533	829.0	581.9	x	1511.0	189.0	x	1069.82	x	x	x	1106.53	1132.83	432.19	2208.91	592.0	x	x	x	
-11730	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [cm]	x	x	x	x	4230.6	3880.27	x	2499.61	3129.13	7971.05	1677.26	4910.78	3294.76	8545.92	2165.83	2944.77	7835.97	5359.83	2859.37	8285.53	x	x	x	6846.67	x	4030.69	4188.85	8656.43	x	6047.12	4113.59	8213.68	3370.96	x	1836.12	x	7378.2	4084.12	9900.45	x	7075.52	7501.34	3226.44	5733.33	x	x	4736.57	x	4614.37	3599.0	x	x	x	5372.53	1982.58	x	x	x	8229.71	3924.21	2838.12	5773.52	x	7151.38	2724.92	4075.17	5681.67	8806.02	5986.97	10547.5	x	4093.9	x	5097.92	x	9198.41	x	x	5200.68	x	x	4458.84	10079.6	4096.85	5672.63	4432.53	x	8866.25	2850.69	x	5557.08	x	x	x	6283.3	8045.93	7588.26	8326.11	2685.01	x	x	x	
-11731	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [cm]	x	x	x	x	3847.64	2138.81	x	2343.12	1786.85	6607.77	2655.28	3615.0	2666.83	5334.81	1190.19	2785.73	6388.96	4266.01	4381.6	7658.9	x	x	x	4566.34	x	2964.01	2225.46	6161.4	x	5996.48	4309.65	7065.5	3173.82	x	952.578	x	6450.89	2791.75	8789.17	x	6109.2	6349.56	2389.77	4663.5	x	x	4878.6	x	4890.48	3404.4	x	x	x	4698.1	1344.05	x	x	x	7613.5	3807.91	2590.36	4600.96	x	6114.99	2651.21	4059.44	5877.66	8440.45	6299.76	9823.25	x	3521.12	x	3962.8	x	6516.93	x	x	4036.14	x	x	3406.68	6553.78	5051.97	4079.95	3520.95	x	6637.42	1539.9	x	5317.39	x	x	x	5203.49	6292.42	3626.54	8862.52	2609.74	x	x	x	
-11732	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [cm]	x	x	x	x	3544.59	1531.03	x	2797.3	1951.93	5387.31	2893.81	3166.58	2677.47	3866.66	1196.1	2341.68	4269.98	1550.33	5562.46	5622.17	x	x	x	4115.45	x	2095.23	2284.8	4063.94	x	4431.44	4134.73	4500.31	2687.4	x	340.694	x	5025.51	2453.9	6403.7	x	3937.17	5230.34	1926.88	5509.04	x	x	4662.84	x	3895.29	2761.68	x	x	x	4553.74	786.603	x	x	x	5510.64	3115.6	2200.11	3763.67	x	4497.07	2515.85	3198.75	4695.52	6971.5	4660.86	7873.86	x	2761.1	x	2558.2	x	4745.46	x	x	2988.76	x	x	2814.35	3900.01	3708.05	3326.33	2143.37	x	5457.19	948.936	x	4193.43	x	x	x	3826.08	4081.13	2002.22	7658.37	2170.65	x	x	x	
-11733	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [cm]	x	x	x	x	2632.07	896.436	x	1690.94	1968.1	4012.88	2573.5	2673.66	1737.93	3192.59	585.927	2802.55	2281.67	665.749	3487.11	4711.07	x	x	x	3214.3	x	1379.0	2455.35	2587.76	x	3142.35	3089.61	4042.58	1801.67	x	107.51	x	3895.06	2290.77	5481.12	x	3296.58	3690.93	1548.02	4438.86	x	x	4021.64	x	3826.03	2259.72	x	x	x	3634.63	334.395	x	x	x	4351.75	2750.54	1314.84	2729.37	x	3638.86	1974.56	2999.73	3524.15	5922.04	3907.72	5983.88	x	1866.53	x	1770.34	x	3881.44	x	x	2364.06	x	x	2659.89	3250.66	2326.26	2672.68	1863.51	x	4779.58	701.345	x	3473.34	x	x	x	3508.65	3298.06	1376.34	6455.46	2009.79	x	x	x	
-11734	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for females [n beam breaks]	x	x	x	x	77.3333	206.9	x	133.273	174.0	275.8	87.6	233.273	125.0	406.5	73.6667	199.0	308.714	212.8	157.75	374.091	x	x	x	246.375	x	331.286	148.0	479.111	x	369.5	298.455	303.833	211.143	x	79.625	x	373.0	157.643	391.143	x	493.867	709.111	222.625	324.875	x	x	457.333	x	279.286	331.133	x	x	x	228.1	53.5263	x	x	x	403.133	329.889	231.667	191.273	x	369.167	186.5	365.462	406.429	463.095	401.2	487.667	x	431.176	x	359.364	x	554.143	x	x	407.444	x	x	364.4	293.188	255.733	295.077	325.5	x	396.25	173.0	x	296.727	x	x	x	533.333	288.333	258.095	416.091	170.714	x	x	x	
-11735	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for females [n beam breaks]	x	x	x	x	130.333	144.4	x	173.091	206.286	294.4	165.5	289.455	144.333	423.357	99.3333	276.75	336.286	253.8	269.0	473.545	x	x	x	240.25	x	307.286	136.0	435.111	x	437.8	363.0	388.833	240.929	x	74.625	x	408.909	144.429	567.643	x	508.933	794.778	194.875	349.625	x	x	581.667	x	325.429	312.8	x	x	x	268.0	67.0	x	x	x	438.2	401.611	341.8	206.273	x	398.583	262.0	397.154	463.571	577.667	473.133	535.417	x	467.294	x	426.091	x	557.857	x	x	398.778	x	x	394.467	326.625	369.667	263.923	272.9	x	417.0	133.6	x	320.182	x	x	x	568.533	334.667	181.048	484.091	246.25	x	x	x	
-11736	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for females [n beam breaks]	x	x	x	x	197.667	125.3	x	188.273	253.143	283.6	205.0	279.636	216.583	387.786	124.167	225.125	312.714	142.0	386.5	393.364	x	x	x	250.375	x	214.857	175.5	326.0	x	397.9	348.091	350.5	233.0	x	28.75	x	425.0	157.857	500.571	x	372.933	636.889	176.375	402.75	x	x	527.889	x	316.857	286.8	x	x	x	334.2	55.0526	x	x	x	382.067	405.056	334.533	169.364	x	326.5	250.875	378.077	390.5	543.429	404.6	544.667	x	374.353	x	355.909	x	545.0	x	x	361.111	x	x	346.533	379.938	310.333	224.462	209.5	x	430.5	86.4	x	281.727	x	x	x	532.6	286.667	171.143	510.909	233.536	x	x	x	
-11737	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for females [n beam breaks]	x	x	x	x	160.0	85.6	x	163.0	262.286	303.6	202.8	230.091	153.75	325.5	74.0	288.125	204.143	83.2	278.25	348.091	x	x	x	224.625	x	154.714	263.5	220.111	x	333.4	278.273	338.25	196.857	x	6.875	x	427.364	187.714	518.571	x	323.6	508.444	163.688	353.375	x	x	507.778	x	322.429	227.8	x	x	x	293.6	24.2632	x	x	x	349.2	410.389	237.4	158.364	x	319.75	277.875	370.385	336.643	563.81	395.933	502.583	x	305.059	x	276.182	x	512.286	x	x	336.667	x	x	325.467	362.562	242.867	238.0	189.0	x	436.75	73.2	x	229.0	x	x	x	505.533	232.5	121.952	515.0	254.643	x	x	x	
-11738	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	3535.0	2876.0	x	1240.09	1327.86	4549.2	830.3	2715.36	2391.75	3816.5	889.167	1885.71	4435.29	4025.2	2861.75	4920.18	x	x	x	2910.62	x	2940.38	3664.5	3602.44	x	2558.1	2296.45	4552.5	1471.71	x	953.5	x	3805.0	2439.64	5736.36	x	3004.67	3185.11	1914.25	2703.88	x	x	2292.56	x	1650.17	2128.4	x	x	x	2669.6	884.684	x	x	x	4290.27	1731.94	1265.4	2942.73	x	3007.45	1959.62	1824.15	2551.07	4942.38	3174.6	5382.25	x	2329.53	x	2853.27	x	4188.57	x	x	2260.83	x	x	2456.33	5058.69	2703.13	3655.46	2652.0	x	3828.25	939.2	x	2790.45	x	x	x	3227.73	5425.4	3167.38	3743.55	1410.5	x	x	x	
-11739	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	2713.33	1178.3	x	797.636	748.0	3926.0	1072.0	1528.73	1587.67	2199.0	735.167	1749.0	2741.71	2792.4	2622.5	2924.82	x	x	x	1941.25	x	1720.54	1858.75	2257.89	x	1994.2	1680.73	3049.75	767.5	x	377.5	x	2554.45	1928.43	3797.5	x	1978.33	2488.67	1385.56	2062.88	x	x	1609.56	x	1407.17	1647.53	x	x	x	2219.6	487.263	x	x	x	3644.47	1221.72	859.067	2492.91	x	2048.18	1453.38	1726.23	2062.57	4189.14	2753.47	4758.58	x	1606.06	x	1664.0	x	2511.71	x	x	1468.06	x	x	1583.8	2921.69	2338.27	2410.54	1828.0	x	2190.25	544.6	x	2252.64	x	x	x	1981.33	2773.2	1607.19	3151.91	909.036	x	x	x	
-11740	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	1600.67	687.7	x	845.455	579.714	2751.0	920.1	1008.45	838.0	1281.36	549.0	1283.14	1497.14	1128.4	1866.5	2094.82	x	x	x	1412.88	x	1063.23	1309.0	1749.33	x	1654.1	1348.45	2130.75	641.929	x	230.75	x	1362.55	1119.93	2394.93	x	1383.13	1525.22	895.5	1897.5	x	x	1214.78	x	1231.5	1117.13	x	x	x	1787.0	319.474	x	x	x	2552.53	968.667	678.6	1718.45	x	1325.27	1208.38	1227.23	1455.64	2966.62	2018.2	3725.58	x	969.647	x	904.909	x	1646.57	x	x	1015.0	x	x	1122.2	1669.5	1388.07	1383.69	1237.5	x	1776.75	322.2	x	1650.45	x	x	x	1314.73	2022.0	815.905	2672.45	775.786	x	x	x	
-11741	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	661.333	514.1	x	799.0	487.286	1831.4	975.6	790.545	701.75	1096.64	470.167	1075.29	857.714	320.8	1210.75	1643.82	x	x	x	857.375	x	761.462	743.0	1266.22	x	1125.7	986.364	1544.83	574.929	x	27.375	x	1054.82	909.214	1838.64	x	1136.73	1232.11	601.875	1250.25	x	x	1191.67	x	1149.33	846.067	x	x	x	1460.7	185.421	x	x	x	1797.73	828.778	357.2	1047.55	x	676.636	927.375	1026.08	1042.0	2313.81	1511.4	2823.08	x	641.235	x	647.273	x	1225.86	x	x	693.056	x	x	864.067	1032.5	1085.2	1074.77	874.4	x	1587.75	144.4	x	1043.55	x	x	x	970.867	1234.0	460.286	2129.18	617.036	x	x	x	
-11742	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for females [cm]	x	x	x	x	9524.15	7599.11	x	3494.01	3656.02	11493.9	2393.81	7493.6	6742.47	10439.3	2713.42	5284.43	11352.3	11094.2	8419.04	12833.2	x	x	x	8046.3	x	8425.87	9787.7	9803.84	x	7394.73	6310.7	11771.3	4418.41	x	2777.14	x	10611.7	6524.19	14368.7	x	8839.97	9608.01	5579.16	7820.48	x	x	6454.29	x	4975.27	6234.04	x	x	x	7917.85	2780.06	x	x	x	11464.4	5006.97	3715.25	8030.78	x	8139.33	5357.53	5513.75	7315.2	12810.4	8823.13	14147.8	x	6592.98	x	8254.81	x	11064.4	x	x	6530.52	x	x	7052.38	13013.1	8106.57	10093.1	7438.16	x	10539.8	3073.48	x	7822.25	x	x	x	8846.96	14075.4	8306.78	10293.6	4169.36	x	x	x	
-11743	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for females [cm]	x	x	x	x	7200.01	3237.57	x	2445.65	2353.06	10046.6	3212.21	4567.87	4718.66	6287.63	2391.69	4805.75	7283.9	8330.69	7933.58	8181.87	x	x	x	5665.02	x	5331.53	5318.87	6472.11	x	5839.64	4855.65	8258.7	2497.33	x	1296.61	x	7389.62	5335.72	9778.14	x	6042.26	7695.64	4216.99	6059.87	x	x	4819.44	x	4202.09	4914.37	x	x	x	6534.23	1712.67	x	x	x	9840.64	3722.5	2615.24	7005.63	x	6023.86	4113.97	5134.96	6162.58	10841.8	7737.16	12473.3	x	4748.33	x	5254.57	x	6974.07	x	x	4391.12	x	x	4775.61	7950.31	7035.53	6911.03	5140.7	x	6468.23	1999.1	x	6500.8	x	x	x	5680.93	7599.26	4417.77	8617.31	2957.26	x	x	x	
-11744	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for females [cm]	x	x	x	x	4628.31	2073.51	x	2625.72	2060.65	7358.3	2905.37	3299.36	2718.04	3930.2	2043.27	3767.69	4285.74	3953.34	5765.79	6168.37	x	x	x	4426.48	x	3603.26	4204.66	5302.73	x	4944.13	3984.07	6235.47	2129.26	x	794.163	x	4435.32	3329.51	6763.34	x	4435.14	5198.77	2873.71	5581.4	x	x	3755.97	x	3827.32	3639.01	x	x	x	5339.45	1173.19	x	x	x	7106.67	3063.62	2254.02	5045.73	x	4216.91	3580.65	3822.39	4584.42	8031.46	5994.75	10009.3	x	3023.18	x	3156.1	x	5091.71	x	x	3163.87	x	x	3640.83	5004.1	4461.65	4308.18	3640.36	x	5438.41	1275.69	x	5045.95	x	x	x	3964.73	5852.9	2539.79	7613.65	2589.4	x	x	x	
-11745	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for females [cm]	x	x	x	x	2105.64	1629.19	x	2526.38	1832.14	5218.03	3050.59	2629.32	2471.64	3435.91	1738.01	3273.38	2462.39	1172.29	3703.43	4914.52	x	x	x	2875.28	x	2690.14	2489.52	3905.14	x	3583.35	3090.7	4715.9	1984.84	x	84.1075	x	3560.47	2897.09	5374.12	x	3716.21	4272.17	2026.55	3876.97	x	x	3711.01	x	3602.32	2911.03	x	x	x	4585.72	664.119	x	x	x	5132.04	2663.01	1242.65	3341.56	x	2328.5	2855.85	3310.81	3473.22	6549.12	4755.22	7869.97	x	2124.36	x	2459.73	x	4174.72	x	x	2239.76	x	x	2911.49	3373.36	3586.15	3540.16	2611.34	x	4865.18	520.602	x	3397.59	x	x	x	3145.28	3714.28	1512.61	6277.72	2133.0	x	x	x	
-11746	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	133.333	330.5	x	184.091	189.0	319.6	98.8	367.636	195.333	524.214	124.667	310.0	461.571	447.0	546.75	492.636	x	x	x	289.625	x	568.0	311.25	558.333	x	439.0	366.455	369.917	284.929	x	98.375	x	490.818	178.857	550.214	x	669.0	882.889	339.375	445.75	x	x	554.889	x	355.5	467.4	x	x	x	424.7	65.4211	x	x	x	572.867	375.278	311.467	234.182	x	311.545	276.25	439.462	425.571	645.762	549.667	617.5	x	449.471	x	493.727	x	579.429	x	x	459.611	x	x	453.6	382.562	441.067	491.846	458.8	x	465.5	185.2	x	332.727	x	x	x	645.933	317.2	337.238	513.455	252.857	x	x	x	
-11747	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	158.0	199.5	x	200.455	212.571	391.0	192.6	318.182	217.75	482.286	169.667	387.857	418.0	469.8	526.0	503.818	x	x	x	278.375	x	485.692	309.5	471.778	x	409.1	379.273	415.917	193.071	x	110.125	x	461.364	217.357	533.786	x	549.933	850.444	315.688	471.125	x	x	553.556	x	304.667	387.2	x	x	x	398.8	85.4737	x	x	x	599.733	444.722	381.267	272.182	x	386.818	376.625	456.923	482.5	671.905	630.8	606.75	x	416.824	x	574.364	x	503.143	x	x	431.611	x	x	458.733	373.625	491.133	409.077	353.1	x	405.75	145.8	x	348.818	x	x	x	574.267	313.6	237.381	507.0	294.929	x	x	x	
-11748	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	151.667	155.5	x	201.364	261.857	391.0	199.8	278.364	194.5	381.071	202.167	296.714	325.714	385.2	412.75	472.818	x	x	x	258.5	x	388.154	329.75	391.111	x	410.6	333.727	389.833	219.429	x	66.0	x	452.273	190.571	516.643	x	456.867	687.0	230.438	420.625	x	x	462.222	x	355.833	308.467	x	x	x	341.0	72.4211	x	x	x	499.467	371.556	380.733	250.818	x	330.455	350.625	404.769	382.643	637.095	566.667	543.583	x	358.0	x	454.727	x	538.0	x	x	355.5	x	x	395.8	379.375	382.267	310.615	296.1	x	390.0	98.2	x	320.636	x	x	x	511.733	375.6	191.143	517.727	318.5	x	x	x	
-11749	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for females [n beam breaks]	None	Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for females [n beam breaks]	x	x	x	x	103.333	190.3	x	192.455	211.571	396.4	218.3	213.909	237.417	391.286	159.667	285.0	218.143	173.6	277.5	420.818	x	x	x	196.125	x	298.0	240.0	348.556	x	406.2	306.0	332.417	232.857	x	14.0	x	430.636	220.857	478.857	x	393.267	570.333	184.188	341.5	x	x	466.111	x	342.667	274.267	x	x	x	352.0	39.6842	x	x	x	419.267	389.111	261.867	205.636	x	224.091	319.625	401.462	350.071	588.429	524.067	496.083	x	301.941	x	376.727	x	529.857	x	x	314.556	x	x	357.067	350.75	400.467	324.615	219.0	x	342.0	45.4	x	239.636	x	x	x	509.533	315.2	128.048	500.182	282.929	x	x	x	
-11750	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for females [sec]	None	Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for females [sec]	x	x	x	x	416.1	392.87	x	446.536	458.043	x	365.112	503.8	332.263	446.378	314.45	379.675	390.55	x	435.65	420.433	x	x	x	448.867	x	389.644	598.525	409.225	x	381.175	391.771	340.731	400.206	x	197.367	x	365.567	395.583	369.444	x	339.73	406.538	455.973	326.087	x	x	403.444	x	419.812	342.106	x	x	x	358.55	300.635	x	x	x	308.944	452.019	386.631	297.194	x	424.064	285.383	351.231	343.744	419.761	443.315	422.386	x	361.438	x	403.425	x	393.1	x	x	335.604	x	x	469.81	399.682	388.906	345.288	389.17	x	362.3	514.567	x	372.493	x	x	x	457.604	413.138	383.743	413.206	452.463	x	x	x	
-11751	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for females [sec]	None	Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for females [sec]	x	x	x	x	471.5	556.94	x	497.75	459.471	x	370.712	445.469	486.888	477.822	528.2	508.35	462.775	x	491.05	403.342	x	x	x	444.217	x	418.494	369.8	499.9	x	537.8	533.25	494.069	497.028	x	689.983	x	449.122	432.328	434.767	x	537.54	464.275	445.136	344.788	x	x	485.756	x	479.025	456.522	x	x	x	474.63	415.946	x	x	x	550.194	419.388	471.45	434.744	x	451.314	376.433	505.65	395.417	427.168	458.795	443.707	x	480.438	x	460.267	x	379.95	x	x	465.381	x	x	478.0	492.368	502.933	502.85	440.35	x	375.95	476.933	x	515.85	x	x	x	475.079	457.525	466.764	484.017	444.661	x	x	x	
-11752	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for females [sec]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for females [sec]	x	x	x	x	523.05	430.48	x	438.679	459.321	x	403.45	693.581	416.306	539.783	321.9	423.45	557.075	x	431.95	452.225	x	x	x	558.742	x	508.494	530.925	344.55	x	538.35	343.514	384.419	600.75	x	237.575	x	486.283	500.378	358.494	x	379.025	459.817	540.15	516.869	x	x	381.044	x	409.217	368.611	x	x	x	432.96	278.7	x	x	x	322.131	441.977	479.531	406.688	x	428.371	564.567	419.45	477.006	498.504	398.96	422.329	x	392.275	x	519.292	x	542.987	x	x	375.369	x	x	454.465	506.635	439.756	461.406	335.03	x	324.15	326.75	x	392.664	x	x	x	389.237	499.85	413.964	379.044	482.365	x	x	x	
-11753	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for females [sec]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for females [sec]	x	x	x	x	174.75	550.78	x	390.579	397.943	x	552.312	235.438	485.45	425.722	157.6	429.587	335.8	x	417.1	396.417	x	x	x	433.642	x	330.562	421.3	456.475	x	460.75	543.343	347.712	289.961	x	673.767	x	321.45	350.222	561.439	x	465.235	409.617	355.395	265.975	x	x	395.163	x	547.117	443.089	x	x	x	434.69	353.181	x	x	x	549.05	486.815	542.744	369.056	x	503.521	337.2	495.9	255.844	341.964	437.605	505.107	x	436.969	x	363.558	x	362.013	x	x	469.404	x	x	387.485	364.105	425.3	384.85	478.72	x	367.95	405.6	x	528.836	x	x	x	527.704	367.35	359.561	489.65	469.287	x	x	x	
-11754	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for females [%]	None	Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for females [%]	x	x	x	x	46.8792	41.4642	x	47.4779	49.6171	x	47.9623	52.9764	40.6174	48.487	37.3168	42.777	45.5089	x	47.01	50.5744	x	x	x	50.0102	x	48.0337	61.805	45.125	x	41.4839	42.2944	40.5973	44.5103	x	23.2035	x	44.5284	47.8228	46.095	x	39.0468	46.5359	50.701	48.5228	x	x	45.2516	x	46.4625	43.1293	x	x	x	43.0788	41.8508	x	x	x	35.5631	52.3091	44.7718	40.702	x	48.1398	45.0249	41.0208	46.1789	49.2875	49.0858	48.8028	x	42.9267	x	46.4217	x	51.6334	x	x	41.5006	x	x	49.6608	44.8981	43.591	40.117	47.0254	x	49.0755	52.19	x	42.2461	x	x	x	48.9635	47.4177	45.2486	45.8164	50.3107	x	x	x	
-11755	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [sec]	None	Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [sec]	x	x	x	x	106.95	37.61	x	-7.85714	1.27857	x	38.3375	189.781	84.0437	93.4056	7.45	43.775	166.525	x	-3.7	31.7917	x	x	x	109.875	x	107.637	-67.6	-64.675	x	157.175	-48.2571	43.6875	200.544	x	40.2083	x	120.717	104.794	-10.95	x	39.295	-61.675	84.1773	190.781	x	x	-22.4	x	50.25	26.5056	x	x	x	74.41	-21.9346	x	x	x	13.1875	-10.0423	92.9	109.494	x	4.30714	279.183	68.2188	133.261	78.7429	-44.355	-0.057143	x	30.8375	x	115.867	x	149.887	x	x	39.7654	x	x	-15.345	96.78	50.85	116.119	-54.14	x	-38.15	-187.817	x	20.1714	x	x	x	-68.3667	86.7125	30.2214	-34.1611	29.9022	x	x	x	
-11756	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [% change]	None	Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [% change]	x	x	x	x	28.0778	1.80665	x	4.4017	3.96045	x	-5.96558	20.9859	5.42069	7.08287	29.8156	7.37825	17.0043	x	3.86	2.6049	x	x	x	6.3378	x	12.0171	-6.085	-2.005	x	12.1334	-2.30311	11.2862	22.9774	x	4.59814	x	14.6315	11.6819	-6.7949	x	5.96568	5.32642	9.44486	17.4434	x	x	3.54304	x	1.15	3.29076	x	x	x	7.06459	3.09155	x	x	x	1.61384	-4.30311	1.80924	10.8895	x	-2.11217	17.2795	5.94599	18.5984	10.2449	-1.29891	-2.86138	x	5.49672	x	12.8228	x	8.14131	x	x	2.92834	x	x	5.45814	12.1983	7.16915	14.3607	-4.99415	x	-2.2398	-7.7	x	0.308785	x	x	x	-5.88903	10.5909	7.91986	-2.44206	0.207328	x	x	x	
-11757	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]	None	Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]	x	x	x	x	950.0	1998.7	x	2312.82	1446.71	3249.4	1381.6	3116.91	836.75	2650.5	785.667	2045.12	4115.57	954.0	2068.75	2520.82	x	x	x	2592.38	x	714.467	1185.75	2990.56	x	966.9	2506.82	2677.25	1452.93	x	414.375	x	2363.0	2051.86	3000.43	x	2245.13	1867.56	997.75	2616.12	x	x	3329.44	x	2471.33	1704.27	x	x	x	2470.9	168.211	x	x	x	2490.33	1829.17	492.2	1052.45	x	2310.67	2239.88	1988.92	1383.86	3215.9	3445.67	3134.17	x	1493.88	x	1722.18	x	2692.14	x	x	2327.11	x	x	1359.33	1473.44	669.8	1777.54	1479.08	x	2693.25	906.8	x	1604.27	x	x	x	2307.6	2708.17	2510.52	3025.27	1378.36	x	x	x	
-11758	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [cm]	None	Novel open field behavior, locomotion in the center from 0-60 min for females [cm]	x	x	x	x	3175.3	5379.71	x	6370.67	4409.6	8875.52	4207.56	8089.85	2851.47	7742.45	2579.01	6066.76	10412.1	3468.43	5151.83	6771.92	x	x	x	7445.92	x	2223.38	3676.85	7774.18	x	2989.19	6922.18	8048.95	4377.0	x	1408.39	x	6723.66	5758.26	8636.59	x	6617.55	5660.48	2986.98	7355.4	x	x	9529.27	x	6681.43	5157.94	x	x	x	7032.16	617.923	x	x	x	7353.17	5319.27	1688.89	3401.28	x	6633.34	6463.86	6260.05	4446.06	9021.29	10001.5	8824.45	x	4515.61	x	5098.12	x	8286.63	x	x	6620.67	x	x	4379.47	4642.9	2097.64	5139.08	4213.61	x	7898.24	3178.4	x	4725.78	x	x	x	6406.52	7751.73	6327.84	8382.01	4060.77	x	x	x	
-11759	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for females [n beam breaks]	x	x	x	x	129.667	155.1	x	226.636	280.571	490.8	182.6	356.364	138.917	609.286	103.833	428.375	431.857	199.6	95.0	264.818	x	x	x	247.75	x	145.733	247.0	255.778	x	141.2	342.636	583.083	240.143	x	46.375	x	410.364	214.5	539.429	x	327.133	512.889	141.625	424.0	x	x	627.889	x	270.778	229.0	x	x	x	203.1	6.42105	x	x	x	470.667	341.389	176.6	139.545	x	360.583	326.625	401.692	274.286	647.476	645.6	547.583	x	424.529	x	237.545	x	668.429	x	x	549.222	x	x	295.6	416.938	179.667	291.769	209.917	x	583.75	206.0	x	174.909	x	x	x	559.267	313.5	169.762	466.727	260.143	x	x	x	
-11760	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for females [n beam breaks]	x	x	x	x	4580.33	2812.4	x	3116.27	2602.0	9065.0	3055.2	4637.09	3156.25	7047.0	1423.33	3507.62	7601.14	3885.0	5267.25	9400.73	x	x	x	6211.5	x	3246.07	3570.75	7245.78	x	6317.5	5294.36	8312.0	3475.5	x	973.25	x	7440.09	3853.93	11169.7	x	6607.6	6948.44	2799.94	6803.0	x	x	6124.0	x	5694.29	3503.27	x	x	x	5864.0	1279.32	x	x	x	9037.47	4389.56	2840.47	5586.27	x	7242.92	3194.75	4533.38	6302.07	10896.6	6834.47	12193.8	x	3783.0	x	4157.91	x	8125.0	x	x	4733.89	x	x	4060.87	8144.62	4590.4	5225.92	3860.4	x	8666.25	1569.4	x	5918.73	x	x	x	6336.8	7808.5	5293.05	10935.3	2874.46	x	x	x	
-11761	Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for females [cm]	x	x	x	x	14254.9	8446.55	x	9330.97	8836.01	23979.0	9799.84	14366.0	10377.0	20940.0	5138.06	10874.7	20776.6	11841.9	16290.5	26277.7	x	x	x	18742.8	x	10468.9	11154.5	21469.5	x	19617.4	15647.6	23822.1	11033.9	x	3236.91	x	22749.7	11620.5	30574.4	x	20418.5	22772.2	9091.11	20344.7	x	x	18299.6	x	17226.2	12024.8	x	x	x	18259.0	4447.62	x	x	x	25705.6	13598.3	8943.43	16867.5	x	21402.3	9866.54	14333.1	19779.0	30140.0	20855.3	34228.5	x	12242.7	x	13389.3	x	24342.2	x	x	14589.6	x	x	13339.8	23784.0	15183.1	15751.6	11960.4	x	25740.4	6040.87	x	18541.2	x	x	x	18821.5	21717.5	14593.4	31302.5	9475.19	x	x	x	
-11762	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for females [n beam breaks]	x	x	x	x	565.333	562.2	x	657.636	895.714	1157.4	660.9	1032.45	639.667	1543.14	371.167	989.0	1161.86	691.8	1091.5	1589.09	x	x	x	961.625	x	1008.14	723.0	1460.33	x	1538.6	1287.82	1381.42	881.929	x	189.875	x	1634.27	647.643	1977.93	x	1699.33	2649.22	757.562	1430.62	x	x	2074.67	x	1244.0	1158.53	x	x	x	1123.9	199.842	x	x	x	1572.6	1546.94	1145.4	725.273	x	1414.0	977.25	1511.08	1597.14	2148.0	1674.87	2070.33	x	1577.88	x	1417.55	x	2169.29	x	x	1504.0	x	x	1430.87	1362.31	1178.6	1021.46	996.9	x	1680.5	466.2	x	1127.64	x	x	x	2140.0	1142.17	732.238	1926.09	905.143	x	x	x	
-11763	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for females [n beam breaks]	None	Novel open field behavior, locomotion in the center from 0-15 min for females [n beam breaks]	x	x	x	x	319.333	992.4	x	680.0	281.857	732.4	213.0	869.909	255.917	878.0	235.0	517.375	1480.0	237.8	593.5	652.818	x	x	x	694.875	x	246.467	265.5	770.222	x	473.0	657.455	629.0	499.214	x	271.875	x	717.818	403.071	905.929	x	836.533	597.333	383.0	676.25	x	x	1005.44	x	398.556	477.8	x	x	x	672.5	142.947	x	x	x	804.667	538.389	220.667	117.455	x	886.417	601.0	431.154	299.0	948.333	869.333	761.917	x	358.294	x	488.727	x	783.857	x	x	610.056	x	x	339.133	375.125	189.4	610.154	399.667	x	755.5	331.6	x	663.273	x	x	x	916.333	651.167	778.333	705.636	398.643	x	x	x	
-11764	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for females [n beam breaks]	None	Novel open field behavior, locomotion in the center from 15-30 min for females [n beam breaks]	x	x	x	x	223.333	504.5	x	727.636	343.143	907.4	461.3	814.364	276.333	673.071	261.0	373.625	1202.57	352.6	599.5	650.636	x	x	x	839.0	x	208.467	437.75	869.556	x	263.2	767.0	694.25	441.0	x	118.25	x	630.182	614.714	753.0	x	580.467	454.778	331.5	766.875	x	x	894.667	x	708.667	543.067	x	x	x	716.0	23.2105	x	x	x	785.6	485.944	134.733	330.182	x	680.0	621.625	634.231	390.857	887.286	858.667	874.25	x	443.176	x	542.273	x	738.143	x	x	639.611	x	x	391.733	399.062	211.067	523.077	428.75	x	748.75	187.0	x	515.636	x	x	x	610.8	766.5	721.667	744.909	442.714	x	x	x	
-11765	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [n beam breaks]	x	x	x	x	263.333	291.4	x	483.545	465.429	926.6	427.5	762.0	180.583	574.929	167.0	512.0	823.286	263.6	473.25	670.364	x	x	x	656.75	x	161.733	301.25	694.556	x	147.2	602.818	746.417	289.857	x	21.875	x	577.182	586.571	682.714	x	454.867	458.778	175.75	685.875	x	x	793.889	x	670.222	397.2	x	x	x	698.3	0.0	x	x	x	548.867	432.111	78.0667	320.727	x	430.0	561.625	522.0	412.5	779.095	882.467	838.583	x	395.765	x	390.364	x	640.857	x	x	621.0	x	x	318.4	366.312	152.733	377.385	370.5	x	753.0	207.2	x	266.636	x	x	x	423.467	793.333	572.905	798.818	315.857	x	x	x	
-11766	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [n beam breaks]	x	x	x	x	144.0	210.4	x	421.636	356.286	683.0	279.8	670.636	123.917	524.5	122.667	642.125	609.714	100.0	402.5	547.0	x	x	x	401.75	x	97.8	181.25	656.222	x	83.5	479.545	607.583	222.857	x	2.375	x	437.818	447.5	658.786	x	373.267	356.667	107.5	487.125	x	x	635.444	x	693.889	286.2	x	x	x	384.1	2.05263	x	x	x	351.2	372.722	58.7333	284.091	x	314.25	455.625	401.538	281.5	601.19	835.2	659.417	x	296.647	x	300.818	x	529.286	x	x	456.444	x	x	310.067	332.938	116.6	266.923	280.167	x	436.0	181.0	x	158.727	x	x	x	357.0	497.167	437.619	775.909	221.143	x	x	x	
-11767	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for females [cm]	x	x	x	x	1006.87	2554.06	x	1799.63	913.39	2021.0	643.637	2194.37	928.47	2465.38	757.71	1471.11	3678.38	832.905	1573.94	1833.99	x	x	x	2131.03	x	777.604	846.059	2025.51	x	1466.23	1795.87	1939.72	1484.51	x	933.852	x	2080.67	1182.66	2569.56	x	2346.37	1753.09	1144.89	1918.33	x	x	2744.15	x	1109.89	1433.09	x	x	x	1991.29	515.944	x	x	x	2359.66	1535.24	737.555	485.639	x	2496.25	1736.57	1443.85	948.442	2600.82	2543.46	2253.75	x	1112.2	x	1446.26	x	2251.02	x	x	1714.66	x	x	1164.03	1172.65	631.906	1856.27	1178.07	x	2175.58	1196.58	x	1919.84	x	x	x	2403.66	1902.14	1910.31	2005.06	1175.32	x	x	x	
-11768	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for females [cm]	x	x	x	x	729.837	1388.46	x	1983.91	1033.56	2414.81	1322.52	2103.87	918.564	1976.55	801.804	1208.04	3019.4	1201.58	1476.82	1710.33	x	x	x	2332.31	x	647.942	1349.05	2227.54	x	834.417	2067.9	2095.6	1317.87	x	395.923	x	1780.14	1658.08	2130.85	x	1760.89	1397.34	964.447	2119.24	x	x	2576.5	x	1888.1	1605.37	x	x	x	1999.44	93.884	x	x	x	2308.85	1392.35	461.035	1074.02	x	1991.52	1785.52	1935.14	1293.27	2455.59	2467.96	2419.97	x	1310.07	x	1549.59	x	2353.88	x	x	1815.92	x	x	1245.25	1231.69	656.974	1476.42	1229.24	x	2136.88	667.522	x	1529.74	x	x	x	1714.06	2191.5	1824.21	2094.79	1287.29	x	x	x	
-11769	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [cm]	x	x	x	x	940.88	811.122	x	1370.62	1382.71	2522.98	1307.56	2008.9	584.535	1737.1	583.299	1523.63	2097.55	1014.21	1127.63	1767.44	x	x	x	1783.69	x	495.506	912.081	1805.81	x	440.101	1686.4	2187.45	881.987	x	73.433	x	1609.84	1606.49	1990.27	x	1388.86	1407.42	544.602	1930.18	x	x	2276.6	x	1798.09	1232.52	x	x	x	1944.28	0.0	x	x	x	1625.96	1294.98	277.391	971.866	x	1235.8	1647.51	1607.56	1312.5	2206.62	2541.07	2291.86	x	1182.9	x	1170.22	x	2032.69	x	x	1746.95	x	x	994.974	1168.22	470.609	1070.39	1034.23	x	2230.81	690.609	x	802.631	x	x	x	1242.43	2233.38	1468.0	2160.41	917.501	x	x	x	
-11770	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [cm]	x	x	x	x	497.716	626.067	x	1216.51	1079.93	1916.73	933.843	1782.71	419.899	1563.42	436.198	1863.97	1616.8	419.731	973.45	1460.16	x	x	x	1198.89	x	302.323	569.665	1715.33	x	248.441	1372.01	1826.17	692.632	x	5.17803	x	1253.02	1311.03	1945.91	x	1121.42	1102.63	333.044	1387.65	x	x	1932.02	x	1885.35	886.966	x	x	x	1097.15	8.09501	x	x	x	1058.69	1096.71	212.909	869.761	x	909.774	1294.26	1273.51	891.842	1758.26	2449.01	1858.88	x	910.439	x	932.042	x	1649.04	x	x	1343.13	x	x	975.222	1070.33	338.15	736.008	772.082	x	1354.96	623.687	x	473.571	x	x	x	1046.36	1424.71	1125.31	2121.74	680.663	x	x	x	
-11771	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for females [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 0-15 min in the center for females [n beam breaks]	x	x	x	x	18.3333	58.4	x	33.9091	29.8571	87.4	14.5	47.1818	16.9167	124.429	23.8333	39.875	142.429	28.6	33.0	66.1818	x	x	x	54.25	x	44.5333	31.75	40.3333	x	52.9	55.3636	98.0833	75.2857	x	30.25	x	56.2727	32.6429	105.857	x	82.1333	125.111	36.75	60.25	x	x	135.0	x	33.2222	59.9333	x	x	x	51.4	5.68421	x	x	x	141.867	72.4444	52.4	12.3636	x	106.417	62.875	72.3077	53.5	117.095	113.733	120.25	x	68.1765	x	43.2727	x	101.286	x	x	88.0556	x	x	48.3333	63.3125	34.0	110.385	47.25	x	99.25	37.4	x	64.8182	x	x	x	156.667	57.6667	30.619	107.273	59.2857	x	x	x	
-11772	Original post publication description: Novel open field behavior, vertical activity (rears) from15-30 min in the center for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from15-30 min in the center for females [n beam breaks]	x	x	x	x	40.0	46.4	x	72.0	58.0	163.0	55.7	90.5455	37.3333	173.429	25.3333	97.625	144.429	52.6	26.25	66.8182	x	x	x	74.0	x	40.9333	105.5	76.7778	x	53.6	87.0	176.917	70.9286	x	13.875	x	103.091	63.7857	131.214	x	91.7333	121.111	50.75	145.375	x	x	172.333	x	73.7778	73.0	x	x	x	58.2	0.736842	x	x	x	144.6	97.2778	45.9333	32.7273	x	125.5	82.875	115.846	63.2857	178.333	149.467	149.083	x	123.647	x	65.0	x	191.571	x	x	151.389	x	x	92.7333	115.75	60.2	79.5385	66.1667	x	153.0	48.8	x	65.5455	x	x	x	156.333	98.5	55.7619	118.909	86.9286	x	x	x	
-11773	Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for females [n beam breaks]	x	x	x	x	50.6667	28.8	x	60.5455	98.8571	133.6	63.6	108.273	41.9167	156.357	28.3333	133.5	78.2857	77.4	20.25	72.3636	x	x	x	59.0	x	36.0667	75.5	70.7778	x	18.0	100.818	163.333	52.6429	x	2.25	x	125.273	63.3571	155.286	x	87.5333	149.0	31.8125	115.375	x	x	177.667	x	77.4444	54.4	x	x	x	57.5	0.0	x	x	x	105.267	95.5556	46.4	46.2727	x	67.75	94.875	112.538	89.9286	194.048	184.533	136.667	x	124.647	x	65.4545	x	205.0	x	x	162.5	x	x	75.5333	118.125	48.8667	53.6923	55.4167	x	190.75	61.0	x	31.2727	x	x	x	132.8	103.5	40.1905	118.727	66.1071	x	x	x	
-11774	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for females [n beam breaks]	None	Novel open field behavior, vertical activity (rears) from 45-60 min in the center for females [n beam breaks]	x	x	x	x	20.6667	21.5	x	60.1818	93.8571	106.8	48.8	110.364	26.75	155.071	26.3333	157.375	66.7143	41.0	15.5	59.4545	x	x	x	60.5	x	24.2	34.25	67.8889	x	16.7	99.4545	144.75	41.2857	x	0.0	x	125.727	54.7143	147.071	x	65.7333	117.667	22.3125	103.0	x	x	142.889	x	86.3333	41.6667	x	x	x	36.0	0.0	x	x	x	78.9333	76.1111	31.8667	48.1818	x	60.9167	86.0	101.0	67.5714	158.0	197.867	141.583	x	108.059	x	63.8182	x	170.571	x	x	147.278	x	x	79.0	119.75	36.6	48.1538	41.0833	x	140.75	58.8	x	13.2727	x	x	x	113.467	53.8333	43.1905	121.818	47.8214	x	x	x	
-11775	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the cocaine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 0-15 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	634.0	495.8	x	1089.36	434.714	666.4	396.9	1052.55	414.667	614.286	444.167	503.25	1127.0	379.4	856.5	491.455	x	x	x	498.0	x	411.733	518.5	1695.44	x	642.9	735.0	514.167	462.143	x	402.875	x	647.364	554.929	709.071	x	824.4	437.556	597.0	833.625	x	x	538.111	x	658.778	644.133	x	x	x	814.1	399.421	x	x	x	834.667	626.667	372.267	368.091	x	532.75	739.875	441.769	534.714	647.571	503.2	737.0	x	585.294	x	585.364	x	497.143	x	x	660.556	x	x	365.4	573.5	451.8	585.0	613.75	x	592.5	474.2	x	571.0	x	x	x	586.267	800.167	1101.29	812.273	310.393	x	x	x	
-11776	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	407.0	341.4	x	722.273	302.143	688.0	348.5	725.364	329.417	353.571	397.833	305.875	826.0	406.6	808.0	417.818	x	x	x	385.375	x	268.667	412.5	1185.78	x	420.7	532.0	440.083	331.0	x	160.5	x	508.636	413.071	500.5	x	560.467	399.889	343.438	712.875	x	x	340.0	x	621.222	604.333	x	x	x	854.3	61.1579	x	x	x	582.8	438.222	202.267	426.091	x	398.167	625.375	445.923	490.929	501.333	459.133	791.167	x	450.294	x	362.182	x	324.571	x	x	482.5	x	x	266.133	473.125	381.933	522.0	470.583	x	537.0	185.0	x	439.091	x	x	x	359.933	570.833	736.238	842.0	246.786	x	x	x	
-11777	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	261.333	226.3	x	463.545	240.0	645.4	299.1	622.091	220.25	280.786	208.333	266.75	600.0	223.8	517.0	375.091	x	x	x	309.25	x	167.267	351.25	905.333	x	223.8	367.091	408.5	254.786	x	39.0	x	425.909	362.714	404.857	x	397.8	393.222	218.625	536.375	x	x	297.667	x	633.667	463.6	x	x	x	635.4	6.8421	x	x	x	399.333	354.778	98.7333	232.727	x	262.5	496.25	374.462	439.214	455.238	431.133	605.5	x	381.588	x	265.727	x	289.714	x	x	411.5	x	x	223.267	390.875	235.667	366.692	383.917	x	389.5	147.6	x	227.818	x	x	x	267.733	436.333	490.095	874.909	197.357	x	x	x	
-11778	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the cocaine test battery [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	150.667	206.3	x	336.091	227.143	590.0	253.5	511.273	113.333	236.857	167.5	279.375	383.429	132.6	506.25	346.091	x	x	x	213.125	x	81.4	218.75	630.778	x	130.0	314.818	323.417	198.786	x	3.75	x	318.455	309.714	422.571	x	281.867	319.444	126.562	351.875	x	x	257.0	x	567.333	378.0	x	x	x	378.1	11.8421	x	x	x	280.133	264.889	75.2	203.455	x	223.417	410.5	268.077	273.786	348.524	450.467	514.333	x	295.118	x	228.091	x	231.0	x	x	325.778	x	x	195.133	340.25	158.6	273.769	245.667	x	307.0	113.6	x	135.182	x	x	x	214.133	275.333	338.476	784.545	152.286	x	x	x	
-11779	Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for females in the cocaine test battery [cm]	None	Novel open field behavior, locomotion from 0-15 min in the periphery for females in the cocaine test battery [cm]	x	x	x	x	2319.93	1907.68	x	3730.99	1817.42	2390.48	1564.67	3545.53	1697.72	2301.26	1940.76	1847.66	3831.63	1629.58	3205.17	1934.81	x	x	x	2053.17	x	1751.48	2279.91	5414.32	x	2535.7	2664.71	2090.22	1886.38	x	1698.95	x	2432.81	2132.19	2687.89	x	2917.58	1919.53	2362.92	3022.28	x	x	2078.55	x	2518.57	2427.61	x	x	x	3098.33	1680.84	x	x	x	3038.94	2472.75	1514.88	1665.19	x	2111.71	2662.72	1801.59	2148.3	2396.77	2026.68	2751.21	x	2255.64	x	2378.92	x	2028.09	x	x	2491.37	x	x	1605.92	2492.23	1923.96	2335.33	2332.84	x	2315.2	2006.81	x	2318.89	x	x	x	2184.52	2880.23	3645.43	3023.05	1460.76	x	x	x	
-11780	Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for females in the cocaine test battery [cm]	x	x	x	x	1588.31	1346.55	x	2592.89	1317.85	2320.89	1483.17	2558.97	1367.73	1421.14	1557.94	1211.55	2920.19	1757.06	2969.02	1642.4	x	x	x	1599.23	x	1095.47	1794.75	3995.27	x	1668.71	1953.2	1811.82	1433.88	x	706.774	x	1988.68	1608.55	2017.86	x	2084.13	1743.92	1392.16	2536.63	x	x	1416.53	x	2365.07	2283.75	x	x	x	3111.76	269.89	x	x	x	2119.33	1747.61	867.814	1668.02	x	1611.64	2247.06	1796.48	1956.94	1944.45	1839.78	2807.49	x	1752.19	x	1551.11	x	1331.72	x	x	1874.67	x	x	1202.97	2061.78	1535.37	2053.11	1779.2	x	2086.72	849.094	x	1760.98	x	x	x	1422.35	2081.62	2415.5	3124.49	1211.14	x	x	x	
-11781	Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for females in the cocaine test battery [cm]	x	x	x	x	1110.87	926.252	x	1711.37	1058.54	2240.85	1273.66	2255.58	907.737	1145.64	917.8	1111.36	2164.75	943.883	1897.22	1437.81	x	x	x	1310.33	x	679.48	1514.39	3137.98	x	871.169	1449.06	1654.17	1118.23	x	165.361	x	1761.52	1441.52	1687.84	x	1511.23	1789.4	881.586	1953.83	x	x	1248.73	x	2376.82	1813.79	x	x	x	2377.0	25.4112	x	x	x	1462.51	1437.26	438.583	929.19	x	1031.21	1885.07	1527.52	1726.36	1790.64	1742.27	2135.87	x	1519.68	x	1172.34	x	1145.01	x	x	1631.25	x	x	1048.7	1761.08	951.977	1429.33	1405.21	x	1559.21	716.598	x	926.687	x	x	x	1089.28	1716.4	1702.83	3217.99	971.179	x	x	x	
-11782	Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for females in the cocaine test battery [cm]	None	Novel open field behavior, locomotion from 45-60 min in the periphery for females in the cocaine test battery [cm]	x	x	x	x	633.643	860.276	x	1262.9	952.934	2126.5	1051.18	1895.84	506.635	1000.25	726.929	1131.3	1434.84	658.46	1826.9	1288.05	x	x	x	929.323	x	342.933	998.967	2250.78	x	496.702	1221.36	1287.89	817.829	x	18.4587	x	1361.2	1250.84	1792.36	x	1097.17	1449.44	507.883	1319.45	x	x	1149.36	x	2189.4	1471.28	x	x	x	1472.66	51.0453	x	x	x	1039.36	1051.33	311.951	856.802	x	870.948	1525.89	1107.38	1115.76	1446.11	1851.93	1864.49	x	1204.47	x	1036.09	x	931.329	x	x	1322.7	x	x	896.355	1564.27	647.824	1042.08	926.396	x	1219.87	638.617	x	558.212	x	x	x	899.879	1106.08	1187.38	2915.28	749.153	x	x	x	
-11783	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for females [n beam breaks]	None	Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for females [n beam breaks]	x	x	x	x	116.667	188.7	x	224.636	181.714	184.2	132.9	278.364	130.75	180.286	146.833	166.5	294.0	185.6	324.0	216.364	x	x	x	125.75	x	196.333	220.5	254.444	x	213.3	234.182	202.417	210.857	x	153.0	x	241.727	160.143	248.571	x	267.2	307.333	190.0	228.875	x	x	238.333	x	264.111	265.0	x	x	x	257.6	100.737	x	x	x	284.6	284.778	218.067	89.8182	x	206.667	247.375	186.231	244.214	239.238	239.067	227.667	x	279.529	x	211.545	x	182.857	x	x	270.0	x	x	163.267	266.875	242.4	236.923	200.5	x	225.25	163.8	x	176.818	x	x	x	296.4	175.5	180.952	337.545	199.25	x	x	x	
-11784	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for females [n beam breaks]	x	x	x	x	128.667	184.2	x	212.818	235.714	207.2	149.9	286.636	151.167	191.5	180.167	140.625	286.286	266.4	298.5	229.909	x	x	x	144.625	x	180.933	268.0	301.333	x	224.3	225.909	228.833	186.071	x	99.25	x	290.545	182.357	265.429	x	247.6	306.889	161.25	223.0	x	x	245.111	x	319.889	241.467	x	x	x	279.3	28.3684	x	x	x	212.4	316.944	187.6	137.818	x	193.75	260.25	219.077	228.0	267.19	264.133	256.333	x	299.647	x	245.455	x	171.571	x	x	295.5	x	x	211.067	293.562	242.8	237.692	211.75	x	235.5	145.0	x	165.091	x	x	x	312.067	186.0	175.333	371.0	222.964	x	x	x	
-11785	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for females [n beam breaks]	None	Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for females [n beam breaks]	x	x	x	x	128.0	133.3	x	193.727	244.286	209.2	144.6	279.091	139.0	180.714	125.667	130.75	256.286	148.6	203.0	220.818	x	x	x	132.25	x	102.667	202.5	273.0	x	150.4	201.0	229.25	153.929	x	40.625	x	294.636	190.286	283.214	x	213.2	323.778	106.312	187.875	x	x	252.111	x	333.0	192.0	x	x	x	231.5	2.0	x	x	x	175.333	282.722	138.867	119.727	x	166.667	252.375	215.308	209.571	269.667	258.733	235.0	x	292.588	x	234.727	x	187.0	x	x	301.889	x	x	191.733	318.188	196.933	179.462	157.417	x	208.25	117.0	x	115.182	x	x	x	294.533	182.833	143.857	406.455	197.643	x	x	x	
-11786	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for females [n beam breaks]	x	x	x	x	86.3333	117.7	x	147.273	219.429	208.2	109.4	247.182	79.0833	165.714	103.667	158.875	235.0	140.6	170.75	162.364	x	x	x	111.5	x	53.9333	165.0	247.889	x	85.0	188.727	194.667	126.357	x	5.5	x	271.182	183.5	281.929	x	184.733	301.778	66.5625	159.75	x	x	222.222	x	339.667	179.067	x	x	x	192.4	2.8421	x	x	x	142.667	251.167	89.6	124.364	x	131.25	226.75	192.154	231.571	256.048	303.533	237.5	x	266.824	x	189.727	x	218.571	x	x	276.778	x	x	193.333	291.938	158.867	128.923	127.833	x	206.5	128.4	x	83.8182	x	x	x	286.133	179.167	154.81	361.909	167.25	x	x	x	
-11787	Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for females [%]	None	Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for females [%]	x	x	x	x	65.6958	48.5248	x	61.2095	56.904	54.1042	56.2651	56.7484	62.7276	43.9076	73.9903	47.216	50.5299	63.2896	72.8388	47.2282	x	x	x	44.3504	x	72.5886	64.126	65.7464	x	68.9551	54.4811	46.6021	56.21	x	67.5658	x	54.2546	54.9714	49.6197	x	53.1022	55.0293	65.0997	57.5273	x	x	38.1267	x	58.5992	61.8665	x	x	x	60.4929	79.1555	x	x	x	52.6249	57.7911	69.6574	67.6576	x	47.6663	56.3496	52.332	63.0567	45.7551	42.1898	53.553	x	61.55	x	57.6221	x	41.0388	x	x	54.0779	x	x	52.8176	63.9722	73.4484	58.6756	63.4772	x	48.2442	60.435	x	56.0406	x	x	x	47.3772	52.0334	63.1972	60.0461	53.9837	x	x	x	
-11788	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [n beam breaks]	x	x	x	x	1453.0	1269.8	x	2611.27	1204.0	2589.8	1298.0	2911.27	1077.67	1485.5	1217.83	1355.25	2936.43	1142.4	2687.75	1630.45	x	x	x	1405.75	x	929.067	1501.0	4417.33	x	1417.4	1948.91	1686.17	1246.71	x	606.125	x	1900.36	1640.43	2037.0	x	2064.53	1550.11	1285.62	2434.75	x	x	1432.78	x	2481.0	2090.07	x	x	x	2681.9	479.263	x	x	x	2096.93	1684.56	748.467	1230.36	x	1416.83	2272.0	1530.23	1738.64	1952.67	1843.93	2648.0	x	1712.29	x	1441.36	x	1342.43	x	x	1880.33	x	x	1049.93	1777.75	1228.0	1747.46	1713.92	x	1826.0	920.4	x	1373.09	x	x	x	1428.07	2082.67	2666.1	3313.73	906.821	x	x	x	
-11789	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [cm]	x	x	x	x	5652.75	5040.76	x	9298.15	5146.75	9078.71	5372.67	10255.9	4479.82	5868.29	5143.43	5301.86	10351.4	4988.98	9898.31	6303.07	x	x	x	5892.05	x	3869.37	6588.01	14798.4	x	5572.28	7288.32	6844.1	5256.32	x	2589.55	x	7544.21	6433.11	8185.95	x	7610.13	6902.29	5144.54	8832.18	x	x	5893.18	x	9449.85	7996.43	x	x	x	10059.8	2027.18	x	x	x	7660.14	6708.95	3133.23	5119.2	x	5625.51	8320.75	6232.97	6947.36	7577.97	7460.65	9559.06	x	6731.99	x	6138.45	x	5436.15	x	x	7319.99	x	x	4753.94	7879.37	5059.13	6859.84	6443.65	x	7181.0	4211.12	x	5564.77	x	x	x	5596.02	7784.32	8951.13	12280.8	4392.23	x	x	x	
-11790	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for females [n beam breaks]	x	x	x	x	459.667	623.9	x	778.455	881.143	808.8	536.8	1091.27	462.667	718.214	556.333	596.75	1071.57	741.2	996.25	829.455	x	x	x	514.125	x	533.867	856.0	1076.67	x	673.0	849.818	855.167	677.214	x	298.375	x	1098.09	716.286	1079.14	x	912.733	1239.78	524.125	799.5	x	x	957.778	x	1256.67	877.533	x	x	x	960.8	133.947	x	x	x	815.0	1135.61	634.133	471.727	x	698.333	986.75	812.769	913.357	1032.14	1065.47	956.5	x	1138.59	x	881.455	x	760.0	x	x	1144.17	x	x	759.4	1170.56	841.0	783.0	697.5	x	875.5	554.2	x	540.909	x	x	x	1189.13	723.5	654.952	1476.91	787.107	x	x	x	
-11791	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [n beam breaks]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [n beam breaks]	x	x	x	x	1613.67	1232.7	x	3212.27	2012.57	6147.8	2070.7	2834.82	1387.42	3355.93	1189.33	2111.88	2999.86	1642.0	2974.25	3975.91	x	x	x	3350.12	x	722.667	1847.25	4526.44	x	1879.9	2568.0	3706.58	1693.5	x	362.25	x	2985.09	2126.57	4190.5	x	2466.27	2954.22	1367.5	3863.0	x	x	3940.89	x	2915.44	2213.4	x	x	x	3928.1	387.737	x	x	x	4888.27	2965.39	655.8	1315.09	x	3136.25	2251.75	2523.31	2583.36	4701.43	4512.0	3700.08	x	1531.94	x	1859.18	x	3246.14	x	x	2292.22	x	x	1665.13	2519.56	1310.8	2552.62	1880.33	x	5307.5	1021.2	x	2323.09	x	x	x	2745.73	3422.67	2307.95	4863.36	1919.5	x	x	x	
-11792	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [cm]	x	x	x	x	5815.59	4248.44	x	9732.8	7283.04	18284.1	7123.17	9259.24	4968.42	10994.8	4932.98	6951.58	9514.06	6510.45	9661.7	12148.6	x	x	x	11321.6	x	2789.58	6576.73	14292.1	x	6629.03	8203.8	12307.3	5888.72	x	1475.56	x	10487.0	7224.61	13670.1	x	8307.66	10709.6	4824.78	12528.2	x	x	12597.9	x	9358.61	8121.53	x	x	x	12873.3	1481.13	x	x	x	15081.8	9838.84	2421.73	4895.96	x	10487.7	7435.72	8955.37	9128.07	14945.7	15127.6	12009.5	x	5486.42	x	6796.37	x	11490.9	x	x	7682.79	x	x	6291.39	9475.09	5062.0	8523.48	6059.67	x	16910.7	3977.23	x	8319.99	x	x	x	9060.38	10743.8	7306.17	15868.0	6858.06	x	x	x	
-11793	Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for females [n beam breaks/60 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for females [n beam breaks/60 min]	x	x	x	x	505.0	441.3	x	743.545	1118.0	1587.6	600.1	910.364	471.583	1260.5	383.833	895.375	827.0	831.6	1013.25	938.455	x	x	x	851.5	x	352.533	669.5	1150.0	x	785.7	883.273	1433.92	660.286	x	148.0	x	1402.36	682.786	1487.64	x	964.867	1588.11	478.562	1107.62	x	x	1704.89	x	966.333	937.6	x	x	x	1004.3	82.1053	x	x	x	1216.2	1527.94	609.8	378.273	x	1007.58	1085.5	1294.0	1185.64	1596.76	1690.6	1267.58	x	1038.88	x	997.091	x	1645.43	x	x	1256.72	x	x	1047.87	1402.19	886.467	844.923	622.0	x	1786.5	354.6	x	622.0	x	x	x	1662.4	832.167	590.048	1585.55	939.893	x	x	x	
-11794	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for females [difference in cm/1 hr test, positive values indicate sensitization]	None	Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for females [difference in cm/1 hr test, positive values indicate sensitization]	x	x	x	x	9203.21	6092.84	x	1760.79	1065.86	10137.8	1762.14	3624.15	6273.82	3153.0	3748.33	4805.1	4607.85	12708.6	9531.42	5820.29	x	x	x	2270.26	x	8785.53	10646.4	4014.22	x	2144.5	2593.5	7159.25	-4.01234	x	1715.16	x	3247.45	6465.89	5709.84	x	2615.15	4002.41	5605.31	2994.0	x	x	440.907	x	-3370.71	5673.66	x	x	x	6118.26	1882.42	x	x	x	7838.17	857.855	883.712	6556.18	x	465.333	6041.5	3448.82	1756.41	8092.79	6454.91	10271.8	x	4246.17	x	5735.92	x	2962.65	x	x	1735.64	x	x	5040.55	5556.91	8006.78	9100.84	6870.2	x	1571.2	827.885	x	4225.35	x	x	x	2816.35	5972.99	2183.59	1499.79	2373.82	x	x	x	
-11795	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [n beam breaks, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [n beam breaks, positive values indicate sensitization]	x	x	x	x	8510.33	5256.1	x	3682.18	3142.86	13057.6	3798.0	6043.09	5519.17	8393.5	2643.5	5993.14	9531.86	8266.8	8561.5	11583.6	x	x	x	7122.12	x	6485.62	7575.25	8875.89	x	7332.1	6312.0	11277.8	3456.07	x	1589.12	x	8776.82	6397.21	13767.4	x	7502.87	8431.11	4797.19	7914.5	x	x	6308.56	x	5438.17	5739.13	x	x	x	8136.9	1876.84	x	x	x	12285.0	4751.11	3160.27	8201.64	x	7057.55	5548.75	5803.69	7111.29	14412.0	9457.67	16689.5	x	5546.47	x	6069.45	x	9572.71	x	x	5436.94	x	x	6026.4	10682.4	7514.67	8524.46	6591.9	x	9383.0	1950.4	x	7737.09	x	x	x	7494.67	11454.6	6050.76	11697.1	3712.36	x	x	x	
-11796	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [cm, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [cm, positive values indicate sensitization]	x	x	x	x	23458.1	14539.4	x	11091.8	9901.87	34116.9	11562.0	17990.2	16650.8	24093.0	8886.39	17131.2	25384.4	24550.5	25821.8	32098.0	x	x	x	21013.1	x	20050.8	21800.7	25483.8	x	21761.9	18241.1	30981.3	11029.8	x	4952.02	x	25997.1	18086.5	36284.3	x	23033.6	26774.6	14696.4	23338.7	x	x	18740.7	x	16607.0	17698.5	x	x	x	24377.3	6330.04	x	x	x	33543.8	14456.1	9827.16	23423.7	x	20708.6	15908.0	17781.9	21535.4	38232.8	27310.3	44500.4	x	16488.9	x	19125.2	x	27304.9	x	x	16325.3	x	x	18380.3	29340.9	23189.9	24852.4	18830.6	x	27311.6	6868.88	x	22766.6	x	x	x	21637.9	31241.8	16776.9	32802.2	11849.0	x	x	x	
-11797	Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	x	x	x	x	546.333	875.8	x	778.364	875.0	1498.0	709.5	1178.09	845.0	1778.86	656.167	1279.57	1423.43	1475.6	1763.0	1890.09	x	x	x	1022.62	x	1739.85	1190.5	1769.78	x	1664.9	1385.45	1508.08	930.286	x	288.5	x	1835.09	807.643	2079.5	x	2069.07	2990.67	1069.69	1679.0	x	x	2036.78	x	1358.67	1437.33	x	x	x	1516.5	263.0	x	x	x	2091.33	1580.67	1335.33	962.818	x	1252.91	1323.12	1702.62	1640.79	2543.19	2271.2	2263.92	x	1526.24	x	1899.55	x	2150.43	x	x	1561.28	x	x	1665.2	1486.31	1714.93	1536.15	1327.0	x	1603.25	474.6	x	1241.82	x	x	x	2241.47	1321.6	893.81	2038.36	1149.21	x	x	x	
-11798	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [n beam breaks/15 min]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [n beam breaks/15 min]	x	x	x	x	647.0	450.9	x	784.818	504.143	1668.2	325.6	883.0	551.5	1219.86	450.167	505.5	1431.29	493.8	694.25	898.091	x	x	x	950.625	x	271.6	478.5	1545.78	x	710.5	620.091	903.083	563.214	x	249.25	x	899.909	460.357	1077.93	x	816.4	778.444	633.312	1070.75	x	x	910.111	x	576.556	553.333	x	x	x	1089.9	289.158	x	x	x	1474.67	764.333	262.267	416.091	x	1034.17	466.875	671.385	729.071	1173.71	1099.4	1040.92	x	481.824	x	718.636	x	1077.43	x	x	660.889	x	x	582.267	752.0	400.4	783.538	604.25	x	1247.5	373.0	x	834.182	x	x	x	907.333	1098.33	945.143	1310.64	443.036	x	x	x	
-11799	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [n beam breaks/15 min]	x	x	x	x	528.667	238.3	x	860.091	472.143	1532.2	519.9	631.091	260.667	788.214	229.667	509.875	653.429	449.2	748.75	1059.0	x	x	x	858.625	x	178.0	474.25	1254.67	x	512.6	696.0	820.25	425.286	x	98.125	x	805.455	566.286	1004.71	x	589.533	622.111	295.562	947.25	x	x	942.222	x	749.333	587.267	x	x	x	1019.5	70.6842	x	x	x	1344.2	687.444	189.8	357.818	x	709.833	633.5	637.231	747.5	1243.71	1031.87	880.333	x	398.824	x	492.818	x	751.143	x	x	566.833	x	x	396.4	580.562	303.4	652.308	465.5	x	1353.75	307.4	x	739.545	x	x	x	683.067	1057.67	528.762	1101.0	459.143	x	x	x	
-11800	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [n beam breaks/15 min]	x	x	x	x	337.333	244.1	x	785.818	552.286	1642.4	598.9	699.0	335.417	728.714	322.5	508.5	515.571	332.0	798.75	1080.82	x	x	x	898.5	x	145.333	402.25	859.778	x	363.2	621.909	1038.5	344.071	x	4.875	x	721.909	515.643	1115.64	x	611.733	768.0	228.75	901.875	x	x	960.889	x	785.556	577.8	x	x	x	873.2	19.5789	x	x	x	1088.6	746.667	114.8	289.545	x	845.667	513.5	603.692	602.071	1214.05	1255.8	916.083	x	373.588	x	333.455	x	707.571	x	x	531.111	x	x	366.667	553.125	339.0	495.615	424.583	x	1462.0	226.8	x	482.182	x	x	x	625.933	757.333	486.333	1135.45	507.25	x	x	x	
-11801	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [n beam breaks/15 min]	x	x	x	x	100.667	299.4	x	781.545	484.0	1305.0	626.3	621.727	239.833	619.143	187.0	588.0	399.571	367.0	732.5	938.0	x	x	x	642.375	x	127.733	492.25	866.222	x	293.6	630.0	944.75	360.929	x	10.0	x	557.818	584.286	992.214	x	448.6	785.667	209.875	943.125	x	x	1127.67	x	804.0	495.0	x	x	x	945.5	8.31579	x	x	x	980.8	766.944	88.9333	251.636	x	546.583	637.875	611.0	504.714	1069.95	1124.93	862.75	x	277.706	x	314.273	x	710.0	x	x	533.389	x	x	319.8	633.875	268.0	621.154	386.0	x	1244.25	114.0	x	267.182	x	x	x	529.4	509.333	347.714	1316.27	510.071	x	x	x	
-11802	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [cm]	None	Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [cm]	x	x	x	x	2258.12	1496.01	x	2412.21	1881.36	4926.43	1174.03	2825.31	1977.51	3881.46	1839.48	1669.57	4424.53	1990.28	2291.71	3090.05	x	x	x	3266.6	x	1033.57	1659.31	4877.23	x	2438.53	2045.52	2996.45	1921.58	x	1006.78	x	3164.91	1595.23	3604.66	x	2771.04	2683.16	2229.01	3553.84	x	x	2885.86	x	1932.74	2089.64	x	x	x	3618.14	1106.35	x	x	x	4584.88	2569.45	951.108	1656.46	x	3487.78	1614.1	2415.94	2607.07	3704.14	3666.82	3418.17	x	1751.51	x	2601.96	x	3631.34	x	x	2203.26	x	x	2151.66	2766.22	1517.57	2664.06	2034.4	x	4042.16	1454.68	x	2996.57	x	x	x	2907.42	3494.86	2897.29	4306.08	1662.24	x	x	x	
-11803	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [cm]	x	x	x	x	1945.13	868.606	x	2573.44	1692.37	4604.82	1816.99	2083.43	962.484	2582.4	1110.33	1758.85	2093.97	1810.05	2454.68	3209.69	x	x	x	2928.15	x	709.215	1718.45	3875.88	x	1901.52	2224.29	2767.33	1522.19	x	405.914	x	2783.92	1987.96	3310.43	x	2012.71	2316.47	1019.72	3123.49	x	x	3114.46	x	2354.1	2197.99	x	x	x	3333.2	271.631	x	x	x	4153.75	2300.27	700.45	1288.02	x	2415.96	2083.83	2310.83	2639.96	3936.86	3514.32	2859.99	x	1438.67	x	1772.86	x	2731.46	x	x	1900.27	x	x	1521.61	2202.72	1188.03	2181.89	1468.48	x	4314.65	1236.69	x	2598.19	x	x	x	2271.2	3194.62	1687.81	3621.7	1659.15	x	x	x	
-11804	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [cm]	x	x	x	x	1215.27	877.301	x	2391.69	1966.64	4897.33	2042.26	2277.84	1189.49	2433.64	1290.43	1634.76	1716.76	1311.11	2532.71	3155.2	x	x	x	2997.23	x	564.307	1486.79	2787.82	x	1255.25	1955.69	3381.16	1215.44	x	23.333	x	2519.57	1722.55	3599.77	x	2046.57	2837.35	823.79	2825.48	x	x	3082.25	x	2493.29	2113.07	x	x	x	2853.2	66.2703	x	x	x	3346.59	2465.05	437.396	1052.08	x	2793.28	1722.73	2145.89	2063.72	3841.9	4152.08	2953.58	x	1302.23	x	1249.22	x	2544.95	x	x	1780.97	x	x	1382.82	2103.0	1317.77	1650.86	1359.52	x	4476.77	833.648	x	1767.37	x	x	x	2096.27	2417.92	1571.53	3678.19	1766.55	x	x	x	
-11805	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [cm]	None	Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [cm]	x	x	x	x	397.073	1006.52	x	2355.46	1742.67	3855.54	2089.88	2072.65	838.928	2097.3	692.745	1888.4	1278.8	1399.01	2382.61	2693.66	x	x	x	2129.6	x	482.487	1712.17	2751.12	x	1033.74	1978.31	3162.34	1229.51	x	39.5273	x	2018.57	1918.87	3155.19	x	1477.34	2872.65	752.26	3025.41	x	x	3515.35	x	2578.48	1720.82	x	x	x	3068.78	36.8821	x	x	x	2996.58	2504.07	332.778	899.389	x	1790.73	2015.06	2082.71	1817.31	3462.78	3794.4	2777.72	x	994.012	x	1172.33	x	2583.18	x	x	1798.28	x	x	1235.29	2403.16	1038.63	2026.67	1197.28	x	4077.07	452.211	x	957.857	x	x	x	1785.49	1636.38	1149.54	4262.05	1770.12	x	x	x	
-11806	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for females [n beam breaks/15 min]	x	x	x	x	147.333	120.8	x	184.182	208.571	386.8	89.6	200.273	139.833	297.214	123.833	169.375	284.571	229.8	233.75	261.182	x	x	x	207.5	x	106.333	124.75	312.667	x	222.9	163.273	289.917	206.286	x	87.375	x	322.818	131.786	278.643	x	276.067	318.778	189.375	260.25	x	x	388.778	x	166.222	256.333	x	x	x	266.0	52.1579	x	x	x	342.933	360.278	178.933	87.0	x	260.333	232.625	284.923	315.429	321.571	348.4	276.167	x	285.765	x	279.273	x	403.0	x	x	289.389	x	x	237.333	292.188	207.667	242.846	185.417	x	369.75	96.0	x	204.636	x	x	x	408.667	207.667	149.857	388.182	170.714	x	x	x	
-11807	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for females [n beam breaks/15 min]	x	x	x	x	153.0	113.1	x	188.0	264.857	427.4	154.2	221.545	107.917	325.357	105.333	261.75	197.714	265.4	285.25	260.273	x	x	x	242.75	x	97.4667	185.0	292.889	x	245.2	254.545	364.25	180.429	x	49.625	x	354.727	192.429	404.429	x	259.267	375.333	113.5	302.875	x	x	463.889	x	237.222	248.667	x	x	x	266.9	22.7368	x	x	x	330.733	405.222	182.133	108.0	x	274.833	292.5	352.846	365.929	433.0	410.467	312.917	x	301.647	x	269.182	x	433.286	x	x	332.0	x	x	287.133	349.688	230.267	228.846	165.083	x	493.25	129.4	x	203.364	x	x	x	424.0	244.667	155.19	376.455	245.607	x	x	x	
-11808	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for females [n beam breaks/15 min]	x	x	x	x	138.667	105.8	x	195.182	331.714	429.2	171.8	249.0	127.75	327.857	92.0	236.875	190.857	178.0	239.25	231.0	x	x	x	226.25	x	85.8	191.75	266.556	x	162.3	219.818	409.167	141.714	x	6.25	x	365.0	181.071	415.214	x	242.533	436.667	94.0	253.875	x	x	418.444	x	274.444	240.667	x	x	x	234.9	4.8421	x	x	x	279.467	397.333	135.8	95.4545	x	280.083	271.0	334.462	269.786	433.952	454.8	360.167	x	257.824	x	214.091	x	398.857	x	x	301.833	x	x	290.333	339.562	253.933	171.692	147.583	x	482.0	73.8	x	149.182	x	x	x	425.667	197.833	146.81	383.091	255.286	x	x	x	
-11809	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for females [n beam breaks/15 min]	x	x	x	x	66.0	101.6	x	176.182	312.857	344.2	184.5	239.545	96.0833	310.071	62.6667	227.375	153.857	158.4	255.0	186.0	x	x	x	175.0	x	62.9333	168.0	277.889	x	155.3	245.636	370.583	131.857	x	4.75	x	359.818	177.5	389.357	x	187.0	457.333	81.6875	290.625	x	x	433.778	x	288.444	191.933	x	x	x	236.5	2.36842	x	x	x	263.067	365.111	112.933	87.8182	x	192.333	289.375	321.769	234.5	408.238	476.933	318.333	x	193.647	x	234.545	x	410.286	x	x	333.5	x	x	233.067	420.75	194.6	201.538	123.917	x	441.5	55.4	x	64.8182	x	x	x	404.067	182.0	138.19	437.818	268.286	x	x	x	
-11810	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	2403.0	3268.5	x	4924.09	2650.71	5839.2	2679.6	6028.18	1914.42	4136.0	2003.5	3400.38	7052.0	2096.4	4756.5	4151.27	x	x	x	3998.12	x	1643.53	2686.75	7407.89	x	2384.3	4455.73	4363.42	2699.64	x	1020.5	x	4263.36	3692.29	5037.43	x	4309.67	3417.67	2283.38	5050.88	x	x	4762.22	x	4952.33	3794.33	x	x	x	5152.8	647.474	x	x	x	4587.27	3513.72	1240.67	2282.82	x	3727.5	4511.88	3519.15	3122.5	5168.57	5289.6	5782.17	x	3206.18	x	3163.55	x	4034.57	x	x	4207.44	x	x	2409.27	3251.19	1897.8	3525.0	3193.0	x	4519.25	1827.2	x	2977.36	x	x	x	3735.67	4790.83	5176.62	6339.0	2285.18	x	x	x	
-11811	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [cm]	x	x	x	x	8828.05	10420.5	x	15668.8	9556.35	17954.2	9580.23	18345.8	7331.29	13610.7	7722.44	11368.6	20763.6	8457.4	15050.1	13074.9	x	x	x	13338.0	x	6092.66	10265.0	22572.5	x	8561.52	14210.5	14893.1	9633.35	x	3997.9	x	14267.9	12191.3	16822.6	x	14227.7	12562.8	8131.41	16187.6	x	x	15422.4	x	16131.3	13154.4	x	x	x	17091.9	2645.11	x	x	x	15013.3	12028.2	4822.11	8520.49	x	12258.9	14784.6	12493.0	11393.4	16599.4	17462.1	18383.5	x	11247.5	x	11236.5	x	13722.8	x	x	13940.7	x	x	9133.41	12522.3	7156.77	11998.9	10657.3	x	15079.2	7389.51	x	10290.5	x	x	x	12002.5	15536.0	15279.0	20662.8	8453.0	x	x	x	
-11812	Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]	x	x	x	x	589.333	779.0	x	1005.09	1161.71	1299.6	719.4	1447.64	601.583	1327.5	660.167	1025.12	1503.43	940.8	1091.25	1094.27	x	x	x	761.875	x	679.6	1103.0	1332.44	x	814.2	1192.45	1438.25	917.357	x	344.75	x	1508.45	930.786	1618.57	x	1239.87	1752.67	665.75	1223.5	x	x	1585.67	x	1527.44	1106.53	x	x	x	1163.9	140.368	x	x	x	1285.67	1477.0	810.733	611.273	x	1058.92	1313.38	1214.46	1187.64	1679.62	1711.07	1504.08	x	1563.12	x	1119.0	x	1428.43	x	x	1693.39	x	x	1055.0	1587.5	1020.67	1074.77	907.417	x	1459.25	760.2	x	715.818	x	x	x	1748.4	1037.0	824.714	1943.64	1047.25	x	x	x	
-11813	Original post publication description: Central nervous systems, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult females [density]	None	Central nervous systems, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult females [density]	x	x	x	x	x	72.5	x	75.0	x	78.75	x	x	x	x	85.0	x	87.5	x	x	x	x	x	x	x	x	59.0	x	x	x	71.0	93.0	x	x	x	93.0	x	x	97.6667	x	x	x	107.25	67.0	118.0	x	x	83.3333	x	x	x	x	x	x	x	x	x	x	x	94.0	97.0	115.333	x	x	85.6667	x	115.0	80.2	131.0	86.3333	x	x	98.0	109.0	143.0	x	79.5	x	x	92.6	x	x	x	x	104.5	89.0	125.25	x	92.0	x	100.0	113.0	157.333	x	x	110.75	95.6667	x	x	x	x	x	x	
-11814	Original post publication description: Adrenal weight (left) of females [mg]	None	Endocrinology: Adrenal weight (left) of females [mg]	x	x	x	x	2.125	2.475	x	2.7625	2.45	2.525	3.025	2.375	2.5	2.35	2.575	3.45	3.1	1.925	2.625	2.35	x	x	x	2.25	x	2.3375	3.475	2.05	x	2.225	3.4	2.75	2.875	x	2.55	x	2.9	2.625	2.225	x	2.6	2.35	1.6	2.475	x	x	2.6875	x	2.75	2.95	x	x	x	2.125	2.925	x	x	x	2.3625	2.225	3.325	2.75	x	2.65	2.85	2.45	2.8	3.275	2.4	1.75	x	2.1	x	2.45	x	2.05	x	x	1.95	x	x	2.6	2.775	2.6	1.95	2.65	x	2.325	2.075	x	3.05	x	x	x	2.425	2.7	2.625	2.425	2.675	x	x	x	
-11815	Original post publication description: Adrenal weight (right) of females [mg]	None	Endocrinology, morphology: Adrenal weight (right) of females [mg]	x	x	x	x	1.9	2.525	x	2.3375	2.0	2.25	3.025	2.15	2.625	2.075	2.3	2.675	2.4875	1.8	2.425	2.125	x	x	x	2.15	x	2.2625	3.525	2.125	x	1.85	3.65	2.55	2.725	x	2.375	x	2.9	2.525	2.1	x	2.3125	2.25	1.525	2.3	x	x	2.6375	x	2.35	2.55	x	x	x	1.775	2.55	x	x	x	2.1125	2.1	2.9	2.325	x	2.325	2.55	2.25	2.725	2.925	2.275	1.625	x	1.9125	x	2.075	x	2.0	x	x	1.7	x	x	2.2	2.5	2.4	1.85	2.725	x	2.15	2.175	x	2.675	x	x	x	2.2	2.425	2.175	2.375	2.3	x	x	x	
-11816	Original post publication description: Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for males and females [mA]	None	Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for males and females [mA]	x	x	x	x	0.24	0.418182	0.355	0.255	0.3	0.265	0.34	0.235	0.3	0.23	0.327778	0.34375	0.38125	0.327778	x	0.275	x	0.485714	x	0.405	x	0.35	0.23	0.33	x	0.33	0.39	0.255	0.36	x	0.320833	x	0.28	0.305	0.34	x	0.27	0.353125	0.325	0.233333	x	x	0.319231	0.295	0.31	0.35	x	x	x	x	x	x	x	x	0.361538	0.38	0.385	0.391667	0.333333	0.34	0.235	0.3	0.3125	0.334615	0.365	0.25625	x	0.305	0.35	0.38	x	0.325	0.375	0.475	0.34	0.275	x	0.345833	0.305	0.339286	0.32	0.35	0.65	0.25	0.275	0.35	0.29	0.2375	x	x	0.29	x	x	x	x	x	x	x	
-11817	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males and females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males and females [sec]	x	x	x	x	165.25	39.6667	x	45.0	x	x	122.818	89.6	81.0	103.0	x	67.6	22.0	108.429	x	56.0	x	x	x	x	x	122.667	63.2727	84.6	x	87.0	70.5625	95.5	68.4	x	124.857	x	57.625	125.182	92.8182	x	110.7	111.0	88.3333	94.375	x	x	89.0	x	94.6	71.4	x	x	x	92.2	39.5	x	x	x	51.125	84.25	86.4	114.5	x	81.5	115.778	75.8	97.375	88.8	68.6667	78.1667	x	102.5	x	100.111	x	x	x	x	87.375	x	x	75.6667	117.625	x	29.4	82.0	x	48.3333	x	x	71.3333	x	x	x	57.5	5.0	82.0	x	185.5	x	x	x	
-11818	Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males and females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males and females [sec]	x	x	x	x	91.25	9.0	x	9.5	x	x	80.7273	14.2	4.0	4.66667	x	8.0	3.88889	60.5714	x	23.0	x	x	x	x	x	81.9167	2.27273	12.8	x	8.0	13.625	9.5	4.0	x	11.5714	x	1.0	66.1818	64.3636	x	77.7	85.5	62.6	11.25	x	x	55.5	x	37.9	20.6	x	x	x	41.7	6.0	x	x	x	11.0	4.5	204.2	42.0	x	12.625	23.5556	4.8	11.375	16.6	8.66667	5.0	x	37.0	x	33.6667	x	x	x	x	3.625	x	x	111.667	77.875	x	10.0	7.85714	x	5.33333	x	x	12.6667	x	x	x	6.5	7.0	7.6	x	14.0	x	x	x	
-11819	Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for males and females [sec]	None	Motor coordination, time on dowel over a 2 min baseline test period for males and females [sec]	x	x	x	x	97.75	120.0	x	85.5	x	x	120.0	120.0	100.0	120.0	x	104.8	72.6667	120.0	x	111.714	x	x	x	x	x	118.75	103.818	120.0	x	110.909	118.5	120.0	113.5	x	107.286	x	116.5	118.182	120.0	x	120.0	120.0	106.6	94.625	x	x	120.0	x	120.0	120.0	x	x	x	120.0	60.0	x	x	x	114.5	115.625	120.0	120.0	x	108.875	120.0	120.0	110.625	120.0	120.0	75.0	x	120.0	x	120.0	x	x	x	x	91.375	x	x	83.3333	120.0	x	51.8	108.571	x	120.0	x	x	89.6667	x	x	x	120.0	69.0	86.4	x	120.0	x	x	x	
-11820	Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for males and females [sec]	None	Depression assay, Porsolt behavioral despair test, time immobile for males and females [sec]	x	x	x	x	3.875	41.8333	x	96.3333	x	x	69.5	45.9	83.0	102.0	x	9.8	107.556	129.333	x	75.8571	x	x	x	x	x	29.9583	139.091	138.6	x	71.5	49.6562	61.1667	169.6	x	29.2857	x	163.438	30.2	128.955	x	76.55	90.3	61.5333	165.0	x	x	114.0	x	85.05	21.1	x	x	x	155.55	223.5	x	x	x	139.375	154.625	62.7	70.5	x	90.125	170.667	183.2	68.75	88.7	136.0	17.75	x	38.7083	x	115.167	x	x	x	x	7.25	x	x	102.5	147.062	x	80.4	112.714	x	78.3333	x	x	59.6667	x	x	x	131.0	12.0	78.4	x	136.0	x	x	x	
-11821	Original post publication description: Pain response, thermal nociception, Hargreaves' test for males and females	None	Pain response, thermal nociception, Hargreaves' test for males and females	x	x	x	x	20.9517	x	x	9.55842	11.9642	x	8.30537	17.5478	14.1515	9.65403	13.7917	8.90639	13.5477	9.61292	10.3367	15.0586	x	x	x	13.4692	x	11.1746	11.1832	13.5293	x	11.9537	10.8349	11.1364	11.4311	x	13.3327	x	14.5914	12.5011	10.4448	x	10.576	12.2506	10.1688	10.7271	x	x	10.5569	x	10.4646	9.23578	x	x	x	10.7231	12.3933	x	x	x	11.7149	10.4769	11.6813	14.57	x	14.2233	15.2628	17.7262	13.4021	12.7248	14.071	14.7875	x	14.3758	x	13.769	x	12.6462	x	x	10.0558	x	x	14.2318	13.1367	20.18	8.80954	10.0257	x	15.12	x	x	15.9138	x	x	x	11.6062	13.2608	14.5966	19.0475	16.434	x	x	x	
-11822	Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for males and females [sec]	None	Pain response, thermal nociception, hot plate test, average of two trials for males and females [sec]	x	x	x	x	8.5075	x	x	7.61475	11.83	x	8.03333	8.97227	4.90192	6.61526	9.7925	5.05833	9.559	5.37042	6.2875	6.62179	x	x	x	11.4871	x	9.77333	8.61	7.28367	x	5.74692	6.09235	9.62714	8.59	x	6.321	x	10.2964	9.24867	12.1532	x	6.17038	10.525	8.53972	14.295	x	x	16.6676	x	12.9196	7.47533	x	x	x	8.40033	6.12	x	x	x	9.05781	7.21583	9.63933	16.0775	x	6.86722	7.41833	7.92278	6.83722	6.1921	10.665	11.87	x	10.8553	x	13.8577	x	7.6025	x	x	7.855	x	x	8.61821	11.3027	9.29	9.61639	6.346	x	8.579	x	x	7.174	x	x	x	11.5157	9.7	8.10029	5.6775	10.4594	x	x	x	
-11823	Original post publication description: Pain response, mechanical nociception, tail clip latency for males and females [sec]	None	Central nervous system, behavior: Pain response, mechanical nociception, tail clip latency for males and females [sec]	x	x	x	x	33.835	x	x	16.94	26.1325	x	22.7833	9.054	24.1069	12.0479	30.025	17.8883	18.017	8.04583	31.96	7.48933	x	x	x	27.9529	x	20.4373	45.2131	30.2613	x	36.2315	33.3024	19.8586	44.1983	x	19.037	x	6.50214	27.8607	22.4677	x	14.65	21.7129	20.2178	30.5133	x	x	35.5184	x	26.08	14.772	x	x	x	11.5363	60.0	x	x	x	13.2512	18.91	42.1293	26.948	x	22.425	15.0433	22.4722	41.4933	18.5347	16.842	29.565	x	23.98	x	35.9167	x	33.386	x	x	21.6946	x	x	19.9679	6.22833	12.18	17.4861	10.228	x	14.477	x	x	16.8836	x	x	x	31.398	36.015	27.069	16.555	9.93	x	x	x	
-11824	Original post publication description: Pain response, thermal nociception, tail withdrawal latency for males and females [sec]	None	Pain response, thermal nociception, tail withdrawal latency for males and females [sec]	x	x	x	x	8.28333	x	x	10.4327	12.2158	x	15.0722	10.617	8.68744	8.20754	19.0733	10.045	10.3753	13.9703	8.48667	8.63178	x	x	x	16.7395	x	11.9158	13.3369	17.6633	x	10.2954	12.0118	12.7662	12.2164	x	13.8443	x	11.4698	12.1571	21.6895	x	12.0862	10.4286	11.6	20.8187	x	x	11.5035	x	15.3738	11.7189	x	x	x	10.6118	28.13	x	x	x	10.6641	10.6483	11.686	10.1927	x	8.42233	11.8969	18.663	10.5098	13.6168	10.4507	10.7933	x	16.3069	x	13.4337	x	15.6072	x	x	11.9772	x	x	11.4305	14.5147	5.64667	16.877	10.0287	x	11.803	x	x	7.83091	x	x	x	10.8727	13.9633	9.02567	9.56833	13.356	x	x	x	
-11825	Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males and females [Force in mg]	None	Central nervous system, peripheral nervous system, skin, behavior: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males and females [force in mg]	x	x	x	x	4.38912	x	x	4.01835	3.96825	x	4.31694	4.18573	4.42469	4.38903	4.37725	4.23723	4.32097	4.11629	4.23112	4.15617	x	x	x	4.22439	x	4.16437	4.32327	4.14855	x	4.19612	4.06056	4.11438	4.2971	x	4.0077	x	4.12986	4.0489	4.06234	x	4.27392	4.02443	4.3796	4.18365	x	x	4.07555	x	4.11968	4.32607	x	x	x	4.39403	4.22	x	x	x	4.10912	4.2086	4.23688	4.1571	x	4.08913	4.1775	4.13694	4.25669	3.98371	4.2419	3.95263	x	4.02855	x	4.00806	x	4.15213	x	x	4.38189	x	x	4.18814	3.78256	4.11475	4.19975	4.06938	x	4.07778	x	x	4.03775	x	x	x	4.09932	3.99612	4.14549	4.07363	4.07552	x	x	x	
-11826	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3949.15	1176.82	x	3652.08	1979.0	3631.0	3243.14	6223.57	2122.11	3757.62	1323.08	4491.62	3465.6	310.75	4738.11	3866.0	x	x	x	3538.33	x	5468.54	683.929	3048.55	x	2862.93	195.75	1292.23	774.154	x	2919.0	x	2191.25	3545.53	5836.12	x	378.706	301.25	1322.69	3619.62	x	x	2068.0	x	901.692	5893.17	x	x	x	206.692	512.2	x	x	x	6.76923	425.75	2000.5	3009.71	x	2118.0	1314.83	2169.33	1673.33	761.714	4230.57	2385.71	x	2247.56	x	2000.5	x	37.25	x	x	3382.8	x	x	782.417	124.818	3349.83	5148.8	70.2727	x	153.091	2014.0	x	2267.33	x	x	x	849.0	1514.75	2006.4	77.4545	2674.21	x	x	x	
-11827	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3777.46	1484.73	x	3240.17	1283.0	2941.73	2253.57	4901.0	2020.56	3465.38	1175.75	2745.88	3195.1	949.0	3919.78	3004.17	x	x	x	2914.89	x	4622.85	843.571	2556.64	x	1890.93	199.25	1341.46	711.308	x	1753.14	x	2072.25	3446.6	4510.41	x	566.353	412.417	1108.62	3378.0	x	x	1786.33	x	689.846	5046.22	x	x	x	371.923	471.2	x	x	x	7.61539	487.25	1766.5	2696.0	x	1788.5	1139.42	1877.33	778.667	675.929	3626.64	1968.14	x	2155.56	x	1799.17	x	16.0	x	x	2438.5	x	x	672.75	259.0	3390.58	5050.5	70.8182	x	243.091	2140.89	x	1866.22	x	x	x	689.167	1944.5	1603.2	195.455	2565.5	x	x	x	
-11828	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3180.31	1681.82	x	2504.75	404.5	2244.18	1304.0	2903.86	1877.44	2737.88	741.417	1733.12	2560.7	1072.88	2970.56	2301.58	x	x	x	1861.0	x	3203.77	980.929	1800.0	x	1610.43	211.75	1226.31	471.308	x	1297.43	x	1857.25	2980.73	3427.12	x	910.118	461.417	898.308	3050.62	x	x	1162.83	x	508.0	4218.94	x	x	x	517.077	402.2	x	x	x	58.3846	638.25	1281.0	2185.71	x	1319.43	840.0	1449.83	229.556	524.429	3443.07	1986.43	x	2141.62	x	1417.33	x	70.25	x	x	2038.0	x	x	605.333	410.273	3330.0	4719.1	82.6364	x	631.364	2027.89	x	1375.11	x	x	x	477.0	2414.5	1251.5	228.273	2062.07	x	x	x	
-11829	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2312.46	464.455	x	855.5	242.75	1246.73	1709.14	2093.71	207.222	1215.12	370.083	2016.75	1433.3	135.875	1550.0	752.833	x	x	x	725.444	x	1051.77	205.214	1391.55	x	2056.57	139.125	823.231	273.692	x	1115.71	x	1097.25	921.0	2798.29	x	572.353	303.25	906.615	814.625	x	x	881.5	x	410.769	1289.61	x	x	x	313.692	373.4	x	x	x	130.0	218.125	340.333	913.714	x	389.143	675.667	286.167	512.222	374.214	2745.07	4767.71	x	596.188	x	685.667	x	494.0	x	x	860.8	x	x	207.75	215.545	869.833	899.9	126.364	x	614.091	1191.67	x	624.556	x	x	x	284.167	402.75	2150.5	307.0	854.5	x	x	x	
-11830	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	1557.31	1704.73	x	1571.67	136.75	1238.55	369.0	1113.86	1137.11	1931.75	343.25	612.75	1218.1	726.375	854.0	1192.67	x	x	x	436.778	x	1573.69	951.786	415.091	x	1010.57	188.25	1056.92	127.769	x	883.429	x	1360.08	1798.2	1667.65	x	1729.65	125.167	367.0	2304.75	x	x	434.5	x	245.385	2495.89	x	x	x	345.308	294.8	x	x	x	51.6154	490.375	514.083	1728.86	x	635.714	527.083	745.667	86.6667	309.286	2702.14	1964.14	x	1908.69	x	550.917	x	182.75	x	x	1200.1	x	x	350.0	726.273	2391.25	3454.9	48.1818	x	717.273	1246.89	x	697.778	x	x	x	296.833	1910.75	197.2	183.636	1315.86	x	x	x	
-11831	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	1098.31	1522.45	x	1162.67	148.0	880.636	265.286	720.714	551.111	1158.88	352.667	394.75	908.8	367.0	465.333	949.167	x	x	x	330.111	x	1169.54	718.357	197.364	x	495.786	144.625	1058.08	180.692	x	492.714	x	1143.0	1391.33	1126.41	x	1814.41	72.4167	191.0	1727.38	x	x	500.0	x	155.154	1642.33	x	x	x	295.923	214.8	x	x	x	101.154	375.0	368.25	1399.86	x	462.929	370.0	338.833	248.778	345.929	2389.0	1564.43	x	1536.38	x	311.333	x	283.5	x	x	883.5	x	x	267.667	989.455	1821.67	2814.9	50.1818	x	595.909	624.667	x	494.778	x	x	x	184.833	1221.25	125.5	174.636	1248.29	x	x	x	
-11832	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2480.08	147.364	x	1402.92	19.0	1292.82	2825.14	5181.0	245.333	1235.0	277.0	3447.62	1504.8	18.25	2761.67	1309.17	x	x	x	1079.44	x	2006.69	34.3571	1999.45	x	5759.64	5.875	661.462	141.077	x	2494.57	x	1191.33	1292.33	3800.18	x	135.941	100.667	975.692	989.5	x	x	1028.0	x	983.923	2229.17	x	x	x	25.3077	217.9	x	x	x	23.0769	49.75	800.333	1289.57	x	410.643	281.333	163.083	1536.56	143.643	1568.29	10056.3	x	501.125	x	673.917	x	137.25	x	x	1327.2	x	x	93.75	2.36364	2334.83	1451.8	5.0	x	52.0	1043.89	x	680.556	x	x	x	248.083	184.25	3311.4	5.72727	951.286	x	x	x	
-11833	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2962.69	247.455	x	2103.58	142.0	2760.55	4345.14	6371.0	653.111	1659.25	446.0	5257.12	2177.3	70.875	3470.0	2458.17	x	x	x	2257.89	x	2902.77	64.7857	2605.91	x	8372.93	6.75	588.538	191.231	x	4442.14	x	1651.83	1553.33	4361.82	x	77.9412	67.8333	997.308	1219.5	x	x	1345.17	x	2133.77	2883.56	x	x	x	9.38461	327.2	x	x	x	15.2308	26.0	1648.5	1528.29	x	658.571	298.667	436.583	2927.56	211.0	1839.29	8775.57	x	703.938	x	936.667	x	27.75	x	x	1909.3	x	x	232.0	0.545455	3275.92	2024.6	20.4545	x	19.3636	966.556	x	1154.78	x	x	x	357.25	164.0	3818.0	3.63636	1242.93	x	x	x	
-11834	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3661.85	356.091	x	3008.83	371.25	3891.73	5110.29	6805.29	1182.78	2228.0	580.75	6470.62	2550.5	149.875	4217.67	3210.0	x	x	x	3005.22	x	4202.08	189.429	3423.82	x	8409.0	20.375	737.462	354.692	x	5041.71	x	1973.33	2232.67	5424.12	x	117.412	116.25	1279.77	1851.62	x	x	1852.0	x	2551.77	4125.06	x	x	x	13.2308	579.1	x	x	x	0.461538	38.0	2109.92	2120.14	x	1048.71	581.667	782.583	3567.22	331.786	2828.07	6575.29	x	1020.0	x	1491.25	x	7.5	x	x	3154.7	x	x	431.417	1.72727	3775.0	3251.6	37.4545	x	12.0909	1305.33	x	1813.56	x	x	x	537.5	349.25	4209.9	35.4545	1654.93	x	x	x	
-11835	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	4131.69	620.818	x	3699.67	1090.0	4283.0	5125.71	7234.71	1639.0	2936.75	846.25	6750.62	3344.4	92.875	4739.44	3951.25	x	x	x	3469.44	x	5139.69	335.357	3774.0	x	6949.36	84.875	878.923	583.692	x	4518.14	x	2355.08	3084.2	6084.65	x	209.176	172.5	1666.31	2689.38	x	x	2122.83	x	2123.77	4985.44	x	x	x	30.7692	610.0	x	x	x	15.8462	106.625	2099.17	2856.29	x	1644.57	982.417	1252.75	3211.22	540.643	3362.14	4689.14	x	1471.81	x	1883.0	x	24.25	x	x	4019.4	x	x	640.667	20.2727	3832.75	4136.5	50.2727	x	21.2727	1757.33	x	2058.22	x	x	x	702.5	565.75	3805.5	126.273	2088.14	x	x	x	
-11836	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3965.46	863.273	x	3775.83	2022.25	3917.55	4135.29	6896.43	1942.67	3402.25	956.417	6131.75	3608.5	157.625	4783.22	4235.58	x	x	x	3739.11	x	5642.62	496.429	3540.0	x	4757.57	149.625	1094.46	770.615	x	3583.71	x	2283.33	3366.07	6270.76	x	288.588	258.333	1673.62	3353.5	x	x	2261.67	x	1515.92	5703.22	x	x	x	104.462	508.7	x	x	x	4.84615	211.375	2153.0	3013.86	x	2069.64	1289.25	2010.33	2271.56	823.429	3926.07	3309.43	x	1950.69	x	2067.25	x	51.25	x	x	4254.7	x	x	714.667	81.3636	3505.42	5163.9	63.2727	x	71.8182	2127.89	x	2226.78	x	x	x	855.583	1027.0	2850.5	125.273	2565.43	x	x	x	
-11837	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males and females [cm]	x	x	x	x	12065.3	3807.04	x	11220.9	5916.96	11000.5	9870.44	16267.3	7093.06	11099.9	4836.38	12051.8	9744.87	1400.95	13715.3	11038.0	x	x	x	10613.7	x	15423.9	2624.27	8920.04	x	8732.37	618.985	4396.28	2765.59	x	8381.9	x	7905.98	10892.3	15576.3	x	1547.39	1044.91	4016.13	10439.8	x	x	6622.84	x	2786.5	16346.6	x	x	x	914.775	2311.03	x	x	x	29.2262	1430.15	5854.45	10049.6	x	7257.09	4250.62	7423.24	5029.98	2468.71	12588.1	8573.89	x	7214.97	x	6059.9	x	301.657	x	x	9733.97	x	x	2532.25	829.259	10516.4	13349.5	233.955	x	696.334	7207.96	x	7678.17	x	x	x	2708.93	5522.48	5993.57	306.717	8372.75	x	x	x	
-11838	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males and females [cm]	x	x	x	x	11638.5	4514.73	x	10147.7	3934.56	9293.54	7065.19	13028.2	6805.56	10161.1	4286.93	7560.49	9018.19	3322.84	11645.6	8917.04	x	x	x	8792.64	x	13372.3	3097.81	7468.73	x	6540.03	623.704	4494.82	2532.83	x	5212.75	x	7543.09	10473.6	12873.7	x	2134.7	1365.4	3244.44	10177.0	x	x	5675.79	x	2163.52	14283.2	x	x	x	1421.35	2099.06	x	x	x	29.6031	1555.56	5199.63	9246.07	x	6221.89	3770.53	6205.55	2410.18	2161.37	11289.6	7714.72	x	6832.65	x	5478.57	x	175.259	x	x	7547.67	x	x	2183.19	1456.59	10576.6	13302.5	230.757	x	1118.24	7427.24	x	6652.02	x	x	x	2216.92	6508.46	4816.4	719.439	8139.17	x	x	x	
-11839	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males and females [cm]	x	x	x	x	9810.1	4916.83	x	8054.35	1352.63	7464.76	4189.27	8354.76	6175.61	8288.75	3014.72	5130.61	7462.82	3580.79	9209.01	7077.72	x	x	x	5925.11	x	9730.65	3442.93	5356.39	x	5651.24	650.489	4218.79	1760.21	x	3927.23	x	6982.26	9036.28	10509.4	x	3071.29	1530.93	2280.74	9383.31	x	x	3812.72	x	1588.37	12176.9	x	x	x	1828.39	1740.29	x	x	x	189.532	1984.52	3876.71	7998.24	x	4729.66	2780.31	4831.36	840.545	1711.87	10745.8	7791.51	x	6703.85	x	4217.26	x	412.085	x	x	6318.4	x	x	1965.99	2034.51	10355.8	12621.9	261.455	x	2315.79	6827.35	x	5258.79	x	x	x	1566.76	7387.58	3796.07	775.677	6893.24	x	x	x	
-11840	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males and females [cm]	x	x	x	x	6848.87	1560.27	x	2694.38	716.861	4294.67	4770.23	6052.03	914.625	3790.1	1899.86	6063.94	4412.47	456.187	5102.15	2695.77	x	x	x	2966.16	x	3532.4	766.514	4274.51	x	5982.61	484.664	2674.26	1170.07	x	3580.22	x	3575.53	3033.79	8032.53	x	1827.84	1050.32	2872.78	2913.66	x	x	2956.46	x	1352.78	4265.92	x	x	x	1220.28	1516.23	x	x	x	443.994	775.943	1360.77	3503.74	x	1503.09	2234.82	1332.77	2156.2	1271.25	8440.31	12519.0	x	1957.66	x	2221.33	x	1684.44	x	x	2627.28	x	x	728.922	669.349	3294.34	2930.12	392.663	x	2298.93	4303.97	x	2479.67	x	x	x	1039.57	1334.7	6238.8	948.5	2928.86	x	x	x	
-11841	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injections in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injections in an activity chamber for males and females [cm]	x	x	x	x	5101.78	5124.28	x	5137.79	505.57	4248.79	1102.92	3514.43	3863.28	5979.65	1537.07	2107.58	3831.07	2455.53	2819.9	3987.79	x	x	x	1541.06	x	5154.82	3129.65	1298.87	x	3234.57	608.797	3700.94	467.552	x	2681.84	x	5301.79	5896.41	5552.55	x	5229.48	496.703	943.93	7117.88	x	x	1472.36	x	787.324	7631.54	x	x	x	1244.55	1150.25	x	x	x	168.938	1538.09	1732.13	6659.51	x	2479.84	1615.39	2476.08	296.446	1120.56	8991.03	7380.67	x	6073.51	x	1739.79	x	829.62	x	x	3732.52	x	x	1156.61	2810.06	7624.42	9597.26	150.425	x	2542.13	4179.65	x	3275.64	x	x	x	1057.01	6108.74	624.487	606.411	4588.99	x	x	x	
-11842	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males and females [cm]	x	x	x	x	3635.49	4666.5	x	3694.69	537.119	2954.77	841.111	2277.24	2075.96	3804.72	1459.7	1468.62	2771.15	1293.59	1621.07	3153.92	x	x	x	1152.24	x	3622.64	2397.88	659.348	x	1658.52	489.778	3626.13	637.685	x	1475.27	x	4526.11	4708.81	3764.68	x	5407.63	298.022	528.7	5814.87	x	x	1670.45	x	482.056	5412.81	x	x	x	1103.93	835.496	x	x	x	331.075	1154.24	1228.55	5481.16	x	1836.54	1139.02	1111.87	903.646	1174.21	8211.38	5999.82	x	5004.04	x	1006.18	x	1064.1	x	x	2814.39	x	x	956.624	3427.3	5938.02	8044.01	181.99	x	2155.78	2162.23	x	2588.39	x	x	x	705.241	4276.96	398.4	584.614	4305.15	x	x	x	
-11843	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males and females [cm]	x	x	x	x	7838.71	796.303	x	4718.53	108.978	4924.84	7702.61	13810.4	1428.85	3925.25	1903.65	10713.4	4922.38	129.873	8734.16	4591.88	x	x	x	4430.91	x	6517.76	325.008	6193.92	x	15011.1	42.7684	2344.54	943.12	x	7518.69	x	4230.72	4699.61	10801.0	x	655.541	482.319	3542.42	3814.36	x	x	3661.9	x	3298.53	7052.33	x	x	x	218.35	1317.47	x	x	x	98.1774	271.437	2859.24	5940.45	x	2257.73	1207.27	1169.76	5457.49	681.727	6601.43	24297.8	x	1914.74	x	2255.67	x	757.578	x	x	4051.5	x	x	382.266	14.3002	7795.03	4776.38	51.1265	x	452.344	4556.91	x	3273.32	x	x	x	927.806	823.354	9558.89	35.5025	3646.89	x	x	x	
-11844	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males and females [cm]	x	x	x	x	9363.14	1162.02	x	6935.09	604.168	8569.1	11720.2	16624.6	3211.77	5109.23	2619.92	14552.1	6605.52	347.1	10449.3	7565.21	x	x	x	7613.01	x	9083.72	615.894	7916.88	x	20670.6	71.4603	2271.54	1159.11	x	12742.5	x	5927.63	5964.9	12615.6	x	535.31	339.725	3754.93	4355.5	x	x	4729.68	x	6428.06	8810.42	x	x	x	119.017	1851.0	x	x	x	74.0679	184.417	5007.84	7046.53	x	3552.3	1363.89	2267.92	9092.51	902.436	7517.55	21834.2	x	2783.0	x	3204.78	x	221.912	x	x	5762.27	x	x	877.207	9.23636	10140.8	6414.65	131.342	x	241.738	4468.51	x	5063.36	x	x	x	1346.67	1105.04	10871.8	35.0098	4690.11	x	x	x	
-11845	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males and females [cm]	x	x	x	x	11283.1	1590.89	x	9490.75	1518.38	11433.7	13704.1	17534.7	4999.17	6903.99	3248.23	16766.8	7752.79	704.189	12410.4	9299.82	x	x	x	9447.03	x	12399.0	1167.22	10042.9	x	20695.6	112.214	2796.28	1695.17	x	14324.2	x	6889.89	7953.0	14906.7	x	684.419	490.773	4469.36	5855.44	x	x	6237.21	x	7413.83	11949.8	x	x	x	143.796	2629.59	x	x	x	13.2841	255.251	6303.22	8609.31	x	4880.94	2214.68	3751.5	10664.5	1401.99	9747.03	17802.7	x	4029.1	x	4809.68	x	73.9509	x	x	8870.36	x	x	1591.63	22.5695	11206.3	9329.36	210.032	x	145.591	5545.82	x	6944.53	x	x	x	1905.83	2039.93	11940.0	207.004	5911.85	x	x	x	
-11846	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males and females [cm]	x	x	x	x	12404.5	2441.99	x	11222.5	4047.53	12268.2	14154.5	18471.7	6205.13	9051.34	3863.96	17282.3	9527.78	576.974	13623.6	11130.6	x	x	x	10581.2	x	14764.8	1555.35	10848.4	x	17871.0	348.105	3254.47	2375.34	x	12764.6	x	8001.51	10024.5	16119.3	x	968.047	700.585	5533.64	8128.29	x	x	6993.69	x	6237.73	14192.7	x	x	x	254.166	2701.06	x	x	x	69.7519	549.283	6355.14	9931.14	x	6354.09	3362.52	5308.92	9637.01	2058.29	10862.5	13812.1	x	5375.38	x	5843.49	x	204.98	x	x	11050.3	x	x	2245.61	165.183	11522.0	11118.4	243.837	x	238.457	6725.48	x	7628.89	x	x	x	2394.08	3014.13	10850.5	512.954	7031.18	x	x	x	
-11847	Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males and females [cm]	x	x	x	x	12152.4	3090.49	x	11431.5	6182.69	11685.5	12263.3	17794.9	6744.89	10385.5	4109.23	16006.3	10039.8	920.005	13528.8	11851.6	x	x	x	11200.9	x	15886.4	2110.35	10200.4	x	12863.1	532.15	3827.6	2838.83	x	10333.4	x	7947.08	10602.9	16478.2	x	1252.12	932.124	5220.27	9633.25	x	x	7267.69	x	4486.25	15951.0	x	x	x	616.183	2413.83	x	x	x	29.5031	852.65	6452.24	10175.4	x	7305.58	4153.03	7288.96	6875.32	2763.69	11970.2	10676.4	x	6590.99	x	6274.53	x	405.169	x	x	11592.8	x	x	2383.54	602.084	10678.7	13354.6	248.016	x	436.685	7626.71	x	7845.82	x	x	x	2807.51	4416.56	8334.15	466.846	8216.83	x	x	x	
-11848	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males and females [ordinal scale, 0=no effect, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males and females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.0	0.181818	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.083333	x	x	x	0.0	x	0.076923	0.0	0.090909	x	0.0	0.0	0.0	0.076923	x	0.0	x	0.0	0.0	0.0	x	0.0	0.0	0.0	0.125	x	x	0.0	x	0.0	0.111111	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	0.0	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	x	0.0	x	0.0	x	x	0.0	x	x	0.0	0.0	0.0	0.1	0.181818	x	0.0	0.222222	x	0.0	x	x	x	0.0	0.0	0.0	0.0	0.0	x	x	x	
-11849	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males and females [n fecal boli]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males and females [n fecal boli]	x	x	x	x	1.84615	3.18182	x	3.08333	2.25	0.727273	1.42857	2.57143	0.888889	2.0	1.91667	0.5	1.6	3.625	1.88889	1.5	x	x	x	1.77778	x	1.30769	0.5	1.63636	x	1.57143	2.375	0.384615	2.84615	x	2.0	x	0.083333	1.46667	1.41176	x	1.82353	2.66667	1.76923	2.25	x	x	1.83333	x	2.53846	2.33333	x	x	x	2.61539	2.9	x	x	x	3.92308	3.25	2.41667	1.14286	x	1.78571	1.58333	3.41667	1.88889	1.5	0.857143	4.28571	x	1.5625	x	3.33333	x	2.33333	x	x	3.0	x	x	2.83333	2.45455	0.333333	2.6	1.81818	x	1.36364	1.88889	x	1.0	x	x	x	1.83333	2.25	2.6	1.90909	0.428571	x	x	x	
-11850	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males and females [n/15 min test]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males and females [n/15 min test]	x	x	x	x	0.0	0.0	x	0.833333	0.0	1.90909	0.0	0.142857	4.77778	0.0	0.0	0.0	5.9	0.0	3.55556	3.66667	x	x	x	0.0	x	3.38461	3.85714	0.0	x	0.0	0.0	0.0	3.23077	x	0.0	x	0.416667	2.26667	0.294118	x	4.64706	1.91667	0.153846	4.875	x	x	2.33333	x	0.538462	2.22222	x	x	x	0.0	3.6	x	x	x	1.92308	0.0	0.916667	0.0	x	2.71429	0.0	0.0	0.0	0.0	1.5	0.0	x	0.3125	x	0.0	x	0.0	x	x	2.0	x	x	0.0	2.63636	0.666667	1.2	0.0	x	0.0	3.66667	x	1.33333	x	x	x	7.83333	3.75	2.7	15.8182	4.21429	x	x	x	
-11851	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	35489.4	11981.5	x	28671.8	7937.5	29816.4	31281.3	52251.9	15006.8	28043.9	7942.83	40994.6	28139.0	4777.12	36326.8	28815.8	x	x	x	24173.8	x	39100.4	6580.14	25545.7	x	45504.9	1538.88	11950.6	4841.77	x	29680.7	x	20751.9	28062.5	47821.9	x	8100.06	2736.67	11974.7	27948.6	x	x	16164.3	x	12654.2	43801.1	x	x	x	2704.23	4872.9	x	x	x	471.231	3571.25	15851.2	24840.9	x	13507.5	8822.5	12635.8	17118.2	5404.79	35760.3	50184.3	x	18561.6	x	14914.2	x	1483.25	x	x	27087.6	x	x	5530.17	3388.09	34814.6	42401.4	692.545	x	3921.0	18147.1	x	16223.6	x	x	x	5842.42	14320.5	25784.7	1690.36	20890.3	x	x	x	
-11852	Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [cm]	None	Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [cm]	x	x	x	x	109836.0	38650.5	x	90417.1	25822.4	93353.1	89351.2	139250.0	54245.5	85658.7	35062.4	112698.0	82523.3	17648.2	108613.0	86485.3	x	x	x	77037.1	x	116370.0	24850.9	75622.1	x	123231.0	5190.27	41702.8	19346.3	x	86450.7	x	74957.8	90952.8	135439.0	x	27460.3	9870.44	37833.7	86471.7	x	x	53528.7	x	38389.2	127859.0	x	x	x	10737.3	22072.7	x	x	x	1659.13	12085.7	48750.2	92402.8	x	51938.9	29841.5	46858.3	53647.9	18988.7	116845.0	146452.0	x	61633.6	x	46452.8	x	6854.36	x	x	79192.7	x	x	18700.7	14433.8	108823.0	116520.0	2536.91	x	15393.0	66799.6	x	62761.3	x	x	x	19922.7	50272.6	74825.1	5942.18	70393.3	x	x	x	
-11853	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males and females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males and females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]	x	x	x	x	2605.15	3370.15	x	2939.93	-613.747	1937.32	5.58881	942.053	1075.43	3178.07	772.615	601.147	1064.23	176.59	-36.2687	1774.72	x	x	x	82.4859	x	1948.92	379.936	-435.694	x	731.174	-1115.65	2196.65	-927.178	x	856.671	x	3491.2	3775.26	2617.96	x	3599.09	-1497.18	-326.82	4172.87	x	x	364.418	x	-596.547	4335.19	x	x	x	-91.6599	-626.672	x	x	x	-897.848	221.714	274.248	4814.89	x	1078.77	465.349	561.742	26.4219	-37.0167	7132.92	5218.38	x	4229.3	x	119.735	x	333.953	x	x	1836.41	x	x	92.0569	2146.61	4897.23	6094.06	-843.791	x	588.285	1352.68	x	1646.06	x	x	x	-686.527	3245.97	-1243.73	-2188.91	2804.36	x	x	x	
-11854	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	5618.77	2440.91	x	6301.17	1113.75	4690.82	2154.71	4679.0	2561.33	7054.0	424.417	8142.5	4791.9	668.0	5083.56	3642.58	x	x	x	3086.78	x	5670.77	1148.93	3353.09	x	4000.93	179.75	1788.62	537.154	x	3198.0	x	4495.42	3998.6	7473.88	x	1415.53	542.25	1563.77	3535.75	x	x	2089.67	x	1510.62	5212.44	x	x	x	169.231	606.9	x	x	x	126.308	925.25	1540.75	3934.71	x	1964.36	2041.5	1970.83	2560.44	916.571	5941.71	7332.71	x	4427.75	x	2801.17	x	438.75	x	x	3711.0	x	x	954.083	536.273	5565.0	5437.8	112.364	x	1105.91	4788.11	x	3363.44	x	x	x	3476.25	3733.0	4004.4	290.091	5349.57	x	x	x	
-11855	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [n beam breaks]	x	x	x	x	1336.46	941.909	x	1677.5	626.5	1105.27	755.714	1560.43	730.222	1055.88	285.25	825.875	2139.6	855.125	922.222	997.25	x	x	x	529.889	x	735.077	472.929	2110.27	x	950.571	959.25	907.231	976.923	x	652.0	x	949.0	509.0	1502.06	x	1483.65	761.333	726.385	1322.12	x	x	996.833	x	1324.69	1071.17	x	x	x	1258.0	411.8	x	x	x	1537.62	1206.38	469.083	385.714	x	856.0	687.75	431.25	944.889	1112.29	1130.0	1246.0	x	710.938	x	783.75	x	1397.5	x	x	816.0	x	x	538.583	874.636	832.583	1234.6	946.091	x	1074.36	1014.44	x	1219.0	x	x	x	968.5	1342.0	1448.0	1679.09	474.643	x	x	x	
-11856	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the morphine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the morphine test battery [n beam breaks]	x	x	x	x	1044.38	591.727	x	1225.92	902.75	1113.18	708.571	1186.86	632.889	697.25	320.833	625.0	1396.8	899.375	645.444	759.583	x	x	x	533.333	x	741.923	507.643	2045.45	x	671.286	655.375	1006.46	651.538	x	183.714	x	656.75	542.467	1243.76	x	989.059	731.25	404.0	1211.38	x	x	893.5	x	1296.08	829.833	x	x	x	920.769	179.7	x	x	x	1025.85	1048.25	329.25	654.571	x	872.071	489.5	465.333	955.556	918.643	1019.57	1295.29	x	625.938	x	631.25	x	1364.5	x	x	503.0	x	x	440.5	803.182	649.083	1024.3	783.636	x	1091.82	506.667	x	950.778	x	x	x	459.333	761.75	1321.9	1458.73	460.071	x	x	x	
-11857	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [n beam breaks]	None	Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [n beam breaks]	x	x	x	x	903.846	322.0	x	873.417	1160.5	914.364	726.0	954.571	392.0	545.5	347.583	509.5	973.0	774.375	336.0	662.667	x	x	x	453.667	x	391.0	324.357	1410.91	x	419.714	537.375	1062.15	437.692	x	83.4286	x	616.75	389.4	1151.0	x	720.294	659.167	281.231	953.625	x	x	790.0	x	1329.08	776.778	x	x	x	688.385	122.6	x	x	x	730.769	907.0	231.25	722.714	x	720.429	445.417	449.583	742.111	931.286	949.929	1290.0	x	467.0	x	507.75	x	1081.0	x	x	396.3	x	x	438.167	746.0	429.167	846.3	696.364	x	1046.27	411.333	x	840.556	x	x	x	330.25	630.75	1227.2	1273.0	472.0	x	x	x	
-11858	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [n beam breaks]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [n beam breaks]	x	x	x	x	688.846	205.545	x	771.25	997.25	617.364	503.857	793.286	183.222	449.125	247.583	445.375	803.0	539.125	289.0	486.583	x	x	x	320.444	x	168.231	213.429	1166.82	x	202.143	326.125	780.923	289.615	x	66.4286	x	513.833	320.733	901.294	x	602.529	570.583	164.0	527.5	x	x	664.0	x	1147.85	520.833	x	x	x	476.846	60.9	x	x	x	450.538	823.625	136.25	575.857	x	548.571	383.083	354.917	572.0	802.0	822.857	1006.0	x	389.812	x	479.667	x	1007.0	x	x	247.6	x	x	370.917	552.091	238.5	527.5	517.455	x	957.545	248.444	x	712.667	x	x	x	246.333	295.0	1151.4	1109.91	406.429	x	x	x	
-11859	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [cm]	x	x	x	x	4313.34	3255.03	x	5262.83	2519.68	3679.57	2702.82	4842.89	2786.4	3737.7	1508.45	2874.04	6340.19	3047.63	3237.13	3414.62	x	x	x	2492.83	x	2856.49	2082.07	6518.33	x	3563.68	3352.83	3311.19	3496.09	x	2566.14	x	3460.22	2198.65	4874.58	x	4787.99	2750.91	2723.51	4570.55	x	x	3386.71	x	4194.37	3619.44	x	x	x	4397.74	1815.25	x	x	x	4964.22	4093.08	1749.43	1870.19	x	3270.99	2627.6	1959.57	3458.84	3699.93	3893.34	4365.75	x	2755.87	x	2923.54	x	4367.48	x	x	2953.62	x	x	2346.1	3267.56	3173.71	4179.15	3241.59	x	3770.73	3742.48	x	4241.66	x	x	x	3314.59	4361.63	4573.7	5239.06	2091.77	x	x	x	
-11860	Original post publication description: Novel open field behavior, locomotion locomotion in the periphery from 15-30 for males and females in the morphine test battery [cm]	None	Novel open field behavior, locomotion locomotion in the periphery from 15-30 for males and females in the morphine test battery [cm]	x	x	x	x	3641.63	2117.99	x	3991.1	3215.68	3627.51	2540.35	3920.09	2550.6	2647.09	1556.34	2274.47	4317.98	3341.51	2358.81	2721.49	x	x	x	2384.53	x	2524.42	2182.03	6107.59	x	2616.52	2437.1	3623.83	2503.03	x	766.286	x	2776.4	2209.68	4224.33	x	3465.6	2714.69	1541.25	4078.95	x	x	2954.64	x	4081.9	3063.68	x	x	x	3245.66	977.658	x	x	x	3432.15	3674.16	1358.49	2672.3	x	3149.42	2039.5	1982.11	3500.06	3141.77	3556.28	4305.41	x	2387.3	x	2477.96	x	4247.02	x	x	2045.61	x	x	1961.5	3039.1	2536.71	3498.94	2603.65	x	3757.07	2289.88	x	3496.85	x	x	x	1830.55	2931.54	4217.74	4633.22	1950.54	x	x	x	
-11861	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [cm]	None	Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [cm]	x	x	x	x	3187.56	1226.24	x	3026.82	3703.54	2993.83	2496.81	3266.39	1694.32	2106.73	1646.62	1882.61	3149.59	2870.78	1212.0	2297.19	x	x	x	2089.01	x	1353.17	1522.57	4420.27	x	1696.06	2024.69	3680.82	1704.46	x	358.046	x	2514.83	1649.98	3917.06	x	2569.88	2504.57	1076.21	3293.45	x	x	2739.68	x	4169.03	2873.1	x	x	x	2509.49	597.881	x	x	x	2441.12	3172.95	918.196	2785.1	x	2532.73	1838.44	1860.61	3014.56	3240.93	3401.55	4220.57	x	1820.99	x	2085.51	x	3494.36	x	x	1589.64	x	x	1921.36	2796.81	1668.07	2852.15	2263.85	x	3589.54	1930.1	x	3119.15	x	x	x	1407.93	2448.8	3958.69	4109.99	1877.38	x	x	x	
-11862	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [cm]	None	Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [cm]	x	x	x	x	2470.61	772.646	x	2735.12	3255.52	2066.19	1854.03	2784.05	892.132	1870.51	1162.81	1632.95	2575.87	1989.23	1016.3	1631.68	x	x	x	1467.61	x	622.564	1015.25	3752.29	x	794.005	1233.75	2767.97	1150.61	x	301.338	x	2198.31	1411.94	3134.11	x	2156.38	2171.4	613.514	1914.72	x	x	2447.13	x	3628.82	1996.44	x	x	x	1715.91	302.454	x	x	x	1421.33	2933.91	614.939	2250.54	x	1918.84	1577.05	1463.41	2340.96	2829.83	3043.82	3433.15	x	1486.25	x	1922.71	x	3242.21	x	x	1011.88	x	x	1604.69	2190.02	924.781	1802.45	1701.76	x	3340.69	1289.25	x	2595.54	x	x	x	1072.74	1208.15	3707.47	3607.9	1617.01	x	x	x	
-11863	Original post publication description: Novel open field behavior,vertical activity (rears) from 0-15 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior,vertical activity (rears) from 0-15 min for males and females [n beam breaks]	x	x	x	x	208.308	212.818	x	292.25	206.25	273.091	153.286	237.571	115.333	276.625	87.0	247.0	307.6	291.375	265.778	255.667	x	x	x	74.5556	x	144.0	107.5	319.909	x	245.714	175.875	291.462	291.385	x	167.571	x	238.0	121.0	353.235	x	304.412	391.417	151.615	266.5	x	x	298.167	x	342.0	270.889	x	x	x	238.462	83.5	x	x	x	357.692	317.125	147.917	100.286	x	163.429	231.5	173.75	336.889	257.143	268.786	280.571	x	307.688	x	258.917	x	239.0	x	x	288.2	x	x	133.833	284.0	311.167	288.2	214.0	x	330.909	228.222	x	199.667	x	x	x	386.917	258.0	241.2	411.636	169.357	x	x	x	
-11864	Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males and females [n beam breaks]	x	x	x	x	258.846	200.091	x	340.333	345.25	342.182	166.0	262.714	181.778	272.75	117.917	300.75	336.4	353.125	256.222	254.667	x	x	x	105.0	x	164.231	183.786	439.727	x	285.643	205.375	402.538	244.538	x	93.4286	x	326.917	176.067	422.882	x	335.235	483.167	138.385	294.75	x	x	346.667	x	393.0	276.778	x	x	x	247.0	68.7	x	x	x	308.769	365.75	178.5	191.429	x	255.286	257.583	280.0	366.444	332.857	340.714	362.143	x	374.75	x	284.667	x	337.25	x	x	311.7	x	x	198.833	373.273	347.167	303.1	218.636	x	397.182	232.0	x	235.556	x	x	x	421.083	249.75	279.4	405.636	242.929	x	x	x	
-11865	Original post publication description: Novel open field behavior, vertical activity (rears) from min 30-45 for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from min 30-45 for males and females [n beam breaks]	x	x	x	x	217.462	175.727	x	325.667	444.75	330.818	156.571	260.571	146.667	250.875	108.75	316.0	301.6	354.0	182.333	222.25	x	x	x	123.333	x	122.846	150.857	428.727	x	264.0	190.75	418.692	179.538	x	59.1429	x	349.083	154.867	423.118	x	288.235	447.667	109.385	207.5	x	x	344.833	x	435.308	259.722	x	x	x	232.769	44.9	x	x	x	263.692	413.375	136.25	204.429	x	205.071	202.5	293.083	291.889	332.214	384.786	371.429	x	341.875	x	265.75	x	363.75	x	x	305.8	x	x	199.083	393.909	274.583	233.5	204.545	x	404.545	194.778	x	247.333	x	x	x	371.583	270.0	265.1	351.273	248.786	x	x	x	
-11866	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males and females [n beam breaks]	x	x	x	x	211.308	97.4545	x	319.583	390.25	305.818	114.571	223.0	90.1111	246.375	104.833	314.625	280.6	254.75	141.444	170.75	x	x	x	93.3333	x	77.3077	121.143	428.091	x	191.071	160.125	357.615	134.923	x	63.0	x	365.833	161.467	397.412	x	270.765	429.417	71.5385	153.875	x	x	341.333	x	409.692	206.389	x	x	x	166.231	35.0	x	x	x	150.308	393.625	109.25	184.429	x	190.143	197.083	266.417	274.222	349.857	358.214	364.714	x	284.062	x	263.833	x	336.25	x	x	238.0	x	x	198.667	338.818	193.833	164.1	191.091	x	417.636	166.222	x	182.333	x	x	x	326.083	199.75	305.7	356.273	234.214	x	x	x	
-11867	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]	x	x	x	x	3973.54	2061.18	x	4548.08	3687.0	3750.18	2694.14	4495.14	1938.33	2747.75	1201.25	2405.75	5312.4	3068.0	2192.67	2906.08	x	x	x	1837.33	x	2036.23	1518.36	6733.45	x	2243.71	2478.12	3756.77	2355.77	x	985.571	x	2736.33	1761.6	4798.12	x	3795.53	2722.33	1575.62	4014.62	x	x	3344.33	x	5097.69	3198.61	x	x	x	3344.0	775.0	x	x	x	3744.77	3985.25	1165.83	2338.86	x	2997.07	2005.75	1701.08	3214.56	3764.21	3922.36	4837.29	x	2193.69	x	2402.42	x	4850.0	x	x	1962.9	x	x	1788.17	2975.91	2149.33	3632.7	2943.55	x	4170.0	2180.89	x	3723.0	x	x	x	2004.42	3029.5	5148.5	5520.73	1813.14	x	x	x	
-11868	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]	None	Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]	x	x	x	x	13613.1	7371.9	x	15015.9	12694.4	12367.1	9594.02	14813.4	7923.46	10362.0	5874.21	8664.06	16383.6	11249.1	7824.25	10065.0	x	x	x	8433.98	x	7356.64	6801.93	20798.5	x	8670.27	9048.37	13383.8	8854.2	x	3991.81	x	10949.8	7470.25	16150.1	x	12979.9	10141.6	5954.49	13857.7	x	x	11528.2	x	16074.1	11552.7	x	x	x	11868.8	3693.24	x	x	x	12258.8	13874.1	4641.05	9578.13	x	10872.0	8082.59	7265.7	12314.4	12912.5	13895.0	16324.9	x	8450.4	x	9409.72	x	15351.1	x	x	7600.75	x	x	7833.66	11293.5	8303.27	12332.7	9810.85	x	14458.0	9251.72	x	13453.2	x	x	x	7625.82	10950.1	16457.6	17590.2	7536.71	x	x	x	
-11869	Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males and females [n beam breaks]	x	x	x	x	895.923	686.091	x	1277.83	1386.5	1251.91	590.429	983.857	533.889	1046.62	418.5	1178.38	1226.2	1253.25	845.778	903.333	x	x	x	396.222	x	508.385	563.286	1616.45	x	986.429	732.125	1470.31	850.385	x	383.143	x	1279.83	613.4	1596.65	x	1198.65	1751.67	470.923	922.625	x	x	1331.0	x	1580.0	1013.78	x	x	x	884.462	232.1	x	x	x	1080.46	1489.88	571.917	680.571	x	813.929	888.667	1013.25	1269.44	1272.07	1352.5	1378.86	x	1308.38	x	1073.17	x	1276.25	x	x	1143.7	x	x	730.417	1390.0	1126.75	988.9	828.273	x	1550.27	821.222	x	864.889	x	x	x	1505.67	977.5	1091.4	1524.82	895.286	x	x	x	
-11870	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males and females [n beam breaks]	x	x	x	x	287.769	397.091	x	216.0	342.0	297.182	229.714	400.714	285.556	163.0	157.583	261.0	582.3	336.375	491.444	421.5	x	x	x	251.667	x	510.308	619.143	359.545	x	251.143	534.125	452.769	513.231	x	179.286	x	309.75	278.8	345.176	x	519.882	583.583	259.385	515.375	x	x	445.5	x	325.462	364.667	x	x	x	334.0	421.9	x	x	x	392.0	302.25	305.25	171.286	x	207.214	214.167	147.25	247.778	374.929	327.714	223.286	x	227.625	x	253.417	x	278.667	x	x	303.5	x	x	215.417	424.273	284.75	652.9	323.455	x	477.727	229.889	x	251.111	x	x	x	450.5	261.5	482.1	942.909	478.071	x	x	x	
-11871	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males and females [cm]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males and females [cm]	x	x	x	x	1030.34	1296.36	x	754.765	1150.87	1017.45	835.522	1335.19	1000.53	626.651	687.085	867.472	1706.93	1117.0	1657.34	1379.2	x	x	x	1069.75	x	1673.72	2017.95	1095.04	x	927.35	1605.43	1429.47	1564.86	x	618.596	x	1034.91	933.544	1146.72	x	1808.53	1795.2	855.52	1642.0	x	x	1306.04	x	1078.6	1077.62	x	x	x	1195.59	1462.17	x	x	x	1228.92	932.527	954.298	666.273	x	757.773	673.676	550.129	877.224	1211.22	1078.45	781.432	x	774.738	x	886.449	x	1084.85	x	x	977.974	x	x	864.567	1280.69	1040.79	1949.96	1025.78	x	1567.5	809.557	x	942.333	x	x	x	1391.77	1030.99	1642.13	2773.53	1500.79	x	x	x	
-11872	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for males and females [n beam breaks]	x	x	x	x	79.0769	108.455	x	98.0	56.25	65.1818	40.2857	72.0	97.8889	73.875	45.8333	72.125	101.9	105.25	161.0	134.0	x	x	x	76.5556	x	117.077	77.8571	76.5455	x	86.7143	85.25	29.0	98.8462	x	44.2857	x	154.667	74.1333	73.3529	x	167.235	150.25	77.6923	135.375	x	x	101.667	x	111.615	117.611	x	x	x	122.154	117.4	x	x	x	80.0	104.875	50.75	51.4286	x	66.8571	110.0	121.75	58.5556	47.3571	122.071	61.7143	x	119.438	x	136.75	x	68.3333	x	x	93.2	x	x	110.75	72.9091	144.5	52.9	54.9091	x	154.727	64.6667	x	104.0	x	x	x	180.083	83.25	111.6	143.909	135.857	x	x	x	
-11873	Original post publication description: Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males and females [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males and females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.076923	0.181818	x	0.0	0.0	0.181818	0.571429	0.285714	0.444444	0.75	0.25	0.0	0.8	0.125	0.0	0.166667	x	x	x	0.111111	x	0.307692	0.071429	0.363636	x	0.071429	0.0	0.0	0.076923	x	0.0	x	0.333333	0.266667	0.058824	x	0.058824	0.166667	0.076923	0.625	x	x	0.166667	x	0.461538	0.5	x	x	x	0.230769	0.0	x	x	x	0.307692	0.25	0.083333	0.0	x	0.142857	0.166667	0.416667	0.111111	0.142857	0.285714	0.285714	x	0.125	x	0.166667	x	0.333333	x	x	0.2	x	x	0.0	0.090909	0.166667	0.6	0.090909	x	0.0	0.222222	x	0.444444	x	x	x	0.25	0.25	0.2	0.0	0.142857	x	x	x	
-11874	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males and females [ordinal scale, 0=no effect, 3=max]	None	Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males and females [ordinal scale, 0=no effect, 3=max]	x	x	x	x	1.53846	0.0	x	0.25	1.5	0.0	0.0	0.142857	0.0	0.125	2.16667	1.375	0.4	0.125	0.0	0.0	x	x	x	0.333333	x	0.307692	0.571429	0.818182	x	0.0	0.5	0.230769	0.230769	x	0.285714	x	0.0	0.533333	0.176471	x	0.058824	0.083333	0.0	0.0	x	x	0.333333	x	0.230769	0.333333	x	x	x	0.615385	0.0	x	x	x	0.769231	0.25	0.833333	0.0	x	0.642857	0.75	0.333333	0.0	0.142857	1.5	0.285714	x	0.125	x	0.166667	x	1.0	x	x	0.4	x	x	0.166667	0.0	0.166667	0.1	0.090909	x	0.0	0.222222	x	0.777778	x	x	x	0.583333	0.0	0.1	0.0	0.0	x	x	x	
-11875	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males and females [ordinal scale, 0=control level, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males and females [ordinal scale, 0=control level, 3=max]	x	x	x	x	0.230769	0.272727	x	0.25	0.25	0.0	0.142857	0.142857	0.222222	0.5	0.0	0.375	0.2	0.0	0.0	0.416667	x	x	x	0.222222	x	0.076923	0.0	0.636364	x	0.5	0.125	0.0	0.0	x	0.571429	x	2.0	0.2	0.058824	x	0.352941	0.166667	0.076923	0.625	x	x	0.166667	x	0.0	0.222222	x	x	x	0.769231	0.3	x	x	x	0.230769	0.375	0.25	0.285714	x	0.214286	0.25	0.0	0.444444	0.285714	0.071429	0.142857	x	0.6875	x	0.5	x	0.0	x	x	0.4	x	x	0.0	0.272727	0.416667	0.0	0.272727	x	0.181818	0.111111	x	0.111111	x	x	x	1.0	0.0	0.1	0.090909	0.0	x	x	x	
-11876	Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]	None	Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]	x	x	x	x	0.153846	1.72727	x	0.833333	0.0	0.0	0.285714	0.0	2.22222	0.875	0.25	0.375	0.7	0.5	0.777778	0.833333	x	x	x	0.444444	x	1.46154	0.642857	0.636364	x	0.357143	0.0	0.538462	0.230769	x	0.0	x	2.83333	0.933333	0.176471	x	1.41176	1.83333	0.461538	0.875	x	x	1.16667	x	0.384615	1.44444	x	x	x	1.15385	2.3	x	x	x	0.153846	2.0	0.25	0.0	x	1.07143	1.08333	0.666667	0.111111	1.28571	0.357143	0.142857	x	1.5	x	1.33333	x	2.33333	x	x	0.0	x	x	1.16667	0.454545	0.666667	0.1	0.636364	x	1.27273	0.666667	x	1.44444	x	x	x	1.25	1.0	1.9	0.909091	0.571429	x	x	x	
-11877	Original post publication description: Novel open field behavior, urinations for males and females [n/test period]	None	Central nervous system, behavior: Novel open field behavior, urinations for males and females [n/test period]	x	x	x	x	1.30769	2.18182	x	1.75	1.25	1.18182	1.57143	1.28571	2.22222	1.5	1.33333	1.25	1.5	1.75	1.66667	1.83333	x	x	x	1.0	x	1.69231	1.07143	1.63636	x	1.0	0.75	1.23077	1.46154	x	0.857143	x	1.66667	1.46667	0.823529	x	1.52941	0.833333	0.538462	1.375	x	x	1.16667	x	1.0	1.5	x	x	x	1.76923	1.3	x	x	x	1.23077	1.75	1.58333	1.57143	x	1.5	1.75	2.25	0.777778	0.714286	2.42857	0.857143	x	1.1875	x	1.33333	x	1.0	x	x	0.9	x	x	0.916667	1.27273	1.33333	1.8	1.0	x	1.54545	1.11111	x	1.22222	x	x	x	1.41667	1.75	1.3	1.45455	1.28571	x	x	x	
-11878	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	598.154	251.727	x	737.583	194.25	596.545	198.0	526.143	295.556	789.375	46.3333	821.875	523.6	52.375	573.778	410.25	x	x	x	357.556	x	705.846	132.857	342.545	x	402.643	23.25	174.923	62.1538	x	316.429	x	531.917	463.733	825.471	x	113.235	52.1667	143.154	381.5	x	x	179.667	x	104.385	650.778	x	x	x	18.6923	45.6	x	x	x	1.07692	84.25	188.5	393.0	x	260.571	303.667	262.917	296.667	94.5714	533.0	544.714	x	497.688	x	349.5	x	30.25	x	x	451.6	x	x	126.75	45.0	502.583	674.7	10.5455	x	61.6364	463.333	x	326.889	x	x	x	445.0	400.25	306.6	12.0	549.143	x	x	x	
-11879	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	573.0	282.364	x	695.5	134.5	495.545	139.429	451.143	270.778	777.5	32.0	631.625	538.0	110.375	476.0	356.25	x	x	x	297.556	x	623.077	141.214	291.818	x	330.786	19.25	165.462	51.5385	x	215.429	x	494.083	428.533	758.706	x	133.176	53.0	112.0	329.375	x	x	165.167	x	125.077	575.667	x	x	x	19.4615	35.9	x	x	x	4.76923	80.125	165.75	383.714	x	212.643	293.25	198.083	146.778	73.2857	498.571	474.429	x	506.812	x	295.0	x	28.0	x	x	382.3	x	x	104.583	79.7273	495.833	635.0	6.90909	x	95.4545	447.333	x	307.778	x	x	x	363.25	506.5	242.2	22.3636	563.571	x	x	x	
-11880	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	536.231	301.182	x	637.333	58.0	370.273	85.1429	273.571	260.889	690.875	14.1667	531.75	481.9	139.125	398.111	285.0	x	x	x	184.556	x	485.615	142.357	220.727	x	242.071	13.875	165.385	31.0	x	179.571	x	409.083	368.867	666.059	x	174.412	56.1667	75.0769	260.375	x	x	134.5	x	126.462	469.167	x	x	x	13.3846	27.4	x	x	x	7.07692	126.5	130.5	342.286	x	161.0	191.0	162.5	66.8889	57.9286	468.5	444.0	x	492.562	x	186.833	x	26.0	x	x	286.0	x	x	95.9167	89.8182	468.417	525.9	7.09091	x	134.909	408.333	x	261.889	x	x	x	278.167	661.75	199.9	22.1818	527.929	x	x	x	
-11881	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	339.462	59.9091	x	145.667	10.25	170.909	108.571	135.571	23.0	193.25	41.75	289.125	123.9	14.75	204.0	71.8333	x	x	x	82.2222	x	158.846	31.0714	186.545	x	150.286	12.0	75.3077	30.5385	x	78.8571	x	130.833	116.667	335.765	x	48.4118	55.3333	94.2308	94.75	x	x	70.6667	x	56.5385	134.167	x	x	x	21.0769	35.3	x	x	x	19.2308	48.0	26.0	81.1429	x	59.0	105.0	52.4167	60.2222	25.5	467.429	527.857	x	81.5	x	82.75	x	69.25	x	x	87.2	x	x	29.5833	18.1818	208.833	72.5	5.63636	x	123.727	285.444	x	139.444	x	x	x	93.0	14.0	267.0	27.1818	130.071	x	x	x	
-11882	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	326.0	304.091	x	453.25	39.5	167.636	23.4286	136.857	176.111	574.375	10.5	369.75	301.9	81.625	134.0	225.75	x	x	x	62.6667	x	318.538	104.357	100.091	x	157.929	19.0	151.923	14.3077	x	107.429	x	280.583	282.867	346.412	x	200.882	16.0833	39.7692	314.875	x	x	123.167	x	82.6923	321.111	x	x	x	9.07692	18.1	x	x	x	17.6154	141.5	74.0833	281.857	x	50.7143	75.5	67.5	60.8889	91.0714	436.143	416.857	x	446.625	x	96.6667	x	8.75	x	x	158.7	x	x	40.0	80.8182	406.583	356.8	4.63636	x	156.818	238.667	x	187.333	x	x	x	200.333	442.5	94.9	20.5455	381.786	x	x	x	
-11883	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	265.077	271.818	x	251.917	50.5	113.727	38.0	137.143	85.3333	387.25	5.08333	271.75	232.4	51.375	105.556	192.833	x	x	x	61.0	x	232.308	67.7143	72.7273	x	102.857	19.875	138.308	28.3846	x	58.8571	x	250.333	211.867	196.706	x	199.294	20.0833	20.3077	296.0	x	x	133.167	x	41.3077	227.278	x	x	x	17.4615	21.3	x	x	x	19.8462	102.25	64.25	239.429	x	27.7143	60.9167	64.4167	64.5556	78.2857	422.5	345.286	x	364.938	x	117.917	x	3.25	x	x	117.7	x	x	37.8333	103.636	278.833	315.6	9.0	x	148.818	90.3333	x	143.333	x	x	x	175.583	286.75	68.2	31.0909	288.571	x	x	x	
-11884	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	469.538	69.8182	x	333.917	9.0	256.909	227.143	382.571	103.222	322.5	61.25	763.0	264.9	12.625	450.667	190.583	x	x	x	229.444	x	362.846	32.6429	313.364	x	399.143	4.375	116.846	42.0	x	245.857	x	282.5	248.733	603.294	x	52.0	73.8333	182.154	225.125	x	x	228.5	x	119.077	309.667	x	x	x	23.3077	68.3	x	x	x	2.07692	39.25	68.6667	277.571	x	109.786	95.0	127.833	231.667	42.5	562.214	1133.0	x	142.0	x	161.25	x	79.75	x	x	224.9	x	x	21.25	0.090909	435.25	228.8	3.90909	x	66.6364	448.556	x	306.333	x	x	x	143.333	21.25	518.7	55.3636	293.857	x	x	x	
-11885	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	397.154	90.7273	x	475.917	67.5	422.727	321.143	603.0	225.778	450.375	53.0833	951.75	370.5	21.75	550.667	319.667	x	x	x	389.0	x	453.923	53.7143	402.909	x	533.214	5.25	138.846	51.7692	x	452.0	x	389.333	307.4	705.882	x	49.1176	33.4167	200.077	226.25	x	x	238.833	x	196.231	393.667	x	x	x	11.0769	81.0	x	x	x	5.53846	32.875	147.333	396.714	x	174.643	118.333	156.833	386.444	54.5714	496.929	869.857	x	206.188	x	233.417	x	33.0	x	x	311.5	x	x	50.5	0.363636	516.167	338.4	12.0	x	52.0909	438.778	x	361.444	x	x	x	228.833	72.0	604.6	17.5455	428.643	x	x	x	
-11886	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	512.154	119.545	x	584.75	99.5	583.455	349.0	656.286	280.556	581.625	49.1667	1062.25	428.8	31.125	656.444	412.75	x	x	x	441.667	x	562.615	85.0714	469.636	x	528.714	12.375	152.769	63.1538	x	507.143	x	442.5	360.867	810.235	x	63.4706	43.0	208.462	293.375	x	x	225.333	x	223.308	513.333	x	x	x	7.0	103.9	x	x	x	14.5385	31.125	188.75	396.0	x	243.857	165.5	204.917	447.778	83.0	532.5	733.857	x	323.875	x	337.833	x	16.75	x	x	418.4	x	x	100.0	7.27273	618.417	503.3	13.9091	x	28.0909	515.889	x	373.111	x	x	x	359.167	143.5	641.3	17.0	529.071	x	x	x	
-11887	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	584.923	165.818	x	682.25	192.5	651.909	332.571	603.286	320.778	790.625	47.0833	1064.0	526.0	28.75	668.111	464.417	x	x	x	464.333	x	672.692	101.857	449.455	x	475.143	15.625	171.769	71.5385	x	479.429	x	486.333	427.933	834.235	x	85.6471	55.4167	238.154	399.875	x	x	225.333	x	174.923	591.611	x	x	x	7.46154	81.8	x	x	x	20.4615	54.375	192.917	409.714	x	281.929	225.0	256.333	394.778	113.714	535.643	717.429	x	391.875	x	390.583	x	47.0	x	x	539.5	x	x	130.333	10.0909	627.333	641.8	17.9091	x	36.9091	554.333	x	375.111	x	x	x	464.75	231.75	590.2	26.1818	599.5	x	x	x	
-11888	Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males and females [n beam breaks]	None	Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	612.0	214.636	x	745.667	228.25	635.909	286.857	575.143	307.444	828.875	56.5833	978.875	542.9	43.75	617.0	461.167	x	x	x	423.778	x	693.923	126.214	385.909	x	480.429	19.25	169.538	75.6154	x	423.429	x	498.833	459.533	855.882	x	89.9412	55.0833	194.769	392.375	x	x	230.333	x	142.923	633.333	x	x	x	15.7692	63.0	x	x	x	2.0	64.25	203.917	406.714	x	276.571	290.25	312.333	340.333	129.0	531.643	678.714	x	466.625	x	396.167	x	68.0	x	x	500.8	x	x	140.583	26.4545	572.5	697.1	14.5455	x	47.6364	561.667	x	360.667	x	x	x	500.667	320.5	395.4	17.2727	608.071	x	x	x	
-11889	Original post publication description: Central nervous system, neuropharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males and females [cm/90 min test]	None	Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males and females [cm/90 min test]	x	x	x	x	x	x	x	812.5	x	x	x	3248.5	x	x	x	735.5	x	x	x	x	x	x	x	x	x	x	1301.5	x	x	x	x	x	x	x	381.2	x	x	1761.75	5446.25	x	12099.0	1463.5	451.5	x	x	x	x	x	x	x	x	x	x	530.5	x	x	x	x	4339.0	1584.5	27235.0	x	x	16648.0	3004.75	x	x	19276.0	x	x	x	22764.0	x	2664.0	x	2974.5	x	x	x	x	x	x	5317.5	x	36001.5	x	x	x	x	x	1622.0	x	x	x	2365.33	x	765.5	x	x	x	x	x	
-11890	Original post publication description: Locomotor activity after first saline injection (day 1) for males and females (MDMA control) [cm/ test period]	None	Locomotor activity after first saline injection (day 1) for males and females (MDMA control) [cm/ test period]	x	x	x	x	x	x	x	6961.0	x	x	2547.67	6521.75	x	x	x	5692.0	x	x	x	x	x	x	x	x	x	x	4383.0	x	x	x	x	x	x	x	1566.4	x	x	3156.25	10970.0	x	5158.0	3902.0	2907.0	x	x	x	x	x	x	x	x	x	x	7717.5	x	x	x	x	4637.0	5058.0	5353.5	x	x	3744.0	7132.0	x	x	16310.0	x	x	x	3506.5	x	5529.0	x	2867.5	x	x	x	x	x	x	5534.0	x	5212.0	x	x	x	x	x	4383.5	x	x	x	6561.33	x	6559.5	x	x	x	x	x	
-11891	Original post publication description: Saline control response, locomotor activity after second injection for males and females (control for MDMA response experiment) [cm/test period]	None	Saline control response, locomotor activity after second injection for males and females (control for MDMA response experiment) [cm/test period]	x	x	x	x	x	x	x	832.5	x	x	2535.0	827.5	x	x	x	1220.0	x	x	x	x	x	x	x	x	x	x	888.0	x	x	x	x	x	x	x	294.8	x	x	897.5	2590.75	x	802.75	1544.0	1303.0	x	x	x	x	x	x	x	x	x	x	2260.5	x	x	x	x	137.5	166.0	544.5	x	x	1258.5	967.0	x	x	7598.5	x	x	x	1611.0	x	1072.0	x	814.0	x	x	x	x	x	x	527.0	x	635.5	x	x	x	x	x	965.0	x	x	x	2219.67	x	580.0	x	x	x	x	x	
-11892	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males and females [ordinal scale]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males and females [ordinal scale]	x	x	x	x	x	x	1.33333	x	x	x	x	x	0.0	0.0	0.0	x	x	x	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.117647	x	0.0	x	x	x	x	0.25	1.0	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.1875	x	0.533333	x	x	0.0	x	x	x	0.055556	0.0	0.0	x	0.05	0.0	0.0	x	0.083333	0.0	x	0.0	0.0	x	0.0	0.0	0.05	0.0	0.0	x	0.066667	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	
-11893	Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males and females [units]	None	Central nervous system, behavior, pharmacology: Ethanol response (4.0 g/kg i.p.), handling-induced convulsions (HIC) 6 hrs after injections for males and females [units]	x	x	x	x	x	x	0.0	x	x	x	x	x	0.166667	1.4	0.0	x	x	x	x	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.941176	x	0.0	x	x	x	x	1.0	2.36842	x	x	x	0.238095	x	x	0.333333	x	x	x	x	x	x	x	x	1.25	x	1.8	x	x	1.2	x	x	x	1.55556	0.0	1.27273	x	0.75	0.125	1.13333	x	0.708333	1.0	x	1.0	0.5	x	3.57143	0.090909	0.4	1.0	0.470588	x	0.733333	x	x	0.266667	x	x	x	x	x	x	x	x	x	x	x	
-11894	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males and females [units]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males and females [ordinal scale]	x	x	x	x	x	x	1.0	x	x	x	x	x	1.16667	2.2	0.0	x	x	x	x	3.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.29412	x	0.0	x	x	x	x	0.75	1.42105	x	x	x	0.047619	x	x	0.666667	x	x	x	x	x	x	x	x	0.3125	x	1.73333	x	x	1.0	x	x	x	2.11111	0.0	0.727273	x	0.45	0.125	0.133333	x	0.875	0.0	x	0.181818	0.0	x	3.0	0.363636	0.1	1.5	0.235294	x	0.733333	x	x	0.133333	x	x	x	x	x	x	x	x	x	x	x	
-11895	Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males and females [score]	None	Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males and females [score]	x	x	x	x	x	x	0.333333	x	x	x	x	x	0.0	1.4	0.0	x	x	x	x	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.176471	x	0.0	x	x	x	x	0.416667	0.578947	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	x	0.3125	x	0.733333	x	x	0.0	x	x	x	0.333333	0.0	0.090909	x	0.0	0.0	0.0	x	0.0	0.833333	x	0.090909	0.0	x	0.428571	0.0	0.0	0.25	0.117647	x	0.266667	x	x	0.133333	x	x	x	x	x	x	x	x	x	x	x	
-11896	Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males and females [explain the score]	None	Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males and females [ordinal scale]	x	x	x	x	x	x	1.33333	x	x	x	x	x	1.33333	2.0	0.0	x	x	x	x	4.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.11765	x	0.0	x	x	x	x	x	3.31579	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.2	x	x	x	3.0	0.0	0.727273	x	1.15	0.25	1.26667	x	1.625	0.166667	x	1.09091	0.5	x	5.71429	0.454545	0.55	2.16667	0.529412	x	1.13333	x	x	0.4	x	x	x	x	x	x	x	x	x	x	x	
-11897	Original post publication description: Pain response, thermal nociception, hot plate latency for males and females [sec]	None	Pain response, thermal nociception, hot plate latency for males and females [sec]	x	x	x	x	8.115	6.46938	x	6.823	10.709	x	7.55933	11.4067	7.55286	7.462	6.83	9.22615	8.74929	8.06619	x	9.8908	x	x	x	8.26158	x	8.70063	8.31053	6.468	x	6.58	6.54375	10.0235	9.77833	x	7.59539	x	8.90818	6.8765	7.05	x	7.38353	6.92167	10.2755	9.86333	x	x	9.84625	x	6.801	7.655	x	x	x	8.43062	7.25091	x	x	x	7.49824	9.34897	7.666	x	x	8.14828	10.8085	7.56765	8.38482	8.65604	10.2157	8.70875	x	8.68588	x	10.2545	x	9.67154	x	x	5.87444	x	x	12.3125	7.41917	8.183	11.7207	8.23583	x	8.63444	x	x	9.24636	x	x	x	9.98944	7.30556	6.28182	4.715	6.63933	x	x	x	
-11898	Original post publication description: Locomotion in dark compartment of a light-dark box for males and females [cm]	None	Locomotion in dark compartment of a light-dark box for males and females [cm]	x	x	x	x	1713.5	768.438	x	968.6	507.875	x	243.667	877.75	418.0	829.3	363.9	640.462	880.786	445.714	x	770.8	x	x	x	345.947	x	392.875	303.684	858.31	x	731.588	925.25	482.824	614.867	x	653.692	x	524.227	393.45	799.765	x	803.059	696.5	592.345	750.059	x	x	776.312	x	654.4	507.45	x	x	x	957.75	285.636	x	x	x	740.824	600.241	407.35	x	x	590.688	578.846	524.059	667.667	769.042	680.429	629.125	x	693.842	x	576.455	x	604.0	x	x	641.188	x	x	534.083	700.267	676.8	634.571	575.083	x	605.0	x	x	544.182	x	x	x	760.611	517.111	907.364	1107.0	522.579	x	x	x	
-11899	Original post publication description: Anxiety assay, time in dark side of a light-dark box for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males and females [sec]	x	x	x	x	486.65	488.2	x	388.035	424.05	x	325.7	444.35	393.956	403.53	375.22	332.308	322.579	349.633	x	371.06	x	x	x	186.005	x	388.294	336.811	382.041	x	398.347	450.438	367.418	364.607	x	437.662	x	410.623	440.995	348.847	x	381.547	405.133	388.414	401.7	x	x	417.594	x	374.52	428.815	x	x	x	412.025	428.909	x	x	x	395.782	394.362	412.06	x	x	451.156	350.346	439.482	387.648	368.833	341.186	394.075	x	431.426	x	359.882	x	412.4	x	x	464.469	x	x	456.925	384.6	383.37	445.5	450.408	x	351.269	x	x	401.791	x	x	x	454.472	425.622	484.355	434.5	412.584	x	x	x	
-11900	Original post publication description: Locomotion in both compartments of a light-dark box for males and females [cm]	None	Locomotion in both compartments of a light-dark box for males and females [cm]	x	x	x	x	2285.5	1008.44	x	1481.75	820.25	x	395.133	1204.42	648.333	1270.9	559.8	1034.0	1503.29	667.476	x	1237.92	x	x	x	788.0	x	509.688	437.421	1292.14	x	1103.65	1226.62	803.353	974.267	x	941.462	x	746.545	535.4	1330.24	x	1320.0	1060.5	919.0	1141.06	x	x	1137.88	x	982.8	753.4	x	x	x	1426.25	422.091	x	x	x	1059.65	937.034	550.05	x	x	808.594	887.0	692.176	980.482	1282.29	1175.93	893.375	x	1011.74	x	910.455	x	864.462	x	x	913.375	x	x	716.083	1061.0	1002.7	865.786	827.167	x	1042.23	x	x	759.545	x	x	x	1037.44	747.222	1137.55	1502.5	788.053	x	x	x	
-11901	Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for males and females [cm]	None	Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males and females [cm]	x	x	x	x	572.0	240.0	x	513.15	312.375	x	151.467	326.667	230.333	441.6	195.9	393.538	622.5	221.762	x	467.12	x	x	x	442.053	x	116.812	133.737	433.828	x	372.059	301.375	320.529	359.4	x	287.769	x	222.318	141.95	530.471	x	516.941	364.0	326.655	391.0	x	x	361.562	x	328.4	245.95	x	x	x	468.5	136.455	x	x	x	318.824	336.793	142.7	x	x	217.906	308.154	168.118	312.815	513.25	495.5	264.25	x	317.895	x	334.0	x	260.462	x	x	272.188	x	x	182.0	360.733	325.9	231.214	252.083	x	437.231	x	x	215.364	x	x	x	276.833	230.111	230.182	395.5	265.474	x	x	x	
-11902	Original post publication description: Anxiety assay, time in light side of a light-dark box for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males and females [sec]	x	x	x	x	113.35	111.8	x	211.965	175.95	x	274.3	155.65	206.044	196.47	224.78	267.692	277.421	250.367	x	228.94	x	x	x	413.995	x	211.706	263.189	217.959	x	201.653	149.562	232.582	235.393	x	162.338	x	189.377	159.005	251.153	x	218.453	194.867	211.586	198.3	x	x	182.406	x	225.48	171.185	x	x	x	187.975	171.091	x	x	x	204.218	205.638	187.94	x	x	148.844	249.654	160.518	212.352	231.167	258.814	205.925	x	168.574	x	240.118	x	187.6	x	x	135.531	x	x	143.075	215.4	216.63	154.5	149.592	x	248.731	x	x	198.209	x	x	x	145.528	174.378	115.645	165.5	187.416	x	x	x	
-11903	Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for males and females [%]	None	Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males and females [%]	x	x	x	x	22.8574	22.5306	x	33.7652	37.3494	x	39.2088	27.861	36.5172	34.5844	31.9681	40.063	43.5114	34.6471	x	37.513	x	x	x	55.9665	x	27.8457	34.3755	30.9011	x	32.7394	24.2211	39.5246	36.6968	x	30.0358	x	31.037	26.7908	39.6491	x	38.8512	33.9092	35.4874	33.864	x	x	31.3725	x	33.4006	32.2123	x	x	x	33.0539	31.5688	x	x	x	30.986	35.1137	27.9034	x	x	26.3236	38.6436	24.9968	30.1645	39.5906	41.9588	27.5866	x	30.1181	x	39.2766	x	29.662	x	x	29.5191	x	x	24.3901	33.1169	31.5351	24.171	29.1023	x	40.7949	x	x	29.2084	x	x	x	25.9099	28.8522	19.0073	26.3724	33.0971	x	x	x	
-11904	Original post publication description: Anxiety assay, percentage time in light side of a light-dark box for males and females [%]	None	Central nervous system, behavior: Anxiety assay, percentage time in light side of a light-dark box for males and females [%]	x	x	x	x	18.8917	18.601	x	35.6692	28.9438	x	46.4389	25.6819	34.6037	32.48	37.83	44.6872	46.2369	41.9381	x	37.7253	x	x	x	68.9991	x	35.3708	43.8649	36.55	x	33.2461	24.6365	38.8588	38.4844	x	27.0564	x	31.2735	25.9467	41.6127	x	35.9882	33.2306	35.2023	33.05	x	x	30.401	x	37.58	29.6775	x	x	x	31.5042	28.5152	x	x	x	33.7608	34.6448	31.0875	x	x	24.6245	42.1449	26.7363	35.7506	38.1531	42.6262	34.2479	x	27.8386	x	40.0197	x	31.2667	x	x	22.675	x	x	24.2833	36.6989	37.2183	25.9726	24.9139	x	41.6462	x	x	33.0348	x	x	x	24.187	29.063	19.2742	27.5833	31.1605	x	x	x	
-11905	Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for males and females [n]	None	Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males and females [n]	x	x	x	x	64.5	28.875	x	47.7	26.25	x	10.0	30.5833	24.1111	45.9	15.4	37.0	54.1429	21.5714	x	39.44	x	x	x	25.5263	x	12.0	10.5263	39.5172	x	37.7647	37.3125	30.0588	32.5333	x	28.3846	x	20.4091	14.6	56.6471	x	50.2941	36.5833	31.0	46.7647	x	x	41.4375	x	28.5	23.8	x	x	x	45.1875	12.2727	x	x	x	31.0	40.6207	16.5	x	x	19.5312	27.5385	16.2941	39.7778	61.7292	49.7143	32.875	x	35.1053	x	41.5455	x	27.6923	x	x	33.875	x	x	20.6667	39.4667	30.8	27.0714	26.75	x	35.5385	x	x	18.5455	x	x	x	33.2222	15.4444	29.3636	59.5	31.3684	x	x	x	
-11906	Original post publication description: Fear conditioning response, activity in altered context for males and females [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context for males and females [units]	x	x	x	x	52.0	33.0729	x	39.9417	35.3542	x	23.8	31.6111	33.7685	43.7667	26.0667	28.3718	39.2619	35.9841	x	39.74	x	x	x	28.7719	x	28.5312	28.7368	52.6437	x	34.3039	32.5729	26.5784	27.8778	x	39.9231	x	40.2652	23.9417	43.8137	x	36.5686	33.9722	34.3046	45.9706	x	x	39.6562	x	29.5167	37.8333	x	x	x	47.0938	26.5455	x	x	x	36.549	39.3851	15.05	x	x	39.0573	36.6795	37.3627	28.9815	34.0694	39.5119	37.0833	x	36.5175	x	31.1667	x	40.2564	x	x	38.0729	x	x	46.9306	42.5667	33.6	30.6905	34.5833	x	40.0897	x	x	41.0	x	x	x	35.2315	41.4074	39.3182	39.5833	34.3772	x	x	x	
-11907	Original post publication description: Fear conditioning response, baseline activity in apparatus for males and females [units]	None	Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for males and females [units]	x	x	x	x	65.125	30.3125	x	36.775	39.25	x	14.9667	37.2708	26.5833	36.125	21.85	33.4808	41.6607	20.6548	x	34.55	x	x	x	29.5395	x	18.4062	20.0526	41.431	x	27.1471	28.9531	26.8676	26.2667	x	37.7692	x	28.0682	17.7	37.5294	x	40.7206	33.9167	29.4483	44.0588	x	x	35.2656	x	26.075	26.7125	x	x	x	35.0781	16.4091	x	x	x	27.8529	38.2759	16.475	x	x	27.7188	36.75	25.8382	21.1667	38.4583	36.1607	33.2812	x	31.8684	x	34.4773	x	31.8846	x	x	29.0938	x	x	32.75	30.7833	25.65	25.5357	31.2708	x	34.8077	x	x	29.7273	x	x	x	28.6667	25.8889	35.1136	17.125	32.7368	x	x	x	
-11908	Original post publication description: Fear conditioning response, contextual activity for males and females [units]	None	Central nervous system, behavior: Fear conditioning response, contextual activity for males and females [units]	x	x	x	x	39.55	20.9562	x	9.175	18.5125	x	11.3533	16.525	15.7556	16.3	19.725	12.55	27.4964	13.4667	x	20.044	x	x	x	12.9	x	11.7406	14.0105	25.9293	x	10.5412	15.7094	11.7559	15.3467	x	11.1538	x	14.2909	6.43	27.6265	x	26.0059	18.7333	25.4207	28.6882	x	x	14.7563	x	16.14	15.7625	x	x	x	31.0844	4.93182	x	x	x	20.3176	20.6328	4.3375	x	x	15.6438	12.9615	19.8794	11.0	10.6469	26.625	21.3375	x	15.4658	x	16.1364	x	22.1808	x	x	14.8687	x	x	26.05	23.3533	15.5	9.30714	11.4833	x	24.9308	x	x	9.96364	x	x	x	11.5611	5.66667	23.95	23.95	15.2553	x	x	x	
-11909	Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for males and females [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context during presentation of cue for males and females [units]	x	x	x	x	9.33333	15.0208	x	17.9417	5.70833	x	2.98889	7.25	4.96296	9.3	2.63333	10.0256	5.90476	9.25397	x	8.03333	x	x	x	4.53509	x	5.29167	5.04386	20.4655	x	6.82353	6.73958	4.36274	3.46667	x	7.92308	x	8.31818	3.475	10.8725	x	17.9804	10.4306	11.5115	18.0882	x	x	16.75	x	6.83333	7.34167	x	x	x	20.4583	1.78788	x	x	x	7.56863	8.9023	4.975	x	x	5.47917	3.76923	10.7941	6.53086	5.64931	6.57143	16.0417	x	9.44737	x	8.16667	x	10.9359	x	x	9.16667	x	x	14.9861	15.0556	12.6667	4.67857	4.25	x	11.1538	x	x	4.54545	x	x	x	9.60185	6.12963	10.4091	11.0	6.79825	x	x	x	
-11910	Original post publication description: Fear conditioning response, suppression of activity in altered context for males and females [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males and females [units]	x	x	x	x	x	0.339603	x	0.410279	0.167587	x	0.091803	0.315306	0.151249	0.213039	0.11787	0.323863	0.155988	0.280816	x	0.181604	x	x	x	0.156241	x	0.136108	0.170368	0.393112	x	0.205088	0.262707	0.161019	0.116979	x	0.191244	x	0.208694	0.147208	0.236695	x	0.503656	0.310512	0.346528	0.389558	x	x	0.430835	x	0.241045	0.190692	x	x	x	0.432982	0.069576	x	x	x	0.205891	0.238324	0.403806	x	x	0.135589	0.111166	0.24568	0.274502	0.15995	0.182562	0.541828	x	0.265725	x	0.285052	x	0.242726	x	x	0.23162	x	x	0.309857	0.383098	0.387818	0.153951	0.120882	x	0.282723	x	x	0.113046	x	x	x	0.269692	0.14248	0.274717	0.291383	0.192217	x	x	x	
-11911	Original post publication description: Fear conditioning response, activity during first tone-shock pairing for males and females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males and females [units]	x	x	x	x	73.0	29.9375	x	38.95	36.75	x	23.6	30.3333	16.4444	25.3	21.0	28.6154	26.8571	23.381	x	36.28	x	x	x	33.0	x	21.25	25.1053	42.1379	x	29.2941	31.5	25.1765	22.6667	x	30.5385	x	29.0	23.55	32.6471	x	33.1176	37.75	33.069	35.3529	x	x	38.0	x	29.4	31.25	x	x	x	42.0	15.0	x	x	x	34.0588	26.1034	21.8	x	x	29.6875	23.6923	28.2353	25.963	46.0	32.2143	45.875	x	23.9474	x	26.3636	x	38.6154	x	x	27.5	x	x	27.1667	27.1333	20.1	27.3571	28.5833	x	31.4615	x	x	31.9091	x	x	x	29.3333	34.1111	38.0909	19.5	28.0	x	x	x	
-11912	Original post publication description: Fear conditioning response, activity during second tone-shock pairing for males and females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males and females [units]	x	x	x	x	38.0	26.4375	x	20.25	24.875	x	16.0667	23.3333	11.8889	21.8	15.1	13.9231	24.1429	21.4286	x	27.64	x	x	x	25.7895	x	21.4375	21.8421	29.4138	x	26.4118	26.75	24.9412	18.1333	x	19.5385	x	17.8636	16.55	28.3529	x	24.8824	27.5833	29.2759	28.7059	x	x	29.8125	x	25.7	21.5	x	x	x	32.25	10.3636	x	x	x	26.0	20.9655	14.85	x	x	21.0625	18.0	22.2353	20.8889	29.375	24.6429	31.75	x	22.7368	x	24.1818	x	25.3077	x	x	22.5625	x	x	26.9167	25.0	19.6	25.5	19.9167	x	18.8462	x	x	20.9091	x	x	x	22.1667	19.4444	29.7273	25.5	21.3684	x	x	x	
-11913	Original post publication description: Fear conditioning response, activity during third tone-shock pairing for males and females [units]	None	Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males and females [units]	x	x	x	x	29.0	15.5625	x	18.0	16.375	x	12.5333	25.9167	9.33333	16.1	9.6	9.46154	22.0	16.619	x	15.08	x	x	x	16.0526	x	17.875	24.7895	22.5517	x	17.8824	19.9375	25.7647	14.2	x	14.3077	x	16.5455	17.55	22.0588	x	27.6471	27.6667	20.8621	27.1765	x	x	19.0	x	18.9	14.25	x	x	x	23.625	7.45455	x	x	x	27.9412	17.5172	14.85	x	x	19.2812	15.0	16.7059	15.5185	26.875	21.0	25.25	x	15.2632	x	21.9091	x	27.8462	x	x	22.8125	x	x	23.0833	26.9333	18.8	24.5	11.8333	x	16.8462	x	x	21.4545	x	x	x	18.3889	17.6667	23.9091	35.0	18.5263	x	x	x	
-11914	Original post publication description: Fear conditioning response, activity after first tone-shock pairing for males and females [n beam breaks/30 sec test]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, activity after first tone-shock pairing for males and females [n beam breaks/30 sec test]	x	x	x	x	27.125	21.3594	x	5.475	11.9688	x	2.76667	14.4375	7.5	13.4	8.1	7.25	19.5714	13.2381	x	15.25	x	x	x	17.3158	x	10.4688	10.3553	19.4397	x	15.7206	9.20312	8.26471	13.4833	x	10.8462	x	6.35227	3.1	16.8824	x	17.6029	20.4583	16.5862	25.5882	x	x	17.7031	x	16.55	13.7375	x	x	x	24.6719	5.68182	x	x	x	18.4853	18.0862	3.875	x	x	9.66406	13.3846	10.6176	12.037	13.6198	11.0	22.5	x	15.0263	x	17.2955	x	14.3654	x	x	13.4219	x	x	22.1875	13.05	25.725	7.98214	7.47917	x	17.4615	x	x	9.90909	x	x	x	15.8333	9.94444	19.6364	4.375	16.5921	x	x	x	
-11915	Original post publication description: Fear conditioning response, activity after second tone-shock pairing for males and females [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males and females [n beam breaks/30 sec test]	x	x	x	x	19.25	15.4375	x	5.9625	5.84375	x	2.21667	14.0417	3.38889	8.675	6.825	3.09615	13.7321	8.71429	x	10.14	x	x	x	10.3026	x	8.25	12.25	21.3362	x	9.75	8.73438	5.38235	4.13333	x	5.65385	x	6.51136	2.725	10.8824	x	19.7353	13.6458	10.1207	25.0294	x	x	9.59375	x	12.9	7.175	x	x	x	21.7969	3.77273	x	x	x	9.95588	14.3879	4.15	x	x	7.9375	8.71154	10.3529	6.96296	10.4688	12.0536	18.6875	x	12.9868	x	11.8636	x	14.8846	x	x	13.375	x	x	13.2083	10.5333	24.45	5.73214	4.375	x	17.4808	x	x	4.90909	x	x	x	10.2917	4.52778	15.5227	5.0	12.7632	x	x	x	
-11916	Original post publication description: Fear conditioning response, activity after third tone-shock pairing for males and females [n beam breaks/30 sec test]	None	Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males and females [n beam breaks/30 sec test]	x	x	x	x	28.0	10.875	x	5.1	10.125	x	2.86667	15.5	5.16667	12.9	15.5	3.76923	12.0	8.7619	x	8.48	x	x	x	8.8421	x	6.75	12.6316	16.6207	x	9.58823	7.6875	5.94118	5.2	x	12.3846	x	10.0455	4.0	10.1765	x	16.1765	14.0833	8.75862	24.4118	x	x	9.1875	x	6.4	7.2	x	x	x	11.125	7.27273	x	x	x	9.17647	9.06897	6.65	x	x	7.5625	4.07692	8.17647	11.2222	8.54167	14.7143	22.25	x	15.3158	x	11.0	x	14.2308	x	x	8.1875	x	x	7.58333	13.8	12.5	4.57143	5.33333	x	13.6154	x	x	3.63636	x	x	x	11.2222	8.66667	13.4545	13.5	12.0	x	x	x	
-11917	Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males and females [units]	None	Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males and females [units]	x	x	x	x	0.419859	0.439442	x	0.146193	0.288017	x	0.319963	0.400589	0.19782	0.337057	0.766264	0.124291	0.283664	0.436399	x	0.248462	x	x	x	0.318221	x	0.778365	0.831256	0.413434	x	0.376735	0.328845	0.266288	0.227491	x	0.328361	x	0.360445	0.236369	0.263294	x	0.397053	0.401629	0.340831	0.555966	x	x	0.295775	x	0.224271	0.298355	x	x	x	0.332277	0.568285	x	x	x	0.385239	0.241301	0.587637	x	x	0.272633	0.109107	0.3716	0.570374	0.226203	0.464133	0.737138	x	0.542972	x	0.348272	x	0.37377	x	x	0.325722	x	x	0.231973	0.482882	0.581566	0.206618	0.168601	x	0.418141	x	x	0.132878	x	x	x	0.408808	0.476566	0.418109	0.907018	0.35389	x	x	x	
-11918	Original post publication description: Open field behavior, percentage of distance in the center for males and females [%]	None	Open field behavior, percentage of distance in the center for males and females [%]	x	x	x	x	47.5922	21.8675	x	31.8817	32.9984	x	26.2193	27.3986	23.7586	32.4208	24.0468	36.0251	33.4233	21.9886	x	33.3988	x	x	x	44.622	x	11.6783	16.9444	18.978	x	28.5214	22.5877	35.4362	26.5704	x	22.0753	x	30.3639	20.9861	34.3503	x	32.6813	31.3457	24.1323	26.4127	x	x	27.7664	x	23.0127	19.776	x	x	x	26.2479	18.9835	x	x	x	23.797	25.5461	21.3111	x	x	23.418	28.4274	26.5605	27.105	35.7322	39.5202	24.769	x	22.3536	x	19.1674	x	34.2467	x	x	27.425	x	x	32.0317	16.7457	21.5318	30.7928	20.5243	x	33.5929	x	x	26.4763	x	x	x	28.7089	24.2081	19.5559	28.5559	37.0287	x	x	x	
-11919	Original post publication description: Open field behavior, percentage of time in center for males and females [%]	None	Open field behavior, percentage of time in center for males and females [%]	x	x	x	x	43.8875	10.275	x	22.4508	17.2658	x	11.2883	12.6972	11.8116	21.6933	15.6275	27.1096	20.6155	12.7254	x	17.931	x	x	x	26.0965	x	5.88021	10.3048	10.3687	x	21.5495	10.7177	23.2696	16.9444	x	8.08846	x	15.4333	10.1825	19.6324	x	19.2696	14.6153	13.1083	13.5652	x	x	15.251	x	12.35	9.13375	x	x	x	15.0417	12.7508	x	x	x	14.1848	11.1434	11.8504	x	x	12.2729	16.9077	18.4642	19.6691	22.1677	24.6601	13.126	x	11.2105	x	8.95682	x	28.9513	x	x	14.8986	x	x	16.8118	8.68194	12.0992	20.6256	10.0403	x	19.0545	x	x	15.5985	x	x	x	19.2194	15.4361	7.18864	16.875	20.7311	x	x	x	
-11920	Original post publication description: Open field behavior, time in corners for males and females [min]	None	Open field behavior, time in corners for males and females [min]	x	x	x	x	41.7125	36.9031	x	42.6054	42.5625	x	27.3944	41.4958	42.1069	42.6525	40.2933	43.4186	44.7839	45.6234	x	39.8923	x	x	x	41.7325	x	26.2854	40.3465	44.902	x	45.6441	38.7854	44.0784	44.0161	x	32.0628	x	43.6261	39.3342	40.4652	x	41.6407	38.7368	43.5773	46.5358	x	x	45.9026	x	38.1642	44.0333	x	x	x	43.8693	47.7371	x	x	x	39.5049	36.9885	36.7875	x	x	40.0435	41.3603	47.2922	43.9198	45.6821	45.4339	46.4573	x	36.3487	x	38.6955	x	48.391	x	x	42.4796	x	x	42.9451	48.8146	43.5192	46.6452	41.6319	x	44.3122	x	x	41.4371	x	x	x	43.0199	45.3861	35.9318	41.8208	46.3518	x	x	x	
-11921	Original post publication description: Open field behavior, locomotion from 0-5 min for males and females [cm]	None	Open field behavior, locomotion from 0-5 min for males and females [cm]	x	x	x	x	1337.5	437.125	x	837.4	414.2	x	177.4	694.583	286.778	721.5	268.5	619.538	800.429	305.143	x	639.76	x	x	x	468.263	x	151.125	150.789	777.724	x	403.059	421.562	489.471	376.4	x	491.846	x	361.182	194.3	784.882	x	741.471	468.25	433.069	631.765	x	x	557.375	x	521.6	442.3	x	x	x	759.125	184.091	x	x	x	453.176	497.069	196.05	x	x	332.469	542.077	336.882	477.519	574.104	691.429	355.5	x	458.421	x	454.455	x	422.154	x	x	540.444	x	x	396.333	397.667	366.3	498.071	386.417	x	585.692	x	x	483.727	x	x	x	497.167	421.556	445.818	706.0	437.895	x	x	x	
-11922	Original post publication description: Open field behavior, locomotion from 10-15 min for males and females [cm]	None	Open field behavior, locomotion from 10-15 min for males and females [cm]	x	x	x	x	1304.5	265.5	x	811.6	356.6	x	245.733	461.667	289.389	487.6	323.0	450.077	602.286	383.476	x	436.04	x	x	x	484.684	x	232.938	265.947	806.517	x	446.882	433.062	409.882	357.933	x	270.538	x	320.273	233.85	647.235	x	480.118	327.667	431.448	512.941	x	x	420.125	x	518.1	357.95	x	x	x	695.938	238.0	x	x	x	476.294	414.621	256.5	x	x	465.875	387.231	479.647	503.296	592.188	634.929	533.25	x	460.263	x	430.818	x	631.231	x	x	497.944	x	x	388.083	379.5	502.3	495.071	347.583	x	504.077	x	x	513.091	x	x	x	380.556	512.444	530.0	650.0	362.526	x	x	x	
-11923	Original post publication description: Open field behavior, locomotion from 15-20 min for males and females [cm]	None	Open field behavior, locomotion from 15-20 min for males and females [cm]	x	x	x	x	1002.0	268.875	x	772.35	347.0	x	227.067	434.25	251.889	462.0	304.9	447.538	613.857	384.333	x	416.88	x	x	x	451.0	x	204.312	251.632	693.276	x	437.941	377.938	385.0	360.533	x	218.538	x	308.364	198.75	591.765	x	430.059	347.417	367.483	483.588	x	x	410.875	x	540.5	361.0	x	x	x	664.5	255.182	x	x	x	452.647	391.414	227.25	x	x	446.062	376.769	483.941	542.852	571.083	608.0	568.25	x	445.895	x	372.0	x	737.0	x	x	512.0	x	x	373.75	347.917	527.9	481.786	338.667	x	509.769	x	x	478.545	x	x	x	320.111	507.0	507.273	636.0	297.684	x	x	x	
-11924	Original post publication description: Open field behavior, locomotion from 5-10 min for males and females [cm]	None	Open field behavior, locomotion from 5-10 min for males and females [cm]	x	x	x	x	1392.5	369.188	x	836.8	420.7	x	223.0	509.0	303.889	537.0	387.6	523.077	704.857	394.81	x	518.88	x	x	x	560.105	x	226.625	253.053	894.931	x	470.765	534.875	441.588	390.467	x	382.231	x	394.091	187.5	670.882	x	589.059	353.5	483.828	614.529	x	x	468.688	x	573.6	411.35	x	x	x	736.5	255.182	x	x	x	568.588	446.897	212.7	x	x	477.156	415.692	449.647	510.444	600.042	633.714	472.375	x	455.947	x	477.273	x	588.077	x	x	523.778	x	x	434.667	407.083	563.6	520.214	352.833	x	507.077	x	x	488.0	x	x	x	451.056	468.778	503.455	633.0	381.737	x	x	x	
-11925	Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for males and females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	None	Central nervous system, behavior: Open field activity, habituation ratio for males and females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]	x	x	x	x	0.412021	0.386653	x	0.48761	0.506446	x	0.615949	0.38028	0.486341	0.376989	0.546626	0.416486	0.464073	0.592234	x	0.388467	x	x	x	0.495752	x	0.547062	0.658897	0.489728	x	0.534302	0.498915	0.4487	0.488507	x	0.275164	x	0.487543	0.501822	0.425078	x	0.36843	0.40233	0.465075	0.424147	x	x	0.427643	x	0.504919	0.453525	x	x	x	0.470356	0.582812	x	x	x	0.5065	0.434781	0.506821	x	x	0.599922	0.428829	0.587016	0.549619	0.504968	0.469627	0.654019	x	0.50382	x	0.454662	x	0.599408	x	x	0.502374	x	x	0.523118	0.481382	0.612408	0.494353	0.456747	x	0.483467	x	x	0.501877	x	x	x	0.404474	0.554618	0.545988	0.476828	0.410459	x	x	x	
-11926	Original post publication description: Open field behavior, percentage of time in perimeter minus time in corners for males and females [%]	None	Open field behavior, percentage of time in perimeter minus time in corners for males and females [%]	x	x	x	x	14.4	52.8219	x	34.9437	40.1717	x	61.3172	45.8069	46.0815	35.6542	44.0792	29.4718	34.6006	41.6512	x	42.1767	x	x	x	32.1711	x	67.8344	49.3487	44.7293	x	32.8064	50.4969	32.652	39.0394	x	59.8487	x	40.9405	50.4833	39.9025	x	39.0897	46.6479	43.3144	39.899	x	x	38.8464	x	49.4858	46.8329	x	x	x	41.0891	39.5121	x	x	x	46.3103	51.8681	51.3621	x	x	47.6836	41.7321	34.2436	36.4111	32.1502	29.906	40.4167	x	52.4408	x	52.3477	x	22.6577	x	x	42.6218	x	x	40.2431	42.5035	44.3817	32.7292	48.3278	x	36.6333	x	x	42.9644	x	x	x	37.7606	39.1778	56.8795	41.3042	32.9171	x	x	x	
-11927	Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for males and females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-20 min for males and females [n beam breaks]	x	x	x	x	88.5	66.125	x	128.9	92.2	x	44.0667	167.417	68.8333	119.7	67.4	84.6923	150.214	84.381	x	176.0	x	x	x	102.789	x	41.875	44.2105	96.6207	x	123.765	73.125	118.706	92.0	x	78.7692	x	63.7273	36.25	155.118	x	127.765	138.0	104.207	137.235	x	x	131.5	x	166.1	138.55	x	x	x	127.688	27.9091	x	x	x	118.235	104.483	49.2	x	x	104.438	138.462	128.765	143.37	156.146	164.929	83.375	x	170.789	x	159.273	x	58.8462	x	x	115.167	x	x	63.4167	105.5	120.0	155.357	88.25	x	174.769	x	x	120.727	x	x	x	133.056	150.556	85.0	168.5	129.158	x	x	x	
-11928	Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for males and females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 0-5 min for males and females [n beam breaks]	x	x	x	x	8.5	16.0625	x	24.6	14.8	x	7.53333	39.0	8.94444	27.8	5.6	16.0	30.3571	8.85714	x	41.0	x	x	x	10.8421	x	2.8125	3.63158	14.5172	x	16.6471	11.1875	23.7647	16.8667	x	26.6923	x	9.31818	5.5	36.7647	x	28.6471	22.3333	20.1034	34.3529	x	x	29.375	x	33.5	34.4	x	x	x	29.5	2.81818	x	x	x	24.1765	21.6207	6.35	x	x	12.25	30.6923	8.88235	20.4815	25.7083	32.7857	11.125	x	34.9474	x	33.3636	x	7.23077	x	x	19.7222	x	x	8.16667	14.75	17.7	26.7143	20.5	x	22.2308	x	x	18.8182	x	x	x	25.2222	16.0	12.0	36.5	20.7895	x	x	x	
-11929	Original post publication description: Open field behavior, vertical activity (rears) from 10-15 min for males and females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 10-15 min for males and females [n beam breaks]	x	x	x	x	27.5	14.625	x	34.55	25.5	x	13.6	44.3333	20.5556	28.4	23.3	21.4615	38.8571	25.1429	x	43.16	x	x	x	31.2105	x	14.0625	13.7368	28.0	x	35.8824	20.5625	31.0	25.6667	x	14.5385	x	16.8182	12.0	40.7647	x	30.7647	42.25	28.2069	30.8824	x	x	35.25	x	43.6	31.35	x	x	x	31.875	8.72727	x	x	x	30.2353	26.6552	16.05	x	x	31.75	35.6923	42.2353	39.5926	42.9375	45.5	25.5	x	44.4737	x	42.2727	x	17.4615	x	x	31.7222	x	x	17.1667	30.8333	32.3	41.4286	24.1667	x	52.9231	x	x	34.1818	x	x	x	37.4444	45.3333	25.6364	52.5	39.8947	x	x	x	
-11930	Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for males and females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 15-20 min for males and females [n beam breaks]	x	x	x	x	22.0	15.3125	x	36.45	26.8	x	11.6	40.6667	20.7222	30.6	20.1	25.8462	41.7143	27.0952	x	43.16	x	x	x	31.6316	x	14.0625	17.0	27.2414	x	37.5294	18.625	33.0588	25.6667	x	12.0769	x	19.7727	11.05	35.0588	x	31.2941	36.6667	29.0	32.6471	x	x	29.875	x	46.3	35.35	x	x	x	30.6875	10.0	x	x	x	27.7647	30.0345	14.45	x	x	32.8125	32.0	45.8235	48.2963	49.1875	43.7857	27.5	x	46.9474	x	40.1818	x	15.9231	x	x	32.8889	x	x	23.6667	32.8333	36.9	41.0714	23.9167	x	58.3846	x	x	37.6364	x	x	x	31.3333	50.2222	25.9091	42.0	32.5789	x	x	x	
-11931	Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for males and females [n beam breaks]	None	Open field behavior, vertical activity (rears) from 5-10 min for males and females [n beam breaks]	x	x	x	x	30.5	20.125	x	33.3	25.1	x	11.3333	43.4167	18.6111	32.9	18.4	21.3846	39.2857	23.2857	x	48.68	x	x	x	29.1053	x	10.9375	9.8421	26.8621	x	33.7059	22.75	30.8824	23.8	x	25.4615	x	17.8182	7.7	42.5294	x	37.0588	36.75	26.8966	39.3529	x	x	37.0	x	42.7	37.45	x	x	x	35.625	6.36364	x	x	x	36.0588	26.1724	12.35	x	x	27.625	40.0769	31.8235	35.0	38.3125	42.8571	19.25	x	44.4211	x	43.4545	x	18.2308	x	x	30.8333	x	x	14.4167	27.0833	33.1	46.1429	19.6667	x	41.2308	x	x	30.0909	x	x	x	39.0556	39.0	21.4545	37.5	35.8947	x	x	x	
-11932	Original post publication description: Open field behavior, locomotion for entire test period for males and females [cm]	None	Open field behavior, locomotion for entire test period for males and females [cm]	x	x	x	x	5036.5	1340.69	x	3258.15	1538.5	x	873.2	2099.5	1131.94	2208.1	1284.0	2040.23	2721.43	1467.76	x	2011.56	x	x	x	1964.05	x	815.0	921.421	3172.45	x	1758.65	1767.44	1725.94	1485.33	x	1363.15	x	1383.91	814.4	2694.76	x	2240.71	1496.83	1715.83	2242.82	x	x	1857.06	x	2153.8	1572.6	x	x	x	2856.06	932.455	x	x	x	1950.71	1750.0	892.5	x	x	1721.56	1721.77	1750.12	2034.11	2337.42	2568.07	1929.38	x	1820.53	x	1734.55	x	2378.46	x	x	2074.17	x	x	1592.83	1532.17	1960.1	1995.14	1425.5	x	2106.62	x	x	1963.36	x	x	x	1648.89	1909.78	1986.55	2625.0	1479.84	x	x	x	
-11933	Original post publication description: Open field behavior, percentage of distance in the perimeter for males and females [%]	None	Open field behavior, percentage of distance in the perimeter for males and females [%]	x	x	x	x	52.4078	78.1325	x	68.1183	67.0016	x	73.7807	72.6014	76.2414	67.5792	75.9532	63.9749	66.5767	78.0114	x	66.6012	x	x	x	55.378	x	88.3217	83.0556	81.022	x	71.4786	77.4123	64.5638	73.4296	x	77.9247	x	69.6361	79.0139	65.6497	x	67.3187	68.6543	75.8677	73.5873	x	x	72.2336	x	76.9873	80.224	x	x	x	73.7521	81.0165	x	x	x	76.203	74.4539	78.6889	x	x	76.582	71.5726	73.4395	72.895	64.2678	60.4798	75.231	x	77.6464	x	80.8326	x	65.7533	x	x	72.575	x	x	67.9683	83.2543	78.4682	69.2072	79.4757	x	66.4071	x	x	73.5237	x	x	x	71.2911	75.7919	80.4441	71.4441	62.9713	x	x	x	
-11934	Original post publication description: Open field behavior, percentage of time in perimeter for males and females [%]	None	Open field behavior, percentage of time in perimeter for males and females [%]	x	x	x	x	56.1125	89.725	x	77.5492	82.7342	x	88.7117	87.3028	88.1884	78.3067	84.3725	72.8904	79.3845	87.2746	x	82.069	x	x	x	73.9035	x	94.1198	89.6952	89.6313	x	78.4505	89.2823	76.7304	83.0556	x	91.9115	x	84.5667	89.8175	80.3676	x	80.7304	85.3847	86.8917	86.4348	x	x	84.749	x	87.65	90.8662	x	x	x	84.9583	87.2492	x	x	x	85.8152	88.8566	88.1496	x	x	87.7271	83.0923	81.5358	80.3309	77.8323	75.3399	86.874	x	88.7895	x	91.0432	x	71.0487	x	x	85.1014	x	x	83.1882	91.3181	87.9008	79.3744	89.9597	x	80.9455	x	x	84.4015	x	x	x	80.7806	84.5639	92.8114	83.125	79.2689	x	x	x	
-11935	Original post publication description: Startle response, baseline level for males and females [units]	None	Central nervous system, behavior: Startle response, baseline level for males and females [amplitude]	x	x	x	x	0.076	0.120676	x	0.14023	0.099739	x	0.071856	0.127682	0.062455	0.113705	0.12074	0.126748	0.079604	0.111172	x	0.110905	x	x	x	0.121144	x	0.151515	0.111984	0.167881	x	0.103786	0.086733	0.063739	0.06883	x	0.07402	x	0.120277	0.071555	0.090027	x	0.114491	0.11147	0.083356	0.090174	x	x	0.093769	x	0.121973	0.117318	x	x	x	0.102966	0.125603	x	x	x	0.108657	0.084812	0.091085	x	x	0.092649	0.056612	0.116679	0.117526	0.116239	0.103078	0.153375	x	0.085603	x	0.036519	x	0.124935	x	x	0.102892	x	x	0.08753	0.127515	0.121545	0.086485	0.073109	x	0.125212	x	x	0.368545	x	x	x	0.123352	0.099468	0.177248	0.077273	0.117517	x	x	x	
-11936	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	3.53121	0.761054	x	1.34953	0.739821	x	1.44077	0.814756	1.78157	2.06	1.31396	0.799011	1.26049	0.732234	x	0.124483	x	x	x	0.987139	x	3.84306	1.18061	1.29984	x	2.97907	0.568174	0.989857	0.529748	x	0.665627	x	0.645071	1.07691	0.441193	x	0.255767	1.78173	1.83885	1.4605	x	x	2.90481	x	1.4639	1.10217	x	x	x	1.10017	1.46213	x	x	x	1.22902	0.781631	0.728607	x	x	1.32842	1.43137	0.332605	0.790516	0.780357	2.50038	1.26663	x	0.33662	x	0.41999	x	0.922694	x	x	1.00006	x	x	2.02771	1.04181	0.260829	0.388435	0.55775	x	0.657302	x	x	1.48195	x	x	x	1.35864	4.46883	0.827727	1.73575	1.54292	x	x	x	
-11937	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	2.3465	0.819863	x	1.22858	0.487262	x	0.756217	0.642158	1.35889	2.17537	0.953614	0.877692	0.641279	0.543689	x	0.111176	x	x	x	0.929168	x	3.51121	1.29225	1.09567	x	2.47602	0.520369	0.75206	0.504267	x	0.451611	x	0.532205	0.801905	0.317082	x	0.1959	1.3085	1.16609	1.08831	x	x	2.82205	x	0.9098	0.753481	x	x	x	0.7411	1.38154	x	x	x	1.16174	0.539303	0.627587	x	x	0.838755	1.14847	0.250012	0.44323	0.734452	2.06949	1.03666	x	0.348742	x	0.292643	x	0.772614	x	x	0.855094	x	x	1.35351	1.03073	0.24436	0.355742	0.29734	x	0.572189	x	x	0.945329	x	x	x	1.13771	3.42066	0.742164	1.27735	1.18215	x	x	x	
-11938	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	0.8255	0.538731	x	0.830171	0.299837	x	0.622858	0.525233	1.06034	1.6423	0.6986	0.666415	0.243171	0.340133	x	0.098568	x	x	x	0.623911	x	2.39714	0.792112	0.645758	x	2.00557	0.314738	0.498867	0.385393	x	0.410889	x	0.41123	0.493035	0.265647	x	0.14846	0.807092	0.596374	0.753725	x	x	2.27054	x	0.29879	0.402431	x	x	x	0.418913	1.12476	x	x	x	1.07818	0.352552	0.438431	x	x	0.414973	0.939318	0.185824	0.208317	0.440515	1.60804	0.560712	x	0.234879	x	0.224271	x	0.439086	x	x	0.509569	x	x	1.2122	0.60036	0.20077	0.189167	0.24079	x	0.444722	x	x	0.564714	x	x	x	0.562913	2.37997	0.418673	0.8686	0.586216	x	x	x	
-11939	Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	None	Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]	x	x	x	x	0.5462	0.37795	x	0.644818	0.208525	x	0.571892	0.53205	0.941957	1.42496	0.621014	0.644092	0.246679	0.320372	x	0.098668	x	x	x	0.560805	x	1.72556	0.742041	0.565323	x	1.79307	0.311725	0.465707	0.301427	x	0.331622	x	0.40225	0.396635	0.267424	x	0.161533	0.5835	0.564704	0.550475	x	x	2.01697	x	0.28394	0.440731	x	x	x	0.338662	0.942036	x	x	x	0.976722	0.306876	0.2938	x	x	0.365336	0.793909	0.188953	0.2072	0.347937	1.47421	0.480413	x	0.195684	x	0.180514	x	0.414057	x	x	0.446244	x	x	1.20193	0.544	0.21761	0.192242	0.26731	x	0.4043	x	x	0.634414	x	x	x	0.407325	2.44234	0.392336	0.73045	0.570316	x	x	x	
-11940	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	31.8625	-10.8649	x	6.95964	31.597	x	46.0606	19.406	22.2427	-7.83911	29.2715	0.636287	48.4957	25.65	x	9.30433	x	x	x	6.47487	x	8.41274	-14.5847	14.5065	x	16.7993	10.704	18.257	-3.58099	x	28.6299	x	14.7677	19.4828	24.7046	x	27.4377	27.4732	32.8657	24.8334	x	x	4.14581	x	34.0551	22.9941	x	x	x	35.9393	4.02356	x	x	x	3.71022	31.9743	14.0044	x	x	35.3395	17.7092	17.3396	42.6765	4.91283	19.3553	21.8225	x	-3.7403	x	29.6678	x	14.4707	x	x	18.1344	x	x	30.5897	1.32596	-0.653405	2.29281	40.1648	x	8.58126	x	x	39.0196	x	x	x	14.1253	22.6134	9.16613	22.712	27.0852	x	x	x	
-11941	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	76.2695	30.9496	x	37.7656	56.4897	x	60.0297	34.2436	37.7881	19.106	43.9674	26.9988	78.9821	53.984	x	17.6888	x	x	x	37.9544	x	38.9074	27.4655	48.0584	x	33.5402	44.1975	41.0279	22.2232	x	36.4967	x	33.5698	46.599	30.2027	x	35.8244	56.1184	66.1655	48.794	x	x	24.0852	x	75.8504	60.1618	x	x	x	63.5106	23.4822	x	x	x	19.7518	54.7779	41.8273	x	x	66.5944	32.5179	38.5011	69.0842	43.706	36.9505	57.5409	x	27.1552	x	48.2998	x	49.8686	x	x	46.2729	x	x	43.3835	46.8395	17.3611	40.8204	53.2063	x	22.7667	x	x	62.5394	x	x	x	54.2501	45.0441	47.6469	49.1563	64.7185	x	x	x	
-11942	Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	None	Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]	x	x	x	x	84.3712	51.6797	x	51.746	69.8231	x	63.7344	34.8348	44.9766	29.6735	48.8105	25.2465	78.4991	58.9724	x	19.1262	x	x	x	45.5381	x	56.0313	32.1142	55.0016	x	41.3386	45.0223	46.8379	38.1217	x	46.9057	x	34.2124	56.8502	30.4442	x	34.3168	67.2489	68.0517	60.4422	x	x	32.2098	x	79.128	58.8666	x	x	x	71.332	33.6089	x	x	x	29.0539	60.5972	59.4338	x	x	69.2335	41.3096	33.7811	70.8617	51.3172	43.7657	62.777	x	38.1008	x	56.8859	x	51.6254	x	x	52.8506	x	x	46.0188	52.3374	11.7799	39.0833	51.9235	x	32.9065	x	x	55.9561	x	x	x	66.7337	44.1512	51.3677	49.939	65.3525	x	x	x	
-11946	Original post publication description: Time below threshold for males and females	None	Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males and females [sec below threshold movement level]	x	x	x	x	x	x	x	x	x	x	x	100.556	199.6	x	x	60.5	127.5	x	x	198.0	x	x	x	x	x	x	150.0	x	x	x	145.857	196.0	214.333	x	107.75	x	180.0	280.0	98.6	x	128.5	x	206.333	x	x	x	x	x	x	116.0	x	x	x	x	x	x	x	x	x	129.333	171.75	x	x	154.167	x	x	29.0	x	78.0	x	x	178.5	x	x	x	x	x	x	x	x	x	x	x	x	x	210.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-11947	Original post publication description: Locomotion in zero maze for males and females [n beam breaks]	None	Central nervous system, behavior: Locomotion in zero maze for males and females [n beam breaks]	x	x	x	x	885.5	557.143	x	705.389	467.6	x	359.667	649.778	449.667	654.5	550.6	514.308	575.214	481.688	x	592.048	x	x	x	485.118	x	494.231	364.6	713.913	x	507.312	592.0	458.067	538.818	x	655.615	x	485.682	400.55	580.529	x	619.529	350.583	503.107	662.8	x	x	504.375	x	368.4	488.95	x	x	x	586.312	542.727	x	x	x	524.118	589.034	386.389	x	x	623.621	440.462	519.727	514.68	596.875	561.786	592.375	x	631.5	x	461.429	x	435.308	x	x	562.722	x	x	493.5	523.2	637.1	555.857	508.417	x	483.154	x	x	590.727	x	x	x	567.389	814.889	606.545	383.5	447.071	x	x	x	
-11948	Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for males and females [n]	None	Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males and females [n]	x	x	x	x	128.5	77.0	x	136.833	55.2	x	37.6667	122.444	21.3333	60.25	47.8	42.4615	51.5	60.6875	x	62.3333	x	x	x	61.6471	x	50.3077	39.6667	92.2174	x	78.5625	108.312	60.4	87.3636	x	71.0769	x	28.8182	41.85	80.0	x	100.706	91.75	62.6786	67.2667	x	x	117.312	x	111.9	73.1	x	x	x	65.9375	62.8182	x	x	x	107.353	101.379	61.9444	x	x	70.4828	74.4615	39.8182	102.32	100.5	77.5714	89.5	x	86.25	x	55.0	x	38.6154	x	x	107.222	x	x	83.5	78.8667	92.3	67.1429	110.417	x	95.9231	x	x	99.3636	x	x	x	122.278	93.6667	98.0909	131.0	73.5	x	x	x	
-11949	Original post publication description: Anxiety assay, entries into open quadrants of a zero maze for males and females [n]	None	Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for males and females [n]	x	x	x	x	128.0	76.9286	x	136.056	55.3	x	37.8333	122.444	21.5	60.25	47.9	42.4615	51.7857	60.8125	x	62.5238	x	x	x	61.8824	x	50.3077	39.7333	91.9565	x	78.75	108.125	60.6	87.1818	x	71.0769	x	28.8182	41.85	80.0	x	100.588	92.0	62.6786	67.4	x	x	117.25	x	111.9	72.95	x	x	x	65.875	62.7273	x	x	x	107.176	100.931	61.8889	x	x	70.4483	74.6154	39.7727	101.68	100.5	77.9286	89.375	x	86.3333	x	54.8571	x	38.4615	x	x	106.833	x	x	83.25	78.9333	91.8	67.2143	110.417	x	96.4615	x	x	99.2727	x	x	x	122.278	93.7778	98.0909	132.0	73.5714	x	x	x	
-11950	Original post publication description: Zero maze, latency to enter an open quadrant for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, latency to enter an open quadrant of a zero maze for males and females [sec]	x	x	x	x	0.45	18.7857	x	18.4444	65.0	x	24.6917	3.11111	27.9167	16.925	61.46	20.6769	27.3923	50.14	x	44.2524	x	x	x	13.2294	x	92.9833	46.9133	18.2864	x	18.175	12.5625	58.6933	23.3455	x	20.5462	x	64.5333	47.9056	27.2588	x	15.5235	22.9083	17.6857	24.1533	x	x	15.2937	x	16.36	20.365	x	x	x	16.2313	37.4182	x	x	x	12.8294	19.8379	30.8706	x	x	32.4172	19.85	43.165	17.844	21.4787	30.7214	43.2375	x	16.1833	x	42.6571	x	96.8333	x	x	9.24444	x	x	29.775	34.44	11.15	50.2786	22.9417	x	30.3923	x	x	19.5	x	x	x	12.0444	24.3778	22.3818	16.1	20.6214	x	x	x	
-11951	Original post publication description: Anxiety assay, percentage time in open quadrants of a zero maze for males and females [%]	None	Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for males and females [%]	x	x	x	x	16.4833	11.131	x	23.9056	13.0633	x	5.74167	18.8519	5.125	7.2875	11.3367	4.54872	11.3738	10.7063	x	8.0873	x	x	x	18.9608	x	8.75897	20.0622	22.0971	x	13.3167	21.7208	12.8267	22.0515	x	10.6667	x	3.52879	9.205	28.7216	x	22.3216	40.3972	15.7702	13.2956	x	x	29.0396	x	39.93	19.7967	x	x	x	11.8292	7.28182	x	x	x	33.8118	23.6701	22.6815	x	x	10.4575	22.959	9.45909	31.468	20.1139	16.1143	24.4792	x	12.6528	x	17.4429	x	17.8769	x	x	21.9778	x	x	17.7583	17.0956	17.7	16.3143	24.375	x	22.0897	x	x	14.2455	x	x	x	21.0556	9.93704	22.3091	43.7	19.181	x	x	x	
-11952	Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males and females [sec]	x	x	x	x	250.55	266.607	x	223.839	260.81	x	282.775	243.444	285.142	278.138	265.99	286.354	265.879	257.669	x	273.729	x	x	x	243.118	x	273.723	254.167	241.343	x	254.575	234.837	261.52	230.955	x	268.0	x	289.414	272.385	213.835	x	233.035	178.808	252.689	269.567	x	x	200.931	x	170.42	240.61	x	x	x	264.513	278.155	x	x	x	198.565	228.99	231.956	x	x	268.628	231.123	271.623	205.596	239.658	251.657	226.562	x	262.042	x	247.671	x	246.369	x	x	234.067	x	x	246.725	243.24	246.9	251.057	226.875	x	221.162	x	x	257.264	x	x	x	228.394	270.189	233.073	168.9	236.736	x	x	x	
-11953	Original post publication description: Anxiety assay, time in open quadrants of a zero maze for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males and females [sec]	x	x	x	x	49.45	33.3929	x	76.1611	39.19	x	17.225	56.5556	14.8583	21.8625	34.01	13.6462	34.1214	42.3312	x	26.2714	x	x	x	56.8824	x	26.2769	45.8333	58.6565	x	45.425	65.1625	38.48	69.0455	x	32.0	x	10.5864	27.615	86.1647	x	66.9647	121.192	47.3107	30.4333	x	x	99.0687	x	129.58	59.39	x	x	x	35.4875	21.8455	x	x	x	101.435	71.0103	68.0444	x	x	31.3724	68.8769	28.3773	94.404	60.3417	48.3429	73.4375	x	37.9583	x	52.3286	x	53.6308	x	x	65.9333	x	x	53.275	56.76	53.1	48.9429	73.125	x	78.8385	x	x	42.7364	x	x	x	71.6056	29.8111	66.9273	131.1	63.2643	x	x	x	
-11954	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]	x	x	x	x	1289.14	894.939	x	637.139	x	663.886	930.582	1820.62	779.449	571.757	435.637	1036.61	1741.22	1022.36	341.965	1647.07	x	x	x	165.613	x	804.495	297.524	1558.32	x	1516.42	950.394	1136.68	1151.47	x	1233.95	x	349.543	1102.48	1029.79	x	1664.17	504.953	608.616	1804.15	x	x	1015.66	x	1397.66	1546.41	x	x	x	724.895	1200.17	x	x	x	505.321	836.355	332.821	441.986	x	1108.12	1516.77	616.141	969.603	427.663	1237.05	1286.74	x	1480.16	x	579.422	x	x	x	x	852.099	x	x	939.669	507.195	318.483	519.39	464.14	x	475.696	771.588	x	1019.64	x	x	x	602.472	603.73	807.435	1282.01	682.678	x	x	x	
-11955	Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]	x	x	x	x	770.251	662.63	x	815.476	x	706.389	664.112	999.114	437.922	745.498	199.228	582.049	1050.13	550.541	795.815	897.588	x	x	x	382.734	x	574.051	317.75	1065.85	x	899.443	584.944	563.971	638.769	x	507.212	x	533.407	486.723	822.766	x	978.5	577.629	786.273	1189.08	x	x	808.735	x	713.927	576.907	x	x	x	842.51	707.29	x	x	x	813.924	587.67	324.418	208.428	x	839.106	472.969	408.996	719.401	830.576	848.154	650.787	x	593.945	x	563.247	x	x	x	x	632.345	x	x	561.096	898.908	579.975	591.88	526.215	x	859.948	661.338	x	926.256	x	x	x	794.7	868.585	904.099	834.084	589.682	x	x	x	
-11956	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males and females [cm]	None	Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males and females [cm]	x	x	x	x	846.53	839.209	x	473.003	x	393.332	766.646	1625.07	471.77	288.187	310.473	1070.79	1521.86	784.664	281.2	1342.2	x	x	x	168.007	x	915.946	343.024	1494.84	x	1116.57	840.677	863.186	1075.98	x	822.07	x	286.803	758.345	924.864	x	1546.23	167.181	559.898	1711.65	x	x	856.962	x	1246.0	1135.39	x	x	x	263.11	641.642	x	x	x	475.688	927.209	259.378	214.333	x	960.065	1009.61	625.861	707.017	232.997	1181.42	1187.24	x	1288.49	x	622.782	x	x	x	x	695.717	x	x	1002.66	501.737	490.465	385.715	473.46	x	533.044	776.237	x	779.233	x	x	x	506.626	345.15	385.104	1007.32	453.573	x	x	x	
-11957	Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males and females [cm]	x	x	x	x	322.402	288.74	x	468.369	x	425.115	525.163	676.658	308.936	458.363	110.654	270.004	499.031	395.937	241.975	577.698	x	x	x	187.493	x	438.126	106.311	707.72	x	674.497	297.575	396.326	354.697	x	75.56	x	371.495	281.496	554.714	x	450.459	248.822	394.176	669.535	x	x	629.273	x	452.275	415.496	x	x	x	664.192	485.36	x	x	x	465.6	290.68	122.539	144.387	x	604.565	172.424	401.619	496.847	534.089	677.317	401.782	x	309.559	x	340.114	x	x	x	x	338.154	x	x	370.144	331.663	412.693	434.48	307.757	x	521.764	272.458	x	417.22	x	x	x	409.125	505.505	391.224	707.528	307.308	x	x	x	
-11958	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]	x	x	x	x	996.99	673.875	x	347.588	x	522.193	594.441	1119.52	472.402	240.461	242.254	1046.35	1323.49	705.073	441.77	1054.16	x	x	x	259.171	x	599.949	312.932	1561.9	x	1132.82	916.061	674.194	846.615	x	696.828	x	396.185	659.211	981.12	x	1386.72	324.36	544.356	1353.56	x	x	964.057	x	981.31	1031.69	x	x	x	332.397	511.936	x	x	x	410.779	844.181	208.795	274.8	x	919.646	876.253	858.745	757.963	175.571	1481.73	1134.19	x	1038.02	x	1058.05	x	x	x	x	920.005	x	x	1175.52	556.261	516.648	288.21	526.098	x	683.497	1082.79	x	1029.22	x	x	x	435.586	453.47	563.245	1113.85	409.477	x	x	x	
-11959	Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]	x	x	x	x	289.635	187.574	x	428.795	x	396.656	458.85	478.462	293.953	389.536	69.574	180.179	351.714	246.127	288.75	435.674	x	x	x	128.426	x	460.041	151.298	608.911	x	527.901	260.814	411.989	352.773	x	206.28	x	352.25	317.073	402.426	x	387.622	359.7	269.25	510.165	x	x	482.837	x	436.519	502.927	x	x	x	520.818	363.3	x	x	x	318.18	279.625	207.855	144.994	x	419.954	140.716	422.334	453.181	500.947	633.621	345.4	x	255.099	x	191.844	x	x	x	x	333.017	x	x	231.777	233.021	314.86	423.967	254.985	x	458.047	157.935	x	374.357	x	x	x	249.605	639.655	340.394	635.792	266.71	x	x	x	
-11960	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males and females [cm]	x	x	x	x	618.579	567.977	x	298.074	x	431.054	603.85	993.125	401.758	281.07	224.842	817.311	1039.28	576.274	306.24	889.959	x	x	x	238.19	x	453.721	268.546	1271.89	x	893.054	790.3	569.223	859.412	x	573.122	x	358.235	544.659	1131.92	x	1002.33	403.13	625.333	1265.22	x	x	850.412	x	702.907	827.626	x	x	x	163.95	403.568	x	x	x	382.584	877.972	164.231	351.647	x	806.479	679.491	824.09	579.05	275.58	1151.42	1002.4	x	832.668	x	1128.79	x	x	x	x	871.987	x	x	1140.73	415.852	405.776	367.656	507.813	x	638.999	1096.02	x	888.191	x	x	x	556.0	621.53	673.266	1084.96	359.643	x	x	x	
-11961	Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males and females [cm]	x	x	x	x	374.767	171.762	x	314.826	x	463.439	420.014	468.116	247.026	316.925	99.925	146.525	368.128	237.021	327.345	408.062	x	x	x	108.16	x	322.332	137.135	608.388	x	443.794	213.693	410.397	380.012	x	162.482	x	264.845	266.809	554.348	x	357.949	289.734	107.079	379.092	x	x	432.567	x	288.517	526.845	x	x	x	396.612	166.593	x	x	x	401.579	294.975	116.421	120.904	x	388.734	123.671	431.97	655.616	537.283	590.651	359.768	x	284.994	x	184.559	x	x	x	x	257.754	x	x	227.18	185.161	312.109	337.039	290.519	x	502.3	111.282	x	371.63	x	x	x	226.634	535.525	320.184	756.102	408.28	x	x	x	
-11962	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males and females [cm]	x	x	x	x	1994.18	1665.29	x	-271.661	x	18.8662	827.379	3373.04	67.0188	-964.146	733.825	2792.3	3356.85	1658.74	-282.71	2614.37	x	x	x	24.1686	x	979.56	509.533	2896.08	x	2113.23	2140.41	1460.6	2207.23	x	2374.44	x	-131.23	1712.59	1733.43	x	3424.92	-251.214	781.425	3386.71	x	x	1333.68	x	1895.66	1951.3	x	x	x	-939.78	575.217	x	x	x	-230.274	2032.77	193.992	664.054	x	1541.95	3172.34	1259.92	688.587	-1291.08	871.586	2852.83	x	1794.11	x	1935.88	x	x	x	x	1644.81	x	x	2868.38	332.292	111.735	-226.395	592.036	x	-10.8227	2523.62	x	1626.82	x	x	x	420.621	-525.39	473.15	1554.63	333.392	x	x	x	
-11963	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males and females [cm]	x	x	x	x	3751.24	2976.0	x	1755.81	x	2010.46	2895.52	5558.33	2125.38	1381.47	1213.21	3971.06	5625.85	3088.37	1371.18	4933.39	x	x	x	830.981	x	2774.11	1222.03	5886.95	x	4658.87	3497.43	3243.28	3933.48	x	3325.97	x	1390.77	3064.7	4067.69	x	5599.45	1224.67	2338.2	6134.58	x	x	3687.09	x	3786.9	3973.48	x	x	x	1484.35	2297.76	x	x	x	1769.01	3485.72	965.225	1282.77	x	3794.31	4082.12	2924.84	3013.63	1111.81	3621.33	4610.57	x	3117.41	x	3215.64	x	x	x	x	3206.08	x	x	4258.58	1981.05	1731.37	1560.97	1971.51	x	2331.24	3726.64	x	3716.28	x	x	x	2100.69	2023.88	2429.05	4488.13	1905.37	x	x	x	
-11964	Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males and females [cm]	x	x	x	x	1757.06	1310.71	x	2027.47	x	1991.6	2068.14	2622.35	2058.36	2345.62	479.381	1178.76	2269.0	1429.63	1653.89	2319.02	x	x	x	806.813	x	1794.55	712.494	2990.87	x	2545.64	1357.03	1782.68	1726.25	x	951.535	x	1522.0	1352.1	2334.25	x	2174.53	1475.89	1556.78	2747.88	x	x	2353.41	x	1891.24	2022.18	x	x	x	2424.13	1722.54	x	x	x	1999.28	1452.95	771.232	618.713	x	2252.36	909.78	1664.92	2325.05	2402.89	2749.74	1757.74	x	1323.3	x	1279.76	x	x	x	x	1561.27	x	x	1390.2	1648.75	1619.64	1787.37	1379.48	x	2342.06	1203.01	x	2089.46	x	x	x	1680.06	2549.27	1955.9	2933.51	1571.98	x	x	x	
-11965	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males and females [cm]	x	x	x	x	518.886	232.309	x	-178.337	x	-42.5025	266.47	988.027	341.526	-173.741	236.409	454.56	691.089	471.816	-453.85	749.483	x	x	x	-217.121	x	230.444	-20.2262	492.472	x	616.977	365.45	572.71	512.705	x	726.737	x	-183.863	615.758	207.02	x	685.669	-135.795	-177.656	615.068	x	x	206.927	x	509.026	776.201	x	x	x	-117.615	292.848	x	x	x	-308.603	248.685	8.40375	233.559	x	269.01	1043.8	207.145	250.201	-402.913	388.896	635.957	x	689.02	x	16.175	x	x	x	x	219.754	x	x	378.573	-391.713	-261.492	-72.49	-62.075	x	-384.252	110.25	x	93.3871	x	x	x	-192.227	-264.855	-96.6637	447.924	92.9967	x	x	x	
-11966	Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males and females [cm]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males and females [cm]	x	x	x	x	243.811	396.215	x	-16.7517	x	-32.385	183.836	603.028	154.731	-35.855	124.917	670.786	671.148	339.253	-21.105	481.897	x	x	x	130.03	x	131.389	131.411	663.504	x	449.26	576.607	158.827	479.4	x	410.64	x	93.39	277.85	577.568	x	644.383	63.005	518.254	886.125	x	x	417.845	x	326.526	197.327	x	x	x	-232.662	169.713	x	x	x	-18.995	582.997	47.81	230.744	x	417.745	555.82	392.12	-76.5657	-261.703	560.771	642.628	x	432.646	x	944.232	x	x	x	x	614.233	x	x	913.548	230.691	93.667	30.617	217.294	x	136.699	984.74	x	516.561	x	x	x	329.366	86.005	353.082	328.855	-48.6367	x	x	x	
-11967	Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males and females [mg/dl XX min after injection]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males and females [mg/dl XX min after injection]	x	x	x	x	278.712	247.971	x	246.85	x	287.263	214.067	228.05	263.667	260.45	258.04	250.9	250.8	169.244	330.5	232.725	x	x	x	243.92	x	237.425	247.7	229.74	x	252.975	237.25	253.65	230.725	x	244.4	x	278.267	224.35	242.622	x	225.825	256.875	334.337	234.0	x	x	211.5	x	226.2	235.1	x	x	x	241.6	270.167	x	x	x	318.1	269.2	258.725	261.038	x	311.033	255.5	278.475	271.033	307.667	250.157	275.1	x	230.956	x	238.125	x	x	x	x	271.73	x	x	229.88	281.3	295.2	240.07	236.492	x	267.6	247.967	x	282.286	x	x	x	225.962	265.8	260.038	239.35	211.367	x	x	x	
-11968	Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males and females [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males and females [n]	x	x	x	x	61.25	55.1429	x	80.6	x	44.625	56.7143	52.6667	37.25	52.0	53.6	37.3333	56.5	49.0	56.0	54.0	x	x	x	45.5	x	48.6	48.25	92.8	x	50.375	40.0	65.75	47.0	x	41.75	x	39.0	51.2857	57.1667	x	39.3833	56.3333	81.75	79.3333	x	x	69.75	x	53.1429	57.875	x	x	x	85.8333	56.5	x	x	x	61.125	51.75	61.5	45.75	x	62.5	36.75	47.875	75.2857	53.4286	45.0	51.6667	x	73.2727	x	91.6667	x	x	x	x	68.1111	x	x	49.7	53.2	54.6	39.0	42.5833	x	35.9	62.6667	x	48.8571	x	x	x	39.875	55.5	54.75	42.7143	46.6667	x	x	x	
-11969	Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males and females [n]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males and females [n]	x	x	x	x	52.625	28.7143	x	81.2	x	57.125	63.0	83.6667	25.75	53.5	25.0	37.0	48.625	49.0	48.5	59.6667	x	x	x	25.25	x	39.4	25.5	56.1	x	44.75	25.75	57.875	62.0	x	74.25	x	41.5	42.2857	38.8333	x	59.1667	33.5	26.5	29.3333	x	x	82.25	x	52.5714	73.375	x	x	x	43.3333	48.0	x	x	x	37.75	31.25	44.625	9.75	x	38.375	38.875	41.125	26.8571	33.1429	47.5714	35.1667	x	67.9091	x	54.6667	x	x	x	x	51.8889	x	x	27.9	40.8	28.6	29.8	34.75	x	43.8	50.0	x	35.0	x	x	x	46.625	22.5	33.5	53.8571	46.3333	x	x	x	
-11970	Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males and females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males and females [%]	x	x	x	x	38.076	55.0919	x	57.356	x	35.042	50.678	37.5019	64.9714	45.8424	65.7627	53.1287	42.4873	48.7675	38.0952	42.7128	x	x	x	38.1542	x	45.5031	60.3875	56.0753	x	53.3763	42.0986	41.6204	40.6374	x	35.75	x	38.6026	48.4362	47.1784	x	36.5664	52.8395	78.4139	80.7333	x	x	39.94	x	48.6802	44.6533	x	x	x	49.6217	56.4833	x	x	x	64.9875	50.6219	57.1422	86.5501	x	53.686	44.2775	42.183	50.6867	57.9361	48.3539	51.6084	x	54.6881	x	52.3249	x	x	x	x	59.6542	x	x	54.7336	55.4513	57.195	41.9528	45.9812	x	44.2819	55.5853	x	66.5859	x	x	x	53.1655	54.1032	57.3989	45.6686	46.3888	x	x	x	
-11971	Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males and females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males and females [%]	x	x	x	x	61.924	44.9081	x	42.644	x	52.458	49.322	62.4981	35.0286	54.1576	24.2373	46.8713	45.0127	51.2325	61.9048	57.2872	x	x	x	61.8458	x	54.4969	39.6125	43.9247	x	46.6237	32.9014	58.3921	59.3626	x	64.25	x	44.7307	51.5638	36.155	x	63.4336	47.1605	21.5861	19.2667	x	x	60.06	x	51.3198	55.3467	x	x	x	45.215	43.5167	x	x	x	35.0125	49.3781	42.8578	13.4499	x	46.314	55.7225	57.817	35.0275	42.0639	51.6461	31.725	x	45.3119	x	31.0084	x	x	x	x	40.3458	x	x	45.2664	44.5487	32.805	58.0472	54.0188	x	55.7181	44.4147	x	33.4141	x	x	x	46.847	45.8968	42.6011	54.3314	53.6112	x	x	x	
-11972	Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males and females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males and females [%]	x	x	x	x	32.8533	45.0267	x	31.5147	x	33.2663	35.4576	34.4794	51.2808	32.8546	71.586	62.2233	43.27	39.43	33.5467	34.3994	x	x	x	25.235	x	38.0547	56.585	53.9897	x	47.7887	33.6217	41.2733	33.3033	x	40.6083	x	49.6289	47.4042	39.1079	x	42.5533	49.8483	79.9371	77.0	x	x	40.385	x	46.0817	43.4029	x	x	x	63.8333	59.9361	x	x	x	69.8983	52.6775	55.4133	83.0171	x	56.5554	27.1075	40.9162	42.8257	45.729	35.9633	47.3594	x	49.2827	x	52.095	x	x	x	x	60.0333	x	x	47.9123	38.6867	53.3263	47.001	37.4231	x	43.922	54.6444	x	67.4352	x	x	x	44.6029	60.7233	49.8279	38.6586	51.1711	x	x	x	
-11973	Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of plus maze for males and females [%]	None	Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of plus maze for males and females [%]	x	x	x	x	55.1542	44.5629	x	60.996	x	44.4658	55.8105	55.9711	17.4775	48.2062	13.2443	31.4928	26.0217	46.3225	60.7967	49.3406	x	x	x	55.3075	x	44.1147	31.7288	38.6987	x	42.6225	30.4058	50.5475	44.4512	x	54.6083	x	28.0278	46.4942	26.7854	x	44.8256	24.8833	13.8554	16.6175	x	x	53.4725	x	45.88	46.855	x	x	x	29.235	33.56	x	x	x	20.7733	24.33	29.2292	7.81208	x	36.8488	31.0521	45.5288	23.8986	33.3671	45.4519	22.9578	x	41.0927	x	22.2222	x	x	x	x	32.8011	x	x	33.9583	39.195	23.3197	45.286	49.2872	x	50.8303	35.0772	x	26.9443	x	x	x	47.1392	34.005	28.065	47.2224	43.4106	x	x	x	
-11974	Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males females [sec]	x	x	x	x	19.3708	5.50833	x	16.1236	x	18.1083	11.3367	-9.38889	0.495833	18.0267	6.4	15.4792	17.14	-2.85556	15.4	-4.52963	x	x	x	9.10476	x	-7.25417	4.6625	15.62	x	9.19167	14.3667	3.56296	42.33	x	-4.44167	x	8.72778	24.8333	-1.01	x	3.95833	0.554167	10.9208	-7.45833	x	x	6.13889	x	-0.9875	11.5871	x	x	x	8.36667	-1.63889	x	x	x	21.125	2.3625	9.07083	0.133333	x	0.7875	0.708333	-0.483333	6.90476	16.0095	7.28571	4.43889	x	24.8364	x	-6.95417	x	x	x	x	21.17	x	x	-14.5667	4.94333	5.16667	2.28567	20.5167	x	15.373	18.8833	x	-8.24286	x	x	x	-3.03333	-9.61667	-7.3375	1.80417	4.93111	x	x	x	
-11975	Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males and females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males and females [sec]	x	x	x	x	24.4538	38.3121	x	41.5933	x	25.4167	50.9181	41.6667	20.9728	24.8003	19.6697	35.3989	23.6863	41.4822	12.4667	37.2696	x	x	x	16.81	x	32.8088	42.5762	28.8723	x	31.9937	34.3658	42.4781	37.4038	x	47.2975	x	12.4522	38.3913	31.8997	x	27.5413	24.2617	24.3879	38.7175	x	x	29.2817	x	59.0033	31.1304	x	x	x	21.3567	18.1033	x	x	x	25.6279	32.6125	40.8421	28.0283	x	30.5492	36.4342	15.4338	48.7619	34.0195	24.7	30.2944	x	49.9897	x	39.9083	x	x	x	x	31.6667	x	x	38.7167	27.1837	28.5967	32.6947	19.2194	x	15.197	38.0556	x	35.5133	x	x	x	31.8412	30.6833	33.2962	41.2708	40.2633	x	x	x	
-11976	Original post publication description: Ethanol response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec]	x	x	x	x	-7.95417	-7.93333	x	8.9125	x	-9.97917	7.49296	14.1778	2.28333	-11.67	-0.626667	1.90417	-12.4567	4.5037	-11.25	-1.8	x	x	x	-1.81429	x	0.683333	-16.7292	-6.88667	x	0.416667	-4.86667	-1.37407	-27.5087	x	4.48333	x	1.92222	-20.7542	-8.06333	x	6.54583	3.47083	-7.50833	-2.525	x	x	-5.44444	x	-4.70792	-8.10833	x	x	x	2.58889	-1.30556	x	x	x	-5.81667	-2.60417	-14.6583	-0.391667	x	-2.92917	-7.3	-4.45417	-15.6333	-2.86191	-5.85238	7.58889	x	-21.903	x	-2.39583	x	x	x	x	-4.62667	x	x	3.44	4.50667	-3.75	-4.00667	-0.316667	x	-3.58	-11.5167	x	11.3286	x	x	x	1.07083	24.15	0.216667	-0.333333	-9.31511	x	x	x	
-11977	Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males and females [sec]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males and females [sec]	x	x	x	x	43.8288	43.8217	x	55.4006	x	43.525	62.2544	32.2767	18.5429	42.827	26.0703	48.0352	40.8253	38.6274	27.8667	32.7422	x	x	x	25.9143	x	25.5533	47.2375	44.4923	x	41.1862	48.7333	46.0396	80.2822	x	42.8575	x	21.1783	63.2246	30.8897	x	31.5	24.8162	35.3088	31.26	x	x	35.4222	x	58.0163	42.7179	x	x	x	29.7233	16.4683	x	x	x	46.7542	34.975	49.9125	28.1667	x	31.3388	37.14	14.9492	55.6667	50.029	31.9857	34.7333	x	70.2815	x	32.9542	x	x	x	x	52.8367	x	x	24.15	32.127	33.7633	34.98	43.3485	x	30.57	56.9389	x	31.8161	x	x	x	32.9238	21.0667	29.6667	43.07	45.1944	x	x	x	
-11978	Original post publication description: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males and females [sec]	None	Central nervous system, behavior: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males and females [sec]	x	x	x	x	11.4167	-2.425	x	25.0361	x	8.12917	18.8296	4.78889	2.77917	6.35667	5.77333	17.3833	4.68333	1.64815	4.15	-6.32963	x	x	x	7.29048	x	-6.57083	-12.0667	8.73333	x	9.60833	9.5	2.18889	14.8213	x	0.041667	x	10.65	4.07917	-9.07333	x	10.5042	4.025	3.4125	-9.98333	x	x	0.694444	x	-5.69542	3.47875	x	x	x	10.9556	-2.94444	x	x	x	15.3083	-0.241667	-5.5875	-0.258333	x	-2.14167	-6.59167	-4.9375	-8.72857	13.1476	1.43333	12.0278	x	2.93333	x	-9.35	x	x	x	x	16.5433	x	x	-11.1267	9.45	1.41667	-1.721	20.2	x	11.793	7.36667	x	3.08571	x	x	x	-1.9625	14.5333	-7.12083	1.47083	-4.384	x	x	x	
-11979	Original post publication description: Motor coordination, rotarod performance, untreated training trial for males and females [sec]	None	Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for males and females [sec]	x	x	x	x	35.8692	35.8875	x	59.6972	x	33.5458	69.7478	46.4544	18.5083	31.1563	25.443	43.9333	28.37	43.1304	16.6167	30.9404	x	x	x	24.0995	x	26.2388	30.5088	37.607	x	41.605	43.8667	44.6667	44.7433	x	47.34	x	23.1006	42.4725	22.826	x	38.0454	28.2879	27.7996	28.7325	x	x	29.9789	x	53.3083	34.6079	x	x	x	32.31	15.16	x	x	x	40.9379	32.3704	35.2542	27.7708	x	28.4083	29.8408	10.4946	40.0333	47.1667	26.1333	42.3222	x	48.3785	x	30.5583	x	x	x	x	48.21	x	x	27.59	36.6333	30.0137	30.9737	39.4194	x	26.99	45.4222	x	38.601	x	x	x	29.8796	45.2167	26.175	42.7412	35.8793	x	x	x	
-11980	Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males and females [sec]	x	x	x	x	98.56	135.077	x	94.516	x	99.7988	106.389	103.43	153.84	98.5713	214.748	186.672	129.8	118.283	100.64	103.17	x	x	x	75.705	x	114.16	169.749	161.966	x	143.339	100.865	123.796	99.9112	x	121.85	x	148.868	142.212	117.321	x	127.66	149.545	239.809	231.003	x	x	121.16	x	138.242	130.21	x	x	x	191.492	179.808	x	x	x	209.695	158.033	166.24	249.051	x	169.666	81.3075	122.753	128.477	137.196	107.889	142.078	x	147.842	x	156.287	x	x	x	x	180.1	x	x	143.736	116.062	159.979	140.993	112.278	x	131.766	163.933	x	202.293	x	x	x	133.827	182.17	149.486	115.97	153.515	x	x	x	
-11981	Original post publication description: Anxiety assay, time in middle of an elevated plus maze for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males and females [sec]	x	x	x	x	35.9787	31.2343	x	22.52	x	66.8037	26.1943	28.6467	93.725	56.8213	45.539	18.85	92.1325	42.73	16.97	48.8067	x	x	x	58.375	x	53.494	35.08	21.931	x	28.7812	107.918	24.5487	66.7363	x	14.34	x	67.0833	18.3025	78.355	x	37.8667	75.805	18.6238	19.145	x	x	18.425	x	24.1162	29.2225	x	x	x	20.8	19.5117	x	x	x	27.9837	68.9775	46.0725	27.51	x	19.7862	125.556	40.6362	99.8271	62.72	55.7571	89.0483	x	28.8882	x	77.0483	x	x	x	x	21.4956	x	x	54.388	66.352	70.063	23.146	39.8542	x	15.743	30.835	x	16.8614	x	x	x	24.7787	15.815	66.32	42.3643	16.2517	x	x	x	
-11982	Original post publication description: Anxiety assay, time in open arms of an elevated plus maze for males and females [sec]	None	Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for males and females [sec]	x	x	x	x	165.461	133.689	x	182.96	x	133.398	167.44	167.922	52.445	144.613	39.713	94.4783	78.06	138.958	182.39	148.023	x	x	x	165.92	x	132.346	95.1712	116.103	x	127.88	91.2175	151.652	133.352	x	163.825	x	84.0467	139.485	104.324	x	134.473	74.65	41.5675	49.8525	x	x	160.415	x	137.641	140.568	x	x	x	87.7083	100.68	x	x	x	62.3213	72.99	87.6875	23.4387	x	110.559	93.1363	136.611	71.6957	100.084	136.354	68.8733	x	123.27	x	66.665	x	x	x	x	98.4044	x	x	101.876	117.586	69.958	135.861	147.867	x	152.491	105.232	x	80.8457	x	x	x	141.394	102.015	84.1937	141.666	130.233	x	x	x	
-11983	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2218.29	1382.0	x	936.292	1016.92	2877.7	814.524	1850.81	1062.81	2774.0	865.643	879.143	2910.88	1757.61	942.0	2825.55	x	x	x	2381.25	x	1511.21	1280.33	2442.82	x	1969.39	1146.17	3376.32	1298.32	x	581.0	x	2184.22	1496.96	4132.07	x	2347.69	2809.0	1260.38	1803.29	x	x	1713.71	x	1640.19	1134.72	x	x	x	1422.36	792.865	x	x	x	2399.24	1306.25	908.645	1918.67	x	2104.58	728.048	1180.89	1898.93	3193.5	2215.65	3434.93	x	1298.62	x	1590.82	x	3770.32	x	x	1563.69	x	x	1326.53	3175.15	1032.72	1887.24	1714.41	x	2550.47	778.0	x	1708.04	x	x	x	2202.7	2952.09	2758.64	2685.5	1178.0	x	x	x	
-11984	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2129.94	769.75	x	830.292	570.417	2546.5	994.143	1443.33	973.308	1915.1	649.214	932.619	2019.42	1809.78	1356.0	2473.55	x	x	x	1672.38	x	1050.71	926.4	1986.68	x	2048.22	1436.17	2804.72	1129.97	x	378.294	x	2083.43	1203.04	3818.27	x	2052.07	2449.29	1026.3	1374.65	x	x	1549.81	x	1759.0	1191.12	x	x	x	1409.95	714.811	x	x	x	2356.76	1327.68	868.774	1742.79	x	1896.31	807.0	1310.33	1930.44	3191.08	2341.44	3409.17	x	1113.18	x	1374.64	x	2818.26	x	x	1263.6	x	x	1095.9	2290.46	1223.62	1634.32	1610.7	x	2226.53	380.2	x	1787.68	x	x	x	1777.22	2298.0	1579.27	3009.57	1103.74	x	x	x	
-11985	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	1479.41	581.95	x	786.375	592.167	2041.6	1088.14	1135.24	875.692	1437.66	532.286	822.952	1288.33	1188.44	1647.83	1873.82	x	x	x	1350.31	x	768.917	762.067	1417.82	x	1400.78	1397.26	1903.08	844.097	x	236.529	x	1592.17	971.482	2752.3	x	1316.17	1717.62	780.324	1381.41	x	x	1568.0	x	1420.56	996.875	x	x	x	1277.05	435.811	x	x	x	1830.76	1138.05	568.484	1215.12	x	1344.54	680.143	1095.81	1561.44	2637.19	1772.0	2572.21	x	864.853	x	1045.5	x	1919.26	x	x	982.343	x	x	895.467	1489.73	803.094	1315.68	1229.74	x	1770.4	222.2	x	1377.88	x	x	x	1202.7	1602.82	820.606	2667.11	879.359	x	x	x	
-11986	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	1107.0	323.85	x	496.125	489.167	1568.6	820.333	1011.52	646.885	1044.62	334.286	860.19	1035.83	631.889	1004.0	1509.32	x	x	x	1097.44	x	473.5	588.2	977.545	x	1084.33	1129.35	1494.2	491.774	x	124.882	x	1174.43	825.963	2172.93	x	1021.97	1294.5	567.162	1059.53	x	x	1281.67	x	1184.38	844.219	x	x	x	975.091	160.486	x	x	x	1397.83	884.15	349.839	774.0	x	1088.5	538.571	969.556	1159.56	2157.78	1464.18	1981.45	x	621.412	x	789.818	x	1398.58	x	x	681.2	x	x	790.1	1098.31	490.688	988.84	874.815	x	1562.0	189.0	x	1055.6	x	x	x	1363.17	1275.64	605.515	2248.5	727.41	x	x	x	
-11987	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [cm]	x	x	x	x	6349.49	4025.16	x	2752.53	3074.33	7746.54	2402.97	5316.68	3311.65	7966.5	2672.08	2715.58	7947.35	5524.57	2884.02	7831.91	x	x	x	6817.69	x	4480.33	3792.76	7087.78	x	5917.91	3333.18	9139.29	3944.94	x	1874.62	x	6522.82	4291.93	10798.8	x	6988.7	8077.35	3899.42	5554.49	x	x	4997.35	x	5016.55	3714.24	x	x	x	4489.45	2660.06	x	x	x	6858.67	3911.6	2758.3	5788.84	x	6094.39	2304.83	3814.56	5895.6	8816.01	6495.88	9588.67	x	4040.2	x	4897.77	x	10079.5	x	x	4669.58	x	x	4342.66	8844.09	3490.75	5501.32	5200.25	x	7492.42	2850.69	x	5197.09	x	x	x	6315.25	8097.77	7354.02	7836.11	3619.18	x	x	x	
-11988	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [cm]	x	x	x	x	6025.83	2380.06	x	2518.11	1933.62	6816.46	3023.85	4422.46	3165.35	5689.82	2087.14	2890.53	5721.15	5864.9	4101.52	6984.94	x	x	x	4951.67	x	3333.1	2963.53	5876.45	x	6114.54	4167.73	7716.64	3510.66	x	1270.0	x	6248.15	3492.62	9998.54	x	6140.96	7310.46	3167.42	4367.91	x	x	4692.46	x	5291.82	3907.71	x	x	x	4425.23	2460.79	x	x	x	6713.74	4019.04	2694.16	5177.35	x	5588.65	2608.88	4099.71	5930.38	8809.0	6771.9	9389.64	x	3556.81	x	4338.31	x	7876.88	x	x	3855.73	x	x	3605.9	6613.51	4005.69	4770.4	4821.53	x	6631.2	1539.9	x	5475.65	x	x	x	5272.33	6477.74	4359.48	8528.54	3501.35	x	x	x	
-11989	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [cm]	x	x	x	x	4377.78	1894.28	x	2423.93	2160.09	5560.45	3332.81	3649.14	2961.2	4392.56	1838.98	2596.93	3737.01	4022.04	5019.79	5457.98	x	x	x	4232.24	x	2520.07	2530.73	4434.92	x	4349.76	4130.41	5607.98	2763.98	x	829.138	x	4976.68	2962.32	7591.93	x	4142.27	5406.92	2493.36	4368.08	x	x	4799.25	x	4368.86	3387.23	x	x	x	4105.91	1507.24	x	x	x	5323.7	3530.46	1894.82	3703.6	x	4143.87	2219.68	3474.06	4912.85	7472.94	5390.14	7246.22	x	2824.54	x	3436.53	x	5719.68	x	x	3070.4	x	x	3043.54	4694.13	2716.32	4018.52	3707.41	x	5374.69	948.936	x	4396.41	x	x	x	3845.17	4589.7	2416.57	7641.35	2866.21	x	x	x	
-11990	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [cm]	x	x	x	x	3412.61	1160.12	x	1618.86	1849.26	4520.89	2581.86	3302.04	2240.15	3282.69	1202.24	2673.25	3164.56	2244.94	3134.91	4550.14	x	x	x	3545.15	x	1651.65	2073.91	3217.98	x	3515.76	3392.79	4647.85	1651.44	x	440.288	x	3864.04	2585.17	6295.94	x	3265.38	4265.82	1860.55	3340.58	x	x	3977.51	x	3712.58	2940.91	x	x	x	3209.98	562.005	x	x	x	4148.4	2861.83	1245.98	2423.47	x	3432.13	1816.99	3109.92	3752.34	6336.52	4599.8	5730.5	x	2030.78	x	2633.22	x	4380.64	x	x	2191.2	x	x	2679.09	3676.11	1699.48	3100.71	2712.61	x	4864.95	701.345	x	3374.57	x	x	x	4107.62	3678.75	1853.93	6600.73	2448.46	x	x	x	
-11991	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males and females [n beam breaks]	x	x	x	x	247.294	260.9	x	211.625	166.667	289.7	104.0	240.524	180.423	486.172	113.714	260.952	271.208	361.056	157.333	364.545	x	x	x	241.562	x	309.125	173.533	460.955	x	339.167	242.174	284.72	262.613	x	113.059	x	349.435	146.963	456.833	x	546.034	621.417	298.595	324.176	x	x	463.571	x	380.625	314.5	x	x	x	255.364	122.162	x	x	x	369.172	309.025	277.806	221.292	x	315.885	177.714	376.815	424.667	553.556	378.5	482.138	x	367.912	x	372.364	x	525.947	x	x	384.486	x	x	359.5	350.923	238.312	304.96	375.185	x	463.4	173.0	x	286.08	x	x	x	525.348	290.273	285.303	453.857	243.897	x	x	x	
-11992	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males and females [n beam breaks]	x	x	x	x	332.529	213.6	x	242.5	209.0	335.4	170.81	327.571	238.808	508.103	158.357	337.857	289.208	466.833	241.0	454.864	x	x	x	244.688	x	294.458	220.467	440.591	x	413.389	351.391	383.84	276.839	x	127.0	x	414.87	169.37	597.633	x	515.276	728.167	279.865	343.941	x	x	522.19	x	401.562	320.375	x	x	x	292.818	166.919	x	x	x	412.69	390.525	359.581	283.542	x	342.577	275.143	429.185	466.704	672.806	448.529	542.345	x	397.559	x	450.864	x	581.579	x	x	410.2	x	x	401.533	387.038	327.438	303.08	362.667	x	521.067	133.6	x	351.32	x	x	x	578.261	329.273	257.303	510.964	321.462	x	x	x	
-11993	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males and females [n beam breaks]	x	x	x	x	308.647	197.1	x	216.958	268.417	336.7	214.952	308.238	270.538	448.31	156.643	293.619	275.792	371.778	320.833	409.0	x	x	x	264.188	x	230.333	182.8	371.364	x	362.556	341.913	385.88	240.161	x	83.6471	x	409.87	176.926	556.667	x	402.172	595.917	255.27	365.294	x	x	526.286	x	400.125	301.562	x	x	x	303.409	117.946	x	x	x	365.517	399.6	338.0	212.333	x	279.692	227.286	409.148	401.963	631.111	416.765	507.793	x	337.441	x	417.091	x	553.368	x	x	354.886	x	x	347.9	429.5	268.344	264.72	311.333	x	463.333	86.4	x	310.32	x	x	x	521.087	276.091	206.788	517.714	308.051	x	x	x	
-11994	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males and females [n beam breaks]	x	x	x	x	311.588	153.1	x	170.792	257.583	365.9	197.0	295.952	219.692	360.138	115.357	311.857	240.375	250.722	238.833	368.909	x	x	x	249.5	x	175.75	222.8	316.909	x	332.333	297.217	368.48	178.419	x	56.1176	x	416.783	195.074	570.7	x	339.207	554.583	196.73	300.941	x	x	490.524	x	368.875	254.75	x	x	x	253.409	45.4865	x	x	x	320.103	383.325	257.161	173.875	x	269.423	221.857	396.407	326.667	623.417	405.059	466.241	x	284.647	x	336.727	x	521.895	x	x	301.629	x	x	337.133	403.692	189.219	250.16	253.259	x	469.267	73.2	x	245.84	x	x	x	499.696	257.636	175.152	522.214	308.692	x	x	x	
-11995	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	4715.47	2410.2	x	1646.58	1718.33	4947.2	1041.9	3016.14	2303.12	3895.93	1127.93	1739.9	4093.38	3382.5	2450.5	4703.36	x	x	x	2991.06	x	3001.7	3193.6	3183.23	x	2667.83	2131.65	5346.2	1781.48	x	820.941	x	3300.65	2417.96	6128.4	x	3418.48	3451.08	2154.46	2236.35	x	x	2433.62	x	1861.27	2203.44	x	x	x	2187.95	1275.95	x	x	x	3779.97	1897.55	1195.81	2873.54	x	2550.8	1607.62	1705.11	2758.81	4620.86	3467.67	4598.59	x	2241.06	x	2740.81	x	4841.58	x	x	2323.6	x	x	2394.33	4643.81	2056.5	3877.35	2709.26	x	3336.4	939.2	x	2572.72	x	x	x	3177.96	4727.4	3609.58	3546.52	1697.38	x	x	x	
-11996	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	3341.29	930.95	x	1095.71	788.75	4321.5	1231.0	1881.19	1763.88	2533.69	1131.64	1604.75	2906.33	2553.0	2341.67	2917.23	x	x	x	1851.0	x	1885.0	1946.73	2197.09	x	2330.44	1748.17	3868.36	1198.1	x	398.059	x	2490.74	1891.93	4635.13	x	2495.1	2620.71	1652.76	1658.0	x	x	1777.38	x	1625.2	1849.47	x	x	x	2137.23	984.541	x	x	x	3327.21	1487.68	849.903	2244.54	x	2060.52	1302.05	1654.63	2126.15	3971.72	3113.09	4128.66	x	1488.76	x	1755.0	x	3158.63	x	x	1517.4	x	x	1704.17	3063.08	1750.66	2924.04	2049.11	x	2376.2	544.6	x	2087.68	x	x	x	1956.96	3057.6	1956.03	3033.19	1204.03	x	x	x	
-11997	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	2315.41	564.7	x	988.375	702.75	2891.3	1068.86	1202.1	1009.62	1590.83	907.071	1252.85	1861.42	1429.78	1951.5	2103.36	x	x	x	1421.0	x	1127.43	1279.73	1738.23	x	1814.39	1431.87	2503.36	861.968	x	288.0	x	1593.26	1236.11	3196.43	x	1799.76	1731.92	1133.62	1608.82	x	x	1453.33	x	1296.13	1317.62	x	x	x	1790.36	569.946	x	x	x	2496.79	1186.6	560.387	1521.08	x	1422.44	1207.62	1280.59	1572.15	3031.67	2403.52	3187.24	x	990.735	x	1165.9	x	2134.79	x	x	1059.77	x	x	1184.5	2041.54	1061.12	1837.87	1441.07	x	1913.27	322.2	x	1531.44	x	x	x	1316.43	2239.8	1078.79	2672.41	979.949	x	x	x	
-11998	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	1533.88	429.85	x	750.458	572.167	1990.4	1000.43	924.81	825.692	1209.69	563.643	998.9	1477.42	613.111	1360.33	1676.55	x	x	x	931.875	x	764.304	857.133	1192.05	x	1319.78	1121.83	1753.68	560.387	x	77.1176	x	1251.09	933.148	2341.83	x	1321.21	1259.54	735.432	882.824	x	x	1205.62	x	1187.13	956.438	x	x	x	1483.64	322.162	x	x	x	1741.0	959.55	321.935	927.792	x	1018.96	781.905	1074.7	1090.33	2450.19	1794.33	2313.34	x	671.324	x	820.143	x	1594.58	x	x	770.0	x	x	918.033	1290.88	768.5	1374.57	1110.04	x	1567.6	144.4	x	1082.32	x	x	x	1044.13	1434.7	665.909	2314.74	767.385	x	x	x	
-11999	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males and females [cm]	x	x	x	x	12026.1	6539.09	x	4676.82	4754.89	12691.9	2989.75	8048.21	6602.42	10635.1	3243.02	4895.12	10601.4	9791.07	7151.07	12271.4	x	x	x	8186.14	x	8299.42	8680.46	8868.43	x	7605.42	5919.73	13555.6	5206.96	x	2426.28	x	9354.75	6594.77	15217.3	x	9763.28	9726.1	6236.25	6665.27	x	x	6891.92	x	5545.57	6480.03	x	x	x	6654.21	3941.34	x	x	x	10279.2	5461.41	3458.17	8043.54	x	7122.34	4537.31	5230.37	8052.87	12291.4	9482.22	12203.1	x	6385.89	x	8086.98	x	12369.2	x	x	6490.59	x	x	6972.35	12031.2	6284.28	10520.7	7632.78	x	9218.11	3073.48	x	7287.56	x	x	x	8708.93	12370.9	9527.6	9749.02	4996.65	x	x	x	
-12000	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males and females [cm]	x	x	x	x	8578.81	2714.56	x	3287.88	2572.22	10972.4	3666.53	5412.5	5219.7	7166.09	3342.88	4588.61	7689.25	7784.13	6989.38	8182.04	x	x	x	5400.69	x	5570.27	5917.09	6357.81	x	6572.72	4984.65	10092.9	3636.25	x	1354.03	x	7245.76	5291.6	11596.4	x	7253.73	7616.04	4879.42	5102.7	x	x	5341.75	x	4907.19	5556.65	x	x	x	6544.6	3267.27	x	x	x	9063.33	4390.98	2541.53	6377.02	x	5968.12	3826.67	5050.64	6389.76	10605.3	8625.35	10948.9	x	4412.49	x	5511.77	x	8622.07	x	x	4493.85	x	x	5152.46	8339.15	5460.52	8156.33	5814.34	x	6883.87	1999.1	x	6069.67	x	x	x	5656.93	8226.19	5392.41	8387.7	3788.79	x	x	x	
-12001	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males and females [cm]	x	x	x	x	6252.76	1803.11	x	3048.87	2472.29	7569.52	3295.62	3808.6	3273.89	4744.18	2939.63	3755.93	5208.34	4682.23	5896.34	6213.28	x	x	x	4435.96	x	3671.4	4255.54	5262.44	x	5224.84	4195.86	7055.59	2796.34	x	964.677	x	5039.27	3693.02	8560.88	x	5417.56	5517.33	3505.57	4981.9	x	x	4490.31	x	4041.87	4277.85	x	x	x	5505.91	1971.89	x	x	x	6955.5	3669.4	1863.79	4497.33	x	4363.64	3554.16	4044.34	4906.16	8390.56	6904.72	8648.24	x	3068.03	x	3910.82	x	6359.85	x	x	3237.34	x	x	3827.16	5970.11	3494.51	5446.08	4271.16	x	5795.45	1275.69	x	4744.72	x	x	x	4016.06	6375.58	3260.98	7625.65	3193.68	x	x	x	
-12002	Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males and females [cm]	x	x	x	x	4424.87	1434.59	x	2342.72	2014.56	5571.94	3110.85	2991.91	2836.44	3738.71	2002.23	3048.73	4146.3	2105.0	3956.2	5146.32	x	x	x	3161.92	x	2648.72	3012.99	3731.74	x	4007.97	3445.83	5264.1	1913.3	x	264.179	x	4107.29	2999.52	6617.9	x	4094.15	4188.06	2381.18	2828.1	x	x	3835.2	x	3769.48	3296.47	x	x	x	4716.05	1147.66	x	x	x	4973.2	3035.87	1118.13	2882.19	x	3199.53	2489.78	3455.27	3579.34	7002.67	5434.24	6435.71	x	2171.09	x	2909.63	x	4983.58	x	x	2404.61	x	x	3083.5	4103.96	2579.69	4254.94	3252.64	x	4794.52	520.602	x	3490.57	x	x	x	3394.57	4285.98	2078.98	6734.78	2623.8	x	x	x	
-12003	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	278.706	341.85	x	314.917	186.75	381.6	123.81	316.238	269.538	612.897	135.643	321.2	403.083	562.889	438.667	511.227	x	x	x	285.5	x	479.87	335.133	571.591	x	421.833	361.13	346.4	344.871	x	123.059	x	465.261	200.407	601.1	x	711.862	701.375	409.162	389.235	x	x	536.286	x	380.733	441.344	x	x	x	373.727	149.676	x	x	x	551.966	374.75	307.935	258.0	x	281.92	256.81	463.963	483.778	722.194	501.667	561.897	x	374.941	x	565.667	x	600.526	x	x	423.114	x	x	440.1	421.923	366.594	487.739	453.0	x	499.133	185.2	x	337.8	x	x	x	630.783	336.8	416.182	495.963	339.103	x	x	x	
-12004	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	369.294	212.6	x	328.542	231.0	459.1	211.857	317.714	322.654	593.034	197.929	393.45	416.083	564.111	430.0	539.091	x	x	x	265.312	x	441.217	425.133	497.591	x	431.778	399.783	412.28	280.097	x	147.294	x	460.609	238.519	605.767	x	601.448	711.75	382.892	399.353	x	x	560.381	x	396.867	402.562	x	x	x	431.136	199.676	x	x	x	569.586	440.0	380.032	285.625	x	340.04	349.19	523.0	489.852	768.111	589.636	577.931	x	356.147	x	581.857	x	620.737	x	x	431.743	x	x	467.933	455.731	416.562	459.565	424.889	x	495.4	145.8	x	352.8	x	x	x	588.826	347.2	308.485	517.593	392.077	x	x	x	
-12005	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	356.353	174.5	x	295.75	286.333	430.7	213.143	281.19	261.962	473.207	220.786	321.15	337.708	421.056	375.833	500.182	x	x	x	279.812	x	357.739	397.6	439.5	x	404.833	361.609	387.36	266.742	x	109.059	x	453.783	233.889	620.033	x	501.069	657.25	300.784	369.412	x	x	486.762	x	386.867	336.625	x	x	x	381.727	142.108	x	x	x	476.655	419.975	362.839	246.583	x	284.52	325.762	477.407	396.926	719.389	535.303	526.655	x	325.206	x	516.714	x	604.158	x	x	352.429	x	x	410.1	444.423	322.375	371.522	366.63	x	489.933	98.2	x	319.4	x	x	x	522.87	365.5	250.818	545.222	392.231	x	x	x	
-12006	Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	316.471	175.8	x	243.333	251.25	440.0	220.143	240.524	279.654	432.103	178.643	319.8	287.708	226.889	265.333	453.364	x	x	x	230.625	x	281.783	307.933	355.636	x	387.611	335.522	354.56	217.0	x	55.1176	x	433.565	232.815	580.2	x	411.448	556.875	229.297	257.176	x	x	476.429	x	387.267	295.844	x	x	x	364.227	94.2432	x	x	x	387.069	402.725	255.774	196.875	x	229.96	280.952	458.444	350.926	657.25	499.909	443.172	x	280.941	x	421.571	x	555.421	x	x	305.914	x	x	364.5	405.808	300.094	361.739	286.778	x	427.0	45.4	x	268.92	x	x	x	530.652	292.9	199.879	543.444	353.128	x	x	x	
-12007	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males and females [sec]	None	Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males and females [sec]	x	x	x	x	397.763	389.864	x	396.612	423.092	x	374.565	468.145	325.153	424.08	283.74	404.459	394.75	388.869	464.05	414.275	x	x	x	472.886	x	390.528	461.464	408.6	x	469.15	420.857	362.625	417.621	x	239.02	x	344.463	390.488	331.05	x	342.442	391.546	405.307	313.318	x	x	425.206	x	372.406	356.087	x	x	x	352.425	325.342	x	x	x	360.339	436.231	391.4	309.575	x	410.053	308.864	358.0	365.059	406.357	429.987	382.297	x	365.426	x	425.315	x	415.027	x	x	368.094	x	x	459.152	379.484	385.557	375.143	441.529	x	432.814	514.567	x	399.632	x	x	x	442.725	429.8	374.607	388.585	463.403	x	x	x	
-12008	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males and females [sec]	None	Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males and females [sec]	x	x	x	x	433.975	563.709	x	522.717	445.242	x	490.32	470.832	428.491	463.987	509.54	442.241	489.542	426.175	442.725	436.754	x	x	x	417.527	x	436.394	426.343	484.033	x	432.317	493.889	499.619	470.931	x	598.68	x	449.774	437.024	471.892	x	552.842	460.337	454.519	377.691	x	x	484.869	x	490.288	490.698	x	x	x	467.083	440.862	x	x	x	531.813	463.737	439.311	444.778	x	476.2	447.109	511.047	406.806	447.767	457.767	432.175	x	459.224	x	499.081	x	414.705	x	x	453.396	x	x	463.038	505.966	483.078	448.339	440.918	x	430.543	476.933	x	469.024	x	x	x	480.089	458.01	478.314	503.455	438.735	x	x	x	
-12009	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males and females [sec]	None	Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on day 5 for males and females [sec]	x	x	x	x	422.319	471.965	x	490.346	467.45	x	379.195	660.964	381.135	544.27	436.4	451.505	477.737	453.294	539.825	450.517	x	x	x	545.223	x	469.189	519.114	373.742	x	605.617	297.661	378.834	568.125	x	231.99	x	455.603	451.094	399.745	x	413.6	516.391	490.374	533.753	x	x	417.892	x	356.513	439.353	x	x	x	472.542	357.898	x	x	x	363.989	457.493	412.611	406.644	x	467.256	463.368	440.562	447.188	479.864	411.721	430.394	x	398.124	x	469.008	x	510.564	x	x	410.83	x	x	458.23	485.57	436.145	412.558	448.706	x	442.4	326.75	x	450.044	x	x	x	422.906	485.36	416.998	419.522	479.643	x	x	x	
-12010	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males and females [sec]	None	Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on day 5 for males and females [sec]	x	x	x	x	353.237	502.405	x	391.858	415.008	x	520.515	262.545	504.624	402.69	329.69	334.882	425.076	382.312	311.925	406.767	x	x	x	416.718	x	369.296	393.4	434.417	x	373.083	523.232	380.331	328.045	x	643.14	x	384.916	410.271	442.033	x	425.65	382.545	394.765	277.021	x	x	411.036	x	476.125	438.867	x	x	x	447.058	353.871	x	x	x	543.337	473.941	505.953	392.831	x	422.206	361.964	476.088	325.271	382.811	427.683	432.478	x	371.124	x	445.996	x	365.132	x	x	452.828	x	x	413.645	373.893	412.9	356.377	416.318	x	396.943	405.6	x	473.706	x	x	x	488.783	416.81	405.974	475.848	462.337	x	x	x	
-12011	Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males and females [%]	None	Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males and females [%]	x	x	x	x	47.8774	41.0773	x	43.2362	48.0929	x	43.6796	49.7033	43.2763	47.9817	36.0795	48.1167	44.7271	47.0787	51.27	48.4541	x	x	x	52.9346	x	47.065	51.5407	45.8322	x	51.8294	46.0017	41.8795	46.9072	x	29.5551	x	43.1972	47.3701	41.26	x	38.5823	46.1526	46.9573	45.5224	x	x	46.5792	x	43.4289	42.2865	x	x	x	43.1771	42.4401	x	x	x	40.132	48.7626	46.3293	41.0806	x	46.2438	41.6103	41.0844	46.8667	47.4856	48.4281	46.7983	x	44.4069	x	45.9008	x	50.098	x	x	44.5679	x	x	49.9041	42.45	44.3466	45.212	49.979	x	49.9002	52.19	x	45.9638	x	x	x	47.8088	48.3158	44.0991	43.3964	51.1721	x	x	x	
-12012	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males and females [sec]	None	Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [sec]	x	x	x	x	24.5562	79.97	x	93.7333	44.3583	x	4.63	192.818	55.9824	120.19	152.66	47.0455	82.9868	64.425	75.775	36.2417	x	x	x	72.3364	x	74.9964	57.65	-34.8583	x	136.467	-123.196	16.2094	149.947	x	-7.03	x	111.139	60.6059	68.695	x	71.1579	81.8125	85.0667	220.435	x	x	-7.31389	x	31.55	83.265	x	x	x	120.117	32.5558	x	x	x	3.65	21.2611	21.2105	97.0694	x	57.2031	154.505	82.5618	82.1294	69.5023	-18.2667	48.0969	x	32.6974	x	43.6923	x	95.5364	x	x	42.736	x	x	-0.9225	100.65	50.5875	36.3654	7.17647	x	9.58571	-187.817	x	50.4118	x	x	x	-19.8194	55.56	42.3905	30.9375	16.24	x	x	x	
-12013	Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males and females [% change]	None	Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [% change]	x	x	x	x	7.2165	6.93789	x	11.413	4.89223	x	-0.802755	21.4102	-0.058834	9.2793	21.8215	9.54156	8.32202	7.65657	12.07	4.10968	x	x	x	3.7118	x	9.16671	5.26925	0.821648	x	9.92777	-8.79587	7.63028	16.5368	x	-2.09512	x	11.0269	5.38153	6.87069	x	9.71925	10.9094	8.78475	19.8748	x	x	3.6014	x	5.74	7.92445	x	x	x	8.29045	7.39579	x	x	x	-0.065991	0.507609	-0.497756	9.93197	x	6.61011	14.1714	7.55735	11.4353	7.99871	0.667304	3.4066	x	6.83382	x	5.8715	x	8.22222	x	x	3.06789	x	x	3.35643	13.184	6.75474	9.10703	1.81803	x	2.76519	-7.7	x	2.6129	x	x	x	-0.898556	6.29417	6.57214	3.58265	-0.414655	x	x	x	
-12014	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]	x	x	x	x	1721.65	1957.38	x	2796.04	1913.17	3508.8	1778.71	3403.81	1057.81	2675.45	733.357	1852.62	3043.25	1122.33	1871.83	2374.77	x	x	x	2221.94	x	610.5	838.8	2956.09	x	1069.0	2602.35	2633.04	1400.87	x	403.765	x	2256.09	1556.11	3013.57	x	2157.72	1676.04	942.595	2019.0	x	x	2836.0	x	2442.05	1639.09	x	x	x	2428.73	244.189	x	x	x	2509.97	1826.53	506.581	1117.08	x	2333.23	1769.86	1728.78	1572.81	3142.22	3267.69	2703.21	x	1223.29	x	2091.78	x	2701.79	x	x	2208.6	x	x	1204.17	1442.88	621.656	1976.68	1752.55	x	2789.8	906.8	x	2052.2	x	x	x	1960.3	2424.73	2867.15	3390.11	1399.67	x	x	x	
-12015	Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]	x	x	x	x	5556.95	5483.38	x	7532.55	5630.44	9554.82	5137.88	8872.53	3555.33	7800.05	2473.07	5512.64	7991.54	3880.0	4867.01	6537.77	x	x	x	6854.02	x	1925.12	2931.86	7629.41	x	3454.2	7207.22	7977.94	4253.02	x	1370.67	x	6560.33	4561.79	8601.47	x	6352.36	5120.55	2794.19	5995.13	x	x	8399.83	x	6619.36	5093.87	x	x	x	6938.38	916.377	x	x	x	7253.94	5416.73	1840.83	3586.32	x	6711.33	5350.13	5520.07	5091.96	8767.08	9631.81	7701.87	x	3734.04	x	6030.59	x	7647.91	x	x	6327.83	x	x	3933.5	4541.92	2036.16	5691.39	4832.39	x	8276.81	3178.4	x	6102.41	x	x	x	5674.13	7044.12	7305.42	9154.79	4217.36	x	x	x	
-12016	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males and females [n beam breaks]	x	x	x	x	295.176	296.429	x	372.167	328.667	513.6	228.429	471.048	210.346	661.379	98.5	363.238	311.542	240.167	119.167	242.636	x	x	x	259.625	x	108.4	166.467	262.182	x	155.333	356.435	608.8	231.71	x	53.9412	x	386.739	172.185	602.933	x	350.759	499.84	125.27	295.765	x	x	626.905	x	338.182	235.281	x	x	x	210.273	21.1622	x	x	x	452.759	330.45	230.194	161.417	x	329.885	265.048	366.481	335.778	699.417	700.114	487.034	x	318.235	x	341.174	x	405.316	x	x	526.686	x	x	239.267	398.308	168.719	304.64	263.414	x	585.6	206.0	x	264.16	x	x	x	596.435	297.091	227.97	506.536	318.051	x	x	x	
-12017	Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males and females [n beam breaks]	x	x	x	x	6934.65	3057.55	x	3049.08	2668.67	9034.4	3717.14	5440.9	3558.69	7171.38	2381.43	3494.9	7254.46	5387.72	4949.83	8682.23	x	x	x	6501.38	x	3804.33	3557.0	6824.86	x	6502.72	5108.96	9578.32	3764.16	x	1320.71	x	7034.26	4497.44	12875.6	x	6737.9	8270.42	3634.16	5618.88	x	x	6113.19	x	6004.12	4166.94	x	x	x	5084.45	2103.97	x	x	x	7984.59	4656.12	2695.74	5650.58	x	6433.92	2753.76	4556.59	6550.37	11179.6	7793.26	11397.8	x	3898.06	x	4800.77	x	9906.42	x	x	4490.83	x	x	4108.0	8053.65	3550.12	5826.08	5429.67	x	8109.4	1569.4	x	5929.2	x	x	x	6545.78	8128.55	5764.03	10610.7	3888.51	x	x	x	
-12018	Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males and females [cm]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males and females [cm]	x	x	x	x	20165.7	9459.62	x	9313.42	9017.3	24644.3	11341.5	16690.3	11678.3	21331.6	7800.44	10876.3	20570.1	17656.5	15140.2	24825.0	x	x	x	19546.8	x	11985.2	11360.9	20617.1	x	19898.0	15024.1	27111.8	11871.0	x	4414.05	x	21611.7	13332.0	34685.2	x	20537.3	25060.6	11420.7	17631.1	x	x	18466.6	x	18389.8	13950.1	x	x	x	16230.6	7190.1	x	x	x	23044.5	14322.9	8593.27	17093.3	x	19259.0	8950.38	14498.3	20491.2	31434.5	23257.7	31955.0	x	12452.3	x	15305.8	x	28056.7	x	x	13786.9	x	x	13671.2	23827.8	11912.2	17391.0	16441.8	x	24363.3	6040.87	x	18443.7	x	x	x	19540.4	22844.0	15984.0	30606.7	12435.2	x	x	x	
-12019	Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in the open field from 0-60 min after first cocaine injection for males and females [n beam breaks]	None	Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in the open field from 0-60 min after first cocaine injection for males and females [n beam breaks]	x	x	x	x	1200.06	824.7	x	841.875	901.667	1327.7	686.762	1172.29	909.462	1802.72	544.071	1204.29	1076.58	1450.39	958.0	1597.32	x	x	x	999.938	x	1009.67	799.6	1589.82	x	1447.44	1232.7	1422.92	958.032	x	379.824	x	1590.96	688.333	2181.83	x	1802.69	2500.08	1030.46	1334.35	x	x	2002.57	x	1551.19	1191.19	x	x	x	1105.0	452.514	x	x	x	1467.48	1482.47	1232.55	891.042	x	1207.58	902.0	1611.56	1620.0	2480.89	1648.85	1998.52	x	1387.56	x	1577.05	x	2182.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12020	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [n beam breaks]	x	x	x	x	519.471	843.905	x	924.792	361.833	930.0	247.238	871.952	312.154	927.483	226.357	420.714	1164.88	262.389	552.667	667.045	x	x	x	586.75	x	239.833	167.267	789.318	x	437.278	734.652	614.44	526.323	x	273.765	x	675.478	343.481	878.033	x	873.138	490.56	403.351	522.529	x	x	871.524	x	483.545	446.406	x	x	x	654.727	145.459	x	x	x	832.586	563.725	210.742	146.542	x	762.038	533.238	397.148	312.407	903.222	826.971	680.69	x	336.971	x	571.609	x	931.684	x	x	581.857	x	x	329.167	400.769	192.656	683.96	467.414	x	807.333	331.6	x	691.68	x	x	x	778.609	684.0	874.061	820.143	390.128	x	x	x	
-12021	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [n beam breaks]	x	x	x	x	455.471	514.333	x	877.5	457.917	988.6	565.857	951.81	342.308	721.483	234.286	408.619	866.208	405.889	565.333	648.409	x	x	x	723.062	x	191.333	274.4	853.818	x	282.833	767.565	702.96	443.129	x	103.353	x	604.957	465.37	752.6	x	566.034	408.16	301.622	619.412	x	x	775.714	x	653.136	463.812	x	x	x	773.409	67.5135	x	x	x	781.207	497.125	138.871	360.417	x	719.231	506.429	560.889	448.778	876.0	806.457	747.828	x	363.118	x	613.217	x	772.895	x	x	623.686	x	x	350.167	403.077	195.844	595.64	494.345	x	798.4	187.0	x	637.36	x	x	x	513.174	734.909	824.758	891.25	451.59	x	x	x	
-12022	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [n beam breaks]	x	x	x	x	444.529	353.19	x	576.25	560.333	965.8	521.952	827.0	247.923	552.103	165.5	492.667	610.542	265.722	445.833	596.364	x	x	x	549.5	x	121.567	268.8	704.182	x	205.611	640.217	726.68	274.0	x	18.7059	x	543.217	435.37	689.6	x	416.103	430.8	153.649	506.176	x	x	655.81	x	653.5	405.938	x	x	x	627.636	23.3784	x	x	x	582.448	425.175	95.6774	334.708	x	541.538	432.571	458.852	471.593	755.944	855.314	680.448	x	318.0	x	509.913	x	574.789	x	x	551.0	x	x	282.833	344.615	142.562	411.92	428.138	x	673.267	207.2	x	466.04	x	x	x	358.652	588.0	663.333	866.321	330.436	x	x	x	
-12023	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [n beam breaks]	x	x	x	x	302.176	245.952	x	417.5	533.083	624.4	443.667	753.048	155.423	474.379	107.214	530.619	401.625	188.333	308.0	462.955	x	x	x	362.625	x	57.7667	128.333	608.773	x	143.278	459.913	588.96	157.419	x	7.94118	x	432.435	311.889	693.333	x	302.448	346.52	83.973	370.882	x	x	532.952	x	651.864	322.938	x	x	x	372.955	7.83784	x	x	x	313.724	340.5	61.2903	275.417	x	310.423	297.619	311.889	340.037	607.056	778.943	594.241	x	205.206	x	397.043	x	422.421	x	x	452.057	x	x	242.0	294.423	90.5938	285.16	362.655	x	510.8	181.0	x	257.12	x	x	x	309.87	417.818	505.0	812.393	227.513	x	x	x	
-12024	Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [cm]	x	x	x	x	1604.64	2263.96	x	2397.44	1111.03	2551.44	744.066	2240.45	1097.41	2594.38	732.929	1267.33	2987.36	912.897	1495.97	1868.69	x	x	x	1856.65	x	759.627	607.005	2035.41	x	1467.29	2004.95	1932.51	1559.44	x	920.184	x	1959.97	1069.25	2494.35	x	2436.08	1466.93	1167.84	1574.3	x	x	2467.13	x	1329.86	1378.37	x	x	x	1947.7	532.723	x	x	x	2386.75	1650.31	732.81	578.552	x	2186.52	1614.11	1372.74	1000.71	2460.02	2432.39	2026.13	x	1053.2	x	1640.12	x	2501.5	x	x	1642.75	x	x	1129.35	1242.08	655.807	2039.39	1324.04	x	2378.11	1196.58	x	2026.82	x	x	x	2108.88	2010.43	2184.56	2258.36	1177.15	x	x	x	
-12025	Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [cm]	x	x	x	x	1464.8	1455.96	x	2329.37	1362.32	2659.84	1587.77	2465.34	1126.46	2086.12	766.231	1243.35	2273.52	1335.18	1468.66	1761.21	x	x	x	2131.44	x	601.428	970.576	2164.7	x	920.603	2078.86	2118.14	1352.39	x	352.082	x	1751.67	1324.57	2162.09	x	1719.56	1258.03	884.627	1803.84	x	x	2306.43	x	1750.4	1411.09	x	x	x	2180.94	264.405	x	x	x	2272.52	1457.95	512.442	1163.7	x	2070.57	1548.39	1726.12	1471.98	2395.28	2368.74	2096.4	x	1092.71	x	1735.71	x	2219.76	x	x	1758.62	x	x	1142.85	1250.34	633.419	1694.44	1360.88	x	2307.58	667.522	x	1898.75	x	x	x	1507.36	2099.19	2093.12	2405.42	1331.69	x	x	x	
-12026	Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [cm]	x	x	x	x	1473.72	1023.26	x	1603.85	1639.06	2620.97	1493.11	2165.79	811.881	1681.44	594.81	1445.16	1620.32	958.743	1149.73	1612.06	x	x	x	1661.01	x	379.784	898.216	1813.26	x	627.876	1807.86	2160.23	850.819	x	65.6158	x	1567.76	1234.39	1978.66	x	1266.79	1323.77	479.554	1506.93	x	x	1951.6	x	1768.04	1280.49	x	x	x	1755.75	88.7473	x	x	x	1665.61	1290.23	349.384	998.194	x	1552.95	1305.98	1422.16	1512.25	2154.57	2499.96	1899.32	x	955.938	x	1487.79	x	1662.32	x	x	1577.85	x	x	890.423	1091.7	454.826	1165.51	1174.74	x	2042.9	690.609	x	1403.18	x	x	x	1102.76	1705.44	1712.27	2308.81	991.194	x	x	x	
-12027	Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [cm]	x	x	x	x	1013.79	740.199	x	1201.9	1518.03	1722.56	1312.93	2000.94	519.572	1438.11	379.105	1556.8	1110.35	673.181	752.654	1295.82	x	x	x	1204.93	x	184.277	456.067	1616.04	x	438.436	1315.55	1767.06	490.377	x	32.7917	x	1280.93	933.586	1966.37	x	929.916	1071.82	262.167	1110.06	x	x	1674.66	x	1771.05	1023.93	x	x	x	1053.99	30.5011	x	x	x	929.062	1018.24	246.191	845.882	x	901.291	881.648	999.054	1107.03	1757.21	2330.72	1680.02	x	632.192	x	1166.96	x	1264.33	x	x	1348.61	x	x	770.885	957.794	292.111	792.039	972.736	x	1548.22	623.687	x	773.659	x	x	x	955.127	1229.06	1315.47	2182.2	717.323	x	x	x	
-12028	Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males and females [n beam breaks]	x	x	x	x	58.2353	98.0952	x	84.4583	36.4167	108.9	21.5714	68.2381	36.1923	157.448	20.5	37.9524	96.875	40.8889	37.0	59.5909	x	x	x	52.875	x	36.7	25.6667	39.9545	x	53.5	66.6956	120.04	79.7742	x	35.1176	x	57.6522	32.3333	122.0	x	94.7931	109.76	38.8108	43.3529	x	x	142.381	x	47.5455	61.375	x	x	x	53.6818	8.97297	x	x	x	141.0	82.7	60.2903	18.3333	x	94.5385	69.7619	72.7037	53.7407	124.111	118.257	104.414	x	58.8529	x	57.8696	x	80.0526	x	x	81.4857	x	x	46.6333	62.2692	35.3125	115.0	54.4138	x	113.2	37.4	x	71.8	x	x	x	154.739	67.0	55.9091	124.929	66.641	x	x	x	
-12029	Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males and females [n beam breaks]	x	x	x	x	87.0	88.8095	x	119.375	75.5833	159.5	72.381	135.0	61.5769	193.034	30.4286	92.2857	98.9167	69.8333	37.5	65.6818	x	x	x	78.875	x	33.2667	52.7333	74.8182	x	56.2778	94.1304	180.6	76.7742	x	14.1765	x	100.609	52.6296	153.567	x	103.069	122.0	45.5135	107.471	x	x	177.524	x	89.7273	70.7188	x	x	x	67.0909	7.64865	x	x	x	144.931	98.325	63.8387	47.2083	x	110.5	71.8571	104.889	87.963	196.083	165.886	129.586	x	93.6176	x	92.0435	x	116.632	x	x	142.343	x	x	75.7667	113.462	55.0625	87.64	76.5862	x	161.2	48.8	x	82.04	x	x	x	170.739	83.5455	67.2424	129.393	102.256	x	x	x	
-12030	Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males and females [n beam breaks]	x	x	x	x	88.6471	63.5714	x	90.75	104.833	148.8	70.5714	134.333	56.8077	160.241	25.2857	107.476	62.9583	78.4444	32.8333	65.3182	x	x	x	66.6875	x	24.9	59.8667	73.8182	x	27.0	102.522	165.2	47.4516	x	1.76471	x	106.13	48.7407	162.267	x	85.5517	149.4	26.5135	79.1176	x	x	167.143	x	95.7273	56.3438	x	x	x	56.2727	3.75676	x	x	x	101.897	86.45	64.9677	48.2917	x	76.3462	71.4286	105.111	103.704	210.167	206.886	125.138	x	93.7059	x	103.739	x	110.895	x	x	152.314	x	x	59.2	113.0	47.1562	57.2	70.0345	x	166.667	61.0	x	72.16	x	x	x	150.391	87.6364	55.2121	132.714	84.1026	x	x	x	
-12031	Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males and females [n beam breaks]	x	x	x	x	61.2941	45.9524	x	77.5833	111.833	96.4	63.9048	133.476	34.9231	150.655	22.2857	125.524	52.7917	51.0	11.8333	52.0455	x	x	x	61.1875	x	13.5333	28.2	73.5909	x	18.5556	93.087	142.96	27.7097	x	2.88235	x	122.348	38.4815	165.1	x	67.3448	118.68	14.4324	65.8235	x	x	139.857	x	105.182	46.8438	x	x	x	33.2273	0.783784	x	x	x	64.931	62.975	41.0968	47.5833	x	48.5	52.0	83.7778	90.3704	169.056	209.086	127.897	x	72.0588	x	87.5217	x	97.7368	x	x	150.543	x	x	57.6667	109.577	31.1875	44.8	62.3793	x	144.533	58.8	x	38.16	x	x	x	120.565	58.9091	49.6061	119.5	65.0513	x	x	x	
-12032	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	509.353	444.571	x	1105.08	513.0	682.6	377.81	955.143	440.462	569.862	377.786	478.952	913.75	510.556	776.667	533.5	x	x	x	397.75	x	422.933	380.0	1524.36	x	546.722	704.913	486.28	435.871	x	391.824	x	575.826	479.63	739.267	x	795.759	389.4	648.946	730.882	x	x	480.143	x	642.318	543.938	x	x	x	797.318	346.946	x	x	x	884.897	613.95	351.29	355.667	x	512.577	538.524	408.444	523.815	689.417	484.857	619.552	x	515.588	x	554.522	x	612.0	x	x	611.4	x	x	337.6	581.038	442.094	604.92	567.931	x	556.533	474.2	x	521.16	x	x	x	481.739	687.636	1008.76	823.429	295.667	x	x	x	
-12033	Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	353.588	302.238	x	676.542	342.0	693.8	337.905	708.571	322.231	338.31	360.5	313.095	591.333	501.444	660.5	431.227	x	x	x	300.062	x	275.0	369.067	1128.95	x	402.778	500.217	433.08	298.452	x	165.529	x	442.13	354.926	520.133	x	537.0	341.32	370.838	627.647	x	x	314.381	x	599.818	488.25	x	x	x	769.227	98.7297	x	x	x	562.207	434.9	210.323	377.625	x	394.154	429.762	412.407	476.407	553.833	427.429	630.345	x	373.588	x	353.478	x	465.526	x	x	431.629	x	x	241.367	439.385	343.688	537.6	431.103	x	544.667	185.0	x	410.76	x	x	x	309.435	484.455	703.697	821.536	233.359	x	x	x	
-12034	Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	279.118	228.905	x	461.875	291.083	629.2	308.143	618.238	228.192	255.172	226.929	300.619	431.25	366.278	412.5	389.0	x	x	x	248.0	x	155.733	283.2	871.364	x	215.278	377.348	385.24	223.097	x	44.8235	x	358.696	306.222	451.967	x	371.793	319.56	220.324	476.882	x	x	282.429	x	643.636	403.375	x	x	x	552.773	23.1622	x	x	x	439.931	356.275	122.516	225.625	x	323.692	352.571	337.926	438.259	476.194	404.171	507.793	x	291.971	x	266.087	x	339.211	x	x	359.886	x	x	199.867	364.231	227.344	395.2	337.345	x	387.8	147.6	x	274.24	x	x	x	232.913	315.364	500.939	767.357	185.487	x	x	x	
-12035	Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	199.824	191.667	x	304.542	254.333	486.4	273.857	524.095	136.5	219.345	128.571	254.857	287.167	253.889	375.667	334.727	x	x	x	191.25	x	63.1667	161.867	624.045	x	133.944	301.043	308.2	144.677	x	7.41177	x	285.435	229.481	440.433	x	242.138	279.16	117.865	346.118	x	x	236.19	x	577.364	334.281	x	x	x	339.409	14.4595	x	x	x	272.897	264.8	73.0	175.292	x	221.692	258.524	220.037	297.037	375.667	393.429	425.724	x	192.618	x	226.435	x	253.684	x	x	285.457	x	x	162.767	280.423	125.0	290.08	255.31	x	333.133	113.6	x	156.32	x	x	x	180.478	244.182	336.273	686.071	144.923	x	x	x	
-12036	Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for males and females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males and females in the cocaine test battery [cm]	x	x	x	x	1959.06	1785.84	x	3729.19	2055.88	2483.57	1522.12	3300.37	1803.1	2156.75	1655.19	1831.05	3216.08	2073.25	2902.08	2060.82	x	x	x	1770.78	x	1753.24	1796.55	4976.96	x	2250.42	2581.81	2038.22	1800.76	x	1673.69	x	2249.05	1982.28	2791.79	x	2835.64	1725.7	2540.95	2757.64	x	x	1967.56	x	2487.5	2114.29	x	x	x	2991.66	1538.69	x	x	x	3210.37	2433.45	1481.61	1629.98	x	2076.81	2094.19	1710.64	2105.31	2560.52	1991.45	2417.92	x	2064.57	x	2260.76	x	2285.95	x	x	2327.94	x	x	1533.29	2489.6	1910.05	2412.19	2226.34	x	2216.76	2006.81	x	2138.97	x	x	x	1875.69	2596.26	3396.29	3066.95	1427.19	x	x	x	
-12037	Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for males and females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for males and females in the cocaine test battery [cm]	x	x	x	x	1458.93	1232.93	x	2419.91	1451.12	2434.67	1449.86	2519.58	1395.39	1382.62	1455.52	1270.03	2209.27	2056.02	2488.1	1714.9	x	x	x	1379.11	x	1103.93	1578.26	3823.82	x	1610.44	1881.56	1789.15	1299.44	x	740.964	x	1794.18	1441.17	2113.81	x	2023.77	1540.17	1477.5	2332.89	x	x	1382.23	x	2314.66	1913.38	x	x	x	2810.81	466.594	x	x	x	2077.04	1768.96	927.119	1496.47	x	1621.92	1717.53	1682.23	1904.48	2149.46	1787.99	2296.23	x	1534.71	x	1516.26	x	1699.33	x	x	1707.86	x	x	1149.34	1966.37	1461.07	2101.93	1686.3	x	2130.97	849.094	x	1678.37	x	x	x	1274.79	1887.22	2374.65	3031.61	1174.87	x	x	x	
-12038	Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for males and females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for males and females in the cocaine test battery [cm]	x	x	x	x	1221.57	972.432	x	1690.29	1278.41	2250.93	1284.12	2244.44	1000.23	1083.27	1002.56	1226.51	1660.21	1504.41	1538.52	1540.29	x	x	x	1181.57	x	614.296	1282.68	3061.44	x	849.334	1475.27	1608.07	988.528	x	193.615	x	1535.33	1251.0	1873.34	x	1420.75	1503.34	889.467	1833.68	x	x	1256.47	x	2465.34	1651.87	x	x	x	2054.83	115.778	x	x	x	1618.28	1460.96	566.716	890.823	x	1286.65	1441.97	1400.94	1737.24	1880.05	1722.25	1825.32	x	1198.29	x	1181.33	x	1314.53	x	x	1456.52	x	x	964.756	1666.48	970.822	1492.54	1292.5	x	1648.12	716.598	x	1115.63	x	x	x	1001.93	1291.17	1761.01	2859.57	937.974	x	x	x	
-12039	Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for males and females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 45-60 min in the periphery for males and females in the cocaine test battery [cm]	x	x	x	x	901.307	822.263	x	1168.43	1077.61	1807.15	1143.52	1943.73	619.713	937.167	563.909	1038.88	1135.83	1081.12	1344.51	1292.64	x	x	x	907.735	x	259.078	742.621	2280.53	x	510.366	1185.47	1275.95	609.1	x	38.5854	x	1263.24	944.846	1842.6	x	934.038	1306.96	473.756	1366.12	x	x	1068.83	x	2232.69	1368.28	x	x	x	1287.26	66.346	x	x	x	1009.57	1068.77	339.341	708.151	x	880.196	1011.26	925.075	1203.95	1547.97	1686.35	1574.85	x	824.585	x	1030.62	x	997.729	x	x	1175.34	x	x	775.546	1317.7	538.016	1113.31	976.022	x	1398.5	638.617	x	641.659	x	x	x	816.423	996.96	1212.07	2589.32	735.719	x	x	x	
-12040	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males and females [n beam breaks]	x	x	x	x	148.294	201.667	x	245.583	204.083	213.1	126.619	281.524	142.577	205.103	144.429	165.333	232.708	211.944	299.167	213.773	x	x	x	117.75	x	186.433	145.667	244.909	x	205.778	230.217	220.92	207.613	x	169.647	x	241.957	161.667	258.5	x	265.966	285.8	222.757	202.235	x	x	249.238	x	275.591	243.25	x	x	x	249.318	111.892	x	x	x	295.552	280.2	218.677	105.208	x	204.923	225.238	185.185	253.037	278.139	241.971	222.448	x	279.118	x	228.13	x	183.842	x	x	258.771	x	x	174.333	279.192	239.062	255.72	233.897	x	246.533	163.8	x	173.84	x	x	x	286.174	176.455	199.606	338.75	196.821	x	x	x	
-12041	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males and females [n beam breaks]	x	x	x	x	169.059	184.714	x	237.417	231.583	233.9	142.571	318.19	184.731	202.414	166.857	161.524	217.875	264.444	270.167	224.818	x	x	x	129.875	x	174.5	173.4	314.182	x	217.222	224.391	243.2	177.065	x	111.529	x	277.391	184.074	293.867	x	253.379	300.68	179.865	216.059	x	x	244.238	x	326.818	227.344	x	x	x	261.409	58.4324	x	x	x	211.828	304.05	211.548	138.583	x	192.308	232.286	225.111	242.556	315.389	264.314	247.483	x	291.265	x	252.087	x	239.0	x	x	288.629	x	x	210.867	290.769	256.906	256.64	228.172	x	276.467	145.0	x	166.92	x	x	x	294.435	173.636	202.273	368.429	222.026	x	x	x	
-12042	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males and females [n beam breaks]	x	x	x	x	166.294	152.238	x	227.375	252.583	244.4	137.238	299.81	169.038	183.034	172.643	184.143	209.375	211.222	210.667	219.545	x	x	x	121.438	x	92.1667	158.867	304.773	x	169.167	206.565	236.84	148.387	x	46.8824	x	271.609	181.519	317.367	x	211.069	318.8	120.162	186.765	x	x	243.19	x	346.591	196.219	x	x	x	222.682	19.2973	x	x	x	181.897	281.375	164.032	110.875	x	163.423	216.619	225.0	217.667	294.194	261.143	236.345	x	259.382	x	248.739	x	272.263	x	x	295.943	x	x	180.367	314.077	206.062	198.84	176.276	x	267.733	117.0	x	138.6	x	x	x	274.0	161.182	176.97	360.893	202.872	x	x	x	
-12043	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males and females [n beam breaks]	x	x	x	x	156.176	133.571	x	191.458	212.5	238.0	122.333	281.524	118.923	174.759	113.571	176.857	168.208	169.5	146.0	164.273	x	x	x	97.875	x	45.0333	123.267	269.364	x	110.0	191.87	217.36	102.323	x	11.7059	x	243.304	173.074	312.067	x	172.759	306.08	69.5676	156.412	x	x	226.381	x	345.182	177.281	x	x	x	175.455	8.45946	x	x	x	139.655	266.125	116.0	103.542	x	145.5	160.429	198.259	219.815	265.111	278.086	225.241	x	224.765	x	221.0	x	255.526	x	x	275.457	x	x	176.433	261.269	131.562	165.2	158.345	x	243.333	128.4	x	111.04	x	x	x	277.261	153.636	180.061	316.571	165.821	x	x	x	
-12044	Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for males and females [%]	None	Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males and females [%]	x	x	x	x	52.0603	47.1297	x	55.8166	53.768	50.514	52.5424	54.0672	59.2209	42.1468	74.3337	50.6329	52.1083	65.1535	67.2584	50.1307	x	x	x	43.6554	x	73.1105	65.9865	65.2189	x	66.2745	51.5857	46.1274	53.6372	x	68.4217	x	52.3869	57.2184	50.8982	x	53.009	54.4764	67.5487	60.8253	x	x	40.8698	x	59.9337	58.711	x	x	x	58.044	75.2333	x	x	x	53.3812	56.7195	67.3742	64.2792	x	49.5456	55.1758	54.2357	60.4214	48.2977	43.1234	54.909	x	62.4545	x	52.6355	x	46.6265	x	x	52.9122	x	x	54.0169	63.2459	73.2354	57.0308	60.1002	x	46.9665	60.435	x	50.6993	x	x	x	47.12	51.0551	58.9073	56.1322	52.0261	x	x	x	
-12045	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [n beam breaks]	x	x	x	x	1341.88	1167.38	x	2548.04	1400.42	2492.0	1297.71	2806.05	1127.38	1382.69	1093.79	1347.52	2223.5	1632.17	2225.33	1688.45	x	x	x	1137.06	x	916.833	1194.13	4148.73	x	1298.72	1883.52	1612.8	1102.1	x	609.588	x	1662.09	1370.26	2151.8	x	1946.69	1329.44	1357.97	2181.53	x	x	1313.14	x	2463.14	1769.84	x	x	x	2458.73	483.297	x	x	x	2159.93	1669.93	757.129	1134.21	x	1452.12	1579.38	1378.81	1735.52	2095.11	1709.89	2183.41	x	1373.76	x	1400.52	x	1670.42	x	x	1688.37	x	x	941.6	1665.08	1138.12	1827.8	1591.69	x	1822.13	920.4	x	1362.48	x	x	x	1204.57	1731.64	2549.67	3098.39	859.436	x	x	x	
-12046	Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [cm]	None	Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [cm]	x	x	x	x	5540.87	4813.46	x	9007.82	5863.02	8976.33	5399.62	10008.1	4818.43	5559.82	4677.18	5366.47	8221.39	6714.8	8273.22	6608.66	x	x	x	5239.2	x	3730.54	5400.11	14142.7	x	5220.57	7124.11	6711.38	4697.83	x	2646.86	x	6841.79	5619.29	8621.54	x	7214.19	6076.17	5381.67	8290.33	x	x	5675.09	x	9500.2	7047.83	x	x	x	9144.55	2187.4	x	x	x	7915.27	6732.13	3314.79	4725.42	x	5865.58	6264.95	5718.88	6950.98	8138.01	7188.04	8114.32	x	5622.16	x	5988.95	x	6297.55	x	x	6667.66	x	x	4422.93	7440.15	4879.96	7119.97	6181.16	x	7394.35	4211.12	x	5574.62	x	x	x	4968.83	6771.6	8744.01	11547.5	4275.75	x	x	x	
-12047	Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males and females [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males and females [n beam breaks]	x	x	x	x	639.824	672.19	x	901.833	900.75	929.4	528.762	1181.05	572.654	765.31	597.5	687.857	828.167	857.111	926.0	822.409	x	x	x	466.938	x	498.133	601.2	1133.23	x	702.167	853.043	918.32	635.387	x	339.765	x	1034.26	700.333	1181.8	x	903.172	1211.36	592.351	761.471	x	x	963.048	x	1294.18	844.094	x	x	x	908.864	198.081	x	x	x	828.931	1131.75	710.258	458.208	x	706.154	834.571	833.556	933.074	1152.83	1045.51	931.517	x	1054.53	x	949.957	x	950.632	x	x	1118.8	x	x	742.0	1145.31	833.594	876.4	796.69	x	1034.07	554.2	x	590.4	x	x	x	1131.87	664.909	758.909	1384.64	787.538	x	x	x	
-12048	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [n beam breaks]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [n beam breaks]	x	x	x	x	1507.24	1144.14	x	2874.67	2031.33	5270.7	2449.38	2945.76	1611.5	2865.38	1198.29	2179.05	2334.83	1704.33	2365.67	3477.36	x	x	x	2750.38	x	673.379	1144.87	4610.59	x	1986.78	2569.35	3528.24	1633.32	x	353.0	x	2826.3	2034.26	4218.73	x	2480.34	2494.52	1295.65	2627.12	x	x	3026.86	x	2651.53	2195.06	x	x	x	3510.27	553.432	x	x	x	4617.48	2508.32	699.387	1245.96	x	2583.96	1387.48	2263.3	2615.59	4768.97	3599.6	3359.59	x	1071.5	x	1801.83	x	3084.16	x	x	2526.83	x	x	1612.73	2357.85	1101.69	2791.8	1750.9	x	4517.8	1021.2	x	2284.68	x	x	x	2439.61	2503.55	2478.18	4179.07	1831.79	x	x	x	
-12049	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [cm]	x	x	x	x	5729.39	4025.52	x	8906.26	7416.29	16055.5	8114.57	9850.75	5976.73	9572.69	4694.48	7260.5	7723.97	6496.44	7759.02	11106.1	x	x	x	9802.61	x	2638.28	4385.18	14945.5	x	6898.12	8270.5	12024.3	5753.65	x	1386.31	x	10152.4	6932.1	13941.6	x	8273.39	9145.85	4575.59	8969.28	x	x	10160.3	x	8805.59	8283.99	x	x	x	11547.2	2163.92	x	x	x	14360.5	8492.37	2688.26	4484.89	x	8694.45	4820.41	8164.94	9286.19	15337.9	12371.3	10981.1	x	3946.14	x	6484.01	x	10570.4	x	x	8423.57	x	x	6193.12	9014.09	4386.67	9344.45	5898.25	x	14989.1	3977.23	x	8143.33	x	x	x	8377.91	8277.37	7689.78	13498.8	6618.58	x	x	x	
-12050	Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males and females [n beam breaks/60 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males and females [n beam breaks/60 min]	x	x	x	x	674.412	451.238	x	934.125	1052.08	1422.7	653.048	1046.76	680.538	1222.62	438.143	1070.62	741.792	836.778	805.667	940.636	x	x	x	727.062	x	320.241	525.333	1287.27	x	811.056	857.87	1331.04	661.516	x	153.059	x	1391.09	684.0	1566.2	x	988.207	1409.8	501.649	852.529	x	x	1534.14	x	1008.53	938.0	x	x	x	937.818	171.405	x	x	x	1160.72	1440.53	737.161	344.583	x	820.385	721.905	1245.22	1189.22	1767.06	1356.63	1217.38	x	787.294	x	947.174	x	1439.21	x	x	1323.43	x	x	981.6	1333.58	780.406	949.6	702.966	x	1704.8	354.6	x	646.56	x	x	x	1639.0	697.091	654.394	1285.11	910.846	x	x	x	
-12051	Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males and females [difference in cm/1 hr test, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males and females [difference in cm/1 hr test, positive values indicate sensitization]	x	x	x	x	11116.9	3031.73	x	4042.85	2796.65	12161.4	1721.28	3570.94	6254.1	4952.51	3727.33	4904.03	7075.26	6705.93	8852.87	6988.05	x	x	x	1637.94	x	7368.25	10505.1	3603.23	x	3512.98	3521.93	8856.46	1681.81	x	595.177	x	4135.38	5246.81	7307.2	x	5991.45	1987.0	5581.7	1946.93	x	x	2092.52	x	-1303.87	5660.9	x	x	x	7190.19	3138.06	x	x	x	8226.77	2234.74	388.324	4706.79	x	1990.27	5457.57	3282.37	2436.93	6855.49	6519.79	6280.87	x	3585.19	x	4394.36	x	4278.09	x	x	2839.48	x	x	5364.28	6616.55	5906.77	10665.2	4529.09	x	2328.7	827.885	x	3148.81	x	x	x	2236.11	6526.43	4275.96	2538.92	2167.71	x	x	x	
-12052	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [n beam breaks, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [n beam breaks, positive values indicate sensitization]	x	x	x	x	11906.1	4335.7	x	4481.12	3782.0	14150.4	4342.19	7024.24	5902.31	9230.14	3730.29	5596.4	10338.5	7978.39	8104.0	11400.5	x	x	x	7194.94	x	6496.0	7277.2	8310.59	x	8132.44	6433.52	13471.6	4401.94	x	1584.12	x	8635.74	6479.15	16301.8	x	9034.55	9063.25	5676.27	6386.0	x	x	6869.95	x	5969.73	6326.97	x	x	x	7599.18	3152.59	x	x	x	11345.0	5531.38	2928.03	7566.96	x	7052.72	4899.19	5715.04	7547.44	14074.4	10778.6	14227.8	x	5391.88	x	6481.86	x	11729.6	x	x	5670.77	x	x	6201.03	11039.3	5636.78	10013.8	7309.48	x	9193.47	1950.4	x	7274.16	x	x	x	7495.48	11459.5	7310.3	11566.9	4648.74	x	x	x	
-12053	Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [cm, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [cm, positive values indicate sensitization]	x	x	x	x	31282.6	12491.4	x	13356.3	11814.0	36805.8	13062.8	20261.2	17932.5	26284.1	11527.8	16288.4	27645.3	24362.4	23993.0	31813.0	x	x	x	21184.7	x	19348.6	21866.1	24220.4	x	23410.9	18546.1	35968.2	13552.8	x	5009.16	x	25747.1	18578.9	41992.5	x	26528.7	27047.5	17002.4	19578.0	x	x	20559.2	x	18264.1	19611.0	x	x	x	23420.8	10328.2	x	x	x	31271.3	16557.7	8981.61	21800.1	x	20653.6	14407.9	17780.6	22928.1	38290.0	30446.5	38235.9	x	16037.5	x	20419.2	x	32334.7	x	x	16626.4	x	x	19035.5	30444.4	17819.0	28378.1	20970.9	x	26692.0	6868.88	x	21592.5	x	x	x	21776.5	31258.7	20260.0	32497.1	14602.9	x	x	x	
-12054	Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males and females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	None	Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males and females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]	x	x	x	x	1320.82	904.75	x	1182.54	955.333	1711.4	768.952	1155.67	1133.81	2111.24	733.0	1355.6	1444.58	1774.94	1509.83	2003.86	x	x	x	1061.25	x	1495.58	1465.8	1864.32	x	1646.06	1458.04	1500.6	1108.71	x	434.529	x	1813.22	905.63	2407.1	x	2225.83	2627.25	1322.14	1415.18	x	x	2059.86	x	1551.73	1476.38	x	x	x	1550.82	585.703	x	x	x	1985.28	1637.45	1306.58	987.083	x	1136.44	1212.71	1922.81	1721.48	2866.94	2126.52	2109.66	x	1337.24	x	2085.81	x	2380.84	x	x	1513.2	x	x	1682.63	1727.88	1405.62	1680.57	1531.3	x	1911.47	474.6	x	1278.92	x	x	x	2273.13	1342.4	1175.36	2102.22	1476.54	x	x	x	
-12055	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	593.353	452.476	x	718.25	536.75	1470.1	413.19	842.762	584.577	1052.07	382.429	461.19	1052.25	506.556	616.833	838.682	x	x	x	841.625	x	261.138	346.467	1524.05	x	624.444	611.174	857.56	570.032	x	255.765	x	777.261	486.778	1063.97	x	893.414	637.2	681.595	820.412	x	x	730.905	x	538.368	500.25	x	x	x	1016.32	337.622	x	x	x	1417.66	696.55	252.677	404.708	x	883.385	419.0	596.704	696.259	1252.17	937.114	990.379	x	401.971	x	720.043	x	1074.68	x	x	708.057	x	x	560.067	752.154	348.438	917.12	555.621	x	1227.07	373.0	x	754.76	x	x	x	817.783	866.818	997.545	1046.54	435.462	x	x	x	
-12056	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	455.353	219.286	x	726.292	451.25	1385.4	603.19	661.857	383.923	673.931	336.143	475.762	569.792	467.111	633.667	879.0	x	x	x	736.562	x	172.414	322.0	1210.95	x	547.944	650.174	777.56	435.645	x	77.8824	x	708.217	557.111	1029.27	x	602.241	574.76	293.27	701.824	x	x	726.905	x	688.0	564.719	x	x	x	1045.86	126.919	x	x	x	1247.38	648.775	182.065	323.542	x	700.538	392.0	602.111	745.148	1255.78	831.457	826.069	x	293.353	x	445.522	x	776.211	x	x	646.4	x	x	415.833	550.615	276.625	705.72	482.448	x	1218.07	307.4	x	752.24	x	x	x	588.0	684.455	588.667	1009.07	452.564	x	x	x	
-12057	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	287.647	208.667	x	744.917	553.417	1290.7	695.429	685.238	373.577	613.103	297.714	551.667	400.417	375.778	593.333	932.591	x	x	x	649.438	x	138.828	198.733	938.136	x	429.278	670.739	963.48	332.548	x	12.8824	x	705.565	470.926	1065.07	x	555.483	650.32	169.946	567.647	x	x	750.286	x	707.421	573.844	x	x	x	804.318	64.1622	x	x	x	1042.76	613.1	153.613	263.417	x	613.538	289.571	554.482	636.111	1218.22	928.257	837.828	x	215.294	x	331.783	x	654.158	x	x	578.857	x	x	348.5	496.231	267.25	587.28	405.241	x	1107.53	226.8	x	466.2	x	x	x	552.565	547.818	493.606	1032.71	474.0	x	x	x	
-12058	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	170.882	263.714	x	685.208	489.917	1124.5	737.571	755.905	269.423	526.276	182.0	690.429	312.375	354.889	521.833	827.091	x	x	x	522.75	x	101.0	277.667	937.455	x	385.111	637.261	929.64	295.097	x	6.47059	x	635.261	519.444	1060.43	x	429.207	632.24	150.838	537.235	x	x	818.762	x	717.737	556.25	x	x	x	643.773	24.7297	x	x	x	909.69	549.9	111.032	254.292	x	386.5	286.905	510.0	538.074	1042.81	902.771	705.31	x	160.882	x	304.478	x	579.105	x	x	593.514	x	x	288.333	558.846	209.375	581.68	307.586	x	965.133	114.0	x	311.48	x	x	x	481.261	404.455	398.364	1090.75	469.769	x	x	x	
-12059	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [cm]	x	x	x	x	2236.57	1524.98	x	2239.14	1998.28	4442.54	1432.9	2804.33	2126.53	3382.52	1520.31	1622.62	3383.93	1976.31	2061.55	2941.45	x	x	x	3027.01	x	993.116	1348.88	4816.58	x	2234.11	2008.53	2964.47	1980.44	x	983.836	x	2815.8	1700.36	3608.83	x	2984.27	2262.78	2366.38	2862.12	x	x	2414.51	x	1852.25	1939.66	x	x	x	3466.38	1347.36	x	x	x	4401.19	2384.11	954.867	1575.53	x	2983.4	1507.84	2217.37	2504.1	3995.1	3163.18	3276.7	x	1507.2	x	2485.24	x	3543.24	x	x	2361.44	x	x	2127.89	2779.53	1390.69	3063.02	1946.53	x	4019.18	1454.68	x	2710.54	x	x	x	2719.81	2876.47	3026.34	3400.8	1637.62	x	x	x	
-12060	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [cm]	x	x	x	x	1751.11	812.862	x	2255.34	1674.61	4196.27	2033.61	2260.62	1470.28	2273.76	1359.98	1652.22	1924.53	1809.82	2107.67	2852.83	x	x	x	2648.4	x	696.721	1237.79	3891.93	x	1955.87	2127.84	2705.23	1559.71	x	319.783	x	2525.94	1918.85	3432.42	x	2025.31	2133.62	1054.84	2452.0	x	x	2494.33	x	2261.63	2175.41	x	x	x	3428.03	493.092	x	x	x	3886.31	2204.85	710.928	1152.4	x	2393.52	1369.76	2211.74	2665.3	4004.77	2878.23	2710.03	x	1094.8	x	1587.01	x	2691.79	x	x	2173.54	x	x	1607.2	2150.62	1120.18	2357.14	1593.34	x	4016.38	1236.69	x	2642.52	x	x	x	2042.98	2193.44	1844.68	3294.33	1650.83	x	x	x	
-12061	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [cm]	x	x	x	x	1082.99	779.869	x	2298.57	1992.79	3988.21	2272.45	2273.82	1401.95	2097.75	1137.61	1801.26	1377.87	1397.4	1895.23	2855.97	x	x	x	2293.08	x	559.332	771.506	3116.64	x	1419.15	2137.37	3233.99	1186.44	x	54.8886	x	2511.4	1577.22	3472.83	x	1860.29	2417.45	623.131	1887.52	x	x	2529.96	x	2330.69	2170.91	x	x	x	2582.72	231.412	x	x	x	3245.72	2059.08	588.214	899.455	x	2044.89	1002.66	1960.23	2206.43	3932.12	3177.27	2725.67	x	761.177	x	1255.29	x	2270.35	x	x	1918.25	x	x	1336.46	1946.59	1052.5	1997.7	1360.84	x	3662.53	833.648	x	1693.41	x	x	x	1908.72	1852.35	1540.87	3302.11	1674.56	x	x	x	
-12062	Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [cm]	None	Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [cm]	x	x	x	x	658.712	907.811	x	2113.21	1750.61	3428.52	2375.61	2511.97	977.978	1818.67	676.587	2184.4	1037.63	1312.92	1694.57	2455.9	x	x	x	1834.12	x	389.112	1027.01	3120.36	x	1288.99	1996.76	3120.59	1027.05	x	27.8056	x	2299.22	1735.67	3427.55	x	1403.51	2332.01	531.238	1767.65	x	x	2721.52	x	2361.03	1998.01	x	x	x	2070.12	92.0585	x	x	x	2827.27	1844.34	434.25	857.506	x	1272.63	940.159	1775.6	1910.37	3405.91	3152.59	2268.68	x	582.955	x	1156.47	x	2064.96	x	x	1970.34	x	x	1121.58	2137.35	823.299	1926.59	997.536	x	3291.06	452.211	x	1096.85	x	x	x	1706.41	1355.11	1277.9	3501.61	1655.56	x	x	x	
-12063	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	170.941	130.238	x	220.625	197.417	347.2	103.81	212.429	168.423	299.345	115.786	203.952	216.542	219.444	196.167	230.318	x	x	x	187.25	x	99.1379	99.6667	315.455	x	207.444	164.478	270.8	208.774	x	88.0	x	305.565	136.259	306.6	x	297.897	269.76	211.919	224.471	x	x	321.667	x	183.526	232.375	x	x	x	268.955	84.9189	x	x	x	330.414	345.65	192.194	82.875	x	223.692	209.0	281.741	318.296	383.306	278.914	274.759	x	258.059	x	254.087	x	346.158	x	x	295.857	x	x	233.1	294.346	205.625	265.04	190.517	x	361.467	96.0	x	189.44	x	x	x	401.348	172.455	173.091	300.893	169.564	x	x	x	
-12064	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	218.059	108.571	x	251.792	265.833	385.2	168.381	254.19	187.0	317.138	125.786	289.381	202.25	252.444	245.667	261.773	x	x	x	215.25	x	90.931	154.333	338.364	x	246.167	240.348	342.72	191.839	x	45.1765	x	361.478	197.074	416.667	x	260.931	362.24	132.324	255.941	x	x	418.524	x	260.947	248.562	x	x	x	277.864	51.3514	x	x	x	315.103	392.675	215.613	96.3333	x	242.538	208.81	347.926	353.407	465.972	332.857	314.414	x	238.706	x	265.13	x	389.842	x	x	358.343	x	x	272.667	339.115	223.062	251.52	203.172	x	468.267	129.4	x	217.2	x	x	x	422.0	194.273	175.364	317.643	241.256	x	x	x	
-12065	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	157.706	98.9048	x	251.667	302.333	362.9	178.19	275.619	188.077	318.69	107.643	287.048	180.125	189.889	190.667	238.0	x	x	x	177.812	x	77.5172	140.267	316.045	x	184.944	226.261	373.12	139.613	x	12.1176	x	362.348	182.111	411.167	x	242.621	398.36	89.9189	191.588	x	x	398.0	x	282.263	239.688	x	x	x	225.636	23.6757	x	x	x	267.103	374.825	180.419	84.75	x	205.615	160.476	321.444	278.037	485.056	359.114	344.483	x	169.412	x	210.13	x	349.684	x	x	325.886	x	x	267.733	328.154	204.031	213.52	176.345	x	449.8	73.8	x	145.64	x	x	x	423.87	179.0	163.636	322.393	244.205	x	x	x	
-12066	Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males and females [n beam breaks/15 min]	None	Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males and females [n beam breaks/15 min]	x	x	x	x	127.706	113.524	x	210.042	286.5	327.4	202.667	304.524	137.038	287.448	88.9286	290.238	142.875	175.0	173.167	210.545	x	x	x	146.75	x	52.6552	131.067	317.409	x	172.5	226.783	344.4	121.29	x	7.76471	x	361.696	168.556	431.767	x	186.759	379.44	67.4865	180.529	x	x	395.952	x	281.789	217.375	x	x	x	165.364	11.4595	x	x	x	248.103	327.375	148.935	80.625	x	148.538	143.619	294.111	239.481	432.722	385.743	283.724	x	121.118	x	217.826	x	353.526	x	x	343.343	x	x	208.1	371.962	147.688	219.52	132.931	x	425.267	55.4	x	94.28	x	x	x	391.783	151.364	142.303	344.179	255.821	x	x	x	
-12067	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	3063.53	3124.76	x	5344.08	3313.58	6000.8	3076.43	6209.86	2185.19	4058.14	1827.14	3200.14	5266.75	2754.5	4097.17	4063.23	x	x	x	3359.0	x	1527.33	2032.93	7104.82	x	2367.72	4485.87	4245.84	2502.97	x	1013.35	x	3918.17	2926.37	5165.37	x	4104.41	3005.48	2300.57	4200.53	x	x	4149.14	x	4905.18	3408.94	x	x	x	4887.45	727.487	x	x	x	4669.9	3496.45	1263.71	2251.29	x	3785.35	3349.24	3107.59	3308.33	5237.33	4977.57	4886.62	x	2597.06	x	3492.3	x	4372.21	x	x	3896.97	x	x	2145.77	3107.96	1759.78	3804.48	3344.24	x	4611.93	1827.2	x	3414.68	x	x	x	3164.87	4156.36	5416.82	6488.5	2259.1	x	x	x	
-12068	Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [cm]	None	Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [cm]	x	x	x	x	11097.8	10296.8	x	16540.4	11493.5	18531.1	10537.5	18880.6	8373.76	13359.9	7150.25	10879.1	16213.0	10594.8	13140.3	13146.4	x	x	x	12093.2	x	5655.63	8331.99	21772.2	x	8674.8	14331.3	14689.4	8950.86	x	4017.51	x	13402.1	10181.1	17223.0	x	13566.6	11196.8	8175.85	14285.5	x	x	14074.9	x	16119.6	12141.7	x	x	x	16082.9	3103.78	x	x	x	15169.2	12148.9	5155.59	8311.75	x	12576.9	11615.1	11238.9	12042.9	16905.1	16819.8	15816.2	x	9356.16	x	12019.5	x	13945.5	x	x	12995.5	x	x	8356.43	11982.1	6916.12	12811.4	11013.6	x	15671.2	7389.51	x	11677.1	x	x	x	10642.9	13815.7	16049.4	20702.2	8493.11	x	x	x	
-12069	Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]	None	Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]	x	x	x	x	935.0	968.619	x	1274.0	1229.42	1443.0	757.19	1652.1	783.0	1426.69	696.0	1051.1	1139.71	1097.28	1045.17	1065.05	x	x	x	726.562	x	606.533	767.667	1395.41	x	857.5	1209.48	1527.12	867.097	x	393.706	x	1421.0	872.518	1784.73	x	1253.93	1711.2	717.622	1057.24	x	x	1589.95	x	1632.36	1079.38	x	x	x	1119.14	219.243	x	x	x	1281.69	1462.2	940.452	619.625	x	1036.04	1099.62	1200.04	1268.85	1852.25	1745.63	1418.55	x	1372.76	x	1291.13	x	1355.95	x	x	1645.49	x	x	981.267	1543.62	1002.31	1181.04	1060.1	x	1619.67	760.2	x	854.56	x	x	x	1728.3	962.0	986.879	1891.18	1105.59	x	x	x	
-12070	Original post publication description: Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males and females [density]	None	Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males and females [density]	x	x	x	x	x	86.25	x	75.5	x	88.625	x	x	x	69.0	96.5	x	82.5	x	x	x	x	x	x	x	x	61.0	x	x	x	71.0	90.6	x	x	x	89.0	x	x	111.6	x	x	x	108.0	76.0	98.0	x	x	83.3333	x	82.75	x	x	x	x	x	x	x	x	x	85.0	99.0	97.0	x	79.5	94.7143	72.5	128.5	92.1429	130.0	90.0	x	x	87.375	103.8	116.714	x	78.3333	x	x	95.2857	x	x	x	x	96.0	91.75	113.444	x	94.75	74.25	94.4	118.667	128.0	x	x	103.0	91.4	74.0	x	x	x	x	x	
-12071	Original post publication description: Adrenal weight (left) of males and females [mg]	None	Endocrinology, morphology: Adrenal weight (left) of males and females [mg]	x	x	x	x	1.9375	2.0375	x	2.4375	2.1125	2.08571	2.5625	2.2	2.0875	2.225	2.2375	2.9625	2.60714	1.725	2.225	2.1625	x	x	x	2.025	x	2.06875	2.9	1.875	x	2.1125	2.65	2.225	2.5	x	2.1125	x	2.3375	2.325	1.8625	x	2.11875	2.0	1.5	2.0625	x	x	2.28125	x	2.1	2.425	x	x	x	1.7	2.3	x	x	x	2.06875	1.9375	2.75	2.2125	x	2.1875	2.225	2.0125	2.3375	2.5125	1.975	1.61429	x	1.825	x	2.05	x	1.7	x	x	1.7875	x	x	2.1375	2.2375	2.15	1.7125	2.2	x	1.95	1.8375	x	2.3875	x	x	x	2.2375	2.175	2.2125	2.025	2.3625	x	x	x	
-12072	Original post publication description: Adrenal weight (right) of males and females [mg]	None	Endocrinology, morphology: Adrenal weight (right) of males and females [mg]	x	x	x	x	1.8	1.9375	x	2.2375	1.9	1.92857	2.475	2.175	2.0875	1.9	2.05	2.4625	2.05	1.6625	2.175	2.0625	x	x	x	1.9	x	2.0625	2.8875	1.8375	x	1.875	2.6625	2.1125	2.4625	x	2.0625	x	2.3375	2.3125	1.875	x	1.85625	1.9625	1.5125	1.8375	x	x	2.25	x	1.95	2.125	x	x	x	1.45	2.025	x	x	x	1.875	1.875	2.325	1.95	x	1.875	2.05	1.825	2.2375	2.325	1.825	1.45714	x	1.7	x	1.7625	x	1.65	x	x	1.575	x	x	1.9375	2.1125	2.0125	1.65	2.175	x	1.8625	1.825	x	1.9875	x	x	x	2.1125	1.9375	1.85	2.1125	2.075	x	x	x	
-12556	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width [um]	x	x	169.849	113.055	140.426	155.528	x	194.493	143.008	136.389	171.845	133.925	159.278	133.979	142.743	202.569	120.205	152.795	165.234	132.921	x	x	x	156.457	x	143.506	138.968	125.675	x	156.502	116.392	152.238	161.865	x	124.413	x	145.227	162.936	160.511	x	149.391	142.924	134.119	166.801	x	x	152.04	x	122.735	206.317	x	x	x	129.221	180.339	x	x	x	156.341	149.779	190.531	173.77	x	153.885	161.882	161.321	151.134	164.188	121.244	129.178	x	125.497	x	136.232	x	118.893	x	x	122.6	x	x	138.847	154.266	137.129	124.111	146.471	x	114.907	128.99	x	154.477	x	x	x	153.921	146.49	147.913	136.506	181.117	x	x	x	
-12073	Original post publication description: Metabolism, blood chemistry: Albuminuria concentration [ACR at ug/mg]	None	Metabolism, blood chemistry: Albuminuria concentration [ACR at ug/mg]	x	x	28.484	81.904	162.387	92.737	x	64.187	x	42.508	60.282	81.417	166.265	69.422	x	52.48	56.37	82.731	62.527	90.893	x	x	x	x	x	100.987	67.346	80.005	x	37.647	258.376	26.578	82.287	x	71.905	x	28.089	x	47.559	x	101.808	67.218	85.44	x	x	x	x	x	x	58.801	x	x	x	98.471	71.65	x	x	x	230.491	69.34	96.116	39.205	x	64.864	48.102	59.076	68.951	124.423	166.275	189.535	x	70.098	x	55.313	x	132.215	x	x	101.154	x	x	109.139	54.075	x	63.403	47.555	x	96.457	56.797	x	x	x	x	x	32.143	x	91.285	74.088	59.325	x	x	x	
-13014	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 10 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 10 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%]	x	94.7	94.0	75.0	97.9	89.0	75.65	x	97.55	101.6	87.95	75.0	94.65	75.0	75.0	75.0	75.0	75.0	88.9	86.7	x	86.7	x	x	x	x	75.0	x	x	75.0	80.4	x	75.0	x	75.0	x	75.0	92.1	75.0	x	95.6	102.8	75.0	x	x	x	x	x	x	75.0	x	x	x	75.0	75.0	x	x	x	86.05	88.25	75.0	x	x	78.45	x	87.02	x	89.46	75.0	86.59	x	75.0	75.0	97.0	x	x	x	90.42	75.0	x	x	x	89.16	x	x	80.17	x	75.0	x	x	89.82	x	x	x	88.8	98.6	99.7	x	90.52	x	75.0	75.0	
-13006	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 2 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 2 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%]	x	92.9	98.2	93.15	95.0	95.0	99.35	x	99.15	98.9	98.0	96.7	97.9	97.2	94.2	97.1	94.9	99.4	97.7	94.7	x	99.4	x	x	x	x	86.95	x	x	96.8	94.9	x	91.8	x	94.7	x	95.3	93.7	98.9	x	100.75	100.0	95.66	x	x	x	x	x	x	96.05	x	x	x	101.0	98.26	x	x	x	93.74	96.3	92.56	x	x	98.83	x	98.47	x	93.5	100.34	99.44	x	97.6	99.71	96.35	x	x	x	99.49	92.61	x	x	x	98.42	x	x	98.22	x	96.68	x	x	99.03	x	x	x	97.75	100.2	100.0	x	95.86	x	98.02	97.85	
-12401	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	887.33	871.43	897.5	902.6	923.33	808.8	756.67	1008.0	683.17	874.4	795.0	1112.33	799.83	x	1108.4	801.67	x	993.0	x	699.33	640.75	x	x	834.0	790.67	707.83	626.33	x	x	795.17	965.71	862.4	756.67	x	x	x	x	554.0	1002.0	x	759.88	750.75	919.0	1024.0	x	x	813.0	915.86	602.13	896.29	x	902.13	x	980.83	1016.67	x	x	x	912.33	695.8	726.75	x	x	1088.14	577.33	929.57	823.5	847.57	799.5	865.75	x	838.0	x	821.5	x	720.8	x	x	916.33	741.4	x	890.17	832.0	947.67	839.0	797.5	x	866.83	957.83	x	912.5	x	x	979.22	941.5	1066.67	1238.5	883.67	832.17	789.0	882.83	906.86	
-13004	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 10 [%], file: hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 10 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%]	x	82.8	100.0	3.3	100.0	60.0	50.0	x	100.0	100.0	100.0	0.0	100.0	0.0	0.0	0.0	0.0	20.0	100.0	100.0	x	88.8	x	x	x	x	0.0	x	x	0.0	57.1	x	0.0	x	0.0	x	0.0	100.0	25.0	x	100.0	100.0	0.0	x	x	x	x	x	x	0.0	x	x	x	20.0	20.0	x	x	x	80.0	80.0	20.0	x	x	50.0	x	80.0	x	80.0	0.0	80.0	x	20.0	0.0	100.0	x	x	x	100.0	0.0	x	x	x	80.0	x	x	100.0	x	0.0	x	x	80.0	x	x	x	100.0	100.0	100.0	x	100.0	x	40.0	0.0	
-13002	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 8 [%], file: hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 8 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%]	x	82.8	100.0	5.0	100.0	60.0	50.0	x	100.0	100.0	100.0	0.0	100.0	20.0	0.0	20.0	0.0	80.0	100.0	100.0	x	88.8	x	x	x	x	0.0	x	x	14.0	71.4	x	0.0	x	0.0	x	0.0	100.0	33.3	x	100.0	100.0	0.0	x	x	x	x	x	x	0.0	x	x	x	100.0	20.0	x	x	x	80.0	80.0	20.0	x	x	75.0	x	80.0	x	80.0	0.0	80.0	x	20.0	0.0	100.0	x	x	x	100.0	0.0	x	x	x	80.0	x	x	100.0	x	0.0	x	x	100.0	x	x	x	100.0	100.0	100.0	x	100.0	x	40.0	0.0	
-13003	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 9 [%], file: hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 9 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%]	x	82.8	100.0	3.3	100.0	60.0	50.0	x	100.0	100.0	100.0	0.0	100.0	0.0	0.0	0.0	0.0	60.0	100.0	100.0	x	88.8	x	x	x	x	0.0	x	x	0.0	57.1	x	0.0	x	0.0	x	0.0	100.0	25.0	x	100.0	100.0	0.0	x	x	x	x	x	x	0.0	x	x	x	20.0	20.0	x	x	x	80.0	80.0	20.0	x	x	62.5	x	80.0	x	80.0	0.0	80.0	x	20.0	0.0	100.0	x	x	x	100.0	0.0	x	x	x	80.0	x	x	100.0	x	0.0	x	x	80.0	x	x	x	100.0	100.0	100.0	x	100.0	x	40.0	0.0	
-13001	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 7 [%], file: hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 7 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%]	x	86.2	100.0	8.3	100.0	60.0	75.0	x	100.0	100.0	100.0	0.0	100.0	100.0	0.0	60.0	0.0	100.0	100.0	100.0	x	100.0	x	x	x	x	0.0	x	x	85.7	100.0	x	0.0	x	0.0	x	0.0	100.0	50.0	x	100.0	100.0	20.0	x	x	x	x	x	x	16.6	x	x	x	100.0	20.0	x	x	x	100.0	100.0	20.0	x	x	100.0	x	100.0	x	100.0	0.0	100.0	x	40.0	80.0	100.0	x	x	x	100.0	0.0	x	x	x	100.0	x	x	100.0	x	0.0	x	x	100.0	x	x	x	100.0	100.0	100.0	x	100.0	x	60.0	0.0	
-13005	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 1 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 1 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%]	x	96.1	98.5	97.5	97.6	94.7	99.55	x	98.8	99.2	99.35	98.9	98.7	100.1	98.5	98.8	99.5	101.3	99.2	94.85	x	96.6	x	x	x	x	92.35	x	x	98.6	95.3	x	96.6	x	97.0	x	99.5	96.4	99.35	x	97.1	101.0	98.03	x	x	x	x	x	x	98.65	x	x	x	102.1	97.63	x	x	x	96.78	95.8	96.85	x	x	98.43	x	98.83	x	97.08	99.22	99.16	x	98.5	99.07	98.75	x	x	x	99.09	96.28	x	x	x	97.42	x	x	99.37	x	97.28	x	x	99.08	x	x	x	98.7	99.4	103.9	x	97.93	x	98.22	98.41	
-13016	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 12 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 12 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%]	x	96.2	96.1	75.0	97.8	91.3	77.5	x	99.0	102.2	91.4	75.0	96.15	75.0	75.0	75.0	75.0	75.0	91.6	92.9	x	91.8	x	x	x	x	75.0	x	x	75.0	87.4	x	75.0	x	75.0	x	75.0	92.85	75.0	x	96.85	104.1	75.0	x	x	x	x	x	x	75.0	x	x	x	75.0	75.0	x	x	x	88.98	92.75	75.0	x	x	81.02	x	91.35	x	93.67	75.0	93.9	x	75.0	75.0	102.06	x	x	x	97.12	75.0	x	x	x	95.25	x	x	87.05	x	75.0	x	x	93.36	x	x	x	92.45	99.6	99.45	x	95.91	x	75.0	75.0	
-13017	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 13 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 13 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%]	x	98.2	98.0	75.0	100.8	86.7	78.95	x	99.2	101.1	92.65	75.0	97.65	75.0	75.0	75.0	75.0	75.0	94.8	95.6	x	95.0	x	x	x	x	75.0	x	x	75.0	89.6	x	75.0	x	75.0	x	75.0	95.4	75.0	x	94.45	105.1	75.0	x	x	x	x	x	x	75.0	x	x	x	75.0	75.0	x	x	x	90.58	94.6	75.0	x	x	84.05	x	95.35	x	95.73	75.0	95.99	x	75.0	75.0	99.68	x	x	x	97.9	75.0	x	x	x	97.77	x	x	92.14	x	75.0	x	x	95.69	x	x	x	95.25	101.3	101.1	x	96.17	x	75.0	75.0	
-12402	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	0.502	0.47	0.465	0.554	0.367	0.494	0.619	0.493	0.788	0.468	0.548	0.367	0.608	x	0.429	0.465	x	0.508	x	0.774	0.696	x	x	0.556	0.436	0.78	0.797	x	x	0.545	0.41	0.522	0.64	x	x	x	x	0.878	0.49	x	0.458	0.544	0.428	0.423	x	x	0.451	0.499	0.487	0.443	x	0.422	x	0.396	0.453	x	x	x	0.372	0.589	0.587	x	x	0.387	0.759	0.504	0.541	0.458	0.495	0.487	x	0.63	x	0.384	x	0.538	x	x	0.525	0.557	x	0.518	0.446	0.468	0.53	0.508	x	0.545	0.371	x	0.477	x	x	0.387	0.434	0.395	0.38	0.424	0.526	0.498	0.429	0.515	
-12996	Infectious disease, immune function: H1N1 (Pr8) influenza A virus (2x10E3 FFU), mean time to death after infection in 9-14 week-old females [days], file mm2_mean_time_death_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, MTTD [days], file hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, MTTD [days], file hko_180311	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), mean time to death after infection in 9-14 week-old females [days]	x	11.07	12.0	6.47	12.0	10.0	9.75	x	12.0	12.0	12.0	7.0	12.0	8.2	7.0	7.8	6.4	9.8	11.8	12.0	x	11.56	x	x	x	x	5.75	x	x	8.0	10.43	x	6.67	x	6.8	x	6.8	12.0	8.33	x	12.0	12.0	7.2	x	x	x	x	x	x	6.5	x	x	x	9.6	8.0	x	x	x	11.2	11.33	7.2	x	x	10.38	x	11.2	x	11.2	6.6	11.2	x	8.2	7.8	12.0	x	x	x	12.0	6.5	x	x	x	11.2	x	x	12.0	x	6.75	x	x	11.4	x	x	x	12.0	12.0	12.0	x	12.0	x	9.2	6.4	
-12995	Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction]	None	Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction]	x	0.5	1.0	0.6	x	x	0.0	x	x	0.0	0.0	1.0	0.0	x	x	x	x	x	x	x	x	x	x	0.0	x	0.0	x	x	x	0.0	0.5	x	1.0	x	x	x	0.0	x	0.0	x	0.0	0.0	0.0	1.0	x	x	0.0	1.0	0.0	0.5	x	x	x	1.0	0.5	x	x	x	1.0	x	1.0	x	x	x	0.0	1.0	0.53	x	1.0	x	x	0.0	0.25	0.0	x	0.0	x	x	0.0	x	x	x	0.0	1.0	0.0	x	x	x	0.9	x	x	x	x	0.8	0.31	x	x	0.0	x	x	0.92	0.0	
-12398	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	17.483	21.869	18.517	19.557	37.478	14.05	7.061	9.26	14.594	26.38	15.017	19.931	4.378	x	8.22	25.789	x	14.414	x	5.256	8.433	x	x	20.35	25.172	22.017	8.839	x	x	14.072	25.526	15.71	41.136	x	x	x	x	2.7	24.944	x	35.919	26.562	25.906	16.175	x	x	26.739	17.121	43.206	25.974	x	23.252	x	28.217	19.781	x	x	x	32.208	21.14	21.585	x	x	23.045	21.95	9.407	32.106	28.662	26.575	32.163	x	14.229	x	35.719	x	27.957	x	x	13.686	25.07	x	18.222	24.252	18.861	15.756	23.75	x	29.786	32.703	x	24.625	x	x	26.424	21.336	17.058	9.369	36.608	18.514	19.85	26.397	13.033	
-12400	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	375.33	393.71	379.5	424.4	409.33	327.4	314.67	434.0	297.67	402.8	314.0	452.33	316.83	x	462.8	340.67	x	475.67	x	285.33	239.0	x	x	386.0	308.0	330.83	248.0	x	x	326.33	434.43	383.4	360.5	x	x	x	x	209.0	523.67	x	323.88	314.25	383.67	441.25	x	x	353.0	411.0	245.75	412.29	x	348.63	x	447.17	474.83	x	x	x	366.67	319.4	318.75	x	x	498.71	294.5	371.14	400.5	371.29	367.67	432.5	x	368.57	x	337.17	x	310.4	x	x	439.17	330.2	x	425.0	335.86	411.5	348.67	332.67	x	397.0	438.83	x	446.33	x	x	416.67	415.5	438.33	508.17	413.83	382.0	271.0	369.67	375.43	
-12968	Original post publication description: Infectious disease, immunology: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]	None	Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]	x	x	0.13	1.0	x	x	1.0	x	x	1.0	1.0	x	0.33	x	x	1.0	x	0.0	x	x	x	x	x	1.0	x	1.0	x	x	x	1.0	1.0	x	x	x	1.0	x	1.0	x	1.0	x	x	1.0	x	x	x	x	0.78	0.0	x	x	x	0.333	x	0.0	1.0	x	x	x	1.0	1.0	0.67	1.0	x	0.86	1.0	0.0	0.56	0.25	1.0	x	x	1.0	0.6	1.0	x	1.0	x	1.0	x	x	x	1.0	1.0	0.75	1.0	1.0	1.0	1.0	0.38	1.0	x	x	x	0.0	0.5	1.0	x	1.0	1.0	0.5	0.0	1.0	
-12966	Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 2 of Ethanol exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. CIE_T2_Etgkgave.	None	Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 2 of ethanol exposure in vapor chamber, average of 5 days ethanol intake [g/kg/2h]	2.109	x	3.184	1.498	x	x	2.763	x	x	x	x	1.8	x	1.296	x	1.053	x	1.847	x	x	x	x	x	x	x	x	x	x	x	x	1.439	x	1.617	x	x	x	x	1.268	x	x	x	1.494	x	0.986	x	x	x	1.891	2.724	2.106	x	x	x	3.106	x	x	x	x	x	x	4.338	x	1.595	x	1.275	x	x	4.065	x	1.61	x	1.925	1.764	1.525	x	1.077	x	x	2.098	5.449	x	2.022	1.572	1.394	x	x	x	2.188	x	x	x	x	x	x	x	x	x	2.3	1.064	2.674	2.043	1.202	
-12965	Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 1 of Ethanol exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. CIE_T1_Etgkgave.	None	Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after first cycle of exposure, intake over 5 days [g/kg/2h]	0.777	x	2.973	1.07	x	x	1.712	x	x	x	x	2.24	x	0.787	x	0.482	x	1.642	x	x	x	x	x	x	x	x	x	x	x	x	1.257	x	2.151	x	1.157	x	x	0.749	x	x	x	0.978	x	1.068	x	x	x	1.305	1.238	2.471	x	x	x	3.022	x	x	x	x	x	x	3.957	x	1.136	x	1.541	x	x	3.748	x	1.768	x	1.165	1.35	1.709	x	0.991	x	x	1.751	5.878	x	1.748	0.994	1.4	x	x	x	1.073	x	x	x	x	x	x	x	x	x	2.434	0.817	1.114	1.232	1.151	
-12962	Original post publication description: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h]	Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h]	Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h]	3.644	x	2.744	1.797	x	x	1.597	x	x	x	x	1.918	x	1.507	x	2.311	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.456	x	2.6	x	x	x	x	1.043	x	x	x	1.448	x	1.513	x	x	x	2.357	3.516	1.604	x	x	x	4.875	x	x	x	x	x	x	3.759	x	1.586	x	1.259	x	x	x	x	2.38	x	2.463	1.06	2.381	x	1.284	x	x	2.507	4.477	x	1.942	x	2.689	x	x	x	1.439	x	x	x	x	x	x	x	x	x	x	1.263	3.098	1.029	1.423	
-12963	Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 2 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T2_Etgkgave.	Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 h access after the second cycle of air exposure (control for CIE) in vapor chamber (average of 5 days ethanol intake, young adult males or females [g/kg/2h]	Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 h access after the second cycle of air exposure (control for CIE) in vapor chamber (average of 5 days ethanol intake, young adult males or females [g/kg/2h]	2.631	x	2.898	1.957	x	x	1.13	x	x	x	x	2.479	x	1.184	x	1.812	x	2.073	x	x	x	x	x	x	x	x	x	x	x	x	1.719	x	1.424	x	x	x	x	1.614	x	x	x	1.362	x	1.131	x	x	x	3.108	3.695	1.59	x	x	x	4.91	x	x	x	x	x	x	3.48	x	0.595	x	1.499	x	x	2.463	x	1.262	x	2.925	2.188	2.657	x	1.962	x	x	1.134	4.225	x	1.316	2.59	2.191	x	x	x	1.51	x	x	x	x	x	x	x	x	x	1.932	1.56	2.374	1.424	1.775	
-12961	Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 4 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T4_Etgkgave.	None	Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2h access after cycle 4 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake [g/kg/2h]	3.916	x	3.011	1.933	x	x	1.007	x	x	x	x	1.884	x	1.702	x	2.653	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.521	x	x	x	x	1.439	x	x	x	1.633	x	1.526	x	x	x	3.646	3.9	x	x	x	x	4.19	x	x	x	x	x	x	3.207	x	x	x	1.78	x	x	x	x	0.982	x	x	1.653	3.052	x	1.681	x	x	1.476	6.114	x	1.424	x	2.281	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.162	2.998	1.021	2.221	
-13011	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 7 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 7 [%], file hko_180311_vII	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%]	x	81.4	82.5	75.0	85.0	83.0	83.2	x	87.9	99.4	85.3	75.0	93.55	75.0	75.0	77.1	75.0	77.9	85.0	79.4	x	84.5	x	x	x	x	75.0	x	x	75.0	79.2	x	75.0	x	75.0	x	75.0	85.7	75.3	x	84.85	95.3	75.0	x	x	x	x	x	x	75.0	x	x	x	79.2	75.0	x	x	x	79.51	82.7	75.0	x	x	81.1	x	82.08	x	80.72	75.0	79.42	x	75.0	75.11	83.57	x	x	x	86.36	75.0	x	x	x	81.95	x	x	81.76	x	75.0	x	x	84.48	x	x	x	81.6	97.45	91.1	x	77.79	x	75.98	75.0	
-12959	Original post publication description: Metabolism: Water intake of 13-week old males [ml/mouse/unit time]	None	Central nervous system, metabolism, behavior: Water intake of 13-week old males [ml/mouse/unit time]	x	x	2.558	x	x	x	x	2.473	2.246	x	x	x	x	x	x	1.113	2.727	x	2.708	x	x	x	x	x	x	x	2.744	x	x	3.091	x	x	x	x	x	x	x	x	x	x	x	x	2.997	3.096	x	x	1.582	x	x	x	x	x	x	x	2.038	x	x	x	x	2.008	x	x	x	1.831	1.336	x	3.01	2.765	x	1.994	x	1.702	x	2.499	x	x	x	x	x	x	x	x	1.492	x	2.544	x	x	1.797	x	x	1.878	x	x	2.166	2.301	x	2.93	x	1.293	1.793	x	1.131	
-12957	Original post publication description: Morphology, metabolism: White adipose tissue mass of 20-week old males [g]	None	Morphology, metabolism: White adipose tissue mass of 20-week old males [g]	x	x	0.575	x	0.351	x	x	0.299	0.465	x	0.406	x	x	x	x	1.005	0.473	x	0.28	x	x	x	x	x	x	x	1.66	x	x	0.515	x	x	0.879	x	x	x	x	x	x	x	0.223	0.651	0.92	x	x	x	1.347	x	x	x	x	x	x	0.281	0.346	x	x	x	x	0.345	0.557	x	x	0.217	0.502	x	0.683	0.939	x	0.532	x	0.3	x	0.265	x	x	x	x	0.479	0.564	x	0.468	0.265	x	0.931	0.645	x	0.758	0.572	x	x	x	x	0.501	0.525	1.35	0.477	x	0.372	0.484	x	0.416	
-12955	Original post publication description: Metabolism: Volume of CO2 production of 13-week old males [ml/kg/h]	None	Respiratory system, metabolism: Volume of CO2 production of 13-week old males [ml/kg/h]	x	x	857.315	x	x	x	x	930.783	1035.96	x	x	x	x	x	x	821.693	1053.11	x	881.893	x	x	x	x	x	x	x	838.238	x	x	770.988	x	x	x	x	x	x	x	x	x	x	x	x	769.857	912.714	x	x	763.357	x	x	x	x	x	x	x	826.75	x	x	x	x	866.575	x	x	x	674.571	765.119	x	973.256	802.648	x	845.286	x	775.5	x	947.25	x	x	x	x	x	x	x	x	590.143	x	909.5	x	x	737.661	x	x	800.071	x	x	738.964	592.286	x	741.905	x	624.286	751.5	x	612.071	
-12953	Original post publication description: Blood chemistry: Blood proteins (total) of 14-week old males [g/l]	None	Blood chemistry: Blood proteins (total) of 14-week old males [g/l]	x	x	46.76	x	43.667	x	x	43.25	41.5	x	45.667	x	x	x	x	43.0	46.0	x	45.25	x	x	x	x	x	x	x	47.333	x	x	45.75	x	x	50.0	x	x	x	x	x	x	x	51.75	48.0	50.0	52.5	x	x	47.5	x	x	x	x	x	x	54.5	48.5	x	x	x	x	x	45.667	x	x	52.5	x	x	x	x	x	49.0	x	x	x	48.0	x	x	x	x	52.0	53.0	x	54.0	51.0	x	x	48.0	x	52.0	54.0	x	50.0	x	x	52.75	50.5	49.0	52.333	x	x	51.0	x	48.5	
-12949	Original post publication description: Metabolism: Body temperature (rectal) of 13-week old males [deg C]	None	Metabolism: Body temperature (rectal) of 13-week old males [deg C]	x	x	37.392	x	38.225	x	x	38.075	37.275	x	36.233	x	x	x	x	36.375	38.05	x	38.15	x	x	x	x	x	x	x	37.033	x	x	37.925	x	x	35.8	x	x	x	x	x	x	x	37.225	36.1	37.971	37.4	x	x	37.75	x	x	x	x	x	x	37.65	38.3	x	x	x	x	36.5	36.675	x	x	36.45	36.25	x	37.163	37.283	x	37.85	x	37.05	x	36.45	x	x	x	x	37.125	36.35	x	37.0	36.45	x	36.76	37.2	x	36.7	36.0	x	37.5	x	x	38.875	38.15	38.175	38.567	x	37.35	36.0	x	36.4	
-12950	Original post publication description: Cardiovascular system: Septum thickness by echocardiography of 17-week old males [mm]	None	Cardiovascular system: Septum thickness by echocardiography of 17-week old males [mm]	x	x	0.632	x	0.675	x	x	x	x	x	0.677	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.647	x	x	x	x	x	0.675	x	x	x	x	x	x	x	0.67	0.64	0.545	x	x	x	0.62	x	x	x	x	x	x	0.65	0.595	x	x	x	x	0.63	0.687	x	x	0.63	0.59	x	0.633	0.54	x	0.7	x	0.61	x	0.6	x	x	x	x	0.609	0.6	x	0.615	0.69	x	0.662	0.657	x	0.623	0.54	x	0.685	x	x	0.653	0.625	0.675	0.635	x	0.595	0.745	x	0.735	
-12951	Original post publication description: Blood chemistry, metabolism: Cholesterol (total) in serum of 14-week old males [mM]	None	Blood chemistry, metabolism: Cholesterol (total) in serum of 14-week old males [mM]	x	x	2.452	x	3.305	x	x	2.095	1.908	x	2.343	x	x	x	x	2.293	2.083	x	2.508	x	x	x	x	x	x	x	2.72	x	x	3.158	x	x	2.073	x	x	x	x	x	x	x	2.815	1.91	2.467	2.675	x	x	3.115	x	x	x	x	x	x	2.805	2.498	x	x	x	x	2.45	3.59	x	x	3.075	2.505	x	2.745	2.53	x	2.385	x	2.24	x	2.505	x	x	x	x	2.788	3.305	x	2.88	2.29	x	2.75	2.843	x	2.23	3.41	x	2.245	x	x	2.345	2.43	3.973	2.053	x	2.695	2.7	x	2.26	
-12947	Original post publication description: Blood chemistry, cardiovascular system: Red blood cell count of 14-week old males [x10^6/ul]	None	Blood chemistry, cardiovascular system: Red blood cell count of 14-week old males [x10^6/ul]	x	x	9.086	x	9.71	x	x	8.935	8.233	x	9.34	x	x	x	x	9.268	11.16	x	10.468	x	x	x	x	x	x	x	10.03	x	x	7.938	x	x	9.715	x	x	x	x	x	x	x	11.178	9.7	9.457	8.955	x	x	10.153	x	x	x	x	x	x	9.035	9.873	x	x	x	x	11.13	9.975	x	x	9.1	12.095	x	10.47	10.015	x	8.44	x	9.405	x	9.96	x	x	x	x	8.84	9.89	x	9.15	10.75	x	9.965	9.05	x	9.803	9.03	x	11.58	x	x	9.385	10.33	10.525	8.59	x	9.91	10.275	x	10.78	
-12945	Original post publication description: Blood chemistry, cardiovascular system: Platelet count of 14-week old males [x10^3/ul]	None	Blood chemistry, cardiovascular system: Platelet count of 14-week old males [x10^3/ul]	x	x	1093.92	x	1001.75	x	x	1161.75	1409.25	x	1255.0	x	x	x	x	1685.75	1107.0	x	1120.0	x	x	x	x	x	x	x	762.333	x	x	1536.25	x	x	1060.25	x	x	x	x	x	x	x	1182.75	1076.0	1049.0	1268.0	x	x	922.0	x	x	x	x	x	x	1089.5	800.25	x	x	x	x	2261.0	938.5	x	x	1302.5	1313.0	x	836.75	1280.5	x	620.5	x	1359.5	x	1276.0	x	x	x	x	1514.67	1055.5	x	1276.0	1309.0	x	1172.0	1294.25	x	1202.25	1497.0	x	906.0	x	x	970.0	916.5	1316.5	892.5	x	1473.0	1157.0	x	1207.0	
-12942	Original post publication description: Blood chemistry, cardiovascular system: Mean cell volume of 14-week old males [fl]	None	Blood chemistry, cardiovascular system: Mean cell volume of 14-week old males [fl]	x	x	46.436	x	43.25	x	x	45.0	45.325	x	43.6	x	x	x	x	45.95	47.3	x	42.225	x	x	x	x	x	x	x	46.267	x	x	43.85	x	x	47.325	x	x	x	x	x	x	x	44.775	44.7	45.833	46.25	x	x	42.225	x	x	x	x	x	x	50.5	50.25	x	x	x	x	48.6	47.775	x	x	41.75	47.7	x	46.125	45.15	x	46.75	x	43.95	x	42.95	x	x	x	x	45.833	47.3	x	46.25	47.25	x	49.0	49.3	x	47.825	44.2	x	45.25	x	x	46.475	44.55	40.425	44.6	x	45.0	44.05	x	45.1	
-12943	Original post publication description: Blood chemistry: Sodium of 14-week old males [mM]	None	Blood chemistry: Sodium of 14-week old males [mM]	x	x	147.84	x	146.25	x	x	148.0	143.5	x	147.0	x	x	x	x	144.25	148.5	x	149.0	x	x	x	x	x	x	x	148.0	x	x	149.5	x	x	149.0	x	x	x	x	x	x	x	159.75	149.0	148.667	150.0	x	x	146.75	x	x	x	x	x	x	148.0	149.0	x	x	x	x	x	145.75	x	x	149.0	x	x	x	x	x	149.5	x	x	x	151.0	x	x	x	x	149.25	149.5	x	150.0	150.5	x	x	164.0	x	151.5	150.0	x	151.0	x	x	150.75	151.5	145.25	149.333	x	x	147.5	x	147.5	
-12940	Original post publication description: Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old males [pg]	None	Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old males [pg]	x	x	15.908	x	14.675	x	x	15.7	15.375	x	14.467	x	x	x	x	15.15	15.575	x	14.6	x	x	x	x	x	x	x	14.967	x	x	15.075	x	x	15.2	x	x	x	x	x	x	x	14.175	15.3	15.367	15.55	x	x	14.25	x	x	x	x	x	x	16.4	16.45	x	x	x	x	13.15	15.825	x	x	13.75	13.45	x	15.05	14.9	x	16.5	x	14.45	x	14.2	x	x	x	x	15.667	15.2	x	14.85	15.2	x	15.2	15.825	x	15.2	15.0	x	15.25	x	x	15.925	15.5	13.65	15.833	x	14.2	15.15	x	15.2	
-12941	Original post publication description: Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old males [g/dl]	None	Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old males [g/dl]	x	x	34.264	x	33.875	x	x	34.95	33.825	x	33.133	x	x	x	x	33.0	32.9	x	34.6	x	x	x	x	x	x	x	32.4	x	x	34.4	x	x	32.125	x	x	x	x	x	x	x	31.65	34.2	33.567	33.6	x	x	33.75	x	x	x	x	x	x	32.45	32.75	x	x	x	x	27.1	33.1	x	x	32.9	28.15	x	32.65	33.0	x	35.25	x	32.85	x	33.05	x	x	x	x	34.233	32.1	x	32.05	32.15	x	31.0	32.075	x	31.775	33.9	x	33.7	x	x	34.275	34.85	33.725	35.533	x	31.6	34.4	x	33.8	
-12938	Original post publication description: Cardiovascular system: Left ventricular mass by echocardiography of 17-week old males [mg]	None	Cardiovascular system: Left ventricular mass by echocardiography of 17-week old males [mg]	x	x	95.216	x	109.589	x	x	x	x	x	104.059	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	103.493	x	x	x	x	x	119.427	x	x	x	x	x	x	x	113.22	77.383	61.001	x	x	x	87.447	x	x	x	x	x	x	95.942	79.864	x	x	x	x	86.189	100.651	x	x	74.4	78.427	x	95.923	74.537	x	87.695	x	89.501	x	77.035	x	x	x	x	79.604	96.555	x	100.319	106.12	x	99.262	107.419	x	84.131	61.087	x	128.117	x	x	83.63	88.5	101.563	85.317	x	84.337	136.689	x	127.784	
-12939	Original post publication description: Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old males [ratio]	None	Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old males [ratio]	x	x	3.457	x	3.519	x	x	x	x	x	4.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.353	x	x	x	x	x	3.937	x	x	x	x	x	x	x	4.456	2.954	2.432	x	x	x	3.097	x	x	x	x	x	x	3.611	3.083	x	x	x	x	3.511	3.767	x	x	3.256	3.234	x	3.49	3.106	x	2.999	x	3.436	x	3.366	x	x	x	x	3.334	3.627	x	3.477	4.405	x	3.511	4.488	x	3.301	2.368	x	3.534	x	x	3.1	2.809	3.2	3.285	x	3.095	5.33	x	4.928	
-12936	Original post publication description: Morphology, metabolism: Body lean mass percentage of 19-week old males [%]	None	Morphology, metabolism: Body lean mass percentage of 19-week old males [%]	x	x	77.628	x	78.055	x	x	75.748	75.438	x	76.53	x	x	x	x	68.848	75.793	x	79.023	x	x	x	x	x	x	x	71.38	x	x	75.228	x	x	72.915	x	x	x	x	x	x	x	78.578	70.44	76.345	x	x	x	76.29	x	x	x	x	x	x	76.37	84.668	x	x	x	x	84.835	75.023	x	x	85.1	77.645	x	81.165	80.435	x	82.035	x	87.05	x	86.255	x	x	x	x	72.923	70.05	x	75.76	86.835	x	82.115	73.977	x	82.265	72.67	x	73.825	x	x	81.63	83.8	67.258	82.83	x	86.055	83.6	x	84.69	
-12937	Original post publication description: Morphology, gastrointestinal system: Liver mass of 20-week old males [g]	None	Liver, morphology, gastrointestinal system: Liver mass of 20-week old males [g]	x	x	1.212	x	1.722	x	x	1.066	1.384	x	1.266	x	x	x	x	1.745	1.238	x	1.414	x	x	x	x	x	x	x	0.658	x	x	1.519	x	x	1.531	x	x	x	x	x	x	x	1.546	1.416	1.32	x	x	x	0.354	x	x	x	x	x	x	1.528	1.488	x	x	x	x	1.383	1.476	x	x	1.501	1.247	x	1.574	1.33	x	1.409	x	1.414	x	1.389	x	x	x	x	1.289	1.249	x	1.397	1.458	x	1.484	1.269	x	1.323	1.368	x	x	x	x	1.384	1.568	1.813	1.398	x	1.655	1.37	x	1.209	
-12934	Original post publication description: Blood chemistry: Potassium of 14-week old males [mM]	None	Blood chemistry: Potassium of 14-week old males [mM]	x	x	4.368	x	5.135	x	x	5.32	4.865	x	3.983	x	x	x	x	4.605	5.31	x	4.87	x	x	x	x	x	x	x	5.047	x	x	4.528	x	x	4.848	x	x	x	x	x	x	x	4.723	4.83	4.657	4.625	x	x	4.738	x	x	x	x	x	x	4.74	4.14	x	x	x	x	x	4.745	x	x	4.54	x	x	x	x	x	4.485	x	x	x	5.27	x	x	x	x	4.725	4.8	x	3.935	4.63	x	x	4.878	x	4.775	4.78	x	5.365	x	x	3.808	4.235	4.675	4.543	x	x	3.95	x	4.325	
-12935	Original post publication description: Morphology, metabolism: Body lean mass of 19-week old males [g]	None	Morphology, metabolism: Body lean mass of 19-week old males [g]	x	x	21.762	x	24.998	x	x	20.15	20.987	x	20.786	x	x	x	x	23.953	21.279	x	24.001	x	x	x	x	x	x	x	24.286	x	x	22.809	x	x	23.757	x	x	x	x	x	x	x	21.491	19.512	20.97	x	x	x	22.429	x	x	x	x	x	x	22.719	22.627	x	x	x	x	21.435	20.985	x	x	19.351	19.574	x	23.198	21.445	x	22.235	x	22.448	x	19.992	x	x	x	x	20.337	17.089	x	19.894	20.924	x	22.526	19.283	x	20.219	19.694	x	27.614	x	x	21.345	25.418	22.455	21.791	x	24.473	21.066	x	21.267	
-12932	Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin of 14-week old males [g/dl]	None	Blood chemistry, cardiovascular system: Hemoglobin of 14-week old males [g/dl]	x	x	14.448	x	14.25	x	x	14.05	12.625	x	13.5	x	x	x	x	14.05	17.375	x	15.3	x	x	x	x	x	x	x	15.033	x	x	11.975	x	x	14.775	x	x	x	x	x	x	x	15.85	14.8	14.5	13.9	x	x	14.45	x	x	x	x	x	x	14.85	16.225	x	x	x	x	14.45	15.75	x	x	12.5	16.2	x	15.8	14.9	x	13.9	x	13.6	x	14.15	x	x	x	x	13.833	15.05	x	13.6	16.3	x	15.1	14.325	x	14.875	13.5	x	17.65	x	x	14.925	16.05	14.375	13.567	x	14.0	15.55	x	16.35	
-12933	Original post publication description: Cardiovascular system: Heart rate during echocardiography of 17-week old males [beat/min]	None	Cardiovascular system: Heart rate during echocardiography of 17-week old males [beat/min]	x	x	557.891	x	541.622	x	x	609.513	655.745	x	693.555	x	x	x	x	464.456	499.576	x	538.847	x	x	x	x	x	x	x	610.617	x	x	593.232	x	x	645.632	x	x	x	x	x	x	x	589.989	653.624	632.445	645.73	x	x	653.034	x	x	x	x	x	x	634.764	652.541	x	x	x	x	556.367	506.083	x	x	534.4	592.858	x	692.363	579.39	x	701.017	x	627.14	x	614.076	x	x	x	x	630.44	488.83	x	498.216	560.911	x	644.316	651.344	x	644.787	573.378	x	497.544	x	x	534.761	614.136	550.284	592.827	x	757.377	553.169	x	622.021	
-12929	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old males [mg/dl]	x	x	322.52	x	306.25	x	x	260.5	191.5	x	277.333	x	x	x	x	246.0	217.75	x	235.0	x	x	x	x	x	x	x	306.5	x	x	287.0	x	x	332.75	x	x	x	x	x	x	x	200.25	304.0	408.5	x	x	x	293.5	x	x	x	x	x	x	160.5	290.75	x	x	x	x	219.0	320.333	x	x	229.0	230.0	x	348.75	345.0	x	257.0	x	265.0	x	251.5	x	x	x	x	195.25	216.5	x	258.0	194.5	x	407.0	256.0	x	272.5	243.0	x	278.0	x	x	343.5	246.5	337.75	315.667	x	267.0	205.5	x	220.5	
-12930	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old males [mg/dl]	x	x	213.88	x	229.5	x	x	205.25	142.75	x	246.0	x	x	x	x	205.5	141.75	x	164.25	x	x	x	x	x	x	x	241.5	x	x	206.75	x	x	218.5	x	x	x	x	x	x	x	150.5	176.0	405.0	x	x	x	199.5	x	x	x	x	x	x	115.5	202.0	x	x	x	x	168.5	204.333	x	x	164.0	214.5	x	292.5	272.0	x	209.5	x	209.5	x	185.0	x	x	x	x	150.0	153.5	x	184.0	153.0	x	327.0	159.0	x	204.5	166.0	x	192.0	x	x	274.75	188.0	251.5	226.333	x	199.5	167.0	x	160.0	
-12927	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old males [mg/dl]	x	x	126.48	x	142.5	x	x	130.75	86.5	x	146.0	x	x	x	x	124.5	92.0	x	112.5	x	x	x	x	x	x	x	164.0	x	x	148.75	x	x	143.25	x	x	x	x	x	x	x	110.0	125.0	246.5	x	x	x	118.5	x	x	x	x	x	x	83.5	112.5	x	x	x	x	125.0	109.0	x	x	131.5	108.5	x	142.25	176.0	x	120.5	x	128.0	x	128.0	x	x	x	x	113.0	94.0	x	136.0	109.0	x	197.0	159.0	x	130.0	129.0	x	129.0	x	x	155.0	129.5	168.5	138.333	x	115.0	106.5	x	131.0	
-12928	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old males [mg/dl]	x	x	307.4	x	274.75	x	x	272.0	233.0	x	239.0	x	x	x	x	266.75	212.75	x	236.5	x	x	x	x	x	x	x	290.5	x	x	270.5	x	x	316.75	x	x	x	x	x	x	x	230.75	298.0	295.0	x	x	x	322.25	x	x	x	x	x	x	195.0	255.25	x	x	x	x	281.5	313.333	x	x	276.0	242.0	x	281.25	315.0	x	249.0	x	317.0	x	271.5	x	x	x	x	220.75	231.5	x	273.0	212.5	x	401.5	241.333	x	242.75	268.0	x	277.5	x	x	273.0	247.0	312.25	246.667	x	278.5	190.0	x	246.0	
-12925	Original post publication description: Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old males [mMl]	None	Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old males [mMl]	x	x	16.0	x	14.38	x	x	16.058	14.685	x	15.227	x	x	x	x	12.038	15.278	x	10.975	x	x	x	x	x	x	x	13.69	x	x	14.198	x	x	13.488	x	x	x	x	x	x	x	14.155	15.43	18.617	15.935	x	x	16.508	x	x	x	x	x	x	15.485	14.963	x	x	x	x	16.195	14.755	x	x	18.47	13.945	x	12.99	15.775	x	15.195	x	13.82	x	16.75	x	x	x	x	15.345	18.48	x	16.165	13.395	x	19.715	14.607	x	13.383	19.67	x	12.79	x	x	16.343	17.195	13.997	16.263	x	15.63	15.085	x	15.755	
-12921	Original post publication description: Cardiovascular system: Ejection Fraction by echocardiography of 17-week old males [%]	None	Cardiovascular system: Ejection fraction by echocardiography of 17-week old males [%]	x	x	67.774	x	68.975	x	x	x	x	x	69.167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	74.767	x	x	x	x	x	71.125	x	x	x	x	x	x	x	72.5	67.4	68.9	x	x	x	72.05	x	x	x	x	x	x	64.25	62.975	x	x	x	x	65.0	73.467	x	x	74.4	67.25	x	66.125	61.0	x	70.6	x	62.0	x	57.5	x	x	x	x	69.511	61.85	x	67.85	75.45	x	67.9	69.333	x	70.025	76.0	x	63.95	x	x	66.425	71.95	75.8	71.8	x	73.5	73.15	x	66.55	
-12922	Original post publication description: Metabolism: Food intake of 13-week old males [g/mouse]	None	Central nervous system, metabolism, behavior: Food intake of 13-week old males [g/mouse]	x	x	2.437	x	x	x	x	1.871	2.45	x	x	x	x	x	x	2.093	2.369	x	2.332	x	x	x	x	x	x	x	2.632	x	x	2.707	x	x	x	x	x	x	x	x	x	x	x	x	3.456	4.183	x	x	2.269	x	x	x	x	x	x	x	1.335	x	x	x	x	2.113	x	x	x	1.481	1.3	x	3.39	2.241	x	3.356	x	6.485	x	1.83	x	x	x	x	x	x	x	x	1.534	x	2.613	x	x	2.202	x	x	1.032	x	x	1.67	1.536	x	2.651	x	0.198	1.956	x	0.843	
-12923	Original post publication description: Cardiovascular system: Shortening fraction by echocardiography of 17-week old males [%]	None	Cardiovascular system: Shortening fraction by echocardiography of 17-week old males [%]	x	x	32.852	x	33.875	x	x	x	x	x	33.833	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	38.3	x	x	x	x	x	34.375	x	x	x	x	x	x	x	36.6	32.1	33.4	x	x	x	35.825	x	x	x	x	x	x	30.3	29.438	x	x	x	x	30.75	37.033	x	x	37.5	32.0	x	31.875	29.0	x	34.65	x	28.75	x	26.2	x	x	x	x	33.921	28.7	x	33.0	39.3	x	33.0	34.0	x	34.25	38.9	x	30.35	x	x	31.725	35.75	39.125	35.65	x	31.0	37.05	x	31.85	
-12919	Original post publication description: Morphology, metabolism: Body fat mass percentage of 19-week old males [%]	None	Morphology, metabolism: Body fat mass percentage of 19-week old males [%]	x	x	13.801	x	11.205	x	x	13.363	12.825	x	13.2	x	x	x	x	19.693	13.035	x	9.645	x	x	x	x	x	x	x	19.02	x	x	14.945	x	x	17.893	x	x	x	x	x	x	x	10.683	19.74	23.655	x	x	x	14.138	x	x	x	x	x	x	12.44	15.333	x	x	x	x	15.165	14.337	x	x	14.9	22.355	x	18.835	19.565	x	17.965	x	12.95	x	13.745	x	x	x	x	16.873	20.23	x	14.41	13.165	x	17.885	16.053	x	17.735	16.2	x	26.175	x	x	18.37	16.2	24.37	17.17	x	13.945	16.4	x	15.31	
-12920	Original post publication description: Morphology, metabolism: Body fat mass of 19-week old males [g]	None	Morphology, metabolism: Body fat mass of 19-week old males [g]	x	x	3.844	x	3.587	x	x	3.555	3.582	x	3.588	x	x	x	x	6.841	3.659	x	2.964	x	x	x	x	x	x	x	6.808	x	x	4.535	x	x	5.85	x	x	x	x	x	x	x	2.924	5.468	6.595	x	x	x	4.16	x	x	x	x	x	x	3.7	4.098	x	x	x	x	3.835	4.007	x	x	3.394	5.646	x	5.414	5.22	x	4.945	x	3.342	x	3.188	x	x	x	x	4.737	4.998	x	3.778	3.176	x	4.974	4.185	x	4.369	4.39	x	9.811	x	x	4.823	4.912	8.19	4.559	x	3.967	4.139	x	3.843	
-12917	Original post publication description: Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old males [mm]	None	Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old males [mm]	x	x	4.27	x	4.503	x	x	x	x	x	4.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.303	x	x	x	x	x	4.693	x	x	x	x	x	x	x	4.645	3.76	3.505	x	x	x	4.008	x	x	x	x	x	x	4.225	4.023	x	x	x	x	4.115	4.207	x	x	3.69	4.005	x	4.275	4.04	x	3.905	x	4.205	x	3.935	x	x	x	x	3.921	4.47	x	4.4	4.15	x	4.286	4.48	x	3.988	3.83	x	4.715	x	x	3.915	4.08	4.293	4.15	x	4.15	4.61	x	4.575	
-12918	Original post publication description: Cardiovascular system: End-systolic diameter by echocardiography of 17-week old males [mm]	None	Cardiovascular system: End-systolic diameter by echocardiography of 17-week old males [mm]	x	x	2.877	x	2.975	x	x	x	x	x	12.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.65	x	x	x	x	x	3.073	x	x	x	x	x	x	x	2.945	2.56	2.34	x	x	x	2.575	x	x	x	x	x	x	2.945	2.84	x	x	x	x	2.875	2.647	x	x	2.305	2.735	x	2.928	2.91	x	2.555	x	3.05	x	2.91	x	x	x	x	2.592	3.195	x	2.945	2.52	x	2.88	2.933	x	2.628	2.34	x	3.3	x	x	2.678	2.625	2.893	2.66	x	2.875	2.91	x	3.12	
-12915	Original post publication description: Blood chemistry: Chloride of 14-week old males [mM]	None	Blood chemistry: Chloride of 14-week old males [mM]	x	x	111.84	x	109.0	x	x	110.0	107.5	x	109.0	x	x	x	x	106.0	112.5	x	110.25	x	x	x	x	x	x	x	110.667	x	x	112.0	x	x	113.0	x	x	x	x	x	x	x	118.0	113.0	110.0	109.5	x	x	111.5	x	x	x	x	x	x	111.0	111.5	x	x	x	x	x	107.75	x	x	112.5	x	x	x	x	x	112.5	x	x	x	113.0	x	x	x	x	111.5	109.5	x	109.5	114.5	x	x	123.25	x	115.0	113.0	x	113.0	x	x	111.25	113.0	109.5	109.333	x	x	111.5	x	112.0	
-12916	Original post publication description: Blood chemistry: Creatinine of 14-week old males [uM]	None	Blood chemistry: Creatinine of 14-week old males [uM]	x	x	7.954	x	x	x	x	13.275	8.575	x	7.667	x	x	x	x	9.3	7.85	x	9.225	x	x	x	x	x	x	x	5.68	x	x	8.025	x	x	10.313	x	x	x	x	x	x	x	9.153	7.2	7.667	6.6	x	x	9.485	x	x	x	x	x	x	7.35	7.725	x	x	x	x	x	x	x	x	9.85	x	x	x	x	x	6.9	x	x	x	7.55	x	x	x	x	7.95	5.8	x	7.85	8.7	x	x	6.243	x	8.7	10.3	x	9.35	x	x	7.65	8.9	x	8.7	x	x	9.05	x	8.2	
-12913	Original post publication description: Morphology: Body weight of 20-week old males at necropsy [g]	None	Musculoskeletal system, morphology: Body weight of 20-week old males at necropsy [g]	x	x	26.741	x	31.963	x	x	24.681	26.608	x	26.049	x	x	x	x	34.663	27.088	x	29.606	x	x	x	x	x	x	x	34.178	x	x	28.223	x	x	32.418	x	x	x	x	x	x	x	28.222	27.889	27.28	x	x	x	29.202	x	x	x	x	x	x	28.623	26.276	x	x	x	x	24.348	27.743	x	x	24.404	24.473	x	29.095	26.583	x	28.815	x	24.597	x	24.304	x	x	x	x	26.737	23.298	x	25.671	25.788	x	30.836	25.239	x	26.419	25.738	x	x	x	x	27.349	29.863	33.575	26.822	x	28.088	27.243	x	27.829	
-12910	Original post publication description: Morphology: Body weight of 19-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 19-week old males [g]	x	x	28.12	x	32.375	x	x	26.125	26.675	x	27.133	x	x	x	x	33.525	27.5	x	29.45	x	x	x	x	x	x	x	34.7	x	x	29.8	x	x	32.65	x	x	x	x	x	x	x	27.2	28.6	27.95	x	x	x	29.075	x	x	x	x	x	x	29.55	26.85	x	x	x	x	24.45	28.0	x	x	23.15	23.2	x	25.95	24.65	x	29.0	x	25.35	x	23.3	x	x	x	x	27.4	24.75	x	26.25	23.5	x	26.0	25.933	x	25.325	26.7	x	37.1	x	x	27.05	31.6	33.625	27.233	x	27.45	25.55	x	26.7	
-12911	Original post publication description: Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old males [g]	None	Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old males [g]	x	x	28.304	x	32.025	x	x	26.6	27.825	x	27.167	x	x	x	x	34.8	28.075	x	30.4	x	x	x	x	x	x	x	34.35	x	x	30.325	x	x	32.6	x	x	x	x	x	x	x	27.35	27.7	28.8	x	x	x	29.4	x	x	x	x	x	x	29.75	27.975	x	x	x	x	26.2	27.967	x	x	24.1	25.9	x	29.4	27.35	x	28.9	x	27.0	x	24.65	x	x	x	x	27.925	24.45	x	26.25	25.65	x	28.6	26.067	x	26.075	27.1	x	38.95	x	x	28.05	31.85	33.45	27.833	x	29.15	26.6	x	26.6	
-12908	Original post publication description: Morphology: Body weight of 18-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 18-week old males [g]	x	x	27.92	x	32.7	x	x	25.775	25.25	x	25.633	x	x	x	x	31.675	26.3	x	28.525	x	x	x	x	x	x	x	31.833	x	x	29.05	x	x	31.55	x	x	x	x	x	x	x	25.675	26.8	28.25	x	x	x	28.775	x	x	x	x	x	x	28.95	25.45	x	x	x	x	23.9	28.233	x	x	23.5	22.8	x	25.625	25.2	x	28.45	x	24.9	x	24.2	x	x	x	x	27.475	24.35	x	26.05	24.75	x	29.48	24.4	x	26.25	25.9	x	36.0	x	x	26.5	30.85	32.275	26.633	x	27.4	25.9	x	26.4	
-12909	Original post publication description: Metabolism: Body weight for glucose tolerance test (ip) test of 18-week old males [g]	None	Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old males [g]	x	x	25.016	x	28.7	x	x	23.8	21.3	x	22.7	x	x	x	x	28.625	23.175	x	25.025	x	x	x	x	x	x	x	29.35	x	x	25.575	x	x	28.475	x	x	x	x	x	x	x	22.875	23.1	26.3	x	x	x	25.5	x	x	x	x	x	x	25.9	23.75	x	x	x	x	21.45	25.133	x	x	21.35	22.25	x	25.3	23.95	x	25.9	x	23.2	x	20.5	x	x	x	x	24.5	21.85	x	23.05	21.9	x	25.65	21.833	x	23.1	23.4	x	33.95	x	x	24.875	27.55	29.6	23.767	x	24.35	23.05	x	23.95	
-12906	Original post publication description: Morphology: Body weight of 17-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 17-week old males [g]	x	x	27.324	x	x	x	x	25.875	24.425	x	25.867	x	x	x	x	30.675	26.4	x	29.475	x	x	x	x	x	x	x	31.467	x	x	28.575	x	x	30.325	x	x	x	x	x	x	x	25.45	25.8	27.533	24.1	x	x	28.275	x	x	x	x	x	x	28.85	26.5	x	x	x	x	24.55	x	x	x	24.05	25.5	x	26.05	25.45	x	27.3	x	26.55	x	24.25	x	x	x	x	25.75	24.15	x	26.6	25.05	x	28.34	23.7	x	25.675	26.2	x	36.45	x	x	27.4	30.0	x	26.767	x	27.25	25.9	x	26.75	
-12907	Original post publication description: Morphology, cardiovascular system: Body weight at echocardiography of 17-week old males [g]	None	Morphology, cardiovascular system: Body weight at echocardiography of 17-week old males [g]	x	x	27.608	x	31.125	x	x	x	x	x	25.867	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	31.167	x	x	x	x	x	30.325	x	x	x	x	x	x	x	25.45	26.2	25.15	22.7	x	x	28.2	x	x	x	x	x	x	26.6	x	x	x	x	x	24.55	26.6	x	x	22.8	24.25	x	28.075	24.0	x	29.0	x	26.05	x	22.85	x	x	x	x	24.105	26.55	x	28.85	24.1	x	28.48	23.7	x	25.55	25.8	x	36.25	x	x	x	31.0	31.85	x	x	27.25	25.6	x	25.9	
-12904	Original post publication description: Morphology: Body weight of 15-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 15-week old males [g]	x	x	27.316	x	30.2	x	x	25.775	23.4	x	25.167	x	x	x	x	30.225	26.4	x	29.575	x	x	x	x	x	x	x	29.967	x	x	27.925	x	x	30.0	x	x	x	x	x	x	x	25.725	25.5	27.171	24.2	x	x	27.125	x	x	x	x	x	x	28.6	26.875	x	x	x	x	24.45	26.425	x	x	22.9	23.2	x	27.763	26.983	x	28.2	x	25.35	x	23.85	x	x	x	x	26.85	23.7	x	26.05	23.15	x	27.9	24.375	x	24.8	26.0	x	32.9	x	x	26.3	30.2	30.55	26.8	x	27.45	25.45	x	25.35	
-12902	Original post publication description: Morphology: Body weight of 13-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 13-week old males [g]	x	x	26.692	x	29.225	x	x	24.85	21.775	x	25.1	x	x	x	x	28.7	24.975	x	29.3	x	x	x	x	x	x	x	28.567	x	x	27.375	x	x	29.425	x	x	x	x	x	x	x	25.225	25.4	25.543	23.1	x	x	26.1	x	x	x	x	x	x	28.9	26.375	x	x	x	x	23.6	25.775	x	x	21.65	22.2	x	26.175	26.133	x	26.0	x	23.95	x	22.7	x	x	x	x	26.35	23.9	x	25.45	20.95	x	27.02	24.15	x	23.825	25.6	x	28.15	x	x	25.4	30.55	29.25	27.467	x	26.75	24.1	x	25.15	
-12900	Original post publication description: Musculoskeletal system, metabolism: Bone surface area by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [cm2]	None	Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [cm2]	x	x	8.063	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.045	x	x	x	x	x	x	x	x	x	x	x	7.225	x	x	x	x	7.55	x	x	x	8.08	6.94	x	7.508	6.97	x	7.865	x	7.57	x	8.25	x	x	x	x	x	x	x	x	8.055	x	6.975	x	x	7.955	x	x	8.195	x	x	7.775	8.315	x	7.66	x	8.325	7.905	x	8.535	
-12898	Original post publication description: Musculoskeletal system, metabolism: Bone mineral content by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g]	None	Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g]	x	x	0.403	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.38	x	x	x	x	x	x	x	x	x	x	x	0.368	x	x	x	x	0.413	x	x	x	0.4	0.321	x	0.371	0.333	x	0.418	x	0.395	x	0.397	x	x	x	x	x	x	x	x	0.362	x	0.356	x	x	0.375	x	x	0.412	x	x	0.424	0.474	x	0.389	x	0.468	0.402	x	0.419	
-12895	Original post publication description: Blood chemistry: Aspartate transaminase of 14-week old males [U/l]	None	Blood chemistry: Aspartate transaminase of 14-week old males [U/l]	x	x	64.72	x	72.0	x	x	97.5	65.5	x	64.333	x	x	x	x	75.75	92.25	x	146.0	x	x	x	x	x	x	x	134.667	x	x	61.5	x	x	172.25	x	x	x	x	x	x	x	104.5	40.0	68.0	47.5	x	x	69.75	x	x	x	x	x	x	47.5	64.5	x	x	x	x	141.0	62.75	x	x	69.5	74.0	x	146.25	121.5	x	42.5	x	125.0	x	76.5	x	x	x	x	76.5	46.0	x	81.0	58.0	x	61.0	75.25	x	103.75	50.0	x	54.0	x	x	55.75	72.5	39.5	99.667	x	105.0	41.5	x	70.0	
-12896	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old males [mg/dl]	x	x	14275.2	x	13380.0	x	x	8278.12	8947.5	x	14850.0	x	x	x	x	13884.4	7891.88	x	8913.75	x	x	x	x	x	x	x	13653.8	x	x	10753.1	x	x	15511.9	x	x	x	x	x	x	x	4117.5	11617.5	26467.5	x	x	x	13338.8	x	x	x	x	x	x	5463.75	12598.1	x	x	x	x	9401.25	14622.5	x	x	8298.75	11756.2	x	18470.6	15326.2	x	13278.8	x	10710.0	x	5133.75	x	x	x	x	6031.88	9352.5	x	8141.25	8831.25	x	22755.0	11892.5	x	13228.1	6652.5	x	11227.5	x	x	16659.4	11133.8	13243.1	14150.0	x	12937.5	9127.5	x	4931.25	
-12893	Original post publication description: Blood chemistry: Albumin of 14-week old males [g/l]	None	Blood chemistry: Albumin of 14-week old males [g/l]	x	x	26.56	x	25.0	x	x	24.5	22.75	x	25.0	x	x	x	x	24.25	24.75	x	24.25	x	x	x	x	x	x	x	24.667	x	x	22.75	x	x	27.75	x	x	x	x	x	x	x	28.25	25.0	27.667	29.0	x	x	25.75	x	x	x	x	x	x	27.0	26.25	x	x	x	x	x	25.5	x	x	27.5	x	x	x	x	x	26.5	x	x	x	24.5	x	x	x	x	27.25	27.0	x	26.5	26.5	x	x	26.667	x	27.0	28.0	x	25.0	x	x	29.25	26.0	29.5	27.667	x	x	26.5	x	25.5	
-12894	Original post publication description: Blood chemistry: Alkaline phosphatase of 14-week old males (ALPL gene product) [U/l]	None	Blood chemistry: Alkaline phosphatase of 14-week old males (ALPL gene product) [U/l]	x	x	100.32	x	152.0	x	x	91.75	232.0	x	78.0	x	x	x	x	225.5	180.75	x	75.25	x	x	x	x	x	x	x	167.333	x	x	44.0	x	x	98.5	x	x	x	x	x	x	x	104.0	105.0	124.333	182.0	x	x	147.5	x	x	x	x	x	x	130.5	133.75	x	x	x	x	160.5	75.25	x	x	100.0	168.5	x	118.75	172.0	x	175.5	x	130.0	x	136.0	x	x	x	x	118.0	195.0	x	140.0	171.0	x	136.5	152.75	x	187.5	245.0	x	120.0	x	x	156.0	107.0	116.5	83.0	x	120.0	130.0	x	116.0	
-12891	Original post publication description: Blood chemistry: Alpha-amylase of 14-week old males [U/l]	None	Blood chemistry: Alpha-amylase of 14-week old males [U/l]	x	x	575.56	x	692.5	x	x	499.25	495.25	x	666.333	x	x	x	x	554.75	735.25	x	879.0	x	x	x	x	x	x	x	496.333	x	x	510.0	x	x	672.0	x	x	x	x	x	x	x	845.75	615.0	643.0	487.5	x	x	598.0	x	x	x	x	x	x	673.0	504.0	x	x	x	x	x	595.25	x	x	524.5	x	x	x	x	x	672.5	x	x	x	457.5	x	x	x	x	756.25	619.0	x	645.0	504.5	x	x	713.75	x	1688.25	529.0	x	620.5	x	x	575.0	625.5	490.25	435.0	x	x	501.5	x	635.5	
-12892	Original post publication description: Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old males [U/L]	None	Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old males [U/L]	x	x	35.84	x	28.75	x	x	51.0	24.25	x	56.667	x	x	x	x	51.0	33.75	x	70.0	x	x	x	x	x	x	x	79.333	x	x	29.25	x	x	115.5	x	x	x	x	x	x	x	51.5	21.0	39.333	36.5	x	x	43.25	x	x	x	x	x	x	24.5	37.0	x	x	x	x	47.0	32.0	x	x	32.0	75.0	x	45.75	39.0	x	24.0	x	79.5	x	29.5	x	x	x	x	32.75	25.5	x	44.5	23.5	x	59.5	67.5	x	30.5	26.0	x	36.0	x	x	40.25	34.0	25.0	74.333	x	81.0	24.0	x	33.5	
-12889	Original post publication description: Metabolism: Water intake of 13-week old females [ml/mouse/unit time]	None	Central nervous system, metabolism, behavior: Water intake of 13-week old females [ml/mouse/unit time]	x	x	2.173	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.819	x	x	x	x	x	x	x	x	x	x	x	3.012	x	x	x	1.779	1.904	x	x	x	1.592	1.679	x	3.681	2.106	x	x	x	1.585	x	1.435	x	x	x	x	x	x	x	x	1.515	x	3.102	x	x	1.455	x	x	x	x	x	3.001	x	x	3.096	x	1.876	1.379	x	1.374	
-12890	Original post publication description: Metabolism, behavior: Activity level of 13-week old females [total counts of fine movements and ambulatory activity/unit time]	None	Central nervous system, metabolism, behavior: Activity of 13-week old females, total counts of fine movements and ambulatory activity [counts/unit time]	x	x	1254.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	255.286	x	x	x	x	x	x	x	x	x	x	x	816.5	x	x	x	2714.57	1189.07	x	x	x	1317.64	651.286	x	1238.71	399.857	x	x	x	811.5	x	862.857	x	x	x	x	x	x	x	x	1643.0	x	936.429	x	x	715.214	x	x	x	x	x	707.929	x	x	1481.93	x	577.571	1971.0	x	807.357	
-12887	Original post publication description: Morphology, metabolism: White adipose tissue mass of 20-week old females [g]	None	Morphology, metabolism: White adipose tissue mass of 20-week old females [g]	x	x	0.271	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.518	0.421	x	x	x	x	x	x	x	x	x	x	0.333	0.345	x	x	x	0.502	0.198	x	x	x	0.349	0.387	x	0.263	0.426	x	x	x	0.249	x	0.091	x	x	x	x	0.496	0.269	x	x	0.121	x	0.252	x	x	0.393	0.627	x	x	x	x	0.334	x	x	0.25	x	0.347	0.293	x	0.256	
-12888	Original post publication description: Blood chemistry, cardiovascular system: White blood cell count of 14-week old females [x10^3/ul]	None	Blood chemistry, cardiovascular system: White blood cell count of 14-week old females [x10^3/ul]	x	x	6.063	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.05	13.75	x	x	x	x	x	x	x	x	x	x	9.6	7.6	x	x	x	9.2	8.9	x	x	x	6.35	6.7	x	6.25	5.95	x	x	x	7.85	x	8.6	x	x	x	x	7.3	8.4	x	x	7.3	x	9.7	x	x	7.9	9.85	x	x	x	x	9.4	x	x	13.9	x	8.4	6.35	x	7.4	
-12885	Original post publication description: Metabolism: Volume of CO2 production of 13-week old females [ml/kg/h]	None	Respiratory system, metabolism: Volume of CO2 production of 13-week old females [ml/kg/h]	x	x	783.048	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	669.929	x	x	x	x	x	x	x	x	x	x	x	1154.64	x	x	x	1102.64	903.583	x	x	x	953.0	803.143	x	1237.09	697.857	x	x	x	802.857	x	723.893	x	x	x	x	x	x	x	x	845.857	x	1026.29	x	x	609.357	x	x	x	x	x	779.571	x	x	959.143	x	861.214	963.143	x	629.857	
-12886	Original post publication description: Metabolism: Volume oxygen consumption of 13-week old females [ml/kg/h]	None	Respiratory system, metabolism: Volume oxygen consumption of 13-week old females [ml/kg/h]	x	x	928.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	741.286	x	x	x	x	x	x	x	x	x	x	x	1181.64	x	x	x	1121.25	882.083	x	x	x	941.643	909.0	x	1211.43	829.429	x	x	x	898.786	x	777.929	x	x	x	x	x	x	x	x	954.071	x	1061.64	x	x	706.071	x	x	x	x	x	900.714	x	x	1033.71	x	869.214	1055.86	x	695.429	
-12883	Original post publication description: Blood chemistry: Blood proteins (total) of 14-week old females [g/l]	None	Blood chemistry: Blood proteins (total) of 14-week old females [g/l]	x	x	53.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	52.5	48.0	x	x	x	x	x	x	x	x	x	x	54.0	49.5	x	x	x	54.0	x	x	x	x	53.0	x	x	x	x	x	x	x	x	x	48.5	x	x	x	x	52.0	51.0	x	x	49.0	x	x	x	x	53.0	53.5	x	x	x	x	51.5	x	x	52.0	x	x	46.5	x	49.5	
-12884	Original post publication description: Blood chemistry: Urea of 14-week old females [mM]	None	Blood chemistry: Urea of 14-week old females [mM]	x	x	7.717	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.65	6.5	x	x	x	x	x	x	x	x	x	x	8.8	6.0	x	x	x	6.7	x	x	x	x	6.25	x	x	x	x	x	x	x	x	x	5.65	x	x	x	x	7.6	8.0	x	x	6.0	x	x	x	x	7.25	8.95	x	x	x	x	6.3	x	x	6.2	x	x	8.55	x	8.55	
-12881	Original post publication description: Blood chemistry: Chlolesterol (total) of 14-week old females [mM]	None	Blood chemistry: Chlolesterol (total) of 14-week old females [mM]	x	x	1.878	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.805	2.165	x	x	x	x	x	x	x	x	x	x	1.68	1.815	x	x	x	2.72	2.095	x	x	x	2.605	2.165	x	2.42	2.73	x	x	x	1.875	x	2.21	x	x	x	x	2.28	2.63	x	x	2.305	x	2.475	x	x	2.175	2.915	x	x	x	x	2.41	x	x	1.79	x	1.935	2.45	x	1.935	
-12882	Original post publication description: Blood chemistry: Triglyceride of 14-week old females [mM]	None	Blood chemistry: Triglyceride of 14-week old females [mM]	x	x	0.659	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.985	0.945	x	x	x	x	x	x	x	x	x	x	0.935	0.94	x	x	x	1.1	1.01	x	x	x	1.28	0.89	x	0.645	0.66	x	x	x	0.875	x	0.66	x	x	x	x	1.64	1.195	x	x	1.43	x	1.365	x	x	0.87	1.16	x	x	x	x	0.735	x	x	0.39	x	1.16	1.465	x	0.665	
-12878	Original post publication description: Metabolism: Respiratory exchange ratio (RER) of 13-week old females [ratio]	None	Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old females [ratio]	x	x	0.835	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.892	x	x	x	x	x	x	x	x	x	x	x	0.971	x	x	x	0.978	1.005	x	x	x	1.008	0.879	x	1.017	0.841	x	x	x	0.881	x	0.909	x	x	x	x	x	x	x	x	0.885	x	0.963	x	x	0.856	x	x	x	x	x	0.855	x	x	0.909	x	0.979	0.911	x	0.891	
-12876	Original post publication description: Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old females [mm]	None	Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old females [mm]	x	x	0.586	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.62	0.58	x	x	x	x	x	x	x	x	x	x	0.58	0.55	x	x	x	0.68	0.585	x	x	x	0.615	0.53	x	0.575	0.555	x	x	x	0.58	x	0.59	x	x	x	x	0.66	0.605	x	x	0.545	x	0.61	x	x	0.62	0.57	x	x	x	x	0.575	x	x	0.54	x	0.565	0.635	x	0.595	
-12874	Original post publication description: Blood chemistry: Phosphorus of 14-week old females [mM]	None	Blood chemistry: Phosphorus of 14-week old females [mM]	x	x	2.596	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.45	2.43	x	x	x	x	x	x	x	x	x	x	2.805	2.25	x	x	x	2.075	x	x	x	x	2.235	x	x	x	x	x	x	x	x	x	1.9	x	x	x	x	2.56	2.965	x	x	2.765	x	x	x	x	2.765	2.665	x	x	x	x	2.29	x	x	2.5	x	x	2.595	x	2.325	
-12872	Original post publication description: Blood chemistry, cardiovascular system: Mean cell volume of 14-week old females [fl]	None	Blood chemistry, cardiovascular system: Mean cell volume of 14-week old females [fl]	x	x	46.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	44.25	46.0	x	x	x	x	x	x	x	x	x	x	52.1	50.95	x	x	x	47.85	49.85	x	x	x	43.05	47.25	x	46.5	45.7	x	x	x	43.55	x	43.1	x	x	x	x	45.9	48.5	x	x	46.9	x	49.55	x	x	47.75	44.2	x	x	x	x	47.3	x	x	44.8	x	42.75	43.95	x	44.75	
-12870	Original post publication description: Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old females [pg]	None	Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old females [pg]	x	x	15.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.25	15.6	x	x	x	x	x	x	x	x	x	x	16.8	16.6	x	x	x	15.65	15.2	x	x	x	14.5	14.55	x	15.5	15.15	x	x	x	14.15	x	14.45	x	x	x	x	15.9	15.9	x	x	14.8	x	15.25	x	x	14.95	15.25	x	x	x	x	15.95	x	x	14.7	x	14.1	15.25	x	15.35	
-12868	Original post publication description: Cardiovascular system: Left ventricular mass by echocardiography of 17-week old females [mg]	None	Cardiovascular system: Left ventricular mass by echocardiography of 17-week old females [mg]	x	x	72.325	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82.914	69.548	x	x	x	x	x	x	x	x	x	x	67.293	68.808	x	x	x	78.06	75.766	x	x	x	65.992	65.501	x	74.531	75.98	x	x	x	77.751	x	73.504	x	x	x	x	80.675	74.093	x	x	82.86	x	76.973	x	x	78.162	62.324	x	x	x	x	67.266	x	x	67.28	x	70.184	75.891	x	84.837	
-12866	Original post publication description: Morphology, metabolism: Body lean mass percentage of 19-week old females [%]	None	Morphology, metabolism: Body lean mass percentage of 19-week old females [%]	x	x	82.206	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	71.015	78.32	x	x	x	x	x	x	x	x	x	x	76.07	86.395	x	x	x	83.355	84.115	x	x	x	83.65	80.79	x	82.905	82.485	x	x	x	83.96	x	86.56	x	x	x	x	71.66	74.515	x	x	87.91	x	83.325	x	x	83.11	67.78	x	x	x	x	85.66	x	x	85.63	x	85.93	84.38	x	82.29	
-12864	Original post publication description: Blood chemistry: Potassium of 14-week old females [mM]	None	Blood chemistry: Potassium of 14-week old females [mM]	x	x	4.326	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.17	3.835	x	x	x	x	x	x	x	x	x	x	4.605	4.09	x	x	x	3.78	x	x	x	x	4.85	x	x	x	x	x	x	x	x	x	4.85	x	x	x	x	3.96	5.2	x	x	4.52	x	x	x	x	4.18	4.395	x	x	x	x	4.055	x	x	4.32	x	x	4.39	x	4.325	
-12862	Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin of 14-week old females [g/dl]	None	Blood chemistry, cardiovascular system: Hemoglobin of 14-week old females [g/dl]	x	x	14.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.6	14.65	x	x	x	x	x	x	x	x	x	x	15.15	10.95	x	x	x	16.85	14.4	x	x	x	14.55	14.9	x	15.0	16.55	x	x	x	16.05	x	13.25	x	x	x	x	14.1	12.9	x	x	15.45	x	17.25	x	x	15.45	13.45	x	x	x	x	14.4	x	x	13.8	x	13.6	15.5	x	14.6	
-12859	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old females [mg/dl]	x	x	240.857	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	247.0	295.5	x	x	x	x	x	x	x	x	x	x	183.5	282.5	x	x	x	199.5	147.0	x	x	x	204.5	201.0	x	219.0	207.0	x	x	x	229.0	x	210.5	x	x	x	x	205.0	176.5	x	x	183.0	x	296.0	x	x	191.5	195.5	x	x	x	x	213.0	x	x	211.0	x	197.0	170.0	x	180.0	
-12860	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old females [mg/dl]	x	x	157.286	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	146.5	216.0	x	x	x	x	x	x	x	x	x	x	124.0	202.0	x	x	x	152.5	99.0	x	x	x	167.0	116.0	x	130.5	142.0	x	x	x	147.0	x	160.5	x	x	x	x	113.0	119.0	x	x	124.5	x	158.5	x	x	129.0	138.5	x	x	x	x	153.5	x	x	134.0	x	125.5	137.0	x	146.5	
-12857	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old females [mg/dl]	x	x	102.571	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	87.5	109.0	x	x	x	x	x	x	x	x	x	x	83.0	100.0	x	x	x	120.0	63.0	x	x	x	133.5	83.5	x	92.0	114.5	x	x	x	126.0	x	112.0	x	x	x	x	66.0	59.0	x	x	101.5	x	121.5	x	x	90.0	102.0	x	x	x	x	106.0	x	x	103.0	x	109.0	96.5	x	101.0	
-12858	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old females [mg/dl]	x	x	269.286	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	237.0	262.5	x	x	x	x	x	x	x	x	x	x	207.5	246.0	x	x	x	211.5	196.0	x	x	x	258.0	236.5	x	234.0	268.5	x	x	x	260.0	x	257.5	x	x	x	x	189.0	219.5	x	x	202.0	x	351.5	x	x	193.5	219.0	x	x	x	x	261.5	x	x	244.0	x	242.5	179.5	x	219.0	
-12856	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old females [mg/dl]	x	x	101.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	84.0	93.0	x	x	x	x	x	x	x	x	x	x	77.5	85.0	x	x	x	102.5	81.5	x	x	x	130.0	83.5	x	104.0	118.5	x	x	x	112.0	x	117.0	x	x	x	x	76.0	78.0	x	x	98.5	x	120.0	x	x	85.0	104.0	x	x	x	x	115.0	x	x	88.0	x	109.0	72.0	x	100.5	
-12854	Original post publication description: Morphology, musculoskeletal system: Gastrocnemius muscle mass of 20-week old females [g]	None	Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old females [g]	x	x	0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.101	0.089	x	x	x	x	x	x	x	x	x	x	0.096	0.108	x	x	x	0.088	0.096	x	x	x	0.095	0.105	x	0.122	0.117	x	x	x	0.087	x	0.095	x	x	x	x	0.065	0.085	x	x	0.108	x	0.089	x	x	0.105	0.083	x	x	x	x	0.114	x	x	0.101	x	0.115	0.106	x	0.094	
-12852	Original post publication description: Metabolism: Food intake of 13-week old females [g/mouse]	None	Central nervous system, metabolism, behavior: Food intake of 13-week old females [g/mouse]	x	x	2.817	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.116	x	x	x	x	x	x	x	x	x	x	x	3.0	x	x	x	2.106	1.244	x	x	x	1.544	0.689	x	4.994	0.887	x	x	x	2.107	x	1.457	x	x	x	x	x	x	x	x	1.834	x	4.442	x	x	1.42	x	x	x	x	x	2.382	x	x	2.181	x	9.824	0.816	x	1.684	
-12850	Original post publication description: Morphology, metabolism: Body fat mass of 19-week old females [g]	None	Morphology, metabolism: Body fat mass of 19-week old females [g]	x	x	2.967	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.726	4.3	x	x	x	x	x	x	x	x	x	x	2.898	2.85	x	x	x	3.657	3.285	x	x	x	3.294	4.025	x	3.768	4.023	x	x	x	3.171	x	2.705	x	x	x	x	4.223	2.945	x	x	2.346	x	3.863	x	x	3.654	5.332	x	x	x	x	3.073	x	x	3.19	x	3.363	3.113	x	3.408	
-12848	Original post publication description: Cardiovascular system: End-systolic diameter by echocardiography of 17-week old females [mm]	None	Cardiovascular system: End-systolic diameter by echocardiography of 17-week old females [mm]	x	x	2.565	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.66	2.52	x	x	x	x	x	x	x	x	x	x	2.52	2.66	x	x	x	2.2	2.63	x	x	x	2.235	2.7	x	2.82	2.785	x	x	x	2.765	x	2.16	x	x	x	x	2.34	2.45	x	x	2.805	x	2.665	x	x	2.59	2.375	x	x	x	x	2.34	x	x	2.34	x	2.55	2.52	x	2.665	
-12846	Original post publication description: Blood chemistry: Creatinine of 14-week old females [uM]	None	Blood chemistry: Creatinine of 14-week old females [uM]	x	x	8.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.4	7.9	x	x	x	x	x	x	x	x	x	x	9.6	7.9	x	x	x	8.2	x	x	x	x	9.2	x	x	x	x	x	x	x	x	x	9.4	x	x	x	x	9.9	8.6	x	x	7.9	x	x	x	x	10.05	8.6	x	x	x	x	8.05	x	x	7.6	x	x	11.0	x	10.4	
-12844	Original post publication description: Blood chemistry: Calcium of 14-week old females [mM]	None	Blood chemistry: Calcium of 14-week old females [mM]	x	x	2.302	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.38	2.3	x	x	x	x	x	x	x	x	x	x	2.585	2.445	x	x	x	2.42	x	x	x	x	2.43	x	x	x	x	x	x	x	x	x	2.285	x	x	x	x	2.7	2.51	x	x	2.44	x	x	x	x	2.27	2.59	x	x	x	x	2.44	x	x	2.21	x	x	2.235	x	2.37	
-12842	Original post publication description: Morphology: Body weight of 20-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 20-week old females [g]	x	x	20.625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.85	21.0	x	x	x	x	x	x	x	x	x	x	22.85	23.35	x	x	x	24.05	20.15	x	x	x	22.6	19.45	x	21.95	21.9	x	x	x	19.05	x	22.95	x	x	x	x	22.8	19.6	x	x	20.45	x	22.05	x	x	23.35	25.05	x	x	x	x	22.95	x	x	23.9	x	24.3	21.8	x	21.8	
-12838	Original post publication description: Morphology: Body weight of 18-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 18-week old females [g]	x	x	20.088	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.4	19.95	x	x	x	x	x	x	x	x	x	x	22.35	21.2	x	x	x	23.05	19.25	x	x	x	21.85	19.5	x	21.35	23.0	x	x	x	18.2	x	20.95	x	x	x	x	22.2	19.55	x	x	20.1	x	21.15	x	x	22.7	23.85	x	x	x	x	22.35	x	x	22.7	x	23.05	20.65	x	19.95	
-12839	Original post publication description: Metabolism: Body weight for glucose tolerance test (ip) test of 18-week old females [g]	None	Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old females [g]	x	x	17.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.35	18.5	x	x	x	x	x	x	x	x	x	x	19.65	19.2	x	x	x	20.75	17.6	x	x	x	19.55	17.1	x	19.3	20.9	x	x	x	17.3	x	18.85	x	x	x	x	18.6	16.85	x	x	17.65	x	20.1	x	x	20.45	21.1	x	x	x	x	20.65	x	x	20.1	x	21.6	18.5	x	18.3	
-12840	Original post publication description: Morphology: Body weight of 19-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 19-week old females [g]	x	x	20.613	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.0	20.9	x	x	x	x	x	x	x	x	x	x	23.1	22.4	x	x	x	22.85	19.0	x	x	x	21.85	18.35	x	20.9	23.0	x	x	x	18.0	x	21.65	x	x	x	x	24.9	20.0	x	x	19.6	x	21.6	x	x	21.85	24.3	x	x	x	x	22.55	x	x	24.5	x	23.75	20.1	x	19.9	
-12836	Original post publication description: Morphology: Body weight of 17-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 17-week old females [g]	x	x	20.413	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.2	20.6	x	x	x	x	x	x	x	x	x	x	21.35	22.1	x	x	x	22.5	20.15	x	x	x	22.2	19.45	x	21.95	21.9	x	x	x	19.05	x	21.25	x	x	x	x	21.6	19.25	x	x	20.85	x	22.05	x	x	23.1	23.4	x	x	x	x	22.1	x	x	24.0	x	24.3	22.0	x	20.75	
-12837	Original post publication description: Morphology, cardiovascular system: Body weight at echocardiography of 17-week old females [g]	None	Morphology, cardiovascular system: Body weight at echocardiography of 17-week old females [g]	x	x	20.267	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.9	x	x	x	x	x	x	x	x	x	x	x	19.25	x	x	x	x	23.05	19.3	x	x	x	21.6	18.95	x	21.3	21.3	x	x	x	18.65	x	21.2	x	x	x	x	21.6	21.35	x	x	19.8	x	21.8	x	x	22.65	23.2	x	x	x	x	x	x	x	x	x	23.5	20.8	x	20.1	
-12832	Original post publication description: Morphology: Body weight of 13-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 13-week old females [g]	x	x	19.813	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.55	21.4	x	x	x	x	x	x	x	x	x	x	21.8	21.65	x	x	x	21.15	19.25	x	x	x	20.7	18.35	x	20.45	22.8	x	x	x	17.45	x	19.8	x	x	x	x	21.8	19.15	x	x	19.15	x	21.25	x	x	21.65	21.1	x	x	x	x	21.75	x	x	23.25	x	22.9	20.2	x	18.55	
-12833	Original post publication description: Morphology: Body weight of 14-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 14-week old females [g]	x	x	19.838	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.0	21.45	x	x	x	x	x	x	x	x	x	x	21.3	22.15	x	x	x	21.4	19.25	x	x	x	21.2	19.5	x	21.35	23.0	x	x	x	18.2	x	21.3	x	x	x	x	21.4	18.65	x	x	20.55	x	21.15	x	x	22.15	21.65	x	x	x	x	21.8	x	x	23.25	x	23.05	20.5	x	19.1	
-12834	Original post publication description: Morphology: Body weight of 15-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 15-week old females [g]	x	x	20.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.65	21.35	x	x	x	x	x	x	x	x	x	x	21.2	22.25	x	x	x	21.8	19.0	x	x	x	21.35	18.35	x	20.9	23.0	x	x	x	18.0	x	20.5	x	x	x	x	22.8	19.35	x	x	20.9	x	21.6	x	x	21.8	23.8	x	x	x	x	22.05	x	x	21.2	x	23.75	20.7	x	18.8	
-12830	Original post publication description: Musculoskeletal system, metabolism: Bone surface area by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [cm2]	None	Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [cm2]	x	x	7.995	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.085	x	x	x	x	x	x	x	x	x	x	x	7.715	x	x	x	8.29	7.89	x	x	x	8.185	6.91	x	7.885	7.435	x	x	x	7.105	x	8.33	x	x	x	x	x	x	x	x	8.205	x	7.43	x	x	8.205	x	x	x	x	x	8.435	x	x	8.22	x	8.01	8.275	x	7.93	
-12828	Original post publication description: Musculoskeletal system, metabolism: Bone mineral content by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g]	None	Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g]	x	x	0.403	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.384	x	x	x	x	x	x	x	x	x	x	x	0.416	x	x	x	0.451	0.416	x	x	x	0.407	0.328	x	0.387	0.388	x	x	x	0.343	x	0.445	x	x	x	x	x	x	x	x	0.385	x	0.362	x	x	0.397	x	x	x	x	x	0.465	x	x	0.451	x	0.433	0.435	x	0.375	
-12826	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old females [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old females [mg/dl]	x	x	8572.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8880.0	13113.8	x	x	x	x	x	x	x	x	x	x	6592.5	12573.8	x	x	x	6592.5	3930.0	x	x	x	5366.25	6401.25	x	5370.0	5178.75	x	x	x	6847.5	x	6018.75	x	x	x	x	5962.5	5613.75	x	x	4713.75	x	9210.0	x	x	6153.75	5276.25	x	x	x	x	5865.0	x	x	7627.5	x	4725.0	7477.5	x	5651.25	
-12824	Original post publication description: Blood chemistry: Alkaline phosphatase of 14-week old females, (ALPL gene product) [U/l]	None	Blood chemistry: Alkaline phosphatase of 14-week old females, (ALPL gene product) [U/l]	x	x	182.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	137.5	138.5	x	x	x	x	x	x	x	x	x	x	195.5	153.0	x	x	x	139.5	226.0	x	x	x	161.0	160.0	x	124.5	204.0	x	x	x	164.5	x	135.5	x	x	x	x	166.0	243.0	x	x	205.5	x	175.5	x	x	254.0	287.0	x	x	x	x	209.5	x	x	149.0	x	139.0	159.5	x	174.5	
-12822	Original post publication description: Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old females [U/L]	None	Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old females [U/L]	x	x	34.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	24.0	33.0	x	x	x	x	x	x	x	x	x	x	21.5	87.0	x	x	x	31.0	47.5	x	x	x	24.5	33.5	x	35.5	42.0	x	x	x	31.0	x	24.5	x	x	x	x	44.0	68.0	x	x	20.5	x	28.5	x	x	18.0	38.0	x	x	x	x	35.0	x	x	26.0	x	27.5	23.5	x	30.0	
-12399	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	512.0	477.71	518.0	478.2	514.0	481.4	442.0	574.0	385.5	471.6	481.0	660.0	483.0	x	645.6	461.0	x	517.33	x	414.0	401.75	x	x	448.0	482.67	377.0	378.33	x	x	468.83	531.29	479.0	396.17	x	x	x	x	345.0	478.33	x	436.0	436.5	535.33	582.75	x	x	460.0	504.86	356.38	484.0	x	553.5	x	533.67	541.83	x	x	x	545.67	376.4	408.0	x	x	589.43	282.83	558.43	423.0	476.29	431.83	433.25	x	469.43	x	484.33	x	410.4	x	x	477.17	411.2	x	465.17	496.14	536.17	490.33	464.83	x	469.83	519.0	x	466.17	x	x	562.56	526.0	628.33	730.33	469.83	450.17	518.0	513.17	531.43	
-12226	Original post publication description: Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cell density in glomerular sections in males (8-20 wks of age) [WT1-positive cell number per 1000 um2 glomerular area]	None	Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cell density in glomerular sections in males (8-20 wks of age) [WT1-positive cell number per 1000 um2 glomerular area]	x	x	5.121	5.009	x	x	x	x	x	4.92	x	x	x	3.636	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.885	3.758	x	4.393	x	x	x	x	x	x	x	4.244	4.119	2.924	4.037	x	x	x	x	x	2.941	x	x	x	x	x	x	x	x	2.063	x	3.343	x	x	3.263	x	x	4.376	4.35	3.976	x	x	3.715	x	4.752	x	3.514	x	x	4.241	x	x	3.755	3.612	4.016	3.229	4.264	x	4.464	3.17	x	3.611	x	3.411	x	x	x	x	x	x	x	x	x	
-12227	Original post publication description: Podocytes per glomerulus in males (8-20 wks) [number per glomerulus in cross sectioned material]	None	Urogenital system, kidney, morphology: Podocytes per glomerulus in males (8-20 wks) [number per glomerulus in cross sectioned material]	x	x	11.236	13.004	x	x	x	x	x	11.33	x	x	x	12.298	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.17	10.933	x	10.055	x	x	x	x	x	x	x	10.052	11.233	9.185	10.59	x	x	x	x	x	8.33	x	x	x	x	x	x	x	x	7.794	x	9.477	x	x	9.9	x	x	11.821	12.597	10.969	x	x	9.104	x	12.283	x	10.579	x	x	11.505	x	x	8.948	10.382	8.903	9.945	11.983	x	11.383	10.155	x	8.85	x	8.427	x	x	x	x	x	x	x	x	x	
-12228	Original post publication description: Urogenital system, kidney, morphology: Glomerular section area (GSA) in glomeruli of males (8-20 wks of age) [um^2]	None	Urogenital system, kidney, morphology: Glomerular section area (GSA) in glomeruli of males (8-20 wks of age) [um^2]	x	x	2457.0	2890.0	x	x	x	x	x	2320.67	x	x	x	3393.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3138.31	2902.68	x	2309.06	x	x	x	x	x	x	x	2415.19	2727.0	3143.0	2661.05	x	x	x	x	x	2876.97	x	x	x	x	x	x	x	x	3822.24	x	2845.99	x	x	3034.0	x	x	2741.72	2920.23	2831.0	x	x	2468.5	x	2599.97	x	3010.0	x	x	2743.85	x	x	2429.34	2967.42	2224.02	3077.0	2810.2	x	2557.95	3203.09	x	2451.0	x	2470.0	x	x	x	x	x	x	x	x	x	
-12229	Original post publication description: Morphology, urogenital system: Kidney weight of males at 8-20 wk [mg]	None	Urogenital system, kidney, morphology: Kidney weight of males at 8-20 wk [mg]	x	x	158.395	186.55	x	x	x	x	x	131.867	x	x	x	95.175	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	121.475	132.9	x	100.4	x	x	x	x	x	x	x	64.45	137.45	203.95	174.875	x	x	x	x	x	216.2	x	x	x	x	x	x	x	x	166.89	x	218.9	x	x	230.475	x	x	107.775	213.4	174.625	x	x	201.525	x	193.6	x	265.05	x	x	142.275	x	x	201.475	182.0	176.825	298.05	114.275	x	157.233	238.025	x	150.925	x	207.3	x	x	x	x	x	x	x	x	x	
-12230	Original post publication description: Wilms tumor 1 homolog positive cells per glomerular section in males (8-20 wks of age) [WT1-positive cells/glomerular section]	None	Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cells per glomerular section in males (8-20 wks of age) [WT1-positive cells/glomerular section]	x	x	11.2362	13.0041	x	x	x	x	x	11.3295	x	x	x	12.2983	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.1704	10.9333	x	10.0548	x	x	x	x	x	x	x	10.0523	11.2333	9.185	10.5902	x	x	x	x	x	8.33295	x	x	x	x	x	x	x	x	9.06667	x	9.47737	x	x	9.9	x	x	11.8214	12.5968	10.9688	x	x	9.10417	x	12.2833	x	10.5789	x	x	11.5054	x	x	8.94786	10.3821	8.90322	9.94462	11.9833	x	11.3825	10.1552	x	8.85	x	8.42692	x	x	x	x	x	x	x	x	x	
-12231	Original post publication description: Kidney weight/body weight ratio in males (8 - 20 wks) [mg/g]	None	Urogenital system, kidney, morphology: Kidney weight/body weight ratio in males (8 - 20 wks) [mg/g]	x	x	6.2638	7.4259	x	x	x	x	x	4.5265	x	x	x	6.9969	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.5694	5.7439	x	5.9496	x	x	x	x	x	x	x	7.8068	5.0642	7.333	7.0809	x	x	x	x	x	8.0181	x	x	x	x	x	x	x	x	7.6934	x	8.3075	x	x	8.0936	x	x	5.2566	8.6566	7.1774	x	x	8.6172	x	7.8378	x	6.5632	x	x	6.4762	x	x	8.2429	8.5875	6.4985	7.2707	5.2297	x	5.7384	9.4999	x	4.5708	x	7.6631	x	x	x	x	x	x	x	x	x	
-12232	Original post publication description: Kidney morphology, glomerular cells per glomerular section in males (8 to 20 weeks of age) [cell density]	None	Urogenital system, kidney, morphology: Glomerular cells per glomerular section in males (8 to 20 weeks of age) [cell density]	x	x	42.95	50.476	x	x	x	x	x	45.07	x	x	x	67.079	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	58.801	50.567	x	43.755	x	x	x	x	x	x	x	44.112	38.833	48.907	40.673	x	x	x	x	x	36.027	x	x	x	x	x	x	x	x	48.867	x	36.856	x	x	48.567	x	x	39.75	47.964	48.562	x	x	37.704	x	41.933	x	46.842	x	x	44.455	x	x	36.943	48.071	41.887	48.976	46.1	x	40.377	43.741	x	49.2	x	37.492	x	x	x	x	x	x	x	x	x	
-12397	Original post publication description: Anxiety assay, saline treated (0.18 ml/kg ip, NOS group), time in open quadrants only during last 5 min of test using an elevated zero maze for 60- to 120-day-old females [%]	None	Central nervous system, behavior: Anxiety assay, saline treated (0.18 ml/kg ip, NOS group), time in open quadrants only during last 5 min of test using an elevated zero maze for 60- to 120-day-old females [%]	18.061	17.757	16.317	20.193	36.661	7.28	4.0	10.893	15.783	25.18	13.622	18.078	3.556	x	7.473	23.767	x	14.744	x	5.578	7.233	x	x	23.8	18.267	27.283	12.056	x	x	13.106	21.324	9.407	38.694	x	x	x	x	1.242	22.689	x	34.158	29.3	25.456	13.783	x	x	21.689	13.529	42.763	22.657	x	24.0	x	26.078	20.572	x	x	x	31.167	16.02	20.892	x	x	20.714	14.661	9.71	30.939	25.871	23.206	32.667	x	11.81	x	33.661	x	23.74	x	x	9.817	25.667	x	16.267	22.329	16.867	13.989	24.767	x	35.861	29.45	x	21.0	x	x	24.781	17.989	16.572	7.539	38.356	15.633	17.956	25.911	9.467	
-12396	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	16.906	25.981	20.717	18.92	38.294	20.82	10.122	7.627	13.406	27.58	16.411	21.783	5.2	x	8.967	27.811	x	14.083	x	4.933	9.633	x	x	16.9	32.078	16.75	5.622	x	x	15.039	29.729	22.013	43.578	x	x	x	x	4.158	27.2	x	37.679	23.825	26.356	18.567	x	x	31.789	20.714	43.65	29.29	x	22.504	x	30.356	18.989	x	x	x	33.25	26.26	22.279	x	x	25.376	29.239	9.105	33.272	31.452	29.944	31.658	x	16.648	x	37.778	x	32.173	x	x	17.556	24.473	x	20.178	26.176	20.856	17.522	22.733	x	23.711	35.956	x	28.25	x	x	28.067	24.683	17.544	11.2	34.861	21.394	21.744	26.883	16.6	
-12395	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	5.083	8.829	2.4	6.44	3.25	0.72	6.6	2.16	17.133	5.92	6.117	1.683	7.917	x	24.32	6.233	x	1.85	x	13.5	12.25	x	x	4.5	3.5	4.917	19.933	x	x	9.017	3.786	3.0	8.633	x	x	x	x	5.7	22.0	x	2.425	2.3	5.033	6.225	x	x	3.233	9.686	5.65	8.8	x	5.213	x	11.967	12.8	x	x	x	3.817	7.24	3.925	x	x	6.4	3.983	10.771	2.333	5.257	5.333	6.7	x	4.186	x	7.467	x	7.06	x	x	2.083	5.9	x	8.633	3.829	9.633	4.567	1.25	x	27.383	2.533	x	8.267	x	x	4.533	4.533	5.9	10.633	3.133	2.433	0.267	3.6	7.486	
-12392	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	0.374	0.449	0.645	0.69	0.317	0.32	0.768	0.308	0.4	2.33	0.493	0.218	0.577	x	0.514	0.317	x	0.48	0.385	0.356	x	x	x	2.821	0.415	0.378	0.651	x	x	0.31	0.224	0.456	0.979	x	1.691	x	0.502	0.296	0.287	x	0.217	0.552	0.56	0.29	x	x	0.496	0.318	0.267	0.363	x	0.39	x	0.516	1.043	x	x	x	0.569	0.383	0.869	x	x	0.447	0.364	0.448	0.316	4.522	0.36	0.278	x	0.34	0.498	0.556	x	0.515	x	x	0.297	0.602	x	0.278	0.459	1.336	0.723	0.431	x	4.095	0.247	x	0.886	x	x	0.39	0.342	0.458	0.751	0.279	0.484	0.332	10.518	0.343	
-12391	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	1157.64	1003.63	832.69	989.78	1460.0	1181.83	560.0	1307.17	1126.7	483.08	864.83	1359.0	950.17	x	1165.0	1261.33	x	1086.43	448.0	1408.57	x	x	x	227.5	978.0	1282.43	889.38	x	x	1070.25	1327.17	1069.4	793.08	x	173.0	x	1069.0	1012.92	1047.31	x	1409.53	708.07	793.0	1302.08	x	x	854.22	1221.36	999.2	992.0	x	602.0	x	854.73	1027.22	x	x	x	702.19	1040.23	680.14	x	x	1211.33	1148.23	1094.78	1405.08	421.29	1002.5	1486.42	x	1244.33	1124.0	846.64	x	864.67	x	x	1291.5	808.67	x	1339.31	1002.25	1098.42	780.82	783.62	x	535.0	1149.85	x	1147.83	x	x	941.71	1226.5	969.17	779.07	1188.3	910.08	998.0	565.93	1077.0	
-12390	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	520.73	457.06	357.54	521.56	768.3	608.83	228.0	678.25	521.6	250.23	414.08	654.75	424.67	x	580.33	704.33	x	581.14	82.0	746.57	x	x	x	173.5	451.0	645.29	384.38	x	x	555.75	632.25	543.1	443.08	x	118.0	x	570.5	447.83	533.31	x	719.87	422.21	413.58	616.31	x	x	424.33	575.55	461.8	454.11	x	157.0	x	397.0	542.11	x	x	x	358.88	581.38	379.5	x	x	602.17	565.15	507.11	742.75	246.21	530.69	718.0	x	710.67	681.0	473.45	x	381.17	x	x	670.33	447.11	x	646.08	468.25	554.5	432.82	382.46	x	303.3	579.08	x	551.42	x	x	420.36	589.17	465.17	393.57	568.1	425.67	516.38	224.2	542.54	
-12389	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	636.91	546.56	475.15	468.22	691.7	573.0	332.0	628.92	605.1	232.85	450.75	704.25	525.5	x	584.67	557.0	x	505.29	366.0	662.0	x	x	x	54.0	527.0	637.14	505.0	x	x	514.5	694.92	526.3	350.0	x	55.0	x	498.5	565.08	514.0	x	689.67	285.86	379.42	685.77	x	x	429.89	645.82	537.4	537.89	x	445.0	x	457.73	485.11	x	x	x	343.31	458.85	300.64	x	x	609.17	583.08	587.67	662.33	175.07	471.81	768.42	x	533.67	443.0	373.18	x	483.5	x	x	621.17	361.56	x	693.23	534.0	543.92	348.0	401.15	x	231.7	570.77	x	596.42	x	x	521.36	637.33	504.0	385.5	620.2	484.42	481.62	341.73	534.46	
-12388	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	24.886	27.213	17.322	35.707	31.168	29.917	7.65	34.494	28.388	15.937	24.506	43.392	9.078	x	17.828	40.419	x	21.862	57.85	20.817	x	x	x	36.508	25.825	30.819	14.267	x	x	41.2	44.699	32.072	48.462	x	34.5	x	21.433	36.64	49.218	x	46.444	49.068	36.542	32.035	x	x	47.561	35.85	52.572	34.419	x	21.117	x	36.47	12.498	x	x	x	31.408	32.101	33.556	x	x	29.065	33.2	15.324	39.385	57.979	49.05	29.369	x	40.004	27.933	31.22	x	34.036	x	x	38.526	30.613	x	32.936	24.026	18.574	33.395	43.551	x	40.942	47.255	x	29.031	x	x	32.151	24.854	37.186	36.282	41.54	26.028	42.127	32.594	36.733	
-12387	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time]	22.015	20.448	11.082	36.044	31.237	20.189	0.333	28.414	25.933	15.351	16.378	38.658	4.183	x	17.028	35.211	x	15.829	62.7	16.405	x	x	x	31.433	23.167	29.595	9.029	x	x	31.971	39.528	27.143	48.144	x	0.0	x	19.65	25.081	44.05	x	40.676	35.914	27.597	27.049	x	x	45.704	36.406	50.533	32.281	x	0.1	x	31.264	12.459	x	x	x	19.812	20.328	27.505	x	x	27.206	30.205	14.222	33.475	54.571	48.858	27.656	x	31.831	29.333	22.891	x	30.433	x	x	33.017	28.593	x	28.805	20.175	14.747	28.779	37.567	x	41.427	40.885	x	27.536	x	x	24.905	17.711	31.506	30.217	37.27	17.736	37.615	20.129	30.669	
-12386	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	27.758	33.979	23.562	35.37	31.1	39.644	14.967	40.575	30.843	16.523	32.633	48.125	13.972	x	18.628	45.628	x	27.895	53.0	25.229	x	x	x	41.583	28.483	32.043	19.504	x	x	50.429	49.869	37.0	48.781	x	69.0	x	23.217	48.2	54.385	x	52.213	62.221	45.486	37.021	x	x	49.419	35.294	54.611	36.556	x	42.133	x	41.676	12.537	x	x	x	43.004	43.874	39.607	x	x	30.925	36.195	16.426	45.294	61.386	49.242	31.083	x	48.178	26.533	39.548	x	37.639	x	x	44.036	32.633	x	37.067	27.878	22.4	38.012	49.536	x	40.457	53.626	x	30.525	x	x	39.398	31.997	42.867	42.348	45.81	34.319	46.638	45.06	42.797	
-12385	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	15.918	15.194	2.454	27.433	4.3	2.683	0.3	7.875	21.06	55.545	8.325	2.725	36.433	x	30.6	8.167	x	36.067	5.6	9.257	x	x	x	17.7	4.85	11.043	4.763	x	x	2.587	2.658	15.96	18.083	x	15.9	x	56.35	4.092	4.05	x	4.187	4.643	25.683	5.815	x	x	7.122	13.609	1.733	10.056	x	4.2	x	11.709	20.967	x	x	x	7.963	8.477	12.464	x	x	12.2	5.992	35.522	9.658	29.45	15.138	3.917	x	1.233	22.8	8.691	x	20.273	x	x	3.1	1.967	x	0.523	9.383	12.764	2.291	13.254	x	42.95	4.177	x	9.242	x	x	3.943	6.108	5.45	27.95	4.31	9.892	4.954	2.867	3.454	
-12384	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	0.368	0.756	0.935	1.511	0.281	0.437	x	0.314	0.365	2.455	0.547	0.277	0.537	x	0.897	0.305	x	0.451	0.565	0.349	x	x	x	0.95	0.586	0.395	0.975	x	x	0.426	0.251	0.494	0.429	x	2.272	x	0.476	0.407	0.25	x	0.23	0.922	0.469	0.392	x	x	0.375	0.384	0.322	0.397	x	0.786	x	1.105	0.531	x	x	x	0.659	0.365	1.299	x	x	0.48	0.351	0.413	0.269	1.498	0.311	0.369	x	0.266	0.385	0.617	x	0.564	x	x	0.426	0.485	x	0.255	0.573	1.075	0.585	0.578	x	8.753	0.287	x	2.475	x	x	0.66	0.393	0.622	0.832	0.349	0.462	0.353	61.34	0.412	
-12383	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	0.442	0.862	1.167	12.746	0.254	0.438	x	0.368	0.457	2.051	0.579	0.309	0.607	x	1.099	0.274	x	0.451	1.365	0.341	x	x	x	0.851	0.624	0.372	1.657	x	x	0.473	0.277	0.51	0.354	x	2.542	x	0.453	0.533	0.278	x	0.253	0.997	0.539	0.537	x	x	0.348	0.435	0.388	0.444	x	1.909	x	3.312	0.454	x	x	x	0.719	0.36	2.022	x	x	0.424	0.339	0.453	0.284	2.208	0.289	0.422	x	0.296	0.311	0.545	x	0.675	x	x	0.488	0.394	x	0.28	0.814	0.775	0.599	0.861	x	53.09	0.308	x	25.293	x	x	4.397	0.425	3.673	0.902	0.399	0.581	0.367	76.69	0.439	
-12393	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	None	Central nervous system, pharmacology, behavior: Ethanol response (1.8 g/kg ip), anxiety assay in ethanol-treated (NOE) group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks/sec]	0.544	0.693	0.95	6.517	0.287	0.43	1.311	0.396	0.527	1.819	0.89	0.279	1.123	x	0.565	0.281	x	0.498	1.365	0.339	x	x	x	1.126	0.516	0.345	1.424	x	x	0.385	0.836	0.445	0.442	x	2.542	x	0.453	0.564	0.331	x	0.258	0.669	0.556	0.458	x	x	0.517	0.38	0.358	0.457	x	1.909	x	2.233	0.534	x	x	x	0.749	0.445	1.267	x	x	0.371	0.428	0.556	0.275	1.265	0.302	0.342	x	0.331	0.311	0.64	x	0.766	x	x	0.355	0.49	x	0.341	0.692	0.673	0.568	0.68	x	31.945	0.446	x	12.854	x	x	2.456	0.443	2.126	1.061	0.365	1.11	0.375	23.117	0.415	
-12382	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	0.31	0.541	0.793	0.977	0.322	0.435	x	0.273	0.297	2.88	0.526	0.245	0.499	x	0.76	0.329	x	0.479	0.385	0.365	x	x	x	1.295	0.552	0.418	0.702	x	x	0.393	0.229	0.518	0.701	x	1.691	x	0.502	0.306	0.225	x	0.209	0.806	0.429	0.313	x	x	0.404	0.351	0.277	0.368	x	0.39	x	0.607	0.717	x	x	x	0.603	0.374	1.01	x	x	0.633	0.397	0.38	0.255	1.267	0.384	0.336	x	0.215	0.498	0.787	x	0.494	x	x	0.367	0.614	x	0.228	0.538	2.253	0.546	0.45	x	5.085	0.266	x	1.455	x	x	0.447	0.357	0.517	0.986	0.298	0.382	0.34	30.677	0.391	
-12381	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	1212.0	830.56	727.33	795.2	1536.5	1070.0	x	1185.5	1219.0	398.67	958.5	1750.0	1027.67	x	611.0	1184.8	x	1150.75	448.0	1417.5	x	x	x	175.0	927.0	1392.0	888.33	x	x	942.75	1373.33	995.0	896.83	x	173.0	x	1069.0	967.17	1382.17	x	1516.0	447.71	794.17	1295.33	x	x	848.6	1120.75	1018.25	979.0	x	602.0	x	718.86	1161.83	x	x	x	751.0	1098.83	724.17	x	x	1146.0	1238.33	1182.25	1530.83	475.57	1089.8	1448.33	x	1418.25	1124.0	906.67	x	955.67	x	x	1073.67	776.4	x	1395.33	882.67	1080.83	774.8	611.5	x	381.0	1226.0	x	1010.5	x	x	752.43	1258.5	887.5	664.0	1196.83	1089.33	1181.0	395.8	1142.0	
-12380	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	547.5	389.56	288.89	427.4	819.0	594.0	x	622.17	533.0	212.33	492.67	885.0	483.67	x	247.0	684.6	x	629.0	82.0	772.33	x	x	x	136.0	431.0	704.0	382.83	x	x	492.5	660.5	506.86	462.17	x	118.0	x	570.5	446.17	672.83	x	748.25	264.0	399.67	597.0	x	x	401.2	504.25	458.5	484.0	x	157.0	x	330.86	619.0	x	x	x	351.0	651.0	386.17	x	x	606.83	671.33	534.25	813.0	280.43	611.1	681.5	x	789.0	681.0	502.0	x	450.0	x	x	522.83	463.2	x	729.67	409.83	588.5	429.4	285.5	x	199.33	607.67	x	534.5	x	x	325.29	611.83	402.33	360.63	584.67	523.5	624.5	150.6	617.17	
-12379	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	664.5	441.0	438.44	367.8	717.5	476.0	x	563.33	686.0	186.33	465.83	865.0	544.0	x	364.0	500.2	x	521.75	366.0	645.17	x	x	x	39.0	496.0	688.0	505.5	x	x	450.25	712.83	488.14	434.67	x	55.0	x	498.5	521.0	709.33	x	767.75	183.71	394.5	698.33	x	x	447.4	616.5	559.75	495.0	x	445.0	x	388.0	542.83	x	x	x	400.0	447.83	338.0	x	x	539.17	567.0	648.0	717.83	195.14	478.7	766.83	x	629.25	443.0	404.67	x	505.67	x	x	550.83	313.2	x	665.67	472.83	492.33	345.4	326.0	x	181.67	618.33	x	476.0	x	x	427.14	646.67	485.17	303.38	612.17	565.83	556.5	245.2	524.83	
-12378	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time]	25.425	30.211	7.832	34.107	30.722	22.15	x	41.994	30.567	16.294	25.217	19.1	11.972	x	8.683	44.097	x	21.221	57.85	19.492	x	x	x	72.3	9.533	8.433	14.756	x	x	35.638	44.869	29.412	49.319	x	34.5	x	21.433	37.606	42.622	x	43.302	53.821	40.6	26.819	x	x	51.073	32.11	49.498	35.128	x	21.117	x	36.15	14.6	x	x	x	24.836	33.4	27.186	x	x	19.164	31.897	20.1	31.994	49.876	45.015	18.836	x	41.321	27.933	15.403	x	30.719	x	x	32.528	41.503	x	42.472	22.242	18.975	41.683	49.277	x	29.333	42.497	x	25.478	x	x	35.536	22.322	38.672	43.006	39.061	25.092	31.185	25.153	31.1	
-12377	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	None	Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time]	20.583	21.007	1.574	33.793	31.767	13.267	x	33.917	25.856	21.694	22.078	8.967	8.144	x	9.533	39.247	x	13.45	62.7	13.35	x	x	x	61.433	10.3	12.733	9.061	x	x	25.467	41.072	22.157	48.4	x	0.0	x	19.65	25.161	37.5	x	38.617	44.857	31.517	21.185	x	x	54.02	33.408	47.283	30.667	x	0.1	x	25.705	13.906	x	x	x	18.856	22.433	16.344	x	x	17.872	27.756	20.65	23.461	42.657	43.537	19.033	x	28.75	29.333	13.428	x	28.633	x	x	25.378	40.993	x	34.0	17.367	16.333	30.673	40.354	x	25.244	39.517	x	23.922	x	x	29.786	16.533	36.617	35.979	33.744	17.239	24.829	13.127	24.617	
-12376	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time]	30.267	39.415	14.089	34.42	29.678	31.033	x	50.072	35.278	10.894	28.356	29.233	15.8	x	7.833	48.947	x	28.992	53.0	25.633	x	x	x	83.167	8.767	4.133	20.45	x	x	45.808	48.667	36.667	50.239	x	69.0	x	23.217	50.05	47.744	x	47.988	62.786	49.683	32.452	x	x	48.127	30.813	51.713	39.589	x	42.133	x	46.595	15.294	x	x	x	30.817	44.367	38.028	x	x	20.456	36.039	19.55	40.528	57.095	46.493	18.639	x	53.892	26.533	17.378	x	32.806	x	x	39.678	42.013	x	50.944	27.117	21.617	52.693	58.2	x	33.422	45.478	x	27.033	x	x	41.286	28.111	40.728	50.033	44.378	32.944	37.542	37.18	37.583	
-12375	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	25.825	22.867	2.578	29.7	3.117	1.9	x	5.65	5.1	92.88	10.3	10.8	25.6	x	31.1	9.7	x	37.3	5.6	9.767	x	x	x	17.7	8.4	43.1	5.3	x	x	1.725	3.583	19.871	10.817	x	15.9	x	56.35	6.4	8.517	x	5.588	4.657	4.217	8.022	x	x	5.22	16.55	2.438	6.433	x	4.2	x	8.9	17.467	x	x	x	12.867	12.017	7.483	x	x	17.633	7.283	10.275	9.533	14.871	9.93	6.233	x	2.2	22.8	14.25	x	32.24	x	x	5.467	0.94	x	0.467	12.083	6.08	2.1	12.463	x	58.567	4.05	x	5.517	x	x	3.357	7.367	2.95	39.075	5.65	8.183	6.025	3.12	3.0	
-12374	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg ip] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	None	Anxiety assay, ethanol treated (1.8 g/kg ip) (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	0.478	0.389	0.38	0.307	0.318	0.351	0.989	0.375	0.52	3.255	0.874	0.238	0.928	x	0.459	0.285	x	0.517	x	0.315	x	x	x	2.127	0.338	0.353	0.595	x	x	0.262	0.647	0.301	0.737	x	x	x	x	0.402	0.333	x	0.243	0.365	0.561	0.261	x	x	0.672	0.231	0.279	0.404	x	x	x	0.35	0.81	x	x	x	0.623	0.45	0.625	x	x	0.285	0.386	0.559	0.308	2.989	0.317	0.24	x	0.345	x	0.605	x	0.652	x	x	0.221	0.591	x	0.323	0.445	0.475	0.663	0.387	x	0.363	0.321	x	0.362	x	x	0.411	0.389	0.483	0.587	0.279	0.832	0.335	0.842	0.344	
-12373	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	0.602	0.475	0.463	0.289	0.337	0.428	1.311	0.424	0.631	1.626	1.202	0.27	1.638	x	0.459	0.317	x	0.561	x	0.331	x	x	x	1.401	0.407	0.341	0.727	x	x	0.297	1.396	0.293	0.529	x	x	x	x	0.595	0.371	x	0.263	0.388	0.573	0.281	x	x	0.73	0.236	0.322	0.463	x	x	x	0.345	0.696	x	x	x	0.769	0.519	0.621	x	x	0.317	0.504	0.639	0.267	0.322	0.322	0.263	x	0.348	x	0.753	x	0.856	x	x	0.222	0.61	x	0.36	0.57	0.57	0.542	0.392	x	0.228	0.564	x	0.415	x	x	0.515	0.46	0.579	1.273	0.315	1.64	0.395	1.688	0.395	
-12372	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	0.41	0.329	0.312	0.332	0.309	0.297	0.768	0.344	0.555	1.858	0.46	0.209	0.656	x	0.465	0.253	x	0.481	x	0.304	x	x	x	4.348	0.278	0.371	0.499	x	x	0.228	0.22	0.312	1.258	x	x	x	x	0.285	0.329	x	0.227	0.298	0.691	0.241	x	x	0.613	0.227	0.257	0.36	x	x	x	0.355	1.696	x	x	x	0.546	0.39	0.764	x	x	0.262	0.337	0.502	0.376	7.776	0.318	0.221	x	0.403	x	0.278	x	0.537	x	x	0.226	0.587	x	0.293	0.381	0.419	0.871	0.4	x	2.611	0.23	x	0.316	x	x	0.333	0.327	0.398	0.438	0.249	0.587	0.32	0.439	0.302	
-12371	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	None	Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	1126.57	1226.14	1069.75	1233.0	1345.25	1204.2	560.0	1428.83	988.25	555.43	771.17	1228.67	872.67	x	1275.8	1644.0	x	1000.67	x	1355.0	x	x	x	280.0	1029.0	1264.17	892.5	x	x	1197.75	1281.0	1243.0	689.33	x	x	x	x	1058.67	846.4	x	1287.86	968.43	791.83	1317.25	x	x	861.25	1489.67	977.43	998.5	x	x	x	1092.5	758.0	x	x	x	672.9	990.0	647.13	x	x	1276.67	1071.0	1024.8	1279.33	367.0	857.0	1524.5	x	1157.38	x	774.6	x	773.67	x	x	1509.33	849.0	x	1322.5	1121.83	1116.0	785.83	1059.0	x	766.0	1084.57	x	1285.17	x	x	1131.0	1194.5	1050.83	932.5	1175.5	730.83	705.2	651.0	1021.29	
-12370	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	505.43	543.86	512.0	639.25	692.25	611.8	228.0	734.33	504.5	282.71	335.5	578.0	365.67	x	647.0	803.0	x	517.33	x	592.0	x	x	x	211.0	471.0	635.5	389.0	x	x	619.0	604.0	627.67	424.0	x	x	x	x	449.5	449.6	x	687.43	580.43	427.5	659.75	x	x	453.25	765.67	465.57	439.17	x	x	x	512.75	388.33	x	x	x	363.6	521.71	374.5	x	x	597.5	474.14	485.4	672.5	212.0	396.67	754.5	x	671.5	x	439.2	x	312.33	x	x	817.83	427.0	x	621.0	526.67	520.5	435.67	537.6	x	459.25	554.57	x	568.33	x	x	515.43	566.5	528.0	437.5	543.25	327.83	343.4	261.0	478.57	
-12369	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	None	Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	621.14	682.29	557.75	593.75	653.0	592.4	332.0	694.5	483.75	272.71	435.67	650.67	507.0	x	628.8	841.0	x	483.33	x	763.0	x	x	x	69.0	558.0	628.67	503.5	x	x	578.75	677.0	615.33	265.33	x	x	x	x	609.17	396.8	x	600.43	388.0	364.33	657.5	x	x	408.0	724.0	511.86	559.33	x	x	x	579.75	369.67	x	x	x	309.3	468.29	272.63	x	x	679.17	596.86	539.4	606.83	155.0	460.33	770.0	x	485.88	x	335.4	x	461.33	x	x	691.5	422.0	x	701.5	595.17	595.5	350.17	521.4	x	306.75	530.0	x	716.83	x	x	615.57	628.0	522.83	495.0	632.25	403.0	361.8	390.0	542.71	
-12368	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during whole 10 min test [% time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during whole 10 min test [% time]	24.579	23.36	38.675	37.708	31.837	31.47	7.65	26.994	25.121	15.631	23.794	51.489	6.183	x	19.657	22.033	x	22.717	x	28.767	x	x	x	0.717	42.117	34.55	12.8	x	x	46.763	44.528	38.278	47.606	x	x	x	x	35.675	53.175	x	50.036	44.314	32.483	43.771	x	x	43.171	45.822	56.086	34.064	x	x	x	37.029	8.294	x	x	x	35.352	30.988	38.333	x	x	38.967	34.317	11.503	46.775	66.081	55.775	39.903	x	39.346	x	50.2	x	37.353	x	x	44.525	17.0	x	30.075	25.811	18.172	26.489	34.39	x	58.354	51.333	x	32.583	x	x	28.767	27.386	35.7	27.317	45.258	26.964	59.633	36.315	41.562	
-12367	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	None	Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percent time]	22.833	19.729	32.475	38.858	30.442	21.573	0.333	22.911	26.05	9.914	10.678	48.556	0.222	x	18.527	15.033	x	19.0	x	34.733	x	x	x	1.433	36.033	32.406	8.933	x	x	38.475	37.983	38.778	47.889	x	x	x	x	25.0	47.98	x	43.029	26.971	23.678	40.242	x	x	35.308	44.4	54.248	33.089	x	x	x	40.992	9.567	x	x	x	20.387	18.524	35.875	x	x	36.539	32.305	9.08	43.489	66.486	57.728	36.278	x	33.371	x	34.247	x	32.233	x	x	40.656	13.092	x	27.247	22.983	13.161	27.2	33.107	x	65.7	42.057	x	31.15	x	x	20.024	18.889	26.394	22.533	42.558	18.233	58.073	23.63	35.857	
-12366	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during first 5 min [% time]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during first 5 min [% time]	26.324	26.99	44.875	36.558	33.233	41.367	14.967	31.078	24.192	21.348	36.911	54.422	12.144	x	20.787	29.033	x	26.433	x	22.8	x	x	x	0.0	48.2	36.694	16.667	x	x	55.05	51.072	37.778	47.322	x	x	x	x	46.35	58.37	x	57.043	61.657	41.289	47.3	x	x	51.033	47.244	57.924	35.039	x	x	x	33.067	7.022	x	x	x	50.317	43.452	40.792	x	x	41.394	36.329	13.927	50.061	65.676	53.822	43.528	x	45.321	x	66.153	x	42.472	x	x	48.394	20.908	x	32.903	28.639	23.183	25.778	35.673	x	51.008	60.61	x	34.017	x	x	37.51	35.883	45.006	32.1	47.958	35.694	61.193	49.0	47.267	
-12365	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	10.257	5.329	2.175	24.6	6.075	2.84	0.3	10.1	45.0	24.433	6.35	0.033	47.267	x	30.5	0.5	x	34.833	x	6.2	x	x	x	x	1.3	5.7	3.15	x	x	3.45	1.733	6.833	25.35	x	x	x	x	1.783	1.37	x	2.586	4.629	47.15	0.85	x	x	9.5	5.767	0.929	11.867	x	x	x	16.625	27.967	x	x	x	5.02	5.443	16.2	x	x	6.767	4.886	55.72	9.783	44.029	23.817	1.6	x	0.75	x	2.02	x	10.3	x	x	0.733	3.25	x	0.54	6.683	18.333	2.45	14.52	x	19.525	4.286	x	12.967	x	x	4.529	4.85	7.95	13.117	2.3	11.6	3.24	2.74	3.843	
-12364	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	0.49	0.482	0.431	0.831	0.354	0.48	x	0.416	0.538	0.493	0.729	0.404	0.538	0.406	0.417	0.569	x	0.436	0.403	0.493	0.514	x	x	0.477	0.509	0.597	0.698	x	x	0.472	0.43	0.467	0.506	x	x	x	0.529	0.572	0.379	x	0.435	0.524	0.551	0.445	x	x	0.431	0.612	0.513	0.517	x	x	x	0.428	0.542	x	x	x	0.408	0.496	0.544	x	x	0.448	0.602	0.486	0.481	0.423	0.497	0.425	x	0.507	0.53	0.442	x	0.505	x	0.361	0.451	0.529	x	0.506	0.593	0.43	0.442	0.547	x	0.497	0.409	x	0.44	x	x	0.421	0.476	0.413	0.385	0.426	0.588	0.487	0.541	0.457	
-12363	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	0.563	0.605	0.488	0.787	0.393	0.57	x	0.505	0.629	0.547	0.913	0.486	0.637	0.387	0.464	0.715	x	0.51	0.429	0.569	0.626	x	x	0.492	0.719	0.644	0.754	x	x	0.546	0.495	0.486	0.586	x	x	x	0.554	0.775	0.422	x	0.512	0.61	0.622	0.535	x	x	0.497	0.719	0.563	0.56	x	x	x	0.451	0.667	x	x	x	0.463	0.607	0.543	x	x	0.494	0.723	0.453	0.56	0.505	0.547	0.445	x	0.586	0.418	0.476	x	0.53	x	0.394	0.547	0.665	x	0.575	0.732	0.468	0.505	0.61	x	0.525	0.468	x	0.475	x	x	0.477	0.59	0.474	0.406	0.448	0.625	0.53	0.773	0.574	
-12362	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	0.436	0.401	0.387	0.958	0.322	0.416	x	0.362	0.48	0.449	0.617	0.347	0.484	0.427	0.385	0.495	x	0.39	0.381	0.445	0.443	x	x	0.465	0.367	0.565	0.663	x	x	0.419	0.379	0.456	0.452	x	x	x	0.515	0.447	0.345	x	0.38	0.458	0.498	0.385	x	x	0.377	0.549	0.484	0.481	x	x	x	0.418	0.461	x	x	x	0.366	0.421	0.649	x	x	0.412	0.525	0.533	0.453	0.37	0.457	0.41	x	0.457	0.679	0.432	x	0.487	x	0.336	0.405	0.428	x	0.456	0.512	0.4	0.398	0.507	x	0.486	0.365	x	0.412	x	x	0.382	0.405	0.367	0.375	0.412	0.591	0.455	0.433	0.389	
-12356	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	25.472	35.181	28.696	21.605	42.275	25.7	x	28.79	12.673	27.614	20.572	30.714	8.753	16.167	28.231	16.642	x	33.421	12.8	24.93	15.611	x	x	27.342	26.467	17.981	9.029	x	x	32.244	34.619	23.545	38.778	x	x	x	15.85	28.9	23.817	x	35.079	34.785	18.572	17.586	x	x	33.904	17.85	42.178	32.205	x	x	x	32.949	11.558	x	x	x	44.758	32.717	33.636	x	x	23.681	23.136	14.556	26.772	32.895	33.895	33.469	x	15.636	26.233	41.488	x	18.048	x	28.0	20.486	37.733	x	27.807	18.749	20.892	25.747	26.972	x	25.611	31.236	x	26.425	x	x	30.626	26.25	18.854	29.06	32.469	21.283	22.986	29.56	26.414	
-12357	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	22.742	27.103	26.665	24.533	40.083	19.7	x	28.959	20.18	27.256	13.883	27.994	14.873	13.0	30.457	17.436	x	39.183	15.567	29.442	16.422	x	x	36.242	2.033	25.443	9.233	x	x	31.844	31.292	35.009	36.753	x	x	x	13.508	18.956	20.406	x	36.44	31.156	14.936	12.997	x	x	22.779	22.722	49.914	30.81	x	x	x	32.682	10.607	x	x	x	47.219	26.278	33.856	x	x	24.192	22.164	32.561	30.419	36.997	30.751	33.162	x	15.942	39.5	40.546	x	21.276	x	35.2	19.793	30.067	x	23.224	19.426	23.985	26.361	31.872	x	29.136	31.618	x	32.642	x	x	34.041	17.986	17.029	32.871	38.697	18.797	27.229	26.802	25.086	
-12358	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	24.107	31.142	27.68	23.069	41.179	22.7	x	28.874	16.427	27.435	17.228	29.354	11.813	14.583	29.344	17.039	x	36.302	14.183	27.186	16.017	x	x	31.792	14.25	21.712	9.131	x	x	32.044	32.956	29.277	37.765	x	x	x	14.679	23.928	22.111	x	35.759	32.97	16.754	15.292	x	x	28.342	20.286	46.046	31.507	x	x	x	32.815	11.082	x	x	x	45.989	29.497	33.746	x	x	23.936	22.65	23.558	28.596	34.946	32.323	33.316	x	15.789	32.867	41.017	x	19.662	x	31.6	20.139	33.9	x	25.515	19.087	22.439	26.054	29.422	x	27.374	31.427	x	29.533	x	x	32.333	22.118	17.942	30.965	35.583	20.04	25.107	28.181	25.75	
-12359	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	528.83	500.08	562.53	535.36	551.38	557.17	x	596.38	549.2	489.42	418.42	622.17	584.2	589.0	566.79	546.91	x	519.63	687.0	519.55	576.67	x	x	473.13	601.0	448.44	430.29	x	x	495.58	529.83	512.36	417.75	x	x	x	494.38	491.4	670.58	x	528.81	442.56	506.17	658.25	x	x	531.88	467.0	365.67	442.93	x	x	x	545.92	587.4	x	x	x	444.17	482.92	386.67	x	x	565.92	448.85	493.0	493.92	559.38	445.77	488.0	x	574.75	326.0	432.75	x	515.82	x	642.0	605.86	440.0	x	482.0	485.08	597.77	564.92	443.92	x	477.92	563.92	x	544.25	x	x	545.89	556.5	673.0	596.0	491.62	422.3	520.29	499.93	577.53	
-12360	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	436.92	398.67	467.53	433.43	472.25	428.67	x	435.92	389.0	400.67	327.67	469.0	430.6	674.0	459.79	409.91	x	361.0	591.0	384.0	419.67	x	x	389.5	409.0	356.5	378.71	x	x	388.0	423.83	410.36	330.67	x	x	x	494.0	341.47	573.58	x	378.0	356.89	422.75	528.58	x	x	484.38	344.17	284.67	394.93	x	x	x	465.77	424.27	x	x	x	345.25	382.33	370.75	x	x	474.75	346.69	461.0	428.25	393.69	389.0	457.36	x	447.5	434.0	383.5	x	457.27	x	494.0	501.79	324.0	x	413.57	351.46	500.38	470.0	336.92	x	410.75	445.15	x	426.75	x	x	420.22	455.17	547.0	514.29	423.92	405.5	423.0	355.0	439.06	
-12361	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	965.75	898.75	1030.06	968.79	1023.63	985.83	x	1032.31	938.2	890.08	746.08	1091.17	1014.8	1263.0	1026.57	956.82	x	880.63	1278.0	903.55	996.33	x	x	862.63	1010.0	804.94	809.0	x	x	883.58	953.67	922.73	748.42	x	x	x	988.38	832.87	1244.17	x	906.81	799.44	928.92	1186.83	x	x	1016.25	811.17	650.33	837.86	x	x	x	1011.69	1011.67	x	x	x	789.42	865.25	757.42	x	x	1040.67	795.54	954.0	922.17	953.08	834.77	945.36	x	1022.25	760.0	816.25	x	973.09	x	1136.0	1107.64	764.0	x	895.57	836.54	1098.15	1034.92	780.85	x	888.67	1009.08	x	971.0	x	x	966.11	1011.67	1220.0	1110.29	915.54	827.8	943.29	854.93	1016.59	
-12355	Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	4.683	7.8	7.176	9.6	4.575	4.85	x	3.908	10.42	17.558	9.433	5.667	9.6	24.3	21.386	4.4	x	6.65	22.8	12.818	7.667	x	x	4.363	20.0	23.178	29.543	x	x	13.033	8.625	10.282	7.983	x	x	x	16.6	8.587	7.492	x	6.219	5.478	3.817	4.508	x	x	9.05	12.833	12.633	10.593	x	x	x	7.215	18.167	x	x	x	8.2	3.583	22.058	x	x	7.783	6.869	9.15	11.642	2.892	5.538	8.007	x	7.025	41.4	6.125	x	22.209	x	0.8	4.7	21.4	x	6.75	10.923	7.823	6.467	6.885	x	10.325	2.285	x	11.0	x	x	14.333	10.108	4.825	6.464	8.892	6.84	2.6	9.979	5.124	
-12354	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	0.42	0.436	0.43	0.417	0.378	0.601	x	0.389	0.538	0.484	0.685	0.451	0.507	0.406	0.438	0.402	x	0.449	0.403	0.483	x	x	x	0.448	0.509	0.621	0.698	x	x	0.488	0.433	0.497	0.505	x	x	x	0.503	0.532	0.389	x	0.399	0.536	0.587	0.413	x	x	0.363	0.746	0.478	0.576	x	x	x	0.374	0.52	x	x	x	0.395	0.468	0.51	x	x	0.454	0.546	0.512	0.47	0.478	0.51	0.423	x	0.53	0.53	0.452	x	0.537	x	0.361	0.431	x	x	0.5	0.573	0.394	0.408	0.518	x	0.508	0.388	x	0.31	x	x	0.426	0.509	0.395	0.352	0.404	0.625	0.482	0.593	0.438	
-12353	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	0.462	0.508	0.51	0.484	0.424	0.63	x	0.48	0.629	0.532	0.91	0.576	0.654	0.387	0.494	0.45	x	0.54	0.429	0.553	x	x	x	0.459	0.719	0.688	0.754	x	x	0.54	0.514	0.532	0.578	x	x	x	0.495	0.719	0.439	x	0.471	0.606	0.656	0.514	x	x	0.371	0.914	0.511	0.633	x	x	x	0.431	0.643	x	x	x	0.462	0.548	0.531	x	x	0.502	0.603	0.454	0.514	0.591	0.546	0.426	x	0.566	0.418	0.434	x	0.544	x	0.394	0.477	x	x	0.522	0.695	0.413	0.448	0.596	x	0.575	0.427	x	0.345	x	x	0.466	0.684	0.45	0.375	0.418	0.572	0.531	0.915	0.524	
-12352	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	0.384	0.375	0.367	0.37	0.339	0.579	x	0.34	0.48	0.441	0.556	0.368	0.426	0.427	0.401	0.364	x	0.395	0.381	0.442	x	x	x	0.439	0.367	0.576	0.663	x	x	0.447	0.369	0.48	0.465	x	x	x	0.514	0.412	0.348	x	0.347	0.481	0.535	0.348	x	x	0.354	0.657	0.461	0.528	x	x	x	0.333	0.446	x	x	x	0.343	0.413	0.528	x	x	0.419	0.5	0.587	0.448	0.406	0.48	0.422	x	0.51	0.679	0.48	x	0.537	x	0.336	0.4	x	x	0.484	0.505	0.379	0.376	0.473	x	0.462	0.356	x	0.284	x	x	0.396	0.403	0.352	0.344	0.399	0.716	0.447	0.453	0.384	
-12351	Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	1083.67	946.67	1000.17	1057.0	973.67	851.0	x	933.67	938.2	810.0	761.33	1009.2	1045.33	1263.0	968.57	1129.33	x	852.67	1278.0	898.0	x	x	x	1000.0	1010.0	741.5	809.0	x	x	897.86	937.17	888.33	691.33	x	x	x	1002.67	848.33	1216.22	x	964.44	805.17	956.0	1265.2	x	x	1064.0	727.0	683.83	764.0	x	x	x	1107.5	1025.5	x	x	x	806.67	878.17	829.38	x	x	1116.5	786.67	892.25	973.33	829.67	841.71	968.12	x	970.0	760.0	878.0	x	973.5	x	1136.0	1157.63	x	x	860.33	869.17	1206.14	1028.25	745.67	x	925.67	1020.33	x	792.0	x	x	952.8	969.0	1205.4	1106.17	918.89	799.0	977.8	822.33	1040.11	
-12350	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	517.67	435.5	451.0	451.14	445.67	397.5	x	400.33	389.0	363.5	336.67	419.4	412.0	674.0	402.14	494.0	x	337.0	591.0	381.83	x	x	x	470.0	409.0	315.4	378.71	x	x	418.14	417.83	396.0	298.83	x	x	x	525.0	362.0	565.89	x	401.89	359.0	427.5	546.4	x	x	520.0	305.67	304.83	356.14	x	x	x	482.67	428.38	x	x	x	363.83	407.83	385.75	x	x	524.17	364.67	448.5	449.17	335.83	398.86	478.0	x	452.6	434.0	448.0	x	470.67	x	494.0	525.0	x	x	423.33	366.17	567.71	473.13	306.5	x	420.33	458.83	x	336.0	x	x	439.8	401.0	543.4	503.17	431.67	446.5	431.4	328.44	439.33	
-12349	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	566.0	511.17	549.17	605.86	528.0	453.5	x	533.33	549.2	446.5	424.67	589.8	633.33	589.0	566.43	635.33	x	515.67	687.0	516.17	x	x	x	530.0	601.0	426.1	430.29	x	x	479.71	519.33	492.33	392.5	x	x	x	477.67	486.33	650.33	x	562.56	446.17	528.5	718.8	x	x	544.0	421.33	379.0	407.86	x	x	x	624.83	597.13	x	x	x	442.83	470.33	443.63	x	x	592.33	422.0	443.75	524.17	493.83	442.86	490.13	x	517.4	326.0	430.0	x	502.83	x	642.0	632.63	x	x	437.0	503.0	638.43	555.13	439.17	x	505.33	561.5	x	456.0	x	x	513.0	568.0	662.0	603.0	487.22	352.5	546.4	493.89	600.78	
-12348	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	25.458	32.6	31.231	26.652	40.031	15.333	x	39.233	16.427	34.192	20.819	27.667	13.672	14.583	29.945	24.572	x	36.464	14.183	28.661	x	x	x	25.267	14.25	25.215	9.131	x	x	28.443	32.728	26.881	42.1	x	x	x	18.128	28.741	21.693	x	37.22	32.158	9.314	16.72	x	x	35.175	9.978	46.422	30.836	x	x	x	32.092	13.7	x	x	x	46.508	33.161	31.637	x	x	17.756	29.083	24.288	26.178	35.147	30.733	31.658	x	16.727	32.867	34.008	x	15.317	x	31.6	18.004	x	x	29.156	18.881	21.331	31.019	35.489	x	21.317	34.219	x	59.05	x	x	32.223	19.491	22.16	36.494	38.561	18.512	23.657	25.704	26.43	
-12347	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	22.2	27.539	28.317	28.081	38.433	18.167	x	39.878	20.18	33.617	15.706	24.593	16.533	13.0	34.705	26.128	x	39.533	15.567	31.994	x	x	x	28.133	2.033	28.577	9.233	x	x	27.181	29.167	31.794	43.217	x	x	x	17.189	22.704	18.33	x	37.911	31.994	8.144	14.747	x	x	34.6	10.656	50.761	29.638	x	x	x	31.833	14.088	x	x	x	44.978	29.633	31.696	x	x	16.528	27.389	34.842	28.994	35.939	28.938	32.604	x	18.487	39.5	37.217	x	17.672	x	35.2	18.4	x	x	28.333	20.567	22.738	31.296	38.3	x	20.606	34.933	x	61.333	x	x	32.473	15.11	20.933	40.111	41.837	16.875	26.347	24.004	28.496	
-12346	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	28.717	37.661	34.144	25.224	41.628	12.5	x	38.589	12.673	34.767	25.933	30.74	10.811	16.167	25.186	23.017	x	33.394	12.8	25.328	x	x	x	22.4	26.467	21.853	9.029	x	x	29.705	36.289	21.967	40.983	x	x	x	19.067	34.778	25.056	x	36.53	32.322	10.483	18.693	x	x	35.75	9.3	42.083	32.033	x	x	x	32.35	13.313	x	x	x	48.039	36.689	31.579	x	x	18.983	30.778	13.733	23.361	34.356	32.529	30.713	x	14.967	26.233	30.8	x	12.961	x	28.0	17.608	x	x	29.978	17.194	19.924	30.742	32.678	x	22.028	33.506	x	56.767	x	x	31.973	23.871	23.387	32.878	35.285	20.15	20.967	27.404	24.363	
-12345	Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	6.067	11.517	5.15	5.429	6.0	8.85	x	4.117	10.42	15.317	6.667	3.9	10.183	24.3	22.743	2.75	x	5.1	22.8	8.35	x	x	x	8.9	20.0	29.9	29.543	x	x	14.657	6.883	8.867	10.917	x	x	x	16.367	8.5	6.556	x	6.2	6.417	4.7	2.46	x	x	8.15	17.533	12.65	10.714	x	x	x	5.217	13.388	x	x	x	9.55	5.6	29.863	x	x	6.2	6.233	12.1	11.067	0.617	3.343	9.4	x	3.76	41.4	16.55	x	31.8	x	0.8	3.625	x	x	5.483	20.133	6.386	4.6	6.35	x	14.8	4.15	x	12.4	x	x	16.66	11.529	4.84	7.683	8.067	5.425	3.44	8.178	3.911	
-12344	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	0.56	0.527	0.432	0.8	0.284	0.42	x	0.44	x	0.502	0.773	0.371	0.585	x	0.396	0.77	x	0.396	x	0.506	0.514	x	x	0.481	x	0.567	x	x	x	0.449	0.427	0.43	0.506	x	x	x	0.608	0.632	0.351	x	0.481	0.501	0.515	0.467	x	x	0.454	0.477	0.548	0.458	x	x	x	0.474	0.566	x	x	x	0.422	0.524	0.612	x	x	0.441	0.65	0.434	0.492	0.376	0.481	0.428	x	0.491	x	0.438	x	0.465	x	x	0.477	0.529	x	0.511	0.61	0.472	0.509	0.572	x	0.485	0.428	x	0.483	x	x	0.416	0.429	0.443	0.41	0.474	0.564	0.5	0.448	0.477	
-12343	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	0.664	0.702	0.476	1.089	0.301	0.541	x	0.526	x	0.563	0.915	0.423	0.611	x	0.433	1.033	x	0.422	x	0.587	0.626	x	x	0.497	x	0.589	x	x	x	0.556	0.477	0.431	0.593	x	x	x	0.731	0.86	0.37	x	0.564	0.619	0.588	0.55	x	x	0.538	0.524	0.615	0.487	x	x	x	0.468	0.694	x	x	x	0.465	0.666	0.566	x	x	0.487	0.826	0.451	0.607	0.432	0.548	0.471	x	0.599	x	0.49	x	0.514	x	x	0.642	0.665	x	0.615	0.763	0.532	0.618	0.622	x	0.475	0.503	x	0.518	x	x	0.491	0.459	0.513	0.429	0.516	0.661	0.528	0.518	0.631	
-12342	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	0.488	0.426	0.399	1.546	0.268	0.334	x	0.38	x	0.457	0.677	0.332	0.572	x	0.369	0.652	x	0.376	x	0.447	0.443	x	x	0.469	x	0.551	x	x	x	0.381	0.389	0.428	0.439	x	x	x	0.521	0.501	0.337	x	0.422	0.413	0.462	0.412	x	x	0.384	0.442	0.507	0.434	x	x	x	0.49	0.479	x	x	x	0.39	0.429	0.89	x	x	0.405	0.547	0.424	0.457	0.339	0.431	0.393	x	0.419	x	0.416	x	0.427	x	x	0.411	0.428	x	0.435	0.519	0.424	0.443	0.535	x	0.511	0.374	x	0.455	x	x	0.365	0.408	0.391	0.398	0.442	0.508	0.474	0.397	0.395	
-12341	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	847.83	850.83	1046.36	880.57	1173.5	1053.25	x	1116.86	x	970.17	730.83	1149.71	969.0	x	1084.57	749.8	x	964.5	x	910.2	996.33	x	x	843.0	x	884.25	x	x	x	863.6	970.17	964.0	805.5	x	x	x	945.5	809.67	1328.0	x	832.71	788.0	901.83	1130.86	x	x	1000.33	895.33	616.83	911.71	x	x	x	929.57	995.86	x	x	x	772.17	852.33	613.5	x	x	964.83	803.14	1077.5	871.0	1058.86	826.67	915.0	x	1059.57	x	795.67	x	972.6	x	x	1041.0	764.0	x	922.0	808.57	972.17	1048.25	811.0	x	851.67	999.43	x	1030.67	x	x	982.75	1071.4	1244.33	1113.38	908.0	847.0	857.0	913.6	990.13	
-12340	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	356.17	361.83	476.55	415.71	552.0	444.25	x	466.43	x	437.83	318.67	504.43	458.5	x	517.43	309.0	x	433.0	x	386.6	419.67	x	x	378.0	x	407.88	x	x	x	345.8	429.83	427.6	362.5	x	x	x	401.0	310.67	596.67	x	347.29	352.67	418.0	515.86	x	x	472.5	382.67	264.5	433.71	x	x	x	451.29	419.57	x	x	x	326.67	356.83	340.75	x	x	425.33	331.29	486.0	407.33	443.29	377.5	429.83	x	443.86	x	362.0	x	441.2	x	x	470.83	324.0	x	406.25	338.86	421.83	463.75	363.0	x	401.17	433.43	x	457.0	x	x	395.75	531.0	553.0	522.63	406.5	378.17	402.0	402.8	438.75	
-12339	Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	491.67	489.0	569.82	464.86	621.5	609.0	x	650.43	x	532.33	412.17	645.29	510.5	x	567.14	440.8	x	531.5	x	523.6	576.67	x	x	465.0	x	476.38	x	x	x	517.8	540.33	536.4	443.0	x	x	x	544.5	499.0	731.33	x	485.43	435.33	483.83	615.0	x	x	527.83	512.67	352.33	478.0	x	x	x	478.29	576.29	x	x	x	445.5	495.5	272.75	x	x	539.5	471.86	591.5	463.67	615.57	449.17	485.17	x	615.71	x	433.67	x	531.4	x	x	570.17	440.0	x	515.75	469.71	550.33	584.5	448.0	x	450.5	566.0	x	573.67	x	x	587.0	540.4	691.33	590.75	501.5	468.83	455.0	510.8	551.38	
-12338	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	22.756	29.683	25.744	19.486	44.625	26.383	x	19.995	x	20.678	13.636	30.559	9.025	x	28.743	8.0	x	35.817	x	25.417	16.017	x	x	32.724	x	17.333	x	x	x	37.087	33.183	32.153	33.431	x	x	x	4.333	16.708	23.367	x	33.881	34.594	24.194	14.271	x	x	26.064	30.594	45.669	32.179	x	x	x	33.436	8.091	x	x	x	45.469	25.833	37.962	x	x	30.117	17.136	22.1	31.014	34.774	34.178	35.525	x	15.119	x	43.353	x	24.877	x	x	22.986	33.9	x	22.785	19.264	23.731	16.125	24.221	x	33.431	29.033	x	19.694	x	x	32.471	25.797	10.911	26.819	28.883	21.058	28.733	32.64	24.985	
-12337	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	None	Central nervous system, pharmacology, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	23.283	26.667	25.764	20.986	45.033	20.467	x	19.6	x	20.894	12.061	30.424	12.383	x	26.21	7.007	x	38.133	x	26.38	16.422	x	x	37.4	x	21.525	x	x	x	38.373	33.417	38.867	30.289	x	x	x	2.467	13.333	26.633	x	34.548	29.478	21.728	11.748	x	x	18.839	34.789	49.067	31.981	x	x	x	33.41	6.629	x	x	x	49.461	22.922	38.175	x	x	31.856	17.686	28.0	31.844	37.905	32.867	33.906	x	14.124	x	41.656	x	25.6	x	x	21.65	30.067	x	19.392	18.448	25.439	16.492	26.362	x	37.667	28.776	x	23.078	x	x	36.0	22.013	10.522	27.442	31.633	20.078	29.433	31.84	21.25	
-12336	Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	22.228	32.7	25.724	17.986	44.217	32.3	x	20.39	x	20.461	15.211	30.695	5.667	x	31.276	8.993	x	33.5	x	24.453	15.611	x	x	28.048	x	13.142	x	x	x	35.8	32.95	25.44	36.572	x	x	x	6.2	20.083	20.1	x	33.214	39.711	26.661	16.795	x	x	33.289	26.4	42.272	32.376	x	x	x	33.462	9.552	x	x	x	41.478	28.744	37.75	x	x	28.378	16.586	16.2	30.183	31.643	35.489	37.144	x	16.114	x	45.05	x	24.153	x	x	24.322	37.733	x	26.179	20.081	22.022	15.758	22.081	x	29.194	29.29	x	16.311	x	x	28.942	29.58	11.3	26.196	26.133	22.039	28.033	33.44	28.721	
-12335	Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	None	Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	3.3	4.083	8.282	14.467	0.3	2.85	x	3.729	x	19.8	12.2	6.929	8.725	x	20.029	6.38	x	11.3	x	18.18	7.667	x	x	3.714	x	14.775	x	x	x	10.76	10.367	11.98	5.05	x	x	x	17.3	8.717	10.3	x	6.243	3.6	2.933	5.971	x	x	9.35	8.133	12.617	10.471	x	x	x	8.929	23.629	x	x	x	6.85	1.567	6.45	x	x	9.367	7.414	3.25	12.217	4.843	8.1	6.15	x	9.357	x	2.65	x	10.7	x	x	6.133	21.4	x	7.7	3.029	9.5	10.2	7.343	x	5.85	0.686	x	10.533	x	x	11.425	8.12	4.8	5.55	10.75	7.783	0.5	13.22	6.488	
-12296	Original post publication description: Central nervous system, behavior: Central motor pattern generation (CPG), lick rate for 0.1 M sucrose over 20 minutes (Davis MS160 lickometer), male and female adults [MPI]	None	Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for 0.1 M sucrose over 20 min (Davis MS160 lickometer), male and female adults [mSec]	x	103.92	115.59	95.67	131.27	99.83	104.87	116.9	116.75	99.65	106.97	114.46	117.15	123.83	131.27	x	113.13	117.15	x	x	x	x	x	102.27	108.87	114.5	x	116.95	x	117.2	99.67	124.23	110.89	x	111.0	x	118.44	103.17	116.54	x	111.32	105.66	113.63	114.7	x	x	117.73	x	123.87	128.34	x	x	x	113.72	118.62	x	x	x	104.72	107.39	111.74	x	x	112.2	122.7	x	111.88	106.39	119.74	98.87	x	102.96	x	100.16	x	102.52	x	x	108.39	x	x	109.36	106.0	110.05	109.44	125.9	x	113.93	113.38	x	102.78	x	x	100.99	120.3	117.57	108.72	114.18	105.5	x	106.7	107.83	
-12297	Original post publication description: Central nervous system, behavior: Central motor pattern generation, lick rate [MPI] for water over 20 minutes (MS160 lickometer), male and female adults [66 strains]	None	Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for water over 20 min (Davis MS160 lickometer), male and female adults [mSec]	x	107.51	116.33	95.39	133.27	100.28	107.73	114.6	111.43	97.44	106.57	110.78	116.7	126.08	123.13	x	115.17	116.7	x	x	x	x	x	102.97	106.98	115.25	x	117.2	x	117.14	98.95	122.12	111.11	x	106.86	x	118.42	106.43	114.41	x	109.27	106.17	114.41	115.18	x	x	113.4	x	119.58	127.31	x	x	x	114.26	116.07	x	x	x	103.37	106.78	108.01	x	x	110.34	120.49	x	109.99	108.0	113.88	98.43	x	102.83	x	99.02	x	100.32	x	x	105.78	x	x	105.91	105.67	110.2	110.23	122.4	x	113.31	112.26	x	100.32	x	x	101.68	119.49	117.28	108.13	113.88	107.7	x	107.12	107.9	
-12555	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal medulla width [um]	x	x	412.943	483.102	515.23	494.848	x	521.594	495.626	581.21	468.108	438.298	487.31	434.655	598.22	480.206	521.697	438.71	558.266	513.968	x	x	x	565.082	x	570.283	532.404	468.265	x	507.998	540.992	573.686	548.203	x	561.391	x	539.905	467.68	463.9	x	386.56	578.511	441.6	508.538	x	x	648.043	x	617.78	580.872	x	x	x	556.5	505.992	x	x	x	510.964	508.153	455.473	679.543	x	463.316	521.813	465.079	516.774	481.956	520.116	546.377	x	547.937	x	483.283	x	462.19	x	x	533.548	x	x	527.298	525.518	532.253	540.114	542.875	x	562.655	591.617	x	500.007	x	x	x	541.68	459.975	589.127	586.995	593.204	x	x	x	
-12300	Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg]	15.667	15.111	15.375	16.714	17.5	x	15.6	x	x	16.083	14.417	17.429	13.944	18.25	16.875	19.833	16.417	15.625	15.25	x	x	x	x	x	x	16.75	x	16.833	x	12.5	14.833	12.667	14.3	x	13.75	x	12.5	15.5	15.5	x	16.7	17.25	14.409	13.125	x	x	16.539	x	14.885	12.556	x	x	x	15.3	15.5	x	x	x	15.375	16.192	19.0	16.071	x	15.7	17.611	16.0	16.167	15.591	11.667	13.056	x	13.75	x	13.111	x	14.208	x	x	13.889	x	x	17.364	15.0	12.458	16.278	16.688	x	14.167	13.375	x	14.378	x	x	15.0	16.533	13.0	11.643	17.0	17.313	12.917	17.333	14.8	
-12303	Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 3 to 5 months old, both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology: Intraocular pressure (IOP), 3 to 5 months old, both sexes, average of left and right eyes [mmHg]	17.375	18.0	15.667	17.183	18.5	x	17.591	17.75	x	17.562	16.864	18.375	13.722	18.0	18.63	17.0	17.3	14.206	16.954	21.75	x	x	x	x	x	17.8	x	18.125	x	15.75	15.571	15.4	13.625	x	18.0	x	12.5	13.667	12.6	x	14.938	14.546	14.875	11.75	x	x	17.5	x	15.0	14.154	x	x	x	15.587	13.833	x	x	x	16.45	17.5	16.455	19.115	x	14.389	20.083	14.062	15.179	16.861	17.235	15.25	x	18.044	x	12.714	x	15.417	x	x	18.562	x	x	14.875	14.961	15.823	18.321	17.556	x	16.25	14.95	x	14.611	x	x	18.0	14.875	14.188	13.5	21.3	14.828	8.85	16.472	16.95	
-12306	Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 6 to 9 months old, both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology: Intraocular pressure (IOP), 6 to 9 months old, both sexes, average of left and right eyes [mmHg]	16.5	20.15	15.1	19.173	17.2	16.125	20.083	16.0	18.929	17.375	15.6	17.0	16.3	18.583	16.5	14.875	17.75	17.964	13.75	13.5	16.5	x	x	x	x	22.125	18.75	x	x	15.167	16.25	17.0	17.357	x	14.583	x	13.318	12.611	13.4	x	12.0	15.857	16.667	13.421	x	x	10.833	x	13.15	14.818	x	x	x	17.2	14.0	x	x	x	17.361	18.167	14.885	19.125	x	13.813	22.5	17.083	18.706	16.864	17.708	14.4	x	20.938	x	15.364	x	15.821	x	x	17.393	x	x	15.706	15.143	16.737	18.188	21.038	x	17.364	17.812	x	19.0	x	13.5	19.938	15.188	15.389	12.167	18.333	14.182	12.7	20.75	16.5	
-12309	Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 10 to 13 months old, both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology: Intraocular pressure (IOP), 10 to 13 months old, both sexes, average of left and right eyes [mmHg]	x	17.625	15.227	16.844	18.5	11.333	13.167	12.5	17.0	14.25	14.75	14.375	13.375	19.375	16.333	16.75	18.125	14.0	9.375	x	x	x	x	x	x	18.375	x	14.667	x	12.625	13.922	18.0	18.955	x	14.833	x	9.583	13.214	13.75	x	11.75	17.875	21.818	15.063	x	x	9.3	x	12.5	17.889	x	x	x	15.0	18.875	x	x	x	14.455	18.237	14.611	16.9	x	13.583	18.5	17.5	16.833	17.038	16.458	12.5	x	16.906	x	14.85	x	17.643	x	x	19.75	x	x	16.208	13.75	16.071	16.667	16.5	x	14.542	15.3	x	14.0	x	x	17.75	14.5	13.3	18.688	18.25	16.546	13.25	15.278	17.15	
-12312	Original post publication description: Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes [mmHg]	x	x	13.091	12.5	14.6	15.75	x	12.5	17.75	21.0	15.5	10.3	12.5	x	13.8	14.5	14.143	14.1	8.25	x	16.333	x	x	x	15.25	18.75	18.25	14.75	x	13.75	14.0	19.125	18.688	x	x	x	12.75	13.375	11.85	x	10.25	12.25	13.214	15.417	x	x	10.375	x	9.7	21.833	x	x	x	18.25	18.1	x	x	x	10.6	15.708	14.364	x	x	12.727	12.5	17.0	11.583	13.529	14.167	12.944	x	14.083	x	13.667	x	10.688	x	x	16.7	x	x	0.5	13.5	11.929	16.9	21.717	x	12.222	14.5	x	13.917	x	x	16.0	11.583	x	14.1	14.375	16.438	9.5	10.6	18.909	
-12315	Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes [mmHg]	None	Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes [mmHg]	16.605	17.813	14.727	17.039	17.163	14.444	16.821	14.923	17.938	16.896	15.463	15.635	14.155	18.435	15.936	16.423	16.442	15.394	14.293	19.0	16.4	x	x	x	13.8	18.776	18.583	16.117	x	14.032	14.833	16.25	16.989	x	15.175	x	12.258	13.586	13.143	x	13.044	15.457	16.432	13.576	x	x	15.29	x	13.796	15.667	x	x	x	16.018	15.909	x	x	x	15.189	17.215	15.815	18.0	x	14.057	19.32	15.958	16.273	15.886	15.856	13.912	x	17.412	x	13.91	x	14.83	x	x	17.517	x	x	15.352	14.623	15.145	17.382	19.35	x	14.914	15.119	x	15.0	x	x	17.105	14.951	14.121	13.644	18.517	15.493	11.172	16.33	17.157	
-12318	Original post publication description: Eye, visual system: Iris pigmentation at 1-2 months in males and females [ordinal scale, 0=full pigmentation, 4=light]	None	Eye, visual system: Iris pigmentation at 1-2 months in males and females [ordinal scale, 0=full pigmentation, 4=light]	0.0	0.0	0.0	2.021	1.5	x	0.0	x	x	1.0	0.0	0.136	1.688	0.0	0.5	0.0	0.0	0.0	0.0	x	x	x	x	1.333	x	0.5	x	0.0	x	0.0	0.0	0.0	0.0	x	0.833	x	0.0	0.0	0.5	x	0.0	0.0	0.909	1.917	x	x	0.0	x	0.0	0.0	x	x	x	2.0	0.0	x	x	x	0.667	1.0	1.091	x	x	x	1.333	0.5	1.0	x	1.0	1.583	x	1.75	x	1.857	x	1.786	x	x	1.7	x	x	1.571	1.286	1.864	0.0	0.0	x	2.4	1.875	x	0.0	x	x	1.0	0.0	0.857	1.036	2.167	0.0	0.0	1.0	1.5	
-12321	Original post publication description: Eye, visual system: Iris pigmentation at 3-5 months in males and females	None	Eye, visual system: Iris pigmentation at 3-5 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed]	0.0	0.0	0.0	1.885	2.0	x	0.0	0.0	x	1.727	0.0	0.2	1.5	0.0	0.5	0.0	0.3	0.0	0.0	2.0	x	x	0.857	x	x	0.75	x	0.0	x	0.0	0.0	0.0	0.0	1.5	1.0	x	0.0	0.0	0.0	x	0.0	0.0	1.083	1.467	x	x	0.0	x	0.0	x	0.0	x	x	1.875	0.0	x	x	x	0.205	1.25	1.421	0.625	x	1.5	1.529	0.955	1.306	0.889	1.221	1.762	x	1.483	x	1.471	x	1.889	x	x	1.732	x	x	1.5	1.1	1.617	0.0	0.0	x	2.182	2.0	x	0.0	x	x	1.0	0.0	1.0	1.5	x	0.0	0.0	1.0	1.667	
-12324	Original post publication description: Eye, visual system: Iris pigmentation at 6-9 months, males and females [ordinal score, 0=normal, 3=light]	None	Eye, visual system: Iris pigmentation at 6-9 months, males and females [ordinal score, 0=normal, 4=light, dispersed]	0.0	0.0	0.0	2.455	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.167	1.5	0.0	0.5	0.0	0.125	0.0	0.0	2.0	0.0	x	x	0.0	x	0.5	1.875	x	x	0.0	0.0	0.0	0.0	x	1.5	x	0.0	0.0	0.0	x	0.0	0.0	1.83	2.0	x	x	0.0	x	0.0	0.0	x	x	x	1.864	0.0	x	x	x	0.211	2.938	1.595	0.5	x	x	1.816	1.0	1.75	0.397	1.078	1.773	x	1.139	x	1.452	x	2.125	x	x	1.667	x	x	1.667	1.583	2.0	0.0	0.0	x	2.154	2.0	x	0.0	x	0.0	1.846	0.0	1.0	2.287	2.5	0.0	0.0	1.0	2.0	
-12327	Original post publication description: Eye, visual system: Iris pigmentation score at 10-13 months in males and females	None	Eye, visual system: Iris pigmentation score at 10-13 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed]	0.0	0.0	0.0	2.967	1.75	0.0	0.0	0.0	x	2.0	0.0	0.563	1.5	0.0	0.667	0.0	0.0	0.0	0.0	x	x	x	x	x	x	0.5	x	0.0	x	0.0	0.0	0.0	0.0	x	1.5	x	0.0	0.0	0.0	x	0.0	0.0	2.824	0.0	x	x	0.0	0.5	0.0	0.0	x	x	x	2.682	0.0	x	x	x	0.0	2.944	2.808	0.833	x	2.0	3.25	1.5	2.393	0.577	0.955	2.0	x	1.722	x	1.429	x	2.333	x	x	1.85	x	x	1.643	1.4	1.9	0.0	0.0	x	2.135	2.0	x	0.167	x	x	2.306	0.0	1.6	2.917	2.5	0.0	0.125	1.0	1.694	
-12330	Original post publication description: Eye, visual system, aging: Iris pigmentation score in old males and females (>13 months)	None	Eye, visual system, aging: Iris pigmentation score in old males and females (>13 months) [ordinal scale, 0=full pigmentation, 4=light, dispersed]	x	x	0.0	3.447	1.167	0.0	x	x	x	2.0	0.0	2.0	x	x	0.812	0.0	0.068	0.0	0.0	x	0.0	x	x	0.2	1.0	0.5	2.0	0.0	x	0.0	0.0	0.0	0.0	x	x	x	0.0	0.571	0.857	x	0.429	3.014	3.8	2.222	x	x	0.0	0.0	0.0	0.889	x	x	x	2.778	0.5	x	x	x	0.375	3.675	3.0	0.666	x	2.15	4.0	2.0	3.0	0.906	1.0	1.5	x	1.6	x	1.333	x	3.5	x	x	1.2	2.0	x	2.0	1.7	2.75	0.0	0.0	x	2.385	2.0	x	0.2	x	x	3.533	0.0	1.6	3.8	2.75	0.0	0.4	1.1	2.111	
-12333	Original post publication description: Eye, visual system: Iris pigmentation (all ages) [ordinal scale, 0=pigmented, 4=light]	None	Eye, visual system: Iris pigmentation (all ages) [ordinal scale, 0=pigmented, 4=light, dispersed]	0.0	0.0	0.0	2.439	1.619	0.0	0.0	0.0	0.0	1.667	0.0	0.64	1.579	0.0	0.621	0.0	0.092	0.0	0.0	2.0	0.0	x	0.823	0.142	1.0	0.581	1.917	0.0	x	0.0	0.0	0.0	0.0	1.5	1.26	x	0.0	0.095	0.276	x	0.13	0.334	1.865	1.729	x	x	0.0	0.375	0.0	0.121	x	x	x	2.132	0.128	x	x	x	0.239	2.381	1.773	0.595	x	1.767	2.18	1.056	1.762	0.642	1.11	1.71	x	1.423	x	1.485	x	2.359	x	x	1.686	2.0	x	1.62	1.328	1.825	0.0	0.0	x	2.246	1.969	x	0.086	x	x	2.066	0.0	1.192	2.037	2.431	0.0	0.155	1.01	1.736	
-12394	Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	0.438	0.596	0.764	0.976	0.296	0.366	0.989	0.345	0.427	2.886	0.71	0.247	0.733	x	0.532	0.302	x	0.48	0.565	0.344	x	x	x	1.539	0.462	0.359	0.88	x	x	0.344	0.449	0.436	0.583	x	2.272	x	0.476	0.404	0.3	x	0.236	0.643	0.515	0.352	x	x	0.507	0.342	0.302	0.402	x	0.786	x	0.83	0.624	x	x	x	0.638	0.411	0.914	x	x	0.382	0.37	0.494	0.288	2.243	0.313	0.305	x	0.319	0.385	0.612	x	0.608	x	x	0.324	0.532	x	0.307	0.509	0.775	0.628	0.505	x	5.397	0.305	x	1.418	x	x	0.535	0.391	0.552	0.727	0.321	0.647	0.346	21.008	0.375	
-12486	Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 3 ppm Fe diet [µg/g]	None	Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 3 ppm Fe diet [µg/g]	x	x	9.4	8.9	11.4	14.3	x	11.6	12.3	11.7	13.6	9.6	11.5	9.7	x	11.3	11.4	11.6	x	12.6	x	x	x	x	x	x	13.2	13.9	x	9.0	13.9	10.0	11.9	x	x	x	10.1	11.4	7.2	x	8.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12334	Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width in males [um]	None	Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width in males [um]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.25	38.52	12.064	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.3	x	x	27.892	x	36.83	x	x	x	x	x	x	x	x	x	x	x	x	14.148	x	x	x	x	20.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12403	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	0.67	0.665	0.663	0.605	0.472	0.888	1.103	0.734	0.9	0.566	0.99	0.555	1.006	x	0.613	0.644	x	0.546	x	1.076	1.264	x	x	0.592	0.795	0.665	1.117	x	x	0.833	0.554	0.799	0.523	x	x	x	x	1.528	0.445	x	0.647	0.678	0.607	0.586	x	x	0.683	0.649	0.751	0.566	x	0.727	x	0.51	0.531	x	x	x	0.578	0.827	0.774	x	x	0.482	0.909	0.736	0.572	0.64	0.685	0.517	x	1.555	x	0.602	x	1.048	x	x	0.652	0.685	x	0.624	0.749	0.654	0.84	0.714	x	0.49	0.491	x	0.532	x	x	0.575	0.608	0.657	0.582	0.45	0.695	1.02	0.657	0.77	
-12404	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	0.573	0.552	0.549	0.558	0.412	0.641	0.749	0.571	0.826	0.508	0.693	0.443	0.736	x	0.505	0.544	x	0.525	x	0.881	0.898	x	x	0.573	0.575	0.719	0.924	x	x	0.657	0.474	0.638	0.474	x	x	x	x	1.106	0.453	x	0.536	0.597	0.502	0.491	x	x	0.556	0.564	0.588	0.498	x	0.519	x	0.445	0.479	x	x	x	0.453	0.685	0.658	x	x	0.429	0.823	0.592	0.546	0.537	0.565	0.499	x	0.795	x	0.47	x	0.737	x	x	0.581	0.606	x	0.556	0.547	0.549	0.637	0.587	x	0.499	0.426	x	0.496	x	x	0.458	0.508	0.477	0.456	0.436	0.596	0.68	0.512	0.615	
-12405	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	8.317	10.1	7.24	8.3	5.833	2.267	7.1	3.257	10.043	19.333	4.125	17.9	10.6	x	0.4	2.68	x	6.625	10.6	13.017	x	x	x	27.283	x	4.0	32.714	x	x	10.7	4.117	10.971	10.85	x	0.2	x	14.129	6.967	3.275	x	5.217	6.175	7.64	3.35	x	x	12.4	11.9	4.867	15.567	x	19.1	x	8.543	18.525	x	x	x	6.35	2.333	4.383	x	x	2.033	3.55	14.5	9.617	3.25	6.113	6.7	x	3.0	85.6	7.033	x	15.5	x	x	2.317	5.55	x	5.2	6.583	8.167	3.733	6.033	x	2.2	2.967	x	6.167	x	x	6.08	4.333	4.267	6.25	8.017	3.417	4.617	6.917	3.4	
-12406	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	19.817	23.4	21.087	20.667	21.456	14.0	5.833	22.414	16.457	26.967	12.533	5.6	1.778	x	22.7	12.42	x	15.692	31.7	19.45	x	x	x	8.922	x	19.117	5.6	x	x	14.956	29.939	17.51	25.583	x	4.633	x	3.333	28.089	35.542	x	38.989	27.925	28.173	11.389	x	x	31.817	5.004	32.294	29.911	x	3.944	x	29.133	8.425	x	x	x	30.528	23.844	41.244	x	x	23.406	37.867	14.219	33.672	25.467	26.142	17.894	x	14.65	1.533	27.472	x	12.144	x	x	19.161	32.775	x	26.644	29.05	21.672	12.628	30.85	x	15.883	28.411	x	20.511	x	x	22.613	24.978	14.267	23.678	31.083	16.872	27.694	38.983	15.478	
-12407	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	14.783	16.344	26.86	21.8	22.017	4.433	0.683	20.376	19.819	23.533	9.067	2.033	7.389	x	15.667	10.827	x	20.592	5.833	27.006	x	x	x	3.694	x	23.25	5.876	x	x	15.489	22.528	13.071	22.289	x	4.133	x	5.543	12.111	34.817	x	36.633	26.013	30.393	6.967	x	x	16.4	5.081	29.594	26.711	x	3.478	x	30.6	2.7	x	x	x	37.278	10.956	36.044	x	x	12.422	24.733	18.824	34.828	26.139	21.758	25.0	x	5.833	39.033	24.139	x	24.367	x	x	16.183	25.025	x	23.522	34.567	25.267	15.583	25.856	x	22.633	26.394	x	15.117	x	x	27.687	18.911	11.694	18.806	31.722	11.094	23.772	37.172	11.233	
-12408	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	17.3	19.872	23.973	21.233	21.736	9.217	3.258	21.395	18.138	25.25	10.8	3.817	4.583	x	19.183	11.623	x	18.142	18.767	23.228	x	x	x	6.308	x	21.183	5.738	x	x	15.222	26.233	15.29	23.936	x	4.383	x	4.438	20.1	35.179	x	37.811	26.969	29.283	9.178	x	x	24.108	5.043	30.944	28.311	x	3.711	x	29.867	5.562	x	x	x	33.903	17.4	38.644	x	x	17.914	31.3	16.521	34.25	25.803	23.95	21.447	x	10.242	20.283	25.806	x	18.256	x	x	17.672	28.9	x	25.083	31.808	23.469	14.106	28.353	x	19.258	27.403	x	17.814	x	x	25.15	21.944	12.981	21.242	31.403	13.983	25.733	38.078	13.356	
-12409	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	572.67	483.33	580.6	616.0	641.5	559.67	445.0	597.43	495.29	487.33	407.0	555.0	408.0	x	391.0	568.6	x	507.75	463.0	457.33	x	x	x	415.83	x	455.5	412.43	x	x	556.33	584.0	404.29	460.83	x	551.0	x	550.71	446.33	563.25	x	584.83	465.62	489.2	639.33	x	x	484.5	479.22	398.17	461.0	x	431.67	x	646.57	571.75	x	x	x	477.17	540.83	392.67	x	x	471.83	378.83	506.57	476.5	597.33	550.13	575.33	x	503.83	415.0	512.17	x	526.33	x	x	491.83	411.25	x	459.67	474.0	575.67	484.17	480.33	x	369.25	523.5	x	418.33	x	x	599.8	566.83	726.33	532.0	458.0	493.67	455.5	400.33	500.17	
-12410	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	456.33	351.33	515.8	368.0	529.17	381.0	216.5	444.29	299.14	455.5	374.0	406.0	349.33	x	385.0	401.8	x	453.0	442.0	340.83	x	x	x	373.67	x	363.5	379.43	x	x	460.5	405.67	283.86	359.17	x	329.0	x	411.43	315.67	443.75	x	424.83	397.63	384.8	409.83	x	x	472.0	367.0	268.33	353.67	x	254.0	x	478.57	451.25	x	x	x	388.67	407.17	377.17	x	x	489.0	317.33	377.14	365.17	488.5	452.88	566.67	x	392.33	184.0	502.67	x	481.67	x	x	376.67	336.0	x	412.83	352.0	508.5	422.83	400.33	x	371.75	452.33	x	362.33	x	x	468.0	441.5	536.0	393.83	353.33	391.17	398.17	252.83	426.67	
-12411	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	1029.0	834.67	1096.4	984.0	1170.67	940.67	661.5	1041.71	794.43	942.83	781.0	961.0	757.33	x	776.0	970.4	x	960.75	905.0	798.17	x	x	x	789.5	x	819.0	791.86	x	x	1016.83	989.67	688.14	820.0	x	880.0	x	962.14	762.0	1007.0	x	1009.67	863.25	874.0	1049.17	x	x	956.5	846.22	666.5	814.67	x	685.67	x	1125.14	1023.0	x	x	x	865.83	948.0	769.83	x	x	960.83	696.17	883.71	841.67	1085.83	1003.0	1142.0	x	896.17	599.0	1014.83	x	1008.0	x	x	868.5	747.25	x	872.5	826.0	1084.17	907.0	880.67	x	741.0	975.83	x	780.67	x	x	1067.8	1008.33	1262.33	925.83	811.33	884.83	853.67	653.17	926.83	
-12412	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	0.425	0.498	0.42	0.386	0.38	0.469	0.638	0.401	0.524	0.446	0.65	0.51	0.731	x	0.593	0.478	x	0.5	0.443	0.596	x	x	x	1.016	x	0.552	0.788	x	x	0.478	0.361	0.63	0.495	x	0.519	x	0.643	0.488	0.348	x	0.314	0.48	0.443	0.426	x	x	0.422	0.606	0.509	0.464	x	0.704	x	0.336	0.517	x	x	x	0.472	0.43	0.432	x	x	0.605	0.499	0.576	0.418	0.382	0.432	0.441	x	0.663	0.712	0.435	x	0.533	x	x	0.508	0.504	x	0.497	0.447	0.415	0.601	0.451	x	0.741	0.418	x	0.632	x	x	0.387	0.416	0.361	0.443	0.475	0.532	0.5	0.478	0.519	
-12413	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	0.623	0.798	0.429	0.637	0.461	0.851	1.43	0.563	0.837	0.521	0.735	0.724	0.823	x	0.657	0.781	x	0.535	0.639	0.678	x	x	x	0.95	x	0.635	0.818	x	x	0.593	0.577	0.974	0.693	x	0.874	x	0.953	0.911	0.447	x	0.449	0.563	0.552	0.716	x	x	0.565	0.807	0.848	0.636	x	1.255	x	0.443	0.733	x	x	x	0.492	0.674	0.57	x	x	0.545	0.746	0.95	0.556	0.473	0.595	0.402	x	0.892	0.994	0.461	x	0.475	x	x	0.698	0.671	x	0.571	0.627	0.455	0.794	0.573	x	0.656	0.491	x	0.762	x	x	0.478	0.616	0.543	0.656	0.639	0.71	0.611	0.911	0.706	
-12414	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	0.499	0.611	0.422	0.48	0.411	0.604	0.889	0.464	0.633	0.477	0.69	0.601	0.762	x	0.625	0.586	x	0.515	0.539	0.636	x	x	x	0.746	x	0.581	0.793	x	x	0.528	0.447	0.755	0.572	x	0.652	x	0.755	0.638	0.391	x	0.371	0.516	0.49	0.533	x	x	0.483	0.691	0.628	0.535	x	0.895	x	0.381	0.59	x	x	x	0.469	0.535	0.461	x	x	0.52	0.599	0.686	0.474	0.421	0.498	0.421	x	0.761	0.798	0.447	x	0.503	x	x	0.585	0.58	x	0.529	0.5	0.432	0.67	0.503	x	0.673	0.45	x	0.69	x	x	0.425	0.495	0.431	0.531	0.531	0.611	0.546	0.59	0.592	
-12415	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	6.7	9.415	5.857	6.75	4.542	1.3	6.8	2.8	13.315	13.236	5.32	4.0	8.811	x	20.333	4.012	x	3.76	10.6	13.178	12.25	x	x	24.029	3.5	4.688	28.88	x	x	9.858	3.938	7.65	9.742	x	0.2	x	14.129	6.243	11.3	x	3.621	4.883	6.663	4.5	x	x	6.9	10.931	5.314	10.83	x	11.164	x	10.123	15.09	x	x	x	5.083	4.564	4.121	x	x	4.385	3.767	12.636	5.975	4.331	5.779	6.7	x	3.638	85.6	7.25	x	10.225	x	x	2.2	5.744	x	6.917	5.1	8.9	4.15	3.642	x	17.31	2.75	x	7.217	x	x	5.086	4.433	5.083	8.442	5.575	2.925	3.167	5.258	5.6	
-12416	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	18.361	24.79	20.981	19.211	29.875	18.263	8.407	16.253	15.049	27.245	14.86	19.471	4.059	x	11.256	18.192	x	14.727	31.7	14.611	9.633	x	x	10.062	32.078	17.342	5.607	x	x	14.997	29.826	19.386	34.581	x	4.633	x	3.333	14.414	31.967	x	38.24	26.558	27.492	14.26	x	x	31.8	11.877	38.783	29.477	x	14.55	x	29.697	14.763	x	x	x	31.889	24.942	30.407	x	x	24.467	33.553	11.662	33.472	28.69	27.771	23.4	x	15.726	1.533	32.625	x	24.662	x	x	18.358	28.163	x	23.411	27.503	21.264	15.075	26.792	x	20.58	32.183	x	24.381	x	x	26.119	24.831	15.906	17.439	32.972	19.133	25.711	32.933	16.082	
-12417	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	16.422	17.105	23.848	20.461	29.339	6.212	2.673	16.425	17.956	24.282	11.8	15.786	4.833	x	8.839	15.679	x	17.083	5.833	19.863	7.233	x	x	6.567	18.267	26.275	7.73	x	x	14.297	21.879	11.544	30.492	x	4.133	x	5.543	5.9	29.619	x	35.219	27.108	28.542	9.693	x	x	19.573	8.777	37.119	23.873	x	15.205	x	28.513	13.423	x	x	x	34.222	13.258	27.386	x	x	16.887	19.697	14.267	32.883	25.995	22.379	28.067	x	9.051	39.033	28.9	x	23.975	x	x	13.0	25.381	x	19.894	27.977	21.067	14.786	25.311	x	30.57	27.922	x	18.058	x	x	25.819	18.45	14.133	13.172	35.039	13.364	21.833	31.542	10.282	
-12418	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	17.392	20.947	22.414	19.836	29.607	12.238	5.54	16.339	16.503	25.764	13.33	17.629	4.446	x	10.047	16.935	x	15.905	18.767	17.237	8.433	x	x	8.314	25.172	21.808	6.668	x	x	14.647	25.853	15.465	32.536	x	4.383	x	4.438	10.157	30.793	x	36.73	26.833	28.017	11.977	x	x	25.687	10.327	37.951	26.675	x	14.877	x	29.105	14.093	x	x	x	33.056	19.1	28.896	x	x	20.677	26.625	12.964	33.178	27.342	25.075	25.733	x	12.389	20.283	30.762	x	24.319	x	x	15.679	26.772	x	21.653	27.74	21.165	14.931	26.051	x	25.575	30.053	x	21.219	x	x	25.969	21.64	15.019	15.306	34.006	16.249	23.772	32.237	13.182	
-12419	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	542.33	480.31	562.71	501.17	577.75	510.75	443.2	587.67	444.62	480.18	451.4	645.0	458.0	x	603.17	528.25	x	513.5	463.0	442.89	401.75	x	x	420.43	482.67	396.63	402.2	x	x	512.58	555.62	435.42	428.5	x	551.0	x	550.71	388.43	526.86	x	499.79	455.92	506.5	616.7	x	x	469.8	490.44	374.29	477.1	x	501.29	x	594.46	553.8	x	x	x	511.42	466.09	401.43	x	x	535.15	330.83	532.5	449.75	532.15	499.43	518.5	x	485.31	415.0	498.25	x	453.88	x	x	484.5	411.22	x	462.42	485.92	555.92	487.25	472.58	x	429.6	521.25	x	442.25	x	x	575.86	546.42	677.33	631.17	463.92	471.92	476.33	456.75	517.0	
-12420	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	415.83	374.15	476.86	415.0	469.25	347.5	275.4	440.0	298.46	431.55	338.0	445.71	327.67	x	449.83	378.88	x	466.6	442.0	322.33	239.0	x	x	375.43	308.0	339.0	340.0	x	x	393.42	421.15	325.33	359.83	x	329.0	x	411.43	254.71	478.0	x	367.14	369.83	384.38	422.4	x	x	400.6	386.25	255.43	394.7	x	308.07	x	464.08	465.4	x	x	x	377.67	367.27	343.79	x	x	494.23	305.92	374.14	382.83	425.38	416.36	513.0	x	379.54	184.0	419.92	x	374.63	x	x	407.92	332.78	x	418.92	343.31	460.0	385.75	366.5	x	386.9	445.58	x	404.33	x	x	435.0	428.5	487.17	451.0	383.58	386.58	355.78	311.25	399.08	
-12421	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	958.17	854.46	1039.57	916.17	1047.0	858.25	718.6	1027.67	743.08	911.73	789.4	1090.71	785.67	x	1053.0	907.13	x	980.1	905.0	765.22	640.75	x	x	795.86	790.67	735.63	742.2	x	x	906.0	976.77	760.75	788.33	x	880.0	x	962.14	643.14	1004.86	x	866.93	825.75	890.88	1039.1	x	x	870.4	876.69	629.71	871.8	x	809.36	x	1058.54	1019.2	x	x	x	889.08	833.36	745.21	x	x	1029.38	636.75	906.64	832.58	957.54	915.79	1031.5	x	864.85	599.0	918.17	x	828.5	x	x	892.42	744.0	x	881.33	829.23	1015.92	873.0	839.08	x	816.5	966.83	x	846.58	x	x	1010.86	974.92	1164.5	1082.17	847.5	858.5	832.11	768.0	916.08	
-12422	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	0.463	0.483	0.433	0.526	0.373	0.485	0.627	0.439	0.646	0.456	0.589	0.388	0.649	x	0.456	0.473	x	0.505	0.443	0.655	0.696	x	x	0.951	0.436	0.723	0.791	x	x	0.511	0.387	0.585	0.567	x	0.519	x	0.643	0.711	0.409	x	0.396	0.501	0.437	0.425	x	x	0.439	0.559	0.497	0.449	x	0.543	x	0.364	0.478	x	x	x	0.422	0.503	0.521	x	x	0.488	0.629	0.54	0.48	0.423	0.459	0.459	x	0.645	0.712	0.41	x	0.536	x	x	0.516	0.533	x	0.507	0.447	0.441	0.566	0.48	x	0.623	0.395	x	0.555	x	x	0.387	0.425	0.378	0.411	0.45	0.529	0.499	0.454	0.517	
-12423	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	0.647	0.726	0.496	0.61	0.466	0.874	1.234	0.634	0.866	0.542	0.888	0.579	0.945	x	0.621	0.73	x	0.541	0.639	0.811	1.264	x	x	0.899	0.795	0.657	0.908	x	x	0.713	0.565	0.901	0.608	x	0.874	x	0.953	1.264	0.446	x	0.562	0.601	0.572	0.664	x	x	0.636	0.738	0.793	0.587	x	0.953	x	0.474	0.612	x	x	x	0.535	0.744	0.686	x	x	0.511	0.827	0.843	0.564	0.563	0.633	0.448	x	1.249	0.994	0.532	x	0.833	x	x	0.675	0.679	x	0.598	0.693	0.555	0.817	0.643	x	0.557	0.491	x	0.647	x	x	0.541	0.612	0.6	0.619	0.545	0.702	0.747	0.784	0.74	
-12424	Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	0.536	0.579	0.458	0.545	0.412	0.627	0.805	0.509	0.722	0.492	0.692	0.465	0.744	x	0.525	0.57	x	0.521	0.539	0.717	0.898	x	x	0.721	0.575	0.685	0.832	x	x	0.592	0.462	0.707	0.523	x	0.652	x	0.755	0.906	0.418	x	0.465	0.543	0.494	0.516	x	x	0.526	0.636	0.605	0.509	x	0.68	x	0.41	0.524	x	x	x	0.461	0.603	0.574	x	x	0.471	0.711	0.639	0.51	0.484	0.527	0.452	x	0.779	0.798	0.458	x	0.649	x	x	0.583	0.595	x	0.543	0.525	0.49	0.653	0.545	x	0.569	0.438	x	0.593	x	x	0.446	0.502	0.454	0.493	0.484	0.603	0.591	0.551	0.605	
-12425	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	8.433	1.467	11.517	7.467	14.1	7.533	34.8	15.267	x	36.02	3.8	3.45	3.85	x	12.1	0.7	x	26.2	x	0.2	x	x	x	x	x	12.8	x	6.333	x	x	2.15	9.0	4.914	x	x	x	x	5.467	5.87	x	2.071	20.85	21.66	1.111	x	x	5.333	14.0	1.938	10.8	x	x	x	8.1	2.275	x	x	x	13.225	5.983	7.15	x	x	15.0	6.617	43.8	4.683	7.583	9.217	2.3	x	5.862	x	5.417	x	7.488	x	x	4.343	5.7	x	2.514	2.083	25.675	3.8	6.788	x	31.875	19.4	x	15.4	x	x	4.183	9.567	1.6	11.314	1.575	5.189	1.3	4.3	5.683	
-12426	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [% time]	36.889	47.372	42.378	31.844	40.733	54.956	61.633	35.467	x	11.533	41.878	46.333	26.817	x	28.567	50.033	x	39.967	x	44.033	x	x	x	x	x	20.333	x	51.167	x	x	49.539	29.7	57.114	x	x	x	x	34.844	47.057	x	52.657	54.867	33.387	56.656	x	x	50.2	17.383	58.0	28.181	x	x	x	36.5	23.817	x	x	x	42.983	55.328	53.95	x	x	42.35	44.967	6.8	43.089	66.839	58.378	43.483	x	60.95	x	36.978	x	20.054	x	x	49.49	61.467	x	31.39	39.739	20.667	34.867	33.708	x	41.996	50.289	x	36.539	x	x	42.45	31.589	38.25	35.019	56.65	40.359	30.733	32.863	66.744	
-12427	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [% time]	24.1	30.372	30.861	25.761	29.05	27.8	2.433	26.078	x	9.2	14.611	42.117	17.15	x	24.633	26.333	x	31.367	x	15.367	x	x	x	x	x	17.467	x	42.578	x	x	45.306	14.933	43.852	x	x	x	x	14.511	31.927	x	41.805	31.667	30.507	44.07	x	x	38.967	10.733	56.759	27.993	x	x	x	20.967	25.483	x	x	x	33.008	32.539	36.717	x	x	32.722	38.906	6.833	34.65	50.356	63.633	39.689	x	39.642	x	30.217	x	10.763	x	x	48.429	70.017	x	24.824	23.544	17.642	19.833	29.688	x	50.919	47.05	x	32.661	x	x	33.589	26.5	29.567	21.7	40.55	17.896	21.967	26.497	50.933	
-12428	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	30.494	38.872	36.619	28.803	34.892	41.378	32.033	30.772	x	10.367	28.244	44.225	21.983	x	26.6	38.183	x	35.667	x	29.7	x	x	x	x	x	18.9	x	46.872	x	x	47.422	22.317	50.483	x	x	x	x	24.678	39.492	x	47.231	43.267	31.947	50.363	x	x	44.583	14.058	57.38	28.087	x	x	x	28.733	24.65	x	x	x	37.996	43.933	45.333	x	x	37.536	41.936	6.817	38.869	58.597	61.006	41.586	x	50.296	x	33.597	x	15.408	x	x	48.959	65.742	x	28.107	31.642	19.154	27.35	31.698	x	46.457	48.669	x	34.6	x	x	38.019	29.044	33.908	28.36	48.6	29.128	26.35	29.68	58.839	
-12429	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	None	Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	689.33	603.0	383.17	679.0	618.5	571.67	141.0	631.33	x	396.83	473.67	700.5	484.5	x	631.0	699.0	x	568.0	x	711.0	x	x	x	x	x	562.0	x	706.33	x	x	828.0	864.0	409.0	x	x	x	x	546.67	457.4	x	739.86	324.88	500.8	619.78	x	x	612.67	631.0	550.54	586.78	x	x	x	663.25	477.25	x	x	x	498.0	371.83	334.25	x	x	518.0	517.0	385.0	702.17	213.17	396.33	689.67	x	418.13	x	526.0	x	523.88	x	x	732.43	198.5	x	614.71	487.5	738.5	256.75	235.5	x	272.44	569.67	x	679.0	x	x	720.0	653.83	299.0	570.86	459.25	453.44	326.0	385.9	458.0	
-12430	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	601.33	581.0	312.17	664.83	734.0	694.0	65.0	621.33	x	227.5	349.33	652.0	442.0	x	576.0	715.0	x	667.0	x	882.0	x	x	x	x	x	512.0	x	605.0	x	x	725.67	722.0	364.0	x	x	x	x	474.33	473.2	x	750.0	421.5	410.0	542.0	x	x	476.0	423.5	400.77	512.89	x	x	x	523.0	431.5	x	x	x	523.25	513.17	458.5	x	x	515.5	461.67	435.0	786.17	315.67	309.83	650.67	x	656.63	x	580.0	x	456.38	x	x	763.71	204.0	x	453.14	382.67	640.75	398.0	247.13	x	356.78	665.67	x	644.17	x	x	585.67	602.67	623.0	582.14	449.0	409.67	421.5	244.0	683.83	
-12431	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	1290.67	1184.0	695.33	1343.83	1352.5	1265.67	206.0	1252.67	x	624.33	823.0	1352.5	926.5	x	1207.0	1414.0	x	1235.0	x	1593.0	x	x	x	x	x	1074.0	x	1311.33	x	x	1553.67	1586.0	773.0	x	x	x	x	1021.0	930.6	x	1489.86	746.38	910.8	1161.78	x	x	1088.67	1054.5	951.31	1099.67	x	x	x	1186.25	908.75	x	x	x	1021.25	885.0	792.75	x	x	1033.5	978.67	820.0	1488.33	528.83	706.17	1340.33	x	1074.75	x	1106.0	x	980.25	x	x	1496.14	402.5	x	1067.86	870.17	1379.25	654.75	482.63	x	629.22	1235.33	x	1323.17	x	x	1305.67	1256.5	922.0	1153.0	908.25	863.11	747.5	629.9	1141.83	
-12432	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	None	Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip)(RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks/sec]	0.286	0.27	0.48	0.333	0.329	0.243	0.816	0.336	x	0.878	0.412	0.231	0.464	x	0.34	0.214	x	0.317	x	0.236	x	x	x	x	x	0.425	x	0.21	x	x	0.188	0.244	0.471	x	x	x	x	0.362	0.518	x	0.193	0.58	0.483	0.199	x	x	0.249	0.396	0.225	0.397	x	x	x	0.31	0.514	x	x	x	0.341	0.561	0.498	x	x	0.405	0.359	0.726	0.248	0.493	0.375	0.272	x	0.358	x	0.464	x	0.489	x	x	0.206	0.543	x	0.346	0.435	0.328	0.918	1.167	x	5.329	0.298	x	0.325	x	x	0.254	0.342	0.665	0.482	0.303	0.426	1.512	0.559	0.231	
-12433	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	0.384	0.367	0.774	0.392	0.363	0.348	4.503	0.39	x	1.751	0.762	0.265	0.561	x	0.393	0.309	x	0.309	x	0.288	x	x	x	x	x	0.484	x	0.285	x	x	0.235	0.353	0.528	x	x	x	x	0.588	0.373	x	0.238	0.561	0.537	0.354	x	x	0.478	0.648	0.335	0.51	x	x	x	0.68	0.534	x	x	x	0.388	0.418	0.417	x	x	0.433	0.391	0.643	0.263	0.56	0.382	0.339	x	0.294	x	0.419	x	0.657	x	x	0.204	0.592	x	0.613	0.637	0.417	0.635	2.664	x	2.237	0.25	x	0.314	x	x	0.368	0.406	0.34	0.848	0.435	0.711	0.551	0.964	0.217	
-12434	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg ip] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females over 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg ip] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females over 10 min [beam breaks/sec]	0.331	0.317	0.588	0.354	0.346	0.299	1.98	0.361	x	1.024	0.552	0.247	0.507	x	0.365	0.262	x	0.313	x	0.265	x	x	x	x	x	0.453	x	0.245	x	x	0.209	0.294	0.481	x	x	x	x	0.448	0.5	x	0.215	0.537	0.484	0.247	x	x	0.331	0.496	0.258	0.44	x	x	x	0.439	0.516	x	x	x	0.362	0.418	0.435	x	x	0.384	0.354	0.682	0.255	0.527	0.388	0.296	x	0.305	x	0.423	x	0.561	x	x	0.205	0.554	x	0.43	0.512	0.366	0.728	1.204	x	2.349	0.265	x	0.303	x	x	0.302	0.369	0.431	0.629	0.374	0.555	0.668	0.788	0.222	
-12435	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	13.1	14.32	10.856	4.25	8.933	1.1	69.4	6.067	7.9	10.9	96.533	3.3	x	x	6.3	8.75	x	11.2	1.5	4.067	x	x	x	x	x	x	17.85	x	x	0.85	5.022	3.05	8.367	x	0.5	x	6.1	2.488	2.133	x	6.833	5.425	12.533	5.35	x	x	13.55	39.8	1.767	9.475	x	x	x	8.85	4.425	x	x	x	5.283	20.35	3.9	x	x	11.5	30.486	x	3.433	15.667	12.4	4.3	x	9.117	5.8	10.167	x	17.5	x	3.05	7.733	x	x	6.4	8.717	13.563	2.863	21.325	x	4.733	1.467	x	4.029	x	x	4.6	10.05	5.78	3.433	6.733	9.729	8.0	7.788	2.283	
-12436	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time]	x	55.987	33.133	41.025	30.067	17.3	41.567	42.061	50.3	x	32.522	39.733	x	x	51.833	80.083	x	44.6	24.867	39.256	x	x	x	x	x	x	6.433	x	x	46.167	51.511	62.067	42.717	x	45.767	x	62.8	46.892	53.883	x	52.922	65.9	36.928	36.839	x	x	49.95	20.433	59.83	56.412	x	x	x	51.528	23.417	x	x	x	40.456	54.267	47.333	x	x	16.028	43.276	x	44.25	71.061	53.0	60.583	x	52.533	50.433	55.45	x	37.52	x	57.767	41.006	x	x	31.61	48.711	32.733	42.9	33.608	x	45.45	42.994	x	35.305	x	x	50.767	44.467	33.447	45.867	62.889	34.905	50.142	31.73	40.783	
-12437	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time]	0.533	43.24	15.293	16.583	33.378	1.467	35.233	24.633	35.833	11.433	51.378	30.767	x	x	31.8	37.633	x	49.167	25.267	37.156	x	x	x	x	x	x	5.35	x	x	35.133	44.27	59.9	38.55	x	24.533	x	49.133	23.146	47.761	x	59.2	47.65	28.65	34.589	x	x	43.35	12.35	64.859	50.7	x	x	x	38.378	14.725	x	x	x	27.272	19.783	18.49	x	x	9.056	43.376	x	40.889	52.272	60.083	50.633	x	50.672	32.333	35.983	x	14.12	x	45.067	22.178	x	x	19.69	25.367	30.083	47.125	39.767	x	50.289	36.183	x	20.476	x	x	24.767	22.533	26.3	34.628	61.933	8.681	23.933	42.077	30.639	
-12438	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time]	1.717	49.613	24.213	28.804	31.722	9.383	38.4	33.347	43.067	6.683	41.95	35.25	x	x	41.817	58.858	x	46.883	25.067	38.206	x	x	x	x	x	x	5.892	x	x	40.65	47.891	60.983	40.633	x	35.15	x	55.967	35.019	50.822	x	56.061	56.775	32.789	35.714	x	x	46.65	16.392	62.344	53.556	x	x	x	44.953	19.071	x	x	x	33.864	37.025	32.912	x	x	12.542	43.326	x	42.569	61.667	56.542	55.608	x	51.603	41.383	45.717	x	25.82	x	51.417	31.592	x	x	25.65	37.039	31.408	45.013	36.688	x	47.869	39.589	x	27.89	x	x	37.767	33.5	29.873	40.247	62.411	21.793	37.038	36.903	35.711	
-12439	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	561.0	549.6	493.44	684.5	936.67	546.0	262.0	532.67	615.0	98.0	381.67	739.0	x	x	365.0	288.5	x	903.0	400.0	844.33	x	x	x	x	x	x	471.5	x	x	386.5	703.22	364.0	590.5	x	400.0	x	320.0	508.63	488.5	x	742.67	295.25	523.67	807.0	x	x	586.5	607.5	355.89	400.75	x	x	x	312.83	542.5	x	x	x	480.5	394.5	400.43	x	x	341.17	499.0	x	806.83	143.17	523.63	534.25	x	431.83	375.0	423.17	x	300.6	x	415.5	555.0	x	x	626.43	496.5	522.25	337.0	372.0	x	331.5	591.17	x	674.43	x	x	537.25	651.67	577.0	439.17	415.0	433.43	482.25	413.8	695.5	
-12440	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	313.0	471.2	446.44	495.75	822.33	467.0	114.0	475.5	566.0	154.0	266.33	783.0	x	x	298.0	640.0	x	971.0	408.0	727.0	x	x	x	x	x	x	354.0	x	x	533.0	624.22	510.0	562.0	x	564.0	x	467.0	393.75	502.5	x	463.33	324.0	460.67	695.33	x	x	504.5	443.5	328.67	394.88	x	x	x	287.83	604.25	x	x	x	510.5	498.17	443.29	x	x	422.67	505.0	x	783.17	205.17	319.63	599.0	x	460.33	478.0	599.67	x	209.0	x	771.5	635.0	x	x	505.43	590.0	588.13	303.13	337.0	x	407.67	622.0	x	696.0	x	x	487.75	664.83	497.6	527.67	540.33	416.43	509.25	267.4	608.83	
-12441	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	None	Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	874.0	1020.8	939.89	1180.25	1759.0	1013.0	376.0	1008.17	1181.0	252.0	648.0	1522.0	x	x	663.0	928.5	x	1874.0	808.0	1571.33	x	x	x	x	x	x	825.5	x	x	919.5	1327.44	874.0	1152.5	x	964.0	x	787.0	902.38	991.0	x	1206.0	619.25	984.33	1502.33	x	x	1091.0	1051.0	684.56	795.63	x	x	x	600.67	1146.75	x	x	x	991.0	892.67	843.71	x	x	763.83	1004.0	x	1590.0	348.33	843.25	1133.25	x	892.17	853.0	1022.83	x	509.6	x	1187.0	1190.0	x	x	1131.86	1086.5	1110.38	640.13	709.0	x	739.17	1213.17	x	1370.43	x	x	1025.0	1316.5	1074.6	966.83	955.33	849.86	991.5	681.2	1304.33	
-12442	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks/sec]	0.519	0.285	0.476	0.268	0.227	0.454	0.669	0.408	0.242	1.3	1.5	0.245	x	x	0.396	0.205	x	0.184	0.564	0.222	x	x	x	x	x	x	0.597	x	x	0.468	0.235	0.381	0.299	x	0.407	x	0.349	0.316	0.364	x	0.188	0.348	0.379	0.257	x	x	0.255	0.41	0.514	0.328	x	x	x	0.594	0.475	x	x	x	0.612	0.364	0.391	x	x	1.277	0.5	x	0.21	1.008	0.476	0.236	x	0.402	0.397	0.318	x	1.6	x	0.3	0.325	x	x	0.333	0.319	0.468	0.809	0.818	x	0.579	0.428	x	0.317	x	x	0.301	0.268	0.416	0.76	0.351	0.495	0.323	1.4	0.257	
-12443	Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	0.953	0.409	0.792	0.623	0.247	0.633	1.704	1.813	0.34	1.725	0.609	0.265	x	x	0.687	0.3	x	0.157	0.55	0.261	x	x	x	x	x	x	0.832	x	x	0.385	0.287	0.23	0.363	x	0.401	x	0.327	0.623	0.302	x	0.222	0.528	0.472	0.308	x	x	0.334	0.625	0.371	0.39	x	x	x	0.966	0.476	x	x	x	0.658	0.722	0.628	x	x	0.712	0.361	x	0.228	1.008	0.896	0.248	x	0.418	0.425	0.344	x	4.463	x	0.228	0.375	x	x	0.499	0.454	0.374	0.587	0.649	x	0.337	0.573	x	0.367	x	x	0.517	0.363	0.461	0.622	0.263	0.736	0.476	1.768	0.366	
-12444	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	0.675	0.342	0.599	0.366	0.233	0.537	0.983	0.65	0.289	2.222	32.286	0.255	x	x	0.527	0.265	x	0.17	0.556	0.24	x	x	x	x	x	x	0.692	x	x	0.42	0.258	0.275	0.321	x	0.404	x	0.336	0.443	0.332	x	0.212	0.472	0.42	0.278	x	x	0.293	0.501	0.441	0.348	x	x	x	0.736	0.476	x	x	x	0.587	0.532	0.5	x	x	1.634	0.406	x	0.219	0.898	0.571	0.241	x	0.412	0.412	0.33	x	121.035	x	0.25	0.351	x	x	0.4	0.372	0.414	0.638	0.734	x	0.456	0.491	x	0.342	x	x	0.404	0.314	0.429	0.6	0.313	0.603	0.405	3.756	0.305	
-12445	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	9.6	7.309	11.12	6.18	11.0	5.925	52.1	9.133	7.9	31.833	50.167	3.4	3.85	x	9.2	6.067	x	18.7	1.5	3.1	x	x	x	x	x	12.8	17.85	6.333	x	0.85	3.873	5.033	6.508	x	0.5	x	6.1	3.3	4.469	x	3.5	15.708	16.682	2.807	x	x	8.62	26.9	1.868	10.176	x	x	x	8.35	3.35	x	x	x	8.46	13.167	5.082	x	x	13.25	19.469	43.8	4.058	11.625	11.036	3.1	x	7.257	5.8	7.792	x	10.825	x	3.05	5.908	5.7	x	4.457	5.4	17.6	3.175	11.633	x	20.243	10.433	x	9.277	x	x	4.35	9.808	4.586	7.677	3.786	7.175	5.767	5.85	3.983	
-12446	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [% time]	28.392	51.288	36.831	35.517	34.333	45.542	51.6	39.863	50.3	10.162	37.2	44.133	26.817	x	40.2	70.067	x	42.283	24.867	40.45	x	x	x	x	x	20.333	6.433	51.167	x	46.167	50.722	51.278	50.469	x	45.767	x	62.8	43.606	49.617	x	52.737	58.544	35.318	48.729	x	x	50.1	18.908	58.748	41.467	x	x	x	41.509	23.617	x	x	x	41.467	54.797	49.739	x	x	29.189	44.056	6.8	43.669	68.95	55.305	50.323	x	57.343	50.433	46.214	x	26.772	x	57.767	45.574	61.467	x	31.5	44.225	28.711	40.222	33.675	x	43.378	46.642	x	35.874	x	x	45.777	38.028	34.819	40.026	59.324	37.973	43.672	32.297	53.764	
-12447	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time]	18.208	36.221	21.52	22.09	31.647	21.217	18.833	25.115	35.833	9.519	32.994	38.333	17.15	x	28.217	33.867	x	40.267	25.267	31.708	x	x	x	x	x	17.467	5.35	42.578	x	35.133	44.684	44.911	41.405	x	24.533	x	49.133	20.791	37.865	x	47.023	36.994	29.494	40.278	x	x	40.72	11.542	60.073	38.678	x	x	x	26.77	20.104	x	x	x	29.567	26.161	25.118	x	x	20.889	41.313	6.833	37.769	51.314	61.605	44.067	x	44.369	32.333	33.1	x	12.054	x	45.067	36.313	70.017	x	22.257	24.456	25.936	38.028	33.047	x	50.667	41.617	x	26.1	x	x	30.06	24.517	27.233	27.667	49.714	13.865	23.278	34.287	40.786	
-12448	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [% time]	23.3	43.755	29.176	28.803	32.99	33.379	35.217	32.489	43.067	9.841	35.097	41.233	21.983	x	34.208	51.967	x	41.275	25.067	36.079	x	x	x	x	x	18.9	5.892	46.872	x	40.65	47.703	48.094	45.937	x	35.15	x	55.967	32.199	43.741	x	49.88	47.769	32.406	44.503	x	x	45.41	15.225	59.411	40.072	x	x	x	34.14	21.86	x	x	x	35.517	40.479	37.429	x	x	25.039	42.685	6.817	40.719	60.132	58.455	47.195	x	50.856	41.383	39.657	x	19.413	x	51.417	40.944	65.742	x	26.879	34.34	27.324	39.125	33.361	x	47.022	44.129	x	30.987	x	x	37.918	31.272	31.026	33.846	54.519	25.919	33.475	33.292	47.275	
-12449	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	657.25	578.73	449.33	681.2	809.4	565.25	201.5	565.56	615.0	354.14	427.67	713.33	484.5	x	498.0	425.33	x	735.5	400.0	811.0	x	x	x	x	x	562.0	471.5	706.33	x	386.5	753.13	530.67	492.77	x	400.0	x	320.0	519.0	469.06	x	740.7	315.0	513.27	694.67	x	x	602.2	619.25	470.91	499.24	x	x	x	546.44	509.88	x	x	x	487.5	383.17	376.36	x	x	429.58	507.31	385.0	754.5	178.17	469.07	627.5	x	424.0	375.0	474.58	x	438.0	x	415.5	650.54	198.5	x	620.57	492.0	594.33	310.25	281.0	x	296.07	580.42	x	676.54	x	x	646.9	652.75	497.57	510.08	440.29	444.69	430.17	399.85	576.75	
-12450	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	529.25	531.09	392.73	597.2	787.0	637.25	89.5	524.11	566.0	217.0	307.83	695.67	442.0	x	437.0	665.0	x	819.0	408.0	765.75	x	x	x	x	x	512.0	354.0	605.0	x	533.0	664.8	580.67	455.38	x	564.0	x	467.0	415.73	484.19	x	664.0	389.0	437.64	603.33	x	x	487.4	433.5	371.27	457.35	x	x	x	444.61	517.88	x	x	x	515.6	505.67	448.82	x	x	469.08	485.0	435.0	784.67	260.42	315.43	630.0	x	572.5	478.0	589.83	x	361.23	x	771.5	704.31	204.0	x	479.29	486.33	605.67	334.75	277.08	x	377.13	643.83	x	672.08	x	x	546.5	633.75	533.43	557.0	488.14	412.63	480.0	255.7	646.33	
-12451	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	1186.5	1109.82	842.07	1278.4	1596.4	1202.5	291.0	1089.67	1181.0	571.14	735.5	1409.0	926.5	x	935.0	1090.33	x	1554.5	808.0	1576.75	x	x	x	x	x	1074.0	825.5	1311.33	x	919.5	1417.93	1111.33	948.15	x	964.0	x	787.0	934.73	953.25	x	1404.7	704.0	950.91	1298.0	x	x	1089.6	1052.75	842.18	956.59	x	x	x	991.06	1027.75	x	x	x	1003.1	888.83	825.18	x	x	898.67	992.31	820.0	1539.17	438.58	784.5	1257.5	x	996.5	853.0	1064.42	x	799.23	x	1187.0	1354.85	402.5	x	1099.86	978.33	1200.0	645.0	558.08	x	673.2	1224.25	x	1348.62	x	x	1193.4	1286.5	1031.0	1067.08	928.43	857.31	910.17	655.55	1223.08	
-12452	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	0.344	0.276	0.478	0.307	0.268	0.296	0.743	0.384	0.242	1.181	16.307	0.235	0.464	x	0.368	0.208	x	0.251	0.564	0.226	x	x	x	x	x	0.425	0.597	0.21	x	0.468	0.216	0.335	0.391	x	0.407	x	0.349	0.329	0.46	x	0.191	0.503	0.426	0.222	x	x	0.252	0.403	0.343	0.365	x	x	x	0.405	0.495	x	x	x	0.504	0.463	0.43	x	x	0.841	0.435	0.726	0.229	0.751	0.433	0.258	x	0.377	0.397	0.391	x	23.562	x	0.3	0.261	0.543	x	0.34	0.377	0.422	0.846	1.051	x	3.429	0.363	x	0.321	x	x	0.273	0.305	0.487	0.61	0.324	0.456	0.719	7.98	0.244	
-12453	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	0.526	0.386	0.785	0.484	0.293	0.419	3.104	1.339	0.34	1.747	0.701	0.265	0.561	x	0.54	0.303	x	0.233	0.55	0.268	x	x	x	x	x	0.484	0.832	0.285	x	0.385	0.266	0.271	0.452	x	0.401	x	0.327	0.613	0.342	x	0.233	0.55	0.501	0.334	x	x	0.42	0.637	0.348	0.462	x	x	x	0.764	0.505	x	x	x	0.55	0.57	0.551	x	x	0.56	0.375	0.643	0.246	0.784	0.682	0.303	x	0.347	0.425	0.381	x	1.926	x	0.228	0.283	0.592	x	0.556	0.546	0.389	0.604	1.992	x	1.36	0.411	x	0.342	x	x	0.428	0.385	0.427	0.744	0.361	0.722	0.501	1.416	0.292	
-12454	Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	0.417	0.328	0.595	0.359	0.278	0.359	1.481	0.554	0.289	1.195	16.419	0.25	0.507	x	0.446	0.264	x	0.241	0.556	0.246	x	x	x	x	x	0.453	0.692	0.245	x	0.42	0.239	0.281	0.407	x	0.404	x	0.336	0.445	0.437	x	0.214	0.515	0.449	0.259	x	x	0.316	0.499	0.333	0.397	x	x	x	0.538	0.496	x	x	x	0.497	0.475	0.477	x	x	1.009	0.382	0.682	0.237	0.713	0.493	0.274	x	0.351	0.412	0.376	x	46.897	x	0.25	0.273	0.554	x	0.415	0.442	0.398	0.668	1.047	x	1.592	0.378	x	0.324	x	x	0.343	0.342	0.43	0.615	0.348	0.576	0.493	2.272	0.264	
-12455	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]	3.767	6.55	6.125	27.75	2.1	5.125	6.4	5.633	5.0	8.663	3.533	2.5	5.7	x	9.45	6.35	x	7.7	x	11.0	x	x	x	124.3	x	4.8	x	7.65	x	13.6	4.1	10.6	5.3	x	x	x	x	7.0	0.95	x	5.943	4.771	5.417	3.883	x	x	11.967	1.4	4.417	6.12	x	x	x	7.957	5.971	x	x	x	3.45	4.567	5.45	x	x	2.9	5.417	17.9	3.683	7.214	4.433	4.85	x	2.15	x	1.775	x	7.75	x	x	1.65	0.95	x	10.075	22.633	12.8	3.489	1.267	x	2.983	1.333	x	6.9	x	x	8.471	12.95	3.325	3.483	6.286	2.8	5.625	3.125	5.52	
-12456	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]	23.322	24.837	24.733	21.096	40.95	38.342	7.6	29.456	35.033	27.642	13.85	14.117	4.8	x	12.417	5.683	x	31.117	x	10.233	x	x	x	1.033	x	7.433	x	33.517	x	22.8	37.856	6.833	39.967	x	x	x	x	35.528	55.467	x	39.7	37.49	24.8	18.8	x	x	33.867	6.517	41.933	27.64	x	x	x	22.681	16.057	x	x	x	39.25	28.233	26.342	x	x	27.339	23.933	13.344	43.956	40.343	20.228	24.706	x	24.506	x	14.567	x	10.822	x	x	20.833	37.233	x	31.45	23.3	16.494	14.856	35.933	x	31.844	37.067	x	27.867	x	x	41.595	35.75	15.042	19.739	36.838	21.883	33.167	31.658	17.453	
-12457	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]	17.856	18.087	18.083	10.504	24.517	28.075	0.333	24.189	16.8	18.779	3.128	12.283	0.367	x	4.217	2.517	x	32.7	x	4.667	x	x	x	0.767	x	6.733	x	13.717	x	29.167	30.278	41.767	39.647	x	x	x	x	12.672	33.161	x	33.033	31.11	18.506	15.772	x	x	18.789	1.333	32.006	23.407	x	x	x	18.652	8.99	x	x	x	27.533	17.45	20.983	x	x	21.528	12.033	13.189	35.572	37.914	12.844	28.761	x	10.894	x	5.875	x	8.306	x	x	25.883	34.417	x	23.725	10.583	21.461	12.307	35.167	x	39.706	32.978	x	16.638	x	x	29.767	25.667	7.55	10.311	25.829	25.0	16.967	28.246	20.207	
-12458	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]	20.589	21.462	21.408	15.8	32.733	33.208	3.967	26.822	25.917	23.21	8.489	13.2	2.583	x	8.317	4.1	x	31.908	x	7.45	x	x	x	0.9	x	7.083	x	23.617	x	25.983	34.067	24.3	39.807	x	x	x	x	24.1	44.314	x	36.367	34.3	21.653	17.286	x	x	26.328	3.925	36.969	25.523	x	x	x	20.667	12.524	x	x	x	33.392	22.842	23.663	x	x	24.433	17.983	13.267	39.764	39.129	16.536	26.733	x	17.7	x	10.221	x	9.564	x	x	23.358	35.825	x	27.587	16.942	18.978	13.582	35.55	x	35.775	35.022	x	22.252	x	x	35.681	30.708	11.296	15.025	31.333	23.442	25.067	29.952	18.83	
-12459	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]	502.67	558.5	517.25	397.0	673.5	475.5	365.0	552.33	352.0	447.38	348.0	667.5	429.0	x	487.5	388.67	x	516.0	x	726.0	x	x	x	325.0	x	484.0	x	512.5	x	468.0	499.33	465.0	419.4	x	x	x	x	460.5	326.33	x	572.43	393.71	420.5	553.17	x	x	493.33	346.5	397.0	495.6	x	x	x	586.43	614.14	x	x	x	438.0	459.5	389.5	x	x	580.67	362.83	491.0	373.17	458.86	425.83	559.0	x	412.33	x	513.5	x	491.17	x	x	595.0	522.0	x	491.25	423.67	632.0	467.0	435.33	x	458.17	485.33	x	562.5	x	x	485.43	536.25	554.75	546.17	429.0	373.75	495.75	389.88	591.2	
-12460	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]	418.33	420.5	374.5	276.88	600.0	378.75	277.0	434.33	336.0	412.75	194.67	367.5	265.0	x	313.5	256.67	x	313.0	x	271.0	x	x	x	264.0	x	308.0	x	305.5	x	302.0	380.17	327.0	312.4	x	x	x	x	255.33	409.17	x	430.29	308.86	297.67	435.5	x	x	434.33	351.0	273.5	378.2	x	x	x	414.86	384.86	x	x	x	291.5	327.17	285.25	x	x	393.67	236.0	313.67	356.67	374.57	306.5	469.67	x	339.5	x	331.25	x	375.5	x	x	455.67	381.5	x	397.0	276.83	385.67	374.11	277.67	x	408.67	330.0	x	457.75	x	x	321.29	436.0	390.25	356.0	399.29	260.25	349.25	330.25	416.6	
-12461	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]	921.0	979.0	891.75	673.88	1273.5	854.25	642.0	986.67	688.0	860.13	542.67	1035.0	694.0	x	801.0	645.33	x	829.0	x	997.0	x	x	x	589.0	x	792.0	x	818.0	x	770.0	879.5	792.0	731.8	x	x	x	x	715.83	735.5	x	1002.71	702.57	718.17	988.67	x	x	927.67	697.5	670.5	873.8	x	x	x	1001.29	999.0	x	x	x	729.5	786.67	674.75	x	x	974.33	598.83	804.67	729.83	833.43	732.33	1028.67	x	751.83	x	844.75	x	866.67	x	x	1050.67	903.5	x	888.25	700.5	1017.67	841.11	713.0	x	866.83	815.33	x	1020.25	x	x	806.71	972.25	945.0	902.17	828.29	634.0	845.0	720.12	1007.8	
-12462	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]	0.46	0.415	0.443	1.117	0.263	0.396	0.759	0.402	0.554	0.492	0.792	0.393	0.666	x	0.54	0.765	x	0.401	x	0.371	x	x	x	0.914	x	0.574	x	0.389	x	0.495	0.384	0.601	0.434	x	x	x	x	0.421	0.437	x	0.325	0.485	0.543	0.463	x	x	0.422	0.829	0.465	0.448	x	x	x	0.399	0.415	x	x	x	0.414	0.471	0.581	x	x	0.379	0.693	0.559	0.47	0.394	0.581	0.427	x	1.176	x	0.506	x	0.591	x	x	0.403	0.361	x	0.437	0.619	0.402	0.72	0.452	x	0.448	0.396	x	0.396	x	x	0.386	0.365	0.473	0.44	0.446	0.675	0.41	0.538	0.423	
-12463	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]	0.607	0.603	0.671	2.0	0.377	0.575	1.079	0.539	0.743	0.586	1.75	0.806	1.128	x	0.981	1.429	x	0.647	x	1.055	x	x	x	1.128	x	0.908	x	0.956	x	0.704	0.559	0.534	0.594	x	x	x	x	1.068	0.485	x	0.482	0.705	0.855	0.61	x	x	0.561	0.886	0.812	0.654	x	x	x	0.649	0.744	x	x	x	0.745	0.779	0.864	x	x	0.626	1.179	0.944	0.595	0.531	1.01	0.486	x	0.824	x	0.893	x	0.802	x	x	0.505	0.518	x	0.594	1.063	0.631	0.919	0.708	x	0.452	0.61	x	0.561	x	x	0.709	0.534	0.846	0.863	0.571	0.896	0.789	0.665	0.579	
-12464	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]	0.525	0.492	0.533	1.944	0.317	0.474	0.898	0.462	0.646	0.535	1.082	0.526	0.842	x	0.7	0.954	x	0.494	x	0.557	x	x	x	1.01	x	0.704	x	0.573	x	0.577	0.46	0.573	0.498	x	x	x	x	0.647	0.457	x	0.389	0.574	0.656	0.521	x	x	0.483	0.856	0.595	0.531	x	x	x	0.486	0.535	x	x	x	0.546	0.597	0.691	x	x	0.472	0.87	0.698	0.522	0.451	0.702	0.448	x	0.759	x	0.645	x	0.677	x	x	0.439	0.426	x	0.507	0.783	0.48	0.805	0.552	x	0.445	0.479	x	0.465	x	x	0.511	0.434	0.594	0.578	0.503	0.742	0.545	0.596	0.488	
-12465	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]	13.5	6.514	8.35	6.86	8.2	2.0	21.6	8.183	12.8	14.429	11.68	4.95	13.5	x	21.4	2.833	x	9.6	10.7	8.25	x	x	x	x	x	21.9	28.1	x	x	8.3	3.433	8.333	5.567	x	2.0	x	8.2	5.575	2.4	x	2.35	1.2	4.183	6.233	x	x	6.533	11.9	3.771	5.783	x	x	x	4.783	16.1	x	x	x	2.95	1.8	4.475	x	x	4.083	8.16	6.133	13.033	2.067	3.82	16.1	x	4.6	42.4	5.55	x	5.95	x	5.85	7.7	x	x	8.483	4.6	15.483	4.633	1.9	x	4.0	1.583	x	5.011	x	x	6.4	7.25	7.067	3.767	2.625	28.417	3.283	4.3	8.217	
-12466	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]	21.2	24.405	22.694	24.893	38.775	9.733	3.433	18.006	5.633	30.662	21.78	20.2	36.55	x	22.667	4.456	x	45.267	11.333	25.15	x	x	x	x	x	32.933	2.411	x	x	17.378	32.222	42.622	36.144	x	11.0	x	1.567	22.858	31.489	x	30.289	22.028	21.633	23.439	x	x	56.244	9.567	41.138	28.172	x	x	x	17.428	8.229	x	x	x	47.761	28.178	23.158	x	x	19.644	22.76	27.356	33.806	20.433	32.467	17.711	x	6.978	2.867	24.95	x	27.625	x	17.133	13.228	x	x	29.028	22.106	13.317	21.933	36.533	x	21.433	31.472	x	24.559	x	x	27.007	27.172	11.644	22.289	42.842	11.494	24.206	25.639	13.033	
-12467	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]	11.667	18.929	14.711	14.127	32.692	0.5	4.5	15.656	13.433	21.119	23.253	11.467	16.9	x	5.7	1.756	x	41.1	5.7	30.908	x	x	x	x	x	0.2	9.333	x	x	19.933	27.15	18.933	29.833	x	10.533	x	11.133	6.813	21.717	x	20.85	28.433	16.056	20.511	x	x	37.178	6.15	28.843	30.356	x	x	x	15.089	9.433	x	x	x	28.95	13.744	17.817	x	x	15.144	20.18	26.544	29.233	22.622	31.713	20.572	x	7.483	0.5	24.156	x	26.15	x	13.933	11.556	x	x	21.156	22.022	9.8	9.5	35.175	x	22.233	27.061	x	16.967	x	x	29.807	11.55	8.706	12.578	43.533	12.378	20.506	21.333	8.633	
-12468	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]	16.433	21.667	18.703	19.51	35.733	5.117	3.967	16.831	9.533	25.89	22.517	15.833	26.725	x	14.183	3.106	x	43.183	8.517	28.029	x	x	x	x	x	16.567	5.872	x	x	18.656	29.686	30.778	32.989	x	10.767	x	6.35	14.835	26.603	x	25.569	25.231	18.844	21.975	x	x	46.711	7.858	34.99	29.264	x	x	x	16.258	8.831	x	x	x	38.356	20.961	20.488	x	x	17.394	21.47	26.95	31.519	21.528	32.09	19.142	x	7.231	1.683	24.553	x	26.887	x	15.533	12.392	x	x	25.092	22.064	11.558	15.717	35.854	x	21.833	29.267	x	20.763	x	x	28.407	19.361	10.175	17.433	43.188	11.936	22.356	23.486	10.833	
-12469	Original post publication description: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg i.p.) for RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) for RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]	624.0	561.14	543.67	551.2	513.25	562.0	679.0	578.67	389.0	480.86	235.2	488.5	465.5	x	779.0	493.67	x	465.0	579.0	448.0	x	x	x	x	x	321.0	434.0	x	x	450.5	576.5	375.33	415.67	x	697.0	x	553.0	460.5	568.0	x	599.83	421.67	482.0	629.5	x	x	453.0	414.5	438.86	454.33	x	x	x	624.83	636.57	x	x	x	465.33	462.83	453.5	x	x	563.17	425.4	535.0	496.17	533.0	422.0	564.33	x	484.67	453.0	559.0	x	447.75	x	634.5	570.5	x	x	457.33	406.33	639.33	394.5	425.25	x	457.25	554.33	x	519.11	x	x	576.4	524.33	700.67	562.17	527.75	386.17	505.17	451.17	586.83	
-12470	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]	500.0	392.57	413.33	383.6	375.75	283.0	502.0	416.5	387.0	368.86	100.8	335.0	400.5	x	522.0	387.0	x	488.0	384.0	269.5	x	x	x	x	x	158.0	329.33	x	x	350.0	433.83	299.0	287.0	x	363.0	x	363.0	281.13	392.67	x	482.83	316.33	315.67	410.5	x	x	423.0	344.0	291.14	321.67	x	x	x	461.33	382.57	x	x	x	441.17	352.17	352.25	x	x	380.17	205.0	306.67	425.83	478.17	305.0	506.83	x	364.67	334.0	396.83	x	232.0	x	433.0	366.5	x	x	352.5	276.83	429.33	289.17	245.5	x	372.75	383.33	x	376.67	x	x	420.0	370.0	517.83	456.0	388.5	362.83	413.0	396.17	434.17	
-12471	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]	1124.0	953.71	957.0	934.8	889.0	845.0	1181.0	995.17	776.0	849.71	336.0	823.5	866.0	x	1301.0	880.67	x	953.0	963.0	717.5	x	x	x	x	x	479.0	763.33	x	x	800.5	1010.33	674.33	702.67	x	1060.0	x	916.0	741.63	960.67	x	1082.67	738.0	797.67	1040.0	x	x	876.0	758.5	730.0	776.0	x	x	x	1086.17	1019.14	x	x	x	906.5	815.0	805.75	x	x	943.33	630.4	841.67	922.0	1011.17	727.0	1071.17	x	849.33	787.0	955.83	x	679.75	x	1067.5	937.0	x	x	809.83	683.17	1068.67	683.67	670.75	x	830.0	937.67	x	895.78	x	x	996.4	894.33	1218.5	1018.17	916.25	749.0	918.17	847.33	1021.0	
-12472	Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]	0.379	0.412	0.434	0.418	0.359	0.482	0.427	0.457	0.728	0.5	1.092	0.49	0.436	x	0.298	0.623	x	0.353	0.459	0.513	x	x	x	x	x	0.627	0.679	x	x	0.712	0.354	0.472	0.472	x	0.383	x	0.534	0.541	0.362	x	0.356	0.586	0.5	0.372	x	x	0.294	0.668	0.416	0.481	x	x	x	0.397	0.447	x	x	x	0.356	0.468	0.563	x	x	0.441	0.553	0.415	0.404	0.46	0.515	0.46	x	0.613	0.643	0.409	x	0.503	x	0.399	0.494	x	x	0.487	0.59	0.41	0.646	0.463	x	0.529	0.38	x	0.445	x	x	0.389	0.423	0.395	0.425	0.324	0.723	0.493	0.513	0.46	
-12473	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]	0.53	0.65	0.713	0.687	0.613	1.055	0.571	0.687	0.671	0.851	2.788	0.798	0.662	x	0.542	0.878	x	0.362	0.737	0.801	x	x	x	x	x	1.895	0.837	x	x	0.719	0.508	0.819	0.747	x	0.739	x	0.734	1.13	0.63	x	0.521	0.717	0.954	0.592	x	x	0.457	0.818	0.806	0.669	x	x	x	0.561	0.776	x	x	x	0.57	0.787	0.705	x	x	0.765	1.255	0.725	0.505	0.494	0.682	0.554	x	0.896	0.894	0.634	x	1.081	x	0.623	1.374	x	x	0.716	1.022	0.957	1.052	0.802	x	0.627	0.584	x	0.753	x	x	0.508	0.79	0.585	0.617	0.422	0.772	0.601	0.623	0.664	
-12474	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]	0.446	0.504	0.535	0.524	0.445	0.674	0.488	0.54	0.699	0.641	1.465	0.615	0.549	x	0.396	0.727	x	0.358	0.57	0.62	x	x	x	x	x	1.045	0.744	x	x	0.664	0.42	0.62	0.581	x	0.505	x	0.613	0.73	0.468	x	0.426	0.639	0.648	0.453	x	x	0.373	0.733	0.553	0.557	x	x	x	0.464	0.562	x	x	x	0.449	0.594	0.621	x	x	0.555	0.772	0.522	0.45	0.475	0.578	0.495	x	0.716	0.75	0.489	x	0.673	x	0.487	0.67	x	x	0.579	0.708	0.527	0.796	0.587	x	0.571	0.463	x	0.548	x	x	0.434	0.566	0.471	0.503	0.366	0.727	0.535	0.561	0.54	
-12475	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]	5.157	6.535	7.46	19.715	6.167	4.5	14.0	7.333	8.9	11.353	7.236	3.725	10.9	x	13.433	5.178	x	8.333	10.7	8.8	x	x	x	124.3	x	13.35	28.1	7.65	x	9.057	3.767	8.9	5.445	x	2.0	x	8.2	6.186	1.675	x	4.285	3.123	4.8	5.058	x	x	9.25	6.65	4.069	5.936	x	x	x	6.492	11.036	x	x	x	3.075	3.183	4.962	x	x	3.492	6.664	12.017	8.358	4.838	4.155	10.475	x	3.375	42.4	4.04	x	7.03	x	5.85	4.675	0.95	x	9.12	13.617	14.142	3.947	1.52	x	3.39	1.458	x	5.9	x	x	7.608	9.53	5.57	3.625	4.955	18.17	4.22	3.629	6.991	
-12476	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]	23.019	24.659	23.51	22.556	39.5	32.62	5.517	21.822	20.333	29.051	17.455	17.158	25.967	x	15.833	5.274	x	35.833	11.333	22.167	x	x	x	1.033	x	20.183	2.411	33.517	x	18.152	35.039	33.675	37.882	x	11.0	x	1.567	28.288	43.478	x	35.356	30.354	23.217	21.119	x	x	45.056	8.042	41.505	27.93	x	x	x	20.256	12.143	x	x	x	45.633	28.206	24.75	x	x	23.492	23.4	20.35	38.881	31.154	25.791	21.208	x	15.742	2.867	20.797	x	17.543	x	17.133	17.031	37.233	x	29.997	22.703	14.906	17.687	36.173	x	27.68	34.269	x	26.116	x	x	35.517	30.603	13.003	21.014	39.021	15.65	27.79	29.079	15.042	
-12477	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]	16.971	18.433	16.06	11.897	29.967	22.56	2.417	18.5	15.117	19.871	12.276	11.875	11.389	x	4.711	2.263	x	35.5	5.7	25.66	x	x	x	0.767	x	3.467	9.333	13.717	x	21.252	28.714	24.642	34.294	x	10.533	x	11.133	9.324	27.439	x	27.41	29.874	17.281	18.142	x	x	27.983	3.742	30.303	27.197	x	x	x	17.008	9.212	x	x	x	28.596	15.597	19.4	x	x	18.336	15.736	19.867	32.403	30.856	21.421	24.667	x	9.189	0.5	16.843	x	15.443	x	13.933	18.719	34.417	x	22.183	16.303	15.631	11.184	35.17	x	32.717	30.019	x	16.812	x	x	29.783	17.197	8.243	11.444	32.267	17.427	19.09	25.283	13.894	
-12478	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]	19.995	21.546	19.785	17.227	34.733	27.59	3.967	20.161	17.725	24.461	14.865	14.517	18.678	x	10.272	3.768	x	35.667	8.517	23.913	x	x	x	0.9	x	11.825	5.872	23.617	x	19.702	31.876	29.158	36.088	x	10.767	x	6.35	18.806	35.458	x	31.383	30.114	20.249	19.631	x	x	36.519	5.892	35.904	27.564	x	x	x	18.632	10.677	x	x	x	37.115	21.901	22.075	x	x	20.914	19.568	20.108	35.642	31.005	23.606	22.938	x	12.465	1.683	18.82	x	16.493	x	15.533	17.875	35.825	x	26.09	19.503	15.268	14.436	35.672	x	30.198	32.144	x	21.464	x	x	32.65	23.9	10.623	16.229	35.644	16.538	23.44	27.181	14.468	
-12479	Original post publication description: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) in the RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) in the RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]	520.0	559.59	533.1	456.31	566.67	492.8	522.0	569.89	370.5	463.0	296.73	578.0	453.33	x	584.67	423.67	x	499.0	579.0	503.6	x	x	x	325.0	x	402.5	434.0	512.5	x	453.0	537.92	397.75	417.36	x	697.0	x	553.0	460.5	447.17	x	585.08	406.62	451.25	591.33	x	x	473.17	380.5	419.54	473.09	x	x	x	604.15	625.36	x	x	x	458.5	461.17	421.5	x	x	571.92	391.27	513.0	434.67	493.08	424.09	561.67	x	448.5	453.0	540.8	x	473.8	x	634.5	582.75	522.0	x	470.9	415.0	635.67	438.0	431.3	x	457.8	519.83	x	539.53	x	x	523.33	529.1	642.3	554.17	464.91	381.2	501.4	416.14	588.82	
-12480	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]	430.0	409.0	397.8	317.92	450.5	359.6	389.5	422.44	361.5	392.27	152.0	351.25	355.33	x	383.0	300.11	x	371.33	384.0	269.8	x	x	x	264.0	x	233.0	329.33	305.5	x	343.14	407.0	306.0	298.55	x	363.0	x	363.0	270.07	400.92	x	454.54	312.31	306.67	423.0	x	x	428.67	347.5	283.0	347.36	x	x	x	436.31	383.71	x	x	x	403.75	339.67	318.75	x	x	386.92	221.91	310.17	391.25	422.38	305.82	488.25	x	352.08	334.0	370.6	x	318.1	x	433.0	411.08	381.5	x	370.3	276.83	407.5	340.13	264.8	x	394.3	356.67	x	414.82	x	x	362.42	396.4	466.8	406.0	395.36	321.8	387.5	358.5	426.18	
-12481	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]	950.0	968.59	930.9	774.23	1017.17	852.4	911.5	992.33	732.0	855.27	448.73	929.25	808.67	x	967.67	723.78	x	870.33	963.0	773.4	x	x	x	589.0	x	635.5	763.33	818.0	x	796.14	944.92	703.75	715.91	x	1060.0	x	916.0	730.57	848.08	x	1039.62	718.92	757.92	1014.33	x	x	901.83	728.0	702.54	820.45	x	x	x	1040.46	1009.07	x	x	x	862.25	800.83	740.25	x	x	958.83	613.18	823.17	825.92	915.46	729.91	1049.92	x	800.58	787.0	911.4	x	791.9	x	1067.5	993.83	903.5	x	841.2	691.83	1043.17	778.13	696.1	x	852.1	876.5	x	954.35	x	x	885.75	925.5	1109.1	960.17	860.27	703.0	888.9	774.64	1015.0	
-12482	Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]	0.449	0.414	0.438	0.848	0.327	0.413	0.593	0.439	0.641	0.496	0.929	0.442	0.513	x	0.46	0.718	x	0.385	0.459	0.485	x	x	x	0.914	x	0.6	0.679	0.389	x	0.681	0.369	0.504	0.454	x	0.383	x	0.534	0.489	0.4	x	0.339	0.532	0.522	0.418	x	x	0.358	0.749	0.439	0.466	x	x	x	0.398	0.431	x	x	x	0.371	0.47	0.572	x	x	0.41	0.63	0.487	0.437	0.424	0.551	0.443	x	0.894	0.643	0.448	x	0.556	x	0.399	0.448	0.361	x	0.467	0.605	0.406	0.69	0.457	x	0.48	0.388	x	0.422	x	x	0.388	0.4	0.426	0.432	0.402	0.704	0.46	0.527	0.443	
-12483	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]	0.596	0.622	x	x	0.535	0.671	0.825	0.638	0.707	0.71	2.165	0.802	0.817	x	0.835	1.245	x	0.552	0.737	0.852	x	x	x	1.128	x	1.402	0.837	0.956	x	0.717	0.534	0.748	0.677	x	0.739	x	0.734	1.103	0.557	x	0.5	0.711	0.905	0.601	x	x	0.509	0.852	0.809	0.662	x	x	x	0.609	0.76	x	x	x	0.614	0.783	0.785	x	x	0.696	1.213	0.834	0.55	0.514	0.861	0.52	x	0.86	0.894	0.737	x	0.914	x	0.623	0.94	0.518	x	0.667	1.042	0.794	0.972	0.745	x	0.522	0.597	x	0.663	x	x	0.625	0.688	0.69	0.74	0.517	0.821	0.676	0.647	0.625	
-12484	Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	None	Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]	0.514	0.497	0.535	1.398	0.402	0.514	0.693	0.514	0.673	0.584	1.256	0.57	0.647	x	0.598	0.878	x	0.449	0.57	0.607	x	x	x	1.01	x	0.875	0.744	0.573	x	0.652	0.44	0.608	0.543	x	0.505	x	0.613	0.694	0.462	x	0.406	0.604	0.652	0.487	x	x	0.428	0.795	0.573	0.545	x	x	x	0.476	0.549	x	x	x	0.473	0.595	0.656	x	x	0.513	0.825	0.61	0.486	0.462	0.646	0.472	x	0.738	0.75	0.551	x	0.675	x	0.487	0.554	0.426	x	0.55	0.745	0.503	0.802	0.566	x	0.495	0.471	x	0.509	x	x	0.479	0.513	0.52	0.54	0.454	0.733	0.539	0.581	0.516	
-12485	Original post publication description: Central nervous system, morphology: Cerebellar Purkinje cell number, with Abercrombie correction, for male and females between 30 and 150-days-of-age [n x1000]	None	Central nervous system, morphology: Cerebellar Purkinje cell number, with Abercrombie correction, for male and females between 30 and 150-days-of-age [n x1000]	x	x	126.321	109.98	168.102	x	x	x	x	97.728	x	105.892	x	x	116.22	117.962	x	140.33	x	146.396	x	x	x	152.56	x	163.444	x	105.924	x	128.254	x	x	131.688	x	x	x	126.424	x	x	x	134.708	109.848	141.028	x	x	x	x	x	126.432	152.26	x	x	x	143.384	x	x	x	x	132.198	117.872	127.568	129.804	x	131.574	119.582	129.092	135.8	151.93	129.882	x	x	x	x	147.702	x	118.96	x	x	123.264	x	x	141.266	126.442	x	133.192	141.718	x	x	136.296	x	121.466	x	x	x	140.372	123.968	151.628	140.446	x	x	x	x	
-12494	Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 3 ppm Fe diet [µg/g]	None	Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 3 ppm Fe diet [µg/g]	x	x	9.7	9.1	10.6	14.3	x	14.2	11.3	9.4	10.6	12.2	12.4	x	x	12.6	8.4	9.2	x	11.4	x	x	x	x	x	x	10.9	11.2	x	9.1	14.7	9.8	13.8	x	x	x	9.4	9.0	9.3	x	10.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12495	Original post publication description: Iron level in ventral midbrain of 120-day-old in males fed 3 ppm Fe diet [µg/g]	None	Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in males fed 3 ppm Fe diet [µg/g]	x	x	12.8	11.3	17.3	13.4	x	17.5	13.8	13.0	14.1	10.8	12.0	x	x	14.8	12.3	13.9	x	13.6	x	x	x	x	x	x	13.5	12.3	x	16.7	11.9	12.6	11.5	x	x	x	10.8	16.6	10.6	x	13.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12496	Original post publication description: Spleen weight of 120-day-old males fed 3 ppm Fe diet [g]	None	Spleen weight of 120-day-old males fed 3 ppm Fe diet [g]	x	x	0.092	0.215	0.062	0.36	x	0.096	0.139	0.095	0.34	0.273	0.356	x	x	0.382	0.289	0.203	x	0.27	x	x	x	x	x	x	0.28	0.191	x	0.118	0.347	0.131	0.087	x	x	x	0.252	0.174	0.072	x	0.299	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12497	Original post publication description: Iron level in spleen of 120 day old males fed 3 ppm Fe diet [µg/g]	None	Iron level in spleen of 120 day old males fed 3 ppm Fe diet [µg/g]	x	x	107.3	53.8	177.3	58.3	x	68.1	60.5	304.7	51.2	60.2	58.2	x	x	47.0	34.3	24.5	x	51.9	x	x	x	x	x	x	39.0	43.6	x	129.7	50.3	99.9	71.7	x	x	x	60.9	63.6	166.6	x	36.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12498	Original post publication description: Iron level of liver of 120-day-old males fed 3 ppm Fe diet [µg/g]	None	Iron level of liver of 120-day-old males fed 3 ppm Fe diet [µg/g]	x	x	27.8	26.9	39.1	29.9	x	32.5	28.2	29.5	34.4	29.1	22.8	x	x	36.0	28.1	23.6	x	37.5	x	x	x	x	x	x	23.1	24.0	x	29.7	28.1	23.0	32.6	x	x	x	29.3	28.0	28.9	x	22.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12499	Original post publication description: Hemoglobin of 120-day-old males fed 3 ppm Fe diet [µg/dl]	None	Hemoglobin of 120-day-old males fed 3 ppm Fe diet [µg/dl]	x	x	8.4	8.0	9.6	8.8	x	9.2	7.8	9.5	6.7	5.4	6.4	x	x	6.2	4.0	2.3	x	4.9	x	x	x	x	x	x	2.8	7.0	x	10.3	6.2	6.7	6.5	x	x	x	5.1	6.6	9.8	x	2.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12500	Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells]	None	Cardiovascular system: Hematocrit of 120-day-old males fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells]	x	x	36.9	33.6	44.3	36.8	x	37.2	32.1	35.3	28.7	24.6	28.0	x	x	32.6	22.5	12.0	x	25.5	x	x	x	x	x	x	21.5	27.9	x	35.9	31.3	34.4	27.3	x	x	x	22.8	28.9	37.9	x	13.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12501	Original post publication description: Body weight of 120-day-old males fed 3 ppm Fe diet [g]	None	Body weight of 120-day-old males fed 3 ppm Fe diet [g]	x	x	26.2	30.9	25.2	30.5	x	26.0	24.8	30.6	27.3	25.8	27.2	x	x	32.2	25.0	21.7	x	25.4	x	x	x	x	x	x	23.5	27.6	x	27.9	28.8	22.1	25.1	x	x	x	26.2	31.3	28.0	x	26.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12502	Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 270 ppm Fe diet [µg/g]	None	Central nervous system, metabolism, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 270 ppm Fe diet [µg/g]	x	x	12.9	10.9	11.9	12.3	x	19.0	15.2	12.6	15.9	10.9	x	12.9	x	16.3	17.0	13.4	x	11.9	x	x	x	x	x	x	13.3	14.2	x	12.4	14.4	13.4	11.3	x	x	x	11.4	13.5	12.0	x	11.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12503	Original post publication description: Iron level in ventral midbrain of 120-day-old in females fed 270 ppm Fe diet [µg/g]	None	Central nervous system, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 270 ppm Fe diet [µg/g]	x	x	14.3	14.6	18.0	15.4	x	19.0	13.1	14.7	12.6	15.8	x	15.4	x	16.3	15.7	13.7	x	15.3	x	x	x	x	x	x	16.7	16.0	x	17.6	13.6	14.6	19.0	x	x	x	16.5	14.0	15.9	x	15.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12504	Original post publication description: Morphology, immune system, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g]	None	Morphology, immune system, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g]	x	x	0.064	0.074	0.062	0.174	x	0.064	0.089	0.074	0.058	0.063	x	0.126	x	0.12	0.086	0.085	x	0.088	x	x	x	x	x	x	0.074	0.062	x	0.042	0.066	0.066	0.074	x	x	x	0.067	0.068	0.058	x	0.075	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12505	Original post publication description: Iron level in spleen of 120-day-old females fed 270 ppm Fe diet [µg/g]	None	Iron level in spleen of 120-day-old females fed 270 ppm Fe diet [µg/g]	x	x	2239.6	1053.2	831.6	370.2	x	1233.7	478.6	1459.5	1389.1	983.7	x	938.1	x	714.1	1050.9	789.5	x	1399.7	x	x	x	x	x	x	842.1	1281.3	x	4837.8	1021.6	1116.2	812.5	x	x	x	793.7	1152.8	1280.6	x	401.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12506	Original post publication description: Iron level of liver of 120-day-old females fed 270 ppm Fe diet [µg/g]	None	Metabolism, liver, nutrition: Iron level in liver of 120-day-old females fed 270 ppm Fe diet [µg/g]	x	x	150.4	145.9	221.8	142.1	x	228.9	112.9	174.7	125.8	277.1	x	175.4	x	213.2	231.9	138.4	x	117.1	x	x	x	x	x	x	126.8	127.2	x	176.4	261.3	150.3	164.1	x	x	x	105.3	97.6	147.6	x	87.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12507	Original post publication description: Hemoglobin of 120-day-old females fed 270 ppm Fe diet [µg/dl]	None	Hematology, nutrition: Hemoglobin of 120-day-old females fed 270 ppm Fe diet [µg/dl]	x	x	13.2	11.5	14.2	11.9	x	11.3	10.9	13.6	12.1	12.6	x	13.4	x	10.8	12.5	12.2	x	13.1	x	x	x	x	x	x	13.2	12.2	x	15.8	12.3	13.3	13.4	x	x	x	11.8	12.8	11.8	x	11.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12508	Original post publication description: Cardiovascular system: Hematocrit of 120-day-old females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	None	Cardiovascular system: Hematocrit of 120-day-old females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	x	x	46.4	42.1	50.5	45.4	x	44.1	43.6	46.6	44.2	44.4	x	48.6	x	42.0	44.0	44.5	x	43.0	x	x	x	x	x	x	50.0	46.0	x	40.8	46.7	48.5	46.1	x	x	x	45.6	48.3	41.6	x	44.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12509	Original post publication description: Musculoskeletal system, morphology: Body weight of 120-day-old females fed 270 ppm Fe diet [g]	None	Musculoskeletal system, morphology: Body weight of 120-day-old females fed 270 ppm Fe diet [g]	x	x	21.7	23.7	20.7	25.2	x	22.2	22.8	34.5	23.8	21.1	x	26.1	x	28.7	28.1	24.0	x	28.1	x	x	x	x	x	x	29.5	23.1	x	25.2	25.9	21.4	28.3	x	x	x	22.9	30.9	24.3	x	22.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12510	Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 270 ppm Fe diet [µg/g]	None	Central nervous system, pharmacology, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 270 ppm Fe diet [µg/g]	x	x	11.8	12.9	12.5	13.4	x	17.5	14.4	15.9	16.6	14.1	x	x	x	15.0	x	14.2	x	13.3	x	x	x	x	x	x	12.9	14.5	x	11.4	13.6	13.3	10.6	x	x	x	10.4	15.9	12.5	x	12.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12511	Original post publication description: Iron level in ventral midbrain of 120-day-old in males fed 270 ppm Fe diet [µg/g]	None	Iron level in ventral midbrain of 120-day-old in males fed 270 ppm Fe diet [µg/g]	x	x	16.0	15.1	18.3	13.0	x	19.9	15.0	14.5	15.3	15.6	x	14.3	x	14.9	x	14.5	x	14.9	x	x	x	x	x	x	15.4	13.1	x	19.0	14.2	17.6	17.6	x	x	x	16.7	17.8	16.3	x	13.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12512	Original post publication description: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g]	None	Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g]	x	x	0.062	0.072	0.12	0.141	x	0.058	0.054	0.099	0.049	0.061	x	0.094	x	0.087	x	0.083	x	0.114	x	x	x	x	x	x	0.117	0.069	x	0.056	0.059	0.072	0.089	x	x	x	0.056	0.07	0.055	x	0.084	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12513	Original post publication description: Iron level in spleen of 120 day old males fed 270 ppm Fe diet [µg/g]	None	Iron level in spleen of 120 day old males fed 270 ppm Fe diet [µg/g]	x	x	1059.0	793.9	863.5	155.7	x	577.5	1153.6	703.5	916.8	707.2	x	856.8	x	871.2	x	355.4	x	371.6	x	x	x	x	x	x	375.8	1103.4	x	1982.1	944.4	700.9	588.2	x	x	x	605.1	890.2	603.0	x	261.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12514	Original post publication description: Iron level of liver of 120-day-old males fed 270 ppm Fe diet [µg/g]	None	Metabolism, nutrition: Iron level of liver of 120-day-old males fed 270 ppm Fe diet [µg/g]	x	x	88.4	117.4	132.0	55.3	x	124.6	115.1	84.0	84.2	174.4	x	138.9	x	122.4	x	50.8	x	58.6	x	x	x	x	x	x	185.1	91.1	x	134.0	180.5	128.0	192.9	x	x	x	87.6	64.3	90.1	x	47.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12515	Original post publication description: Hemoglobin of 120-day-old males fed 270 ppm Fe diet [µg/dl]	None	Hemoglobin of 120-day-old males fed 270 ppm Fe diet [µg/dl]	x	x	13.1	13.4	22.7	11.9	x	11.5	12.7	13.3	13.0	11.3	x	13.4	x	12.5	x	13.1	x	11.1	x	x	x	x	x	x	11.8	12.6	x	12.2	13.1	12.3	10.4	x	x	x	12.2	13.7	12.2	x	12.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12516	Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	None	Cardiovascular system: Hematocrit of 120-day-old males fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	x	x	44.9	45.8	61.3	45.1	x	43.8	47.7	46.8	44.5	43.6	x	49.7	x	45.9	x	47.9	x	42.4	x	x	x	x	x	x	47.1	44.3	x	42.6	48.1	46.3	38.7	x	x	x	43.7	48.7	42.0	x	45.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12517	Original post publication description: Body weight of 120-day-old males fed 270 ppm Fe diet [g]	None	Body weight of 120-day-old males fed 270 ppm Fe diet [g]	x	x	28.7	32.6	27.0	34.8	x	28.2	26.9	38.5	31.4	27.4	x	33.2	x	45.9	x	37.3	x	31.9	x	x	x	x	x	x	28.3	29.1	x	32.1	27.7	26.0	28.1	x	x	x	29.1	42.3	29.1	x	32.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12518	Original post publication description: Iron level in caudate-putamen of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	None	Iron level in caudate-putamen of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	x	x	9.533	9.003	11.242	14.272	x	12.965	11.709	10.747	12.337	10.817	x	9.65	x	12.132	10.2	10.87	x	11.64	x	x	x	x	x	x	11.974	12.319	x	9.071	14.296	9.927	12.744	x	x	x	9.758	10.258	8.355	x	9.037	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12519	Original post publication description: Iron level in ventral midbrain of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	None	Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	x	x	13.425	11.814	16.564	12.168	x	17.25	12.474	14.913	13.667	11.536	x	14.15	x	13.55	12.84	13.462	x	13.315	x	x	x	x	x	x	14.304	12.745	x	17.295	12.223	12.463	13.871	x	x	x	10.445	14.621	10.455	x	13.166	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12520	Original post publication description: Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g]	None	Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g]	x	x	0.103	0.199	0.066	0.456	x	0.104	0.146	0.18	0.198	0.217	0.272	0.244	x	0.306	0.191	0.295	x	0.3	x	x	x	x	x	x	0.214	0.169	x	0.091	0.287	0.164	0.077	x	x	x	0.195	0.14	0.084	x	0.265	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12521	Original post publication description: Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [µg/g]	None	Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [µg/g]	x	x	109.37	57.51	190.818	67.055	x	72.505	56.452	181.781	65.53	102.448	57.729	54.75	x	52.509	133.35	27.069	x	49.433	x	x	x	x	x	x	60.108	54.376	x	178.175	67.619	89.361	129.681	x	x	x	64.217	83.017	139.255	x	40.647	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12522	Original post publication description: Iron level of liver of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	None	Iron level of liver of 120-day-old males and females fed 3 ppm Fe diet [µg/g]	x	x	28.426	29.155	33.364	38.214	x	30.886	28.6	28.412	30.209	28.929	24.913	20.5	x	33.057	40.98	23.231	x	36.108	x	x	x	x	x	x	26.112	25.046	x	33.943	31.53	24.661	80.088	x	x	x	29.017	25.92	27.289	x	21.336	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12523	Original post publication description: Transferrin saturation in plasma of 120-day-old males and females fed 3 ppm Fe diet [%]	None	Transferrin saturation in plasma of 120-day-old males and females fed 3 ppm Fe diet [%]	x	x	25.515	13.118	22.4	14.535	x	16.224	7.167	20.275	18.795	23.256	34.05	25.85	x	21.076	30.22	26.677	x	26.4	x	x	x	x	x	x	17.652	12.589	x	17.489	23.304	11.294	24.347	x	x	x	22.013	15.328	14.555	x	16.018	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12524	Original post publication description: Iron binding capacity (total) in plasma of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]	None	Iron binding capacity (total) in plasma of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]	x	x	531.721	698.193	668.5	873.932	x	699.281	827.596	983.725	755.437	715.956	448.95	781.95	x	852.523	724.16	914.392	x	1159.67	x	x	x	x	x	x	839.554	816.944	x	778.716	656.521	853.4	916.765	x	x	x	686.409	785.62	808.505	x	1026.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12525	Original post publication description: Iron level of plasma of 120-day-old males and females fed 3 ppm Fe diet [µg/dl]	None	Blood chemistry, nutrition: Iron level of plasma of 120-day-old males and females fed 3 ppm Fe diet [µg/dl]	x	x	130.831	86.914	149.9	136.99	x	92.19	73.146	210.792	143.014	173.436	122.425	246.05	x	192.214	186.48	287.862	x	320.442	x	x	x	x	x	x	138.983	92.322	x	137.575	144.227	84.912	234.865	x	x	x	142.173	110.544	119.016	x	149.808	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12526	Original post publication description: Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]	None	Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]	x	x	8.678	8.463	9.305	8.494	x	8.805	6.402	8.865	8.323	6.176	9.225	9.5	x	6.622	9.13	3.8	x	4.871	x	x	x	x	x	x	5.634	7.078	x	11.416	7.687	7.589	9.026	x	x	x	6.824	7.783	9.298	x	4.316	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12527	Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet.	Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet [% packed red blood cells]	Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet [% packed red blood cells]	x	x	37.643	35.345	40.111	35.571	x	36.909	27.963	34.059	34.5	28.346	31.875	41.5	x	32.714	34.4	19.385	x	25.0	x	x	x	x	x	x	29.115	31.0	x	37.0	34.75	35.722	37.118	x	x	x	29.2	30.615	36.381	x	20.069	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12528	Original post publication description: Body weight of 120-day-old males and females fed 3 ppm Fe diet [g]	None	Body weight of 120-day-old males and females fed 3 ppm Fe diet [g]	x	x	23.756	27.145	21.133	27.838	x	25.477	22.938	27.341	24.508	22.65	25.85	24.9	x	30.667	30.1	23.033	x	24.608	x	x	x	x	x	x	23.212	24.97	x	26.438	26.839	20.9	25.194	x	x	x	24.234	26.988	25.345	x	24.203	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12529	Original post publication description: Iron level in caudate-putamen of 120-day-old males and females fed 270 ppm Fe diet [µg/g]	None	Iron level in caudate-putamen of 120-day-old males and females fed 270 ppm Fe diet [µg/g]	x	x	12.266	11.897	12.231	12.953	x	18.111	14.695	14.167	16.145	12.578	x	12.867	x	15.716	16.967	13.806	x	12.795	x	x	x	x	x	x	13.135	14.314	x	11.794	14.0	13.305	11.1	x	x	x	10.819	14.867	12.227	x	11.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12530	Original post publication description: Iron level in ventral midbrain of 120-day-old in males and females fed 270 ppm Fe diet [µg/g]	None	Iron level in ventral midbrain of 120-day-old in males and females fed 270 ppm Fe diet [µg/g]	x	x	15.231	14.81	18.162	14.019	x	19.543	14.208	14.645	13.68	15.715	x	15.05	x	15.62	15.7	14.119	x	15.04	x	x	x	x	x	x	16.215	14.485	x	18.406	13.908	16.342	18.619	x	x	x	16.616	16.103	16.129	x	14.409	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12531	Original post publication description: Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g]	None	Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g]	x	x	0.063	0.073	0.093	0.156	x	0.061	0.069	0.086	0.054	0.062	x	0.116	x	0.104	0.086	0.084	x	0.105	x	x	x	x	x	x	0.092	0.066	x	0.05	0.062	0.07	0.078	x	x	x	0.06	0.069	0.056	x	0.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12532	Original post publication description: Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [µg/g]	None	Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [µg/g]	x	x	1609.93	932.821	848.785	246.0	x	850.9	877.459	1099.53	1204.27	834.831	x	913.73	x	788.5	1050.87	572.45	x	750.395	x	x	x	x	x	x	645.737	1199.17	x	3251.32	983.035	873.946	748.433	x	x	x	685.097	1017.29	921.853	x	326.669	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12533	Original post publication description: Iron level of liver of 120-day-old males and females fed 270 ppm Fe diet [µg/g]	None	Iron level of liver of 120-day-old males and females fed 270 ppm Fe diet [µg/g]	x	x	118.334	132.613	173.477	92.481	x	169.909	114.183	131.481	108.479	222.064	x	164.41	x	167.8	231.9	94.588	x	80.163	x	x	x	x	x	x	150.14	108.47	x	152.839	219.389	136.908	172.348	x	x	x	95.409	80.96	118.822	x	67.359	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12534	Original post publication description: Transferrin saturation in plasma of 120-day-old males and females fed 270 ppm Fe diet [%]	None	Blood chemistry, pharmacology, nutrition: Transferrin saturation in plasma of 120-day-old males and females fed 270 ppm Fe diet [%]	x	x	31.59	40.16	17.64	21.345	x	33.33	27.559	29.968	30.468	27.977	x	32.52	x	34.53	38.233	23.327	x	24.689	x	x	x	x	x	x	21.805	35.481	x	24.664	42.8	25.121	38.509	x	x	x	26.964	32.773	27.894	x	28.809	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12535	Original post publication description: Iron binding capacity (total) in plasma of 120-day-old males and females fed 270 ppm Fe diet [ug/dl]	None	Blood chemistry, metabolism, nutrition: Iron binding capacity (total) in plasma of 120-day-old males and females fed 270 ppm Fe diet [ug/dl]	x	x	428.359	501.76	818.26	823.275	x	472.914	661.268	733.414	572.005	482.262	x	742.08	x	705.574	523.233	692.933	x	673.787	x	x	x	x	x	x	934.872	581.262	x	668.24	516.123	687.316	490.79	x	x	x	462.031	652.662	521.5	x	762.878	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12536	Original post publication description: Iron level of plasma of 120-day-old males and females fed 270 ppm Fe diet [µg/dl]	None	Iron level of plasma of 120-day-old males and females fed 270 ppm Fe diet [µg/dl]	x	x	131.737	190.197	188.0	170.665	x	148.326	191.662	204.732	171.64	129.73	x	228.29	x	231.665	199.0	162.7	x	161.325	x	x	x	x	x	x	197.215	208.982	x	162.143	191.654	173.652	186.041	x	x	x	121.958	204.114	137.776	x	191.009	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12537	Original post publication description: Hemoglobin of 120-day-old males and females fed 270 ppm Fe diet [µg/dl]	None	Hemoglobin of 120-day-old males and females fed 270 ppm Fe diet [µg/dl]	x	x	13.145	12.361	18.419	11.898	x	11.418	11.968	13.452	12.503	11.941	x	13.384	x	11.637	12.547	12.679	x	11.817	x	x	x	x	x	x	12.617	12.41	x	14.012	12.727	12.71	12.555	x	x	x	12.037	13.248	12.006	x	12.076	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12538	Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males and females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	None	Cardiovascular system: Hematocrit of 120-day-old males and females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]	x	x	45.621	43.821	56.308	45.25	x	43.955	46.087	46.714	44.333	43.962	x	48.9	x	43.95	44.0	46.067	x	42.579	x	x	x	x	x	x	48.789	45.185	x	41.706	47.423	47.192	43.9	x	x	x	44.562	48.484	41.824	x	45.306	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12539	Original post publication description: Body weight of 120-day-old males and females fed 270 ppm Fe diet [g]	None	Morphology, nutrition, metabolism: Body weight of 120-day-old males and females fed 270 ppm Fe diet [g]	x	x	25.436	27.672	24.123	30.686	x	25.6	25.223	36.405	26.824	24.359	x	28.26	x	37.32	28.133	30.612	x	30.58	x	x	x	x	x	x	29.03	26.096	x	29.212	26.837	24.046	28.227	x	x	x	26.368	36.769	26.739	x	27.457	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12540	Original post publication description: Transferrin saturation of 120-day-old females fed 3 ppm iron diet [%]	None	Transferrin saturation of 120-day-old females fed 3 ppm iron diet [%]	x	x	18.515	13.713	x	15.578	x	9.04	7.018	26.2	15.338	25.985	51.3	25.85	x	23.7	45.4	18.762	x	15.05	x	x	x	x	x	x	16.446	13.692	x	14.9	20.95	13.289	21.16	x	x	x	17.964	15.785	12.911	x	11.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12541	Original post publication description: Iron binding capacity in plasma of 120-day-old females fed 3 ppm iron diet [µg/dL]	None	Iron binding capacity in plasma of 120-day-old females fed 3 ppm iron diet [µg/dL]	x	x	583.086	692.5	x	810.856	x	673.93	890.991	1079.3	718.55	581.577	478.975	781.95	x	738.44	645.033	821.514	x	1112.15	x	x	x	x	x	x	753.933	818.846	x	825.557	608.55	798.611	904.93	x	x	x	583.885	795.7	755.889	x	920.894	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12542	Original post publication description: Plasma iron of 120-day-old females fed 3 ppm iron diet [ug/dL]	None	Blood chemistry, nutrition: Iron level of plasma of 120-day-old females fed 3 ppm Fe diet [ug/dL]	x	x	106.462	84.493	x	127.456	x	59.49	63.1	273.933	106.354	140.7	177.25	246.05	x	177.24	268.767	195.425	x	209.4	x	x	x	x	x	x	115.8	94.977	x	120.443	106.7	84.287	198.78	x	x	x	85.093	100.5	102.211	x	81.386	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12543	Original post publication description: Transferrin saturation of 120-day-old males fed 3 ppm iron diet [%]	None	Transferrin saturation of 120-day-old males fed 3 ppm iron diet [%]	x	x	32.515	12.431	22.4	13.682	x	22.755	7.292	14.35	23.789	20.3	16.8	x	x	18.691	7.45	39.34	x	28.67	x	x	x	x	x	x	18.958	11.564	x	19.0	25.838	9.3	28.9	x	x	x	25.556	14.833	15.9	x	21.531	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12544	Original post publication description: Iron binding capacity in plasma of 120-day-old males fed 3 ppm iron diet [µg/dL]	None	Iron binding capacity in plasma of 120-day-old males fed 3 ppm iron diet [µg/dL]	x	x	480.357	703.887	668.5	930.7	x	722.327	777.786	888.15	807.08	861.533	418.925	x	x	947.592	842.85	1044.42	x	1168.31	x	x	x	x	x	x	925.175	815.179	x	751.392	704.493	902.71	933.671	x	x	x	788.933	774.7	855.86	x	1156.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12545	Original post publication description: Metabolism, blood chemistry, nutrition: Plasma iron of 120-day-old males fed 3 ppm iron (Fe) diet [ug/dL]	None	Metabolism, blood chemistry, nutrition: Plasma iron of 120-day-old males fed 3 ppm iron (Fe) diet [ug/dL]	x	x	155.2	89.336	149.9	144.142	x	121.918	81.04	147.65	195.967	208.9	67.6	x	x	204.692	63.05	435.76	x	342.65	x	x	x	x	x	x	162.167	89.857	x	146.8	181.754	85.467	286.414	x	x	x	192.119	121.425	134.14	x	229.633	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12546	Original post publication description: Transferrin saturation of 120-day-old females fed 270 ppm iron diet [%]	None	Blood chemistry, pharmacology, nutrition: Transferrin saturation of 120-day-old females fed 270 ppm iron diet [%]	x	x	33.523	43.981	22.45	20.289	x	36.711	31.589	28.592	33.393	27.15	x	33.929	x	39.57	38.233	22.857	x	24.143	x	x	x	x	x	x	23.183	39.962	x	21.86	49.062	29.17	40.275	x	x	x	32.087	30.521	26.444	x	31.144	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12547	Original post publication description: Iron binding capacity in plasma of 120-day-old females fed 270 ppm iron diet [µg/dL]	None	Blood chemistry, metabolism, nutrition: Iron binding capacity in plasma of 120-day-old females fed 270 ppm iron diet [µg/dL]	x	x	458.971	457.781	835.85	843.222	x	466.289	579.86	636.992	539.386	479.4	x	750.114	x	684.26	523.233	635.071	x	687.257	x	x	x	x	x	x	931.77	609.683	x	716.28	458.6	696.836	504.96	x	x	x	403.429	660.236	484.05	x	747.672	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12548	Original post publication description: Plasma iron of 120-day-old females fed 270 ppm iron diet [ug/dL]	None	Plasma iron of 120-day-old females fed 270 ppm iron diet [ug/dL]	x	x	150.393	193.869	183.775	157.678	x	163.28	195.01	176.783	177.373	133.6	x	237.571	x	244.12	199.0	160.843	x	161.314	x	x	x	x	x	x	207.833	239.321	x	156.88	209.2	203.409	202.575	x	x	x	132.286	187.364	120.238	x	206.212	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12549	Original post publication description: Transferrin saturation of 120-day-old males fed 270 ppm iron diet [%]	None	Blood chemistry, pharmacology, nutrition: Transferrin saturation of 120-day-old males fed 270 ppm iron diet [%]	x	x	30.019	35.793	14.433	22.209	x	31.157	24.769	31.62	25.35	28.686	x	29.233	x	29.49	x	23.737	x	25.008	x	x	x	x	x	x	19.737	31.0	x	26.222	36.538	22.229	33.8	x	x	x	22.694	34.744	29.344	x	26.335	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12550	Original post publication description: Iron binding capacity in plasma of 120-day-old males fed 270 ppm iron diet [µg/dL]	None	Iron binding capacity in plasma of 120-day-old males fed 270 ppm iron diet [µg/dL]	x	x	399.787	552.021	806.533	806.955	x	477.5	729.108	849.12	637.243	484.714	x	723.333	x	729.256	x	743.562	x	666.535	x	x	x	x	x	x	939.525	556.9	x	644.22	565.429	679.836	455.367	x	x	x	507.611	645.593	554.789	x	778.083	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12551	Original post publication description: Plasma iron of 120-day-old males fed 270 ppm iron diet [ug/dL]	None	Plasma iron of 120-day-old males fed 270 ppm iron diet [ug/dL]	x	x	115.413	185.677	193.633	181.291	x	136.823	189.271	238.27	163.04	126.136	x	206.633	x	219.21	x	164.325	x	161.331	x	x	x	x	x	x	181.287	178.643	x	165.067	174.108	150.271	141.95	x	x	x	113.453	219.747	153.367	x	174.856	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12553	Original post publication description: Cocaine and amphetamine-regulated transcript expression level in hypothalamus [relative concentration by PCR cycle count]	None	Cocaine and amphetamine-regulated transcript expression level in hypothalamus [relative concentration by PCR cycle count]	x	x	24.85	25.3	x	x	24.3	25.2	23.6	x	24.95	23.4	x	26.87	x	25.95	26.1	25.75	x	25.8	22.5	24.55	x	24.05	24.25	23.2	24.6	x	x	22.44	24.9	25.0	25.85	x	24.0	x	25.45	24.8	23.9	x	23.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12554	Original post publication description: Depression assay, duration of immobility during trial 1 of a tail suspension test (TST) using a 20% mobility threshold over a 5 min test for males [sec]	None	Central nervous system, behavior: Depression assay, duration of immobility during trial 1 of a tail suspension test (TST) using a 20% mobility threshold over a 5 min test for males [sec]	x	x	225.0	160.0	155.0	x	180.0	177.0	240.0	110.0	230.0	175.0	x	x	x	178.0	148.0	210.0	x	105.0	254.0	245.0	x	190.0	x	154.0	160.0	x	176.0	205.0	195.0	184.0	226.0	x	x	x	x	228.0	196.0	x	147.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12557	Original post publication description: Neurexin 1 (Nrxn1) expression in hippocampus, principal component trait 1 (n=74 strains, all coding exons) from hippocampus Exon ST [PC z score]	Central nervous system, gene expression: Neurexin 1 (Nrxn1) expression in hippocampus, first principal component generated using all coding exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	Central nervous system, gene expression: Neurexin 1 (Nrxn1) expression in hippocampus, first principal component generated using all coding exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	1.438	-1.427	-0.33	-2.209	1.487	-3.072	0.675	1.618	1.298	1.543	-1.025	-1.17	2.902	-1.513	-0.279	1.757	1.02	2.134	-2.563	-3.854	0.863	0.368	x	3.06	-1.326	-2.317	-1.264	2.004	x	-0.598	-1.462	1.023	1.055	x	-3.769	x	-2.951	-1.305	-2.059	x	2.37	1.215	x	2.242	x	x	3.103	x	2.518	4.93	x	x	x	-1.648	x	x	x	x	3.987	1.462	-0.579	-3.843	0.652	-1.583	1.873	-5.141	1.315	3.806	0.321	x	x	0.721	-1.533	-2.434	-3.481	1.193	x	-3.984	0.987	x	x	1.734	1.795	-0.232	1.559	3.984	x	-1.769	0.81	x	-0.103	-0.261	-4.213	x	1.008	-0.779	-2.635	0.881	x	x	x	x	
-13015	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 11 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 11 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%]	x	95.3	95.48	75.0	100.3	90.0	75.85	x	98.35	100.8	89.65	75.0	95.55	75.0	75.0	75.0	75.0	75.0	90.7	90.05	x	89.6	x	x	x	x	75.0	x	x	75.0	84.1	x	75.0	x	75.0	x	75.0	92.15	75.0	x	96.85	103.3	75.0	x	x	x	x	x	x	75.0	x	x	x	75.0	75.0	x	x	x	87.57	92.2	75.0	x	x	78.95	x	89.35	x	91.3	75.0	89.94	x	75.0	75.0	99.04	x	x	x	94.62	75.0	x	x	x	92.93	x	x	82.26	x	75.0	x	x	91.37	x	x	x	94.9	99.15	96.8	x	92.94	x	75.0	75.0	
-12560	Original post publication description: Infectious disease, immune function: weight loss [percent]	None	Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [percent]	x	x	2.159	1.836	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-6.069	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.26	x	3.184	x	x	x	x	1.636	x	x	x	x	x	x	x	x	x	x	x	x	-6.407	2.938	x	x	0.796	x	x	x	x	x	x	x	-1.577	x	x	x	x	x	x	x	-4.355	x	x	x	x	x	x	4.046	x	x	x	x	x	x	2.072	
-12561	Original post publication description: Infectious disease, immune function: weight loss [slope]	None	Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [slope]	x	x	0.396	0.369	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.076	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.787	x	-0.334	x	x	x	x	0.674	x	x	x	x	x	x	x	x	x	x	x	x	-0.735	0.324	x	x	-0.363	x	x	x	x	x	x	x	0.837	x	x	x	x	x	x	x	0.356	x	x	x	x	x	x	-0.478	x	x	x	x	x	x	-0.334	
-12562	Original post publication description: Infectious disease, immune function: survival [coefficient]	None	Infectious disease, immune system: Survival after Francisella tularensis live vaccine strain (FTLVS) intratracheal [coefficient]	x	x	0.469	0.797	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.839	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.211	x	0.155	x	x	x	x	0.255	x	x	x	x	x	x	x	x	x	x	x	x	0.2	-0.197	x	x	-0.093	x	x	x	x	x	x	x	-0.078	x	x	x	x	x	x	x	-1.245	x	x	x	x	x	x	-0.245	x	x	x	x	x	x	-0.645	
-12563	Original post publication description: Life span, longevity of males on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=116 days and BXD31=434 days are deleted outliers)	None	Life history, aging: Life span, longevity of males on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=116 days and BXD31=434 days are deleted outliers)	x	x	781.0	673.0	x	769.0	x	704.0	722.0	x	845.0	792.0	x	570.0	x	677.0	x	951.0	x	x	727.0	x	x	814.0	x	832.0	588.0	804.0	700.0	x	561.0	911.0	763.0	x	x	x	866.0	669.0	796.0	x	760.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12564	Original post publication description: Life history, aging: Life span, longevity of females on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=158 days and BXD31=264 days are deleted outliers)	None	Life history, aging: Life span, longevity of females on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=158 days and BXD31=264 days are deleted outliers)	x	x	704.0	645.0	x	463.0	x	717.0	618.0	x	797.0	671.0	x	428.0	x	681.0	x	893.0	x	x	697.0	x	x	775.0	x	860.0	798.0	792.0	815.0	x	704.0	821.0	942.0	x	x	x	689.0	747.0	610.0	x	575.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12565	Original post publication description: Ethanol response (10% in tap water), average daily preference ratio, two-bottle choice in males and females [EtOH/water ratio]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily preference ratio, two-bottle choice in males and females [EtOH/water ratio]	x	x	x	x	0.46	x	x	0.49	x	0.11	0.24	0.22	0.07	0.2	x	0.43	x	0.2	x	x	0.04	x	0.25	0.11	x	0.54	x	x	x	0.86	0.03	x	0.16	x	0.12	x	0.19	x	0.39	0.21	0.12	0.28	0.17	0.16	x	x	0.81	0.67	x	0.21	x	x	x	0.29	0.25	x	x	x	0.48	x	x	x	x	x	0.19	0.19	0.19	0.23	0.48	0.16	x	0.25	x	0.19	x	0.27	x	0.37	0.46	x	x	0.02	0.37	0.18	0.3	0.18	x	0.12	0.31	x	0.2	x	x	x	x	x	0.07	x	0.19	x	0.08	0.23	
-12566	Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]	None	Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]	x	1.229	3.113	1.105	x	1.066	5.074	1.446	x	3.97	x	3.15	1.639	2.116	1.21	2.388	2.197	0.874	x	0.714	x	x	x	2.769	x	2.482	1.773	2.229	x	1.92	4.324	x	3.532	x	x	x	x	2.794	2.188	x	x	1.741	2.713	1.287	x	x	1.091	x	x	0.915	x	x	x	x	x	x	x	x	2.571	x	2.059	x	x	x	1.908	x	x	0.766	1.397	x	x	1.17	x	1.113	x	2.09	x	x	1.117	x	x	x	0.646	1.319	1.68	0.809	x	0.607	x	x	3.571	x	x	x	1.314	x	x	x	1.406	x	1.646	1.377	
-12567	Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after saline control injection (ip) in adult males [ng/g]	None	Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after saline control injection (ip) in adult males [ng/g]	x	7.616	4.655	4.177	x	5.565	8.757	5.341	x	5.528	x	9.56	5.55	7.574	4.675	10.319	8.456	3.803	x	5.082	x	x	x	6.623	x	12.13	8.492	5.407	x	6.004	8.905	x	8.155	x	x	x	x	6.178	3.947	x	x	4.969	7.042	5.809	x	x	5.962	x	x	4.596	x	x	x	x	x	x	x	x	7.07	x	8.328	x	x	x	4.484	x	x	5.255	3.847	x	x	4.149	x	3.642	x	6.266	x	x	4.869	x	x	x	5.695	5.272	8.388	4.802	x	2.841	x	x	4.543	x	x	x	5.24	x	x	x	7.234	x	4.808	5.27	
-12568	Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after saline control injection (ip) in adult males [ng/g]	None	Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after saline control injection (ip) in adult males [ng/g]	x	5.906	3.369	2.469	x	6.9	8.826	8.284	x	4.488	x	12.192	4.521	8.212	5.786	9.405	8.421	4.305	x	6.137	x	x	x	3.574	x	9.928	x	7.039	x	7.45	10.216	x	x	x	x	x	x	4.744	x	x	x	4.004	6.882	3.933	x	x	6.42	x	x	1.938	x	x	x	x	x	x	x	x	x	x	6.548	x	x	x	3.055	x	x	4.028	1.431	x	x	3.327	x	1.865	x	2.845	x	x	1.954	x	x	x	3.566	2.963	4.663	5.968	x	2.962	x	x	3.066	x	x	x	3.665	x	x	x	x	x	2.943	2.942	
-12569	Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]	None	Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]	x	0.609	1.641	0.481	x	0.589	4.181	1.569	x	3.472	x	4.472	0.467	1.306	0.678	1.607	1.357	0.747	x	0.367	x	x	x	1.008	x	1.329	x	0.532	x	1.665	2.657	x	x	x	x	x	x	3.545	x	x	x	0.871	2.052	0.155	x	x	0.368	x	x	0.36	x	x	x	x	x	x	x	x	x	x	0.939	x	x	x	0.331	x	x	0.371	0.161	x	x	0.824	x	0.384	x	0.386	x	x	0.378	x	x	x	0.225	0.042	0.598	1.783	x	0.502	x	x	1.857	x	x	x	0.032	x	x	x	x	x	0.641	0.253	
-12574	Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 6 average [log g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 6th week average, young adult male or female [log g/kg/2h]	x	0.391	0.359	0.143	x	x	0.14	x	x	x	x	0.294	x	0.094	x	0.255	x	0.004	x	x	x	x	x	0.277	x	x	x	x	x	x	0.099	x	0.246	x	0.23	x	0.329	0.11	x	x	x	0.255	0.171	0.379	x	x	x	0.221	0.237	0.224	x	x	x	0.35	x	x	x	x	x	0.071	0.509	x	0.194	x	0.09	x	0.426	0.419	x	0.095	x	0.251	0.147	0.222	x	0.041	x	x	0.199	0.744	x	-0.037	0.085	0.291	x	0.111	x	0.028	-0.035	x	x	x	x	x	x	x	x	0.508	0.222	0.225	0.269	0.228	
-12575	Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 5 average [log g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 5th week average, young adult male or female [log g/kg/2h]	x	0.359	0.359	0.2	x	x	0.072	x	x	x	x	0.142	x	0.096	x	0.292	x	0.156	x	x	x	x	x	0.291	x	x	x	x	x	x	0.063	x	0.384	x	0.14	x	0.215	-0.033	x	x	x	0.41	0.059	0.155	x	x	x	0.214	0.507	-0.015	x	x	x	0.618	x	x	x	x	x	0.09	0.437	x	0.416	x	0.1	x	0.345	0.327	x	0.327	x	0.257	0.316	0.361	x	0.02	x	x	0.343	0.656	x	0.136	0.268	0.409	x	0.322	x	0.164	0.07	x	x	x	x	x	x	x	x	0.394	0.105	0.225	0.312	0.079	
-12576	Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, week 4 [log transformed g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 4th week average, young adult male or female [log g/kg/2h]	x	0.32	0.421	0.198	x	x	0.221	x	x	x	x	0.254	x	0.07	x	0.357	x	0.123	x	x	x	x	x	0.306	x	x	x	x	x	x	0.119	x	0.268	x	0.259	x	0.1	-0.239	x	x	x	0.354	0.113	0.153	x	x	x	0.361	0.387	0.102	x	x	x	0.544	x	x	x	x	x	0.099	0.61	x	0.06	x	0.216	x	0.398	0.439	x	0.088	x	0.46	0.057	0.156	x	0.113	x	x	0.341	0.571	x	0.485	0.131	0.286	x	0.275	x	-0.045	0.029	x	x	x	x	x	x	x	x	0.488	0.171	0.145	0.161	0.168	
-12577	Original post publication description: Ethanol response, consumption using a two-bottle choice, 2 hour access (g/kg/2h), third week average, data log transformed [log ml]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 3rd week average, young adult male or female [log g/kg/2h]	x	0.349	0.41	0.077	x	x	0.105	x	x	x	x	0.166	x	0.166	x	0.283	x	0.09	x	x	x	x	x	0.089	x	x	x	x	x	x	0.136	x	0.289	x	0.098	x	0.023	-0.036	x	x	x	-0.02	-0.112	0.182	x	x	x	0.183	0.509	0.057	x	x	x	0.601	x	x	x	x	x	0.201	0.681	x	0.108	x	0.327	x	0.382	0.631	x	0.232	x	0.365	0.191	0.375	x	0.22	x	x	0.437	0.617	x	0.243	0.286	0.277	x	0.427	x	0.307	0.082	x	x	x	x	x	x	x	x	0.596	0.192	0.035	0.033	0.026	
-12578	Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 2 average [log g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 2nd week average, young adult male or female [log g/kg/2h]	x	0.312	0.389	0.106	x	x	0.075	x	x	x	x	0.073	x	-0.02	x	0.132	x	0.017	x	x	x	x	x	0.207	x	x	x	x	x	x	0.113	x	0.364	x	0.203	x	0.213	0.022	x	x	x	0.262	0.093	0.139	x	x	x	0.072	0.267	-0.011	x	x	x	0.39	x	x	x	x	x	-0.044	0.65	x	0.021	x	0.168	x	0.306	0.413	x	0.421	x	0.27	0.106	0.16	x	0.127	x	x	0.357	0.373	x	0.227	0.119	0.26	x	0.116	x	-0.057	0.081	x	x	x	x	x	x	x	x	0.408	0.179	0.054	0.189	0.091	
-12579	Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, week 1 [log transformed g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 1st week average, young adult male or female [log g/kg/2h]	x	0.321	0.445	0.059	x	x	0.207	x	x	x	x	0.194	x	0.118	x	0.29	x	0.161	x	x	x	x	x	0.064	x	x	x	x	x	x	-0.051	x	0.022	x	0.149	x	0.179	0.092	x	x	x	0.243	0.093	0.165	x	x	x	0.281	0.341	0.197	x	x	x	0.362	x	x	x	x	x	0.071	0.526	x	0.013	x	0.176	x	0.04	0.402	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12580	Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, principal component 1 based on weeks 1-6 [log transformed g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response, 2-bottle choice 2 h access consumption, principal component 1 based on weeks 1-6 data [log transformed g/kg/2h]	x	-1.882	-2.692	1.354	x	x	1.233	x	x	x	x	0.429	x	2.055	x	-0.712	x	1.996	x	x	x	x	x	0.16	x	x	x	x	x	x	2.178	x	-0.563	x	0.542	x	0.488	3.439	x	x	x	-0.592	2.131	0.261	x	x	x	-0.051	-2.184	1.82	x	x	x	-3.742	x	x	x	x	x	2.191	-5.24	x	1.302	x	0.735	x	-1.428	-3.228	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12974	Original post publication description: Hippocampus dentate gyrus cells positive for Calretinin immunohistochemistry [Number of cells]	None	Central nervous system, morphology, protein expression: Hippocampus dentate gyrus cells positive for calretinin protein (CALB2) by immunohistochemistry [n total, unilateral]	x	x	x	1065.0	951.0	x	2367.0	3147.0	x	1716.0	648.0	962.0	x	3139.0	x	1834.0	1726.5	3301.0	x	x	2691.0	x	x	x	2781.0	2352.0	1222.0	2461.0	1513.0	1952.0	726.0	1682.0	841.0	x	x	x	2410.5	1274.0	2110.0	x	2218.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12975	Original post publication description: Hippocampus dentate gyrus cells positive for Doublecortin immunohistochemistry [Number of cells]	None	Central nervous system, behavior, neurogenesis: Hippocampus dentate gyrus cells positive for doublecortin protein (DCX) by immunohistochemistry [n total, unilateral]	x	x	1956.0	842.4	1467.0	738.0	1745.0	2926.0	x	1678.0	555.0	1062.0	x	3039.0	1959.0	1220.0	1159.5	2212.0	x	x	2099.0	x	x	1457.0	2319.0	2433.0	2319.0	3288.0	3052.0	2986.0	1479.0	2784.0	1615.0	x	x	x	2748.0	1381.0	2930.0	x	2283.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12977	Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in males and females [U/L]	None	Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in males and females [U/L]	x	x	520.62	x	x	x	x	x	x	x	x	x	x	x	x	545.66	x	519.4	x	x	x	x	593.2	x	x	x	x	x	x	x	527.64	x	659.96	x	x	x	481.76	674.24	609.8	x	642.7	544.12	644.16	512.72	x	x	442.72	x	581.32	515.84	x	x	x	560.54	613.92	x	x	x	624.08	471.64	605.88	x	x	x	698.12	x	544.28	600.88	624.6	505.82	x	403.64	x	744.52	x	535.48	x	x	x	x	x	507.04	494.96	x	454.18	731.24	x	582.82	587.32	x	x	x	x	x	478.0	x	373.2	x	594.34	570.18	473.84	451.48	
-12978	Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in males and females [U/L]	None	Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in males and females [U/L]	x	x	16.68	19.71	x	x	x	x	x	x	x	x	x	x	x	21.3	x	54.6	x	x	x	x	54.84	x	x	x	x	x	x	x	20.62	x	19.2	x	x	x	71.96	24.08	43.28	x	45.62	28.8	40.56	50.28	x	x	35.88	x	32.16	34.76	x	x	x	33.86	19.38	x	x	x	15.98	21.3	36.68	x	x	x	13.28	x	29.6	23.93	19.52	44.56	x	25.88	x	14.2	x	34.24	x	x	x	x	x	41.0	51.04	x	26.28	17.64	x	33.0	39.32	x	x	x	x	x	17.04	x	25.33	x	22.26	21.32	37.96	31.8	
-12979	Original post publication description: Liver distress test activity (serum alanine aminotransferase activity at 24hr post-gavage) [IU/L]	None	Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity at 24 hr post-gavage [IU/L]	x	x	78.58	89.37	x	x	x	x	x	x	x	x	x	x	x	107.49	x	45.34	x	x	x	x	61.7	x	x	x	x	x	x	x	57.46	x	59.23	x	x	x	60.46	56.22	56.05	x	78.62	65.36	66.81	51.98	x	x	50.92	x	48.97	51.27	x	x	x	53.1	61.0	x	x	x	53.18	68.07	54.28	x	x	x	57.64	x	52.68	91.05	67.36	52.69	x	47.03	x	54.98	x	52.69	x	x	x	x	x	55.16	50.04	x	54.28	69.42	x	52.33	46.67	x	x	x	x	x	53.57	x	46.26	x	83.27	62.58	48.44	71.43	
-12980	Original post publication description: Liver distress test fold change (serum alanine aminotransferase activity fold change at 24hr post-gavage relative to averaged saline control activity) [ratio]	None	Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity fold change at 24 hr post-gavage in adults relative to averaged saline control activity) [ratio]	x	x	1.58	1.8	x	x	x	x	x	x	x	x	x	x	x	2.16	x	0.91	x	x	x	x	1.24	x	x	x	x	x	x	x	1.16	x	1.19	x	x	x	1.22	1.13	1.13	x	1.58	1.32	1.34	1.05	x	x	1.02	x	0.99	1.03	x	x	x	1.07	1.23	x	x	x	1.07	1.37	1.09	x	x	x	1.16	x	1.06	1.83	1.36	1.06	x	0.95	x	1.11	x	1.06	x	x	x	x	x	1.11	1.01	x	1.09	1.4	x	1.05	0.94	x	x	x	x	x	1.08	x	0.93	x	1.68	1.26	0.97	1.44	
-12981	Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in females [U/L]	None	Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in females [U/L]	x	x	438.2	507.25	x	x	x	x	x	x	x	x	x	x	x	506.27	x	457.07	x	x	x	x	600.6	x	x	x	x	x	x	x	360.93	x	747.2	x	x	x	544.13	655.0	521.67	x	455.43	514.0	576.0	475.13	x	x	453.53	x	600.2	491.4	x	x	x	521.27	488.6	x	x	x	604.4	481.4	639.5	x	x	x	533.33	x	448.8	563.9	531.47	387.6	x	471.93	x	478.53	x	527.27	x	x	x	x	x	385.2	364.73	x	421.2	625.0	x	621.07	619.4	x	x	x	x	x	411.4	x	375.67	x	618.35	546.9	452.1	483.4	
-12983	Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in females [U/L]	None	Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in females [U/L]	x	x	21.63	14.7	x	x	x	x	x	x	x	x	x	x	x	20.57	x	51.4	x	x	x	x	42.73	x	x	x	x	x	x	x	30.53	x	27.4	x	x	x	51.47	18.6	47.2	x	25.83	30.0	31.47	27.07	x	x	35.4	x	32.33	25.47	x	x	x	48.13	19.0	x	x	x	15.05	21.3	18.0	x	x	x	13.33	x	36.27	14.13	20.67	34.8	x	26.73	x	16.67	x	49.1	x	x	x	x	x	54.0	39.07	x	41.93	24.2	x	40.6	50.67	x	x	x	x	x	11.4	x	28.4	x	17.15	18.13	15.8	28.07	
-12984	Original post publication description: Liver distress test activity in females (serum alanine aminotransferase activity at 24hr post-gavage) [IU/L]	None	Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity at 24 hr post-gavage in females [IU/L]	x	x	81.91	77.34	x	x	x	x	x	x	x	x	x	x	x	73.96	x	48.44	x	x	x	x	65.71	x	x	x	x	x	x	x	62.17	x	66.3	x	x	x	47.14	51.57	49.5	x	74.45	52.74	67.29	54.81	x	x	56.28	x	62.47	49.8	x	x	x	45.47	64.98	x	x	x	49.95	70.72	52.16	x	x	x	51.86	x	38.3	80.15	43.91	43.32	x	44.17	x	51.56	x	43.91	x	x	x	x	x	60.11	48.03	x	42.14	67.18	x	50.09	48.03	x	x	x	x	x	57.91	x	48.32	x	83.1	38.89	68.51	80.74	
-12584	Original post publication description: Endocrinology: Thyroxine (T4), free level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ng/dL]	None	Endocrinology: Thyroxine (T4), free level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ng/dL]	x	x	0.57	0.48	x	x	x	x	x	x	0.49	0.46	0.5	x	x	0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.54	x	x	x	x	x	x	x	0.41	x	x	0.51	x	x	x	x	0.65	0.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.59	x	0.44	x	x	0.58	x	x	0.29	x	0.31	x	x	x	x	0.37	x	x	x	x	x	x	0.39	x	x	x	x	x	x	x	x	x	0.45	x	0.47	0.5	0.55	x	0.46	
-12585	Original post publication description: Endocrinology: Thyroxine (T4), total level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ug/dL]	None	Endocrinology: Thyroxine (T4), total level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ug/dL]	x	x	3.7	3.37	x	x	x	x	x	x	4.18	3.74	4.64	x	x	3.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.15	x	x	x	x	x	x	x	4.01	x	x	4.15	x	x	x	x	4.19	3.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.11	x	3.97	x	x	4.91	x	x	3.55	x	2.73	x	x	x	x	3.44	x	x	x	x	x	x	3.94	x	x	x	x	x	x	x	x	x	2.96	x	3.5	4.0	3.52	x	3.66	
-12586	Original post publication description: Ethanol response (10% in tap water), average daily consumption, two-bottle choice, males and females [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily consumption, two-bottle choice, males and females [g/kg]	x	x	x	x	2.86	x	x	7.6	x	1.85	2.34	1.96	0.94	3.93	x	4.37	x	3.59	x	x	0.61	x	4.56	2.33	x	4.76	x	x	x	4.67	0.7	x	2.76	x	1.7	x	2.16	x	4.25	1.81	3.08	8.38	2.57	3.28	x	x	6.4	1.43	x	3.42	x	x	x	3.86	5.99	x	x	x	7.04	x	5.62	x	x	x	2.99	4.0	3.7	4.4	8.07	3.41	x	3.19	x	3.44	x	5.05	x	8.17	5.44	x	x	1.24	5.37	3.41	5.75	3.74	x	3.42	3.49	x	3.17	x	x	x	x	x	0.68	x	3.96	x	x	5.52	
-12587	Original post publication description: Hippocampus mossy fiber pathway volume, total without IMF (hilus + SMF) [mm^3]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total without IMF (hilus + SMF) [mm^3]	x	x	0.28	0.308	0.325	0.251	0.298	0.297	x	0.359	0.229	0.22	x	0.251	0.244	0.323	0.311	0.329	x	0.284	0.29	x	x	0.173	0.214	0.219	0.177	0.184	0.202	0.234	0.231	0.217	0.2	0.358	x	x	0.273	0.312	0.285	x	0.227	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12588	Original post publication description: Hippocampus mossy fiber pathway volume, infrapyramidal (IMF) [mm^3]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, infrapyramidal (IMF) [mm^3]	x	x	0.044	0.02	0.036	0.042	0.046	0.024	x	0.028	0.021	0.035	x	0.021	0.024	0.038	0.052	0.029	x	0.037	0.025	x	x	0.026	0.021	0.028	0.022	0.015	0.028	0.023	0.021	0.028	0.036	0.037	x	x	0.036	0.025	0.03	x	0.029	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12589	Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal (SMF) [mm^3]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal (SMF) [mm^3]	x	x	0.155	0.217	0.206	0.158	0.163	0.189	x	0.199	0.111	0.136	x	0.162	0.165	0.19	0.166	0.197	x	0.185	0.185	x	x	0.107	0.15	0.148	0.112	0.114	0.118	0.145	0.13	0.118	0.114	0.198	x	x	0.159	0.158	0.156	x	0.115	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12590	Original post publication description: Hippocampus mossy fiber pathway volume, hilus [mm^3]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, hilus [mm^3]	x	x	0.125	0.09	0.119	0.093	0.135	0.108	x	0.16	0.118	0.084	x	0.089	0.08	0.133	0.145	0.132	x	0.099	0.105	x	x	0.066	0.064	0.071	0.065	0.07	0.084	0.089	0.1	0.099	0.086	0.161	x	x	0.114	0.154	0.129	x	0.112	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12591	Original post publication description: Hippocampus mossy fiber pathway volume, total (hilus + IMF + SMF) [mm^3]	None	Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total (hilus + IMF + SMF) [mm^3]	x	x	0.324	0.327	0.361	0.293	0.344	0.321	x	0.387	0.249	0.255	x	0.272	0.269	0.361	0.364	0.358	x	0.322	0.316	x	x	0.199	0.236	0.247	0.199	0.199	0.231	0.257	0.252	0.245	0.236	0.395	x	x	0.309	0.337	0.314	x	0.256	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12592	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per unit glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]	None	Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per unit glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]	x	x	4.508	2.684	x	x	x	4.911	x	6.174	3.7	2.82	2.899	3.241	x	x	5.128	x	5.243	x	x	x	x	x	x	x	3.957	x	x	x	x	4.928	5.099	x	3.455	x	x	x	5.376	x	3.576	5.214	x	x	x	x	x	x	x	5.854	x	x	x	6.032	x	x	x	x	x	3.737	2.385	5.687	x	5.289	2.927	2.822	5.328	3.313	2.891	4.713	x	5.858	x	6.737	x	x	x	x	6.447	x	x	5.941	5.789	x	5.637	6.536	x	4.852	6.448	x	x	x	x	x	5.24	x	x	x	5.536	x	x	x	
-12593	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, total glomerular cell count per glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]	None	Urogenital system, kidney, morphology: Kidney morphology, total glomerular cell count per glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]	x	x	13.73	11.284	x	x	x	15.589	x	16.916	12.891	11.456	12.073	14.456	x	x	15.783	x	16.713	x	x	x	x	x	x	x	13.412	x	x	x	x	15.099	16.886	x	12.435	x	x	x	15.094	x	14.502	14.83	x	x	x	x	x	x	x	16.729	x	x	x	16.43	x	x	x	x	x	14.315	11.275	16.351	x	15.135	12.614	12.054	16.167	12.601	11.293	16.062	x	17.87	x	19.465	x	x	x	x	18.072	x	x	17.183	16.829	x	19.318	17.363	x	17.136	18.136	x	x	x	x	x	16.971	x	x	x	15.967	x	x	x	
-12594	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, podocyte (WT1-positive cells) count per glomerular section following longterm diabetes (streptozotocin treatment) [n]	None	Urogenital system, kidney, morphology: Kidney morphology, podocyte (WT1-positive cells) count per glomerular section following longterm diabetes (streptozotocin treatment) [n]	x	x	12.587	9.335	x	x	x	12.467	x	12.807	11.244	9.896	10.033	9.8	x	x	12.527	x	13.057	x	x	x	x	x	x	x	11.384	x	x	x	x	12.3	12.841	x	9.661	x	x	x	12.583	x	9.443	12.433	x	x	x	x	x	x	x	12.909	x	x	x	13.997	x	x	x	x	x	11.065	9.35	12.533	x	12.244	9.067	9.11	12.684	9.386	8.7	13.25	x	12.68	x	13.4	x	x	x	x	12.34	x	x	13.09	12.17	x	12.88	12.22	x	10.33	13.15	x	x	x	x	x	11.72	x	x	x	13.07	x	x	x	
-12595	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, glomerular surface area following longterm diabetes (streptozotocin treatment) [1000 um2]	None	Urogenital system, kidney, morphology: Kidney morphology, glomerular surface area following longterm diabetes (streptozotocin treatment) [1000 um2]	x	x	3050.63	3958.44	x	x	x	2722.64	x	2237.87	3251.71	3937.85	3653.4	3187.0	x	x	2544.4	x	2755.01	x	x	x	x	x	x	x	3049.43	x	x	x	x	2785.51	2705.88	x	3136.59	x	x	x	2478.85	x	2843.48	2517.37	x	x	x	x	x	x	x	2367.36	x	x	x	2442.37	x	x	x	x	x	3191.15	4286.01	2398.83	x	2450.01	3393.94	3487.5	2509.83	3150.41	3239.77	2985.55	x	2235.75	x	2122.05	x	x	x	x	1998.94	x	x	2321.1	2268.0	x	2369.2	1975.0	x	2236.63	2195.18	x	x	x	x	x	2362.19	x	x	x	2495.35	x	x	x	
-12596	Original post publication description: Kidney morphology, WT1-negative cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units]	None	Urogenital system, kidney, morphology: WT1-negative cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units]	x	x	28.042	33.343	x	x	x	28.967	x	24.226	29.208	33.579	33.367	35.35	x	x	27.682	x	31.281	x	x	x	x	x	x	x	28.327	x	x	x	x	27.4	31.272	x	27.706	x	x	x	24.633	x	30.485	24.467	x	x	x	x	x	x	x	25.812	x	x	x	25.562	x	x	x	x	x	33.96	36.25	25.322	x	24.444	32.533	31.425	27.25	29.024	26.69	34.042	x	27.029	x	27.733	x	x	x	x	23.29	x	x	26.24	25.584	x	32.967	21.156	x	27.446	25.744	x	x	x	x	x	27.689	x	x	x	25.91	x	x	x	
-12597	Original post publication description: Urogenital system, morphology: Kidney, total glomerular cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units]	None	Urogenital system, kidney, morphology: Kidney, total glomerular cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units]	x	x	40.628	42.678	x	x	x	41.434	x	37.033	40.452	43.475	43.4	45.15	x	x	40.209	x	44.338	x	x	x	x	x	x	x	39.711	x	x	x	x	39.7	44.112	x	37.367	x	x	x	37.217	x	39.928	36.9	x	x	x	x	x	x	x	38.721	x	x	x	39.559	x	x	x	x	x	45.024	45.6	37.856	x	36.689	41.6	40.535	39.934	38.41	35.33	47.29	x	39.71	x	41.13	x	x	x	x	35.63	x	x	39.33	37.75	x	45.85	33.38	x	37.77	38.89	x	x	x	x	x	39.41	x	x	x	38.98	x	x	x	
-12598	Original post publication description: Kidney morphology, WT1-negative cells per glomerular surface area in longterm diabetes [n/1000 um2]	None	Urogenital system, kidney, morphology: Wilm's tumor 1 (WT1) -negative cells per glomerular surface area in longterm diabetes [n/1000 um2]	x	x	9.222	8.6	x	x	x	10.678	x	10.742	9.191	8.636	9.175	11.215	x	x	10.655	x	11.47	x	x	x	x	x	x	x	9.455	x	x	x	x	10.171	11.787	x	8.979	x	x	x	9.718	x	10.926	9.617	x	x	x	x	x	x	x	10.875	x	x	x	10.398	x	x	x	x	x	10.578	8.89	10.663	x	9.846	9.688	9.232	10.839	9.287	8.42	11.349	x	12.012	x	12.727	x	x	x	x	11.626	x	x	11.242	11.04	x	13.681	10.827	x	12.284	11.688	x	x	x	x	x	11.731	x	x	x	10.431	x	x	x	
-12599	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per 1000 um2 [units]	None	Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per 1000 um2 [units]	x	x	4.508	2.684	x	x	x	4.911	x	6.174	3.7	2.82	2.899	3.241	x	x	5.128	x	5.243	x	x	x	x	x	x	x	3.957	x	x	x	x	4.928	5.099	x	3.455	x	x	x	5.376	x	3.576	5.214	x	x	x	x	x	x	x	5.854	x	x	x	6.032	x	x	x	x	x	3.737	5.462	5.687	x	5.289	2.927	2.822	5.328	3.313	2.891	4.713	x	5.858	x	6.737	x	x	x	x	6.447	x	x	5.941	5.789	x	5.637	6.536	x	x	x	x	x	x	x	x	x	x	x	4.305	x	x	x	x	
-12600	Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, podocytes (WT1-positive cells) per glomerular section, 6 months after induction of type I diabetes by streptozotocin treatment [n/section]	None	Urogenital system, kidney, morphology: Kidney morphology, podocytes (WT1-positive cells) per glomerular section, 6 months after induction of type I diabetes by streptozotocin treatment [n/section]	x	x	12.59	9.33	x	x	x	12.47	x	12.81	11.24	9.9	10.03	9.8	x	x	12.53	x	13.06	x	x	x	x	x	x	x	11.38	x	x	x	x	12.3	12.84	x	9.66	x	x	x	12.58	x	9.44	12.43	x	x	x	x	x	x	x	12.91	x	x	x	14.0	x	x	x	x	x	11.06	9.35	12.53	x	12.24	9.07	9.11	12.68	9.39	8.7	13.25	x	12.68	x	13.4	x	x	x	x	12.34	x	x	13.09	12.17	x	12.88	12.22	x	10.33	13.15	x	x	x	x	x	11.72	x	10.38	8.77	13.07	x	x	x	
-12601	Original post publication description: Central motor pattern generator, lick count for water over 20 minutes (MS160 lickometer), male and female adults [66 strainsl]	None	Central motor pattern generator, lick count for water over 20 minutes (MS160 lickometer), male and female adults [n]	x	624.38	679.0	480.29	832.0	885.67	751.83	611.6	906.0	848.88	581.29	1280.2	761.83	621.33	737.67	x	741.0	496.0	x	x	x	x	x	343.33	370.67	687.25	x	695.75	x	425.57	818.33	562.67	953.57	x	665.0	x	538.6	620.11	840.78	x	599.17	913.11	614.9	651.5	x	x	495.0	x	879.33	682.78	x	x	x	1024.44	943.11	x	x	x	590.0	872.0	864.38	x	x	502.0	647.29	x	603.5	425.56	656.4	777.0	x	875.67	x	792.33	x	540.2	x	x	697.5	x	x	814.8	601.5	511.83	447.0	798.17	x	661.6	395.6	x	629.4	x	x	603.63	982.5	828.2	705.83	670.67	543.14	x	560.17	617.0	
-12602	Original post publication description: Central motor pattern generation, lick count for 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [66 strains]	None	Central motor pattern generation, lick count for 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [66 strains]	x	1082.0	1227.85	865.21	1093.67	1197.33	1417.5	1644.0	1664.5	1621.75	1086.43	2140.6	1223.33	820.17	1298.67	x	1028.33	1219.33	x	x	x	x	x	536.0	861.33	1277.5	x	1328.75	x	920.29	1217.17	1164.0	1400.0	x	1193.33	x	1244.0	1043.44	1548.89	x	966.0	1243.33	917.3	952.33	x	x	970.67	x	1199.33	1175.56	x	x	x	2139.33	1834.44	x	x	x	1595.17	1366.8	1311.63	x	x	932.4	1253.14	x	1001.38	891.11	1206.2	1344.5	x	1823.56	x	1471.22	x	898.4	x	x	1335.38	x	x	1126.1	1152.7	964.5	1025.89	1522.33	x	1452.3	936.6	x	1293.2	x	x	1194.5	1627.63	1574.1	1364.67	1322.5	914.43	x	1145.67	1069.33	
-12603	Original post publication description: Immune function, blood: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio]	None	Immune system, cardiovascular system: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio]	x	1.674	1.727	3.102	2.597	1.475	x	2.0	2.188	1.197	2.535	2.254	2.143	2.4	2.133	1.301	1.549	1.563	0.984	1.884	1.9	1.667	x	2.5	2.444	0.815	1.449	1.282	1.368	1.045	2.222	1.429	2.74	1.146	1.667	1.409	1.146	2.111	1.507	x	1.579	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12604	Original post publication description: Central nervous system, behavior: Central motor pattern generation, volume per lick, water over 20 minutes (MS160 lickometer), adults [66 strains]	None	Central nervous system, behavior: Central motor pattern generation (CPG), volume per lick, water over 20 min (MS160 lickometer), male and female adults [ul]	x	1.48	1.26	1.0	1.01	0.94	0.87	0.82	0.62	1.08	0.94	0.9	1.01	1.15	1.21	x	0.6	0.95	x	x	x	x	x	1.11	0.71	1.0	x	1.27	x	0.81	0.87	1.02	0.83	x	0.98	x	1.15	1.03	1.2	x	0.91	0.83	0.85	0.86	x	x	1.1	x	0.89	0.94	x	x	x	0.84	0.89	x	x	x	1.18	0.87	0.75	x	x	1.01	0.73	x	1.01	1.04	1.08	0.97	x	0.87	x	0.75	x	1.02	x	x	0.86	x	x	0.74	0.92	1.06	1.08	0.99	x	1.1	1.01	x	1.1	x	x	0.8	1.29	0.91	1.02	1.02	1.16	x	0.95	0.93	
-12605	Original post publication description: Central motor pattern generation, volume per lick, 0.1 M sucrose over 20 minutes (MS160 lickometer), adults [66 strains] by Boughter JD Jr., and colleagues	None	Central motor pattern generation, volume per lick, 0.1 M sucrose over 20 minutes (MS160 lickometer), male and femal adults [ul]	x	1.52	1.25	1.17	1.17	0.96	0.83	0.74	0.69	0.8	0.89	0.98	1.2	1.36	1.34	x	0.78	0.96	x	x	x	x	x	0.94	0.88	1.04	x	1.28	x	1.06	0.88	1.01	1.0	x	1.16	x	1.0	1.1	1.33	x	1.01	0.97	0.87	0.89	x	x	1.42	x	0.99	0.85	x	x	x	0.88	0.91	x	x	x	0.94	1.05	0.94	x	x	1.2	0.89	x	1.14	1.01	1.03	1.09	0.92	x	x	0.8	x	1.11	x	x	0.97	x	x	0.94	0.91	0.99	0.98	1.08	x	0.96	1.34	x	1.01	x	x	0.88	1.37	1.07	1.06	0.99	1.25	x	1.02	1.09	
-12727	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) tumor necrosis factor alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	Infectious disease, immune system: Bix2	Infectious disease, immune system, protein expression: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), tumor necrosis factor alpha level (TNFA, Chr 17 at 35 Mb) from draining lymph node 3 weeks post infection in females using Luminex assay [% of C57BL/6 control]	x	44.215	100.0	46.2	x	x	x	x	x	x	186.337	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	173.708	107.994	110.056	76.548	x	x	x	55.379	67.269	x	x	x	x	135.58	18.15	x	x	x	66.132	122.988	75.666	x	x	x	x	x	x	57.785	116.947	x	x	x	46.115	x	x	18.446	x	x	51.451	x	x	124.939	x	x	x	x	x	126.409	x	x	x	x	x	x	93.358	x	x	x	x	x	x	x	
-12728	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Vascular endothelial growth factor from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), vascular endothelial growth factor (VEGF) level from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	73.506	100.0	146.37	x	x	x	x	x	x	90.218	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	65.77	180.234	68.28	175.427	x	x	x	135.955	94.594	x	x	x	x	152.576	26.434	x	x	x	78.516	103.749	63.957	x	x	x	x	x	x	148.294	79.074	x	x	x	53.842	x	x	79.615	x	x	40.204	x	x	54.517	x	x	x	x	x	115.774	x	x	x	x	x	x	298.424	x	x	x	x	x	x	x	
-12726	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	35.453	100.0	37.957	x	x	x	x	x	x	93.351	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	88.456	56.779	48.033	59.889	x	x	x	58.915	67.386	x	x	x	x	73.501	21.126	x	x	x	33.392	103.818	106.75	x	x	x	x	x	x	31.471	48.984	x	x	x	56.897	x	x	32.301	x	x	43.13	x	x	93.076	x	x	x	x	x	83.135	x	x	x	x	x	x	98.642	x	x	x	x	x	x	x	
-12751	Original post publication description: Reproduction, urogenital system, morphology: Uterus body width at maturity, unadjusted for body weight, age, or parity [cm]	None	Reproduction, urogenital system, morphology: Uterus body width at maturity, unadjusted for body weight, age, or parity [cm]	0.265	0.28	0.259	0.305	0.27	x	0.165	x	0.21	0.235	0.257	0.253	0.252	0.34	x	0.227	x	0.313	x	x	0.2	x	x	0.27	x	0.284	x	0.285	x	0.293	0.324	0.31	0.284	x	0.36	x	0.32	0.254	0.345	x	0.268	0.316	0.247	0.319	x	x	0.267	0.337	0.276	0.31	x	x	x	0.344	0.372	x	x	x	0.288	0.262	0.275	0.257	x	0.288	0.289	x	0.237	0.28	0.321	0.214	x	0.263	x	0.328	x	0.293	x	0.286	0.258	x	x	0.287	0.281	0.352	0.29	0.332	x	0.313	0.273	x	0.28	x	x	0.291	0.343	0.293	0.23	0.31	0.299	0.29	0.279	0.248	
-12752	Original post publication description: Reproduction, urogenital system, morphology: Ovary weight at maturity, unilateral (average of right and left), unadjusted for body weight, age, or parity [mg]	None	Reproduction, urogenital system, morphology: Ovary weight at maturity, unilateral (average of right and left), unadjusted for body weight, age, or parity [mg]	3.75	5.0	2.467	9.96	4.667	x	1.5	x	3.5	2.75	5.591	5.125	2.5	x	x	4.5	x	2.615	x	x	2.5	x	x	3.5	x	4.3	x	4.25	x	5.5	8.4	3.5	2.267	x	2.0	x	3.0	3.682	3.5	x	2.5	4.5	3.357	7.3	x	x	4.8	5.0	4.188	6.385	x	x	x	4.071	7.885	x	x	x	2.37	4.636	5.789	2.25	x	3.6	3.393	x	3.192	2.857	3.348	3.038	x	3.58	x	3.605	x	5.0	x	2.9	3.269	x	x	5.357	3.769	4.375	2.556	4.053	x	3.708	7.083	x	6.0	x	x	3.0	5.25	5.0	3.0	4.0	6.015	4.5	3.895	2.542	
-12730	Original post publication description: Central nervous system, behavior, learning and memory: Learning speed, initial acquisition of task, trials to criterion in naive 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]	None	Central nervous system, behavior, learning and memory: Learning speed, initial acquisition of task, trials to criterion in naive 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]	x	x	103.0	172.0	84.8	40.0	x	x	x	x	x	55.5	165.0	114.5	x	200.0	35.0	x	x	x	76.5	x	x	101.4	135.5	x	x	97.0	x	103.5	118.75	x	78.33	x	31.0	x	62.5	116.33	118.2	x	135.8	120.75	91.5	44.5	x	x	x	73.5	77.5	88.67	x	x	x	135.33	42.0	x	x	x	54.0	88.0	23.6	x	x	71.0	109.0	x	146.33	x	164.67	96.75	x	199.5	x	148.0	x	119.0	x	x	91.8	x	x	75.25	76.0	123.6	164.25	x	x	104.67	157.5	x	x	x	x	129.0	118.25	x	45.0	x	189.6	x	176.0	162.25	
-12747	Original post publication description: Reproduction, urogenital system, morphology: Uterus and ovary weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]	None	Reproduction, urogenital system, morphology: Uterus and ovary weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]	100.0	106.2	76.4	129.72	79.5	x	28.5	x	95.0	60.0	81.091	75.0	75.0	x	x	59.0	x	64.538	x	x	57.5	x	x	70.5	x	60.4	x	64.0	x	103.5	138.8	175.0	100.267	x	110.0	x	98.0	82.091	127.5	x	65.0	91.818	61.114	112.857	x	x	94.4	187.5	96.75	114.308	x	x	x	94.857	145.077	x	x	x	109.13	82.546	91.053	78.5	x	84.8	90.571	x	75.538	75.476	156.794	79.75	x	90.04	x	119.105	x	112.714	x	71.8	71.462	x	x	100.571	81.0	151.625	75.722	97.895	x	126.417	119.5	x	88.0	x	x	110.5	93.182	97.333	51.0	102.0	107.941	145.0	94.389	80.208	
-12622	Original post publication description: Catechol-o-methyl transferase expression level by RNA-seq, distal 3' UTR, whole brain [normalized RNA-seq counts]	None	Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, distal 3' UTR, whole brain [normalized RNA-seq counts]	x	x	x	x	x	x	x	38.0	13.0	34.0	x	x	68.0	34.0	35.0	92.0	66.0	x	x	x	x	x	x	74.0	x	x	x	121.0	x	x	96.0	x	x	x	23.0	x	104.0	49.0	104.0	x	12.0	9.0	x	66.0	x	x	x	39.0	44.0	10.0	x	x	x	14.0	80.0	x	x	x	66.0	x	x	x	x	69.0	79.0	x	x	100.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12635	Original post publication description: Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks].	None	Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks].	x	x	9.75	18.769	14.625	11.125	3.143	12.25	13.375	11.333	6.833	35.143	x	18.429	7.625	13.0	15.0	8.625	19.857	15.0	6.75	7.5	x	x	x	6.5	2.375	x	x	6.0	10.25	14.75	13.25	x	8.833	x	1.75	8.667	x	x	33.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12636	Original post publication description: Anxiety assay (E10_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [%]	x	x	38.627	31.226	46.442	58.51	40.138	46.542	29.81	26.386	28.708	61.21	x	41.171	42.419	59.183	56.248	35.683	43.04	42.998	28.192	36.964	x	x	x	23.544	16.667	x	x	38.395	29.363	55.615	45.425	x	18.697	x	29.417	23.653	x	x	48.527	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12637	Original post publication description: Anxiety assay (E10_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec].	None	Central nervous system, pharmacology, behavior: Anxiety assay (E10_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]	x	x	231.762	187.354	278.65	351.062	240.829	279.25	178.863	158.317	172.25	367.257	x	247.029	254.512	355.1	337.488	214.1	258.243	257.986	169.15	221.783	x	x	x	141.262	100.0	x	x	230.371	176.175	333.688	272.55	x	112.183	x	176.5	141.917	x	x	291.163	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12621	Original post publication description: Catechol-o-methyl transferase expression level by RNA-seq, last two coding exons and entire 3' UTR, whole brain [normalized RNA-seq counts]	None	Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, last two coding exons and entire 3' UTR, whole brain [normalized RNA-seq counts]	x	x	x	x	x	x	x	243.0	262.0	266.0	x	x	235.0	276.0	278.0	317.0	241.0	x	x	x	x	x	x	268.0	x	x	x	354.0	x	x	316.0	x	x	x	136.0	x	331.0	160.0	327.0	x	180.0	188.0	x	191.0	x	x	x	316.0	149.0	160.0	x	x	x	149.0	253.0	x	x	x	304.0	x	x	x	x	254.0	303.0	x	x	302.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12713	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	19.971	100.0	23.245	x	x	x	x	x	x	81.251	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	98.327	85.862	52.17	100.395	x	x	x	42.487	58.416	x	x	x	x	125.259	7.163	x	x	x	18.151	80.431	77.566	x	x	x	x	x	x	49.064	49.979	x	x	x	22.597	x	x	14.356	x	x	29.19	x	x	81.169	x	x	x	x	x	95.613	x	x	x	x	x	x	159.626	x	x	x	x	x	x	x	
-12714	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	128.087	100.0	194.383	x	x	x	x	x	x	56.941	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	55.697	16.826	57.13	86.512	x	x	x	110.427	99.783	x	x	x	x	194.625	93.595	x	x	x	43.793	65.611	209.812	x	x	x	x	x	x	261.063	35.782	x	x	x	66.245	x	x	71.064	x	x	167.936	x	x	18.817	x	x	x	x	x	30.834	x	x	x	x	x	x	38.807	x	x	x	x	x	x	x	
-12715	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	29.37	100.0	124.109	x	x	x	x	x	x	9.128	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.864	6.7	25.975	106.279	x	x	x	93.729	190.183	x	x	x	x	83.991	37.998	x	x	x	34.869	43.322	175.793	x	x	x	x	x	x	341.497	9.723	x	x	x	90.573	x	x	22.812	x	x	268.859	x	x	14.503	x	x	x	x	x	28.288	x	x	x	x	x	x	65.287	x	x	x	x	x	x	x	
-12718	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	22.482	100.0	25.396	x	x	x	x	x	x	203.397	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	204.694	218.63	233.681	92.433	x	x	x	34.644	103.963	x	x	x	x	221.283	6.782	x	x	x	20.714	156.605	59.961	x	x	x	x	x	x	57.606	64.526	x	x	x	42.526	x	x	11.004	x	x	47.447	x	x	196.774	x	x	x	x	x	268.943	x	x	x	x	x	x	261.055	x	x	x	x	x	x	x	
-12624	Original post publication description: Ethanol response (10% EtOH in tap water), average daily consumption using two-bottle choice method in females [g/kg]	None	Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water), average daily consumption using two-bottle choice method in females [g/kg]	x	x	x	x	x	x	x	10.71	x	x	3.15	x	1.96	4.84	x	4.07	x	4.9	x	x	0.04	x	5.84	0.66	x	11.17	x	x	x	4.47	1.11	x	2.9	x	x	x	1.07	x	4.94	1.81	3.46	x	2.13	3.28	x	x	6.28	x	x	2.95	x	x	x	x	8.15	x	x	x	6.97	x	x	x	x	x	4.04	4.0	x	4.13	10.94	4.46	x	2.8	x	2.82	x	2.73	x	x	4.63	x	x	2.01	4.63	3.14	7.65	3.7	x	3.23	2.44	x	3.17	x	x	x	x	x	x	x	x	x	x	9.33	
-12644	Original post publication description: Anxiety assay (S10_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %].	None	Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTR), percent time spent without locomotion in the light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during 10 min test [n %]	x	x	17.153	28.012	9.737	14.138	2.867	14.05	25.981	28.79	1.4	27.104	x	8.367	24.121	56.438	8.186	22.915	21.881	42.624	14.452	11.99	x	x	x	6.719	1.715	x	x	18.121	15.004	12.008	17.7	x	6.752	x	16.11	4.783	x	x	19.93	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12645	Original post publication description: Anxiety assay (S10_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %].	None	Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %].	x	x	22.266	28.832	14.578	20.517	3.352	17.779	26.41	28.362	1.794	33.108	x	11.856	25.994	45.343	12.179	23.741	11.471	40.398	14.388	12.802	x	x	x	6.955	1.783	x	x	18.89	16.127	14.477	19.826	x	9.08	x	18.683	4.665	x	x	29.454	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12646	Original post publication description: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec].	Central nervous system, pharmacology, behavior: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]	Central nervous system, pharmacology, behavior: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]	x	x	51.46	84.037	29.211	42.414	8.6	42.15	77.943	86.371	4.2	81.312	x	25.1	72.362	169.314	24.557	68.744	65.643	127.871	43.357	35.971	x	x	x	20.157	5.144	x	x	54.362	45.013	36.025	53.1	x	20.256	x	48.329	14.35	x	x	59.789	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12647	Original post publication description: Anxiety assay (S10_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec].	None	Central nervous system, pharmacology, behavior: Anxiety assay (S10_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec].	x	x	133.593	172.994	87.467	123.1	20.111	106.675	158.457	170.171	10.767	198.65	x	71.133	155.963	272.057	73.071	142.444	68.829	242.386	86.329	76.814	x	x	x	41.729	10.7	x	x	113.338	96.763	86.862	118.956	x	54.478	x	112.1	27.988	x	x	176.722	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12709	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	404.145	100.0	424.758	x	x	x	x	x	x	222.835	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	127.202	335.749	939.916	211.589	x	x	x	232.172	239.918	x	x	x	x	370.11	480.583	x	x	x	327.209	75.757	179.74	x	x	x	x	x	x	210.778	304.227	x	x	x	159.672	x	x	1054.02	x	x	439.931	x	x	93.846	x	x	x	x	x	122.027	x	x	x	x	x	x	95.469	x	x	x	x	x	x	x	
-12710	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	64.683	100.0	149.71	x	x	x	x	x	x	96.465	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	108.179	103.375	161.814	81.4	x	x	x	132.112	297.066	x	x	x	x	110.957	114.781	x	x	x	82.924	47.956	127.062	x	x	x	x	x	x	166.438	130.568	x	x	x	136.652	x	x	45.766	x	x	302.37	x	x	69.518	x	x	x	x	x	172.826	x	x	x	x	x	x	64.107	x	x	x	x	x	x	x	
-12708	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 beta from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control] entered at October/25 13:43:35 from IP 172.2	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), interleukin-1 beta level (IL1B, Chr 2 at 129 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control]	x	44.495	100.0	47.312	x	x	x	x	x	x	235.124	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	201.142	177.814	138.743	89.64	x	x	x	68.021	137.325	x	x	x	x	165.831	16.832	x	x	x	76.548	189.606	75.285	x	x	x	x	x	x	75.347	83.784	x	x	x	31.469	x	x	44.947	x	x	39.608	x	x	183.611	x	x	x	x	x	284.835	x	x	x	x	x	x	196.864	x	x	x	x	x	x	x	
-12705	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) G-CSF from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), granulocyte colony-stimulating factor (G-CSF, CSF3, Chr 11 at 98.6 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control]	x	28.434	100.0	55.754	x	x	x	x	x	x	155.468	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	145.985	81.161	69.705	41.138	x	x	x	38.232	76.646	x	x	x	x	174.311	9.88	x	x	x	11.707	178.677	49.044	x	x	x	x	x	x	46.236	32.142	x	x	x	33.141	x	x	10.617	x	x	32.821	x	x	35.797	x	x	x	x	x	87.751	x	x	x	x	x	x	65.91	x	x	x	x	x	x	x	
-12703	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Parasite Burden in feet, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), parasite burden in feet 3 weeks post infection in females [% of C57BL/6 control]	x	64.3	100.0	46.4	x	x	x	x	x	x	100.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	111.6	65.1	76.7	64.3	x	x	x	82.1	46.4	x	x	x	x	82.1	46.4	x	x	x	53.5	100.0	64.3	x	x	x	x	x	x	64.3	76.7	x	x	x	28.6	x	x	46.4	x	64.3	82.1	x	x	76.7	x	x	x	x	x	53.5	x	x	x	x	x	x	28.6	x	x	x	x	x	x	x	
-12702	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control]	None	Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control]	x	91.2	100.0	44.2	x	x	x	x	x	x	66.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	95.2	78.3	52.2	57.9	x	x	117.7	57.2	65.1	x	x	x	x	49.7	68.2	x	x	x	40.1	84.9	82.6	x	x	x	x	x	x	78.6	40.0	x	x	x	68.0	x	x	49.2	x	65.6	120.0	x	x	55.8	x	x	x	33.8	x	71.4	x	x	x	x	x	x	65.4	x	x	x	x	x	x	x	
-12659	Original post publication description: Central nervous system, morphology: Brain weight, corrected only for dissection error [mg]	None	Central nervous system, morphology: Brain weight, corrected only for dissection error [mg]	x	460.121	470.253	400.692	470.588	432.944	514.051	389.764	436.857	435.807	444.262	444.003	398.062	421.972	455.929	448.976	428.546	425.081	391.707	437.124	449.665	421.082	385.6	409.5	408.762	367.645	402.813	395.046	372.922	416.129	430.71	428.577	420.545	417.244	415.869	424.187	420.67	416.726	436.781	x	442.56	421.38	438.364	442.016	x	x	412.269	405.833	417.544	440.517	x	x	x	469.816	434.81	x	x	x	448.498	457.539	437.164	408.1	446.6	424.386	410.231	408.775	444.11	451.167	429.748	443.741	x	439.678	390.75	421.067	436.1	453.04	417.172	374.017	439.776	406.688	x	439.462	409.604	431.285	484.774	429.752	x	446.717	434.574	462.85	434.901	415.322	x	442.48	416.705	443.842	412.735	452.074	445.842	378.333	402.891	452.84	
-12660	Original post publication description: Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, corrected only for initial dissection errors [mg]	None	Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, corrected only for initial dissection errors [mg]	x	469.31	485.055	410.091	483.953	444.595	525.3	399.5	445.898	443.584	453.038	456.622	406.734	433.693	466.823	461.849	440.3	436.898	404.593	448.585	464.446	435.918	385.6	422.906	421.032	378.007	410.553	408.068	386.165	428.674	440.238	441.843	426.309	429.194	423.973	438.875	431.658	423.244	444.022	x	448.86	430.715	447.31	452.188	x	x	426.145	405.833	418.835	450.949	x	x	x	470.787	434.81	x	x	x	458.608	462.095	446.616	418.356	463.25	430.269	414.089	408.775	448.166	459.29	432.61	443.741	x	447.399	390.75	426.632	452.333	462.698	432.592	376.25	443.226	410.863	x	439.462	409.604	442.554	493.732	433.656	x	452.848	442.911	480.033	447.012	425.9	x	442.48	422.709	452.41	418.7	452.074	446.227	378.333	402.891	452.84	
-12661	Original post publication description: Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight and for dissection error [mg]	None	Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight and for dissection error (Hager et al., 2012) [mg]	x	465.968	488.776	414.383	492.576	438.697	530.186	400.747	445.859	437.196	452.583	461.049	411.334	438.413	462.643	466.364	442.305	442.403	415.123	450.265	469.971	442.154	389.581	417.29	427.953	381.942	412.801	415.167	398.138	430.899	437.842	449.352	421.077	436.49	427.587	429.919	438.688	420.157	446.549	x	448.954	432.182	446.894	457.649	x	x	426.057	405.682	419.602	450.419	x	x	x	470.528	429.871	x	x	x	447.543	458.602	446.437	424.192	454.906	428.059	416.054	412.731	443.091	455.804	429.612	444.027	x	450.786	396.589	427.256	452.429	447.104	434.523	386.006	444.4	418.587	x	448.472	411.292	439.863	487.895	432.278	x	446.726	441.078	483.377	437.93	423.064	x	438.51	420.545	443.171	419.56	450.869	436.924	382.171	397.68	444.23	
-12662	Original post publication description: Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, and dissection error [mg]	None	Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, and dissection error [mg]	x	457.375	474.438	404.971	478.054	427.536	519.353	390.511	437.676	429.642	443.651	448.963	403.899	426.136	452.669	454.554	431.124	430.41	402.79	438.8	455.448	427.6	390.801	403.73	415.684	372.155	406.136	402.946	385.661	418.728	428.894	436.37	415.725	425.596	419.859	410.872	428.497	414.214	439.594	x	443.02	423.284	437.138	446.642	x	x	412.671	407.057	418.391	439.887	x	x	x	469.944	429.454	x	x	x	437.122	454.284	437.106	414.111	436.282	421.458	411.204	412.544	437.758	447.899	426.008	443.397	x	442.63	397.488	421.741	433.432	437.88	419.535	382.556	440.205	412.357	x	448.101	411.322	429.114	478.721	426.975	x	439.92	432.472	464.823	426.579	413.024	x	438.914	414.948	434.971	412.886	449.968	436.52	383.553	398.186	443.996	
-12663	Original post publication description: Gastrointestinal system, morphology: Small intestine length, statistically adjusted for variation in sex and age [cm]	None	Gastrointestinal system, morphology: Small intestine length, statistically adjusted for variation in sex and age [cm]	x	33.236	29.27	29.527	32.957	40.752	34.008	x	x	33.221	36.99	32.807	32.038	x	x	34.425	x	30.357	x	x	x	x	30.918	x	x	38.272	x	31.226	x	34.323	x	x	36.822	x	32.236	x	x	30.429	28.558	x	31.756	32.651	32.665	32.61	x	x	36.878	x	x	32.178	x	x	x	39.078	38.437	x	x	x	31.025	32.294	31.632	x	x	x	27.772	x	33.477	30.301	29.291	35.699	x	31.625	x	31.002	x	34.69	x	x	31.485	x	x	28.192	31.764	33.551	36.669	29.186	x	34.984	34.622	x	x	x	x	36.233	33.775	x	35.665	36.369	38.719	x	33.616	33.098	
-12664	Original post publication description: Gastrointestinal system, morphology: small intestine length, without statistical adjustment [cm]	None	Gastrointestinal system, morphology: small intestine length, without statistical adjustment [cm]	x	32.962	29.492	30.613	33.25	43.833	33.81	x	x	31.833	37.1	34.25	30.65	x	x	35.0	x	30.03	x	x	x	x	29.75	x	x	39.714	x	29.85	x	34.667	x	x	37.3	x	31.333	x	x	30.19	29.0	x	32.34	32.42	33.123	32.567	x	x	36.0	x	x	31.682	x	x	x	38.5	38.9	x	x	x	31.382	32.17	31.309	x	x	x	27.333	x	34.39	31.333	28.454	36.29	x	30.991	x	30.742	x	35.664	x	x	30.96	x	x	28.21	31.409	33.4	37.182	29.03	x	35.936	35.667	x	x	x	x	35.083	32.975	x	36.0	37.75	38.136	x	32.314	32.47	
-12667	Original post publication description: Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit]	None	Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit]	x	x	0.915	-1.395	x	x	x	-0.548	x	x	x	0.745	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.323	x	-1.759	x	x	x	x	x	-1.079	x	x	x	-1.15	0.721	x	x	0.896	0.941	0.523	0.101	x	x	x	x	x	x	x	x	x	x	0.774	x	0.479	x	0.75	x	0.943	-1.385	-0.385	x	x	-0.737	x	0.544	x	0.244	x	x	-1.026	-1.606	x	0.03	0.957	x	0.857	-1.208	x	-1.14	0.947	x	x	x	x	0.949	0.948	x	0.949	-1.259	0.869	0.741	0.953	-0.737	
-12668	Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.8 is all animals present with lesions]	None	Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.8 is all animals present with lesions]	x	x	-0.309	-0.284	x	x	x	-0.0675	x	x	x	-0.1586	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.305	x	-0.03311	x	x	x	x	x	-0.3542	x	x	x	-0.1771	-0.1886	x	x	-0.0791	-0.2781	-0.1299	0.2298	x	x	x	x	x	x	x	x	x	x	0.0806	x	0.7233	x	0.1801	x	-0.052	-0.2963	-0.1222	x	x	0.3579	x	0.4935	x	0.1538	x	x	-0.0509	-0.3481	x	0.0572	-0.0503	x	-0.0261	-0.3832	x	-0.2086	0.6191	x	x	x	x	0.6673	0.4587	x	0.1712	-0.1809	0.2758	0.078	0.0309	-0.1965	
-12669	Original post publication description: Infectious disease, immune function: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid unpredictable death]	None	Infectious disease, immune function: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid unpredictable death]	x	x	-1.183	1.108	x	x	x	0.003	x	x	x	-0.716	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.819	x	2.772	x	x	x	x	x	1.405	x	x	x	0.394	-1.095	x	x	-1.147	-1.139	-0.366	0.015	x	x	x	x	x	x	x	x	x	x	-1.055	x	-0.667	x	-1.092	x	-1.174	2.119	1.033	x	x	1.402	x	-0.451	x	0.909	x	x	1.318	2.088	x	0.361	-1.15	x	-0.935	1.098	x	1.212	-1.158	x	x	x	x	-1.137	-1.131	x	-1.141	0.564	-1.135	-0.982	-1.158	1.391	
-12670	Original post publication description: Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.83 is early onset (before day 8) and 0.9 is late onset (<11 days)]	None	Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.83 is early onset (before day 8) and 0.9 is late onset (<11 days)]	x	x	0.256	-0.73	x	x	x	-0.558	x	x	x	0.294	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.833	x	-0.357	x	x	x	x	x	-0.616	x	x	x	-0.544	-0.031	x	x	0.277	0.117	-0.053	0.262	x	x	x	x	x	x	x	x	x	x	0.648	x	0.352	x	0.669	x	0.012	-0.331	-0.065	x	x	-0.341	x	0.623	x	0.389	x	x	-0.361	-0.651	x	-0.267	0.182	x	0.275	-0.465	x	-0.682	0.425	x	x	x	x	0.817	0.943	x	0.555	-0.656	0.539	-0.14	0.415	-0.369	
-12671	Original post publication description: Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.93 is unaffected animal to 0.65 is severe disease]	None	Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.93 is unaffected animal to 0.65 is severe disease]	x	x	-0.641	0.179	x	x	x	0.128	x	x	x	-0.61	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.119	x	0.556	x	x	x	x	x	0.457	x	x	x	0.65	-0.353	x	x	-0.096	-0.78	-0.236	0.426	x	x	x	x	x	x	x	x	x	x	-0.345	x	0.245	x	-0.309	x	-0.93	0.387	0.446	x	x	0.65	x	0.374	x	0.311	x	x	0.395	0.279	x	0.205	-0.679	x	-0.628	0.172	x	0.52	-0.315	x	x	x	x	0.123	-0.197	x	-0.474	-0.136	0.067	0.101	-0.702	0.643	
-12672	Original post publication description: Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit]	None	Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit]	x	x	0.504	-1.397	x	x	x	x	x	-1.12	x	0.697	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.386	x	-1.738	x	x	x	x	x	-0.677	x	x	0.657	-1.602	0.756	x	x	0.765	0.604	0.796	-0.054	x	x	x	1.119	0.593	x	x	x	-0.487	0.905	0.482	x	0.466	x	0.716	x	0.467	x	0.484	-0.733	x	-1.108	x	-0.086	x	0.822	x	-0.255	-0.784	-0.852	x	0.156	0.51	0.702	0.237	-1.133	x	0.401	0.849	x	x	x	x	0.481	0.781	0.83	-1.526	-1.39	0.428	-0.046	0.166	x	
-12673	Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.3 is where no lesions present on animals and 0.7 is where all animals present with lesions]	None	Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.3 is where no lesions present on animals and 0.7 is where all animals present with lesions]	x	x	0.575	-0.273	x	x	x	x	x	-0.325	x	-0.103	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.059	x	0.008	x	x	x	x	x	-0.039	x	x	0.175	-0.325	0.675	x	x	0.362	0.175	-0.325	0.402	x	x	x	0.075	0.425	x	x	x	-0.125	0.275	-0.047	x	0.508	x	0.3	x	0.05	x	-0.013	-0.2	x	-0.025	x	-0.004	x	0.29	x	-0.159	-0.103	-0.325	x	-0.075	-0.325	-0.325	0.059	-0.325	x	0.342	0.425	x	x	x	x	-0.325	0.087	-0.325	-0.225	-0.325	-0.075	-0.325	-0.225	x	
-12674	Original post publication description: Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -1.1 is unaffected animal to 1.2 is severe disease]	None	Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -1.1 is unaffected animal to 1.2 is severe disease]	x	x	0.015	-0.349	x	x	x	x	x	0.99	x	-0.503	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.985	x	0.803	x	x	x	x	x	-0.233	x	x	-0.622	0.178	-0.104	x	x	0.06	-0.221	-1.01	-0.243	x	x	x	-0.022	-0.26	x	x	x	1.003	0.203	-0.232	x	-0.531	x	-0.525	x	-0.682	x	-0.104	1.193	x	0.734	x	0.106	x	-0.217	x	0.449	0.4	0.278	x	0.131	-0.372	0.142	-0.265	0.383	x	-0.156	-0.401	x	x	x	x	-0.547	-0.253	-0.916	0.278	1.017	-0.135	-0.147	-0.297	x	
-12675	Original post publication description: Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body [scaled days where -1.1 is >8 days and 0.96 is <11 days]	None	Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body [scaled days where -1.1 is >8 days and 0.96 is <11 days]	x	x	0.346	-0.087	x	x	x	x	x	-0.666	x	0.459	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.743	x	-0.75	x	x	x	x	x	-0.291	x	x	-0.329	-0.274	0.646	x	x	0.318	0.505	-1.041	0.095	x	x	x	-0.566	0.177	x	x	x	-0.466	-0.016	0.313	x	-0.333	x	-0.182	x	-0.494	x	0.162	-0.573	x	0.115	x	0.057	x	0.401	x	0.292	-0.166	-0.129	x	0.24	0.434	0.298	0.526	-0.131	x	0.209	0.193	x	x	x	x	-0.229	0.429	-0.838	-0.091	-0.166	0.959	0.759	0.634	x	
-12676	Original post publication description: Infectious disease, immune function: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit]	None	Infectious disease, immune system: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit]	x	x	0.052	0.045	x	x	x	0.205	x	x	x	0.311	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.098	x	0.382	x	x	x	x	x	x	x	x	x	-0.176	-0.019	x	x	-0.109	0.105	x	-0.041	x	x	x	x	0.285	x	x	x	x	x	0.264	x	0.21	x	0.295	x	-1.608	x	0.145	x	x	0.172	x	0.442	x	0.132	x	x	-0.301	-0.784	x	0.334	0.097	x	-0.346	0.332	x	0.014	x	x	x	x	x	0.163	0.295	x	x	0.329	0.486	-0.446	-0.749	-0.613	
-12677	Original post publication description: Infectious disease, immune function: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body [ordinal scale where -0.5 = relatively unaffected and +0.5 is most severe disease]	None	Infectious disease, immune system: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body [ordinal scale where -0.5 = relatively unaffected and +0.5 is most severe disease]	x	x	0.16	0.072	x	x	x	-0.098	x	x	x	0.023	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.056	x	0.021	x	x	x	x	x	x	x	x	x	-0.148	-0.029	x	x	0.003	0.488	x	0.023	x	x	x	x	0.085	x	x	x	x	x	-0.319	x	-0.3	x	0.083	x	-0.073	x	0.391	x	x	-0.198	x	-0.309	x	0.023	x	x	-0.132	0.223	x	-0.001	0.32	x	0.205	0.221	x	0.088	x	x	x	x	x	-0.26	0.114	x	x	-0.486	0.07	-0.126	0.139	-0.217	
-12678	Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.40 is early onset (6 days) and +0.5 is late onset (>10 days)]	None	Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.40 is early onset (6 days) and +0.5 is late onset (>10 days)]	x	x	0.092	-0.034	x	x	x	0.037	x	x	x	-0.325	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.424	x	-0.426	x	x	x	x	x	x	x	x	x	0.127	0.266	x	x	0.507	0.274	x	-0.299	x	x	x	x	0.009	x	x	x	x	x	-0.208	x	-0.105	x	0.504	x	0.004	x	-0.276	x	x	0.265	x	-0.301	x	-0.223	x	x	0.174	0.196	x	0.177	0.134	x	0.091	-0.223	x	0.068	x	x	x	x	x	-0.02	0.044	x	x	-0.144	-0.203	-0.083	0.072	0.25	
-12679	Original post publication description: Infectious disease, immune function: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >34.5 and 0.5 is <38]	None	Infectious disease, immune system: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >34.5 and 0.5 is <38]	x	x	0.303	0.357	x	x	x	0.035	x	x	x	0.453	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.006	x	-0.234	x	x	x	x	x	x	x	x	x	0.075	0.22	x	x	0.025	-0.289	x	-0.245	x	x	x	x	0.365	x	x	x	x	x	0.191	x	0.298	x	-0.475	x	0.149	x	-0.004	x	x	0.243	x	0.103	x	-0.441	x	x	-0.072	-0.15	x	0.119	0.101	x	-0.179	0.052	x	-0.014	x	x	x	x	x	-0.079	-0.284	x	x	-0.041	-0.029	-0.112	-0.343	-0.09	
-12680	Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.6 is >5 days and 0.6 is <10 days]	None	Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.6 is >5 days and 0.6 is <10 days]	x	x	-0.248	0.377	x	x	x	-0.211	x	x	x	-0.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.076	x	0.57	x	x	x	x	x	x	x	x	x	0.418	0.132	x	x	-0.532	-0.05	x	0.151	x	x	x	x	0.199	x	x	x	x	x	0.047	x	0.51	x	0.231	x	0.01	x	0.072	x	x	-0.125	x	-0.096	x	-0.156	x	x	0.041	-0.003	x	-0.186	-0.196	x	0.073	0.078	x	-0.02	x	x	x	x	x	-0.242	-0.452	x	x	0.28	0.023	-0.213	-0.329	0.041	
-12681	Original post publication description: infectious disease, immune function: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % loss where -0.6 = minimal weight loss of 3% and +0.7 is maximal weight loss of 34%]	None	infectious disease, immune system: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % loss where -0.6 = minimal weight loss of 3% and +0.7 is maximal weight loss of 34%]	x	x	0.18	0.318	x	x	x	0.21	x	x	x	-0.024	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.242	x	-0.044	x	x	x	x	x	x	x	x	x	0.124	-0.287	x	x	-0.28	-0.371	x	0.006	x	x	x	x	-0.085	x	x	x	x	x	-0.274	x	-0.208	x	0.668	x	0.609	x	-0.598	x	x	0.292	x	-0.484	x	0.321	x	x	0.44	0.193	x	-0.494	-0.564	x	0.44	0.235	x	-0.035	x	x	x	x	x	-0.539	-0.377	x	x	0.159	-0.392	0.342	0.191	0.086	
-12682	Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days in which -0.8 is >5 days and 1.7 is <13 days]	None	Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days in which -0.8 is >5 days and 1.7 is <13 days]	x	x	0.63	0.394	x	x	x	-0.115	x	x	x	0.019	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.269	x	-0.378	x	x	x	x	x	x	x	x	x	0.049	0.012	x	x	0.224	0.084	x	0.23	x	x	x	x	-0.275	x	x	x	x	x	-0.304	x	0.533	x	1.721	x	0.022	x	-0.51	x	x	-0.093	x	0.126	x	-0.761	x	x	-0.199	0.122	x	0.248	-0.292	x	0.251	-0.029	x	0.055	x	x	x	x	x	-0.097	-0.142	x	x	-0.582	-0.433	-0.153	-0.052	-0.037	
-12683	Original post publication description: Infectious disease, immune function: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]	None	Infectious disease, immune function: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]	x	3.0	3.0	1.0	2.0	3.0	1.0	2.5	3.0	1.0	2.0	3.0	2.0	2.0	3.0	2.0	3.0	3.0	x	3.0	2.0	3.0	x	1.0	2.0	3.0	3.0	3.0	3.0	2.0	1.0	x	1.0	x	x	x	x	x	1.0	x	x	x	1.0	3.0	x	x	3.0	3.0	3.0	2.0	x	x	x	x	x	x	x	x	x	x	3.0	x	2.0	x	3.0	x	3.0	1.0	2.0	x	x	1.0	x	2.0	x	2.0	x	x	2.0	1.0	x	2.0	3.0	x	3.0	1.0	x	1.0	3.0	x	x	x	x	3.0	3.0	x	3.0	2.0	3.0	3.0	3.0	2.0	
-12684	Original post publication description: Radiation biology: Rad6.5 (contact Ryan Yates at cyates4@uthsc.edu)	Radiation biology: Rad6.5 (contact Ryan Yates at cyates4@uthsc.edu)	Radiation biology, environmental genetics: High-dose total body gamma-irradiation survival for 12-week-old females, mean survival time (MST) after a 137-Cesium 6 Gy single exposure (LD80/30) evaluated over a 30 day post-exposure, no supportive care [residual days]	x	x	x	x	1.984	x	x	x	x	x	-5.516	3.484	x	x	x	x	x	x	x	x	-7.016	x	x	-2.266	x	-4.516	x	0.1842	x	-0.3492	-1.349	x	-5.516	x	x	x	9.184	8.234	2.484	x	x	2.484	-0.3492	-3.016	x	x	6.984	x	x	-5.516	x	x	x	x	x	x	x	x	0.2342	5.984	-2.266	x	x	-5.349	x	x	-1.216	-2.682	-0.0158	x	x	0.4842	x	-6.682	x	9.984	x	-1.682	-2.349	x	x	x	0.2342	-4.266	x	-4.616	x	0.9842	x	x	x	x	x	x	-0.5158	3.784	x	9.318	2.784	0.6508	-2.416	x	
-12685	Original post publication description: Musculoskeletal system, morphology: Body weight, statistically adjusted for variation in sex and age, and corrected for pregnancy [g]	None	Musculoskeletal system, morphology: Body weight, statistically adjusted for variation in sex and age, and corrected for pregnancy (Hager et al., 2012) [g]	32.214	29.154	24.273	22.755	24.076	26.971	23.559	22.986	24.495	25.206	24.37	23.698	25.696	24.092	27.645	26.3	25.281	22.033	20.848	23.991	22.911	22.509	24.021	26.648	21.688	24.622	24.476	23.14	20.878	24.64	25.778	21.534	27.948	23.71	24.095	x	23.21	27.484	24.651	x	24.708	24.878	26.165	22.757	x	x	26.954	28.464	24.637	25.796	x	x	x	26.225	26.877	x	x	x	31.705	28.106	25.455	23.609	24.574	24.462	21.328	26.315	27.245	27.515	26.571	23.913	x	22.523	24.805	24.62	18.693	34.962	24.259	23.516	24.097	22.267	x	21.018	24.55	27.498	28.368	22.683	x	25.556	27.504	20.392	31.262	27.293	x	27.686	27.992	31.93	24.836	24.363	29.085	26.419	27.895	24.029	
-12686	Original post publication description: Musculoskeletal system, morphology: Body weight (no statistical adjustment) [g]	None	Musculoskeletal system, morphology: Body weight (no statistical adjustment) [g]	31.298	28.897	23.343	23.465	23.487	27.74	21.58	23.263	24.576	25.678	23.633	23.323	23.035	23.652	27.111	23.832	23.51	22.444	19.928	24.426	22.162	21.88	22.375	27.948	21.047	22.562	22.597	20.086	18.117	23.995	25.878	21.413	28.19	21.572	22.73	x	21.328	26.442	23.523	x	23.997	24.491	26.656	21.874	x	x	26.625	26.033	24.172	26.276	x	x	x	26.924	27.894	x	x	x	32.786	27.488	25.596	22.544	30.6	26.453	23.072	26.988	30.879	28.007	28.027	26.45	x	23.049	21.2	24.806	24.533	36.483	24.392	19.9	25.798	24.6	x	21.093	25.121	27.274	29.852	23.751	x	27.637	27.331	22.733	31.29	28.483	x	28.94	27.52	32.328	25.467	24.809	30.027	23.55	27.504	22.5	
-12687	Original post publication description: Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days]	None	Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days]	x	x	454.0	278.0	x	x	x	516.0	x	x	x	x	x	x	x	x	x	x	x	274.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12711	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	585.976	100.0	1778.71	x	x	x	x	x	x	72.257	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	90.412	33.252	88.84	258.032	x	x	x	483.745	398.74	x	x	x	x	385.872	895.398	x	x	x	57.165	83.886	476.484	x	x	x	x	x	x	1191.08	68.244	x	x	x	385.853	x	x	455.644	x	x	1110.81	x	x	45.155	x	x	x	x	x	44.675	x	x	x	x	x	x	60.112	x	x	x	x	x	x	x	
-12688	Original post publication description: BXD epoch batch trait 1 [-1 = Taylor BXD series BXD1 to 32, 0 = Taylor series BXD33 to 42, 1 = UTHSC BXD series BXD43 and higher]	None	Genetics, statistics, cofactors: BXD epoch batch trait 1 [-1 = Taylor BXD series BXD1 to 32, 0 = Taylor series BXD33 to 42, 1 = UTHSC BXD series BXD43 and higher]	x	x	x	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	
-12689	Original post publication description: BXD epoch batch trait 2 [-1 = Taylor BXD series BXD1 to 42, 1 = UTHSC BXD series BXD43 and higher]	None	Genetics, statistics, cofactors: BXD epoch batch trait 2 [-1 = Taylor BXD series BXD1 to 42, 1 = UTHSC BXD series BXD43 and higher]	x	x	x	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	
-12690	Original post publication description: BXD epoch batch trait 3 [-1 = Taylor BXD series BXD1 to 32, 1 = Taylor series BXD33 to 42 and all UTHSC BXD series BXD43 and higher]	None	Genetics, statistics, cofactors: BXD epoch batch trait 3 [-1 = Taylor BXD series BXD1 to 32, 1 = Taylor series BXD33 to 42 and all UTHSC BXD series BXD43 and higher]	x	x	x	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	
-12717	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	38.225	100.0	52.081	x	x	x	x	x	x	207.908	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	98.339	99.589	85.412	66.698	x	x	x	62.542	39.591	x	x	x	x	118.556	20.952	x	x	x	51.195	147.18	61.076	x	x	x	x	x	x	37.512	114.35	x	x	x	44.901	x	x	47.614	x	x	94.918	x	x	129.057	x	x	x	x	x	79.522	x	x	x	x	x	x	119.363	x	x	x	x	x	x	x	
-12748	Original post publication description: Reproduction, urogenital system, morphology: Uterus weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]	None	Reproduction, urogenital system, morphology: Uterus weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]	72.5	88.75	63.8	97.16	58.667	x	24.5	x	81.5	49.5	65.636	58.75	64.667	101.0	x	42.333	x	54.462	x	x	48.0	x	x	53.667	x	49.6	x	47.25	x	70.0	112.4	158.0	89.533	x	99.0	x	85.0	66.909	113.25	x	57.333	74.083	48.714	90.643	x	x	66.333	174.667	79.5	95.923	x	x	x	80.286	119.154	x	x	x	96.783	66.454	72.158	68.5	x	69.0	77.714	x	62.538	63.809	139.147	68.0	x	76.16	x	104.368	x	94.714	x	56.8	59.923	x	x	85.857	66.692	131.625	65.444	82.842	x	109.25	100.333	x	67.0	x	x	94.286	76.182	81.667	42.0	90.0	87.177	118.5	80.556	69.846	
-12749	Original post publication description: Reproduction, urogenital system, morphology: Uterus horn length at maturity (average of right and left sides), unadjusted for body weight, age, or parity [mg]	None	Reproduction, urogenital system, morphology: Uterus horn length at maturity (average of right and left sides), unadjusted for body weight, age, or parity [mg]	1.395	1.486	1.583	1.681	1.26	x	1.36	x	2.09	2.1	1.314	1.228	1.675	1.01	x	1.233	x	1.66	x	x	1.335	x	x	1.1	x	1.47	x	1.445	x	1.34	1.2	1.78	1.623	x	1.47	x	1.41	1.491	1.295	x	1.737	1.879	1.663	1.706	x	x	1.638	1.432	1.724	1.758	x	x	x	1.854	1.515	x	x	x	1.732	1.775	1.555	1.624	x	1.506	1.602	x	1.945	1.797	1.909	1.721	x	1.753	x	1.851	x	2.124	x	0.772	1.681	x	x	1.869	1.875	1.791	1.861	1.592	x	1.807	1.572	x	1.97	x	x	1.977	1.825	1.463	1.535	1.77	1.894	1.212	2.182	1.708	
-12741	Original post publication description: T4_EtPerchangebas entered at December/14 16:45:32 from IP 128.172.54.246	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 4th cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 4th cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	-52.941	x	54.034	48.063	x	x	59.247	x	x	x	x	-9.524	x	-20.032	x	-4.721	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	59.859	x	x	x	x	-4.829	x	x	x	-52.714	x	-40.815	x	x	x	232.241	54.635	x	x	x	x	87.057	x	x	x	x	x	x	-7.359	x	x	x	136.328	x	x	x	x	14.43	x	x	4.621	16.739	x	88.907	x	x	-0.467	-22.834	x	118.698	x	-22.775	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-6.811	24.703	-33.069	-32.946	
-12721	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) monocyte chemoattractant protein-1 from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control] entered at October/25 13:43:	None	Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), monocyte chemoattractant protein-1 (MCP1) level from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]	x	63.925	100.0	105.434	x	x	x	x	x	x	56.884	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	118.692	160.797	103.141	185.247	x	x	x	165.307	132.888	x	x	x	x	134.849	88.703	x	x	x	32.467	196.178	99.984	x	x	x	x	x	x	187.658	29.996	x	x	x	84.863	x	x	48.206	x	x	146.373	x	x	81.64	x	x	x	x	x	237.805	x	x	x	x	x	x	415.571	x	x	x	x	x	x	x	
-12704	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	39.33	100.0	49.031	x	x	x	x	x	x	167.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	122.1	49.3	41.9	72.0	x	x	x	52.1	104.3	x	x	x	x	93.9	8.4	x	x	x	43.4	73.5	94.2	x	x	x	x	x	x	73.3	144.7	x	x	x	25.1	x	x	7.5	x	x	39.1	x	x	76.8	x	x	x	x	x	77.8	x	x	x	x	x	x	81.7	x	x	x	x	x	x	x	
-12725	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	47.697	100.0	71.666	x	x	x	x	x	x	283.788	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	119.086	166.411	129.236	95.292	x	x	x	95.097	83.179	x	x	x	x	125.017	30.504	x	x	x	52.537	105.035	124.839	x	x	x	x	x	x	56.295	70.545	x	x	x	62.808	x	x	40.4	x	x	75.889	x	x	124.378	x	x	x	x	x	200.42	x	x	x	x	x	x	164.616	x	x	x	x	x	x	x	
-12743	Original post publication description: T2_EtPerchangebas	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 2nd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 2nd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	25.12	x	29.322	12.106	x	x	66.351	x	x	x	x	-12.088	x	17.538	x	-37.212	x	4.825	x	x	x	x	x	x	x	x	x	x	x	x	-1.639	x	-19.855	x	x	x	x	-12.457	x	x	x	-24.544	x	-59.219	x	x	x	65.657	75.499	28.046	x	x	x	81.158	x	x	x	x	x	x	67.635	x	33.884	x	31.829	x	x	32.666	x	3.67	x	17.208	17.857	-15.265	x	-25.0	x	x	25.001	-5.971	x	166.821	46.728	-13.535	x	x	x	91.48	x	x	x	x	x	x	x	x	x	-29.644	-32.438	93.524	-5.34	-22.32	
-12744	Original post publication description: T1_Etchangebas entered at December/14 16:45:32 from IP 128.172.54.246	None	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 1st cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	-0.91	x	0.54	-0.305	x	x	0.05	x	x	x	x	0.19	x	-0.32	x	-1.19	x	-0.12	x	x	x	x	x	x	x	x	x	x	x	x	-0.21	x	0.13	x	-0.2	x	x	-0.695	x	x	x	-1.0	x	-1.35	x	x	x	0.16	-0.31	0.83	x	x	x	1.18	x	x	x	x	x	x	1.37	x	-0.06	x	0.57	x	x	0.68	x	0.21	x	-0.48	-0.15	-0.13	x	-0.44	x	x	0.05	0.08	x	0.99	-0.08	-0.24	x	x	x	-0.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12745	Original post publication description: Base_w6_Etgkg_ave entered at December/14 16:45:32 from IP 128.172.54.246	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 before any ethanol vapor chamber treatment (baseline consumption), young adult males or females [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 before any ethanol vapor chamber treatment (baseline consumption), young adult males or females [g/kg]	1.69	x	2.435	1.375	x	x	1.66	x	x	x	x	2.05	x	1.1	x	1.68	x	1.76	x	x	x	x	x	x	x	x	x	x	x	x	1.46	x	2.02	x	1.36	x	x	1.44	x	x	x	1.98	x	2.42	x	x	x	1.14	1.55	1.64	x	x	x	1.84	x	x	x	x	x	x	2.59	x	1.19	x	0.97	x	x	3.06	x	1.55	x	1.64	1.5	1.84	x	1.44	x	x	1.7	5.8	x	0.76	1.07	1.645	x	x	x	1.14	x	x	x	x	x	x	x	x	x	3.275	1.57	1.38	2.16	1.55	
-12706	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) GM-CSF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	Infectious disease, immune function: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [% of C57BL/6 control]	Infectious disease, immune function: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [% of C57BL/6 control]	x	77.509	100.0	137.731	x	x	x	x	x	x	91.452	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	142.127	132.701	141.659	81.406	x	x	x	125.5	139.319	x	x	x	x	93.38	51.459	x	x	x	102.549	68.936	104.99	x	x	x	x	x	x	136.904	309.576	x	x	x	95.847	x	x	34.699	x	x	217.279	x	x	174.556	x	x	x	x	x	225.295	x	x	x	x	x	x	119.077	x	x	x	x	x	x	x	
-12707	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	41.424	100.0	92.671	x	x	x	x	x	x	186.976	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	223.0	136.656	88.363	136.094	x	x	x	131.21	79.368	x	x	x	x	219.335	20.84	x	x	x	84.758	190.276	142.043	x	x	x	x	x	x	137.928	116.049	x	x	x	42.752	x	x	21.007	x	x	49.527	x	x	140.971	x	x	x	x	x	176.818	x	x	x	x	x	x	204.109	x	x	x	x	x	x	x	
-12742	Original post publication description: T3_EtPerchangebas entered at December/14 16:45:32 from IP 128.172.54.246	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 3rd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 3rd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline]	-5.976	x	58.766	15.022	x	x	47.292	x	x	x	x	-16.715	x	21.088	x	-29.975	x	x	x	x	x	x	x	x	x	x	x	x	x	x	76.707	x	57.288	x	x	x	x	5.147	x	x	x	-31.645	x	-28.571	x	x	x	121.622	153.927	115.704	x	x	x	91.931	x	x	x	x	x	x	37.425	x	18.732	x	67.918	x	x	-100.0	x	-2.164	x	8.686	13.793	27.063	x	90.519	x	x	14.877	14.31	x	171.7	-100.0	27.87	x	x	x	86.954	x	x	x	x	x	x	x	x	x	-100.0	5.145	125.323	15.35	6.296	
-12750	Original post publication description: Reproduction, urogenital system, morphology: Uterus body length, unadjusted for body weight, age, or parity [cm]	None	Reproduction, urogenital system, morphology: Uterus body length, unadjusted for body weight, age, or parity [cm]	0.205	0.297	0.304	0.436	0.313	x	0.29	x	0.42	0.215	0.408	0.325	0.358	0.265	x	0.533	x	0.355	x	x	0.375	x	x	0.32	x	0.354	x	0.28	x	0.293	0.418	0.31	0.44	x	0.33	x	0.39	0.37	0.378	x	0.3	0.418	0.384	0.383	x	x	0.337	0.403	0.331	0.489	x	x	x	0.473	0.359	x	x	x	0.505	0.471	0.429	0.267	x	0.35	0.454	x	0.315	0.463	0.443	0.368	x	0.41	x	0.335	x	0.461	x	0.38	0.362	x	x	0.399	0.345	0.419	0.465	0.384	x	0.422	0.397	x	0.4	x	x	0.474	0.43	0.3	0.29	0.49	0.379	0.372	0.321	0.357	
-12720	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	137.739	100.0	323.238	x	x	x	x	x	x	51.298	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	44.516	17.626	61.482	95.444	x	x	x	184.204	81.386	x	x	x	x	225.91	111.072	x	x	x	60.783	44.934	282.44	x	x	x	x	x	x	161.229	35.496	x	x	x	99.916	x	x	186.197	x	x	210.85	x	x	24.359	x	x	x	x	x	45.467	x	x	x	x	x	x	64.277	x	x	x	x	x	x	x	
-12724	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 beta from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), macrophage inflammatory protein-1 beta (MIP1B) from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]	x	59.523	100.0	86.965	x	x	x	x	x	x	100.436	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	69.874	73.572	59.952	125.137	x	x	x	95.716	180.706	x	x	x	x	105.703	85.767	x	x	x	81.095	85.262	103.587	x	x	x	x	x	x	82.8	92.53	x	x	x	110.16	x	x	55.449	x	x	100.21	x	x	69.92	x	x	x	x	x	107.984	x	x	x	x	x	x	87.187	x	x	x	x	x	x	x	
-12723	Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	None	Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]	x	54.613	100.0	77.667	x	x	x	x	x	x	226.531	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	78.96	69.189	66.375	80.611	x	x	x	79.6	223.961	x	x	x	x	73.327	77.584	x	x	x	180.382	126.273	96.971	x	x	x	x	x	x	77.174	191.574	x	x	x	114.373	x	x	33.214	x	x	138.564	x	x	77.72	x	x	x	x	x	214.245	x	x	x	x	x	x	74.52	x	x	x	x	x	x	x	
-12731	Original post publication description: Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, trials to criterion after acquisition in 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]	None	Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, trials to criterion after acquisition in 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]	x	x	183.2	233.75	150.8	296.5	x	x	x	x	x	196.0	180.0	164.5	x	310.5	138.0	x	x	x	235.5	x	x	205.8	220.0	x	x	220.0	x	110.75	229.0	x	180.83	x	137.0	x	118.5	211.33	132.0	x	259.8	168.75	202.0	205.5	x	x	x	77.0	136.0	206.67	x	x	x	157.33	210.0	x	x	x	97.0	164.0	117.0	x	x	123.0	91.0	x	255.0	x	128.33	203.5	x	80.5	x	213.8	x	211.0	x	x	115.2	x	x	102.5	144.33	172.4	110.25	x	x	197.67	102.5	x	x	x	x	122.5	166.0	x	141.0	x	251.0	x	252.8	210.25	
-12732	Original post publication description: Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, residual trials to criterion after acquisition in 4-month adult males corrected for variation in acquisition learning (Med Associates nose poke chamber) [residual n]	None	Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, residual trials to criterion after acquisition in 4-month adult males corrected for variation in acquisition learning (Med Associates nose poke chamber) [residual n]	x	x	9.77	24.27	-13.13	155.97	x	x	x	x	x	47.38	-25.82	-14.94	x	86.4	0.09	x	x	x	75.91	x	x	33.2	29.59	x	x	49.7	x	-62.95	47.34	x	20.28	x	1.18	x	-33.78	30.93	-49.37	x	69.23	-13.96	34.57	62.62	x	x	x	-81.02	-24.11	40.72	x	x	x	-32.99	68.43	x	x	x	-50.84	-1.6	-14.96	x	x	-33.72	-85.57	x	58.93	x	-77.31	33.33	x	-143.34	x	16.86	x	29.21	x	x	-52.38	x	x	-56.44	-15.0	-11.79	-95.18	x	x	23.36	-99.4	x	x	x	x	-64.52	-15.4	x	-2.14	x	32.33	x	41.23	5.87	
-12733	Original post publication description: Ethanol response (10% v/v ethanol), average daily consumption at 2 hr, males and females combined [g/kg]	None	Ethanol response (10% v/v ethanol), average daily consumption at 2 hr, males and females combined [g/kg]	x	x	x	x	0.1	x	x	1.15	x	0.18	0.6	0.06	0.11	0.9	x	0.4	x	0.53	x	x	0.06	x	1.54	0.54	x	0.52	x	x	x	0.74	0.12	x	0.51	x	0.21	x	0.3	x	0.45	0.7	0.26	1.21	0.87	0.43	x	x	2.25	x	x	1.08	x	x	x	1.95	0.81	x	x	x	1.35	x	0.22	x	x	x	0.21	0.52	0.2	0.55	1.36	0.59	x	0.41	x	0.4	x	0.98	x	1.38	0.79	x	x	0.16	1.09	0.65	0.72	0.66	x	0.41	0.49	x	0.42	x	x	x	x	x	0.07	x	1.54	x	0.06	1.09	
-12735	Original post publication description: 3alpha,5alpha-tetrahydroprogesterone (THP) levels 6 hrs after saline injection, afternoon sample collection (preliminary) [pg/g]	Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP, allopregnanolone) level in the olfactory bulb and tubercle 6 hrs after saline injection, afternoon sample collection (control for dexamethasone injection) [pg/g]	Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP, allopregnanolone) level in the olfactory bulb and tubercle 6 hrs after saline injection, afternoon sample collection (control for dexamethasone injection) [pg/g]	x	127.68	465.39	229.94	x	120.82	547.85	17.9	x	90.06	x	394.97	63.36	369.97	147.88	255.92	299.92	205.45	x	81.87	x	x	x	199.62	x	175.34	x	x	x	x	158.09	x	x	x	x	x	x	x	x	x	x	x	139.8	x	x	x	291.39	x	x	x	x	x	x	x	x	x	x	x	x	x	259.87	x	x	x	x	x	x	197.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	150.53	x	189.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12736	Original post publication description: 3alpha,5alpha-tetrahydroprogesterone (THP) levels 1 hrs after saline injection, morning sample collection (preliminary) [pg/g]	None	Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP) level in the olfactory bulb and tubercle 1 hrs after saline injection, morning sample collection (control for ethanol experiments) [pg/g]	x	x	1440.0	1234.8	x	x	x	x	x	x	x	1489.4	947.0	x	x	850.7	x	x	x	1371.7	x	x	x	x	x	595.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1802.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	805.7	x	x	x	1174.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12737	Original post publication description: Central nervous system: level of allopregnanolone in the olfactory bulb and tubercle 1 hour after control saline injection ((3alpha,5alpha) 3-hydroxy-5-pregnane-20-one (3alpha,5alpha-THP)) [pg/g]	None	Central nervous system, pharmacology, endocrinology: 3a,5a-pregnane-3a,21-diol-20-one (THDOC) level in the olfactory bulb and tubercle 1 hour after saline injection, morning sample collection (control for dexamethasone injection) [pg/g]	x	112.05	136.52	216.0	x	122.96	2301.4	974.32	x	278.2	x	475.07	85.32	359.75	647.61	147.41	464.25	3502.93	x	175.22	x	x	x	1000.0	x	2034.15	x	612.11	x	314.09	245.99	x	x	x	x	x	x	x	x	x	x	x	270.0	x	x	x	141.72	x	x	x	x	x	x	x	x	x	x	x	x	x	605.45	x	x	x	x	x	x	55.12	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	522.33	x	1369.68	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12738	Original post publication description: Pregnenolone levels X hrs after saline injection, XX sample collection (preliminary) [pg/g]	None	Pregnenolone levels X hrs after saline injection, XX sample collection (preliminary) [pg/g]	x	1573.81	1464.92	1266.92	x	1402.71	1066.2	1141.1	x	1119.54	x	1596.29	3832.29	4067.29	940.1	1678.94	6381.52	1286.82	x	1348.52	x	x	x	1921.86	x	1759.52	x	x	x	1262.06	x	x	x	x	x	x	x	x	x	x	x	x	1303.63	x	x	x	1227.8	x	x	x	x	x	x	x	x	x	x	x	x	x	1128.8	x	x	x	x	x	x	1479.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1784.28	x	133.83	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12746	Original post publication description: Nowak2_Dec2010	None	Nowak2_Dec2010	x	x	19.0	0.0	x	x	x	x	x	x	x	0.0	10.0	x	x	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.0	x	7.0	17.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13007	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 3 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 3 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 3 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 3 after infection in 9-14 week-old females [%]	x	90.3	95.4	86.75	90.6	89.8	91.35	x	96.95	99.5	97.1	92.3	97.05	89.0	92.5	90.5	85.4	89.1	88.4	94.35	x	95.0	x	x	x	x	79.45	x	x	87.8	87.9	x	85.0	x	85.4	x	85.0	88.7	90.25	x	96.85	100.6	89.85	x	x	x	x	x	x	89.45	x	x	x	93.5	94.44	x	x	x	88.9	94.75	86.63	x	x	95.1	x	90.17	x	89.62	91.63	93.81	x	90.7	92.72	93.64	x	x	x	95.39	86.49	x	x	x	92.87	x	x	96.72	x	90.09	x	x	96.51	x	x	x	96.65	101.45	93.1	x	89.23	x	91.93	90.89	
-13008	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 4 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 4 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%]	x	88.1	92.73	82.35	89.5	86.5	89.8	x	92.3	100.5	91.05	86.3	95.1	83.4	86.0	86.0	81.2	85.0	87.0	91.15	x	95.6	x	x	x	x	76.05	x	x	85.1	85.0	x	84.3	x	82.8	x	82.6	87.75	85.35	x	94.1	102.2	82.81	x	x	x	x	x	x	82.25	x	x	x	88.2	88.56	x	x	x	83.89	90.6	82.83	x	x	93.85	x	85.76	x	86.46	84.1	88.47	x	87.8	85.69	91.38	x	x	x	94.25	80.32	x	x	x	87.09	x	x	92.69	x	85.31	x	x	95.28	x	x	x	94.7	99.8	93.8	x	85.63	x	81.64	83.23	
-13009	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 5 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 5 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%]	x	87.5	90.1	78.0	89.0	87.3	89.4	x	89.4	100.7	89.95	80.0	93.5	80.1	81.3	84.4	76.2	83.2	85.0	89.0	x	91.7	x	x	x	x	75.0	x	x	81.7	83.7	x	80.6	x	78.1	x	77.9	88.5	82.3	x	93.2	99.5	80.71	x	x	x	x	x	x	77.85	x	x	x	86.7	82.24	x	x	x	83.47	88.3	77.9	x	x	90.72	x	85.13	x	87.18	78.77	86.69	x	82.9	83.39	89.46	x	x	x	94.28	78.13	x	x	x	85.41	x	x	90.31	x	81.16	x	x	93.42	x	x	x	92.35	97.5	94.15	x	82.84	x	81.55	79.71	
-13000	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 11 [%], file: hko_180311	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 11 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%]	x	82.8	100.0	3.3	100.0	60.0	50.0	x	100.0	100.0	100.0	0.0	100.0	0.0	0.0	0.0	0.0	20.0	80.0	100.0	x	88.8	x	x	x	x	0.0	x	x	0.0	57.1	x	0.0	x	0.0	x	0.0	100.0	25.0	x	100.0	100.0	0.0	x	x	x	x	x	x	0.0	x	x	x	20.0	20.0	x	x	x	80.0	80.0	20.0	x	x	50.0	x	80.0	x	80.0	0.0	80.0	x	20.0	0.0	100.0	x	x	x	100.0	0.0	x	x	x	80.0	x	x	100.0	x	0.0	x	x	80.0	x	x	x	100.0	100.0	100.0	x	100.0	x	40.0	0.0	
-13012	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 8 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 8 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%]	x	84.2	85.8	75.0	89.2	87.8	77.0	x	90.4	99.2	85.8	75.0	93.95	75.0	75.0	75.0	75.0	77.7	85.5	78.55	x	79.7	x	x	x	x	75.0	x	x	75.0	77.5	x	75.0	x	75.0	x	75.0	85.6	75.0	x	89.05	95.8	75.0	x	x	x	x	x	x	75.0	x	x	x	75.7	75.0	x	x	x	81.77	82.35	75.0	x	x	78.01	x	82.64	x	83.57	75.0	80.13	x	75.0	75.0	87.46	x	x	x	85.85	75.0	x	x	x	86.55	x	x	79.07	x	75.0	x	x	79.84	x	x	x	78.9	98.05	91.1	x	81.66	x	75.0	75.0	
-13013	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 9 [%], file hko_180311_vII	Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 9 [%]	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%]	x	90.6	90.0	75.0	93.3	88.0	76.5	x	93.8	100.0	87.35	75.0	94.45	75.0	75.0	75.0	75.0	75.0	87.0	82.05	x	82.9	x	x	x	x	75.0	x	x	75.0	77.1	x	75.0	x	75.0	x	75.0	87.95	75.0	x	94.0	101.1	75.0	x	x	x	x	x	x	75.0	x	x	x	75.0	75.0	x	x	x	83.38	85.1	75.0	x	x	76.06	x	83.99	x	84.6	75.0	81.0	x	75.0	75.0	91.01	x	x	x	86.63	75.0	x	x	x	88.38	x	x	78.64	x	75.0	x	x	83.91	x	x	x	81.4	97.45	94.45	x	85.54	x	75.0	75.0	
-12994	Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction]	None	Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction]	x	0.5	0.87	0.0	x	x	0.0	x	x	x	0.0	x	0.67	x	x	x	x	1.0	x	x	x	x	x	0.0	x	0.0	x	x	x	0.0	x	x	x	x	0.0	x	0.0	x	0.0	x	x	0.0	x	x	x	x	0.22	1.0	x	x	x	x	x	1.0	0.0	x	x	x	x	0.0	0.33	x	x	0.5	0.0	1.0	0.46	x	0.0	x	x	0.0	0.4	0.0	x	0.0	x	x	x	x	x	0.0	0.0	0.25	0.0	0.0	x	0.0	0.62	x	x	x	x	1.0	0.5	0.0	x	0.0	0.0	x	1.0	0.0	
-12969	Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]	None	Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]	x	x	0.0	0.4	x	x	1.0	x	x	1.0	1.0	0.0	1.0	x	x	1.0	x	x	x	x	x	x	x	1.0	x	1.0	x	x	x	1.0	0.5	x	0.571	x	x	x	1.0	1.0	1.0	x	1.0	1.0	1.0	0.0	x	x	1.0	0.0	1.0	0.5	x	0.0	x	0.0	0.5	x	x	x	0.0	x	0.0	1.0	x	0.0	1.0	0.0	0.47	0.0	0.0	x	x	1.0	0.75	1.0	x	1.0	x	1.0	1.0	x	x	x	1.0	0.0	1.0	x	0.333	x	0.1	1.0	x	x	x	0.2	0.69	x	x	1.0	x	0.0	0.08	1.0	
-12967	Original post publication description: Ethanol response (post vapor inhalation chamber treatment), 2-bottle choice consumption, 2h access after cycle 3 of ethanol exposure in chambers, average intake over 5 days [g/kg/2h]	None	Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after third cycle of exposure, intake over 5 days [g/kg/2h]	1.585	x	3.88	1.557	x	x	2.446	x	x	x	x	1.705	x	1.335	x	1.174	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.584	x	3.173	x	x	x	x	1.518	x	x	x	1.353	x	1.727	x	x	x	2.53	3.941	3.548	x	x	x	3.574	x	x	x	x	x	x	3.556	x	1.415	x	1.624	x	x	x	x	1.519	x	1.785	1.703	2.323	x	2.735	x	x	1.96	6.625	x	2.059	x	2.033	x	x	x	2.136	x	x	x	x	x	x	x	x	x	x	1.655	3.114	2.489	1.645	
-12964	Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 1 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T1_Etgkgave.	None	Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 hr access after cycle 1 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake, 16 to 18 weeks males or females [g/kg/2h]	3.276	x	2.492	1.369	x	x	1.21	x	x	x	x	2.274	x	0.794	x	1.753	x	1.554	x	x	x	x	x	x	x	x	x	x	x	x	1.387	x	2.12	x	2.349	x	x	1.145	x	x	x	1.775	x	1.036	x	x	x	3.343	2.863	1.462	x	x	x	3.426	x	x	x	x	x	x	3.175	x	1.134	x	1.813	x	x	1.895	x	1.262	x	1.25	1.193	1.282	x	1.148	x	x	1.927	4.721	x	1.141	1.152	2.026	x	x	x	1.541	x	x	x	x	x	x	x	x	x	2.541	0.962	2.737	1.2	1.236	
-12971	Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 3)	None	Infectious disease, immune system: TNFa cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]	x	49.0	21.0	301.0	x	x	x	83.0	x	168.0	x	183.0	148.0	85.0	x	x	58.0	x	x	x	165.0	x	x	x	x	233.0	100.0	x	x	55.0	102.0	x	x	x	x	x	x	x	x	x	x	37.0	191.0	73.0	x	x	97.0	x	207.0	11.0	x	x	x	79.0	77.0	x	x	x	179.0	45.0	180.0	131.0	x	51.0	51.0	88.0	45.0	133.0	29.0	15.0	x	118.0	x	21.0	x	x	x	x	44.0	x	x	34.0	120.0	39.0	269.0	63.0	x	53.0	x	x	25.0	x	x	x	77.0	x	126.0	78.0	27.0	x	x	x	
-12960	Original post publication description: Metabolism, behavior: Activity level of 13-week old males [total counts of fine movements and ambulatory activity/unit time]	None	Central nervous system, metabolism, behavior: Activity of 13-week old males, total counts of fine movements and ambulatory activity [counts/unit time]	x	x	724.205	x	x	x	x	700.643	1304.79	x	x	x	x	x	x	905.607	1189.39	x	682.321	x	x	x	x	x	x	x	661.333	x	x	467.071	x	x	x	x	x	x	x	x	x	x	x	x	487.857	557.786	x	x	636.107	x	x	x	x	x	x	x	674.464	x	x	x	x	768.286	x	x	x	942.0	782.071	x	836.821	451.81	x	424.786	x	797.071	x	1244.36	x	x	x	x	x	x	x	x	755.786	x	1155.79	x	x	907.054	x	x	570.5	x	x	525.393	362.0	x	765.048	x	579.286	691.286	x	567.929	
-12958	Original post publication description: Blood chemistry, cardiovascular system: White blood cell count of 14-week old males [x10^3/ul]	None	Blood chemistry, cardiovascular system: White blood cell count of 14-week old males [x10^3/ul]	x	x	8.924	x	13.6	x	x	6.425	7.775	x	10.2	x	x	x	x	9.125	9.825	x	6.95	x	x	x	x	x	x	x	12.267	x	x	8.775	x	x	9.45	x	x	x	x	x	x	x	10.925	6.9	14.1	8.85	x	x	11.475	x	x	x	x	x	x	13.15	15.425	x	x	x	x	9.9	7.85	x	x	5.8	7.65	x	8.975	7.45	x	10.8	x	5.1	x	11.65	x	x	x	x	8.067	7.4	x	6.95	8.5	x	11.35	9.15	x	6.75	9.0	x	5.05	x	x	9.225	11.8	8.05	12.933	x	7.0	9.45	x	6.4	
-12956	Original post publication description: Metabolism: Volume oxygen consumption of 13-week old males [ml/kg/h]	None	Respiratory system, metabolism: Volume oxygen consumption of 13-week old males [ml/kg/h]	x	x	937.619	x	x	x	x	1197.62	1110.54	x	x	x	x	x	x	966.95	1202.79	x	1038.79	x	x	x	x	x	x	x	899.0	x	x	913.161	x	x	x	x	x	x	x	x	x	x	x	x	827.238	965.429	x	x	882.071	x	x	x	x	x	x	x	938.464	x	x	x	x	831.85	x	x	x	731.536	752.524	x	983.202	843.662	x	930.214	x	886.357	x	952.417	x	x	x	x	x	x	x	x	668.071	x	978.143	x	x	823.696	x	x	825.571	x	x	867.929	746.786	x	855.571	x	659.429	782.071	x	684.214	
-12954	Original post publication description: Blood chemistry: Urea of 14-week old males [mM]	None	Blood chemistry: Urea of 14-week old males [mM]	x	x	7.496	x	6.6	x	x	8.325	5.375	x	6.833	x	x	x	x	6.725	5.5	x	7.6	x	x	x	x	x	x	x	6.067	x	x	6.4	x	x	9.2	x	x	x	x	x	x	x	8.325	10.0	8.133	8.0	x	x	7.925	x	x	x	x	x	x	7.55	7.6	x	x	x	x	x	5.85	x	x	8.25	x	x	x	x	x	7.05	x	x	x	7.85	x	x	x	x	9.325	7.25	x	9.05	7.05	x	x	8.625	x	7.55	11.9	x	7.65	x	x	7.775	8.3	7.433	7.867	x	x	9.6	x	7.4	
-12952	Original post publication description: Blood chemistry: Triglyceride of 14-week old males [mM]	None	Blood chemistry: Triglyceride of 14-week old males [mM]	x	x	0.912	x	1.523	x	x	0.773	1.06	x	1.463	x	x	x	x	1.233	1.445	x	1.743	x	x	x	x	x	x	x	0.773	x	x	1.278	x	x	0.89	x	x	x	x	x	x	x	1.753	1.27	1.353	0.975	x	x	1.123	x	x	x	x	x	x	1.31	0.628	x	x	x	x	1.665	1.555	x	x	1.43	1.15	x	0.903	0.83	x	0.89	x	0.955	x	0.95	x	x	x	x	0.955	1.635	x	1.3	1.36	x	1.06	2.433	x	1.295	1.26	x	1.74	x	x	1.078	0.805	1.198	0.58	x	1.415	1.745	x	0.765	
-12948	Original post publication description: Metabolism: Respiratory exchange ratio (RER) of 13-week old males [ratio]	None	Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old males [ratio]	x	x	0.905	x	x	x	x	0.761	0.918	x	x	x	x	x	x	0.835	0.864	x	0.838	x	x	x	x	x	x	x	0.927	x	x	0.828	x	x	x	x	x	x	x	x	x	x	x	x	0.924	0.94	x	x	0.85	x	x	x	x	x	x	x	0.872	x	x	x	x	1.037	x	x	x	0.921	1.005	x	0.981	0.946	x	0.899	x	0.869	x	0.988	x	x	x	x	x	x	x	x	0.889	x	0.912	x	x	0.88	x	x	0.967	x	x	0.836	0.777	x	0.851	x	0.951	0.959	x	0.892	
-12946	Original post publication description: Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old males [mm]	None	Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old males [mm]	x	x	0.608	x	0.62	x	x	x	x	x	0.607	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.667	x	x	x	x	x	0.638	x	x	x	x	x	x	x	0.605	0.62	0.605	x	x	x	0.645	x	x	x	x	x	x	0.625	0.585	x	x	x	x	0.585	0.643	x	x	0.62	0.58	x	0.618	0.57	x	0.61	x	0.605	x	0.58	x	x	x	x	0.601	0.58	x	0.635	0.72	x	0.618	0.623	x	0.62	0.48	x	0.685	x	x	0.615	0.625	0.633	0.555	x	0.585	0.74	x	0.695	
-12944	Original post publication description: Blood chemistry: Phosphorus of 14-week old males [mM]	None	Blood chemistry: Phosphorus of 14-week old males [mM]	x	x	2.338	x	2.325	x	x	2.738	2.173	x	1.597	x	x	x	x	2.29	2.063	x	2.24	x	x	x	x	x	x	x	1.617	x	x	2.043	x	x	1.923	x	x	x	x	x	x	x	2.238	2.71	2.56	1.98	x	x	2.04	x	x	x	x	x	x	2.79	1.89	x	x	x	x	x	1.308	x	x	2.385	x	x	x	x	x	2.045	x	x	x	2.86	x	x	x	x	2.813	2.595	x	3.13	2.245	x	x	1.883	x	2.213	3.35	x	2.46	x	x	2.59	2.365	1.438	2.66	x	x	2.73	x	2.09	
-12931	Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 14-week old males [%]	None	Blood chemistry, cardiovascular system: Hematocrit of 14-week old males [%]	x	x	42.18	x	41.975	x	x	40.2	37.3	x	40.733	x	x	x	x	42.55	52.825	x	44.2	x	x	x	x	x	x	x	46.4	x	x	34.725	x	x	45.95	x	x	x	x	x	x	x	50.025	43.3	43.4	41.4	x	x	42.875	x	x	x	x	x	x	45.6	49.6	x	x	x	x	54.1	47.65	x	x	38.15	57.6	x	48.3	45.2	x	39.4	x	41.35	x	42.8	x	x	x	x	40.5	46.85	x	42.35	50.8	x	48.8	44.625	x	46.875	39.9	x	52.4	x	x	43.6	46.0	42.55	38.3	x	44.5	45.25	x	48.6	
-12926	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old males [mg/dl]	None	Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old males [mg/dl]	x	x	97.88	x	108.75	x	x	131.75	70.0	x	92.667	x	x	x	x	76.75	83.0	x	95.0	x	x	x	x	x	x	x	119.0	x	x	120.25	x	x	96.5	x	x	x	x	x	x	x	123.75	101.0	113.5	x	x	x	94.5	x	x	x	x	x	x	78.0	91.0	x	x	x	x	98.5	86.667	x	x	109.5	88.5	x	98.0	130.5	x	82.5	x	118.0	x	149.0	x	x	x	x	105.0	77.5	x	125.5	79.0	x	116.0	83.667	x	85.75	x	x	104.0	x	x	108.25	93.0	137.0	97.667	x	86.0	80.5	x	132.0	
-12924	Original post publication description: Morphology, musculoskeletal system: Gastrocnemius muscle mass of 20-week old males [g]	None	Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old males [g]	x	x	0.171	x	0.181	x	x	0.152	0.141	x	0.147	x	x	x	x	0.157	0.193	x	0.183	x	x	x	x	x	x	x	0.333	x	x	0.137	x	x	0.223	x	x	x	x	x	x	x	0.149	0.14	0.105	x	x	x	0.173	x	x	x	x	x	x	0.132	0.12	x	x	x	x	0.149	0.133	x	x	0.118	0.157	x	0.167	0.145	x	0.143	x	0.127	x	0.109	x	x	x	x	0.116	0.092	x	0.11	0.107	x	0.167	0.183	x	0.117	0.062	x	x	x	x	0.131	0.155	0.154	0.111	x	0.186	0.112	x	0.125	
-12914	Original post publication description: Blood chemistry: Calcium of 14-week old males [mM]	None	Blood chemistry: Calcium of 14-week old males [mM]	x	x	2.351	x	2.32	x	x	2.275	2.338	x	2.49	x	x	x	x	2.378	2.398	x	2.29	x	x	x	x	x	x	x	2.273	x	x	2.295	x	x	2.438	x	x	x	x	x	x	x	2.473	2.3	2.367	2.33	x	x	2.393	x	x	x	x	x	x	2.505	2.423	x	x	x	x	x	2.4	x	x	2.36	x	x	x	x	x	2.285	x	x	x	2.365	x	x	x	x	2.585	2.56	x	2.625	2.375	x	x	2.47	x	2.29	2.68	x	2.385	x	x	2.4	2.35	2.497	2.33	x	x	2.35	x	2.295	
-12912	Original post publication description: Morphology: Body weight of 20-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 20-week old males [g]	x	x	28.456	x	33.625	x	x	26.9	27.5	x	26.633	x	x	x	x	34.6	28.575	x	30.225	x	x	x	x	x	x	x	36.1	x	x	30.3	x	x	33.475	x	x	x	x	x	x	x	27.5	28.2	28.15	x	x	x	29.4	x	x	x	x	x	x	29.15	26.825	x	x	x	x	24.55	28.233	x	x	24.25	24.25	x	28.075	25.45	x	29.05	x	26.55	x	24.45	x	x	x	x	27.625	23.85	x	26.45	25.5	x	26.85	26.0	x	26.5	26.4	x	38.65	x	x	27.2	31.6	34.575	26.9	x	27.25	27.05	x	27.3	
-12905	Original post publication description: Morphology, metabolism: Body weight of 16-week old males, normal diet [g]	None	Musculoskeletal system, morphology, metabolism: Body weight of 16-week old males, normal diet [g]	x	x	27.152	x	30.25	x	x	26.125	23.825	x	26.0	x	x	x	x	29.575	26.85	x	29.025	x	x	x	x	x	x	x	30.433	x	x	28.15	x	x	29.575	x	x	x	x	x	x	x	25.25	25.9	27.214	24.05	x	x	30.05	x	x	x	x	x	x	28.2	26.775	x	x	x	x	24.15	25.325	x	x	23.2	22.95	x	27.575	25.95	x	28.55	x	25.7	x	23.7	x	x	x	x	26.875	23.8	x	25.95	23.85	x	28.26	23.875	x	25.038	25.9	x	34.5	x	x	26.925	31.0	30.1	27.033	x	26.95	25.2	x	26.0	
-12903	Original post publication description: Morphology: Body weight of 14-week old males [g]	None	Musculoskeletal system, morphology: Body weight of 14-week old males [g]	x	x	27.132	x	30.25	x	x	25.275	22.625	x	25.067	x	x	x	x	29.3	26.275	x	29.9	x	x	x	x	x	x	x	29.133	x	x	27.575	x	x	29.9	x	x	x	x	x	x	x	25.325	24.7	26.714	24.5	x	x	27.425	x	x	x	x	x	x	28.25	26.875	x	x	x	x	23.9	26.825	x	x	22.6	22.8	x	26.988	26.217	x	27.8	x	24.9	x	23.55	x	x	x	x	26.325	23.75	x	24.75	22.1	x	27.04	24.425	x	24.088	25.7	x	31.05	x	x	26.425	29.55	30.175	26.067	x	27.4	25.15	x	25.65	
-12901	Original post publication description: Cardiovascular system: Blood pressure by tail cuff system of 16-week old males [mmHg]	None	Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old males [mmHg]	x	x	103.242	x	92.781	x	x	98.611	93.67	x	97.853	x	x	x	x	106.699	99.526	x	96.274	x	x	x	x	x	x	x	87.658	x	x	96.356	x	x	95.061	x	x	x	x	x	x	x	98.629	83.042	109.426	103.342	x	x	104.655	x	x	x	x	x	x	98.355	107.73	x	x	x	x	101.008	95.922	x	x	111.014	102.093	x	90.335	97.031	x	107.988	x	95.536	x	106.821	x	x	x	x	91.585	81.667	x	89.986	91.752	x	105.179	96.584	x	127.95	94.79	x	98.399	x	x	102.915	99.812	92.29	96.073	x	100.545	99.594	x	112.782	
-12899	Original post publication description: Musculoskeletal system, metabolism: Bone mineral density by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g/cm2]	None	Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g/cm2]	x	x	0.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.054	x	x	x	x	x	x	x	x	x	x	x	0.051	x	x	x	x	0.055	x	x	x	0.05	0.046	x	0.049	0.048	x	0.053	x	0.052	x	0.048	x	x	x	x	x	x	x	x	0.045	x	0.051	x	x	0.047	x	x	0.05	x	x	0.055	0.057	x	0.051	x	0.056	0.051	x	0.049	
-12897	Original post publication description: Morphology, metabolism: Brown adipose tissue mass of 20-week old males [g]	None	Morphology, metabolism: Brown adipose tissue mass of 20-week old males [g]	x	x	0.124	x	0.105	x	x	0.094	0.155	x	0.104	x	x	x	x	0.209	0.136	x	0.108	x	x	x	x	x	x	x	0.349	x	x	0.156	x	x	0.281	x	x	x	x	x	x	x	0.126	0.156	0.171	x	x	x	0.169	x	x	x	x	x	x	0.065	0.102	x	x	x	x	0.131	0.179	x	x	0.093	0.119	x	0.16	0.249	x	0.154	x	0.116	x	0.123	x	x	x	x	0.091	0.095	x	0.105	0.13	x	0.249	0.135	x	0.114	0.108	x	x	x	x	0.154	0.132	0.183	0.144	x	0.136	0.157	x	0.119	
-12880	Original post publication description: Cardiovascular system: Septum thickness by echocardiography of 17-week old females [mm]	None	Cardiovascular system: Septum thickness by echocardiography of 17-week old females [mm]	x	x	0.614	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.615	0.615	x	x	x	x	x	x	x	x	x	x	0.575	0.585	x	x	x	0.655	0.59	x	x	x	0.62	0.535	x	0.61	0.605	x	x	x	0.62	x	0.62	x	x	x	x	0.61	0.625	x	x	0.62	x	0.6	x	x	0.62	0.565	x	x	x	x	0.6	x	x	0.59	x	0.575	0.645	x	0.605	
-12877	Original post publication description: Blood chemistry, cardiovascular system: Red blood cell count of 14-week old females [x10^6/ul]	None	Blood chemistry, cardiovascular system: Red blood cell count of 14-week old females [x10^6/ul]	x	x	9.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.895	9.43	x	x	x	x	x	x	x	x	x	x	9.005	6.605	x	x	x	10.78	9.47	x	x	x	9.605	10.255	x	9.675	10.915	x	x	x	11.31	x	9.205	x	x	x	x	8.84	8.13	x	x	10.43	x	11.3	x	x	10.32	8.85	x	x	x	x	9.02	x	x	9.37	x	9.64	10.145	x	9.505	
-12875	Original post publication description: Blood chemistry, cardiovascular system: Platelet count of 14-week old females [x10^3/ul]	None	Blood chemistry, cardiovascular system: Platelet count of 14-week old females [x10^3/ul]	x	x	1098.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1000.5	982.0	x	x	x	x	x	x	x	x	x	x	1080.0	690.5	x	x	x	1242.0	1125.5	x	x	x	1323.0	875.5	x	898.5	1092.5	x	x	x	1020.5	x	1040.0	x	x	x	x	1290.0	843.0	x	x	1227.5	x	978.0	x	x	1242.5	1267.5	x	x	x	x	966.0	x	x	1202.0	x	916.0	1178.5	x	1278.5	
-12873	Original post publication description: Blood chemistry: Sodium of 14-week old females [mM]	None	Blood chemistry: Sodium of 14-week old females [mM]	x	x	150.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	149.0	149.0	x	x	x	x	x	x	x	x	x	x	148.5	149.5	x	x	x	149.0	x	x	x	x	152.5	x	x	x	x	x	x	x	x	x	151.5	x	x	x	x	151.0	149.0	x	x	149.5	x	x	x	x	149.0	150.0	x	x	x	x	151.0	x	x	149.0	x	x	149.5	x	153.5	
-12871	Original post publication description: Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old females [g/dl]	None	Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old females [g/dl]	x	x	34.113	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	34.55	33.8	x	x	x	x	x	x	x	x	x	x	32.25	32.6	x	x	x	32.7	30.55	x	x	x	33.7	30.8	x	33.3	33.15	x	x	x	32.55	x	33.4	x	x	x	x	34.6	32.7	x	x	31.6	x	30.8	x	x	31.35	34.45	x	x	x	x	33.6	x	x	32.9	x	32.95	34.7	x	34.35	
-12869	Original post publication description: Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old females [ratio]	None	Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old females [ratio]	x	x	3.572	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.616	3.523	x	x	x	x	x	x	x	x	x	x	3.488	3.278	x	x	x	3.39	3.932	x	x	x	3.1	3.461	x	3.495	3.564	x	x	x	4.18	x	3.465	x	x	x	x	3.735	3.486	x	x	4.184	x	3.532	x	x	3.464	2.688	x	x	x	x	3.011	x	x	2.938	x	2.991	3.655	x	4.229	
-12867	Original post publication description: Morphology, gastrointestinal system: Liver mass of 20-week old females [g]	None	Liver, morphology, gastrointestinal system: Liver mass of 20-week old females [g]	x	x	1.082	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.135	0.896	x	x	x	x	x	x	x	x	x	x	1.052	1.32	x	x	x	1.512	1.27	x	x	x	1.287	1.416	x	1.441	1.221	x	x	x	1.019	x	1.178	x	x	x	x	1.112	1.035	x	x	1.211	x	1.195	x	x	1.072	1.216	x	x	x	x	1.081	x	x	0.932	x	1.844	1.254	x	1.064	
-12865	Original post publication description: Morphology, metabolism: Body lean mass of 19-week old females [g]	None	Morphology, metabolism: Body lean mass of 19-week old females [g]	x	x	16.467	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.746	15.56	x	x	x	x	x	x	x	x	x	x	17.456	18.04	x	x	x	18.303	17.39	x	x	x	16.876	16.95	x	18.307	18.777	x	x	x	16.674	x	17.42	x	x	x	x	16.553	14.608	x	x	17.094	x	19.197	x	x	17.961	16.575	x	x	x	x	18.197	x	x	19.01	x	20.347	16.817	x	15.832	
-12863	Original post publication description: Cardiovascular system: Heart rate during echocardiography of 17-week old females [beat/min]	None	Cardiovascular system: Heart rate during echocardiography of 17-week old females [beat/min]	x	x	574.148	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	626.798	582.035	x	x	x	x	x	x	x	x	x	x	627.468	583.109	x	x	x	595.813	577.687	x	x	x	572.504	517.822	x	643.769	613.106	x	x	x	685.573	x	591.408	x	x	x	x	616.109	507.007	x	x	544.445	x	604.007	x	x	568.162	632.1	x	x	x	x	538.684	x	x	545.539	x	690.352	540.981	x	630.877	
-12861	Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 14-week old females [%]	None	Blood chemistry, cardiovascular system: Hematocrit of 14-week old females [%]	x	x	43.588	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	39.35	43.35	x	x	x	x	x	x	x	x	x	x	46.95	33.6	x	x	x	51.6	47.2	x	x	x	43.3	48.5	x	45.0	49.9	x	x	x	49.25	x	39.7	x	x	x	x	40.6	39.4	x	x	48.9	x	55.95	x	x	49.25	39.1	x	x	x	x	42.7	x	x	41.9	x	41.2	44.6	x	42.55	
-12855	Original post publication description: Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old females [mMl]	None	Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old females [mMl]	x	x	16.581	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	17.985	16.27	x	x	x	x	x	x	x	x	x	x	17.57	13.55	x	x	x	19.71	15.36	x	x	x	15.94	14.04	x	14.655	16.88	x	x	x	15.725	x	13.155	x	x	x	x	15.35	17.685	x	x	14.75	x	18.115	x	x	16.625	17.62	x	x	x	x	13.975	x	x	14.16	x	17.315	16.61	x	15.69	
-12853	Original post publication description: Cardiovascular system: Shortening fraction by echocardiography of 17-week old females [%]	None	Cardiovascular system: Shortening fraction by echocardiography of 17-week old females [%]	x	x	31.55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.05	31.65	x	x	x	x	x	x	x	x	x	x	31.8	29.9	x	x	x	39.1	33.5	x	x	x	34.95	30.25	x	26.75	30.0	x	x	x	29.5	x	42.6	x	x	x	x	38.9	33.65	x	x	32.55	x	31.25	x	x	32.45	33.6	x	x	x	x	34.6	x	x	31.7	x	33.5	31.25	x	35.2	
-12851	Original post publication description: Cardiovascular system: Ejection Fraction by echocardiography of 17-week old females [%]	None	Cardiovascular system: Ejection fraction by echocardiography of 17-week old females [%]	x	x	66.313	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	68.4	66.55	x	x	x	x	x	x	x	x	x	x	66.65	63.95	x	x	x	76.15	68.5	x	x	x	70.65	64.75	x	59.5	63.0	x	x	x	62.75	x	78.9	x	x	x	x	75.9	69.4	x	x	67.45	x	66.0	x	x	67.8	69.5	x	x	x	x	70.6	x	x	74.7	x	69.0	65.75	x	71.35	
-12849	Original post publication description: Morphology, metabolism: Body fat mass percentage of 19-week old females [%]	None	Morphology, metabolism: Body fat mass percentage of 19-week old females [%]	x	x	14.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.74	21.68	x	x	x	x	x	x	x	x	x	x	12.62	13.605	x	x	x	16.645	15.885	x	x	x	16.35	19.21	x	17.095	17.515	x	x	x	16.04	x	13.44	x	x	x	x	18.28	15.045	x	x	12.09	x	16.675	x	x	16.89	21.82	x	x	x	x	14.34	x	x	14.37	x	14.07	15.62	x	17.71	
-12847	Original post publication description: Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old females [mm]	None	Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old females [mm]	x	x	3.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.97	3.685	x	x	x	x	x	x	x	x	x	x	3.685	3.795	x	x	x	3.62	3.91	x	x	x	3.44	3.865	x	3.845	3.95	x	x	x	3.9	x	3.76	x	x	x	x	3.83	3.69	x	x	4.15	x	3.865	x	x	3.83	3.585	x	x	x	x	3.65	x	x	3.76	x	3.83	3.655	x	4.115	
-12845	Original post publication description: Blood chemistry: Chloride of 14-week old females [mM]	None	Blood chemistry: Chloride of 14-week old females [mM]	x	x	118.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	114.0	113.0	x	x	x	x	x	x	x	x	x	x	115.5	112.0	x	x	x	112.0	x	x	x	x	116.5	x	x	x	x	x	x	x	x	x	115.0	x	x	x	x	112.0	110.5	x	x	115.0	x	x	x	x	115.5	114.0	x	x	x	x	113.0	x	x	115.0	x	x	116.5	x	118.5	
-12843	Original post publication description: Morphology: Body weight of 20-week old females at necropsy [g]	None	Musculoskeletal system, morphology: Body weight of 20-week old females at necropsy [g]	x	x	20.805	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.647	19.476	x	x	x	x	x	x	x	x	x	x	21.581	22.171	x	x	x	24.865	20.385	x	x	x	22.507	20.781	x	22.993	22.759	x	x	x	20.221	x	22.541	x	x	x	x	21.597	18.467	x	x	20.71	x	20.393	x	x	22.122	23.613	x	x	x	x	21.772	x	x	18.745	x	24.014	22.353	x	19.766	
-12841	Original post publication description: Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old females [g]	None	Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old females [g]	x	x	21.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.6	21.25	x	x	x	x	x	x	x	x	x	x	22.95	22.55	x	x	x	23.65	21.4	x	x	x	22.3	21.4	x	22.95	23.4	x	x	x	20.35	x	21.8	x	x	x	x	23.1	19.6	x	x	20.9	x	23.65	x	x	23.25	24.45	x	x	x	x	23.25	x	x	24.4	x	24.8	21.55	x	20.6	
-12835	Original post publication description: Morphology: Body weight of 16-week old females [g]	None	Musculoskeletal system, morphology: Body weight of 16-week old females [g]	x	x	19.688	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.65	21.8	x	x	x	x	x	x	x	x	x	x	21.4	22.9	x	x	x	21.75	19.5	x	x	x	21.45	18.8	x	21.25	22.8	x	x	x	18.05	x	21.1	x	x	x	x	21.5	19.35	x	x	20.3	x	21.65	x	x	22.85	23.65	x	x	x	x	22.5	x	x	22.0	x	22.9	21.35	x	19.4	
-12831	Original post publication description: Cardiovascular system: Blood pressure by tail cuff system of 16-week old females [mmHg]	None	Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old females [mmHg]	x	x	98.863	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	95.02	110.996	x	x	x	x	x	x	x	x	x	x	101.924	103.788	x	x	x	99.494	96.503	x	x	x	104.532	95.544	x	93.53	92.879	x	x	x	108.771	x	105.771	x	x	x	x	90.971	80.291	x	x	89.234	x	108.246	x	x	123.23	101.578	x	x	x	x	107.024	x	x	94.463	x	95.515	100.702	x	115.071	
-12829	Original post publication description: Musculoskeletal system, metabolism: Bone mineral density by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g/cm2]	None	Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g/cm2]	x	x	0.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.054	x	x	x	x	x	x	x	x	x	x	x	0.054	x	x	x	0.055	0.053	x	x	x	0.05	0.047	x	0.049	0.052	x	x	x	0.048	x	0.054	x	x	x	x	x	x	x	x	0.047	x	0.049	x	x	0.048	x	x	x	x	x	0.055	x	x	0.055	x	0.054	0.053	x	0.047	
-12827	Original post publication description: Morphology, metabolism: Brown adipose tissue mass of 20-week old females [g]	None	Morphology, metabolism: Brown adipose tissue mass of 20-week old females [g]	x	x	0.088	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.1	0.089	x	x	x	x	x	x	x	x	x	x	0.053	0.093	x	x	x	0.105	0.161	x	x	x	0.142	0.189	x	0.143	0.17	x	x	x	0.163	x	0.118	x	x	x	x	0.089	0.074	x	x	0.126	x	0.137	x	x	0.09	0.068	x	x	x	x	0.145	x	x	0.066	x	0.091	0.129	x	0.12	
-12825	Original post publication description: Blood chemistry: Aspartate transaminase of 14-week old females [U/l]	None	Blood chemistry: Aspartate transaminase of 14-week old females [U/l]	x	x	86.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	60.5	90.0	x	x	x	x	x	x	x	x	x	x	49.0	83.0	x	x	x	55.0	152.0	x	x	x	56.5	74.0	x	126.0	158.5	x	x	x	91.0	x	64.0	x	x	x	x	133.0	149.0	x	x	44.5	x	61.0	x	x	63.5	67.5	x	x	x	x	55.0	x	x	65.0	x	72.0	68.5	x	63.0	
-12823	Original post publication description: Blood chemistry: Albumin of 14-week old females [g/l]	None	Blood chemistry: Albumin of 14-week old females [g/l]	x	x	30.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.0	27.5	x	x	x	x	x	x	x	x	x	x	29.0	29.0	x	x	x	29.0	x	x	x	x	30.0	x	x	x	x	x	x	x	x	x	25.5	x	x	x	x	29.0	27.5	x	x	27.0	x	x	x	x	29.0	30.5	x	x	x	x	30.0	x	x	30.0	x	x	25.5	x	28.0	
-12821	Original post publication description: Blood chemistry: Alpha-amylase of 14-week old females [U/l]	None	Blood chemistry: Alpha-amylase of 14-week old females [U/l]	x	x	554.167	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	593.5	492.0	x	x	x	x	x	x	x	x	x	x	531.0	518.0	x	x	x	577.0	x	x	x	x	455.5	x	x	x	x	x	x	x	x	x	380.5	x	x	x	x	723.0	489.5	x	x	383.5	x	x	x	x	635.0	516.0	x	x	x	x	500.5	x	x	514.0	x	x	413.5	x	557.0	
-12973	Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 5)	Boon-Webby Trait 5	Infectious disease, immune system: Interferon alpha (IFNa) cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]	x	378.0	185.0	1024.0	x	x	x	716.0	x	982.0	x	537.0	494.0	868.0	x	x	279.0	x	x	x	703.0	x	x	x	x	844.0	495.0	x	x	368.0	616.0	x	x	x	x	x	x	x	x	x	x	349.0	789.0	353.0	x	x	748.0	x	844.0	186.0	x	x	x	397.0	248.0	x	x	x	652.0	411.0	651.0	545.0	x	418.0	159.0	514.0	230.0	635.0	274.0	127.0	x	594.0	x	501.0	x	x	x	x	199.0	x	x	x	623.0	199.0	677.0	628.0	x	482.0	x	x	394.0	x	x	x	531.0	x	525.0	358.0	412.0	x	x	x	
-12972	Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 4)	None	Infectious disease, immune system: MCP1 cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]	x	2597.0	1982.0	8270.0	x	x	x	3880.0	x	4147.0	x	5609.0	6128.0	4365.0	x	x	2064.0	x	x	x	5453.0	x	x	x	x	6068.0	2945.0	x	x	2143.0	4504.0	x	x	x	x	x	x	x	x	x	x	1548.0	4632.0	3341.0	x	x	3503.0	x	3961.0	1147.0	x	x	x	2744.0	2195.0	x	x	x	2637.0	2181.0	5063.0	3343.0	x	2554.0	1611.0	1703.0	1845.0	5081.0	2040.0	728.0	x	4125.0	x	2523.0	x	x	x	x	2360.0	x	x	1005.0	4348.0	1173.0	2986.0	3081.0	x	2668.0	x	x	1503.0	x	x	x	2364.0	x	2024.0	3098.0	1627.0	x	x	x	
-12970	Original post publication description: 3a,5a-THP_CIE Ethanol vapor, from plasma entered at February/03/2011	Endocrinology, pharmacology: 3a,5a-THP_CIE Ethanol vapor, from plasma entered at February/03/2011	Endocrinology, blood chemistry, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3a,5a-tetrahydroprogesterone (THP, allopregnanolone) in plasma 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [units]	53.0	x	177.171	x	x	x	290.2	x	x	x	x	198.3	x	205.1	x	125.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	404.2	x	x	x	x	75.5	x	x	x	x	x	x	x	x	x	x	83.9	x	x	x	x	31.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	172.2	x	x	19.1	x	x	59.95	5.8	x	92.7	x	49.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	66.5	126.4	241.9	46.2	
-13057	Original post publication description: Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg] Original pre publication description: Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg]	Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg]	Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg]	164.889	x	152.86	211.403	214.75	224.42	x	141.63	254.64	151.78	176.38	209.33	x	159.97	x	x	x	146.31	x	x	x	122.99	x	162.85	132.4	141.85	x	x	x	128.61	164.54	144.26	194.76	x	131.94	x	202.23	158.18	161.11	x	x	143.11	136.13	166.91	x	x	155.39	x	182.2	197.63	x	x	x	205.12	236.08	x	x	x	164.07	166.01	152.17	140.12	198.08	176.3	149.79	x	180.84	177.67	173.13	144.14	x	144.37	x	181.0	x	293.0	x	x	159.66	x	x	156.09	204.62	134.86	152.71	148.74	x	172.72	193.81	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12753	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model, wildtype cases only [cm]	None	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model, wildtype cases only [cm]	x	4458.0	5917.1	x	x	3979.1	6354.7	5134.2	x	4402.9	3526.4	5251.2	x	5204.3	x	x	5363.0	x	5829.1	x	4066.2	x	x	x	x	x	3718.0	x	x	3622.3	x	x	4555.8	x	x	x	x	4224.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12754	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [cm]	None	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [cm]	x	4229.0	3165.7	x	x	3603.3	3121.9	4617.1	x	3132.7	3673.0	4501.9	x	3571.5	x	x	5016.2	x	2634.5	x	2975.0	x	x	x	x	x	2909.9	x	x	3121.8	x	x	3298.4	x	x	x	x	3484.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12755	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	94.8	53.5	x	x	90.5	49.1	89.9	x	71.1	104.1	83.6	x	68.6	x	x	93.5	x	45.1	x	73.2	x	x	x	x	x	78.2	x	x	86.1	x	x	72.4	x	x	x	x	82.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12756	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [n vertical beam breaks]	None	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [n vertical beam breaks]	x	466.7	430.2	x	x	422.2	426.4	436.7	x	408.2	265.2	453.0	x	378.1	x	x	496.5	x	411.5	x	424.6	x	x	x	x	x	357.8	x	x	327.1	x	x	419.7	x	x	x	x	342.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12757	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks]	None	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks]	x	294.0	105.7	x	x	195.2	115.5	171.0	x	254.7	243.3	190.7	x	112.0	x	x	235.4	x	104.3	x	177.6	x	x	x	x	x	138.3	x	x	218.9	x	x	177.2	x	x	x	x	150.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12758	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	62.9	24.5	x	x	46.2	27.0	39.1	x	62.3	91.7	42.0	x	29.7	x	x	47.4	x	25.3	x	41.8	x	x	x	x	x	38.6	x	x	66.9	x	x	42.2	x	x	x	x	44.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12759	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	None	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	x	214.6	206.4	x	x	216.1	188.8	211.2	x	191.1	267.9	240.0	x	221.2	x	x	218.4	x	242.2	x	170.7	x	x	x	x	x	175.9	x	x	177.4	x	x	202.2	x	x	x	x	208.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12760	Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in the open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio]	None	Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in the open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio]	x	0.15	0.275	x	x	0.246	0.319	0.234	x	0.175	0.19	0.273	x	0.28	x	x	0.248	x	0.235	x	0.244	x	x	x	x	x	0.217	x	x	0.184	x	x	0.225	x	x	x	x	0.294	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12761	Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 mutant cases only [ratio]	None	Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 mutant cases only [ratio]	x	0.136	0.244	x	x	0.232	0.245	0.225	x	0.184	0.18	0.223	x	0.3	x	x	0.241	x	0.241	x	0.178	x	x	x	x	x	0.185	x	x	0.243	x	x	0.217	x	x	x	x	0.193	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12762	Original post publication description: Central nervous system, behavior: Anxiety (center-distance ratio) in open-field (OFA) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% of WT]	None	Central nervous system, behavior: Anxiety (center-distance ratio) in open-field (OFA) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% of WT]	x	90.6	88.7	x	x	94.3	76.8	96.1	x	105.1	94.7	81.6	x	107.1	x	x	97.1	x	102.5	x	72.9	x	x	x	x	x	85.2	x	x	132.6	x	x	96.4	x	x	x	x	65.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12763	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	None	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	x	61.2	131.1	x	x	100.9	111.2	122.7	x	95.1	155.0	142.0	x	88.3	x	x	95.6	x	131.1	x	95.0	x	x	x	x	x	80.6	x	x	97.2	x	x	110.9	x	x	x	x	87.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12764	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	28.5	63.5	x	x	46.6	58.8	58.0	x	49.7	57.8	59.1	x	39.9	x	x	43.7	x	54.1	x	55.6	x	x	x	x	x	45.8	x	x	54.7	x	x	54.8	x	x	x	x	41.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12765	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [gm]	None	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [gm]	x	24.76	21.5	x	x	25.21	22.2	22.2	x	24.18	20.8	21.4	x	22.99	x	x	24.31	x	21.1	x	21.6	x	x	x	x	x	23.5	x	x	25.7	x	x	23.88	x	x	x	x	25.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12766	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, R6/2 cases only [gm]	None	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, R6/2 cases only [gm]	x	25.37	19.0	x	x	23.62	19.6	19.5	x	24.18	19.7	20.3	x	21.04	x	x	22.0	x	19.8	x	20.6	x	x	x	x	x	22.1	x	x	24.0	x	x	22.03	x	x	x	x	25.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12767	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% wildtype]	None	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% wildtype]	x	102.4	88.3	x	x	93.6	88.2	87.8	x	99.9	94.7	94.8	x	91.5	x	x	90.4	x	93.8	x	95.3	x	x	x	x	x	94.0	x	x	93.3	x	x	92.2	x	x	x	x	97.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12768	Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [arbitrary units]	None	Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [arbitrary units]	x	187.4	1254.4	x	x	197.6	864.8	320.2	x	157.8	469.3	434.6	x	606.1	x	x	571.8	x	661.4	x	203.0	x	x	x	x	x	556.3	x	x	1447.4	x	x	177.9	x	x	x	x	470.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12769	Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [arbitrary units]	None	Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [arbitrary units]	x	189.7	1076.4	x	x	234.7	876.2	291.2	x	143.6	272.4	614.2	x	810.4	x	x	691.3	x	1212.9	x	293.3	x	x	x	x	x	463.3	x	x	794.0	x	x	257.6	x	x	x	x	242.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12770	Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model mouse [% of WT]	None	Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model mouse [% of WT]	x	101.2	85.8	x	x	118.7	101.3	90.9	x	91.0	58.0	141.3	x	133.7	x	x	120.8	x	183.3	x	144.4	x	x	x	x	x	83.2	x	x	54.8	x	x	144.8	x	x	x	x	51.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12771	Original post publication description: Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition for 4, 8, and 12 dB above background in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [%]	None	Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition for 4, 8, and 12 dB above background in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [%]	x	38.5	13.5	x	x	37.9	22.4	36.8	x	27.8	43.1	17.0	x	17.5	x	x	47.3	x	28.5	x	37.0	x	x	x	x	x	30.1	x	x	21.9	x	x	37.5	x	x	x	x	52.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12772	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [%]	None	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [%]	x	21.6	1.4	x	x	19.8	4.4	15.5	x	18.5	22.4	11.5	x	6.1	x	x	8.3	x	22.3	x	16.8	x	x	x	x	x	4.9	x	x	6.5	x	x	21.1	x	x	x	x	22.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12773	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode (all R6/2 hybrids, including the B6-R6/2 and F1-R6/2 had less PPI than wildtype) [% of WT PPI%]	x	56.1	10.3	x	x	52.2	19.6	42.1	x	66.5	51.9	67.6	x	34.8	x	x	17.5	x	78.2	x	45.4	x	x	x	x	x	16.2	x	x	29.6	x	x	56.2	x	x	x	x	42.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12774	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	x	13.0	7.4	x	x	10.4	8.5	9.4	x	14.0	17.9	5.0	x	8.3	x	x	8.6	x	9.9	x	9.5	x	x	x	x	x	12.9	x	x	6.0	x	x	21.0	x	x	x	x	11.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12775	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	x	36.0	25.2	x	x	27.7	26.3	24.7	x	20.4	22.5	9.9	x	17.6	x	x	26.8	x	19.2	x	19.2	x	x	x	x	x	28.1	x	x	21.0	x	x	56.1	x	x	x	x	29.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12776	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	x	211.8	147.8	x	x	81.3	228.2	135.6	x	225.7	227.0	227.0	x	192.7	x	x	167.1	x	196.0	x	157.1	x	x	x	x	x	149.8	x	x	272.0	x	x	221.6	x	x	x	x	205.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12777	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	x	127.7	78.9	x	x	108.7	177.1	94.1	x	132.9	117.8	56.5	x	139.2	x	x	143.4	x	192.7	x	97.6	x	x	x	x	x	145.1	x	x	159.5	x	x	107.6	x	x	x	x	105.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12778	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]	x	201.1	263.5	x	x	228.1	274.5	230.4	x	292.6	283.1	129.7	x	249.9	x	x	212.4	x	283.0	x	211.2	x	x	x	x	x	278.2	x	x	198.1	x	x	224.9	x	x	x	x	250.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12779	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	x	223.7	197.8	x	x	121.9	292.1	168.3	x	209.7	235.5	132.7	x	203.3	x	x	240.5	x	240.3	x	166.7	x	x	x	x	x	235.9	x	x	191.1	x	x	179.7	x	x	x	x	225.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12879	Original post publication description: Metabolism: Body temperature (rectal) of 13-week old females [deg C]	None	Metabolism: Body temperature (rectal) of 13-week old females [deg C]	x	x	37.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	37.15	38.45	x	x	x	x	x	x	x	x	x	x	37.65	38.55	x	x	x	36.6	36.95	x	x	x	37.1	37.65	x	36.5	37.25	x	x	x	36.3	x	37.75	x	x	x	x	37.6	37.0	x	x	37.4	x	36.6	x	x	37.2	37.55	x	x	x	x	38.25	x	x	38.4	x	37.25	36.8	x	37.1	
-12780	Original post publication description: Cau_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid (DOPAC) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	68.54	x	78.53	32.63	x	x	98.94	x	x	x	x	x	x	97.47	x	110.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	54.22	x	x	x	x	102.28	x	x	x	47.92	x	46.39	x	x	x	80.02	44.82	x	x	x	x	108.55	x	x	x	x	x	x	177.65	x	x	x	87.13	x	x	x	x	39.31	x	x	41.19	193.1	x	101.32	x	x	80.16	42.03	x	114.23	x	105.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	145.15	177.44	63.23	
-12781	Original post publication description: Cau_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine (NE) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	18.44	x	19.94	24.81	x	x	13.34	x	x	x	x	x	x	20.11	x	46.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.57	x	x	x	x	22.88	x	x	x	22.17	x	18.92	x	x	x	14.02	7.8	x	x	x	x	15.07	x	x	x	x	x	x	17.99	x	x	x	21.19	x	x	x	x	21.32	x	x	15.48	45.92	x	13.32	x	x	15.97	19.04	x	14.26	x	47.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.83	14.74	19.27	
-12782	Original post publication description: Cau_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), dopamine (DA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	1001.9	x	533.72	175.01	x	x	304.86	x	x	x	x	x	x	255.54	x	355.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	618.94	x	x	x	x	664.63	x	x	x	475.23	x	186.15	x	x	x	342.13	445.71	x	x	x	x	870.19	x	x	x	x	x	x	450.07	x	x	x	632.73	x	x	x	x	284.95	x	x	264.0	841.8	x	309.54	x	x	647.63	401.66	x	386.26	x	476.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	453.11	956.68	130.22	
-12783	Original post publication description: Cau_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxyindoleacetic acid (5-HIAA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	30.18	x	23.55	28.37	x	x	21.45	x	x	x	x	x	x	33.25	x	25.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.06	x	x	x	x	20.09	x	x	x	12.17	x	15.6	x	x	x	11.5	9.31	x	x	x	x	26.86	x	x	x	x	x	x	21.59	x	x	x	37.79	x	x	x	x	29.4	x	x	20.15	36.59	x	11.9	x	x	28.91	25.59	x	16.3	x	36.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.35	30.07	22.68	
-12784	Original post publication description: Cau_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	87.68	x	60.9	21.15	x	x	45.89	x	x	x	x	x	x	32.85	x	42.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	46.26	x	x	x	x	65.02	x	x	x	53.36	x	17.43	x	x	x	45.5	30.92	x	x	x	x	92.1	x	x	x	x	x	x	63.86	x	x	x	69.71	x	x	x	x	24.18	x	x	26.69	90.35	x	36.81	x	x	48.55	34.65	x	42.26	x	49.49	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	42.35	84.4	24.54	
-12785	Original post publication description: Cau_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	35.47	x	17.54	8.95	x	x	6.41	x	x	x	x	x	x	4.56	x	16.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.63	x	x	x	x	19.77	x	x	x	14.0	x	13.68	x	x	x	8.83	8.49	x	x	x	x	26.67	x	x	x	x	x	x	8.02	x	x	x	3.66	x	x	x	x	39.43	x	x	12.32	37.55	x	0.0	x	x	28.73	23.78	x	13.62	x	53.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.32	19.74	12.14	
-12786	Original post publication description: Cau_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	20.85	x	16.25	27.3	x	x	21.39	x	x	x	x	13.14	x	16.3	x	23.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	17.53	x	x	x	x	x	x	x	x	20.91	x	21.4	x	x	x	14.08	10.1	x	x	x	x	19.95	x	x	x	x	x	x	12.05	x	x	x	19.53	x	x	x	x	13.55	x	x	19.77	39.31	x	9.64	x	x	19.13	18.58	x	20.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.76	10.34	22.32	
-12787	Original post publication description: Cau_C_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	68.82	x	58.74	58.36	x	x	125.86	x	x	x	x	119.71	x	116.11	x	107.83	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	135.84	x	x	x	x	x	x	x	x	94.3	x	59.19	x	x	x	91.05	37.69	x	x	x	x	67.09	x	x	x	x	x	x	55.1	x	x	x	54.54	x	x	x	x	125.19	x	x	59.74	205.66	x	61.87	x	x	19.67	27.5	x	73.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	117.2	36.47	99.66	
-12788	Original post publication description: Cau_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid (5-HIAA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid (5-HIAA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	29.86	x	18.29	31.98	x	x	20.18	x	x	x	x	13.59	x	28.98	x	14.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.54	x	x	x	x	x	x	x	x	13.14	x	16.24	x	x	x	14.37	11.59	x	x	x	x	25.92	x	x	x	x	x	x	11.98	x	x	x	32.09	x	x	x	x	34.77	x	x	31.85	70.27	x	11.44	x	x	17.63	28.94	x	15.11	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	29.82	17.73	16.23	
-12789	Original post publication description: Cau_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, homovanilic acid (HVA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, homovanilic acid (HVA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	61.07	x	51.45	65.02	x	x	62.22	x	x	x	x	42.21	x	65.04	x	31.97	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	58.66	x	x	x	x	x	x	x	x	75.14	x	36.06	x	x	x	40.0	13.45	x	x	x	x	46.81	x	x	x	x	x	x	52.21	x	x	x	33.4	x	x	x	x	77.66	x	x	50.97	64.25	x	31.2	x	x	12.75	17.07	x	51.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	69.44	24.47	30.64	
-12790	Original post publication description: Cau_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	26.25	x	16.88	18.28	x	x	9.04	x	x	x	x	11.72	x	24.41	x	13.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.63	x	x	x	x	x	x	x	x	17.68	x	23.39	x	x	x	2.43	7.04	x	x	x	x	9.83	x	x	x	x	x	x	11.8	x	x	x	34.18	x	x	x	x	52.13	x	x	4.97	32.16	x	10.08	x	x	6.57	7.04	x	28.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.48	15.0	14.11	
-12791	Original post publication description: Sep_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine levels (NE) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	69.16	x	22.65	19.02	x	x	31.35	x	x	x	x	19.17	x	12.84	x	6.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	85.53	x	x	x	x	43.56	x	x	x	22.0	x	11.08	x	x	x	33.48	32.51	x	x	x	x	38.64	x	x	x	x	x	x	8.38	x	x	x	68.45	x	x	x	x	3.7	x	x	10.3	76.58	x	16.12	x	x	42.53	23.09	x	22.26	x	13.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	39.97	28.68	45.26	10.28	
-12792	Original post publication description: Sep_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid levels (DOPAC) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	177.84	x	136.19	114.84	x	x	132.54	x	x	x	x	138.65	x	120.61	x	133.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	262.46	x	x	x	x	136.78	x	x	x	134.36	x	135.53	x	x	x	98.72	97.52	x	x	x	x	213.6	x	x	x	x	x	x	151.43	x	x	x	194.23	x	x	x	x	55.19	x	x	35.28	199.09	x	177.89	x	x	117.27	141.36	x	148.77	x	150.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.05	104.19	126.01	85.79	
-12793	Original post publication description: Sep_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Sep_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	962.92	x	361.51	75.32	x	x	364.41	x	x	x	x	289.96	x	218.18	x	246.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	399.37	x	x	x	x	307.01	x	x	x	268.03	x	204.67	x	x	x	314.78	175.27	x	x	x	x	602.02	x	x	x	x	x	x	335.55	x	x	x	291.29	x	x	x	x	81.36	x	x	33.45	367.61	x	359.99	x	x	123.44	314.76	x	351.07	x	91.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.5	252.08	168.55	244.21	
-12794	Original post publication description: Sep_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxyindoleacetic acid levels (5-HIAA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	47.48	x	54.49	34.24	x	x	79.32	x	x	x	x	41.44	x	41.53	x	38.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	61.81	x	x	x	x	56.05	x	x	x	67.13	x	39.24	x	x	x	43.65	37.94	x	x	x	x	61.65	x	x	x	x	x	x	40.95	x	x	x	51.89	x	x	x	x	24.42	x	x	36.49	84.31	x	49.33	x	x	63.68	51.77	x	79.03	x	71.61	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.69	51.07	65.58	44.26	
-12795	Original post publication description: Sep_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	None	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	74.81	x	56.16	30.89	x	x	59.28	x	x	x	x	41.56	x	36.82	x	38.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	62.96	x	x	x	x	43.01	x	x	x	62.78	x	33.47	x	x	x	43.61	34.68	x	x	x	x	91.75	x	x	x	x	x	x	59.35	x	x	x	67.63	x	x	x	x	11.64	x	x	24.85	50.52	x	48.2	x	x	36.48	40.41	x	38.64	x	34.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.46	44.76	44.75	28.53	
-12796	Original post publication description: Sep_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Sep_E_5HT [ng/mg]	Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	87.27	x	89.05	58.08	x	x	133.45	x	x	x	x	82.37	x	74.81	x	66.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	72.2	x	x	x	x	84.47	x	x	x	94.45	x	70.28	x	x	x	86.09	72.32	x	x	x	x	59.18	x	x	x	x	x	x	74.52	x	x	x	62.53	x	x	x	x	52.59	x	x	39.98	112.69	x	66.88	x	x	50.57	82.1	x	100.86	x	62.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	75.44	38.64	91.04	72.17	
-12797	Original post publication description: Sep_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	12.24	x	26.97	18.32	x	x	18.22	x	x	x	x	4.87	x	60.64	x	34.72	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.12	x	x	x	x	x	x	x	x	68.14	x	71.6	x	x	x	12.43	11.1	x	x	x	x	9.08	x	x	x	x	x	x	16.85	x	x	x	14.65	x	x	x	x	96.66	x	x	7.2	13.58	x	105.33	x	x	3.65	6.72	x	11.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	59.67	0.0	7.91	78.66	
-12798	Original post publication description: Dopac concentration in medial septum of air control for CIE 72 hr after 4th cycle [ng/mg]	Central nervous system, pharmacology: Ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC, a dopamine metabolite) in the medial septal nucleus 72 h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 15 to 17 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC, a dopamine metabolite) in the medial septal nucleus 72 h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 15 to 17 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	158.98	x	120.12	67.93	x	x	154.02	x	x	x	x	77.93	x	264.98	x	85.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	215.57	x	x	x	x	x	x	x	x	151.13	x	167.74	x	x	x	169.25	159.44	x	x	x	x	201.25	x	x	x	x	x	x	110.46	x	x	x	112.46	x	x	x	x	179.04	x	x	268.9	105.51	x	145.91	x	x	92.45	139.38	x	208.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	159.87	142.9	95.24	145.67	
-12799	Original post publication description: Sep_C_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	114.28	x	387.37	228.09	x	x	285.57	x	x	x	x	227.09	x	382.73	x	126.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	406.16	x	x	x	x	x	x	x	x	597.8	x	309.11	x	x	x	312.26	287.59	x	x	x	x	187.29	x	x	x	x	x	x	166.8	x	x	x	53.52	x	x	x	x	508.64	x	x	441.07	529.12	x	322.19	x	x	158.59	181.78	x	656.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	224.13	227.14	188.12	402.34	
-12800	Original post publication description: Sep_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in the medial septal nucleus 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in the medial septal nucleus 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	69.53	x	41.31	29.18	x	x	68.96	x	x	x	x	20.84	x	62.82	x	29.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	66.37	x	x	x	x	x	x	x	x	58.38	x	46.7	x	x	x	47.59	36.84	x	x	x	x	54.94	x	x	x	x	x	x	61.22	x	x	x	64.4	x	x	x	x	61.27	x	x	62.0	47.24	x	16.77	x	x	43.52	41.69	x	53.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	101.16	31.93	43.2	56.67	
-12801	Original post publication description: Sep_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	56.61	x	49.98	27.36	x	x	55.06	x	x	x	x	29.88	x	72.41	x	27.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	58.51	x	x	x	x	x	x	x	x	73.75	x	42.33	x	x	x	47.61	41.52	x	x	x	x	63.65	x	x	x	x	x	x	51.78	x	x	x	36.43	x	x	x	x	53.25	x	x	52.25	37.49	x	47.07	x	x	27.54	30.47	x	50.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	50.02	37.92	37.95	40.77	
-12802	Original post publication description: Sep_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	70.58	x	81.17	88.93	x	x	118.15	x	x	x	x	55.09	x	84.73	x	63.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	76.46	x	x	x	x	x	x	x	x	106.12	x	59.15	x	x	x	59.12	80.87	x	x	x	x	83.99	x	x	x	x	x	x	100.07	x	x	x	32.67	x	x	x	x	99.01	x	x	59.6	147.79	x	69.74	x	x	35.17	54.13	x	87.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	130.72	48.22	49.19	136.28	
-12803	Original post publication description: BrS_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (chronic intermittent vapor exposure CIE), norepinephrine (NE) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (chronic intermittent vapor exposure CIE), norepinephrine (NE) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	102.49	x	122.39	98.7	x	x	121.27	x	x	x	x	104.54	x	90.58	x	141.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	121.64	x	x	x	x	115.68	x	x	x	123.82	x	148.83	x	x	x	86.45	143.47	x	x	x	x	106.18	x	x	x	x	x	x	143.8	x	x	x	153.16	x	x	x	x	65.65	x	x	45.48	154.64	x	91.94	x	x	105.88	97.34	x	105.4	x	129.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	112.85	94.47	76.67	142.59	
-12804	Original post publication description: BrS_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	BrS_E_Dopac [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	7.12	x	6.74	8.7	x	x	7.66	x	x	x	x	6.81	x	6.17	x	8.71	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.07	x	x	x	x	9.34	x	x	x	8.68	x	9.76	x	x	x	7.31	11.47	x	x	x	x	8.38	x	x	x	x	x	x	7.85	x	x	x	10.06	x	x	x	x	8.9	x	x	9.42	10.3	x	8.88	x	x	8.71	10.8	x	9.24	x	6.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.03	11.09	8.5	11.98	
-12805	Original post publication description: BrS_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), dopamine level in hindbrain tissue 72h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), dopamine level in hindbrain tissue 72h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	10.51	x	9.68	14.49	x	x	8.75	x	x	x	x	9.78	x	10.29	x	9.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.19	x	x	x	x	13.3	x	x	x	10.45	x	12.82	x	x	x	6.27	14.81	x	x	x	x	10.57	x	x	x	x	x	x	9.2	x	x	x	17.58	x	x	x	x	8.01	x	x	10.72	14.07	x	12.6	x	x	12.61	12.49	x	20.44	x	8.68	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.23	12.01	11.92	16.41	
-12806	Original post publication description: BrS_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	94.55	x	74.22	72.07	x	x	83.12	x	x	x	x	52.25	x	69.53	x	75.55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	47.84	x	x	x	x	103.61	x	x	x	102.26	x	91.29	x	x	x	85.24	97.84	x	x	x	x	81.01	x	x	x	x	x	x	46.17	x	x	x	108.95	x	x	x	x	112.91	x	x	46.73	88.76	x	67.19	x	x	86.89	41.95	x	58.98	x	81.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	73.94	63.47	109.91	114.17	
-12807	Original post publication description: BrS_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), homovanillic (HVA) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), homovanillic (HVA) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	21.06	x	13.67	15.13	x	x	17.33	x	x	x	x	22.58	x	21.44	x	13.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	10.9	x	x	x	x	21.18	x	x	x	18.49	x	19.82	x	x	x	12.54	24.22	x	x	x	x	18.38	x	x	x	x	x	x	14.86	x	x	x	8.93	x	x	x	x	17.67	x	x	11.94	21.04	x	19.49	x	x	18.21	4.97	x	10.13	x	13.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.33	17.94	17.1	23.04	
-12808	Original post publication description: BrS_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Ethanol response, 5-hydroxytrptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Ethanol response, 5-hydroxytrptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	100.37	x	79.53	88.06	x	x	28.34	x	x	x	x	31.1	x	85.5	x	35.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	117.62	x	x	x	x	45.38	x	x	x	42.15	x	61.69	x	x	x	23.24	34.68	x	x	x	x	95.88	x	x	x	x	x	x	36.16	x	x	x	136.59	x	x	x	x	85.5	x	x	59.0	52.92	x	36.12	x	x	125.83	112.25	x	36.78	x	117.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.03	95.8	106.65	60.09	
-12809	Original post publication description: BrS_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	122.77	x	137.7	106.39	x	x	129.77	x	x	x	x	121.16	x	91.65	x	172.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	119.07	x	x	x	x	x	x	x	x	131.95	x	144.37	x	x	x	96.5	141.96	x	x	x	x	121.63	x	x	x	x	x	x	142.87	x	x	x	119.34	x	x	x	x	106.09	x	x	46.96	162.2	x	85.95	x	x	105.67	131.81	x	131.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	109.48	82.16	0.0	136.92	
-12810	Original post publication description: BrS_C_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	8.64	x	6.46	8.93	x	x	8.74	x	x	x	x	8.12	x	5.65	x	8.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.62	x	x	x	x	x	x	x	x	6.43	x	8.82	x	x	x	6.19	10.72	x	x	x	x	6.95	x	x	x	x	x	x	10.49	x	x	x	7.1	x	x	x	x	8.35	x	x	8.38	10.35	x	6.78	x	x	5.89	8.13	x	7.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.16	6.17	6.37	9.42	
-12811	Original post publication description: BrS_C_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, dopamine levels (DA) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, dopamine levels (DA) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	11.69	x	12.4	12.08	x	x	13.89	x	x	x	x	12.26	x	7.88	x	8.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.66	x	x	x	x	x	x	x	x	9.16	x	14.6	x	x	x	8.55	15.93	x	x	x	x	10.04	x	x	x	x	x	x	13.87	x	x	x	11.81	x	x	x	x	14.48	x	x	7.55	15.62	x	5.95	x	x	12.45	12.93	x	7.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.3	9.52	9.16	14.3	
-12812	Original post publication description: BrS_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	50.28	x	60.33	109.84	x	x	99.72	x	x	x	x	71.71	x	78.16	x	81.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	95.84	x	x	x	x	x	x	x	x	78.81	x	89.63	x	x	x	72.59	109.06	x	x	x	x	97.2	x	x	x	x	x	x	145.33	x	x	x	96.19	x	x	x	x	124.76	x	x	46.19	107.17	x	81.21	x	x	100.79	94.16	x	52.56	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	68.08	31.21	32.86	108.14	
-12813	Original post publication description: BrS_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA, a dopamine metabolite) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA, a dopamine metabolite) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	10.5	x	16.27	24.55	x	x	19.59	x	x	x	x	35.72	x	21.63	x	15.56	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.61	x	x	x	x	x	x	x	x	12.91	x	19.88	x	x	x	18.97	25.67	x	x	x	x	22.4	x	x	x	x	x	x	26.94	x	x	x	17.02	x	x	x	x	21.83	x	x	5.45	25.58	x	10.27	x	x	18.7	22.77	x	11.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	17.63	4.56	5.9	23.21	
-12814	Original post publication description: BrS_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]	107.61	x	73.1	79.95	x	x	41.17	x	x	x	x	45.07	x	94.52	x	47.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	100.52	x	x	x	x	x	x	x	x	40.53	x	57.49	x	x	x	26.65	43.57	x	x	x	x	117.0	x	x	x	x	x	x	44.53	x	x	x	89.41	x	x	x	x	132.29	x	x	36.59	60.97	x	34.39	x	x	120.65	98.7	x	32.19	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	34.14	76.81	86.31	41.74	
-12815	Original post publication description: Cau_C_DA[ng/mg] entered at January/05 11:10:32 from IP 128.172.53.136	Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]	587.93	x	471.75	133.58	x	x	437.56	x	x	x	x	392.16	x	673.49	x	290.26	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	727.0	x	x	x	x	x	x	x	x	687.97	x	361.97	x	x	x	197.25	146.89	x	x	x	x	419.51	x	x	x	x	x	x	488.49	x	x	x	235.08	x	x	x	x	841.35	x	x	573.63	447.73	x	458.24	x	x	131.03	112.08	x	564.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	789.0	245.93	354.25	
-12816	Original post publication description: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE). Expressed as percent change from baseline intake prior to CIE.	Central nervous system, pharmacology: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE) [% from baseline]	Central nervous system, pharmacology: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE) [% from baseline]	-53.92	x	22.033	-19.345	x	x	3.1	x	x	x	x	9.42	x	-28.61	x	-71.22	x	-6.82	x	x	x	x	x	x	x	x	x	x	x	x	-14.05	x	6.62	x	-14.81	x	x	-48.49	x	x	x	-50.57	x	-55.84	x	x	x	14.29	-20.23	50.26	x	x	x	68.58	x	x	x	x	x	x	52.91	x	-4.68	x	59.34	x	x	22.31	x	13.84	x	-29.05	-9.82	-11.335	x	-30.98	x	x	6.585	1.42	x	130.6	-7.22	-9.725	x	x	x	-6.13	x	x	x	x	x	x	x	x	x	-26.05	-48.1	-19.37	-42.93	-25.65	
-12817	Original post publication description: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 4 of chronic intermittent Ethanol vapor (CIE). Average of 5 days ethanol intake [g/kg/2h]. CIE_T4_Etgkgave.	None	Central nervous system, pharmacology, behavior: Ethanol response, ethanol consumption using a 2-bottle choice with 2 h access/day from day 3 to day 8 after the fourth cycle of treatment in a chronic intermittent ethanol vapor chamber (CIE) [g/kg/2h/day]	0.793	x	3.685	2.451	x	x	2.645	x	x	x	x	1.853	x	0.882	x	1.597	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.225	x	x	x	x	1.369	x	x	x	0.936	x	1.431	x	x	x	3.792	2.4	x	x	x	x	3.652	x	x	x	x	x	x	2.397	x	x	x	2.285	x	x	x	x	1.777	x	x	1.566	2.185	x	2.712	x	x	1.692	4.472	x	1.657	x	1.271	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.467	1.723	1.444	1.038	
-12819	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-weeK-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-weeK-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	60.2	53.3	x	x	133.7	77.6	69.3	x	58.8	51.8	82.6	x	72.2	x	x	85.8	x	98.3	x	62.1	x	x	x	x	x	96.8	x	x	58.6	x	x	48.5	x	x	x	x	51.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-12820	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	None	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	111.2	75.0	x	x	53.4	106.4	73.0	x	71.6	83.1	102.6	x	81.3	x	x	113.2	x	84.9	x	78.9	x	x	x	x	x	84.7	x	x	96.4	x	x	79.9	x	x	x	x	89.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13018	Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, all three experiments averaged (not in Table 4) [area under curve]	None	Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, all three experiments averaged (not in Table 4) [area under curve]	x	x	13.0	28.5	24.415	32.165	x	12.735	x	x	32.375	21.13	x	24.355	13.375	x	8.0	x	x	7.5	x	15.0	25.46	x	7.5	33.9	9.83	4.5	24.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13019	Original post publication description: Central nervous system, endocrinology: 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g].	None	Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]	50.7	x	39.417	12.9	x	x	48.9	x	x	x	x	14.6	x	11.7	x	5.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.1	x	x	x	x	5.5	x	x	x	5.7	x	x	x	x	x	10.7	11.8	x	x	x	x	50.2	x	x	x	x	x	x	23.5	x	x	x	2.7	x	x	x	x	42.3	x	x	9.2	20.0	x	2.6	x	x	43.15	14.9	x	38.9	x	62.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	41.0	45.1	56.4	38.1	
-13020	Original post publication description: Central nervous system, endocrinology: 3a,5a-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g].	None	Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]	5.2	x	243.9	12.8	x	x	153.7	x	x	x	x	125.2	x	192.0	x	82.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	160.0	x	x	x	x	79.75	x	x	x	131.0	x	x	x	x	x	52.7	43.8	x	x	x	x	22.95	x	x	x	x	x	x	154.1	x	x	x	27.6	x	x	x	x	68.3	x	x	294.4	14.85	x	169.1	x	x	107.65	62.9	x	81.2	x	17.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	94.4	308.8	75.6	32.0	
-13021	Original post publication description: Central nervous system, endocrinology: 3a,5b-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g].	None	Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	78.3	x	x	x	x	167.5	x	x	x	x	x	x	540.8	x	x	x	x	x	x	x	x	277.1	x	x	x	314.9	x	x	x	x	x	x	x	x	x	140.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13022	Original post publication description: Central nervous system, endocrinology: 3a,5a-Androsterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g].	None	Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-androsterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]	31.4	x	29.717	70.8	x	x	41.4	x	x	x	x	136.4	x	93.6	x	95.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	41.7	x	x	x	x	77.2	x	x	x	71.3	x	x	x	x	x	75.2	37.2	x	x	x	x	26.25	x	x	x	x	x	x	52.3	x	x	x	42.6	x	x	x	x	32.7	x	x	x	34.2	x	34.8	x	x	28.3	38.0	x	44.7	x	28.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	29.6	36.3	37.1	
-13023	Original post publication description: Central nervous system, endocrinology: Corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [ng/g].	None	Endocrinology, blood chemistry: Ethanol response (CIE), corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor chamber treatment [ng/g]	39.6	x	101.058	39.0	x	x	49.7	x	x	x	x	93.2	x	31.3	x	25.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	46.2	x	x	x	x	31.753	x	x	x	93.7	x	34.1	x	x	x	69.6	56.4	x	x	x	x	281.737	x	x	x	x	x	x	214.0	x	x	x	39.5	x	x	x	x	190.3	x	x	62.6	212.182	x	154.7	x	x	140.27	90.8	x	56.8	x	122.683	x	x	x	x	x	x	x	x	x	x	x	x	x	x	100.8	166.1	57.6	49.5	
-13024	Original post publication description: Central nervous system, endocrinology: Corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [ng/g].	None	Endocrinology, blood chemistry: Control for ethanol response, corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [ng/g]	383.5	x	102.632	63.7	x	x	53.1	x	x	x	x	26.4	x	41.3	x	45.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.6	x	x	x	x	x	x	x	x	112.9	x	57.9	x	x	x	108.0	540.9	x	x	x	x	299.1	x	x	x	x	x	x	495.6	x	x	x	154.8	x	x	x	x	190.7	x	x	77.1	76.5	x	54.3	x	x	74.6	249.2	x	95.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	92.6	128.1	117.2	71.8	
-13025	Original post publication description: Central nervous system, endocrinology: 3a,5a-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g].	None	Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-THP (3a-hydroxy-5a-pregnan-20-one) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]	66.1	x	109.3	x	x	x	343.2	x	x	x	x	187.6	x	133.8	x	226.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	106.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	26.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	158.6	x	x	24.8	x	x	114.5	161.8	x	117.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	124.3	94.5	51.3	49.4	
-13026	Original post publication description: Central nervous system, endocrinology: 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g].	None	Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]	78.9	x	37.967	32.3	x	x	39.6	x	x	x	x	25.3	x	17.5	x	15.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	99.7	x	x	x	x	x	x	x	x	4.9	x	1.6	x	x	x	11.6	x	x	x	x	x	52.8	x	x	x	x	x	x	x	x	x	x	6.5	x	x	x	x	52.6	x	x	4.8	6.4	x	3.6	x	x	55.9	3.3	x	42.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	42.6	38.7	45.5	40.6	
-13027	Original post publication description: Central nervous system, endocrinology: 3a,5a-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g].	None	Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]	x	x	169.76	81.3	x	x	152.6	x	x	x	x	127.6	x	251.6	x	634.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	470.4	x	x	x	x	x	x	x	x	115.8	x	126.2	x	x	x	26.7	x	x	x	x	x	21.9	x	x	x	x	x	x	x	x	x	x	217.8	x	x	x	x	56.8	x	x	258.6	4.1	x	156.0	x	x	9.1	353.0	x	135.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	97.1	155.7	58.8	9.2	
-13028	Original post publication description: Central nervous system, endocrinology: 3a,5b-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g].	None	Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]	814.2	x	x	69.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	43.1	x	x	x	x	x	204.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	563.4	x	x	x	29.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13029	Original post publication description: Central nervous system, endocrinology: 3a,5a-Androsterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g].	None	Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-androsterone in blood plasma 3 days after 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [pg/g]	62.7	x	30.029	36.1	x	x	x	x	x	x	x	39.3	x	56.7	x	453.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	55.9	x	x	x	x	x	x	x	x	54.5	x	51.3	x	x	x	34.3	x	x	x	x	x	21.5	x	x	x	x	x	x	x	x	x	x	36.9	x	x	x	x	30.2	x	x	51.6	32.6	x	39.8	x	x	31.9	51.9	x	36.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	28.7	25.0	31.6	
-13030	VGX hepatocytes [n +/- 2x via]	Liver, metabolism, toxicology: CQ-0	Liver, metabolism, toxicology: Vials of hepatocyte obtained per strain from first run of spring 2011 by Piedmont and Varigenix, one vial of approximately 1 million cells (the error term is 2 times the percentage of non-viable cells) [n]	x	x	80.0	75.0	88.0	x	74.0	73.0	19.0	x	61.0	x	76.0	x	70.0	85.0	44.0	92.0	70.0	42.0	73.0	x	x	x	x	64.0	x	60.0	x	74.0	74.0	x	53.0	x	x	x	76.0	65.0	75.0	x	42.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13034	Original post publication description: Transthyretin protein serum band (prealbumin, Pre locus) detected by acylamide electrophoresis in adult males [a-genotype of DBA/2J with band is coded as 1, o-genotype without band is coded as -1]	None	Hematology: Transthyretin protein serum band (prealbumin, Pre locus) detected by acylamide electrophoresis in adult males [a-genotype of DBA/2J with band is coded as 1, o-genotype without band is coded as -1]	x	x	-1.0	1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	1.0	-1.0	-1.0	-1.0	1.0	1.0	-1.0	1.0	1.0	-1.0	-1.0	-1.0	x	1.0	1.0	1.0	1.0	-1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13031	Original post publication description: Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment for age, sex, body weight, and brain minus hippocampus weight.	None	Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment for age, sex, body weight, and brain minus hippocampus weight.	x	x	27.4	26.4	27.5	25.8	25.2	28.3	26.5	25.1	25.9	25.7	25.5	26.7	25.8	27.1	25.8	28.1	26.0	25.9	24.0	24.7	x	23.8	24.8	25.6	24.9	24.8	23.9	24.7	23.5	27.4	25.0	27.3	27.6	25.1	28.5	26.7	30.8	x	27.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13032	Original post publication description: Gastrointestinal system, biochemistry: electrophoretic band variant of Lap-1 protein (ANPEP) that maps to proximal Chr 9 (this is not the Anpep locus, but is a possible trans-effect) [-1 band present, 1 band absent]	None	Gastrointestinal system, biochemistry: electrophoretic band variant of Lap-1 protein (ANPEP) that maps to proximal Chr 9 (this is not the Anpep locus, but is a possible trans-effect) [-1 band present, 1 band absent]	x	x	-1.0	1.0	-1.0	1.0	-1.0	1.0	1.0	1.0	1.0	1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	-1.0	1.0	1.0	x	x	1.0	1.0	-1.0	-1.0	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13033	Original post publication description: BXD epoch batch trait 4 [-1 = Taylor BXD series BXD1 to 30, 0 = BXD31 and higher]	None	Genetics, statistics, cofactors: BXD epoch batch trait 4 [-1 = Taylor BXD series BXD1 to 30, 0 = BXD31 and higher]	x	x	x	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	x	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	x	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	
-13037	Original post publication description: Liver function, hepatocyte phase I metabolic activity measured by 7-ethoxycoumarin-O-deethylase (ECOD) consumption at 0 and 30 minutes (25 uM/sample) using cryorederived hepatocytes from young adult male liver [ECOD pmol/million cells/min] Original pre publication description: CQ-1	Liver, metabolism, toxicology: CQ-1	Liver, metabolism, toxicology: Hepatocyte phase I (CYP1A) metabolic activity measured by 7-ethoxycoumarin-o-deethylase (ECOD, 7EC) consumption at 0 and 30 minutes (25 uM/sample) using cryorederived hepatocytes from young adult male liver (BXD31 winsorized from 1394 to 1250) [ECOD pmol/million cells/min]	x	x	465.0	589.0	736.0	854.0	791.0	787.0	x	x	676.0	x	1079.0	325.0	1081.0	432.0	548.0	407.0	x	631.0	1046.0	x	x	x	x	488.0	466.0	573.0	x	1250.0	724.0	x	x	x	x	x	967.0	644.0	659.0	x	357.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13038	Original post publication description: Liver function: hepatocyte metabolic activity measured by production of 7-hydroxycoumarin glucouronide at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [pmol/million cells/min] Original pre publication description: CQ-2	Liver, metabolism, toxicology: CQ-2	Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity (7HC, glucuronidation and sulfation) measured by production of 7-hydroxycoumarin glucouronide at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver (BXD15 and BXD13 winsorized from 4125 and 4485 to 3300 and 3500) [7-HCG pmol/million cells/min]	x	x	2526.0	2085.0	2929.0	1614.0	1255.0	1687.0	x	x	2040.0	x	3500.0	2016.0	3300.0	795.0	1852.0	1551.0	x	2877.0	1789.0	x	x	x	x	2613.0	1103.0	2400.0	x	2319.0	2662.0	x	x	x	x	x	1280.0	3103.0	2208.0	x	1552.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13040	Original post publication description: Liver function: Hepatocyte viability, fraction of viable cells after rederivation relative to viable cells immediately after isolation , data from first run of spring 2011 by Piedmont and Varigenix [ratio] Original pre publication description: CQ-4	Liver, metabolism, toxicology: CQ-4	Liver, metabolism, toxicology: Hepatocyte viability, fraction of viable cells after rederivation relative to viable cells immediately after isolation in suspension (data from first run of spring 2011 by Piedmont and Varigenix) [ratio]	x	x	1.02	0.98	1.0	0.99	0.95	0.96	x	x	0.94	x	0.92	0.95	0.96	0.92	0.97	0.94	x	0.95	0.96	x	x	x	x	0.94	1.01	1.0	x	0.97	0.91	x	x	x	x	x	0.94	0.97	0.98	x	0.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13042	Original post publication description: Liver function: Hepatocyte phase II metabolic activity measured by 7-HCS sulfation assay at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [7-HCS pmol/million cells/min] Original pre publication description: CQ-3	Liver, metabolism, toxicology: CQ-3	Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity measured by 7-HCS sulfation assay at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [7-HCS pmol/million cells/min]	x	x	87.0	71.0	123.0	67.0	84.0	133.0	x	x	180.0	x	281.0	100.0	154.0	71.0	96.0	102.0	x	98.0	191.0	x	x	x	x	119.0	164.0	101.0	x	96.0	100.0	x	x	x	x	x	131.0	119.0	174.0	x	69.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13043	Original post publication description: Infectious disease, immune function: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) [median CFU per lung 15 days after infection]	None	Infectious disease, immune system: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) in 7 to 12-week-old females, 10 per strain [log10 median CFU per lung 15 days after infection]	x	x	6.3	4.0	3.8	6.2	5.9	5.9	5.7	6.2	4.8	3.5	2.7	2.5	2.9	6.2	6.6	6.0	6.6	5.1	3.9	5.0	x	6.2	5.6	6.3	7.0	3.2	5.6	6.0	3.8	4.3	6.3	x	x	x	5.1	3.0	5.7	x	5.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13044	Original post publication description: Central nervous system, behavior, metabolism: Activity level (running wheel) in 3-4 month old females, average restriction day 2 and 3, 2-hour daily scheduled food restriction paradigm [revolutions/day] Original pre publication description: Kas01	Kas01	Central nervous system, behavior, metabolism: Body weight in 3-4 month old test naive females [g].	x	x	20.6	19.8	19.144	25.8	x	x	21.6	x	20.04	x	31.0	23.76	25.8	27.79	x	x	x	x	x	x	x	25.7	x	x	x	21.13	x	x	21.5	x	24.65	x	x	x	x	x	x	x	21.8	21.3	x	x	x	x	x	x	x	x	x	x	x	20.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.04	x	x	x	x	x	x	x	x	x	x	x	x	26.6	x	x	x	x	x	x	x	x	x	24.9	x	21.1	x	x	x	x	x	
-13045	Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of femur of 70 days old male mice Original pre publication description: BMD of femur of male mice	Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur of males (dual energy X-ray absorptiometry PIXImus) [mg/cm2]	Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur of males (dual energy X-ray absorptiometry PIXImus) [mg/cm2]	469.459	424.186	360.993	384.392	469.952	x	x	x	x	x	444.064	401.15	x	331.03	x	x	x	x	x	x	x	x	x	401.285	x	353.768	x	373.348	x	368.018	419.57	x	405.397	x	x	x	420.659	344.65	389.159	x	381.662	389.779	412.199	341.774	x	x	412.188	461.409	344.897	x	x	x	x	x	366.797	x	x	x	396.389	x	425.656	348.397	x	377.332	x	x	372.521	346.903	440.532	360.188	x	389.282	x	388.667	x	x	x	433.828	315.521	x	x	401.903	322.521	381.768	x	450.323	x	359.279	431.779	x	x	x	x	414.521	x	332.139	x	328.897	420.656	338.914	331.495	314.817	
-13046	Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of tibia of 70 days old male mice Original pre publication description: BMD of tibia of male mice	Musculoskeletal system, morphology, metabolism: Age adjusted bone mineral density (BMD) of tibia in adult males (dual energy X-ray absorptiometry DEXA using PIXIimus) [mg/cm2]	Musculoskeletal system, morphology, metabolism: Age adjusted bone mineral density (BMD) of tibia in adult males (dual energy X-ray absorptiometry DEXA using PIXIimus) [mg/cm2]	408.732	368.749	317.44	314.567	393.991	x	x	x	x	x	375.517	342.339	x	318.469	x	x	x	x	x	x	x	x	x	289.324	x	288.971	x	296.996	x	315.221	353.38	x	357.517	x	x	x	331.192	290.993	319.17	x	319.228	296.706	322.848	310.089	x	x	342.28	360.42	297.184	x	x	x	x	x	301.784	x	x	x	293.758	x	359.361	292.184	x	290.315	x	x	346.78	278.002	371.715	291.28	x	355.015	x	349.569	x	x	x	392.895	275.341	x	x	333.302	268.78	287.971	x	364.278	x	301.456	349.039	x	x	x	x	371.28	x	250.758	x	322.184	354.944	293.704	317.502	287.66	
-13047	Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of femur of 70 days old female mice Original pre publication description: BMD of femur of female mice	Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]	Musculoskeletal system, morphology, metabolism: Age adjusted one mineral density (BMD) of femur females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]	405.796	378.48	301.046	378.701	405.406	x	x	x	x	x	332.764	318.978	x	324.519	x	x	x	x	x	x	x	x	x	345.563	x	334.308	x	376.073	x	327.357	382.786	x	341.284	x	x	x	x	313.902	361.588	x	322.038	335.661	360.712	351.759	x	x	357.058	365.888	380.284	x	x	x	x	x	393.612	x	x	x	334.098	x	378.337	328.043	x	360.362	x	x	345.975	300.955	359.03	327.932	x	304.445	x	369.975	x	x	x	343.038	288.857	x	x	364.936	320.311	331.857	x	340.637	x	313.661	371.494	x	x	x	x	381.131	x	369.764	x	331.784	369.47	355.322	397.656	281.235	
-13048	Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of tibia of 70 days old female mice Original pre publication description: BMD of tibia of female mice	Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of tibia of females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]	Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of tibia females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]	339.49	317.175	255.989	315.869	337.221	x	x	x	x	x	300.314	248.783	x	289.757	x	x	x	x	x	x	x	x	x	293.166	x	278.682	x	287.221	x	232.451	313.157	x	291.797	x	x	x	x	253.86	290.218	x	298.115	274.373	288.403	279.412	x	x	282.932	276.218	314.297	x	x	x	x	x	283.603	x	x	x	263.606	x	304.988	295.188	x	259.435	x	x	318.349	265.74	297.65	302.092	x	267.936	x	324.349	x	x	x	284.048	247.451	x	x	330.007	262.625	292.951	x	252.988	x	269.373	298.706	x	x	x	x	328.349	x	309.939	x	296.297	315.321	284.679	323.346	238.527	
-13049	Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of femur of 70 days old male mice Original pre publication description: BMC of femur of male mice	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA PIXImus) [g hydroxyapatite]	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA PIXImus) [g hydroxyapatite]	0.018	0.014	0.012	0.01	0.017	x	x	x	x	x	0.015	0.013	x	0.01	x	x	x	x	x	x	x	x	x	0.011	x	0.01	x	0.012	x	0.011	0.013	x	0.013	x	x	x	0.014	0.01	0.009	x	0.011	0.012	0.013	0.008	x	x	0.014	0.014	0.009	x	x	x	x	x	0.011	x	x	x	0.013	x	0.016	0.01	x	0.011	x	x	0.01	0.008	0.013	0.01	x	0.012	x	0.011	x	x	x	0.016	0.007	x	x	0.014	0.006	0.012	x	0.014	x	0.01	0.016	x	x	x	x	0.013	x	0.011	x	0.007	0.016	0.008	0.013	0.008	
-13050	Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of tibia of 70 days old male mice Original pre publication description: BMC of tibia of male mice	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]	0.015	0.01	0.008	0.007	0.012	x	x	x	x	x	0.011	0.009	x	0.007	x	x	x	x	x	x	x	x	x	0.006	x	0.006	x	0.007	x	0.007	0.01	x	0.01	x	x	x	0.009	0.006	0.008	x	0.007	0.005	0.009	0.008	x	x	0.01	0.01	0.007	x	x	x	x	x	0.006	x	x	x	0.007	x	0.011	0.004	x	0.006	x	x	0.01	0.006	0.009	0.006	x	0.01	x	0.009	x	x	x	0.012	0.005	x	x	0.009	0.004	0.007	x	0.009	x	0.007	0.01	x	x	x	x	0.012	x	0.003	x	0.007	0.01	0.005	0.007	0.004	
-13051	Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of femur of 70 days old female mice entered at July/08 13:52:42 from IP 172.23.19.221 Original pre publication description: BMC of femur of female mice	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old females (dual energy X-ray absorptiometry PIXImus) [mg]	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old females (dual energy X-ray absorptiometry PIXImus) [mg]	0.013	0.009	0.008	0.01	0.012	x	x	x	x	x	0.008	0.008	x	0.008	x	x	x	x	x	x	x	x	x	0.009	x	0.009	x	0.01	x	x	0.011	x	0.009	x	x	x	x	0.005	0.007	x	0.01	0.007	0.01	0.009	x	x	0.009	0.011	0.011	x	x	x	x	x	0.012	x	x	x	0.006	x	0.011	0.008	x	0.01	x	x	0.009	0.005	0.01	0.008	x	0.007	x	0.009	x	x	x	0.008	0.005	x	x	0.011	0.008	0.009	x	0.008	x	0.009	0.011	x	x	x	x	0.011	x	0.01	x	0.006	0.012	0.01	0.008	0.004	
-13052	Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of tibia of 70 days old female mice Original pre publication description: BMC of tibia of female mice	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]	Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]	0.009	0.007	0.005	0.007	0.008	x	x	x	x	x	0.008	0.004	x	0.005	x	x	x	x	x	x	x	x	x	0.006	x	0.005	x	0.005	x	x	0.008	x	0.006	x	x	x	x	0.004	0.007	x	0.008	0.007	0.005	0.006	x	x	0.005	0.006	0.008	x	x	x	x	x	0.007	x	x	x	0.004	x	0.007	0.003	x	0.006	x	x	0.008	0.003	0.007	0.007	x	0.004	x	0.008	x	x	x	0.006	0.005	x	x	0.009	0.005	0.005	x	0.004	x	0.005	0.007	x	x	x	x	0.008	x	0.008	x	0.007	0.009	0.007	0.007	0.001	
-13053	Original post publication description: Musculoskeletal system, morphology: Area of femur of 70 days old male mice Original pre publication description: Area of femur of male mice	Musculoskeletal system, morphology: Surface area of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	Musculoskeletal system, morphology: Surface area of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	0.388	0.328	0.329	0.268	0.363	x	x	x	x	x	0.333	0.313	x	0.278	x	x	x	x	x	x	x	x	x	0.283	x	0.265	x	0.32	x	0.293	0.323	x	0.313	x	x	x	0.325	0.285	0.23	x	0.285	0.3	0.317	0.28	x	x	0.34	0.32	0.225	x	x	x	x	x	0.288	x	x	x	0.33	x	0.358	0.285	x	0.292	x	x	0.273	0.244	0.326	0.273	x	0.315	x	0.28	x	x	x	0.353	0.209	x	x	0.333	0.195	0.32	x	0.31	x	0.28	0.37	x	0.285	x	x	0.32	x	0.32	x	0.205	0.39	0.257	0.313	0.24	
-13054	Original post publication description: Musculoskeletal system, morphology: Area of tibia of 70 days old male mice Original pre publication description: Area of tibia of male mice	Musculoskeletal system, morphology: Surface area of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	Musculoskeletal system, morphology: Surface area of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	0.357	0.278	0.258	0.212	0.303	x	x	x	x	x	0.293	0.255	x	0.21	x	x	x	x	x	x	x	x	x	0.203	x	0.21	x	0.25	x	0.215	0.277	x	0.293	x	x	x	0.265	0.2	0.26	x	0.22	0.18	0.26	0.24	x	x	0.283	0.283	0.215	x	x	x	x	x	0.214	x	x	x	0.21	x	0.298	0.23	x	0.208	x	x	0.265	0.194	0.266	0.193	x	0.268	x	0.264	x	x	x	0.303	0.178	x	x	0.27	0.145	0.232	x	0.263	x	0.235	0.29	x	0.175	x	x	0.315	x	0.125	x	0.21	0.28	0.193	0.22	0.143	
-13055	Original post publication description: Musculoskeletal system, morphology: Area of femur of 70 days old female mice Original pre publication description: Area of femur of female mice	Musculoskeletal system, morphology: Surface area of femur of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	Musculoskeletal system, morphology: Surface area of femur of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	0.313	0.256	0.268	0.263	0.31	x	x	x	x	x	0.235	0.248	x	0.243	x	x	x	x	x	x	x	x	x	0.26	x	0.257	x	0.283	x	0.22	0.286	x	0.265	x	x	x	x	0.24	0.27	x	0.28	0.29	0.264	0.267	x	x	0.29	0.278	0.29	x	x	x	x	x	0.317	x	x	x	0.207	x	0.288	0.25	x	0.265	x	x	0.27	0.178	0.27	0.226	x	0.227	x	0.25	x	x	x	0.23	0.23	x	x	0.298	0.234	0.265	x	0.235	x	0.275	0.29	x	x	x	x	0.287	x	0.3	x	0.17	0.323	0.273	0.25	0.12	
-13056	Original post publication description: Musculoskeletal system, morphology: Area of tibia of 70 days old female mice Original pre publication description: Area of tibia of female mice	Musculoskeletal system, morphology: Surface area of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	Musculoskeletal system, morphology: Surface area of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]	0.273	0.227	0.188	0.218	0.255	x	x	x	x	x	0.24	0.173	x	0.173	x	x	x	x	x	x	x	x	x	0.217	x	0.197	x	0.187	x	0.21	0.238	x	0.21	x	x	x	x	0.153	0.215	x	0.24	0.23	0.178	0.21	x	x	0.17	0.196	0.25	x	x	x	x	x	0.218	x	x	x	0.153	x	0.223	0.133	x	0.215	x	x	0.247	0.118	0.216	0.213	x	0.17	x	0.24	x	x	x	0.218	0.125	x	x	0.265	0.166	0.15	x	0.145	x	0.185	0.24	x	x	x	x	0.25	x	0.247	x	0.225	0.27	0.25	0.223	0.06	
-13058	Original post publication description: Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg] Original pre publication description: Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg]	Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg]	Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg]	257.46	208.34	158.09	289.2	217.24	243.83	x	179.25	262.61	189.37	208.61	206.45	x	192.16	x	x	x	203.23	x	269.77	x	182.07	x	236.79	161.4	200.42	x	x	x	172.9	240.9	157.29	278.19	x	212.25	230.53	212.84	188.0	213.84	x	x	178.01	195.83	260.2	x	x	184.32	x	209.4	237.6	x	x	x	262.97	x	x	x	x	218.54	241.96	238.66	163.95	252.23	203.82	215.6	x	229.69	267.51	233.25	233.81	x	201.03	x	242.76	x	359.19	x	x	218.84	x	x	198.51	211.76	170.49	217.0	176.34	x	224.33	239.84	x	241.66	x	x	265.7	203.69	240.27	247.1	226.84	202.06	x	x	x	
-13059	Original post publication description: Skeletal system, morphology: Cortical tissue mineral density (TMD) of femur of 16-week-old females measured by microcomputed tomography (uCT) [mg/ml] Original pre publication description: Skeletal system, morphology: VDavid1	Musculoskeletal system, morphology: VDavid1.	Musculoskeletal system, morphology: Femur length (FL) of 12-week-old males measured by microcomputed tomography (µCT) [mm]	13.8	13.002	13.11	12.66	13.288	x	x	x	x	x	12.393	12.44	x	12.946	x	x	x	x	x	x	x	x	x	x	x	x	x	12.67	x	12.0	12.568	x	12.889	x	x	x	14.29	12.304	x	x	x	x	13.091	x	x	x	12.728	13.258	x	x	x	x	x	x	13.066	x	x	x	12.52	x	13.6	x	x	13.7	x	x	12.46	12.545	14.09	12.67	x	13.38	x	13.27	x	x	x	13.378	12.796	x	x	13.33	x	x	x	12.48	x	12.785	13.85	x	x	x	x	x	x	x	12.773	x	13.951	x	12.15	x	
-13060	Original post publication description: Central nervous system, morphology, stereology: Neuron number in cerebral neocortex of adults, unilateral (disector method) [millions] Original pre publication description: Cortex 1: Glenn Rosen	Cortex 1: Glenn Rosen	Central nervous system, morphology, stereology: Neuron number in cerebral neocortex of adults, bilateral (direct 3D counting method) [millions]	x	x	12.05	11.343	10.763	11.324	13.15	10.782	11.856	10.878	12.353	11.698	11.404	11.666	12.337	11.333	12.24	11.752	11.38	10.688	13.085	10.899	x	11.468	11.399	11.127	11.444	10.514	10.187	12.132	11.966	10.903	11.979	12.581	11.224	x	10.467	11.407	10.863	x	10.363	11.136	x	10.122	x	x	11.996	x	12.07	10.617	x	x	x	11.294	11.503	x	x	x	x	10.965	x	10.86	10.106	10.864	11.473	10.17	10.246	11.563	10.963	10.577	x	11.335	10.87	10.236	11.619	10.053	x	11.73	12.23	x	x	11.056	12.24	10.073	11.775	11.549	x	9.953	12.177	x	10.782	12.574	x	x	10.975	11.694	x	x	x	x	x	x	
-13061	Original post publication description: Central nervous system, morphology, stereology: Non-neuronal cell number in cerebral neocortex of adults, unilateral (disector method) [millions] Original pre publication description: Cortex 2: Glenn Rosen	Cortex 2: Glenn Rosen	Central nervous system, morphology, stereology: Non-neuronal cell number in cerebral neocortex of adults, bilateral (direct 3D counting method) [millions]	x	x	8.309	7.024	6.74	7.139	7.949	7.299	7.091	6.963	8.081	8.13	7.606	7.631	8.215	7.327	7.21	7.208	7.352	7.155	8.132	7.379	x	6.859	7.019	6.995	7.95	6.404	6.718	8.32	7.078	6.873	7.124	7.899	6.592	x	6.405	6.944	7.105	x	6.743	8.139	x	6.985	x	x	6.34	x	5.864	7.226	x	x	x	8.161	7.699	x	x	x	x	7.152	x	7.161	6.856	7.142	7.251	6.676	7.587	7.25	7.245	7.98	x	7.868	6.251	7.152	5.766	7.256	x	6.178	7.781	x	x	7.022	6.817	6.887	6.962	7.882	x	6.442	7.152	x	6.995	6.452	x	x	4.856	7.849	x	x	x	x	x	x	
-13062	Original post publication description: Central nervous system, morphology, stereology: Total cell number in cerebral neocortex of adults (neurons, glial cells, endothelial cells), unilateral (disector method) [millions] Original pre publication description: Cortex 3: Glenn Rosen	Cortex 3: Glenn Rosen	Central nervous system, morphology, stereology: Total cell number in cerebral neocortex of adults (neurons, glial cells, endothelial cells), bilateral (direct 3D counting method) [millions]	x	x	20.359	18.367	17.503	18.462	21.099	18.082	18.947	17.841	20.434	19.828	19.01	19.297	20.552	18.66	19.45	18.96	18.732	17.844	21.218	18.278	x	18.327	18.418	18.122	19.394	16.919	16.905	20.452	19.044	17.776	19.103	20.48	17.816	x	16.872	18.351	17.969	x	17.106	19.275	x	17.107	x	x	18.336	x	17.934	17.843	x	x	x	19.455	19.202	x	x	x	x	18.117	x	18.02	16.962	18.005	18.723	16.846	17.833	18.813	18.207	18.557	x	19.202	17.121	17.388	17.385	17.309	x	17.908	20.011	x	x	18.078	19.057	16.959	18.737	19.431	x	16.395	19.329	x	17.777	19.026	x	x	15.831	19.543	x	x	x	x	x	x	
-15178	Original post publication description: Trait 4 Original pre publication description: Trait 4	Trait 4	Reproduction, development: Trait 4, SCNT Blastocysts/ 4 cell; lathamk1@msu.edu	x	0.363	0.379	0.0	0.0	0.295	0.179	0.25	0.168	0.319	0.43	0.0	0.345	0.273	0.0	0.0	0.254	0.091	x	0.312	0.193	x	x	x	x	0.379	0.329	0.058	x	0.556	0.215	0.0	0.266	x	0.544	x	0.069	0.278	0.242	x	0.107	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15177	Original post publication description: Trait 3 Original pre publication description: Trait 3	Trait 3	Reproduction, development: Trait 3, SCNT Blastocysts/2 cell; lathamk1@msu.edu	x	0.274	0.209	0.0	0.0	0.076	0.119	0.012	0.068	0.045	0.275	0.0	0.165	0.057	0.0	0.0	0.104	0.046	x	0.045	0.11	x	x	x	x	0.237	0.087	0.01	x	0.052	0.08	0.0	0.139	x	0.175	x	0.043	0.012	0.161	x	0.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15176	Original post publication description: Trait 2 Original pre publication description: Trait 2, klatham@temple.edu	Reproduction, development: Trait 2 klatham@temple.edu	Reproduction, development: Trait 2, SCNT 4cell/2cell; lathamk1@msu.edu	x	0.66	0.536	0.43	0.0	0.205	0.523	0.012	0.281	0.15	0.642	0.153	0.539	0.174	0.04	0.152	0.421	0.497	x	0.147	0.545	x	x	x	x	0.59	0.298	0.107	x	0.073	0.506	0.0	0.489	x	0.372	x	0.458	0.03	0.66	x	0.392	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15175	Original post publication description: Trait1 entered at July/30 09:53:36 from IP 155.247.231.93 Original pre publication description: Trait 1, klatham@temple.edu	Reproduction, development: Trait 1, lathamk1@msu.edu	Reproduction, development: Trait 1, SCNT 2 cell/constructs; lathamk1@msu.edu	x	0.873	0.683	0.647	0.596	0.754	0.774	0.382	0.807	0.977	0.798	0.116	0.571	0.712	0.806	0.82	0.66	0.844	x	0.852	0.774	x	x	x	x	0.51	0.821	0.785	x	0.438	0.701	0.156	0.848	x	0.863	x	0.569	0.724	0.935	x	0.231	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14803	Original post publication description: Nicotine Place Preference Scores for 0.5mg/kg nicotine on Day 5 of CPP Original pre publication description: Nicotine Place Preference Scores for 0.5mg/kg nicotine on Day 5 of CPP	Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg nicotine), conditioned place preference (CPP) on day 5	Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec]	x	4.4	96.82	-140.42	75.94	51.28	88.65	x	-66.12	-36.37	-26.25	108.87	x	16.1	27.16	152.16	74.12	x	-5.14	12.27	x	x	x	x	x	131.882	57.62	x	x	-25.15	-146.61	63.23	22.2	x	-35.52	x	0.68	109.96	x	x	24.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14804	Original post publication description: Saline Place Preference Scores for 0.9% saline on Day 5 of CPP Original pre publication description: Saline Place Preference Scores for 0.9% saline on Day 5 of CPP	Central nervous system, pharmacology, behavior: Saline control response (3 days of 0.9% sc) for nicotine experiment, conditioned place preference (CPP) on day 5	Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, conditioned place preference (CPP) on day 5 in 7-8-week old males [sec]	x	x	47.25	-20.37	50.17	76.58	55.48	x	15.27	29.99	31.91	79.48	x	-0.29	20.69	61.51	22.92	x	51.73	34.93	x	x	x	x	x	43.586	36.03	x	x	80.23	90.8	61.64	72.4	x	15.1	x	23.32	98.67	x	x	7.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14805	Original post publication description: Nicotine Post-Conditioning Scores for 0.5mg/kg nicotine on Day 5 of CPP Original pre publication description: Nicotine Post-Conditioning Scores for 0.5mg/kg nicotine on Day 5 of CPP	Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg), post-conditioning conditioned place preference (CPP) scores on day 5 of conditioning [units]	Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4), post-conditioning scores on day 5 in 7-8-week old males [sec]	x	56.3	91.47	-203.74	77.74	68.24	5.46	x	20.66	-114.89	-37.58	124.87	x	22.84	-125.73	141.22	126.49	x	-57.71	16.9	x	x	x	x	x	34.832	42.3	x	x	-146.82	-128.21	64.6	24.32	x	-1.5	x	6.91	90.17	x	x	52.37	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14806	Original post publication description: Saline Post-Conditioning Scores for 0.9% saline on Day 5 of CPP Original pre publication description: Saline Post-Conditioning Scores for 0.9% saline on Day 5 of CPP	Post-Conditioning Scores for 0.9% saline on Day 5 of CPP	Post-Conditioning Scores for 0.9% saline on Day 5 of CPP	x	x	137.36	-41.56	87.0	-80.29	48.34	x	-60.83	-100.75	-62.75	-138.73	x	-29.4	49.88	-108.77	36.72	x	-92.52	61.95	x	x	x	x	x	-32.018	-151.41	x	x	-92.98	-35.55	-23.83	182.51	x	-6.81	x	-65.04	-15.73	x	x	-59.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14801	Original post publication description: Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13)	Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13)	Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals]	x	x	0.403	0.416	0.344	x	x	x	x	-0.207	-0.11	x	x	x	x	x	x	x	x	x	x	x	x	0.027	x	-0.618	x	0.11	x	x	x	x	x	x	x	x	0.906	x	x	x	0.221	-0.091	x	-0.269	x	x	-0.142	-0.05	-0.322	0.452	x	x	x	-0.093	0.208	x	x	x	0.082	-0.039	-0.077	0.207	x	-0.035	-0.093	0.107	-0.852	0.045	0.147	-0.203	x	-0.292	x	-0.128	x	-0.102	-0.785	-0.209	0.001	x	x	0.042	-0.101	0.073	0.115	x	x	0.231	0.425	x	0.152	x	x	x	0.418	x	0.064	0.145	-0.083	0.049	0.029	-0.127	
-14800	Original post publication description: Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1)	Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1)	Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals]	x	x	0.018	0.354	0.174	x	x	x	x	0.042	-0.078	x	x	x	x	x	x	x	x	x	x	x	x	0.261	x	-0.328	x	0.033	x	x	x	x	x	x	x	x	x	x	x	x	0.157	-0.205	x	-0.038	x	x	-0.105	-0.104	-0.123	0.072	x	x	x	-0.114	0.121	x	x	x	0.036	-0.116	-0.096	0.151	x	-0.017	-0.112	0.166	-0.384	0.098	-0.153	-0.048	x	0.063	x	-0.16	x	0.017	-0.371	-0.039	0.041	x	x	0.027	-0.01	0.218	0.225	x	x	0.045	0.014	x	0.093	x	x	x	0.201	x	-0.205	-0.033	-0.086	-0.094	0.033	0.03	
-14799	Original post publication description: Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp)	Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp), Chr8: 72.905142	Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals]	x	x	0.233	0.606	0.062	x	x	x	x	-0.391	-0.569	x	x	x	x	x	x	x	x	x	x	x	x	0.311	x	-0.306	x	0.412	x	x	x	x	x	x	x	x	x	x	x	x	-0.077	-0.726	x	0.32	x	x	-0.196	-0.656	-0.247	-0.232	x	x	x	-0.081	0.284	x	x	x	-0.128	-0.304	0.246	0.724	x	0.331	-0.304	0.818	-0.71	-0.025	-0.268	-0.097	x	-0.133	x	-0.39	x	0.152	-0.318	0.039	0.364	x	x	-0.195	-0.399	0.327	0.722	x	x	0.007	0.502	x	0.46	x	x	x	0.397	x	0.098	-0.118	-0.416	-0.308	-0.29	0.199	
-14797	Original post publication description: Musculoskeletal system: Hip cartilage aggrecan 1 (Agc1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] Original pre publication description: Musculoskeletal system: Hip cartilage aggrecan 1 (Agc1)	Musculoskeletal system: Hip cartilage aggrecan 1 (Acan)	Musculoskeletal system: Hip cartilage aggrecan 1 (Acan, Agc1, Chr7 at 86.2 Mb) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals]	x	x	-0.208	0.873	0.234	x	x	x	x	0.222	-0.426	x	x	x	x	x	x	x	x	x	x	x	x	0.728	x	-0.854	x	0.1	x	x	x	x	x	x	x	x	-0.079	x	x	x	0.101	-0.712	x	-0.096	x	x	-0.293	-0.969	-0.243	-0.309	x	x	x	-0.492	-0.029	x	x	x	-0.055	-0.317	0.227	0.681	x	0.264	-0.191	0.72	-0.864	-0.005	-0.428	-0.031	x	-0.123	x	-0.191	x	0.036	-0.972	-0.03	0.621	x	x	0.143	-0.26	0.42	0.52	x	x	0.272	0.528	x	0.372	x	x	x	0.46	x	-0.072	0.147	-0.439	-0.462	-0.253	0.514	
-14794	Original post publication description: Central nervous system, behavior, sleep: Sleep percent in 10-14 week-old males [% day] Original pre publication description: Central nervous system, behavior, sleep: Bruce 1, Contact Bruce O'Hara	Central nervous system, behavior, sleep: Bruce 1, Contact Bruce O'Hara	Central nervous system, behavior, sleep: Sleep percent in 10-14 week-old males [% day]	x	x	10.0	20.0	20.0	30.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14793	Original post publication description: Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	x	1485.5	1357.4	x	x	1741.5	1447.7	1420.1	x	1368.3	1337.0	1489.6	x	1458.6	x	x	1411.6	x	1527.7	x	1451.4	x	x	x	x	x	1482.7	x	x	1358.7	x	x	1447.2	x	x	x	x	1516.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14792	Original post publication description: Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	x	372.0	161.4	x	x	134.6	127.2	150.1	x	145.6	188.1	133.6	x	137.6	x	x	145.6	x	155.7	x	237.9	x	x	x	x	x	267.6	x	x	133.1	x	x	119.3	x	x	x	x	98.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14791	Original post publication description: Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	x	190.1	163.1	x	x	95.4	102.0	106.7	x	190.1	125.1	123.8	x	163.7	x	x	141.4	x	171.2	x	152.6	x	x	x	x	x	104.9	x	x	131.3	x	x	154.5	x	x	x	x	113.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14802	Original post publication description: Musculoskeletal system, dentition: Malocclusion of incisors in females on high and low fat diet [percent cases] Original pre publication description: Musculoskeletal system, dentition: Malocclusion of incisors in females on 60% high fat diet [percent cases]	Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in females on 60% high fat diet [% cases]	Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in females on 60% high fat diet [% cases]	x	x	x	x	x	x	x	x	x	0.0	0.0	50.0	33.3	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	x	x	x	100.0	x	x	x	x	x	x	x	100.0	x	x	x	0.0	75.0	x	0.0	x	x	25.0	100.0	x	x	100.0	x	x	0.0	100.0	x	x	0.0	x	x	x	0.0	x	0.0	x	0.0	0.0	60.0	x	0.0	0.0	x	33.3	x	x	x	0.0	x	50.0	x	x	x	100.0	0.0	
-14796	Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control] Original pre publication description: Liver, metabolism, toxicology: CQ-14b(Log2)	Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control]	Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control]	x	x	-0.934	0.701	0.302	-0.361	0.97	-0.04	x	x	0.307	x	0.98	-0.632	0.593	-0.463	-0.682	0.934	x	-0.633	-1.193	x	x	x	x	-0.614	-1.425	0.754	x	1.282	-0.186	x	x	x	x	x	-0.518	0.516	-0.596	x	-0.468	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14798	Original post publication description: Musculoskeletal system: Hip cartilage collagen, type II, alpha 1 (Col2a1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage collagen, type II alpha 1 (Col2a1)	Musculoskeletal system: Hip cartilage collagen, type II alpha 1 (Col2a1)	Musculoskeletal system: Hip cartilage collagen, type II, alpha 1 (Col2a1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals]	x	x	0.244	0.377	0.782	x	x	x	x	0.633	0.188	x	x	x	x	x	x	x	x	x	x	x	x	0.429	x	-0.298	x	0.64	x	x	x	x	x	x	x	x	-0.275	x	x	x	0.821	-0.202	x	-0.314	x	x	-0.15	0.113	0.065	0.139	x	x	x	-0.254	0.341	x	x	x	-0.478	-0.452	-0.067	0.972	x	0.31	-0.153	0.359	-1.185	-0.257	-0.308	-0.102	x	-0.706	x	-0.637	x	-0.428	-0.746	0.311	0.37	x	x	0.031	-0.655	0.264	0.828	x	x	-0.054	0.212	x	0.465	x	x	x	0.035	x	-0.145	0.798	0.186	0.206	-0.23	-0.151	
-14790	Original post publication description: un-named trait	Morphology, development, lung: Metzger 1	Morphology, development, lung: Metzger 1	0.0	0.0	1.0	0.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14789	Original post publication description: Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]	x	190.1	163.1	x	x	95.4	x	x	x	x	125.1	123.8	x	162.7	x	x	141.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14788	Original post publication description: Central nervous system, morphology:Midsagittal area of the corpus callosum corrected for shrinkage [mm2] Original pre publication description: Central nervous system, morphology: MSACC corrected for shrinkage [mm2]	Central nervous system, morphology: MSACC corrected for shrinkage [mm2]	Central nervous system, morphology:Midsagittal area of the corpus callosum corrected for shrinkage [mm2]	x	x	1.251	0.767	1.136	0.884	0.967	0.907	0.92	1.242	1.346	0.994	0.975	1.027	1.338	0.998	0.801	0.809	1.013	1.201	0.875	1.19	x	0.885	0.788	0.776	0.74	0.905	0.767	1.105	0.974	1.28	0.773	1.045	0.888	x	0.695	1.072	1.242	x	1.167	1.2	1.191	1.135	x	x	1.078	x	1.08	0.996	x	x	x	1.748	1.128	x	x	x	1.244	1.235	1.16	1.177	1.294	0.993	1.105	1.32	1.119	1.279	0.993	1.168	x	1.147	0.83	1.171	0.998	1.349	0.825	1.439	1.261	x	x	1.244	0.925	1.118	1.47	1.215	x	1.125	1.203	1.322	1.237	1.386	x	x	1.177	1.124	1.008	1.573	x	x	x	x	
-13346	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 100 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 100 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	382.208	307.731	715.778	192.722	755.056	269.952	260.45	755.262	214.943	x	x	x	725.781	420.837	212.783	132.163	x	x	x	x	x	65.3449	x	128.663	x	x	469.234	157.92	x	x	415.435	265.03	328.229	x	x	x	564.831	173.372	232.206	x	167.226	395.191	x	x	x	x	x	x	x	324.938	x	x	x	205.192	x	x	x	x	x	565.839	779.044	x	x	821.047	x	x	308.621	98.5673	x	x	x	112.399	x	145.904	x	x	x	x	x	x	x	x	x	x	145.5	295.366	x	x	327.841	x	x	x	x	x	919.682	1414.75	x	x	x	x	x	x	
-13347	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 105 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 105 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	441.519	400.113	925.86	281.122	1189.67	383.699	364.523	991.012	224.71	x	x	x	913.212	695.937	319.273	282.871	x	x	x	x	x	65.1949	x	280.743	x	x	552.576	323.508	x	x	568.935	426.465	416.247	x	x	x	588.431	329.131	266.576	x	235.696	461.684	x	x	x	x	x	x	x	647.43	x	x	x	263.979	x	x	x	x	x	637.903	959.98	x	x	984.797	x	x	410.298	169.155	x	x	x	157.806	x	239.784	x	x	x	x	x	x	x	x	x	x	152.409	502.957	x	x	457.414	x	x	x	x	x	1130.7	1619.9	x	x	x	x	x	x	
-13348	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 110 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 110 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	396.163	407.886	1091.17	378.0	1434.66	444.332	463.523	1139.57	272.563	x	x	x	1124.55	863.103	459.663	425.038	x	x	x	x	x	58.6699	x	523.383	x	x	684.919	670.633	x	x	597.96	559.037	372.811	x	x	x	560.948	349.489	323.206	x	243.696	624.316	x	x	x	x	x	x	x	710.672	x	x	x	279.142	x	x	x	x	x	754.384	1014.39	x	x	1160.4	x	x	571.752	305.305	x	x	x	267.045	x	276.874	x	x	x	x	x	x	x	x	x	x	176.745	696.741	x	x	510.159	x	x	x	x	x	1083.22	1764.63	x	x	x	x	x	x	
-13349	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 115 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 115 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	381.086	421.895	1199.87	344.622	1469.93	492.879	473.341	1135.33	343.457	x	x	x	1237.26	1063.55	550.233	546.138	x	x	x	x	x	78.0824	x	809.383	x	x	609.819	891.858	x	x	910.548	759.48	447.756	x	x	x	510.465	467.797	386.496	x	267.656	750.928	x	x	x	x	x	x	x	834.938	x	x	x	357.885	x	x	x	x	x	757.212	1096.24	x	x	1297.08	x	x	637.452	490.93	x	x	x	344.306	x	322.164	x	x	x	x	x	x	x	x	x	x	246.5	911.232	x	x	699.741	x	x	x	x	x	1156.02	1797.17	x	x	x	x	x	x	
-13350	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 120 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 120 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	377.626	429.34	1102.62	542.593	1563.14	558.821	539.614	1237.38	318.997	x	x	x	1201.9	1097.68	634.476	614.366	x	x	x	x	x	79.2866	x	811.679	x	x	709.572	1139.87	x	x	852.731	802.303	482.268	x	x	x	477.654	522.722	443.316	x	253.626	856.447	x	x	x	x	x	x	x	860.494	x	x	x	333.8	x	x	x	x	x	796.754	1191.14	x	x	1435.31	x	x	704.264	547.326	x	x	x	427.332	x	320.75	x	x	x	x	x	x	x	x	x	x	255.354	819.196	x	x	842.49	x	x	x	x	x	1219.68	1782.98	x	x	x	x	x	x	
-13351	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 65 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 65 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	-2.78095	3.44026	9.09647	0.911111	14.0096	-10.7147	5.57774	4.03674	-3.3566	x	x	x	21.9559	9.4034	-1.61714	0.021429	x	x	x	x	x	-6.8551	x	-0.147347	x	x	-0.523615	14.3202	x	x	2.2602	4.92959	7.61058	x	x	x	8.99796	0.539116	19.4559	x	-4.76429	-2.54681	x	x	x	x	x	x	x	14.8551	x	x	x	-1.97717	x	x	x	x	x	4.18442	0.152876	x	x	5.55493	x	x	15.7516	-0.032653	x	x	x	-0.508948	x	-1.82633	x	x	x	x	x	x	x	x	x	x	-2.57291	-0.967517	x	x	24.0503	x	x	x	x	x	-9.05935	12.3663	x	x	x	x	x	x	
-13352	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 70 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 70 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	18.4302	9.3948	5.07829	4.01111	13.0403	-3.75469	0.032282	13.6451	-3.60993	x	x	x	25.3746	21.4617	8.80286	-1.8869	x	x	x	x	x	7.9574	x	-3.01735	x	x	0.790671	1.79515	x	x	5.21645	7.67245	-1.3167	x	x	x	-10.8187	-1.26922	24.5359	x	-1.02429	0.596939	x	x	x	x	x	x	x	6.02177	x	x	x	6.77908	x	x	x	x	x	30.5481	-0.374397	x	x	7.95493	x	x	26.244	1.64235	x	x	x	-0.424333	x	-5.07633	x	x	x	x	x	x	x	x	x	x	-0.34564	3.65748	x	x	29.8321	x	x	x	x	x	-3.67602	12.583	x	x	x	x	x	x	
-13353	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 75 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 75 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	26.0968	32.0039	18.9328	1.46667	4.64804	10.4253	-3.82226	35.1867	0.370068	x	x	x	51.6934	24.0284	12.9029	2.60476	x	x	x	x	x	29.2324	x	-3.11735	x	x	16.7478	16.2827	x	x	18.6352	21.3224	16.3924	x	x	x	-6.56871	6.32245	20.8859	x	-7.18429	23.0719	x	x	x	x	x	x	x	21.7051	x	x	x	-0.027168	x	x	x	x	x	70.6844	14.7438	x	x	20.2133	x	x	34.0516	9.37985	x	x	x	1.99874	x	9.00367	x	x	x	x	x	x	x	x	x	x	17.5271	12.6325	x	x	42.4776	x	x	x	x	x	20.024	14.8163	x	x	x	x	x	x	
-13354	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 80 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 80 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	62.6857	52.813	37.8056	11.0556	12.5711	17.012	19.0414	102.453	2.1834	x	x	x	89.8434	25.8201	10.7129	-8.27024	x	x	x	x	x	27.2074	x	2.74265	x	x	17.9907	9.09515	x	x	17.3665	17.7939	25.3378	x	x	x	3.03129	19.5808	37.6059	x	-2.04429	59.5219	x	x	x	x	x	x	x	44.1218	x	x	x	0.847832	x	x	x	x	x	101.83	33.0711	x	x	55.2466	x	x	59.444	14.3423	x	x	x	6.29874	x	24.4737	x	x	x	x	x	x	x	x	x	x	19.3089	14.4158	x	x	57.0866	x	x	x	x	x	47.499	98.4997	x	x	x	x	x	x	
-13355	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 85 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 85 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	85.3079	78.2494	77.9419	31.5222	16.1019	54.2786	25.2414	244.353	29.8301	x	x	x	115.162	47.9951	28.0129	-11.0286	x	x	x	x	x	36.8949	x	-1.45735	x	x	23.505	15.7202	x	x	65.6165	60.7367	56.0288	x	x	x	16.0313	49.1058	81.0159	x	25.1857	82.1594	x	x	x	x	x	x	x	65.3134	x	x	x	13.7728	x	x	x	x	x	181.812	57.0529	x	x	146.872	x	x	104.813	19.7548	x	x	x	16.368	x	28.8037	x	x	x	x	x	x	x	x	x	x	61.2907	38.0075	x	x	88.4957	x	x	x	x	x	158.024	150.666	x	x	x	x	x	x	
-13356	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 90 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 90 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	192.752	197.304	216.042	63.2	72.048	55.2453	50.5959	427.112	72.7034	x	x	x	262.156	88.3034	74.0829	3.88809	x	x	x	x	x	48.1824	x	3.04265	x	x	96.7764	44.1702	x	x	100.173	100.565	124.265	x	x	x	82.2313	57.7225	134.886	x	99.2457	152.141	x	x	x	x	x	x	x	116.605	x	x	x	63.6103	x	x	x	x	x	266.03	226.017	x	x	390.663	x	x	180.09	35.4548	x	x	x	27.8218	x	68.1937	x	x	x	x	x	x	x	x	x	x	114.791	95.4492	x	x	165.505	x	x	x	x	x	344.382	428.416	x	x	x	x	x	x	
-13357	Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 95 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	None	Central nervous system, behavior: Acoustic startle response for males, 95 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]	283.397	243.595	436.015	143.111	214.202	140.852	169.123	640.045	127.03	x	x	x	473.8	194.345	115.133	26.8131	x	x	x	x	x	65.7074	x	18.7327	x	x	312.162	76.0077	x	x	209.548	169.18	242.438	x	x	x	176.981	122.422	176.276	x	135.436	266.047	x	x	x	x	x	x	x	241.872	x	x	x	133.435	x	x	x	x	x	446.366	470.098	x	x	617.622	x	x	268.359	73.9548	x	x	x	60.1526	x	88.2337	x	x	x	x	x	x	x	x	x	x	128.618	191.216	x	x	276.214	x	x	x	x	x	612.257	922.616	x	x	x	x	x	x	
-13358	Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 10 dB below startle threshold, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	None	Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 10 dB below startle threshold, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	65.9778	68.6224	54.6888	53.1348	x	79.1614	57.8942	x	80.4647	x	x	x	52.7166	52.9969	75.8969	60.1899	x	x	x	x	x	62.2352	x	68.3288	x	x	64.468	74.3049	x	x	60.246	61.6684	72.9968	x	x	x	50.1803	62.5145	63.0393	x	58.1836	78.0346	x	x	x	x	x	x	x	67.3539	x	x	x	79.8955	x	x	x	x	x	70.7585	52.169	x	x	74.792	x	x	82.1751	67.3598	x	x	x	82.5733	x	62.0206	x	x	x	x	x	x	x	x	x	x	70.8317	78.7242	x	x	58.1782	x	x	x	x	x	87.4171	x	x	x	x	x	x	x	
-13359	Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 65 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	None	Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 65 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	43.117	57.5775	32.6451	19.5275	x	55.162	28.4076	x	69.9467	x	x	x	39.4635	31.7891	33.4971	6.98185	x	x	x	x	x	45.5609	x	20.3974	x	x	30.5944	48.3531	x	x	11.8689	28.3759	55.5333	x	x	x	34.302	43.2264	45.6141	x	47.3866	57.8806	x	x	x	x	x	x	x	25.9346	x	x	x	61.9751	x	x	x	x	x	60.8657	30.9863	x	x	56.5985	x	x	62.5242	47.3231	x	x	x	43.4051	x	57.2907	x	x	x	x	x	x	x	x	x	x	52.184	59.8378	x	x	40.5147	x	x	x	x	x	45.9218	x	x	x	x	x	x	x	
-13360	Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 70 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	None	Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 70 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	56.5044	65.8379	46.2731	31.4974	x	58.5375	35.2957	x	74.976	x	x	x	49.3294	32.6946	53.8192	8.02341	x	x	x	x	x	23.1303	x	27.9424	x	x	33.4863	50.6034	x	x	22.5011	46.3026	60.3252	x	x	x	41.4239	46.7399	52.2273	x	51.0168	57.9787	x	x	x	x	x	x	x	33.5521	x	x	x	66.2089	x	x	x	x	x	65.3252	42.6441	x	x	58.3317	x	x	73.2073	53.5126	x	x	x	61.3865	x	62.9406	x	x	x	x	x	x	x	x	x	x	63.9713	68.4832	x	x	50.0048	x	x	x	x	x	63.7027	x	x	x	x	x	x	x	
-13361	Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 75 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	None	Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 75 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	75.2453	72.6888	46.8179	42.4904	x	79.8942	52.4181	x	76.6211	x	x	x	55.7052	40.2159	65.6251	13.4468	x	x	x	x	x	21.183	x	32.8933	x	x	48.1406	59.8987	x	x	36.2659	57.1702	74.0278	x	x	x	48.5587	58.6324	60.7314	x	68.7968	76.8194	x	x	x	x	x	x	x	44.2997	x	x	x	75.4393	x	x	x	x	x	78.6096	55.5403	x	x	67.2861	x	x	77.7321	62.5809	x	x	x	64.6551	x	69.3516	x	x	x	x	x	x	x	x	x	x	70.4359	70.2635	x	x	53.1137	x	x	x	x	x	80.7338	x	x	x	x	x	x	x	
-13362	Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 80 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	None	Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 80 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]	72.4039	66.4171	56.0335	40.9981	x	81.9604	51.3066	x	79.279	x	x	x	62.6147	52.7366	64.4486	11.7144	x	x	x	x	x	39.1047	x	45.0939	x	x	53.8586	59.7833	x	x	46.1477	60.2431	73.6666	x	x	x	45.0398	57.1598	50.2924	x	61.7846	78.5572	x	x	x	x	x	x	x	56.3207	x	x	x	77.9137	x	x	x	x	x	78.6219	58.4722	x	x	78.6582	x	x	80.3017	69.0673	x	x	x	68.3489	x	64.9978	x	x	x	x	x	x	x	x	x	x	66.2297	80.676	x	x	62.8885	x	x	x	x	x	83.8537	x	x	x	x	x	x	x	
-13363	Original post publication description: Central nervous system, behavior, cognition: Response accuracy, measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]	None	Central nervous system, behavior, cognition: Response accuracy, measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]	88.024	88.03	85.4002	84.0182	81.0886	77.2932	x	80.2533	x	88.8599	86.8307	x	83.6821	87.5787	81.5931	73.1448	x	78.6071	x	85.4253	x	84.7057	x	82.9782	x	81.595	86.1814	83.9659	x	86.9866	73.2228	87.2761	88.8636	x	x	x	81.2007	89.6141	83.0772	x	88.8617	83.0561	x	x	x	x	x	x	x	84.2119	x	x	x	90.2168	x	x	x	x	x	88.3626	91.5259	x	x	87.0317	x	x	77.6037	80.7893	x	x	x	86.3884	x	86.4651	x	x	x	x	x	x	x	x	x	x	88.153	89.3044	x	x	69.0123	x	x	x	x	x	81.0584	88.5034	x	x	x	x	x	x	
-13364	Original post publication description: Central nervous system, behavior, cognition: Errors of omission, measure of attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]	None	Central nervous system, behavior, cognition: Errors of omission, measure of attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]	55.5575	45.4849	50.0506	49.0978	41.6667	53.15	x	51.2636	x	58.295	38.5841	x	49.5547	50.8488	56.8234	53.5191	x	43.5916	x	43.6575	x	58.0978	x	57.3426	x	35.0188	47.8876	60.5648	x	44.1828	58.4305	54.6428	54.7703	x	x	x	37.3168	57.8335	56.8533	x	52.8864	51.4022	x	x	x	x	x	x	x	42.2218	x	x	x	57.3249	x	x	x	x	x	40.4303	52.8256	x	x	40.1452	x	x	45.3682	43.2294	x	x	x	52.6427	x	53.2198	x	x	x	x	x	x	x	x	x	x	59.5597	48.7437	x	x	58.615	x	x	x	x	x	43.3469	45.625	x	x	x	x	x	x	
-13365	Original post publication description: Central nervous system, behavior, cognition: Mean correct response latency, measure of attention/motivation/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s]	None	Central nervous system, behavior, cognition: Mean correct response latency, measure of attention/motivation/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s]	0.994983	0.846152	0.826474	0.917111	0.980806	1.07461	x	0.892184	x	0.914058	0.961635	x	0.930905	0.9295	1.01717	1.01419	x	1.22608	x	0.897747	x	1.0888	x	0.968544	x	1.04714	1.16037	1.01618	x	1.00293	1.13263	0.996089	1.14303	x	x	x	1.01652	0.943766	0.911038	x	0.853759	0.876475	x	x	x	x	x	x	x	0.887883	x	x	x	0.831325	x	x	x	x	x	0.833536	0.789666	x	x	1.01108	x	x	0.871041	0.917328	x	x	x	1.16945	x	0.952281	x	x	x	x	x	x	x	x	x	x	1.1703	0.862446	x	x	1.29953	x	x	x	x	x	0.971128	0.998622	x	x	x	x	x	x	
-13366	Original post publication description: Central nervous system, behavior, cognition: Mode of correct response latencies, measure of processing speed/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s]	None	Central nervous system, behavior, cognition: Mode of correct response latencies, measure of processing speed/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s]	0.661533	0.584194	0.538814	0.6554	0.711909	0.723596	x	0.616229	x	0.665185	0.731738	x	0.646379	0.695606	0.802273	0.689444	x	0.853571	x	0.583104	x	0.86074	x	0.635917	x	0.716944	0.923667	0.729929	x	0.718	0.774903	0.72231	0.867256	x	x	x	0.749852	0.7025	0.674508	x	0.634528	0.601178	x	x	x	x	x	x	x	0.613944	x	x	x	0.623667	x	x	x	x	x	0.562233	0.595917	x	x	0.768667	x	x	0.589639	0.633472	x	x	x	0.888048	x	0.716236	x	x	x	x	x	x	x	x	x	x	0.893083	0.624778	x	x	0.876714	x	x	x	x	x	0.68825	0.769389	x	x	x	x	x	x	
-13367	Original post publication description: Central nervous system, behavior, cognition: Standard deviation of correct response latencies, measure of lapses in attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = better performance [s]	None	Central nervous system, behavior, cognition: Standard deviation of correct response latencies, measure of lapses in attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = better performance [s]	0.611188	0.541374	0.528164	0.569068	0.506052	0.687859	x	0.568218	x	0.457572	0.51579	x	0.576225	0.470685	0.492817	0.708137	x	0.632652	x	0.569075	x	0.599769	x	0.651596	x	0.658887	0.619917	0.603861	x	0.591735	0.723933	0.530922	0.582113	x	x	x	0.597666	0.518896	0.480044	x	0.485109	0.550638	x	x	x	x	x	x	x	0.522143	x	x	x	0.425338	x	x	x	x	x	0.494154	0.400127	x	x	0.575321	x	x	0.573143	0.610262	x	x	x	0.630086	x	0.52968	x	x	x	x	x	x	x	x	x	x	0.590415	0.485964	x	x	0.824235	x	x	x	x	x	0.557196	0.566831	x	x	x	x	x	x	
-13368	Original post publication description: Central nervous system, behavior, cognition: Mean latency to retrieve food pellet, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = low motivation [s]	None	Central nervous system, behavior, cognition: Mean latency to retrieve food pellet, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = low motivation [s]	3.23107	2.28585	2.34962	2.51732	2.49107	3.1134	x	2.40557	x	2.33016	2.15208	x	2.36702	2.71318	2.59887	2.48233	x	4.20857	x	2.85759	x	3.3886	x	3.56041	x	2.21289	2.685	4.47298	x	2.46307	2.38549	2.18486	2.67439	x	x	x	2.27875	2.92457	2.87834	x	2.22727	3.52675	x	x	x	x	x	x	x	2.25333	x	x	x	3.14587	x	x	x	x	x	2.18931	2.31359	x	x	2.40142	x	x	2.66319	2.04977	x	x	x	3.31886	x	2.4524	x	x	x	x	x	x	x	x	x	x	3.16395	2.10292	x	x	4.19956	x	x	x	x	x	2.50386	2.17456	x	x	x	x	x	x	
-13369	Original post publication description: Central nervous system, behavior, cognition: Number of completed trials in a 25 min session, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = low motivation [n]	None	Central nervous system, behavior, cognition: Number of completed trials in a 25 min session, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = low motivation [n]	53.24	58.7333	59.3588	57.63	57.3045	52.5895	x	57.25	x	57.4444	58.1286	x	56.1333	58.8909	51.7818	47.4476	x	51.7143	x	57.6	x	55.2156	x	54.8667	x	58.7667	54.3556	57.8571	x	59.2167	54.8083	57.4143	55.4	x	x	x	56.8667	59.2714	57.1619	x	57.8	54.8533	x	x	x	x	x	x	x	54.9	x	x	x	58.7889	x	x	x	x	x	55.84	59.5667	x	x	57.5556	x	x	55.3833	56.5333	x	x	x	55.5571	x	53.3333	x	x	x	x	x	x	x	x	x	x	56.7	59.4333	x	x	53.9714	x	x	x	x	x	56.9667	59.6	x	x	x	x	x	x	
-13370	Original post publication description: Central nervous system, behavior, cognition: Response accuracy during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]	None	Central nervous system, behavior, cognition: Response accuracy during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]	86.2968	81.9455	77.0523	71.7341	67.0815	70.037	x	66.1383	x	68.8566	79.0151	x	79.106	81.3237	71.1187	64.6684	x	69.4884	x	82.3538	x	76.4564	x	79.349	x	74.7884	72.0212	78.8787	x	76.0999	66.5549	73.7938	80.0532	x	x	x	76.1884	80.7254	68.0892	x	82.2518	73.6082	x	x	x	x	x	x	x	74.5352	x	x	x	82.7415	x	x	x	x	x	76.3257	85.0286	x	x	77.5208	x	x	68.9687	75.4859	x	x	x	68.5767	x	76.4432	x	x	x	x	x	x	x	x	x	x	75.0752	82.5418	x	x	57.9245	x	x	x	x	x	76.8109	80.8792	x	x	x	x	x	x	
-13371	Original post publication description: Central nervous system, behavior, cognition: Errors of omission during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]	None	Central nervous system, behavior, cognition: Errors of omission during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]	60.9464	45.1515	52.6619	52.5572	38.6842	57.96	x	52.7994	x	67.7113	45.8708	x	55.303	53.4782	60.3362	51.0831	x	45.8077	x	51.0531	x	59.0913	x	69.6741	x	39.0207	50.0117	66.8076	x	47.5	59.5133	59.2213	53.8254	x	x	x	43.6508	61.8315	59.5962	x	58.3359	57.358	x	x	x	x	x	x	x	40.5666	x	x	x	58.3488	x	x	x	x	x	46.5333	55.4167	x	x	41.2011	x	x	43.515	51.5682	x	x	x	52.9317	x	66.1916	x	x	x	x	x	x	x	x	x	x	59.967	51.3867	x	x	54.7868	x	x	x	x	x	51.5094	48.2341	x	x	x	x	x	x	
-13372	Original post publication description: Central nervous system, behavior: Acoustic startle threshold for males, lowest sound pressure level at which startle response can be detected [dB]	None	Central nervous system, behavior: Acoustic startle threshold for males, lowest sound pressure level at which startle response can be detected [dB]	82.2222	83.6364	85.4545	101.667	93.0769	92.6667	94.5455	83.75	100.0	x	x	x	77.8125	88.3333	96.5	104.583	x	x	x	x	x	96.25	x	104.0	x	x	93.5714	98.75	x	x	95.9375	86.4286	89.0909	x	x	x	93.3333	89.1667	90.0	x	101.5	89.0625	x	x	x	x	x	x	x	95.8333	x	x	x	97.5	x	x	x	x	x	80.0	85.9091	x	x	84.5833	x	x	88.0769	94.375	x	x	x	100.0	x	95.5	x	x	x	x	x	x	x	x	x	x	90.4545	94.1667	x	x	77.7273	x	x	x	x	x	92.0833	85.8333	x	x	x	x	x	x	
-13396	Original post publication description: Musculoskeletal system, morphology:Femur mineralized volume (FMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology:VDavid102	Musculoskeletal system, morphology:VDavid102	Musculoskeletal system, morphology:Femur mineralized volume (FMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3]	16.48	13.787	13.758	13.33	x	x	x	x	x	x	13.423	11.558	x	11.943	x	x	x	x	x	x	x	x	x	x	x	11.977	x	x	x	x	14.435	x	x	x	x	x	x	x	x	x	12.774	x	12.825	x	x	x	x	15.216	14.147	x	x	x	x	x	16.226	x	x	x	10.75	x	14.039	11.597	x	13.626	x	x	13.15	9.898	12.99	12.346	x	x	x	x	x	x	x	10.976	x	x	x	14.158	11.78	x	x	x	x	x	13.78	x	14.51	x	x	13.92	x	14.478	x	x	16.028	15.077	x	x	
-13397	Original post publication description: Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology:VDavid103	Musculoskeletal system, morphology:VDavid103	Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3]	1034.94	1046.29	1002.38	1079.5	x	x	x	x	x	x	1020.93	1047.85	x	1020.93	x	x	x	x	x	x	x	x	x	x	x	1036.52	x	x	x	x	1060.16	x	x	x	x	x	x	x	x	x	1087.33	x	1079.74	x	x	x	x	1053.94	1064.75	x	x	x	x	x	1075.17	x	x	x	999.114	x	1070.72	1053.18	x	1078.2	x	x	1054.76	1016.62	1039.7	1065.56	x	x	x	x	x	x	x	1098.45	x	x	x	1073.05	1046.26	x	x	x	x	x	1054.48	x	1050.4	x	x	1039.8	x	1057.62	x	x	1048.3	1042.46	x	x	
-13398	Original post publication description: Musculoskeletal system, morphology: Femur length (FL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid104	Musculoskeletal system, morphology: VDavid104	Musculoskeletal system, morphology: Femur length (FL) of 12-week-old females measured by microcomputed tomography (µCT) [mm]	13.365	12.896	12.776	12.524	x	x	x	x	x	x	12.264	12.41	x	12.228	x	x	x	x	x	x	x	x	x	x	x	12.0	x	x	x	x	12.401	x	x	x	x	x	x	x	x	x	12.753	x	12.575	x	x	x	x	13.3	12.764	x	x	x	x	x	13.447	x	x	x	11.736	x	12.518	12.765	x	13.73	x	x	13.18	12.1	12.8	12.63	x	x	x	x	x	x	x	11.754	x	x	x	13.358	12.84	x	x	x	x	x	12.87	x	13.6	x	x	12.362	x	13.735	x	x	13.238	13.381	x	x	
-13399	Original post publication description: Central nervous system, morphology, Septum volume, corrected for shrinkage, age, sex, plane of section, brain weight, and epoch [mm3] Original pre publication description: Central nervous system, morphology, Sept Corr Resid [mm3]	Central nervous system, morphology: Sept Corr Resid [mm3]	Central nervous system, morphology: Septum volume corrected for shrinkage, age, sex, plane of section, brain weight, and epoch [mm3]	x	x	2.537	3.006	3.239	3.349	3.393	2.735	3.528	3.764	3.111	3.037	2.987	2.948	2.727	2.674	3.154	3.571	3.236	3.206	3.991	3.097	x	3.714	3.794	3.313	3.045	x	3.285	3.21	3.782	2.746	3.067	2.768	3.128	x	2.826	3.579	3.479	x	3.218	3.281	x	3.148	x	x	3.33	x	3.134	x	x	x	x	2.751	3.07	x	x	x	3.101	3.767	x	3.171	3.394	3.172	3.263	3.225	3.17	3.381	3.083	3.495	x	3.173	3.321	3.418	2.842	3.311	x	2.881	3.096	x	x	3.385	2.774	3.556	3.477	3.198	x	3.289	3.248	x	3.48	3.188	x	x	3.001	2.913	2.991	x	x	x	x	x	
-13405	Original post publication description: Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid115.	Musculoskeletal system, morphology: VDavid115.	Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old females measured by microcomputed tomography (µCT) [mm]	16.631	16.316	15.63	15.773	x	x	x	x	x	x	x	15.609	x	15.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.934	x	x	x	x	x	x	x	x	x	x	x	x	15.347	x	x	15.527	15.705	16.32	x	x	x	x	x	x	x	x	x	15.05	x	16.04	x	x	x	x	x	16.088	x	16.279	15.137	x	16.255	x	x	x	x	x	16.163	x	x	x	16.559	15.67	x	x	x	x	x	15.98	x	16.024	x	x	15.48	x	16.43	x	x	16.614	16.255	15.84	x	
-13385	Original post publication description: Central nervous system, morphology:Midsagittal area of the corpus callosum, corrected for shrinkage, age, sex, brain weight, epoch [mm2] Original pre publication description: Central nervous system, morphology:MSACC Corr Resid [mm2]	Central nervous system, morphology: MSACC Corr Resid [mm2]	Central nervous system, morphology: Midsagittal area of the corpus callosum, corrected for shrinkage, age, sex, brain weight, epoch [mm2]	x	x	1.115	0.761	1.099	0.978	0.84	1.064	1.084	1.283	1.313	1.052	1.114	1.055	1.281	1.053	0.933	1.0	1.242	1.228	0.877	1.251	x	1.051	1.019	1.061	0.988	1.142	1.152	1.159	1.008	1.412	0.915	1.227	1.027	x	0.835	1.207	1.385	x	1.163	1.139	1.172	1.064	x	x	1.047	x	0.989	0.904	x	x	x	1.515	0.989	x	x	x	1.096	1.041	1.082	1.119	1.198	0.897	1.045	1.01	0.916	1.172	0.925	1.117	x	1.093	0.837	1.117	0.974	1.237	0.842	1.347	1.101	x	x	1.111	0.944	0.99	1.163	1.162	x	1.058	1.116	1.427	1.181	1.324	x	x	1.189	0.943	1.007	1.481	x	x	x	x	
-13406	Original post publication description: Musculoskeletal system, morphology: Femur Cortical Thickness (F.Ct.Th) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid120.	Musculoskeletal system, morphology: VDavid120	Musculoskeletal system, morphology: Femur cortical thickness (F.Ct.Th) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm]	x	0.248	x	x	0.236	x	x	x	x	x	x	0.222	x	0.195	x	x	x	x	x	x	x	x	x	0.261	x	0.192	x	0.217	x	0.236	x	x	0.218	x	x	x	x	0.202	x	x	x	x	0.233	x	x	x	0.224	0.235	x	x	x	x	x	x	0.217	x	x	x	0.208	x	0.257	x	x	0.229	x	x	0.233	0.225	x	0.224	x	0.235	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.184	x	0.209	
-13404	Original post publication description: Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid114.	Musculoskeletal system, morphology: VDavid114.	Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3]	1033.7	1033.46	1024.51	1040.86	x	x	x	x	x	x	x	1046.17	x	1026.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1040.5	x	x	x	x	x	x	x	x	x	x	x	x	1000.77	x	x	980.96	1024.69	1082.26	x	x	x	x	x	x	x	x	x	980.737	x	1038.59	x	x	x	x	x	1029.63	x	1057.75	1064.5	x	1030.77	x	x	x	x	x	1051.0	x	x	x	1054.76	1044.54	x	x	x	x	x	1031.7	x	1020.55	x	x	1027.28	x	1013.6	x	x	1015.14	1025.96	1019.43	x	
-13384	Original post publication description: Central nervous system, morphology:Lateral Septum Volume Raw values (no residual, no correction) [mm3] Original pre publication description: Central nervous system, morphology:Sept Raw [mm3]	Central nervous system, morphology: Sept Raw [mm3]	Central nervous system, morphology: Lateral septum volume, adult both sexes (MBL samples), morphometric point counting estimate from serial sections (without corrections) [mm3]	x	x	0.966	1.159	1.314	1.353	1.372	1.032	1.3	1.536	1.298	1.065	1.094	1.3	1.175	1.124	1.321	1.324	1.06	1.18	1.748	1.161	x	1.536	1.474	1.144	1.197	x	1.216	1.279	1.46	1.085	1.072	1.007	1.067	x	1.037	1.19	1.207	x	1.242	1.003	x	0.946	x	x	1.046	x	1.011	x	x	x	x	0.979	0.977	x	x	x	0.953	1.185	x	0.91	1.027	0.955	0.934	0.954	0.98	0.991	0.95	1.032	x	1.028	0.994	0.985	0.866	1.017	x	0.853	0.977	x	x	1.034	0.816	1.026	1.098	0.961	x	1.073	0.978	x	1.027	0.96	x	x	0.892	0.93	0.896	x	x	x	x	x	
-13400	Original post publication description: Musculoskeletal system, morphology:Tibia mineralized volume (TMV) of 12-week-old males measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid110	Musculoskeletal system, morphology: VDavid110	Musculoskeletal system, morphology: Tibia mineralized volume (TMV) of 12-week-old males measured by microcomputed tomography (µCT) [mm3]	18.313	14.803	14.33	11.468	15.67	x	x	x	x	x	12.237	12.73	x	x	x	x	x	x	x	x	x	x	x	x	x	10.073	x	12.667	x	x	12.98	x	14.381	x	x	x	x	x	12.561	x	x	x	x	x	x	x	14.536	14.65	x	x	x	x	x	x	11.566	x	x	x	12.78	x	14.53	x	x	x	x	x	x	11.49	13.97	x	x	x	x	13.36	x	x	x	14.355	9.94	x	x	13.97	x	x	x	13.66	x	12.298	14.76	x	x	x	x	x	x	x	x	x	14.68	x	12.54	x	
-13401	Original post publication description: Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid111.	Musculoskeletal system, morphology: VDavid111.	Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3]	1052.49	1035.63	1011.48	1071.06	1009.46	x	x	x	x	x	x	1043.39	x	x	x	x	x	x	x	x	x	x	x	x	x	1034.93	x	1028.49	x	x	1011.63	x	1035.06	x	x	x	x	x	1060.32	x	x	x	x	x	x	x	1000.86	1009.5	x	x	x	x	x	x	1052.19	x	x	x	1004.99	x	1063.59	x	x	x	x	x	x	1026.72	1016.2	x	x	x	x	1069.29	x	x	x	1054.82	1018.58	x	x	1028.1	x	x	x	1067.95	x	1045.66	1041.55	x	x	x	x	x	x	x	x	x	1014.8	x	1026.88	x	
-13402	Original post publication description: Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old males measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid112.	Musculoskeletal system, morphology: VDavid112.	Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old males measured by microcomputed tomography (µCT) [mm]	16.921	16.478	16.24	15.325	15.92	x	x	x	x	x	x	15.732	x	x	x	x	x	x	x	x	x	x	x	x	x	15.317	x	16.268	x	x	15.69	x	15.956	x	x	x	x	x	15.946	x	x	x	x	x	x	x	16.214	16.668	x	x	x	x	x	x	16.726	x	x	x	15.93	x	16.443	x	x	x	x	x	x	15.74	15.682	x	x	x	x	15.928	x	x	x	16.659	16.076	x	x	16.48	x	x	x	15.227	x	16.028	16.6	x	x	x	x	x	x	x	x	x	16.51	x	15.366	x	
-13403	Original post publication description: Musculoskeletal system, morphology:Tibia mineralized volume (TMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology:VDavid113	Musculoskeletal system, morphology:VDavid113	Musculoskeletal system, morphology: Tibia mineralized volume (TMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3]	13.534	11.68	12.74	12.093	x	x	x	x	x	x	x	9.845	x	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.252	x	x	x	x	x	x	x	x	x	x	x	x	10.885	x	x	10.558	11.75	11.83	x	x	x	x	x	x	x	x	x	9.63	x	11.89	x	x	x	x	x	11.84	x	12.297	11.256	x	11.56	x	x	x	x	x	10.898	x	x	x	13.066	10.32	x	x	x	x	x	11.93	x	11.489	x	x	12.79	x	12.22	x	x	13.38	11.898	12.195	x	
-13426	Original post publication description: Central nervous system, morphology: Striatal Non-neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str NN Resid	Central nervous system, morphology:Str NN Resid	Central nervous system, morphology: Striatal Non-neuron Number corrected for age, sex, plane of section, and brain weight	x	x	1457230.0	1374880.0	1383470.0	1464340.0	1599320.0	1523880.0	1282930.0	1384450.0	1591630.0	1593970.0	1423940.0	1499750.0	1643880.0	1400400.0	1492800.0	1463970.0	1457360.0	1325860.0	1597330.0	1360440.0	x	1389670.0	1382210.0	1322690.0	1572750.0	1491460.0	1476010.0	1692130.0	1460540.0	1364040.0	1369820.0	1683460.0	1261700.0	x	1299250.0	1339050.0	1437650.0	x	1366520.0	x	x	1441910.0	x	x	1450810.0	x	1364900.0	x	x	x	x	1499410.0	1610670.0	x	x	x	1599540.0	1451980.0	x	1299830.0	1364430.0	1517320.0	1488500.0	1430670.0	1574700.0	1354470.0	1275740.0	1470440.0	x	1483210.0	1374600.0	1460190.0	x	1542520.0	x	1254800.0	1532390.0	x	x	1741490.0	1234300.0	1486870.0	1479170.0	1521950.0	x	1287520.0	1463250.0	x	1596070.0	1385870.0	x	x	1251420.0	1524240.0	1412130.0	x	x	x	x	x	
-13425	Original post publication description: Central nervous system, morphology:Striatal Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Neur Resid	Central nervous system, morphology: Str Neur Resid	Central nervous system, morphology: Neurons in the dorsal striatum (caudate-putamen) of adults corrected for age, sex, plane of section, and brain weight [n]	x	x	2157160.0	2355930.0	2184800.0	2183760.0	2246080.0	2246090.0	2384020.0	2287210.0	2563510.0	2212650.0	2242510.0	2491740.0	2466720.0	2178600.0	2328050.0	2390850.0	2291920.0	2087130.0	2446620.0	1930790.0	x	2325900.0	2250800.0	2010080.0	2321390.0	2135860.0	2272030.0	2375900.0	2275920.0	2394360.0	2339490.0	2334250.0	2282690.0	x	2089120.0	2189860.0	2296580.0	x	2393110.0	x	x	2583710.0	x	x	2170540.0	x	2267540.0	x	x	x	x	2315800.0	2783840.0	x	x	x	2453920.0	2309070.0	x	2377520.0	2275460.0	2102480.0	2352960.0	2102220.0	2059780.0	2293550.0	1993630.0	2248530.0	x	2392760.0	2176760.0	2348460.0	x	2224700.0	x	1910920.0	2135650.0	x	x	2400380.0	1969980.0	2210230.0	2463570.0	2287730.0	x	2221140.0	2204350.0	x	2463940.0	2303040.0	x	x	1926430.0	2391080.0	2245770.0	x	x	x	x	x	
-13424	Original post publication description: Central nervous system, morphology; Neocortical Total Cell number (neurons and non-neurons), corrected for age, sex, plane of section, brain weight, and epoch. Original pre publication description: Central nervous system, morphology; CX Tot Cell Resid Epoch	Central nervous system, morphology: CX tot cell resid Epoch	Central nervous system, morphology: Neocortex total cell number (neurons and non-neurons) in adults (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million]	x	x	20020800.0	18080300.0	17254300.0	18215400.0	21383600.0	18585500.0	19154600.0	18232800.0	20212500.0	19556900.0	18795300.0	19034000.0	20208900.0	18420300.0	19212200.0	18757200.0	18552900.0	17528500.0	20840000.0	17995400.0	x	18116800.0	18270800.0	17970000.0	19220200.0	16800700.0	16763100.0	20271200.0	18725000.0	17558700.0	18919600.0	20307800.0	17637600.0	x	16688000.0	18222100.0	17767000.0	x	16883400.0	19301500.0	x	17393300.0	x	x	18707000.0	x	18055900.0	17867100.0	x	x	x	19403000.0	19199700.0	x	x	x	x	18388300.0	x	18313700.0	17233600.0	18344000.0	19020400.0	17088600.0	18065200.0	19115100.0	18474200.0	18841300.0	x	19557800.0	17567700.0	17739500.0	17490700.0	17528900.0	x	18006700.0	20052300.0	x	x	18340300.0	19402200.0	17314500.0	18781000.0	19722100.0	x	16651700.0	19625000.0	x	17860400.0	19172600.0	x	x	16021000.0	19815100.0	x	x	x	x	x	x	
-13427	Original post publication description: Central nervous system, morphology:Striatal Tot Cell Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Tot Cell Resid	Central nervous system, morphology:Str Tot Cell Resid	Central nervous system, morphology:Striatal Tot Cell Number corrected for age, sex, plane of section, and brain weight	x	x	3614390.0	3730810.0	3568280.0	3648110.0	3845390.0	3769970.0	3666950.0	3671660.0	4155140.0	3806620.0	3666460.0	3991490.0	4110600.0	3578990.0	3820860.0	3854820.0	3749280.0	3412990.0	4043950.0	3291230.0	x	3715570.0	3633010.0	3332770.0	3894140.0	3627320.0	3748030.0	4068020.0	3736470.0	3758400.0	3709310.0	4017710.0	3544390.0	x	3388370.0	3528910.0	3734230.0	x	3759630.0	x	x	4025630.0	x	x	3621360.0	x	3632440.0	x	x	x	x	3815220.0	4394510.0	x	x	x	4053460.0	3761050.0	x	3677340.0	3639890.0	3619800.0	3841460.0	3532880.0	3634470.0	3648010.0	3269370.0	3718980.0	x	3875970.0	3551360.0	3808650.0	x	3767220.0	x	3165720.0	3668040.0	x	x	4141860.0	3204280.0	3697100.0	3942740.0	3809680.0	x	3508660.0	3667600.0	x	4060010.0	3688910.0	x	x	3177850.0	3915310.0	3657900.0	x	x	x	x	x	
-13428	Original post publication description: Central nervous system, morphology:Striatal Volume corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Vol Resid	Central nervous system, morphology: Str vol resid	Central nervous system, morphology: Striatal volume, adult both sexes (MBL samples), morphometric point counting estimate from serial sections corrected for age, sex, plane of section, and brain weight [mm3]	x	x	21.865	22.151	22.265	21.312	23.105	21.924	24.203	23.309	22.558	20.691	20.278	21.173	20.774	22.063	22.251	23.765	21.471	22.369	25.774	19.325	x	22.734	22.871	23.467	21.335	20.292	23.329	21.966	23.853	22.094	24.85	21.424	22.386	x	21.159	22.667	21.296	x	21.576	x	x	22.523	x	x	21.123	x	24.28	x	x	x	x	23.241	23.428	x	x	x	23.698	23.063	x	22.558	22.569	22.358	23.416	19.775	21.483	22.405	19.7	23.667	x	22.698	23.624	22.714	x	21.866	x	19.045	20.43	x	x	22.336	21.868	21.068	24.397	21.469	x	20.818	21.776	x	22.46	23.843	x	x	20.452	21.468	23.738	x	x	x	x	x	
-13429	Original post publication description: Central nervous system, morphology; Neocortical Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Neuron Resid	Central nervous system, morphology; CX Neuron Resid	Central nervous system, morphology; Neocortical Neuron Number corrected for age, sex, plane of section, and brain weight	x	x	12050300.0	11343100.0	10763000.0	11323600.0	13149700.0	10782300.0	11856400.0	10878000.0	12353100.0	11697500.0	11404200.0	11666200.0	12336900.0	11333100.0	12239900.0	11751800.0	11380100.0	10688300.0	13085200.0	10898500.0	x	11468000.0	11398500.0	11126800.0	11443800.0	10514300.0	10187400.0	12131700.0	11966200.0	10903100.0	11978600.0	12580600.0	11224300.0	x	10466600.0	11406700.0	10863300.0	x	10362900.0	11135600.0	x	10121700.0	x	x	11996400.0	x	12070400.0	10617300.0	x	x	x	11293700.0	11503500.0	x	x	x	x	10965300.0	x	10859600.0	10106200.0	10863700.0	11472800.0	10170300.0	10246400.0	11562700.0	10962500.0	10577200.0	x	11334600.0	10870100.0	10235600.0	11619000.0	10053100.0	x	11730300.0	12229600.0	x	x	11055500.0	12240400.0	10072800.0	11774700.0	11549300.0	x	9953010.0	12176900.0	x	10782000.0	12573900.0	x	x	10974900.0	11693700.0	x	x	x	x	x	x	
-13430	Original post publication description: Central nervous system, morphology; Neocortical Non-Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX NonNeuron Resid	Central nervous system, morphology; CX NonNeuron Resid	Central nervous system, morphology; Neocortical Non-Neuron Number corrected for age, sex, plane of section, and brain weight	x	x	8308930.0	7023870.0	6740080.0	7138890.0	7948800.0	7299220.0	7091080.0	6962850.0	8080620.0	8130190.0	7605760.0	7630570.0	8215350.0	7326700.0	7210140.0	7207740.0	7351870.0	7155370.0	8132480.0	7379140.0	x	6858870.0	7019480.0	6995200.0	7949900.0	6404380.0	6717680.0	8320050.0	7078250.0	6872560.0	7124320.0	7899300.0	6591960.0	x	6405400.0	6944430.0	7105190.0	x	6743160.0	8139170.0	x	6984900.0	x	x	6339610.0	x	5863790.0	7226090.0	x	x	x	8161150.0	7698580.0	x	x	x	x	7152020.0	x	7160850.0	6855600.0	7141500.0	7250710.0	6675650.0	7587050.0	7250140.0	7244530.0	7979860.0	x	7867880.0	6251360.0	7152100.0	5765780.0	7255550.0	x	6177530.0	7781270.0	x	x	7022030.0	6816790.0	6886610.0	6962440.0	7881640.0	x	6442400.0	7152020.0	x	6995390.0	6452280.0	x	x	4855740.0	7848950.0	x	x	x	x	x	x	
-13431	Original post publication description: Central nervous system, morphology; Neocortical Tot Cell Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Tot Cell Resid	Central nervous system, morphology; CX Tot Cell Resid	Central nervous system, morphology; Neocortical Tot Cell Number corrected for age, sex, plane of section, and brain weight	x	x	20359200.0	18366900.0	17503100.0	18462500.0	21098500.0	18081600.0	18947500.0	17840800.0	20433700.0	19827700.0	19010000.0	19296800.0	20552200.0	18659800.0	19450000.0	18959500.0	18732000.0	17843700.0	21217700.0	18277700.0	x	18326900.0	18418000.0	18122000.0	19393800.0	16918700.0	16905100.0	20451800.0	19044500.0	17775700.0	19102900.0	20479900.0	17816200.0	x	16872000.0	18351100.0	17968500.0	x	17106000.0	19274800.0	x	17106600.0	x	x	18336000.0	x	17934100.0	17843400.0	x	x	x	19454900.0	19202000.0	x	x	x	x	18117400.0	x	18020500.0	16961800.0	18005200.0	18723500.0	16845900.0	17833500.0	18812900.0	18207100.0	18557100.0	x	19202400.0	17121500.0	17387700.0	17384800.0	17308600.0	x	17907800.0	20010900.0	x	x	18077500.0	19057200.0	16959400.0	18737100.0	19430900.0	x	16395400.0	19329000.0	x	17777400.0	19026200.0	x	x	15830600.0	19542700.0	x	x	x	x	x	x	
-13432	Original post publication description: Central nervous system, morphology; Neocortical volume, shrinkage corrected, corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Vol Resid	Central nervous system, morphology; CX Vol Resid	Central nervous system, morphology; Neocortical volume, shrinkage corrected, corrected for age, sex, plane of section, and brain weight	x	x	97.174	95.527	99.262	90.148	104.306	90.571	109.36	102.22	102.624	93.478	103.837	89.945	105.722	96.918	96.826	97.577	94.067	98.262	103.285	97.872	x	96.313	99.901	101.936	93.254	91.949	90.33	95.779	98.879	98.844	106.738	96.11	102.452	x	92.365	103.643	96.342	x	90.194	98.68	x	97.095	x	x	83.727	x	94.118	96.844	x	x	x	91.948	102.55	x	x	x	x	95.024	x	97.42	86.307	90.59	99.979	96.287	85.953	88.818	95.522	93.958	x	100.745	92.214	92.945	87.894	91.826	x	100.431	99.927	x	x	94.327	87.491	93.007	94.006	91.927	x	97.436	98.654	x	93.279	89.883	x	x	91.972	96.574	x	x	x	x	x	x	
-13433	Original post publication description: Central nervous system, morphology; Neocortical neuron number, raw data Original pre publication description: Central nervous system, morphology; CX Neuron Raw	Central nervous system, morphology; CX Neuron Raw	Central nervous system, morphology; Neocortical neuron number, raw data	x	x	12394000.0	11256300.0	11112700.0	11532700.0	13735900.0	10740400.0	11699900.0	11040200.0	12511900.0	11843600.0	11385100.0	11837800.0	12539800.0	11590800.0	12379800.0	11915100.0	11386900.0	10812300.0	13259500.0	10972400.0	x	11479800.0	11429200.0	10800300.0	11418700.0	10213100.0	9987910.0	12211000.0	12177100.0	10993900.0	12113400.0	12683700.0	11248500.0	x	10560900.0	11515100.0	11078300.0	x	10732500.0	10566200.0	x	10302200.0	x	x	12153700.0	x	11534700.0	9899770.0	x	x	x	10835700.0	10956900.0	x	x	x	x	11136400.0	x	10791700.0	10236800.0	10980200.0	11360500.0	10022000.0	10371500.0	11523700.0	11021500.0	10705200.0	x	11501200.0	10996500.0	10242000.0	11317500.0	10197400.0	x	11440700.0	11825000.0	x	x	11310000.0	11997500.0	10268300.0	11597900.0	11414300.0	x	10212400.0	12272900.0	x	10355100.0	12483700.0	x	x	10653200.0	11927300.0	x	x	x	x	x	x	
-13434	Original post publication description: Central nervous system, morphology; Neocortical non-neuron number, raw data Original pre publication description: Central nervous system, morphology; CX NonNeuron Raw	Central nervous system, morphology; CX NonNeuron Raw	Central nervous system, morphology; Neocortical non-neuron number, raw data	x	x	8988280.0	6680530.0	7050750.0	7407130.0	9136880.0	6722810.0	6803510.0	7167730.0	8045810.0	8039780.0	7139460.0	7799380.0	8661420.0	7527680.0	7302380.0	7299270.0	7121640.0	7274270.0	8341560.0	7343430.0	x	6748510.0	6629140.0	5991360.0	7582570.0	5437620.0	5830430.0	8329390.0	7515160.0	6595460.0	7029930.0	7723950.0	6236690.0	x	6194090.0	6726010.0	7196900.0	x	7266670.0	8042290.0	x	7333890.0	x	x	6160770.0	x	5571500.0	7096120.0	x	x	x	8716330.0	7678450.0	x	x	x	x	7662850.0	x	7021300.0	7129800.0	7206920.0	7057760.0	6498580.0	7856160.0	7215700.0	7356570.0	8253840.0	x	8113500.0	6376960.0	7083450.0	5395420.0	7607540.0	x	6236600.0	7883350.0	x	x	7529820.0	6178630.0	6825830.0	7624770.0	7298180.0	x	6986220.0	7140070.0	x	6914680.0	6580860.0	x	x	4562950.0	8098750.0	x	x	x	x	x	x	
-13435	Original post publication description: Central nervous system, morphology; Neocortical total cell number, raw data Original pre publication description: Central nervous system, morphology; CX Tot Cell Raw	Central nervous system, morphology; CX Tot Cell Raw	Central nervous system, morphology; Neocortical total cell number, raw data	x	x	21382300.0	17936800.0	18163400.0	18939800.0	22872800.0	17463200.0	18503400.0	18207900.0	20557700.0	19883400.0	18524500.0	19637100.0	21201200.0	19118500.0	19682100.0	19214400.0	18508600.0	18086600.0	21601100.0	18315900.0	x	18228300.0	18058300.0	16791700.0	19001200.0	15650700.0	15818300.0	20540400.0	19692300.0	17589400.0	19143400.0	20407600.0	17485200.0	x	16755000.0	18241100.0	18275200.0	x	17999200.0	18608500.0	x	17636100.0	x	x	18314500.0	x	17106200.0	16995900.0	x	x	x	19552000.0	18635400.0	x	x	x	x	18799200.0	x	17813000.0	17366600.0	18187100.0	18418300.0	16520600.0	18227700.0	18739400.0	18378100.0	18959000.0	x	19614700.0	17373500.0	17325400.0	16712900.0	17804900.0	x	17677300.0	19708400.0	x	x	18839800.0	18176100.0	17094100.0	19222700.0	18712500.0	x	17198600.0	19412900.0	x	17269700.0	19064500.0	x	x	15216100.0	20026000.0	x	x	x	x	x	x	
-13436	Original post publication description: Central nervous system, morphology; Neocortical Volume, corrected for shrinkage. Original pre publication description: Central nervous system, morphology; CX Vol Raw	Central nervous system, morphology; CX Vol Raw	Central nervous system, morphology; Neocortical Volume, corrected for shrinkage.	x	x	104.812	86.225	107.435	90.323	120.157	82.025	102.751	103.039	104.728	95.342	103.074	91.762	108.937	102.306	95.196	97.03	86.114	99.303	109.929	96.716	x	91.176	93.447	87.013	87.055	78.922	77.178	90.384	100.6	101.206	106.107	94.234	100.297	x	91.382	99.215	98.695	x	96.922	97.843	x	101.792	x	x	86.531	x	91.749	96.147	x	x	x	101.974	102.761	x	x	x	x	104.303	x	93.635	84.484	90.693	96.546	89.456	89.183	90.91	98.125	97.126	x	104.995	91.635	90.278	84.235	95.24	x	103.814	103.22	x	x	96.74	81.552	93.958	107.69	86.333	x	101.076	100.905	x	93.72	95.054	x	x	90.111	102.26	x	x	x	x	x	x	
-13437	Original post publication description: Central nervous system, morphology; Striatal neuron number, raw data Original pre publication description: Central nervous system, morphology; Str Neuron Raw	Central nervous system, morphology; Str Neuron Raw	Central nervous system, morphology; Striatal neuron number, raw data	x	x	2291360.0	2364870.0	2302900.0	2246530.0	2445980.0	2216540.0	2381630.0	2357720.0	2605120.0	2268900.0	2246240.0	2563990.0	2557040.0	2264230.0	2381500.0	2437920.0	2298470.0	2151370.0	2518740.0	1974330.0	x	2352140.0	2245440.0	1925310.0	2324310.0	2048850.0	2203370.0	2413290.0	2379030.0	2428960.0	2375380.0	2359280.0	2294210.0	x	2133480.0	2197420.0	2357440.0	x	2496720.0	x	x	2578000.0	x	x	2120020.0	x	2196420.0	x	x	x	x	2359990.0	2731590.0	x	x	x	2442450.0	2334480.0	x	2304010.0	2200980.0	2048960.0	2268770.0	2038670.0	2033890.0	2271560.0	1949750.0	2215930.0	x	2357380.0	2093210.0	2247530.0	x	2196090.0	x	1866700.0	2127780.0	x	x	2372550.0	1909750.0	2165320.0	2496410.0	2211670.0	x	2166890.0	2160960.0	x	2406490.0	2274960.0	x	x	1853470.0	2362240.0	2165160.0	x	x	x	x	x	
-13438	Original post publication description: Central nervous system, morphology; Striatal non-neuron number, raw data Original pre publication description: Central nervous system, morphology; Str NonNeuron Raw	Central nervous system, morphology; Str NonNeuron Raw	Central nervous system, morphology; Striatal non-neuron number, raw data	x	x	1595730.0	1396460.0	1468600.0	1538520.0	1829180.0	1436630.0	1309740.0	1456660.0	1587460.0	1622550.0	1348010.0	1556290.0	1750880.0	1450480.0	1544150.0	1483710.0	1450030.0	1387410.0	1649120.0	1390820.0	x	1391150.0	1322960.0	1181090.0	1535920.0	1339880.0	1338630.0	1735030.0	1598530.0	1316160.0	1360870.0	1660110.0	1208280.0	x	1290640.0	1288580.0	1459420.0	x	1455440.0	x	x	1469090.0	x	x	1408610.0	x	1264400.0	x	x	x	x	1489240.0	1494550.0	x	x	x	1567860.0	1525090.0	x	1246660.0	1346080.0	1499230.0	1434270.0	1421490.0	1608520.0	1372100.0	1247620.0	1512830.0	x	1472720.0	1296200.0	1372580.0	x	1584720.0	x	1135300.0	1475350.0	x	x	1718680.0	1111650.0	1475550.0	1550540.0	1491230.0	x	1285130.0	1456690.0	x	1470450.0	1319730.0	x	x	1075370.0	1537580.0	1258850.0	x	x	x	x	x	
-13439	Original post publication description: Central nervous system, morphology; Striatal total cell number, raw data Original pre publication description: Central nervous system, morphology; Str Tot Cell Raw	Central nervous system, morphology; Str Tot Cell Raw	Central nervous system, morphology; Striatal total cell number, raw data	x	x	3887100.0	3761330.0	3771500.0	3785060.0	4275160.0	3653170.0	3691370.0	3814380.0	4192590.0	3891450.0	3594250.0	4120290.0	4307920.0	3714710.0	3925650.0	3921630.0	3748500.0	3538790.0	4167860.0	3365140.0	x	3743280.0	3568410.0	3106410.0	3860230.0	3388730.0	3542000.0	4148320.0	3977560.0	3745120.0	3736250.0	4019400.0	3502490.0	x	3424130.0	3486000.0	3816860.0	x	3952160.0	x	x	4047100.0	x	x	3528640.0	x	3460830.0	x	x	x	x	3849220.0	4226140.0	x	x	x	4010310.0	3859570.0	x	3550670.0	3547060.0	3548190.0	3703040.0	3460160.0	3642410.0	3643660.0	3197370.0	3728760.0	x	3830100.0	3389410.0	3620110.0	x	3780820.0	x	3002000.0	3603130.0	x	x	4091230.0	3021390.0	3640870.0	4046960.0	3702900.0	x	3452020.0	3617650.0	x	3876940.0	3594690.0	x	x	2928840.0	3899820.0	3424010.0	x	x	x	x	x	
-13440	Original post publication description: Central nervous system, morphology; Striatal volume, shrinkage corrected. Original pre publication description: Central nervous system, morphology; Str Vol Raw	Central nervous system, morphology: Str Vol Raw	Central nervous system, morphology: Striatal volume (caudate putamen), both sexes, shrinkage corrected [mm^3]	x	x	23.949	21.012	24.047	21.728	27.095	19.248	23.259	23.637	22.549	21.012	19.611	21.671	21.885	23.015	21.923	23.342	19.785	22.824	27.144	19.164	x	21.602	20.884	19.889	19.75	16.894	19.868	20.877	24.846	22.052	24.262	20.527	21.425	x	20.77	20.989	21.403	x	22.798	x	x	23.867	x	x	20.897	x	25.088	x	x	x	x	26.441	23.941	x	x	x	25.098	25.265	x	21.897	22.411	22.413	22.622	19.872	22.623	23.309	20.09	24.619	x	23.146	22.822	21.363	x	23.199	x	19.842	22.229	x	x	22.515	22.493	21.403	26.849	20.998	x	21.01	22.436	x	23.121	25.328	x	x	19.843	22.211	23.662	x	x	x	x	x	
-13441	Original post publication description: unpublished Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [sec]	x	55.0	104.5	x	x	78.2	93.5	91.1	x	73.6	113.7	107.0	x	65.0	x	x	81.9	x	99.3	x	86.9	x	x	x	x	x	72.6	x	x	72.1	x	x	81.0	x	x	x	x	75.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13442	Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only	None	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only	x	10.6	7.2	x	x	9.1	7.5	8.1	x	11.1	9.0	7.8	x	8.6	x	x	5.5	x	9.0	x	7.2	x	x	x	x	x	9.4	x	x	8.1	x	x	9.2	x	x	x	x	10.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13443	Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only	Central nervous system, behavior: anxiety assay, number of fecal boli produced in an open field activity (OFA) test in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only	x	7.8	5.0	x	x	7.1	4.5	5.4	x	7.7	6.4	6.8	x	6.3	x	x	6.2	x	5.3	x	5.7	x	x	x	x	x	7.6	x	x	7.1	x	x	6.6	x	x	x	x	8.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13444	Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only] Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only]	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only]	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only]	x	135.8	144.0	x	x	128.1	166.6	150.0	x	144.1	140.6	114.7	x	136.5	x	x	88.7	x	169.8	x	126.3	x	x	x	x	x	123.6	x	x	114.0	x	x	139.3	x	x	x	x	118.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13446	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only	x	130.2	138.1	x	x	119.8	126.7	163.4	x	108.9	191.6	163.3	x	156.1	x	x	176.4	x	173.4	x	121.5	x	x	x	x	x	104.7	x	x	129.8	x	x	139.5	x	x	x	x	121.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13447	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	42.2	75.6	x	x	65.2	73.7	55.7	x	67.5	59.3	65.5	x	41.6	x	x	46.4	x	57.2	x	71.5	x	x	x	x	x	69.3	x	x	55.5	x	x	58.0	x	x	x	x	62.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13448	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement]	x	16.5	32.5	x	x	33.8	26.2	27.7	x	31.9	39.8	68.2	x	44.6	x	x	24.4	x	31.0	x	3.2	x	x	x	x	x	17.3	x	x	43.7	x	x	44.1	x	x	x	x	17.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13449	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec]	x	6.2	26.6	x	x	22.7	17.7	24.5	x	21.5	41.3	34.9	x	23.3	x	x	13.7	x	31.8	x	8.0	x	x	x	x	x	8.0	x	x	25.1	x	x	29.9	x	x	x	x	11.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13450	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec]	x	84.3	68.3	x	x	96.3	62.1	47.8	x	82.2	76.2	76.7	x	65.0	x	x	42.0	x	68.7	x	49.2	x	x	x	x	x	71.1	x	x	47.6	x	x	62.7	x	x	x	x	87.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13451	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement]	x	79.6	57.1	x	x	96.2	74.3	41.7	x	85.4	45.0	62.9	x	42.6	x	x	46.6	x	41.9	x	41.9	x	x	x	x	x	87.1	x	x	37.7	x	x	47.7	x	x	x	x	96.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13452	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement]	x	20.7	56.9	x	x	35.1	35.2	66.4	x	37.3	88.4	108.4	x	104.6	x	x	52.3	x	73.9	x	7.6	x	x	x	x	x	19.8	x	x	115.9	x	x	92.4	x	x	x	x	18.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13453	Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1]	Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1]	x	7.3	38.9	x	x	23.5	28.5	51.2	x	26.1	54.1	45.5	x	35.8	x	x	32.6	x	46.2	x	16.2	x	x	x	x	x	11.2	x	x	52.7	x	x	47.6	x	x	x	x	12.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13454	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm	x	4445.3	3492.0	x	x	3228.1	2936.7	4372.5	x	3032.6	3225.8	4857.8	x	3911.0	x	x	5327.2	x	3025.2	x	3056.0	x	x	x	x	x	3192.8	x	x	2058.2	x	x	3309.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13455	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm]	x	4089.1	2730.3	x	x	4032.1	3325.7	4749.6	x	3318.5	3986.0	4012.6	x	3300.0	x	x	4808.9	x	2411.2	x	x	x	x	x	x	x	2740.2	x	x	3820.8	x	x	3277.2	x	x	x	x	3437.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13456	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm]	x	4281.9	6435.2	x	x	4436.6	6579.0	5293.1	x	4507.0	3643.0	x	x	5045.9	x	x	6075.2	x	7352.5	x	4144.4	x	x	x	x	x	3672.0	x	x	4486.6	x	x	4580.8	x	x	x	x	3931.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13457	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm]	x	4657.7	5235.5	x	x	3729.5	6186.5	5020.8	x	4239.4	3363.2	4434.7	x	5461.8	x	x	4864.4	x	4305.8	x	3847.2	x	x	x	x	x	3696.0	x	x	2758.0	x	x	4526.3	x	x	x	x	4282.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13458	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model Females only [% WT] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model Females only [% WT]	Central nervous system, behavior: Open field activity (OFA), total distance by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [% of wildtype control]	Central nervous system, behavior: Open field activity (OFA), total distance by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [% of wildtype control]	x	103.8	54.1	x	x	72.8	44.6	82.6	x	67.3	88.5	x	x	77.5	x	x	87.7	x	41.1	x	73.7	x	x	x	x	x	86.9	x	x	45.9	x	x	72.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13459	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT]	x	87.8	52.1	x	x	108.1	53.8	94.6	x	78.3	118.5	90.5	x	60.4	x	x	98.9	x	55.9	x	x	x	x	x	x	x	74.1	x	x	138.5	x	x	72.4	x	x	x	x	80.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13460	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing in open field test by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [n beam breaks]	Central nervous system, behavior: Rearing in open field test by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [n beam breaks]	x	301.6	104.9	x	x	162.1	92.7	133.7	x	232.5	133.1	184.0	x	131.2	x	x	251.7	x	89.7	x	177.0	x	x	x	x	x	295.6	x	x	142.0	x	x	162.1	x	x	x	x	170.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13461	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks]	x	289.1	106.7	x	x	233.1	140.7	191.2	x	295.4	32.4	200.0	x	97.8	x	x	224.5	x	112.7	x	x	x	x	x	x	x	126.3	x	x	270.1	x	x	205.2	x	x	x	x	144.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13462	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks]	x	396.6	376.2	x	x	448.1	369.1	388.6	x	362.1	263.0	405.0	x	319.3	x	x	495.4	x	439.6	x	377.8	x	x	x	x	x	295.6	x	x	329.0	x	x	387.1	x	x	x	x	350.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13463	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks]	x	546.1	501.3	x	x	408.1	469.3	471.2	x	480.7	268.4	489.0	x	473.6	x	x	497.3	x	383.3	x	555.6	x	x	x	x	x	389.0	x	x	325.3	x	x	458.1	x	x	x	x	341.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13464	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	x	76.0	27.9	x	x	36.2	25.1	34.4	x	64.2	50.6	45.4	x	41.1	x	x	50.8	x	20.4	x	46.9	x	x	x	x	x	53.6	x	x	43.2	x	x	41.9	x	x	x	x	48.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13465	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	x	52.9	21.3	x	x	57.1	29.9	40.6	x	61.5	119.4	40.9	x	20.7	x	x	45.1	x	29.4	x	x	x	x	x	x	x	32.5	x	x	83.0	x	x	44.8	x	x	x	x	42.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13466	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm]	x	21.9	17.0	x	x	21.0	17.7	17.5	x	22.8	17.5	18.3	x	18.8	x	x	20.2	x	15.9	x	19.9	x	x	x	x	x	18.7	x	x	20.8	x	x	20.4	x	x	x	x	22.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13467	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm]	x	27.5	21.6	x	x	26.5	24.5	25.0	x	26.5	21.3	23.1	x	22.8	x	x	24.6	x	20.6	x	x	x	x	x	x	x	24.1	x	x	26.2	x	x	26.8	x	x	x	x	26.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13468	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype]	x	100.5	89.5	x	x	99.1	92.2	87.5	x	105.1	93.1	97.9	x	92.6	x	x	99.5	x	85.5	x	98.0	x	x	x	x	x	93.0	x	x	92.4	x	x	95.8	x	x	x	x	109.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13469	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype]	x	98.2	86.7	x	x	96.7	88.9	86.8	x	94.6	90.3	98.7	x	83.5	x	x	90.8	x	86.9	x	x	x	x	x	x	x	95.6	x	x	90.7	x	x	92.9	x	x	x	x	96.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13470	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm]	x	21.8	19.0	x	x	21.2	19.2	20.0	x	21.7	18.8	18.7	x	20.3	x	x	20.3	x	18.6	x	20.3	x	x	x	x	x	20.1	x	x	22.5	x	x	21.3	x	x	x	x	20.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13471	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm]	x	28.0	24.9	x	x	27.4	24.5	25.0	x	28.0	23.6	23.4	x	27.3	x	x	27.1	x	23.7	x	25.2	x	x	x	x	x	25.2	x	x	28.9	x	x	26.8	x	x	x	x	27.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13472	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec]	x	59.8	113.8	x	x	118.7	167.8	174.2	x	117.0	206.3	187.4	x	168.2	x	x	222.8	x	180.3	x	89.6	x	x	x	x	x	110.5	x	x	156.3	x	x	142.3	x	x	x	x	159.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13473	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	x	51.8	92.0	x	x	72.4	90.6	94.1	x	74.2	108.3	75.6	x	61.3	x	x	68.0	x	99.7	x	x	x	x	x	x	x	76.7	x	x	58.2	x	x	75.3	x	x	x	x	76.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13474	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec]	x	135.66	x	x	x	118.79	158.8	174.2	x	117.0	206.39	187.42	x	168.29	x	x	222.82	x	180.33	x	122.07	x	x	x	x	x	110.55	x	x	156.33	x	x	142.31	x	x	x	x	159.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13475	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec]	Central nervous system, behavior: Motor performance, accelerating rotarod test, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec]	x	124.1	138.3	x	x	120.4	95.8	155.7	x	96.2	171.0	145.2	x	136.5	x	x	143.9	x	166.5	x	119.9	x	x	x	x	x	101.9	x	x	103.3	x	x	136.2	x	x	x	x	114.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13476	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	x	44.1	82.5	x	x	70.1	57.2	60.5	x	62.6	58.8	69.3	x	41.4	x	x	46.1	x	54.7	x	73.4	x	x	x	x	x	59.5	x	x	59.4	x	x	59.0	x	x	x	x	46.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13477	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	x	41.7	66.5	x	x	60.1	94.6	60.4	x	77.1	63.3	52.1	x	44.9	x	x	47.3	x	59.9	x	x	x	x	x	x	x	75.3	x	x	56.3	x	x	55.3	x	x	x	x	66.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13478	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	x	27.6	62.6	x	x	48.4	73.9	60.4	x	48.5	56.5	53.0	x	48.4	x	x	41.5	x	60.1	x	x	x	x	x	x	x	45.3	x	x	49.5	x	x	50.3	x	x	x	x	38.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13479	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	x	30.5	64.2	x	x	44.7	45.9	60.5	x	50.2	57.9	62.7	x	34.9	x	x	46.9	x	47.2	x	58.9	x	x	x	x	x	47.6	x	x	63.6	x	x	58.0	x	x	x	x	50.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13480	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec]	x	67.9	133.3	x	x	98.9	98.8	105.4	x	98.0	150.2	154.5	x	83.9	x	x	109.2	x	121.1	x	98.1	x	x	x	x	x	76.0	x	x	121.9	x	x	114.4	x	x	x	x	106.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13481	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	x	56.8	128.2	x	x	103.2	124.9	94.1	x	89.6	158.4	124.8	x	91.9	x	x	86.5	x	136.8	x	x	x	x	x	x	x	83.3	x	x	80.8	x	x	104.6	x	x	x	x	80.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13482	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec]	x	222.3	207.5	x	x	221.5	215.1	174.2	x	195.2	259.0	246.3	x	240.5	x	x	232.8	x	256.7	x	166.6	x	x	x	x	x	159.7	x	x	191.8	x	x	197.2	x	x	x	x	210.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13483	Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec]	Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec]	x	205.7	204.9	x	x	213.2	169.0	155.7	x	184.7	280.3	235.3	x	189.7	x	x	208.3	x	227.7	x	182.4	x	x	x	x	x	184.0	x	x	163.1	x	x	208.1	x	x	x	x	208.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13484	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)]	x	x	0.562	0.702	0.602	0.585	x	x	0.629	x	0.572	0.539	0.653	x	x	0.561	x	x	x	x	x	x	x	x	x	0.585	0.786	0.701	x	0.555	0.591	0.608	0.561	x	x	x	x	0.658	0.519	x	0.562	0.881	x	x	x	x	x	x	x	0.759	x	x	x	0.726	x	x	x	x	x	0.814	x	x	x	0.855	x	x	0.831	0.669	x	x	x	0.737	x	0.648	x	x	x	x	x	x	x	x	x	x	x	0.622	x	x	0.711	x	x	x	x	x	0.776	x	x	x	x	x	x	x	
-13485	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%]	x	25.6	2.5	x	x	14.5	1.7	12.8	x	20.9	28.6	5.7	x	25.1	x	x	5.8	x	39.9	x	14.7	x	x	x	x	x	9.1	x	x	8.2	x	x	19.7	x	x	x	x	34.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13486	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]	x	x	-1.863	-1.254	-1.655	-1.839	x	x	-1.737	x	-1.74	-1.922	-1.727	x	x	-1.715	x	x	x	x	x	x	x	x	x	-1.686	-1.683	-1.596	x	-1.842	-1.788	-1.7	-1.804	x	x	x	x	-1.747	-1.848	x	-1.857	-1.282	x	x	x	x	x	x	x	-1.603	x	x	x	-1.898	x	x	x	x	x	-1.763	x	x	x	-1.514	x	x	-1.344	-1.574	x	x	x	-1.742	x	-1.762	x	x	x	x	x	x	x	x	x	x	x	-1.604	x	x	-1.362	x	x	x	x	x	-1.711	x	x	x	x	x	x	x	
-13487	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak amplitude, both sexes at 2 weeks-of-age [ln(uV)]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak amplitude, both sexes at 2 weeks-of-age [ln(uV)]	x	x	1.088	1.028	0.934	1.146	x	x	1.492	x	1.42	0.907	1.638	x	x	1.412	x	x	x	x	x	x	x	x	x	1.239	1.713	1.278	x	1.131	1.153	1.257	1.519	x	x	x	x	1.563	0.933	x	1.116	1.269	x	x	x	x	x	x	x	2.03	x	x	x	1.333	x	x	x	x	x	1.35	x	x	x	1.255	x	x	1.715	1.38	x	x	x	1.751	x	0.838	x	x	x	x	x	x	x	x	x	x	x	1.476	x	x	1.084	x	x	x	x	x	1.693	x	x	x	x	x	x	x	
-13488	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak frequency, both sexes at 2 weeks-of-age [Hz]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak frequency, both sexes at 2 weeks-of-age [Hz]	x	x	18.933	20.396	20.616	18.697	x	x	22.418	x	19.745	17.061	19.468	x	x	20.594	x	x	x	x	x	x	x	x	x	18.824	22.052	21.3	x	17.438	16.964	16.142	18.35	x	x	x	x	20.356	18.958	x	18.457	21.252	x	x	x	x	x	x	x	22.048	x	x	x	21.225	x	x	x	x	x	21.213	x	x	x	19.611	x	x	21.025	20.334	x	x	x	21.713	x	17.384	x	x	x	x	x	x	x	x	x	x	x	20.206	x	x	20.409	x	x	x	x	x	21.624	x	x	x	x	x	x	x	
-13489	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%]	x	19.1	0.01	x	x	25.9	7.4	17.0	x	14.0	18.0	19.6	x	9.0	x	x	9.9	x	12.3	x	x	x	x	x	x	x	2.5	x	x	5.6	x	x	23.6	x	x	x	x	18.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13490	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)]	x	x	0.194	0.16	0.167	0.263	x	x	0.359	x	0.303	0.243	0.366	x	x	0.4	x	x	x	x	x	x	x	x	x	0.327	0.533	0.367	x	0.213	0.221	0.364	0.452	x	x	x	x	0.39	0.202	x	0.257	0.23	x	x	x	x	x	x	x	0.524	x	x	x	0.294	x	x	x	x	x	0.386	x	x	x	0.33	x	x	0.318	0.382	x	x	x	0.402	x	0.237	x	x	x	x	x	x	x	x	x	x	x	0.379	x	x	0.27	x	x	x	x	x	0.42	x	x	x	x	x	x	x	
-13491	Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]	None	Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]	x	x	-0.757	-0.882	-0.925	-0.581	x	x	0.02	x	-0.284	-0.729	-0.041	x	x	-0.137	x	x	x	x	x	x	x	x	x	-0.359	0.407	-0.63	x	-0.494	-0.686	-0.574	-0.072	x	x	x	x	-0.225	-0.822	x	-0.78	-0.673	x	x	x	x	x	x	x	0.441	x	x	x	-0.225	x	x	x	x	x	-0.367	x	x	x	-0.442	x	x	-0.249	-0.274	x	x	x	0.324	x	-0.803	x	x	x	x	x	x	x	x	x	x	x	-0.251	x	x	-0.659	x	x	x	x	x	0.4	x	x	x	x	x	x	x	
-13492	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%]	x	32.0	15.1	x	x	30.0	18.4	22.6	x	31.7	47.9	27.8	x	20.8	x	x	43.6	x	24.8	x	37.3	x	x	x	x	x	17.6	x	x	14.9	x	x	40.2	x	x	x	x	56.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13493	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%]	x	45.8	11.4	x	x	42.2	25.3	46.9	x	21.6	36.4	8.9	x	12.0	x	x	49.9	x	32.1	x	36.0	x	x	x	x	x	36.3	x	x	29.0	x	x	34.2	x	x	x	x	51.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13494	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%]	Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%]	Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%]	x	80.0	16.6	x	x	48.3	9.2	56.6	x	65.9	59.7	20.5	x	120.7	x	x	13.3	x	160.9	x	39.4	x	x	x	x	x	51.7	x	x	55.0	x	x	49.0	x	x	x	x	60.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13495	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%]	Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%]	Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%]	x	41.7	0.09	x	x	61.4	29.2	36.2	x	64.8	49.5	220.2	x	75.0	x	x	19.8	x	38.3	x	x	x	x	x	x	x	6.9	x	x	19.3	x	x	69.0	x	x	x	x	35.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13496	Original post publication description: Musculoskeletal system, morphology: Femur Cortical Thickness (F.Ct.Th) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid201	Musculoskeletal system, morphology: VDavid201	Musculoskeletal system, morphology: Femur cortical thickness (F.Ct.Th) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm]	x	0.202	x	x	x	x	x	x	x	x	0.202	x	x	0.186	x	x	x	x	x	x	x	x	x	0.23	x	x	x	x	x	x	0.226	x	x	x	x	x	x	x	x	x	0.192	x	0.201	0.196	x	x	0.188	0.211	0.196	x	x	x	x	x	0.204	x	x	x	0.166	x	0.215	0.194	x	x	x	x	0.225	0.177	0.193	x	x	0.197	x	x	x	x	x	0.226	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.202	0.193	0.188	0.154	
-13497	Original post publication description: Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid202	Musculoskeletal system, morphology: VDavid202	Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3]	x	1039.45	x	x	x	x	x	x	x	x	1024.02	x	x	1009.8	x	x	x	x	x	x	x	x	x	1059.34	x	x	x	x	x	x	1066.59	x	x	x	x	x	x	x	x	x	1060.39	x	1075.65	1038.89	x	x	993.089	1038.68	1049.82	x	x	x	x	x	1082.08	x	x	x	979.418	x	1066.01	1060.34	x	x	x	x	1073.98	1000.84	1039.83	x	x	1055.58	x	x	x	x	x	1108.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1063.14	1037.64	1046.76	995.721	
-13498	Original post publication description: Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid203.	Musculoskeletal system, morphology: VDavid203.	Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3]	x	1116.35	x	x	x	x	x	x	x	x	1096.27	x	x	1090.33	x	x	x	x	x	x	x	x	x	1130.19	x	x	x	x	x	x	1140.08	x	x	x	x	x	x	x	x	x	1146.15	x	1158.63	1118.38	x	x	1069.31	1114.82	1131.13	x	x	x	x	x	1163.83	x	x	x	1062.87	x	1140.75	1147.19	x	x	x	x	1149.39	1085.53	1120.75	x	x	1140.85	x	x	x	x	x	1188.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1092.21	1116.62	1128.83	1086.33	
-13499	Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid204	Musculoskeletal system, morphology: VDavid204	Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3]	x	1.517	x	x	x	x	x	x	x	x	1.633	x	x	1.526	x	x	x	x	x	x	x	x	x	1.285	x	x	x	x	x	x	1.505	x	x	x	x	x	x	x	x	x	1.725	x	2.355	2.023	x	x	1.772	2.195	1.646	x	x	x	x	x	1.762	x	x	x	1.491	x	1.992	1.663	x	x	x	x	1.791	1.483	1.66	x	x	1.715	x	x	x	x	x	1.515	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.014	1.591	1.506	1.131	
-13500	Original post publication description: Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid205.	Musculoskeletal system, morphology: VDavid205.	Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.55	x	x	x	x	x	x	x	x	0.574	x	x	0.516	x	x	x	x	x	x	x	x	x	0.535	x	x	x	x	x	x	0.579	x	x	x	x	x	x	x	x	x	0.565	x	0.547	0.579	x	x	0.564	0.652	0.559	x	x	x	x	x	0.583	x	x	x	0.434	x	0.639	0.498	x	x	x	x	0.573	0.447	0.502	x	x	0.496	x	x	x	x	x	0.552	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.645	0.535	0.519	0.37	
-13501	Original post publication description: Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid206	Musculoskeletal system, morphology: VDavid206	Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.967	x	x	x	x	x	x	x	x	1.059	x	x	1.011	x	x	x	x	x	x	x	x	x	0.75	x	x	x	x	x	x	0.926	x	x	x	x	x	x	x	x	x	1.16	x	1.808	1.444	x	x	1.208	1.542	1.087	x	x	x	x	x	1.179	x	x	x	1.057	x	1.353	1.165	x	x	x	x	1.218	1.036	1.158	x	x	1.219	x	x	x	x	x	0.963	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.369	1.055	0.987	0.76	
-13502	Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid207.	Musculoskeletal system, morphology: VDavid207.	Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2]	x	1.935	x	x	x	x	x	x	x	x	2.082	x	x	1.947	x	x	x	x	x	x	x	x	x	1.639	x	x	x	x	x	x	1.919	x	x	x	x	x	x	x	x	x	2.2	x	3.004	2.581	x	x	2.26	2.799	2.099	x	x	x	x	x	2.248	x	x	x	1.902	x	2.541	2.121	x	x	x	x	2.284	1.892	2.117	x	x	2.188	x	x	x	x	x	1.932	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.569	2.029	1.921	1.443	
-13503	Original post publication description: Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid208	Musculoskeletal system, morphology: VDavid208	Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2]	x	0.702	x	x	x	x	x	x	x	x	0.732	x	x	0.658	x	x	x	x	x	x	x	x	x	0.683	x	x	x	x	x	x	0.738	x	x	x	x	x	x	x	x	x	0.721	x	0.698	0.739	x	x	0.719	0.832	0.713	x	x	x	x	x	0.744	x	x	x	0.554	x	0.815	0.635	x	x	x	x	0.73	0.57	0.64	x	x	0.632	x	x	x	x	x	0.704	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.822	0.683	0.662	0.473	
-13504	Original post publication description: Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid209.	Musculoskeletal system, morphology: VDavid209.	Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2]	x	1.233	x	x	x	x	x	x	x	x	1.351	x	x	1.289	x	x	x	x	x	x	x	x	x	0.956	x	x	x	x	x	x	1.181	x	x	x	x	x	x	x	x	x	1.479	x	2.306	1.842	x	x	1.541	1.967	1.386	x	x	x	x	x	1.504	x	x	x	1.349	x	1.726	1.486	x	x	x	x	1.554	1.321	1.477	x	x	1.555	x	x	x	x	x	1.229	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.747	1.346	1.259	0.97	
-13505	Original post publication description: Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid210	Musculoskeletal system, morphology: VDavid210	Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.228	x	x	x	x	x	x	x	x	0.249	x	x	0.22	x	x	x	x	x	x	x	x	x	0.174	x	x	x	x	x	x	0.217	x	x	x	x	x	x	x	x	x	0.265	x	0.222	0.278	x	x	0.277	0.367	0.249	x	x	x	x	x	0.257	x	x	x	0.163	x	0.312	0.188	x	x	x	x	0.217	0.16	0.187	x	x	0.187	x	x	x	x	x	0.193	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.342	0.224	0.21	0.113	
-13506	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid211.	Musculoskeletal system, morphology: VDavid211.	Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.149	x	x	x	x	x	x	x	x	0.165	x	x	0.133	x	x	x	x	x	x	x	x	x	0.119	x	x	x	x	x	x	0.141	x	x	x	x	x	x	x	x	x	0.173	x	0.15	0.19	x	x	0.181	0.236	0.156	x	x	x	x	x	0.168	x	x	x	0.108	x	0.217	0.13	x	x	x	x	0.146	0.104	0.122	x	x	0.132	x	x	x	x	x	0.127	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.231	0.147	0.13	0.073	
-13507	Original post publication description: Infectious disease, immune function: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Original pre publication description: Infectious disease, immune function: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	x	x	1.0	0.0	0.0	x	x	x	x	0.0	x	x	0.0	x	x	x	x	x	x	x	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.0	x	x	x	x	0.25	x	1.0	x	x	x	1.0	1.0	x	x	x	x	1.0	x	x	x	x	x	0.75	0.0	0.0	0.5	1.0	0.75	x	0.0	0.0	1.0	x	x	0.0	x	0.6	x	x	x	x	1.0	x	x	1.0	x	x	0.2	1.0	x	x	1.0	x	x	x	x	x	1.0	x	x	x	x	x	x	0.833	
-13508	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid212	Musculoskeletal system, morphology: VDavid212	Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2]	x	0.08	x	x	x	x	x	x	x	x	0.085	x	x	0.086	x	x	x	x	x	x	x	x	x	0.055	x	x	x	x	x	x	0.075	x	x	x	x	x	x	x	x	x	0.092	x	0.072	0.088	x	x	0.096	0.131	0.093	x	x	x	x	x	0.089	x	x	x	0.055	x	0.095	0.058	x	x	x	x	0.071	0.056	0.065	x	x	0.055	x	x	x	x	x	0.065	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.111	0.077	0.079	0.04	
-13509	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid213.	Musculoskeletal system, morphology: VDavid213.	Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.189	x	x	x	x	x	x	x	x	0.2	x	x	0.173	x	x	x	x	x	x	x	x	x	0.155	x	x	x	x	x	x	0.186	x	x	x	x	x	x	x	x	x	0.21	x	0.184	0.217	x	x	0.213	0.264	0.189	x	x	x	x	x	0.204	x	x	x	0.146	x	0.233	0.165	x	x	x	x	0.183	0.142	0.16	x	x	0.16	x	x	x	x	x	0.168	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.248	0.184	0.171	0.108	
-13510	Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid214.	Musculoskeletal system, morphology: VDavid214.	Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3]	x	0.142	x	x	x	x	x	x	x	x	0.15	x	x	0.143	x	x	x	x	x	x	x	x	x	0.11	x	x	x	x	x	x	0.136	x	x	x	x	x	x	x	x	x	0.158	x	0.136	0.15	x	x	0.159	0.192	0.153	x	x	x	x	x	0.154	x	x	x	0.102	x	0.163	0.116	x	x	x	x	0.129	0.105	0.121	x	x	0.108	x	x	x	x	x	0.123	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.187	0.138	0.14	0.084	
-13511	Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg]	x	232.6	229.9	x	x	229.5	254.9	223.6	x	238.8	239.4	229.6	x	231.7	x	x	230.6	x	223.9	x	239.6	x	x	x	x	x	247.7	x	x	212.5	x	x	234.0	x	x	x	x	235.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13512	Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg]	x	190.8	205.6	x	x	195.4	221.3	181.7	x	205.8	191.5	206.6	x	193.0	x	x	197.7	x	208.7	x	196.9	x	x	x	x	x	197.4	x	x	198.7	x	x	195.9	x	x	x	x	195.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13513	Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]	x	82.0	89.4	x	x	85.1	86.8	81.2	x	86.1	79.9	89.9	x	83.2	x	x	85.7	x	93.2	x	82.1	x	x	x	x	x	79.6	x	x	93.5	x	x	83.0	x	x	x	x	83.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13514	Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight]	x	0.0097	0.0106	x	x	0.0092	0.0116	0.0098	x	0.0099	0.0116	0.0109	x	0.0103	x	x	0.0096	x	0.0107	x	0.0111	x	x	x	x	x	0.0105	x	x	0.0083	x	x	0.0099	x	x	x	x	0.0092	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13515	Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight]	x	0.0077	0.0107	x	x	0.0084	0.0114	0.0091	x	0.0085	0.0098	0.0103	x	0.0092	x	x	0.009	x	0.0113	x	0.0096	x	x	x	x	x	0.0093	x	x	0.0083	x	x	0.009	x	x	x	x	0.0078	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13516	Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight]	Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight]	x	79.3	100.9	x	x	91.3	98.2	92.8	x	85.8	84.4	94.4	x	89.3	x	x	93.7	x	105.6	x	86.4	x	x	x	x	x	88.5	x	x	100.0	x	x	90.9	x	x	x	x	84.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13518	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm]	x	2.83	0.05	x	x	-4.17	-0.54	-1.26	x	0.236	0.48	1.72	x	-0.19	x	x	0.29	x	-1.39	x	x	x	x	x	x	x	0.61	x	x	0.52	x	x	-1.1	x	x	x	x	-0.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13519	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm]	x	-2.82	-4.47	x	x	-4.17	-4.64	-5.4	x	-1.3	-3.33	-3.11	x	-4.14	x	x	-4.09	x	-5.24	x	-1.7	x	x	x	x	x	-4.83	x	x	-4.95	x	x	-3.44	x	x	x	x	-3.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13520	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [gm]	Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]	x	-75.25	-33.63	x	x	-41.64	-27.32	-65.34	x	-35.33	-77.94	-56.23	x	-91.12	x	x	-94.51	x	-74.37	x	-34.54	x	x	x	x	x	-32.17	x	x	-57.76	x	x	-58.52	x	x	x	x	-45.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13521	Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm]	Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm]	x	0.61	-2.54	x	x	-1.59	-2.69	-2.72	x	x	-1.09	-1.08	x	x	x	x	-14.46	x	-3.1	x	-0.99	x	x	x	x	x	-1.43	x	x	-1.67	x	x	-1.85	x	x	x	x	-0.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13522	Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]	x	153.4	-75.28	x	x	-115.23	-75.36	-88.58	x	-96.04	-112.87	-98.03	x	-132.85	x	x	-122.81	x	123.06	x	-75.78	x	x	x	x	x	-95.31	x	x	-80.18	x	x	-91.24	x	x	x	x	-121.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13523	Original post publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED Female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED Female R6/2 cases only [sec]	Central nervous system, behavior: Motor performance measured by the rotarod test on day 1 (first test) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model (corrected female R6/2 cases only) [sec]	Central nervous system, behavior: Motor performance measured by the rotarod test on day 1 (first test) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model (corrected female R6/2 cases only) [sec]	x	-70.39	-24.28	x	x	x	-24.81	-57.97	x	-35.66	-70.25	-33.37	x	-86.49	x	x	-73.72	x	-74.77	x	-31.83	x	x	x	x	x	-38.99	x	x	-36.95	x	x	-55.46	x	x	x	x	-47.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13524	Original post publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	x	-78.39	-46.1	x	x	-47.39	-30.1	-69.33	x	-34.72	-83.32	-87.66	x	-94.83	x	x	-108.37	x	-74.06	x	x	x	x	x	x	x	-28.08	x	x	-71.63	x	x	64.2	x	x	x	x	-45.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13525	Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec]	Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec]	Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec]	x	-146.65	-73.06	x	x	-117.27	-83.3	-74.3	x	-93.12	-117.7	85.53	x	-137.28	x	x	-109.19	x	-121.06	x	-72.6	x	x	x	x	x	-99.85	x	x	-55.49	x	x	-87.82	x	x	x	x	-102.88	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13526	Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	Central nervous system, behavior: day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	Central nervous system, behavior: motor performance, accelerating rotarod test, day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]	x	-157.76	-78.23	x	x	-112.89	-66.53	-96.31	x	-101.46	-109.49	-115.23	x	-129.31	x	x	-131.89	x	-124.65	x	x	x	x	x	x	x	92.58	x	x	96.64	x	x	-97.61	x	x	x	x	-128.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13527	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm]	x	-12.73	-2425.18	x	x	-750.99	-3213.52	-761.75	x	-1370.32	-300.53	-393.47	x	-1293.38	x	x	-35.75	x	-2803.92	x	-1010.21	x	x	x	x	x	-525.17	x	x	-1564.08	x	x	-1246.11	x	x	x	x	-597.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13528	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm]	x	-368.91	-3186.45	x	x	53.02	-2855.36	-384.62	x	-1084.37	459.58	-1238.67	x	-1904.38	x	x	-554.08	x	-3444.97	x	x	x	x	x	x	x	-997.8	x	x	208.5	x	x	-1278.59	x	x	x	x	-786.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13529	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks]	x	-165.08	-325.32	x	x	-260.17	-316.47	-303.02	x	-175.43	-132.11	-268.91	x	-246.89	x	x	-244.78	x	-321.75	x	-247.63	x	x	x	x	x	-199.37	x	x	-185.17	x	x	-252.56	x	x	x	x	-172.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13530	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks]	x	-177.6	-323.54	x	x	-189.15	-272.95	-245.54	x	-112.85	55.21	-253.0	x	-280.34	x	x	-272.03	x	-309.5	x	x	x	x	x	x	x	-231.57	x	x	-57.0	x	x	-214.42	x	x	x	x	-198.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13531	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%]	x	-12.9	-10.9	x	x	-23.3	-22.1	-23.9	x	-6.91	-14.4	-11.3	x	-15.0	x	x	-41.4	x	11.44	x	-22.2	x	x	x	x	x	-21.0	x	x	-15.7	x	x	-17.7	x	x	x	x	18.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13532	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%]	x	-19.3	-13.5	x	x	-11.9	-11.7	-19.8	x	-13.7	-25.0	2.55	x	-8.49	x	x	-37.3	x	-16.0	x	x	x	x	x	x	x	-27.6	x	x	-163.3	x	x	-13.8	x	x	x	x	-34.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13533	Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only	Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only	x	2.83	2.2	x	x	2.01	2.49	2.73	x	3.38	2.58	0.98	x	2.34	x	x	-0.69	x	3.56	x	1.51	x	x	x	x	x	1.84	x	x	0.93	x	x	2.58	x	x	x	x	1.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13534	Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm]	Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm]	x	-228.98	-2751.44	x	x	-375.79	-3043.87	-517.13	x	-1270.24	146.58	-749.34	x	-1632.82	x	x	-346.75	x	-3160.06	x	-1091.21	x	x	x	x	x	-808.06	x	x	-500.53	x	x	-1257.48	x	x	x	x	-739.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13535	Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks]	Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks]	x	-172.68	-324.56	x	x	-227.02	-295.85	-265.74	x	-153.53	-21.92	-262.21	x	-265.47	x	x	261.13	x	-314.94	x	-247.0	x	x	x	x	x	-219.5	x	x	-108.27	x	x	-242.46	x	x	x	x	-191.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13536	Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio] Original pre publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio]	Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio]	Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio]	x	-0.01	-0.04	x	x	-0.02	-0.06	0.0	x	0.0	0.0	-0.05	x	0.02	x	x	0.0	x	0.0	x	-0.06	x	x	x	x	x	-0.03	x	x	0.06	x	x	-0.01	x	x	x	x	-0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13537	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]	x	22.94	17.74	x	x	17.36	17.53	15.3	x	6.34	4.67	4.95	x	9.3	x	x	18.15	x	12.64	x	9.67	x	x	x	x	x	15.26	x	x	15.0	x	x	35.1	x	x	x	x	18.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13538	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	x	-84.09	-68.86	x	x	27.43	-70.45	-41.49	x	-92.82	-109.12	-11.85	x	-53.46	x	x	-23.78	x	7.7	x	-59.49	x	x	x	x	x	-4.68	x	x	-112.5	x	x	-113.97	x	x	x	x	-100.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13539	Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]	x	22.7	-65.78	x	x	-106.22	12.83	-62.1	x	-82.91	-47.64	3.03	x	-46.58	x	x	28.09	x	-55.97	x	-44.51	x	x	x	x	x	-42.26	x	x	-7.07	x	x	-45.26	x	x	x	x	-25.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13540	Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units] Original pre publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units]	Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units]	Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units]	x	2.26	177.0	x	x	37.11	63.82	-29.0	x	-14.2	196.0	179.6	x	204.2	x	x	119.4	x	575.3	x	90.29	x	x	x	x	x	-92.9	x	x	-653.0	x	x	79.61	x	x	x	x	-228.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13541	Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%]	Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%]	x	-16.8	-12.0	x	x	-18.0	-17.2	-21.2	x	-9.32	-20.7	-5.5	x	-11.3	x	x	-38.9	x	-3.84	x	-20.1	x	x	x	x	x	-25.1	x	x	-16.0	x	x	-16.4	x	x	x	x	-30.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13542	Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency at time point 0 hours using cryorederived hepatocytes from young adult male liver [attached cells/cell] Original pre publication description: CQ-5	Liver, metabolism, toxicology: CQ-5	Liver, metabolism, toxicology: Hepatocyte general viability at 0 hr post-thaw in suspension, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well]	x	x	47450.0	35508.0	38367.0	45022.0	51008.0	54457.0	x	x	35930.0	x	40045.0	55541.0	50044.0	42710.0	47937.0	42486.0	x	39821.0	28721.0	x	x	x	x	43031.0	43016.0	51463.0	x	34848.0	34293.0	x	x	x	x	x	35437.0	42140.0	48097.0	x	38398.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13543	Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency at time point 4 hours using cryorederived hepatocytes from young adult male liver [attached cells/cell] Original pre publication description: CQ-6	Liver, metabolism, toxicology: CQ-6	Liver, metabolism, toxicology: Hepatocyte general viability at 4 hr post-thaw on plates, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well]	x	x	53497.0	44332.0	21059.0	32272.0	20508.0	32795.0	x	x	49123.0	x	39624.0	50016.0	37801.0	46734.0	34950.0	48402.0	x	25099.0	21079.0	x	x	x	x	41726.0	27329.0	45056.0	x	47401.0	36261.0	x	x	x	x	x	35772.0	36958.0	51124.0	x	40556.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13546	Original post publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Cerebellum, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch [mg]	Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight [residual mg]	Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight [residual mg]	6.109	5.671	4.59	-2.9	5.57	-5.14	8.17	-2.32	2.84	-1.34	-0.61	-6.15	-5.41	-4.34	-6.4	-0.66	-0.77	-2.34	-2.83	-5.44	0.99	-2.51	x	-2.63	-0.64	-4.25	-1.75	-2.89	2.27	-4.52	-1.37	-0.99	-0.8	-1.7	-7.83	5.68	-2.56	0.56	-0.6	x	5.18	2.98	2.51	11.06	x	x	4.82	x	-0.1	1.44	x	x	x	1.94	-3.25	x	x	x	-0.42	6.88	3.48	x	x	-0.73	-2.55	x	x	8.69	1.47	x	x	0.65	x	1.38	x	1.42	x	x	-4.63	x	x	6.38	x	-0.76	5.89	-3.71	x	-3.13	-1.93	x	-0.59	x	x	x	-0.39	0.15	0.89	2.15	3.75	x	x	x	
-13545	Original post publication description: BrdU+ cells/mm of RMS length in BXD RI Original pre publication description: BrdU+ cells/mm of RMS length in BXD RI	Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in young adult rostral migratory stream (RMS), unadjusted data [N per mm of RMS length]	Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in young adult rostral migratory stream (RMS), unadjusted data [N per mm of RMS length]	x	x	43.17	73.34	61.91	61.0	x	63.35	46.7	68.35	54.38	66.93	47.35	65.09	74.18	73.89	54.55	40.23	84.87	63.27	x	x	x	54.62	x	58.82	96.09	96.67	x	58.29	62.03	48.81	69.02	x	x	x	84.91	103.21	58.94	x	59.81	64.3	58.32	60.86	x	x	68.75	x	44.29	57.16	x	x	x	36.79	60.72	x	x	x	52.71	65.48	52.55	40.56	x	53.66	62.32	82.46	111.83	x	x	67.67	x	58.07	x	77.79	x	63.83	x	x	68.1	x	x	64.37	90.27	66.43	68.7	70.34	x	74.8	76.06	x	60.5	x	x	x	64.52	53.44	74.21	89.23	68.77	x	x	x	
-13548	Original post publication description: Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3]	Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3]	Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3]	x	x	0.492	-0.738	3.69	-2.444	5.776	-2.58	-0.891	2.093	2.646	-0.89	-3.049	-0.73	-0.595	-1.201	-0.84	1.202	-1.659	1.983	3.761	-2.325	x	0.658	-1.486	-1.656	-1.639	-2.458	-2.026	-1.388	4.309	1.856	0.445	-1.526	-0.188	x	-1.842	0.036	1.573	x	2.129	-0.836	3.583	-0.809	x	x	x	x	x	1.689	x	x	x	x	x	x	x	x	0.402	x	2.065	0.408	x	x	x	x	x	-0.775	x	x	x	0.911	x	-0.652	x	-0.157	x	x	x	x	x	1.211	x	-1.507	3.059	-1.705	x	-3.585	-1.652	x	-1.588	x	x	x	x	-1.559	x	x	x	x	x	x	
-13549	Original post publication description: Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3] Original pre publication description: Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3]	Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, body weight (Hager et al., 2012, data from Mozhui et al. 2007) [residual mm^3]	Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, body weight (Hager et al., 2012, data from Mozhui et al. 2007) [residual mm^3]	0.244	0.363	0.158	0.085	0.071	-0.088	0.104	-0.218	0.03	0.057	0.057	-0.022	-0.124	-0.035	-0.072	0.04	-0.013	0.316	0.032	-0.004	0.102	-0.009	x	0.017	-0.039	-0.032	-0.091	-0.378	-0.283	0.04	0.211	-0.201	0.016	-0.008	0.001	0.083	-0.046	-0.133	0.027	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13550	Original post publication description: Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mm^3] Original pre publication description: Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mm^3]	Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3]	Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3]	x	x	10.901	-10.901	9.828	-11.162	25.348	-20.623	6.966	10.256	7.86	-4.389	-0.234	-1.469	8.674	-2.024	-4.873	3.076	-3.614	5.01	6.013	9.543	x	-0.559	1.746	-8.595	-2.957	-11.075	-27.757	-12.506	8.058	-0.875	1.139	-3.006	-0.319	x	-3.698	5.88	7.524	x	-0.403	-1.346	9.195	-0.165	x	x	-18.728	x	x	9.658	x	x	x	x	x	x	x	x	-5.824	x	6.727	4.659	x	x	x	x	x	-3.906	x	x	x	4.393	x	-3.857	x	-3.189	x	x	x	x	x	11.074	x	-3.244	15.296	-8.499	x	8.545	-0.383	x	-11.737	x	x	x	x	-5.94	x	x	x	x	x	x	
-13551	Original post publication description: Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg]	Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]	Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]	1.253	1.231	2.082	-3.107	2.044	-1.959	0.994	0.722	1.333	-0.612	0.492	0.785	-0.461	0.955	1.509	2.089	0.586	2.253	-0.676	0.338	-0.046	-1.08	x	-2.263	-0.71	-2.396	-2.531	-3.871	-3.793	-1.69	-1.411	1.422	-1.795	0.1	0.991	-1.378	2.167	-0.715	5.152	x	1.946	1.627	1.565	-1.14	x	x	x	x	-0.464	0.733	x	x	x	1.181	1.993	x	x	x	0.2	-1.121	1.211	x	x	-1.725	-2.229	x	x	-0.12	-0.616	x	x	2.213	x	0.107	x	2.718	x	x	-0.836	x	x	1.903	x	1.405	0.891	-4.487	x	1.154	-0.727	x	-0.661	x	x	x	-1.11	0.995	x	0.557	-1.996	x	x	x	
-13552	Original post publication description: Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells corrected for DNA content 33 hours after seeding with 20,000 cells, young adult male liver [ratio LDH/DNA] Original pre publication description: Liver, metabolism, toxicology: CQ-11	Liver, metabolism, toxicology: CQ-11	Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells corrected for DNA content 31.5 hr after seeding with 20,000 cells, young adult male liver (BXD15 winsorized from 223 to 160) [ratio LDH/DNA]	x	x	82.09	101.01	107.6	124.69	123.49	137.57	x	x	110.6	x	102.09	107.16	160.0	104.72	86.26	128.55	x	91.63	56.05	x	x	x	x	97.94	47.04	146.39	x	73.31	58.1	x	x	x	x	x	62.08	99.02	102.15	x	83.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13553	Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency, cells per control wells (DNA content assay) 33 hours after seeding with 20,000 cells/well, young adult male liver [DNA units] Original pre publication description: CQ-12	Liver, metabolism, toxicology: CQ-12	Liver, metabolism, toxicology: Hepatocyte plating efficiency, cells per control wells (DNA assay) 31.5 hr after seeding with 20,000 cells/well, young adult male liver [ng/ml]	x	x	95.7	80.82	45.42	47.09	44.8	43.94	x	x	48.4	x	53.68	58.72	52.1	55.03	50.9	51.55	x	43.04	72.76	x	x	x	x	62.2	86.62	74.04	x	74.76	80.16	x	x	x	x	x	66.92	68.76	77.32	x	69.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13554	Original post publication description: Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells (uncorrected for viable cell number) 33 hours after seeding with 20,000 cells, young adult male liver [LDH units] Original pre publication description: Liver, metabolism, toxicology: CQ-13	Liver, metabolism, toxicology: CQ-13	Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells (uncorrected for viable cell number) 33 hours after seeding with 20,000 cells, young adult male liver (BXD29 and BXD15 winsorized from 10821 and 11658 to 8500 and 9000) [LDH units]	x	x	7754.0	8157.0	4650.0	5835.0	5540.0	5967.0	x	x	5340.0	x	5473.0	6297.0	9000.0	5744.0	4382.0	6658.0	x	3919.0	4082.0	x	x	x	x	6098.0	4074.0	8500.0	x	5470.0	4666.0	x	x	x	x	x	4135.0	6773.0	7902.0	x	5803.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13555	Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte cytotoxicity response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [LDH/DNA ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-14	Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD31 winsorized from 243 to 200) [LDH/DNA ratio]	Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD31 winsorized from 243 to 200) [LDH/DNA ratio]	x	x	52.34	162.55	123.31	77.87	195.87	97.29	x	x	123.73	x	197.28	64.51	150.79	72.56	62.51	191.03	x	64.48	43.75	x	x	x	x	65.33	37.25	168.67	x	200.0	87.92	x	x	x	x	x	69.83	142.95	66.16	x	72.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13556	Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [LDH/DNA ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-15	Liver, metabolism, toxicology: CQ-15	Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1223 to 900) [LDH/DNA ratio]	x	x	615.05	322.22	368.88	352.73	528.23	853.37	x	x	593.12	x	564.19	889.59	x	570.01	624.49	827.58	x	900.0	300.6	x	x	x	x	210.83	491.16	449.61	x	529.7	388.67	x	x	x	x	x	280.33	308.99	587.68	x	508.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13557	Original post publication description: Liver, metabolism, toxicology: Maximal hepatocyte cytotoxicity response 9 hr after treatment with lysis buffer, lactate dehydrogenase (LDH) release assay, young adult male liver [LDH] Original pre publication description: Liver, metabolism, toxicology: CQ-16	Liver, metabolism, toxicology: CQ-16	Liver, metabolism, toxicology: Maximal hepatocyte cytotoxicity response 9 hr after treatment with lysis buffer, lactate dehydrogenase (LDH) release assay, young adult male liver [LDH]	x	x	31865.0	21537.0	15429.0	15998.0	17958.0	23778.0	x	x	21932.0	x	23427.0	40841.0	40062.0	29188.0	29289.0	33391.0	x	33991.0	22450.0	x	x	x	x	16769.0	27856.0	19771.0	x	29081.0	21438.0	x	x	x	x	x	19616.0	20263.0	29022.0	x	24299.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13558	Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte cytotoxicity response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver [LDH/DNA ratio difference] Original pre publication description: Liver, metabolism, toxicology: CQ-17	Liver, metabolism, toxicology: CQ-17	Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad control LDH, BXD31 winsorized from 169.8 to 100) to [LDH/DNA ratio difference]	x	x	-29.75	61.53	15.71	-46.82	72.37	-40.29	x	x	13.13	x	95.18	-42.65	x	-32.15	-23.92	62.47	x	-27.15	-12.3	x	x	x	x	-32.61	-9.79	22.28	x	100.0	29.82	x	x	x	x	x	7.75	43.94	-35.99	x	-11.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13559	Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hrs after treatment (1.0 M), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver [LDH/DNA ratio difference] Original pre publication description: Liver, metabolism, toxicology: CQ-18	Liver, metabolism, toxicology: CQ-18	Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1131 to 800) [LDH/DNA ratio difference]	x	x	532.96	221.2	261.28	228.05	404.74	715.8	x	x	482.52	x	462.1	782.43	x	465.3	538.23	699.03	x	800.0	244.54	x	x	x	x	112.89	444.12	303.23	x	456.4	330.57	x	x	x	x	x	218.25	209.97	485.53	x	425.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13560	Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), lactate dehydrogenase (LDH) release assay, young adult male liver [LDH] Original pre publication description: Liver, metabolism, toxicology: CQ-19	Liver, metabolism, toxicology: CQ-19	Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay (relative fluorescent units), young adult male liver [RFU]	x	x	35405.0	20184.0	13528.0	13729.0	18219.0	23972.0	x	x	20769.0	x	21166.0	39807.0	42347.0	26870.0	25016.0	33619.0	x	34045.0	20677.0	x	x	x	x	15562.0	33108.0	30980.0	x	29743.0	19803.0	x	x	x	x	x	16243.0	19259.0	31913.0	x	23654.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13561	Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), ratio of ethanol-induced release to maximal (lysis) lactate dehydrogenase (LDH) release, young adult male liver [ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-20	Liver, metabolism, toxicology: CQ-20	Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), ratio of ethanol-induced release to maximal (lysis) lactate dehydrogenase (LDH) release, young adult male liver (BXD15 deleted due to bad LDH control, BXD29 winsorized from 1.57 to 1.20) [ratio]	x	x	1.11	0.94	0.88	0.86	1.01	1.01	x	x	0.95	x	0.9	0.97	x	0.92	0.85	1.01	x	1.0	0.92	x	x	x	x	0.93	1.19	1.2	x	1.02	0.92	x	x	x	x	x	0.83	0.95	1.1	x	0.97	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-13562	Original post publication description: Endocrine system: Serum coricosterone 15 min following 15 min restraint in normally housed controls [ng/ml] Original pre publication description: Trait 1 for Byron Jones	Endocrine system: Corticosterone in serum 15 min following 15 min restraint in females (6-8 months) for normally housed control group for chronic mild stress (CMS) [ng/ml]	Endocrine system: Corticosterone in serum 15 min following 15 min restraint in females (6-8 months) for normally housed control group for chronic mild stress (CMS) [ng/ml]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	353.21	162.11	x	x	x	x	x	586.39	x	x	x	x	355.64	x	x	x	x	x	x	267.94	x	x	x	330.04	x	x	x	246.48	272.36	x	x	x	x	x	x	x	x	352.44	x	x	382.06	x	x	200.73	345.46	x	x	157.2	x	x	x	x	x	x	x	240.99	x	266.11	x	x	x	
-13563	Original post publication description: Endocrine system: Serum coricosterone 15 min following 15 min restraint following 7 weeks of chronic mild stress (CMS) [ng/ml] Original pre publication description: Trait 2 for Byron Jones	Endocrine system: Corticosterone in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS) [ng/ml]	Endocrine system: Corticosterone in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS) [ng/ml]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	311.0	235.77	x	x	x	x	x	577.09	x	x	x	x	310.97	x	x	x	x	x	x	543.51	x	x	x	256.44	x	x	x	330.5	450.75	x	x	x	x	x	x	x	x	472.77	x	x	555.5	x	x	209.07	369.9	x	x	166.61	x	x	x	x	x	x	x	187.88	x	281.86	x	x	x	
-13564	Original post publication description: Endocrine system: Serum coricosterone difference, 15 min following 15 min restraint, chronic mild stress (CMS) cases minus contro casesl [ng/ml] Original pre publication description: Trait 3 for Byron Jones	Endocrine system: Corticosterone difference in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS), CMS group minus control [ng/ml]	Endocrine system: Corticosterone difference in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS), CMS group minus control [ng/ml]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-42.21	73.66	x	x	x	x	x	-9.3	x	x	x	x	-44.67	x	x	x	x	x	x	275.57	x	x	x	-73.6	x	x	x	84.02	178.39	x	x	x	x	x	x	x	x	120.32	x	x	173.44	x	x	8.35	24.44	x	x	9.41	x	x	x	x	x	x	x	-53.11	x	15.75	x	x	x	
-13565	Original post publication description: Ethanol response, EtOH consumed ( 20%v/v), drinking in the dark paradigm, 4h on day 4, at baseline in normally housed controls [g/kg] Original pre publication description: Trait 4 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in normally housed group, control for chronic mild stress (CMS) group (Phase 1) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in normally housed group, control for chronic mild stress (CMS) group (Phase 1) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.98	7.63	x	x	x	x	x	7.6	x	x	x	x	7.97	x	x	x	x	x	x	17.89	x	x	x	10.2	x	x	x	8.79	5.1	x	x	x	x	x	x	x	x	4.06	x	x	4.75	x	x	10.81	4.32	x	x	10.54	x	x	x	x	x	x	x	15.73	x	7.21	x	x	x	
-13566	Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline in chronic mild stress (CMS) cases but prior to CMS [g/kg] Original pre publication description: Trait 5 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in chronic mild (CMS) stress group 1 week before start of 7 weeks of CMS (Phase 1) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in chronic mild (CMS) stress group 1 week before start of 7 weeks of CMS (Phase 1) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.3	3.79	x	x	x	x	x	5.68	x	x	x	x	12.05	x	x	x	x	x	x	5.3	x	x	x	4.44	x	x	x	8.36	5.27	x	x	x	x	x	x	x	x	5.51	x	x	4.99	x	x	7.56	7.61	x	x	4.63	x	x	x	x	x	x	x	10.51	x	8.31	x	x	x	
-13567	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline in chronic mild stress (CMS) cases vs control, but prior to chronic mild stress [g/kg] Original pre publication description: Trait 6 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, first DID) in females, difference between chronic mild stress (CMS) and control groups one week before the start of 7 weeks of CMS (Phase 1) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, first DID), difference between chronic mild stress (CMS) and control groups one week before the start of 7 weeks of CMS (Phase 1) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.68	-3.84	x	x	x	x	x	-1.92	x	x	x	x	4.08	x	x	x	x	x	x	-12.59	x	x	x	-5.76	x	x	x	-0.44	0.17	x	x	x	x	x	x	x	x	1.45	x	x	0.24	x	x	-3.25	3.29	x	x	-5.91	x	x	x	x	x	x	x	-5.22	x	1.11	x	x	x	
-13568	Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 6 or 7 in normally housed controls [g/kg] Original pre publication description: Trait 7 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID phase) in females, control group for chronic mild stress (CMS) group (Phase 1) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID phase) in females, control group for chronic mild stress (CMS) group (Phase 1) [g/kg][g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.18	3.76	x	x	x	x	x	4.24	x	x	x	x	5.36	x	x	x	x	x	x	3.69	x	x	x	7.44	x	x	x	6.38	5.4	x	x	x	x	x	x	x	x	3.54	x	x	2.15	x	x	7.15	4.67	x	x	4.13	x	x	x	x	x	x	x	8.35	x	4.7	x	x	x	
-13569	Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, in CMS animals during chronic mild stress [g/kg] Original pre publication description: Trait 8 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, chronic mild stress (CMS) group (Phase 2) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, chronic mild stress (CMS) group (Phase 2) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.99	3.78	x	x	x	x	x	3.54	x	x	x	x	6.38	x	x	x	x	x	x	6.43	x	x	x	6.76	x	x	x	6.49	4.83	x	x	x	x	x	x	x	x	2.5	x	x	3.42	x	x	6.86	6.96	x	x	4.78	x	x	x	x	x	x	x	10.5	x	5.51	x	x	x	
-13570	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline CMS vs control, during chronic mild stress [g/kg] Original pre publication description: Trait 9 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, difference between chronic mild stress (CMS) group and control group (Phase 2) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, difference between chronic mild stress (CMS) group and control group (Phase 2) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.81	0.02	x	x	x	x	x	-0.69	x	x	x	x	1.02	x	x	x	x	x	x	2.75	x	x	x	-0.68	x	x	x	0.11	-0.57	x	x	x	x	x	x	x	x	-1.05	x	x	1.27	x	x	-0.29	2.29	x	x	0.65	x	x	x	x	x	x	x	2.16	x	0.82	x	x	x	
-13571	Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 7 or 8 in normally housed controls [g/kg] Original pre publication description: Trait 10 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID)in females, in the control group for the chronic mild stress (CMS) group (Phase 3) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID)in females, in the control group for the chronic mild stress (CMS) group (Phase 3) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.03	4.8	x	x	x	x	x	3.44	x	x	x	x	4.09	x	x	x	x	x	x	5.51	x	x	x	8.25	x	x	x	5.22	5.03	x	x	x	x	x	x	x	x	2.87	x	x	2.6	x	x	7.23	4.25	x	x	-6.01	x	x	x	x	x	x	x	10.6	x	4.62	x	x	x	
-13572	Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, in chronic mild stress (CMS) cases one week following CMS [g/kg] Original pre publication description: Trait 11 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, chronic mild stress (CMS) group following CMS (Phase 3) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, chronic mild stress (CMS) group following CMS (Phase 3) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.14	4.62	x	x	x	x	x	4.32	x	x	x	x	8.02	x	x	x	x	x	x	6.12	x	x	x	6.49	x	x	x	4.22	4.63	x	x	x	x	x	x	x	x	4.26	x	x	3.3	x	x	7.27	7.03	x	x	-0.31	x	x	x	x	x	x	x	10.31	x	4.17	x	x	x	
-13573	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline CMS vs control, following chronic mild stress [g/kg] Original pre publication description: Trait 12 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, difference between chronic mild stress (CMS) group and control group following CMS (Phase 3) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, difference between chronic mild stress (CMS) group and control group following CMS (Phase 3) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.12	-0.18	x	x	x	x	x	0.88	x	x	x	x	3.93	x	x	x	x	x	x	0.62	x	x	x	-1.76	x	x	x	-1.0	-0.4	x	x	x	x	x	x	x	x	1.4	x	x	0.71	x	x	0.04	2.78	x	x	5.7	x	x	x	x	x	x	x	-0.29	x	-0.45	x	x	x	
-13574	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 8-9 vs week 6-7 [g/kg] Original pre publication description: Trait 13 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the control group [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the control group [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.85	1.05	x	x	x	x	x	-0.79	x	x	x	x	-1.27	x	x	x	x	x	x	1.83	x	x	x	0.81	x	x	x	-1.15	-0.37	x	x	x	x	x	x	x	x	-0.68	x	x	0.45	x	x	0.08	-0.42	x	x	0.4	x	x	x	x	x	x	x	2.26	x	-0.07	x	x	x	
-13575	Original post publication description: Ethanol response, difference in EtOH consumed (g/kg, 20%v/v), drinking in the dark paradigm, 4h on day 4, post stress vs chronic mild stress (CMS) [g/kg] Original pre publication description: Trait 14 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the chronic mild stress (CMS) group [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the chronic mild stress (CMS) group [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.16	0.84	x	x	x	x	x	0.78	x	x	x	x	1.64	x	x	x	x	x	x	-0.31	x	x	x	-0.27	x	x	x	-2.27	-0.19	x	x	x	x	x	x	x	x	1.77	x	x	-1.68	x	x	0.41	0.07	x	x	-0.46	x	x	x	x	x	x	x	-0.19	x	-1.34	x	x	x	
-13576	Original post publication description: Ethanol response, difference in EtOH consumed ( 20%v/v), drinking in the dark paradigm, 4h on day 4, week 6 or 7 vs basseline [g/kg] Original pre publication description: Trait 15 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) in the control group for chronic mild stress (CMS) group [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) in the control group for chronic mild stress (CMS) group [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-2.8	-3.87	x	x	x	x	x	-3.36	x	x	x	x	-2.61	x	x	x	x	x	x	-14.21	x	x	x	-2.76	x	x	x	-2.41	0.29	x	x	x	x	x	x	x	x	-0.53	x	x	-2.6	x	x	-3.66	0.36	x	x	-6.41	x	x	x	x	x	x	x	-7.38	x	-2.51	x	x	x	
-13577	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, chronic mild stress (CMS) vs baseline [g/kg] Original pre publication description: Trait 16 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) for the chronic mild stress (CMS) group [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) for the chronic mild stress (CMS) group [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.31	-0.01	x	x	x	x	x	-2.13	x	x	x	x	-5.67	x	x	x	x	x	x	1.13	x	x	x	2.32	x	x	x	-1.87	-0.44	x	x	x	x	x	x	x	x	-3.02	x	x	-1.57	x	x	-0.7	-0.65	x	x	0.15	x	x	x	x	x	x	x	0.0	x	-2.8	x	x	x	
-13578	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 8-9 vs baseline [g/kg] Original pre publication description: Trait 17 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the control group for chronic mild stress (CMS) [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the control group for chronic mild stress (CMS) [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.95	-2.83	x	x	x	x	x	-4.16	x	x	x	x	-3.88	x	x	x	x	x	x	-12.38	x	x	x	-1.95	x	x	x	-3.57	-0.07	x	x	x	x	x	x	x	x	-1.2	x	x	-2.15	x	x	-3.58	-0.06	x	x	-6.01	x	x	x	x	x	x	x	-5.13	x	-2.59	x	x	x	
-13579	Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, post stress stress vs baseline [g/kg] Original pre publication description: Trait 18 for Byron Jones	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the chronic mild stress (CMS) group [g/kg]	Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the chronic mild stress (CMS) group [g/kg]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.15	0.84	x	x	x	x	x	-1.36	x	x	x	x	-4.03	x	x	x	x	x	x	0.82	x	x	x	2.05	x	x	x	-4.14	-0.64	x	x	x	x	x	x	x	x	-1.25	x	x	-1.68	x	x	-0.29	-0.58	x	x	-0.31	x	x	x	x	x	x	x	-0.19	x	-4.14	x	x	x	
-13580	Original post publication description: Endocrine system: Adrenal gland weights in normally housed controls [mg] Original pre publication description: Trait 19 for Byron Jones	Endocrinology, neuroendocrine system, morphology: Adrenal gland weight in normally housed females (6–8 months) [mg x 10]	Endocrinology, neuroendocrine system, morphology: Adrenal gland weight in normally housed females (6–8 months) [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.0	10.0	x	x	x	x	x	22.0	x	x	x	x	23.0	x	x	x	x	x	x	12.0	x	x	x	12.0	x	x	x	18.0	28.0	x	x	x	x	x	x	x	x	15.0	x	x	17.0	x	x	15.0	19.0	x	x	13.0	x	x	x	x	x	x	x	11.0	x	29.0	x	x	x	
-13581	Original post publication description: Endocrine system: Adrenal gland weights in chronic mild stress (CMS) cases following CMS [mg] Original pre publication description: Trait 20 for Byron Jones	Endocrinology, neuroendocrine system, morphology: Adrenal gland weights in chronic mild stress (CMS) cases following CMS in adult females (6-8 months) [mg x 10]	Endocrinology, neuroendocrine system, morphology: Adrenal gland weights in chronic mild stress (CMS) cases following CMS in adult females (6-8 months) [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.0	26.0	x	x	x	x	x	13.0	x	x	x	x	16.0	x	x	x	x	x	x	12.0	x	x	x	19.0	x	x	x	10.0	10.0	x	x	x	x	x	x	x	x	12.0	x	x	12.0	x	x	12.0	16.0	x	x	8.0	x	x	x	x	x	x	x	11.0	x	14.0	x	x	x	
-13582	Original post publication description: Endocrine system: Thymus gland weight differences, chronic mild stress (CMS) vs control [mg] Original pre publication description: Trait 21 for Byron Jones	Endocrinology, neuroendocrine system, morphology: Adrenal weight difference in adult females (6-8 months) between chronic mild stress group (CMS for 7 weeks) and control group [mg x 10]	Endocrinology, neuroendocrine system, morphology: Adrenal weight difference in adult females (6-8 months) between chronic mild stress group (CMS for 7 weeks) and control group [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.0	16.0	x	x	x	x	x	-9.0	x	x	x	x	-7.0	x	x	x	x	x	x	0.0	x	x	x	7.0	x	x	x	-8.0	-18.0	x	x	x	x	x	x	x	x	-3.0	x	x	-5.0	x	x	-3.0	-3.0	x	x	-5.0	x	x	x	x	x	x	x	0.0	x	-15.0	x	x	x	
-13583	Original post publication description: Endocrine system: Thymus gland weights in normally housed controls [mg] Original pre publication description: Trait 22 for Byron Jones	Endocrine system, immune system: Thymus weight in normally housed adult female controls (6–8 months) for chronic mild stress (CMS) [mg x 10]	Endocrine system, immune system: Thymus weight in normally housed adult female controls (6–8 months) for chronic mild stress (CMS) [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.0	40.0	x	x	x	x	x	32.0	x	x	x	x	41.0	x	x	x	x	x	x	27.0	x	x	x	21.0	x	x	x	35.0	37.0	x	x	x	x	x	x	x	x	39.0	x	x	21.0	x	x	25.0	38.0	x	x	45.0	x	x	x	x	x	x	x	20.0	x	43.0	x	x	x	
-13584	Original post publication description: Endocrine system: Thymus gland weights in chronic mild stress (CMS) cases following CMS [mg] Original pre publication description: Trait 23 for Byron Jones	Endocrine system, immune system: Thymus weight in adult females (6–8 months) following 7 weeks of chronic mild stress (CMS) [mg x 10]	Endocrine system, immune system: Thymus weight in adult females (6–8 months) following 7 weeks of chronic mild stress (CMS) [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.0	24.0	x	x	x	x	x	36.0	x	x	x	x	31.0	x	x	x	x	x	x	26.0	x	x	x	24.0	x	x	x	26.0	33.0	x	x	x	x	x	x	x	x	34.0	x	x	27.0	x	x	17.0	36.0	x	x	35.0	x	x	x	x	x	x	x	24.0	x	43.0	x	x	x	
-13585	Original post publication description: Endocrine system: Thymus gland weight differences, chronic mild stress (CMS) vs control [mg] Original pre publication description: Trait 24 for Byron Jones	Endocrine system: Thymus gland weight difference in adult females (6-8 months), chronic mild stress (CMS) group minus control group [mg x 10]	Endocrine system: Thymus gland weight difference in adult females (6-8 months), chronic mild stress (CMS) group minus control group [mg x 10]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-3.0	-16.0	x	x	x	x	x	4.0	x	x	x	x	-10.0	x	x	x	x	x	x	-1.0	x	x	x	3.0	x	x	x	-9.0	-4.0	x	x	x	x	x	x	x	x	-5.0	x	x	6.0	x	x	-8.0	-2.0	x	x	-10.0	x	x	x	x	x	x	x	4.0	x	0.0	x	x	x	
-13586	Original post publication description: BrdU+ cells/mm of RMS length in BXD RI (adjusted for differences in age) Original pre publication description: BrdU+ cells/mm of RMS length in BXD RI (adjusted for differences in age)	Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age effects [N cells per mm of RMS length]	Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age effects [N cells per mm of RMS length]	x	x	x	x	54.32	57.46	x	60.65	27.18	69.15	42.63	70.58	29.31	64.05	83.25	83.76	47.64	15.14	103.52	62.95	x	x	x	45.49	x	52.63	130.5	128.41	x	47.45	57.76	35.41	71.72	x	x	x	102.85	138.25	53.81	x	54.48	61.89	49.17	56.58	x	x	71.78	x	25.03	47.66	x	x	x	8.47	59.45	x	x	x	42.1	63.06	40.92	14.95	x	41.45	56.57	97.01	157.35	x	x	67.43	x	53.15	x	87.95	x	63.86	x	x	72.22	x	x	62.69	114.56	67.47	72.76	74.28	x	86.33	85.59	x	54.43	x	x	x	65.46	45.75	85.21	117.19	73.06	x	x	x	
-13587	Original post publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]	Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]	Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]	7.844	6.948	5.487	-2.234	6.382	-3.908	9.07	-1.901	3.422	-0.252	-0.039	-5.693	-4.862	-3.508	-5.451	0.636	0.37	-1.556	-2.507	-4.864	1.79	-1.85	x	-2.63	-0.137	-3.542	-0.619	-1.859	2.706	-3.747	-0.487	-0.673	0.582	-0.761	-7.355	5.435	-2.161	1.606	0.054	x	6.132	0.956	0.527	8.447	x	x	3.143	x	-2.476	-0.456	x	x	x	0.257	-5.786	x	x	x	-1.987	5.694	1.869	x	x	-2.725	-5.306	x	x	6.743	-1.254	x	x	-1.171	x	-0.853	x	-0.261	x	x	-6.109	x	x	3.633	x	-1.917	4.611	-6.091	x	-4.777	-3.334	x	-2.223	x	x	x	-1.69	-1.241	-0.429	0.673	3.136	x	x	x	
-13588	Original post publication description: Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3] Original pre publication description: Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3]	Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3]	Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3]	0.313	0.334	0.303	0.261	0.291	0.228	0.356	x	0.207	0.267	0.327	0.224	0.247	0.251	0.276	0.256	0.239	0.302	0.239	x	0.341	0.358	x	0.242	0.254	0.243	0.221	0.256	0.235	0.261	0.266	0.225	0.265	0.266	0.265	x	0.258	0.294	0.338	x	0.298	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15731	None	Trait_170_AUW-BXD	Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber, high fat diet, males [%]	x	x	1.3355	2.6927	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.525	1.1043	2.2636	x	x	-0.4	0.1	0.4	-0.446	x	x	x	1.0762	1.6	x	x	x	x	0.9258	2.39	5.27	2.2	0.27	10.0	x	-1.8	-0.44	-1.2276	1.3	x	-2.7547	x	0.1024	x	x	x	-0.5	0.4817	-0.9	x	-3.86	1.315	0.455	x	0.8088	x	0.908	0.764	x	x	x	x	-1.78	-1.04	3.3	2.61	0.98	1.96	2.1	x	-0.5	
-15732	None	Trait_171_AUW-BXD	Metabolism: Body temperature, high fat diet / chow diet, basal, males [ratio]	x	x	1.0016	1.0061	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.0136	1.0065	1.0011	x	x	1.011	1.005	1.0823	0.9847	x	x	x	1.0012	0.9843	x	x	x	x	0.9781	0.984	0.9906	0.998	0.9882	1.0091	x	0.9925	0.9861	1.0066	1.0114	x	1.0148	x	0.9948	x	x	x	1.0335	1.0143	0.996	x	0.9887	0.9881	0.9997	x	1.008	x	1.0107	0.9928	x	x	x	x	0.9711	1.0082	1.013	1.0257	1.0	0.9992	1.0137	x	1.0309	
-15733	None	Trait_172_AUW-BXD	Metabolism: Body temperature after 6 hours in 4 deg C chamber, high fat diet / chow diet, males [ratio]	x	x	1.0227	0.9913	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.9944	0.9613	1.0101	x	x	1.065	1.003	1.0152	0.9863	x	x	x	1.0017	1.0322	x	x	x	x	0.9993	0.999	0.9971	0.9838	1.0337	0.956	x	1.0077	1.0234	1.0372	1.0525	x	1.0393	x	1.0032	x	x	x	0.9803	1.0177	1.047	x	1.013	1.0973	1.0021	x	1.005	x	1.054	1.0205	x	x	x	x	0.9926	1.0503	0.9474	1.0125	0.96	1.0076	0.9829	x	1.0315	
-15734	None	Trait_173_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage, chow diet, males [counts/hour]	x	x	4764.0	4471.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4423.0	2753.0	5237.0	x	x	3893.0	3090.0	3224.0	3342.0	x	x	x	4129.0	6964.0	x	x	x	3972.0	2958.0	3006.0	3114.0	4080.0	3526.0	3045.0	x	4241.0	4524.0	4427.0	2906.0	x	3742.0	x	3554.0	x	x	x	2659.0	3398.0	3186.0	x	3072.0	3619.0	2585.0	x	3148.0	x	3388.0	2563.0	x	4003.0	x	x	3406.0	3462.0	3572.0	3785.0	4548.0	4149.0	5817.0	x	2829.0	
-15735	None	Trait_174_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage, chow diet, males [counts/hour]	x	x	3644.0	2058.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3209.0	2220.0	2334.0	x	x	2475.0	1892.0	1937.0	2084.0	x	x	x	2033.0	4126.0	x	x	x	2881.0	1407.0	2416.0	2104.0	3068.0	2435.0	2557.0	x	2845.0	3031.0	3512.0	2240.0	x	1982.0	x	2979.0	x	x	x	1776.0	1966.0	2658.0	x	2039.0	1793.0	1814.0	x	1262.0	x	3156.0	1526.0	x	2886.0	x	x	2481.0	1827.0	3372.0	2372.0	2688.0	1981.0	3302.0	x	1741.0	
-15709	None	Trait_148_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected, metabolic cage, high fat diet, males [ml/kg/h]	x	x	4197.0	4368.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3769.0	x	4414.0	x	x	x	x	x	4740.0	x	x	x	5001.0	x	x	x	x	x	3592.0	3589.0	4238.0	x	4432.0	4620.0	x	x	4693.0	4670.0	x	x	4478.0	x	4192.0	x	x	x	x	4490.0	x	x	4613.0	3832.0	x	x	4440.0	x	4179.0	4175.0	x	x	x	x	x	4044.0	x	x	x	4202.0	x	x	x	
-15707	None	Trait_146_AUW-BXD	Central nervous system, metabolism, behavior: Water intake in 24 h, metabolic cage, high fat diet, males [ml]	x	x	1.535	1.533	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.447	0.895	1.79	x	x	1.17	2.55	0.548	0.81	x	x	x	3.44	1.535	x	x	x	x	1.632	1.695	1.79	1.365	1.395	2.432	x	2.05	1.24	3.0	2.785	x	0.764	x	1.148	x	x	x	1.464	1.62	0.985	x	1.08	2.01	3.27	x	1.845	x	2.645	1.48	x	x	x	x	0.652	0.275	1.53	1.184	1.148	2.512	1.335	x	1.77	
-15705	None	Trait_144_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, high fat diet, males [kCal]	x	x	9.4962	11.1333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.2863	15.7335	8.2722	x	x	x	x	x	9.231	x	x	x	15.5448	6.7218	x	x	x	x	13.3926	8.67	11.4852	9.0882	11.6688	11.1996	x	x	8.0376	13.5558	11.6127	x	5.763	x	5.0592	x	x	x	10.9446	x	10.4295	x	6.8187	22.2207	17.748	x	10.2255	x	10.8477	x	x	x	x	x	7.4766	5.814	11.8575	9.0372	x	9.8328	6.885	x	16.2435	
-15703	None	Trait_142_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, high fat diet, males [g]	x	x	1.862	2.183	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.213	3.085	1.622	x	x	x	x	x	1.81	x	x	x	3.048	1.318	x	x	x	x	2.626	1.7	2.252	1.782	2.288	2.196	x	x	1.576	2.658	2.277	x	1.13	x	0.992	x	x	x	2.146	x	2.045	x	1.337	4.357	3.48	x	2.005	x	2.127	x	x	x	x	x	1.466	1.14	2.325	1.772	x	1.928	1.35	x	3.185	
-15701	None	Trait_140_AUW-BXD	Metabolism, behavior: Activty (rearing) at night, metabolic cage, high fat diet, males [AUC]	x	x	525.4	241.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	436.02	302.4	141.0	x	x	438.99	336.5	571.9	111.2	x	x	x	167.32	178.0	x	x	x	x	267.4	268.15	316.99	4010.5	470.4	97.82	x	323.4	372.13	207.5	352.0	x	27.5	x	115.8	x	x	x	331.8	208.74	284.14	x	191.38	490.86	356.7	x	309.32	x	577.64	61.115	x	x	x	x	411.7	148.99	409.9	614.9	1417.8	513.84	1004.8	x	337.47	
-15699	None	Trait_138_AUW-BXD	Metabolism, behavior: Activty (ambulations) at night, metabolic cage, high fat diet, males [AUC]	x	x	607.708	460.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	671.2	296.2	302.8	x	x	415.07	505.86	677.5	223.4	x	x	x	370.3	481.0	x	x	x	x	408.4	501.2	534.3	685.03	794.7	203.66	x	585.92	475.5	352.115	610.0	x	101.3	x	306.6	x	x	x	611.99	434.3	378.2	x	378.76	697.35	499.9	x	537.2	x	871.3	236.4	x	x	x	x	426.5	273.8	645.6	788.4	965.6	563.9	1272.4	x	567.2	
-15697	None	Trait_136_AUW-BXD	Metabolism, behavior: Activity (movement) at night, metabolic cage, high fat diet, males [AUC]	x	x	1488.0	1245.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1655.1	775.03	774.4	x	x	1062.0	1142.0	1436.2	570.7	x	x	x	833.0	1277.0	x	x	x	x	1138.0	1328.6	1201.9	1723.1	1619.0	805.6	x	1501.3	1213.4	790.9	1610.0	x	395.08	x	763.6	x	x	x	1501.4	1150.4	1050.6	x	1159.95	1640.2	1319.7	x	1379.6	x	1911.97	773.6	x	x	x	x	1083.7	994.0	1557.8	1709.7	1869.8	1375.8	2453.4	x	1212.2	
-15695	None	Trait_128_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours, metabolic cage, high fat diet, males [mL/kg/h]	x	x	2529.0	2226.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2282.0	1696.0	2563.0	x	x	1421.0	1692.0	1923.0	1957.0	x	x	x	3471.0	1776.0	x	x	x	x	1925.0	1924.0	1999.0	2084.0	1973.0	1920.0	x	2605.0	2153.0	2775.0	1547.0	x	2400.0	x	2013.0	x	x	x	2141.0	2438.0	1418.0	x	2534.0	1939.0	1935.0	x	2634.0	x	2196.0	1909.0	x	x	x	x	1858.0	1805.0	1975.0	1796.0	2040.0	2316.0	1826.0	x	2020.0	
-15693	None	Trait_126_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average, metabolic cage, high fat diet, males [mL/kg/h]	x	x	2701.0	2376.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2543.0	1772.0	2764.0	x	x	1481.0	1832.0	2086.0	2083.0	x	x	x	3710.0	1920.0	x	x	x	x	2080.0	2099.0	2223.0	2239.0	2129.0	2067.0	x	2812.0	2340.0	2887.0	1656.0	x	2588.0	x	2127.0	x	x	x	2289.0	2669.0	1477.0	x	2729.0	2128.0	1898.0	x	2816.0	x	2378.0	2076.0	x	x	x	x	1955.0	1863.0	2111.5	1975.0	2136.0	2468.0	1927.0	x	2225.0	
-15691	None	Trait_124_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average, metabolic cage, high fat diet, males [mL/kg/h]	x	x	2256.0	1988.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1988.0	1576.0	2244.0	x	x	1353.0	1524.0	1629.0	1758.0	x	x	x	3092.0	1536.0	x	x	x	x	1680.0	1749.0	1769.0	1910.0	1786.0	1689.0	x	2385.0	1951.0	2599.0	1387.0	x	2101.0	x	1834.0	x	x	x	1924.0	2073.0	1322.0	x	2225.0	1711.0	1963.0	x	2346.0	x	1978.0	1707.0	x	x	x	x	1710.0	1713.0	1808.0	1580.0	1932.0	2074.0	1643.0	x	1789.0	
-15689	None	Trait_122_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours, metabolic cage, high fat diet, males [mL/kg/h]	x	x	3246.0	2845.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2971.0	2155.0	3280.0	x	x	1832.0	2089.0	2856.0	2533.0	x	x	x	4268.0	3118.0	x	x	x	x	2401.0	2491.0	2566.0	2728.0	2581.0	2476.0	x	3445.0	2840.0	3462.0	2817.0	x	3142.0	x	2681.0	x	x	x	3116.0	3179.0	2574.0	x	3393.0	2502.0	2418.0	x	3374.0	x	2910.0	2502.0	x	x	x	x	2862.0	2405.0	2860.0	2417.0	2664.0	2983.0	2784.0	x	2642.0	
-15687	None	Trait_120_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, metabolic cage, high fat diet, males [mL/kg/h]	x	x	3441.0	3023.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3257.0	2247.0	3511.0	x	x	1935.0	2257.0	3079.0	2689.0	x	x	x	4518.0	3331.0	x	x	x	x	2573.0	2673.0	2814.0	2891.0	2772.0	2646.0	x	3668.0	3069.0	3594.0	3003.0	x	3391.0	x	2811.0	x	x	x	3309.0	3470.0	2665.0	x	3645.0	2693.0	2391.0	x	3603.0	x	3145.0	2698.0	x	x	x	x	2986.0	2488.0	3068.0	2621.0	2771.0	3156.0	2942.0	x	2861.0	
-15685	None	Trait_118_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, metabolic cage, high fat diet, males [mL/kg/h]	x	x	2936.0	2565.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2649.0	2010.0	2914.0	x	x	1716.0	1887.0	2452.0	2287.0	x	x	x	3871.0	2760.0	x	x	x	x	2129.0	2309.0	2312.0	2490.0	2353.0	2208.0	x	3208.0	2593.0	3253.0	2545.0	x	2748.0	x	2474.0	x	x	x	2834.0	2718.0	2422.0	x	2996.0	2271.0	2435.0	x	3011.0	x	2646.0	2282.0	x	x	x	x	2674.0	2274.0	2604.0	2173.0	2544.0	2709.0	2498.0	x	2395.0	
-15683	None	Trait_116_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours, metabolic cage, high fat diet, males [ratio]	x	x	0.776875	0.7821	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.765	0.7838	0.7796	x	x	0.774	0.808	0.67	0.771175	x	x	x	0.81082	0.568	x	x	x	x	0.79982	0.77	0.776	0.761	0.763	0.77366	x	0.755	0.757	0.799	0.545	x	0.76188	x	0.74754	x	x	x	0.688	0.76736	0.55	x	0.7459	0.773	0.7925	x	0.78015	x	0.75	0.758	x	x	x	x	0.649	0.748325	0.69	0.74	0.764	0.77494	0.654	x	0.764	
-15681	None	Trait_114_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night), metabolic cage, high fat diet, males [ratio]	x	x	0.7833	0.78555	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.779	0.78628	0.78605	x	x	0.764	0.809	0.674	0.773325	x	x	x	0.81788	0.576	x	x	x	x	0.80688	0.784	0.788	0.768	0.767	0.77864	x	0.766	0.762	0.8011	0.548	x	0.76286	x	0.75422	x	x	x	0.693	0.76986	0.553	x	0.748875	0.789	0.80261	x	0.780125	x	0.755	0.766	x	x	x	x	0.654	0.7466	0.688	0.751	0.769	0.78026	0.653	x	0.778	
-15679	None	Trait_112_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day), metabolic cage, high fat diet, males [ratio]	x	x	0.76725	0.776925	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.749	0.7803	0.769975	x	x	0.786	0.806	0.664	0.768	x	x	x	0.79976	0.556	x	x	x	x	0.78924	0.757	0.763	0.753	0.758	0.76622	x	0.743	0.751	0.7958	0.541	x	0.7604	x	0.7373	x	x	x	0.68	0.76364	0.544	x	0.74145	0.753	0.78247	x	0.780175	x	0.744	0.749	x	x	x	x	0.64	0.750875	0.693	0.726	0.758	0.767	0.657	x	0.748	
-15677	None	Trait_108_AUW-BXD	Musculoskeletal system, morphology: Soleus muscle mass, percentage of body, high fat diet, males [%]	x	x	0.049	0.038	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.038	0.027	0.044	x	x	0.05	0.051	0.041	0.031	x	x	x	0.034	0.046	x	x	x	x	0.028	0.037	0.034	0.045	0.035	0.026	x	0.053	0.049	0.037	0.048	x	0.042	x	0.033	x	x	x	0.028	0.038	0.038	x	0.042	0.033	0.034	x	0.042	x	0.038	0.029	x	x	x	x	0.05	0.038	0.041	0.047	0.045	0.037	0.038	x	0.046	
-15675	None	Trait_106_AUW-BXD	Musculoskeletal system, morphology: Gastrocnemius muscle mass, percentage of body, high fat diet, males [%]	x	x	0.735	0.634	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.71	0.457	0.749	x	x	0.617	0.743	0.615	0.528	x	x	x	0.71	0.783	x	x	x	x	0.582	0.634	0.567	0.61	0.519	0.437	x	0.755	0.756	0.728	0.636	x	0.747	x	0.646	x	x	x	0.584	0.614	0.587	x	0.706	0.561	0.657	x	0.713	x	0.672	0.52	x	x	x	x	0.789	0.567	0.615	0.601	0.658	0.664	0.627	x	0.643	
-15673	None	Trait_104_AUW-BXD	Morphology: Epididymal white adipose mass, percentage of body, high fat diet, males [%]	x	x	4.114	5.229	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.853	5.67	4.6	x	x	3.584	6.147	6.213	4.791	x	x	x	4.267	2.822	x	x	x	x	7.521	4.73	4.382	4.963	3.408	6.891	x	3.41	1.863	2.798	2.681	x	4.401	x	4.747	x	x	x	4.115	3.565	3.88	x	4.109	5.48	2.61	x	5.187	x	2.634	4.455	x	x	x	x	5.228	3.487	4.796	4.735	5.129	5.936	6.344	x	3.337	
-15671	None	Trait_102_AUW-BXD	Urogenital system, morphology: Kidney mass, percentage of body, high fat diet, males [%]	x	x	0.945	1.455	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.796	0.778	1.25	x	x	0.763	1.034	1.099	0.837	x	x	x	1.325	1.437	x	x	x	x	0.962	0.945	0.905	1.012	0.754	0.882	x	1.013	1.484	1.533	1.237	x	1.512	x	1.14	x	x	x	1.255	1.037	0.969	x	1.309	1.276	0.954	x	1.138	x	1.308	0.974	x	x	x	x	1.03	0.897	1.11	1.087	0.996	0.922	0.977	x	1.091	
-15669	None	Trait_100_AUW-BXD	Morphology: Perirenal white adipose mass, percentage of body, high fat diet, males [%]	x	x	3.39	3.393	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.918	5.491	3.354	x	x	3.807	2.987	3.088	7.13	x	x	x	1.236	1.915	x	x	x	x	4.15	5.22	3.73	6.35	6.303	4.924	x	3.61	3.308	4.18	4.814	x	3.16	x	3.071	x	x	x	5.63	3.082	3.778	x	2.093	4.927	3.41	x	3.675	x	3.041	3.375	x	x	x	x	5.97	4.694	4.65	5.179	4.887	4.35	3.395	x	3.347	
-15667	None	Trait_98_AUW-BXD	Morphology: Subcutaneous white adipose mass, percentage of body, high fat diet, males [%]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.477	7.792	2.954	x	x	5.234	2.725	4.533	7.272	x	x	x	3.832	2.225	x	x	x	x	4.031	3.4	3.462	5.737	3.884	5.036	x	5.171	5.008	5.095	5.097	x	3.791	x	4.366	x	x	x	3.141	x	7.53	x	3.257	4.071	4.34	x	3.492	x	3.66	5.515	x	x	x	x	4.01	4.047	4.14	5.155	5.219	4.1	7.002	x	5.201	
-15665	None	Trait_96_AUW-BXD	Cardiovascular systen, morphology: Heart mass, percentage of body, high fat diet, males [%]	x	x	0.489	0.485	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.289	0.308	0.481	x	x	0.302	0.393	0.37	0.32	x	x	x	0.449	0.491	x	x	x	x	0.343	x	0.508	0.373	0.336	0.347	x	0.419	0.435	0.479	0.416	x	0.51	x	0.356	x	x	x	0.42	0.516	0.389	x	0.534	0.356	0.372	x	0.552	x	0.396	0.328	x	x	x	x	0.342	0.329	0.442	0.364	0.41	0.436	0.37	x	0.432	
-15663	None	Trait_94_AUW-BXD	Gastrointestinal system, morphology: Liver mass, percentage of body, high fat diet, males [%]	x	x	4.745	4.023	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.69	4.014	3.942	x	x	3.44	5.106	2.574	3.901	x	x	x	4.621	3.728	x	x	x	x	6.167	3.405	2.796	4.083	5.898	2.671	x	3.059	4.394	4.841	4.264	x	2.816	x	5.664	x	x	x	4.043	3.646	4.157	x	4.678	4.709	5.396	x	3.216	x	4.075	2.588	x	x	x	x	3.264	5.311	5.361	6.9	4.121	5.396	5.075	x	3.483	
-15661	None	Trait_90_AUW-BXD	Musculoskeletal system, morphology: Soleus muscle mass, high fat diet, males [g]	x	x	0.0232	0.0185	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0187	0.017	0.0198	x	x	0.0279	0.0234	0.0195	0.0197	x	x	x	0.015	0.0189	x	x	x	x	0.0149	0.017	0.0165	0.02	0.0223	0.0158	x	0.0231	0.0179	0.0186	0.0258	x	0.0188	x	0.0153	x	x	x	0.0136	0.0178	0.0187	x	0.0154	0.0188	0.0194	x	0.0164	x	0.0174	0.0141	x	x	x	x	0.0267	0.0231	0.0207	0.0248	0.0233	0.0209	0.0195	x	0.0222	
-15659	None	Trait_88_AUW-BXD	Musculoskeletal system, morphology: Gastrocnemius muscle mass, high fat diet, males [g]	x	x	0.346	0.306	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.35	0.294	0.335	x	x	0.342	0.343	0.295	0.338	x	x	x	0.313	0.323	x	x	x	x	0.306	0.289	0.275	0.302	0.333	0.265	x	0.333	0.297	0.367	0.337	x	0.326	x	0.299	x	x	x	0.279	0.287	0.291	x	0.259	0.317	0.372	x	0.279	x	0.306	0.258	x	x	x	x	0.418	0.348	0.315	0.315	0.339	0.376	0.324	x	0.312	
-15657	None	Trait_86_AUW-BXD	Morphology: Epididymal white adipose mass, high fat diet, males [g]	x	x	1.914	2.527	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.896	3.66	2.077	x	x	1.951	2.97	2.98	3.041	x	x	x	1.864	1.164	x	x	x	x	4.013	2.14	2.13	2.478	2.173	4.19	x	1.342	1.288	1.406	1.417	x	1.923	x	2.193	x	x	x	2.023	1.664	1.923	x	1.511	3.106	1.48	x	2.002	x	1.199	2.86	x	x	x	x	2.8	2.13	2.498	2.504	2.65	3.364	3.344	x	1.613	
-15655	None	Trait_84_AUW-BXD	Urogenital system, morphology: Kidney mass, high fat diet, males [g]	x	x	0.446	0.704	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.392	0.502	0.556	x	x	0.424	0.486	0.527	0.538	x	x	x	0.576	0.593	x	x	x	x	0.506	0.43	0.439	0.504	0.483	0.535	x	0.466	0.452	0.796	0.659	x	0.663	x	0.528	x	x	x	0.616	0.484	0.479	x	0.482	0.722	0.542	x	0.444	x	0.596	0.483	x	x	x	x	0.537	0.551	0.565	0.57	0.513	0.523	0.505	x	0.53	
-15653	None	Trait_82_AUW-BXD	Morphology: Perirenal white adipose mass, high fat diet, males [g]	x	x	1.618	1.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.43	3.541	1.417	x	x	2.17	1.241	1.483	4.595	x	x	x	0.54	0.79	x	x	x	x	2.255	2.374	1.81	3.245	4.046	3.012	x	1.359	0.951	0.213	2.588	x	1.397	x	1.424	x	x	x	2.744	1.444	1.868	x	0.785	2.864	1.95	x	1.451	x	1.39	1.74	x	x	x	x	3.28	2.899	2.543	2.74	2.533	2.496	1.766	x	1.622	
-15651	None	Trait_80_AUW-BXD	Morphology: Subcutaneous white adipose mass, high fat diet, males [g]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.197	5.025	1.33	x	x	2.934	1.396	2.176	4.672	x	x	x	1.677	0.919	x	x	x	x	2.159	1.55	1.68	2.905	2.496	3.163	x	1.848	0.876	2.556	2.738	x	1.692	x	2.045	x	x	x	1.554	x	3.727	x	1.229	2.366	2.47	x	1.38	x	1.67	2.89	x	x	x	x	2.202	2.493	2.223	2.72	2.71	2.35	3.642	x	2.536	
-15649	None	Trait_76_AUW-BXD	Cardiovascular system, morphology: Heart mass, high fat diet, males [g]	x	x	0.231	0.234	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.142	0.199	0.218	x	x	0.168	0.181	0.178	0.205	x	x	x	0.2	0.203	x	x	x	x	0.18	x	0.246	0.185	0.215	0.21	x	0.17	0.178	0.24	0.221	x	0.223	x	0.167	x	x	x	0.206	0.242	0.192	x	0.197	0.201	0.211	x	0.215	x	0.181	0.162	x	x	x	x	0.179	0.204	0.231	0.192	0.212	0.247	0.191	x	0.209	
-15647	None	Trait_74_AUW-BXD	Gastrointestinal system, liver, morphology, metabolism: Liver mass, high fat diet, males [g]	x	x	2.271	1.947	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.33	2.585	1.749	x	x	1.968	2.37	1.235	2.275	x	x	x	2.02	1.539	x	x	x	x	3.245	1.56	1.35	2.051	3.783	1.623	x	1.294	1.207	2.455	2.302	x	1.24	x	2.627	x	x	x	1.989	1.716	2.054	x	1.735	2.693	3.054	x	1.498	x	1.857	1.289	x	x	x	x	1.753	3.315	2.817	3.648	2.138	3.104	2.634	x	1.692	
-15645	None	Trait_72_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel, high fat diet, males [km]	x	x	4.07342	8.47794	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.839	0.58742	6.92763	x	x	2.41702	0.343074	1.876	1.37038	x	x	x	7.43505	1.434	x	x	x	x	1.74106	0.436	2.525	3.1639	0.661	0.07354	x	7.94	2.41	6.56752	2.25	x	1.8023	x	4.50654	x	x	x	0.34705	0.79265	3.231	x	2.3104	5.402	1.224	x	1.5181	x	5.202	3.142	x	x	x	x	3.42	0.9941	0.48	1.75	7.19	5.9094	4.781	x	2.221	
-15644	None	Trait_71_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor activity, dark phase (night) running distance, activity wheel, high fat diet, males [km]	x	x	3.81538	7.37066	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.6368	0.58448	6.39895	x	x	2.40864	0.33061	1.876	1.24505	x	x	x	7.1339	1.351	x	x	x	x	1.73806	0.373	2.396	3.105	0.658	0.06072	x	7.851	2.377	5.62775	2.2485	x	1.80218	x	4.47518	x	x	x	0.34535	0.78425	3.215	x	2.2919	4.8732	1.21	x	1.515	x	5.137	3.109	x	x	x	x	2.93	0.968	0.43	1.65	7.01	5.74158	4.744	x	2.213	
-15642	None	Trait_69_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel, chow diet, males [km]	x	x	6.87665	3.65133	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.303	2.88284	5.10822	x	x	3.0462	0.657987	2.075	5.0758	x	x	x	4.10118	5.45	x	x	x	1.23443	3.18617	2.664	2.18	3.8823	0.8544	0.27982	x	7.38	3.363	4.2289	5.81	x	1.8	x	4.38496	x	x	x	0.8729	1.05327	6.685	x	1.7471	7.12	1.44	x	1.17795	x	6.096	3.274	x	1.45	x	x	2.8	3.47655	3.91	5.22	6.42	2.82097	8.46	x	2.678	
-15640	None	Trait_67_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor actvity, light phase (day) running distance, activity wheel, chow diet, males [km]	x	x	0.1108	0.0008	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.382	0.2998	0.3963	x	x	0.1098	0.0121	0.001	1.0126	x	x	x	0.1365	0.032	x	x	x	0.001	0.0973	0.156	0.181	0.02	0.0043	0.0134	x	0.641	0.111	0.3269	0.256	x	0.0001	x	0.0364	x	x	x	0.0019	0.0004	0.1243	x	0.0395	1.02	0.056	x	0.0104	x	0.247	0.029	x	0.063	x	x	0.35	0.0204	0.253	0.053	1.02	0.3769	0.114	x	0.025	
-15638	None	Trait_65_AUW-BXD	Cardiovascular system, physiology: Systolic blood pressure, high fat diet, males [mmHg]	x	x	111.5	108.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	101.7	126.875	101.857	x	x	107.2	107.175	105.6	98.625	x	x	x	116.0	119.9	x	x	x	x	110.375	101.54	105.625	121.8	101.0	106.5	x	109.1	110.65	131.25	107.3	x	104.75	x	100.625	x	x	x	100.6	123.375	115.6	x	104.875	99.61	104.7	x	112.875	x	123.0	98.25	x	x	x	x	120.8	111.333	111.3	103.6	117.655	99.385	105.886	x	128.8	
-15636	None	Trait_63_AUW-BXD	Cardiovascular system, physiology: Heart rate, chow diet, males [bpm]	x	x	716.125	702.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	758.0	625.375	763.125	x	x	714.887	712.0	657.0	691.0	x	x	x	682.25	726.6	x	x	x	663.43	743.0	628.59	694.625	674.55	644.72	698.25	x	750.33	700.0	671.875	680.2	x	639.75	x	711.625	x	x	x	753.929	673.0	648.287	x	626.2	667.9	700.538	x	735.28	x	708.375	705.0	x	652.41	x	x	680.959	676.0	643.2	661.2	676.58	792.8	702.2	x	672.6	
-15634	None	Trait_61_AUW-BXD	Cardiovascular system, physiology: Diastolic blood pressure, chow diet, males [mmHg]	x	x	93.5	87.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	68.5	79.625	88.875	x	x	77.9	68.3	58.6	75.625	x	x	x	93.0	73.6	x	x	x	91.58	79.857	74.281	93.11	89.84	80.9	75.75	x	78.1	83.17	73.625	100.3	x	80.125	x	91.875	x	x	x	65.6571	92.75	76.1	x	91.5	83.4	69.28	x	80.14	x	78.875	84.625	x	73.411	x	x	94.739	77.83	83.4	74.6	85.475	68.67	80.9	x	89.6	
-15632	None	Trait_59_AUW-BXD	Metabolism, morphology: Body weight loss pre-sacrifice, chow diet, males [g]	x	x	x	1.3275	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.22	3.884	1.7	x	x	2.15	2.0	2.62	1.81	x	x	x	1.96	2.39	x	x	x	2.57	x	2.75	1.3	2.26	2.07	2.2	x	1.52	0.79	1.91	2.32	x	2.8	x	2.52	x	x	x	1.92	2.6	1.64	x	1.72	1.94	3.88	x	0.392	x	2.08	1.29	x	3.1	x	x	0.95	2.85	2.72	2.1	2.43	2.82	0.94	x	2.54	
-15631	None	Trait_58_AUW-BXD	Metabolism, morphology: Body weight fat loss percentage after exercise, high fat diet, males [%]	x	x	16.59	51.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	48.13	2.65	x	x	x	18.94	5.57	x	x	x	x	x	x	68.94	x	x	x	x	2.54	5.56	25.33	17.65	-2.61	1.47	x	42.7	13.89	x	7.96	x	x	x	24.92	x	x	x	-2.63	x	14.0	x	14.38	37.71	3.98	x	19.4	x	15.73	39.09	x	x	x	x	26.61	12.11	9.0	6.46	38.42	23.78	16.83	x	7.83	
-15629	None	Trait_50_AUW-BXD	Metabolism, morphology: Body weight loss percentage after exercise, high fat diet, males [%]	x	x	8.16	19.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.37	2.19	17.75	x	x	10.02	2.38	8.32	9.19	x	x	x	14.88	2.78	x	x	x	x	0.91	2.49	10.64	7.93	-1.53	0.74	x	19.37	5.96	22.81	5.54	x	3.87	x	10.82	x	x	x	-1.67	3.17	9.09	x	5.4	16.2	-1.27	x	5.57	x	5.7	17.21	x	x	x	x	10.94	9.23	4.21	2.66	19.58	10.26	8.8	x	3.23	
-15627	None	Trait_48_AUW-BXD	Metabolism, morphology: Body weight gain 8-28 weeks, high fat diet, males [g]	x	x	22.18	18.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.59	39.94	22.72	x	x	30.83	20.75	20.75	31.83	x	x	x	19.98	18.73	x	x	x	x	26.21	19.67	19.09	24.67	35.24	29.03	x	19.33	15.4	19.5	23.47	x	16.12	x	19.34	x	x	x	29.62	22.46	28.09	x	13.35	32.94	27.15	x	14.87	x	19.52	26.03	x	x	x	x	26.9	28.34	24.16	26.84	26.0	25.53	22.67	x	21.28	
-15625	None	Trait_46_AUW-BXD	Metabolism, morphology: Body weight gain 8-16 weeks, high fat diet, males [g]	x	x	9.48	17.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.59	26.56	13.89	x	x	21.64	10.67	16.45	23.48	x	x	x	11.36	13.55	x	x	x	x	18.51	12.91	15.7	17.85	22.08	17.43	x	19.37	17.77	12.32	16.91	x	14.65	x	15.76	x	x	x	21.21	17.52	21.24	x	10.26	21.14	20.4	x	10.2	x	14.95	21.31	x	x	x	x	19.17	20.14	17.97	17.51	18.86	16.76	16.58	x	16.96	
-15623	None	Trait_44_AUW-BXD	Metabolism, morphology: Body weight gain percentage 8-28 weeks, chow diet, males [%]	x	x	39.45	46.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	44.82	50.25	34.68	x	x	39.54	26.92	36.47	34.88	x	x	x	25.49	26.26	x	x	x	68.42	31.07	26.1	36.23	37.64	72.89	55.99	x	52.22	43.43	31.62	43.79	x	21.51	x	28.22	x	x	x	54.74	47.92	34.84	x	27.28	43.3	59.67	x	25.39	x	34.43	46.4	x	78.12	x	x	43.34	47.69	43.51	47.15	30.64	51.12	43.48	x	34.44	
-15621	None	Trait_42_AUW-BXD	Metabolism, morphology: Body weight percentage gain 8-16 weeks, chow diet, males [%]	x	x	30.53	34.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	32.5	41.52	25.38	x	x	27.87	13.79	15.73	21.46	x	x	x	22.22	19.52	x	x	x	16.66	24.01	17.48	22.05	35.03	42.9	33.64	x	64.97	60.65	31.98	52.84	x	22.75	x	29.62	x	x	x	98.23	71.05	94.56	x	43.57	87.5	69.92	x	16.47	x	11.6	21.31	x	46.08	x	x	72.28	66.78	60.15	62.4	75.68	58.65	61.13	x	59.23	
-15619	None	Trait_40_AUW-BXD	Metabolism, morphology: Lean mass percentage after activity wheel, high fat diet, males [%]	x	x	62.189	75.596	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	74.99	40.62	x	x	x	54.211	61.0697	61.85	x	x	x	x	x	73.66	x	x	x	x	55.25	59.16	63.6	59.34	48.45	45.263	x	70.67	61.84	74.405	58.7	x	x	x	62.42	x	x	x	59.86	58.1	53.62	x	67.8	66.38	59.89	x	69.59	x	70.48	62.12	x	x	x	x	64.33	56.3	57.5	58.3	63.67	62.412	58.6	x	58.13	
-15617	None	Trait_38_AUW-BXD	Metabolism, morphology: Lean mass after activity wheel, high fat diet, males [g]	x	x	26.63	26.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.756	25.269	x	x	x	26.9638	30.8532	26.17	x	x	x	x	x	29.486	x	x	x	x	29.36	25.313	26.15	25.767	28.975	25.4526	x	24.52	23.5	26.997	29.9	x	x	x	24.0294	x	x	x	28.48	26.44	24.14	x	23.85	28.61	32.01	x	23.48	x	26.86	26.13	x	x	x	x	28.895	31.713	29.17	29.4	26.454	30.186	27.23	x	27.25	
-15615	None	Trait_36_AUW-BXD	Metabolism, morphology: Fat mass after activity wheel, high fat diet, males [%]	x	x	35.4	20.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.04	57.36	x	x	x	43.067	35.567	34.71	x	x	x	x	x	22.6	x	x	x	x	41.732	37.77	33.65	37.986	48.66	51.94	x	25.7	35.17	21.4975	38.4	x	x	x	33.682	x	x	x	37.15	39.1	43.29	x	29.54	30.39	37.4	x	26.39	x	26.54	34.75	x	x	x	x	32.79	41.02	38.95	39.02	33.1	32.91	38.2	x	38.82	
-15613	None	Trait_34_AUW-BXD	Metabolism, morphology: Fat mass after activity wheel, high fat diet, males [g]	x	x	15.296	7.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.504	35.74	x	x	x	21.6498	19.2298	14.758	x	x	x	x	x	9.045	x	x	x	x	22.25	16.14	13.9	16.66	29.1	29.855	x	9.169	13.5514	8.236	19.72	x	x	x	13.361	x	x	x	17.74	17.83	19.51	x	10.62	15.24	20.1	x	9.09	x	10.18	15.77	x	x	x	x	15.762	23.192	20.1	19.74	14.279	16.5	18.06	x	18.21	
-15611	None	Trait_32_AUW-BXD	Metabolism, morphology: Body weight after activity wheel, high fat diet, males [g]	x	x	35.866	41.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	37.1	62.245	39.486	x	x	49.97	51.72	42.39	55.378	x	x	x	35.125	40.0	x	x	x	x	53.21	42.77	41.18	43.58	59.805	56.876	x	34.94	38.172	36.7325	51.1	x	41.82	x	38.896	x	x	x	47.65	45.558	45.04	x	35.38	45.25	53.5	x	33.935	x	38.55	43.26	x	x	x	x	45.97	56.4	51.03	50.494	42.112	49.046	46.783	x	46.886	
-15609	None	Trait_30_AUW-BXD	Metabolism, morphology: Lean mass percentage before activity wheel, high fat diet, males [%]	x	x	58.035	59.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	63.44	39.59	x	x	x	49.65	60.665	x	x	x	x	x	77.845	69.83	x	x	x	x	55.388	58.44	57.05	54.5	49.03	44.464	x	60.2	58.57	x	57.4	x	x	x	56.358	x	x	x	60.15	56.382	51.99	x	64.6	54.6	57.91	x	65.6075	x	66.0	48.29	x	x	x	x	56.32	55.55	55.45	56.95	54.08	56.44	54.77	x	56.56	
-15607	None	Trait_28_AUW-BXD	Metabolism, morphology: Lean mass before activity wheel, high fat diet, males [g]	x	x	27.074	26.8646	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.79	24.73	x	x	x	27.51	31.291	x	x	x	x	x	27.2925	28.77	x	x	x	x	29.7338	25.65	26.3	25.7	28.887	25.2768	x	26.14	23.772	x	30.97	x	x	x	24.4252	x	x	x	28.1772	26.511	25.89	x	24.05	28.891	30.995	x	23.4695	x	27.0	25.051	x	x	x	x	28.84	34.45	29.43	29.497	28.1304	30.913	28.05	x	27.42	
-15605	None	Trait_26_AUW-BXD	Metabolism, morphology: Fat mass percentage before activity wheel, high fat diet, males [%]	x	x	39.09	36.898	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	32.3	58.68	x	x	x	47.92	36.545	x	x	x	x	x	16.5825	26.41	x	x	x	x	42.42	39.01	40.3	42.77	48.15	52.505	x	36.82	38.94	x	39.4	x	x	x	40.306	x	x	x	36.79	40.161	45.5	x	32.65	42.36	38.87	x	30.8025	x	31.1	48.34	x	x	x	x	41.07	42.36	41.04	40.63	43.23	40.01	42.09	x	40.81	
-15603	None	Trait_24_AUW-BXD	Metabolism, morphology: Fat mass before activity wheel, high fat diet, males [g]	x	x	18.275	16.7448	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.23	36.77	x	x	x	26.57	19.954	x	x	x	x	x	5.877	10.9	x	x	x	x	22.7954	17.1	18.57	20.41	28.37	30.177	x	15.99	15.848	x	21.4	x	x	x	17.9242	x	x	x	17.2818	18.908	22.68	x	12.25	22.686	20.87	x	11.1217	x	12.7	25.16	x	x	x	x	21.27	26.32	21.96	21.1176	22.637	21.5514	21.58	x	19.78	
-15601	None	Trait_22_AUW-BXD	Metabolism, morphology: Body weight before activity wheel, high fat diet, males [g]	x	x	46.7	44.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	43.87	62.57	44.958	x	x	55.414	52.69	46.07	61.973	x	x	x	41.908	41.18	x	x	x	x	53.706	43.86	46.1	47.4	58.913	57.166	x	43.43	40.644	47.583	54.1	x	42.736	x	43.814	x	x	x	46.898	47.0475	49.85	x	37.32	53.187	53.593	x	35.905	x	40.84	51.96	x	x	x	x	51.46	62.08	53.245	51.884	52.156	54.396	51.24	x	48.48	
-15599	None	Trait_20_AUW-BXD	Metabolism, morphology: Lean mass percentage pre-metabolic caging, high fat diet, males [%]	x	x	70.855	58.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	70.77	45.0816	66.4	x	x	53.46	68.14	x	48.285	x	x	x	77.718	70.0	x	x	x	x	59.442	64.47	54.64	57.4	53.22	48.686	x	67.56	40.88	69.89	59.48	x	61.548	x	58.428	x	x	x	60.96	60.192	55.055	x	65.319	59.45	59.34	x	69.614	x	63.53	54.52	x	x	x	x	58.797	56.312	59.94	57.8	59.24	63.712	58.98	x	58.05	
-15597	None	Trait_18_AUW-BXD	Metabolism, morphology: Lean mass pre-metabolic caging, high fat diet, males [g]	x	x	24.337	24.7945	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	25.52	23.2312	24.5798	x	x	26.3398	30.023	x	25.2878	x	x	x	26.132	27.46	x	x	x	x	28.994	25.778	24.8	24.83	27.3	23.7436	x	24.228	22.54	26.912	29.07	x	25.9488	x	25.073	x	x	x	26.06	25.4716	24.14	x	22.49	26.86	29.55	x	22.411	x	25.9	24.58	x	x	x	x	26.869	28.217	28.63	26.9	25.94	28.7404	25.73	x	26.478	
-15595	None	Trait_16_AUW-BXD	Metabolism, morphology: Fat mass percentage pre-metabolic caging, high fat diet, males [%]	x	x	26.025	38.8475	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	24.56	52.8775	30.62	x	x	43.71	29.1	x	48.8175	x	x	x	18.422	26.8	x	x	x	x	38.546	32.54	42.82	39.73	44.14	48.218	x	29.11	41.99	27.3425	37.46	x	36.098	x	38.468	x	x	x	36.03	37.334	41.62	x	31.963	37.78	38.1	x	28.35	x	33.76	42.83	x	x	x	x	38.361	41.158	37.91	39.7	38.1	33.368	37.7	x	39.33	
-15593	None	Trait_14_AUW-BXD	Metabolism, morphology: Fat mass pre-metabolic caging, high fat diet, males [g]	x	x	9.0395	16.4597	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.017	28.0572	11.391	x	x	21.6	12.92	x	25.7155	x	x	x	6.2582	10.5	x	x	x	x	18.827	13.0	19.376	17.34	22.63	23.6828	x	10.67	17.17	10.8695	18.44	x	15.3182	x	16.5952	x	x	x	15.43	15.903	18.26	x	11.112	17.16	18.98	x	9.1762	x	13.766	19.25	x	x	x	x	17.68	20.698	18.16	18.49	16.7	15.2578	16.48	x	17.949	
-15591	None	Trait_12_AUW-BXD	Metabolism, morphology: Body weight pre-metabolic caging, high fat diet, males [g]	x	x	34.4525	42.4075	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.21	52.46	37.08	x	x	49.3	44.17	43.82	52.523	x	x	x	33.694	39.22	x	x	x	x	48.8	39.97	45.45	43.42	51.28	48.936	x	36.11	40.88	38.815	49.0	x	42.262	x	43.002	x	x	x	42.78	42.422	43.855	x	34.538	45.28	49.82	x	32.246	x	38.96	45.13	x	x	x	x	45.856	50.185	47.81	46.55	43.816	45.32	43.67	x	45.62	
-15589	None	Trait_10_AUW-BXD	Metabolism, morphology: Body weight at blood pressure measurement, high fat diet, males [g]	x	x	37.7	43.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	39.2	56.2	38.1	x	x	50.49	46.18	40.956	54.5	x	x	x	36.7	39.88	x	x	x	x	50.5	41.57	48.47	44.25	52.65	50.77	x	37.52	41.42	42.7	48.48	x	40.0	x	40.6	x	x	x	44.252	44.0	45.36	x	35.56	x	51.57	x	32.36	x	39.07	47.0	x	x	x	x	45.844	54.3	47.09	46.074	48.168	50.7	45.14	x	47.95	
-15587	None	Trait_8_AUW-BXD	Metabolism, morphology: Body weight at sacrifice, high fat diet, males [g]	x	x	47.228	48.328	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	49.24	64.536	44.6	x	x	49.1	47.02	48.02	64.07	x	x	x	43.6475	41.285	x	x	x	x	53.032	45.54	48.5	50.065	64.05	60.922	x	41.49	33.72	50.2833	53.4	x	43.915	x	46.39	x	x	x	49.036	46.844	49.5	x	36.94	53.59	56.78	x	39.14	x	45.535	50.1	x	x	x	x	53.43	61.386	52.24	52.64	51.67	56.956	51.87	x	48.51	
-15585	None	Trait_6_AUW-BXD	Metabolism, morphology: Body weight at 28 weeks, high fat diet, males [g]	x	x	43.9	40.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	50.22	65.79	43.7	x	x	56.52	52.64	48.116	59.6	x	x	x	41.7	44.79	x	x	x	x	53.2	45.51	47.87	50.24	64.44	54.4	x	41.23	41.05	49.6	56.3	x	44.8	x	46.6	x	x	x	51.192	47.1	51.08	x	36.8	53.09	56.58	x	36.56	x	45.35	49.85	x	x	x	x	53.59	58.7	54.0	54.88	50.95	54.1	49.905	x	49.94	
-15583	None	Trait_4_AUW-BXD	Metabolism, morphology: Body weight at 16 weeks, high fat diet, males [g]	x	x	31.196	39.914	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.21	50.36	34.886	x	x	47.32	44.17	43.818	51.2275	x	x	x	32.964	39.22	x	x	x	x	45.514	38.75	46.45	43.42	51.28	42.84	x	36.11	40.88	39.57	49.0	x	41.648	x	43.002	x	x	x	40.64	42.186	43.85	x	33.71	45.28	49.82	x	31.886	x	40.78	45.13	x	x	x	x	45.856	50.3	47.81	45.55	43.82	45.32	43.82	x	45.62	
-15581	None	Trait_2_AUW-BXD	Metabolism, morphology: Body weight at 8 weeks, high fat diet, males [g]	x	x	21.718	22.214	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.364	23.8	21.0	x	x	25.69	32.1	27.37	27.75	x	x	x	21.6	25.87	x	x	x	x	27.0	25.84	30.75	25.01	29.2	25.414	x	21.91	25.65	26.8	36.08	x	27.0	x	27.246	x	x	x	21.57	24.664	22.61	x	23.45	24.14	29.42	x	21.69	x	25.825	23.82	x	x	x	x	26.69	30.2	29.85	28.04	24.95	28.558	27.24	x	28.66	
-15579	None	Trait_387_AUW-BXD	Metadata: Cohort study order, high fat diet, males [weeks]	x	x	34.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	78.0	22.0	25.0	x	x	92.0	92.0	134.0	25.0	x	x	x	27.0	112.0	x	x	x	x	31.0	53.0	51.0	94.0	84.0	38.0	x	109.0	94.0	28.0	110.0	x	26.0	x	29.0	x	x	x	127.0	35.0	98.0	x	45.0	84.0	106.0	x	31.0	x	80.0	54.0	x	x	x	x	140.0	45.0	123.0	116.0	101.0	37.0	136.0	x	107.0	
-15577	None	Trait_385_AUW-BXD	Metadata: Cohort study order, high fat diet, males [rank]	x	x	10.0	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.0	1.0	2.0	x	x	23.0	23.0	38.0	3.0	x	x	x	5.0	32.0	x	x	x	x	8.0	16.0	15.0	24.0	21.0	13.0	x	30.0	24.0	6.0	31.0	x	4.0	x	7.0	x	x	x	37.0	11.0	25.0	x	14.0	21.0	28.0	x	9.0	x	20.0	17.0	x	x	x	x	40.0	14.0	35.0	33.0	26.0	12.0	39.0	x	29.0	
-15711	None	Trait_150_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected, metabolic cage, high fat diet, males [ml/kg/h]	x	x	4872.0	5201.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4739.0	x	5290.0	x	x	x	x	x	5632.0	x	x	x	5828.0	x	x	x	x	x	4359.0	4154.0	5151.0	x	4941.0	5470.0	x	x	5281.0	5140.0	x	x	5554.0	x	4891.0	x	x	x	x	5821.0	x	x	5651.0	4542.0	x	x	5336.0	x	4957.0	4924.0	x	x	x	x	x	4438.0	x	x	x	4968.0	x	x	x	
-15712	None	Trait_151_AUW-BXD	Metabolism: Body temperature, basal, chow diet, males [Celsius]	x	x	38.16	37.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.9	36.78	36.32	x	x	36.8	37.8	36.575	37.22	x	x	x	37.18	38.3	x	x	x	37.5	38.6667	37.125	37.3	37.35	38.15	37.0	x	37.28	37.3	37.65	36.78	x	36.4	x	38.44	x	x	x	35.8	37.64	36.9	x	37.93	37.75	37.46	x	37.66	x	37.53	37.55	x	37.5	x	x	38.0	36.8	37.02	36.15	37.68	37.93	36.6	x	35.6	
-15713	None	Trait_152_AUW-BXD	Metabolism: Body temperature after 1 hour in 4 deg C chamber, chow diet, males [deg C]	x	x	36.84	36.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	37.5	36.32	36.58	x	x	35.6	36.0	35.25	36.64	x	x	x	36.48	35.8	x	x	x	35.6	37.2333	36.45	35.35	35.5	36.77	35.7	x	35.1	35.4	36.825	34.44	x	35.775	x	36.72	x	x	x	35.7	36.42	36.7	x	35.8	36.15	36.38	x	36.96	x	36.28	35.9	x	35.4	x	x	36.0	36.3	36.46	35.15	36.6	38.03	36.9	x	35.4	
-15714	None	Trait_153_AUW-BXD	Metabolism: Body temperature after 2 hours in 4 deg C chamber, chow diet, males [deg C]	x	x	36.36	36.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	37.4	36.3	36.78	x	x	34.1	35.7	34.28	35.92	x	x	x	36.46	35.7	x	x	x	33.8	36.4	35.83	35.8	34.725	35.6	34.9	x	35.1	35.0	36.4	34.34	x	34.75	x	36.68	x	x	x	35.2	36.46	35.93	x	36.63	35.275	35.98	x	36.76	x	35.55	35.5	x	35.2	x	x	35.4	36.1	35.88	34.8	35.6	36.63	36.0	x	35.1	
-15715	None	Trait_154_AUW-BXD	Metabolism: Body temperature after 3 hours in 4 deg C chamber, chow diet, males [deg C]	x	x	36.66	36.825	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.3	35.76	36.82	x	x	33.3	34.5	35.03	35.4	x	x	x	36.08	35.1	x	x	x	33.6	35.73	36.0	36.68	34.05	35.48	33.9	x	34.98	35.5	36.2	34.66	x	35.375	x	36.24	x	x	x	34.9	35.68	35.675	x	35.7	34.95	35.02	x	36.34	x	34.9	35.03	x	35.0	x	x	35.2	35.9	35.84	34.43	35.18	36.47	35.3	x	35.4	
-15716	None	Trait_155_AUW-BXD	Metabolism: Body temperature after 4 hours in 4 deg C chamber, chow diet, males [deg C]	x	x	36.24	36.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.7	35.16	36.38	x	x	33.7	35.0	34.45	35.78	x	x	x	35.56	34.5	x	x	x	34.8	35.53	35.7	35.83	33.9	35.6	32.8	x	35.08	34.7	36.275	33.92	x	35.075	x	36.62	x	x	x	35.4	36.16	35.475	x	35.6	34.425	35.5	x	36.62	x	34.58	35.18	x	34.7	x	x	35.5	35.2	35.08	34.4	35.4	36.13	34.9	x	35.1	
-15717	None	Trait_156_AUW-BXD	Metabolism: Body temperature after 5 hours in 4 deg C chamber, chow diet, males [deg C]	x	x	36.46	36.325	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.4	35.44	36.16	x	x	32.5	34.2	34.35	35.64	x	x	x	35.74	34.2	x	x	x	32.9	35.87	36.23	35.43	33.5	34.98	34.1	x	34.85	34.5	35.7	32.88	x	34.55	x	36.74	x	x	x	35.6	35.58	33.6	x	35.77	33.8	34.32	x	36.02	x	34.9	35.13	x	34.7	x	x	35.5	34.5	35.82	33.45	35.08	35.3	34.7	x	35.2	
-15718	None	Trait_157_AUW-BXD	Metabolism: Body temperature after 6 hours in 4 deg C chamber, chow diet, males [deg C]	x	x	35.32	36.275	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.0	35.14	35.52	x	x	32.5	34.4	34.28	35.46	x	x	x	36.14	34.2	x	x	x	33.8	35.87	35.55	34.15	33.85	34.1	32.8	x	34.93	33.3	36.25	32.78	x	34.6	x	37.18	x	x	x	35.6	36.24	32.1	x	36.23	32.05	35.0	x	36.28	x	33.8	35.18	x	34.9	x	x	34.9	33.8	34.2	31.98	35.78	35.63	35.0	x	34.9	
-15719	None	Trait_158_AUW-BXD	Metabolism: Body temperature, basal, high fat diet, males [deg C]	x	x	38.22	38.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	37.4	37.02	36.36	x	x	37.2	37.9	37.1	36.65	x	x	x	37.225	37.7	x	x	x	x	37.82	36.53	36.95	37.275	37.7	37.3	x	37.0	36.78	37.9	37.2	x	36.94	x	38.24	x	x	x	37.0	38.18	36.8	x	37.5	37.3	37.45	x	37.96	x	37.93	37.28	x	x	x	x	36.9	37.1	37.5	37.08	37.8	37.9	37.1	x	36.7	
-15720	None	Trait_159_AUW-BXD	Metabolism: Body temperature after 1 hour in 4 deg C chamber, high fat diet, males [deg C]	x	x	37.0	37.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.3	35.8	36.52	x	x	35.6	35.3	35.7	35.4	x	x	x	37.025	37.1	x	x	x	x	36.42	36.28	33.6	34.625	36.03	35.6	x	35.4	33.8	36.95	35.0	x	35.56	x	37.42	x	x	x	35.5	37.22	34.9	x	36.0	36.2	35.6	x	37.16	x	36.85	36.48	x	x	x	x	35.18	35.9	34.7	35.24	36.32	37.0	35.7	x	35.9	
-15721	None	Trait_160_AUW-BXD	Metabolism: Body temperature after 2 hours in 4 deg C chamber, high fat diet, males [deg C]	x	x	37.02	37.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.4	35.4	36.54	x	x	35.5	35.9	35.3	35.025	x	x	x	36.85	36.6	x	x	x	x	36.56	36.5	35.4	33.975	36.05	34.6	x	34.5	33.88	37.225	34.6	x	35.04	x	37.48	x	x	x	35.0	37.52	33.98	x	35.7	36.2	35.45	x	37.18	x	36.125	36.63	x	x	x	x	34.78	35.4	33.9	33.84	35.5	37.0	34.6	x	35.6	
-15722	None	Trait_161_AUW-BXD	Metabolism: Body temperature after 3 hours in 4 deg C chamber, high fat diet, males [deg C]	x	x	36.62	36.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	36.7	34.16	36.72	x	x	34.4	34.8	34.9	34.825	x	x	x	36.6	35.9	x	x	x	x	36.18	36.38	35.95	34.05	35.35	33.6	x	34.5	33.92	37.15	35.0	x	35.0	x	37.34	x	x	x	34.7	37.06	33.3	x	35.4	35.63	35.25	x	36.76	x	35.95	36.18	x	x	x	x	34.04	35.1	33.5	33.24	34.76	36.6	35.1	x	35.8	
-15723	None	Trait_162_AUW-BXD	Metabolism: Body temperature after 4 hours in 4 deg C chamber, high fat diet, males [deg C]	x	x	36.3	36.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.5	34.08	36.88	x	x	35.2	35.5	34.5	35.425	x	x	x	36.275	35.7	x	x	x	x	36.06	35.9	35.35	33.65	35.18	30.7	x	34.6	33.66	37.1	34.7	x	35.28	x	36.98	x	x	x	35.1	36.24	33.6	x	35.9	35.47	35.15	x	36.74	x	36.0	35.48	x	x	x	x	34.46	35.0	32.9	32.8	34.48	36.1	34.5	x	35.6	
-15724	None	Trait_163_AUW-BXD	Metabolism: Body temperature after 5 hours in 4 deg C chamber, high fat diet, males [deg C]	x	x	36.54	36.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.1	33.6	36.32	x	x	34.4	34.6	34.5	34.975	x	x	x	36.5	35.2	x	x	x	x	35.9	36.28	34.1	33.3	35.2	30.4	x	34.9	33.82	37.3	34.5	x	35.26	x	37.12	x	x	x	35.5	36.7	33.65	x	36.0	35.47	35.4	x	36.58	x	36.125	36.1	x	x	x	x	33.96	35.6	32.6	32.2	35.04	35.7	34.9	x	35.6	
-15725	None	Trait_164_AUW-BXD	Metabolism: Body temperature after 6 hours in 4 deg C chamber, high fat diet, males [deg C]	x	x	36.12	35.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.8	33.78	35.88	x	x	34.6	34.7	34.8	34.975	x	x	x	36.2	35.3	x	x	x	x	35.84	35.5	34.05	33.3	35.25	30.2	x	35.2	34.08	37.6	34.5	x	35.96	x	37.3	x	x	x	34.9	36.88	33.6	x	36.7	35.17	35.075	x	36.46	x	35.625	35.9	x	x	x	x	34.64	35.5	32.4	32.38	34.48	35.9	34.4	x	36.0	
-15726	None	Trait_165_AUW-BXD	Metabolism: Body temperature loss after 3 hours in 4 deg C chamber, chow diet, males [%]	x	x	3.9239	2.6934	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.768	2.7694	-1.3737	x	x	9.6	8.7	4.235	4.8911	x	x	x	2.8897	8.3	x	x	x	10.6	7.5794	3.02	1.67	8.84	7.011	8.27	x	6.17	4.92	3.8486	5.7716	x	2.8138	x	5.721	x	x	x	2.4	5.2001	2.64	x	5.89	6.55	6.51	x	3.5082	x	6.99	6.71	x	6.52	x	x	7.47	2.45	3.177	4.77	6.99	3.9	3.6	x	0.6	
-15727	None	Trait_166_AUW-BXD	Metabolism: Body temperature loss after 6 hours in 4 deg C chamber, chow diet, males [%]	x	x	7.4276	4.1486	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.558	4.4468	2.2048	x	x	8.6	4.2	6.284	4.7189	x	x	x	2.7362	10.7	x	x	x	10.0	7.2429	4.2	8.45	9.36	10.61	11.1	x	6.27	10.71	3.7114	10.8856	x	4.9401	x	3.2745	x	x	x	0.5	3.719	13.1	x	4.49	15.1	6.5414	x	3.6632	x	9.86	6.31	x	6.85	x	x	8.14	8.09	7.65	11.55	5.47	6.055	4.5	x	2.1	
-15728	None	Trait_167_AUW-BXD	Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber, chow diet, males [%]	x	x	3.6498	1.487	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.792	1.7077	3.5285	x	x	2.3	0.3	2.127	-0.1897	x	x	x	-0.1789	2.7	x	x	x	-0.7	-0.3709	1.2	6.89	0.526	3.87	3.01	x	0.11	6.09	-0.1393	5.422	x	2.1793	x	-2.6022	x	x	x	-1.9	-1.6059	10.1	x	-1.51	8.35	0.0399	x	0.1465	x	3.06	-0.44	x	0.363	x	x	0.714	5.8	4.62	7.13	-1.66	2.29	0.9	x	1.6	
-15729	None	Trait_168_AUW-BXD	Metabolism: Body temperature loss after 3 hours in 4 deg C chamber, high fat diet, males [%]	x	x	4.1888	2.9287	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.755	7.7195	-0.9958	x	x	7.4	8.3	5.8	4.9816	x	x	x	1.6573	4.7	x	x	x	x	4.3377	0.403	2.68	8.65	6.23	9.72	x	6.6	7.76	1.9959	5.9	x	5.2442	x	2.3526	x	x	x	6.2	2.9335	7.55	x	5.67	4.45	5.3	x	3.1484	x	5.211	2.95	x	x	x	x	7.744	5.3	10.9	10.35	8.07	3.48	5.3	x	2.4	
-14787	Original post publication description: Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio]	x	1.491	1.292	x	x	1.933	1.682	1.44	x	1.481	1.314	1.495	x	1.453	x	x	1.37	x	1.511	x	1.484	x	x	x	x	x	1.301	x	x	1.371	x	x	1.414	x	x	x	x	1.416	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14786	Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection [n cells]	None	Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, unadjusted data [n cells]	x	x	54.8	15.83	22.0	15.0	x	34.33	42.0	30.33	15.0	29.0	21.63	28.4	29.75	32.5	24.0	44.67	20.0	20.0	x	x	x	17.67	x	28.38	25.5	37.6	x	31.25	18.67	23.14	23.25	x	x	x	17.0	28.5	22.0	x	25.75	23.5	28.75	22.5	x	x	25.25	x	11.5	16.0	x	x	x	18.75	20.5	x	x	x	22.67	23.25	25.5	29.0	x	34.67	27.0	21.5	36.0	x	x	36.0	x	20.0	x	25.0	x	36.4	x	x	28.75	x	x	19.4	28.2	26.5	24.75	23.67	x	18.25	34.6	x	33.5	x	x	x	18.75	22.67	24.83	26.33	13.17	x	x	x	
-14785	Original post publication description: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Ordinal scale 0 = no disease, 4 = severe disease. Original pre publication description: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Ordinal scale 0 = no disease, 4 = severe disease.	Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease]	Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14783	Original post publication description: Chlamydia muridarum upper genital tract disease severity (endometrium; uterine horn) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Original pre publication description: Chlamydia muridarum upper genital tract disease severity (endometrium) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum.	Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe]	Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe]	x	x	2.67	3.3	1.5	x	x	x	x	x	4.0	x	3.0	x	x	x	x	x	x	x	x	x	x	3.2	x	x	x	x	x	2.0	3.3	x	2.5	x	x	x	3.5	3.3	2.5	x	4.0	x	x	x	x	x	2.75	x	x	3.67	x	x	x	x	x	x	x	x	x	3.0	x	4.0	x	x	3.3	x	3.67	x	4.0	2.5	x	x	4.0	3.0	x	4.0	x	3.4	2.5	x	x	x	2.25	x	2.3	x	x	3.0	x	x	4.0	x	x	x	x	2.4	x	x	3.0	x	2.75	2.75	
-14781	Original post publication description: Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2012) [ordinal scale, 0=poor, 1=fair, 2=good] Original pre publication description: Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good]	Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good]	Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good]	x	x	2.0	2.0	2.0	x	x	1.0	x	0.0	1.0	1.0	0.0	1.0	x	2.0	x	1.0	1.0	x	1.0	x	x	1.0	x	1.0	x	1.0	x	1.0	1.0	x	2.0	x	2.0	x	2.0	2.0	2.0	x	2.0	1.0	2.0	1.0	x	x	1.0	1.0	1.0	2.0	x	x	x	2.0	2.0	x	x	x	2.0	2.0	1.0	1.0	1.0	2.0	2.0	1.0	1.0	2.0	2.0	1.0	x	2.0	2.0	2.0	x	1.0	x	2.0	1.0	1.0	x	1.0	1.0	1.0	1.0	1.0	x	2.0	2.0	x	1.0	x	x	2.0	1.0	1.0	1.0	2.0	2.0	1.0	2.0	x	
-14779	Original post publication description: Central nervous system, adult neurogenesis: In vitro proliferation rate of adult hippocampal precursor cells (AHPC) measured by BrdU incorporation (Hoechst) after rederivation by cyropreservation [% positive cells] Original pre publication description: Kempermann 2012	Kempermann 2012	Central nervous system, adult neurogenesis: In vitro proliferation rate of adult hippocampal precursor cells (AHPC) measured by BrdU incorporation (Hoechst) after rederivation by cyropreservation [% positive cells]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15737	None	Trait_176_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage, high fat diet, males [counts/hour]	x	x	2704.0	4114.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4375.0	2012.0	3714.0	x	x	2216.0	1876.0	2943.0	1910.0	x	x	x	3611.0	3115.0	x	x	x	x	2258.0	2021.0	2757.0	3072.0	2310.0	1974.0	x	3308.0	4223.0	3069.0	2916.0	x	3130.0	x	2649.0	x	x	x	3272.0	2552.0	2790.0	x	2677.0	2648.0	2486.0	x	2462.0	x	3742.0	1739.0	x	x	x	x	2851.0	2921.0	3579.0	2931.0	3905.0	3302.0	3666.0	x	2689.0	
-15738	None	Trait_177_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage, high fat diet, males [counts/hour]	x	x	2212.0	1938.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3261.0	1905.0	1617.0	x	x	2007.0	1215.0	1852.0	1517.0	x	x	x	1426.0	2706.0	x	x	x	x	1472.0	1595.0	1442.0	2371.0	1797.0	1439.0	x	2067.0	2760.0	2544.0	2606.0	x	1666.0	x	2135.0	x	x	x	2537.0	1582.0	2244.0	x	2089.0	1611.0	1643.0	x	1447.0	x	2397.0	1126.0	x	x	x	x	2053.0	2257.0	2564.0	2196.0	2900.0	2303.0	2100.0	x	1752.0	
-15739	None	Trait_178_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage, high fat diet, males [counts/hour]	x	x	3195.0	6291.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5489.0	2055.0	5811.0	x	x	2425.0	2537.0	4034.0	2302.0	x	x	x	5696.0	3524.0	x	x	x	x	3045.0	2446.0	4072.0	3773.0	2823.0	2509.0	x	4548.0	5686.0	3594.0	3226.0	x	4594.0	x	3162.0	x	x	x	4007.0	3521.0	3333.0	x	3266.0	3685.0	3328.0	x	3478.0	x	5087.0	2351.0	x	x	x	x	3515.0	3586.0	4594.0	3552.0	4826.0	4302.0	5233.0	x	3626.0	
-15740	None	Trait_179_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage, chow diet, males [counts/hour]	x	x	537.0	749.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	695.0	374.0	808.0	x	x	451.0	524.0	403.0	405.0	x	x	x	503.0	236.0	x	x	x	332.0	399.0	339.0	334.0	293.0	373.0	294.0	x	538.0	603.0	327.0	904.0	x	438.0	x	263.0	x	x	x	225.0	334.0	388.0	x	221.0	710.0	886.0	x	308.0	x	553.0	256.0	x	438.0	x	x	505.0	427.0	433.0	421.0	692.0	504.0	790.0	x	265.0	
-15741	None	Trait_180_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage, chow diet, males [counts/hour]	x	x	299.0	179.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	421.0	279.0	383.0	x	x	291.0	269.0	201.0	184.0	x	x	x	141.0	115.0	x	x	x	171.0	92.0	143.0	125.0	150.0	204.0	220.0	x	147.0	334.0	193.0	755.0	x	125.0	x	125.0	x	x	x	72.0	92.0	402.0	x	98.0	223.0	739.0	x	61.0	x	245.0	45.0	x	195.0	x	x	315.0	88.0	325.0	266.0	202.0	250.0	245.0	x	44.0	
-15742	None	Trait_181_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night), in standard housing cage, chow diet, males [counts/hour]	x	x	774.0	1320.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	968.0	462.0	1233.0	x	x	608.0	779.0	573.0	626.0	x	x	x	865.0	356.0	x	x	x	493.0	706.0	536.0	543.0	435.0	541.0	368.0	x	898.0	872.0	462.0	1052.0	x	750.0	x	400.0	x	x	x	378.0	575.0	374.0	x	344.0	1197.0	1032.0	x	556.0	x	673.0	466.0	x	681.0	x	x	695.0	765.0	541.0	552.0	1142.0	759.0	1335.0	x	486.0	
-15743	None	Trait_182_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage, high fat diet, males [counts/hour]	x	x	276.0	416.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	517.0	100.0	436.0	x	x	189.0	244.0	393.0	280.1	x	x	x	459.0	167.0	x	x	x	x	115.0	196.0	253.0	176.0	303.0	129.0	x	244.0	314.0	219.0	140.0	x	188.0	x	126.0	x	x	x	191.0	340.0	133.0	x	196.0	233.0	124.0	x	215.0	x	288.0	147.0	x	x	x	x	132.0	258.0	233.0	231.0	541.0	246.0	290.0	x	185.0	
-15744	None	Trait_183_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage, high fat diet, males [counts/hour]	x	x	180.0	114.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	307.0	67.0	306.0	x	x	141.0	85.0	151.0	225.0	x	x	x	91.0	119.0	x	x	x	x	33.0	68.0	93.0	71.0	195.0	61.0	x	81.0	119.0	162.0	91.0	x	43.0	x	61.0	x	x	x	64.0	213.0	88.0	x	192.0	66.0	54.0	x	49.0	x	168.0	34.0	x	x	x	x	43.0	89.0	136.0	164.0	218.0	151.0	127.0	x	26.0	
-15745	None	Trait_184_AUW-BXD	Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night) in standard housing cage, high fat diet, males [counts/hour]	x	x	372.0	719.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	728.0	129.0	567.0	x	x	238.0	403.0	636.0	335.0	x	x	x	828.0	215.0	x	x	x	x	198.0	324.0	413.0	280.0	411.0	198.0	x	408.0	509.0	276.0	189.0	x	333.0	x	192.0	x	x	x	319.0	468.0	178.0	x	200.0	399.0	193.0	x	380.0	x	408.0	261.0	x	x	x	x	210.0	427.0	330.0	287.0	837.0	342.0	453.0	x	345.0	
-15746	None	Trait_185_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, chow diet, males [g]	x	x	4.5175	4.75667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.48	3.36	3.43	x	x	1.66	3.71	3.0	4.72	x	x	x	3.752	3.86	x	x	x	4.73	5.07333	4.08	3.02	3.73	4.59	5.838	x	4.51	3.27	4.4875	2.68	x	2.7425	x	3.044	x	x	x	3.64	2.916	1.67	x	3.64	2.71	3.54	x	3.6575	x	3.05	3.2	x	4.53	x	x	2.34	4.2775	4.54	3.99	2.75	5.34	2.18	x	2.98	
-15747	None	Trait_186_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, high fat diet, males [g]	x	x	4.5925	3.364	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.71	3.874	2.965	x	x	1.73	2.86	7.56	5.99	x	x	x	2.695	2.6	x	x	x	x	2.696	3.32	7.0	2.26	5.23	3.736	x	10.0	10.0	3.18667	2.93	x	2.618	x	1.928	x	x	x	2.88	2.634	2.31	x	2.8	3.09	2.98	x	1.84333	x	2.57	1.87	x	x	x	x	x	2.435	x	3.41	3.19	3.685	3.85	x	2.61	
-15748	None	Trait_187_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, chow diet, males [kCal]	x	x	14.0042	14.7457	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.9	10.416	10.633	x	x	5.13	11.49	9.3	14.632	x	x	x	11.6312	11.97	x	x	x	14.66	15.7273	12.66	9.35	11.57	14.23	18.0978	x	13.98	13.39	13.9113	8.3	x	8.50175	x	9.4364	x	x	x	11.29	9.0396	5.18	x	11.284	8.4	10.99	x	11.3383	x	9.46	9.913	x	14.05	x	x	7.24	13.2603	14.08	12.38	8.51	16.554	6.77	x	9.24	
-15749	None	Trait_188_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, high fat diet, males [kCal]	x	x	23.4217	17.1564	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.5	19.7574	15.1215	x	x	5.35	14.62	38.55	30.549	x	x	x	13.7445	13.27	x	x	x	x	13.7496	16.93	35.0	11.54	26.0	19.0536	x	40.0	40.0	16.252	14.96	x	13.3518	x	9.8328	x	x	x	14.7	13.4334	11.78	x	14.28	15.77	15.22	x	9.401	x	13.12	9.52	x	x	x	x	x	12.4185	x	17.38	16.27	18.7935	19.64	x	13.32	
-15750	None	Trait_189_AUW-BXD	Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage, chow diet, males [g/g]	x	x	14.12	14.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.95	11.98	14.64	x	x	4.2	6.22	x	9.94	x	x	x	12.18	x	x	x	x	11.92	15.13	x	x	6.2	4.59	5.84	x	11.6	8.06	14.93	6.66	x	8.41	x	3.04	x	x	x	x	2.92	5.76	x	x	x	7.46	x	13.82	x	8.42	10.48	x	9.73	x	x	6.65	10.16	x	x	6.92	14.33	x	x	7.1	
-15751	None	Trait_190_AUW-BXD	Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage, high fat diet, males [g/g]	x	x	9.79	7.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.7	6.23	19.31	x	x	3.03	8.03	x	4.71	x	x	x	6.43	x	x	x	x	x	4.96	x	x	6.36	4.06	3.74	x	x	x	6.98	x	x	6.12	x	1.93	x	x	x	x	2.63	4.59	x	x	3.09	x	x	5.22	x	6.25	3.57	x	x	x	x	x	x	x	x	5.59	6.547	x	x	5.24	
-15752	None	Trait_191_AUW-BXD	Morphology, metabolism: Body weight in home cage, chow diet, males [g]	x	x	32.08	33.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	32.6	31.3	32.116	x	x	39.72	37.53	38.29	35.36	x	x	x	30.858	33.71	x	x	x	40.43	33.44	32.0	37.42	34.71	44.69	44.81	x	40.91	40.61	31.5	39.42	x	33.45	x	38.68	x	x	x	37.262	44.66	28.47	x	28.6	37.1	47.27	x	26.6	x	36.25	30.77	x	46.59	x	x	35.32	42.2	44.7	35.6	39.91	39.4	33.83	x	42.54	
-15753	None	Trait_192_AUW-BXD	Morphology, metabolism: Body weight in home cage, high fat diet, males [g]	x	x	46.66	44.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	43.62	41.52	44.96	x	x	57.22	53.04	47.5	61.97	x	x	x	41.91	41.52	x	x	x	x	54.39	44.48	46.11	48.52	59.58	56.47	x	43.94	41.62	47.33	50.09	x	42.29	x	45.23	x	x	x	47.5	46.33	50.57	x	37.188	53.96	53.8	x	35.08	x	41.35	53.51	x	x	x	x	x	61.79	53.55	51.77	52.42	55.1	52.24	x	49.51	
-15754	None	Trait_193_AUW-BXD	Metabolism: Glycemia after overnight fast, chow diet, males [mg/mL]	x	x	103.5	86.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82.3	120.6	154.75	x	x	93.0	89.0	91.0	119.0	x	x	x	91.2	82.0	x	x	x	110.8	96.3333	137.0	122.0	79.0	143.0	113.5	x	95.4	171.5	83.25	79.2	x	157.75	x	96.2	x	x	x	91.6	128.0	87.75	x	106.0	81.6	97.2	x	96.0	x	117.0	94.0	x	156.3	x	x	123.0	124.6	146.4	107.2	84.8	121.0	68.0	x	103.4	
-15755	None	Trait_194_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, chow diet, males [mg/mL]	x	x	294.5	186.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	367.3	356.4	320.0	x	x	317.0	311.0	258.0	215.75	x	x	x	183.4	267.0	x	x	x	210.6	207.333	272.0	344.0	246.0	302.5	234.3	x	389.0	461.0	225.0	295.0	x	217.25	x	240.0	x	x	x	163.6	284.0	295.0	x	229.0	221.2	363.4	x	267.8	x	269.0	252.0	x	292.0	x	x	270.0	326.8	343.0	324.0	214.0	362.0	310.0	x	298.0	
-15756	None	Trait_195_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, chow diet, males [mg/mL]	x	x	260.5	179.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	431.5	447.0	280.25	x	x	340.0	266.0	280.0	222.25	x	x	x	217.8	295.0	x	x	x	235.6	221.333	189.0	380.0	263.0	327.88	223.6	x	385.0	490.0	201.0	373.0	x	189.0	x	272.6	x	x	x	196.2	271.0	228.0	x	201.0	262.2	429.0	x	252.8	x	222.0	238.0	x	243.0	x	x	285.0	304.4	365.0	381.0	260.0	439.0	302.8	x	322.0	
-15757	None	Trait_196_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, chow diet, males [mg/mL]	x	x	225.5	166.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	390.3	521.6	237.75	x	x	310.0	239.0	262.0	202.0	x	x	x	197.4	305.4	x	x	x	219.8	201.667	186.0	359.0	268.0	331.25	224.8	x	317.0	479.0	165.25	367.0	x	200.5	x	277.4	x	x	x	214.5	261.0	191.0	x	175.0	244.2	431.4	x	247.6	x	198.0	197.0	x	279.0	x	x	273.0	285.8	361.0	363.0	267.0	404.0	264.0	x	308.0	
-15758	None	Trait_197_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, chow diet, males [mg/mL]	x	x	205.5	143.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	343.0	554.2	223.0	x	x	264.0	212.0	268.0	179.0	x	x	x	172.6	284.6	x	x	x	201.8	191.0	168.0	348.0	254.0	307.25	207.8	x	261.0	474.0	137.5	354.8	x	218.25	x	235.4	x	x	x	193.4	233.0	168.8	x	165.0	237.6	405.6	x	224.6	x	177.0	166.0	x	265.0	x	x	261.0	260.2	350.0	332.0	243.0	355.33	228.0	x	298.0	
-15759	None	Trait_198_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, chow diet, males [mg/mL]	x	x	155.5	105.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	245.5	379.8	x	x	x	180.0	159.0	229.0	x	x	x	x	133.8	221.4	x	x	x	150.2	159.667	142.0	295.0	213.0	244.75	147.0	x	197.0	454.0	109.0	250.2	x	196.5	x	159.4	x	x	x	182.2	180.0	127.5	x	148.0	207.4	325.6	x	165.2	x	122.0	122.0	x	213.0	x	x	193.0	199.6	297.0	258.0	174.0	243.33	195.8	x	231.2	
-15760	None	Trait_199_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, chow diet, males [mg/mL]	x	x	142.0	99.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	180.0	211.6	155.25	x	x	145.0	144.0	179.0	142.5	x	x	x	118.4	176.2	x	x	x	136.2	135.667	134.0	221.0	195.0	210.0	127.3	x	163.0	425.0	94.5	174.4	x	170.75	x	133.8	x	x	x	181.4	155.0	117.8	x	142.0	199.6	262.4	x	134.6	x	103.0	104.0	x	206.0	x	x	174.0	182.0	263.0	208.0	148.0	196.66	167.0	x	200.0	
-15761	None	Trait_200_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, chow diet, males [mg/mL]	x	x	122.75	95.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	144.5	144.0	142.0	x	x	125.0	130.0	157.0	125.25	x	x	x	108.4	139.0	x	x	x	119.6	108.667	127.0	187.0	180.0	181.25	118.0	x	141.0	360.0	87.25	144.6	x	157.0	x	118.0	x	x	x	156.8	137.0	104.0	x	128.0	189.5	236.2	x	114.8	x	84.0	102.0	x	195.0	x	x	148.0	158.6	219.0	176.0	127.0	157.66	133.3	x	168.2	
-15762	None	Trait_201_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, chow diet, males [mg/mL]	x	x	112.0	96.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	125.3	136.2	x	x	x	113.0	127.0	150.0	x	x	x	x	109.0	127.8	x	x	x	110.2	103.0	121.0	168.0	168.0	169.75	111.3	x	126.0	294.0	90.25	122.2	x	x	x	105.0	x	x	x	146.0	134.0	100.8	x	117.0	160.4	203.4	x	108.4	x	79.3	96.0	x	189.0	x	x	138.0	147.6	189.0	155.0	118.0	144.333	116.5	x	169.6	
-15763	None	Trait_202_AUW-BXD	Metabolism: Glycemia after overnight fast, high fat diet, males [mg/mL]	x	x	163.0	132.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	89.3	238.4	163.25	x	x	145.0	113.0	144.2	178.25	x	x	x	77.5	118.8	x	x	x	x	144.4	132.0	198.0	138.0	198.5	146.5	x	78.5	202.0	122.0	161.0	x	125.8	x	163.4	x	x	x	133.4	162.0	158.5	x	186.0	127.5	134.75	x	191.0	x	95.3	157.0	x	x	x	x	131.6	159.3	149.25	158.0	111.6	163.0	94.0	x	102.0	
-15764	None	Trait_203_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, high fat diet, males [mg/mL]	x	x	349.5	256.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	344.7	370.0	277.5	x	x	390.0	267.0	327.8	313.0	x	x	x	199.5	311.3	x	x	x	x	250.8	315.0	440.0	358.0	379.75	243.3	x	406.8	465.0	333.5	472.0	x	299.8	x	294.6	x	x	x	275.8	244.0	433.3	x	340.0	357.7	466.5	x	359.0	x	261.0	318.0	x	x	x	x	329.6	417.7	326.5	439.0	319.0	352.4	213.0	x	241.0	
-15765	None	Trait_204_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, high fat diet, males [mg/mL]	x	x	302.0	251.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	487.0	566.0	286.75	x	x	477.0	273.0	290.2	358.25	x	x	x	251.25	421.3	x	x	x	x	293.8	364.0	506.0	468.0	396.5	246.1	x	468.5	555.0	340.0	528.0	x	312.6	x	339.6	x	x	x	337.6	286.0	493.5	x	373.0	443.0	404.5	x	366.2	x	296.0	335.0	x	x	x	x	430.6	445.3	398.0	536.0	419.0	378.4	260.0	x	279.0	
-15766	None	Trait_205_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, high fat diet, males [mg/mL]	x	x	302.5	223.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	492.0	600.0	288.5	x	x	473.0	237.0	294.4	382.25	x	x	x	251.5	425.3	x	x	x	x	321.0	371.0	546.0	511.0	392.25	257.8	x	432.0	587.0	328.0	547.0	x	330.6	x	380.2	x	x	x	370.8	301.0	534.0	x	343.0	500.0	460.0	x	325.8	x	285.0	291.0	x	x	x	x	425.4	454.7	459.8	591.0	482.0	381.4	300.0	x	302.0	
-15767	None	Trait_206_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, high fat diet, males [mg/mL]	x	x	295.625	205.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	462.8	572.6	283.0	x	x	464.0	220.0	291.2	367.0	x	x	x	231.0	420.3	x	x	x	x	332.0	361.0	547.0	511.0	350.75	250.8	x	406.8	591.0	301.0	544.0	x	319.0	x	386.8	x	x	x	367.2	284.0	508.8	x	318.0	560.0	512.0	x	328.8	x	231.0	254.0	x	x	x	x	433.2	451.0	472.3	597.0	502.0	348.6	253.0	x	289.0	
-15768	None	Trait_207_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, high fat diet, males [mg/mL]	x	x	266.5	197.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	353.7	543.8	x	x	x	371.0	196.0	223.2	x	x	x	x	173.75	324.5	x	x	x	x	243.4	313.0	529.0	476.0	325.5	178.3	x	315.0	577.0	248.5	504.0	x	255.4	x	316.6	x	x	x	366.2	244.0	430.0	x	257.0	498.0	440.0	x	277.6	x	149.0	208.0	x	x	x	x	358.2	390.7	383.5	585.0	396.0	292.6	196.0	x	235.8	
-15769	None	Trait_208_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, high fat diet, males [mg/mL]	x	x	229.75	197.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	262.3	370.0	219.5	x	x	271.0	187.0	187.0	193.5	x	x	x	144.25	271.8	x	x	x	x	207.0	253.0	444.0	437.0	292.75	153.0	x	231.0	489.0	170.75	440.0	x	215.6	x	234.8	x	x	x	348.4	198.0	375.8	x	231.0	472.3	423.5	x	227.6	x	143.0	184.0	x	x	x	x	286.2	341.7	289.8	543.0	331.0	233.4	171.0	x	225.2	
-15770	None	Trait_209_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, high fat diet, males [mg/mL]	x	x	227.5	195.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	190.0	349.0	182.0	x	x	206.0	172.0	161.8	191.25	x	x	x	133.0	219.5	x	x	x	x	180.2	213.0	365.0	390.0	247.75	147.0	x	162.0	404.0	145.0	384.3	x	190.6	x	180.4	x	x	x	333.8	176.0	303.3	x	211.0	416.3	392.0	x	192.2	x	141.0	158.0	x	x	x	x	234.0	276.7	221.5	489.0	286.0	176.6	151.0	x	208.4	
-15771	None	Trait_210_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, high fat diet, males [mg/mL]	x	x	196.5	180.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	154.0	276.6	x	x	x	175.0	166.0	156.6	x	x	x	x	131.25	188.3	x	x	x	x	160.6	178.0	281.0	340.0	208.25	136.3	x	125.5	278.0	141.5	357.7	x	x	x	150.6	x	x	x	292.8	173.0	250.0	x	191.3	334.33	329.3	x	157.6	x	123.0	151.0	x	x	x	x	204.8	240.7	178.0	407.0	230.0	155.4	151.0	x	197.2	
-15772	None	Trait_211_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), chow diet, males [AUC]	x	x	31387.0	22298.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	45148.0	70698.0	35661.0	x	x	36359.0	33064.0	37750.0	28369.0	x	x	x	25999.8	38051.0	x	x	x	29195.0	28140.3	28389.8	48595.8	38095.0	44016.0	29202.0	x	39899.0	78779.0	22663.2	43011.0	x	33566.0	x	31779.2	x	x	x	31234.6	34552.8	27156.0	x	27893.0	37191.2	55989.0	x	31360.0	x	25617.0	26027.0	x	40575.0	x	x	36717.0	38964.2	51219.0	45876.0	32448.0	47073.0	35419.0	x	41913.0	
-15773	None	Trait_212_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, chow diet, males [mg/mL/min]	x	x	12.283	4.98	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.84111	11.0167	x	x	x	x	x	4.55	x	x	x	4.73778	x	x	x	x	x	5.26667	x	x	x	x	6.55	x	x	x	7.875	x	x	3.48194	x	5.86667	x	x	x	x	x	x	x	x	x	x	x	5.20444	x	x	x	x	x	x	x	x	7.022	x	x	x	10.6	x	x	x	
-15774	None	Trait_213_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, chow diet, males [mg/mL/min]	x	x	1.24	0.627	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.44593	1.31852	x	x	x	x	x	0.991766	x	x	x	0.734707	x	x	x	x	x	0.79899	x	x	x	x	0.967	x	x	x	0.866212	x	x	0.873611	x	1.26885	x	x	x	x	x	x	x	x	x	x	x	1.13452	x	x	x	x	x	x	x	x	1.16	x	x	x	x	x	x	x	
-15775	None	Trait_214_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), high fat diet, males [AUC]	x	x	46844.3	36968.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	57433.0	88299.0	41125.0	x	x	59689.0	36531.0	41021.0	46108.0	x	x	x	31811.5	55009.0	x	x	x	x	42864.4	50864.0	80500.0	76776.0	56012.0	34339.0	x	52472.0	87212.0	41760.2	81873.0	x	44394.0	x	49357.8	x	x	x	59870.0	41217.0	71567.0	x	48199.0	81533.0	78105.0	x	47882.0	x	33370.0	39758.0	x	x	x	x	57942.0	64988.0	59021.0	92703.0	63851.0	49158.0	35706.0	x	42630.0	
-15776	None	Trait_215_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, high fat diet, males [mg/mL/min]	x	x	10.17	7.033	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.72889	4.81667	x	x	x	x	x	7.775	x	x	x	6.80278	x	x	x	x	x	3.58889	x	x	x	x	2.85	x	x	x	10.0583	x	x	4.15778	x	5.74444	x	x	x	x	x	x	x	x	x	x	x	4.70889	x	x	x	x	x	x	x	x	9.19	x	x	x	8.66	x	x	x	
-15777	None	Trait_216_AUW-BXD	Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, high fat diet, males [mg/mL/min]	x	x	1.02	0.5178	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.34281	1.15093	x	x	x	x	x	1.87212	x	x	x	0.85798	x	x	x	x	x	1.41444	x	x	x	x	0.995	x	x	x	1.57977	x	x	1.64413	x	1.92879	x	x	x	x	x	x	x	x	x	x	x	1.56993	x	x	x	x	x	x	x	x	1.82	x	x	x	1.78	x	x	x	
-15778	None	Trait_217_AUW-BXD	Metabolism: Insulin response from oral glucose tolerance test (OGTT), chow diet, males [AUC]	x	x	40.93	68.335	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.61	37.346	28.095	x	x	29.86	13.03	48.02	29.8975	x	x	x	41.034	20.914	x	x	x	47.03	28.84	22.38	44.3	25.42	79.25	153.645	x	25.39	44.538	50.16	34.29	x	49.1333	x	68.328	x	x	x	45.11	121.728	22.48	x	35.75	23.558	52.886	x	28.96	x	37.22	7.435	x	54.72	x	x	24.73	73.06	91.992	12.559	33.562	43.096	20.633	x	44.87	
-15779	None	Trait_218_AUW-BXD	Metabolism: Insulin response from oral glucose tolerance test (OGTT), high fat diet, males [AUC]	x	x	127.2	192.675	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	26.69	57.96	97.5425	x	x	105.45	54.24	122.05	82.7875	x	x	x	45.9625	58.92	x	x	x	x	263.5	103.1	100.17	28.34	156.45	215.575	x	25.3295	48.51	104.773	72.15	x	82.66	x	172.06	x	x	x	70.73	141.495	118.9	x	205.675	61.58	68.87	x	100.464	x	93.66	59.25	x	x	x	x	98.02	331.1	120.55	56.82	63.872	129.266	99.52	x	70.854	
-15781	None	Trait_220_AUW-BXD	Metabolism: Insulin after overnight fast, high fat diet, males [ug/mL]	x	x	3.3	3.7855	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.007	1.9148	2.114	x	x	1.418	0.606	1.896	1.8715	x	x	x	0.43275	0.729	x	x	x	x	4.805	1.57	2.46	1.048	4.35	4.175	x	0.0975	1.733	1.32325	3.32	x	1.3462	x	2.4586	x	x	x	0.971	4.743	2.723	x	3.82975	2.105	2.277	x	2.0186	x	1.401	1.188	x	x	x	x	1.44	9.79333	2.275	1.39	0.8936	2.561	0.9775	x	1.2394	
-15782	None	Trait_221_AUW-BXD	Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, chow diet, males [ug/mL]	x	x	1.999	1.85225	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.77	1.1992	0.88925	x	x	1.307	0.795	2.0735	1.09125	x	x	x	1.0912	0.872	x	x	x	1.762	1.06233	1.36	1.79	1.072	3.13	6.98925	x	1.2442	1.7	2.597	1.098	x	1.89775	x	2.9756	x	x	x	1.918	4.593	0.9503	x	1.77767	0.9452	2.0616	x	0.834	x	1.822	0.395	x	1.9068	x	x	1.14125	3.5046	3.766	0.601	1.4468	1.67933	0.895	x	1.7078	
-15783	None	Trait_222_AUW-BXD	Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, high fat diet, males [ug/mL]	x	x	4.98	7.42825	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.175	1.33733	4.2285	x	x	3.878	2.3535	5.084	2.802	x	x	x	2.172	2.49	x	x	x	x	10.1946	4.11	3.32	0.9523	4.44	8.774	x	1.153	1.604	3.8255	1.745	x	3.56325	x	7.3964	x	x	x	3.11	4.84	4.564	x	8.70325	1.9197	2.504	x	3.8362	x	3.7155	2.151	x	x	x	x	3.886	11.7487	4.74	1.815	2.6132	5.2104	4.375	x	2.7762	
-15784	None	Trait_223_AUW-BXD	Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, chow diet, males [ug/mL]	x	x	1.072	2.68625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.521	1.0418	1.4595	x	x	1.018	0.344	2.11	0.81375	x	x	x	0.9934	0.72	x	x	x	1.547	1.03033	0.256	1.372	0.919	3.12	4.22725	x	0.6898	1.06	1.22367	1.3486	x	1.41133	x	1.7996	x	x	x	1.99	3.6885	0.617	x	1.08233	0.7782	1.711	x	0.559	x	1.008	0.181	x	2.154	x	x	0.665	1.8986	3.65	0.462	1.413	1.10867	0.622	x	1.5648	
-15785	None	Trait_224_AUW-BXD	Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, high fat diet, males [ug/mL]	x	x	3.694	7.0495	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.2	1.6365	2.43375	x	x	3.242	1.995	4.22	3.56375	x	x	x	1.3515	2.15	x	x	x	x	9.9428	3.45	4.267	1.019	5.17	7.02125	x	0.9735	1.625	3.08433	2.02	x	2.2222	x	5.6896	x	x	x	2.236	4.43975	3.856	x	6.1865	2.267	1.898	x	3.703	x	3.6548	2.41	x	x	x	x	4.144	10.8543	4.33	2.02	2.3962	4.2542	3.535	x	2.6552	
-15786	None	Trait_225_AUW-BXD	Blood chemistry, metabolism: Basal glucose, fasted state, chow diet, males [mmol/L]	x	x	15.1	15.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.83	15.425	15.54	x	x	16.28	13.825	14.23	14.9	x	x	x	15.0	13.1	x	x	x	20.75	14.0	14.25	17.05	14.975	18.525	18.14	x	16.6	21.08	17.375	16.1	x	14.725	x	19.2	x	x	x	18.8	15.7	15.075	x	13.733	12.2	14.12	x	14.12	x	12.8	16.775	x	18.35	x	x	15.9	19.85	x	19.03	14.3	16.6333	17.4	x	15.54	
-15787	None	Trait_226_AUW-BXD	Blood chemistry, metabolism: Cholesterol, fasted state, chow diet, males [mmol/L]	x	x	3.66667	3.55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.5	3.375	4.26	x	x	3.16	2.88	3.225	3.0	x	x	x	3.46	2.87	x	x	x	5.15	3.58	3.775	3.35	4.7	4.25	3.84	x	3.83	3.24	3.55	3.55	x	2.825	x	4.5	x	x	x	2.96	3.1	3.075	x	3.033	3.37	3.12	x	3.52	x	2.675	3.55	x	4.48	x	x	4.075	3.6	x	3.0	3.3	4.6	3.48	x	3.02	
-15788	None	Trait_227_AUW-BXD	Blood chemistry, metabolism: High-density lipoprotein (HDL), fasted state, chow diet, males [mmol/L]	x	x	2.07	1.925	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.26	1.5125	1.92	x	x	2.914	2.805	3.205	1.46333	x	x	x	1.75	2.73	x	x	x	4.525	1.366	3.77	3.305	4.12	3.4975	3.73	x	3.72	2.802	1.61	3.563	x	1.315	x	2.154	x	x	x	2.936	1.31	2.69	x	2.993	3.32	3.09	x	1.954	x	2.8	3.52	x	3.9275	x	x	3.72	1.695	x	2.943	3.31	2.05333	3.303	x	2.964	
-15789	None	Trait_228_AUW-BXD	Blood chemistry, metabolism: Low-density lipoprotein (LDL), fasted state, chow diet, males [mmol/L]	x	x	0.0666667	0.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.01	0.0133333	0.1	x	x	0.102	0.095	0.1175	0.035	x	x	x	0.054	0.1433	x	x	x	0.2425	0.148	0.135	0.07	0.23	0.1675	0.046	x	0.13	0.084	0.23	0.1175	x	0.095	x	0.138	x	x	x	0.136	0.124	0.2325	x	0.0733	0.2	0.112	x	0.054	x	0.075	0.095	x	0.2175	x	x	0.115	0.105	x	0.1033	0.09	0.123333	0.135	x	0.148	
-15790	None	Trait_229_AUW-BXD	Blood chemistry, metabolism: Triglycerides, fasted state, chow diet, males [mmol/L]	x	x	1.28	1.66667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.36	0.5625	1.318	x	x	0.652	1.13	0.635	0.916667	x	x	x	0.92	0.797	x	x	x	0.66	0.418	0.32	1.96	1.1925	0.6725	1.622	x	1.297	1.484	1.0175	1.125	x	0.6425	x	0.932	x	x	x	0.926	0.864	0.8375	x	0.9533	1.483	0.728	x	1.51	x	1.083	1.428	x	0.79	x	x	1.8	0.95	x	0.963	0.844	1.46667	1.883	x	1.06	
-15791	None	Trait_230_AUW-BXD	Blood chemistry, metabolism: Free fatty acids (FFA), fasted state, chow diet, males [mmol/L]	x	x	2.34333	3.475	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.76	0.735	1.69	x	x	0.752	1.3875	0.555	1.42667	x	x	x	1.486	0.897	x	x	x	0.75	0.888	0.6425	1.1733	0.7125	0.475	0.79	x	0.807	0.618	1.22	0.6325	x	1.22	x	1.4925	x	x	x	0.662	1.388	0.4775	x	0.513	0.8133	0.662	x	1.652	x	0.865	0.99	x	1.0975	x	x	0.875	1.695	x	0.72	0.66	1.27333	1.025	x	0.636	
-15792	None	Trait_231_AUW-BXD	Blood chemistry, metabolism: Bile acids, fasted state, chow diet, males [umol/L]	x	x	x	5.43333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.6	8.86	x	x	x	x	x	8.6	x	x	x	4.5	x	x	x	x	x	377.533	x	x	x	x	x	x	x	x	13.7	x	x	5.53333	x	12.3	x	x	x	11.18	119.2	x	x	x	x	x	x	1.1	x	x	x	x	x	x	x	x	11.6	x	x	x	15.7	x	x	x	
-15793	None	Trait_232_AUW-BXD	Blood chemistry, metabolism: Lactic acid, fasted state, chow diet, males [mmol/L]	x	x	8.73333	6.425	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.7	8.5	x	x	x	x	x	5.3	x	x	x	4.04	x	x	x	x	x	5.22	5.325	7.7	x	x	5.62	x	x	x	4.7	x	x	6.05	x	7.7	x	x	x	x	6.54	x	x	4.2	x	x	x	7.02	x	4.95	5.325	x	x	x	x	x	4.5	x	x	x	2.7	x	x	x	
-15794	None	Trait_233_AUW-BXD	Blood chemistry, metabolism: Total protein, fasted state, chow diet, males [g/L]	x	x	59.7	56.625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	47.76	53.05	53.06	x	x	51.14	51.225	51.225	52.4333	x	x	x	56.04	50.2	x	x	x	55.675	49.94	54.775	57.25	50.275	51.95	59.4	x	51.667	47.24	58.7	57.125	x	50.425	x	58.22	x	x	x	45.25	48.46	45.625	x	51.467	52.67	53.48	x	45.52	x	50.48	54.8	x	52.225	x	x	55.05	54.45	x	56.4	52.38	53.8	48.93	x	50.02	
-15795	None	Trait_234_AUW-BXD	Blood chemistry, metabolism: Alanine transaminase (ALAT), fasted state, chow diet, males [U/L]	x	x	26.0	30.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	123.3	44.25	29.2	x	x	48.8	45.25	51.0	38.0	x	x	x	26.4	47.33	x	x	x	149.75	146.6	34.75	44.0	168.25	139.0	44.0	x	73.67	81.0	27.5	55.75	x	32.3333	x	26.6	x	x	x	84.0	31.2	53.0	x	67.33	52.0	63.4	x	34.6	x	28.25	30.0	x	118.25	x	x	66.0	22.0	x	76.33	51.4	24.3333	58.5	x	67.4	
-15796	None	Trait_235_AUW-BXD	Blood chemistry, metabolism: Aspartate transaminase (ASAT), fasted state, chow diet, males [U/L]	x	x	48.3333	43.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	118.7	43.0	35.25	x	x	35.6	93.25	71.5	84.0	x	x	x	62.0	65.0	x	x	x	147.25	348.8	31.0	48.0	191.0	143.0	33.8	x	105.3	148.2	50.25	55.75	x	72.75	x	56.6	x	x	x	84.6	78.6	115.25	x	75.33	48.33	76.4	x	175.8	x	28.5	28.5	x	156.0	x	x	91.75	110.0	x	92.33	67.4	33.6667	81.0	x	91.6	
-15797	None	Trait_236_AUW-BXD	Blood chemistry, metabolism: Lactate dehydrogenase (LDH), fasted state, chow diet, males [U/L]	x	x	193.333	55.3333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.33	336.0	231.0	x	x	130.0	196.5	170.0	95.3333	x	x	x	163.0	296.0	x	x	x	622.5	326.75	273.25	218.0	539.0	444.5	211.6	x	396.3	435.8	179.75	236.3	x	84.25	x	177.0	x	x	x	350.0	168.0	239.0	x	302.3	290.7	233.8	x	194.0	x	249.25	169.0	x	411.0	x	x	237.75	16.0	x	242.0	280.2	107.0	296.0	x	353.8	
-15798	None	Trait_237_AUW-BXD	Blood chemistry, metabolism: Bilirubin, fasted state, chow diet, males [umol/L]	x	x	1.2	1.975	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.9	0.7	x	x	x	0.35	x	0.55	x	x	x	0.4	x	x	x	x	x	10.28	2.15	3.25	x	x	2.92	x	x	x	0.6	x	x	0.733333	x	1.1	x	x	x	x	3.475	0.0	x	1.6	x	x	x	3.33333	x	x	x	x	x	x	x	x	0.85	x	x	x	1.55	x	x	x	
-15799	None	Trait_238_AUW-BXD	Blood chemistry, metabolism: Alkaline phosphatase (ALPL), fasted state, chow diet, males [U/L]	x	x	63.3333	95.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	88.0	82.25	106.6	x	x	94.2	82.0	73.0	110.0	x	x	x	77.6	67.67	x	x	x	91.0	104.67	52.75	51.0	124.75	93.5	78.6	x	70.67	141.6	94.75	117.25	x	57.25	x	78.0	x	x	x	109.8	74.2	198.5	x	126.67	62.67	129.2	x	78.6	x	100.25	137.25	x	95.25	x	x	111.75	78.5	x	70.33	95.4	94.3333	77.3	x	64.0	
-15800	None	Trait_239_AUW-BXD	Blood chemistry, metabolism: Amylase, fasted state, chow diet, males [U/L]	x	x	1199.67	1021.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1120.7	1045.75	924.2	x	x	1104.4	923.5	1047.5	1079.33	x	x	x	1086.6	995.3	x	x	x	1154.5	1272.0	1059.5	1122.0	1083.5	1266.0	1396.0	x	1127.3	1207.6	1341.5	1192.3	x	1047.5	x	1265.4	x	x	x	939.0	1181.0	889.0	x	1052.3	881.0	1377.0	x	1260.0	x	1257.5	977.25	x	1299.75	x	x	1057.75	1135.5	x	941.0	928.0	1051.0	878.3	x	1180.0	
-15801	None	Trait_240_AUW-BXD	Blood chemistry, metabolism: Creatine kinase (CPK), fasted state, chow diet, males [U/L]	x	x	148.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	122.3	55.6667	203.0	x	x	88.0	62.5	56.5	14.5	x	x	x	53.0	147.67	x	x	x	164.0	36.5	171.5	122.5	79.0	201.5	113.0	x	339.0	157.0	62.75	130.0	x	87.3333	x	53.75	x	x	x	158.6	34.2	181.75	x	145.67	112.7	179.2	x	82.25	x	684.0	37.0	x	327.5	x	x	101.5	189.5	x	62.7	173.6	57.6667	256.8	x	273.4	
-15802	None	Trait_241_AUW-BXD	Blood chemistry, metabolism: Creatinine, fasted state, chow diet, males [umol/L]	x	x	24.3333	21.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.33	24.25	29.2	x	x	11.25	10.5	13.5	22.3333	x	x	x	21.0	10.3	x	x	x	7.5	26.2	x	x	7.5	12.5	x	x	x	11.6	20.75	32.3	x	23.5	x	29.4	x	x	x	19.4	27.8	2.5	x	x	20.0	22.2	x	23.2	x	x	x	x	4.0	x	x	15.25	22.0	x	9.0	7.4	29.0	9.25	x	14.8	
-15803	None	Trait_242_AUW-BXD	Blood chemistry, metabolism: Iron (Fe) level in serum, fasted state, chow diet, males [umol/L]	x	x	21.8667	40.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.5	29.1	26.4	x	x	20.62	27.6	20.075	26.7667	x	x	x	28.86	29.6	x	x	x	31.3	34.68	20.85	30.8	32.075	27.1	25.22	x	38.2	32.3	29.875	27.85	x	28.6	x	30.36	x	x	x	26.85	25.7	47.85	x	19.73	29.4	25.5	x	29.02	x	26.95	26.8	x	25.2	x	x	30.625	20.15	x	26.83	22.76	26.5	26.05	x	28.38	
-15804	None	Trait_243_AUW-BXD	Blood chemistry, metabolism: Basal glucose, fasted state, high fat diet, males [mmol/L]	x	x	21.46	16.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.53	16.2	17.975	x	x	21.28	13.825	11.98	18.45	x	x	x	16.575	13.6	x	x	x	x	14.4	13.925	14.0	10.325	15.55	15.55	x	13.75	16.72	20.8667	12.3	x	14.2	x	18.2	x	x	x	12.72	15.54	13.35	x	14.625	15.1	14.7	x	16.74	x	14.625	16.7	x	x	x	x	x	19.3667	11.85	15.76	19.66	17.92	11.83	x	17.78	
-15805	None	Trait_244_AUW-BXD	Blood chemistry, metabolism: Cholesterol, fasted state, high fat diet, males [mmol/L]	x	x	5.6	4.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.7	6.0	5.1	x	x	4.72	4.375	4.46	5.175	x	x	x	5.3	3.85	x	x	x	x	4.13333	6.125	2.6	2.925	7.1	4.3	x	4.55	3.98	5.5	3.47	x	3.575	x	6.06	x	x	x	4.16	4.54	5.2	x	4.3	6.3	4.3	x	5.54	x	3.45	4.2	x	x	x	x	x	3.83333	6.025	6.8	5.12	6.52	5.03	x	4.3	
-15806	None	Trait_245_AUW-BXD	Blood chemistry, metabolism: High-density lipoprotein (HDL), fasted state, high fat diet, males [mmol/L]	x	x	2.168	2.318	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.29	1.875	1.91	x	x	4.248	3.645	4.35	1.8025	x	x	x	2.1375	3.675	x	x	x	x	2.09667	5.708	2.8	2.8275	5.225	4.8125	x	4.1975	3.554	2.29333	3.4	x	1.485	x	2.438	x	x	x	4.208	1.582	4.36	x	4.048	5.38	x	x	2.556	x	3.26	4.37	x	x	x	x	x	1.79667	5.59	5.884	4.68	2.59	4.783	x	4.184	
-15807	None	Trait_246_AUW-BXD	Blood chemistry, metabolism: Low-density lipoprotein (LDL), fasted state, high fat diet, males [mmol/L]	x	x	0.372	0.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.14	0.285	0.2075	x	x	0.198	0.265	0.238	0.2425	x	x	x	0.1975	0.23	x	x	x	x	0.06	0.395	0.11	0.045	0.57	0.125	x	0.305	0.132	0.323333	0.303	x	0.17	x	0.222	x	x	x	0.21	0.234	0.466	x	0.2125	0.447	0.2575	x	0.182	x	0.0825	0.2175	x	x	x	x	x	0.185	0.0433	0.566	0.194	0.334	0.348	x	0.226	
-15808	None	Trait_247_AUW-BXD	Blood chemistry, metabolism: Triglycerides, fasted state, high fat diet, males [mmol/L]	x	x	0.91	1.855	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.29	0.85	1.49	x	x	1.052	1.855	0.904	0.93	x	x	x	1.29	1.2	x	x	x	x	0.783333	0.8925	1.68	1.1875	0.655	1.2575	x	0.8525	1.06	1.68333	1.593	x	1.41	x	0.868	x	x	x	0.888	1.128	1.353	x	1.025	1.147	1.785	x	2.34	x	2.2275	1.41	x	x	x	x	x	0.733333	0.628	0.798	1.502	1.324	0.83	x	1.392	
-15809	None	Trait_248_AUW-BXD	Blood chemistry, metabolism: Free fatty acids (FFA), fasted state, high fat diet, males [mmol/L]	x	x	2.182	2.428	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.847	1.065	1.5075	x	x	0.86	0.695	0.848	1.4575	x	x	x	1.6775	1.02	x	x	x	x	1.49667	0.475	0.885	0.93	0.63	0.9775	x	0.67	0.632	1.79	0.74	x	1.3225	x	0.45	x	x	x	0.598	1.608	0.743	x	0.395	0.51	0.4267	x	2.354	x	0.775	0.875	x	x	x	x	x	1.61333	0.493	0.638	0.54	1.224	0.715	x	0.63	
-15810	None	Trait_249_AUW-BXD	Blood chemistry, metabolism: Bile acids, fasted state, high fat diet, males [umol/L]	x	x	7.4	6.23333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.0	9.75	x	x	x	x	x	12.225	x	x	x	13.1333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	22.2	x	x	74.55	x	20.55	x	x	x	x	13.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	21.0	8.525	x	x	5.8	x	x	x	
-15811	None	Trait_250_AUW-BXD	Blood chemistry, metabolism: Lactic acid, fasted state, high fat diet, males [mmol/L]	x	x	3.66	5.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.95	6.35	x	x	x	x	x	2.35	x	x	x	4.9	x	x	x	x	x	6.06667	6.175	10.63	x	x	5.775	x	x	x	5.86667	x	x	5.475	x	4.34	x	x	x	x	3.96	x	x	x	x	x	x	6.16	x	x	4.6	x	x	x	x	x	3.23333	x	x	x	3.7	x	x	x	
-15812	None	Trait_251_AUW-BXD	Blood chemistry, metabolism: Total protein, fasted state, high fat diet, males [g/L]	x	x	64.32	59.76	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	50.8	55.35	51.4	x	x	50.0	57.0	54.34	54.85	x	x	x	60.2	52.7	x	x	x	x	52.7667	56.7	54.67	48.525	56.55	61.525	x	47.675	46.68	62.8	53.5	x	50.65	x	52.96	x	x	x	49.58	49.24	53.03	x	49.43	49.8	51.125	x	53.22	x	51.4	55.38	x	x	x	x	x	58.4	58.45	61.38	53.74	50.22	52.73	x	55.38	
-15813	None	Trait_252_AUW-BXD	Blood chemistry, metabolism: Alanine transaminase (ALAT), fasted state, high fat diet, males [U/L]	x	x	32.0	32.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	74.33	89.0	31.75	x	x	86.2	85.5	123.6	81.0	x	x	x	36.75	78.5	x	x	x	x	31.5	67.5	40.0	60.75	243.25	68.0	x	90.25	103.4	54.3333	132.67	x	37.25	x	72.0	x	x	x	132.8	39.0	88.67	x	61.25	87.67	139.0	x	41.0	x	63.0	39.5	x	x	x	x	x	32.6667	176.3	373.4	77.6	52.4	279.5	x	97.8	
-15814	None	Trait_253_AUW-BXD	Blood chemistry, metabolism: Aspartate transaminase (ASAT), fasted state, high fat diet, males [U/L]	x	x	54.0	50.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	73.33	197.0	38.0	x	x	113.4	129.5	157.0	119.25	x	x	x	73.0	94.0	x	x	x	x	23.5	80.25	40.0	86.75	247.25	77.5	x	123.5	191.6	45.3333	156.0	x	93.0	x	117.6	x	x	x	134.0	90.4	133.0	x	73.0	121.7	112.5	x	110.0	x	103.25	23.0	x	x	x	x	x	63.0	162.75	496.0	79.0	52.4	281.0	x	105.4	
-15815	None	Trait_254_AUW-BXD	Blood chemistry, metabolism: Lactate dehydrogenase (LDH), fasted state, high fat diet, males [U/L]	x	x	146.8	87.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	214.33	819.0	296.0	x	x	280.2	303.8	270.2	338.0	x	x	x	181.333	406.5	x	x	x	x	277.667	891.0	201.0	251.25	707.0	235.0	x	281.8	503.6	400.0	445.0	x	237.75	x	262.5	x	x	x	426.2	214.25	614.3	x	535.0	330.67	688.8	x	485.0	x	480.25	355.5	x	x	x	x	x	236.0	398.0	1392.0	354.4	200.8	479.5	x	386.4	
-15816	None	Trait_255_AUW-BXD	Blood chemistry, metabolism: Bilirubin, fasted state, high fat diet, males [umol/L]	x	x	0.45	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.6	0.3	x	x	x	x	x	1.2	x	x	x	0.5	x	x	x	x	x	1.8	2.167	2.93	x	x	3.5	x	x	x	x	x	x	0.65	x	1.3	x	x	x	x	2.28	0.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.5	x	x	x	2.4	x	x	x	
-15817	None	Trait_256_AUW-BXD	Blood chemistry, metabolism: Alkaline phosphatase (ALPL), fasted state, high fat diet, males [U/L]	x	x	61.6	62.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	79.0	76.5	83.25	x	x	71.8	97.5	69.6	117.25	x	x	x	66.5	59.5	x	x	x	x	104.667	50.5	73.3	109.75	115.0	61.5	x	54.25	119.8	104.333	122.3	x	45.75	x	68.0	x	x	x	122.0	56.6	160.67	x	82.5	58.7	96.0	x	62.8	x	81.5	96.75	x	x	x	x	x	77.3333	95.3	161.4	93.2	68.0	79.75	x	59.0	
-15818	None	Trait_257_AUW-BXD	Blood chemistry, metabolism: Amylase, fasted state, high fat diet, males [U/L]	x	x	1169.2	1145.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1155.0	1014.5	858.5	x	x	945.0	1077.0	973.8	1048.75	x	x	x	1173.25	1181.0	x	x	x	x	1189.0	897.0	912.0	1048.0	981.0	1113.0	x	1078.0	1142.2	1467.67	1228.0	x	1168.5	x	1065.4	x	x	x	863.4	1234.4	842.3	x	1229.0	928.3	1309.0	x	1375.0	x	1488.0	1037.3	x	x	x	x	x	1178.67	116.0	952.0	925.4	1099.6	919.75	x	1326.4	
-15819	None	Trait_258_AUW-BXD	Blood chemistry, metabolism: Creatine kinase (CPK), fasted state, high fat diet, males [U/L]	x	x	146.4	11.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	131.67	225.0	117.0	x	x	106.2	71.3	72.8	26.5	x	x	x	149.75	83.0	x	x	x	x	30.0	208.25	92.3	243.25	127.3	77.25	x	110.0	157.0	29.3333	117.67	x	17.0	x	55.0	x	x	x	113.6	41.8	251.67	x	237.0	77.67	267.3	x	77.4	x	602.5	68.75	x	x	x	x	x	50.67	100.75	88.0	74.4	65.6	55.8	x	103.2	
-15820	None	Trait_259_AUW-BXD	Blood chemistry, metabolism: Creatinine, fasted state, high fat diet, males [umol/L]	x	x	26.0	25.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.67	32.5	26.0	x	x	4.4	15.25	15.4	19.25	x	x	x	28.75	3.0	x	x	x	x	26.2	x	x	11.0	10.5	x	x	21.5	6.0	24.3333	8.0	x	27.5	x	22.2	x	x	x	18.2	41.8	3.33	x	x	7.33	23.25	x	28.8	x	x	x	x	x	x	x	x	x	20.5	22.2	17.6	25.2	16.3	x	19.8	
-15821	None	Trait_260_AUW-BXD	Blood chemistry, metabolism: Iron (Fe) level in serum, fasted state, high fat diet, males [umol/L]	x	x	22.94	43.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.37	22.5	25.5	x	x	25.3	26.65	15.9	25.25	x	x	x	28.5	22.9	x	x	x	x	32.0333	16.775	31.37	26.95	33.73	29.2	x	21.7	27.4	31.7333	23.1	x	22.25	x	38.22	x	x	x	15.3	24.5	60.5	x	27.13	35.0	27.63	x	35.42	x	33.22	25.63	x	x	x	x	x	20.4	9.05	21.86	35.02	24.22	21.4	x	29.64	
-15822	None	Trait_377_AUW-BXD	Blood chemistry, metabolism: Interferon-gamma (IFN-g) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	16.476	18.1325	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.0567	8.74	8.995	x	x	14.29	x	x	8.87	x	x	x	12.04	x	x	x	x	x	9.86	11.11	x	11.94	13.93	15.42	78.705	8.85	13.87	9.74	10.56	x	12.55	x	8.08	x	x	x	x	19.46	9.23	x	14.84	11.87	11.03	x	15.18	x	32.1	21.6	x	x	x	x	x	16.32	x	8.88	7.29	14.22	x	x	20.71	
-15823	None	Trait_378_AUW-BXD	Blood chemistry, metabolism: Tumer necrosis factor-alpha (TNF, cachexin) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	85.1	116.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	70.6	67.5	68.2	x	x	62.98	x	x	58.6	x	x	x	70.82	78.36	x	x	x	x	61.81	79.52	x	79.28	78.57	78.71	x	43.75	69.98	58.85	63.94	x	70.05	x	58.52	x	x	x	x	104.7	60.85	x	61.71	70.6	103.8	x	87.3	x	101.55	98.66	x	x	x	x	x	78.53	x	73.22	57.13	65.2	x	x	92.1	
-15824	None	Trait_379_AUW-BXD	Blood chemistry, metabolism: Interleukin 15 (IL15) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	276.92	298.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	298.77	234.36	324.135	x	x	328.192	x	x	234.36	x	x	x	234.36	339.3	x	x	x	x	234.36	263.11	x	262.98	234.36	277.392	x	234.36	234.36	234.36	269.85	x	236.07	x	327.4	x	x	x	x	327.396	234.36	x	271.88	234.36	234.36	x	234.36	x	325.99	234.36	x	x	x	x	x	322.79	x	600.0	234.36	292.848	x	x	339.674	
-15825	None	Trait_380_AUW-BXD	Blood chemistry, metabolism: Monocyte chemotactic protein 1 (MCP1, CCL2) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	139.24	84.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	50.5767	48.08	53.06	x	x	59.268	x	x	61.7925	x	x	x	74.8025	55.72	x	x	x	x	245.024	59.39	x	53.27	80.36	35.11	x	44.9	109.397	49.17	55.5633	x	82.88	x	33.786	x	x	x	x	141.292	50.8867	x	43.81	84.08	93.43	x	81.2175	x	105.582	71.005	x	x	x	x	x	124.985	x	84.91	48.924	59.585	x	x	113.25	
-15826	None	Trait_381_AUW-BXD	Blood chemistry, metabolism: Interleukin 10 (IL10) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	177.15	105.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	51.7067	65.8	33.6675	x	x	104.416	x	x	50.775	x	x	x	68.2975	83.02	x	x	x	x	296.694	132.97	x	94.46	181.337	131.415	x	58.625	108.07	44.83	91.3667	x	61.91	x	46.438	x	x	x	x	139.21	75.4667	x	111.92	77.36	72.2167	x	77.69	x	75.755	153.31	x	x	x	x	x	151.705	x	127.78	41.476	80.9075	x	x	158.896	
-15827	None	Trait_382_AUW-BXD	Blood chemistry, metabolism: Macrophage inflammatory protein 1-beta (MIP1B, CCL4) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	32.462	26.8425	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.5967	30.8	28.4275	x	x	17.818	x	x	26.2175	x	x	x	32.66	36.7	x	x	x	x	46.294	34.15	x	39.14	17.2825	17.855	x	34.1275	47.31	35.0867	40.6033	x	36.0725	x	31.286	x	x	x	x	33.126	40.48	x	30.8	51.15	38.83	x	15.9175	x	75.47	27.54	x	x	x	x	x	28.44	x	51.58	32.974	16.2875	x	x	61.828	
-15828	None	Trait_383_AUW-BXD	Blood chemistry, metabolism: Macrophage inflammatory protein 1-alpha (MIP1A, CCL3) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	13.732	16.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.0633	8.12	15.9975	x	x	7.416	x	x	5.6825	x	x	x	12.8825	12.94	x	x	x	x	19.09	18.58	x	11.95	4.685	6.6	x	16.635	11.3725	8.53	5.79	x	13.42	x	8.796	x	x	x	x	14.648	7.73667	x	8.21	19.28	10.16	x	16.275	x	28.8525	11.94	x	x	x	x	x	6.125	x	14.26	9.338	8.5175	x	x	10.196	
-15829	None	Trait_388_AUW-BXD	Blood chemistry, metabolism: Interleukin 6 (IL6) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	6.92	6.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.97	2.8	2.8	x	x	4.456	x	x	3.59	x	x	x	3.15	2.8	x	x	x	x	13.51	4.97	x	3.98	8.65	4.99	x	6.63	4.59	5.28	2.8	x	3.32	x	6.46	x	x	x	x	5.93	3.45	x	4.22	5.12	4.04	x	4.44	x	8.81	10.39	x	x	x	x	x	6.16	x	4.37	2.8	3.38	x	x	4.25	
-15830	None	Trait_389_AUW-BXD	Blood chemistry, metabolism: Interleukin 18 (IL18) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	351.28	724.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	430.2	493.5	862.2	x	x	481.9	x	x	771.6	x	x	x	922.1	1333.4	x	x	x	x	175.6	692.2	x	679.5	318.8	506.6	x	508.1	940.5	776.3	669.2	x	828.0	x	579.5	x	x	x	x	748.6	396.0	x	657.0	790.7	1032.3	x	565.5	x	820.3	741.3	x	x	x	x	x	425.5	x	1008.8	643.4	434.2	x	x	1361.0	
-15831	None	Trait_390_AUW-BXD	Blood chemistry, metabolism: Regulated and normal T cell expressed and secreted (RANTES, CCL5) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL]	x	x	9.312	11.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.61	22.3	7.06	x	x	10.01	x	x	8.48	x	x	x	9.65	22.12	x	x	x	x	25.6	11.79	x	11.81	5.55	3.14	x	13.77	8.73	5.52	1.04	x	16.6	x	30.2	x	x	x	x	26.32	7.33	x	10.29	7.19	10.4	x	9.92	x	12.98	10.33	x	x	x	x	x	5.98	x	12.69	8.17	6.89	x	x	19.2	
-15832	None	Trait_261_AUW-BXD	Hematology: Red blood cells, chow diet, males [10^6/uL]	x	x	9.38	10.185	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.91	10.45	x	x	x	10.43	10.02	11.26	x	x	x	x	x	x	x	x	x	9.99	x	10.94	9.97	10.23	11.11	11.356	x	11.92	9.01	x	9.98	x	x	x	x	x	x	x	10.86	10.4275	11.5	x	9.34	10.94	9.92	x	x	x	9.23	10.11	x	9.71	x	x	8.85	9.71	11.22	9.71	10.51	9.89	11.37	x	10.15	
-15833	None	Trait_262_AUW-BXD	Hematology: Mature red blood cells, chow diet, males [%]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	97.2	97.05	x	x	x	97.54	96.4	97.13	x	x	x	x	x	x	x	x	x	97.05	x	97.225	97.3	97.4	97.65	x	x	97.43	97.5	x	97.83	x	x	x	x	x	x	x	97.6	x	97.73	x	96.97	98.3	97.85	x	x	x	97.8	97.73	x	97.73	x	x	97.57	x	97.6	97.97	97.62	x	97.45	x	97.98	
-15834	None	Trait_263_AUW-BXD	Hematology: Mature red blood cells, chow diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	85338.0	83480.0	x	x	x	87986.0	83825.0	91285.0	x	x	x	x	x	x	x	x	x	89340.5	x	84852.0	83385.7	88042.0	92663.0	x	x	96587.0	78346.0	x	82654.0	x	x	x	x	x	x	x	91570.0	x	94505.5	x	87109.0	90312.0	73112.0	x	x	x	76277.0	82496.5	x	82706.0	x	x	77880.7	x	92389.0	83473.0	87668.0	x	91682.0	x	85200.4	
-15835	None	Trait_264_AUW-BXD	Hematology: Hemoglobin, chow diet, males [g/dL]	x	x	13.63	13.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.33	13.8	x	x	x	13.64	14.0	14.95	x	x	x	x	x	x	x	x	x	14.1	x	14.4	13.5	13.0	14.8	13.86	x	17.73	12.95	x	14.3	x	x	x	x	x	x	x	15.0	13.8	15.65	x	12.44	15.4	13.95	x	x	x	13.6	13.35	x	13.07	x	x	12.13	12.825	14.72	13.13	14.48	13.95	15.75	x	14.2	
-15836	None	Trait_265_AUW-BXD	Hematology: Hematocrit, chow diet, males [%]	x	x	45.47	44.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	45.67	x	x	x	x	42.64	43.7	51.55	x	x	x	x	x	x	x	x	x	43.75	x	23.85	47.67	42.33	47.75	48.86	x	55.0	41.7	x	45.4	x	x	x	x	x	x	x	48.44	47.2	47.5	x	13.27	47.7	45.1	x	x	x	42.5	46.2	x	41.87	x	x	39.73	44.325	50.44	45.02	44.16	46.95	51.0	x	44.68	
-15837	None	Trait_266_AUW-BXD	Hematology: Mean corpuscular volume (MCV), chow diet, males [fL/RBC]	x	x	48.37	43.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	46.13	47.4	x	x	x	40.84	43.58	45.8	x	x	x	x	x	x	x	x	x	43.85	x	43.625	47.8	41.4	43.03	43.06	x	46.13	46.3	x	45.5	x	x	x	x	x	x	x	44.6	45.25	41.28	x	44.17	43.5	45.53	x	x	x	46.1	45.65	x	43.13	x	x	44.9	45.65	44.94	46.33	42.02	47.5	44.88	x	43.96	
-15838	None	Trait_267_AUW-BXD	Hematology: Mean corpuscular hemoglobin (MCH), chow diet, males [pg/RBC]	x	x	15.5	13.175	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.47	13.4	x	x	x	13.04	14.0	13.3	x	x	x	x	x	x	x	x	x	14.1	x	13.175	13.5	12.67	13.33	12.22	x	14.83	14.35	x	14.38	x	x	x	x	x	x	x	13.85	13.25	13.6	x	13.37	14.05	14.1	x	x	x	14.85	13.175	x	13.47	x	x	13.8	13.225	13.12	13.6	13.78	13.3	13.85	x	14.0	
-15839	None	Trait_268_AUW-BXD	Hematology: Mean corpuscular hemoglobin concentration (MCHC), chow diet, males [g/dL]	x	x	29.98	30.275	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	31.4	28.266	x	x	x	31.88	32.08	28.98	x	x	x	x	x	x	x	x	x	32.15	x	30.15	28.26	30.63	31.0	28.98	x	32.17	30.98	x	31.5	x	x	x	x	x	x	x	31.0	29.25	32.98	x	30.27	32.3	30.88	x	x	x	32.25	28.85	x	31.2	x	x	30.67	28.95	29.18	29.27	32.76	27.95	30.88	x	31.84	
-15840	None	Trait_269_AUW-BXD	Hematology: Red blood cell hemoglobin content, chow diet, males [pg/RBC]	x	x	12.52	12.05	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.37	12.1667	x	x	x	12.86	14.23	12.85	x	x	x	x	x	x	x	x	x	14.65	x	12.35	12.47	12.63	13.8	11.6	x	14.3	14.1	x	14.38	x	x	x	x	x	x	x	13.6	12.05	13.75	x	11.97	14.2	14.05	x	x	x	12.75	12.2	x	13.3	x	x	14.0	12.125	12.38	13.0	13.84	12.35	13.38	x	14.06	
-15841	None	Trait_270_AUW-BXD	Hematology: Red blood cell distribution width, chow diet, males [%]	x	x	12.666	13.525	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.27	12.55	x	x	x	12.92	14.13	12.63	x	x	x	x	x	x	x	x	x	13.55	x	12.8	14.4	16.87	13.83	13.02	x	13.5	14.93	x	12.75	x	x	x	x	x	x	x	13.7	14.03	14.43	x	13.1	12.9	14.38	x	x	x	12.0	12.575	x	13.97	x	x	13.27	12.625	13.12	14.03	13.84	14.3	12.48	x	13.18	
-15842	None	Trait_271_AUW-BXD	Hematology: Hemoglobin concentration distribution width, chow diet, males [g/dL]	x	x	1.657	1.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.11	1.885	x	x	x	2.03	2.11	1.61	x	x	x	x	x	x	x	x	x	2.24	x	1.9325	2.097	2.36	2.02	1.922	x	2.15	2.09	x	2.09	x	x	x	x	x	x	x	1.83	1.898	2.16	x	1.91	2.08	2.1	x	x	x	1.855	1.8575	x	2.13	x	x	2.08	1.82	1.76	1.81	2.22	2.0	1.85	x	2.09	
-15843	None	Trait_272_AUW-BXD	Hematology: Reticulocytes, chow diet, males [%]	x	x	3.0	1.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.8	2.7667	x	x	x	2.46	3.6	2.88	x	x	x	x	x	x	x	x	x	2.95	x	2.775	2.67	2.6	2.35	3.08	x	2.57	2.5	x	2.18	x	x	x	x	x	x	x	2.4	2.7	2.28	x	3.03	1.7	2.15	x	x	x	2.2	2.275	x	2.27	x	x	2.43	3.175	2.4	2.03	2.38	2.95	2.55	x	2.02	
-15844	None	Trait_273_AUW-BXD	Hematology: Reticulocytes, chow diet, males [10^9/L]	x	x	297.166	193.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	279.0	282.7	x	x	x	256.36	363.35	320.4	x	x	x	x	x	x	x	x	x	294.25	x	303.6	266.3	263.93	263.65	347.0	x	305.0	224.9	x	217.95	x	x	x	x	x	x	x	261.87	282.4	262.05	x	283.0	186.7	213.3	x	x	x	202.3	231.1	x	219.13	x	x	215.73	307.5	269.64	200.47	252.2	294.1	290.3	x	205.52	
-15845	None	Trait_274_AUW-BXD	Hematology: Mean corpuscular volume reticulocytes, chow diet, males [fL/RTC]	x	x	58.3667	53.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	54.93	55.4	x	x	x	50.26	56.05	56.38	x	x	x	x	x	x	x	x	x	57.0	x	52.375	55.4	53.93	51.13	54.54	x	56.4	56.9	x	54.13	x	x	x	x	x	x	x	57.3	57.45	52.78	x	53.3	51.25	58.5	x	x	x	54.3	53.975	x	52.83	x	x	54.37	56.075	55.74	59.67	52.48	57.35	55.53	x	51.6	
-15846	None	Trait_275_AUW-BXD	Hematology: Mean corpuscular hemoglobin concentration reticulocytes, chow diet, males [g/dL]	x	x	29.98	26.825	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	28.77	25.7667	x	x	x	29.22	29.38	24.95	x	x	x	x	x	x	x	x	x	29.6	x	27.575	27.2	27.43	29.7	25.4	x	29.13	28.7	x	30.78	x	x	x	x	x	x	x	27.15	25.35	30.23	x	27.0	31.85	29.95	x	x	x	27.8	27.25	x	28.63	x	x	28.97	25.375	25.22	24.67	30.5	24.95	27.63	x	31.36	
-15847	None	Trait_276_AUW-BXD	Hematology: Red cell hemoglobin content reticulocytes, chow diet, males [pg/RTC]	x	x	14.667	14.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.73	14.233	x	x	x	14.5	16.33	13.98	x	x	x	x	x	x	x	x	x	16.6	x	14.35	15.03	14.67	15.03	13.74	x	16.33	16.2	x	16.53	x	x	x	x	x	x	x	15.3	14.45	15.75	x	14.33	16.15	17.4	x	x	x	14.95	14.6	x	15.03	x	x	15.63	14.18	13.86	14.57	15.78	14.3	15.15	x	16.02	
-15848	None	Trait_277_AUW-BXD	Hematology: Low mature reticulocytes, chow diet, males [%]	x	x	42.566	56.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	51.6	51.3666	x	x	x	63.98	54.4	74.53	x	x	x	x	x	x	x	x	x	37.0	x	53.275	56.97	59.57	65.45	50.54	x	61.4	47.0	x	62.2	x	x	x	x	x	x	x	74.2	61.98	55.13	x	47.2	64.95	65.85	x	x	x	53.45	56.15	x	63.83	x	x	48.4	58.35	67.82	73.2	60.88	58.15	75.63	x	71.26	
-15849	None	Trait_278_AUW-BXD	Hematology: Low mature reticulocytes, chow diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	637.67	598.3	x	x	x	708.8	848.0	996.75	x	x	x	x	x	x	x	x	x	411.5	x	646.25	583.7	688.0	736.0	x	x	781.0	469.0	x	573.75	x	x	x	x	x	x	x	796.5	x	601.25	x	141.0	511.5	522.5	x	x	x	457.5	542.0	x	609.67	x	x	472.0	x	771.8	623.0	655.2	x	908.3	x	626.2	
-15850	None	Trait_279_AUW-BXD	Hematology: Medium mature reticulocytes, chow diet, males [%]	x	x	41.8	325.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	39.77	42.4	x	x	x	33.28	39.88	24.43	x	x	x	x	x	x	x	x	x	42.65	x	41.3	38.3	33.53	31.9	41.52	x	33.43	37.45	x	33.45	x	x	x	x	x	x	x	23.7	33.25	39.55	x	40.67	31.8	29.2	x	x	x	39.65	37.375	x	32.8	x	x	41.2	37.4	30.02	24.5	34.02	35.8	22.45	x	26.22	
-15851	None	Trait_280_AUW-BXD	Hematology: Medium mature reticulocytes, chow diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	491.0	498.7	x	x	x	370.4	634.25	326.5	x	x	x	x	x	x	x	x	x	476.5	x	498.25	395.7	395.67	359.5	x	x	420.67	374.25	x	307.5	x	x	x	x	x	x	x	254.5	x	439.0	x	353.0	248.5	239.0	x	x	x	339.0	361.0	x	315.0	x	x	401.0	x	339.6	210.0	367.0	x	269.0	x	231.4	
-15852	None	Trait_281_AUW-BXD	Hematology: High mature reticulocytes, chow diet, males [%]	x	x	15.633	8.025	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.63	6.233	x	x	x	2.74	5.65	1.08	x	x	x	x	x	x	x	x	x	20.4	x	5.4	4.7	6.83	2.68	7.96	x	5.13	15.55	x	4.35	x	x	x	x	x	x	x	2.05	4.75	5.38	x	12.2	3.25	4.98	x	x	x	6.95	6.45	x	3.33	x	x	10.43	4.225	2.18	2.3	5.14	6.05	1.95	x	2.52	
-15853	None	Trait_282_AUW-BXD	Hematology: High mature reticulocytes, chow diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	106.7	75.0	x	x	x	29.8	93.5	14.25	x	x	x	x	x	x	x	x	x	227.0	x	64.75	46.0	83.67	30.25	x	x	65.67	157.75	x	40.25	x	x	x	x	x	x	x	22.5	x	60.75	x	104.3	25.5	37.25	x	x	x	59.5	62.25	x	32.0	x	x	99.33	x	24.6	20.33	55.4	x	23.25	x	22.2	
-15854	None	Trait_283_AUW-BXD	Hematology: Platelets, chow diet, males [10^3/uL]	x	x	931.333	1239.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1410.7	1387.0	x	x	x	1284.0	1267.0	1827.5	x	x	x	x	x	x	x	x	x	1469.5	x	1772.0	1162.0	1126.0	1327.0	1095.4	x	830.0	946.0	x	1412.5	x	x	x	x	x	x	x	1532.36	1024.3	1186.5	x	1585.5	1325.0	1249.0	x	x	x	1061.0	1686.0	x	1178.0	x	x	1319.33	917.5	1546.4	1197.33	1558.4	899.0	1228.5	x	1497.6	
-15855	None	Trait_284_AUW-BXD	Hematology: Mean platelet volume, chow diet, males [fL/PLT]	x	x	5.66	4.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.47	4.1	x	x	x	5.26	5.28	7.1	x	x	x	x	x	x	x	x	x	5.55	x	4.325	4.57	5.73	5.35	3.9	x	6.4	6.1	x	6.0	x	x	x	x	x	x	x	4.95	3.98	4.93	x	4.7	6.65	5.93	x	x	x	11.95	4.45	x	6.23	x	x	5.4	3.925	4.94	7.4	5.36	4.45	4.5	x	4.88	
-15856	None	Trait_285_AUW-BXD	Hematology: Platelet distribution width, chow diet, males [%]	x	x	83.8	58.425	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	64.47	48.35	x	x	x	51.02	50.98	49.1	x	x	x	x	x	x	x	x	x	58.25	x	49.3	66.63	56.47	56.53	52.76	x	64.27	67.73	x	49.55	x	x	x	x	x	x	x	53.85	55.7	54.0	x	64.8	57.35	48.7	x	x	x	71.3	47.4	x	61.6	x	x	57.07	47.725	45.14	53.7	48.98	65.75	44.5	x	42.28	
-15857	None	Trait_286_AUW-BXD	Hematology: Plateletcrit, chow diet, males [%]	x	x	0.5233	0.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.38	0.28	x	x	x	0.34	0.34	0.65	x	x	x	x	x	x	x	x	x	0.32	x	0.385	0.243	0.32	0.36	0.428	x	0.27	0.29	x	0.43	x	x	x	x	x	x	x	0.37	0.403	0.29	x	0.21	0.44	0.37	x	x	x	0.265	0.375	x	0.37	x	x	0.36	0.3575	0.38	0.43	0.43	0.385	0.28	x	0.36	
-15858	None	Trait_287_AUW-BXD	Hematology: Platelet component concentration, chow diet, males [g/dL]	x	x	226.0	271.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	237.3	272.0	x	x	x	239.4	257.5	195.25	x	x	x	x	x	x	x	x	x	232.0	x	255.75	264.0	227.0	232.0	291.2	x	227.0	223.5	x	226.8	x	x	x	x	x	x	x	252.0	288.0	243.75	x	261.0	192.5	234.5	x	x	x	202.5	254.25	x	205.0	x	x	226.0	294.25	238.8	190.67	247.6	295.5	256.0	x	256.8	
-15859	None	Trait_288_AUW-BXD	Hematology: Platelet component distribution width, chow diet, males [g/dL]	x	x	72.866	75.825	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82.17	73.75	x	x	x	76.82	74.9	69.68	x	x	x	x	x	x	x	x	x	80.75	x	69.98	81.0	77.87	79.1	68.62	x	78.1	78.15	x	75.2	x	x	x	x	x	x	x	75.25	70.4	80.05	x	79.0	76.35	75.8	x	x	x	68.95	75.45	x	76.43	x	x	75.97	68.325	64.6	69.73	75.38	66.95	74.73	x	72.32	
-15860	None	Trait_289_AUW-BXD	Hematology: Platelet mass, chow diet, males [pg/PLT]	x	x	1.08667	1.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.11	1.025	x	x	x	1.12	1.22	1.2	x	x	x	x	x	x	x	x	x	1.13	x	1.0225	1.05	1.14	1.09	1.074	x	1.25	1.16	x	1.21	x	x	x	x	x	x	x	1.14	1.07	1.06	x	1.1	1.08	1.23	x	x	x	1.52	1.0325	x	1.09	x	x	1.07	1.0875	1.1	1.22	1.19	1.225	1.06	x	1.15	
-15861	None	Trait_290_AUW-BXD	Hematology: White blood cells, chow diet, males [10^3/uL]	x	x	7.948	3.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.14	8.74	x	x	x	7.78	11.33	5.99	x	x	x	x	x	x	x	x	x	18.19	x	5.21	5.447	7.95	8.32	7.536	x	8.42	6.84	x	5.96	x	x	x	x	x	x	x	12.97	7.783	7.03	x	3.61	5.96	8.54	x	x	x	4.81	6.37	x	3.41	x	x	3.97	3.68	9.28	6.75	9.9	5.135	9.08	x	4.34	
-15862	None	Trait_291_AUW-BXD	Hematology: Neutrophils, chow diet, males [%]	x	x	9.933	15.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.33	19.85	x	x	x	9.4	14.3	14.63	x	x	x	x	x	x	x	x	x	13.75	x	11.85	12.67	13.03	19.05	13.9	x	5.7	15.2	x	10.23	x	x	x	x	x	x	x	15.55	12.55	10.88	x	9.0	10.2	17.7	x	x	x	10.9	7.75	x	32.9	x	x	19.53	30.8	12.9	12.67	12.68	10.85	7.98	x	9.4	
-15863	None	Trait_292_AUW-BXD	Hematology: Lymphocytes, chow diet, males [%]	x	x	80.833	79.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	78.23	74.65	x	x	x	84.78	79.08	76.1	x	x	x	x	x	x	x	x	x	81.75	x	80.85	81.4	77.6	60.83	80.34	x	87.97	80.15	x	84.55	x	x	x	x	x	x	x	79.7	76.88	84.8	x	83.87	83.75	75.8	x	x	x	84.1	87.275	x	62.47	x	x	73.87	73.975	81.06	82.03	77.52	84.25	86.58	x	83.82	
-15864	None	Trait_293_AUW-BXD	Hematology: Monocytes, chow diet, males [%]	x	x	1.3	1.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.37	1.75	x	x	x	1.42	3.6	6.4	x	x	x	x	x	x	x	x	x	2.55	x	1.625	1.67	2.1	3.08	2.58	x	1.53	2.83	x	1.15	x	x	x	x	x	x	x	1.8	1.35	0.95	x	3.47	1.3	1.95	x	x	x	0.8	1.45	x	2.7	x	x	3.07	2.375	3.7	2.7	1.4	2.05	3.25	x	1.74	
-15865	None	Trait_294_AUW-BXD	Hematology: Eosinophils, chow diet, males [%]	x	x	7.2	2.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.6	2.95	x	x	x	3.94	1.6	2.13	x	x	x	x	x	x	x	x	x	1.1	x	5.2	3.53	5.27	12.73	1.32	x	3.67	1.45	x	2.83	x	x	x	x	x	x	x	2.2	7.73	2.9	x	3.33	3.0	2.95	x	x	x	3.3	3.05	x	1.4	x	x	3.2	7.375	1.38	1.97	7.3	2.2	1.45	x	3.4	
-15866	None	Trait_295_AUW-BXD	Hematology: Basophils, chow diet, males [%]	x	x	0.2	0.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.2	0.2	x	x	x	0.1	0.13	0.13	x	x	x	x	x	x	x	x	x	0.1	x	0.1	0.0667	0.33	0.23	0.24	x	0.23	0.1	x	0.1	x	x	x	x	x	x	x	0.15	0.2	0.08	x	0.13	0.05	0.1	x	x	x	0.2	0.025	x	0.17	x	x	0.03	0.125	0.16	0.13	0.24	0.15	0.05	x	0.16	
-15867	None	Trait_296_AUW-BXD	Hematology: Large unknown cells, chow diet, males [%]	x	x	0.6	0.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.23	0.55	x	x	x	0.34	1.25	0.7	x	x	x	x	x	x	x	x	x	0.7	x	0.375	0.633	1.63	4.18	1.62	x	0.83	0.23	x	1.2	x	x	x	x	x	x	x	0.6	1.275	0.4	x	0.2	1.6	1.5	x	x	x	0.7	0.425	x	0.37	x	x	0.23	0.3	0.78	0.53	0.86	0.8	0.7	x	1.46	
-15868	None	Trait_297_AUW-BXD	Hematology: Nucleated red blood cells, chow diet, males [%]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	x	x	x	x	x	x	x	x	x	0.0	x	0.0	0.0	0.0	0.0	0.0	x	0.0	0.0	x	0.0	x	x	x	x	x	x	x	0.0	0.0	0.0	x	0.0	0.0	0.0	x	x	x	0.0	0.0	x	0.0	x	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	
-15869	None	Trait_298_AUW-BXD	Hematology: Neutrophils, chow diet, males [10^3/uL]	x	x	0.71667	0.6175	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.75	1.69	x	x	x	0.73	1.62	0.87	x	x	x	x	x	x	x	x	x	2.54	x	0.665	0.743	1.01	1.59	1.09	x	0.49	1.0	x	0.63	x	x	x	x	x	x	x	2.01	0.938	0.76	x	0.32	0.59	1.5	x	x	x	0.54	0.49	x	1.13	x	x	0.76	0.58	1.19	0.85	1.13	0.525	0.72	x	0.42	
-15870	None	Trait_299_AUW-BXD	Hematology: Lymphocytes, chow diet, males [10^3/uL]	x	x	5.92	3.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.25	6.58	x	x	x	6.61	8.97	4.59	x	x	x	x	x	x	x	x	x	14.86	x	4.15	4.397	6.23	5.08	6.0	x	7.39	5.5	x	5.02	x	x	x	x	x	x	x	10.33	6.18	5.96	x	3.03	5.02	6.46	x	x	x	4.03	5.565	x	2.13	x	x	2.97	2.7325	7.53	5.52	7.8	4.355	7.88	x	3.62	
-15871	None	Trait_300_AUW-BXD	Hematology: Monocytes, chow diet, males [10^3/uL]	x	x	0.0933	0.0825	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.05	0.15	x	x	x	0.1	0.4	0.35	x	x	x	x	x	x	x	x	x	0.42	x	0.08	0.103	0.16	0.26	0.188	x	0.13	0.22	x	0.08	x	x	x	x	x	x	x	0.23	0.113	0.08	x	0.12	0.08	0.17	x	x	x	0.04	0.09	x	0.1	x	x	0.11	0.088	0.34	0.2	0.16	0.105	0.29	x	0.08	
-15872	None	Trait_301_AUW-BXD	Hematology: Eosinophils, chow diet, males [10^3/uL]	x	x	0.547	0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.06	0.24	x	x	x	0.3	0.18	0.12	x	x	x	x	x	x	x	x	x	0.22	x	0.29	0.177	0.41	1.04	0.098	x	0.31	0.11	x	0.16	x	x	x	x	x	x	x	0.29	0.42	0.2	x	0.12	0.18	0.26	x	x	x	0.16	0.185	x	0.05	x	x	0.13	0.2575	0.13	0.12	0.7	0.11	0.13	x	0.16	
-15873	None	Trait_302_AUW-BXD	Hematology: Basophils, chow diet, males [10^3/uL]	x	x	0.016	0.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.01	0.02	x	x	x	0.01	0.02	0.01	x	x	x	x	x	x	x	x	x	0.01	x	0.005	0.0	0.03	0.03	0.018	x	0.02	0.0	x	0.01	x	x	x	x	x	x	x	0.02	0.02	0.0	x	0.0	0.0	0.01	x	x	x	0.04	0.03	x	0.0	x	x	0.0	0.0075	0.02	0.0	0.02	0.01	0.01	x	0.0	
-15874	None	Trait_303_AUW-BXD	Hematology: Large unknown cells, chow diet, males [10^3/uL]	x	x	0.046	0.005	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.01	0.05	x	x	x	0.03	0.15	0.04	x	x	x	x	x	x	x	x	x	0.12	x	0.02	0.033	0.12	0.36	0.132	x	0.07	0.02	x	0.07	x	x	x	x	x	x	x	0.08	0.11	0.03	x	0.01	0.1	0.13	x	x	x	0.01	0.0	x	0.01	x	x	0.01	0.0125	0.08	0.05	0.08	0.07	0.07	x	0.06	
-15875	None	Trait_304_AUW-BXD	Hematology: Nucleated red blood cells, chow diet, males [10^3/uL]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	x	x	x	x	x	x	x	x	x	0.0	x	0.0	0.0	0.0	0.0	0.0	x	0.0	0.0	x	0.0	x	x	x	x	x	x	x	0.0	0.0	0.0	x	0.0	0.0	0.0	x	x	x	4.32	4.345	x	0.0	x	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	
-15876	None	Trait_305_AUW-BXD	Hematology: Red blood cells, high fat diet, males [10^6/uL]	x	x	8.88	9.256	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.76	10.22	x	x	x	10.44	9.62	11.01	x	x	x	x	x	x	x	x	x	x	x	9.91	9.3	9.96	10.21	11.46	x	11.04	10.32	x	10.64	x	x	x	x	x	x	x	10.17	10.27	12.35	x	9.95	x	9.61	x	x	x	8.45	9.62	x	x	x	x	11.1	8.33	10.22	10.72	11.11	9.55	10.11	x	10.34	
-15877	None	Trait_306_AUW-BXD	Hematology: Mature red blood cells, high fat diet, males [%]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	96.93	96.0	x	x	x	96.9	95.6	96.94	x	x	x	x	x	x	x	x	x	x	x	94.75	96.15	97.67	96.1	x	x	97.33	97.98	x	96.8	x	x	x	x	x	x	x	94.22	x	96.95	x	96.67	97.45	97.1	x	x	x	96.57	97.1	x	x	x	x	97.14	96.2	89.65	97.44	96.18	x	96.65	x	97.74	
-15878	None	Trait_307_AUW-BXD	Hematology: Mature red blood cells, high fat diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82614.0	82544.0	x	x	x	87539.6	80426.5	89280.0	x	x	x	x	x	x	x	x	x	x	x	77783.0	75007.0	85756.0	84951.5	x	x	91030.0	92576.0	x	87899.0	x	x	x	x	x	x	x	81424.8	x	98997.0	x	84443.0	x	80161.0	x	x	x	72666.0	77017.0	x	x	x	x	91306.0	74388.0	79314.0	88916.0	89609.0	x	85242.0	x	86238.4	
-15879	None	Trait_308_AUW-BXD	Hematology: Hemoglobin, high fat diet, males [g/dL]	x	x	13.03	12.58	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.13	13.6	x	x	x	14.32	13.05	14.4	x	x	x	x	x	x	x	x	x	x	x	13.2	12.7	12.47	13.75	14.74	x	15.65	14.63	x	15.6	x	x	x	x	x	x	x	14.88	13.7	18.2	x	12.43	x	13.7	x	x	x	12.07	12.8	x	x	x	x	15.44	11.84	11.9	14.68	16.32	12.7	14.45	x	14.4	
-15880	None	Trait_309_AUW-BXD	Hematology: Hematocrit, high fat diet, males [%]	x	x	44.4	41.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	45.33	x	x	x	x	45.2	41.95	49.56	x	x	x	x	x	x	x	x	x	x	x	x	45.8	40.07	46.0	50.2	x	51.65	46.53	x	51.47	x	x	x	x	x	x	x	50.16	46.15	54.1	x	15.6	x	46.4	x	x	x	39.27	43.86	x	x	x	x	51.0	44.33	46.4	51.2	49.96	45.5	48.05	x	45.48	
-15881	None	Trait_310_AUW-BXD	Hematology: Mean corpuscular volume (MCV), high fat diet, males [fL/RBC]	x	x	50.0	44.82	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	46.53	50.25	x	x	x	43.3	43.48	45.08	x	x	x	x	x	x	x	x	x	x	x	45.35	49.25	40.2	45.05	43.82	x	46.83	45.08	x	48.37	x	x	x	x	x	x	x	49.48	44.95	43.85	x	45.8	44.2	48.35	x	x	x	46.47	45.6	x	x	x	x	45.98	46.93	45.58	47.8	45.0	47.65	47.53	x	43.96	
-15882	None	Trait_311_AUW-BXD	Hematology: Mean corpuscular hemoglobin (MCH), high fat diet, males [pg/RBC]	x	x	14.7	13.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.53	13.85	x	x	x	13.74	13.5	13.16	x	x	x	x	x	x	x	x	x	x	x	13.35	13.65	12.47	13.43	12.86	x	14.15	14.15	x	14.73	x	x	x	x	x	x	x	14.7	13.35	14.8	x	13.53	14.1	14.25	x	x	x	14.33	13.33	x	x	x	x	13.86	14.17	11.65	13.68	14.7	13.3	14.28	x	13.94	
-15883	None	Trait_312_AUW-BXD	Hematology: Mean corpuscular hemoglobin concentration (MCHC), high fat diet, males [g/dL]	x	x	29.4	30.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	31.27	27.65	x	x	x	31.72	31.05	29.16	x	x	x	x	x	x	x	x	x	x	x	29.35	27.7	31.03	29.85	29.38	x	30.25	31.38	x	30.43	x	x	x	x	x	x	x	29.7	29.7	33.7	x	29.6	31.9	29.45	x	x	x	30.8	29.2	x	x	x	x	30.2	30.1	25.58	28.64	32.68	27.95	30.08	x	31.66	
-15884	None	Trait_313_AUW-BXD	Hematology: Red blood cell hemoglobin content, high fat diet, males [pg/RBC]	x	x	x	12.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	14.53	12.6	x	x	x	13.36	13.73	12.92	x	x	x	x	x	x	x	x	x	x	x	12.4	12.6	12.47	13.23	11.74	x	13.7	13.98	x	14.3	x	x	x	x	x	x	x	14.4	12.2	14.6	x	12.15	13.95	14.0	x	x	x	14.5	12.367	x	x	x	x	13.6	12.47	11.53	13.18	14.74	x	13.8	x	13.94	
-15885	None	Trait_314_AUW-BXD	Hematology: Red blood cell distribution width, high fat diet, males [%]	x	x	14.87	15.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.47	15.0	x	x	x	14.14	17.3	13.1	x	x	x	x	x	x	x	x	x	x	x	14.15	15.4	15.2	15.65	13.72	x	14.48	15.93	x	14.27	x	x	x	x	x	x	x	14.98	14.25	15.1	x	14.1	15.5	15.05	x	x	x	14.63	14.5	x	x	x	x	14.44	14.93	19.83	15.4	15.34	14.3	13.35	x	14.72	
-15886	None	Trait_315_AUW-BXD	Hematology: Hemoglobin concentration distribution width, high fat diet, males [g/dL]	x	x	1.91	2.102	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.27	2.06	x	x	x	2.17	2.36	1.74	x	x	x	x	x	x	x	x	x	x	x	2.305	2.48	2.2	2.16	2.0	x	2.06	2.31	x	2.03	x	x	x	x	x	x	x	1.99	2.035	2.3	x	1.96	2.13	2.13	x	x	x	2.1	2.15	x	x	x	x	2.21	2.09	2.52	2.01	2.37	1.97	2.0	x	2.25	
-15887	None	Trait_316_AUW-BXD	Hematology: Reticulocytes, high fat diet, males [%]	x	x	4.0	3.46	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.07	5.3	x	x	x	3.1	4.4	3.06	x	x	x	x	x	x	x	x	x	x	x	5.25	3.85	2.33	3.9	2.76	x	2.68	2.03	x	3.2	x	x	x	x	x	x	x	5.78	2.4	3.05	x	3.53	2.55	2.9	x	x	x	3.43	2.9	x	x	x	x	2.86	3.8	10.35	2.56	3.82	3.4	3.35	x	2.26	
-15888	None	Trait_317_AUW-BXD	Hematology: Reticulocytes, high fat diet, males [10^9/L]	x	x	355.0	304.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	300.8	512.5	x	x	x	320.1	418.7	336.2	x	x	x	x	x	x	x	x	x	x	x	521.2	355.7	229.93	399.05	316.16	x	293.85	209.1	x	342.3	x	x	x	x	x	x	x	570.12	244.05	378.9	x	321.57	499.85	278.1	x	x	x	292.4	276.4	x	x	x	x	315.5	315.3	1005.65	273.8	149.6	321.9	336.3	x	233.0	
-15889	None	Trait_318_AUW-BXD	Hematology: Mean corpuscular volume reticulocytes, high fat diet, males [fL/RTC]	x	x	60.6	55.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	56.17	58.4	x	x	x	53.28	55.43	58.2	x	x	x	x	x	x	x	x	x	x	x	52.2	56.0	52.07	52.6	55.46	x	57.8	55.38	x	59.37	x	x	x	x	x	x	x	56.44	57.8	54.25	x	53.88	53.05	55.55	x	x	x	56.83	53.933	x	x	x	x	56.5	56.2	52.78	61.1	57.34	59.15	60.7	x	52.32	
-15890	None	Trait_319_AUW-BXD	Hematology: Mean corpuscular hemoglobin concentration reticulocytes, high fat diet, males [g/dL]	x	x	25.13	26.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	28.67	25.4	x	x	x	29.06	28.1	24.12	x	x	x	x	x	x	x	x	x	x	x	26.35	26.85	27.4	28.88	25.36	x	26.18	28.1	x	26.87	x	x	x	x	x	x	x	27.12	25.6	30.35	x	26.95	30.6	29.7	x	x	x	29.8	27.233	x	x	x	x	26.78	26.63	22.8	24.2	30.56	24.55	25.2	x	31.12	
-15891	None	Trait_320_AUW-BXD	Hematology: Red cell hemoglobin content reticulocytes, high fat diet, males [pg/RTC]	x	x	15.17	14.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.07	14.8	x	x	x	15.28	15.5	13.92	x	x	x	x	x	x	x	x	x	x	x	13.7	15.0	14.17	15.15	13.94	x	15.03	15.38	x	15.8	x	x	x	x	x	x	x	15.22	14.7	16.4	x	14.45	16.1	16.4	x	x	x	16.77	14.633	x	x	x	x	15.06	14.87	12.0	14.68	17.26	14.4	15.1	x	16.14	
-15892	None	Trait_321_AUW-BXD	Hematology: Low mature reticulocytes, high fat diet, males [%]	x	x	41.2	45.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	47.73	44.45	x	x	x	56.62	56.38	67.2	x	x	x	x	x	x	x	x	x	x	x	47.9	51.6	60.93	52.35	51.46	x	65.65	56.1	x	74.7	x	x	x	x	x	x	x	79.86	65.4	47.3	x	46.95	49.7	58.4	x	x	x	40.77	57.633	x	x	x	x	35.66	44.83	65.7	68.78	52.44	53.05	57.1	x	68.44	
-15893	None	Trait_322_AUW-BXD	Hematology: Low mature reticulocytes, high fat diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	628.0	944.5	x	x	x	777.6	1033.25	944.6	x	x	x	x	x	x	x	x	x	x	x	1000.5	779.0	616.67	896.75	x	x	823.3	443.3	x	1070.0	x	x	x	x	x	x	x	1925.4	x	741.0	x	493.0	596.0	702.0	x	x	x	521.67	660.0	x	x	x	x	475.8	458.0	2782.25	801.6	910.8	x	841.3	x	677.6	
-15894	None	Trait_323_AUW-BXD	Hematology: Medium mature reticulocytes, high fat diet, males [%]	x	x	37.7	35.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	40.03	43.8	x	x	x	36.54	37.8	30.3	x	x	x	x	x	x	x	x	x	x	x	42.65	41.0	34.03	38.53	40.32	x	29.15	34.53	x	21.9	x	x	x	x	x	x	x	19.1	30.4	44.6	x	42.3	42.15	34.5	x	x	x	40.0	35.866	x	x	x	x	33.5	38.6	31.7	28.1	38.44	37.75	37.8	x	28.08	
-15895	None	Trait_324_AUW-BXD	Hematology: Medium mature reticulocytes, high fat diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	526.0	961.0	x	x	x	512.2	693.0	428.4	x	x	x	x	x	x	x	x	x	x	x	928.0	606.5	344.67	669.5	x	x	358.75	268.75	x	338.0	x	x	x	x	x	x	x	484.6	x	698.5	x	445.0	505.0	407.0	x	x	x	521.67	408.0	x	x	x	x	445.2	394.0	1481.0	328.2	693.8	x	554.3	x	280.6	
-15896	None	Trait_325_AUW-BXD	Hematology: High mature reticulocytes, high fat diet, males [%]	x	x	21.2	18.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.27	11.8	x	x	x	6.86	5.83	2.5	x	x	x	x	x	x	x	x	x	x	x	9.45	7.4	5.0	9.1	8.2	x	5.18	9.35	x	3.33	x	x	x	x	x	x	x	1.02	4.15	8.15	x	10.75	8.15	7.1	x	x	x	19.23	6.433	x	x	x	x	30.8	16.6	2.58	3.08	9.12	9.15	5.1	x	3.48	
-15897	None	Trait_326_AUW-BXD	Hematology: High mature reticulocytes, high fat diet, males [10^9/L]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	160.33	265.0	x	x	x	98.4	107.0	35.2	x	x	x	x	x	x	x	x	x	x	x	232.5	106.0	51.0	160.25	x	x	62.75	71.5	x	53.67	x	x	x	x	x	x	x	25.0	x	127.5	x	116.5	98.0	82.5	x	x	x	255.67	72.33	x	x	x	x	413.0	167.0	121.0	35.6	159.6	x	73.5	x	35.4	
-15898	None	Trait_327_AUW-BXD	Hematology: Platelets, high fat diet, males [10^3/uL]	x	x	917.0	946.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1055.33	1222.0	x	x	x	1045.6	1366.0	1404.8	x	x	x	x	x	x	x	x	x	x	x	1424.0	899.0	1453.33	1121.5	854.8	x	835.5	896.5	x	958.7	x	x	x	x	x	x	x	1528.8	774.5	950.0	x	1350.7	2142.5	974.0	x	x	x	1320.0	1467.33	x	x	x	x	1240.0	1141.0	1400.0	1211.0	1331.0	909.5	997.0	x	1342.8	
-15899	None	Trait_328_AUW-BXD	Hematology: Platelet volume, high fat diet, males [fL/PLT]	x	x	5.3	4.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.83	4.0	x	x	x	5.28	5.45	5.22	x	x	x	x	x	x	x	x	x	x	x	4.55	4.15	5.63	5.53	3.84	x	5.73	5.73	x	5.1	x	x	x	x	x	x	x	6.78	3.9	5.55	x	4.77	5.25	6.15	x	x	x	5.43	4.4667	x	x	x	x	7.54	5.07	7.53	7.72	6.18	4.2	6.56	x	4.82	
-15900	None	Trait_329_AUW-BXD	Hematology: Platelet distribution width, high fat diet, males [%]	x	x	82.5	72.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	66.03	54.2	x	x	x	55.74	54.18	47.92	x	x	x	x	x	x	x	x	x	x	x	55.0	54.6	53.53	57.0	45.5	x	52.28	62.5	x	47.87	x	x	x	x	x	x	x	47.72	55.5	58.65	x	66.87	52.9	63.95	x	x	x	60.7	46.333	x	x	x	x	57.16	56.57	60.1	50.58	51.64	54.15	46.73	x	42.4	
-15901	None	Trait_330_AUW-BXD	Hematology: Plateletcrit, high fat diet, males [%]	x	x	0.487	0.448	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.31	0.24	x	x	x	0.28	0.37	0.37	x	x	x	x	x	x	x	x	x	x	x	0.325	0.185	0.41	0.31	0.33	x	0.24	0.22	x	0.24	x	x	x	x	x	x	x	0.51	0.295	0.27	x	0.26	0.32	0.3	x	x	x	0.36	0.327	x	x	x	x	0.47	0.2	0.53	0.47	0.42	0.38	0.33	x	0.33	
-15902	None	Trait_331_AUW-BXD	Hematology: Platelet component concentration, high fat diet, males [g/dL]	x	x	248.3	258.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	232.67	284.0	x	x	x	242.2	247.5	228.8	x	x	x	x	x	x	x	x	x	x	x	249.5	282.0	223.67	239.25	295.2	x	234.5	237.75	x	254.3	x	x	x	x	x	x	x	210.2	290.5	234.5	x	258.0	233.0	218.5	x	x	x	229.33	257.67	x	x	x	x	184.8	250.33	198.5	190.2	226.8	295.0	209.75	x	258.4	
-15903	None	Trait_332_AUW-BXD	Hematology: Platelet component distribution width, high fat diet, males [g/dL]	x	x	71.8	77.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82.2	68.8	x	x	x	78.2	78.15	77.1	x	x	x	x	x	x	x	x	x	x	x	70.7	74.1	78.77	79.43	67.34	x	77.18	80.68	x	78.6	x	x	x	x	x	x	x	72.1	69.75	80.8	x	75.4	79.15	84.35	x	x	x	78.73	78.8	x	x	x	x	72.14	77.13	74.95	68.96	74.9	68.0	68.9	x	74.78	
-15904	None	Trait_333_AUW-BXD	Hematology: Mean platelet mass, high fat diet, males [pg/PLT]	x	x	1.15	1.094	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.17	1.06	x	x	x	1.13	1.2	1.06	x	x	x	x	x	x	x	x	x	x	x	1.04	1.075	1.09	1.16	1.082	x	1.2	1.18	x	1.18	x	x	x	x	x	x	x	1.25	1.055	1.14	x	1.11	1.08	1.12	x	x	x	1.08	1.0433	x	x	x	x	1.18	1.14	1.28	1.27	1.22	1.18	1.23	x	1.15	
-15905	None	Trait_334_AUW-BXD	Hematology: White blood cells, high fat diet, males [10^3/uL]	x	x	6.927	5.382	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.47	12.8	x	x	x	12.74	10.91	7.27	x	x	x	x	x	x	x	x	x	x	x	8.79	6.03	4.85	6.29	7.244	x	10.41	7.03	x	10.9	x	x	x	x	x	x	x	12.67	8.565	9.32	x	6.68	12.05	7.77	x	x	x	7.23	4.113	x	x	x	x	7.04	8.59	8.43	8.88	19.04	8.155	9.37	x	7.55	
-15906	None	Trait_335_AUW-BXD	Hematology: Neutrophils, high fat diet, males [%]	x	x	x	30.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.47	17.2	x	x	x	9.92	15.55	18.88	x	x	x	x	x	x	x	x	x	x	x	8.9	8.4	13.6	37.33	11.2	x	8.95	12.75	x	7.87	x	x	x	x	x	x	x	20.92	10.05	9.3	x	16.8	23.25	16.45	x	x	x	13.4	20.033	x	x	x	x	12.86	5.77	9.58	18.32	10.92	8.55	9.15	x	10.68	
-15907	None	Trait_336_AUW-BXD	Hematology: Lymphocytes, high fat diet, males [%]	x	x	78.3	61.16	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	82.43	77.6	x	x	x	84.02	75.15	75.5	x	x	x	x	x	x	x	x	x	x	x	84.15	87.05	77.2	27.75	81.84	x	86.23	80.53	x	87.03	x	x	x	x	x	x	x	74.08	83.15	86.05	x	78.2	42.9	69.4	x	x	x	81.97	74.33	x	x	x	x	80.88	89.23	84.78	74.66	82.76	84.1	83.53	x	80.06	
-15908	None	Trait_337_AUW-BXD	Hematology: Monocytes, high fat diet, males [%]	x	x	1.77	3.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.63	2.2	x	x	x	1.24	4.75	2.4	x	x	x	x	x	x	x	x	x	x	x	2.85	1.15	3.0	2.73	3.06	x	1.58	1.68	x	2.53	x	x	x	x	x	x	x	1.92	1.9	1.1	x	2.1	1.1	1.5	x	x	x	1.47	1.933	x	x	x	x	2.92	2.17	1.88	3.6	0.86	1.55	3.68	x	2.54	
-15909	None	Trait_338_AUW-BXD	Hematology: Eosinophils, high fat diet, males [%]	x	x	4.7	5.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.93	1.8	x	x	x	3.46	2.05	2.04	x	x	x	x	x	x	x	x	x	x	x	3.1	2.8	5.13	29.7	2.18	x	2.33	4.08	x	1.37	x	x	x	x	x	x	x	1.82	3.35	2.85	x	2.53	30.75	3.55	x	x	x	2.63	3.133	x	x	x	x	2.66	1.97	0.78	1.56	3.26	4.85	1.33	x	3.62	
-15910	None	Trait_339_AUW-BXD	Hematology: Basophils, high fat diet, males [%]	x	x	0.5	0.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.13	0.1	x	x	x	0.16	0.15	0.1	x	x	x	x	x	x	x	x	x	x	x	0.15	0.25	0.17	0.15	0.22	x	0.23	0.08	x	0.13	x	x	x	x	x	x	x	0.14	0.25	0.1	x	0.18	0.1	0.15	x	x	x	0.07	0.066	x	x	x	x	0.14	0.1	0.38	0.2	0.22	0.2	0.15	x	0.12	
-15911	None	Trait_340_AUW-BXD	Hematology: Large unknown cells, high fat diet, males [%]	x	x	1.2	0.26	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.47	1.2	x	x	x	1.18	2.35	1.14	x	x	x	x	x	x	x	x	x	x	x	0.9	0.3	0.97	2.38	1.5	x	0.73	0.85	x	1.0	x	x	x	x	x	x	x	1.1	1.25	0.6	x	0.23	1.95	8.9	x	x	x	0.47	0.5	x	x	x	x	0.54	0.77	2.63	1.62	1.98	0.8	2.18	x	3.0	
-15912	None	Trait_341_AUW-BXD	Hematology: Nucleated red blood cells, high fat diet, males [%]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	0.0	0.0	0.0	x	0.0	0.0	x	0.0	x	x	x	x	x	x	x	0.0	0.0	0.0	x	0.0	0.0	0.0	x	x	x	0.0	0.0	x	x	x	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	
-15913	None	Trait_342_AUW-BXD	Hematology: Neutrophils, high fat diet, males [10^3/uL]	x	x	0.94	1.548	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.78	2.2	x	x	x	1.19	1.63	1.32	x	x	x	x	x	x	x	x	x	x	x	0.78	0.47	0.61	2.35	0.816	x	0.93	0.88	x	0.81	x	x	x	x	x	x	x	2.59	0.875	0.87	x	1.01	3.01	1.27	x	x	x	0.95	0.7866	x	x	x	x	0.83	0.5	0.78	1.58	2.02	0.67	0.85	x	0.76	
-15914	None	Trait_343_AUW-BXD	Hematology: Lymphocytes, high fat diet, males [10^3/uL]	x	x	5.42	3.386	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.45	9.94	x	x	x	10.79	8.34	5.52	x	x	x	x	x	x	x	x	x	x	x	7.39	5.29	3.81	1.62	5.916	x	8.99	5.7	x	9.54	x	x	x	x	x	x	x	9.43	7.115	8.01	x	5.35	4.7	5.41	x	x	x	5.95	3.093	x	x	x	x	5.74	7.65	7.16	6.67	15.82	6.845	7.85	x	6.1	
-15915	None	Trait_344_AUW-BXD	Hematology: Monocytes, high fat diet, males [10^3/uL]	x	x	0.13	0.164	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.09	0.28	x	x	x	0.15	0.48	0.17	x	x	x	x	x	x	x	x	x	x	x	0.25	0.05	0.13	0.18	0.222	x	0.16	0.12	x	0.27	x	x	x	x	x	x	x	0.26	0.165	0.1	x	0.13	0.14	0.12	x	x	x	0.1	0.08667	x	x	x	x	0.22	0.19	0.17	0.32	0.17	0.12	0.35	x	0.18	
-15916	None	Trait_345_AUW-BXD	Hematology: Eosinophils, high fat diet, males [10^3/uL]	x	x	0.3	0.262	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.11	0.24	x	x	x	0.42	0.22	0.15	x	x	x	x	x	x	x	x	x	x	x	0.27	0.18	0.25	1.97	0.156	x	0.24	0.28	x	0.15	x	x	x	x	x	x	x	0.23	0.275	0.27	x	0.18	3.95	0.27	x	x	x	0.2	0.12667	x	x	x	x	0.21	0.17	0.07	0.14	0.6	0.43	0.12	x	0.27	
-15917	None	Trait_346_AUW-BXD	Hematology: Basophils, high fat diet, males [10^3/uL]	x	x	0.3	0.006	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.01	x	x	x	0.02	0.2	0.0	x	x	x	x	x	x	x	x	x	x	x	0.01	0.01	0.01	0.01	0.014	x	0.02	0.0	x	0.01	x	x	x	x	x	x	x	0.01	0.025	0.02	x	0.0	0.0	0.01	x	x	x	0.01	0.0	x	x	x	x	0.01	0.02	0.04	0.02	0.04	0.015	0.01	x	0.01	
-15918	None	Trait_347_AUW-BXD	Hematology: Large unknown cells, high fat diet, males [10^3/uL]	x	x	0.093	0.016	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.03	0.14	x	x	x	0.16	0.25	0.1	x	x	x	x	x	x	x	x	x	x	x	0.08	0.02	0.05	0.16	0.118	x	0.07	0.06	x	0.11	x	x	x	x	x	x	x	0.14	0.105	0.05	x	0.01	0.24	0.69	x	x	x	0.03	0.02	x	x	x	x	0.04	0.08	0.23	0.14	0.38	0.07	0.21	x	0.23	
-15919	None	Trait_348_AUW-BXD	Hematology: Nucleated red blood cells, high fat diet, males [10^3/uL]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	x	x	x	0.0	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	0.0	0.0	0.0	0.0	0.0	x	0.0	0.0	x	0.0	x	x	x	x	x	x	x	0.0	0.0	0.0	x	0.0	0.0	0.0	x	x	x	0.0	0.0	x	x	x	x	0.0	0.0	0.0	0.0	0.0	0.0	0.0	x	0.0	
-15920	None	Trait_349_AUW-BXD	Cardiovascular system, behavior: Run distance untrained, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m]	x	x	437.25	648.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	828.3	272.25	661.775	x	x	318.0	227.0	233.4	529.22	x	x	x	237.8	286.0	x	x	x	312.0	391.33	587.75	497.3	380.3	239.0	107.2	x	309.7	481.8	546.75	263.4	x	442.5	x	535.6	x	x	x	218.4	219.8	629.0	x	503.66	398.75	156.2	x	245.0	x	452.5	233.3	x	195.0	x	x	562.0	389.0	228.0	585.0	413.6	552.2	321.0	x	225.2	
-15921	None	Trait_350_AUW-BXD	Cardiovascular system, behavior: Run distance untrained, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m]	x	x	236.25	395.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	759.67	85.25	501.45	x	x	234.5	85.0	106.0	135.025	x	x	x	212.5	170.0	x	x	x	x	154.8	224.0	276.0	130.75	101.3	38.0	x	377.0	593.4	317.125	325.0	x	403.0	x	395.2	x	x	x	88.8	124.0	219.8	x	168.25	207.0	76.5	x	251.25	x	359.5	165.5	x	x	x	x	213.6	96.33	85.8	207.0	358.8	441.08	245.0	x	216.0	
-15922	None	Trait_351_AUW-BXD	Cardiovascular system, behavior: Run distance trained, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m]	x	x	614.25	1024.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1184.33	746.5	864.25	x	x	509.2	366.5	418.0	1000.5	x	x	x	815.2	454.0	x	x	x	330.2	915.33	613.75	761.3	706.5	352.3	150.48	x	707.3	599.4	768.3	446.6	x	600.575	x	563.6	x	x	x	322.2	404.3	1086.5	x	816.33	885.3	177.0	x	582.0	x	709.3	560.75	x	407.3	x	x	946.0	539.0	449.6	897.0	1158.6	1016.9	989.0	x	414.4	
-15923	None	Trait_352_AUW-BXD	Cardiovascular system, behavior: Run distance trained, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m]	x	x	478.75	1215.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1148.67	132.0	954.5	x	x	442.0	109.3	282.4	314.75	x	x	x	600.5	461.0	x	x	x	x	252.4	429.75	617.0	336.0	161.0	25.92	x	791.5	684.0	700.525	263.0	x	519.75	x	588.4	x	x	x	162.2	340.3	312.0	x	607.75	678.0	249.0	x	473.75	x	703.0	437.75	x	x	x	x	807.4	259.33	244.5	399.0	929.6	686.84	790.8	x	325.6	
-15924	None	Trait_353_AUW-BXD	Cardiovascular system, behavior: Run distance improvement, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m]	x	x	177.0	375.663	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	356.0	474.25	202.475	x	x	191.2	139.5	184.0	471.28	x	x	x	577.4	169.0	x	x	x	18.2	524.0	26.0	264.0	326.3	113.3	43.28	x	397.7	117.6	221.55	183.2	x	158.075	x	28.0	x	x	x	103.8	184.5	457.5	x	312.67	486.5	20.8	x	337.0	x	256.8	327.45	x	212.3	x	x	384.0	148.775	221.6	312.0	745.0	464.7	669.0	x	189.2	
-15925	None	Trait_354_AUW-BXD	Cardiovascular system, behavior: Run distance improvement, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m]	x	x	242.5	832.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	389.0	46.75	453.05	x	x	209.0	13.0	176.5	179.725	x	x	x	388.0	283.0	x	x	x	x	97.6	205.75	340.5	205.3	59.5	-12.08	x	414.8	90.6	383.4	63.3	x	116.75	x	193.2	x	x	x	73.4	216.3	92.3	x	439.5	471.0	53.6	x	222.5	x	343.5	272.25	x	x	x	x	593.8	163.0	159.0	192.0	571.0	245.76	546.0	x	109.4	
-15926	None	Trait_355_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	96.285	80.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	87.4	64.8525	108.585	x	x	56.61	66.73	72.1	107.295	x	x	x	89.8874	73.67	x	x	x	80.4	91.83	81.75	74.77	75.6	61.98	65.838	x	73.97	72.6	98.655	72.53	x	79.54	x	79.414	x	x	x	66.08	67.44	75.25	x	77.96	67.7	63.72	x	96.7525	x	81.2917	72.92	x	57.6	x	x	59.1	71.04	57.8	71.1675	66.484	93.1933	77.9	x	64.684	
-15927	None	Trait_356_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	73.0417	72.4046	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	75.6	48.9875	87.2115	x	x	50.19	51.9	58.23	63.375	x	x	x	87.895	63.6	x	x	x	x	64.038	63.3575	61.25	62.2	52.99	52.5846	x	67.4	73.5	82.005	61.1	x	69.8125	x	71.516	x	x	x	63.24	66.3783	59.63	x	74.3975	57.8	55.71	x	86.275	x	68.7	71.1	x	x	x	x	58.78	55.0267	57.84	54.98	54.624	70.216	57.5	x	55.92	
-15928	None	Trait_357_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	129.0	130.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	122.3	87.25	128.0	x	x	86.8	98.3	102.5	126.5	x	x	x	112.6	125.0	x	x	x	103.4	120.0	111.75	103.5	105.5	82.5	87.8	x	95.0	96.6	120.25	94.4	x	123.0	x	123.6	x	x	x	90.6	96.0	99.5	x	103.667	101.5	84.0	x	131.0	x	114.75	95.0	x	82.5	x	x	94.25	97.5	83.8	95.0	91.0	117.0	92.5	x	93.0	
-15929	None	Trait_358_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	87.25	100.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	88.7	60.75	98.0	x	x	64.2	68.5	75.0	69.25	x	x	x	96.0	81.7	x	x	x	x	80.4	74.25	85.0	77.3	65.5	65.8	x	83.3	91.6	93.75	74.67	x	108.25	x	95.0	x	x	x	72.6	80.75	76.0	x	89.25	72.33	70.75	x	106.25	x	99.5	87.75	x	x	x	x	71.6	69.3333	65.75	67.6	75.4	85.0	67.0	x	79.6	
-15930	None	Trait_359_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 10 degree incline, chow diet, males [ratio]	x	x	0.83675	0.826333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.825	0.78825	0.830075	x	x	0.783	0.7977	0.763	0.821	x	x	x	0.83026	0.8	x	x	x	0.8404	0.807667	0.8235	0.796125	0.8398	0.845	0.8484	x	0.8476	0.765	0.81225	0.8132	x	0.796475	x	0.7735	x	x	x	0.6195	0.789813	0.8353	x	0.836	0.798	0.84477	x	0.78675	x	0.8145	0.79605	x	0.825	x	x	0.757	0.8168	0.8984	0.86525	0.82774	0.818	0.841	x	0.7968	
-15931	None	Trait_360_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 0 degree incline, high fat diet, males [ratio]	x	x	0.76875	0.7976	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.769	0.759	0.774	x	x	0.7706	0.7595	0.909	0.76635	x	x	x	0.821	0.7697	x	x	x	x	0.771	0.78825	0.7635	0.7885	0.7853	0.7928	x	0.776	0.778	0.7815	0.794	x	0.760188	x	0.7626	x	x	x	0.797	0.79375	0.808975	x	0.7885	0.785	0.7958	x	0.79175	x	0.773	0.80675	x	x	x	x	0.7659	0.768667	0.7963	0.7986	0.8124	0.8098	0.7978	x	0.7754	
-15932	None	Trait_361_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 10 degree incline, chow diet, males [ratio]	x	x	0.97975	0.969333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.9343	0.9365	0.94325	x	x	0.9292	0.99225	0.887	0.95275	x	x	x	0.912	0.93	x	x	x	9824.0	0.98	1.01825	0.92125	0.9755	0.939	1.0262	x	0.9827	0.911	0.98825	0.9914	x	1.03425	x	0.9712	x	x	x	0.7343	0.93575	1.026	x	0.976667	0.951	0.9966	x	0.97575	x	0.95425	0.93725	x	0.922	x	x	0.931	0.93425	0.9972	1.003	0.9822	0.955333	0.9593	x	0.9562	
-15933	None	Trait_362_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 0 degree incline, high fat diet, males [ratio]	x	x	0.96075	0.9472	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.9153	0.9145	0.941	x	x	0.9136	0.9625	0.9898	0.909	x	x	x	0.90825	0.931	x	x	x	x	0.9728	0.9565	0.928	0.945	0.959	0.9836	x	0.911	0.9338	0.98725	0.966	x	0.968	x	0.9246	x	x	x	0.894	0.92675	0.97425	x	0.9585	0.992	0.941	x	0.97075	x	0.944	0.96125	x	x	x	x	0.933	0.908333	0.93325	0.918	0.979	0.9416	0.9573	x	0.9306	
-15934	None	Trait_363_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	90.9425	100.193	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	94.8333	97.94	98.8975	x	x	66.73	63.5	78.28	108.868	x	x	x	93.716	74.4	x	x	x	73.67	90.75	85.7125	83.915	61.9	61.91	67.14	x	87.77	81.82	99.505	x	x	90.9782	x	78.78	x	x	x	74.7	72.6465	90.9	x	93.64	83.5	x	x	100.702	x	91.19	89.145	x	53.83	x	x	70.83	71.395	62.6	74.245	90.368	93.39	91.03	x	64.3333	
-15935	None	Trait_364_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	81.2958	96.318	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	73.6	66.13	93.8175	x	x	51.9	55.3	71.134	59.525	x	x	x	92.8118	77.6	x	x	x	x	69.172	64.7325	66.0415	55.35	52.988	55.7166	x	79.7	76.95	103.395	68.75	x	82.9782	x	76.884	x	x	x	61.85	63.935	62.54	x	74.9175	69.5	56.4	x	86.9607	x	77.3	74.9225	x	x	x	x	66.076	59.6667	60.3	55.68	65.202	76.166	72.21	x	64.14	
-15936	None	Trait_365_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	138.25	153.667	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	128.333	120.5	138.5	x	x	98.3	93.0	98.0	143.5	x	x	x	141.0	124.0	x	x	x	85.8	148.0	115.0	110.0	85.33	82.5	76.6	x	121.3	103.6	126.75	x	x	129.25	x	133.6	x	x	x	92.8	110.0	116.75	x	131.667	139.8	x	x	138.25	x	132.5	127.0	x	88.0	x	x	117.8	104.25	98.6	111.5	138.8	117.333	114.5	x	101.333	
-15937	None	Trait_366_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	99.25	135.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	110.0	63.0	116.25	x	x	68.5	73.8	79.8	75.0	x	x	x	124.25	100.5	x	x	x	x	81.4	76.5	88.0	68.3	65.5	62.4	x	106.5	99.33	120.25	77.33	x	109.0	x	106.6	x	x	x	71.0	96.25	77.0	x	98.75	92.67	77.0	x	120.0	x	105.0	98.5	x	x	x	x	84.4	74.6667	0.826	71.6	101.6	93.2	82.75	x	88.4	
-15938	None	Trait_367_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 10 degree incline, chow diet, males [ratio]	x	x	0.8277	0.850333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.85	0.84825	0.83	x	x	0.7977	0.8199	0.797	0.835	x	x	x	0.81498	0.802	x	x	x	0.8468	0.812067	0.87675	0.850025	0.8543	0.844	0.84336	x	0.8423	0.801	0.88	x	x	0.89075	x	0.85118	x	x	x	0.8534	0.81	0.8572	x	0.856	0.798	x	x	0.825125	x	0.871	0.795125	x	0.8183	x	x	0.793	0.8645	0.8722	0.8489	0.83446	0.8352	0.8081	x	0.829333	
-15939	None	Trait_368_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 0 degree incline, high fat diet, males [ratio]	x	x	0.7725	0.80022	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.767333	0.778175	0.76475	x	x	0.7595	0.7699	0.775	0.78175	x	x	x	0.78125	0.774	x	x	x	x	0.7728	0.791	0.8025	0.7952	0.785	0.8139	x	0.7735	0.763	0.813	0.825	x	0.800375	x	0.7656	x	x	x	0.8203	0.77775	0.7954	x	0.7905	0.7596	0.7883	x	0.79525	x	0.786	0.79995	x	x	x	x	0.7701	0.7981	0.826	0.7974	0.781	0.78218	0.7822	x	0.7791	
-15940	None	Trait_369_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 10 degree incline, chow diet, males [ratio]	x	x	0.9545	0.941	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.930333	0.97575	1.00225	x	x	0.99225	0.97275	0.9313	0.9505	x	x	x	0.9684	0.957	x	x	x	0.9885	0.961667	0.996	0.92775	1.0	0.9393	1.08	x	0.9147	0.939	1.021	x	x	1.118	x	0.987	x	x	x	0.9744	0.97675	0.987	x	0.981333	0.914	x	x	0.97725	x	0.978	0.96475	x	0.973	x	x	0.95	1.0	0.973	0.946	0.9428	1.005	0.943	x	0.971	
-15941	None	Trait_370_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 0 degree incline, high fat diet, males [ratio]	x	x	0.964	0.9486	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.91	0.92825	0.9435	x	x	0.9625	0.961	0.8616	0.92425	x	x	x	0.89625	0.902	x	x	x	x	0.9554	0.9505	0.912	0.9695	0.959	1.0048	x	0.9045	0.902	0.9705	0.97	x	1.0145	x	0.9342	x	x	x	0.906	0.98725	0.94	x	0.96675	0.947	0.985	x	0.95125	x	0.97	0.96875	x	x	x	x	0.9456	0.940667	1.0025	0.882	0.9246	0.917	0.917	x	0.9464	
-15942	None	Trait_371_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	-5.3425	19.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.46	20.67	-9.6875	x	x	6.34	-3.25	6.2	1.573	x	x	x	3.8286	14.89	x	x	x	-6.7	-1.1	3.96	9.145	10.83	-0.595	1.302	x	13.8	9.26	0.85	x	x	11.4382	x	-0.634	x	x	x	8.62	5.2065	15.65	x	15.68	15.82	x	x	3.95	x	9.89825	16.225	x	-3.79	x	x	11.73	0.355	4.76	3.08	23.884	0.19667	13.15	x	-0.061	
-15943	None	Trait_372_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	8.254	23.9134	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-2.0	7.053	6.606	x	x	10.3	3.36	12.9	-3.85	x	x	x	4.91675	13.59	x	x	x	x	5.134	1.375	4.7915	5.78	2.37	3.132	x	12.3	-0.82	26.5	7.67	x	13.1657	x	5.368	x	x	x	-1.39	-2.44325	3.26	x	0.52	14.71	0.693	x	0.68575	x	x	3.8225	x	x	x	x	10.11	4.64	2.46	-0.75	10.578	5.95	14.76	x	8.22	
-15944	None	Trait_373_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [mL/kg/min]	x	x	9.25	23.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.0	33.25	10.5	x	x	-7.8	-5.25	-4.5	17.0	x	x	x	28.4	2.5	x	x	x	-17.6	28.0	3.25	6.5	-1.0	2.5	-11.2	x	26.33	7.0	6.5	x	x	6.25	x	10.0	x	x	x	2.2	14.0	17.25	x	28.0	38.3	x	x	7.25	x	17.75	32.0	x	5.5	x	x	23.55	6.75	14.8	16.5	47.8	0.333	22.0	x	9.3	
-15945	None	Trait_374_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [mL/kg/min]	x	x	12.0	35.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	21.33	2.25	18.25	x	x	19.0	5.25	4.8	7.66667	x	x	x	28.25	19.5	x	x	x	x	1.0	2.25	3.0	5.5	2.75	-3.4	x	23.2	3.25	26.5	2.66	x	1.0	x	11.6	x	x	x	-1.6	15.5	5.25	x	9.5	20.34	6.25	x	13.75	x	5.5	10.75	x	x	x	x	16.5	5.33333	4.0	4.5	26.2	8.2	15.8	x	8.8	
-15946	None	Trait_375_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [ratio]	x	x	-0.00905	0.024	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0253	0.06	-7.5e-05	x	x	0.043	0.02218	-0.0523	0.014	x	x	x	-0.01528	0.0075	x	x	x	0.0064	0.0044	0.0533	0.0539	-0.0003	0.0263	-0.00504	x	-0.00525	0.036	0.0678	x	x	0.094275	x	0.078	x	x	x	0.242	0.0201875	0.02185	x	0.02	0.0004	x	x	0.0384	x	0.0565	-0.000925	x	-0.00675	x	x	0.0363	0.0477	-0.0262	-0.0163	0.00672	0.0172	-0.0331	x	0.033	
-15947	None	Trait_376_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [ratio]	x	x	0.00375	0.00262	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.0017	0.019175	-0.00925	x	x	0.0415	0.0104	-0.1344	0.0154	x	x	x	-0.03975	-0.001	x	x	x	x	0.00225	0.00275	0.039	0.014	0.00995	0.0211	x	-0.0028	-0.0065	0.0315	0.031	x	0.0401875	x	0.003	x	x	x	0.0235	-0.016	-0.001575	x	0.002	-0.0253	-0.00755	x	0.0035	x	0.0133	-0.0068	x	x	x	x	-0.002	0.0294333	0.0298	0.00525	-0.03172	-0.02762	-0.028	x	0.0037	
-15966	Original post publication description: Somite counts; embryonic development	None	Somite counts; embryonic development	x	x	18.091	15.929	13.923	19.0	x	x	x	x	x	x	x	x	x	x	x	x	17.478	x	x	x	x	x	x	x	x	15.083	x	x	16.054	x	x	x	x	x	x	20.161	x	x	x	x	x	x	x	x	x	x	x	19.3	x	x	x	x	x	x	x	x	20.438	x	x	17.667	x	x	x	x	x	x	x	15.526	x	15.841	x	x	x	x	x	x	17.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.955	x	x	x	25.381	x	18.909	18.204	
-13966	Original post publication description: Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Original pre publication description: Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	Central nervous system, protein expression: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]	x	1013.0	1059.0	x	x	920.9	894.8	1002.0	x	927.0	1033.0	1006.0	x	1008.0	x	x	1044.0	x	1018.0	x	1163.0	x	x	x	x	x	1163.0	x	x	997.4	x	x	1033.0	x	x	x	x	1105.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15173	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 3, Trait Lat3 Table 1), males and females combined [sec]	None	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Lat3 Table 1), males and females combined [sec]	x	x	17.75	20.361	38.805	19.305	11.694	17.666	17.666	22.694	12.944	22.111	23.416	22.388	32.972	29.222	22.5	29.36	26.888	25.472	13.361	25.666	x	28.861	13.611	17.194	21.861	29.777	17.527	39.222	13.972	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15174	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec]	x	x	12.972	12.055	36.194	10.527	14.805	12.611	21.611	11.75	14.75	20.444	24.277	21.805	28.0	17.777	23.694	26.972	22.805	23.25	10.055	26.472	x	22.305	12.027	21.111	17.416	24.25	13.083	40.472	13.138	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15169	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, escape latency to reach platform using Morris water maze, training session (test 3) [log sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, crossing over trained platform location Morris water maze, final test [n annulus crossings]	Central nervous system, behavior, learning and memory: Spatial navigation, crossing events over location of trained platform in Morris water maze, final probe trial, males and females combined [n annulus crossings]	Central nervous system, behavior, learning and memory: Spatial navigation, crossing events over location of trained platform in Morris water maze, final probe trial, males and females combined [n annulus crossings]	x	x	4.166	4.666	2.333	3.416	3.916	3.166	3.083	3.0	3.833	3.166	3.166	3.333	2.0	2.833	3.583	3.333	2.333	3.583	5.0	2.416	x	3.333	3.75	2.166	2.5	2.833	2.75	2.416	4.333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15133	Original post publication description: malaria lethality entered at June/16 17:55:21 from IP 75.66.47.130 Original pre publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]	Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = resistant, 1 = susceptible) [fraction of cohort that survives]	Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = 100% resistant, 1 = 100% susceptible) [fraction of cohort that survives]	x	0.5	0.15	0.85	x	x	1.0	x	x	1.0	1.0	0.0	0.71	x	x	1.0	x	0.0	x	x	x	x	x	1.0	x	1.0	x	x	x	1.0	0.71	x	0.57	x	1.0	x	1.0	1.0	1.0	x	1.0	1.0	1.0	0.0	x	x	0.88	0.0	1.0	0.5	x	0.17	x	0.0	0.78	x	x	x	0.625	1.0	0.36	1.0	x	0.55	1.0	0.0	0.51	0.125	0.4	x	x	1.0	0.67	1.0	x	1.0	x	1.0	1.0	x	x	1.0	1.0	0.46	1.0	1.0	0.67	1.0	0.22	1.0	x	x	x	0.125	0.63	1.0	x	1.0	1.0	0.22	0.05	1.0	
-15134	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.56	x	0.61	x	x	0.47	x	x	x	x	x	x	x	0.54	x	x	x	x	x	x	x	0.41	x	x	x	x	x	x	x	x	x	x	x	0.6	x	0.5	x	x	x	x	x	x	0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15135	None	Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.25	x	0.35	x	x	0.35	x	x	x	x	x	x	x	0.02	x	x	x	x	x	x	x	0.11	x	x	x	x	x	x	x	x	x	x	x	0.3	x	0.38	x	x	x	x	x	x	0.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.34	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15136	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group)	Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) concentration in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.31	x	0.26	x	x	0.12	x	x	x	x	x	x	x	0.52	x	x	x	x	x	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	0.3	x	0.12	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15137	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	19.64	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.86	x	11.0	x	x	12.47	x	x	x	x	x	x	x	13.06	x	x	x	x	x	x	x	15.31	x	x	x	x	x	x	x	x	x	x	x	13.69	x	12.68	x	x	x	x	x	x	16.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.95	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15138	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	7.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.42	x	8.75	x	x	7.0	x	x	x	x	x	x	x	1.16	x	x	x	x	x	x	x	4.08	x	x	x	x	x	x	x	x	x	x	x	2.82	x	8.06	x	x	x	x	x	x	8.85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15139	None	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg wet weight]	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	11.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.44	x	2.25	x	x	5.47	x	x	x	x	x	x	x	11.9	x	x	x	x	x	x	x	11.23	x	x	x	x	x	x	x	x	x	x	x	10.87	x	4.62	x	x	x	x	x	x	7.66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.47	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15140	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.41	x	0.52	x	x	0.12	x	x	x	x	x	x	x	0.72	x	x	x	x	x	x	x	0.68	x	x	x	x	x	x	x	x	x	x	x	0.62	x	0.63	x	x	x	x	x	x	0.81	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.47	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15141	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.24	x	0.34	x	x	0.34	x	x	x	x	x	x	x	0.28	x	x	x	x	x	x	x	0.34	x	x	x	x	x	x	x	x	x	x	x	0.31	x	0.54	x	x	x	x	x	x	0.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15142	None	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in males 48h after injection (saline-MPTP group) [ug/mg wet weight]	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in males 48h after injection (saline-MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.17	x	0.18	x	x	-0.22	x	x	x	x	x	x	x	0.44	x	x	x	x	x	x	x	0.34	x	x	x	x	x	x	x	x	x	x	x	0.31	x	0.09	x	x	x	x	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15143	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 3-methoxytyramine (3-MT, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 3-methoxytyramine (3-MT, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.44	x	0.4	x	x	0.35	x	x	x	x	x	x	x	0.46	x	x	x	x	x	x	x	0.39	x	x	x	x	x	x	x	x	x	x	x	0.36	x	0.46	x	x	x	x	x	x	0.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15144	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	0.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.22	x	0.33	x	x	0.26	x	x	x	x	x	x	x	0.1	x	x	x	x	x	x	x	0.24	x	x	x	x	x	x	x	x	x	x	x	0.15	x	0.44	x	x	x	x	x	x	0.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.23	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15145	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after injection (saline-MPTP group) [ug/mg total protein]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after injection (saline-MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.22	x	0.07	x	x	0.09	x	x	x	x	x	x	x	0.36	x	x	x	x	x	x	x	0.15	x	x	x	x	x	x	x	x	x	x	x	0.21	x	0.02	x	x	x	x	x	x	-0.04	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15146	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]	x	x	x	x	x	x	x	x	x	2.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.35	x	5.53	x	x	3.74	x	x	x	x	x	x	x	4.13	x	x	x	x	x	x	x	2.69	x	x	x	x	x	x	x	x	x	x	x	4.37	x	3.96	x	x	x	x	x	x	3.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15147	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	3.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.06	x	3.34	x	x	5.06	x	x	x	x	x	x	x	1.33	x	x	x	x	x	x	x	2.77	x	x	x	x	x	x	x	x	x	x	x	5.32	x	4.81	x	x	x	x	x	x	4.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.24	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15148	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group)	Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	-0.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.29	x	2.19	x	x	-1.32	x	x	x	x	x	x	x	2.8	x	x	x	x	x	x	x	-0.08	x	x	x	x	x	x	x	x	x	x	x	-9.55	x	-0.85	x	x	x	x	x	x	-1.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.74	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15149	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]	x	x	x	x	x	x	x	x	x	3.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.21	x	4.78	x	x	1.02	x	x	x	x	x	x	x	5.58	x	x	x	x	x	x	x	4.46	x	x	x	x	x	x	x	x	x	x	x	4.52	x	4.98	x	x	x	x	x	x	4.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.94	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15150	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	5.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.93	x	3.92	x	x	5.18	x	x	x	x	x	x	x	25.45	x	x	x	x	x	x	x	8.46	x	x	x	x	x	x	x	x	x	x	x	8.01	x	6.84	x	x	x	x	x	x	5.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15151	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline minus MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	-1.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.72	x	0.86	x	x	-4.16	x	x	x	x	x	x	x	-19.87	x	x	x	x	x	x	x	-4.0	x	x	x	x	x	x	x	x	x	x	x	-3.49	x	-1.86	x	x	x	x	x	x	-0.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-2.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15152	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]	x	x	x	x	x	x	x	x	x	0.59	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.42	x	0.44	x	x	0.63	x	x	x	x	x	x	x	0.43	x	x	x	x	x	x	x	0.71	x	x	x	x	x	x	x	x	x	x	x	0.51	x	0.64	x	x	x	x	x	x	0.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.59	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15153	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HT Concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), 5-HT concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g wet weight]	x	x	x	x	x	x	x	x	x	0.49	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.51	x	0.53	x	x	0.44	x	x	x	x	x	x	x	0.4	x	x	x	x	x	x	x	0.71	x	x	x	x	x	x	x	x	x	x	x	0.36	x	0.45	x	x	x	x	x	x	0.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15154	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HT Concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group)	Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), serotonin (5-HT) concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.09	x	-0.09	x	x	0.19	x	x	x	x	x	x	x	0.03	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	0.15	x	0.19	x	x	x	x	x	x	-0.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15155	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]	x	x	x	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.14	x	0.13	x	x	0.06	x	x	x	x	x	x	x	0.09	x	x	x	x	x	x	x	0.18	x	x	x	x	x	x	x	x	x	x	x	0.14	x	0.13	x	x	x	x	x	x	0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15156	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HIAA (5-HT metabolite) concentration in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group)	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on 5-HIAA (5-HT metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.14	x	0.07	x	x	0.06	x	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	0.18	x	x	x	x	x	x	x	x	x	x	x	0.34	x	0.11	x	x	x	x	x	x	0.11	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.12	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15157	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.02	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	0.06	x	x	0.0	x	x	x	x	x	x	x	-0.08	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	x	-0.2	x	0.02	x	x	x	x	x	x	-0.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15158	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.1	x	0.12	x	x	0.08	x	x	x	x	x	x	x	0.17	x	x	x	x	x	x	x	0.16	x	x	x	x	x	x	x	x	x	x	x	0.16	x	0.17	x	x	x	x	x	x	0.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.11	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15159	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen (ug/mg total protein) in males 48h after injection (MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g total protein]	x	x	x	x	x	x	x	x	x	0.61	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.33	x	0.2	x	x	0.16	x	x	x	x	x	x	x	0.48	x	x	x	x	x	x	x	0.47	x	x	x	x	x	x	x	x	x	x	x	0.28	x	0.27	x	x	x	x	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15160	None	Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen (ug/mg total protein) in males 48h after injection (Saline-MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/g total protein]	x	x	x	x	x	x	x	x	x	-0.44	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.23	x	-0.08	x	x	-0.08	x	x	x	x	x	x	x	-0.31	x	x	x	x	x	x	x	-0.31	x	x	x	x	x	x	x	x	x	x	x	-0.12	x	-0.1	x	x	x	x	x	x	-0.22	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15161	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]	x	x	x	x	x	x	x	x	x	1.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.31	x	1.06	x	x	1.5	x	x	x	x	x	x	x	1.22	x	x	x	x	x	x	x	1.51	x	x	x	x	x	x	x	x	x	x	x	1.48	x	1.3	x	x	x	x	x	x	1.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.03	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15162	None	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Tyrosine Hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) Concentration in Caudate-putamen (ug/mg total protein) in males 48h after injection (MPTP group)	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g total protein]	x	x	x	x	x	x	x	x	x	0.92	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.8	x	0.83	x	x	0.87	x	x	x	x	x	x	x	0.31	x	x	x	x	x	x	x	0.61	x	x	x	x	x	x	x	x	x	x	x	0.55	x	1.08	x	x	x	x	x	x	0.98	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15163	None	Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/g total protein]	x	x	x	x	x	x	x	x	x	0.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.51	x	0.23	x	x	0.63	x	x	x	x	x	x	x	0.91	x	x	x	x	x	x	x	0.9	x	x	x	x	x	x	x	x	x	x	x	0.93	x	0.22	x	x	x	x	x	x	0.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15164	None	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	30.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	21.74	x	25.14	x	x	26.13	x	x	x	x	x	x	x	24.41	x	x	x	x	x	x	x	24.02	x	x	x	x	x	x	x	x	x	x	x	34.43	x	24.95	x	x	x	x	x	x	29.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	28.02	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15165	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection (MPTP group) [ug/mg wet weight]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection (MPTP group) [ug/mg wet weight]	x	x	x	x	x	x	x	x	x	25.12	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.56	x	29.89	x	x	24.96	x	x	x	x	x	x	x	33.46	x	x	x	x	x	x	x	28.1	x	x	x	x	x	x	x	x	x	x	x	29.24	x	24.98	x	x	x	x	x	x	24.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15166	None	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response difference (12.5 mg/kg sc vs saline), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection [difference ug/mg]	Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response difference (12.5 mg/kg sc vs saline), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection [difference ug/mg]	x	x	x	x	x	x	x	x	x	-5.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.82	x	4.75	x	x	-1.17	x	x	x	x	x	x	x	9.05	x	x	x	x	x	x	x	4.08	x	x	x	x	x	x	x	x	x	x	x	-5.19	x	0.03	x	x	x	x	x	x	-4.91	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15167	Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.6 is all animals present with lesions]	None	Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, females between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.6 is all animals present with lesions]	x	x	-0.271	-0.37	x	x	x	0.065	x	x	x	-0.081	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.527	x	x	x	x	x	x	x	-0.28	x	x	x	-0.154	-0.228	x	x	-0.691	-0.333	0.024	0.199	x	x	x	x	x	x	x	x	x	x	0.134	x	0.736	x	0.482	x	0.062	-0.579	-0.117	x	x	0.16	x	0.436	x	0.332	x	x	0.142	-0.354	x	0.311	-0.17	x	-0.282	-0.492	x	-0.116	0.439	x	x	x	x	0.523	0.293	x	0.612	0.027	0.315	-0.29	0.054	-0.011	
-15168	Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.7 is all animals present with lesions]	None	Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.7 is all animals present with lesions]	x	x	-0.3339	-0.2218	x	x	x	-0.3265	x	x	x	0.0409	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.2807	x	-0.3065	x	x	x	x	x	x	x	x	x	-0.2528	-0.1256	x	x	0.3892	-0.2945	-0.2744	0.1892	x	x	x	x	x	x	x	x	x	x	0.00911	x	0.7142	x	-0.0476	x	-0.1816	-0.2808	-0.1698	x	x	0.71	x	0.4406	x	0.0135	x	x	-0.1213	-0.3378	x	-0.1262	0.0596	x	0.0054	-0.3454	x	-0.3158	0.698	x	x	x	x	0.7261	0.5237	x	-0.279	-0.2449	0.2604	0.3179	0.0621	-0.2928	
-15022	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, males	Morphology, metabolism: Body weight at 119 days (17 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.885	5.124	4.8	4.769	4.944	x	4.917	4.946	x	5.166	x	x	5.374	4.915	5.329	x	x	x	x	x	x	4.825	x	x	5.221	x	x	x	5.14	4.878	4.793	x	x	x	x	5.081	5.374	4.769	x	5.194	4.844	x	x	x	x	x	x	x	5.004	x	x	x	x	x	x	x	x	x	4.769	5.374	x	x	x	x	x	5.053	5.024	x	x	x	4.959	x	4.989	x	x	x	x	x	x	x	x	x	x	5.374	4.769	x	x	5.125	x	x	x	x	x	5.043	x	x	x	x	x	x	x	
-15023	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, males	Morphology, metabolism: Body weight at 126 days (18 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.944	5.144	4.843	4.818	4.956	x	4.946	4.966	x	5.254	x	x	5.406	x	5.369	x	x	x	x	x	x	4.869	x	x	5.27	x	x	x	5.177	4.878	4.823	x	x	x	x	5.083	5.406	4.818	x	5.24	4.901	x	x	x	x	x	x	x	5.052	x	x	x	x	x	x	x	x	x	4.818	5.406	x	x	x	x	x	5.11	5.097	x	x	x	4.971	x	5.02	x	x	x	x	x	x	x	x	x	x	5.406	4.818	x	x	5.182	x	x	x	x	x	5.109	x	x	x	x	x	x	x	
-15024	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, males	Morphology, metabolism: Body weight at 133 days (19 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.959	5.165	4.853	4.853	4.983	x	4.967	5.035	x	5.323	x	x	5.439	x	5.439	x	x	x	x	x	x	4.899	x	x	5.275	x	x	x	5.236	4.898	4.881	x	x	x	x	5.11	5.439	4.858	x	5.261	4.931	x	x	x	x	x	x	x	5.106	x	x	x	x	x	x	x	x	x	4.853	5.439	x	x	x	x	x	5.121	5.11	x	x	x	4.999	x	5.044	x	x	x	x	x	x	x	x	x	x	5.388	4.853	x	x	5.195	x	x	x	x	x	5.163	x	x	x	x	x	x	x	
-15025	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, males	Morphology, metabolism: Body weight at 140 days (20 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	5.011	5.262	4.931	4.854	4.998	x	4.987	5.1	x	5.363	x	x	5.467	x	5.467	x	x	x	x	x	x	4.934	x	x	5.307	x	x	x	5.297	4.93	4.854	x	x	x	x	5.087	5.467	4.945	x	5.274	4.964	x	x	x	x	x	x	x	5.153	x	x	x	x	x	x	x	x	x	4.854	5.467	x	x	x	x	x	5.15	5.175	x	x	x	5.049	x	5.083	x	x	x	x	x	x	x	x	x	x	5.394	4.854	x	x	5.251	x	x	x	x	x	5.19	x	x	x	x	x	x	x	
-15026	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, males	Morphology, metabolism: Body weight gain between 4 and 5 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.585	2.62	2.479	2.055	2.677	x	2.493	2.491	x	x	x	x	2.911	2.641	2.911	x	x	x	x	x	x	2.857	x	x	2.804	x	x	x	2.423	2.707	2.139	x	x	x	x	2.055	2.911	2.578	x	2.657	2.055	x	x	x	x	x	x	x	2.491	x	x	x	x	x	x	x	x	x	2.332	2.897	x	x	x	x	x	2.457	2.558	x	x	x	2.723	x	2.538	x	x	x	x	x	x	x	x	x	x	2.489	2.055	x	x	2.403	x	x	x	x	x	2.911	x	x	x	x	x	x	x	
-15027	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, males	Morphology, metabolism: Body weight gain between 5 and 6 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.244	2.502	2.252	2.176	2.176	x	2.547	2.475	x	2.554	x	x	2.24	2.176	2.629	x	x	x	x	x	x	2.689	x	x	2.689	x	x	x	2.505	2.629	2.468	x	x	x	x	2.428	2.627	2.323	x	2.269	2.176	x	x	x	x	x	x	x	2.689	x	x	x	x	x	x	x	x	x	2.287	2.689	x	x	x	x	x	2.205	2.327	x	x	x	2.485	x	2.239	x	x	x	x	x	x	x	x	x	x	2.604	2.184	x	x	2.671	x	x	x	x	x	2.575	x	x	x	x	x	x	x	
-15028	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, males	Morphology, metabolism: Body weight gain between 6 and 7 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.638	1.91	1.803	1.585	1.585	x	2.01	1.853	x	1.595	x	x	1.774	1.623	1.82	x	x	x	x	x	x	1.921	x	x	2.043	x	x	x	1.869	1.966	1.988	x	x	x	x	1.886	1.991	1.585	x	1.726	1.93	x	x	x	x	x	x	x	1.756	x	x	x	x	x	x	x	x	x	2.043	1.955	x	x	x	x	x	1.976	1.652	x	x	x	2.043	x	1.585	x	x	x	x	x	x	x	x	x	x	2.043	1.873	x	x	2.019	x	x	x	x	x	1.812	x	x	x	x	x	x	x	
-15029	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, males	Morphology, metabolism: Body weight gain between 7 and 8 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.644	1.91	1.968	1.434	1.626	x	1.491	1.434	x	1.7	x	x	2.221	1.56	1.728	x	x	x	x	x	x	1.727	x	x	1.695	x	x	x	1.719	1.816	1.742	x	x	x	x	2.221	2.221	1.434	x	1.593	1.599	x	x	x	x	x	x	x	1.655	x	x	x	x	x	x	x	x	x	1.434	1.849	x	x	x	x	x	1.873	1.658	x	x	x	1.815	x	1.758	x	x	x	x	x	x	x	x	x	x	2.221	1.757	x	x	1.736	x	x	x	x	x	1.669	x	x	x	x	x	x	x	
-15030	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, males	Morphology, metabolism: Body weight gain between 8 and 9 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.332	1.511	1.631	1.332	1.344	x	1.643	1.388	x	1.872	x	x	1.872	1.705	1.714	x	x	x	x	x	x	1.604	x	x	1.852	x	x	x	1.636	1.744	1.501	x	x	x	x	1.753	1.872	1.353	x	1.561	1.397	x	x	x	x	x	x	x	1.332	x	x	x	x	x	x	x	x	x	1.483	1.581	x	x	x	x	x	1.463	1.763	x	x	x	1.586	x	1.747	x	x	x	x	x	x	x	x	x	x	1.872	1.332	x	x	1.504	x	x	x	x	x	1.369	x	x	x	x	x	x	x	
-15031	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, males	Morphology, metabolism: Body weight gain between 9 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.664	1.61	1.605	1.238	1.491	x	1.701	1.238	x	1.786	x	x	1.786	1.526	1.73	x	x	x	x	x	x	1.238	x	x	1.786	x	x	x	1.5	1.63	1.515	x	x	x	x	1.336	1.688	1.393	x	1.52	1.239	x	x	x	x	x	x	x	1.583	x	x	x	x	x	x	x	x	x	1.445	1.776	x	x	x	x	x	1.654	1.698	x	x	x	1.49	x	1.479	x	x	x	x	x	x	x	x	x	x	1.786	1.238	x	x	1.752	x	x	x	x	x	1.245	x	x	x	x	x	x	x	
-15032	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, males	Morphology, metabolism: Body weight gain between 10 and 11 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.388	1.8	1.3	1.3	1.487	x	1.335	1.581	x	1.963	x	x	2.038	1.512	1.913	x	x	x	x	x	x	1.345	x	x	1.999	x	x	x	1.418	1.451	1.468	x	x	x	x	1.778	2.038	1.585	x	1.627	1.633	x	x	x	x	x	x	x	1.3	x	x	x	x	x	x	x	x	x	1.362	2.038	x	x	x	x	x	1.54	1.409	x	x	x	1.3	x	1.7	x	x	x	x	x	x	x	x	x	x	2.038	1.493	x	x	1.608	x	x	x	x	x	1.49	x	x	x	x	x	x	x	
-15033	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, males	Morphology, metabolism: Body weight gain between 11 and 12 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.46	1.913	1.443	1.287	1.407	x	1.551	1.651	x	1.987	x	x	1.987	1.37	1.709	x	x	x	x	x	x	1.611	x	x	1.709	x	x	x	1.857	1.309	1.331	x	x	x	x	1.621	1.987	1.286	x	1.286	1.429	x	x	x	x	x	x	x	1.434	x	x	x	x	x	x	x	x	x	1.455	1.91	x	x	x	x	x	1.805	1.715	x	x	x	1.526	x	1.688	x	x	x	x	x	x	x	x	x	x	1.987	1.286	x	x	1.931	x	x	x	x	x	1.286	x	x	x	x	x	x	x	
-15034	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, males	Morphology, metabolism: Body weight gain between 12 and 13 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.151	1.469	1.328	1.151	1.432	x	1.543	1.205	x	1.942	x	x	1.961	1.895	1.629	x	x	x	x	x	x	1.151	x	x	1.877	x	x	x	1.897	1.181	1.422	x	x	x	x	1.567	1.961	1.637	x	1.272	1.525	x	x	x	x	x	x	x	1.531	x	x	x	x	x	x	x	x	x	1.151	1.961	x	x	x	x	x	1.223	1.408	x	x	x	1.259	x	1.516	x	x	x	x	x	x	x	x	x	x	1.961	1.367	x	x	1.49	x	x	x	x	x	1.673	x	x	x	x	x	x	x	
-15035	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, males	Morphology, metabolism: Body weight gain between 13 and 14 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.458	1.577	1.448	1.517	1.245	x	1.55	1.7	x	1.907	x	x	1.669	1.28	1.832	x	x	x	x	x	x	1.243	x	x	1.243	x	x	x	1.423	1.243	1.533	x	x	x	x	1.568	1.907	1.508	x	1.629	1.458	x	x	x	x	x	x	x	1.358	x	x	x	x	x	x	x	x	x	1.406	1.907	x	x	x	x	x	1.818	1.907	x	x	x	1.459	x	1.523	x	x	x	x	x	x	x	x	x	x	1.564	1.243	x	x	1.554	x	x	x	x	x	1.397	x	x	x	x	x	x	x	
-15036	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, males	Morphology, metabolism: Body weight gain between 14 and 15 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.585	1.51	1.398	1.39	1.418	x	1.201	1.824	x	1.95	x	x	1.871	1.592	1.688	x	x	x	x	x	x	1.291	x	x	1.713	x	x	x	1.742	1.282	1.281	x	x	x	x	1.274	1.73	1.512	x	1.941	1.234	x	x	x	x	x	x	x	1.706	x	x	x	x	x	x	x	x	x	1.452	1.95	x	x	x	x	x	1.696	1.625	x	x	x	1.438	x	1.201	x	x	x	x	x	x	x	x	x	x	1.95	1.201	x	x	1.95	x	x	x	x	x	1.201	x	x	x	x	x	x	x	
-15037	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, males	Morphology, metabolism: Body weight gain between 15 and 16 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.302	1.502	1.382	1.21	1.665	x	1.428	1.403	x	1.535	x	x	1.907	1.597	1.907	x	x	x	x	x	x	1.21	x	x	1.706	x	x	x	1.561	1.404	1.432	x	x	x	x	1.21	1.826	1.571	x	1.907	1.474	x	x	x	x	x	x	x	1.514	x	x	x	x	x	x	x	x	x	1.21	1.907	x	x	x	x	x	1.279	1.624	x	x	x	1.329	x	1.55	x	x	x	x	x	x	x	x	x	x	1.373	1.24	x	x	1.646	x	x	x	x	x	1.636	x	x	x	x	x	x	x	
-15038	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, males	Morphology, metabolism: Body weight gain between 16 and 17 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.751	1.62	1.368	1.247	1.485	x	1.535	1.92	x	2.001	x	x	1.677	1.247	2.001	x	x	x	x	x	x	1.421	x	x	1.377	x	x	x	1.929	1.37	1.592	x	x	x	x	1.524	2.001	1.247	x	1.699	1.408	x	x	x	x	x	x	x	1.668	x	x	x	x	x	x	x	x	x	1.366	1.845	x	x	x	x	x	1.651	2.001	x	x	x	1.247	x	1.49	x	x	x	x	x	x	x	x	x	x	1.817	1.399	x	x	1.46	x	x	x	x	x	1.8	x	x	x	x	x	x	x	
-15039	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, males	Morphology, metabolism: Body weight gain between 17 and 18 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.696	1.309	1.51	1.428	1.179	x	1.399	1.286	x	1.821	x	x	1.276	x	1.65	x	x	x	x	x	x	1.528	x	x	1.726	x	x	x	1.547	1.179	1.367	x	x	x	x	1.179	1.821	1.588	x	1.677	1.662	x	x	x	x	x	x	x	1.623	x	x	x	x	x	x	x	x	x	1.331	1.776	x	x	x	x	x	1.748	1.821	x	x	x	1.179	x	1.43	x	x	x	x	x	x	x	x	x	x	1.474	1.318	x	x	1.775	x	x	x	x	x	1.821	x	x	x	x	x	x	x	
-15040	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, males	Morphology, metabolism: Body weight gain between 18 and 19 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.519	1.616	1.45	1.506	1.641	x	1.566	2.016	x	2.016	x	x	1.45	x	2.016	x	x	x	x	x	x	1.657	x	x	1.45	x	x	x	2.011	1.561	1.882	x	x	x	x	1.664	1.782	1.732	x	1.624	1.654	x	x	x	x	x	x	x	1.924	x	x	x	x	x	x	x	x	x	1.609	2.016	x	x	x	x	x	1.472	1.513	x	x	x	1.655	x	1.62	x	x	x	x	x	x	x	x	x	x	1.45	1.634	x	x	1.502	x	x	x	x	x	1.938	x	x	x	x	x	x	x	
-15041	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, males	Morphology, metabolism: Body weight gain between 19 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.889	1.758	2.032	1.584	1.559	x	1.593	2.032	x	1.886	x	x	1.598	x	1.818	x	x	x	x	x	x	1.721	x	x	1.782	x	x	x	2.032	1.688	1.459	x	x	x	x	1.459	1.784	1.882	x	1.535	1.708	x	x	x	x	x	x	x	1.886	x	x	x	x	x	x	x	x	x	1.621	1.459	x	x	x	x	x	1.712	2.032	x	x	x	1.883	x	1.794	x	x	x	x	x	x	x	x	x	x	1.459	1.612	x	x	2.014	x	x	x	x	x	1.705	x	x	x	x	x	x	x	
-15042	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, males	Morphology, metabolism: Body length from the nose until the tail at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.487	6.488	6.366	6.403	6.488	x	6.421	6.43	x	6.384	x	x	6.488	6.392	6.484	x	x	x	x	x	x	6.406	x	x	6.366	x	x	x	6.415	6.399	6.38	x	x	x	x	6.443	6.438	6.375	x	6.462	6.314	x	x	x	x	x	x	x	6.473	x	x	x	x	x	x	x	x	x	6.314	6.426	x	x	x	x	x	6.402	6.314	x	x	x	6.34	x	6.426	x	x	x	x	x	x	x	x	x	x	6.488	6.314	x	x	6.413	x	x	x	x	x	6.452	x	x	x	x	x	x	x	
-15043	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, males	Morphology, metabolism: Body length from the nose until the tail at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.592	6.61	6.478	6.489	6.55	x	6.583	6.533	x	6.5	x	x	6.61	6.566	6.597	x	x	x	x	x	x	6.542	x	x	6.539	x	x	x	6.577	6.518	6.508	x	x	x	x	6.607	6.559	6.492	x	6.478	6.508	x	x	x	x	x	x	x	6.605	x	x	x	x	x	x	x	x	x	6.478	6.543	x	x	x	x	x	6.508	6.498	x	x	x	6.57	x	6.567	x	x	x	x	x	x	x	x	x	x	6.61	6.478	x	x	6.573	x	x	x	x	x	6.61	x	x	x	x	x	x	x	
-15044	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, males	Morphology, metabolism: Body length from the nose until the tail at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.647	6.672	6.611	6.577	6.647	x	6.687	6.577	x	6.658	x	x	6.707	x	6.707	x	x	x	x	x	x	6.632	x	x	6.607	x	x	x	6.615	6.607	6.596	x	x	x	x	6.707	6.674	6.58	x	6.689	6.579	x	x	x	x	x	x	x	6.646	x	x	x	x	x	x	x	x	x	6.577	6.665	x	x	x	x	x	6.658	6.607	x	x	x	6.649	x	6.624	x	x	x	x	x	x	x	x	x	x	6.707	6.577	x	x	6.67	x	x	x	x	x	6.702	x	x	x	x	x	x	x	
-15045	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, males	Morphology, metabolism: Serum glucose level at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.511	6.579	6.408	6.681	6.747	x	6.389	6.389	x	6.409	x	x	6.618	6.389	6.71	x	x	x	x	x	x	6.389	x	x	6.409	x	x	x	6.465	6.778	6.861	x	x	x	x	6.592	6.822	6.495	x	6.473	6.634	x	x	x	x	x	x	x	6.861	x	x	x	x	x	x	x	x	x	6.79	6.43	x	x	x	x	x	6.766	6.861	x	x	x	6.861	x	6.524	x	x	x	x	x	x	x	x	x	x	6.52	6.806	x	x	6.545	x	x	x	x	x	6.757	x	x	x	x	x	x	x	
-15046	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, males	Morphology, metabolism: Serum glucose level at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.778	6.594	6.426	6.931	6.664	x	6.392	6.833	x	6.392	x	x	7.006	x	6.392	x	x	x	x	x	x	6.667	x	x	6.94	x	x	x	6.777	6.508	6.421	x	x	x	x	7.017	7.025	6.52	x	6.392	6.448	x	x	x	x	x	x	x	6.714	x	x	x	x	x	x	x	x	x	6.458	6.392	x	x	x	x	x	6.618	7.025	x	x	x	7.025	x	6.866	x	x	x	x	x	x	x	x	x	x	7.025	6.888	x	x	6.618	x	x	x	x	x	6.691	x	x	x	x	x	x	x	
-15047	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, males	Morphology, metabolism: Food Intake between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.511	1.549	1.433	1.504	1.679	x	1.475	1.611	x	1.724	x	x	1.75	1.891	1.743	x	x	x	x	x	x	1.469	x	x	1.672	x	x	x	1.668	1.549	1.634	x	x	x	x	1.729	1.891	1.433	x	1.889	1.48	x	x	x	x	x	x	x	1.664	x	x	x	x	x	x	x	x	x	1.433	1.629	x	x	x	x	x	1.692	1.891	x	x	x	1.79	x	1.676	x	x	x	x	x	x	x	x	x	x	1.803	1.541	x	x	1.433	x	x	x	x	x	1.891	x	x	x	x	x	x	x	
-15048	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, males	Metabolism: Food intake between 17 and 20 weeks in males on a high fat diet (45% energy from fat, Ssniff(R) diet S8074-E010, Germany) initiated at 4 weeks [g/day]	x	1.485	1.67	1.592	1.473	1.79	x	1.735	1.708	x	1.876	x	x	2.06	x	1.791	x	x	x	x	x	x	1.473	x	x	1.928	x	x	x	1.723	1.588	1.626	x	x	x	x	1.774	1.815	1.548	x	1.783	1.601	x	x	x	x	x	x	x	1.794	x	x	x	x	x	x	x	x	x	1.473	1.792	x	x	x	x	x	1.585	2.06	x	x	x	1.996	x	1.712	x	x	x	x	x	x	x	x	x	x	2.06	1.473	x	x	2.06	x	x	x	x	x	1.844	x	x	x	x	x	x	x	
-15049	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain, males	Morphology, metabolism: Brain weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.287	1.289	1.257	1.279	1.268	x	1.257	1.273	x	1.267	x	x	1.282	1.282	1.289	x	x	x	x	x	x	1.257	x	x	1.257	x	x	x	1.277	1.259	1.274	x	x	x	x	1.286	1.271	1.276	x	1.289	1.268	x	x	x	x	x	x	x	1.286	x	x	x	x	x	x	x	x	x	1.26	1.28	x	x	x	x	x	1.279	1.284	x	x	x	1.279	x	1.271	x	x	x	x	x	x	x	x	x	x	1.289	1.261	x	x	1.267	x	x	x	x	x	1.271	x	x	x	x	x	x	x	
-15050	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, males	Morphology, metabolism: Liver weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	0.345	0.614	0.466	0.202	0.793	x	0.562	0.586	x	0.601	x	x	1.082	0.202	0.952	x	x	x	x	x	x	0.202	x	x	0.902	x	x	x	0.564	0.503	0.202	x	x	x	x	0.35	1.082	0.435	x	1.082	0.445	x	x	x	x	x	x	x	0.685	x	x	x	x	x	x	x	x	x	0.425	1.082	x	x	x	x	x	0.541	0.842	x	x	x	0.596	x	0.817	x	x	x	x	x	x	x	x	x	x	1.019	0.225	x	x	0.935	x	x	x	x	x	0.588	x	x	x	x	x	x	x	
-15051	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, males	Morphology, metabolism: Kidney weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.286	1.235	1.327	1.235	1.286	x	1.241	1.302	x	1.252	x	x	1.335	1.242	1.264	x	x	x	x	x	x	1.246	x	x	1.286	x	x	x	1.245	1.335	1.268	x	x	x	x	1.307	1.308	1.252	x	1.323	1.235	x	x	x	x	x	x	x	1.32	x	x	x	x	x	x	x	x	x	1.258	1.302	x	x	x	x	x	1.27	1.335	x	x	x	1.335	x	1.296	x	x	x	x	x	x	x	x	x	x	1.322	1.235	x	x	1.31	x	x	x	x	x	1.273	x	x	x	x	x	x	x	
-15052	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, males	Morphology, metabolism: Spleen weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.041	1.074	1.049	1.059	1.081	x	1.081	1.052	x	1.041	x	x	1.081	1.041	1.081	x	x	x	x	x	x	1.045	x	x	1.067	x	x	x	1.065	1.067	1.05	x	x	x	x	1.045	1.08	1.041	x	1.062	1.066	x	x	x	x	x	x	x	1.064	x	x	x	x	x	x	x	x	x	1.044	1.057	x	x	x	x	x	1.067	1.048	x	x	x	1.056	x	1.065	x	x	x	x	x	x	x	x	x	x	1.059	1.041	x	x	1.059	x	x	x	x	x	1.072	x	x	x	x	x	x	x	
-15053	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, males	Morphology, metabolism: Heart weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.101	1.101	1.103	1.089	1.097	x	1.098	1.104	x	1.099	x	x	1.125	1.089	1.11	x	x	x	x	x	x	1.089	x	x	1.125	x	x	x	1.096	1.096	1.092	x	x	x	x	1.125	1.12	1.116	x	1.109	1.097	x	x	x	x	x	x	x	1.098	x	x	x	x	x	x	x	x	x	1.089	1.103	x	x	x	x	x	1.095	1.109	x	x	x	1.116	x	1.097	x	x	x	x	x	x	x	x	x	x	1.125	1.092	x	x	1.112	x	x	x	x	x	1.108	x	x	x	x	x	x	x	
-15054	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, males	Morphology, metabolism: Lung weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.156	1.132	1.119	1.119	1.146	x	1.142	1.124	x	1.126	x	x	1.147	1.142	1.144	x	x	x	x	x	x	1.123	x	x	1.134	x	x	x	1.134	1.149	1.132	x	x	x	x	1.157	1.157	1.141	x	1.157	1.134	x	x	x	x	x	x	x	1.119	x	x	x	x	x	x	x	x	x	1.132	1.136	x	x	x	x	x	1.157	1.138	x	x	x	1.139	x	1.139	x	x	x	x	x	x	x	x	x	x	1.132	1.119	x	x	1.135	x	x	x	x	x	1.155	x	x	x	x	x	x	x	
-15055	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, males	Morphology, metabolism: Pancreas weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.145	1.169	1.151	1.145	1.163	x	1.163	1.239	x	1.181	x	x	1.24	1.19	1.206	x	x	x	x	x	x	1.166	x	x	1.153	x	x	x	1.166	1.164	1.159	x	x	x	x	1.202	1.24	1.145	x	1.148	1.193	x	x	x	x	x	x	x	1.203	x	x	x	x	x	x	x	x	x	1.153	1.24	x	x	x	x	x	1.189	1.183	x	x	x	1.161	x	1.162	x	x	x	x	x	x	x	x	x	x	1.24	1.16	x	x	1.145	x	x	x	x	x	1.233	x	x	x	x	x	x	x	
-15056	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Testis, males	Urogenital system, reproduction, morphology, metabolism: Testis weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.175	1.143	1.154	1.107	1.157	x	1.175	1.145	x	1.138	x	x	1.107	1.164	1.165	x	x	x	x	x	x	1.156	x	x	1.143	x	x	x	1.126	1.165	1.163	x	x	x	x	1.107	1.175	1.107	x	1.108	1.163	x	x	x	x	x	x	x	1.122	x	x	x	x	x	x	x	x	x	1.154	1.124	x	x	x	x	x	1.135	1.175	x	x	x	1.143	x	1.147	x	x	x	x	x	x	x	x	x	x	1.171	1.115	x	x	1.124	x	x	x	x	x	1.145	x	x	x	x	x	x	x	
-15057	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, males	Morphology, metabolism: The quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.229	1.241	1.212	1.212	1.245	x	1.25	1.22	x	1.231	x	x	1.27	1.27	1.27	x	x	x	x	x	x	1.204	x	x	1.225	x	x	x	1.211	1.204	1.259	x	x	x	x	1.259	1.254	1.233	x	1.233	1.249	x	x	x	x	x	x	x	1.259	x	x	x	x	x	x	x	x	x	1.204	1.27	x	x	x	x	x	1.258	1.217	x	x	x	1.235	x	1.245	x	x	x	x	x	x	x	x	x	x	1.235	1.204	x	x	1.212	x	x	x	x	x	1.254	x	x	x	x	x	x	x	
-15058	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, males	Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.381	1.38	1.313	1.313	1.387	x	1.402	1.366	x	1.423	x	x	1.423	1.38	1.366	x	x	x	x	x	x	1.337	x	x	1.321	x	x	x	1.39	1.321	1.37	x	x	x	x	1.385	1.402	1.395	x	1.379	1.368	x	x	x	x	x	x	x	1.377	x	x	x	x	x	x	x	x	x	1.313	1.423	x	x	x	x	x	1.39	1.332	x	x	x	1.356	x	1.362	x	x	x	x	x	x	x	x	x	x	1.367	1.313	x	x	1.343	x	x	x	x	x	1.423	x	x	x	x	x	x	x	
-15059	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, males	Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.716	1.868	1.744	1.479	1.496	x	1.479	1.969	x	2.234	x	x	1.864	1.683	2.234	x	x	x	x	x	x	1.846	x	x	1.991	x	x	x	2.011	1.767	1.618	x	x	x	x	1.799	2.234	1.771	x	1.738	1.699	x	x	x	x	x	x	x	2.005	x	x	x	x	x	x	x	x	x	1.479	2.234	x	x	x	x	x	1.877	1.966	x	x	x	1.626	x	1.811	x	x	x	x	x	x	x	x	x	x	2.08	1.479	x	x	2.081	x	x	x	x	x	1.753	x	x	x	x	x	x	x	
-15060	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, males	Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.172	1.245	1.229	1.13	1.13	x	1.135	1.295	x	1.341	x	x	1.271	1.185	1.341	x	x	x	x	x	x	1.242	x	x	1.302	x	x	x	1.341	1.156	1.143	x	x	x	x	1.17	1.341	1.157	x	1.185	1.215	x	x	x	x	x	x	x	1.298	x	x	x	x	x	x	x	x	x	1.136	1.335	x	x	x	x	x	1.229	1.25	x	x	x	1.137	x	1.13	x	x	x	x	x	x	x	x	x	x	1.289	1.13	x	x	1.161	x	x	x	x	x	1.225	x	x	x	x	x	x	x	
-15061	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, males	Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.068	1.077	1.07	1.053	1.053	x	1.053	1.147	x	1.316	x	x	1.316	1.065	1.296	x	x	x	x	x	x	1.096	x	x	1.156	x	x	x	1.094	1.114	1.12	x	x	x	x	1.06	1.204	1.053	x	1.058	1.056	x	x	x	x	x	x	x	1.185	x	x	x	x	x	x	x	x	x	1.057	1.316	x	x	x	x	x	1.181	1.108	x	x	x	1.149	x	1.067	x	x	x	x	x	x	x	x	x	x	1.316	1.065	x	x	1.141	x	x	x	x	x	1.15	x	x	x	x	x	x	x	
-15062	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, males	Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.233	1.309	1.288	1.175	1.175	x	1.175	1.416	x	1.599	x	x	1.546	1.242	1.599	x	x	x	x	x	x	1.323	x	x	1.43	x	x	x	1.416	1.259	1.252	x	x	x	x	1.223	1.599	1.19	x	1.236	1.263	x	x	x	x	x	x	x	1.45	x	x	x	x	x	x	x	x	x	1.188	1.599	x	x	x	x	x	1.385	1.341	x	x	x	1.273	x	1.175	x	x	x	x	x	x	x	x	x	x	1.555	1.188	x	x	1.287	x	x	x	x	x	1.355	x	x	x	x	x	x	x	
-15063	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, males	Morphology, metabolism: Adipose tissue hanging at the intestine in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.296	1.275	1.258	1.208	1.247	x	1.231	1.379	x	1.527	x	x	1.585	1.214	1.585	x	x	x	x	x	x	1.286	x	x	1.49	x	x	x	1.462	1.292	1.208	x	x	x	x	1.274	1.585	1.222	x	1.288	1.208	x	x	x	x	x	x	x	1.535	x	x	x	x	x	x	x	x	x	1.236	1.479	x	x	x	x	x	1.482	1.457	x	x	x	1.382	x	1.236	x	x	x	x	x	x	x	x	x	x	1.585	1.208	x	x	1.478	x	x	x	x	x	1.436	x	x	x	x	x	x	x	
-15064	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, males	Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.309	1.437	1.424	1.255	1.382	x	1.333	1.44	x	1.791	x	x	1.781	1.293	1.791	x	x	x	x	x	x	1.487	x	x	1.63	x	x	x	1.631	1.317	1.255	x	x	x	x	1.359	1.791	1.367	x	1.565	1.314	x	x	x	x	x	x	x	1.401	x	x	x	x	x	x	x	x	x	1.255	1.67	x	x	x	x	x	1.683	1.535	x	x	x	1.339	x	1.346	x	x	x	x	x	x	x	x	x	x	1.791	1.255	x	x	1.599	x	x	x	x	x	1.464	x	x	x	x	x	x	x	
-15065	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, males	Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.197	1.344	1.34	1.16	1.225	x	1.19	1.368	x	1.311	x	x	1.392	1.335	1.41	x	x	x	x	x	x	1.402	x	x	1.507	x	x	x	1.507	1.249	1.16	x	x	x	x	1.228	1.337	1.303	x	1.485	1.31	x	x	x	x	x	x	x	1.187	x	x	x	x	x	x	x	x	x	1.16	1.507	x	x	x	x	x	1.366	1.398	x	x	x	1.215	x	1.264	x	x	x	x	x	x	x	x	x	x	1.421	1.16	x	x	1.507	x	x	x	x	x	1.299	x	x	x	x	x	x	x	
-15066	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, males	Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.926	2.173	2.103	1.749	2.008	x	1.908	2.242	x	2.753	x	x	2.729	1.903	2.753	x	x	x	x	x	x	2.182	x	x	2.609	x	x	x	2.534	1.945	1.749	x	x	x	x	1.99	2.753	2.106	x	2.475	1.86	x	x	x	x	x	x	x	2.132	x	x	x	x	x	x	x	x	x	1.749	2.699	x	x	x	x	x	2.458	2.375	x	x	x	1.963	x	2.066	x	x	x	x	x	x	x	x	x	x	2.753	1.749	x	x	2.663	x	x	x	x	x	2.22	x	x	x	x	x	x	x	
-15067	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, males	Morphology, metabolism: White adipose weight, total of whole body, at 20 weeks in males on a high fat diet (45% energy from fat) initiated at 4 weeks [g]	x	2.073	2.428	2.267	1.716	1.927	x	1.738	2.706	x	3.293	x	x	3.194	1.941	3.293	x	x	x	x	x	x	2.437	x	x	3.005	x	x	x	2.97	2.17	1.716	x	x	x	x	2.165	3.293	2.238	x	2.608	2.036	x	x	x	x	x	x	x	2.702	x	x	x	x	x	x	x	x	x	1.716	3.293	x	x	x	x	x	2.828	2.784	x	x	x	2.128	x	2.195	x	x	x	x	x	x	x	x	x	x	3.287	1.716	x	x	3.044	x	x	x	x	x	2.539	x	x	x	x	x	x	x	
-15068	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, males	Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.149	1.143	1.154	1.106	1.183	x	1.138	1.312	x	1.313	x	x	1.384	1.106	1.384	x	x	x	x	x	x	1.158	x	x	1.212	x	x	x	1.233	1.198	1.106	x	x	x	x	1.117	1.384	1.158	x	1.193	1.197	x	x	x	x	x	x	x	1.197	x	x	x	x	x	x	x	x	x	1.132	1.298	x	x	x	x	x	1.181	1.218	x	x	x	1.169	x	1.143	x	x	x	x	x	x	x	x	x	x	1.384	1.106	x	x	1.195	x	x	x	x	x	1.25	x	x	x	x	x	x	x	
-15069	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, males	Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.338	3.506	3.106	3.092	3.337	x	3.425	3.284	x	3.311	x	x	3.517	3.396	3.44	x	x	x	x	x	x	3.091	x	x	3.394	x	x	x	3.36	3.172	3.261	x	x	x	x	3.488	3.517	3.091	x	3.498	3.281	x	x	x	x	x	x	x	3.344	x	x	x	x	x	x	x	x	x	3.091	3.517	x	x	x	x	x	3.343	3.248	x	x	x	3.273	x	3.32	x	x	x	x	x	x	x	x	x	x	3.507	3.091	x	x	3.374	x	x	x	x	x	3.517	x	x	x	x	x	x	x	
-15070	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Resistin, males	Morphology, metabolism: Serum level of resistin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	2725.88	2423.4	1868.42	2485.18	2610.99	x	1880.06	2113.04	x	3703.85	x	x	2630.38	2258.24	3448.68	x	x	x	x	x	x	2823.34	x	x	3194.58	x	x	x	3137.04	1568.2	3703.85	x	x	x	x	2136.98	3135.45	3185.19	x	2544.43	2417.36	x	x	x	x	x	x	x	2576.26	x	x	x	x	x	x	x	x	x	1568.2	2139.48	x	x	x	x	x	3703.85	1982.69	x	x	x	2102.79	x	1568.2	x	x	x	x	x	x	x	x	x	x	3703.85	1568.2	x	x	2273.27	x	x	x	x	x	2622.8	x	x	x	x	x	x	x	
-15071	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Insulin, males	Morphology, metabolism: Serum level of insulin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	1678.25	1013.47	1254.75	1013.47	2317.6	x	1959.96	2383.44	x	2393.53	x	x	3977.62	2219.9	3067.39	x	x	x	x	x	x	2120.35	x	x	4213.13	x	x	x	1313.71	1574.32	2027.41	x	x	x	x	1831.03	4213.13	1509.44	x	1599.43	1820.81	x	x	x	x	x	x	x	1335.32	x	x	x	x	x	x	x	x	x	1396.92	3305.29	x	x	x	x	x	1425.11	4213.13	x	x	x	1726.51	x	1013.47	x	x	x	x	x	x	x	x	x	x	4213.13	1013.47	x	x	1898.41	x	x	x	x	x	1980.55	x	x	x	x	x	x	x	
-15072	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Leptin, males	Morphology, metabolism: Serum level of leptin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	4894.75	13548.2	5880.08	3538.04	7614.48	x	3538.04	7985.99	x	15455.4	x	x	11927.5	3902.77	16119.4	x	x	x	x	x	x	8604.11	x	x	16119.4	x	x	x	14856.0	4234.93	4388.05	x	x	x	x	3538.04	16119.4	6311.42	x	7823.96	5657.44	x	x	x	x	x	x	x	6314.4	x	x	x	x	x	x	x	x	x	9088.7	14889.8	x	x	x	x	x	14755.1	16119.4	x	x	x	5336.81	x	8059.42	x	x	x	x	x	x	x	x	x	x	13773.7	3538.04	x	x	9077.01	x	x	x	x	x	6597.1	x	x	x	x	x	x	x	
-15073	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL1B, males	Morphology, metabolism: Serum level of Interleukin 1 beta at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	2.84	67.233	4.924	1.982	18.758	x	22.695	1.982	x	33.24	x	x	1.982	8.293	23.486	x	x	x	x	x	x	6.254	x	x	67.233	x	x	x	1.982	12.946	9.896	x	x	x	x	4.165	2.72	12.368	x	6.58	24.032	x	x	x	x	x	x	x	12.736	x	x	x	x	x	x	x	x	x	67.233	7.362	x	x	x	x	x	67.233	4.618	x	x	x	6.17	x	62.332	x	x	x	x	x	x	x	x	x	x	2.765	9.436	x	x	8.872	x	x	x	x	x	5.626	x	x	x	x	x	x	x	
-15074	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL6, males	Morphology, metabolism: Serum level of Interleukin 6 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	1.7	1.7	5.814	1.754	5.232	x	2.92	4.414	x	3.39	x	x	1.7	1.7	2.706	x	x	x	x	x	x	1.7	x	x	1.7	x	x	x	1.7	3.758	4.88	x	x	x	x	1.7	15.692	1.7	x	1.7	15.692	x	x	x	x	x	x	x	1.7	x	x	x	x	x	x	x	x	x	15.692	3.595	x	x	x	x	x	1.7	1.7	x	x	x	6.548	x	15.692	x	x	x	x	x	x	x	x	x	x	4.27	1.7	x	x	4.272	x	x	x	x	x	1.7	x	x	x	x	x	x	x	
-15075	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL10, males	Morphology, metabolism: Serum level of Interleukin 10 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	2.7	21.472	3.158	2.7	16.625	x	9.682	3.064	x	21.472	x	x	2.7	2.7	3.284	x	x	x	x	x	x	2.7	x	x	4.303	x	x	x	3.178	5.144	2.7	x	x	x	x	3.315	10.056	3.572	x	3.826	10.298	x	x	x	x	x	x	x	2.946	x	x	x	x	x	x	x	x	x	21.472	7.163	x	x	x	x	x	2.7	3.562	x	x	x	3.074	x	21.472	x	x	x	x	x	x	x	x	x	x	2.7	3.058	x	x	2.7	x	x	x	x	x	8.938	x	x	x	x	x	x	x	
-15076	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL17, males	Morphology, metabolism: Serum level of Interleukin 17 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	0.4	15.165	2.192	1.51	4.708	x	0.4	4.386	x	3.66	x	x	0.4	0.4	0.4	x	x	x	x	x	x	0.4	x	x	4.362	x	x	x	9.214	1.244	0.4	x	x	x	x	2.805	1.486	0.4	x	15.165	7.327	x	x	x	x	x	x	x	7.394	x	x	x	x	x	x	x	x	x	15.165	5.425	x	x	x	x	x	1.167	6.534	x	x	x	9.592	x	15.165	x	x	x	x	x	x	x	x	x	x	0.4	2.464	x	x	8.208	x	x	x	x	x	5.294	x	x	x	x	x	x	x	
-15077	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_MCP1, males	Morphology, metabolism: Serum level of monocyte chemoattractant protein 1 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	9.723	69.007	9.723	12.136	61.678	x	34.855	9.723	x	69.007	x	x	24.162	23.988	38.392	x	x	x	x	x	x	11.37	x	x	69.007	x	x	x	36.952	17.048	30.512	x	x	x	x	54.31	64.074	13.0	x	23.546	49.797	x	x	x	x	x	x	x	55.838	x	x	x	x	x	x	x	x	x	69.007	22.64	x	x	x	x	x	23.315	19.754	x	x	x	62.882	x	46.268	x	x	x	x	x	x	x	x	x	x	9.723	43.748	x	x	37.116	x	x	x	x	x	51.056	x	x	x	x	x	x	x	
-15078	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_TNFa, males	Morphology, metabolism: Serum level of tumor necrosis factor alpha at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml]	x	0.9	6.392	2.898	1.842	1.475	x	4.407	1.736	x	6.392	x	x	0.9	0.9	2.69	x	x	x	x	x	x	1.518	x	x	3.882	x	x	x	3.552	4.11	0.9	x	x	x	x	4.075	5.3	0.9	x	2.93	3.69	x	x	x	x	x	x	x	4.35	x	x	x	x	x	x	x	x	x	6.392	2.0	x	x	x	x	x	2.215	2.11	x	x	x	5.478	x	6.392	x	x	x	x	x	x	x	x	x	x	0.9	4.546	x	x	3.592	x	x	x	x	x	4.468	x	x	x	x	x	x	x	
-15079	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, males	Morphology, metabolism: Fat weight around the neck at 20 weeks in males on a high fat diet (45% energy from fat, Ssniff(R) diet S8074-E010, Germany) initiated at 4 weeks [g]	x	1.091	1.127	1.105	1.085	1.088	x	1.1	1.215	x	1.239	x	x	1.227	1.093	1.187	x	x	x	x	x	x	1.121	x	x	1.239	x	x	x	1.239	1.09	1.085	x	x	x	x	1.1	1.177	1.136	x	1.192	1.097	x	x	x	x	x	x	x	1.128	x	x	x	x	x	x	x	x	x	1.085	1.207	x	x	x	x	x	1.134	1.195	x	x	x	1.121	x	1.114	x	x	x	x	x	x	x	x	x	x	1.231	1.085	x	x	1.239	x	x	x	x	x	1.146	x	x	x	x	x	x	x	
-15080	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, males	Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.041	1.027	1.041	1.027	1.027	x	1.039	1.058	x	1.067	x	x	1.092	1.027	1.102	x	x	x	x	x	x	1.027	x	x	1.029	x	x	x	1.102	1.048	1.033	x	x	x	x	1.04	1.102	1.053	x	1.027	1.062	x	x	x	x	x	x	x	1.073	x	x	x	x	x	x	x	x	x	1.059	1.087	x	x	x	x	x	1.102	1.081	x	x	x	1.045	x	1.055	x	x	x	x	x	x	x	x	x	x	1.07	1.031	x	x	1.084	x	x	x	x	x	1.057	x	x	x	x	x	x	x	
-15081	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, males	Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.329	1.323	1.372	1.274	1.409	x	1.287	1.526	x	1.904	x	x	1.904	1.301	1.884	x	x	x	x	x	x	1.411	x	x	1.569	x	x	x	1.753	1.291	1.296	x	x	x	x	1.424	1.904	1.429	x	1.425	1.274	x	x	x	x	x	x	x	1.581	x	x	x	x	x	x	x	x	x	1.274	1.904	x	x	x	x	x	1.731	1.585	x	x	x	1.386	x	1.495	x	x	x	x	x	x	x	x	x	x	1.775	1.274	x	x	1.657	x	x	x	x	x	1.44	x	x	x	x	x	x	x	
-15082	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_UnsatF, males	Morphology, metabolism: Unsaturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	4.362	1.231	0.486	4.679	4.044	x	2.848	5.686	x	3.807	x	x	x	5.611	5.73	x	x	x	x	x	x	5.04	x	x	1.926	x	x	x	5.829	0.71	3.049	x	x	x	x	5.571	0.845	0.86	x	1.599	2.049	x	x	x	x	x	x	x	5.557	x	x	x	x	x	x	x	x	x	5.798	2.69	x	x	x	x	x	5.493	0.236	x	x	x	5.305	x	1.492	x	x	x	x	x	x	x	x	x	x	1.604	1.198	x	x	6.262	x	x	x	x	x	6.735	x	x	x	x	x	x	x	
-15083	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_SatF, males	Morphology, metabolism: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	197.621	51.471	22.001	214.716	170.7	x	117.907	247.761	x	159.489	x	x	x	251.299	254.804	x	x	x	x	x	x	219.035	x	x	80.805	x	x	x	278.074	31.409	133.131	x	x	x	x	244.641	35.758	36.398	x	65.636	89.993	x	x	x	x	x	x	x	268.285	x	x	x	x	x	x	x	x	x	250.695	116.944	x	x	x	x	x	245.671	10.801	x	x	x	235.027	x	62.718	x	x	x	x	x	x	x	x	x	x	66.254	53.899	x	x	278.587	x	x	x	x	x	295.375	x	x	x	x	x	x	x	
-15084	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_TotF, males	Morphology, metabolism: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	675.789	178.696	77.739	726.826	586.846	x	405.022	848.798	x	561.865	x	x	x	874.999	883.9	x	x	x	x	x	x	756.547	x	x	272.278	x	x	x	954.17	109.445	461.076	x	x	x	x	849.712	124.605	126.146	x	224.75	308.771	x	x	x	x	x	x	x	923.461	x	x	x	x	x	x	x	x	x	873.463	400.136	x	x	x	x	x	848.967	38.493	x	x	x	795.886	x	216.189	x	x	x	x	x	x	x	x	x	x	226.061	190.064	x	x	956.162	x	x	x	x	x	1019.08	x	x	x	x	x	x	x	
-15085	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_acylchainlength, males	Morphology, metabolism: Acyl chain length measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	21.615	20.665	19.669	21.677	21.372	x	20.915	21.464	x	20.645	x	x	x	21.439	21.54	x	x	x	x	x	x	21.359	x	x	21.033	x	x	x	21.674	19.919	20.987	x	x	x	x	21.373	20.24	20.693	x	20.223	20.772	x	x	x	x	x	x	x	21.841	x	x	x	x	x	x	x	x	x	21.498	20.976	x	x	x	x	x	21.67	19.418	x	x	x	21.405	x	20.484	x	x	x	x	x	x	x	x	x	x	20.828	20.555	x	x	21.648	x	x	x	x	x	21.528	x	x	x	x	x	x	x	
-15086	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_SatF.unsatF, males	Morphology, metabolism: Ratio of saturated to unsaturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	45.305	41.806	45.264	45.887	42.216	x	41.398	43.577	x	41.895	x	x	x	44.789	44.468	x	x	x	x	x	x	43.459	x	x	41.964	x	x	x	47.704	44.221	43.659	x	x	x	x	43.916	42.3	42.308	x	41.053	43.916	x	x	x	x	x	x	x	48.278	x	x	x	x	x	x	x	x	x	43.242	43.472	x	x	x	x	x	44.725	45.738	x	x	x	44.301	x	42.05	x	x	x	x	x	x	x	x	x	x	41.305	44.99	x	x	44.489	x	x	x	x	x	43.855	x	x	x	x	x	x	x	
-15087	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_lipid.prot, males	Morphology, metabolism: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	200.454	12.598	5.615	71.244	56.64	x	41.585	344.076	x	39.421	x	x	x	449.242	423.808	x	x	x	x	x	x	93.835	x	x	19.003	x	x	x	294.583	7.121	33.561	x	x	x	x	110.579	8.257	10.105	x	19.187	32.669	x	x	x	x	x	x	x	501.377	x	x	x	x	x	x	x	x	x	526.98	46.303	x	x	x	x	x	446.915	2.75	x	x	x	89.672	x	18.165	x	x	x	x	x	x	x	x	x	x	14.735	20.604	x	x	169.359	x	x	x	x	x	442.823	x	x	x	x	x	x	x	
-15088	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_Tot_lipid.Tot_prot, males	Morphology, metabolism: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) spectroscopy in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	264.241	37.798	17.987	154.153	130.753	x	102.647	317.003	x	99.082	x	x	x	387.808	348.275	x	x	x	x	x	x	183.612	x	x	54.369	x	x	x	315.125	22.33	87.43	x	x	x	x	200.54	25.405	30.836	x	54.536	86.368	x	x	x	x	x	x	x	416.191	x	x	x	x	x	x	x	x	x	425.689	111.518	x	x	x	x	x	380.042	9.164	x	x	x	177.461	x	52.208	x	x	x	x	x	x	x	x	x	x	43.407	58.577	x	x	253.013	x	x	x	x	x	373.354	x	x	x	x	x	x	x	
-15089	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_collagen, males	Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	1.277	0.345	0.174	1.345	1.076	x	0.799	1.597	x	1.028	x	x	x	1.528	1.563	x	x	x	x	x	x	1.358	x	x	0.532	x	x	x	1.682	0.237	0.872	x	x	x	x	1.544	0.255	0.249	x	0.449	0.579	x	x	x	x	x	x	x	1.634	x	x	x	x	x	x	x	x	x	1.541	0.797	x	x	x	x	x	1.513	0.094	x	x	x	1.462	x	0.414	x	x	x	x	x	x	x	x	x	x	0.438	0.362	x	x	1.688	x	x	x	x	x	1.833	x	x	x	x	x	x	x	
-15090	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_collagenintegrity, males	Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.806	12.488	19.586	2.297	2.967	x	3.741	0.475	x	4.298	x	x	x	0.259	0.41	x	x	x	x	x	x	1.823	x	x	8.209	x	x	x	0.587	19.466	4.839	x	x	x	x	1.535	18.002	15.213	x	7.985	4.968	x	x	x	x	x	x	x	0.143	x	x	x	x	x	x	x	x	x	0.121	3.308	x	x	x	x	x	0.265	19.913	x	x	x	1.858	x	8.79	x	x	x	x	x	x	x	x	x	x	10.695	7.75	x	x	1.027	x	x	x	x	x	0.278	x	x	x	x	x	x	x	
-15091	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_SatF, males	Metabolism, liver: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.986	1.254	0.946	1.205	0.951	x	0.927	0.898	x	0.911	x	x	1.056	x	1.088	x	x	x	x	x	x	0.873	x	x	1.568	x	x	x	1.023	0.811	0.898	x	x	x	x	0.771	1.395	1.209	x	1.29	0.913	x	x	x	x	x	x	x	1.428	x	x	x	x	x	x	x	x	x	1.397	0.965	x	x	x	x	x	0.943	1.716	x	x	x	0.903	x	1.374	x	x	x	x	x	x	x	x	x	x	1.622	0.981	x	x	1.32	x	x	x	x	x	1.32	x	x	x	x	x	x	x	
-15092	None	Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_TotF, males	Metabolism, liver: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	2.228	2.746	2.199	2.592	2.279	x	2.139	2.183	x	2.193	x	x	2.722	x	2.527	x	x	x	x	x	x	2.128	x	x	3.329	x	x	x	2.414	1.973	2.12	x	x	x	x	1.988	3.072	2.665	x	2.812	2.091	x	x	x	x	x	x	x	3.138	x	x	x	x	x	x	x	x	x	3.124	2.208	x	x	x	x	x	2.238	3.785	x	x	x	2.153	x	2.994	x	x	x	x	x	x	x	x	x	x	3.555	2.172	x	x	2.833	x	x	x	x	x	2.833	x	x	x	x	x	x	x	
-15093	None	Morphology, biochemistry: FTIR_liver_acylchainlength, males (contact Gudrun Brockmann at gudrun.brockmann@agrar.hu-berlin.de)	Morphology, biochemistry: Acyl chain length measured by Fourier transform infrared spectroscopy (FTIR) in liver at 140 days in males on a high fat diet (45% energy from far) feeding from 4 weeks [arbitrary unit]	x	7.701	11.015	9.621	12.957	10.758	x	9.844	10.524	x	9.765	x	x	13.578	x	11.586	x	x	x	x	x	x	9.344	x	x	13.716	x	x	x	10.592	9.661	9.1	x	x	x	x	9.077	13.646	12.202	x	10.328	9.012	x	x	x	x	x	x	x	13.759	x	x	x	x	x	x	x	x	x	12.996	9.264	x	x	x	x	x	9.472	14.752	x	x	x	9.165	x	11.762	x	x	x	x	x	x	x	x	x	x	14.581	9.306	x	x	10.325	x	x	x	x	x	10.325	x	x	x	x	x	x	x	
-15094	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_lipid.prot, males	Metabolism, liver: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	2.112	4.583	2.695	2.683	2.507	x	1.978	2.414	x	2.435	x	x	5.442	x	4.407	x	x	x	x	x	x	2.43	x	x	6.032	x	x	x	3.218	1.989	1.8	x	x	x	x	2.107	6.533	3.789	x	5.106	1.944	x	x	x	x	x	x	x	5.237	x	x	x	x	x	x	x	x	x	6.535	2.402	x	x	x	x	x	2.64	8.482	x	x	x	2.449	x	5.235	x	x	x	x	x	x	x	x	x	x	7.109	2.058	x	x	4.679	x	x	x	x	x	4.679	x	x	x	x	x	x	x	
-15095	None	Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_Tot_lipid.Tot_prot, males	Metabolism, liver: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [ratio]	x	0.329	0.428	0.351	0.379	0.358	x	0.344	0.347	x	0.346	x	x	0.448	x	0.423	x	x	x	x	x	x	0.323	x	x	0.51	x	x	x	0.366	0.318	0.335	x	x	x	x	0.291	0.516	0.415	x	0.446	0.339	x	x	x	x	x	x	x	0.487	x	x	x	x	x	x	x	x	x	0.506	0.357	x	x	x	x	x	0.333	0.592	x	x	x	0.34	x	0.463	x	x	x	x	x	x	x	x	x	x	0.551	0.339	x	x	0.452	x	x	x	x	x	0.452	x	x	x	x	x	x	x	
-15096	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagen, males	Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.849	0.899	0.689	0.844	1.108	x	0.737	0.886	x	0.983	x	x	0.977	x	1.17	x	x	x	x	x	x	1.064	x	x	0.722	x	x	x	0.731	0.606	1.124	x	x	x	x	1.195	0.863	0.856	x	0.841	0.81	x	x	x	x	x	x	x	0.972	x	x	x	x	x	x	x	x	x	0.927	0.908	x	x	x	x	x	1.181	0.954	x	x	x	0.768	x	0.824	x	x	x	x	x	x	x	x	x	x	1.204	0.857	x	x	0.872	x	x	x	x	x	0.872	x	x	x	x	x	x	x	
-15097	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagenintegrity, males	Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	796.691	712.683	906.2	809.549	573.395	x	842.167	707.849	x	642.127	x	x	619.983	x	509.584	x	x	x	x	x	x	617.29	x	x	901.257	x	x	x	900.579	1020.86	561.792	x	x	x	x	545.778	687.567	749.413	x	746.889	759.493	x	x	x	x	x	x	x	660.556	x	x	x	x	x	x	x	x	x	663.385	679.4	x	x	x	x	x	548.141	641.78	x	x	x	822.573	x	782.529	x	x	x	x	x	x	x	x	x	x	507.475	745.537	x	x	717.526	x	x	x	x	x	717.526	x	x	x	x	x	x	x	
-15098	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_glycogen, males	Morphology, metabolism: Glycogen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	1.491	2.134	1.916	1.885	2.355	x	2.219	2.215	x	2.798	x	x	2.867	x	2.581	x	x	x	x	x	x	2.071	x	x	2.033	x	x	x	1.524	1.885	2.126	x	x	x	x	1.248	2.249	2.37	x	1.828	2.262	x	x	x	x	x	x	x	2.732	x	x	x	x	x	x	x	x	x	2.271	2.649	x	x	x	x	x	1.819	2.464	x	x	x	2.246	x	1.6	x	x	x	x	x	x	x	x	x	x	2.709	2.355	x	x	2.19	x	x	x	x	x	2.19	x	x	x	x	x	x	x	
-15099	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_SatF, males	Morphology, metabolism: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	1.946	0.807	1.022	1.91	1.234	x	1.559	2.349	x	3.41	x	x	1.905	1.508	1.803	x	x	x	x	x	x	1.485	x	x	5.362	x	x	x	2.621	1.777	1.262	x	x	x	x	1.556	2.299	1.716	x	1.918	1.27	x	x	x	x	x	x	x	3.951	x	x	x	x	x	x	x	x	x	2.364	1.144	x	x	x	x	x	2.635	1.789	x	x	x	1.692	x	2.594	x	x	x	x	x	x	x	x	x	x	1.98	1.22	x	x	3.406	x	x	x	x	x	1.673	x	x	x	x	x	x	x	
-15100	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_TotF, males	Morphology, metabolism: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	3.12	1.483	1.796	2.965	1.988	x	2.581	3.768	x	5.572	x	x	3.157	2.372	2.911	x	x	x	x	x	x	2.38	x	x	8.543	x	x	x	4.279	2.992	2.06	x	x	x	x	2.57	3.643	2.911	x	3.042	2.124	x	x	x	x	x	x	x	6.262	x	x	x	x	x	x	x	x	x	3.843	1.894	x	x	x	x	x	4.186	2.882	x	x	x	2.744	x	4.105	x	x	x	x	x	x	x	x	x	x	3.159	1.974	x	x	5.441	x	x	x	x	x	2.663	x	x	x	x	x	x	x	
-15101	None	Morphology, metabolism: Acyl chain length measured by Fourier transform infrared spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	Morphology, metabolism: Acyl chain length measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	11.829	9.876	12.454	16.459	14.466	x	14.483	19.28	x	16.997	x	x	19.926	14.469	15.72	x	x	x	x	x	x	16.19	x	x	20.423	x	x	x	16.643	15.405	12.06	x	x	x	x	15.52	15.233	18.354	x	12.012	11.435	x	x	x	x	x	x	x	19.554	x	x	x	x	x	x	x	x	x	17.529	11.707	x	x	x	x	x	17.429	14.838	x	x	x	13.273	x	16.362	x	x	x	x	x	x	x	x	x	x	15.657	11.092	x	x	20.33	x	x	x	x	x	11.643	x	x	x	x	x	x	x	
-15102	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_lipid.prot, males	Morphology, metabolism: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.091	0.058	0.065	0.076	0.055	x	0.09	0.115	x	0.194	x	x	0.105	0.061	0.088	x	x	x	x	x	x	0.064	x	x	0.292	x	x	x	0.16	0.114	0.056	x	x	x	x	0.081	0.107	0.103	x	0.091	0.075	x	x	x	x	x	x	x	0.206	x	x	x	x	x	x	x	x	x	0.128	0.065	x	x	x	x	x	0.129	0.105	x	x	x	0.088	x	0.126	x	x	x	x	x	x	x	x	x	x	0.089	0.052	x	x	0.169	x	x	x	x	x	0.08	x	x	x	x	x	x	x	
-15103	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_Tot_lipid.Tot_prot, males	Morphology, metabolism: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.451	0.249	0.301	0.398	0.296	x	0.41	0.525	x	0.788	x	x	0.451	0.315	0.408	x	x	x	x	x	x	0.318	x	x	1.193	x	x	x	0.672	0.492	0.286	x	x	x	x	0.373	0.501	0.441	x	0.445	0.352	x	x	x	x	x	x	x	0.883	x	x	x	x	x	x	x	x	x	0.544	0.33	x	x	x	x	x	0.57	0.486	x	x	x	0.426	x	0.589	x	x	x	x	x	x	x	x	x	x	0.427	0.276	x	x	0.733	x	x	x	x	x	0.406	x	x	x	x	x	x	x	
-15104	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagen, males	Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	9.794	7.436	7.637	6.02	4.594	x	6.113	7.21	x	6.734	x	x	3.652	2.779	5.329	x	x	x	x	x	x	4.2	x	x	8.987	x	x	x	7.602	8.404	4.114	x	x	x	x	5.393	4.456	7.783	x	5.658	5.788	x	x	x	x	x	x	x	8.114	x	x	x	x	x	x	x	x	x	5.999	5.55	x	x	x	x	x	4.69	6.337	x	x	x	7.219	x	6.349	x	x	x	x	x	x	x	x	x	x	5.537	5.033	x	x	8.831	x	x	x	x	x	6.013	x	x	x	x	x	x	x	
-15105	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagenintegrity, males	Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	69.572	78.909	77.102	122.609	145.155	x	101.81	98.538	x	103.946	x	x	190.453	204.086	132.905	x	x	x	x	x	x	177.059	x	x	78.557	x	x	x	82.741	71.358	173.799	x	x	x	x	126.647	161.944	83.794	x	119.626	103.332	x	x	x	x	x	x	x	86.335	x	x	x	x	x	x	x	x	x	116.751	102.465	x	x	x	x	x	155.444	92.477	x	x	x	88.11	x	108.664	x	x	x	x	x	x	x	x	x	x	132.407	140.767	x	x	82.924	x	x	x	x	x	108.001	x	x	x	x	x	x	x	
-15106	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_glycogen, males	Morphology, metabolism: Glycogen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]	x	0.622	0.71	0.728	1.375	1.475	x	0.816	1.583	x	1.148	x	x	2.674	1.694	1.561	x	x	x	x	x	x	1.797	x	x	1.226	x	x	x	0.718	0.7	1.23	x	x	x	x	1.699	1.174	0.678	x	0.778	0.7	x	x	x	x	x	x	x	1.547	x	x	x	x	x	x	x	x	x	1.661	0.684	x	x	x	x	x	1.559	0.794	x	x	x	0.727	x	1.11	x	x	x	x	x	x	x	x	x	x	1.188	0.792	x	x	1.507	x	x	x	x	x	0.811	x	x	x	x	x	x	x	
-15107	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+, frequency of CD45+	Immune function: CD45 cells as a percentage of CD3 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	24.0	21.5333	24.775	24.3	11.566	x	x	21.625	x	33.0545	x	15.6075	10.7267	28.6375	25.7125	x	x	x	23.8667	x	x	x	21.4333	x	x	x	x	x	16.9833	22.5667	27.2	x	x	x	x	x	25.1444	20.875	x	32.6	19.425	x	x	x	x	x	x	x	33.0	x	x	x	12.8889	x	x	x	x	x	24.025	44.025	x	x	x	x	x	x	19.55	x	x	x	23.15	x	21.025	x	x	x	x	x	x	x	x	x	x	10.99	21.85	x	x	15.0333	x	x	x	x	x	13.96	x	x	x	x	x	x	x	
-15108	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ CD4+, frequency of CD45+	Immune system: CD45-positive cells as a percentage of CD3 CD4-positive cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	13.3	11.2867	18.15	16.8625	8.536	x	x	9.52	x	18.9545	x	12.4	8.17833	17.7875	13.8875	x	x	x	17.7667	x	x	x	11.975	x	x	x	x	x	8.75	14.1	16.7333	x	x	x	x	x	16.1667	12.3575	x	22.86	13.525	x	x	x	x	x	x	x	23.2	x	x	x	8.63556	x	x	x	x	x	16.8875	22.85	x	x	x	x	x	x	11.5533	x	x	x	15.0	x	12.15	x	x	x	x	x	x	x	x	x	x	6.1425	15.0	x	x	8.89	x	x	x	x	x	8.68	x	x	x	x	x	x	x	
-15109	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ CD8a+, frequency of CD45+	Immune function: CD45 cells as a percentage of CD3 CD8a cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	10.4	9.53	8.1525	7.785	5.29	x	x	11.265	x	14.3182	x	6.3975	2.975	10.5375	12.255	x	x	x	8.34	x	x	x	9.395	x	x	x	x	x	8.68667	9.21	10.0467	x	x	x	x	x	9.78	8.05125	x	11.698	5.035	x	x	x	x	x	x	x	9.35	x	x	x	5.70778	x	x	x	x	x	7.31	19.075	x	x	x	x	x	x	7.80667	x	x	x	7.9975	x	7.235	x	x	x	x	x	x	x	x	x	x	4.77	7.06167	x	x	6.60333	x	x	x	x	x	5.504	x	x	x	x	x	x	x	
-15110	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD25+, frequency of CD4+CD3+	Immune function: CD4 CD3 cells as a percentage of CD25 cell in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	5.31	5.81667	6.1575	2.98875	8.886	x	x	3.9425	x	3.08818	x	8.2325	5.29833	3.76875	4.7575	x	x	x	6.21	x	x	x	5.345	x	x	x	x	x	6.39167	9.63	2.75	x	x	x	x	x	4.10444	3.0175	x	3.138	4.0825	x	x	x	x	x	x	x	3.11	x	x	x	5.63	x	x	x	x	x	5.30875	6.2775	x	x	x	x	x	x	8.625	x	x	x	3.6525	x	4.5925	x	x	x	x	x	x	x	x	x	x	7.3625	8.38667	x	x	6.73	x	x	x	x	x	8.112	x	x	x	x	x	x	x	
-15111	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ gammadelta TCR+, frequency of CD45+	Immune function: CD45 cells as a percentage of CD3gammadelta TCR cells peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	0.711	0.559333	0.67225	0.494	0.5372	x	x	1.3225	x	0.549182	x	0.754	0.712167	0.80975	0.824375	x	x	x	0.402	x	x	x	0.988167	x	x	x	x	x	0.656	0.921333	0.595	x	x	x	x	x	0.728889	0.685625	x	0.9504	0.75525	x	x	x	x	x	x	x	1.23	x	x	x	0.451444	x	x	x	x	x	1.27625	1.86	x	x	x	x	x	x	0.437333	x	x	x	0.64975	x	1.675	x	x	x	x	x	x	x	x	x	x	0.57875	0.668167	x	x	0.697	x	x	x	x	x	0.4862	x	x	x	x	x	x	x	
-15112	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), Ly6C+, frequency of CD4+CD3+	Immune system: CD4 CD3 cells as a percentage of Ly6C cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	16.0	27.3667	22.6	32.9625	7.028	x	x	11.75	x	2.95909	x	14.2875	13.6667	14.125	9.51125	x	x	x	7.29	x	x	x	10.32	x	x	x	x	x	11.55	26.1	5.04	x	x	x	x	x	19.2889	21.4125	x	21.48	8.9375	x	x	x	x	x	x	x	11.6	x	x	x	21.5333	x	x	x	x	x	28.7	32.675	x	x	x	x	x	x	20.0833	x	x	x	6.1775	x	28.125	x	x	x	x	x	x	x	x	x	x	12.325	25.2833	x	x	18.5667	x	x	x	x	x	13.06	x	x	x	x	x	x	x	
-15113	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD62L+, frequency of CD4+CD3+	Immune function: CD4 CD3 cells as a percentage of CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	64.4	58.8667	42.675	75.05	36.98	x	x	32.1	x	60.8727	x	26.3	45.95	70.7125	57.3	x	x	x	38.7	x	x	x	27.3333	x	x	x	x	x	61.4333	33.0	45.5333	x	x	x	x	x	61.0778	74.9875	x	54.24	44.175	x	x	x	x	x	x	x	61.9	x	x	x	31.9222	x	x	x	x	x	43.8625	64.3	x	x	x	x	x	x	44.1	x	x	x	48.9	x	49.475	x	x	x	x	x	x	x	x	x	x	16.6	56.15	x	x	53.3333	x	x	x	x	x	40.94	x	x	x	x	x	x	x	
-15114	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+, frequency of CD4+CD3+	Immune function: CD4 CD3 cells as a percentage of CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	78.0	79.4333	68.525	66.9375	80.22	x	x	81.925	x	79.4273	x	83.525	78.3167	65.25	79.95	x	x	x	74.2	x	x	x	78.65	x	x	x	x	x	75.3167	79.3	67.7667	x	x	x	x	x	66.2556	84.2875	x	75.24	60.775	x	x	x	x	x	x	x	58.6	x	x	x	86.5889	x	x	x	x	x	79.475	68.35	x	x	x	x	x	x	73.45	x	x	x	72.25	x	65.4	x	x	x	x	x	x	x	x	x	x	75.8	81.8	x	x	79.0	x	x	x	x	x	65.44	x	x	x	x	x	x	x	
-15115	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+CD62L-, frequency of CD4+CD3+	Immune function: CD4 CD3 cells as a percentage of CD44 cells without CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	28.6	33.4	41.3	18.5125	51.5	x	x	56.3	x	31.4545	x	60.825	44.4167	20.2375	35.4125	x	x	x	46.7	x	x	x	57.2333	x	x	x	x	x	31.35	53.3	38.5333	x	x	x	x	x	27.9778	21.825	x	34.8	35.85	x	x	x	x	x	x	x	24.6	x	x	x	58.5	x	x	x	x	x	44.975	26.15	x	x	x	x	x	x	42.75	x	x	x	39.3	x	34.7	x	x	x	x	x	x	x	x	x	x	62.65	36.7833	x	x	38.8333	x	x	x	x	x	39.84	x	x	x	x	x	x	x	
-15116	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44-CD62L+, frequency of CD4+CD3+	Immune function: CD4 CD3 cells as a percentage of CD62L cells without CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	15.4	13.4633	16.1	27.3375	8.444	x	x	6.575	x	12.91	x	3.7775	12.3217	25.7	12.9062	x	x	x	11.4733	x	x	x	5.94	x	x	x	x	x	17.85	7.53667	16.3667	x	x	x	x	x	23.2889	12.9625	x	14.076	19.325	x	x	x	x	x	x	x	28.2	x	x	x	4.17111	x	x	x	x	x	9.87375	23.0	x	x	x	x	x	x	13.8817	x	x	x	15.9	x	19.54	x	x	x	x	x	x	x	x	x	x	3.66	11.62	x	x	13.6033	x	x	x	x	x	15.94	x	x	x	x	x	x	x	
-15117	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), Ly6C+, frequency of CD8+CD3+	Immune function: CD8 CD3 cells as a percentage of Ly6C cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	28.0	34.3	48.025	39.1625	64.26	x	x	36.35	x	10.4955	x	46.375	49.5667	34.0625	28.425	x	x	x	49.1333	x	x	x	44.2	x	x	x	x	x	38.5	54.3333	20.8667	x	x	x	x	x	41.3333	36.6125	x	25.34	40.0	x	x	x	x	x	x	x	29.0	x	x	x	59.4222	x	x	x	x	x	25.55	43.65	x	x	x	x	x	x	47.3667	x	x	x	37.925	x	21.65	x	x	x	x	x	x	x	x	x	x	64.725	26.1833	x	x	40.7333	x	x	x	x	x	52.58	x	x	x	x	x	x	x	
-15118	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD62L+, frequency of CD8+CD3+	Immune function: CD8 CD3 cells as a percentage of CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	83.1	74.5667	71.55	88.7875	73.18	x	x	57.075	x	75.9273	x	61.825	72.6	89.0125	79.15	x	x	x	65.0333	x	x	x	42.0833	x	x	x	x	x	73.65	69.4	62.1	x	x	x	x	x	76.0556	87.8375	x	79.34	68.2	x	x	x	x	x	x	x	84.0	x	x	x	61.9	x	x	x	x	x	68.6375	76.55	x	x	x	x	x	x	69.75	x	x	x	74.85	x	70.0	x	x	x	x	x	x	x	x	x	x	56.5	79.45	x	x	84.9333	x	x	x	x	x	75.72	x	x	x	x	x	x	x	
-15119	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+, frequency of CD8+CD3+	Immune function: CD8 CD3 cells as a percentage of CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	67.8	65.1667	59.1	61.675	79.32	x	x	73.6	x	64.5545	x	68.925	74.1333	57.95	70.2375	x	x	x	65.8	x	x	x	58.4833	x	x	x	x	x	64.0333	69.0333	54.7333	x	x	x	x	x	61.0333	68.6125	x	61.4	58.5	x	x	x	x	x	x	x	53.4	x	x	x	72.1222	x	x	x	x	x	64.9125	59.675	x	x	x	x	x	x	68.7	x	x	x	62.775	x	58.8	x	x	x	x	x	x	x	x	x	x	70.175	67.2167	x	x	70.9	x	x	x	x	x	76.56	x	x	x	x	x	x	x	
-15120	None	Immune function: CD8+ CD3+ T cel lymphocytes as a percentage of CD44+ Ly6C+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	Immune function: CD8+ CD3+ T cel lymphocytes as a percentage of CD44+ Ly6C+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	21.2	25.5667	29.2	25.9875	52.36	x	x	32.3	x	8.11727	x	32.8	41.7333	24.65	21.5	x	x	x	36.4333	x	x	x	30.0833	x	x	x	x	x	28.9	39.2333	13.8667	x	x	x	x	x	28.5889	27.9375	x	18.56	28.7	x	x	x	x	x	x	x	18.7	x	x	x	42.6556	x	x	x	x	x	17.7875	28.075	x	x	x	x	x	x	34.8167	x	x	x	26.375	x	17.1	x	x	x	x	x	x	x	x	x	x	49.475	17.21	x	x	33.2667	x	x	x	x	x	39.8	x	x	x	x	x	x	x	
-15121	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+62L-, frequency of CD8+CD3+	Immune function: CD8 CD3 cells as a percentage of CD44 cells excluding CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	11.0	16.5967	16.65	6.61375	22.14	x	x	28.875	x	14.6145	x	24.125	19.7333	6.675	13.4838	x	x	x	21.88	x	x	x	31.0167	x	x	x	x	x	16.7833	19.9667	20.4533	x	x	x	x	x	14.3011	8.7375	x	12.604	18.875	x	x	x	x	x	x	x	11.5	x	x	x	25.6333	x	x	x	x	x	21.225	15.4025	x	x	x	x	x	x	20.005	x	x	x	15.4	x	17.59	x	x	x	x	x	x	x	x	x	x	26.725	13.6633	x	x	10.88	x	x	x	x	x	17.44	x	x	x	x	x	x	x	
-15122	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44-62L+, frequency of CD8+CD3+	Immune function: CD8 CD3 cells as a percentage of CD62L cells excluding CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	26.0	25.7667	28.8	33.475	15.84	x	x	12.1875	x	25.6364	x	16.9	18.25	37.475	22.175	x	x	x	20.9	x	x	x	14.6217	x	x	x	x	x	26.05	20.0667	27.7	x	x	x	x	x	29.1556	27.625	x	30.08	28.5	x	x	x	x	x	x	x	41.6	x	x	x	15.4	x	x	x	x	x	24.725	32.25	x	x	x	x	x	x	20.95	x	x	x	27.3	x	28.75	x	x	x	x	x	x	x	x	x	x	13.0475	25.7167	x	x	24.7	x	x	x	x	x	16.64	x	x	x	x	x	x	x	
-15123	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), GR-1++ CD11b+, frequency of CD45+	Immune function: CD45 cells as a percentage of GR-1 CD11b cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	8.54	9.51	26.35	7.0825	24.34	x	x	14.825	x	15.2836	x	23.125	22.0833	13.575	18.4375	x	x	x	24.4667	x	x	x	15.1	x	x	x	x	x	16.6267	16.5667	13.3667	x	x	x	x	x	15.9656	11.0312	x	18.34	10.21	x	x	x	x	x	x	x	14.7	x	x	x	13.7344	x	x	x	x	x	14.6	19.3	x	x	x	x	x	x	11.7117	x	x	x	13.625	x	13.525	x	x	x	x	x	x	x	x	x	x	14.0025	14.145	x	x	14.3	x	x	x	x	x	16.23	x	x	x	x	x	x	x	
-15124	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD11b+, not Gr-1++, not NKp46+, frequency of CD45+	Immune function: CD45 cells as a percentage of CD11b cells, not Gr-1, not Nkp46, in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	1.91	1.94333	3.055	1.58125	6.934	x	x	2.355	x	3.22727	x	3.585	2.53167	1.85125	2.98625	x	x	x	2.21333	x	x	x	3.94167	x	x	x	x	x	4.155	2.15333	3.76333	x	x	x	x	x	3.13556	3.5325	x	2.468	1.8075	x	x	x	x	x	x	x	4.08	x	x	x	2.39667	x	x	x	x	x	3.1525	3.435	x	x	x	x	x	x	1.78	x	x	x	2.1825	x	2.565	x	x	x	x	x	x	x	x	x	x	2.1875	2.20333	x	x	2.02667	x	x	x	x	x	3.31	x	x	x	x	x	x	x	
-15125	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD5-NKp46+cells, frequency of CD45+	Immune function: CD45 cells as a percentage of Nkp46 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	4.09	4.46	7.64	5.9125	6.478	x	x	4.955	x	4.39545	x	13.875	7.31167	6.64125	4.24	x	x	x	3.66333	x	x	x	1.92	x	x	x	x	x	6.88667	7.5	5.54	x	x	x	x	x	7.11778	4.225	x	4.686	3.1625	x	x	x	x	x	x	x	8.1	x	x	x	3.32556	x	x	x	x	x	9.3375	4.885	x	x	x	x	x	x	6.51	x	x	x	3.8775	x	4.1825	x	x	x	x	x	x	x	x	x	x	4.8525	5.54167	x	x	4.04333	x	x	x	x	x	4.572	x	x	x	x	x	x	x	
-15126	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), B (=CD19+OR(B220+AND IgD+), frequency of CD45+	Immune function: CD45 cells as a percentage of B cells (CD19 or B220 and IgD) in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	54.7	56.7333	27.125	54.6875	35.48	x	x	43.775	x	31.8091	x	26.225	48.7833	33.8875	36.3625	x	x	x	31.7667	x	x	x	48.1833	x	x	x	x	x	41.8	45.8333	42.8	x	x	x	x	x	36.3	54.7	x	26.16	57.65	x	x	x	x	x	x	x	30.8	x	x	x	54.6889	x	x	x	x	x	35.0	21.25	x	x	x	x	x	x	51.3167	x	x	x	44.325	x	46.15	x	x	x	x	x	x	x	x	x	x	60.35	43.7667	x	x	59.5667	x	x	x	x	x	51.24	x	x	x	x	x	x	x	
-15127	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD5+, frequency of B cells	Immune system: B cells as a percentage of CD5 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	2.59	1.88667	4.675	3.1725	3.696	x	x	2.37	x	3.22182	x	4.5775	2.79833	2.4375	3.155	x	x	x	3.09667	x	x	x	2.47333	x	x	x	x	x	3.03167	4.68667	2.89667	x	x	x	x	x	4.31667	4.13375	x	6.762	1.7925	x	x	x	x	x	x	x	5.34	x	x	x	2.77778	x	x	x	x	x	4.17875	4.33	x	x	x	x	x	x	2.36	x	x	x	2.445	x	2.0575	x	x	x	x	x	x	x	x	x	x	1.21275	3.7	x	x	1.72	x	x	x	x	x	1.608	x	x	x	x	x	x	x	
-15128	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), IgD+, frequency of B cells	Immune function: B cells as a percentage of IgD cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	94.0	90.6	89.75	90.35	91.74	x	x	94.175	x	88.6	x	89.475	85.4667	89.025	88.25	x	x	x	95.0333	x	x	x	95.5167	x	x	x	x	x	90.2	93.1	94.6333	x	x	x	x	x	90.0444	90.5	x	88.4	91.0	x	x	x	x	x	x	x	93.4	x	x	x	90.3111	x	x	x	x	x	92.875	86.1	x	x	x	x	x	x	90.0333	x	x	x	93.15	x	86.975	x	x	x	x	x	x	x	x	x	x	92.875	92.4	x	x	91.5	x	x	x	x	x	84.54	x	x	x	x	x	x	x	
-15129	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), MHC class II (I/A-E)+, frequency Of B cells	Immune function: B cells as a percentage of MHC class II (I/A-E) cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	63.6	72.1	82.65	62.7	79.82	x	x	72.75	x	76.3	x	67.225	61.8667	79.675	73.25	x	x	x	61.2	x	x	x	71.5333	x	x	x	x	x	75.55	75.1667	62.0333	x	x	x	x	x	71.4778	72.0625	x	75.6	72.75	x	x	x	x	x	x	x	75.3	x	x	x	68.5222	x	x	x	x	x	74.225	81.25	x	x	x	x	x	x	64.7333	x	x	x	79.625	x	69.125	x	x	x	x	x	x	x	x	x	x	79.375	75.4167	x	x	76.4	x	x	x	x	x	70.86	x	x	x	x	x	x	x	
-15130	None	Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD11b+, frequency of NKp46+ CD5-cell	Immune system, hematology: NKp46 as a percentage of CD11b cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]	x	59.4	77.7667	61.8	70.675	63.76	x	x	57.55	x	53.7	x	81.55	53.8333	47.7125	61.2875	x	x	x	81.4667	x	x	x	57.5667	x	x	x	x	x	68.8	63.5333	63.3667	x	x	x	x	x	69.9556	54.325	x	54.92	71.2	x	x	x	x	x	x	x	71.3	x	x	x	74.5667	x	x	x	x	x	58.8375	59.025	x	x	x	x	x	x	71.1167	x	x	x	76.275	x	80.825	x	x	x	x	x	x	x	x	x	x	68.0	76.8833	x	x	81.1333	x	x	x	x	x	78.76	x	x	x	x	x	x	x	
-14902	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, females	Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.036	1.034	1.039	1.038	1.038	x	1.029	1.043	x	1.178	x	1.178	1.032	1.05	1.169	x	x	x	x	x	x	1.094	x	x	1.055	x	x	x	1.068	1.041	1.037	x	x	x	x	1.029	1.13	1.032	x	1.029	1.037	x	x	x	x	x	x	x	1.059	x	x	x	x	x	x	x	x	x	1.146	1.046	x	x	x	x	x	1.036	1.178	x	x	x	1.04	x	1.046	x	x	x	x	x	x	x	x	x	x	1.178	1.057	x	x	1.05	x	x	x	x	x	1.029	x	x	x	x	x	x	x	
-14903	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, females	Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.075	1.119	1.088	1.07	1.083	x	1.056	1.084	x	1.315	x	1.315	1.056	1.108	1.315	x	x	x	x	x	x	1.209	x	x	1.109	x	x	x	1.193	1.094	1.089	x	x	x	x	1.059	1.291	1.056	x	1.068	1.132	x	x	x	x	x	x	x	1.116	x	x	x	x	x	x	x	x	x	1.282	1.153	x	x	x	x	x	1.061	1.253	x	x	x	1.064	x	1.124	x	x	x	x	x	x	x	x	x	x	1.315	1.102	x	x	1.1	x	x	x	x	x	1.056	x	x	x	x	x	x	x	
-14904	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, females	Morphology, metabolism: Adipose tissue hanging at the intestine in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.209	1.18	1.134	1.112	1.163	x	1.1	1.136	x	1.334	x	1.334	1.1	1.143	1.26	x	x	x	x	x	x	1.212	x	x	1.1	x	x	x	1.266	1.171	1.103	x	x	x	x	1.115	1.334	1.106	x	1.149	1.138	x	x	x	x	x	x	x	1.21	x	x	x	x	x	x	x	x	x	1.231	1.205	x	x	x	x	x	1.1	1.19	x	x	x	1.109	x	1.149	x	x	x	x	x	x	x	x	x	x	1.334	1.11	x	x	1.294	x	x	x	x	x	1.108	x	x	x	x	x	x	x	
-14905	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, females	Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.14	1.25	1.198	1.14	1.196	x	1.173	1.151	x	1.458	x	1.458	1.14	1.226	1.385	x	x	x	x	x	x	1.411	x	x	1.143	x	x	x	1.406	1.186	1.143	x	x	x	x	1.143	1.443	1.151	x	1.212	1.247	x	x	x	x	x	x	x	1.192	x	x	x	x	x	x	x	x	x	1.458	1.232	x	x	x	x	x	1.14	1.256	x	x	x	1.142	x	1.252	x	x	x	x	x	x	x	x	x	x	1.458	1.159	x	x	1.347	x	x	x	x	x	1.18	x	x	x	x	x	x	x	
-14906	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, females	Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.063	1.237	1.079	1.061	1.092	x	1.058	1.095	x	1.428	x	1.428	1.089	1.218	1.218	x	x	x	x	x	x	1.253	x	x	1.094	x	x	x	1.42	1.092	1.058	x	x	x	x	1.136	1.058	1.088	x	1.166	1.188	x	x	x	x	x	x	x	1.106	x	x	x	x	x	x	x	x	x	1.161	1.131	x	x	x	x	x	1.06	1.114	x	x	x	1.058	x	1.143	x	x	x	x	x	x	x	x	x	x	1.428	1.06	x	x	1.428	x	x	x	x	x	1.116	x	x	x	x	x	x	x	
-14907	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, females	Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.431	1.772	1.566	1.41	1.46	x	1.406	1.469	x	2.312	x	2.312	1.406	1.68	2.187	x	x	x	x	x	x	2.031	x	x	1.481	x	x	x	2.201	1.573	1.406	x	x	x	x	1.534	2.312	1.542	x	1.685	1.685	x	x	x	x	x	x	x	1.596	x	x	x	x	x	x	x	x	x	2.26	1.704	x	x	x	x	x	1.406	1.773	x	x	x	1.414	x	1.802	x	x	x	x	x	x	x	x	x	x	2.312	1.538	x	x	2.184	x	x	x	x	x	1.487	x	x	x	x	x	x	x	
-14908	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, females	Morphology, metabolism: Total white adipose weight at 20 weeks in the whole body in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	0.682	1.446	0.885	0.413	0.62	x	0.359	0.7	x	2.502	x	2.502	0.359	1.244	2.211	x	x	x	x	x	x	2.056	x	x	0.655	x	x	x	2.16	0.962	0.379	x	x	x	x	0.664	2.502	0.511	x	1.007	1.276	x	x	x	x	x	x	x	1.186	x	x	x	x	x	x	x	x	x	2.435	1.439	x	x	x	x	x	0.359	1.645	x	x	x	0.359	x	1.429	x	x	x	x	x	x	x	x	x	x	2.502	0.873	x	x	2.111	x	x	x	x	x	0.508	x	x	x	x	x	x	x	
-14909	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, females	Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.067	1.074	1.079	1.049	1.092	x	1.066	1.087	x	1.147	x	1.147	1.065	1.058	1.14	x	x	x	x	x	x	1.107	x	x	1.059	x	x	x	1.14	1.089	1.068	x	x	x	x	1.055	1.147	1.049	x	1.072	1.112	x	x	x	x	x	x	x	1.075	x	x	x	x	x	x	x	x	x	1.112	1.102	x	x	x	x	x	1.049	1.099	x	x	x	1.049	x	1.097	x	x	x	x	x	x	x	x	x	x	1.147	1.057	x	x	1.105	x	x	x	x	x	1.077	x	x	x	x	x	x	x	
-14910	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, females	Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.115	3.233	2.903	2.864	3.103	x	3.193	3.025	x	3.051	x	3.238	3.072	3.158	3.158	x	x	x	x	x	x	2.933	x	x	2.864	x	x	x	3.068	2.973	3.161	x	x	x	x	3.16	3.238	2.864	x	3.238	3.025	x	x	x	x	x	x	x	3.052	x	x	x	x	x	x	x	x	x	3.147	3.034	x	x	x	x	x	2.868	2.996	x	x	x	3.004	x	3.137	x	x	x	x	x	x	x	x	x	x	3.238	2.864	x	x	3.047	x	x	x	x	x	3.221	x	x	x	x	x	x	x	
-14911	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, females	Morphology, metabolism: Fat weight around the neck at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.032	1.087	1.066	1.042	1.036	x	1.032	1.049	x	1.08	x	1.125	1.052	1.065	1.094	x	x	x	x	x	x	1.103	x	x	1.057	x	x	x	1.125	1.048	1.032	x	x	x	x	1.048	1.039	1.098	x	1.074	1.056	x	x	x	x	x	x	x	1.045	x	x	x	x	x	x	x	x	x	1.075	1.083	x	x	x	x	x	1.032	1.051	x	x	x	1.043	x	1.069	x	x	x	x	x	x	x	x	x	x	1.125	1.043	x	x	1.125	x	x	x	x	x	1.042	x	x	x	x	x	x	x	
-14912	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, females	Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.015	1.016	1.014	1.01	1.014	x	1.068	1.024	x	1.074	x	1.074	1.011	1.025	1.063	x	x	x	x	x	x	1.028	x	x	1.013	x	x	x	1.039	1.034	1.01	x	x	x	x	1.024	1.074	1.01	x	1.014	1.026	x	x	x	x	x	x	x	1.021	x	x	x	x	x	x	x	x	x	1.062	1.03	x	x	x	x	x	1.022	1.04	x	x	x	1.019	x	1.04	x	x	x	x	x	x	x	x	x	x	1.074	1.026	x	x	1.011	x	x	x	x	x	1.01	x	x	x	x	x	x	x	
-14913	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, females	Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.139	1.19	1.245	1.173	1.12	x	1.142	1.287	x	1.879	x	1.879	1.12	1.246	1.696	x	x	x	x	x	x	1.327	x	x	1.134	x	x	x	1.514	1.131	1.12	x	x	x	x	1.172	1.879	1.177	x	1.236	1.198	x	x	x	x	x	x	x	1.257	x	x	x	x	x	x	x	x	x	1.85	1.307	x	x	x	x	x	1.13	1.397	x	x	x	1.164	x	1.436	x	x	x	x	x	x	x	x	x	x	1.879	1.285	x	x	1.314	x	x	x	x	x	1.12	x	x	x	x	x	x	x	
-14914	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42 in females + males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.669	1.826	2.173	1.812	1.767	x	1.715	1.688	x	2.182	x	x	2.131	1.669	2.132	x	x	x	x	x	x	2.284	x	x	2.181	x	x	x	2.179	2.284	1.669	x	x	x	x	2.284	2.226	1.967	x	1.977	2.153	x	x	x	x	x	x	x	2.003	x	x	x	x	x	x	x	x	x	2.284	2.106	x	x	x	x	x	2.084	1.944	x	x	x	1.914	x	1.988	x	x	x	x	x	x	x	x	x	x	2.05	1.669	x	x	2.256	x	x	x	x	x	1.991	x	x	x	x	x	x	x	
-14915	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56 in females + males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.705	1.967	2.407	1.705	1.874	x	1.759	1.793	x	2.325	x	x	2.452	1.89	2.317	x	x	x	x	x	x	2.523	x	x	2.31	x	x	x	2.24	2.523	1.705	x	x	x	x	2.507	2.523	1.831	x	1.94	2.101	x	x	x	x	x	x	x	1.993	x	x	x	x	x	x	x	x	x	2.307	2.103	x	x	x	x	x	2.266	1.705	x	x	x	2.197	x	2.005	x	x	x	x	x	x	x	x	x	x	2.523	1.708	x	x	2.247	x	x	x	x	x	2.056	x	x	x	x	x	x	x	
-14916	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70 in females + males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.865	2.192	2.545	1.794	1.968	x	1.868	1.794	x	2.788	x	x	2.853	1.964	2.572	x	x	x	x	x	x	2.853	x	x	2.693	x	x	x	2.5	2.667	1.794	x	x	x	x	2.311	2.853	1.807	x	2.147	2.031	x	x	x	x	x	x	x	2.089	x	x	x	x	x	x	x	x	x	2.341	2.182	x	x	x	x	x	2.457	2.047	x	x	x	2.331	x	2.201	x	x	x	x	x	x	x	x	x	x	2.853	1.794	x	x	2.411	x	x	x	x	x	1.977	x	x	x	x	x	x	x	
-14917	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84 in females + males	Morphology, metabolism: Total fat weight measured by magnetic resonance interference analysis at 84 days in females and males on a high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.984	2.474	2.51	1.872	2.02	x	2.025	1.872	x	3.067	x	x	3.067	2.024	2.85	x	x	x	x	x	x	2.974	x	x	2.994	x	x	x	2.684	2.656	1.872	x	x	x	x	2.324	3.067	1.961	x	2.236	2.2	x	x	x	x	x	x	x	2.159	x	x	x	x	x	x	x	x	x	2.66	2.297	x	x	x	x	x	2.599	2.176	x	x	x	2.278	x	2.327	x	x	x	x	x	x	x	x	x	x	3.067	1.872	x	x	2.709	x	x	x	x	x	2.146	x	x	x	x	x	x	x	
-14918	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112 in females + males	Morphology, metabolism: Total fat weight measured by magnetic resonance interference analysis (EchoMRI-100 system) at 112 days in females and males on a high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.442	2.385	1.929	1.222	1.784	x	1.222	1.604	x	3.242	x	x	3.157	1.956	2.915	x	x	x	x	x	x	2.627	x	x	2.92	x	x	x	2.798	2.104	1.222	x	x	x	x	1.818	3.242	1.57	x	2.15	1.708	x	x	x	x	x	x	x	1.882	x	x	x	x	x	x	x	x	x	3.242	1.913	x	x	x	x	x	2.382	2.068	x	x	x	1.663	x	2.13	x	x	x	x	x	x	x	x	x	x	3.242	1.222	x	x	2.772	x	x	x	x	x	1.757	x	x	x	x	x	x	x	
-14919	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140 in females + males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.056	2.838	2.237	1.685	1.98	x	1.773	2.411	x	3.608	x	x	3.123	2.08	3.582	x	x	x	x	x	x	2.892	x	x	3.097	x	x	x	3.171	2.222	1.685	x	x	x	x	2.102	3.608	2.111	x	2.692	2.196	x	x	x	x	x	x	x	2.586	x	x	x	x	x	x	x	x	x	3.608	2.138	x	x	x	x	x	2.61	2.882	x	x	x	1.685	x	2.543	x	x	x	x	x	x	x	x	x	x	3.608	1.685	x	x	3.168	x	x	x	x	x	2.416	x	x	x	x	x	x	x	
-14920	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10 in females + males	Morphology, metabolism: Fat gain between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.644	1.827	1.966	1.207	1.6	x	1.532	1.468	x	2.284	x	x	2.284	1.7	2.032	x	x	x	x	x	x	2.234	x	x	2.155	x	x	x	1.869	1.789	1.236	x	x	x	x	1.207	2.284	1.207	x	1.593	1.207	x	x	x	x	x	x	x	1.47	x	x	x	x	x	x	x	x	x	1.438	1.464	x	x	x	x	x	1.916	1.49	x	x	x	1.921	x	1.656	x	x	x	x	x	x	x	x	x	x	2.284	1.503	x	x	1.614	x	x	x	x	x	1.314	x	x	x	x	x	x	x	
-14921	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20 in females + males	Morphology, metabolism: Fat gain between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.065	2.078	1.598	1.535	1.535	x	1.746	2.516	x	3.165	x	x	2.152	2.052	3.093	x	x	x	x	x	x	1.812	x	x	2.203	x	x	x	2.721	1.535	1.882	x	x	x	x	1.704	3.165	2.039	x	2.521	2.005	x	x	x	x	x	x	x	2.47	x	x	x	x	x	x	x	x	x	3.165	1.836	x	x	x	x	x	2.017	2.781	x	x	x	1.535	x	2.237	x	x	x	x	x	x	x	x	x	x	3.165	1.747	x	x	2.687	x	x	x	x	x	2.222	x	x	x	x	x	x	x	
-14922	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.091	4.11	3.844	3.94	4.131	x	4.007	4.008	x	3.844	x	x	4.172	4.156	4.172	x	x	x	x	x	x	3.844	x	x	3.961	x	x	x	4.093	3.888	3.883	x	x	x	x	4.064	4.047	3.928	x	4.172	3.899	x	x	x	x	x	x	x	4.119	x	x	x	x	x	x	x	x	x	4.01	3.882	x	x	x	x	x	3.944	3.845	x	x	x	4.062	x	4.104	x	x	x	x	x	x	x	x	x	x	4.006	3.844	x	x	3.898	x	x	x	x	x	4.172	x	x	x	x	x	x	x	
-14923	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.16	4.275	3.971	4.08	4.227	x	4.185	4.125	x	3.971	x	x	4.275	4.232	4.272	x	x	x	x	x	x	3.971	x	x	4.086	x	x	x	4.202	4.041	4.138	x	x	x	x	4.231	4.237	4.003	x	4.275	4.099	x	x	x	x	x	x	x	4.234	x	x	x	x	x	x	x	x	x	4.2	4.023	x	x	x	x	x	4.055	4.046	x	x	x	4.21	x	4.218	x	x	x	x	x	x	x	x	x	x	4.177	3.971	x	x	4.115	x	x	x	x	x	4.275	x	x	x	x	x	x	x	
-14924	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.269	4.337	4.045	4.102	4.3	x	4.331	4.203	x	4.045	x	x	4.35	4.343	4.35	x	x	x	x	x	x	4.045	x	x	4.155	x	x	x	4.261	4.119	4.231	x	x	x	x	4.343	4.348	4.069	x	4.35	4.173	x	x	x	x	x	x	x	4.324	x	x	x	x	x	x	x	x	x	4.279	4.138	x	x	x	x	x	4.154	4.112	x	x	x	4.286	x	4.284	x	x	x	x	x	x	x	x	x	x	4.283	4.045	x	x	4.196	x	x	x	x	x	4.35	x	x	x	x	x	x	x	
-14925	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 84 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.297	4.402	4.124	4.148	4.373	x	4.367	4.277	x	4.124	x	x	4.423	4.398	4.419	x	x	x	x	x	x	4.124	x	x	4.216	x	x	x	4.319	4.197	4.294	x	x	x	x	4.423	4.423	4.149	x	4.423	4.23	x	x	x	x	x	x	x	4.336	x	x	x	x	x	x	x	x	x	4.368	4.157	x	x	x	x	x	4.19	4.228	x	x	x	4.329	x	4.361	x	x	x	x	x	x	x	x	x	x	4.366	4.124	x	x	4.263	x	x	x	x	x	4.394	x	x	x	x	x	x	x	
-14926	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.368	4.44	4.215	4.211	4.424	x	4.457	4.365	x	4.213	x	x	4.517	4.458	4.517	x	x	x	x	x	x	4.211	x	x	4.297	x	x	x	4.358	4.278	4.375	x	x	x	x	4.507	4.517	4.211	x	4.517	4.312	x	x	x	x	x	x	x	4.373	x	x	x	x	x	x	x	x	x	4.494	4.234	x	x	x	x	x	4.235	4.284	x	x	x	4.374	x	4.411	x	x	x	x	x	x	x	x	x	x	4.515	4.211	x	x	4.344	x	x	x	x	x	4.471	x	x	x	x	x	x	x	
-14927	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140 in females + males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.401	4.499	4.299	4.266	4.45	x	4.481	4.442	x	4.305	x	x	4.58	4.528	4.58	x	x	x	x	x	x	4.266	x	x	4.375	x	x	x	4.451	4.334	4.397	x	x	x	x	4.506	4.58	4.266	x	4.58	4.388	x	x	x	x	x	x	x	4.415	x	x	x	x	x	x	x	x	x	4.542	4.306	x	x	x	x	x	4.312	4.388	x	x	x	4.501	x	4.466	x	x	x	x	x	x	x	x	x	x	4.54	4.266	x	x	4.43	x	x	x	x	x	4.544	x	x	x	x	x	x	x	
-14928	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10 in females + males	Morphology, metabolism: Lean gain between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.169	1.558	1.427	0.967	1.122	x	1.928	1.214	x	1.254	x	x	1.377	1.303	1.175	x	x	x	x	x	x	0.967	x	x	1.164	x	x	x	1.077	1.361	1.928	x	x	x	x	1.84	1.928	0.967	x	1.928	1.643	x	x	x	x	x	x	x	1.407	x	x	x	x	x	x	x	x	x	1.721	1.516	x	x	x	x	x	1.27	1.55	x	x	x	1.488	x	1.195	x	x	x	x	x	x	x	x	x	x	1.763	0.967	x	x	1.776	x	x	x	x	x	1.1	x	x	x	x	x	x	x	
-14929	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20 in females + males	Morphology, metabolism: Lean gain between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.797	1.831	2.132	1.707	1.719	x	1.886	2.119	x	2.123	x	x	2.192	1.999	2.119	x	x	x	x	x	x	1.926	x	x	2.056	x	x	x	1.972	1.94	1.785	x	x	x	x	1.707	2.192	1.762	x	2.192	2.059	x	x	x	x	x	x	x	1.707	x	x	x	x	x	x	x	x	x	2.179	1.984	x	x	x	x	x	1.848	2.069	x	x	x	2.184	x	1.804	x	x	x	x	x	x	x	x	x	x	2.192	1.707	x	x	2.124	x	x	x	x	x	2.097	x	x	x	x	x	x	x	
-14930	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4 in females + males	Morphology, metabolism: Body weight at 28 days (4 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.73	3.815	3.48	3.599	3.782	x	3.561	3.588	x	x	x	x	3.833	3.514	3.675	x	x	x	x	x	x	x	x	x	3.544	x	x	x	3.8	3.674	3.48	x	x	x	x	3.857	3.55	3.485	x	3.857	3.851	x	x	x	x	x	x	x	3.764	x	x	x	x	x	x	x	x	x	3.497	3.62	x	x	x	x	x	3.703	3.48	x	x	x	3.642	x	3.799	x	x	x	x	x	x	x	x	x	x	3.56	3.537	x	x	3.563	x	x	x	x	x	3.857	x	x	x	x	x	x	x	
-14931	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5 in females + males	Morphology, metabolism: Body weight at 35 days (5 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.187	4.244	3.957	4.131	4.281	x	4.083	4.055	x	3.98	x	x	4.294	4.089	4.294	x	x	x	x	x	x	3.957	x	x	4.058	x	x	x	4.206	4.084	3.957	x	x	x	x	4.257	4.222	4.019	x	4.294	4.164	x	x	x	x	x	x	x	4.227	x	x	x	x	x	x	x	x	x	4.15	4.087	x	x	x	x	x	4.164	3.987	x	x	x	4.154	x	4.291	x	x	x	x	x	x	x	x	x	x	4.095	3.957	x	x	4.061	x	x	x	x	x	4.294	x	x	x	x	x	x	x	
-14932	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6 in females + males	Morphology, metabolism: Body weight at 42 days (6 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.309	4.382	4.159	4.208	4.385	x	4.252	4.227	x	4.176	x	x	4.46	4.344	4.46	x	x	x	x	x	x	4.24	x	x	4.278	x	x	x	4.389	4.3	4.159	x	x	x	x	4.46	4.392	4.201	x	4.442	4.251	x	x	x	x	x	x	x	4.394	x	x	x	x	x	x	x	x	x	4.361	4.181	x	x	x	x	x	4.249	4.159	x	x	x	4.306	x	4.401	x	x	x	x	x	x	x	x	x	x	4.307	4.159	x	x	4.28	x	x	x	x	x	4.46	x	x	x	x	x	x	x	
-14834	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), median survival	Infectious disease, immune function: Median survival time in log10 after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days in log10 * 100]	x	234.138	235.773	209.5	225.954	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	197.469	x	x	x	x	x	x	221.206	201.408	149.136	x	x	x	x	x	212.385	x	x	222.42	207.188	x	x	x	x	x	x	x	x	x	x	x	212.385	x	x	x	x	x	217.894	x	x	x	180.426	x	x	x	x	x	x	x	226.476	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	228.33	x	x	x	x	x	x	x	
-14835	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.572	1.903	2.149	1.786	1.822	x	1.572	1.58	x	2.415	x	2.415	1.958	1.658	2.144	x	x	x	x	x	x	2.215	x	x	1.668	x	x	x	2.352	2.41	1.572	x	x	x	x	2.415	1.953	1.936	x	1.841	2.345	x	x	x	x	x	x	x	1.883	x	x	x	x	x	x	x	x	x	2.415	2.082	x	x	x	x	x	1.944	1.953	x	x	x	1.806	x	1.933	x	x	x	x	x	x	x	x	x	x	2.145	1.572	x	x	2.214	x	x	x	x	x	1.938	x	x	x	x	x	x	x	
-14836	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.48	1.872	2.254	1.785	1.867	x	1.471	1.654	x	2.4	x	2.4	1.932	1.895	2.117	x	x	x	x	x	x	2.4	x	x	1.471	x	x	x	2.4	2.292	1.471	x	x	x	x	2.294	1.824	1.489	x	1.645	2.174	x	x	x	x	x	x	x	1.728	x	x	x	x	x	x	x	x	x	2.208	1.979	x	x	x	x	x	1.826	1.471	x	x	x	1.76	x	1.914	x	x	x	x	x	x	x	x	x	x	2.374	1.663	x	x	2.095	x	x	x	x	x	1.896	x	x	x	x	x	x	x	
-14837	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.654	1.937	2.275	1.704	1.911	x	1.62	1.731	x	2.695	x	2.695	1.888	1.811	2.35	x	x	x	x	x	x	2.695	x	x	1.739	x	x	x	2.689	2.276	1.62	x	x	x	x	2.102	1.993	1.62	x	1.95	2.059	x	x	x	x	x	x	x	1.84	x	x	x	x	x	x	x	x	x	1.972	2.059	x	x	x	x	x	1.828	1.62	x	x	x	1.85	x	1.965	x	x	x	x	x	x	x	x	x	x	2.695	1.723	x	x	2.22	x	x	x	x	x	1.78	x	x	x	x	x	x	x	
-14838	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 84 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.695	2.046	2.179	1.775	1.785	x	1.642	1.713	x	2.874	x	2.874	1.587	1.863	2.613	x	x	x	x	x	x	2.874	x	x	1.702	x	x	x	2.755	2.256	1.587	x	x	x	x	2.001	2.053	1.587	x	2.026	2.192	x	x	x	x	x	x	x	1.847	x	x	x	x	x	x	x	x	x	2.058	2.149	x	x	x	x	x	1.996	1.587	x	x	x	1.805	x	1.981	x	x	x	x	x	x	x	x	x	x	2.874	1.78	x	x	2.528	x	x	x	x	x	1.853	x	x	x	x	x	x	x	
-14839	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 112 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.887	2.35	2.07	1.79	2.095	x	1.727	1.863	x	3.065	x	3.065	1.727	2.345	2.72	x	x	x	x	x	x	2.954	x	x	2.198	x	x	x	3.065	2.33	1.727	x	x	x	x	2.082	2.623	1.727	x	2.028	2.266	x	x	x	x	x	x	x	1.976	x	x	x	x	x	x	x	x	x	3.026	2.514	x	x	x	x	x	2.046	1.877	x	x	x	1.741	x	2.449	x	x	x	x	x	x	x	x	x	x	3.065	2.039	x	x	2.932	x	x	x	x	x	1.906	x	x	x	x	x	x	x	
-14840	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, females	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.008	2.183	1.251	0.781	1.371	x	0.85	0.949	x	3.2	x	3.2	0.781	1.622	2.907	x	x	x	x	x	x	2.735	x	x	1.52	x	x	x	2.567	1.715	0.781	x	x	x	x	1.474	2.929	0.781	x	1.921	1.936	x	x	x	x	x	x	x	1.99	x	x	x	x	x	x	x	x	x	3.2	2.113	x	x	x	x	x	0.865	1.879	x	x	x	0.838	x	2.13	x	x	x	x	x	x	x	x	x	x	3.2	1.505	x	x	2.812	x	x	x	x	x	1.256	x	x	x	x	x	x	x	
-14841	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, females	Morphology, metabolism: Fat gain between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.882	1.847	1.968	1.73	1.901	x	1.791	1.94	x	2.391	x	2.391	1.732	1.949	2.065	x	x	x	x	x	x	2.391	x	x	1.875	x	x	x	2.278	1.603	1.793	x	x	x	x	1.463	1.855	1.463	x	1.921	1.602	x	x	x	x	x	x	x	1.766	x	x	x	x	x	x	x	x	x	1.463	1.782	x	x	x	x	x	1.683	1.463	x	x	x	1.855	x	1.846	x	x	x	x	x	x	x	x	x	x	2.391	2.022	x	x	1.818	x	x	x	x	x	1.637	x	x	x	x	x	x	x	
-14842	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, females	Morphology, metabolism: Fat gain between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.557	2.196	1.31	1.31	1.731	x	1.511	1.496	x	3.017	x	3.017	1.589	1.851	2.144	x	x	x	x	x	x	1.664	x	x	1.919	x	x	x	1.742	1.42	1.564	x	x	x	x	1.557	2.933	1.611	x	1.957	1.777	x	x	x	x	x	x	x	2.184	x	x	x	x	x	x	x	x	x	3.017	2.059	x	x	x	x	x	1.31	2.284	x	x	x	1.31	x	2.178	x	x	x	x	x	x	x	x	x	x	3.017	1.838	x	x	2.439	x	x	x	x	x	1.348	x	x	x	x	x	x	x	
-14843	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, females	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.949	3.94	3.674	3.807	3.903	x	3.852	3.812	x	3.674	x	4.051	4.051	4.051	4.001	x	x	x	x	x	x	3.674	x	x	3.705	x	x	x	3.941	3.745	3.708	x	x	x	x	3.967	3.815	3.789	x	3.956	3.702	x	x	x	x	x	x	x	3.94	x	x	x	x	x	x	x	x	x	3.778	3.762	x	x	x	x	x	3.757	3.694	x	x	x	3.892	x	4.007	x	x	x	x	x	x	x	x	x	x	3.913	3.674	x	x	3.715	x	x	x	x	x	4.051	x	x	x	x	x	x	x	
-14844	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, females	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.014	4.098	3.832	3.912	3.994	x	4.054	3.966	x	3.816	x	4.134	4.134	4.129	4.089	x	x	x	x	x	x	3.816	x	x	3.816	x	x	x	3.994	3.874	3.981	x	x	x	x	4.092	4.047	3.861	x	4.134	3.908	x	x	x	x	x	x	x	4.068	x	x	x	x	x	x	x	x	x	3.967	3.91	x	x	x	x	x	3.849	3.927	x	x	x	4.006	x	4.094	x	x	x	x	x	x	x	x	x	x	4.059	3.816	x	x	3.925	x	x	x	x	x	4.134	x	x	x	x	x	x	x	
-14845	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, females	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.12	4.176	3.935	3.951	4.124	x	4.217	4.051	x	3.901	x	4.256	4.256	4.256	4.184	x	x	x	x	x	x	3.901	x	x	3.901	x	x	x	4.042	3.939	4.05	x	x	x	x	4.164	4.223	3.919	x	4.256	4.01	x	x	x	x	x	x	x	4.18	x	x	x	x	x	x	x	x	x	4.061	4.052	x	x	x	x	x	3.985	3.985	x	x	x	4.094	x	4.158	x	x	x	x	x	x	x	x	x	x	4.164	3.901	x	x	3.988	x	x	x	x	x	4.243	x	x	x	x	x	x	x	
-14846	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, females	Morphology, metabolism: Total lean weight measured by magnetic resonance interference analysis at 84 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.15	4.225	3.999	3.986	4.209	x	4.236	4.123	x	3.958	x	4.274	4.274	4.274	4.26	x	x	x	x	x	x	3.958	x	x	3.973	x	x	x	4.114	4.031	4.158	x	x	x	x	4.23	4.247	4.007	x	4.274	4.07	x	x	x	x	x	x	x	4.186	x	x	x	x	x	x	x	x	x	4.147	4.062	x	x	x	x	x	3.958	4.109	x	x	x	4.118	x	4.229	x	x	x	x	x	x	x	x	x	x	4.258	3.958	x	x	4.054	x	x	x	x	x	4.263	x	x	x	x	x	x	x	
-14847	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, females	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.238	4.267	4.121	4.044	4.301	x	4.339	4.222	x	4.039	x	4.315	4.362	4.343	4.353	x	x	x	x	x	x	4.037	x	x	4.032	x	x	x	4.144	4.124	4.274	x	x	x	x	4.336	4.362	4.032	x	4.362	4.191	x	x	x	x	x	x	x	4.212	x	x	x	x	x	x	x	x	x	4.282	4.168	x	x	x	x	x	4.032	4.135	x	x	x	4.159	x	4.261	x	x	x	x	x	x	x	x	x	x	4.362	4.032	x	x	4.103	x	x	x	x	x	4.358	x	x	x	x	x	x	x	
-14848	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, females	Morphology, metabolism: Total lean weight measured by magnetic resonance interference analysis at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.25	4.299	4.172	4.065	4.302	x	4.367	4.304	x	4.137	x	4.354	4.426	4.396	4.424	x	x	x	x	x	x	4.087	x	x	4.065	x	x	x	4.251	4.191	4.29	x	x	x	x	4.341	4.426	4.075	x	4.426	4.255	x	x	x	x	x	x	x	4.237	x	x	x	x	x	x	x	x	x	4.26	4.246	x	x	x	x	x	4.065	4.226	x	x	x	4.249	x	4.315	x	x	x	x	x	x	x	x	x	x	4.426	4.065	x	x	4.206	x	x	x	x	x	4.375	x	x	x	x	x	x	x	
-14849	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, females	Morphology, metabolism: Lean gain between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	0.961	1.446	1.365	0.551	1.306	x	1.771	1.341	x	1.077	x	1.265	0.546	1.294	1.112	x	x	x	x	x	x	0.513	x	x	0.882	x	x	x	0.513	0.948	1.771	x	x	x	x	1.193	1.771	0.513	x	1.771	1.631	x	x	x	x	x	x	x	1.474	x	x	x	x	x	x	x	x	x	1.572	1.596	x	x	x	x	x	1.207	1.534	x	x	x	1.16	x	0.833	x	x	x	x	x	x	x	x	x	x	1.516	0.513	x	x	1.454	x	x	x	x	x	0.792	x	x	x	x	x	x	x	
-14850	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, females	Morphology, metabolism: Lean gain between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.71	1.574	2.012	1.523	1.722	x	1.923	2.112	x	2.142	x	1.911	1.949	1.718	1.779	x	x	x	x	x	x	1.994	x	x	1.566	x	x	x	1.898	1.97	1.893	x	x	x	x	1.809	2.142	1.523	x	2.142	2.102	x	x	x	x	x	x	x	1.523	x	x	x	x	x	x	x	x	x	1.807	2.075	x	x	x	x	x	1.681	1.786	x	x	x	1.869	x	1.602	x	x	x	x	x	x	x	x	x	x	2.142	1.523	x	x	1.944	x	x	x	x	x	1.797	x	x	x	x	x	x	x	
-14851	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, females	Morphology, metabolism: Body weight at 28 days (4 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.691	3.816	3.388	3.388	3.567	x	3.493	3.539	x	3.467	x	3.684	3.692	3.497	3.588	x	x	x	x	x	x	x	x	x	3.559	x	x	x	3.768	3.604	3.388	x	x	x	x	3.816	3.423	3.399	x	3.816	3.816	x	x	x	x	x	x	x	3.739	x	x	x	x	x	x	x	x	x	3.48	3.629	x	x	x	x	x	3.564	3.388	x	x	x	3.694	x	3.756	x	x	x	x	x	x	x	x	x	x	3.577	3.49	x	x	3.482	x	x	x	x	x	3.801	x	x	x	x	x	x	x	
-14852	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, females	Morphology, metabolism: Body weight at 35 days (5 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.075	4.183	3.809	4.051	4.077	x	3.997	3.914	x	3.986	x	4.057	4.215	4.021	4.142	x	x	x	x	x	x	3.809	x	x	3.849	x	x	x	4.115	4.005	3.809	x	x	x	x	4.178	4.065	3.869	x	4.215	4.095	x	x	x	x	x	x	x	4.172	x	x	x	x	x	x	x	x	x	4.057	4.065	x	x	x	x	x	4.013	3.876	x	x	x	4.053	x	4.215	x	x	x	x	x	x	x	x	x	x	4.08	3.809	x	x	3.959	x	x	x	x	x	4.215	x	x	x	x	x	x	x	
-14853	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, females	Morphology, metabolism: Body weight at 42 days (6 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.17	4.249	4.024	4.085	4.197	x	4.087	4.031	x	4.112	x	4.37	4.37	4.257	4.332	x	x	x	x	x	x	4.048	x	x	4.024	x	x	x	4.277	4.173	4.024	x	x	x	x	4.37	4.134	4.061	x	4.224	4.13	x	x	x	x	x	x	x	4.222	x	x	x	x	x	x	x	x	x	4.209	4.076	x	x	x	x	x	4.038	4.036	x	x	x	4.124	x	4.299	x	x	x	x	x	x	x	x	x	x	4.246	4.024	x	x	4.124	x	x	x	x	x	4.37	x	x	x	x	x	x	x	
-14854	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, females	Morphology, metabolism: Body weight at 49 days (7 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.179	4.3	4.123	4.15	4.254	x	4.172	4.089	x	4.162	x	4.338	4.317	4.33	4.326	x	x	x	x	x	x	4.246	x	x	4.072	x	x	x	4.308	4.205	4.084	x	x	x	x	4.338	4.245	4.069	x	4.329	4.222	x	x	x	x	x	x	x	4.268	x	x	x	x	x	x	x	x	x	4.28	4.151	x	x	x	x	x	4.069	4.069	x	x	x	4.228	x	4.332	x	x	x	x	x	x	x	x	x	x	4.338	4.069	x	x	4.178	x	x	x	x	x	4.338	x	x	x	x	x	x	x	
-14855	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, females	Morphology, metabolism: Body weight at 56 days (8 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.236	4.368	4.209	4.17	4.287	x	4.276	4.196	x	4.225	x	4.406	4.363	4.37	4.4	x	x	x	x	x	x	4.333	x	x	4.149	x	x	x	4.394	4.281	4.186	x	x	x	x	4.406	4.314	4.149	x	4.406	4.262	x	x	x	x	x	x	x	4.328	x	x	x	x	x	x	x	x	x	4.306	4.221	x	x	x	x	x	4.16	4.149	x	x	x	4.288	x	4.397	x	x	x	x	x	x	x	x	x	x	4.405	4.149	x	x	4.248	x	x	x	x	x	4.406	x	x	x	x	x	x	x	
-14856	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, females	Morphology, metabolism: Body weight at 63 days (9 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.313	4.403	4.249	4.227	4.361	x	4.349	4.268	x	4.325	x	4.496	4.396	4.454	4.474	x	x	x	x	x	x	4.355	x	x	4.19	x	x	x	4.462	4.291	4.26	x	x	x	x	4.437	4.37	4.19	x	4.496	4.326	x	x	x	x	x	x	x	4.367	x	x	x	x	x	x	x	x	x	4.317	4.303	x	x	x	x	x	4.19	4.24	x	x	x	4.326	x	4.437	x	x	x	x	x	x	x	x	x	x	4.496	4.19	x	x	4.277	x	x	x	x	x	4.496	x	x	x	x	x	x	x	
-14857	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, females	Morphology, metabolism: Body weight at 70 days (10 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.352	4.446	4.304	4.211	4.399	x	4.429	4.309	x	4.456	x	4.549	4.446	4.483	4.549	x	x	x	x	x	x	4.342	x	x	4.211	x	x	x	4.514	4.331	4.258	x	x	x	x	4.476	4.494	4.211	x	4.549	4.342	x	x	x	x	x	x	x	4.43	x	x	x	x	x	x	x	x	x	4.332	4.354	x	x	x	x	x	4.246	4.266	x	x	x	4.358	x	4.444	x	x	x	x	x	x	x	x	x	x	4.549	4.211	x	x	4.324	x	x	x	x	x	4.5	x	x	x	x	x	x	x	
-14858	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, females	Morphology, metabolism: Body weight at 77 days (11 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	21.101	22.583	20.411	19.074	21.792	x	21.782	20.613	x	22.905	x	24.271	21.645	23.152	24.271	x	x	x	x	x	x	22.424	x	x	19.074	x	x	x	23.544	20.279	20.472	x	x	x	x	22.557	22.372	19.074	x	24.271	21.133	x	x	x	x	x	x	x	21.623	x	x	x	x	x	x	x	x	x	20.87	20.921	x	x	x	x	x	19.491	20.063	x	x	x	20.896	x	22.749	x	x	x	x	x	x	x	x	x	x	24.271	19.074	x	x	21.552	x	x	x	x	x	23.418	x	x	x	x	x	x	x	
-14859	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, females	Morphology, metabolism: Body weight at 84 days (12 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.423	4.527	4.359	4.258	4.462	x	4.464	4.406	x	4.568	x	4.608	4.521	4.561	4.608	x	x	x	x	x	x	4.527	x	x	4.258	x	x	x	4.59	4.389	4.4	x	x	x	x	4.547	4.549	4.258	x	4.608	4.441	x	x	x	x	x	x	x	4.468	x	x	x	x	x	x	x	x	x	4.433	4.418	x	x	x	x	x	4.294	4.35	x	x	x	4.415	x	4.539	x	x	x	x	x	x	x	x	x	x	4.608	4.258	x	x	4.477	x	x	x	x	x	4.573	x	x	x	x	x	x	x	
-14860	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, females	Morphology, metabolism: Body weight at 91 days (13 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.433	4.536	4.405	4.282	4.521	x	4.506	4.45	x	4.654	x	4.659	4.506	4.581	4.659	x	x	x	x	x	x	4.535	x	x	4.282	x	x	x	4.637	4.435	4.418	x	x	x	x	4.542	4.631	4.282	x	4.659	4.447	x	x	x	x	x	x	x	4.455	x	x	x	x	x	x	x	x	x	4.494	4.467	x	x	x	x	x	4.33	4.405	x	x	x	4.376	x	4.554	x	x	x	x	x	x	x	x	x	x	4.659	4.282	x	x	4.507	x	x	x	x	x	4.572	x	x	x	x	x	x	x	
-14861	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, females	Morphology, metabolism: Body weight at 98 days (14 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.461	4.553	4.419	4.307	4.529	x	4.539	4.454	x	4.729	x	4.729	4.506	4.611	4.729	x	x	x	x	x	x	4.602	x	x	4.309	x	x	x	4.708	4.404	4.47	x	x	x	x	4.585	4.7	4.307	x	4.64	4.5	x	x	x	x	x	x	x	4.504	x	x	x	x	x	x	x	x	x	4.561	4.512	x	x	x	x	x	4.307	4.472	x	x	x	4.397	x	4.597	x	x	x	x	x	x	x	x	x	x	4.729	4.307	x	x	4.549	x	x	x	x	x	4.606	x	x	x	x	x	x	x	
-14862	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, females	Morphology, metabolism: Body weight at 105 days (15 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.486	4.577	4.443	4.345	4.576	x	4.546	4.495	x	4.809	x	4.809	4.545	4.611	4.809	x	x	x	x	x	x	4.583	x	x	4.363	x	x	x	4.733	4.5	4.432	x	x	x	x	4.573	4.648	4.345	x	4.685	4.505	x	x	x	x	x	x	x	4.504	x	x	x	x	x	x	x	x	x	4.66	4.549	x	x	x	x	x	4.345	4.455	x	x	x	4.438	x	4.6	x	x	x	x	x	x	x	x	x	x	4.809	4.345	x	x	4.614	x	x	x	x	x	4.596	x	x	x	x	x	x	x	
-14863	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, females	Morphology, metabolism: Body weight at 112 days (16 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.509	4.607	4.432	4.331	4.582	x	4.575	4.487	x	4.832	x	4.832	4.522	4.674	4.832	x	x	x	x	x	x	4.612	x	x	4.389	x	x	x	4.702	4.502	4.506	x	x	x	x	4.621	4.755	4.331	x	4.69	4.547	x	x	x	x	x	x	x	4.516	x	x	x	x	x	x	x	x	x	4.79	4.578	x	x	x	x	x	4.331	4.48	x	x	x	4.432	x	4.652	x	x	x	x	x	x	x	x	x	x	4.832	4.331	x	x	4.627	x	x	x	x	x	4.629	x	x	x	x	x	x	x	
-14864	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, females	Morphology, metabolism: Body weight at 119 days (17 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.503	4.688	4.45	4.324	4.608	x	4.564	4.511	x	4.951	x	4.951	4.582	4.641	4.951	x	x	x	x	x	x	4.604	x	x	4.345	x	x	x	4.725	4.481	4.532	x	x	x	x	4.615	4.794	4.324	x	4.725	4.547	x	x	x	x	x	x	x	4.558	x	x	x	x	x	x	x	x	x	4.863	4.565	x	x	x	x	x	4.324	4.529	x	x	x	4.446	x	4.624	x	x	x	x	x	x	x	x	x	x	4.951	4.324	x	x	4.666	x	x	x	x	x	4.637	x	x	x	x	x	x	x	
-14865	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, females	Morphology, metabolism: Body weight at 126 days (18 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.529	4.733	4.457	4.375	4.627	x	4.593	4.499	x	4.892	x	4.892	4.567	4.796	4.892	x	x	x	x	x	x	4.614	x	x	4.415	x	x	x	4.739	4.549	4.54	x	x	x	x	4.601	4.879	4.375	x	4.752	4.609	x	x	x	x	x	x	x	4.57	x	x	x	x	x	x	x	x	x	4.848	4.607	x	x	x	x	x	4.375	4.574	x	x	x	4.458	x	4.661	x	x	x	x	x	x	x	x	x	x	4.892	4.375	x	x	4.683	x	x	x	x	x	4.64	x	x	x	x	x	x	x	
-14866	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, females	Morphology, metabolism: Body weight at 133 days (19 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.52	4.732	4.444	4.392	4.637	x	4.604	4.542	x	4.968	x	4.968	4.601	4.841	4.968	x	x	x	x	x	x	4.668	x	x	4.453	x	x	x	4.8	4.558	4.531	x	x	x	x	4.688	4.831	4.392	x	4.777	4.637	x	x	x	x	x	x	x	4.586	x	x	x	x	x	x	x	x	x	4.878	4.621	x	x	x	x	x	4.392	4.528	x	x	x	4.474	x	4.688	x	x	x	x	x	x	x	x	x	x	4.968	4.392	x	x	4.749	x	x	x	x	x	4.649	x	x	x	x	x	x	x	
-14867	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, females	Morphology, metabolism: Body weight at 140 days (20 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.541	4.738	4.483	4.386	4.618	x	4.63	4.58	x	4.981	x	4.981	4.609	x	4.977	x	x	x	x	x	x	4.686	x	x	4.459	x	x	x	4.781	4.541	4.548	x	x	x	x	4.672	4.981	4.386	x	4.818	4.651	x	x	x	x	x	x	x	4.655	x	x	x	x	x	x	x	x	x	4.959	4.664	x	x	x	x	x	4.386	4.636	x	x	x	4.507	x	4.728	x	x	x	x	x	x	x	x	x	x	4.981	4.386	x	x	4.756	x	x	x	x	x	4.679	x	x	x	x	x	x	x	
-14868	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, females	Morphology, metabolism: Body weight gain between 4 and 5 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.979	1.85	1.924	2.507	2.33	x	2.236	1.788	x	2.26	x	1.924	2.507	2.305	2.494	x	x	x	x	x	x	x	x	x	1.598	x	x	x	1.889	1.959	2.23	x	x	x	x	1.598	2.507	2.023	x	2.024	1.598	x	x	x	x	x	x	x	2.225	x	x	x	x	x	x	x	x	x	2.456	2.127	x	x	x	x	x	2.109	2.11	x	x	x	1.872	x	2.369	x	x	x	x	x	x	x	x	x	x	2.315	1.598	x	x	2.13	x	x	x	x	x	2.507	x	x	x	x	x	x	x	
-14869	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, females	Morphology, metabolism: Body weight gain between 5 and 6 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.736	1.605	2.175	1.372	1.864	x	1.683	1.789	x	1.859	x	2.317	2.065	2.317	2.223	x	x	x	x	x	x	2.317	x	x	1.703	x	x	x	2.085	2.061	2.18	x	x	x	x	2.317	1.587	2.089	x	1.372	1.38	x	x	x	x	x	x	x	1.5	x	x	x	x	x	x	x	x	x	2.012	1.372	x	x	x	x	x	1.372	1.963	x	x	x	1.594	x	1.679	x	x	x	x	x	x	x	x	x	x	2.084	1.797	x	x	2.025	x	x	x	x	x	1.86	x	x	x	x	x	x	x	
-14870	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, females	Morphology, metabolism: Body weight gain between 6 and 7 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.596	1.842	2.026	1.886	1.87	x	1.976	1.839	x	1.816	x	2.111	1.516	1.962	1.516	x	x	x	x	x	x	2.111	x	x	2.087	x	x	x	1.736	1.726	2.111	x	x	x	x	1.516	2.111	1.516	x	2.11	2.025	x	x	x	x	x	x	x	1.81	x	x	x	x	x	x	x	x	x	1.942	1.928	x	x	x	x	x	1.708	1.702	x	x	x	2.073	x	1.749	x	x	x	x	x	x	x	x	x	x	2.067	1.973	x	x	1.837	x	x	x	x	x	1.795	x	x	x	x	x	x	x	
-14871	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, females	Morphology, metabolism: Body weight gain between 7 and 8 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.524	1.638	1.691	1.338	1.378	x	1.766	1.766	x	1.557	x	1.766	1.482	1.442	1.683	x	x	x	x	x	x	1.737	x	x	1.338	x	x	x	1.752	1.659	1.765	x	x	x	x	1.766	1.62	1.338	x	1.706	1.42	x	x	x	x	x	x	x	1.569	x	x	x	x	x	x	x	x	x	1.338	1.603	x	x	x	x	x	1.7	1.639	x	x	x	1.563	x	1.623	x	x	x	x	x	x	x	x	x	x	1.629	1.46	x	x	1.609	x	x	x	x	x	1.636	x	x	x	x	x	x	x	
-14872	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, females	Morphology, metabolism: Body weight gain between 8 and 9 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.806	1.567	1.576	1.667	1.801	x	1.791	1.764	x	1.92	x	1.92	1.552	1.891	1.838	x	x	x	x	x	x	1.469	x	x	1.785	x	x	x	1.795	1.389	1.769	x	x	x	x	1.389	1.699	1.533	x	1.92	1.732	x	x	x	x	x	x	x	1.59	x	x	x	x	x	x	x	x	x	1.389	1.83	x	x	x	x	x	1.437	1.866	x	x	x	1.57	x	1.609	x	x	x	x	x	x	x	x	x	x	1.92	1.426	x	x	1.506	x	x	x	x	x	1.389	x	x	x	x	x	x	x	
-14873	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, females	Morphology, metabolism: Body weight gain between 9 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.513	1.558	1.606	1.211	1.513	x	1.799	1.518	x	1.848	x	1.531	1.611	1.455	1.848	x	x	x	x	x	x	1.211	x	x	1.531	x	x	x	1.641	1.517	1.211	x	x	x	x	1.535	1.848	1.515	x	1.782	1.34	x	x	x	x	x	x	x	1.695	x	x	x	x	x	x	x	x	x	1.336	1.589	x	x	x	x	x	1.66	1.407	x	x	x	1.465	x	1.273	x	x	x	x	x	x	x	x	x	x	1.848	1.392	x	x	1.562	x	x	x	x	x	1.211	x	x	x	x	x	x	x	
-14874	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, females	Morphology, metabolism: Body weight gain between 10 and 11 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.503	1.561	1.494	1.441	1.511	x	1.258	1.561	x	1.636	x	1.897	1.216	1.563	1.897	x	x	x	x	x	x	1.897	x	x	1.342	x	x	x	1.515	1.216	1.806	x	x	x	x	1.303	1.216	1.396	x	1.5	1.592	x	x	x	x	x	x	x	1.216	x	x	x	x	x	x	x	x	x	1.529	1.398	x	x	x	x	x	1.417	1.576	x	x	x	1.353	x	1.648	x	x	x	x	x	x	x	x	x	x	1.897	1.422	x	x	1.881	x	x	x	x	x	1.56	x	x	x	x	x	x	x	
-14875	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, females	Morphology, metabolism: Body weight gain between 11 and 12 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	0.348	0.473	0.139	0.139	0.244	x	0.287	0.587	x	0.81	x	0.991	0.991	0.45	0.567	x	x	x	x	x	x	0.63	x	x	0.27	x	x	x	0.532	0.669	0.638	x	x	x	x	0.813	0.991	0.518	x	0.139	0.581	x	x	x	x	x	x	x	0.512	x	x	x	x	x	x	x	x	x	0.735	0.451	x	x	x	x	x	0.139	0.336	x	x	x	0.43	x	0.492	x	x	x	x	x	x	x	x	x	x	0.991	0.211	x	x	0.717	x	x	x	x	x	0.388	x	x	x	x	x	x	x	
-14876	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, females	Morphology, metabolism: Body weight gain between 12 and 13 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.443	1.441	1.693	1.397	1.802	x	1.685	1.688	x	1.944	x	1.944	1.259	1.538	1.259	x	x	x	x	x	x	1.431	x	x	1.575	x	x	x	1.751	1.701	1.503	x	x	x	x	1.314	1.944	1.551	x	1.764	1.415	x	x	x	x	x	x	x	1.259	x	x	x	x	x	x	x	x	x	1.808	1.725	x	x	x	x	x	1.616	1.744	x	x	x	1.259	x	1.495	x	x	x	x	x	x	x	x	x	x	1.944	1.606	x	x	1.6	x	x	x	x	x	1.352	x	x	x	x	x	x	x	
-14877	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, females	Morphology, metabolism: Body weight gain between 13 and 14 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.525	1.446	1.408	1.453	1.372	x	1.576	1.336	x	1.912	x	1.912	1.305	1.566	1.912	x	x	x	x	x	x	1.831	x	x	1.577	x	x	x	1.893	1.305	1.696	x	x	x	x	1.664	1.871	1.372	x	1.305	1.71	x	x	x	x	x	x	x	1.685	x	x	x	x	x	x	x	x	x	1.814	1.659	x	x	x	x	x	1.305	1.791	x	x	x	1.466	x	1.664	x	x	x	x	x	x	x	x	x	x	1.912	1.5	x	x	1.648	x	x	x	x	x	1.596	x	x	x	x	x	x	x	
-14878	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, females	Morphology, metabolism: Body weight gain between 14 and 15 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.728	1.73	1.715	1.591	1.881	x	1.601	1.827	x	2.125	x	2.11	1.826	1.539	2.082	x	x	x	x	x	x	1.425	x	x	1.879	x	x	x	1.754	2.125	1.425	x	x	x	x	1.447	1.425	1.51	x	1.893	1.585	x	x	x	x	x	x	x	1.543	x	x	x	x	x	x	x	x	x	2.125	1.811	x	x	x	x	x	1.758	1.425	x	x	x	1.819	x	1.569	x	x	x	x	x	x	x	x	x	x	2.125	1.69	x	x	1.999	x	x	x	x	x	1.453	x	x	x	x	x	x	x	
-14879	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, females	Morphology, metabolism: Body weight gain between 15 and 16 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.54	1.615	1.258	1.5	1.408	x	1.6	1.281	x	1.506	x	1.696	1.185	1.868	1.185	x	x	x	x	x	x	1.609	x	x	1.552	x	x	x	1.185	1.371	1.879	x	x	x	x	1.748	1.879	1.388	x	1.408	1.692	x	x	x	x	x	x	x	1.455	x	x	x	x	x	x	x	x	x	1.879	1.604	x	x	x	x	x	1.185	1.55	x	x	x	1.303	x	1.783	x	x	x	x	x	x	x	x	x	x	1.879	1.49	x	x	1.471	x	x	x	x	x	1.644	x	x	x	x	x	x	x	
-14880	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, females	Morphology, metabolism: Body weight gain between 16 and 17 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.347	2.011	1.54	1.391	1.623	x	1.293	1.588	x	2.078	x	2.078	1.851	1.221	2.078	x	x	x	x	x	x	1.318	x	x	1.221	x	x	x	1.606	1.221	1.607	x	x	x	x	1.341	1.753	1.535	x	1.708	1.393	x	x	x	x	x	x	x	1.732	x	x	x	x	x	x	x	x	x	2.024	1.508	x	x	x	x	x	1.419	1.769	x	x	x	1.512	x	1.221	x	x	x	x	x	x	x	x	x	x	2.078	1.468	x	x	1.727	x	x	x	x	x	1.495	x	x	x	x	x	x	x	
-14881	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, females	Morphology, metabolism: Body weight gain between 17 and 18 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.017	2.156	1.905	2.051	1.983	x	2.046	1.789	x	2.284	x	2.18	1.769	2.284	1.769	x	x	x	x	x	x	1.93	x	x	2.218	x	x	x	1.963	2.238	1.917	x	x	x	x	1.769	2.284	1.986	x	2.044	2.224	x	x	x	x	x	x	x	1.938	x	x	x	x	x	x	x	x	x	1.769	2.114	x	x	x	x	x	2.097	2.128	x	x	x	1.932	x	2.094	x	x	x	x	x	x	x	x	x	x	2.284	1.795	x	x	1.976	x	x	x	x	x	1.882	x	x	x	x	x	x	x	
-14882	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, females	Morphology, metabolism: Body weight gain between 18 and 19 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.635	1.8	1.721	1.635	1.873	x	1.877	2.064	x	2.211	x	2.008	2.015	2.067	2.298	x	x	x	x	x	x	2.143	x	x	2.018	x	x	x	2.217	1.822	1.743	x	x	x	x	2.298	1.635	1.946	x	1.984	1.988	x	x	x	x	x	x	x	1.905	x	x	x	x	x	x	x	x	x	2.03	1.901	x	x	x	x	x	1.884	1.635	x	x	x	1.898	x	1.99	x	x	x	x	x	x	x	x	x	x	2.298	2.056	x	x	2.298	x	x	x	x	x	1.861	x	x	x	x	x	x	x	
-14883	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, females	Morphology, metabolism: Body weight gain between 19 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.953	4.944	4.966	4.94	4.954	x	4.959	4.967	x	5.009	x	4.924	4.946	4.924	4.925	x	x	x	x	x	x	4.954	x	x	4.943	x	x	x	4.924	4.926	4.952	x	x	x	x	4.926	5.009	4.965	x	4.976	4.95	x	x	x	x	x	x	x	4.993	x	x	x	x	x	x	x	x	x	5.009	4.973	x	x	x	x	x	4.924	5.009	x	x	x	4.963	x	4.963	x	x	x	x	x	x	x	x	x	x	4.975	4.956	x	x	4.945	x	x	x	x	x	4.963	x	x	x	x	x	x	x	
-14884	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, females	Morphology, metabolism: Body length from the nose until the tail at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.41	6.439	6.295	6.362	6.34	x	6.402	6.322	x	6.304	x	6.439	6.384	6.347	6.437	x	x	x	x	x	x	6.248	x	x	6.235	x	x	x	6.392	6.332	6.226	x	x	x	x	6.432	6.308	6.276	x	6.387	6.232	x	x	x	x	x	x	x	6.375	x	x	x	x	x	x	x	x	x	6.384	6.256	x	x	x	x	x	6.304	6.226	x	x	x	6.226	x	6.399	x	x	x	x	x	x	x	x	x	x	6.439	6.226	x	x	6.372	x	x	x	x	x	6.439	x	x	x	x	x	x	x	
-14885	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, females	Morphology, metabolism: Body length from the nose until the tail at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.537	6.548	6.448	6.459	6.456	x	6.546	6.454	x	6.426	x	6.545	6.531	6.536	6.508	x	x	x	x	x	x	6.485	x	x	6.41	x	x	x	6.548	6.487	6.44	x	x	x	x	6.544	6.496	6.445	x	6.41	6.436	x	x	x	x	x	x	x	6.526	x	x	x	x	x	x	x	x	x	6.484	6.428	x	x	x	x	x	6.41	6.412	x	x	x	6.476	x	6.537	x	x	x	x	x	x	x	x	x	x	6.548	6.41	x	x	6.489	x	x	x	x	x	6.548	x	x	x	x	x	x	x	
-14363	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in females_data, trimmed [g] Original pre publication description: Hall trait 9	Hall trait 9	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g]	x	0.07	0.048	0.057	0.053	0.058	x	x	x	x	0.049	x	0.066	x	x	x	x	0.082	x	x	x	x	0.051	x	x	x	x	x	x	0.045	0.07	0.064	x	x	x	x	0.062	0.06	0.078	x	0.054	0.062	x	x	x	x	x	x	x	0.046	x	x	x	0.069	x	x	x	x	x	0.067	0.049	x	x	0.052	x	x	x	x	x	x	x	0.062	x	0.053	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.054	x	x	x	x	x	0.062	x	0.066	x	x	x	x	x	
-14359	Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in males and females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 5	Hall trait 5	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data, trimmed [ug hydroxyproline/g liver]	x	325.87	419.3	570.89	462.29	478.58	x	335.81	x	x	403.13	472.41	368.24	357.81	x	x	x	403.06	x	x	x	181.2	334.27	x	x	327.64	282.62	253.97	x	333.13	406.14	373.12	273.19	x	x	x	394.81	298.07	283.1	x	385.05	408.5	x	x	x	x	x	x	x	421.34	x	x	x	391.98	x	x	x	x	x	351.17	402.27	x	x	507.9	x	x	x	380.88	x	x	257.72	547.9	x	416.88	x	x	x	x	x	x	x	x	x	x	x	335.07	x	x	307.36	x	x	x	x	x	296.23	x	559.49	x	x	x	x	x	
-14360	Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in males and females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 6	Hall trait 6	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen data, trimmed [ug hydroxyproline/g liver]	x	337.37	425.12	542.4	476.38	445.79	x	325.96	x	x	414.98	475.42	380.33	361.7	x	x	x	351.92	x	x	x	181.2	326.41	x	x	331.86	292.31	289.35	x	337.0	472.87	356.72	280.62	x	x	x	409.63	294.83	294.4	x	387.36	396.56	x	x	x	x	x	x	x	415.07	x	x	x	405.38	x	x	x	x	x	330.27	385.58	x	x	489.62	x	x	x	366.11	x	x	257.72	482.38	x	410.68	x	x	x	x	x	x	x	x	x	x	x	331.31	x	x	320.06	x	x	x	x	x	275.53	x	538.41	x	x	x	x	x	
-14361	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in males_data, trimmed [g] Original pre publication description: Hall trait 7	Hall trait 7	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, trimmed [g]	x	0.051	0.046	0.049	0.068	0.061	x	x	x	x	0.063	x	x	0.074	x	x	x	0.081	x	x	x	x	0.064	x	x	x	x	x	x	x	0.064	0.064	x	x	x	x	0.052	x	0.08	x	x	0.063	x	x	x	x	x	x	x	0.047	x	x	x	0.075	x	x	x	x	x	0.058	0.049	x	x	0.054	x	x	x	0.044	x	x	0.061	0.049	x	0.051	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.063	x	x	x	x	x	0.055	x	0.072	x	x	x	x	x	
-15171	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec]	x	x	34.916	25.027	70.138	38.916	22.138	49.277	33.111	24.555	29.027	54.166	51.555	30.0	75.583	41.277	46.805	51.0	61.194	74.25	27.138	24.444	x	38.555	30.916	55.166	56.611	70.722	47.194	47.444	25.583	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15172	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec]	x	x	17.388	17.333	36.388	24.194	13.5	33.75	34.25	30.0	17.416	31.416	36.861	28.805	45.194	34.416	32.416	44.638	41.222	40.111	17.444	24.388	x	23.388	18.388	28.638	31.916	47.944	21.222	42.944	20.638	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15131	Original post publication description: Cardiovascular system: Systolic blood pressure of adult males raised in Memphis measured using a tail cuff system [mm Hg]	None	Cardiovascular system: Systolic blood pressure of adult males raised in Memphis measured using a tail cuff system (originally known as GN Trait 11017) [mm Hg]	x	x	100.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	83.0	112.8	103.3	x	x	x	x	x	x	x	x	x	98.4	107.7	x	x	x	x	101.0	x	x	x	111.0	102.1	x	89.9	91.9	x	108.0	x	95.5	x	106.8	x	x	x	x	91.6	81.7	x	90.0	91.8	x	112.4	x	x	128.3	94.8	x	98.4	x	x	102.9	99.8	x	96.1	x	100.5	99.6	x	112.8	
-15132	Original post publication description: Cardiovascular system: Systolic blood pressure of adult females raised in Memphis measured using a tail cuff system [mm Hg]	None	Cardiovascular system: Systolic blood pressure of adult females raised in Memphis measured using a tail cuff system (originally known as GN Trait 12076) [mm Hg]	x	x	98.9	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	95.0	111.0	x	x	x	x	x	x	x	x	x	x	101.9	103.8	x	x	x	99.5	96.5	x	x	x	104.5	95.5	x	93.5	92.9	x	x	x	108.8	x	105.8	x	x	x	x	91.0	80.3	x	x	89.2	x	108.2	x	x	123.2	101.6	x	x	x	x	107.0	x	x	94.5	x	95.5	x	x	x	
-14933	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7 in females + males	Morphology, metabolism: Body weight at 49 days (7 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.353	4.464	4.242	4.271	4.441	x	4.363	4.313	x	4.24	x	x	4.529	4.419	4.529	x	x	x	x	x	x	4.401	x	x	4.419	x	x	x	4.46	4.383	4.232	x	x	x	x	4.507	4.501	4.232	x	4.529	4.358	x	x	x	x	x	x	x	4.46	x	x	x	x	x	x	x	x	x	4.457	4.297	x	x	x	x	x	4.333	4.232	x	x	x	4.466	x	4.45	x	x	x	x	x	x	x	x	x	x	4.443	4.232	x	x	4.376	x	x	x	x	x	4.529	x	x	x	x	x	x	x	
-14934	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8 in females + males	Morphology, metabolism: Body weight at 56 days (8 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.417	4.55	4.353	4.297	4.492	x	4.435	4.374	x	4.315	x	x	4.622	4.469	4.618	x	x	x	x	x	x	4.486	x	x	4.46	x	x	x	4.539	4.468	4.323	x	x	x	x	4.622	4.622	4.297	x	4.598	4.412	x	x	x	x	x	x	x	4.523	x	x	x	x	x	x	x	x	x	4.52	4.34	x	x	x	x	x	4.429	4.297	x	x	x	4.542	x	4.525	x	x	x	x	x	x	x	x	x	x	4.564	4.297	x	x	4.451	x	x	x	x	x	4.622	x	x	x	x	x	x	x	
-14935	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9 in females + males	Morphology, metabolism: Body weight at 63 days (9 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.471	4.591	4.41	4.384	4.538	x	4.505	4.423	x	4.421	x	x	4.678	4.55	4.678	x	x	x	x	x	x	4.526	x	x	4.544	x	x	x	4.603	4.518	4.384	x	x	x	x	4.639	4.678	4.384	x	4.669	4.46	x	x	x	x	x	x	x	4.551	x	x	x	x	x	x	x	x	x	4.555	4.406	x	x	x	x	x	4.462	4.387	x	x	x	4.59	x	4.579	x	x	x	x	x	x	x	x	x	x	4.678	4.384	x	x	4.49	x	x	x	x	x	4.654	x	x	x	x	x	x	x	
-14936	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10 in females + males	Morphology, metabolism: Body weight at 70 days (10 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.525	4.641	4.469	4.418	4.579	x	4.579	4.449	x	4.53	x	x	4.752	4.589	4.752	x	x	x	x	x	x	4.528	x	x	4.612	x	x	x	4.65	4.569	4.418	x	x	x	x	4.674	4.752	4.418	x	4.726	4.477	x	x	x	x	x	x	x	4.609	x	x	x	x	x	x	x	x	x	4.605	4.454	x	x	x	x	x	4.526	4.442	x	x	x	4.627	x	4.603	x	x	x	x	x	x	x	x	x	x	4.752	4.418	x	x	4.553	x	x	x	x	x	4.663	x	x	x	x	x	x	x	
-14937	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11 in females + males	Morphology, metabolism: Body weight at 77 days (11 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.566	4.705	4.503	4.481	4.623	x	4.602	4.506	x	4.616	x	x	4.837	4.638	4.837	x	x	x	x	x	x	4.619	x	x	4.686	x	x	x	4.688	4.596	4.481	x	x	x	x	4.717	4.837	4.481	x	4.773	4.539	x	x	x	x	x	x	x	4.622	x	x	x	x	x	x	x	x	x	4.694	4.488	x	x	x	x	x	4.57	4.489	x	x	x	4.641	x	4.667	x	x	x	x	x	x	x	x	x	x	4.837	4.481	x	x	4.631	x	x	x	x	x	4.708	x	x	x	x	x	x	x	
-14938	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12 in females + males	Morphology, metabolism: Body weight at 84 days (12 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.6	4.766	4.53	4.515	4.648	x	4.638	4.56	x	4.696	x	x	4.881	4.669	4.881	x	x	x	x	x	x	4.668	x	x	4.731	x	x	x	4.748	4.629	4.515	x	x	x	x	4.769	4.881	4.515	x	4.783	4.576	x	x	x	x	x	x	x	4.657	x	x	x	x	x	x	x	x	x	4.762	4.526	x	x	x	x	x	4.618	4.541	x	x	x	4.678	x	4.713	x	x	x	x	x	x	x	x	x	x	4.881	4.515	x	x	4.702	x	x	x	x	x	4.729	x	x	x	x	x	x	x	
-14939	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13 in females + males	Morphology, metabolism: Body weight at 91 days (13 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.599	4.784	4.558	4.538	4.685	x	4.676	4.577	x	4.779	x	x	4.902	4.717	4.902	x	x	x	x	x	x	4.671	x	x	4.784	x	x	x	4.81	4.648	4.538	x	x	x	x	4.783	4.902	4.538	x	4.811	4.601	x	x	x	x	x	x	x	4.67	x	x	x	x	x	x	x	x	x	4.83	4.548	x	x	x	x	x	4.636	4.577	x	x	x	4.671	x	4.735	x	x	x	x	x	x	x	x	x	x	4.902	4.538	x	x	4.73	x	x	x	x	x	4.757	x	x	x	x	x	x	x	
-14940	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14 in females + males	Morphology, metabolism: Body weight at 98 days (14 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.632	4.814	4.584	4.584	4.696	x	4.714	4.619	x	4.861	x	x	4.989	4.742	4.989	x	x	x	x	x	x	4.713	x	x	4.803	x	x	x	4.855	4.633	4.584	x	x	x	x	4.825	4.989	4.584	x	4.825	4.642	x	x	x	x	x	x	x	4.705	x	x	x	x	x	x	x	x	x	4.899	4.587	x	x	x	x	x	4.668	4.657	x	x	x	4.699	x	4.777	x	x	x	x	x	x	x	x	x	x	4.989	4.584	x	x	4.772	x	x	x	x	x	4.785	x	x	x	x	x	x	x	
-14941	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15 in females + males	Morphology, metabolism: Body weight at 105 days (15 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.669	4.844	4.61	4.583	4.73	x	4.714	4.682	x	4.954	x	x	5.043	4.765	5.043	x	x	x	x	x	x	4.706	x	x	4.852	x	x	x	4.898	4.682	4.583	x	x	x	x	4.828	5.043	4.583	x	4.888	4.651	x	x	x	x	x	x	x	4.737	x	x	x	x	x	x	x	x	x	5.003	4.624	x	x	x	x	x	4.713	4.68	x	x	x	4.73	x	4.785	x	x	x	x	x	x	x	x	x	x	5.043	4.583	x	x	4.856	x	x	x	x	x	4.784	x	x	x	x	x	x	x	
-14942	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16 in females + males	Morphology, metabolism: Body weight at 112 days (16 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.686	4.87	4.617	4.617	4.759	x	4.738	4.691	x	4.975	x	x	5.103	4.815	5.089	x	x	x	x	x	x	4.723	x	x	4.887	x	x	x	4.903	4.693	4.621	x	x	x	x	4.85	5.103	4.617	x	4.938	4.682	x	x	x	x	x	x	x	4.758	x	x	x	x	x	x	x	x	x	5.103	4.638	x	x	x	x	x	4.709	4.713	x	x	x	4.734	x	4.829	x	x	x	x	x	x	x	x	x	x	5.103	4.617	x	x	4.882	x	x	x	x	x	4.821	x	x	x	x	x	x	x	
-14943	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17 in females + males	Morphology, metabolism: Body weight at 119 days (17 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.71	4.922	4.63	4.63	4.782	x	4.749	4.746	x	5.076	x	x	5.17	4.792	5.17	x	x	x	x	x	x	4.728	x	x	4.88	x	x	x	4.949	4.691	4.653	x	x	x	x	4.86	5.17	4.63	x	4.975	4.691	x	x	x	x	x	x	x	4.798	x	x	x	x	x	x	x	x	x	5.159	4.631	x	x	x	x	x	4.732	4.8	x	x	x	4.736	x	4.825	x	x	x	x	x	x	x	x	x	x	5.17	4.63	x	x	4.91	x	x	x	x	x	4.855	x	x	x	x	x	x	x	
-14944	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18 in females + males	Morphology, metabolism: Body weight at 126 days (18 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.754	4.953	4.659	4.659	4.796	x	4.778	4.753	x	5.15	x	x	5.185	x	5.184	x	x	x	x	x	x	4.756	x	x	4.935	x	x	x	4.977	4.718	4.673	x	x	x	x	4.856	5.185	4.659	x	5.012	4.749	x	x	x	x	x	x	x	4.831	x	x	x	x	x	x	x	x	x	5.185	4.664	x	x	x	x	x	4.785	4.862	x	x	x	4.745	x	4.861	x	x	x	x	x	x	x	x	x	x	5.185	4.659	x	x	4.949	x	x	x	x	x	4.899	x	x	x	x	x	x	x	
-14945	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19 in females + males	Morphology, metabolism: Body weight at 133 days (19 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.758	4.965	4.659	4.659	4.816	x	4.794	4.814	x	5.21	x	x	5.259	x	5.259	x	x	x	x	x	x	4.799	x	x	4.949	x	x	x	5.037	4.728	4.705	x	x	x	x	4.914	5.259	4.659	x	5.035	4.777	x	x	x	x	x	x	x	4.869	x	x	x	x	x	x	x	x	x	5.231	4.686	x	x	x	x	x	4.797	4.853	x	x	x	4.767	x	4.89	x	x	x	x	x	x	x	x	x	x	5.259	4.659	x	x	4.989	x	x	x	x	x	4.936	x	x	x	x	x	x	x	
-14946	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20 in females + males	Morphology, metabolism: Body weight at 140 days (20 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.796	5.014	4.722	4.692	4.815	x	4.817	4.871	x	5.262	x	x	5.254	x	5.262	x	x	x	x	x	x	4.826	x	x	4.973	x	x	x	5.067	4.741	4.692	x	x	x	x	4.898	5.262	4.692	x	5.062	4.802	x	x	x	x	x	x	x	4.925	x	x	x	x	x	x	x	x	x	5.246	4.719	x	x	x	x	x	4.806	4.934	x	x	x	4.812	x	4.929	x	x	x	x	x	x	x	x	x	x	5.262	4.692	x	x	5.025	x	x	x	x	x	4.964	x	x	x	x	x	x	x	
-14947	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5 in females + males	Morphology, metabolism: Body weight gain between 4 and 5 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.305	2.285	2.231	2.202	2.509	x	2.365	2.204	x	x	x	x	2.744	2.483	2.744	x	x	x	x	x	x	x	x	x	2.323	x	x	x	2.182	2.356	1.943	x	x	x	x	1.929	2.744	2.327	x	2.368	1.929	x	x	x	x	x	x	x	2.364	x	x	x	x	x	x	x	x	x	2.694	2.233	x	x	x	x	x	2.293	2.351	x	x	x	2.413	x	2.497	x	x	x	x	x	x	x	x	x	x	2.405	1.929	x	x	2.282	x	x	x	x	x	2.74	x	x	x	x	x	x	x	
-14948	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6 in females + males	Morphology, metabolism: Body weight gain between 5 and 6 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.848	1.965	2.044	1.629	1.795	x	2.037	2.041	x	2.104	x	x	1.933	1.629	2.26	x	x	x	x	x	x	2.26	x	x	2.247	x	x	x	2.17	2.245	2.179	x	x	x	x	2.26	2.121	2.063	x	1.629	1.648	x	x	x	x	x	x	x	2.102	x	x	x	x	x	x	x	x	x	2.26	1.654	x	x	x	x	x	1.629	1.997	x	x	x	1.997	x	1.82	x	x	x	x	x	x	x	x	x	x	2.235	1.811	x	x	2.245	x	x	x	x	x	2.128	x	x	x	x	x	x	x	
-14949	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7 in females + males	Morphology, metabolism: Body weight gain between 6 and 7 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.433	1.685	1.723	1.495	1.496	x	1.82	1.655	x	1.493	x	x	1.433	1.621	1.508	x	x	x	x	x	x	1.978	x	x	1.978	x	x	x	1.611	1.666	1.934	x	x	x	x	1.433	1.868	1.433	x	1.763	1.793	x	x	x	x	x	x	x	1.579	x	x	x	x	x	x	x	x	x	1.768	1.812	x	x	x	x	x	1.654	1.455	x	x	x	1.978	x	1.452	x	x	x	x	x	x	x	x	x	x	1.978	1.731	x	x	1.737	x	x	x	x	x	1.604	x	x	x	x	x	x	x	
-14950	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8 in females + males	Morphology, metabolism: Body weight gain between 7 and 8 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.55	1.748	1.811	1.391	1.476	x	1.611	1.519	x	1.595	x	x	1.948	1.465	1.655	x	x	x	x	x	x	1.711	x	x	1.391	x	x	x	1.695	1.707	1.707	x	x	x	x	1.948	1.948	1.391	x	1.625	1.475	x	x	x	x	x	x	x	1.576	x	x	x	x	x	x	x	x	x	1.575	1.391	x	x	x	x	x	1.757	1.609	x	x	x	1.677	x	1.658	x	x	x	x	x	x	x	x	x	x	1.948	1.594	x	x	1.639	x	x	x	x	x	1.613	x	x	x	x	x	x	x	
-14951	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9 in females + males	Morphology, metabolism: Body weight gain between 8 and 9 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.499	1.421	1.499	1.343	1.446	x	1.614	1.44	x	1.802	x	x	1.802	1.708	1.674	x	x	x	x	x	x	1.396	x	x	1.735	x	x	x	1.612	1.473	1.518	x	x	x	x	1.299	1.802	1.32	x	1.69	1.438	x	x	x	x	x	x	x	1.299	x	x	x	x	x	x	x	x	x	1.361	1.559	x	x	x	x	x	1.324	1.718	x	x	x	1.484	x	1.528	x	x	x	x	x	x	x	x	x	x	1.802	1.299	x	x	1.378	x	x	x	x	x	1.299	x	x	x	x	x	x	x	
-14952	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10 in females + males	Morphology, metabolism: Body weight gain between 9 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	0.839	0.844	0.886	0.208	0.669	x	1.202	0.386	x	1.389	x	x	1.389	0.651	1.258	x	x	x	x	x	x	0.208	x	x	1.125	x	x	x	0.802	0.83	0.461	x	x	x	x	0.599	1.389	0.587	x	1.022	0.271	x	x	x	x	x	x	x	0.962	x	x	x	x	x	x	x	x	x	0.82	0.711	x	x	x	x	x	0.998	0.81	x	x	x	0.628	x	0.395	x	x	x	x	x	x	x	x	x	x	1.389	0.208	x	x	0.989	x	x	x	x	x	0.208	x	x	x	x	x	x	x	
-14953	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11 in females + males	Morphology, metabolism: Body weight gain between 10 and 11 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.415	1.649	1.344	1.28	1.454	x	1.28	1.531	x	1.776	x	x	1.828	1.502	1.828	x	x	x	x	x	x	1.804	x	x	1.717	x	x	x	1.42	1.295	1.578	x	x	x	x	1.475	1.705	1.452	x	1.522	1.576	x	x	x	x	x	x	x	1.28	x	x	x	x	x	x	x	x	x	1.828	1.336	x	x	x	x	x	1.438	1.447	x	x	x	1.28	x	1.634	x	x	x	x	x	x	x	x	x	x	1.828	1.42	x	x	1.73	x	x	x	x	x	1.481	x	x	x	x	x	x	x	
-14954	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12 in females + males	Morphology, metabolism: Body weight gain between 11 and 12 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.355	1.641	1.274	1.261	1.286	x	1.385	1.52	x	1.757	x	x	1.757	1.344	1.56	x	x	x	x	x	x	1.511	x	x	1.487	x	x	x	1.634	1.35	1.335	x	x	x	x	1.57	1.757	1.309	x	1.261	1.379	x	x	x	x	x	x	x	1.382	x	x	x	x	x	x	x	x	x	1.699	1.377	x	x	x	x	x	1.49	1.497	x	x	x	1.403	x	1.497	x	x	x	x	x	x	x	x	x	x	1.757	1.261	x	x	1.696	x	x	x	x	x	1.261	x	x	x	x	x	x	x	
-14955	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13 in females + males	Morphology, metabolism: Body weight gain between 12 and 13 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.13	1.299	1.36	1.13	1.466	x	1.475	1.259	x	1.767	x	x	1.67	1.572	1.323	x	x	x	x	x	x	1.13	x	x	1.636	x	x	x	1.718	1.293	1.31	x	x	x	x	1.248	1.767	1.453	x	1.408	1.337	x	x	x	x	x	x	x	1.231	x	x	x	x	x	x	x	x	x	1.767	1.31	x	x	x	x	x	1.274	1.434	x	x	x	1.13	x	1.332	x	x	x	x	x	x	x	x	x	x	1.767	1.326	x	x	1.4	x	x	x	x	x	1.39	x	x	x	x	x	x	x	
-14956	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14 in females + males	Morphology, metabolism: Body weight gain between 13 and 14 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.491	1.511	1.43	1.49	1.356	x	1.562	1.578	x	1.875	x	x	1.562	1.441	1.862	x	x	x	x	x	x	1.587	x	x	1.398	x	x	x	1.657	1.356	1.605	x	x	x	x	1.62	1.875	1.44	x	1.356	1.569	x	x	x	x	x	x	x	1.529	x	x	x	x	x	x	x	x	x	1.875	1.536	x	x	x	x	x	1.5	1.859	x	x	x	1.467	x	1.609	x	x	x	x	x	x	x	x	x	x	1.875	1.356	x	x	1.603	x	x	x	x	x	1.493	x	x	x	x	x	x	x	
-14957	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15 in females + males	Morphology, metabolism: Body weight gain between 14 and 15 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.444	1.407	1.332	1.255	1.432	x	1.061	1.662	x	1.874	x	x	1.704	1.323	1.654	x	x	x	x	x	x	1.061	x	x	1.608	x	x	x	1.558	1.546	1.061	x	x	x	x	1.092	1.301	1.275	x	1.734	1.153	x	x	x	x	x	x	x	1.41	x	x	x	x	x	x	x	x	x	1.874	1.429	x	x	x	x	x	1.526	1.308	x	x	x	1.395	x	1.147	x	x	x	x	x	x	x	x	x	x	1.874	1.191	x	x	1.874	x	x	x	x	x	1.061	x	x	x	x	x	x	x	
-14958	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16 in females + males	Morphology, metabolism: Body weight gain between 15 and 16 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.255	1.392	1.131	1.131	1.388	x	1.339	1.171	x	1.348	x	x	1.577	1.605	1.627	x	x	x	x	x	x	1.253	x	x	1.488	x	x	x	1.137	1.2	1.482	x	x	x	x	1.321	1.627	1.305	x	1.627	1.405	x	x	x	x	x	x	x	1.307	x	x	x	x	x	x	x	x	x	1.627	1.226	x	x	x	x	x	1.131	1.428	x	x	x	1.131	x	1.551	x	x	x	x	x	x	x	x	x	x	1.566	1.158	x	x	1.382	x	x	x	x	x	1.483	x	x	x	x	x	x	x	
-14959	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17 in females + males	Morphology, metabolism: Body weight gain between 16 and 17 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.519	1.812	1.425	1.236	1.528	x	1.402	1.783	x	1.963	x	x	1.713	1.236	1.963	x	x	x	x	x	x	1.345	x	x	1.236	x	x	x	1.772	1.268	1.575	x	x	x	x	1.399	1.91	1.32	x	1.687	1.375	x	x	x	x	x	x	x	1.682	x	x	x	x	x	x	x	x	x	1.906	1.411	x	x	x	x	x	1.52	1.963	x	x	x	1.309	x	1.236	x	x	x	x	x	x	x	x	x	x	1.963	1.401	x	x	1.595	x	x	x	x	x	1.659	x	x	x	x	x	x	x	
-14960	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18 in females + males	Morphology, metabolism: Body weight gain between 17 and 18 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.525	1.45	1.367	1.418	1.235	x	1.402	1.176	x	1.696	x	x	1.176	x	1.284	x	x	x	x	x	x	1.376	x	x	1.696	x	x	x	1.427	1.365	1.292	x	x	x	x	1.176	1.696	1.458	x	1.543	1.661	x	x	x	x	x	x	x	1.444	x	x	x	x	x	x	x	x	x	1.456	1.418	x	x	x	x	x	1.625	1.696	x	x	x	1.176	x	1.485	x	x	x	x	x	x	x	x	x	x	1.639	1.184	x	x	1.541	x	x	x	x	x	1.576	x	x	x	x	x	x	x	
-14961	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19 in females + males	Morphology, metabolism: Body weight gain between 18 and 19 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.407	1.552	1.416	1.407	1.607	x	1.57	1.932	x	1.952	x	x	1.407	x	1.952	x	x	x	x	x	x	1.799	x	x	1.56	x	x	x	1.952	1.534	1.698	x	x	x	x	1.952	1.501	1.699	x	1.674	1.672	x	x	x	x	x	x	x	1.777	x	x	x	x	x	x	x	x	x	1.947	1.606	x	x	x	x	x	1.532	1.407	x	x	x	1.625	x	1.7	x	x	x	x	x	x	x	x	x	x	1.669	1.696	x	x	1.839	x	x	x	x	x	1.785	x	x	x	x	x	x	x	
-14962	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20 in females + males	Morphology, metabolism: Body weight gain between 19 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.602	1.474	1.787	1.358	1.413	x	1.469	1.79	x	1.803	x	x	1.391	x	1.517	x	x	x	x	x	x	1.519	x	x	1.506	x	x	x	1.599	1.355	1.355	x	x	x	x	1.355	1.803	1.666	x	1.556	1.486	x	x	x	x	x	x	x	1.803	x	x	x	x	x	x	x	x	x	1.435	1.556	x	x	x	x	x	1.355	1.803	x	x	x	1.666	x	1.614	x	x	x	x	x	x	x	x	x	x	1.495	1.453	x	x	1.649	x	x	x	x	x	1.545	x	x	x	x	x	x	x	
-14963	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6 in females + males	Morphology, metabolism: Body length from the nose until the tail at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.448	6.464	6.331	6.381	6.445	x	6.41	6.382	x	6.344	x	x	6.464	6.371	6.459	x	x	x	x	x	x	6.321	x	x	6.307	x	x	x	6.402	6.366	6.292	x	x	x	x	6.442	6.384	6.326	x	6.425	6.275	x	x	x	x	x	x	x	6.425	x	x	x	x	x	x	x	x	x	6.405	6.275	x	x	x	x	x	6.354	6.275	x	x	x	6.29	x	6.419	x	x	x	x	x	x	x	x	x	x	6.464	6.275	x	x	6.394	x	x	x	x	x	6.464	x	x	x	x	x	x	x	
-14964	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10 in females + males	Morphology, metabolism: Body length from the nose until the tail at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.564	6.579	6.45	6.473	6.508	x	6.565	6.498	x	6.464	x	x	6.579	6.552	6.56	x	x	x	x	x	x	6.513	x	x	6.481	x	x	x	6.562	6.502	6.476	x	x	x	x	6.574	6.53	6.468	x	6.449	6.474	x	x	x	x	x	x	x	6.566	x	x	x	x	x	x	x	x	x	6.514	6.449	x	x	x	x	x	6.449	6.457	x	x	x	6.53	x	6.555	x	x	x	x	x	x	x	x	x	x	6.579	6.449	x	x	6.53	x	x	x	x	x	6.579	x	x	x	x	x	x	x	
-14965	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20 in females + males	Morphology, metabolism: Body length from the nose until the tail at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.626	6.651	6.596	6.55	6.635	x	6.662	6.55	x	6.618	x	x	6.67	x	6.67	x	x	x	x	x	x	6.616	x	x	6.559	x	x	x	6.604	6.573	6.558	x	x	x	x	6.635	6.634	6.55	x	6.67	6.565	x	x	x	x	x	x	x	6.627	x	x	x	x	x	x	x	x	x	6.632	6.555	x	x	x	x	x	6.598	6.572	x	x	x	6.608	x	6.614	x	x	x	x	x	x	x	x	x	x	6.67	6.55	x	x	6.638	x	x	x	x	x	6.67	x	x	x	x	x	x	x	
-14966	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10 in females + males	Morphology, metabolism: Serum glucose level at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.447	6.546	6.502	6.468	6.621	x	6.416	6.454	x	6.665	x	x	6.477	6.416	6.641	x	x	x	x	x	x	6.612	x	x	6.416	x	x	x	6.445	6.565	6.774	x	x	x	x	6.521	6.727	6.419	x	6.432	6.625	x	x	x	x	x	x	x	6.774	x	x	x	x	x	x	x	x	x	6.416	6.726	x	x	x	x	x	6.705	6.774	x	x	x	6.774	x	6.461	x	x	x	x	x	x	x	x	x	x	6.539	6.742	x	x	6.489	x	x	x	x	x	6.724	x	x	x	x	x	x	x	
-14967	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20 in females + males	Morphology, metabolism: Serum glucose level at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.668	6.574	6.429	6.607	6.612	x	6.367	6.618	x	6.527	x	x	6.885	x	6.342	x	x	x	x	x	x	6.531	x	x	6.704	x	x	x	6.619	6.342	6.56	x	x	x	x	6.961	6.961	6.478	x	6.342	6.434	x	x	x	x	x	x	x	6.768	x	x	x	x	x	x	x	x	x	6.342	6.424	x	x	x	x	x	6.662	6.961	x	x	x	6.961	x	6.673	x	x	x	x	x	x	x	x	x	x	6.919	6.797	x	x	6.518	x	x	x	x	x	6.596	x	x	x	x	x	x	x	
-14968	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10 in females + males	Morphology, metabolism: Food Intake between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.504	1.485	1.402	1.43	1.592	x	1.613	1.704	x	1.58	x	x	1.687	1.767	1.641	x	x	x	x	x	x	1.454	x	x	1.57	x	x	x	1.639	1.491	1.634	x	x	x	x	1.846	1.83	1.402	x	1.856	1.444	x	x	x	x	x	x	x	1.724	x	x	x	x	x	x	x	x	x	1.484	1.402	x	x	x	x	x	1.613	1.856	x	x	x	1.856	x	1.566	x	x	x	x	x	x	x	x	x	x	1.818	1.505	x	x	1.402	x	x	x	x	x	1.856	x	x	x	x	x	x	x	
-14969	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20 in females + males	Morphology, metabolism: Food Intake between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.497	1.75	1.534	1.497	1.847	x	1.743	1.735	x	1.775	x	x	2.003	x	1.758	x	x	x	x	x	x	1.497	x	x	1.964	x	x	x	1.614	1.591	1.703	x	x	x	x	1.642	1.887	1.566	x	1.777	1.682	x	x	x	x	x	x	x	1.767	x	x	x	x	x	x	x	x	x	1.754	1.537	x	x	x	x	x	1.648	2.003	x	x	x	2.003	x	1.653	x	x	x	x	x	x	x	x	x	x	1.99	1.497	x	x	2.003	x	x	x	x	x	1.764	x	x	x	x	x	x	x	
-14970	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain in females + males	Morphology, metabolism: Brain weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.292	1.294	1.259	1.28	1.262	x	1.259	1.274	x	1.267	x	x	1.283	1.282	1.294	x	x	x	x	x	x	1.259	x	x	1.259	x	x	x	1.281	1.268	1.277	x	x	x	x	1.289	1.274	1.277	x	1.294	1.272	x	x	x	x	x	x	x	1.286	x	x	x	x	x	x	x	x	x	1.287	1.265	x	x	x	x	x	1.276	1.287	x	x	x	1.283	x	1.274	x	x	x	x	x	x	x	x	x	x	1.294	1.259	x	x	1.267	x	x	x	x	x	1.275	x	x	x	x	x	x	x	
-14971	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver in females + males	Morphology, metabolism: Liver weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.692	1.755	1.714	1.611	1.811	x	1.741	1.725	x	1.737	x	x	1.969	1.611	1.885	x	x	x	x	x	x	1.631	x	x	1.822	x	x	x	1.718	1.708	1.611	x	x	x	x	1.665	1.969	1.68	x	1.969	1.705	x	x	x	x	x	x	x	1.796	x	x	x	x	x	x	x	x	x	1.969	1.741	x	x	x	x	x	1.675	1.82	x	x	x	1.735	x	1.811	x	x	x	x	x	x	x	x	x	x	1.969	1.611	x	x	1.889	x	x	x	x	x	1.75	x	x	x	x	x	x	x	
-14972	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney in females + males	Morphology, metabolism: Kidney weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.25	1.22	1.264	1.205	1.239	x	1.22	1.261	x	1.217	x	x	1.272	1.225	1.228	x	x	x	x	x	x	1.21	x	x	1.235	x	x	x	1.205	1.257	1.225	x	x	x	x	1.258	1.262	1.21	x	1.272	1.205	x	x	x	x	x	x	x	1.272	x	x	x	x	x	x	x	x	x	1.244	1.222	x	x	x	x	x	1.22	1.272	x	x	x	1.271	x	1.252	x	x	x	x	x	x	x	x	x	x	1.267	1.205	x	x	1.254	x	x	x	x	x	1.242	x	x	x	x	x	x	x	
-14973	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen in females + males	Morphology, metabolism: Spleen weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.052	1.076	1.06	1.061	1.089	x	1.076	1.059	x	1.05	x	x	1.089	1.05	1.089	x	x	x	x	x	x	1.055	x	x	1.073	x	x	x	1.066	1.077	1.052	x	x	x	x	1.068	1.077	1.05	x	1.087	1.089	x	x	x	x	x	x	x	1.075	x	x	x	x	x	x	x	x	x	1.055	1.05	x	x	x	x	x	1.064	1.063	x	x	x	1.059	x	1.058	x	x	x	x	x	x	x	x	x	x	1.061	1.05	x	x	1.061	x	x	x	x	x	1.074	x	x	x	x	x	x	x	
-14974	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart in females + males	Morphology, metabolism: Heart weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.098	1.092	1.094	1.085	1.096	x	1.092	1.096	x	1.09	x	x	1.109	1.085	1.101	x	x	x	x	x	x	1.085	x	x	1.109	x	x	x	1.085	1.085	1.092	x	x	x	x	1.109	1.107	1.104	x	1.102	1.093	x	x	x	x	x	x	x	1.09	x	x	x	x	x	x	x	x	x	1.088	1.085	x	x	x	x	x	1.089	1.099	x	x	x	1.107	x	1.09	x	x	x	x	x	x	x	x	x	x	1.109	1.085	x	x	1.102	x	x	x	x	x	1.103	x	x	x	x	x	x	x	
-14975	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung in females + males	Cardiovascular pulmonary system, morphology, metabolism: Lung weight at 20 weeks in females and males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.153	1.128	1.121	1.121	1.157	x	1.144	1.134	x	1.134	x	x	1.143	1.141	1.138	x	x	x	x	x	x	1.131	x	x	1.141	x	x	x	1.121	1.136	1.124	x	x	x	x	1.138	1.157	1.145	x	1.157	1.138	x	x	x	x	x	x	x	1.126	x	x	x	x	x	x	x	x	x	1.127	1.134	x	x	x	x	x	1.157	1.138	x	x	x	1.143	x	1.143	x	x	x	x	x	x	x	x	x	x	1.134	1.121	x	x	1.136	x	x	x	x	x	1.153	x	x	x	x	x	x	x	
-14976	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas in females + males	Morphology, metabolism: Pancreas weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.133	1.155	1.153	1.133	1.183	x	1.181	1.223	x	1.162	x	x	1.223	1.183	1.2	x	x	x	x	x	x	1.161	x	x	1.16	x	x	x	1.16	1.154	1.155	x	x	x	x	1.179	1.223	1.133	x	1.153	1.184	x	x	x	x	x	x	x	1.206	x	x	x	x	x	x	x	x	x	1.204	1.163	x	x	x	x	x	1.163	1.192	x	x	x	1.162	x	1.158	x	x	x	x	x	x	x	x	x	x	1.223	1.158	x	x	1.133	x	x	x	x	x	1.209	x	x	x	x	x	x	x	
-14977	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis in females + males	Morphology, metabolism: The quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.218	1.231	1.202	1.202	1.22	x	1.238	1.223	x	1.197	x	x	1.253	1.253	1.253	x	x	x	x	x	x	1.197	x	x	1.204	x	x	x	1.2	1.196	1.243	x	x	x	x	1.245	1.243	1.207	x	1.231	1.231	x	x	x	x	x	x	x	1.233	x	x	x	x	x	x	x	x	x	1.253	1.196	x	x	x	x	x	1.214	1.214	x	x	x	1.217	x	1.238	x	x	x	x	x	x	x	x	x	x	1.227	1.196	x	x	1.196	x	x	x	x	x	1.238	x	x	x	x	x	x	x	
-14978	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi in females + males	Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.34	1.343	1.294	1.294	1.341	x	1.375	1.336	x	1.368	x	x	1.375	1.347	1.339	x	x	x	x	x	x	1.305	x	x	1.294	x	x	x	1.363	1.302	1.352	x	x	x	x	1.348	1.375	1.353	x	1.36	1.332	x	x	x	x	x	x	x	1.34	x	x	x	x	x	x	x	x	x	1.375	1.309	x	x	x	x	x	1.341	1.303	x	x	x	1.322	x	1.35	x	x	x	x	x	x	x	x	x	x	1.34	1.294	x	x	1.309	x	x	x	x	x	1.375	x	x	x	x	x	x	x	
-14979	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF in females + males	Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.494	1.664	1.529	1.371	1.371	x	1.371	1.688	x	2.043	x	x	1.626	1.56	2.025	x	x	x	x	x	x	1.779	x	x	1.688	x	x	x	1.792	1.539	1.437	x	x	x	x	1.516	2.043	1.483	x	1.499	1.533	x	x	x	x	x	x	x	1.724	x	x	x	x	x	x	x	x	x	2.043	1.45	x	x	x	x	x	1.511	1.754	x	x	x	1.414	x	1.607	x	x	x	x	x	x	x	x	x	x	2.043	1.371	x	x	1.84	x	x	x	x	x	1.494	x	x	x	x	x	x	x	
-14980	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF in females + males	Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.108	1.168	1.143	1.082	1.082	x	1.082	1.188	x	1.285	x	x	1.185	1.126	1.285	x	x	x	x	x	x	1.185	x	x	1.192	x	x	x	1.244	1.104	1.094	x	x	x	x	1.103	1.285	1.092	x	1.119	1.155	x	x	x	x	x	x	x	1.184	x	x	x	x	x	x	x	x	x	1.245	1.123	x	x	x	x	x	1.122	1.167	x	x	x	1.082	x	1.12	x	x	x	x	x	x	x	x	x	x	1.285	1.083	x	x	1.109	x	x	x	x	x	1.132	x	x	x	x	x	x	x	
-14981	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF in females + males	Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.054	1.055	1.055	1.04	1.048	x	1.04	1.102	x	1.252	x	x	1.252	1.059	1.252	x	x	x	x	x	x	1.099	x	x	1.11	x	x	x	1.079	1.079	1.081	x	x	x	x	1.046	1.169	1.04	x	1.04	1.043	x	x	x	x	x	x	x	1.123	x	x	x	x	x	x	x	x	x	1.245	1.052	x	x	x	x	x	1.098	1.139	x	x	x	1.104	x	1.063	x	x	x	x	x	x	x	x	x	x	1.252	1.057	x	x	1.094	x	x	x	x	x	1.093	x	x	x	x	x	x	x	
-14982	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF in females + males	Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.158	1.217	1.192	1.127	1.127	x	1.127	1.279	x	1.47	x	x	1.413	1.18	1.47	x	x	x	x	x	x	1.272	x	x	1.289	x	x	x	1.312	1.178	1.171	x	x	x	x	1.146	1.47	1.127	x	1.156	1.194	x	x	x	x	x	x	x	1.293	x	x	x	x	x	x	x	x	x	1.455	1.171	x	x	x	x	x	1.212	1.292	x	x	x	1.175	x	1.167	x	x	x	x	x	x	x	x	x	x	1.47	1.137	x	x	1.197	x	x	x	x	x	1.217	x	x	x	x	x	x	x	
-14983	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF in females + males	Morphology, metabolism: Adipose tissue hanging at the intestine in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.258	1.228	1.198	1.164	1.21	x	1.164	1.273	x	1.511	x	x	1.46	1.185	1.511	x	x	x	x	x	x	1.257	x	x	1.323	x	x	x	1.369	1.231	1.164	x	x	x	x	1.197	1.511	1.165	x	1.222	1.164	x	x	x	x	x	x	x	1.381	x	x	x	x	x	x	x	x	x	1.361	1.22	x	x	x	x	x	1.273	1.337	x	x	x	1.268	x	1.21	x	x	x	x	x	x	x	x	x	x	1.511	1.164	x	x	1.387	x	x	x	x	x	1.287	x	x	x	x	x	x	x	
-14984	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF in females + males	Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.226	1.347	1.316	1.226	1.293	x	1.254	1.313	x	1.66	x	x	1.621	1.268	1.66	x	x	x	x	x	x	1.465	x	x	1.427	x	x	x	1.527	1.25	1.226	x	x	x	x	1.255	1.66	1.263	x	1.393	1.268	x	x	x	x	x	x	x	1.3	x	x	x	x	x	x	x	x	x	1.572	1.247	x	x	x	x	x	1.388	1.411	x	x	x	1.241	x	1.318	x	x	x	x	x	x	x	x	x	x	1.66	1.226	x	x	1.476	x	x	x	x	x	1.332	x	x	x	x	x	x	x	
-14985	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF in females + males	Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.132	1.292	1.215	1.112	1.161	x	1.112	1.254	x	1.37	x	x	1.296	1.279	1.331	x	x	x	x	x	x	1.328	x	x	1.354	x	x	x	1.37	1.172	1.112	x	x	x	x	1.188	1.226	1.199	x	1.328	1.249	x	x	x	x	x	x	x	1.147	x	x	x	x	x	x	x	x	x	1.345	1.127	x	x	x	x	x	1.199	1.28	x	x	x	1.139	x	1.208	x	x	x	x	x	x	x	x	x	x	1.37	1.112	x	x	1.37	x	x	x	x	x	1.212	x	x	x	x	x	x	x	
-14986	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF in females + males	Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.701	1.987	1.859	1.679	1.757	x	1.679	1.945	x	2.557	x	x	2.45	1.81	2.557	x	x	x	x	x	x	2.128	x	x	2.202	x	x	x	2.377	1.768	1.679	x	x	x	x	1.783	2.557	1.851	x	2.118	1.748	x	x	x	x	x	x	x	1.889	x	x	x	x	x	x	x	x	x	2.496	1.688	x	x	x	x	x	1.921	2.12	x	x	x	1.719	x	1.968	x	x	x	x	x	x	x	x	x	x	2.557	1.679	x	x	2.435	x	x	x	x	x	1.91	x	x	x	x	x	x	x	
-14987	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT in females + males	Morphology, metabolism: Total white adipose weight at 20 weeks in the whole body in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.546	2.019	1.736	1.216	1.433	x	1.216	2.116	x	3.058	x	x	2.739	1.669	3.058	x	x	x	x	x	x	2.298	x	x	2.339	x	x	x	2.627	1.685	1.216	x	x	x	x	1.598	3.058	1.619	x	2.002	1.66	x	x	x	x	x	x	x	2.135	x	x	x	x	x	x	x	x	x	2.927	1.484	x	x	x	x	x	1.873	2.343	x	x	x	1.517	x	1.923	x	x	x	x	x	x	x	x	x	x	3.058	1.216	x	x	2.64	x	x	x	x	x	1.878	x	x	x	x	x	x	x	
-14988	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT in females + males	Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.11	1.108	1.117	1.081	1.139	x	1.101	1.219	x	1.249	x	x	1.303	1.081	1.303	x	x	x	x	x	x	1.138	x	x	1.141	x	x	x	1.187	1.145	1.081	x	x	x	x	1.092	1.303	1.102	x	1.133	1.153	x	x	x	x	x	x	x	1.137	x	x	x	x	x	x	x	x	x	1.208	1.117	x	x	x	x	x	1.108	1.161	x	x	x	1.111	x	1.131	x	x	x	x	x	x	x	x	x	x	1.303	1.081	x	x	1.151	x	x	x	x	x	1.169	x	x	x	x	x	x	x	
-14989	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass in females + males	Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.233	3.376	3.008	3.008	3.225	x	3.313	3.161	x	3.187	x	x	3.399	3.282	3.318	x	x	x	x	x	x	3.008	x	x	3.168	x	x	x	3.223	3.073	3.199	x	x	x	x	3.324	3.399	3.008	x	3.399	3.158	x	x	x	x	x	x	x	3.205	x	x	x	x	x	x	x	x	x	3.345	3.03	x	x	x	x	x	3.096	3.126	x	x	x	3.146	x	3.242	x	x	x	x	x	x	x	x	x	x	3.399	3.008	x	x	3.216	x	x	x	x	x	3.388	x	x	x	x	x	x	x	
-14990	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF in females + males	Morphology, metabolism: Fat weight around the neck at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.062	1.107	1.085	1.062	1.064	x	1.064	1.147	x	1.185	x	x	1.174	1.081	1.147	x	x	x	x	x	x	1.116	x	x	1.176	x	x	x	1.185	1.068	1.062	x	x	x	x	1.076	1.121	1.116	x	1.132	1.075	x	x	x	x	x	x	x	1.087	x	x	x	x	x	x	x	x	x	1.143	1.084	x	x	x	x	x	1.07	1.131	x	x	x	1.084	x	1.096	x	x	x	x	x	x	x	x	x	x	1.185	1.062	x	x	1.185	x	x	x	x	x	1.096	x	x	x	x	x	x	x	
-14991	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF in females + males	Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.029	1.017	1.028	1.017	1.021	x	1.045	1.041	x	1.074	x	x	1.068	1.027	1.074	x	x	x	x	x	x	1.029	x	x	1.017	x	x	x	1.073	1.039	1.019	x	x	x	x	1.034	1.074	1.03	x	1.017	1.045	x	x	x	x	x	x	x	1.048	x	x	x	x	x	x	x	x	x	1.074	1.045	x	x	x	x	x	1.059	1.061	x	x	x	1.031	x	1.048	x	x	x	x	x	x	x	x	x	x	1.073	1.027	x	x	1.059	x	x	x	x	x	1.034	x	x	x	x	x	x	x	
-14992	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF in females + males	Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.236	1.258	1.31	1.216	1.263	x	1.216	1.43	x	1.881	x	x	1.738	1.28	1.811	x	x	x	x	x	x	1.376	x	x	1.388	x	x	x	1.638	1.216	1.216	x	x	x	x	1.295	1.881	1.309	x	1.333	1.225	x	x	x	x	x	x	x	1.428	x	x	x	x	x	x	x	x	x	1.881	1.256	x	x	x	x	x	1.399	1.498	x	x	x	1.288	x	1.48	x	x	x	x	x	x	x	x	x	x	1.881	1.262	x	x	1.486	x	x	x	x	x	1.292	x	x	x	x	x	x	x	
-14993	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.675	1.745	2.196	1.838	1.734	x	1.839	1.76	x	1.675	x	x	2.219	1.675	2.137	x	x	x	x	x	x	2.384	x	x	2.384	x	x	x	2.02	2.384	1.675	x	x	x	x	2.384	2.37	1.997	x	2.117	2.034	x	x	x	x	x	x	x	2.113	x	x	x	x	x	x	x	x	x	2.13	2.115	x	x	x	x	x	2.211	1.943	x	x	x	1.981	x	2.072	x	x	x	x	x	x	x	x	x	x	1.947	1.723	x	x	2.302	x	x	x	x	x	2.038	x	x	x	x	x	x	x	
-14994	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.904	2.056	2.542	1.848	1.926	x	1.999	1.937	x	1.989	x	x	2.703	1.848	2.464	x	x	x	x	x	x	2.731	x	x	2.731	x	x	x	2.109	2.724	1.848	x	x	x	x	2.731	2.731	2.107	x	2.199	2.092	x	x	x	x	x	x	x	2.218	x	x	x	x	x	x	x	x	x	2.217	2.399	x	x	x	x	x	2.603	1.917	x	x	x	2.444	x	2.029	x	x	x	x	x	x	x	x	x	x	2.711	1.848	x	x	2.387	x	x	x	x	x	2.199	x	x	x	x	x	x	x	
-14995	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.029	2.41	2.761	1.945	2.075	x	2.131	1.945	x	2.488	x	x	3.152	2.077	2.748	x	x	x	x	x	x	3.014	x	x	3.152	x	x	x	2.354	2.955	1.945	x	x	x	x	2.492	3.152	2.103	x	2.315	2.083	x	x	x	x	x	x	x	2.301	x	x	x	x	x	x	x	x	x	2.297	2.635	x	x	x	x	x	2.893	2.354	x	x	x	2.615	x	2.406	x	x	x	x	x	x	x	x	x	x	3.152	1.945	x	x	2.578	x	x	x	x	x	2.159	x	x	x	x	x	x	x	
-14996	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 84 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.381	2.316	2.272	1.164	1.465	x	1.596	1.164	x	2.623	x	x	3.204	1.241	2.639	x	x	x	x	x	x	2.584	x	x	3.204	x	x	x	2.11	2.526	1.164	x	x	x	x	2.014	3.204	1.572	x	1.722	1.534	x	x	x	x	x	x	x	1.737	x	x	x	x	x	x	x	x	x	1.764	2.696	x	x	x	x	x	2.615	1.968	x	x	x	2.01	x	2.075	x	x	x	x	x	x	x	x	x	x	3.204	1.164	x	x	2.4	x	x	x	x	x	1.704	x	x	x	x	x	x	x	
-14997	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 112 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.849	2.878	2.43	1.762	2.221	x	1.762	2.156	x	3.53	x	x	3.626	2.176	3.284	x	x	x	x	x	x	2.68	x	x	3.545	x	x	x	2.933	2.483	1.762	x	x	x	x	2.246	3.626	2.264	x	2.797	2.008	x	x	x	x	x	x	x	2.443	x	x	x	x	x	x	x	x	x	1.934	3.626	x	x	x	x	x	3.053	2.687	x	x	x	2.27	x	2.252	x	x	x	x	x	x	x	x	x	x	3.626	1.762	x	x	2.997	x	x	x	x	x	2.317	x	x	x	x	x	x	x	
-14998	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, males	Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.669	3.325	2.805	2.234	2.44	x	2.342	3.026	x	3.87	x	x	3.822	2.37	3.87	x	x	x	x	x	x	2.99	x	x	3.735	x	x	x	3.574	2.614	2.234	x	x	x	x	2.479	3.87	2.809	x	3.21	2.513	x	x	x	x	x	x	x	3.007	x	x	x	x	x	x	x	x	x	2.234	3.87	x	x	x	x	x	3.377	3.411	x	x	x	2.28	x	2.773	x	x	x	x	x	x	x	x	x	x	3.845	2.234	x	x	3.454	x	x	x	x	x	3.002	x	x	x	x	x	x	x	
-14999	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, males	Morphology, metabolism: Fat gain between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.86	2.21	2.331	1.572	1.829	x	1.795	1.635	x	2.372	x	x	2.588	1.889	2.318	x	x	x	x	x	x	2.345	x	x	2.588	x	x	x	1.897	2.294	1.572	x	x	x	x	1.616	2.588	1.572	x	1.724	1.572	x	x	x	x	x	x	x	1.709	x	x	x	x	x	x	x	x	x	1.68	2.184	x	x	x	x	x	2.45	1.975	x	x	x	2.277	x	1.911	x	x	x	x	x	x	x	x	x	x	2.588	1.583	x	x	1.889	x	x	x	x	x	1.598	x	x	x	x	x	x	x	
-15000	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, males	Morphology, metabolism: Fat gain between 17 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	2.525	2.012	2.056	1.648	1.648	x	2.017	2.985	x	3.337	x	x	2.539	2.265	3.337	x	x	x	x	x	x	1.98	x	x	2.478	x	x	x	3.262	1.648	2.196	x	x	x	x	1.822	3.337	2.415	x	2.992	2.267	x	x	x	x	x	x	x	2.746	x	x	x	x	x	x	x	x	x	1.719	3.337	x	x	x	x	x	2.647	3.125	x	x	x	1.648	x	2.209	x	x	x	x	x	x	x	x	x	x	2.442	1.844	x	x	2.941	x	x	x	x	x	2.756	x	x	x	x	x	x	x	
-15001	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.22	4.263	3.993	4.066	4.308	x	4.147	4.167	x	4.001	x	x	4.315	4.236	4.315	x	x	x	x	x	x	4.018	x	x	4.159	x	x	x	4.229	4.02	4.038	x	x	x	x	4.133	4.219	4.055	x	4.315	4.061	x	x	x	x	x	x	x	4.278	x	x	x	x	x	x	x	x	x	3.993	4.211	x	x	x	x	x	4.11	3.993	x	x	x	4.205	x	4.157	x	x	x	x	x	x	x	x	x	x	4.093	3.993	x	x	4.063	x	x	x	x	x	4.315	x	x	x	x	x	x	x	
-15002	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.29	4.431	4.128	4.231	4.409	x	4.308	4.268	x	4.128	x	x	4.431	4.317	4.418	x	x	x	x	x	x	4.128	x	x	4.295	x	x	x	4.376	4.191	4.279	x	x	x	x	4.354	4.391	4.131	x	4.431	4.262	x	x	x	x	x	x	x	4.382	x	x	x	x	x	x	x	x	x	4.128	4.401	x	x	x	x	x	4.235	4.161	x	x	x	4.37	x	4.312	x	x	x	x	x	x	x	x	x	x	4.286	4.148	x	x	4.287	x	x	x	x	x	4.431	x	x	x	x	x	x	x	
-15003	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.406	4.483	4.206	4.241	4.45	x	4.438	4.34	x	4.223	x	x	4.488	4.411	4.486	x	x	x	x	x	x	4.206	x	x	4.355	x	x	x	4.442	4.276	4.384	x	x	x	x	4.488	4.467	4.206	x	4.488	4.317	x	x	x	x	x	x	x	4.454	x	x	x	x	x	x	x	x	x	4.218	4.468	x	x	x	x	x	4.306	4.233	x	x	x	4.438	x	4.385	x	x	x	x	x	x	x	x	x	x	4.392	4.206	x	x	4.386	x	x	x	x	x	4.488	x	x	x	x	x	x	x	
-15004	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 84 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.429	4.559	4.25	4.296	4.517	x	4.489	4.417	x	4.299	x	x	4.58	4.475	4.555	x	x	x	x	x	x	4.25	x	x	4.409	x	x	x	4.491	4.345	4.422	x	x	x	x	4.58	4.58	4.278	x	4.58	4.374	x	x	x	x	x	x	x	4.472	x	x	x	x	x	x	x	x	x	4.25	4.56	x	x	x	x	x	4.393	4.343	x	x	x	4.491	x	4.468	x	x	x	x	x	x	x	x	x	x	4.468	4.25	x	x	4.452	x	x	x	x	x	4.517	x	x	x	x	x	x	x	
-15005	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.483	4.594	4.319	4.361	4.541	x	4.568	4.497	x	4.368	x	x	4.673	4.559	4.652	x	x	x	x	x	x	4.319	x	x	4.507	x	x	x	4.536	4.418	4.481	x	x	x	x	4.673	4.673	4.356	x	4.673	4.432	x	x	x	x	x	x	x	4.518	x	x	x	x	x	x	x	x	x	4.319	4.664	x	x	x	x	x	4.438	4.421	x	x	x	4.539	x	4.552	x	x	x	x	x	x	x	x	x	x	4.631	4.319	x	x	4.564	x	x	x	x	x	4.58	x	x	x	x	x	x	x	
-15006	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, males	Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	23.174	25.824	21.444	20.819	24.023	x	24.09	23.846	x	21.922	x	x	26.915	25.038	26.374	x	x	x	x	x	x	20.819	x	x	24.39	x	x	x	24.624	22.133	22.795	x	x	x	x	25.24	26.915	21.52	x	26.915	22.922	x	x	x	x	x	x	x	23.815	x	x	x	x	x	x	x	x	x	20.819	26.915	x	x	x	x	x	23.003	23.186	x	x	x	25.683	x	24.192	x	x	x	x	x	x	x	x	x	x	24.947	20.819	x	x	24.796	x	x	x	x	x	25.833	x	x	x	x	x	x	x	
-15007	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, males	Morphology, metabolism: Lean gain between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.359	1.662	1.486	1.115	1.115	x	1.985	1.197	x	1.411	x	x	1.719	1.277	1.283	x	x	x	x	x	x	1.115	x	x	1.38	x	x	x	1.574	1.66	1.985	x	x	x	x	1.985	1.807	1.115	x	1.742	1.697	x	x	x	x	x	x	x	1.336	x	x	x	x	x	x	x	x	x	1.431	1.856	x	x	x	x	x	1.331	1.579	x	x	x	1.693	x	1.61	x	x	x	x	x	x	x	x	x	x	1.974	1.36	x	x	1.985	x	x	x	x	x	1.34	x	x	x	x	x	x	x	
-15008	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, males	Morphology, metabolism: Lean gain between 17 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.862	2.086	2.242	1.745	1.746	x	1.864	2.166	x	2.083	x	x	2.374	2.263	2.285	x	x	x	x	x	x	1.814	x	x	2.362	x	x	x	2.051	1.929	1.745	x	x	x	x	1.745	2.374	2.014	x	2.144	2.064	x	x	x	x	x	x	x	1.858	x	x	x	x	x	x	x	x	x	1.913	2.374	x	x	x	x	x	1.996	2.29	x	x	x	2.374	x	2.02	x	x	x	x	x	x	x	x	x	x	2.27	1.745	x	x	2.294	x	x	x	x	x	2.306	x	x	x	x	x	x	x	
-15009	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, males	Morphology, metabolism: Body weight at 28 days (4 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	3.769	3.765	3.523	3.751	3.928	x	3.624	3.634	x	x	x	x	3.917	3.532	3.736	x	x	x	x	x	x	3.556	x	x	3.544	x	x	x	3.832	3.751	3.523	x	x	x	x	3.928	3.691	3.565	x	3.928	3.885	x	x	x	x	x	x	x	3.788	x	x	x	x	x	x	x	x	x	3.61	3.523	x	x	x	x	x	3.829	3.523	x	x	x	3.632	x	3.846	x	x	x	x	x	x	x	x	x	x	3.542	3.583	x	x	3.645	x	x	x	x	x	3.928	x	x	x	x	x	x	x	
-15010	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, males	Morphology, metabolism: Body weight at 35 days (5 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.295	4.303	4.088	4.212	4.406	x	4.167	4.173	x	4.036	x	x	4.406	4.154	4.406	x	x	x	x	x	x	4.036	x	x	4.221	x	x	x	4.293	4.162	4.036	x	x	x	x	4.325	4.342	4.154	x	4.406	4.238	x	x	x	x	x	x	x	4.281	x	x	x	x	x	x	x	x	x	4.108	4.238	x	x	x	x	x	4.3	4.089	x	x	x	4.248	x	4.335	x	x	x	x	x	x	x	x	x	x	4.11	4.036	x	x	4.154	x	x	x	x	x	4.404	x	x	x	x	x	x	x	
-15011	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, males	Morphology, metabolism: Body weight at 42 days (6 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.436	4.504	4.254	4.326	4.539	x	4.398	4.384	x	4.254	x	x	4.606	4.416	4.606	x	x	x	x	x	x	4.425	x	x	4.51	x	x	x	4.496	4.417	4.254	x	x	x	x	4.505	4.569	4.328	x	4.606	4.369	x	x	x	x	x	x	x	4.547	x	x	x	x	x	x	x	x	x	4.279	4.499	x	x	x	x	x	4.433	4.272	x	x	x	4.452	x	4.472	x	x	x	x	x	x	x	x	x	x	4.366	4.254	x	x	4.423	x	x	x	x	x	4.606	x	x	x	x	x	x	x	
-15012	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, males	Morphology, metabolism: Body weight at 49 days (7 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.509	4.611	4.362	4.392	4.6	x	4.531	4.491	x	4.362	x	x	4.695	4.488	4.695	x	x	x	x	x	x	4.54	x	x	4.666	x	x	x	4.598	4.541	4.37	x	x	x	x	4.609	4.684	4.396	x	4.695	4.491	x	x	x	x	x	x	x	4.63	x	x	x	x	x	x	x	x	x	4.429	4.614	x	x	x	x	x	4.557	4.362	x	x	x	4.641	x	4.527	x	x	x	x	x	x	x	x	x	x	4.539	4.362	x	x	4.555	x	x	x	x	x	4.695	x	x	x	x	x	x	x	
-15013	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, males	Morphology, metabolism: Body weight at 56 days (8 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.578	4.711	4.489	4.434	4.663	x	4.58	4.535	x	4.434	x	x	4.771	4.547	4.771	x	x	x	x	x	x	4.619	x	x	4.735	x	x	x	4.673	4.632	4.461	x	x	x	x	4.763	4.771	4.434	x	4.771	4.555	x	x	x	x	x	x	x	4.695	x	x	x	x	x	x	x	x	x	4.451	4.706	x	x	x	x	x	4.655	4.434	x	x	x	4.727	x	4.611	x	x	x	x	x	x	x	x	x	x	4.706	4.434	x	x	4.634	x	x	x	x	x	4.761	x	x	x	x	x	x	x	
-15014	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, males	Morphology, metabolism: Body weight at 63 days (9 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.609	4.757	4.558	4.503	4.693	x	4.647	4.573	x	4.51	x	x	4.833	4.623	4.833	x	x	x	x	x	x	4.679	x	x	4.82	x	x	x	4.734	4.709	4.514	x	x	x	x	4.833	4.833	4.503	x	4.821	4.593	x	x	x	x	x	x	x	4.715	x	x	x	x	x	x	x	x	x	4.503	4.76	x	x	x	x	x	4.698	4.524	x	x	x	4.78	x	4.689	x	x	x	x	x	x	x	x	x	x	4.817	4.503	x	x	4.682	x	x	x	x	x	4.791	x	x	x	x	x	x	x	
-15015	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, males	Morphology, metabolism: Body weight at 70 days (10 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.676	4.812	4.62	4.549	4.738	x	4.717	4.594	x	4.599	x	x	4.911	4.674	4.911	x	x	x	x	x	x	4.694	x	x	4.898	x	x	x	4.778	4.768	4.567	x	x	x	x	4.86	4.911	4.549	x	4.864	4.615	x	x	x	x	x	x	x	4.769	x	x	x	x	x	x	x	x	x	4.549	4.833	x	x	x	x	x	4.76	4.6	x	x	x	4.822	x	4.732	x	x	x	x	x	x	x	x	x	x	4.911	4.549	x	x	4.757	x	x	x	x	x	4.81	x	x	x	x	x	x	x	
-15016	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, males	Morphology, metabolism: Body weight at 77 days (11 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.711	4.887	4.647	4.585	4.781	x	4.745	4.652	x	4.708	x	x	4.994	4.721	4.994	x	x	x	x	x	x	4.723	x	x	4.992	x	x	x	4.813	4.806	4.613	x	x	x	x	4.93	4.994	4.585	x	4.917	4.678	x	x	x	x	x	x	x	4.788	x	x	x	x	x	x	x	x	x	4.585	4.95	x	x	x	x	x	4.808	4.639	x	x	x	4.832	x	4.799	x	x	x	x	x	x	x	x	x	x	4.994	4.585	x	x	4.812	x	x	x	x	x	4.851	x	x	x	x	x	x	x	
-15017	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, males	Morphology, metabolism: Body weight at 84 days (12 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.752	4.97	4.688	4.628	4.814	x	4.794	4.716	x	4.814	x	x	5.051	4.753	5.051	x	x	x	x	x	x	4.78	x	x	5.048	x	x	x	4.894	4.831	4.643	x	x	x	x	4.98	5.051	4.628	x	4.934	4.717	x	x	x	x	x	x	x	4.824	x	x	x	x	x	x	x	x	x	4.628	5.029	x	x	x	x	x	4.883	4.711	x	x	x	4.876	x	4.861	x	x	x	x	x	x	x	x	x	x	5.051	4.628	x	x	4.902	x	x	x	x	x	4.873	x	x	x	x	x	x	x	
-15018	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, males	Morphology, metabolism: Body weight at 91 days (13 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.739	4.995	4.703	4.652	4.838	x	4.83	4.72	x	4.894	x	x	5.109	4.83	5.088	x	x	x	x	x	x	4.776	x	x	5.109	x	x	x	4.965	4.832	4.669	x	x	x	x	5.013	5.109	4.652	x	4.943	4.752	x	x	x	x	x	x	x	4.857	x	x	x	x	x	x	x	x	x	4.652	5.101	x	x	x	x	x	4.888	4.734	x	x	x	4.884	x	4.892	x	x	x	x	x	x	x	x	x	x	5.109	4.652	x	x	4.93	x	x	x	x	x	4.92	x	x	x	x	x	x	x	
-15019	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, males	Morphology, metabolism: Body weight at 98 days (14 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.775	5.035	4.739	4.696	4.853	x	4.872	4.783	x	4.977	x	x	5.171	4.848	5.149	x	x	x	x	x	x	4.785	x	x	5.122	x	x	x	4.993	4.828	4.714	x	x	x	x	5.052	5.171	4.696	x	4.99	4.787	x	x	x	x	x	x	x	4.881	x	x	x	x	x	x	x	x	x	4.696	5.171	x	x	x	x	x	4.956	4.823	x	x	x	4.916	x	4.929	x	x	x	x	x	x	x	x	x	x	5.171	4.696	x	x	4.97	x	x	x	x	x	4.946	x	x	x	x	x	x	x	
-15020	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, males	Morphology, metabolism: Body weight at 105 days (15 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.823	5.069	4.769	4.734	4.882	x	4.868	4.858	x	5.069	x	x	5.272	4.894	5.195	x	x	x	x	x	x	4.805	x	x	5.171	x	x	x	5.049	4.846	4.734	x	x	x	x	5.067	5.272	4.736	x	5.068	4.802	x	x	x	x	x	x	x	4.938	x	x	x	x	x	x	x	x	x	4.734	5.272	x	x	x	x	x	5.01	4.874	x	x	x	4.946	x	4.936	x	x	x	x	x	x	x	x	x	x	5.272	4.734	x	x	5.071	x	x	x	x	x	4.953	x	x	x	x	x	x	x	
-15021	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, males	Morphology, metabolism: Body weight at 112 days (16 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	4.833	5.093	4.786	4.759	4.922	x	4.889	4.876	x	5.096	x	x	5.328	4.931	5.253	x	x	x	x	x	x	4.807	x	x	5.21	x	x	x	5.079	4.865	4.759	x	x	x	x	5.057	5.328	4.774	x	5.157	4.828	x	x	x	x	x	x	x	4.965	x	x	x	x	x	x	x	x	x	4.759	5.328	x	x	x	x	x	5.017	4.913	x	x	x	4.958	x	4.967	x	x	x	x	x	x	x	x	x	x	5.328	4.759	x	x	5.107	x	x	x	x	x	4.991	x	x	x	x	x	x	x	
-14886	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, females	Morphology, metabolism: Body length from the nose until the tail at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm]	x	6.603	6.628	6.583	6.512	6.626	x	6.637	6.512	x	6.577	x	6.643	6.607	x	6.643	x	x	x	x	x	x	6.597	x	x	6.512	x	x	x	6.597	6.537	6.514	x	x	x	x	6.575	6.581	6.52	x	6.643	6.557	x	x	x	x	x	x	x	6.607	x	x	x	x	x	x	x	x	x	6.595	6.564	x	x	x	x	x	6.55	6.535	x	x	x	6.555	x	6.596	x	x	x	x	x	x	x	x	x	x	6.643	6.512	x	x	6.607	x	x	x	x	x	6.637	x	x	x	x	x	x	x	
-14887	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, females	Morphology, metabolism: Serum glucose level at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.379	6.513	6.619	6.288	6.453	x	6.456	6.682	x	6.745	x	6.495	6.288	6.288	6.56	x	x	x	x	x	x	6.745	x	x	6.328	x	x	x	6.436	6.288	6.745	x	x	x	x	6.448	6.592	6.338	x	6.385	6.64	x	x	x	x	x	x	x	6.745	x	x	x	x	x	x	x	x	x	6.29	6.658	x	x	x	x	x	6.642	6.678	x	x	x	6.524	x	6.392	x	x	x	x	x	x	x	x	x	x	6.558	6.672	x	x	6.429	x	x	x	x	x	6.696	x	x	x	x	x	x	x	
-14888	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, females	Morphology, metabolism: Serum glucose level at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l]	x	6.555	6.53	6.453	6.225	6.57	x	6.377	6.31	x	6.651	x	6.225	6.7	x	6.358	x	x	x	x	x	x	6.389	x	x	6.352	x	x	x	6.426	6.225	6.768	x	x	x	x	6.819	6.581	6.435	x	6.317	6.459	x	x	x	x	x	x	x	6.819	x	x	x	x	x	x	x	x	x	6.225	6.399	x	x	x	x	x	6.648	6.819	x	x	x	6.819	x	6.509	x	x	x	x	x	x	x	x	x	x	6.804	6.696	x	x	6.412	x	x	x	x	x	6.495	x	x	x	x	x	x	x	
-14889	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, females	Morphology, metabolism: Food Intake between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.489	1.418	1.372	1.369	1.48	x	1.757	1.87	x	1.42	x	1.901	1.596	1.651	1.458	x	x	x	x	x	x	1.43	x	x	1.394	x	x	x	1.611	1.429	1.65	x	x	x	x	1.901	1.69	1.403	x	1.901	1.411	x	x	x	x	x	x	x	1.781	x	x	x	x	x	x	x	x	x	1.369	1.369	x	x	x	x	x	1.528	1.584	x	x	x	1.901	x	1.484	x	x	x	x	x	x	x	x	x	x	1.833	1.472	x	x	1.369	x	x	x	x	x	1.444	x	x	x	x	x	x	x	
-14890	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, females	Morphology, metabolism: Food Intake between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.455	1.826	1.455	1.455	1.907	x	1.748	1.755	x	1.667	x	2.107	1.871	2.107	1.575	x	x	x	x	x	x	1.59	x	x	2.001	x	x	x	1.463	1.571	1.79	x	x	x	x	1.561	1.98	1.584	x	1.777	1.775	x	x	x	x	x	x	x	1.74	x	x	x	x	x	x	x	x	x	1.69	1.599	x	x	x	x	x	1.708	2.107	x	x	x	2.107	x	1.642	x	x	x	x	x	x	x	x	x	x	1.912	1.455	x	x	1.959	x	x	x	x	x	1.628	x	x	x	x	x	x	x	
-14891	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain, females	Morphology, metabolism: Brain weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.296	1.296	1.262	1.28	1.259	x	1.256	1.274	x	1.265	x	1.282	1.279	1.282	1.293	x	x	x	x	x	x	1.256	x	x	1.256	x	x	x	1.285	1.276	1.281	x	x	x	x	1.292	1.279	1.28	x	1.296	1.276	x	x	x	x	x	x	x	1.285	x	x	x	x	x	x	x	x	x	1.294	1.27	x	x	x	x	x	1.275	1.292	x	x	x	1.286	x	1.276	x	x	x	x	x	x	x	x	x	x	1.296	1.256	x	x	1.268	x	x	x	x	x	1.28	x	x	x	x	x	x	x	
-14892	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, females	Morphology, metabolism: Liver weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.658	1.688	1.67	1.57	1.719	x	1.685	1.633	x	1.656	x	1.78	1.627	1.57	1.741	x	x	x	x	x	x	1.599	x	x	1.61	x	x	x	1.632	1.644	1.574	x	x	x	x	1.605	1.801	1.613	x	1.801	1.676	x	x	x	x	x	x	x	1.739	x	x	x	x	x	x	x	x	x	1.718	1.74	x	x	x	x	x	1.57	1.698	x	x	x	1.655	x	1.719	x	x	x	x	x	x	x	x	x	x	1.801	1.57	x	x	1.801	x	x	x	x	x	1.693	x	x	x	x	x	x	x	
-14893	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, females	Morphology, metabolism: Kidney weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.212	1.205	1.197	1.175	1.189	x	1.204	1.219	x	1.181	x	1.219	1.181	1.201	1.202	x	x	x	x	x	x	1.173	x	x	1.177	x	x	x	1.169	1.169	1.181	x	x	x	x	1.209	1.213	1.169	x	1.219	1.172	x	x	x	x	x	x	x	1.219	x	x	x	x	x	x	x	x	x	1.183	1.185	x	x	x	x	x	1.171	1.197	x	x	x	1.189	x	1.209	x	x	x	x	x	x	x	x	x	x	1.21	1.169	x	x	1.198	x	x	x	x	x	1.211	x	x	x	x	x	x	x	
-14894	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, females	Morphology, metabolism: Spleen weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.061	1.077	1.071	1.061	1.111	x	1.066	1.069	x	1.055	x	1.087	1.101	1.055	1.111	x	x	x	x	x	x	1.062	x	x	1.079	x	x	x	1.065	1.087	1.055	x	x	x	x	1.085	1.068	1.062	x	1.111	1.111	x	x	x	x	x	x	x	1.085	x	x	x	x	x	x	x	x	x	1.055	1.056	x	x	x	x	x	1.065	1.081	x	x	x	1.059	x	1.057	x	x	x	x	x	x	x	x	x	x	1.063	1.055	x	x	1.064	x	x	x	x	x	1.076	x	x	x	x	x	x	x	
-14895	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, females	Morphology, metabolism: Heart weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.094	1.083	1.085	1.074	1.093	x	1.087	1.089	x	1.081	x	1.087	1.085	1.082	1.089	x	x	x	x	x	x	1.081	x	x	1.094	x	x	x	1.074	1.075	1.094	x	x	x	x	1.096	1.091	1.091	x	1.096	1.09	x	x	x	x	x	x	x	1.083	x	x	x	x	x	x	x	x	x	1.074	1.081	x	x	x	x	x	1.082	1.087	x	x	x	1.096	x	1.083	x	x	x	x	x	x	x	x	x	x	1.096	1.074	x	x	1.092	x	x	x	x	x	1.096	x	x	x	x	x	x	x	
-14896	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, females	Morphology, metabolism: Lung weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.151	1.124	1.112	1.13	1.153	x	1.146	1.151	x	1.142	x	1.112	1.128	1.141	1.122	x	x	x	x	x	x	1.136	x	x	1.151	x	x	x	1.112	1.122	1.114	x	x	x	x	1.124	1.153	1.149	x	1.153	1.143	x	x	x	x	x	x	x	1.132	x	x	x	x	x	x	x	x	x	1.118	1.136	x	x	x	x	x	1.153	1.137	x	x	x	1.15	x	1.145	x	x	x	x	x	x	x	x	x	x	1.137	1.112	x	x	1.136	x	x	x	x	x	1.149	x	x	x	x	x	x	x	
-14897	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, females	Morphology, metabolism: Pancreas weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.131	1.141	1.156	1.131	1.198	x	1.202	1.208	x	1.144	x	1.208	1.175	1.175	1.196	x	x	x	x	x	x	1.155	x	x	1.171	x	x	x	1.154	1.143	1.153	x	x	x	x	1.162	1.208	1.131	x	1.156	1.174	x	x	x	x	x	x	x	1.208	x	x	x	x	x	x	x	x	x	1.165	1.174	x	x	x	x	x	1.146	1.205	x	x	x	1.17	x	1.153	x	x	x	x	x	x	x	x	x	x	1.204	1.158	x	x	1.131	x	x	x	x	x	1.181	x	x	x	x	x	x	x	
-14898	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, females	Morphology, metabolism: Quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.207	1.221	1.192	1.193	1.196	x	1.225	1.235	x	1.18	x	1.225	1.21	1.235	1.235	x	x	x	x	x	x	1.189	x	x	1.18	x	x	x	1.19	1.18	1.227	x	x	x	x	1.231	1.233	1.18	x	1.227	1.211	x	x	x	x	x	x	x	1.206	x	x	x	x	x	x	x	x	x	1.235	1.197	x	x	x	x	x	1.182	1.215	x	x	x	1.194	x	1.228	x	x	x	x	x	x	x	x	x	x	1.219	1.18	x	x	1.18	x	x	x	x	x	1.22	x	x	x	x	x	x	x	
-14899	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, females	Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.301	1.306	1.268	1.268	1.298	x	1.338	1.306	x	1.298	x	1.332	1.278	1.314	1.314	x	x	x	x	x	x	1.271	x	x	1.268	x	x	x	1.337	1.285	1.338	x	x	x	x	1.313	1.338	1.31	x	1.338	1.292	x	x	x	x	x	x	x	1.301	x	x	x	x	x	x	x	x	x	1.337	1.305	x	x	x	x	x	1.299	1.274	x	x	x	1.283	x	1.329	x	x	x	x	x	x	x	x	x	x	1.312	1.268	x	x	1.275	x	x	x	x	x	1.338	x	x	x	x	x	x	x	
-14900	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, females	Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.236	1.427	1.275	1.213	1.172	x	1.178	1.238	x	1.786	x	1.786	1.167	1.407	1.483	x	x	x	x	x	x	1.672	x	x	1.241	x	x	x	1.521	1.263	1.247	x	x	x	x	1.202	1.709	1.167	x	1.219	1.364	x	x	x	x	x	x	x	1.375	x	x	x	x	x	x	x	x	x	1.786	1.435	x	x	x	x	x	1.167	1.487	x	x	x	1.174	x	1.376	x	x	x	x	x	x	x	x	x	x	1.786	1.306	x	x	1.567	x	x	x	x	x	1.167	x	x	x	x	x	x	x	
-14901	None	Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, females	Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g]	x	1.039	1.087	1.05	1.033	1.045	x	1.029	1.041	x	1.175	x	1.175	1.026	1.061	1.17	x	x	x	x	x	x	1.123	x	x	1.055	x	x	x	1.131	1.054	1.054	x	x	x	x	1.032	1.175	1.026	x	1.049	1.097	x	x	x	x	x	x	x	1.059	x	x	x	x	x	x	x	x	x	1.15	1.109	x	x	x	x	x	1.026	1.075	x	x	x	1.026	x	1.08	x	x	x	x	x	x	x	x	x	x	1.175	1.048	x	x	1.051	x	x	x	x	x	1.027	x	x	x	x	x	x	x	
-14807	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), blood	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in blood 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]	x	1.1	1.1	2.0	1.8	1.3	x	0.0	x	x	1.4	x	1.7	x	x	0.5	x	x	x	0.7	x	x	x	x	x	x	0.0	x	x	1.3	1.2	x	1.1	x	x	x	x	0.0	1.0	x	x	3.0	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	1.0	x	x	x	x	x	1.6	0.7	x	x	x	0.9	x	0.7	x	x	x	x	x	x	x	x	x	x	0.5	0.0	x	x	0.7	x	x	x	x	x	0.9	x	x	x	x	x	x	x	
-14808	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), kidney	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in kidney 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]	x	5.6	4.9	8.3	7.3	5.7	x	7.6	x	x	7.6	x	8.1	x	x	6.8	x	x	x	6.6	x	x	x	x	x	x	6.3	x	x	6.3	7.2	x	6.6	x	x	x	x	5.1	6.0	x	x	6.8	x	x	x	x	x	x	x	6.3	x	x	x	x	x	x	x	x	x	x	5.9	x	x	x	x	x	5.8	7.5	x	x	x	6.2	x	5.9	x	x	x	x	x	x	x	x	x	x	6.8	6.4	x	x	6.5	x	x	x	x	x	7.3	x	x	x	x	x	x	x	
-14809	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), liver	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in liver 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]	x	5.3	5.6	6.3	7.0	6.0	x	3.2	x	x	5.8	x	6.7	x	x	5.4	x	x	x	5.5	x	x	x	x	x	x	5.3	x	x	5.4	5.8	x	5.4	x	x	x	x	5.4	5.8	x	x	6.5	x	x	x	x	x	x	x	5.7	x	x	x	x	x	x	x	x	x	x	6.3	x	x	x	x	x	7.6	5.8	x	x	x	5.8	x	5.8	x	x	x	x	x	x	x	x	x	x	4.9	6.0	x	x	5.9	x	x	x	x	x	5.9	x	x	x	x	x	x	x	
-14810	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), heart	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in heart 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]	x	3.2	4.9	7.9	6.1	5.7	x	0.0	x	x	7.9	x	7.4	x	x	5.1	x	x	x	5.6	x	x	x	x	x	x	2.0	x	x	5.6	7.0	x	5.3	x	x	x	x	2.9	6.1	x	x	5.2	x	x	x	x	x	x	x	5.6	x	x	x	x	x	x	x	x	x	x	1.8	x	x	x	x	x	3.2	6.9	x	x	x	4.2	x	5.3	x	x	x	x	x	x	x	x	x	x	6.6	6.8	x	x	3.6	x	x	x	x	x	7.3	x	x	x	x	x	x	x	
-14811	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), death	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, mean time of death in days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [days]	x	10.0	10.0	3.8	4.22	4.75	x	9.78	x	x	2.11	x	2.56	x	x	x	x	x	x	6.2	x	x	x	x	x	x	10.0	x	x	3.44	7.0	x	8.2	x	x	x	x	5.89	7.56	x	x	6.5	x	x	x	x	x	x	x	3.22	x	x	x	x	x	x	x	x	x	x	8.0	x	x	x	x	x	5.89	7.89	x	x	x	6.56	x	9.78	x	x	x	x	x	x	x	x	x	x	x	6.44	x	x	9.25	x	x	x	x	x	8.33	x	x	x	x	x	x	x	
-14812	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), survival 10d	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, survival 10 days after infection with 10E5 colony forming units (CFU) in 10 to 14 day-old females [%]	x	100.0	100.0	0.0	0.0	25.0	x	88.9	x	x	0.0	x	11.1	x	x	x	x	x	x	40.0	x	x	x	x	x	x	100.0	x	x	0.0	11.1	x	0.0	x	x	x	x	33.3	44.4	x	x	0.0	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	44.4	x	x	x	x	x	44.4	55.6	x	x	x	44.4	x	88.9	x	x	x	x	x	x	x	x	x	x	x	44.4	x	x	75.0	x	x	x	x	x	55.6	x	x	x	x	x	x	x	
-14813	None	bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), suvival 4d	Infectious disease, immune function: Susceptibility to Staphylococcus aureus, % survival after 4 days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [%]	x	100.0	100.0	20.0	33.3	50.0	x	100.0	x	x	0.0	x	11.1	x	x	x	x	x	x	40.0	x	x	x	x	x	x	100.0	x	x	0.0	100.0	x	100.0	x	x	x	x	50.0	88.9	x	x	100.0	x	x	x	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	44.4	x	x	x	x	x	44.4	77.8	x	x	x	66.7	x	100.0	x	x	x	x	x	x	x	x	x	x	x	55.6	x	x	100.0	x	x	x	x	x	88.9	x	x	x	x	x	x	x	
-14814	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d	Infectious disease, immune system, pulmonary system: Mycobacterium tuberculosis (H37Rv, 100 colony forming units (CFU)) response, bacterial load in lung 21 days after aerosol infection in 12-23 week-old females [linear CFU/lung/1000]	x	3815.7	3052.54	2899.6	1944.88	302.995	x	3644.5	x	x	8785.86	x	x	x	x	x	x	x	x	4302.47	x	x	8068.37	x	x	x	x	x	x	x	4092.5	6201.75	3600.68	x	x	x	x	8605.99	742.283	x	1103.78	4449.75	x	x	x	x	x	x	x	x	x	x	x	2652.86	x	x	x	x	x	5165.71	x	x	x	x	x	x	x	x	x	x	x	1706.8	x	x	x	x	x	x	x	x	x	x	x	x	6363.21	2615.45	x	x	x	x	x	x	x	x	4845.04	x	x	x	x	x	x	x	
-14815	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d	Infectious disease, immune function: Linear bacterial load in lung 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / lung / 10000]	x	2599.04	125.19	2325.1	x	53.1012	x	602.82	x	x	140.865	x	x	x	x	x	x	x	x	423.281	x	x	2580.67	x	x	x	x	x	x	x	1931.55	1029.45	826.57	x	x	x	x	80.925	454.5	x	252.428	x	x	x	x	x	x	x	x	x	x	x	x	2095.66	x	x	x	x	x	77.3545	x	x	x	x	x	x	x	x	x	x	x	500.638	x	x	x	x	x	x	x	x	x	x	x	x	1028.05	1382.8	x	x	x	x	x	x	x	x	1460.81	x	x	x	x	x	x	x	
-14816	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 21d	Infectious disease, immune function: Linear bacterial load in spleen 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / spleen / 100]	x	116.893	439.905	40.3	97.7333	107.572	x	30.3333	x	x	71.1111	x	x	x	x	x	x	x	x	348.503	x	x	1499.6	x	x	x	x	x	x	x	370.893	50.194	247.315	x	x	x	x	814.514	245.0	x	148.043	122.362	x	x	x	x	x	x	x	x	x	x	x	460.5	x	x	x	x	x	958.242	x	x	x	x	x	x	x	x	x	x	x	271.389	x	x	x	x	x	x	x	x	x	x	x	x	210.04	807.667	x	x	x	x	x	x	x	x	3043.38	x	x	x	x	x	x	x	
-14817	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 90d	Infectious disease, immune function: Linear bacterial load in spleen 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / spleen / 1000]	x	757.251	360.192	924.4	x	42.7435	x	292.347	x	x	124.373	x	x	x	x	x	x	x	x	1169.83	x	x	621.409	x	x	x	x	x	x	x	93.4875	419.429	94.0667	x	x	x	x	37.888	49.0	x	83.9314	x	x	x	x	x	x	x	x	x	x	x	x	1220.17	x	x	x	x	x	77.71	x	x	x	x	x	x	x	x	x	x	x	69.0917	x	x	x	x	x	x	x	x	x	x	x	x	218.369	215.156	x	x	x	x	x	x	x	x	636.438	x	x	x	x	x	x	x	
-14818	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 21d	Infectious disease, immune function: Linear bacterial load in liver 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / liver / 10]	x	1403.1	943.362	391.17	877.319	671.584	x	262.218	x	x	981.274	x	x	x	x	x	x	x	x	1795.62	x	x	4790.37	x	x	x	x	x	x	x	5625.05	651.831	5591.72	x	x	x	x	8558.57	2403.92	x	1154.51	802.874	x	x	x	x	x	x	x	x	x	x	x	2572.85	x	x	x	x	x	8672.05	x	x	x	x	x	x	x	x	x	x	x	1397.81	x	x	x	x	x	x	x	x	x	x	x	x	2067.79	4939.65	x	x	x	x	x	x	x	x	8781.86	x	x	x	x	x	x	x	
-14819	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 90d	Infectious disease, immune function: Linear bacterial load in liver 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / liver / 100]	x	346.499	61.3661	394.058	x	32.38	x	70.9128	x	x	56.7719	x	x	x	x	x	x	x	x	124.022	x	x	3037.59	x	x	x	x	x	x	x	355.56	195.514	49.3084	x	x	x	x	49.185	807.266	x	18.6884	x	x	x	x	x	x	x	x	x	x	x	x	185.705	x	x	x	x	x	36.7999	x	x	x	x	x	x	x	x	x	x	x	74.3727	x	x	x	x	x	x	x	x	x	x	x	x	316.042	213.446	x	x	x	x	x	x	x	x	650.922	x	x	x	x	x	x	x	
-14820	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 21d	Infectious disease, immune function: Quantity of lung pathology 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [quantitative score (10 lowest - 70 highest)]	x	26.0	18.0	14.0	16.0	15.0	x	12.5	x	x	18.0	x	x	x	x	x	x	x	x	20.0	x	x	12.0	x	x	x	x	x	x	x	16.0	20.0	18.0	x	x	x	x	20.0	25.0	x	18.0	x	x	x	x	x	x	x	x	x	x	x	x	22.0	x	x	x	x	x	10.0	x	x	x	x	x	x	x	x	x	x	x	24.0	x	x	x	x	x	x	x	x	x	x	x	x	x	26.0	x	x	x	x	x	x	x	x	26.0	x	x	x	x	x	x	x	
-14821	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 90d	Infectious disease, immune function: Quantity of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [quantitative score (10 lowest - 70 highest)]	x	56.0	32.0	46.0	x	30.0	x	28.0	x	x	24.0	x	x	x	x	x	x	x	x	26.6667	x	x	40.0	x	x	x	x	x	x	x	44.0	63.3333	36.0	x	x	x	x	44.0	40.0	x	34.0	x	x	x	x	x	x	x	x	x	x	x	x	48.0	x	x	x	x	x	36.0	x	x	x	x	x	x	x	x	x	x	x	32.5	x	x	x	x	x	x	x	x	x	x	x	x	40.0	58.0	x	x	x	x	x	x	x	x	42.5	x	x	x	x	x	x	x	
-14822	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 21d	Infectious disease, immune function: Lung weight/body weight 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [lung weight/body weight * 10000]	x	68.76	83.3757	66.7694	75.0141	58.2149	x	79.7307	x	x	81.2873	x	x	x	x	x	x	x	x	88.219	x	x	62.8335	x	x	x	x	x	x	x	71.2147	69.0492	64.682	x	x	x	x	73.6894	59.9548	x	81.5543	90.1594	x	x	x	x	x	x	x	x	x	x	x	75.4202	x	x	x	x	x	63.5377	x	x	x	x	x	x	x	x	x	x	x	67.1041	x	x	x	x	x	x	x	x	x	x	x	x	82.1231	69.2244	x	x	x	x	x	x	x	x	90.9621	x	x	x	x	x	x	x	
-14823	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 90d	Infectious disease, immune function: Lung weight/body weight 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [lung weight/body weight * 10000]	x	133.877	111.627	101.865	x	107.626	x	95.8023	x	x	125.566	x	x	x	x	x	x	x	x	88.093	x	x	132.617	x	x	x	x	x	x	x	104.785	230.425	91.4527	x	x	x	x	118.21	85.2689	x	114.229	x	x	x	x	x	x	x	x	x	x	x	x	188.651	x	x	x	x	x	104.237	x	x	x	x	x	x	x	x	x	x	x	80.8601	x	x	x	x	x	x	x	x	x	x	x	x	174.533	126.451	x	x	x	x	x	x	x	x	102.651	x	x	x	x	x	x	x	
-14824	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), survival	Infectious disease, immune function: Linear median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days]	x	219.5	228.0	124.5	182.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	94.5	x	x	x	x	x	x	x	103.5	31.0	x	x	x	x	x	133.0	x	x	168.0	118.0	x	x	x	x	x	x	x	x	x	x	x	133.0	x	x	x	x	x	151.0	x	x	x	64.0	x	x	x	x	x	x	x	184.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	192.0	x	x	x	x	x	x	x	
-14825	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d, log10	Infectious disease, immune function: Bacterial load in lungs 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [log10 CFU / lung * 100]	x	643.885	642.7	644.233	603.378	506.369	x	645.042	x	x	686.054	x	x	x	x	x	x	x	x	660.329	x	x	681.727	x	x	x	x	x	x	x	651.001	665.416	648.18	x	x	x	x	677.573	584.762	x	601.933	663.208	x	x	x	x	x	x	x	x	x	x	x	640.108	x	x	x	x	x	670.253	x	x	x	x	x	x	x	x	x	x	x	609.675	x	x	x	x	x	x	x	x	x	x	x	x	673.872	636.497	x	x	x	x	x	x	x	x	664.464	x	x	x	x	x	x	x	
-14826	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d, log10	Infectious disease, immune function: Bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [log10 CFU / lung * 100]	x	733.103	604.956	732.976	x	567.713	x	653.158	x	x	605.038	x	x	x	x	x	x	x	x	657.305	x	x	724.6	x	x	x	x	x	x	x	720.448	701.001	689.637	x	x	x	x	573.486	665.58	x	624.704	x	x	x	x	x	x	x	x	x	x	x	x	729.18	x	x	x	x	x	584.392	x	x	x	x	x	x	x	x	x	x	x	653.33	x	x	x	x	x	x	x	x	x	x	x	x	693.723	711.895	x	x	x	x	x	x	x	x	651.423	x	x	x	x	x	x	x	
-14827	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized CFU lung 90d, log10	Infectious disease, immune function: Normalized bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ratio CFU BXD / CFU C57BL/6J * 100]	x	223.473	100.0	1000.0	x	78.3158	x	159.679	x	x	112.521	x	x	x	x	x	x	x	x	112.122	x	x	2061.4	x	x	x	x	x	x	x	1542.89	1518.28	218.947	x	x	x	x	78.06	120.391	x	21.7045	x	x	x	x	x	x	x	x	x	x	x	x	555.114	x	x	x	x	x	20.4902	x	x	x	x	x	x	x	x	x	x	x	132.613	x	x	x	x	x	x	x	x	x	x	x	x	404.546	366.286	x	x	x	x	x	x	x	x	386.948	x	x	x	x	x	x	x	
-14828	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), histology lung 90d	Infectious disease, immune function: Quality of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ordinal scale (10 = normal, 20 = intermediate, 30 = severe)]	x	20.0	10.0	20.0	x	12.5	x	18.0	x	x	30.0	x	x	x	x	x	x	x	x	20.0	x	x	22.0	x	x	x	x	x	x	x	22.0	30.0	20.0	x	x	x	x	24.0	20.0	x	20.0	x	x	x	x	x	x	x	x	x	x	x	x	20.0	x	x	x	x	x	14.0	x	x	x	x	x	x	x	x	x	x	x	20.0	x	x	x	x	x	x	x	x	x	x	x	x	21.6667	22.0	x	x	x	x	x	x	x	x	22.5	x	x	x	x	x	x	x	
-14829	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), body weight 13 weeks pi, 1000 CFU	Infectious disease, immune system, morphology: Body weight 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [g]	x	26.24	22.442	23.078	21.607	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	21.572	x	x	x	x	x	x	21.51	22.224	x	x	x	x	x	x	19.05	x	x	23.8	14.218	x	x	x	x	x	x	x	x	x	x	x	22.922	x	x	x	x	x	23.854	x	x	x	19.68	x	x	x	x	x	x	x	22.646	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	26.431	x	x	x	x	x	x	x	
-14830	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund body weight 1000 CFU	Infectious disease, immune function: Mean moribund body weight after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [g * 10]	x	177.95	165.978	176.6	171.45	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	183.03	x	x	x	x	x	x	184.0	185.69	141.133	x	x	x	x	x	151.367	x	x	185.1	127.322	x	x	x	x	x	x	x	x	x	x	x	168.778	x	x	x	x	x	190.76	x	x	x	170.83	x	x	x	x	x	x	x	169.411	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	207.15	x	x	x	x	x	x	x	
-14831	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), temperature 13 week pi 1000 CFU	Infectious disease, immune function: Mean temperature 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [deg C * 10]	x	369.4	358.5	359.33	354.456	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	341.612	x	x	x	x	x	x	355.79	361.06	x	x	x	x	x	x	347.914	x	x	365.444	338.778	x	x	x	x	x	x	x	x	x	x	x	362.111	x	x	x	x	x	355.7	x	x	x	354.833	x	x	x	x	x	x	x	353.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	353.133	x	x	x	x	x	x	x	
-14832	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund temperature 1000 CFU	Infectious disease, immune function: Mean moribund temperature after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [deg C * 10]	x	336.0	316.7	335.3	333.556	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	329.625	x	x	x	x	x	x	340.3	349.8	348.222	x	x	x	x	x	330.111	x	x	334.0	329.5	x	x	x	x	x	x	x	x	x	x	x	304.222	x	x	x	x	x	336.1	x	x	x	351.556	x	x	x	x	x	x	x	328.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	345.333	x	x	x	x	x	x	x	
-14833	None	Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized median survival	Infectious disease, immune function: Normalized median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [ratio survival time BXD / survival time C57BL/6J * 100]	x	76.8827	100.885	49.0157	71.6535	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.0998	x	x	x	x	x	x	57.0928	36.2522	13.7168	x	x	x	x	x	58.8496	x	x	58.8441	52.2124	x	x	x	x	x	x	x	x	x	x	x	46.5849	x	x	x	x	x	66.8142	x	x	x	22.4168	x	x	x	x	x	x	x	72.4409	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	67.2504	x	x	x	x	x	x	x	
-14393	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in females, data trimmed [%] Original pre publication description: Hall trait 39	Hall trait 39	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]	x	2.24	x	5.776	2.129	1.55	x	1.393	x	x	2.474	2.375	2.534	2.055	x	x	x	x	x	x	x	x	1.928	x	x	2.088	x	x	x	2.417	2.521	1.877	2.063	x	x	x	x	1.639	1.566	x	2.089	1.839	x	x	x	x	x	x	x	2.192	x	x	x	x	x	x	x	x	x	1.877	2.202	x	x	5.185	x	x	x	2.727	x	x	x	3.226	x	3.485	x	x	x	x	x	x	x	x	x	x	x	1.949	x	x	2.077	x	x	x	x	x	2.271	x	2.391	x	x	x	x	x	
-14392	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males, data trimmed [%] Original pre publication description: Hall trait 38	Hall trait 38	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, Homburg Laboratory), trimmed [%]	x	1.707	2.554	5.449	2.57	1.792	x	0.397	x	x	0.968	2.027	1.063	2.788	x	x	x	1.642	x	x	x	x	x	x	x	x	x	x	x	1.63	2.321	1.261	x	x	x	x	x	1.571	0.899	x	x	2.63	x	x	x	x	x	x	x	2.752	x	x	x	3.021	x	x	x	x	x	2.583	1.29	x	x	x	x	x	x	x	x	x	x	3.298	x	3.38	x	x	x	x	x	x	x	x	x	x	x	1.517	x	x	1.596	x	x	x	x	x	2.281	x	0.976	x	x	x	x	x	
-14391	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in males, data trimmed [%] Original pre publication description: Hall trait 37	Hall trait 37	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]	x	1.87	2.72	4.91	2.59	1.73	x	0.4	x	x	0.96	1.74	1.81	2.44	x	x	x	1.58	x	x	x	x	x	x	x	x	x	x	x	1.78	2.2	1.21	x	x	x	x	x	1.48	1.14	x	x	2.66	x	x	x	x	x	x	x	2.56	x	x	x	3.02	x	x	x	x	x	2.36	1.33	x	x	x	x	x	x	x	x	x	x	3.61	x	3.38	x	x	x	x	x	x	x	x	x	x	x	1.52	x	x	1.71	x	x	x	x	x	2.22	x	0.97	x	x	x	x	x	
-14390	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) in males and females [%] Original pre publication description: Hall trait 36	Hall trait 36	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	2.03	0.28	2.23	2.14	2.69	x	1.22	x	x	2.02	1.9	1.87	1.77	x	x	x	2.64	x	x	x	x	1.29	x	x	2.57	x	x	x	2.43	2.54	1.78	x	x	x	x	x	1.81	1.3	x	2.05	1.81	x	x	x	x	x	x	x	1.76	x	x	x	1.44	x	x	x	x	x	1.49	1.07	x	x	2.62	x	x	x	2.09	x	x	x	2.0	x	2.38	x	x	x	x	x	x	x	x	x	x	x	2.07	x	x	1.56	x	x	x	x	x	1.56	x	1.77	x	x	x	x	x	
-14389	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in males and females [%] Original pre publication description: Hall trait 35	Hall trait 35	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	1.87	0.89	1.76	2.09	2.59	x	1.13	x	x	2.0	2.05	1.7	1.73	x	x	x	2.15	x	x	x	x	1.19	x	x	2.44	x	x	x	2.81	2.33	1.86	x	x	x	x	x	1.84	1.3	x	2.08	1.95	x	x	x	x	x	x	x	1.9	x	x	x	1.81	x	x	x	x	x	1.54	1.12	x	x	2.49	x	x	x	2.21	x	x	x	2.03	x	2.1	x	x	x	x	x	x	x	x	x	x	x	2.15	x	x	1.6	x	x	x	x	x	1.93	x	1.9	x	x	x	x	x	
-14387	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in females [%] Original pre publication description: Hall trait 33	Hall trait 33	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	2.59	1.06	2.21	2.36	2.72	x	1.1	x	x	2.38	2.31	1.75	2.46	x	x	x	x	x	x	x	x	1.4	x	x	2.51	0.9	x	x	3.24	2.28	2.06	x	x	x	x	x	1.87	1.02	x	2.76	1.99	x	x	x	x	x	x	x	2.44	x	x	x	2.21	x	x	x	x	x	1.78	0.88	x	x	2.63	x	x	x	2.03	x	x	x	2.08	x	1.61	x	x	x	x	x	x	x	x	x	x	x	2.42	x	x	1.6	x	x	x	x	x	2.44	x	2.68	x	x	x	x	x	
-14384	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, in males and females Original pre publication description: Hall trait 30	Hall trait 30	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severety]	x	2.0	2.0	3.5	3.0	2.5	x	1.0	x	x	2.0	2.5	3.0	3.0	x	x	x	2.0	x	x	x	x	2.0	x	x	2.0	x	x	x	3.0	3.0	2.0	x	x	x	x	x	2.0	1.0	x	3.0	2.0	x	x	x	x	x	x	x	2.0	x	x	x	2.0	x	x	x	x	x	2.0	1.0	x	x	4.0	x	x	x	2.0	x	x	x	2.0	x	2.75	x	x	x	x	x	x	x	x	x	x	x	2.0	x	x	1.5	x	x	x	x	x	1.13	x	2.0	x	x	x	x	x	
-14383	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, in males and females Original pre publication description: Hall trait 29	Hall trait 29	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]	x	2.0	1.93	3.43	2.82	2.75	x	1.14	x	x	1.97	2.55	2.63	2.58	x	x	x	2.07	x	x	x	x	1.56	x	x	2.57	x	x	x	3.0	3.25	2.4	x	x	x	x	x	2.06	1.43	x	2.43	2.06	x	x	x	x	x	x	x	1.67	x	x	x	1.88	x	x	x	x	x	1.88	1.23	x	x	3.86	x	x	x	2.43	x	x	x	2.0	x	2.6	x	x	x	x	x	x	x	x	x	x	x	2.29	x	x	1.6	x	x	x	x	x	1.31	x	1.86	x	x	x	x	x	
-14381	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, males Original pre publication description: Hall trait 27	Hall trait 27	Liver, toxicology: Fibrosis susceptibility in males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]	x	2.0	1.71	3.31	2.71	3.0	x	1.33	x	x	2.25	2.71	2.25	2.45	x	x	x	2.5	x	x	x	x	1.5	x	x	2.67	x	x	x	3.25	3.75	2.33	x	x	x	x	x	2.1	1.25	x	2.0	1.8	x	x	x	x	x	x	x	1.6	x	x	x	1.5	x	x	x	x	x	2.0	1.07	x	x	3.67	x	x	x	2.25	x	x	x	2.0	x	3.1	x	x	x	x	x	x	x	x	x	x	x	2.0	x	x	1.56	x	x	x	x	x	1.25	x	1.75	x	x	x	x	x	
-14378	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 24	Hall trait 24	Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	435.0	107.0	585.0	370.0	83.6	x	212.0	x	x	82.1	131.0	87.0	83.6	x	x	x	737.4	x	x	x	x	672.0	x	x	149.0	x	x	x	171.0	318.5	575.0	x	x	x	x	x	130.0	1080.0	x	58.5	799.0	x	x	x	x	x	x	x	314.0	x	x	x	390.0	x	x	x	x	x	294.5	1560.0	x	x	438.0	x	x	x	185.0	x	x	80.15	146.0	x	160.0	x	x	x	x	x	x	x	x	x	x	x	325.0	x	x	55.6	x	x	x	x	x	372.0	x	168.0	x	x	x	x	x	
-14377	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 23	Hall trait 23	Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	475.91	93.67	710.85	431.93	91.65	x	223.86	x	x	225.39	257.89	88.59	135.8	x	x	x	721.88	x	x	x	x	626.0	x	x	165.86	x	x	x	189.86	316.5	730.83	x	x	x	x	x	161.81	1096.33	x	60.39	879.93	x	x	x	x	x	x	x	427.45	x	x	x	361.64	x	x	x	x	x	326.17	1547.33	x	x	479.78	x	x	x	220.46	x	x	80.15	161.33	x	227.88	x	x	x	x	x	x	x	x	x	x	x	312.71	x	x	106.62	x	x	x	x	x	353.33	x	192.8	x	x	x	x	x	
-14375	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 21	Hall trait 21	Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) activity, trimmed [U/l]	x	463.24	108.0	565.33	459.67	75.93	x	242.5	x	x	484.67	362.42	100.02	83.5	x	x	x	781.54	x	x	x	x	546.8	x	x	125.65	x	x	x	180.34	300.0	663.0	x	x	x	x	x	142.87	970.0	x	96.3	473.8	x	x	x	x	x	x	x	308.86	x	x	x	251.2	x	x	x	x	x	325.44	x	x	x	451.5	x	x	x	214.33	x	x	x	161.33	x	233.6	x	x	x	x	x	x	x	x	x	x	x	298.0	x	x	48.95	x	x	x	x	x	341.0	x	186.89	x	x	x	x	x	
-14372	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 18	Hall trait 18	Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	23.915	34.01	22.615	30.1	24.75	x	19.05	x	x	35.48	23.5	18.2	25.85	x	x	x	24.15	x	x	x	x	17.65	x	x	32.8	x	x	x	22.85	27.865	30.0	x	x	x	x	33.3	20.2	52.9	x	20.45	27.3	x	x	x	x	x	x	x	34.78	x	x	x	16.0	x	x	x	x	x	23.95	54.445	x	x	x	x	x	x	27.05	x	x	27.6	32.35	x	33.33	x	x	x	x	x	x	x	x	x	x	x	20.35	x	x	30.385	x	x	x	x	x	27.085	x	30.0	x	x	x	x	x	
-14371	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 17	Hall trait 17	Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	25.264	34.3	24.504	29.815	23.67	x	18.7	x	x	33.942	24.036	20.318	27.685	x	x	x	28.388	x	x	x	x	17.03	x	x	32.491	x	x	x	22.863	28.574	30.16	x	x	x	x	33.3	20.807	50.271	x	23.74	30.254	x	x	x	x	x	x	x	34.28	x	x	x	16.436	x	x	x	x	x	24.44	54.49	x	x	x	x	x	x	25.538	x	x	27.6	32.257	x	32.573	x	x	x	x	x	x	x	x	x	x	x	20.988	x	x	31.006	x	x	x	x	x	26.429	x	30.151	x	x	x	x	x	
-14370	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 16	Hall trait 16	Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	25.0	33.005	14.2	26.67	22.5	x	18.8	x	x	40.835	20.95	17.6	23.45	x	x	x	35.05	x	x	x	x	x	x	x	32.85	x	x	x	23.05	25.66	30.0	x	x	x	x	x	20.7	52.9	x	22.7	39.475	x	x	x	x	x	x	x	x	x	x	x	20.0	x	x	x	x	x	26.9	57.14	x	x	x	x	x	x	24.0	x	x	x	25.71	x	34.2	x	x	x	x	x	x	x	x	x	x	x	22.6	x	x	27.55	x	x	x	x	x	26.67	x	30.555	x	x	x	x	x	
-14369	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 15	Hall trait 15	Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	24.429	33.07	23.536	28.429	22.283	x	17.32	x	x	41.885	22.233	18.613	21.495	x	x	x	35.05	x	x	x	x	x	x	x	32.9	x	x	x	22.975	25.898	31.1	x	x	x	x	x	22.383	48.733	x	23.725	38.992	x	x	x	x	x	x	x	x	x	x	x	20.173	x	x	x	x	x	27.5	55.366	x	x	x	x	x	x	24.0	x	x	x	24.833	x	34.798	x	x	x	x	x	x	x	x	x	x	x	22.54	x	x	28.213	x	x	x	x	x	26.714	x	33.502	x	x	x	x	x	
-14368	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 14	Hall trait 14	Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	23.33	37.57	31.03	33.85	28.4	x	21.6	x	x	25.0	26.8	28.3	29.0	x	x	x	24.15	x	x	x	x	16.515	x	x	26.6	x	x	x	22.7	32.5	28.75	x	x	x	x	33.3	18.7	49.55	x	18.9	25.0	x	x	x	x	x	x	x	34.78	x	x	x	15.0	x	x	x	x	x	20.5	54.05	x	x	x	x	x	x	27.05	x	x	27.6	34.89	x	30.635	x	x	x	x	x	x	x	x	x	x	x	18.0	x	x	36.725	x	x	x	x	x	27.5	x	28.335	x	x	x	x	x	
-14367	Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 13	Hall trait 13	Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	25.913	34.847	26.117	31.433	25.75	x	21.0	x	x	29.609	26.2	24.867	31.221	x	x	x	26.167	x	x	x	x	16.927	x	x	31.4	x	x	x	22.75	31.25	28.75	x	x	x	x	33.3	19.625	51.425	x	23.75	26.222	x	x	x	x	x	x	x	34.28	x	x	x	14.301	x	x	x	x	x	19.85	53.614	x	x	x	x	x	x	26.05	x	x	27.6	35.968	x	29.793	x	x	x	x	x	x	x	x	x	x	x	18.4	x	x	34.732	x	x	x	x	x	26.144	x	26.8	x	x	x	x	x	
-14366	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in males and females_data, trimmed [g] Original pre publication description: Hall trait 12	Hall trait 12	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data trimmed [g]	x	0.054	0.047	0.054	0.062	0.06	x	x	x	x	0.054	x	0.067	0.076	x	x	x	0.081	x	x	x	x	0.061	x	x	x	x	x	x	0.044	0.068	0.066	x	x	x	x	0.058	0.061	0.078	x	0.053	0.065	x	x	x	x	x	x	x	0.046	x	x	x	0.071	x	x	x	x	x	0.062	0.05	x	x	0.054	x	x	x	0.041	x	x	0.061	0.054	x	0.053	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.057	x	x	x	x	x	0.058	x	0.066	x	x	x	x	x	
-14364	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in females_data, trimmed [g] Original pre publication description: Hall trait 10	Hall trait 10	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio, data trimmed [g]	x	0.071	0.049	0.056	0.05	0.059	x	x	x	x	0.045	x	0.065	x	x	x	x	0.082	x	x	x	x	0.048	x	x	x	x	x	x	0.044	0.071	0.066	x	x	x	x	0.062	0.06	0.077	x	0.053	0.065	x	x	x	x	x	x	x	0.046	x	x	x	0.069	x	x	x	x	x	0.068	0.052	x	x	0.052	x	x	x	x	x	x	x	0.062	x	0.054	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.055	x	x	x	x	x	0.06	x	0.064	x	x	x	x	x	
-14358	Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 4	Hall trait 4	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver]	x	325.1	356.05	518.42	403.16	451.82	x	327.98	x	x	414.98	493.7	403.68	385.36	x	x	x	319.71	x	x	x	x	316.02	x	x	346.76	299.4	198.75	x	332.9	391.55	400.69	289.75	x	x	x	409.63	289.87	273.16	x	457.63	416.4	x	x	x	x	x	x	x	494.17	x	x	x	475.68	x	x	x	x	x	354.85	385.58	x	x	554.26	x	x	x	359.93	x	x	x	717.63	x	408.3	x	x	x	x	x	x	x	x	x	x	x	347.41	x	x	288.63	x	x	x	x	x	295.05	x	573.88	x	x	x	x	x	
-14394	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 40	Hall trait 40	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]	x	2.246	x	5.768	2.133	1.36	x	0.929	x	x	2.4	2.404	2.494	1.668	x	x	x	x	x	x	x	x	1.826	x	x	1.606	x	x	x	2.558	2.738	2.017	1.865	x	x	x	x	1.781	1.566	x	2.082	1.878	x	x	x	x	x	x	x	2.187	x	x	x	x	x	x	x	x	x	1.511	2.084	x	x	4.55	x	x	x	2.817	x	x	x	3.227	x	3.461	x	x	x	x	x	x	x	x	x	x	x	1.878	x	x	2.14	x	x	x	x	x	2.427	x	2.188	x	x	x	x	x	
-14357	Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 3	Hall trait 3	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, trimmed [ug hydroxyproline/g liver]	x	313.8	371.086	539.484	426.63	491.355	x	341.325	x	x	410.687	488.662	413.672	414.365	x	x	x	354.934	x	x	x	x	330.707	x	x	361.439	295.013	218.575	x	284.597	355.033	393.882	269.902	x	x	x	404.304	288.89	282.837	x	455.838	412.678	x	x	x	x	x	x	x	472.84	x	x	x	508.316	x	x	x	x	x	376.668	417.256	x	x	536.31	x	x	x	377.564	x	x	x	691.782	x	393.322	x	x	x	x	x	x	x	x	x	x	x	338.768	x	x	282.924	x	x	x	x	x	300.26	x	625.432	x	x	x	x	x	
-14356	Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in males_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 2	Hall trait 2	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver]	x	352.03	441.275	577.47	497.915	430.275	x	297.33	x	x	384.59	457.13	298.35	342.7	x	x	x	454.39	x	x	x	x	331.1	x	x	256.425	270.14	324.75	x	337.0	574.235	345.22	277.14	x	x	x	405.785	299.78	294.87	x	321.07	396.56	x	x	x	x	x	x	x	359.69	x	x	x	285.78	x	x	x	x	x	311.01	370.7	x	x	422.42	x	x	x	373.835	x	x	257.715	417.46	x	457.35	x	x	x	x	x	x	x	x	x	x	x	325.36	x	x	321.28	x	x	x	x	x	273.54	x	472.435	x	x	x	x	x	
-14355	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in males_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 1	Hall trait 1	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data trimmed [ug hydroxyproline/g liver]	x	332.569	461.485	605.794	497.95	459.418	x	324.787	x	x	397.468	453.194	300.093	327.646	x	x	x	451.177	x	x	x	x	338.544	x	x	276.932	266.51	324.75	x	365.479	559.475	343.13	275.383	x	x	x	383.732	304.432	283.257	x	334.493	406.225	x	x	x	x	x	x	x	369.836	x	x	x	308.88	x	x	x	x	x	330.299	392.909	x	x	441.617	x	x	x	383.635	x	x	257.715	404.013	x	459.27	x	x	x	x	x	x	x	x	x	x	x	330.13	x	x	335.289	x	x	x	x	x	293.54	x	460.58	x	x	x	x	x	
-15170	Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec]	Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec]	x	x	1.043	1.014	1.457	0.997	1.12	1.031	1.246	1.017	1.143	1.21	1.278	1.198	1.373	1.149	1.295	1.347	1.294	1.318	0.936	1.329	x	1.258	0.97	1.193	1.189	1.347	1.035	1.478	1.011	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14308	Original post publication description: Blood [serum] urea nitrogen (BUN), expressed in mg/dL, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum]	x	x	x	x	39.0	31.0	250.0	32.0	x	x	32.0	31.0	172.0	x	x	250.0	24.0	174.0	x	x	75.0	x	x	57.0	x	x	42.0	35.0	37.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14309	Original post publication description: Serum glucose (unfasted), expressed in mg/dL, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Serum glucose (unfasted) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [mg/dL serum)	x	x	x	x	144.0	140.0	101.0	116.0	x	x	141.0	99.0	55.0	x	x	83.0	125.0	66.0	x	x	70.0	x	x	102.0	x	x	137.0	137.0	45.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14310	Original post publication description: Brain Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system, central nervous system: Candida albicans titer in brain at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]	x	x	x	x	0.2	0.1	3.2	1.0	x	x	0.6	0.5	6.6	x	x	2.1	0.6	5.1	x	x	1.0	x	x	1.5	x	x	1.3	1.1	0.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14311	Original post publication description: Kidney Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system, urogenital system: Candida albicans titer, renal, at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [CFU x 10^4 per gram tissue weight]	x	x	x	x	1.0	x	191.0	1.0	x	x	2.0	3.0	863.0	x	x	26.0	x	277.0	x	x	9.0	x	x	98.0	x	x	25.0	3.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14312	Original post publication description: Log kidney Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system, urogenital system: Candida albicans titer in kidney (log) at 72 h after inoculation with 1 x 10^6 cfu (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]	x	x	x	x	-0.22	-0.52	2.28	0.0	x	x	0.36	0.4	2.94	x	x	1.41	-0.4	2.44	x	x	0.97	x	x	1.99	x	1.4	0.4	0.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14313	Original post publication description: White blood cell count (number per ul of whole blood), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Blood chemistry, infectious disease, immune system: White blood cell (WBC) count 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [number per ul of whole blood]	x	x	x	x	x	x	x	x	x	x	x	6.9	5.1	x	x	x	x	x	x	x	8.2	x	x	9.4	x	x	8.5	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14314	Original post publication description: Ratio of number of neutrophils to lymphocytes in whole blood, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: Ratio of number of neutrophil to lymphocyte ratio at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [neutrophil to lymphocyte ratio, whole blood]	x	x	x	x	x	x	x	x	x	x	x	1.44	4.72	x	x	x	x	x	x	x	1.94	x	x	2.3	x	x	2.27	1.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14315	Original post publication description: Hematocrit (proportional packed cell volume of RBCs in whole blood), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: Hematocrit 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [proportional packed cell volume of RBCs in whole blood]	x	x	x	x	x	x	x	x	x	x	x	66.0	66.0	x	x	x	x	x	x	x	44.0	x	x	57.0	x	x	44.0	66.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14316	Original post publication description: Lipocalin-2 (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: lipocalin-2 (LCN-2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	159.0	105.0	2720.0	95.0	x	x	82.0	158.0	1282.0	x	x	3852.0	66.0	1130.0	x	x	1397.0	x	x	1013.0	x	x	123.0	90.0	124.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14317	Original post publication description: Interleukin-6 (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: Interleukin-6 (IL-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein]	x	x	x	x	39.0	31.0	135.0	49.0	x	x	23.0	25.0	92.0	x	x	58.0	28.0	123.0	x	x	20.0	x	x	18.0	x	x	18.0	16.0	19.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14318	Original post publication description: G-CSF (granulocyte colony stimulating factor; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: G-CSF (granulocyte colony stimulating factor) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	22.0	12.0	197.0	9.0	x	x	4.0	9.0	120.0	x	x	220.0	6.0	194.0	x	x	110.0	x	x	88.0	x	x	12.0	5.0	3.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14319	Original post publication description: IP-10 (Interferon gamma-induced protein 10 or CXLC10; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, kidney]	x	x	x	x	38.0	17.0	51.0	23.0	x	x	17.0	22.0	60.0	x	x	43.0	15.0	34.0	x	x	28.0	x	x	29.0	x	x	36.0	19.0	18.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14320	Original post publication description: MIP2 (macrophage inflammatory protein 2-alpha or CXCL2; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	33.0	20.0	584.0	29.0	x	x	14.0	6.0	390.0	x	x	180.0	16.0	710.0	x	x	75.0	x	x	103.0	x	x	33.0	15.0	16.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14321	Original post publication description: KC (CXCL1; keratinocyte-derived chemokine; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	39.0	23.0	248.0	28.0	x	x	12.0	18.0	161.0	x	x	153.0	17.0	121.0	x	x	106.0	x	x	147.0	x	x	27.0	17.0	13.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14322	Original post publication description: MCP-1 (CCL2 or monocyte chemotactic protein-1; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	18.0	6.0	311.0	12.0	x	x	6.0	12.0	138.0	x	x	222.0	4.0	100.0	x	x	65.0	x	x	131.0	x	x	9.0	8.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14323	Original post publication description: TNF-alpha (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system, urogenital system: TNF-a at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]	x	x	x	x	0.6	0.6	7.9	0.7	x	x	0.6	0.4	4.3	x	x	7.6	0.4	2.0	x	x	3.1	x	x	5.2	x	x	0.6	0.3	0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14324	Original post publication description: Temperature (difference from baseline, C) during hours 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: temperature during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C)	x	x	x	x	0.2	0.3	0.8	0.1	x	x	0.2	0.2	-0.3	x	x	0.1	0.1	-0.9	x	x	0.5	x	x	0.8	x	x	-1.0	-0.7	-0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14325	Original post publication description: Temperature (difference from baseline, C) during hours 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Temperature during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C)	x	x	x	x	0.5	-0.1	-0.8	x	x	x	-0.1	x	-1.0	x	x	-1.1	-0.7	-3.2	x	x	-3.7	x	x	-0.5	x	x	-2.7	-1.2	-1.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14326	Original post publication description: Temperature (difference from baseline, C) during hours 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Temperature during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]	x	x	x	x	1.8	0.9	0.7	1.7	x	x	1.1	1.0	0.8	x	x	1.4	1.1	-1.8	x	x	-1.2	x	x	1.7	x	x	0.9	1.2	1.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14327	Original post publication description: Temperature (difference from baseline, C) during hours 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Temperature during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]	x	x	x	x	-0.2	0.4	-0.8	0.3	x	x	0.2	x	-0.6	x	x	0.7	-0.3	-3.5	x	x	-3.8	x	x	0.5	x	x	-0.5	-0.5	-0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14328	Original post publication description: Temperature (difference from baseline, C) during hours 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Temperature during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]	x	x	x	x	0.6	0.7	0.8	0.9	x	x	0.6	0.3	0.3	x	x	1.1	0.8	-1.9	x	x	-3.3	x	x	1.5	x	x	0.7	0.8	0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14329	Original post publication description: Temperature (difference from baseline, C) during hours 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: Temperature during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus ; immediately after light onset [difference from baseline, C]	x	x	x	x	0.2	x	-0.8	-0.3	x	x	-0.2	-0.3	-1.3	x	x	-0.2	-0.3	-4.2	x	x	-5.3	x	x	x	x	x	-0.7	-0.6	-0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14330	Original post publication description: Activity (ratio to baseline) during hours 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: locomotor activity during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]	x	x	x	x	0.97	0.93	1.72	0.81	x	x	1.49	0.75	0.85	x	x	1.02	0.89	1.05	x	x	1.0	x	x	1.63	x	x	0.67	0.72	0.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14331	Original post publication description: Activity (ratio of baseline) during hours 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: locomotor activity during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]	x	x	x	x	0.25	0.42	0.16	0.42	x	x	0.24	0.31	0.12	x	x	0.03	0.13	0.35	x	x	0.07	x	x	0.2	x	x	0.15	0.21	0.27	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14332	Original post publication description: Activity (ratio to baseline) during hours 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: locomotor activity during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]	x	x	x	x	0.76	0.64	0.37	0.76	x	x	1.18	0.55	0.54	x	x	0.27	0.49	0.31	x	x	0.22	x	x	0.75	x	x	0.52	0.58	0.75	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14333	Original post publication description: Activity (ratio to baseline) during hours 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: locomotor activity during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]	x	x	x	x	0.29	0.77	0.19	0.69	x	x	0.44	0.44	0.19	x	x	0.15	0.41	0.12	x	x	0.14	x	x	0.57	x	x	0.34	0.34	0.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14334	Original post publication description: Activity (ratio to baseline) during hours 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune function: locomotor activity during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]	x	x	x	x	0.81	0.77	0.35	0.8	x	x	0.68	0.61	0.77	x	x	0.27	0.79	0.49	x	x	0.47	x	x	0.89	x	x	0.75	0.58	0.79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14335	Original post publication description: Activity (ratio to baseline) during hours 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset	None	Infectious disease, immune system: locomotor activity during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]	x	x	x	x	0.34	0.81	0.11	0.64	x	x	0.63	0.53	0.21	x	x	0.2	0.78	0.17	x	x	0.21	x	x	0.37	x	x	0.45	0.52	0.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14386	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) in males [%] Original pre publication description: Hall trait 32	Hall trait 32	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	1.2	0.51	2.37	2.03	2.46	x	x	x	x	1.62	1.73	1.6	1.12	x	x	x	2.64	x	x	x	x	0.85	x	x	2.69	x	x	x	2.16	2.47	1.65	x	x	x	x	x	1.74	1.52	x	1.31	1.72	x	x	x	x	x	x	x	1.37	x	x	x	1.36	x	x	x	x	x	1.32	1.28	x	x	2.26	x	x	x	2.35	x	x	x	2.0	x	2.65	x	x	x	x	x	x	x	x	x	x	x	1.73	x	x	1.53	x	x	x	x	x	1.42	x	1.37	x	x	x	x	x	
-14365	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in males and females_data, trimmed [g] Original pre publication description: Hall trait 11	Hall trait 11	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g]	x	0.059	0.047	0.053	0.061	0.06	x	x	x	x	0.052	x	0.067	0.074	x	x	x	0.081	x	x	x	x	0.057	x	x	x	x	x	x	0.045	0.067	0.064	x	x	x	x	0.055	0.063	0.079	x	0.054	0.063	x	x	x	x	x	x	x	0.047	x	x	x	0.073	x	x	x	x	x	0.063	0.049	x	x	0.053	x	x	x	0.044	x	x	0.061	0.056	x	0.052	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.057	x	x	x	x	x	0.058	x	0.069	x	x	x	x	x	
-14362	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in males_data, trimmed [g] Original pre publication description: Hall trait 8	Hall trait 8	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data trimmed [g]	x	0.052	0.046	0.049	0.07	0.061	x	x	x	x	0.063	x	x	0.076	x	x	x	0.081	x	x	x	x	0.064	x	x	x	x	x	x	x	0.064	0.064	x	x	x	x	0.056	x	0.08	x	x	0.064	x	x	x	x	x	x	x	0.047	x	x	x	0.076	x	x	x	x	x	0.058	0.05	x	x	0.055	x	x	x	0.041	x	x	0.061	0.049	x	0.051	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.063	x	x	x	x	x	0.057	x	0.07	x	x	x	x	x	
-14388	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) females [%] Original pre publication description: Hall trait 34	Hall trait 34	Liver, toxicology: Fibrosis susceptibility in females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	2.61	0.21	2.16	2.22	2.71	x	1.22	x	x	2.17	2.17	1.87	2.55	x	x	x	x	x	x	x	x	1.47	x	x	2.57	x	x	x	2.58	2.67	2.06	x	x	x	x	x	1.81	1.1	x	2.8	1.96	x	x	x	x	x	x	x	2.46	x	x	x	2.3	x	x	x	x	x	1.98	0.65	x	x	2.66	x	x	x	2.03	x	x	x	2.07	x	1.88	x	x	x	x	x	x	x	x	x	x	x	2.56	x	x	1.58	x	x	x	x	x	1.71	x	2.5	x	x	x	x	x	
-14385	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in males [%] Original pre publication description: Hall trait 31	Hall trait 31	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]	x	1.14	0.74	1.5	1.81	2.41	x	x	x	x	1.63	1.85	1.6	1.18	x	x	x	2.15	x	x	x	x	0.92	x	x	2.35	x	x	x	2.24	2.37	1.72	x	x	x	x	x	1.81	1.52	x	1.57	1.91	x	x	x	x	x	x	x	1.35	x	x	x	1.27	x	x	x	x	x	1.3	1.3	x	x	2.32	x	x	x	2.3	x	x	x	1.99	x	2.58	x	x	x	x	x	x	x	x	x	x	x	1.78	x	x	1.6	x	x	x	x	x	1.42	x	1.31	x	x	x	x	x	
-14382	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, males Original pre publication description: Hall trait 28	Hall trait 28	Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]	x	2.0	1.63	3.13	3.0	3.0	x	1.0	x	x	2.5	2.5	2.0	3.0	x	x	x	2.5	x	x	x	x	1.5	x	x	2.0	x	x	x	3.0	4.0	2.0	x	x	x	x	x	2.0	1.0	x	2.0	2.0	x	x	x	x	x	x	x	1.75	x	x	x	1.5	x	x	x	x	x	2.0	1.0	x	x	4.0	x	x	x	2.0	x	x	x	2.0	x	3.0	x	x	x	x	x	x	x	x	x	x	x	2.0	x	x	1.5	x	x	x	x	x	1.0	x	2.0	x	x	x	x	x	
-14379	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, females Original pre publication description: Hall trait 25	Hall trait 25	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]	x	2.0	2.25	3.57	3.0	2.5	x	1.0	x	x	1.69	2.25	3.0	3.0	x	x	x	1.0	x	x	x	x	1.6	x	x	2.5	x	x	x	2.75	2.75	2.5	x	x	x	x	x	2.0	1.67	x	3.0	2.38	x	x	x	x	x	x	x	1.75	x	x	x	2.25	x	x	x	x	x	1.75	1.5	x	x	4.0	x	x	x	2.67	x	x	x	2.0	x	2.1	x	x	x	x	x	x	x	x	x	x	x	2.5	x	x	1.69	x	x	x	x	x	1.38	x	2.0	x	x	x	x	x	
-14380	Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, females Original pre publication description: Hall trait 26	Hall trait 26	Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]	x	2.0	2.0	3.75	3.0	2.5	x	1.0	x	x	1.88	2.0	3.0	3.0	x	x	x	1.0	x	x	x	x	2.0	x	x	2.5	x	x	x	3.0	3.0	2.5	x	x	x	x	x	2.0	2.0	x	3.0	2.25	x	x	x	x	x	x	x	2.0	x	x	x	2.0	x	x	x	x	x	2.0	1.5	x	x	4.0	x	x	x	3.0	x	x	x	2.0	x	2.0	x	x	x	x	x	x	x	x	x	x	x	2.5	x	x	1.75	x	x	x	x	x	1.38	x	2.0	x	x	x	x	x	
-14376	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 22	Hall trait 22	Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) activity, trimmed [U/l]	x	520.0	110.0	523.0	411.0	78.7	x	251.5	x	x	448.0	206.0	87.0	90.5	x	x	x	815.8	x	x	x	x	514.0	x	x	110.5	x	x	x	207.0	266.0	551.0	x	x	x	x	x	158.0	970.0	x	74.0	438.0	x	x	x	x	x	x	x	304.0	x	x	x	218.0	x	x	x	x	x	289.0	x	x	x	413.0	x	x	x	166.0	x	x	x	146.0	x	179.0	x	x	x	x	x	x	x	x	x	x	x	301.0	x	x	40.5	x	x	x	x	x	341.0	x	152.0	x	x	x	x	x	
-14373	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 19	Hall trait 19	Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	487.0	79.33	856.38	390.33	115.23	x	199.0	x	x	69.82	106.91	74.3	163.7	x	x	x	638.34	x	x	x	x	824.0	x	x	286.5	x	x	x	199.38	333.0	798.67	x	x	x	x	x	172.63	1159.5	x	33.45	1105.56	x	x	x	x	x	x	x	635.0	x	x	x	453.67	x	x	x	x	x	326.89	1547.33	x	x	x	x	x	x	224.14	x	x	80.15	x	x	219.3	x	x	x	x	x	x	x	x	x	x	x	349.5	x	x	221.97	x	x	x	x	x	359.5	x	201.67	x	x	x	x	x	
-14374	Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 20	Hall trait 20	Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) aktivity, trimmed [U/l]	x	417.5	48.0	674.5	88.85	115.0	x	196.0	x	x	71.5	89.1	75.95	83.6	x	x	x	281.0	x	x	x	x	824.0	x	x	286.5	x	x	x	135.0	349.0	599.0	x	x	x	x	x	100.0	1096.0	x	28.55	1024.0	x	x	x	x	x	x	x	687.0	x	x	x	418.5	x	x	x	x	x	300.0	1560.0	x	x	x	x	x	x	204.0	x	x	80.15	x	x	142.0	x	x	x	x	x	x	x	x	x	x	x	349.5	x	x	249.0	x	x	x	x	x	372.0	x	205.0	x	x	x	x	x	
-14336	Original post publication description: Infectious disease, immune function: Candida titer brain (log)	None	Infectious disease, immune system, central nervous system: Candida albicans titer in brain (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue weight]	x	x	x	x	-0.7	-1.0	0.51	x	x	x	-0.22	-0.3	0.82	x	x	0.32	-0.22	0.71	x	x	x	x	x	0.18	x	x	0.11	0.04	-0.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14337	Original post publication description: BUN (log)	Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum, log]	Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum, log]	x	x	x	x	1.59	1.49	2.4	1.51	x	x	1.51	1.49	2.24	x	x	2.4	1.38	2.24	x	x	1.88	x	x	1.76	x	x	1.62	1.54	1.57	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14338	Original post publication description: G-CSF (log) candida	None	Infectious disease, immune function: G-CSF (granulocyte colony stimulating factor) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	1.34	1.07	2.29	0.97	x	x	0.54	0.95	2.08	x	x	2.34	0.78	2.29	x	x	2.04	x	x	1.94	x	x	1.08	0.7	0.52	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14339	Original post publication description: IL-6 (log) candida	None	Infectious disease, immune system: IL-6 (interleukin-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]	x	x	x	x	1.59	1.49	2.13	1.69	x	x	1.35	1.39	1.96	x	x	1.77	1.45	2.09	x	x	1.29	x	x	1.26	x	x	1.26	1.19	1.29	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14340	Original post publication description: KC (log) candida	None	Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	1.59	1.36	2.39	1.44	x	x	1.06	1.27	2.21	x	x	2.18	1.23	2.08	x	x	2.02	x	x	2.17	x	x	1.43	1.23	1.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14341	Original post publication description: Infectious disease, immune function, IP-10 (log)	None	Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	1.58	1.22	1.71	1.35	x	x	1.22	1.35	1.78	x	x	1.64	1.19	1.53	x	x	1.44	x	x	1.46	x	x	1.56	1.28	1.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14342	Original post publication description: LCN-2 candida log	None	Infectious disease, immune system, protein expression: Lipocalin-2 (LCN-2) level in kidney 72 h after inoculation with 1 x 10^6 CFU Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]	x	x	x	x	2.2	2.02	3.43	1.98	x	x	1.91	2.2	3.11	x	x	3.59	1.82	3.05	x	x	3.15	x	x	3.01	x	x	2.09	1.95	2.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14343	Original post publication description: MCP-1 (log) candida	None	Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	1.26	0.8	2.49	1.08	x	x	0.75	1.06	2.14	x	x	2.35	0.6	2.0	x	x	1.81	x	x	2.12	x	x	0.95	0.9	0.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14344	Original post publication description: MIP-2 (log) candida	None	Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	1.52	1.31	2.77	1.46	x	x	1.15	0.78	2.59	x	x	2.25	1.21	2.85	x	x	1.87	x	x	2.01	x	x	1.52	1.17	1.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14345	Original post publication description: TNF-a (log) candida	None	Infectious disease, immune system, urogenital system: TNF-a (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]	x	x	x	x	-0.21	-0.21	0.9	-0.14	x	x	-0.23	-0.35	0.64	x	x	0.88	-0.39	0.29	x	x	0.5	x	x	0.71	x	x	-0.22	-0.49	-0.21	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14348	Original post publication description: Log activity candida 0-12	None	Infectious disease, immune function: locomotor activity (log) during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline, log]	x	x	x	x	-0.01	-0.03	0.24	-0.09	x	x	0.17	-0.12	-0.07	x	x	0.01	-0.05	0.02	x	x	x	x	x	0.21	x	x	-0.18	-0.15	-0.09	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14349	Original post publication description: Log, activity candida 12-24	None	Infectious disease, immune function: locomotor activity (log) during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline. log]	x	x	x	x	-0.61	-0.38	-0.78	-0.38	x	x	-0.61	-0.5	-0.94	x	x	-1.52	-0.89	-0.45	x	x	-1.16	x	x	-0.7	x	x	-0.82	-0.67	-0.56	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14350	Original post publication description: Log activity candida h 24-36	None	Infectious disease, immune function: locomotor activity (log) during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]	x	x	x	x	-0.12	-0.19	-0.43	-0.12	x	x	0.07	-0.26	-0.27	x	x	-0.57	-0.31	-0.51	x	x	-0.66	x	x	-0.12	x	x	-0.28	-0.24	-0.12	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14351	Original post publication description: Log activity candida 36-48	None	Infectious disease, immune function: locomotor activity (log) during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]	x	x	x	x	-0.54	-0.11	-0.71	-0.16	x	x	-0.36	-0.36	-0.73	x	x	-0.81	-0.39	-0.93	x	x	-0.86	x	x	-0.24	x	x	-0.47	-0.47	-0.39	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14352	Original post publication description: Log candida activity 48-60	None	Infectious disease, immune function: locomotor activity (log) during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]	x	x	x	x	-0.09	-0.12	-0.45	-0.1	x	x	-0.17	-0.21	-0.11	x	x	-0.57	-0.1	-0.31	x	x	-0.33	x	x	-0.05	x	x	-0.13	-0.23	-0.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14353	Original post publication description: Activity candida log 60-72	None	Infectious disease, immune system: Locomotor activity (log) during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]	x	x	x	x	-0.46	-0.09	-0.94	-0.2	x	x	-0.2	-0.27	-0.69	x	x	-0.71	-0.11	-0.76	x	x	-0.67	x	x	-0.43	x	x	-0.34	-0.28	-0.28	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14395	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 41	Hall trait 41	Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]	x	2.057	2.721	5.225	2.405	1.642	x	0.995	x	x	1.827	2.105	2.174	2.275	x	x	x	1.44	x	x	x	x	1.642	x	x	2.088	x	x	x	2.178	2.384	1.626	2.063	x	x	x	x	1.57	1.307	x	2.089	2.249	x	x	x	x	x	x	x	2.435	x	x	x	3.021	x	x	x	x	x	2.009	1.706	x	x	5.185	x	x	x	2.489	x	x	x	3.416	x	3.459	x	x	x	x	x	x	x	x	x	x	x	1.805	x	x	1.921	x	x	x	x	x	2.248	x	1.821	x	x	x	x	x	
-14396	Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 42	Hall trait 42	Liver, toxicology: fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]	x	2.153	2.554	5.766	2.412	1.618	x	0.763	x	x	2.001	2.027	1.977	2.655	x	x	x	1.353	x	x	x	x	1.578	x	x	1.606	x	x	x	2.297	2.72	1.42	1.865	x	x	x	x	1.781	1.519	x	2.082	2.579	x	x	x	x	x	x	x	2.257	x	x	x	3.021	x	x	x	x	x	1.514	1.882	x	x	4.55	x	x	x	2.307	x	x	x	3.298	x	3.38	x	x	x	x	x	x	x	x	x	x	x	1.712	x	x	2.091	x	x	x	x	x	2.281	x	1.908	x	x	x	x	x	
-14397	Original post publication description: Visual system, eye: Corneal neovascular response to FGF2 (10 ng in corneal micro pocket assay), vessel length five days postoperatively measured by slit lamp (from Fig 1) [mm]	None	Visual system, eye: Corneal neovascular response to FGF2 (10 ng in corneal micro pocket assay), vessel length five days postoperatively measured by slit lamp (from Fig 1) [mm]	x	0.57	0.47	0.61	0.33	0.49	0.17	0.52	0.18	0.51	0.32	0.34	0.25	0.48	0.51	0.63	0.61	0.68	0.46	0.56	0.53	0.24	x	0.77	0.43	0.4	0.56	0.06	0.73	0.41	0.52	0.43	0.64	0.55	0.48	x	0.78	0.56	0.53	x	0.51	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14398	Original post publication description: Visual system, eye: Corneal neovascular response to FGF2 (10 ng, corneal micro pocket assay), vessel area five days postoperatively measured by slit lamp (from Fig 2) [mm2]	None	Visual system, eye: Corneal neovascular response to FGF2 (10 ng, corneal micro pocket assay), vessel area five days postoperatively measured by slit lamp (from Fig 2) [mm2]	x	x	x	x	0.43	0.76	0.15	0.79	0.17	0.73	0.31	0.31	0.24	0.56	0.61	1.8	0.75	1.03	0.5	0.79	0.83	0.24	x	1.45	0.41	0.44	0.68	0.61	1.2	0.57	0.73	0.45	0.97	0.7	0.58	x	1.15	0.62	0.76	x	0.7	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-14399	Original post publication description: Visual system, eye: Central corneal thickness measured by ocular coherence tomography (OCT) in 60 to 100-day-old males and females [um] Original pre publication description: Geisert Eye 1	Visual system, eye: Eldon Geisert trait, contact <egeisert@uthsc.edu>	Visual system, eye: Central corneal thickness measured by ocular coherence tomography (OCT) in 60 to 100-day-old males and females [um]	x	x	102.0	125.0	89.0	x	x	x	x	98.0	98.0	x	94.0	110.0	x	94.0	x	x	x	x	88.0	x	x	106.0	x	85.0	x	104.0	x	91.0	121.0	x	x	x	x	x	x	105.0	75.0	x	x	83.0	85.0	86.0	x	x	117.0	96.0	107.0	102.0	x	x	x	x	100.0	x	x	x	89.0	111.0	91.0	x	x	x	109.0	91.0	97.0	85.0	109.0	103.0	x	100.0	128.0	100.0	x	108.0	x	97.0	96.0	x	x	104.0	97.0	111.0	96.0	101.0	x	102.0	95.0	x	x	x	x	96.0	109.0	x	109.0	x	92.0	87.0	97.0	89.0	
-14400	Original post publication description: Gene expression, retina: Hspa5 expression from denoised Original pre publication description: Hspa5 denoised	Hspa5 denoised	Gene expression, retina: Hspa5 expression from denoised	-0.582	-0.384	-0.007	-0.188	-0.068	0.06	-0.217	0.139	0.023	0.291	-0.442	-0.397	0.533	-0.206	0.342	-0.473	0.546	-0.281	-0.2	0.069	-0.278	x	0.267	0.311	x	0.202	-0.098	0.302	x	0.339	0.274	0.469	-0.319	x	-0.285	x	0.02	-0.465	0.319	x	0.179	-0.501	-0.498	-0.14	x	x	-0.124	-0.094	-0.186	-0.437	x	-0.499	x	-0.229	0.07	x	x	x	0.226	-0.52	-0.19	0.411	x	0.81	0.094	0.03	-0.136	0.401	0.356	-0.128	x	-0.079	0.473	-0.225	x	-0.193	x	x	-0.66	0.166	x	0.057	0.099	-0.05	0.094	0.294	x	-0.05	0.69	x	-0.556	x	x	0.059	-0.18	0.057	-0.175	0.413	0.511	-0.071	0.743	0.069	
-14401	Original post publication description: Immune function, infectious disease: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul] Original pre publication description: Immune function infectious disease: MA Miller Trait 1	Immune function infectious disease: MA Miller Trait 1	Infectious disease, immune system: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii (BXD65 winsorized from 47.5 to 26.0) [units/ul]	x	x	5.065	23.699	x	x	x	x	x	x	x	4.764	x	x	x	x	x	x	x	x	10.478	x	x	x	x	x	x	x	x	7.67	x	x	x	x	x	x	5.107	x	1.463	x	x	11.371	x	3.682	x	x	x	5.091	5.531	x	x	x	x	10.222	x	x	x	x	x	7.185	9.492	x	x	26.0	12.512	x	12.774	19.377	11.654	x	x	x	x	25.002	x	x	x	x	x	x	x	6.871	x	x	11.293	8.708	x	x	15.358	x	11.739	x	x	9.509	3.001	x	x	x	x	12.865	22.495	x	
-14402	Original post publication description: Immune function, infectious disease: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul] Original pre publication description: Immune function infectious disease: MA Miller Trait 1	Immune function infectious disease: MA Miller Trait 1	Infectious disease, immune system: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul]	x	x	5.065	23.699	x	x	x	x	x	x	x	4.764	x	x	x	x	x	x	x	x	10.478	x	x	x	x	x	x	x	x	7.67	x	x	x	x	x	x	5.107	x	1.463	x	x	11.371	x	3.682	x	x	x	5.091	5.531	x	x	x	x	10.222	x	x	x	x	x	7.185	9.492	x	x	47.517	12.512	x	12.774	19.377	11.654	x	x	x	x	25.002	x	x	x	x	x	x	x	6.871	x	x	11.293	8.708	x	x	15.358	x	11.739	x	x	9.509	3.001	x	x	x	x	12.865	22.495	x	
-15179	Original post publication description: un-named trait Original pre publication description: Orofacial system, dentition: incisor malocclusion frequency scale (3 = very common problem, 2 = occasional, 1 = rare, 0 =none)	Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in adults of both sexes [frequency scale: 3 = common, 2 = occasional, 1 = rare, 0 =none]	Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in adults of both sexes [frequency scale: 3 = common, 2 = occasional, 1 = rare, 0 =none]	x	x	1.0	1.0	2.0	2.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15180	Original post publication description: Infectious disease, immune function: Burkholderia pseudomallei (strain 1026b, 100 CFU intranasal under isoflurane) survival to 11-days in 12–13 week-old males and females [%] Original pre publication description: Infectious disease, immune function: UTHSC RBL Trait 1	Infectious disease, immune system: UTHSC RBL Trait 1	Infectious disease, immune system: Burkholderia pseudomallei (strain 1026b, 100 CFU intranasal under isoflurane) survival to 11-days in 12–13 week-old males and females [%]	x	x	100.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	26.0	45.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15181	Original post publication description: Central nervous system, gene expression, learning and memory: Kcnq5 expression level (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [log2 relative concentration] Original pre publication description: Central nervous system, gene expression, learning and memory: Kcnq5 expression level (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [log2 relative concentration]	Central nervous system, gene expression, learning and memory: Kcnq5 mRNA expression in hippocampus (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [relative residual concentration]	Central nervous system, gene expression: Kcnq5 mRNA expression in hippocampus (Kv7.5, potassium voltage-gated channel, subfamily Q, member 5, M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	2.285	0.682	-2.162	-0.638	0.207	-1.006	-0.105	1.995	1.836	2.353	2.709	-1.639	0.819	-1.262	1.203	1.985	2.474	1.504	0.546	-5.373	-0.622	-3.078	x	3.41	-0.305	2.661	5.371	-0.176	x	-3.716	1.712	1.256	2.888	x	0.493	x	-5.468	0.259	-2.573	x	-2.474	2.389	x	0.653	x	x	0.844	x	-2.485	4.861	x	x	x	-3.056	x	x	x	x	-0.243	-0.858	-1.767	1.926	1.278	-2.836	1.268	0.418	-2.213	2.55	-0.397	x	x	0.998	-4.961	-0.809	-1.242	0.58	x	-3.669	2.161	x	x	-4.095	1.844	2.399	1.91	4.439	x	1.554	-4.238	x	3.099	-5.187	-1.999	x	-1.074	-2.071	-2.21	2.187	x	x	x	x	
-15183	Original post publication description: Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Pdyn probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Pdyn probe sets and Striatum_Exon_0209 data [relative residual concentration]	x	-0.733	2.638	2.303	-1.281	-1.264	x	x	1.85	0.041	0.495	-0.136	0.183	-1.57	-1.057	1.654	2.51	-1.575	-0.383	0.378	1.256	-0.941	x	-1.436	x	-0.056	-2.405	-1.144	x	-2.222	0.894	-2.207	3.0	x	0.249	x	-1.6	1.958	-0.72	x	-0.133	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15184	Original post publication description: Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, substance P, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Tac1 probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, substance P, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Tac1 probe sets and Striatum_Exon_0209 data [relative residual concentration]	x	0.089	-2.022	3.178	0.677	1.236	x	x	-3.856	-2.913	0.114	-2.861	0.778	-0.621	0.155	-2.661	-0.039	-1.361	-0.835	0.37	0.781	-3.154	x	1.001	x	1.403	-0.954	1.056	x	2.206	5.0	2.757	0.018	x	-1.769	x	-2.335	4.485	-0.088	x	-0.693	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15185	Original post publication description: Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration]	x	0.729	0.517	-1.322	-0.794	1.033	x	x	1.394	1.331	1.512	0.482	0.7	0.165	1.547	0.554	1.39	0.921	1.619	1.175	0.964	-2.5	x	-2.826	x	-1.85	-2.9	-1.78	x	-3.617	-0.789	-1.565	0.521	x	1.204	x	1.801	-1.452	0.374	x	1.463	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15186	Original post publication description: Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd2 probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd2 probe sets and Striatum_Exon_0209 data [relative residual concentration]	x	-0.463	-2.059	2.978	1.728	-1.374	x	x	-2.722	-2.785	-0.954	-1.597	1.567	0.404	0.358	-1.208	-0.608	-0.826	-0.476	-3.734	-1.494	2.768	x	1.726	x	2.757	4.065	1.863	x	5.634	0.828	4.17	-0.171	x	-2.571	x	-3.265	-2.501	-0.003	x	-2.037	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15736	None	Trait_175_AUW-BXD	Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage, chow diet, males [counts/hour]	x	x	5883.0	6884.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5637.0	3147.0	8139.0	x	x	5311.0	4288.0	4312.0	4599.0	x	x	x	6226.0	9801.0	x	x	x	5063.0	4510.0	3596.0	4125.0	5092.0	4618.0	3533.0	x	5520.0	6017.0	5343.0	3573.0	x	5502.0	x	4128.0	x	x	x	3542.0	4829.0	3714.0	x	4105.0	5446.0	3356.0	x	5033.0	x	5012.0	3601.0	x	5120.0	x	x	4331.0	5098.0	3371.0	4980.0	6253.0	6316.0	8332.0	x	3917.0	
-15730	None	Trait_169_AUW-BXD	Metabolism: Body temperature loss after 6 hours in 4 deg C chamber, high fat diet, males [%]	x	x	5.4922	5.5658	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.2657	8.7561	1.3186	x	x	2.8	1.7	6.2	4.5712	x	x	x	2.7384	6.2	x	x	x	x	5.2348	2.8	7.84	10.66	6.5	18.8	x	4.9	7.34	0.8011	7.1	x	2.6549	x	2.4576	x	x	x	5.7	3.4042	8.62	x	2.07	5.71	6.33	x	3.9478	x	6.07	3.67	x	x	x	x	6.119	4.31	13.8	12.65	9.01	5.38	7.3	x	1.9	
-15710	None	Trait_149_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected, metabolic cage, chow diet, males [ml/kg/h]	x	x	3776.0	5159.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3927.0	x	3893.0	x	x	x	x	x	4531.0	x	x	x	4190.0	x	x	x	x	x	4249.0	3542.0	4266.0	x	4129.0	4043.0	x	x	2508.0	3899.0	x	x	4233.0	x	3779.0	x	x	x	x	4203.0	x	x	3857.0	4363.0	x	x	4611.0	x	4288.0	4530.0	x	3681.0	x	x	3861.0	3652.0	x	x	x	4045.0	x	x	x	
-15708	None	Trait_147_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected, metabolic cage, chow diet, males [ml/kg/h]	x	x	3172.0	4568.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3244.0	x	3192.0	x	x	x	x	x	3675.0	x	x	x	3366.0	x	x	x	x	x	3490.0	2851.0	3620.0	x	3525.0	3232.0	x	x	2177.0	3208.0	x	x	3400.0	x	3105.0	x	x	x	x	3639.0	x	x	3471.0	3276.0	x	x	3987.0	x	3519.0	3573.0	x	3297.0	x	x	3431.0	3135.0	x	x	x	3423.0	x	x	x	
-15706	None	Trait_145_AUW-BXD	Central nervous system, metabolism, behavior: Water intake in 24 h, metabolic cage, chow diet, males [ml]	x	x	1.82	2.295	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.99	0.69	2.85	x	x	1.42	3.16	1.176	2.0	x	x	x	2.224	2.132	x	x	x	3.596	2.487	2.775	2.588	1.315	1.3	2.648	x	1.656	1.325	3.045	0.632	x	3.044	x	2.392	x	x	x	1.236	1.128	1.665	x	0.347	1.37	1.776	x	3.215	x	2.205	3.935	x	1.155	x	x	1.57	1.464	2.04	1.032	1.356	1.793	1.53	x	1.388	
-15704	None	Trait_143_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, chow diet, males [kCal]	x	x	10.9337	9.6348	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.2938	4.2625	12.8433	x	x	x	x	5.9148	8.7265	x	x	x	8.1778	7.5144	x	x	x	13.4044	11.3677	10.416	9.8952	6.2403	10.8872	9.7216	x	x	10.4315	11.8482	2.1886	x	8.7854	x	4.6562	x	x	x	7.8244	x	8.0817	x	6.1163	5.3692	4.1292	x	10.0688	x	6.5472	x	x	8.8412	x	x	10.6702	7.099	8.9156	5.4436	x	11.3677	5.5552	x	4.1788	
-15702	None	Trait_141_AUW-BXD	Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, chow diet, males [g]	x	x	3.527	3.108	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.998	1.375	4.143	x	x	x	x	1.908	2.815	x	x	x	2.638	2.424	x	x	x	4.324	3.667	3.36	3.192	2.013	3.512	3.136	x	x	3.365	3.822	0.706	x	2.834	x	1.502	x	x	x	2.524	x	2.607	x	1.973	1.732	1.332	x	3.248	x	2.112	x	x	2.852	x	x	3.442	2.29	2.876	1.756	x	3.667	1.792	x	1.348	
-15700	None	Trait_139_AUW-BXD	Metabolism, behavior: Activty (rearing) at night, metabolic cage, chow diet, males [AUC]	x	x	689.0	155.13	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	760.92	234.8	154.14	x	x	381.5	353.2	680.7	322.141	x	x	x	129.93	258.0	x	x	x	575.2	287.7	153.63	436.2	266.7	362.3	264.42	x	463.97	281.67	224.2	420.86	x	137.3	x	155.01	x	x	x	395.65	239.34	175.76	x	302.68	536.5	219.6	x	117.9	x	693.15	60.08	x	434.3	x	x	301.3	321.884	480.4	717.1	1455.03	483.06	1094.0	x	191.8	
-15698	None	Trait_137_AUW-BXD	Metabolism, behavior: Activty (ambulations) at night, metabolic cage, chow diet, males [AUC]	x	x	887.5	507.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1091.47	463.76	378.6	x	x	501.5	674.08	829.0	565.95	x	x	x	335.98	626.0	x	x	x	901.97	638.2	409.1	785.6	574.97	644.4	351.55	x	949.089	510.97	348.6	792.6	x	206.7	x	383.4	x	x	x	626.65	475.4	455.8	x	395.8	804.4	501.1	x	365.65	x	977.2	366.5	x	708.5	x	x	472.64	443.67	829.3	1060.34	1032.26	646.0	978.0	x	525.5	
-15696	None	Trait_135_AUW-BXD	Metabolism, behavior: Activity (movement) at dark phase (night), metabolic cage, chow diet, males [AUC]	x	x	1892.0	1407.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2224.0	1082.7	815.2	x	x	1268.0	1398.0	1621.8	1094.2	x	x	x	740.05	1539.0	x	x	x	1991.8	1606.0	1269.4	1609.4	1503.5	1517.6	1125.0	x	1986.2	1257.86	759.4	1827.06	x	552.6	x	994.1	x	x	x	1522.0	1118.6	1115.7	x	1063.8	1678.2	1315.99	x	1090.6	x	1973.0	1080.5	x	1582.6	x	x	1216.6	1279.8	1975.0	2141.02	2019.3	1491.2	2018.0	x	1339.5	
-15694	None	Trait_127_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours, metabolic cage, chow diet, males [mL/kg/h]	x	x	2741.0	2969.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2532.0	2180.0	3031.0	x	x	1740.0	1899.0	2139.0	2830.0	x	x	x	2805.0	1853.0	x	x	x	2460.0	2794.0	2421.0	2303.0	2108.0	2113.0	2052.0	x	2363.0	1964.0	2683.0	1878.0	x	2722.0	x	2162.0	x	x	x	2067.0	2049.0	1772.0	x	2652.0	2051.0	1766.0	x	3296.0	x	2226.0	3048.0	x	1923.0	x	x	2398.0	2196.0	2066.0	2204.0	2334.0	2533.0	1898.0	x	2048.0	
-15692	None	Trait_125_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average, metabolic cage, chow diet, males [mL/kg/h]	x	x	2972.0	3185.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2841.0	2307.0	3358.0	x	x	1967.0	2240.0	2330.0	3113.0	x	x	x	3133.0	2082.0	x	x	x	2769.0	3098.0	2793.0	2631.0	2327.0	2289.0	2268.0	x	2607.0	2133.0	2964.0	1991.0	x	2990.0	x	2360.0	x	x	x	2224.0	2182.0	1896.0	x	2785.0	2335.0	1978.0	x	3549.0	x	2483.0	3489.0	x	2086.0	x	x	2640.0	2382.0	2324.0	2494.0	2513.0	2710.0	2100.0	x	2288.0	
-15690	None	Trait_123_AUW-BXD	Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average, metabolic cage, chow diet, males [mL/kg/h]	x	x	2376.0	2629.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2108.0	1978.0	2514.0	x	x	1499.0	1491.0	1909.0	2382.0	x	x	x	2286.0	1519.0	x	x	x	2112.0	2311.0	2049.0	1975.0	1870.0	1902.0	1710.0	x	2102.0	1762.0	2239.0	1751.0	x	2298.0	x	1847.0	x	x	x	1799.0	1839.0	1544.0	x	2443.0	1767.0	1539.0	x	2894.0	x	1919.0	2518.0	x	1750.0	x	x	2126.0	1902.0	1756.0	1855.0	2132.0	2253.0	1571.0	x	1793.0	
-15688	None	Trait_121_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours, metabolic cage, chow diet, males [mL/kg/h]	x	x	3000.0	3466.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2943.0	2521.0	3163.0	x	x	1985.0	2149.0	2762.0	3263.0	x	x	x	3160.0	3181.0	x	x	x	2920.0	3088.0	2751.0	2738.0	2584.0	2529.0	2364.0	x	2699.0	2358.0	2809.0	2450.0	x	3072.0	x	2639.0	x	x	x	2947.0	2543.0	3076.0	x	3160.0	2528.0	2251.0	x	3705.0	x	2800.0	3413.0	x	2328.0	x	x	2792.0	2598.0	2746.0	2817.0	2852.0	2854.0	3102.0	x	2554.0	
-15686	None	Trait_119_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, metabolic cage, chow diet, males [mL/kg/h]	x	x	3205.0	3616.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3230.0	2633.0	3394.0	x	x	2195.0	2487.0	2923.0	3490.0	x	x	x	3417.0	3452.0	x	x	x	3198.0	3322.0	3049.0	2967.0	2730.0	2649.0	2563.0	x	2870.0	2508.0	3013.0	2563.0	x	3301.0	x	2831.0	x	x	x	3125.0	2672.0	3196.0	x	3277.0	2768.0	2444.0	x	3899.0	x	3059.0	3815.0	x	2453.0	x	x	2946.0	2772.0	2976.0	3103.0	3012.0	2997.0	3333.0	x	2790.0	
-15684	None	Trait_117_AUW-BXD	Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, metabolic cage, chow diet, males [mL/kg/h]	x	x	2675.0	3227.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2621.0	2344.0	2799.0	x	x	1762.0	1744.0	2569.0	2904.0	x	x	x	2753.0	2786.0	x	x	x	2608.0	2716.0	2452.0	2508.0	2336.0	2385.0	2054.0	x	2515.0	2177.0	2487.0	2323.0	x	2710.0	x	2334.0	x	x	x	2640.0	2338.0	2858.0	x	2974.0	2289.0	2045.0	x	3399.0	x	2509.0	2982.0	x	2196.0	x	x	2618.0	2322.0	2469.0	2473.0	2673.0	2545.0	2722.0	x	2303.0	
-15682	None	Trait_115_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours, metabolic cage, chow diet, males [ratio]	x	x	0.9128	0.85645	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.851	0.8609	0.956675	x	x	0.874	0.88	0.769	0.86715	x	x	x	0.88288	0.574	x	x	x	0.834	0.9005	0.874	0.836	0.812	0.834	0.86352	x	0.872	0.832	0.95135	0.764	x	0.87586	x	0.81496	x	x	x	0.701	0.80198	0.57	x	0.838	0.8034	0.78	x	0.8841	x	0.785	0.871	x	0.825	x	x	0.853	0.84154	0.749	0.777	0.816	0.874467	0.605	x	0.796	
-15680	None	Trait_113_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night), metabolic cage, chow diet, males [ratio]	x	x	0.93275	0.88225	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.896	0.87498	0.992625	x	x	0.895	0.899	0.793	0.895775	x	x	x	0.91928	0.598	x	x	x	0.861	0.936033	0.915	0.886	0.839	0.866	0.88416	x	0.908	0.851	0.987475	0.775	x	0.90668	x	0.83306	x	x	x	0.711	0.81672	0.588	x	0.8501	0.8453	0.806	x	0.909975	x	0.805	0.924	x	0.85	x	x	0.892	0.85586	0.781	0.801	0.834	0.889433	0.626	x	0.816	
-15678	None	Trait_111_AUW-BXD	Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day), metabolic cage, chow diet, males [ratio]	x	x	0.88285	0.81775	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.8	0.84006	0.90285	x	x	0.851	0.857	0.741	0.824175	x	x	x	0.82776	0.538	x	x	x	0.805	0.847233	0.834	0.786	0.782	0.797	0.83262	x	0.833	0.808	0.89735	0.752	x	0.82964	x	0.78882	x	x	x	0.685	0.77986	0.537	x	0.819833	0.762	0.752	x	0.84525	x	0.763	0.814	x	0.798	x	x	0.809	0.8201	0.71	0.748	0.796	0.852	0.573	x	0.775	
-15676	None	Trait_107_AUW-BXD	Musculoskeletal system, morphology: Soleus muscle mass, percentage of body, chow diet, males [%]	x	x	0.054	0.044	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.052	0.043	0.052	x	x	0.062	0.05	0.039	0.048	x	x	x	0.041	0.046	x	x	x	0.033	0.047	0.059	0.04	0.052	0.046	0.037	x	0.058	0.041	0.039	0.052	x	0.049	x	0.047	x	x	x	0.042	0.038	0.061	x	0.051	0.048	0.044	x	0.042	x	0.043	0.039	x	0.035	x	x	0.054	0.045	0.052	0.055	0.065	0.045	0.045	x	0.046	
-15674	None	Trait_105_AUW-BXD	Musculoskeletal system, Musculoskeletal system, morphology: Gastrocnemius muscle mass, percentage of body, chow diet, males [%]	x	x	1.061	0.81	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.071	0.674	0.951	x	x	0.828	0.916	0.777	1.132	x	x	x	0.949	0.812	x	x	x	0.654	0.836	0.88	0.775	0.916	0.755	0.549	x	0.829	0.769	0.926	0.833	x	0.902	x	0.908	x	x	x	0.787	0.714	1.067	x	0.867	0.793	0.763	x	0.896	x	0.813	0.674	x	0.619	x	x	0.882	0.754	0.715	0.813	0.909	0.799	0.855	x	0.751	
-15672	None	Trait_103_AUW-BXD	Morphology: Epididymal white adipose mass, percentage of body, chow diet, males [%]	x	x	2.38	3.865	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.468	6.299	1.782	x	x	4.347	2.801	4.062	3.157	x	x	x	2.275	2.27	x	x	x	3.96	3.731	3.185	3.643	4.337	3.996	5.608	x	2.862	4.016	2.813	3.229	x	2.124	x	3.44	x	x	x	5.64	3.505	3.289	x	3.572	3.57	3.101	x	3.219	x	4.235	3.917	x	4.039	x	x	3.469	5.241	5.01	5.007	2.964	5.145	3.284	x	2.985	
-15670	None	Trait_101_AUW-BXD	Urogenital system, morphology: Kidney mass, percentage of body, chow diet, males [%]	x	x	1.208	1.99	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.115	1.228	1.675	x	x	1.005	1.3	1.216	1.646	x	x	x	1.678	1.997	x	x	x	1.189	1.38	1.507	1.023	1.302	1.076	1.216	x	1.085	1.406	1.849	1.25	x	1.724	x	1.67	x	x	x	1.347	1.196	1.484	x	1.592	1.73	0.95	x	1.282	x	1.258	1.395	x	0.921	x	x	1.331	1.014	1.278	1.465	1.322	1.075	1.229	x	1.316	
-15668	None	Trait_99_AUW-BXD	Morphology: Perirenal white adipose mass, percentage of body, chow diet, males [%]	x	x	0.855	1.625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.179	2.311	0.953	x	x	2.581	1.722	1.86	1.813	x	x	x	0.864	1.159	x	x	x	2.628	1.592	1.825	2.455	2.658	2.881	3.722	x	2.297	2.654	1.571	1.74	x	1.489	x	1.324	x	x	x	2.33	2.412	1.28	x	1.224	1.95	1.881	x	1.653	x	2.084	1.007	x	2.924	x	x	2.427	2.489	1.025	2.93	1.54	2.399	1.244	x	2.997	
-15666	None	Trait_97_AUW-BXD	Morphology: Subcutaneous white adipose mass, percentage of body, chow diet, males [%]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.843	3.282	0.724	x	x	2.079	1.586	1.685	1.241	x	x	x	1.081	0.923	x	x	x	2.565	1.37	1.028	1.531	1.835	3.027	3.243	x	1.976	3.193	1.912	2.375	x	1.007	x	1.649	x	x	x	1.76	x	2.073	x	1.008	1.404	2.361	x	0.923	x	1.862	1.862	x	2.895	x	x	1.483	1.862	1.905	2.088	1.525	2.499	2.196	x	2.937	
-15664	None	Trait_95_AUW-BXD	Cardiovascular systen, morphology: Heart mass, percentage of body, chow diet, males [%]	x	x	0.763	0.616	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.465	0.486	0.638	x	x	0.429	0.455	0.471	0.658	x	x	x	0.595	0.583	x	x	x	0.392	0.49	x	0.548	0.556	0.398	0.473	x	0.502	0.429	0.585	0.59	x	0.681	x	0.519	x	x	x	0.505	0.566	0.486	x	0.609	0.578	0.451	x	0.718	x	0.478	0.488	x	0.356	x	x	0.433	0.431	0.504	0.465	0.641	0.529	0.554	x	0.59	
-15662	None	Trait_93_AUW-BXD	Gastrointestinal system, morphology: Liver mass, percentage of body, chow diet, males [%]	x	x	5.024	4.11	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.403	4.257	5.1	x	x	3.207	4.479	3.31	4.287	x	x	x	4.901	3.972	x	x	x	6.94	4.787	3.814	2.942	3.524	5.929	4.009	x	4.715	4.622	4.487	3.802	x	3.678	x	4.238	x	x	x	4.03	3.322	4.513	x	3.721	4.105	4.06	x	4.24	x	3.216	3.908	x	5.242	x	x	3.777	4.142	5.748	3.748	4.137	4.117	4.152	x	3.382	
-15660	None	Trait_89_AUW-BXD	Musculoskeletal system, morphology: Soleus muscle mass, chow diet, males [g]	x	x	0.017	0.0148	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0162	0.016	0.0157	x	x	0.0227	0.0193	0.018	0.0154	x	x	x	0.0123	0.0149	x	x	x	0.0152	0.0161	0.018	0.0142	0.0181	0.0215	0.0176	x	0.0238	0.0161	0.0116	0.019	x	0.0147	x	0.0152	x	x	x	0.0158	0.0158	0.0155	x	0.0145	0.0172	0.0191	x	0.0119	x	0.0179	0.013	x	0.0167	x	x	0.0182	0.0201	0.0233	0.0197	0.0205	0.0158	0.0141	x	0.0172	
-15658	None	Trait_87_AUW-BXD	Musculoskeletal system, morphology: Gastrocnemius muscle mass, chow diet, males [g]	x	x	0.331	0.271	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.325	0.231	0.305	x	x	0.305	0.363	0.277	0.365	x	x	x	0.283	0.262	x	x	x	0.297	0.287	0.273	0.274	0.288	0.354	0.276	x	0.34	0.303	0.27	0.304	x	0.275	x	0.298	x	x	x	0.294	0.293	0.265	x	0.247	0.282	0.334	x	0.25	x	0.276	0.221	x	0.3	x	x	0.303	0.33	0.317	0.291	0.286	0.322	0.267	x	0.281	
-15656	None	Trait_85_AUW-BXD	Morphology: Epididymal white adipose mass, chow diet, males [g]	x	x	0.753	1.299	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.789	2.149	0.602	x	x	1.612	1.115	1.482	1.017	x	x	x	0.698	0.732	x	x	x	1.787	1.288	1.01	1.297	0.693	1.88	2.666	x	1.214	1.583	0.887	1.192	x	0.694	x	1.166	x	x	x	2.13	1.444	0.932	x	1.029	1.29	1.37	x	0.91	x	1.438	1.311	x	1.956	x	x	1.214	2.355	2.224	1.866	0.937	2.147	1.04	x	1.128	
-15654	None	Trait_83_AUW-BXD	Urogenital system, morphology: Kidney mass, chow diet, males [g]	x	x	0.378	0.666	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.342	0.417	0.535	x	x	0.371	0.514	0.438	0.528	x	x	x	0.501	0.648	x	x	x	0.538	0.475	0.468	0.362	0.567	0.508	0.57	x	0.451	0.554	0.586	0.459	x	0.448	x	0.547	x	x	x	0.506	0.492	0.385	x	0.453	0.62	0.418	x	0.359	x	0.426	0.459	x	0.445	x	x	0.457	0.449	0.567	0.527	0.417	0.426	0.383	x	0.496	
-15652	None	Trait_81_AUW-BXD	Morphology: Perirenal white adipose mass, chow diet, males [g]	x	x	0.273	0.555	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.377	0.789	0.324	x	x	0.954	0.686	0.685	0.584	x	x	x	0.266	0.377	x	x	x	1.19	0.553	0.575	0.872	1.266	1.367	1.782	x	0.986	1.047	0.565	0.659	x	0.49	x	0.45	x	x	x	0.875	0.998	0.362	x	0.35	0.701	0.833	x	0.467	x	0.709	0.337	x	1.42	x	x	0.858	1.114	0.456	1.096	0.488	1.011	0.393	x	1.193	
-15650	None	Trait_79_AUW-BXD	Morphology: Subcutaneous white adipose mass, chow diet, males [g]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.264	1.112	0.261	x	x	0.778	0.632	0.612	0.401	x	x	x	0.331	0.299	x	x	x	1.17	0.474	0.328	0.546	1.897	1.417	1.564	x	0.871	1.26	0.659	0.886	x	0.338	x	0.558	x	x	x	0.688	x	0.582	x	0.288	0.515	1.044	x	0.261	x	0.437	0.525	x	1.403	x	x	0.528	0.835	0.845	0.778	0.484	1.089	0.697	x	1.146	
-15648	None	Trait_75_AUW-BXD	Cardiovascular system, morphology: Heart mass, chow diet, males [g]	x	x	0.239	0.206	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.142	0.165	0.204	x	x	0.158	0.18	0.168	0.21	x	x	x	0.178	0.188	x	x	x	0.177	0.168	x	0.194	0.165	0.188	0.223	x	0.205	0.169	0.174	0.216	x	0.207	x	0.17	x	x	x	0.189	0.233	0.124	x	0.173	0.205	0.197	x	0.201	x	0.162	0.16	x	0.169	x	x	0.146	0.191	0.224	0.168	0.201	0.214	0.172	x	0.22	
-15646	None	Trait_73_AUW-BXD	Gastrointestinal system, liver, morphology, metabolism: Liver mass, chow diet, males [g]	x	x	1.579	1.382	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.04	1.458	1.648	x	x	1.187	1.773	1.186	1.379	x	x	x	1.46	1.285	x	x	x	3.164	1.661	1.191	1.04	1.742	2.81	1.898	x	1.972	1.824	1.384	1.4	x	1.13	x	1.397	x	x	x	1.523	1.369	1.18	x	1.061	1.46	1.793	x	1.193	x	1.091	1.29	x	2.54	x	x	1.293	1.846	2.553	1.361	1.302	1.699	1.299	x	1.278	
-15643	None	Trait_70_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor activity, light phase (day) running distance, activity wheel, high fat diet, males [km]	x	x	0.258075	0.8074	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.203	0.00292	0.52865	x	x	0.00838	0.012464	0.0006	0.125325	x	x	x	0.30115	0.083	x	x	x	x	0.00298	0.063	0.13	0.059	0.0028	0.01282	x	0.086	0.037	0.939775	0.0043	x	0.000125	x	0.03132	x	x	x	0.00169	0.0084	0.016	x	0.01847	0.529	0.02	x	0.0031	x	0.065	0.033	x	x	x	x	0.4881	0.02595	0.05	0.095	0.26	0.16782	0.04	x	0.0072	
-15641	None	Trait_68_AUW-BXD	Central nervous system, metabolism, behavior: Locomotor actvity, dark phase (night) running distance, activity wheel, chow diet, males [km]	x	x	6.7659	3.39047	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.92	2.58306	4.71195	x	x	2.9364	0.645839	2.074	4.06325	x	x	x	3.96468	5.417	x	x	x	1.2339	3.08883	2.508	1.999	3.8623	0.85	0.26638	x	6.738	3.252	3.902	5.55	x	1.79995	x	4.34858	x	x	x	0.8711	1.05288	6.56	x	1.7076	6.1	1.38	x	1.1676	x	5.849	3.245	x	1.392	x	x	2.45	3.45613	3.655	5.17	5.49	2.44407	8.347	x	2.653	
-15639	None	Trait_66_AUW-BXD	Cardiovascular system, physiology: Heart rate, high fat diet, males [bpm]	x	x	697.25	688.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	709.5	584.0	760.143	x	x	737.0	736.919	655.3	660.75	x	x	x	624.75	719.1	x	x	x	x	683.625	691.88	661.375	636.37	637.0	678.125	x	774.5	681.31	706.75	690.9	x	644.5	x	685.0	x	x	x	724.9	658.5	621.0	x	633.875	706.53	700.9	x	714.25	x	687.0	708.75	x	x	x	x	666.3	685.167	622.3	621.0	643.89	756.5	691.4	x	664.0	
-15637	None	Trait_64_AUW-BXD	Cardiovascular system, physiology: Diastolic blood pressure, high fat diet, males [mmHg]	x	x	77.125	80.25	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	67.3	82.625	78.7143	x	x	73.8	73.8225	73.75	62.5	x	x	x	87.75	85.2	x	x	x	x	79.75	74.0	76.0	97.3	79.5	76.75	x	83.8	82.43	104.5	76.3	x	82.25	x	72.75	x	x	x	62.7	97.25	91.3	x	80.05	71.6	72.7	x	80.5	x	90.52	80.75	x	x	x	x	90.85	74.0	81.4	76.8	98.49	59.7625	82.99	x	105.5	
-15635	None	Trait_62_AUW-BXD	Cardiovascular system, physiology: Systolic blood pressure, chow diet, males [mmHg]	x	x	117.0	115.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	97.3	107.75	111.875	x	x	110.0	97.0	96.0	101.625	x	x	x	122.0	104.0	x	x	x	117.22	111.0	103.504	114.125	120.0	109.489	105.125	x	106.64	115.467	100.625	124.1	x	102.75	x	119.125	x	x	x	95.0714	115.25	101.93	x	115.5	108.1	101.025	x	108.86	x	116.0	109.375	x	102.61	x	x	123.019	109.67	108.3	104.6	105.01	104.3	103.2	x	120.6	
-15633	None	Trait_60_AUW-BXD	Metabolism, morphology: Body weight loss pre-sacrifice, high fat diet, males [g]	x	x	x	1.072	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.46	1.86	1.3	x	x	1.29	1.103	2.71	2.375	x	x	x	1.65	3.22	x	x	x	x	x	1.96	-0.6	1.41	1.58	1.58	x	2.44	2.52	0.617	2.92	x	1.69	x	1.31	x	x	x	2.156	2.16	2.82	x	1.66	0.02	1.3	x	-0.74	x	0.94	1.5	x	x	x	x	2.22	1.61	2.76	3.16	1.79	1.24	x	x	2.59	
-15630	None	Trait_57_AUW-BXD	Metabolism, morphology: Body weight fat loss percentage after exercise, chow diet, males [%]	x	x	52.11	40.43	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	43.77	44.17	x	x	x	24.51	-24.41	14.49	x	x	x	x	x	41.16	x	x	x	5.49	50.15	-33.7	25.66	30.17	-4.52	-4.88	x	49.07	25.02	x	49.83	x	x	x	39.26	x	x	x	13.35	x	45.62	x	10.56	61.2	7.87	x	17.77	x	15.73	16.75	x	-3.89	x	x	41.38	22.06	32.11	37.9	66.23	-3.86	28.17	x	20.39	
-15628	None	Trait_49_AUW-BXD	Metabolism, morphology: Body weight gain percentage 8-28 weeks, high fat diet, males [%]	x	x	102.1	83.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	121.95	170.36	108.17	x	x	120.23	64.19	76.66	115.26	x	x	x	92.31	72.34	x	x	x	x	97.5	76.12	66.31	96.53	122.6	114.16	x	89.55	61.44	66.4	71.26	x	59.55	x	71.07	x	x	x	137.15	91.18	123.01	x	56.8	137.35	93.12	x	68.49	x	75.51	109.9	x	x	x	x	100.94	93.24	80.73	95.71	104.26	89.22	88.52	x	74.39	
-15626	None	Trait_47_AUW-BXD	Metabolism, morphology: Body weight gain percentage 8-16 weeks, high fat diet, males [%]	x	x	43.65	80.1	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	59.9	112.2	66.12	x	x	83.97	33.06	60.72	84.72	x	x	x	52.79	52.84	x	x	x	x	68.59	49.94	51.23	70.01	76.63	68.58	x	64.97	60.65	31.98	52.84	x	54.7	x	57.92	x	x	x	98.23	71.05	94.56	x	43.57	87.5	69.92	x	46.99	x	57.9	89.64	x	x	x	x	72.28	66.78	60.15	62.4	75.68	58.65	61.13	x	59.23	
-15624	None	Trait_45_AUW-BXD	Metabolism, morphology: Body weight loss percentage after exercise, chow diet, males [%]	x	x	3.78	8.54	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.9	7.44	1.96	x	x	5.5	-5.68	2.62	6.46	x	x	x	4.55	5.09	x	x	x	2.99	11.13	-0.78	5.67	6.38	-0.88	0.2	x	17.88	8.23	6.91	14.69	x	0.38	x	9.32	x	x	x	3.73	7.03	8.45	x	0.14	15.78	0.12	x	-0.52	x	4.86	-2.32	x	-0.55	x	x	5.27	5.01	9.67	10.92	20.31	1.12	3.51	x	4.95	
-15622	None	Trait_43_AUW-BXD	Metabolism, morphology: Body weight gain 8-28 weeks, chow diet, males [g]	x	x	8.42	10.33	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	10.17	12.058	8.376	x	x	10.9	8.668	10.22	9.284	x	x	x	6.222	7.15	x	x	x	19.25	8.27	6.64	9.41	9.19	20.12	16.016	x	14.1	11.828	7.4	11.66	x	5.67	x	7.77	x	x	x	13.62	13.616	7.25	x	6.23	10.89	17.72	x	5.58	x	9.19	10.75	x	21.56	x	x	10.13	14.23	13.314	11.94	7.63	14.15	9.81	x	10.388	
-15620	None	Trait_41_AUW-BXD	Metabolism, morphology: Body weight gain 8-16 weeks, chow diet, males [g]	x	x	6.54	7.73	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.62	9.95	6.07	x	x	7.7	4.44	4.48	5.63	x	x	x	5.43	5.27	x	x	x	4.68	6.3	4.4	5.96	8.59	11.9	9.71	x	11.53	11.81	6.52	12.4	x	6.12	x	8.07	x	x	x	10.69	12.93	5.04	x	2.53	10.87	15.33	x	3.62	x	5.33	4.92	x	13.4	x	x	10.36	8.44	11.52	7.17	10.55	8.87	6.13	x	11.01	
-15618	None	Trait_39_AUW-BXD	Metabolism, morphology: Lean mass percentage after activity wheel, chow diet, males [%]	x	x	89.64	82.06	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	85.22	70.2	x	x	x	75.1799	80.6278	34.72	x	x	x	x	x	87.87	x	x	x	72.31	84.29	83.5	75.95	80.01	63.5	64.036	x	79.83	66.98	82.64	79.13	x	x	x	77.304	x	x	x	70.99	65.4	83.23	x	82.85	85.97	68.2	x	84.05	x	82.66	85.05	x	61.5	x	x	85.63	76.14	75.212	76.62	82.858	75.35	79.15	x	70.33	
-15616	None	Trait_37_AUW-BXD	Metabolism, morphology: Lean mass after activity wheel, chow diet, males [g]	x	x	27.24	24.83	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	25.761	24.32	x	x	x	26.223	32.2195	26.49	x	x	x	x	x	27.95	x	x	x	27.779	26.04	26.54	26.33	25.44	28.884	28.0416	x	26.47	24.0	23.7245	25.1	x	x	x	25.847	x	x	x	24.72	26.64	20.9	x	23.35	25.97	31.22	x	22.571	x	27.1	26.35	x	28.4	x	x	26.94	29.899	30.385	24.48	25.1796	28.14	23.7	x	27.145	
-15614	None	Trait_35_AUW-BXD	Metabolism, morphology: Fat mass after activity wheel, chow diet, males [%]	x	x	6.633	13.81	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.75	26.23	x	x	x	21.288	16.42	17.36	x	x	x	x	x	7.48	x	x	x	23.37	10.85	13.59	20.79	17.18	33.201	32.2216	x	15.67	30.34	11.575	16.52	x	x	x	15.626	x	x	x	25.76	30.73	13.04	x	13.99	9.93	28.0	x	10.7	x	13.37	11.14	x	34.63	x	x	10.65	20.59	20.85	19.34	13.23	18.82	17.0	x	26.04	
-15612	None	Trait_33_AUW-BXD	Metabolism, morphology: Fat mass after activity wheel, chow diet, males [g]	x	x	1.998	4.281	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.065	9.13	x	x	x	7.56	6.564	6.15	x	x	x	x	x	2.38	x	x	x	9.44	3.36	4.35	7.43	5.47	15.11	14.596	x	5.33	10.9	3.74825	5.27	x	x	x	5.343	x	x	x	9.0252	12.57	3.43	x	3.98	2.97	12.82	x	2.89	x	4.38	3.45	x	15.96	x	x	3.49	8.2	8.556	6.31	4.03	7.62	5.19	x	10.26	
-15610	None	Trait_31_AUW-BXD	Metabolism, morphology: Body weight after activity wheel, chow diet, males [g]	x	x	30.357	30.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.37	34.685	30.288	x	x	35.02	39.97	34.72	32.896	x	x	x	29.45	31.8	x	x	x	38.858	30.917	31.81	34.9	31.8	45.49	44.298	x	33.31	35.51	29.155	31.74	x	32.015	x	33.554	x	x	x	34.872	40.765	25.26	x	28.22	30.2	45.8	x	26.868	x	32.78	30.98	x	46.1	x	x	31.6	41.4	40.538	32.08	30.4	37.973	30.05	x	38.798	
-15608	None	Trait_29_AUW-BXD	Metabolism, morphology: Lean mass before activity wheel, chow diet, males [%]	x	x	84.132	72.18	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	79.81	56.1	x	x	x	69.98	82.521	74.49	x	x	x	x	86.676	82.99	x	x	x	72.1	78.2033	83.45	70.11	73.52	60.59	63.801	x	71.32	61.9	x	66.95	x	x	x	72.128	x	x	x	67.7	60.718	74.58	x	81.53	73.84	66.49	x	83.2825	x	74.66	81.06	x	63.1	x	x	78.16	71.833	68.52	69.1	64.82	75.09	73.8	x	65.56	
-15606	None	Trait_27_AUW-BXD	Metabolism, morphology: Lean mass before activity wheel, chow diet, males [g]	x	x	26.555	23.963	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	25.67	22.55	x	x	x	25.84	31.2085	26.3	x	x	x	x	25.4842	27.8	x	x	x	28.056	27.2063	26.29	25.81	25.03	28.003	28.009	x	28.8	23.83	x	24.91	x	x	x	26.654	x	x	x	24.48	26.591	20.52	x	23.01	25.996	30.135	x	22.2447	x	25.73	24.525	x	28.92	x	x	25.97	29.822	30.755	24.7927	24.73	28.468	24.5	x	26.72	
-15604	None	Trait_25_AUW-BXD	Metabolism, morphology: Fat mass percentage before activity wheel, chow diet, males [%]	x	x	12.1	23.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.4	40.699	x	x	x	26.87	14.1037	22.03	x	x	x	x	7.01	12.1	x	x	x	24.32	19.22	13.1	26.32	23.52	31.26	31.737	x	24.9	35.7	x	29.0449	x	x	x	23.248	x	x	x	28.76	35.522	21.5	x	15.61	22.75	30.777	x	13.26	x	21.69	14.86	x	33.5	x	x	18.17	25.29	27.96	27.46	31.548	20.865	22.2	x	31.13	
-15602	None	Trait_23_AUW-BXD	Metabolism, morphology: Fat mass before activity wheel, chow diet, males [g]	x	x	3.79	7.97	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.08	16.44	x	x	x	10.22	5.33575	8.26	x	x	x	x	2.105	4.1	x	x	x	9.88	6.68467	4.23	9.89	8.06	14.47	14.66	x	10.5	13.8	x	10.995	x	x	x	8.6312	x	x	x	10.44	15.57	6.28	x	4.45	8.125	13.904	x	3.57575	x	7.474	4.56	x	15.4	x	x	6.11	10.567	12.5536	9.9845	12.047	9.058	7.55	x	12.74	
-15600	None	Trait_21_AUW-BXD	Metabolism, morphology: Body weight before activity wheel, chow diet, males [g]	x	x	31.55	33.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	32.29	40.27	32.116	x	x	37.228	37.82	35.83	35.364	x	x	x	30.858	33.52	x	x	x	38.46	34.7833	31.63	37.01	34.1	46.43	44.656	x	40.8	38.71	30.735	37.38	x	33.398	x	36.978	x	x	x	36.21	43.8075	27.91	x	28.27	35.31	45.27	x	26.7475	x	34.47	30.32	x	45.86	x	x	33.31	41.567	44.886	36.015	38.164	39.1133	33.4	x	40.81	
-15598	None	Trait_19_AUW-BXD	Metabolism, morphology: Lean mass percentage pre-metabolic caging, chow diet, males [%]	x	x	85.1725	70.17	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	77.96	63.884	87.555	x	x	77.07	83.94	70.26	77.975	x	x	x	82.532	79.823	x	x	x	73.76	78.41	86.32	69.59	73.6	67.66	64.332	x	71.1	60.65	78.625	67.3	x	79.7125	x	75.18	x	x	x	67.15	63.702	78.48	x	84.81	73.1	64.54	x	84.822	x	71.23	84.33	x	66.7	x	x	76.2	75.67	70.23	71.8	69.87	74.3167	79.562	x	64.61	
-15596	None	Trait_17_AUW-BXD	Metabolism, morphology: Lean mass pre-metabolic caging, chow diet, males [g]	x	x	25.2083	22.062	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.801	21.8926	26.392	x	x	26.086	30.73	25.6	24.4735	x	x	x	24.887	25.7	x	x	x	26.67	25.7263	25.36	24.0	24.36	27.17	27.145	x	26.1	23.59	23.4923	25.93	x	26.9755	x	26.5004	x	x	x	23.95	26.5004	19.698	x	22.06	25.64	29.215	x	21.81	x	24.36	23.59	x	28.53	x	x	25.3	28.8072	29.675	23.3	24.75	26.061	22.69	x	26.42	
-15594	None	Trait_15_AUW-BXD	Metabolism, morphology: Fat mass percentage pre-metabolic caging, chow diet, males [%]	x	x	10.87	26.0375	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	17.32	33.4962	8.7275	x	x	19.1	12.91	25.7	17.6525	x	x	x	12.736	16.31	x	x	x	22.04	19.4867	9.91	27.34	23.22	29.03	32.354	x	25.885	36.7	17.7775	29.01	x	16.88	x	21.552	x	x	x	29.14	33.4	17.15	x	12.076	24.3	31.41	x	12.636	x	24.67	12.1	x	30.32	x	x	20.62	21.952	26.41	24.3	27.1	21.8367	17.57	x	31.98	
-15592	None	Trait_13_AUW-BXD	Metabolism, morphology: Fat mass pre-metabolic caging, chow diet, males [g]	x	x	3.21375	8.22625	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.529	13.7978	2.61975	x	x	6.48	4.76	9.8	5.69225	x	x	x	3.8924	5.27	x	x	x	8.15	6.38067	2.88	9.467	7.71	11.6	14.0626	x	9.8698	14.3	5.92975	11.21	x	6.0055	x	7.6118	x	x	x	10.402	13.884	4.604	x	3.171	8.56	14.228	x	3.2676	x	8.54	3.34	x	12.96	x	x	7.04	8.508	11.15	7.97	9.66	8.77333	5.058	x	13.15	
-15590	None	Trait_11_AUW-BXD	Metabolism, morphology: Body weight pre-metabolic caging, chow diet, males [g]	x	x	29.5925	31.4775	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.75	36.8325	29.7	x	x	33.88	36.64	36.93	31.545	x	x	x	30.198	32.22	x	x	x	36.34	32.7967	29.48	34.56	33.12	40.07	42.632	x	37.064	38.91	30.503	38.586	x	34.145	x	35.264	x	x	x	35.67	41.588	25.3875	x	26.036	35.124	45.282	x	25.728	x	34.31	28.04	x	42.75	x	x	33.34	38.216	42.246	32.53	35.498	36.1767	28.57	x	40.97	
-15588	None	Trait_9_AUW-BXD	Metabolism, morphology: Body weight at blood pressure measurement, chow diet, males [g]	x	x	30.0	32.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.52	34.4	31.3	x	x	35.51	37.1	35.0225	33.0	x	x	x	30.6	31.22	x	x	x	37.94	32.0	30.5	34.98	32.6	39.46	42.41	x	35.41	38.78	30.6	36.01	x	33.2	x	35.2	x	x	x	34.516	41.6	26.54	x	27.24	34.64	44.2	x	26.51	x	33.97	28.85	x	42.16	x	x	32.78	39.4	40.91	31.752	38.018	36.6	30.21	x	40.85	
-15586	None	Trait_7_AUW-BXD	Metabolism, morphology: Body weight at sacrifice, chow diet, males [g]	x	x	31.302	33.5725	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.78	34.116	32.4375	x	x	37.01	39.62	35.96	32.09	x	x	x	30.044	32.32	x	x	x	45.38	34.39	31.15	35.4	32.49	47.113	47.298	x	41.72	39.45	30.09	36.86	x	30.8025	x	32.876	x	x	x	37.606	41.2	26.15	x	28.48	35.61	43.98	x	28.008	x	33.92	33.01	x	48.38	x	x	34.49	44.354	44.406	36.32	31.43	40.976	31.305	x	37.69	
-15584	None	Trait_5_AUW-BXD	Metabolism, morphology: Body weight at 28 weeks, chow diet, males [g]	x	x	30.0	32.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	32.78	37.32	32.6	x	x	38.44	40.87	38.58	35.5	x	x	x	30.6	34.38	x	x	x	45.34	34.8	31.96	36.95	33.72	48.3	44.3	x	40.95	39.61	31.4	38.16	x	31.9	x	35.0	x	x	x	38.596	41.4	27.6	x	29.0	36.02	47.68	x	27.51	x	35.96	33.87	x	49.21	x	x	33.7	44.0	44.04	37.14	32.58	41.5	32.24	x	40.35	
-15582	None	Trait_3_AUW-BXD	Metabolism, morphology: Body weight at 16 weeks, chow diet, males [g]	x	x	28.084	30.146	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.75	33.954	30.266	x	x	35.24	36.64	33.89	31.828	x	x	x	29.828	32.22	x	x	x	34.48	32.7967	29.72	33.21	33.12	40.07	38.0	x	37.06	38.91	30.0775	38.59	x	32.37	x	35.264	x	x	x	35.67	40.9	25.39	x	25.32	28.92	45.28	x	25.556	x	32.23	28.04	x	41.62	x	x	33.91	38.216	41.87	32.53	35.5	36.1767	28.57	x	40.97	
-15580	None	Trait_1_AUW-BXD	Metabolism, morphology: Body weight at 8 weeks, chow diet, males [g]	x	x	21.548	22.414	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	23.13	24.0	24.2	x	x	27.53	32.0	27.65	26.2	x	x	x	24.4	26.95	x	x	x	27.94	26.5	25.32	27.25	25.57	28.18	28.29	x	25.35	27.7	24.0	26.18	x	27.0	x	27.198	x	x	x	24.98	27.982	20.348	x	22.8	22.17	29.95	x	21.932	x	27.0	23.12	x	28.4	x	x	23.8	29.78	30.72	25.37	24.95	27.3067	22.44	x	29.96	
-15578	None	Trait_386_AUW-BXD	Metadata: Cohort study order, chow diet, males [weeks]	x	x	34.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	78.0	22.0	25.0	x	x	92.0	92.0	116.0	25.0	x	x	x	27.0	112.0	x	x	x	86.0	31.0	53.0	51.0	94.0	84.0	38.0	x	101.0	80.0	28.0	103.0	x	26.0	x	29.0	x	x	x	125.0	35.0	98.0	x	45.0	106.0	103.0	x	31.0	x	56.0	54.0	x	80.0	x	x	80.0	37.0	121.0	116.0	101.0	37.0	110.0	x	107.0	
-15576	None	Trait_384_AUW-BXD	Metadata: Cohort study order, chow diet, males [rank]	x	x	10.0	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.0	1.0	2.0	x	x	23.0	23.0	33.0	3.0	x	x	x	5.0	32.0	x	x	x	22.0	8.0	16.0	15.0	24.0	21.0	13.0	x	26.0	20.0	6.0	27.0	x	4.0	x	7.0	x	x	x	36.0	11.0	25.0	x	14.0	28.0	27.0	x	9.0	x	18.0	17.0	x	20.0	x	x	20.0	12.0	34.0	33.0	26.0	12.0	31.0	x	29.0	
-15552	Original post publication description: Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron developmental expression signature) mRNA expression in adult striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron developmental expression signature) mRNA expression in adult striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration]	x	0.533	2.824	0.265	-1.376	0.208	x	x	2.689	2.71	-0.148	-1.108	-0.412	-0.994	2.845	-3.033	0.038	0.247	1.64	0.657	1.111	-4.648	x	-3.353	x	-1.585	-4.415	-2.342	x	-2.203	1.307	-1.55	4.134	x	3.141	x	3.265	-3.662	0.385	x	2.83	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15553	Original post publication description: Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using four Affymetrix exon-level Dock1 probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using four Affymetrix exon-level Dock1 probe sets and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using six Affymetrix exon-level Dock1 probe sets (exon 45 to 50) and Striatum_Exon_0209 data [relative residual concentration]	Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using six Affymetrix exon-level Dock1 probe sets (exon 45 to 50) and Striatum_Exon_0209 data [relative residual concentration]	x	-0.978	0.287	3.192	-1.084	-2.207	x	x	-2.19	-1.503	-1.926	-0.695	-0.409	0.016	-1.753	-0.406	-1.026	-0.36	-2.939	-3.398	-2.423	4.039	x	3.551	x	2.974	4.882	3.182	x	3.678	2.005	2.707	-1.72	x	-0.564	x	-1.331	0.265	-1.776	x	-2.089	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15554	Original post publication description: ROY Original pre publication description: gy6ye6bjhu56IUM'P P'JH	Central nervous system, gene expression: Dopamine-associated trait (rwilliams@uthsc.edu)	Central nervous system, gene expression: Dopamine receptor ratio in striatum based on relative expression using Affymetrix Exon array probe sets for Drd1 and Drd2 [ratio]	x	0.939	0.948	0.885	0.901	0.946	x	x	0.962	0.964	0.946	0.939	0.922	0.92	0.942	0.941	0.948	0.942	0.954	0.966	0.945	0.867	x	0.875	x	0.88	0.854	0.878	x	0.844	0.909	0.877	0.941	x	0.959	x	0.968	0.905	0.933	x	0.96	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15555	Original post publication description: Infectious disease, immune system: Kramer1 Original pre publication description: Infectious disease, immune system: Kramer1	TAFI1	TAFI1	x	x	-4.879	3.121	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-5.212	x	x	x	x	x	x	x	x	x	-9.212	8.121	x	x	3.454	4.121	x	4.121	x	x	x	4.121	6.788	x	x	x	1.454	-5.212	x	x	-2.99	x	2.521	x	3.454	0.121	5.454	-0.879	x	4.121	x	5.454	x	x	x	x	5.454	-11.88	x	-6.546	-1.546	x	-11.88	-9.212	x	-5.212	-5.212	x	x	x	x	x	-6.546	-1.212	-2.736	x	1.454	x	-3.879	10.79	
-15556	Original post publication description: Infectious disease, immune system: Kramer3 Original pre publication description: Infectious disease, immune system: Kramer3	TAFI3	TAFI3	x	x	-1.004	11.753	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.754	x	x	x	x	x	x	x	x	x	-10.028	6.604	x	x	5.459	-0.695	x	-15.848	x	x	x	5.575	4.218	x	x	x	6.408	6.964	x	x	-1.479	x	-3.114	21.642	1.895	-2.388	0.301	-13.842	x	-9.161	x	8.109	x	x	x	x	-6.158	-7.552	x	0.404	-0.949	x	-7.81	-9.029	x	-5.32	-3.316	x	x	x	x	x	-1.284	-0.586	4.671	x	16.118	x	3.902	-2.7	
-15557	Original post publication description: Infectious disease, immune system: Kramer2 Original pre publication description: Infectious disease, immune system: Kramer2	TAFI2	TAFI2	x	x	-2.797	-8.797	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-3.63	x	x	x	x	x	x	x	x	x	0.56	1.703	x	x	0.37	3.989	x	17.7	x	x	x	-0.297	3.036	x	x	x	-4.697	-12.3	x	x	1.703	x	7.036	-0.964	4.37	3.303	5.703	3.703	x	13.7	x	-2.297	x	x	x	x	12.37	-5.097	x	-8.297	-0.583	x	-3.63	-3.63	x	0.37	-0.964	x	x	x	x	x	-8.297	-0.297	x	x	-15.63	x	-7.63	14.5	
-15558	Original post publication description: Infectious disease, immune system: Kramer4 Original pre publication description: Infectious disease, immune system: Kramer4	TAFI4	TAFI4	x	x	0.233	-0.076	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.017	-0.119	-0.321	x	x	x	x	x	x	x	x	x	0.504	0.174	x	x	0.055	x	x	0.649	x	x	x	x	-0.241	x	x	x	-0.034	0.465	-0.206	x	-0.45	x	0.54	-0.367	-0.242	0.423	0.518	0.131	x	-0.326	x	-0.535	x	x	x	x	x	x	x	-0.068	0.883	x	0.331	-0.451	x	-0.23	-0.41	x	x	x	x	x	-0.735	0.418	-0.072	x	-0.327	x	-0.004	-0.091	
-15559	Original post publication description: Infectious disease, immune system: Kramer5 Original pre publication description: Infectious disease, immune system: Kramer5	TAFI5	TAFI5	x	x	6.176	-8.023	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-16.67	-7.526	x	x	x	x	x	x	x	x	x	-14.24	3.902	x	x	10.03	6.759	x	-16.67	x	x	x	13.62	1.159	x	x	x	-12.24	-8.641	-2.241	x	11.76	x	-0.241	-8.669	2.759	10.76	18.76	21.85	x	-7.241	x	7.759	x	x	x	x	4.359	x	x	-1.241	-2.574	x	x	8.759	x	-5.241	-5.241	x	x	x	x	x	-4.491	1.759	x	x	-14.24	-3.241	x	9.305	
-15560	Original post publication description: Infectious disease, immune system: Kramer6 Original pre publication description: Infectious disease, immune system: Kramer6	TAFI6	TAFI6	x	x	-0.608	-0.38	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.475	x	x	x	x	x	x	x	x	x	-0.545	1.208	x	x	-0.084	0.002	x	0.465	x	x	x	0.318	0.028	x	x	x	0.118	-0.649	0.464	x	0.275	x	-0.292	-0.623	0.975	-0.269	-0.034	0.101	x	1.072	x	-0.275	x	x	x	x	0.297	-1.525	x	-0.703	-0.096	x	-0.149	0.714	x	0.501	-0.283	x	x	x	x	x	0.647	-0.313	0.055	x	-0.559	-0.37	0.406	0.589	
-15561	Original post publication description: Infectious disease, immune system: Kramer7 Original pre publication description: Infectious disease, immune system: Kramer7	TAFI7	TAFI7	x	x	0.575	-0.084	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.557	x	x	x	x	x	x	x	x	x	-0.215	0.493	x	x	0.202	-0.029	x	0.077	x	x	x	0.406	0.654	x	x	x	-0.277	-0.709	0.064	x	0.09	x	0.039	-0.559	0.674	0.107	0.077	0.429	x	0.029	x	-0.355	x	x	x	x	0.515	-0.974	x	-0.3	0.501	x	-0.42	-0.069	x	0.239	-0.191	x	x	x	x	x	0.33	-0.444	0.271	x	-0.539	0.104	-0.34	0.188	
-15562	Original post publication description: Infectious disease, immune system: Kramer8 Original pre publication description: Infectious disease, immune system: Kramer8	TAFI8	TAFI8	x	x	1.701	-2.306	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-2.401	x	x	x	x	x	3.493	x	x	x	-1.605	-0.559	x	x	-2.354	-1.965	x	-2.255	x	x	x	-1.951	-2.107	x	x	x	-2.293	-2.225	-2.126	x	0.575	x	-1.739	-2.011	-2.748	-1.811	10.3	-2.377	x	0.716	x	-1.624	x	x	x	x	-1.509	-1.342	x	6.355	-2.19	x	-1.254	6.224	x	4.613	x	x	x	x	x	-2.518	-0.305	2.682	-0.192	14.55	-2.16	-1.337	-1.505	-0.449	
-15563	Original post publication description: Infectious disease, immune system: Kramer9 Original pre publication description: Infectious disease, immune system: Kramer9	TAFI9	TAFI9	x	x	4.699	-3.488	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-4.379	x	x	x	x	x	13.0	x	x	x	-1.684	-2.38	x	x	-4.341	4.141	x	-3.725	x	x	x	-3.467	-3.519	x	x	x	-3.796	-3.545	-2.742	x	4.151	x	-3.179	-3.604	-4.087	-3.592	12.68	1.644	x	1.779	x	-3.121	x	x	x	x	-2.447	-1.999	x	10.07	-2.976	x	-3.52	4.688	x	2.199	x	x	x	x	x	-3.969	-1.855	11.04	-2.223	10.18	-3.341	-2.707	-1.299	0.718	
-15564	Original post publication description: Infectious disease, immune system: Kramer10 Original pre publication description: Infectious disease, immune system: Kramer10	TAFI10	TAFI10	x	x	6.688	-2.457	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-5.193	x	x	x	x	x	x	x	x	x	2.992	2.266	x	x	-3.314	7.232	x	-4.704	x	x	x	2.028	-4.222	x	x	x	-4.443	-3.459	-3.045	x	-0.582	x	-4.473	-4.873	-5.234	-5.051	10.49	1.455	x	4.057	x	-5.087	x	x	x	x	6.366	0.945	x	7.949	2.52	x	3.491	3.491	x	12.62	4.116	x	x	x	x	-4.551	1.588	-3.522	-3.704	x	-5.329	-4.384	-5.084	2.422	
-15565	Original post publication description: Infectious disease, immune system: Kramer11 Original pre publication description: Infectious disease, immune system: Kramer11	TAFI11	TAFI11	x	x	7.305	-1.729	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-5.499	x	x	x	x	x	x	x	x	x	-2.378	3.714	x	x	2.8	9.139	x	-5.006	x	x	x	-3.828	-4.336	x	x	x	-5.036	-4.54	0.025	x	1.14	x	-2.745	-5.317	-5.045	-5.211	6.876	-4.733	x	-2.881	x	-4.911	x	x	x	x	-0.119	-3.229	x	8.589	-1.411	x	0.692	5.839	x	10.42	12.42	x	x	x	x	-4.578	2.843	2.214	3.046	x	-4.111	-5.278	-5.003	-2.562	
-15566	Original post publication description: Infectious disease, immune system: Kramer12 Original pre publication description: Infectious disease, immune system: Kramer12	TAFI12	TAFI12	x	x	-0.277	-0.444	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.374	x	x	x	x	x	x	x	x	x	1.8	1.181	x	x	0.542	1.042	x	-1.863	x	x	x	-1.541	0.042	x	x	x	-1.791	-1.125	1.25	x	-1.416	x	-1.25	-1.458	-1.583	-1.5	0.233	-1.291	x	-0.27	x	1.783	x	6.042	x	x	-0.791	-1.958	x	2.709	0.042	x	-1.583	-1.166	x	-1.75	-1.625	x	x	x	x	1.709	0.5	-1.333	2.264	1.542	0.576	0.167	0.126	2.837	
-15567	Original post publication description: Infectious disease, immune system: Kramer13 Original pre publication description: Infectious disease, immune system: Kramer13	TAFI13	TAFI13	x	x	0.019	-0.453	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.759	x	x	x	x	x	3.783	x	x	x	-0.753	1.239	x	x	0.533	0.566	x	-1.675	x	x	x	-1.384	-0.277	x	x	x	-2.05	-1.181	-1.023	x	-1.562	x	-1.675	-1.3	-2.092	-1.675	-1.086	0.255	x	0.111	x	-1.4	x	1.616	x	x	1.325	-0.324	x	1.116	-1.009	x	-1.175	3.283	x	-1.8	-1.759	x	x	x	x	6.45	1.394	-1.675	3.866	-0.05	-1.217	2.408	-0.495	2.89	
-15568	Original post publication description: Infectious disease, immune system: Kramer13 Original pre publication description: Infectious disease, immune system: Kramer13	Infectious disease, immune system: Kramerxxx3	Infectious disease, immune system: Kramerxxx3	x	x	0.019	-0.453	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.759	x	x	x	x	x	3.783	x	x	x	-0.753	1.239	x	x	0.533	0.566	x	-1.675	x	x	x	-1.384	-0.277	x	x	x	-2.05	-1.181	-1.023	x	-1.562	x	-1.675	-1.3	-2.092	-1.675	-1.086	0.255	x	0.111	x	-1.4	x	1.616	x	x	1.325	-0.324	x	1.116	-1.009	x	-1.175	3.283	x	-1.8	-1.759	x	x	x	x	6.45	1.394	-1.675	3.866	-0.05	-1.217	2.408	-0.495	2.89	
-15569	Original post publication description: Kramer14 Original pre publication description: Kramer14	TAFI14	TAFI14	x	x	-3.091	7.47	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-3.068	x	x	x	x	x	x	x	x	x	-8.856	7.989	x	x	3.891	3.013	x	-2.839	x	x	x	4.842	6.087	x	x	x	4.053	0.632	x	x	-3.122	x	0.113	x	2.184	-0.694	3.615	-1.865	x	-1.131	x	7.029	x	x	x	x	0.769	-9.11	x	-2.41	-0.703	x	-9.736	-7.068	x	-4.775	-4.206	x	x	x	x	x	-2.41	-0.491	x	x	8.719	x	-0.028	5.196	
-15570	Original post publication description: Infectious disease, immune system: Kramer15 (F=Y axis) Original pre publication description: Infectious disease, immune system: Kramer15	TAFI15	TAFI15 (F=Y axis)	x	x	0.017	-11.448	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.589	x	x	x	x	x	x	x	x	x	6.334	-4.363	x	x	-2.508	0.655	x	14.366	x	x	x	-3.631	-2.12	x	x	x	-6.209	-9.259	x	x	3.227	x	4.795	x	1.492	2.702	1.459	3.785	x	10.366	x	-6.541	x	x	x	x	8.126	2.499	x	-4.344	-0.046	x	3.966	2.144	x	3.411	2.077	x	x	x	x	x	-4.344	0.012	x	x	-17.142	x	-5.499	6.611	
-15571	Original post publication description: Skin, pigmentation: Hair coat color, ordinal scale version 2 where black=2, grey=1, brown=4, dba dilute=3 [color intensity]	None	Skin, pigmentation: Hair coat color, ordinal scale version 3 where grey=1, black=2, brown=3, dba dilute=4 [color intensity]	2.0	2.0	2.0	4.0	4.0	2.0	1.0	1.0	1.0	4.0	2.0	1.0	3.0	2.0	3.0	1.0	1.0	1.0	2.0	4.0	1.0	2.0	3.0	3.0	3.0	3.0	3.0	1.0	4.0	2.0	2.0	1.0	2.0	2.0	3.0	x	1.0	1.0	1.0	x	2.0	2.0	4.0	4.0	x	x	2.0	1.0	2.0	2.0	4.0	3.0	x	3.0	2.0	x	x	3.0	3.0	4.0	3.0	4.0	4.0	3.0	4.0	3.0	3.0	4.0	4.0	4.0	3.0	4.0	3.0	4.0	1.0	4.0	3.0	1.0	4.0	4.0	x	4.0	4.0	4.0	2.0	2.0	3.0	4.0	4.0	4.0	4.0	4.0	2.0	4.0	2.0	4.0	2.0	4.0	2.0	1.0	3.0	4.0	
-15572	Original post publication description: Withdrawal anxiety assay (Nic_Mec_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 mecamylamine (2.0mg/kg, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number].	None	Central nervous system, pharmacology, behavior: Withdrawal anxiety assay, 7-day nicotine-treated (24 mg/kg/day, s.c. minipump) + day 8 mecamylamine (2.0 mg/kg, s.c.), number of somatic signs observed in 8- to 12-week-old males during 20 min session [n]	x	x	7.333	8.75	18.143	5.571	13.167	4.25	8.625	3.429	6.25	11.833	x	6.375	4.286	8.5	7.5	9.0	11.833	10.714	x	x	x	x	x	17.4	8.125	x	x	9.625	7.143	13.4	5.875	x	2.714	x	12.714	4.167	x	x	13.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15573	Original post publication description: Withdrawal anxiety assay (Nic_Sal_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number].	None	Central nervous system, pharmacology, behavior: withdrawal anxiety assay (Nic_Sal_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number].	x	x	3.667	4.625	5.25	2.0	2.75	1.25	3.857	2.0	3.25	4.0	x	7.5	1.8	3.143	6.143	2.143	2.6	2.875	x	x	x	x	x	2.5	6.875	x	x	3.0	4.429	4.0	1.375	x	1.5	x	4.875	1.4	x	x	4.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15574	Original post publication description: Withdrawal anxiety assay (Nic_Mec_PTO), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 mecamylamine (2mg/kg, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session [n %]. Original pre publication description: Nic (24mg/kg/day) + Mec (2mg/kg), percent time in open arms of the EPM [%]	Nic (24mg/kg/day) + Mec (2mg/kg), percent time in open arms of the EPM [%]	Central nervous system, pharmacology, behavior: Withdrawal anxiety assay, 7-day nicotine-treated (24 mg/kg/day, s.c. minipump) + day 8 mecamylamine (2 mg/kg, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session (Nic_Mec_PTO) [n %].	x	x	4.529	2.92	10.431	5.223	3.601	1.954	2.042	1.836	1.373	2.966	x	5.825	5.134	1.523	2.297	2.233	14.736	6.443	x	x	x	x	x	4.635	12.208	x	x	8.287	3.375	5.467	4.851	x	0.794	x	1.178	1.802	x	x	6.372	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15575	Original post publication description: Withdrawal anxiety assay (Nic_Sal_PTO), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session [n %]. Original pre publication description: Nic (24mg/kg/day) + Sal (0.01mL/g), percent time in open arms of the EPM [%]	Nic (24mg/kg/day) + Sal (0.01mL/g), percent time in open arms of the EPM [%]	Central nervous system, pharmacology, behavior: Nicotine response (nicotine at 24 mg/kg/day for 7 days, s.c. by minipump followed by s.c. saline injection on day 8), withdrawal anxiety, percentage of time spent in open arms of an elevated plus maze in 8-12 week old males during 5 minute session (Nic_Sal_PTO) [%]	x	x	5.089	2.264	7.369	2.899	2.174	2.751	3.26	1.866	1.967	4.449	x	4.51	0.929	3.863	2.536	2.023	13.798	5.468	x	x	x	x	x	9.867	5.929	x	x	2.558	2.989	7.997	5.106	x	1.061	x	4.488	1.974	x	x	5.837	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15948	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2)	x	x	4073.6	725.616	306.716	2561.82	x	x	x	x	x	x	x	x	x	x	x	x	4706.39	x	x	x	x	x	x	x	x	850.617	x	x	563.284	x	x	x	x	x	x	397.657	x	x	x	x	x	x	x	x	x	x	x	6020.52	x	x	x	x	x	x	x	x	677.627	x	x	x	x	x	x	x	x	x	x	732.251	x	1972.58	x	x	x	x	x	x	589.189	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2133.11	x	x	x	1797.23	x	3939.37	513.065	
-15949	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in the forebrain following ethanol exposure at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in the forebrain following ethanol exposure at E9 (TUNEL+ cells/mm2)	x	x	3172.6	1892.73	842.364	3859.58	x	x	x	x	x	x	x	x	x	x	x	x	2011.71	x	x	x	x	x	x	x	x	1934.4	x	x	2306.93	x	x	x	x	x	x	1048.45	x	x	x	x	x	x	x	x	x	x	x	3815.18	x	x	x	x	x	x	x	x	444.812	x	x	x	x	x	x	x	x	x	x	1235.32	x	4940.97	x	x	x	x	x	x	2626.86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1359.66	x	x	x	858.692	x	2159.83	1664.57	
-15950	Original post publication description: un-named trait Original pre publication description: Trait 5	Trait 5	Reproduction, development: Trait 5, Parthenote 2 cell/constructs; lathamk1@msu.edu	x	1.0	0.84	0.726	0.854	0.974	0.919	0.982	0.917	0.977	0.957	0.227	0.974	0.784	0.975	0.992	0.802	1.0	x	0.986	0.957	x	x	x	x	0.667	0.975	0.912	x	0.951	0.943	0.194	1.0	x	0.901	x	0.663	0.844	0.957	x	0.396	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15951	Original post publication description: Trait 6 Original pre publication description: Trait 6	Trait 6	Reproduction, development: Trait 6, Parthenote 4cell/2cell; lathamk1@msu.edu	x	0.996	1.0	0.59	0.053	1.0	0.593	0.831	0.529	0.864	0.95	0.795	0.778	0.55	0.492	0.094	0.736	0.814	x	0.793	0.78	x	x	x	x	1.0	0.971	0.317	x	0.852	0.613	0.467	0.898	x	0.601	x	0.135	0.846	1.0	x	0.8	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15952	Original post publication description: Trait 7 Original pre publication description: Trait 7	Trait 7	Reproduction, development: Trait 7, Parthenote Blastocyst/2cell; lathamk1@msu.edu	x	0.723	0.368	0.021	0.0	0.915	0.056	0.0	0.025	0.388	0.836	0.073	0.387	0.117	0.337	0.0	0.409	0.188	x	0.575	0.126	x	x	x	x	0.771	0.647	0.033	x	0.399	0.225	0.125	0.486	x	0.147	x	0.038	0.615	0.745	x	0.083	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15953	Original post publication description: Trait 8 Original pre publication description: Trait 8	Trait 8	Reproduction, development: Trait 8, Parthenote Blastocyst/4cell; lathamk1@msu.edu	x	0.726	0.368	0.025	0.0	0.915	0.079	0.061	0.036	0.446	0.888	0.075	0.469	0.167	0.628	0.0	0.548	0.234	x	0.72	0.164	x	x	x	x	0.771	0.664	0.067	x	0.467	0.395	0.17	0.547	x	0.263	x	0.35	0.738	0.745	x	0.083	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15954	Original post publication description: Trait 9 Original pre publication description: Trait 9	Trait 9	Reproduction, development: Trait 9, SCNT:Parthenote 2 cell/constructs; lathamk1@msu.edu	x	0.873	0.813	0.89	0.698	0.775	0.842	0.389	0.88	1.0	0.834	0.509	0.587	0.908	0.826	0.827	0.823	0.844	x	0.864	0.809	x	x	x	x	0.765	0.842	0.861	x	0.461	0.743	0.803	0.848	x	0.957	x	0.858	0.859	0.977	x	0.584	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15955	Original post publication description: Trait 10 Original pre publication description: Trait 10	Trait 10	Reproduction, development: Trait 10, SCNT:Parthenote 4cell/2cell; lathamk1@msu.edu	x	0.663	0.536	0.729	0.0	0.205	0.882	0.014	0.532	0.174	0.675	0.192	0.693	0.317	0.08	1.628	0.572	0.611	x	0.186	0.699	x	x	x	x	0.59	0.307	0.337	x	0.086	0.825	0.0	0.544	x	0.619	x	3.394	0.036	0.66	x	0.491	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15956	Original post publication description: Trait 11 Original pre publication description: Trait 11	Trait 11	Reproduction, development: Trait 11, SCNT:Parthenote Blastocyst/2cell; lathamk1@msu.edu	x	0.379	0.568	0.0	0.0	0.083	2.149	0.0	2.733	0.115	0.329	0.0	0.427	0.489	0.0	0.0	0.254	0.247	x	0.079	0.877	x	x	x	x	0.307	0.134	0.289	x	0.13	0.357	0.0	0.286	x	1.191	x	1.145	0.02	0.216	x	0.845	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15957	Original post publication description: Trait 12 Original pre publication description: Trait 12	Trait 12	Reproduction, development: Trait 12 SCNT:Parthenote Blastocyst/4cell; lathamk1@msu.edu	x	0.499	1.03	0.0	0.0	0.323	2.27	4.083	4.693	0.714	0.484	0.0	0.735	1.636	0.0	0.0	0.462	0.391	x	0.434	1.177	x	x	x	x	0.492	0.496	0.877	x	1.189	0.545	0.0	0.487	x	2.069	x	0.198	0.377	0.325	x	1.286	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15958	Original post publication description: Metabolism, pancreas, visual system: Alloxan response (80 mg/kg iv to induce diabetes by killing pancretic beta cells), retinopathy severity score, males and females from 7 to 17 weeks of age [ordinal scale, 1=normal, 2=slight retinopathy, 3=moderate, 4=severe retinopathy] Original pre publication description: Metabolism, pancreas, visual system: Lucki 1	Metabolism, pancreas, visual system: Lucki 1	Metabolism, pancreas, visual system: Alloxan response (80 mg/kg iv to induce diabetes by killing pancretic beta cells), retinopathy severity score, males and females from 7 to 17 weeks of age [ordinal scale, 1=normal, 2=slight retinopathy, 3=moderate, 4=severe retinopathy]	x	x	2.0	4.0	1.0	1.0	1.0	3.0	3.0	3.0	4.0	4.0	4.0	4.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-15959	Original post publication description: Central nervous system, toxicology: 3-NP response (dose and route here), short description of trait here [-1 = sensitive, +1 = resistant] Original pre publication description: Central nervous system, toxicology: I.Dragatsis 1	Central nervous system, toxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu)	Central nervous system, toxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults, presence or absence of lesions [-1 = lesions, +1 = no lesions]	x	x	-1.0	1.0	x	x	x	x	x	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	-1.0	x	1.0	x	1.0	x	x	1.0	x	x	x	x	x	x	x	1.0	x	x	-1.0	x	x	x	x	1.0	x	x	1.0	x	x	x	x	1.0	x	x	x	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.0	x	1.0	x	x	x	x	x	x	x	-1.0	x	1.0	x	x	x	x	x	x	x	x	x	x	-1.0	x	-1.0	1.0	
-15960	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2)	x	x	3510.35	302.783	x	1722.8	x	x	x	x	x	x	x	x	x	x	x	x	3379.48	x	x	x	x	x	x	x	x	x	x	x	321.561	x	x	x	x	x	x	196.63	x	x	x	x	x	x	x	x	x	x	x	5488.26	x	x	x	x	x	x	x	x	-115.188	x	x	x	x	x	x	x	x	x	x	x	x	1814.31	x	x	x	x	x	x	130.77	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1764.4	x	x	x	1504.88	x	x	115.628	
-15961	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to ethanol at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to ethanol at E9 (TUNEL+ cells/mm2)	x	x	2807.34	1130.68	x	2921.76	x	x	x	x	x	x	x	x	x	x	x	x	670.908	x	x	x	x	x	x	x	x	x	x	x	1548.51	x	x	x	x	x	x	532.978	x	x	x	x	x	x	x	x	x	x	x	2830.62	x	x	x	x	x	x	x	x	144.004	x	x	x	x	x	x	x	x	x	x	x	x	3693.12	x	x	x	x	x	x	258.192	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	885.807	x	x	x	729.545	x	x	272.43	
-15962	Original post publication description: Infectious disease, immune system: Tuberculosis, bacterial load in lung [CFU] Original pre publication description: Infectious disease, immune system: Sassetti, Christopher	Infectious disease, immune system: Sassetti, Christopher, Trait 1	Infectious disease, immune system: Tuberculosis, bacterial load in lung [CFU]	x	x	704667.0	219000.0	x	x	x	x	x	2646670.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6253330.0	1760000.0	x	x	x	x	x	x	x	596000.0	x	x	130667.0	x	x	354000.0	x	2753330.0	x	x	x	123500.0	x	183333.0	x	x	x	x	1153330.0	x	2380000.0	x	x	x	3513330.0	x	x	x	15080.0	x	983600.0	x	x	x	x	x	x	x	x	x	x	1578000.0	x	x	101000.0	x	x	x	x	x	x	x	x	393333.0	513000.0	
-15963	Original post publication description: Infectious disease, immune system: Tuberculosis, bacterial load in lung [log CFU] Original pre publication description: Infectious disease, immune system: Sassetti, Christopher, Trait 2	Infectious disease, immune system: Sassetti, Christopher, Trait 2	Infectious disease, immune system: Tuberculosis, bacterial load in lung (BXD71 winsorized from 4.18 to 4.98) [log CFU]	x	x	5.85	5.34	x	x	x	x	x	6.42	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.45	x	x	x	x	x	x	x	x	x	6.8	6.25	x	x	x	x	x	x	x	x	x	x	5.12	x	x	5.55	x	6.44	x	x	x	5.09	x	5.26	x	x	x	x	6.06	x	6.38	x	x	x	6.55	x	x	x	4.98	x	5.99	x	x	x	x	x	x	x	x	x	x	6.2	x	x	5.0	x	x	5.78	x	x	x	x	x	5.59	5.71	
-15964	Original post publication description: malaria susceptibility entered at November/13 14:57:41 from IP 192.55.208.10	None	Infectious disease, immune system: Malaria susceptibility	0.5	0.5	1.0	0.0	x	x	1.0	x	x	1.0	1.0	0.0	1.0	x	x	1.0	x	0.0	x	x	x	x	x	1.0	x	1.0	x	x	x	1.0	1.0	x	x	x	1.0	x	1.0	1.0	1.0	x	1.0	1.0	1.0	0.0	x	x	1.0	0.0	1.0	1.0	x	0.0	x	0.0	1.0	x	x	x	1.0	1.0	0.0	1.0	x	1.0	1.0	0.0	x	0.0	x	x	x	1.0	1.0	1.0	x	1.0	x	1.0	1.0	x	x	1.0	1.0	x	1.0	1.0	1.0	1.0	0.0	1.0	x	x	x	0.0	0.0	1.0	x	1.0	1.0	0.0	0.0	1.0	
-15965	Original post publication description: Central nervous system, gene expression: Vasopressin receptor expression gene family mapping to Avpr1a using Hypothalamus data set (BXD84 winsorized from 6.26 to 3.7)	None	Central nervous system, gene expression: Vasopressin receptor expression gene family mapping to Avpr1a using Hypothalamus data set (BXD84 winsorized from 6.26 to 3.7)	-0.8	0.69	-0.217	-0.745	-2.505	x	x	x	x	x	-0.329	-2.272	x	-1.094	x	x	x	x	x	x	x	x	x	2.597	x	-1.3	x	-3.307	x	3.19	0.361	x	-2.108	x	x	x	x	-2.828	0.001	x	2.474	2.649	2.155	1.159	x	x	-1.549	2.17	-0.753	x	x	x	x	x	-2.62	x	x	x	1.34	x	2.987	-0.948	x	-0.271	x	x	-2.132	1.448	-1.076	-0.704	x	1.453	x	-1.154	x	x	x	0.345	2.635	x	x	-1.654	3.7	-0.198	x	1.409	x	-0.391	-2.712	x	-0.752	x	x	-0.304	x	-2.159	x	-0.922	-3.085	0.697	3.645	1.219	
-15967	Original post publication description: un-named trait Original pre publication description: age_gender adjusted_ femur_BMD	age_gender adjusted_ femur_BMD	un-named trait	437.606	401.376	334.809	387.543	432.844	x	x	x	x	x	388.178	361.868	x	337.781	x	x	x	x	x	x	x	x	x	365.093	x	349.577	x	374.015	x	356.624	404.699	x	374.11	x	x	x	395.925	325.386	372.01	x	350.798	362.355	383.123	357.651	x	x	382.292	400.995	368.538	x	x	x	x	x	379.438	x	x	x	367.478	x	401.183	338.532	x	367.075	x	x	358.495	314.85	378.341	348.01	x	349.851	x	372.68	x	x	x	382.912	295.69	x	x	382.918	331.491	355.88	x	x	x	337.757	401.016	x	x	x	x	400.284	x	355.287	x	329.441	394.454	347.549	365.437	297.369	
-15968	Original post publication description: un-named trait Original pre publication description: age_gender adjusted_BMD_Tibia	Musculoskeletal system, morphology, metabolism: Bone mineral density of the tibia in young adults corrected for sex and age [units]	Musculoskeletal system, morphology, metabolism: Bone mineral density of the tibia in young adults corrected for sex and age [units]	373.936	343.086	290.81	320.534	362.124	x	x	x	x	x	338.342	290.625	x	301.176	x	x	x	x	x	x	x	x	x	291.11	x	285.222	x	291.154	x	282.611	336.192	x	327.417	x	x	x	310.545	271.867	302.358	310.576	x	285.207	304.032	294.237	x	x	309.947	304.76	310.039	x	x	x	x	x	293.581	x	x	x	278.135	x	325.378	274.745	x	281.124	x	x	328.752	266.745	322.442	311.97	x	314.262	x	332.069	x	x	x	329.922	256.743	x	x	331.069	273.668	289.604	x	315.261	x	284.66	323.301	x	x	x	x	358.052	x	287.291	x	308.673	334.448	289.273	320.483	263.527	
-15969	Original post publication description: Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age, sex, body weight, and strain epoch effects [N cells per mm of RMS length]	None	Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age, sex, body weight, and strain epoch effects [N cells per mm of RMS length]	x	x	x	x	59.88	57.92	x	61.74	27.92	72.88	44.5	68.9	32.34	68.31	84.67	84.53	45.53	16.73	105.38	62.88	x	x	x	45.96	x	54.19	127.77	129.55	x	53.03	61.78	49.07	63.68	x	x	x	90.24	120.24	57.7	x	52.6	60.51	49.27	55.57	x	x	72.22	x	24.61	47.58	x	x	x	7.39	56.16	x	x	x	41.71	64.68	38.72	14.05	x	40.7	54.85	97.72	156.58	x	x	67.1	x	50.48	x	88.45	x	67.57	x	x	69.62	x	x	61.41	113.51	70.84	70.81	72.32	x	83.91	85.97	x	54.83	x	x	x	65.11	42.99	82.31	114.18	72.1	x	x	x	
-15970	Original post publication description: David J. Reiner, Taha A. Jan, John D. Boughter Jr, Cheng-Xiang Li, Lu Lu, Robert W. Williams and Robert S. Waters. Genetic Analysis of Tongue Size and Taste Papillae Number and Size in Recombinant Inbred Strains of Mice. Chem. Senses 33: 693–707, 2008 Original pre publication description: This is a set of data published by Reiner et al. in 2008. W. Gu put the data for his analysis with other traits.	Gustation: Filiform papillae number [adjusted n]	Gustation: Filiform papillae number [adjusted n]	x	x	242.61	336.87	344.3	x	x	x	x	x	x	328.78	x	258.01	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	385.13	x	317.13	x	273.36	x	x	x	x	x	267.11	x	x	299.78	x	x	x	x	288.67	394.69	x	x	x	x	x	x	x	x	x	x	346.58	x	x	287.64	314.17	x	x	332.97	387.74	227.94	x	x	x	x	x	321.85	x	x	x	x	x	x	361.44	326.7	355.05	341.27	x	223.39	x	x	x	x	x	264.85	x	x	x	x	x	x	x	x	
-15971	None	Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes	Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg]	15.6667	15.1111	15.375	16.7143	17.5	x	15.6	x	x	16.0833	14.4167	17.4286	13.9444	18.25	16.875	18.0714	16.4167	15.625	15.25	x	x	x	x	13.75	x	16.75	x	16.8333	x	12.5	14.8333	12.6667	14.3	x	13.75	x	12.5	15.5	15.5	x	16.7	17.25	14.4091	13.125	x	x	16.5385	x	14.8846	12.5556	x	x	x	15.3	15.5	x	x	x	15.375	16.1923	19.0	16.0714	x	15.7	17.6111	16.0	16.1667	15.5909	11.6667	13.0556	x	13.75	x	13.1111	x	14.2083	x	x	13.8889	x	x	17.3636	15.0	12.4583	16.2778	16.6875	x	14.1667	13.375	x	15.1667	x	x	15.0	16.5333	13.0	11.6429	17.0	17.3125	12.9167	17.3333	14.8	
-15972	None	Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes	Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes	17.375	18.0	15.6667	17.1833	18.5	x	17.5909	17.75	x	17.5625	16.8636	18.375	13.7222	18.0	18.3	17.0	17.3	14.2059	16.9545	21.75	x	x	x	16.9286	x	17.8	x	18.125	x	15.75	15.5714	15.4	13.625	16.25	18.0	x	12.5	13.6667	12.6	x	14.9375	14.5455	14.875	11.75	x	x	17.5	x	15.0	14.1538	x	x	x	15.587	13.8333	x	x	x	16.45	17.5	16.4545	19.1154	x	14.3889	20.0833	14.0625	15.1786	16.8611	17.2353	15.0714	x	18.0435	x	12.7143	x	15.4167	x	x	18.5625	x	x	14.875	14.9615	15.8235	18.3214	17.5556	x	16.25	14.95	x	14.4	x	x	18.0	14.875	14.1875	13.5	21.3	14.8889	8.75	16.9688	17.3824	
-15973	None	Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes	Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes	16.5	20.15	15.1	19.1731	17.25	16.125	20.0833	16.0	18.9286	17.375	15.6	17.0	16.3	18.5833	16.5	14.875	17.75	17.9643	13.5	13.5	16.5	x	19.125	18.625	x	22.125	18.75	15.0833	x	15.1667	16.25	17.0	17.3571	x	14.5833	x	13.3182	12.6111	13.4	x	12.0	15.8571	16.6667	13.4211	x	x	10.8333	x	13.15	14.8182	x	x	x	17.2	14.0	x	x	x	17.3611	18.1667	14.8846	19.125	x	13.3571	22.5	17.0833	18.7059	16.8636	17.7083	14.75	x	20.9375	x	15.3636	x	15.8214	x	x	17.3929	x	x	15.7059	15.1429	16.7368	18.1875	21.0385	x	17.3636	17.8125	x	19.0	x	x	19.9375	15.1875	15.3889	12.1667	18.3333	14.1538	12.7	18.6875	15.75	
-15974	None	Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes	Eye, visual system, physiology: Intraocular pressure (IOP), 9 to 13 months old, both sexes, average of left and right eyes (BXD44 winsorized from 21.8 to 19.4, BXD38 winsorized from 9.58 to 10.9, BXD48 outlier deleted (9.300 +/- 0.768 SE), BXD80/73a and BXD103/73b merged with BXD73 (original values BXD73=16.906 +/- 0.8, BXD73a=19.750 +/- 1.37, BXD73b=17.150+/- 0.48), BXD65 merged with BXD92/65b and with BXD97/65a (original values BXD65=14.071 +/- 0.834, BXD65b=14.0 +/- 1.618, BXD65a=12.833 +/- 0.928) [mmHg]	x	17.625	15.227	16.844	18.2	11.333	13.167	12.5	17.0	14.25	14.75	14.375	13.375	19.375	16.333	16.75	18.125	14.167	11.0	x	x	x	17.0	x	x	18.375	x	14.667	x	12.625	13.9	18.0	18.954	x	14.833	x	10.9	13.214	13.75	x	11.75	17.875	19.4	16.5	x	x	x	x	12.5	17.889	x	x	x	15.0	18.875	x	x	x	14.454	18.237	14.611	17.333	x	13.635	18.5	17.5	16.833	17.038	16.458	12.5	x	17.935	x	14.85	x	17.643	x	x	x	x	x	16.208	13.75	16.071	16.667	16.5	x	14.542	15.3	x	x	x	x	17.75	14.5	x	18.688	18.25	16.546	13.25	15.278	x	
-15975	None	Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes	Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes	x	x	13.0909	12.5	14.6	15.75	x	12.5	17.75	21.0	15.5	10.3	13.25	x	13.8	14.5	14.1429	12.5	8.25	x	16.3333	x	18.0	12.6667	13.8	18.75	18.25	14.75	x	13.75	14.0	19.125	18.6875	x	x	x	12.75	13.375	11.85	x	10.25	12.25	13.2143	14.25	x	x	10.375	x	9.7	21.8333	x	x	x	18.25	18.1	x	x	x	10.6	15.7083	14.3636	16.25	x	12.7273	12.5	17.0	11.5833	13.5294	14.1667	12.9444	x	14.0833	x	13.6667	x	10.6875	x	x	16.7	x	x	11.5	13.5	11.9286	16.9	21.7174	x	12.2222	14.5	x	13.9167	x	x	16.0	11.5833	14.0	14.1	14.375	16.4375	9.5	10.6	18.9091	
-15976	None	Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes	Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes	16.6053	17.8125	14.7273	17.0385	17.1364	14.4444	16.8214	14.9231	17.9375	16.8958	15.4634	15.6346	14.1552	18.4348	15.9355	16.4231	16.4423	15.3942	14.2931	19.0	16.4	x	16.1562	18.05	13.8	18.7763	18.5833	16.1167	x	14.0323	14.8333	16.25	16.9891	16.25	15.175	x	12.2581	13.5857	13.1429	x	13.0435	15.4574	16.4322	13.5755	x	x	14.2895	x	13.7959	15.6667	x	x	x	16.0175	15.9091	x	x	x	15.1885	17.2154	15.8148	18.0	x	14.0568	19.32	15.9583	16.2727	15.8857	15.8559	13.9118	x	17.4123	x	13.91	x	14.8302	x	x	17.5172	x	x	15.3516	14.6228	15.1449	17.3824	19.35	x	14.9135	15.119	x	15.0	x	x	17.1047	14.951	14.1207	13.6444	18.5167	15.4925	11.1724	16.3298	17.1569	
-16012	None	Blood Chemistry: AMC Trait 186 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.155108	0.267777	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.365803	x	0.148832	x	x	0.309468	0.0724903	0.238557	0.293197	x	x	x	0.0937477	0.204429	x	x	x	x	0.534185	0.912412	0.250145	0.341112	0.207595	0.0779967	x	0.266411	0.0496962	0.184132	0.0576657	x	0.457957	x	0.191647	x	x	x	0.0696836	0.0568522	0.0452565	x	0.441061	0.346879	0.141076	x	0.198179	x	0.0707373	0.09654	x	x	x	x	0.258673	0.165997	0.0666198	0.0781471	0.13501	0.174553	0.426706	x	0.158838	
-16011	None	Blood Chemistry: AMC Trait 185 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/Cer levels in pooled plasma of young adult males on a normal chow diet	x	x	0.154372	0.148613	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0615432	0.0875224	0.0637467	x	x	0.495506	0.145948	0.0878838	0.0965124	x	x	x	0.260126	0.368497	x	x	x	0.0	0.304686	0.370375	0.160103	0.311237	0.0680125	0.231786	x	0.163177	0.0339353	0.110893	0.0526276	x	0.132119	x	0.193074	x	x	x	0.276088	0.0329535	0.0372791	x	0.304108	0.434445	0.221706	x	0.129337	x	0.270025	0.133848	x	0.090848	x	x	0.164171	0.277335	x	0.0820764	0.123088	0.233484	0.1416	x	0.0784866	
-16010	None	Blood Chemistry: AMC Trait 184 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GM2-gl/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	3.60375	10.7349	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.9126	x	5.44204	x	x	4.68577	8.20116	16.1485	8.79258	x	x	x	9.33104	7.67861	x	x	x	x	8.72621	4.23032	6.25358	6.25943	6.92834	8.44527	x	6.32065	3.58809	4.39816	9.16663	x	6.42687	x	2.49028	x	x	x	x	13.54	x	x	7.88031	5.70207	x	x	9.17102	x	8.36986	x	x	x	x	x	x	x	4.52619	7.31891	6.94779	x	6.72985	x	8.55274	
-16009	None	Blood Chemistry: AMC Trait 183 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GM2-gl/GlcCer levels in pooled plasma of young adult males on a normal chow diet	x	x	6.14798	14.0691	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.54281	4.80155	9.48394	x	x	12.3696	14.805	8.99453	17.9217	x	x	x	29.8512	14.8391	x	x	x	8.33594	9.08991	7.29957	21.2709	13.0005	7.77509	9.27902	x	9.45795	9.58734	11.2096	13.0434	x	8.49512	x	5.90177	x	x	x	x	12.814	x	x	x	17.3122	14.2613	x	14.4736	x	21.048	20.2444	x	x	x	x	x	x	x	11.417	12.359	12.9172	9.38688	x	10.2172	
-16008	None	Blood Chemistry: AMC Trait 32 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GM2-gl/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	3.59286	4.48077	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.14758	x	5.63123	x	x	4.58977	5.3796	7.42923	9.42062	x	x	x	10.861	4.92066	x	x	x	x	7.84375	4.53553	2.72316	3.79501	3.08	6.63673	x	6.80745	4.40078	3.82938	6.81376	x	9.40102	x	2.40265	x	x	x	x	13.8116	x	x	6.16653	5.48822	x	x	5.62594	x	6.30479	x	x	x	x	x	x	x	4.39743	5.90595	5.41901	x	9.03293	x	9.03257	
-16007	None	Blood Chemistry: AMC Trait 31 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GM2-gl/Cer levels in pooled plasma of young adult males on a normal chow diet	x	x	5.44243	3.72044	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.80801	7.2372	6.3846	x	x	8.72378	9.4706	8.24976	7.97551	x	x	x	15.6702	6.52054	x	x	x	4.95983	5.63239	5.74075	8.72726	6.52532	3.67409	5.78348	x	3.69279	4.86389	4.99809	8.56081	x	10.3479	x	4.74243	x	x	x	x	10.8739	x	x	x	7.71403	7.79451	x	8.02846	x	10.2794	8.77325	x	x	x	x	x	x	x	7.46696	9.42981	7.02157	4.97206	x	7.86657	
-16006	None	Blood Chemistry: AMC Trait 30 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of totalSM/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	40.9188	63.7285	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	103.184	x	92.089	x	x	75.1719	29.4489	83.54	134.099	x	x	x	102.86	92.7186	x	x	x	x	78.9296	84.363	34.6735	64.9284	28.1273	99.3822	x	69.4868	109.291	56.9369	89.5225	x	109.563	x	37.0935	x	x	x	53.5134	100.915	76.9016	x	44.8658	69.1727	51.7555	x	31.1651	x	52.0868	70.3182	x	x	x	x	70.1362	31.9398	49.6217	64.6421	41.5531	38.4138	108.863	x	90.6997	
-16005	None	Blood Chemistry: AMC Trait 29 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of totalSM/Cer levels in pooled plasma of young adult males on a normal chow diet	x	x	42.5918	61.4163	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	49.2213	85.8082	61.6624	x	x	83.4514	45.4668	73.8458	53.7325	x	x	x	97.448	72.9689	x	x	x	50.5008	50.3689	70.1437	44.5358	61.0518	42.3642	69.6853	x	36.6306	45.9545	37.4907	59.3526	x	78.5021	x	65.6446	x	x	x	45.3858	72.5452	39.683	x	51.8406	65.3484	57.1143	x	64.9961	x	56.5212	56.2746	x	46.488	x	x	60.0647	75.4802	x	64.247	42.0869	71.2327	55.9205	x	85.4141	
-16004	None	Blood Chemistry: AMC Trait 28 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GlcCer/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.996979	0.417401	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.600001	x	1.03477	x	x	0.979512	0.655956	0.460058	1.07143	x	x	x	1.16397	0.640826	x	x	x	x	0.898872	1.07215	0.435457	0.606288	0.444551	0.785851	x	1.07702	1.2265	0.870677	0.743322	x	1.46277	x	0.964812	x	x	x	1.03518	1.02006	1.23352	x	0.782523	0.962495	1.13568	x	0.613448	x	0.753273	0.573687	x	x	x	x	0.940763	0.567621	0.971552	0.806944	0.779962	0.956349	1.34222	x	1.0561	
-16003	None	Blood Chemistry: AMC Trait 27 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of GlcCer/Cer levels in pooled plasma of young adult males on a normal chow diet	x	x	0.88524	0.264441	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.867431	1.50726	0.673202	x	x	0.70526	0.639689	0.917198	0.44502	x	x	x	0.524944	0.439417	x	x	x	0.594993	0.619631	0.786451	0.410292	0.501927	0.472546	0.623285	x	0.390443	0.507324	0.445876	0.656333	x	1.2181	x	0.80356	x	x	x	0.734845	0.84859	0.574079	x	0.641833	0.445584	0.546548	x	0.554696	x	0.488377	0.433367	x	0.332603	x	x	0.510515	0.770421	x	0.654019	0.762994	0.543581	0.529682	x	0.769931	
-16002	None	Blood Chemistry: AMC Trait 26 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ceramide (d18:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	5.56514	3.24193	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.98252	x	3.06209	x	x	3.636	4.3715	2.63198	2.31252	x	x	x	2.58112	3.48527	x	x	x	x	2.28586	3.58786	5.49278	3.99795	9.44685	2.63565	x	3.27115	3.01753	4.91869	2.1856	x	1.81858	x	8.43291	x	x	x	2.94748	2.1285	4.20008	x	4.24871	4.95804	3.75202	x	5.14474	x	4.29267	2.97984	x	x	x	x	3.57144	5.56653	5.06445	5.0365	5.28772	6.52647	2.84124	x	2.59007	
-16001	None	Blood Chemistry: AMC Trait 25 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylceramide levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	5.54833	1.35318	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.78951	x	3.16855	x	x	3.56151	2.86751	1.21086	2.4777	x	x	x	3.00434	2.23345	x	x	x	x	2.0547	3.84672	2.39187	2.42391	4.1996	2.07123	x	3.52309	3.70099	4.28259	1.6246	x	2.66015	x	8.13618	x	x	x	3.05116	2.17121	5.1809	x	3.32472	4.77209	4.26111	x	3.15603	x	3.23355	1.70949	x	x	x	x	3.35988	3.15968	4.92037	4.06417	4.12422	6.24158	3.81357	x	2.73538	
-16000	None	Blood Chemistry: AMC Trait 24 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Unknown lipid (16minRT) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	1.56651	0.776809	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.771129	x	1.15316	x	x	0.906502	0.744311	0.611137	0.863067	x	x	x	0.863348	0.62246	x	x	x	x	0.453403	0.841625	0.830902	0.930096	1.00356	0.850837	x	0.87014	0.962472	1.03404	0.487266	x	0.563704	x	2.07126	x	x	x	0.70045	0.38586	0.634337	x	0.912325	0.842501	0.602052	x	0.881615	x	0.726571	0.537518	x	x	x	x	0.719745	0.58018	0.702087	1.10033	1.05791	1.04615	0.564843	x	0.595122	
-15999	None	Blood Chemistry: AMC Trait 23 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ceramide (d18:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	3.06387	3.257	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.45277	3.20497	2.69901	x	x	1.78927	2.36855	2.26594	2.60214	x	x	x	1.75218	2.6373	x	x	x	4.11832	2.65481	2.54967	3.22987	2.51154	4.6892	2.50186	x	4.23769	3.19964	4.02113	3.57028	x	1.87896	x	3.06888	x	x	x	2.39272	1.61926	3.49081	x	2.90234	2.60031	2.40846	x	2.37453	x	2.36994	2.7266	x	4.47033	x	x	3.1234	1.8017	x	2.17826	3.23433	2.69502	2.7763	x	1.87711	
-15998	None	Blood Chemistry: AMC Trait 22 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylceramide levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	2.71226	0.861283	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.99504	x	1.81698	x	x	1.2619	1.51513	2.07831	1.158	x	x	x	0.919798	1.15887	x	x	x	2.45037	1.645	2.0052	1.32519	1.26061	2.21586	1.55937	x	1.65457	1.62325	1.79292	2.34329	x	2.28877	x	2.46603	x	x	x	1.75828	1.37409	2.004	x	1.86282	1.15866	1.31634	x	1.31714	x	1.15742	1.18162	x	1.48684	x	x	1.59454	1.38807	x	1.42462	2.46777	1.46496	1.47056	x	1.44525	
-15997	None	Blood Chemistry: AMC Trait 21 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Unknown lipid (16minRT) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.837553	0.471368	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.52387	0.749601	0.592535	x	x	0.406074	0.464238	0.547141	0.492687	x	x	x	0.401813	0.410858	x	x	x	0.595942	0.541271	0.623336	0.529768	0.446967	0.564448	0.506163	x	0.647668	0.606059	0.449488	0.819465	x	0.540631	x	0.666303	x	x	x	0.491658	0.267113	0.452561	x	0.583173	0.452609	0.462888	x	0.545704	x	0.320743	0.427205	x	0.388019	x	x	0.503471	0.316916	x	0.446191	0.560253	0.506938	0.511883	x	0.319714	
-15996	None	Blood Chemistry: AMC Trait 20 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: N-glycolyl ganglioside GM2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	19.9948	14.5263	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	21.3178	x	17.2434	x	x	16.6884	23.5169	19.5536	21.7854	x	x	x	28.0336	17.1498	x	x	x	x	17.9297	16.2728	14.9577	15.1723	29.0963	17.4921	x	22.2682	13.2795	18.8355	14.8921	x	17.0965	x	20.2614	x	x	x	x	29.3981	x	x	26.1998	27.2108	x	x	28.944	x	27.0644	x	x	x	x	x	x	x	22.2706	29.7453	28.6542	x	25.6647	x	23.395	
-15995	None	Blood Chemistry: AMC Trait 19 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: N-glycolyl ganglioside GM2 levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	16.6749	12.1175	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.6009	23.195	17.2321	x	x	15.6092	22.4316	18.6935	20.7534	x	x	x	27.4571	17.1966	x	x	x	20.4262	14.9529	14.6371	28.1879	16.3886	17.2285	14.4694	x	15.6489	15.5627	20.098	30.5644	x	19.4434	x	14.554	x	x	x	x	17.6076	x	x	x	20.0588	18.7727	x	19.0638	x	24.3615	23.9211	x	x	x	x	x	x	x	16.265	30.4991	18.9232	13.8039	x	14.7664	
-15994	None	Blood Chemistry: AMC Trait 18 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Globotriaosylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	1.38445	1.41488	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.09481	x	0.63225	x	x	0.722969	0.135937	0.89351	0.571093	x	x	x	0.355449	1.28927	x	x	x	x	1.05828	3.225	1.12202	1.44396	1.44148	0.634122	x	0.807727	0.346213	2.05096	0.516168	x	1.14335	x	3.15986	x	x	x	0.970696	0.578668	0.519078	x	1.82576	1.62378	0.582272	x	1.06147	x	0.870234	0.929146	x	x	x	x	0.940048	0.744537	0.135388	0.417064	0.440303	0.985202	0.869348	x	0.208715	
-15993	None	Blood Chemistry: AMC Trait 17 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.237365	0.16489	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.368463	x	0.802144	x	x	0.122188	0.0	0.175001	0.81038	x	x	x	0.0	0.0	x	x	x	x	0.0	0.457431	0.39596	0.00947024	0.0	0.487123	x	0.635972	0.112106	0.189443	0.160348	x	0.0	x	0.00440551	x	x	x	0.0	0.957429	0.232911	x	0.411214	0.3306	0.0	x	0.0	x	0.459384	0.253594	x	x	x	x	0.0	0.0	0.479808	0.172845	0.0	0.18934	0.846982	x	0.0	
-15992	None	Blood Chemistry: AMC Trait 16 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Globotriaosylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.863201	0.868115	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.09101	x	0.455739	x	x	1.12522	0.316891	0.627877	0.678025	x	x	x	0.241974	0.712491	x	x	x	x	1.22107	x	1.37399	1.36375	1.96112	0.205572	x	0.871473	0.14996	0.905686	0.126034	x	0.83283	x	1.61614	x	x	x	0.205391	0.12101	0.190081	x	1.87394	1.71984	0.529321	x	1.01958	x	0.303652	0.287673	x	x	x	x	0.923836	0.924027	0.337392	0.393587	0.713897	1.13921	1.21237	x	0.411401	
-15991	None	Blood Chemistry: AMC Trait 15 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.375718	0.306835	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	0.403665	x	x	0.0	1.23157	0.207471	0.41094	x	x	x	0.197817	0.0968738	x	x	x	x	0.811978	0.0	0.521789	0.0	0.556245	0.0	x	0.257244	0.317355	1.15608	0.154402	x	0.227199	x	0.0576161	x	x	x	0.0	0.142236	0.080884	x	0.0	0.53578	0.267229	x	0.0170099	x	0.0910954	0.295086	x	x	x	x	0.0	0.0	0.0	0.45464	0.0	0.0	0.533734	x	0.492763	
-15990	None	Blood Chemistry: AMC Trait 14 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Globotriaosylsphingosine levels mesaured with sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.597553	0.416822	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.225424	0.121534	0.109931	x	x	0.549402	0.556443	0.352988	0.579273	x	x	x	0.523802	0.741169	x	x	x	0.455955	0.893569	1.13714	0.603848	1.40228	1.06872	0.509372	x	1.1104	0.431484	0.555801	0.0	x	0.0	x	0.825922	x	x	x	0.511999	0.189321	0.647277	x	0.654106	0.519485	0.683867	x	0.420211	x	0.391526	0.446482	x	0.448502	x	x	0.46438	0.171525	x	1.22008	0.416815	1.17531	0.378831	x	0.336236	
-15989	None	Blood Chemistry: AMC Trait 13 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	1.1909	0.305256	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0871082	0.0	0.339091	x	x	0.271791	0.266327	0.0	0.0	x	x	x	0.0	0.328363	x	x	x	0.339052	0.0918689	0.0	0.0	0.370662	0.0	0.156274	x	0.277142	0.0889031	0.0	0.165369	x	0.0	x	0.0571129	x	x	x	0.0	0.0	0.244763	x	0.515216	0.0	0.0	x	0.170414	x	0.246824	0.0	x	0.769041	x	x	0.560106	0.647522	x	0.0	0.0	0.0	0.265087	x	-0.03483	
-15988	None	Blood Chemistry: AMC Trait 12 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Globotriaosylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.472975	0.484034	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.212494	0.280506	0.172053	x	x	0.886596	0.345685	0.199139	0.251138	x	x	x	0.455789	0.971837	x	x	x	0.0	0.808885	0.944336	0.517112	0.781684	0.318924	0.579894	x	0.691494	0.108581	0.445914	0.187895	x	0.248247	x	0.592521	x	x	x	0.660601	0.0533601	0.130134	x	0.882626	1.12969	0.53397	x	0.307113	x	0.639942	0.364949	x	0.40612	x	x	0.512774	0.499674	x	0.178784	0.398107	0.629242	0.393123	x	0.147328	
-15987	None	Blood Chemistry: AMC Trait 11 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.628469	0.175789	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.697978	0.621789	0.0373505	x	x	0.363173	0.0	0.0	0.0	x	x	x	0.156859	0.0	x	x	x	1.74051	0.0	0.0	0.0	0.323365	0.20012	0.0	x	x	0.0	0.061498	0.0997759	x	0.377981	x	0.0	x	x	x	0.310748	0.0	0.343429	x	0.693611	0.456131	0.0333046	x	0.120073	x	0.121931	0.405994	x	0.0	x	x	0.381194	0.0633987	x	0.0	0.0	0.279074	0.59026	x	0.0	
-15986	None	Blood Chemistry: AMC Trait 10 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Total sphingomyelin levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	227.719	206.603	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	307.748	x	281.985	x	x	273.325	128.736	219.876	310.107	x	x	x	265.494	323.149	x	x	x	x	180.422	302.683	190.454	259.58	265.715	261.937	x	227.302	329.788	280.055	195.66	x	199.25	x	312.806	x	x	x	157.729	214.799	322.993	x	190.622	342.961	194.188	x	160.336	x	223.592	209.537	x	x	x	x	250.487	177.794	251.307	325.57	219.721	250.707	309.306	x	234.919	
-15985	None	Blood Chemistry: AMC Trait 09 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d18:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	166.538	136.935	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	224.36	x	203.103	x	x	204.437	110.355	158.614	235.33	x	x	x	197.651	250.451	x	x	x	x	124.276	225.164	127.491	194.421	204.632	185.396	x	173.893	249.745	195.373	149.861	x	134.626	x	220.925	x	x	x	111.216	153.993	257.919	x	133.529	247.601	144.903	x	112.599	x	160.367	147.721	x	x	x	x	178.59	137.572	200.055	275.818	161.755	179.109	249.065	x	172.317	
-15984	None	Blood Chemistry: AMC Trait 08 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d16:0) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	14.276	16.7836	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.0347	x	18.1281	x	x	18.6325	2.72951	14.4644	19.6077	x	x	x	14.8138	15.8457	x	x	x	x	13.9024	21.0653	15.5997	17.6184	16.229	19.634	x	11.8972	19.8832	19.8546	10.9291	x	16.2405	x	25.3475	x	x	x	10.3597	16.2135	13.4979	x	16.1042	22.0731	11.7922	x	11.0063	x	13.1718	14.5875	x	x	x	x	19.5507	11.1158	11.4466	12.3707	11.3947	18.9473	15.6352	x	14.0783	
-15983	None	Blood Chemistry: AMC Trait 07 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d18:2) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	41.7432	45.9173	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	56.5765	x	54.0538	x	x	43.5548	14.692	42.5234	47.381	x	x	x	47.9461	52.0359	x	x	x	x	40.2471	50.6531	40.1967	42.1485	38.5775	49.1542	x	37.3207	55.1643	56.8759	31.6166	x	42.9254	x	56.2218	x	x	x	33.0599	39.9762	47.4703	x	36.6075	63.631	33.3665	x	32.2534	x	44.698	41.7951	x	x	x	x	43.945	25.7568	36.4182	34.3522	42.2595	45.4048	39.8712	x	44.1489	
-15982	None	Blood Chemistry: AMC Trait 06 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d16:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	5.16169	6.96722	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	6.77745	x	6.70048	x	x	6.70078	0.959885	4.27432	7.78848	x	x	x	5.08258	4.81636	x	x	x	x	1.99641	5.80034	7.16639	5.3921	6.27653	7.75308	x	4.19064	4.99533	7.9513	3.25282	x	5.45714	x	10.3112	x	x	x	3.09394	4.61661	4.10572	x	4.38115	9.65642	4.12659	x	4.47784	x	5.35528	5.43294	x	x	x	x	8.401	3.3495	3.3872	3.02891	4.31162	7.24557	4.7349	x	4.37445	
-15981	None	Blood Chemistry: AMC Trait 05 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Total sphingomyelin levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	130.496	200.033	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	169.95	275.012	166.428	x	x	149.317	107.69	167.33	139.819	x	x	x	170.747	192.441	x	x	x	207.979	133.72	178.844	143.845	153.334	198.654	174.342	x	155.229	147.038	150.755	211.905	x	147.502	x	201.456	x	x	x	108.596	117.469	138.525	x	150.459	169.926	137.557	x	154.335	x	133.952	153.438	x	207.817	x	x	187.606	135.993	x	139.947	136.123	191.973	155.252	x	160.332	
-15980	None	Blood Chemistry: AMC Trait 04 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d18:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	98.8667	135.635	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	130.723	x	123.311	x	x	114.585	86.2414	118.624	100.572	x	x	x	124.168	142.986	x	x	x	161.967	106.502	130.826	104.928	113.051	147.822	123.33	x	115.161	102.722	117.543	152.685	x	104.439	x	140.82	x	x	x	73.9013	85.7081	106.815	x	102.075	123.266	104.75	x	107.097	x	99.8944	111.77	x	158.245	x	x	137.706	106.327	x	98.1681	103.214	145.575	117.178	x	114.105	
-15979	None	Blood Chemistry: AMC Trait 03 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d16:0) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	7.23526	14.08	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.05345	13.3682	8.41062	x	x	8.45901	4.24063	11.7893	7.50615	x	x	x	9.9686	9.40388	x	x	x	12.9876	7.53178	10.2157	10.587	9.37767	14.1416	12.0628	x	8.18091	10.5243	6.95301	13.9747	x	11.0258	x	12.6216	x	x	x	9.31586	8.54172	6.99506	x	11.2566	9.07188	7.70672	x	13.282	x	4.66825	8.09724	x	12.9248	x	x	13.6989	5.89396	x	9.11979	6.04789	8.67687	8.99341	x	11.2527	
-15978	None	Blood Chemistry: AMC Trait 02 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d18:2) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	23.3064	48.4583	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	28.9196	45.1203	33.421	x	x	25.23	16.5164	35.5091	30.5538	x	x	x	35.1135	38.6335	x	x	x	31.7206	17.182	36.2703	26.6925	29.5627	34.9038	37.6086	x	30.4926	32.2449	25.1958	43.3493	x	30.5416	x	46.4304	x	x	x	24.4657	22.1925	23.6356	x	35.8174	36.2587	24.0508	x	32.1698	x	28.3696	32.5965	x	35.3705	x	x	34.1986	22.9219	x	31.5308	25.7975	36.3645	27.6077	x	33.3637	
-15977	None	Blood Chemistry: AMC Trait 01 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Sphingomyelin (d16:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	1.08748	1.85997	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.25399	x	1.28458	x	x	1.04338	0.6918	1.40723	1.18697	x	x	x	1.49661	1.41731	x	x	x	1.30325	2.50426	1.53187	1.63754	1.34245	1.78674	1.34121	x	1.39429	1.54675	1.06304	1.89571	x	1.49549	x	1.58408	x	x	x	0.912691	1.02695	1.08001	x	1.31054	1.32935	1.04984	x	1.78629	x	1.01944	0.974135	x	1.27681	x	x	2.00293	0.850016	x	1.12812	1.06389	1.35703	1.47322	x	1.6105	
-16013	None	Blood Chemistry: AMC Trait 187 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/GlcCer levels in pooled plasma of young adult males on a normal chow diet	x	x	0.174384	0.561992	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0709488	0.0580671	0.0946918	x	x	0.702587	0.228155	0.0958177	0.216872	x	x	x	0.495532	0.838606	x	x	x	0.0	0.491722	0.470944	0.390218	0.620084	0.143928	0.371877	x	0.417929	0.0668908	0.248708	0.0801843	x	0.108463	x	0.240273	x	x	x	0.375709	0.0388332	0.0649372	x	0.473813	0.975	0.405648	x	0.233167	x	0.552901	0.308856	x	0.273142	x	x	0.32158	0.359978	x	0.125495	0.161323	0.429529	0.267329	x	0.10194	
-16014	None	Blood Chemistry: AMC Trait 188 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.155579	0.641535	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.609671	x	0.143832	x	x	0.315941	0.110511	0.518537	0.273651	x	x	x	0.0805414	0.319009	x	x	x	x	0.594284	0.851012	0.574442	0.562624	0.466976	0.0992512	x	0.24736	0.0405188	0.211481	0.0775784	x	0.313076	x	0.198636	x	x	x	0.0673157	0.0557339	0.0366888	x	0.563639	0.360396	0.124221	x	0.323058	x	0.0939066	0.16828	x	x	x	x	0.274961	0.292443	0.0685705	0.0968433	0.173099	0.18252	0.317911	x	0.1504	
-16015	None	Blood Chemistry: AMC Trait 189 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGlcCer(noSmase)/GlcCer levels in pooled plasma of young adult males on a normal chow diet	x	x	0.231714	0.204101	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.233045	0.128715	0.0205564	x	x	0.287798	0.0	0.0	0.0	x	x	x	0.170536	0.0	x	x	x	0.710306	0.0	0.0	0.0	0.256515	0.0903127	0.0	x	1.76238	0.0	0.0343004	0.0425794	x	0.165146	x	0.0	x	x	x	0.176734	0.0	0.171372	x	0.372345	0.393673	0.0253009	x	0.0911622	x	0.105347	0.343592	x	0.0	x	x	0.239062	0.045674	x	0.0	0.0	0.190499	0.401386	x	0.0	
-16016	None	Blood Chemistry: AMC Trait 190 contact <c.a.argmann@amc.uva.nl>	Blood chemistry, metabolism: Ratio of lysoGlcCer(noSmase)/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.0677173	0.22675	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	0.127397	x	x	0.0	0.429492	0.171341	0.165855	x	x	x	0.0658437	0.0433741	x	x	x	x	0.395181	0.0	0.218151	0.0	0.132452	0.0	x	0.0730166	0.0857487	0.26995	0.0950397	x	0.0854082	x	0.00708147	x	x	x	0.0	0.0655101	0.0156119	x	0.0	0.112274	0.0627133	x	0.00538965	x	0.0281719	0.172616	x	x	x	x	0.0	0.0	0.0	0.111865	0.0	0.0	0.139957	x	0.180144	
-16017	None	Blood Chemistry: AMC Trait 33 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Phenylalanine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	86.0	73.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	70.0	85.0	87.0	x	x	67.0	69.0	72.0	64.0	x	x	x	74.0	71.0	x	x	x	72.0	74.0	69.0	84.0	73.0	84.0	73.0	x	87.0	109.0	84.0	83.0	x	119.0	x	79.0	x	x	x	98.0	84.0	74.0	x	88.0	75.0	96.0	x	114.0	x	70.0	74.0	x	70.0	x	x	58.0	64.0	x	62.0	66.0	74.0	74.0	x	73.0	
-16018	None	Blood Chemistry: AMC Trait 34 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Tyrosine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	79.0	87.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	56.0	62.0	83.0	x	x	65.0	83.0	58.0	80.0	x	x	x	80.0	72.0	x	x	x	67.0	65.0	73.0	92.0	79.0	74.0	57.0	x	64.0	92.0	60.0	59.0	x	61.0	x	62.0	x	x	x	71.0	59.0	47.0	x	66.0	61.0	70.0	x	72.0	x	71.0	75.0	x	56.0	x	x	54.0	52.0	x	61.0	63.0	56.0	75.0	x	64.0	
-16019	None	Blood Chemistry: AMC Trait 35 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Tryptophan levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	75.0	65.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	57.0	96.0	70.0	x	x	75.0	71.0	79.0	77.0	x	x	x	75.0	66.0	x	x	x	97.0	80.0	76.0	60.0	66.0	84.0	75.0	x	54.0	64.0	63.0	73.0	x	78.0	x	68.0	x	x	x	69.0	71.0	51.0	x	82.0	49.0	70.0	x	67.0	x	79.0	72.0	x	83.0	x	x	49.0	65.0	x	82.0	61.0	78.0	65.0	x	76.0	
-16020	None	Blood Chemistry: AMC Trait 36 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Alanine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	750.0	549.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	355.0	571.0	633.0	x	x	425.0	653.0	512.0	542.0	x	x	x	480.0	518.0	x	x	x	711.0	514.0	491.0	935.0	704.0	762.0	465.0	x	739.0	964.0	452.0	847.0	x	583.0	x	801.0	x	x	x	858.0	573.0	683.0	x	658.0	862.0	775.0	x	863.0	x	529.0	595.0	x	487.0	x	x	690.0	414.0	x	565.0	563.0	333.0	578.0	x	518.0	
-16021	None	Blood Chemistry: AMC Trait 37 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Methionine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	89.0	72.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	60.0	53.0	74.0	x	x	54.0	69.0	62.0	74.0	x	x	x	73.0	74.0	x	x	x	67.0	58.0	55.0	83.0	68.0	52.0	34.0	x	54.0	56.0	36.0	45.0	x	54.0	x	48.0	x	x	x	53.0	41.0	40.0	x	54.0	52.0	55.0	x	79.0	x	56.0	49.0	x	39.0	x	x	48.0	39.0	x	45.0	51.0	40.0	60.0	x	49.0	
-16022	None	Blood Chemistry: AMC Trait 38 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glycine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	187.0	147.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	195.0	101.0	184.0	x	x	147.0	171.0	118.0	174.0	x	x	x	196.0	151.0	x	x	x	193.0	124.0	84.0	228.0	151.0	387.0	233.0	x	246.0	319.0	241.0	407.0	x	301.0	x	347.0	x	x	x	298.0	237.0	244.0	x	216.0	267.0	299.0	x	385.0	x	254.0	302.0	x	271.0	x	x	253.0	178.0	x	244.0	214.0	242.0	236.0	x	255.0	
-16023	None	Blood Chemistry: AMC Trait 39 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Valine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	230.0	211.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	212.0	212.0	240.0	x	x	185.0	194.0	198.0	201.0	x	x	x	199.0	231.0	x	x	x	207.0	176.0	188.0	201.0	173.0	217.0	179.0	x	191.0	247.0	209.0	187.0	x	280.0	x	212.0	x	x	x	250.0	196.0	187.0	x	198.0	203.0	235.0	x	251.0	x	216.0	230.0	x	218.0	x	x	183.0	200.0	x	189.0	201.0	231.0	238.0	x	264.0	
-16024	None	Blood Chemistry: AMC Trait 40 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Leucine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	191.0	151.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	170.0	171.0	201.0	x	x	156.0	152.0	169.0	162.0	x	x	x	168.0	190.0	x	x	x	165.0	158.0	159.0	176.0	139.0	188.0	170.0	x	175.0	215.0	182.0	148.0	x	x	x	168.0	x	x	x	215.0	175.0	153.0	x	160.0	166.0	204.0	x	225.0	x	158.0	196.0	x	194.0	x	x	142.0	158.0	x	146.0	173.0	196.0	193.0	x	230.0	
-16025	None	Blood Chemistry: AMC Trait 41 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Isoleucine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	156.0	145.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	161.0	177.0	184.0	x	x	149.0	152.0	163.0	151.0	x	x	x	151.0	183.0	x	x	x	168.0	135.0	151.0	159.0	126.0	126.0	123.0	x	120.0	141.0	128.0	112.0	x	202.0	x	130.0	x	x	x	152.0	135.0	116.0	x	133.0	124.0	152.0	x	144.0	x	110.0	134.0	x	129.0	x	x	95.0	116.0	x	111.0	117.0	140.0	142.0	x	182.0	
-16026	None	Blood Chemistry: AMC Trait 42 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glutamine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	662.0	565.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	474.0	558.0	604.0	x	x	451.0	541.0	469.0	547.0	x	x	x	532.0	477.0	x	x	x	445.0	573.0	443.0	704.0	471.0	582.0	571.0	x	552.0	497.0	431.0	529.0	x	500.0	x	527.0	x	x	x	465.0	506.0	587.0	x	367.0	441.0	536.0	x	514.0	x	471.0	556.0	x	558.0	x	x	437.0	519.0	x	459.0	429.0	530.0	440.0	x	368.0	
-16027	None	Blood Chemistry: AMC Trait 43 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Asparagine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	36.0	24.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	24.0	14.0	24.0	x	x	21.0	26.0	24.0	27.0	x	x	x	26.0	27.0	x	x	x	31.0	19.0	18.0	39.0	24.0	24.0	14.0	x	22.0	24.0	17.0	19.0	x	18.0	x	25.0	x	x	x	20.0	21.0	14.0	x	22.0	18.0	18.0	x	23.0	x	24.0	22.0	x	20.0	x	x	32.0	21.0	x	24.0	24.0	21.0	27.0	x	24.0	
-16028	None	Blood Chemistry: AMC Trait 44 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Citrulline levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	61.0	48.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	30.0	53.0	51.0	x	x	44.0	59.0	36.0	32.0	x	x	x	43.0	35.0	x	x	x	33.0	50.0	34.0	66.0	55.0	53.0	48.0	x	59.0	42.0	36.0	34.0	x	45.0	x	42.0	x	x	x	52.0	36.0	36.0	x	46.0	35.0	50.0	x	x	x	47.0	45.0	x	48.0	x	x	39.0	48.0	x	41.0	43.0	37.0	48.0	x	36.0	
-16029	None	Blood Chemistry: AMC Trait 45 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ornithine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	117.0	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	55.0	120.0	109.0	x	x	52.0	87.0	48.0	103.0	x	x	x	89.0	58.0	x	x	x	124.0	136.0	41.0	88.0	100.0	163.0	144.0	x	154.0	230.0	94.0	199.0	x	150.0	x	94.0	x	x	x	193.0	132.0	116.0	x	142.0	178.0	154.0	x	243.0	x	104.0	127.0	x	143.0	x	x	181.0	95.0	x	121.0	155.0	80.0	149.0	x	152.0	
-16030	None	Blood Chemistry: AMC Trait 46 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Lysine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	296.0	243.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	190.0	195.0	243.0	x	x	177.0	244.0	197.0	224.0	x	x	x	258.0	258.0	x	x	x	209.0	238.0	182.0	301.0	230.0	241.0	178.0	x	194.0	252.0	171.0	271.0	x	288.0	x	236.0	x	x	x	264.0	203.0	176.0	x	231.0	242.0	265.0	x	287.0	x	265.0	230.0	x	209.0	x	x	257.0	188.0	x	186.0	233.0	166.0	240.0	x	243.0	
-16031	None	Blood Chemistry: AMC Trait 47 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Arginine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	92.0	105.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	63.0	30.0	68.0	x	x	68.0	54.0	83.0	47.0	x	x	x	68.0	80.0	x	x	x	22.0	42.0	66.0	108.0	66.0	5.0	19.0	x	11.0	14.0	29.0	26.0	x	101.0	x	64.0	x	x	x	10.0	26.0	7.0	x	18.0	39.0	24.0	x	31.0	x	56.0	47.0	x	9.0	x	x	6.0	46.0	x	5.0	34.0	45.0	20.0	x	16.0	
-16032	None	Blood Chemistry: AMC Trait 48 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Serine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	169.0	125.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	119.0	103.0	131.0	x	x	108.0	147.0	115.0	128.0	x	x	x	131.0	148.0	x	x	x	144.0	103.0	100.0	x	131.0	136.0	98.0	x	140.0	151.0	86.0	161.0	x	120.0	x	134.0	x	x	x	132.0	98.0	88.0	x	133.0	156.0	142.0	x	155.0	x	129.0	129.0	x	117.0	x	x	139.0	97.0	x	131.0	128.0	124.0	142.0	x	123.0	
-16033	None	Blood Chemistry: AMC Trait 49 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Proline levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	x	75.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	72.0	65.0	79.0	x	x	61.0	93.0	58.0	73.0	x	x	x	61.0	74.0	x	x	x	72.0	67.0	56.0	104.0	78.0	99.0	54.0	x	105.0	x	71.0	83.0	x	82.0	x	77.0	x	x	x	86.0	58.0	56.0	x	71.0	71.0	94.0	x	x	x	87.0	87.0	x	68.0	x	x	83.0	63.0	x	75.0	92.0	62.0	99.0	x	74.0	
-16034	None	Blood Chemistry: AMC Trait 50 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glutamate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	49.0	58.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	31.0	41.0	48.0	x	x	27.0	51.0	30.0	74.0	x	x	x	50.0	38.0	x	x	x	59.0	47.0	31.0	46.0	30.0	72.0	35.0	x	42.0	60.0	38.0	41.0	x	48.0	x	45.0	x	x	x	49.0	55.0	52.0	x	35.0	40.0	46.0	x	72.0	x	45.0	41.0	x	67.0	x	x	38.0	59.0	x	33.0	49.0	56.0	40.0	x	48.0	
-16035	None	Blood Chemistry: AMC Trait 51 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Aspartate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	15.0	12.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	10.0	27.0	11.0	x	x	10.0	14.0	15.0	14.0	x	x	x	13.0	15.0	x	x	x	28.0	12.0	13.0	20.0	16.0	24.0	11.0	x	15.0	24.0	10.0	21.0	x	12.0	x	11.0	x	x	x	16.0	11.0	11.0	x	12.0	14.0	17.0	x	19.0	x	11.0	12.0	x	20.0	x	x	14.0	14.0	x	10.0	13.0	15.0	12.0	x	14.0	
-16036	None	Blood Chemistry: AMC Trait 52 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C0-carnitine_free carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	59.2376	69.4798	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	40.5504	x	73.6438	x	x	47.5177	54.2582	46.5409	55.9957	x	x	x	53.2618	53.6643	x	x	x	61.8974	68.435	49.4491	75.2234	49.3457	62.971	52.524	x	54.4082	67.7503	47.8849	57.074	x	57.7203	x	x	x	x	x	53.8184	44.2612	38.076	x	44.4127	58.4286	55.7503	x	52.4179	x	56.8498	56.83	x	59.2726	x	x	43.4842	52.4112	x	67.0863	52.3442	49.0809	49.2264	x	46.5937	
-16037	None	Blood Chemistry: AMC Trait 53 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C2-carnitine_acetylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	25.6869	38.099	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	50.7096	x	46.5	x	x	37.707	34.287	21.8906	39.3744	x	x	x	42.4185	44.6954	x	x	x	41.2118	39.2562	42.5583	38.1022	34.9569	31.8307	35.6117	x	25.8681	33.8898	37.0945	35.7493	x	54.0636	x	35.345	x	x	x	36.9552	36.8733	28.479	x	30.0106	31.6896	42.453	x	25.506	x	31.263	36.4584	x	36.1993	x	x	25.3089	33.6983	x	32.615	39.2476	33.6748	30.8656	x	37.4545	
-16038	None	Blood Chemistry: AMC Trait 54 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C3-carnitine_propionylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	1.0111	1.23926	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.513217	0.35569	1.17799	x	x	0.801992	0.920865	0.517603	0.891594	x	x	x	0.718422	0.804187	x	x	x	0.862003	0.920116	0.913295	1.13585	0.831362	0.767327	0.604338	x	0.609514	0.861498	0.705084	1.02412	x	1.04177	x	1.16275	x	x	x	0.756388	0.818464	0.436337	x	0.706718	0.711361	0.757618	x	0.606191	x	0.764695	0.766239	x	0.669429	x	x	0.599696	0.595128	x	0.642084	1.05996	0.579247	0.847644	x	0.791438	
-16039	None	Blood Chemistry: AMC Trait 55 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.625631	0.908038	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.710315	0.339409	0.950612	x	x	0.475166	0.542004	0.366578	0.713857	x	x	x	0.562021	0.708624	x	x	x	0.579219	0.653529	0.558812	0.901365	0.416209	0.689425	0.460233	x	0.527825	0.733512	0.579434	0.51623	x	0.918553	x	0.675517	x	x	x	0.626094	0.618148	0.288087	x	0.468853	0.452073	0.515643	x	0.635957	x	0.562348	0.464417	x	0.408932	x	x	0.320844	0.5287	x	0.480629	0.48314	0.459512	0.495002	x	0.608389	
-16040	None	Blood Chemistry: AMC Trait 56 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.13798	0.201298	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.133324	0.0575821	0.175231	x	x	0.0927413	0.134488	0.0599981	0.13073	x	x	x	0.0959635	0.136256	x	x	x	0.127	0.193499	0.135985	0.204038	0.103531	0.12014	0.0923092	x	0.0950895	0.17774	0.122688	0.136514	x	0.208474	x	0.215635	x	x	x	0.149438	0.131663	0.0531473	x	0.0943484	0.0892563	0.166992	x	0.14356	x	0.126925	0.15662	x	0.0848122	x	x	0.0791336	0.0859795	x	0.0911961	0.104707	0.0829709	0.11837	x	0.0910037	
-16041	None	Blood Chemistry: AMC Trait 57 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.181332	0.234818	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.570621	0.155218	0.479179	x	x	0.446694	0.445088	0.190805	0.472492	x	x	x	0.560745	0.551887	x	x	x	0.286363	0.345965	0.517129	0.357659	0.282824	0.24658	0.3894	x	0.159091	0.257989	0.501821	0.375264	x	x	x	0.461847	x	x	x	0.295152	0.496979	0.249319	x	0.284684	0.275779	0.483621	x	0.194359	x	0.309843	0.57942	x	0.297606	x	x	0.20372	0.416176	x	0.284042	0.284669	0.386333	0.271938	x	0.490368	
-16042	None	Blood Chemistry: AMC Trait 58 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C6-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0479489	0.168154	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.213177	0.0289184	0.100847	x	x	0.0693108	0.0855967	0.0496767	0.100517	x	x	x	0.0900533	0.159158	x	x	x	0.0619366	0.106929	0.0994334	0.0824717	0.0584567	0.0594947	0.0572769	x	0.0403708	0.0429981	0.0797469	0.099357	x	0.115603	x	0.0780349	x	x	x	0.0830841	0.0837578	0.0490691	x	0.0847708	0.0959621	0.0691614	x	0.0526463	x	0.0853916	0.090194	x	0.0845947	x	x	0.0425243	0.0650707	x	0.0787591	0.071737	0.055301	0.0510094	x	0.0987516	
-16043	None	Blood Chemistry: AMC Trait 59 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0878644	0.0980409	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0963722	0.0	0.124171	x	x	0.0	0.074765	0.0546858	0.116701	x	x	x	0.0927526	0.0839052	x	x	x	0.0953569	0.122979	0.0814434	0.136179	0.0670168	0.090386	0.100832	x	0.075652	0.109981	0.102217	0.0877428	x	0.1081	x	0.141726	x	x	x	0.0855166	0.0975749	0.0	x	0.0	0.0868555	0.113326	x	0.0708311	x	0.0846399	0.0801398	x	0.106188	x	x	0.0	0.0733813	x	0.0772489	0.10097	0.0687667	0.10622	x	0.0709472	
-16044	None	Blood Chemistry: AMC Trait 60 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C8-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0231702	0.0469644	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0355373	0.0276258	0.0392384	x	x	0.0308488	0.0248848	0.0197768	0.0288607	x	x	x	0.0224547	0.0446965	x	x	x	0.0238735	0.0254726	0.0273812	0.0359847	0.0255028	0.033211	0.0214373	x	0.0246314	0.0292101	0.0321557	0.0289852	x	0.0382469	x	0.0350051	x	x	x	0.0280344	0.0263746	0.0239005	x	0.0347802	0.0268263	0.0290377	x	0.0272657	x	0.025981	0.0336114	x	0.0205841	x	x	0.025984	0.0299357	x	0.0282566	0.0234227	0.02159	0.020906	x	0.0262019	
-16045	None	Blood Chemistry: AMC Trait 61 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C3 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0068433	0.0590135	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0275243	0.20921	0.0253876	x	x	0.0181887	0.0173493	0.0852996	0.0173498	x	x	x	0.0220461	0.0214023	x	x	x	0.0295761	0.074889	0.0664593	0.069462	0.067797	0.215178	0.0199914	x	0.0160963	0.0884412	0.0181902	0.0250495	x	0.0322478	x	0.109726	x	x	x	0.121639	0.0314844	0.0129527	x	0.0682598	0.0293473	0.0239535	x	0.0571791	x	0.0736304	0.0160051	x	0.203534	x	x	0.0344284	0.0248036	x	0.0796194	0.0468902	0.0121659	0.0183953	x	0.0329326	
-16046	None	Blood Chemistry: AMC Trait 62 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00828746	0.0221405	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0603748	0.00300191	0.0231658	x	x	0.0159938	0.0140166	0.0132655	0.0215886	x	x	x	0.01199	0.0198788	x	x	x	0.0103246	0.0116234	0.0252659	0.0208332	0.0164659	0.0117574	0.0158136	x	0.0108945	0.0	0.0147349	0.0172399	x	0.0246159	x	0.0172426	x	x	x	0.0143863	0.0203059	0.0117888	x	0.0177067	0.0185857	0.0201438	x	0.0122669	x	0.0129239	0.0128864	x	0.014102	x	x	0.0117205	0.0109557	x	0.0111199	0.0236842	0.0182568	0.0105737	x	0.0135756	
-16047	None	Blood Chemistry: AMC Trait 63 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0150004	0.0252527	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0299477	0.0179673	0.0235287	x	x	0.0213626	0.0180078	0.0158702	0.0263831	x	x	x	0.0153764	0.0250647	x	x	x	0.0216692	0.0218127	0.0212238	0.0233017	0.0146897	0.0213138	0.0245704	x	0.0159896	0.0164696	0.0215183	0.0174341	x	0.0256081	x	0.0186071	x	x	x	0.0153744	0.0176981	0.0160221	x	0.016396	0.0190022	0.0271493	x	0.0160893	x	0.0162066	0.0268656	x	0.0204871	x	x	0.0160072	0.0174575	x	0.0149755	0.0194862	0.014073	0.0151407	x	0.0135679	
-16048	None	Blood Chemistry: AMC Trait 64 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.033798	0.045786	0.0507752	x	x	0.0481011	0.0	0.0	0.0	x	x	x	0.0	0.0399091	x	x	x	0.0436652	0.0408731	0.0	0.0472332	0.0423078	0.046003	0.0385065	x	0.044734	0.0410284	0.0	0.0	x	0.0	x	0.0	x	x	x	0.0379445	0.0340322	0.0	x	0.0432447	0.0	0.0	x	0.0403284	x	0.0	0.0	x	0.0495571	x	x	0.0346079	0.0400426	x	0.0	0.041382	0.0	0.0	x	0.0	
-16049	None	Blood Chemistry: AMC Trait 65 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0159964	0.0175068	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0210882	0.0208941	0.0214302	x	x	0.0168328	0.0134341	0.0173862	0.0152265	x	x	x	0.0160401	0.0167666	x	x	x	0.0263861	0.0119756	0.0130236	0.0207719	0.0138674	0.0231699	0.015395	x	0.0163972	0.0142509	0.0197908	0.0142611	x	0.0234861	x	0.0228792	x	x	x	0.0185639	0.0231828	0.0091307	x	0.0142589	0.0145395	0.0254415	x	0.0125118	x	0.0132184	0.0126195	x	0.0207071	x	x	0.00940179	0.0239234	x	0.0119705	0.0186245	0.0109988	0.0153053	x	0.0205419	
-16050	None	Blood Chemistry: AMC Trait 66 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00825853	0.0210746	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00762712	0.0148737	x	x	0.0192674	0.0128811	0.0126128	0.0146123	x	x	x	0.00847982	0.0257926	x	x	x	0.0100502	0.0187129	0.0230105	0.0212396	0.0147969	0.0233865	0.0181346	x	0.0101344	0.0119767	0.0141991	0.0150945	x	0.0244774	x	0.0187046	x	x	x	0.0168442	0.0153012	0.00922831	x	0.021932	0.0129789	0.0166717	x	0.00747797	x	0.00910212	0.0117427	x	0.0161397	x	x	0.0102545	0.0143823	x	0.0090881	0.0228621	0.00895254	x	x	0.016345	
-16051	None	Blood Chemistry: AMC Trait 67 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0190409	0.0519005	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0791146	0.0163854	0.0442606	x	x	0.0360178	0.0260645	0.0354555	0.0358749	x	x	x	0.0284169	0.0642503	x	x	x	0.0250054	0.0367363	0.054416	0.0324575	0.0406457	0.028407	0.0351429	x	0.0235309	0.0283433	0.0301498	0.0410238	x	0.0616966	x	0.0414538	x	x	x	0.0394444	0.0333463	0.0173453	x	0.0313531	0.0356107	0.0318209	x	0.0222992	x	0.0232672	0.0306986	x	0.037139	x	x	0.0217356	0.0336766	x	0.0289575	0.033004	0.0277609	0.0302324	x	0.0303774	
-16052	None	Blood Chemistry: AMC Trait 68 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C6 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0114477	0.0147402	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0421493	0.015274	0.0116122	x	x	0.0242716	0.0103521	0.00931162	0.0201175	x	x	x	0.0162956	0.0157774	x	x	x	0.0142435	0.0137068	0.0247426	0.0121534	0.012402	0.00992882	0.0180357	x	0.00678769	0.00554004	0.0224904	0.0118379	x	0.0223854	x	0.0194437	x	x	x	0.013224	0.019179	0.00828972	x	0.0175209	0.0130001	0.0138609	x	0.00867788	x	0.0138145	0.00914249	x	0.0104958	x	x	0.00627459	0.0142487	x	0.0111436	0.0180042	0.00917635	0.0107829	x	0.010692	
-16053	None	Blood Chemistry: AMC Trait 69 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0103106	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0170952	0.00626644	0.0143371	x	x	0.00696908	0.00499244	0.00636939	0.00886445	x	x	x	0.00543745	0.00895374	x	x	x	0.00976722	0.0106417	0.00702698	0.0103821	0.0114318	0.00575278	0.00640913	x	0.00802837	0.00529491	0.0	0.00881286	x	0.0125376	x	0.00594274	x	x	x	0.0102557	0.0130613	0.0	x	0.0	0.00907392	0.00954144	x	0.00831821	x	0.0	0.00739558	x	0.0	x	x	0.00633219	0.00859795	x	0.00614038	0.00772036	0.00283284	0.00626132	x	0.00776565	
-16054	None	Blood Chemistry: AMC Trait 70 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.02688	0.0233953	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0274769	x	0.0264356	x	x	0.0270133	0.0351705	0.0262653	0.033054	x	x	x	0.0281104	0.0198715	x	x	x	0.0387602	0.0218454	0.0225683	0.0266607	0.0183994	0.0338847	0.0405841	x	0.0202293	0.0473849	0.0400899	0.0297955	x	0.0329768	x	0.0493645	x	x	x	0.0389026	0.0300354	0.0315069	x	0.0259028	0.0215515	0.0414037	x	0.0277784	x	0.0213388	0.0374011	x	0.0334404	x	x	0.0288935	0.0380699	x	0.0337851	0.0337588	0.033636	0.0373378	x	0.0267872	
-16055	None	Blood Chemistry: AMC Trait 71 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.038885	0.0652938	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0832848	0.0187849	0.0519736	x	x	0.0491348	0.0448148	0.0452188	0.0496418	x	x	x	0.0327734	0.0541387	x	x	x	0.0303111	0.0601183	0.0608963	0.0523908	0.0447205	0.0383262	0.0330165	x	0.0232863	0.0372196	0.0425188	0.0438832	x	0.0642125	x	0.0522253	x	x	x	0.0410267	0.0353878	0.0307455	x	0.0567085	0.0412127	0.0425103	x	0.0289145	x	0.0341645	0.0448751	x	0.0487749	x	x	0.0324416	0.0286138	x	0.0302006	0.0488467	0.0327005	0.0291845	x	0.0344792	
-16056	None	Blood Chemistry: AMC Trait 72 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0273196	0.168399	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.208993	0.0654487	0.0948342	x	x	0.135224	0.108013	0.157093	0.109221	x	x	x	0.0717206	0.175414	x	x	x	0.0943377	0.148124	0.194085	0.101697	0.101159	0.0994792	0.0847762	x	0.056666	0.0657063	0.127652	0.0812967	x	0.16489	x	0.107987	x	x	x	0.129558	0.104888	0.0714909	x	0.15508	0.0667959	0.0903455	x	0.0558504	x	0.0852575	0.117087	x	0.136122	x	x	0.0608269	0.118673	x	0.0879547	0.112397	0.0879332	0.0419615	x	0.087456	
-16057	None	Blood Chemistry: AMC Trait 73 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0382878	0.177661	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.397966	0.0923823	0.115682	x	x	0.165699	0.125969	0.194894	0.185986	x	x	x	0.132908	0.288217	x	x	x	0.096796	0.204121	0.265337	0.133905	0.210588	0.102294	0.110149	x	0.0793787	0.0708785	0.188393	0.131547	x	0.248353	x	0.127167	x	x	x	0.168622	0.154407	0.106545	x	0.151394	0.120925	0.126792	x	0.0696905	x	0.131665	0.162052	x	0.126992	x	x	0.101646	0.106725	x	0.139506	0.183469	0.100495	0.08834	x	0.109409	
-16058	None	Blood Chemistry: AMC Trait 74 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C8 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0048975	0.00739361	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0364598	0.0	0.0	x	x	0.00672765	0.00961047	0.00725249	0.0135569	x	x	x	0.00736867	0.0148203	x	x	x	0.0	0.00811773	0.0179141	0.0105406	0.017237	0.0	0.00609904	x	0.00750012	0.0	0.0149898	0.0106267	x	0.013462	x	0.0	x	x	x	0.00747805	0.00827841	0.00481546	x	0.013682	0.00573499	0.0	x	0.00872135	x	0.00628316	0.0107139	x	0.0	x	x	0.00717857	0.0	x	0.00679659	0.00961119	0.00492584	0.0	x	0.00593553	
-16059	None	Blood Chemistry: AMC Trait 75 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00311308	0.0242965	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0450172	0.0122681	0.0187047	x	x	0.0261727	0.0281709	0.023203	0.0189815	x	x	x	0.0201408	0.0378213	x	x	x	0.0135047	0.0232397	0.0455276	0.0155181	0.0181859	0.0207208	0.015804	x	0.0191	0.0151222	0.0329514	0.0214969	x	0.0333232	x	0.0146047	x	x	x	0.020268	0.0260605	0.0191545	x	0.0269097	0.0152051	0.024847	x	0.00973023	x	0.0152954	0.0304406	x	0.0241219	x	x	0.0274208	0.0180862	x	0.0264424	0.0185634	0.0159941	0.0153183	x	0.0211907	
-16060	None	Blood Chemistry: AMC Trait 76 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0262382	0.0108916	0.00617837	x	x	0.0111265	0.0	0.0109794	0.0107033	x	x	x	0.0132108	0.0211518	x	x	x	0.00433736	0.00944373	0.0143949	0.00434215	0.0124315	0.0140144	0.00588494	x	0.0116331	0.0	0.0101583	0.0081175	x	0.0163474	x	0.00401679	x	x	x	0.00881486	0.00676316	0.00292909	x	0.010433	0.00920462	0.0126305	x	0.0	x	0.00750235	0.00959974	x	0.00934502	x	x	0.00645807	0.0	x	0.0	0.00886658	0.0	0.0	x	0.00653262	
-16061	None	Blood Chemistry: AMC Trait 77 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0115215	0.0384594	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.117928	0.0226904	0.0330089	x	x	0.0450714	0.0381535	0.0476978	0.0431231	x	x	x	0.0186285	0.0424885	x	x	x	0.0175778	0.0340326	0.0570782	0.0286158	0.044085	0.0281647	0.0293073	x	0.0122168	0.0144574	0.0443958	0.0330692	x	0.06685	x	0.0276111	x	x	x	0.0302891	0.0333966	0.0217455	x	0.0548653	0.021888	0.0328426	x	0.0136149	x	0.02022	0.0346784	x	0.0200131	x	x	0.0163201	0.0330765	x	0.0198149	0.0544665	0.0332247	0.0190294	x	0.0391745	
-16062	None	Blood Chemistry: AMC Trait 78 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0339409	0.153856	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.279953	0.152057	0.110064	x	x	0.163304	0.144204	0.200878	0.129278	x	x	x	0.138068	0.237583	x	x	x	0.115299	0.160414	0.236894	0.117411	0.16114	0.124713	0.121793	x	0.0600775	0.0589565	0.166061	0.124525	x	0.171617	x	0.118176	x	x	x	0.152231	0.138949	0.108455	x	0.187142	0.116181	0.115996	x	0.0687012	x	0.122859	0.201744	x	0.151868	x	x	0.097202	0.139312	x	0.125015	0.136025	0.136895	0.0723158	x	0.120925	
-16063	None	Blood Chemistry: AMC Trait 79 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.164655	0.433687	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.923322	0.343845	0.395524	x	x	0.532749	0.467034	0.604343	0.620955	x	x	x	0.471139	0.826962	x	x	x	0.342607	0.583904	0.816932	0.343351	0.643341	0.326195	0.383878	x	0.253392	0.251061	0.634176	0.508491	x	0.703284	x	0.387394	x	x	x	0.424205	0.475622	0.409182	x	0.46867	0.445001	0.450997	x	0.270828	x	0.505116	0.620551	x	0.451971	x	x	0.361671	0.374668	x	0.395815	0.615549	0.428489	0.335813	x	0.41655	
-16064	None	Blood Chemistry: AMC Trait 80 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0461238	0.0	0.0270271	x	x	0.0	0.0	0.0457982	0.0	x	x	x	0.026119	0.0	x	x	x	0.0317202	0.0	0.0	0.0	0.0367462	0.0	0.0	x	0.0	0.0	0.0408677	0.0383779	x	0.0405632	x	0.0276311	x	x	x	0.0	0.0	0.0	x	0.0	0.0266568	0.0	x	0.0242717	x	0.0381743	0.0419006	x	0.0	x	x	0.033633	0.0	x	0.0349925	0.0308763	0.0	0.0242633	x	0.0351879	
-16065	None	Blood Chemistry: AMC Trait 81 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00564921	0.0201745	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0503561	0.027924	0.0173211	x	x	0.0219176	0.025752	0.0284268	0.0187991	x	x	x	0.0146697	0.0317101	x	x	x	0.0135356	0.025864	0.036262	0.0229161	0.0268305	0.0122966	0.0106487	x	0.0105362	0.0108064	0.0244094	0.0227608	x	0.033633	x	0.0187404	x	x	x	0.0205526	0.0151962	0.0118818	x	0.0214832	0.0215884	0.0257237	x	0.00829332	x	0.0148337	0.0245913	x	0.0205721	x	x	0.0145047	0.0193173	x	0.017873	0.0245975	0.0171613	0.00884711	x	0.0217488	
-16066	None	Blood Chemistry: AMC Trait 82 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0148206	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0081915	0.0153133	x	x	0.0143274	0.0152763	0.0213605	0.0184618	x	x	x	0.0113782	0.0343959	x	x	x	0.0128773	0.0188967	0.0372937	0.00927673	0.0181946	0.0102876	0.00881567	x	0.00929138	0.00682867	0.0290845	0.0192498	x	0.0378902	x	0.0118276	x	x	x	0.0246946	0.0206633	0.0104727	x	0.0167939	0.0176602	0.0167054	x	0.00292279	x	0.0117387	0.0188712	x	0.0182987	x	x	0.0078414	0.0109621	x	0.0164915	0.0201826	0.0148665	0.00836608	x	0.0138555	
-16067	None	Blood Chemistry: AMC Trait 83 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.072501	0.192204	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.468672	0.11379	0.215239	x	x	0.258181	0.241425	0.238394	0.230659	x	x	x	0.166803	0.268228	x	x	x	0.138853	0.21715	0.305735	0.157036	0.280319	0.12151	0.174191	x	0.0919779	0.0924801	0.234275	0.216279	x	0.349695	x	0.192498	x	x	x	0.210924	0.206633	0.192818	x	0.2889	0.141898	0.202932	x	0.129292	x	0.180142	0.217561	x	0.162769	x	x	0.113371	0.183668	x	0.139796	0.245598	0.209793	0.144006	x	0.201276	
-16068	None	Blood Chemistry: AMC Trait 84 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.151307	0.366809	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.754708	0.797765	0.406655	x	x	0.529203	0.502015	0.512024	0.447642	x	x	x	0.461442	0.625835	x	x	x	0.425816	0.476807	0.730254	0.357893	0.54697	0.394326	0.38632	x	0.206799	0.212297	0.598895	0.374323	x	0.570522	x	0.365817	x	x	x	0.44089	0.456583	0.418182	x	0.554226	0.333064	0.437279	x	0.222833	x	0.372681	0.516794	x	0.481879	x	x	0.329144	0.442197	x	0.413399	0.491761	0.463702	0.301728	x	0.416993	
-16069	None	Blood Chemistry: AMC Trait 85 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0523911	0.0992051	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.128065	0.147105	0.113913	x	x	0.0901332	0.0953605	0.103051	0.121164	x	x	x	0.0948328	0.183603	x	x	x	0.0873848	0.1253	0.160243	0.0759315	0.11944	0.0707224	0.0837902	x	0.053476	0.0531419	0.141469	0.116941	x	0.122406	x	0.0831629	x	x	x	0.0767043	0.101395	0.0774636	x	0.103816	0.103781	0.116402	x	0.0769583	x	0.0884038	0.11848	x	0.0906179	x	x	0.0829999	0.0884755	x	0.0936644	0.119552	0.0980223	0.0681005	x	0.0697735	
-16070	None	Blood Chemistry: AMC Trait 86 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:2hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.0	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0416635	0.010617	0.0169154	x	x	0.0109636	0.0228679	0.0172954	0.018088	x	x	x	0.0103907	0.0222613	x	x	x	0.00735509	0.0128812	0.0228988	0.0172749	0.0105947	0.00465174	0.010536	x	0.00571994	0.00914321	0.0210291	0.0112072	x	0.0256938	x	0.0	x	x	x	0.0203465	0.0163839	0.0179909	x	0.0137078	0.00912139	0.0169814	x	0.00516092	x	0.00981504	0.0183639	x	0.0107519	x	x	0.00875952	0.0107811	x	0.0118445	0.0159653	0.0108705	0.00764605	x	0.0136694	
-16071	None	Blood Chemistry: AMC Trait 87 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00493	0.0156172	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.058508	0.0395056	0.0235109	x	x	0.0285781	0.0292036	0.0246182	0.026275	x	x	x	0.0251583	0.0393448	x	x	x	0.0251375	0.0227223	0.0370237	0.0229747	0.0270917	0.018508	0.0189779	x	0.0128205	0.0139503	0.0433009	0.0255322	x	0.0361997	x	0.0249139	x	x	x	0.0266281	0.0233968	0.0198182	x	0.0270555	0.0228035	0.0254396	x	0.00618546	x	0.0114737	0.0356931	x	0.0356285	x	x	0.0171995	0.0243502	x	0.0215539	0.0193353	0.0157864	0.010387	x	0.0214122	
-16072	None	Blood Chemistry: AMC Trait 88 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.00519081	0.0161359	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00982455	0.0145304	0.0123172	x	x	0.0113373	0.0205327	0.0251026	0.0185074	x	x	x	0.011645	0.0313226	x	x	x	0.0116019	0.0211329	0.0271411	0.0118094	0.0106904	0.0135874	0.0102167	x	0.00869966	0.0145476	0.0187177	0.0120686	x	0.0191443	x	0.0242246	x	x	x	0.0344997	0.00397109	0.00812636	x	0.0156452	0.0113352	0.011697	x	0.00886828	x	0.00927641	0.0340716	x	0.0130532	x	x	0.0198659	0.0104281	x	0.0181242	0.0177162	0.0131158	0.00838625	x	0.0118445	
-16073	None	Blood Chemistry: AMC Trait 89 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Total amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	3488.0	2845.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2404.0	2734.0	3124.0	x	x	2342.0	2930.0	2506.0	2794.0	x	x	x	2767.0	2766.0	x	x	x	2914.0	2671.0	2330.0	3693.0	2780.0	3373.0	2581.0	x	3024.0	3632.0	2438.0	3345.0	x	3320.0	x	3170.0	x	x	x	3351.0	2717.0	2738.0	x	2732.0	3093.0	3302.0	x	3779.0	x	2782.0	3023.0	x	2806.0	x	x	2798.0	2436.0	x	2590.0	2709.0	2526.0	2878.0	x	2809.0	
-16074	None	Blood Chemistry: AMC Trait 90 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Total branched chain amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	577.0	507.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	543.0	560.0	625.0	x	x	490.0	498.0	530.0	514.0	x	x	x	518.0	604.0	x	x	x	540.0	469.0	498.0	536.0	438.0	531.0	472.0	x	486.0	603.0	519.0	447.0	x	760.0	x	510.0	x	x	x	617.0	506.0	456.0	x	491.0	493.0	591.0	x	620.0	x	484.0	560.0	x	541.0	x	x	420.0	474.0	x	446.0	491.0	567.0	573.0	x	676.0	
-16075	None	Blood Chemistry: AMC Trait 91 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Total AA levels in pooled plasma of young adult males on a normal chow diet	x	x	0.165424	0.178207	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.225874	0.204828	0.200064	x	x	0.209223	0.169966	0.211492	0.183966	x	x	x	0.187206	0.218366	x	x	x	0.185312	0.17559	0.213734	0.145139	0.157554	0.157427	0.182875	x	0.160714	0.166024	0.212879	0.133632	x	0.228916	x	0.160883	x	x	x	0.184124	0.186235	0.166545	x	0.179722	0.159392	0.178982	x	0.164065	x	0.173976	0.185246	x	0.192801	x	x	0.150107	0.194581	x	0.172201	0.181248	0.224466	0.199097	x	0.240655	
-16076	None	Blood Chemistry: AMC Trait 92 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Gln levels in pooled plasma of young adult males on a normal chow diet	x	x	0.871601	0.897345	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.14557	1.00358	1.03477	x	x	1.08647	0.920518	1.13006	0.939671	x	x	x	0.973684	1.26625	x	x	x	1.21348	0.818499	1.12415	0.761364	0.929936	0.912371	0.82662	x	0.880435	1.21328	1.20418	0.844991	x	1.52	x	0.967742	x	x	x	1.32688	1.0	0.776831	x	1.33787	1.11791	1.10261	x	1.20623	x	1.0276	1.00719	x	0.969534	x	x	0.961098	0.913295	x	0.971678	1.14452	1.06981	1.30227	x	1.83696	
-16077	None	Blood Chemistry: AMC Trait 93 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Ala levels in pooled plasma of young adult males on a normal chow diet	x	x	0.769333	0.923497	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.52958	0.980736	0.987362	x	x	1.15294	0.762634	1.03516	0.948339	x	x	x	1.07917	1.16602	x	x	x	0.759494	0.912451	1.01426	0.573262	0.622159	0.69685	1.01505	x	0.657645	0.625519	1.14823	0.527745	x	1.3036	x	0.636704	x	x	x	0.719114	0.883072	0.667643	x	0.746201	0.571926	0.762581	x	0.718424	x	0.914934	0.941176	x	1.11088	x	x	0.608696	1.14493	x	0.789381	0.872114	1.7027	0.991349	x	1.30502	
-16078	None	Blood Chemistry: AMC Trait 94 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/C3 levels in pooled plasma of young adult males on a normal chow diet	x	x	570.664	409.117	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1058.03	1574.41	530.564	x	x	610.979	540.796	1023.95	576.496	x	x	x	721.024	751.069	x	x	x	626.448	509.718	545.278	471.894	526.846	692.013	781.02	x	797.356	699.943	736.083	436.473	x	729.528	x	438.617	x	x	x	815.719	618.231	1045.06	x	694.76	693.037	780.076	x	1022.78	x	632.932	730.843	x	808.151	x	x	700.355	796.468	x	694.613	463.224	978.856	675.991	x	854.141	
-16079	None	Blood Chemistry: AMC Trait 95 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Val/C3 levels in pooled plasma of young adult males on a normal chow diet	x	x	227.474	170.264	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	413.08	x	203.737	x	x	230.676	210.672	382.533	225.439	x	x	x	276.996	287.246	x	x	x	240.138	191.28	205.848	176.96	208.092	282.8	296.192	x	313.364	286.71	296.419	182.596	x	268.774	x	182.327	x	x	x	330.518	239.473	428.568	x	280.168	285.368	310.183	x	414.061	x	282.466	300.168	x	325.651	x	x	305.155	336.062	x	294.354	189.629	398.793	280.778	x	333.57	
-16080	None	Blood Chemistry: AMC Trait 96 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Ile/C3 levels in pooled plasma of young adult males on a normal chow diet	x	x	154.287	117.006	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	313.707	x	156.198	x	x	185.788	165.062	314.913	169.36	x	x	x	210.183	227.559	x	x	x	194.895	146.721	165.335	139.983	151.559	164.206	203.528	x	196.878	163.668	181.539	109.362	x	193.901	x	111.804	x	x	x	200.955	164.943	265.85	x	188.194	174.314	200.629	x	237.549	x	143.848	174.88	x	192.702	x	x	158.414	194.916	x	172.874	110.381	241.693	167.523	x	229.961	
-16081	None	Blood Chemistry: AMC Trait 97 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C0/C2 levels in pooled plasma of young adult males on a normal chow diet	x	x	2.30614	1.82367	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.79966	2.20312	1.58374	x	x	1.26018	1.58247	2.12607	1.42213	x	x	x	1.25563	1.20067	x	x	x	1.50193	1.74329	1.16191	1.97425	1.41162	1.97831	1.47491	x	2.10329	1.99914	1.29089	1.59651	x	1.06764	x	2.65102	x	x	x	1.45631	1.20036	1.33698	x	1.4799	1.84378	1.31322	x	2.05512	x	1.81844	1.55876	x	1.6374	x	x	1.71814	1.55531	x	2.05692	1.33369	1.4575	1.59487	x	1.24401	
-16082	None	Blood Chemistry: AMC Trait 98 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C18/C18:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.346257	0.270455	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.169689	0.184396	0.280123	x	x	0.170319	0.189956	0.201261	0.270672	x	x	x	0.205514	0.293373	x	x	x	0.205217	0.262791	0.219435	0.212163	0.218367	0.17935	0.216894	x	0.258589	0.250318	0.236216	0.312406	x	0.214552	x	0.227335	x	x	x	0.173976	0.222073	0.185239	x	0.187316	0.311594	0.266196	x	0.345363	x	0.23721	0.229259	x	0.188051	x	x	0.252169	0.200082	x	0.226572	0.243109	0.211391	0.225702	x	0.167325	
-16083	None	Blood Chemistry: AMC Trait 99 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C18:2/C18:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.479164	0.52399	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.620998	x	0.529291	x	x	0.487867	0.480912	0.465591	0.515275	x	x	x	0.361481	0.428592	x	x	x	0.326087	0.455426	0.418669	0.438778	0.512494	0.308147	0.450899	x	0.444769	0.435616	0.391178	0.577789	x	0.612938	x	0.526215	x	x	x	0.478406	0.452563	0.461087	x	0.521268	0.426037	0.46408	x	0.58022	x	0.483368	0.420982	x	0.33778	x	x	0.344441	0.415353	x	0.338163	0.499426	0.452432	0.477273	x	0.482685	
-16084	None	Blood Chemistry: AMC Trait 100 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C16:2/C16:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.339457	0.24997	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.421243	0.149223	0.299905	x	x	0.275998	0.264581	0.237447	0.333568	x	x	x	0.134923	0.178836	x	x	x	0.152453	0.212154	0.240944	0.243724	0.273582	0.225837	0.240632	x	0.20335	0.245222	0.267347	0.265564	x	0.389531	x	0.233643	x	x	x	0.198968	0.240352	0.200503	x	0.293175	0.188395	0.283135	x	0.198175	x	0.164579	0.171893	x	0.131779	x	x	0.167899	0.237427	x	0.158501	0.400415	0.242702	0.263143	x	0.323956	
-16085	None	Blood Chemistry: AMC Trait 101 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C16/C16:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	4.85123	2.81878	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.29813	2.26129	3.59357	x	x	3.26232	3.23871	3.00851	4.80324	x	x	x	3.41237	3.48073	x	x	x	2.97145	3.63998	3.44851	2.92436	3.99244	2.61556	3.15189	x	4.21776	4.25841	3.81894	4.08346	x	4.09799	x	3.27811	x	x	x	2.78659	3.423	3.77284	x	2.50435	3.83023	3.88803	x	3.94212	x	4.11134	3.07594	x	2.97607	x	x	3.72082	2.68941	x	3.16615	4.52526	3.13006	4.6437	x	3.44469	
-16086	None	Blood Chemistry: AMC Trait 102 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14/C14:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	1.40148	1.05501	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.9042	1.41152	1.21983	x	x	1.22537	1.16624	1.24063	1.70284	x	x	x	1.85314	1.64307	x	x	x	1.02606	1.37804	1.36711	1.3167	2.08176	1.02829	1.29929	x	1.40082	1.07872	1.47583	1.6181	x	1.50617	x	1.17761	x	x	x	1.30152	1.47211	1.49034	x	0.97623	1.81037	1.40341	x	1.24781	x	1.54432	1.38403	x	0.932923	x	x	1.67107	0.899314	x	1.58612	1.63233	1.14286	2.10526	x	1.25101	
-16087	None	Blood Chemistry: AMC Trait 103 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14:2/C14:1 levels in pooled plasma of young adult males on a normal chow diet	x	x	1.42334	0.387734	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.398504	0.287016	0.548047	x	x	0.363359	0.414901	0.287848	0.454507	x	x	x	0.456959	0.308635	x	x	x	0.321304	0.405864	0.313761	0.515163	0.442083	0.385268	0.389455	x	0.410939	0.566455	0.333084	0.53979	x	0.389426	x	0.483626	x	x	x	0.316667	0.337386	0.430061	x	0.365672	0.616995	0.47053	x	0.517713	x	0.400722	0.383263	x	0.358316	x	x	0.533344	0.241114	x	0.343366	0.43459	0.371879	0.695506	x	0.394246	
-16088	None	Blood Chemistry: AMC Trait 104 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Total long chain amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.579288	1.65711	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.24496	1.73118	1.50389	x	x	1.92363	1.72883	2.0559	1.89455	x	x	x	1.56969	2.65998	x	x	x	1.3314	1.97594	2.77038	1.33962	2.10768	1.27756	1.37791	x	0.825054	0.841741	2.13344	1.59728	x	2.39498	x	1.43443	x	x	x	1.64416	1.67387	1.41488	x	1.96594	1.36886	1.58325	x	0.923069	x	1.52029	1.99914	x	1.65099	x	x	1.1793	1.48233	x	1.42535	1.9532	1.55803	1.08145	x	1.45686	
-16089	None	Blood Chemistry: AMC Trait 105 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of total LCAC/C2 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.0225519	0.043495	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0639911	0.160494	0.0323416	x	x	0.0510151	0.0504224	0.0939169	0.0481163	x	x	x	0.0370048	0.0595135	x	x	x	0.0323064	0.0503344	0.065096	0.0351585	0.0602936	0.0401362	0.0386927	x	0.0318946	0.0248376	0.0575137	0.0446802	x	0.0442993	x	0.0405837	x	x	x	0.0444906	0.045395	0.0496816	x	0.0655081	0.0431958	0.0372943	x	0.0361903	x	0.048629	0.0548335	x	0.0456085	x	x	0.0465963	0.0439884	x	0.0437023	0.049766	0.0462669	0.0350374	x	0.0388969	
-16090	None	Blood Chemistry: AMC Trait 106 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of total LCAC/C0 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.00977906	0.0238503	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.080023	0.0728484	0.0204211	x	x	0.0404823	0.0318631	0.0441739	0.0338338	x	x	x	0.0294712	0.049567	x	x	x	0.0215099	0.0288732	0.0560248	0.0178085	0.0427124	0.0202881	0.026234	x	0.0151641	0.0124242	0.0445534	0.0279862	x	0.0414928	x	0.0153087	x	x	x	0.0305502	0.0378179	0.0371594	x	0.0442652	0.0234279	0.028399	x	0.0176098	x	0.0267422	0.0351776	x	0.0278543	x	x	0.0271202	0.0282827	x	0.0212465	0.0373145	0.0317441	0.0219689	x	0.0312674	
-16091	None	Blood Chemistry: AMC Trait 107 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14:1/C2 levels in pooled plasma of young adult males on a normal chow diet	x	x	0.00106356	0.00442003	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00412138	0.00606761	0.00203944	x	x	0.00358617	0.00315026	0.00717628	0.00277391	x	x	x	0.00169079	0.00392464	x	x	x	0.00228909	0.00377327	0.00456045	0.00266907	0.00289381	0.00312526	0.00238057	x	0.00219057	0.00193882	0.00344127	0.00227408	x	0.00304993	x	0.00305523	x	x	x	0.00350581	0.00284456	0.0025103	x	0.00516752	0.00210782	0.00212813	x	0.00218969	x	0.00272711	0.00321152	x	0.00376036	x	x	0.00240338	0.00352165	x	0.00269676	0.0028638	0.00261124	0.00135949	x	0.002335	
-16092	None	Blood Chemistry: AMC Trait 108 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Phenylalanine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	77.0	88.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	61.0	x	77.0	x	x	67.0	65.0	68.0	62.0	x	x	x	68.0	72.0	x	x	x	x	79.0	66.0	93.0	72.0	87.0	75.0	x	81.0	85.0	82.0	83.0	x	83.0	x	91.0	x	x	x	94.0	78.0	66.0	x	79.0	84.0	99.0	x	98.0	x	66.0	64.0	x	x	x	x	60.0	53.0	78.0	68.0	62.0	62.0	59.0	x	73.0	
-16093	None	Blood Chemistry: AMC Trait 109 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Tyrosine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	83.0	104.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	52.0	x	87.0	x	x	76.0	73.0	59.0	68.0	x	x	x	72.0	73.0	x	x	x	x	88.0	62.0	106.0	91.0	82.0	65.0	x	49.0	60.0	74.0	59.0	x	62.0	x	71.0	x	x	x	53.0	50.0	41.0	x	58.0	59.0	72.0	x	95.0	x	78.0	65.0	x	x	x	x	56.0	50.0	73.0	51.0	69.0	77.0	46.0	x	67.0	
-16094	None	Blood Chemistry: AMC Trait 110 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Tryptophan levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	78.0	90.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	71.0	x	66.0	x	x	87.0	74.0	89.0	97.0	x	x	x	81.0	85.0	x	x	x	x	75.0	68.0	67.0	85.0	90.0	94.0	x	68.0	82.0	74.0	102.0	x	67.0	x	76.0	x	x	x	76.0	70.0	79.0	x	83.0	70.0	78.0	x	68.0	x	64.0	82.0	x	x	x	x	77.0	57.0	112.0	93.0	86.0	67.0	71.0	x	97.0	
-16095	None	Blood Chemistry: AMC Trait 111 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Alanine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	607.0	574.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	276.0	x	554.0	x	x	559.0	808.0	272.0	374.0	x	x	x	528.0	605.0	x	x	x	x	565.0	715.0	1006.0	781.0	867.0	507.0	x	294.0	512.0	746.0	517.0	x	582.0	x	929.0	x	x	x	360.0	465.0	317.0	x	810.0	1128.0	1165.0	x	900.0	x	910.0	492.0	x	x	x	x	292.0	592.0	466.0	383.0	546.0	662.0	227.0	x	597.0	
-16096	None	Blood Chemistry: AMC Trait 112 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Methionine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	78.0	74.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	56.0	x	75.0	x	x	62.0	71.0	54.0	54.0	x	x	x	76.0	77.0	x	x	x	x	56.0	57.0	x	72.0	60.0	34.0	x	44.0	42.0	44.0	37.0	x	41.0	x	56.0	x	x	x	41.0	36.0	31.0	x	46.0	53.0	59.0	x	80.0	x	64.0	44.0	x	x	x	x	49.0	42.0	58.0	41.0	39.0	61.0	35.0	x	50.0	
-16097	None	Blood Chemistry: AMC Trait 113 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glycine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	164.0	124.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	256.0	x	133.0	x	x	141.0	163.0	88.0	144.0	x	x	x	124.0	187.0	x	x	x	x	142.0	134.0	175.0	146.0	330.0	232.0	x	226.0	270.0	279.0	245.0	x	259.0	x	334.0	x	x	x	200.0	236.0	201.0	x	224.0	282.0	247.0	x	299.0	x	235.0	245.0	x	x	x	x	181.0	173.0	330.0	195.0	153.0	288.0	146.0	x	213.0	
-16098	None	Blood Chemistry: AMC Trait 114 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Valine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	260.0	279.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	169.0	x	225.0	x	x	206.0	213.0	157.0	156.0	x	x	x	188.0	180.0	x	x	x	x	182.0	143.0	364.0	236.0	270.0	157.0	x	180.0	186.0	236.0	196.0	x	189.0	x	299.0	x	x	x	239.0	180.0	187.0	x	183.0	241.0	297.0	x	323.0	x	256.0	189.0	x	x	x	x	193.0	187.0	249.0	197.0	204.0	289.0	217.0	x	239.0	
-16099	None	Blood Chemistry: AMC Trait 115 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Leucine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	182.0	178.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	127.0	x	146.0	x	x	139.0	161.0	127.0	133.0	x	x	x	147.0	141.0	x	x	x	x	150.0	133.0	x	174.0	204.0	149.0	x	150.0	188.0	176.0	155.0	x	169.0	x	212.0	x	x	x	210.0	163.0	150.0	x	162.0	188.0	212.0	x	217.0	x	166.0	156.0	x	x	x	x	133.0	148.0	194.0	155.0	157.0	195.0	177.0	x	198.0	
-16100	None	Blood Chemistry: AMC Trait 116 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Isoleucine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	186.0	180.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	122.0	x	152.0	x	x	147.0	166.0	133.0	133.0	x	x	x	144.0	143.0	x	x	x	x	153.0	126.0	x	183.0	153.0	107.0	x	119.0	135.0	132.0	128.0	x	128.0	x	169.0	x	x	x	148.0	124.0	129.0	x	129.0	142.0	160.0	x	170.0	x	125.0	110.0	x	x	x	x	100.0	107.0	143.0	117.0	118.0	147.0	140.0	x	151.0	
-16101	None	Blood Chemistry: AMC Trait 117 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glutamine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	563.0	580.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	442.0	x	536.0	x	x	514.0	634.0	477.0	527.0	x	x	x	619.0	533.0	x	x	x	x	626.0	548.0	544.0	604.0	643.0	647.0	x	489.0	567.0	493.0	442.0	x	504.0	x	575.0	x	x	x	476.0	485.0	651.0	x	436.0	634.0	600.0	x	521.0	x	457.0	556.0	x	x	x	x	438.0	610.0	507.0	553.0	521.0	541.0	464.0	x	540.0	
-16102	None	Blood Chemistry: AMC Trait 118 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Asparagine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	28.0	22.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	24.0	x	22.0	x	x	23.0	29.0	16.0	22.0	x	x	x	25.0	30.0	x	x	x	x	28.0	25.0	45.0	27.0	27.0	18.0	x	20.0	16.0	24.0	14.0	x	23.0	x	20.0	x	x	x	16.0	14.0	13.0	x	22.0	26.0	22.0	x	32.0	x	37.0	25.0	x	x	x	x	23.0	30.0	28.0	20.0	21.0	42.0	18.0	x	28.0	
-16103	None	Blood Chemistry: AMC Trait 119 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Citrulline levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	53.0	77.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	44.0	x	56.0	x	x	50.0	56.0	44.0	41.0	x	x	x	53.0	55.0	x	x	x	x	45.0	47.0	78.0	68.0	55.0	54.0	x	58.0	40.0	47.0	37.0	x	41.0	x	67.0	x	x	x	61.0	41.0	51.0	x	51.0	45.0	65.0	x	77.0	x	51.0	45.0	x	x	x	x	50.0	53.0	57.0	46.0	43.0	48.0	39.0	x	47.0	
-16104	None	Blood Chemistry: AMC Trait 120 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ornithine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	116.0	97.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	61.0	x	113.0	x	x	77.0	113.0	73.0	137.0	x	x	x	101.0	76.0	x	x	x	x	143.0	111.0	182.0	152.0	155.0	158.0	x	110.0	165.0	114.0	160.0	x	155.0	x	164.0	x	x	x	150.0	148.0	128.0	x	146.0	219.0	198.0	x	195.0	x	140.0	117.0	x	x	x	x	163.0	164.0	129.0	109.0	180.0	139.0	104.0	x	168.0	
-16105	None	Blood Chemistry: AMC Trait 121 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Lysine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	322.0	349.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	166.0	x	292.0	x	x	235.0	331.0	160.0	195.0	x	x	x	308.0	290.0	x	x	x	x	255.0	197.0	x	269.0	352.0	175.0	x	161.0	211.0	244.0	219.0	x	228.0	x	329.0	x	x	x	189.0	196.0	143.0	x	205.0	335.0	281.0	x	423.0	x	372.0	201.0	x	x	x	x	231.0	205.0	248.0	142.0	226.0	337.0	125.0	x	243.0	
-16106	None	Blood Chemistry: AMC Trait 122 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Arginine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	56.0	86.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	63.0	x	71.0	x	x	75.0	42.0	57.0	15.0	x	x	x	74.0	89.0	x	x	x	x	17.0	85.0	51.0	43.0	0.0	7.0	x	6.0	7.0	23.0	10.0	x	20.0	x	14.0	x	x	x	5.0	17.0	6.0	x	10.0	27.0	11.0	x	11.0	x	48.0	25.0	x	x	x	x	0.0	3.0	15.0	0.0	13.0	22.0	0.0	x	9.0	
-16107	None	Blood Chemistry: AMC Trait 123 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Serine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	173.0	146.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	131.0	x	141.0	x	x	145.0	183.0	115.0	123.0	x	x	x	154.0	218.0	x	x	x	x	146.0	213.0	257.0	183.0	175.0	117.0	x	115.0	139.0	145.0	115.0	x	120.0	x	157.0	x	x	x	105.0	102.0	98.0	x	128.0	218.0	165.0	x	167.0	x	194.0	141.0	x	x	x	x	129.0	143.0	166.0	135.0	147.0	187.0	104.0	x	153.0	
-16108	None	Blood Chemistry: AMC Trait 124 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Proline levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	118.0	122.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	56.0	x	97.0	x	x	76.0	109.0	44.0	57.0	x	x	x	85.0	82.0	x	x	x	x	99.0	65.0	272.0	114.0	166.0	54.0	x	63.0	69.0	119.0	62.0	x	61.0	x	161.0	x	x	x	54.0	46.0	45.0	x	60.0	80.0	126.0	x	198.0	x	163.0	70.0	x	x	x	x	65.0	67.0	99.0	62.0	72.0	154.0	51.0	x	93.0	
-16109	None	Blood Chemistry: AMC Trait 125 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Glutamate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	41.0	59.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	25.0	x	46.0	x	x	33.0	40.0	28.0	58.0	x	x	x	48.0	29.0	x	x	x	x	54.0	44.0	67.0	43.0	96.0	47.0	x	25.0	44.0	55.0	37.0	x	49.0	x	80.0	x	x	x	34.0	60.0	68.0	x	40.0	46.0	58.0	x	77.0	x	48.0	52.0	x	x	x	x	46.0	43.0	61.0	55.0	57.0	57.0	46.0	x	48.0	
-16110	None	Blood Chemistry: AMC Trait 126 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Aspartate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	14.0	15.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.0	x	12.0	x	x	14.0	16.0	14.0	18.0	x	x	x	11.0	15.0	x	x	x	x	16.0	37.0	32.0	18.0	30.0	17.0	x	11.0	15.0	14.0	12.0	x	9.0	x	15.0	x	x	x	12.0	11.0	14.0	x	17.0	18.0	18.0	x	14.0	x	20.0	15.0	x	x	x	x	14.0	17.0	23.0	14.0	15.0	16.0	12.0	x	19.0	
-16111	None	Blood Chemistry: AMC Trait 127 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C0-carnitine_free carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	46.872	57.5257	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	27.1416	x	50.0711	x	x	36.5941	39.7748	21.615	24.038	x	x	x	32.7922	35.3532	x	x	x	x	50.278	32.6556	42.5969	32.3282	40.9566	27.211	x	25.2389	38.0838	39.8934	28.7475	x	35.6411	x	81.9169	x	x	x	26.5066	28.9124	26.7508	x	30.5938	46.815	40.8492	x	38.0051	x	37.872	40.3888	x	x	x	x	20.8532	33.9476	26.986	41.5341	36.2204	38.5283	19.6596	x	28.1558	
-16112	None	Blood Chemistry: AMC Trait 128 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C2-carnitine_acetylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	17.3025	24.4047	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	24.7517	x	20.2441	x	x	16.7096	18.7622	12.6428	12.6229	x	x	x	14.7462	19.0193	x	x	x	x	22.7033	16.7434	23.1327	14.2398	17.7147	16.272	x	20.5944	18.9705	16.2154	15.3895	x	20.5216	x	27.3201	x	x	x	20.1531	17.2154	23.5852	x	15.0478	21.4474	20.6076	x	16.8627	x	15.1843	20.9421	x	x	x	x	16.4119	17.8401	19.7173	20.0007	18.018	13.9221	22.1954	x	16.7124	
-16113	None	Blood Chemistry: AMC Trait 129 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C3-carnitine_propionylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.405511	0.879148	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.248598	x	0.626149	x	x	0.457881	0.579887	0.327822	0.302233	x	x	x	0.336397	0.416305	x	x	x	x	0.639659	0.374409	0.942899	0.354771	0.512022	0.332366	x	0.253181	0.410084	0.494666	0.353916	x	0.623967	x	0.774069	x	x	x	0.403874	0.369784	0.183379	x	0.380143	0.357855	0.683424	x	0.442632	x	0.391779	0.479294	x	x	x	x	0.418358	0.364984	0.369415	0.321998	0.39909	0.350806	0.272948	x	0.446634	
-16114	None	Blood Chemistry: AMC Trait 130 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.372031	0.794137	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.393434	x	0.546073	x	x	0.279763	0.369191	0.237842	0.254017	x	x	x	0.331425	0.409835	x	x	x	x	0.449578	0.296809	0.669324	0.263842	0.50119	0.29198	x	0.30704	0.265134	0.510946	0.347923	x	0.39541	x	0.793241	x	x	x	0.336867	0.364049	0.287883	x	0.254368	0.281744	0.508117	x	0.39418	x	0.263118	0.309814	x	x	x	x	0.246738	0.342948	0.382621	0.44677	0.270075	0.358995	0.335718	x	0.381847	
-16115	None	Blood Chemistry: AMC Trait 131 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0966913	0.206512	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0948345	x	0.130355	x	x	0.0809191	0.0718048	0.048825	0.0461324	x	x	x	0.080648	0.0795418	x	x	x	x	0.137685	0.078702	0.194224	0.0601519	0.0935555	0.0502183	x	0.0685319	0.0695783	0.104346	0.0851591	x	0.0955153	x	0.233525	x	x	x	0.0925341	0.0661903	0.0467828	x	0.0523397	0.0886092	0.124104	x	0.105236	x	0.0796745	0.0828205	x	x	x	x	0.058763	0.0450505	0.0725834	0.0683329	0.0634835	0.0683021	0.0494519	x	0.0690885	
-16116	None	Blood Chemistry: AMC Trait 132 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.146375	0.232481	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.404046	x	0.14692	x	x	0.132956	0.171734	0.142995	0.191983	x	x	x	0.171715	0.230797	x	x	x	x	0.25459	0.232925	0.253905	0.104176	0.228666	0.272139	x	0.292803	0.275568	0.132979	0.182791	x	0.278936	x	0.32366	x	x	x	0.261522	0.274719	0.305448	x	0.160743	0.21997	0.178843	x	0.125307	x	0.122866	0.431796	x	x	x	x	0.262523	0.132877	0.294735	0.212722	0.120193	0.0927158	0.510989	x	0.283873	
-16117	None	Blood Chemistry: AMC Trait 133 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C6-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0453345	0.0737519	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0790899	x	0.061435	x	x	0.0409305	0.044	0.0531482	0.0361763	x	x	x	0.0493847	0.0675953	x	x	x	x	0.0488558	0.049213	0.0708006	0.0301066	0.0437032	0.0475855	x	0.054148	0.0522503	0.0386254	0.0487127	x	0.0535952	x	0.0617025	x	x	x	0.0528256	0.0666949	0.0561814	x	0.0472705	0.0391294	0.0261803	x	0.0453055	x	0.037541	0.0553627	x	x	x	x	0.0469374	0.0361101	0.0516414	0.0396023	0.0460617	0.0301192	0.0530131	x	0.0643725	
-16118	None	Blood Chemistry: AMC Trait 134 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0783035	0.0869953	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0479234	x	0.0914075	x	x	0.048905	0.0590579	0.0289159	0.0	x	x	x	0.0527579	0.0	x	x	x	x	0.101181	0.0	0.107566	0.0459585	0.0645276	0.0	x	0.0418802	0.0	0.0555376	0.0351886	x	0.0596878	x	0.122736	x	x	x	0.0	0.0487573	0.0515772	x	0.0	0.0	0.066824	x	0.0721939	x	0.0477383	0.0724562	x	x	x	x	0.0	0.0489307	0.0	0.041441	0.0601543	0.0630882	0.0420093	x	0.0462029	
-16119	None	Blood Chemistry: AMC Trait 135 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C8-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0260695	0.0294549	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0275113	x	0.0229005	x	x	0.0184049	0.0264498	0.0259364	0.0217613	x	x	x	0.0295736	0.034082	x	x	x	x	0.028993	0.0273906	0.0302947	0.0232992	0.0244537	0.0251206	x	0.0275788	0.0273648	0.0262438	0.0266591	x	0.0247624	x	0.0320836	x	x	x	0.0325406	0.0271666	0.029243	x	0.0210695	0.0301064	0.0313126	x	0.0294597	x	0.0262535	0.0211028	x	x	x	x	0.0285637	0.0213848	0.0353797	0.0251627	0.0260115	0.022608	0.0243223	x	0.0219808	
-16120	None	Blood Chemistry: AMC Trait 136 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C3 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0180767	0.0679591	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.01922	x	0.0193325	x	x	0.0126619	0.0164355	0.265295	0.0189478	x	x	x	0.016306	0.02571	x	x	x	x	0.0970497	0.114806	0.0527155	0.0610835	0.187277	0.0239885	x	0.018861	0.0699588	0.0119465	0.0288	x	0.0285353	x	0.105191	x	x	x	0.13321	0.0235434	0.0243518	x	0.088074	0.0400939	0.0211431	x	0.0472603	x	0.0455862	0.0205491	x	x	x	x	0.101665	0.015582	0.181588	0.155968	0.0796268	0.0142694	0.0267714	x	0.0332202	
-16121	None	Blood Chemistry: AMC Trait 137 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0110689	0.014787	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0146581	x	0.00864883	x	x	0.0	0.00812614	0.009525	0.0	x	x	x	0.00977236	0.0164509	x	x	x	x	0.00732106	0.00989558	0.0127585	0.0	0.0091981	0.0185039	x	0.0120528	0.0112503	0.00996268	0.00550909	x	0.0139582	x	0.01087	x	x	x	0.0092861	0.0105726	0.00722959	x	0.00540173	0.00888489	0.00747452	x	0.00712823	x	0.0077537	0.0134447	x	x	x	x	0.0112394	0.00561056	0.00851446	0.0	0.01301	0.0090556	0.0124766	x	0.00680093	
-16122	None	Blood Chemistry: AMC Trait 138 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0182263	0.034031	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.024999	x	0.0224853	x	x	0.0172478	0.0177309	0.0169504	0.0199026	x	x	x	0.0180435	0.0259137	x	x	x	x	0.0179435	0.0216853	0.0203549	0.0136115	0.0216065	0.0231291	x	0.0219731	0.0173376	0.0208421	0.0191327	x	0.0199762	x	0.0273042	x	x	x	0.0164979	0.0129519	0.0191606	x	0.0162013	0.0216748	0.0323337	x	0.0162764	x	0.0263328	0.0214137	x	x	x	x	0.0216267	0.0202475	0.0257087	0.0176741	0.021623	0.0233405	0.0176475	x	0.0167423	
-16123	None	Blood Chemistry: AMC Trait 139 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C4 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0412428	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0	x	0.0	x	x	0.0	0.0	0.04095	0.0	x	x	x	0.0	0.0	x	x	x	x	0.0403302	0.0404648	0.0457935	0.0550238	0.0470098	0.0	x	0.0426205	0.0	0.0461866	0.0	x	0.0	x	0.0514339	x	x	x	0.0396687	0.0	0.0433582	x	0.0493968	0.0471011	0.0	x	0.0	x	0.0	0.0452159	x	x	x	x	0.0333205	0.0422889	0.0438646	0.0	0.0364076	0.0506777	0.0441464	x	0.0	
-16124	None	Blood Chemistry: AMC Trait 140 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C5 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0145167	0.0143553	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0157836	x	0.0112427	x	x	0.0213907	0.0210642	0.0128864	0.0180843	x	x	x	0.0220379	0.0138117	x	x	x	x	0.0173985	0.0247004	0.0247874	0.00998076	0.0228627	0.0220226	x	0.0203278	0.0190842	0.0202574	0.0235909	x	0.0154122	x	0.0168439	x	x	x	0.0195597	0.0200316	0.0150682	x	0.0254626	0.0168589	0.0235328	x	0.0189441	x	0.0131857	0.0156595	x	x	x	x	0.015456	0.0263924	0.0180037	0.0156394	0.0173779	0.0146589	0.0181823	x	0.0162283	
-16125	None	Blood Chemistry: AMC Trait 141 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12:1-carnitine_ levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0136871	0.0207479	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0174751	x	0.0149696	x	x	0.0175084	0.0110978	0.0133091	0.0118169	x	x	x	0.0124099	0.0177338	x	x	x	x	0.025451	0.0230811	0.0183815	0.00868456	0.0215948	0.0147022	x	0.0195459	0.012334	0.0185883	0.00942955	x	0.0157552	x	0.0153901	x	x	x	0.0179771	0.0145002	0.00545477	x	0.0112812	0.0149573	0.00770531	x	0.0137543	x	0.00829175	0.0187477	x	x	x	x	0.0261177	0.0107579	0.0151163	0.00964259	0.0139977	0.00679834	0.0143016	x	0.0102599	
-16126	None	Blood Chemistry: AMC Trait 142 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0313663	0.0317395	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0500878	x	0.0269807	x	x	0.0201896	0.0315167	0.0273068	0.0267092	x	x	x	0.0180376	0.0365819	x	x	x	x	0.0315327	0.0425382	0.0279993	0.0177823	0.0316796	0.0368931	x	0.0423922	0.0326011	0.0324311	0.0300205	x	0.0342021	x	0.0496376	x	x	x	0.0357253	0.0252139	0.0323995	x	0.0250076	0.0354757	0.02459	x	0.0210232	x	0.0207846	0.031857	x	x	x	x	0.0421064	0.0242513	0.0383114	0.0319773	0.0302602	0.0229267	0.0344854	x	0.0223709	
-16127	None	Blood Chemistry: AMC Trait 143 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C6 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0124774	0.00788837	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0279575	x	0.00403695	x	x	0.0138375	0.0134161	0.00940227	0.0121273	x	x	x	0.0105179	0.0	x	x	x	x	0.0132808	0.0122602	0.0138439	0.0	0.00675356	0.0198043	x	0.0290318	0.0131695	0.0118241	0.0110932	x	0.0139657	x	0.0132929	x	x	x	0.00891989	0.0103796	0.00983451	x	0.0118569	0.00910861	0.0077202	x	0.0114992	x	0.00533989	0.0101381	x	x	x	x	0.0125899	0.010522	0.0212234	0.00967666	0.007296	0.00542628	0.022443	x	0.0116794	
-16128	None	Blood Chemistry: AMC Trait 144 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.00698441	0.0114456	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00957669	x	0.0056867	x	x	0.00562467	0.0076569	0.00619023	0.00906834	x	x	x	0.00399633	0.0117003	x	x	x	x	0.00942053	0.0108552	0.00580893	0.0	0.00644696	0.00978359	x	0.00624917	0.0	0.00922858	0.00702273	x	0.0048988	x	0.010636	x	x	x	0.0	0.00659675	0.00522993	x	0.00546429	0.0	0.0	x	0.00632377	x	0.0	0.0103955	x	x	x	x	0.00737163	0.00806016	0.00567951	0.00674044	0.00542113	0.00606274	0.00721187	x	0.0052055	
-16129	None	Blood Chemistry: AMC Trait 145 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C12hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0355658	0.0177488	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0286568	x	0.034099	x	x	0.0485413	0.027836	0.0263727	0.0514781	x	x	x	0.027842	0.0240165	x	x	x	x	0.0279026	0.0429751	0.0327592	0.0223757	0.0289864	0.0339557	x	0.0255516	0.0335111	0.0405236	0.023925	x	0.0319205	x	0.0657963	x	x	x	0.023333	0.0283991	0.0339406	x	0.0389118	0.0245293	0.0209048	x	0.0377843	x	0.0287005	0.0421043	x	x	x	x	0.0534884	0.0588934	0.0308308	0.0338342	0.0489749	0.0477477	0.0299805	x	0.0466677	
-16130	None	Blood Chemistry: AMC Trait 146 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0402376	0.0373783	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0373137	x	0.0423172	x	x	0.0289745	0.027848	0.030037	0.0264637	x	x	x	0.0271084	0.0437747	x	x	x	x	0.0360236	0.0355814	0.0414268	0.0317817	0.0321419	0.0428521	x	0.0382368	0.0398022	0.0333924	0.0227345	x	0.0382923	x	0.055179	x	x	x	0.0316873	0.0243132	0.0222136	x	0.0208721	0.0259516	0.0216952	x	0.0247313	x	0.0220607	0.0424405	x	x	x	x	0.0329337	0.0205717	0.0354506	0.0221374	0.0188977	0.0235776	0.0310051	x	0.0248977	
-16131	None	Blood Chemistry: AMC Trait 147 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0846289	0.113224	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.164818	x	0.0766422	x	x	0.101916	0.0961015	0.136023	0.0905317	x	x	x	0.0807144	0.176763	x	x	x	x	0.158564	0.166203	0.0729225	0.0767405	0.123631	0.117153	x	0.147779	0.124171	0.0827377	0.0914945	x	0.13453	x	0.16376	x	x	x	0.134045	0.0896238	0.132912	x	0.119569	0.0950776	0.0585883	x	0.0734786	x	0.0593219	0.108248	x	x	x	x	0.134139	0.107371	0.138732	0.133387	0.0840868	0.0563591	0.121911	x	0.0967386	
-16132	None	Blood Chemistry: AMC Trait 148 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.106046	0.112364	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.218971	x	0.0863078	x	x	0.0940103	0.10848	0.134017	0.11493	x	x	x	0.0691552	0.168258	x	x	x	x	0.129994	0.162355	0.0754288	0.0771739	0.104397	0.0908668	x	0.19992	0.129969	0.101588	0.0832473	x	0.121151	x	0.135229	x	x	x	0.126294	0.0900506	0.139236	x	0.0993821	0.114975	0.0698093	x	0.0710911	x	0.0595927	0.108606	x	x	x	x	0.157322	0.083315	0.127657	0.0994454	0.0986301	0.0653683	0.144077	x	0.0848935	
-16133	None	Blood Chemistry: AMC Trait 149 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C8 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.00399242	0.00922992	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0135871	x	0.0	x	x	0.00802732	0.00790487	0.0126414	0.00463115	x	x	x	0.0	0.00615896	x	x	x	x	0.00800217	0.00327597	0.0055389	0.0	0.0	0.00974856	x	0.0136836	0.0	0.0	0.0	x	0.00597267	x	0.0103435	x	x	x	0.0	0.0	0.00510728	x	0.0	0.00208739	0.011165	x	0.00490294	x	0.00250845	0.0	x	x	x	x	0.0143298	0.0	0.00970836	0.00600347	0.0	0.0	0.0103142	x	0.00428527	
-16134	None	Blood Chemistry: AMC Trait 150 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.018126	0.0166253	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0343784	x	0.021632	x	x	0.0179508	0.027753	0.0326104	0.0206589	x	x	x	0.016351	0.0349273	x	x	x	x	0.0239821	0.0401666	0.019925	0.0200184	0.0219285	0.0216057	x	0.0382	0.0253296	0.012708	0.0319261	x	0.0292313	x	0.0297697	x	x	x	0.0248713	0.0157577	0.0223887	x	0.0247725	0.0224413	0.0181011	x	0.011595	x	0.00706682	0.0201378	x	x	x	x	0.0296995	0.0196086	0.0148642	0.0146574	0.0219639	0.0163313	0.0256246	x	0.0314239	
-16135	None	Blood Chemistry: AMC Trait 151 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C14hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.00600542	0.00721481	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0116763	x	0.00877389	x	x	0.0	0.0132223	0.00543423	0.0	x	x	x	0.0	0.029593	x	x	x	x	0.00310995	0.0136917	0.0	0.0	0.0126305	0.0113087	x	0.0107041	0.00836521	0.00879577	0.0163425	x	0.00970686	x	0.0135014	x	x	x	0.0	0.011816	0.00624764	x	0.0106598	0.00707028	0.0	x	0.00890427	x	0.0	0.00804884	x	x	x	x	0.00784989	0.0	0.0153402	0.00524899	0.00970863	0.00821538	0.0	x	0.00985706	
-16136	None	Blood Chemistry: AMC Trait 152 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0118227	0.014485	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0315244	x	0.00759156	x	x	0.0124496	0.0123886	0.0146801	0.0185043	x	x	x	0.00731069	0.0231123	x	x	x	x	0.0231502	0.0251389	0.00951345	0.00887928	0.0168475	0.019847	x	0.0213162	0.0210079	0.0202178	0.0187711	x	0.0200135	x	0.0212749	x	x	x	0.0199594	0.0151765	0.0211628	x	0.0184332	0.0268714	0.00559464	x	0.00778909	x	0.00769145	0.0130435	x	x	x	x	0.020636	0.0180936	0.0262795	0.0148844	0.00778692	0.00881563	0.021978	x	0.0179134	
-16137	None	Blood Chemistry: AMC Trait 153 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.123713	0.0817125	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.197993	x	0.0762459	x	x	0.102087	0.109218	0.147052	0.119923	x	x	x	0.087062	0.124437	x	x	x	x	0.155119	0.186404	0.0690169	0.0718185	0.14307	0.111952	x	0.180333	0.129336	0.0767364	0.104228	x	0.133146	x	0.128661	x	x	x	0.152918	0.0939106	0.16288	x	0.128886	0.116008	0.0686237	x	0.0682704	x	0.0523354	0.137413	x	x	x	x	0.202639	0.127802	0.173998	0.157707	0.101153	0.058003	0.20244	x	0.111165	
-16138	None	Blood Chemistry: AMC Trait 154 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.350652	0.28779	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.624226	x	0.326737	x	x	0.350504	0.374508	0.479255	0.467804	x	x	x	0.298861	0.566991	x	x	x	x	0.34822	0.587857	0.328637	0.335978	0.419439	0.377556	x	0.673696	0.540218	0.30191	0.376181	x	0.464582	x	0.370695	x	x	x	0.473077	0.38091	0.531453	x	0.411413	0.433715	0.258307	x	0.280758	x	0.244527	0.438271	x	x	x	x	0.656193	0.369339	0.596511	0.431615	0.387962	0.286284	0.556644	x	0.398966	
-16139	None	Blood Chemistry: AMC Trait 155 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C10 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0362631	0.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0363786	x	0.0	x	x	0.0	0.0285339	0.0	0.0	x	x	x	0.0266885	0.0	x	x	x	x	0.0294357	0.0	0.026504	0.0	0.0286551	0.0	x	0.0361769	0.0401395	0.0	0.0	x	0.0	x	0.038523	x	x	x	0.0	0.0	0.0	x	0.0331761	0.0	0.0207243	x	0.0250335	x	0.0	0.0372249	x	x	x	x	0.0	0.0	0.032983	0.0447504	0.0266165	0.0	0.0	x	0.0	
-16140	None	Blood Chemistry: AMC Trait 156 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0179021	0.0187751	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0364193	x	0.020399	x	x	0.0213133	0.0208306	0.0335796	0.0281494	x	x	x	0.0195486	0.0440705	x	x	x	x	0.0185118	0.0370563	0.0180766	0.0223091	0.0216405	0.0214639	x	0.0435704	0.0315066	0.0260455	0.0244547	x	0.0385229	x	0.0229437	x	x	x	0.0252167	0.0321694	0.0372465	x	0.0264623	0.0227417	0.0191	x	0.0185459	x	0.0156338	0.0241725	x	x	x	x	0.0340499	0.0191108	0.0309428	0.0339411	0.0281709	0.0151848	0.0259195	x	0.0246583	
-16141	None	Blood Chemistry: AMC Trait 157 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C16hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0118115	0.00446113	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0341832	x	0.0175368	x	x	0.00915523	0.0141192	0.0143626	0.0178326	x	x	x	0.0117502	0.0248041	x	x	x	x	0.0122768	0.0161821	0.00748753	0.00726646	0.0164464	0.00889947	x	0.0211967	0.0223255	0.0	0.0184675	x	0.0154738	x	0.0138674	x	x	x	0.0141038	0.0118069	0.014488	x	0.0139939	0.0205829	0.00789579	x	0.0106078	x	0.0135307	0.0181964	x	x	x	x	0.0141294	0.0174768	0.0177885	0.0152087	0.0144261	0.0	0.0240068	x	0.0110228	
-16142	None	Blood Chemistry: AMC Trait 158 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0919621	0.0752439	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.162216	x	0.0720076	x	x	0.093723	0.107319	0.12491	0.139923	x	x	x	0.0812967	0.145053	x	x	x	x	0.133692	0.175074	0.0688498	0.0824984	0.115608	0.13786	x	0.160102	0.139982	0.108338	0.106336	x	0.127887	x	0.131353	x	x	x	0.127895	0.10817	0.154026	x	0.104041	0.123798	0.0607727	x	0.0787573	x	0.0575257	0.10968	x	x	x	x	0.157036	0.115141	0.167586	0.119443	0.0996522	0.079212	0.130491	x	0.117827	
-16143	None	Blood Chemistry: AMC Trait 159 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.490487	0.321136	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.805387	x	0.399724	x	x	0.4584	0.541026	0.73601	0.795305	x	x	x	0.419226	0.687822	x	x	x	x	0.642913	0.890122	0.345763	0.41275	0.662894	0.578201	x	0.83674	0.706342	0.437889	0.601249	x	0.616459	x	0.523043	x	x	x	0.710584	0.517598	0.890685	x	0.651099	0.584451	0.322814	x	0.340798	x	0.252019	0.572911	x	x	x	x	0.849673	0.580575	0.820445	0.790158	0.454716	0.38373	0.961703	x	0.53938	
-16144	None	Blood Chemistry: AMC Trait 160 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.160324	0.166444	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.185715	x	0.173166	x	x	0.166739	0.149529	0.158916	0.261468	x	x	x	0.140983	0.213927	x	x	x	x	0.149069	0.256306	0.168235	0.168918	0.176806	0.186367	x	0.247831	0.233374	0.172226	0.118816	x	0.137944	x	0.197137	x	x	x	0.14702	0.146679	0.195378	x	0.156472	0.176921	0.112117	x	0.166118	x	0.11265	0.163446	x	x	x	x	0.225059	0.169141	0.190028	0.18819	0.184612	0.146657	0.151227	x	0.146138	
-16145	None	Blood Chemistry: AMC Trait 161 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:2hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0	0.00390695	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0086759	x	0.00663381	x	x	0.00799646	0.00765055	0.00630567	0.0195436	x	x	x	0.00567368	0.0110477	x	x	x	x	0.0112432	0.0175823	0.00748753	0.00621704	0.0091715	0.0055078	x	0.0109064	0.0146728	0.0	0.0103132	x	0.0137391	x	0.00727286	x	x	x	0.00598781	0.00963628	0.00693263	x	0.00891607	0.0102305	0.00840363	x	0.0	x	0.0120864	0.0125425	x	x	x	x	0.00913022	0.0110704	0.0118428	0.0108741	0.016087	0.00870099	0.0103589	x	0.00400423	
-16146	None	Blood Chemistry: AMC Trait 162 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.017096	0.0194535	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0427534	x	0.0160506	x	x	0.0221752	0.0259802	0.0339054	0.0405194	x	x	x	0.0168473	0.0417685	x	x	x	x	0.0228982	0.0444313	0.0170845	0.0164274	0.0285317	0.0271844	x	0.0585598	0.037304	0.0254486	0.047965	x	0.0356902	x	0.0238589	x	x	x	0.0281992	0.0252033	0.030309	x	0.0323449	0.0286829	0.0218072	x	0.0129147	x	0.0105068	0.0240383	x	x	x	x	0.0412816	0.0216755	0.0388898	0.0357031	0.0219001	0.017813	0.0499442	x	0.0330685	
-16147	None	Blood Chemistry: AMC Trait 163 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: C18hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.0154838	0.0116568	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0199294	x	0.0141791	x	x	0.008703	0.0234898	0.0100597	0.011133	x	x	x	0.00657189	0.0171401	x	x	x	x	0.0126381	0.0121633	0.0	0.0111133	0.00796605	0.00929848	x	0.0163872	0.0197957	0.016897	0.0187543	x	0.00812719	x	0.0152455	x	x	x	0.00900657	0.00395078	0.021046	x	0.011692	0.015815	0.0118838	x	0.0135896	x	0.0112199	0.00791733	x	x	x	x	0.0214947	0.00874488	0.011425	0.024029	0.0162041	0.0124593	0.0112526	x	0.0089515	
-16148	None	Blood Chemistry: AMC Trait 164 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Total amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	3199.0	3244.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2215.0	x	2901.0	x	x	2726.0	3347.0	2075.0	2414.0	x	x	x	2906.0	2980.0	x	x	x	x	2919.0	2876.0	4558.0	3361.0	3842.0	2714.0	x	2269.0	2833.0	3121.0	2630.0	x	2790.0	x	3819.0	x	x	x	2523.0	2522.0	2418.0	x	2889.0	3895.0	3933.0	x	3965.0	x	3494.0	2694.0	x	x	x	x	2300.0	2744.0	3036.0	2436.0	2729.0	3391.0	2081.0	x	3033.0	
-16149	None	Blood Chemistry: AMC Trait 165 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Total branched chain amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	628.0	637.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	418.0	x	523.0	x	x	492.0	540.0	417.0	422.0	x	x	x	479.0	464.0	x	x	x	x	485.0	402.0	871.0	593.0	627.0	413.0	x	449.0	509.0	544.0	479.0	x	486.0	x	680.0	x	x	x	597.0	467.0	466.0	x	474.0	571.0	669.0	x	710.0	x	547.0	455.0	x	x	x	x	426.0	442.0	586.0	469.0	479.0	631.0	534.0	x	588.0	
-16150	None	Blood Chemistry: AMC Trait 166 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Total AA levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.196311	0.196363	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.188713	x	0.180283	x	x	0.180484	0.161339	0.200964	0.174814	x	x	x	0.164831	0.155705	x	x	x	x	0.166153	0.139777	0.191093	0.176436	0.163196	0.152174	x	0.197885	0.179668	0.174303	0.182129	x	0.174194	x	0.178057	x	x	x	0.236623	0.185171	0.192721	x	0.164071	0.146598	0.170099	x	0.179067	x	0.156554	0.168894	x	x	x	x	0.185217	0.161079	0.193017	0.192529	0.175522	0.186081	0.256607	x	0.193867	
-16151	None	Blood Chemistry: AMC Trait 167 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Gln levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	1.11545	1.09828	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.945701	x	0.975746	x	x	0.957198	0.851735	0.874214	0.800759	x	x	x	0.773829	0.870544	x	x	x	x	0.77476	0.733577	1.6011	0.981788	0.975117	0.638331	x	0.9182	0.897707	1.10345	1.08371	x	0.964286	x	1.18261	x	x	x	1.2542	0.962887	0.715822	x	1.08716	0.900631	1.115	x	1.36276	x	1.19694	0.818345	x	x	x	x	0.972603	0.72459	1.15582	0.848101	0.919386	1.16636	1.15086	x	1.08889	
-16152	None	Blood Chemistry: AMC Trait 168 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/Ala levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	1.0346	1.10976	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.51449	x	0.944043	x	x	0.880143	0.668317	1.53309	1.12834	x	x	x	0.907197	0.766942	x	x	x	x	0.858407	0.562238	0.865805	0.759283	0.723183	0.814596	x	1.52721	0.994141	0.729223	0.926499	x	0.835052	x	0.73197	x	x	x	1.65833	1.0043	1.47003	x	0.585185	0.506206	0.574249	x	0.788889	x	0.601099	0.924797	x	x	x	x	1.4589	0.746622	1.25751	1.22454	0.877289	0.953172	2.35242	x	0.984925	
-16153	None	Blood Chemistry: AMC Trait 169 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of BCAA/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	1548.66	724.565	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1681.43	x	835.264	x	x	1074.52	931.216	1272.03	1396.27	x	x	x	1423.91	1114.57	x	x	x	x	758.216	1073.69	923.747	1671.5	1224.56	1242.6	x	1773.43	1241.21	1099.73	1353.43	x	778.887	x	878.475	x	x	x	1478.18	1262.9	2541.18	x	1246.9	1595.62	978.895	x	1604.04	x	1396.2	949.314	x	x	x	x	1018.27	1211.01	1586.29	1456.53	1200.23	1798.72	1956.42	x	1316.51	
-16154	None	Blood Chemistry: AMC Trait 170 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Val/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	641.166	317.353	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	679.812	x	359.339	x	x	449.899	367.313	478.918	516.158	x	x	x	558.863	432.376	x	x	x	x	284.526	381.935	386.043	665.219	527.321	472.37	x	710.954	453.566	477.09	553.803	x	302.901	x	386.271	x	x	x	591.768	486.771	1019.74	x	481.398	673.457	434.577	x	729.726	x	653.43	394.33	x	x	x	x	461.328	512.351	674.038	611.806	511.163	823.818	795.023	x	535.114	
-16155	None	Blood Chemistry: AMC Trait 171 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Ile/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	458.68	204.744	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	490.752	x	242.754	x	x	321.044	286.263	405.708	440.058	x	x	x	428.065	343.498	x	x	x	x	239.19	336.53	274.685	515.826	298.815	321.934	x	470.019	329.201	266.847	361.667	x	205.139	x	218.327	x	x	x	366.45	335.331	703.46	x	339.346	396.809	234.115	x	384.066	x	319.058	229.504	x	x	x	x	239.03	293.164	387.098	363.357	295.673	419.035	512.918	x	338.084	
-16156	None	Blood Chemistry: AMC Trait 172 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C0/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	2.70897	2.35716	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.09655	x	2.47337	x	x	2.19001	2.11995	1.70967	1.90431	x	x	x	2.22378	1.85881	x	x	x	x	2.21457	1.95036	1.84142	2.27026	2.31201	1.67226	x	1.22552	2.00753	2.46022	1.86799	x	1.73676	x	2.99841	x	x	x	1.31527	1.67945	1.13422	x	2.03311	2.18278	1.98224	x	2.25379	x	2.49415	1.92859	x	x	x	x	1.27061	1.90288	1.36865	2.07664	2.01024	2.76741	0.885751	x	1.68472	
-16157	None	Blood Chemistry: AMC Trait 173 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C18/C18:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.326866	0.518298	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.230591	x	0.433214	x	x	0.363742	0.27638	0.215916	0.328765	x	x	x	0.336293	0.311022	x	x	x	x	0.231865	0.287944	0.48656	0.40925	0.266718	0.322322	x	0.296186	0.330398	0.393309	0.197616	x	0.223769	x	0.376904	x	x	x	0.206901	0.283383	0.219358	x	0.24032	0.302714	0.347311	x	0.487437	x	0.446991	0.28529	x	x	x	x	0.264878	0.291333	0.231616	0.238167	0.405994	0.382187	0.157249	x	0.270938	
-16158	None	Blood Chemistry: AMC Trait 174 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C18:2/C18:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.187491	0.234305	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.201413	x	0.180143	x	x	0.204457	0.198362	0.169713	0.175936	x	x	x	0.193921	0.210887	x	x	x	x	0.207947	0.196686	0.199124	0.199875	0.174399	0.23843	x	0.19134	0.198179	0.24741	0.176858	x	0.207454	x	0.251132	x	x	x	0.179986	0.208984	0.17293	x	0.159792	0.211819	0.188259	x	0.231097	x	0.228259	0.191443	x	x	x	x	0.184819	0.198322	0.204263	0.151163	0.219152	0.206426	0.135688	x	0.218448	
-16159	None	Blood Chemistry: AMC Trait 175 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C16:2/C16:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.0955656	0.177268	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.15922	x	0.0995668	x	x	0.121951	0.11343	0.0998295	0.154301	x	x	x	0.0839711	0.185736	x	x	x	x	0.149242	0.134862	0.137842	0.123635	0.117757	0.17728	x	0.118205	0.162429	0.263471	0.180097	x	0.150312	x	0.165356	x	x	x	0.130523	0.161605	0.129928	x	0.143019	0.231634	0.0815263	x	0.114092	x	0.146964	0.0949219	x	x	x	x	0.101836	0.141575	0.151033	0.0943797	0.0769814	0.151986	0.108565	x	0.161142	
-16160	None	Blood Chemistry: AMC Trait 176 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C16/C16:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	2.83439	3.52198	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	3.15277	x	4.2853	x	x	3.4334	3.42899	3.25909	3.90087	x	x	x	3.43274	4.55646	x	x	x	x	2.24485	3.15367	4.76169	4.67816	2.9317	3.37247	x	3.73585	4.17685	3.93438	3.60922	x	3.48926	x	2.88117	x	x	x	3.09366	4.05609	3.26284	x	3.19206	3.73867	3.76411	x	4.11244	x	4.6723	3.18945	x	x	x	x	3.23823	2.88992	3.42825	2.73681	3.83539	4.93567	2.74967	x	3.58895	
-16161	None	Blood Chemistry: AMC Trait 177 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14/C14:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	1.25308	0.992405	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.32856	x	1.12611	x	x	0.922426	1.1288	0.985258	1.26949	x	x	x	0.856788	0.951883	x	x	x	x	0.81982	0.976849	1.03437	1.00565	0.844426	0.775626	x	1.35283	1.04669	1.22783	0.909862	x	0.900549	x	0.825773	x	x	x	0.942175	1.00476	1.04758	x	0.831169	1.20928	1.19152	x	0.967508	x	1.00456	1.00331	x	x	x	x	1.17283	0.775952	0.920168	0.745543	1.17296	1.15985	1.18182	x	0.877555	
-16162	None	Blood Chemistry: AMC Trait 178 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14:2/C14:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.47546	0.330127	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.226394	x	0.55214	x	x	0.284297	0.289777	0.220823	0.292314	x	x	x	0.335856	0.247646	x	x	x	x	0.227186	0.214084	0.568094	0.414145	0.259983	0.365779	x	0.258743	0.320543	0.403594	0.248479	x	0.284636	x	0.336949	x	x	x	0.236392	0.271281	0.16713	x	0.174561	0.272952	0.3703	x	0.336578	x	0.371881	0.392066	x	x	x	x	0.245519	0.191594	0.255532	0.165964	0.22474	0.418346	0.254326	x	0.25737	
-16163	None	Blood Chemistry: AMC Trait 179 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of total long chain amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	1.44805	1.19529	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.39664	x	1.25315	x	x	1.39635	1.51403	1.94622	2.01635	x	x	x	1.20441	2.12702	x	x	x	x	1.7536	2.4599	1.17028	1.25766	1.77799	1.64281	x	2.48464	2.04319	1.31482	1.50429	x	1.77399	x	1.70506	x	x	x	1.90352	1.45125	2.22878	x	1.69173	1.6709	0.972728	x	1.104	x	0.860033	1.68101	x	x	x	x	2.415	1.57326	2.25041	1.94208	1.42971	1.09919	2.2995	x	1.52001	
-16164	None	Blood Chemistry: AMC Trait 180 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of total LCAC/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.0836901	0.0489779	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0968271	x	0.0619018	x	x	0.083566	0.0806959	0.153939	0.159737	x	x	x	0.0816759	0.111835	x	x	x	x	0.0772396	0.146918	0.0505899	0.0883197	0.100368	0.100959	x	0.120646	0.107704	0.0810848	0.0977474	x	0.0864452	x	0.0624104	x	x	x	0.0944532	0.0842997	0.0944992	x	0.112424	0.0779068	0.0472023	x	0.06547	x	0.0566395	0.0802696	x	x	x	x	0.147149	0.0881863	0.114134	0.0971008	0.0793491	0.0789527	0.103602	x	0.0909507	
-16165	None	Blood Chemistry: AMC Trait 181 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of total LCAC/C0 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.0308937	0.0207784	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0883012	x	0.0250273	x	x	0.0381579	0.038065	0.0900404	0.0838818	x	x	x	0.0367284	0.060165	x	x	x	x	0.034878	0.0753286	0.0274734	0.0389029	0.0434115	0.0603729	x	0.0984447	0.05365	0.0329583	0.0523276	x	0.0497738	x	0.0208145	x	x	x	0.071813	0.0501949	0.0833166	x	0.0552967	0.0356915	0.0238126	x	0.0290488	x	0.0227089	0.0416208	x	x	x	x	0.115809	0.0463436	0.0833916	0.0467587	0.0394725	0.0285295	0.116966	x	0.0539856	
-16166	None	Blood Chemistry: AMC Trait 182 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of C14:1/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.00489113	0.00463944	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00665884	x	0.0037859	x	x	0.00609927	0.00512209	0.0107589	0.007172	x	x	x	0.00547358	0.00929387	x	x	x	x	0.0069842	0.0099265	0.00315236	0.00538914	0.00697898	0.00719967	x	0.00717568	0.00654549	0.00510243	0.00594524	x	0.00655556	x	0.00599414	x	x	x	0.00665137	0.00520602	0.00563539	x	0.00794596	0.00443306	0.00284304	x	0.00435745	x	0.00390679	0.00516893	x	x	x	x	0.00817327	0.00601852	0.00703607	0.0066691	0.00466683	0.00404816	0.00549262	x	0.00578843	
-16167	None	Blood Chemistry: AMC Trait 194 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of a-NH2-adipate/Lys levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.010559	0.0017192	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.00301205	x	0.00239726	x	x	0.00808511	0.00453172	0.01125	0.00307692	x	x	x	0.0012987	0.00586207	x	x	x	x	0.00196078	0.00203046	0.00582192	0.00185874	0.00511364	0.0125714	x	0.00745342	0.0042654	0.00163934	0.00319635	x	0.00614035	x	0.0012158	x	x	x	0.00634921	0.00153061	0.0020979	x	0.00146341	0.00507463	0.00569395	x	0.00851064	x	0.00430107	0.00696517	x	x	x	x	0.00562771	0.00780488	0.00443548	0.00140845	0.00486726	0.00237389	0.0088	x	0.00164609	
-16168	None	Blood Chemistry: AMC Trait 198 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Kynurenine/Trp levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks	x	x	0.0051282	0.00333333	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0084507	x	0.00454545	x	x	0.00574713	0.00540541	0.00898876	0.00206186	x	x	x	0.00493827	0.00588235	x	x	x	x	0.00533333	0.00735294	0.00447761	0.00705882	0.00444444	0.00531915	x	x	0.00731707	0.0027027	0.00490196	x	0.00895522	x	0.00526316	x	x	x	0.00657895	x	0.00506329	x	0.00481928	0.00571429	0.00897436	x	0.00588235	x	0.0078125	0.00609756	x	x	x	x	0.00909091	0.00350877	0.00625	0.00645161	0.0104651	0.00597015	0.00704225	x	x	
-16169	None	Blood Chemistry: AMC Trait 199 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Kynurenine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	0.5	0.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.6	0.4	0.4	x	x	0.6	0.7	0.8	0.4	x	x	x	0.4	0.1	x	x	x	0.5	0.4	0.6	0.7	1.1	0.5	0.5	x	1.0	0.3	0.7	0.8	x	1.4	x	0.5	x	x	x	0.4	1.3	0.4	x	0.6	x	0.8	x	0.6	x	0.5	0.6	x	0.6	x	x	0.7	0.7	x	0.6	0.8	0.5	0.5	x	1.9	
-16170	None	Blood Chemistry: AMC Trait 195 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Anthranilic acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.3	5.1	3.4	221.3	x	6.0	9.3	9.8	7.7	x	11.7	x	6.0	x	x	x	14.1	7.8	27.5	x	4.8	3.5	50.1	x	4.0	x	4.5	30.0	x	3.5	x	x	6.5	3.8	x	3.4	3.9	5.6	3.5	x	3.6	
-16171	None	Blood Chemistry: AMC Trait 191 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: a-NH2-adipate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml]	x	x	2.8	0.4	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.6	1.3	0.4	x	x	1.6	1.7	1.4	0.6	x	x	x	0.4	1.6	x	x	x	0.4	0.4	0.5	3.0	0.6	1.2	2.1	x	1.3	1.0	0.3	1.0	x	1.3	x	0.3	x	x	x	1.4	0.3	0.4	x	0.3	1.3	1.0	x	1.4	x	1.6	1.2	x	0.7	x	x	2.9	1.5	x	0.2	1.6	0.4	1.5	x	0.3	
-16172	None	Blood Chemistry: AMC Trait 200 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Kynurenine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	0.4	0.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.6	x	0.3	x	x	0.5	0.4	0.8	0.2	x	x	x	0.4	0.5	x	x	x	x	0.4	0.5	0.3	0.6	0.4	0.5	x	1.0	0.6	0.2	0.5	x	0.6	x	0.4	x	x	x	0.5	x	0.4	x	0.4	0.4	0.7	x	0.4	x	0.5	0.5	x	x	x	x	0.7	0.2	0.7	0.6	0.9	0.4	0.5	x	x	
-16173	None	Blood Chemistry: AMC Trait 196 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Anthranilic acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	4.1	x	x	8.3	8.9	7.7	x	x	6.6	x	5.5	x	x	x	4.2	6.8	4.4	x	4.6	3.7	4.1	x	6.2	x	4.2	3.6	x	x	x	x	3.2	3.1	4.1	4.4	3.4	3.2	3.2	x	3.3	
-16174	None	Blood Chemistry: AMC Trait 193 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: a-NH2-adipate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml]	x	x	3.4	0.6	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.5	x	0.7	x	x	1.9	1.5	1.8	0.6	x	x	x	0.4	1.7	x	x	x	x	0.5	0.4	3.4	0.5	1.8	2.2	x	1.2	0.9	0.4	0.7	x	1.4	x	0.4	x	x	x	1.2	0.3	0.3	x	0.3	1.7	1.6	x	3.6	x	1.6	1.4	x	x	x	x	1.3	1.6	1.1	0.2	1.1	0.8	1.1	x	0.4	
-16175	None	Blood Chemistry: AMC Trait 192 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of a-NH2-adipate/Lys levels in pooled plasma of young adult males on a normal chow diet	x	x	0.00945946	0.00164609	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0031579	0.00666667	0.00164609	x	x	0.00903955	0.00696721	0.0071066	0.00267857	x	x	x	0.00155039	0.00620155	x	x	x	0.00191388	0.00168067	0.00274725	0.00996678	0.0026087	0.00497925	0.0117978	x	0.00670103	0.00396825	0.00175439	0.00369004	x	0.00451389	x	0.00127119	x	x	x	0.00530303	0.00147783	0.00227273	x	0.0012987	0.0053719	0.00377358	x	0.00487805	x	0.00603774	0.00521739	x	0.00334928	x	x	0.011284	0.00797872	x	0.00107527	0.00686695	0.00240964	0.00625	x	0.00123457	
-16176	None	Blood Chemistry: AMC Trait 197 contact <s.m.houten@amc.uva.nl>	Blood chemistry, metabolism: Ratio of Kynurenine/Trp levels in pooled plasma of young adult males on a normal chow diet	x	x	0.00666667	0.00307692	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.0105263	0.00416667	0.00571429	x	x	0.008	0.00985915	0.0101266	0.00519481	x	x	x	0.00533333	0.00151515	x	x	x	0.00515464	0.005	0.00789474	0.0116667	0.0166667	0.00595238	0.00666667	x	0.0185185	0.0046875	0.0111111	0.0109589	x	0.0179487	x	0.00735294	x	x	x	0.0057971	0.0183099	0.00784314	x	0.00731707	0.283673	0.0114286	x	0.00895522	x	0.00632911	0.00833333	x	0.00722892	x	x	0.0142857	0.0107692	x	0.00731707	0.0131148	0.00641026	0.00769231	x	0.025	
-16177	Original post publication description: un-named trait Original pre publication description: CA1 Apoptosis; Post-natal	CA1 Apoptosis; Post-natal	CA1 Apoptosis; Post-natal	x	x	3.031	2.416	5.796	4.627	x	x	x	x	x	x	x	x	x	x	x	x	1.958	x	x	x	x	x	x	x	x	x	x	x	2.384	x	x	x	x	x	x	2.512	x	x	x	x	x	x	x	x	x	x	x	3.152	x	x	x	x	x	x	x	x	2.082	x	x	x	x	x	x	x	x	x	x	1.996	x	3.364	x	x	x	x	x	x	2.531	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	5.871	x	x	x	5.831	x	x	3.722	
-16178	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)	x	x	563.251	422.833	x	839.028	x	x	x	x	x	x	x	x	x	x	x	x	1326.91	x	x	x	x	x	x	x	x	x	x	x	241.722	x	x	x	x	x	x	201.027	x	x	x	x	x	x	x	x	x	x	x	532.259	x	x	x	x	x	x	x	x	718.987	x	x	x	x	x	x	x	x	x	x	x	x	158.266	x	x	x	x	x	x	458.418	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	368.717	x	x	x	292.349	x	x	414.908	
-16179	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)	x	x	365.258	762.053	x	937.825	x	x	x	x	x	x	x	x	x	x	x	x	1340.81	x	x	x	x	x	x	x	x	x	x	x	758.416	x	x	x	x	x	x	515.469	x	x	x	x	x	x	x	x	x	x	x	984.566	x	x	x	x	x	x	x	x	387.084	x	x	x	x	x	x	x	x	x	x	x	x	1247.85	x	x	x	x	x	x	2368.67	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	473.854	x	x	x	129.146	x	x	1392.14	
-16180	None	Trait_1_GENEX_CB_BXD	Pharmacology, metabolism: Ethanol response (4.0 g/kg ethanol in saline, IP), blood alcohol concentration (BAC) 1 hour after injection, male and females average (associated with GenEx EtOH cerebellum gene expression data) [mg/dl]	x	507.92	423.133	442.267	435.167	477.914	x	507.533	x	x	x	535.971	x	x	x	549.117	x	x	502.9	x	x	x	x	x	x	x	x	x	x	432.867	594.967	x	539.033	x	473.933	x	417.35	610.733	460.733	x	400.425	531.833	545.622	490.8	x	x	528.0	577.467	538.967	476.667	x	x	x	616.625	491.633	x	x	x	594.067	515.233	409.767	444.814	558.033	469.167	491.467	484.3	583.2	571.267	513.367	525.0	x	502.467	479.4	528.333	x	566.6	x	451.033	473.7	631.733	x	472.933	496.486	478.08	506.3	478.833	x	430.233	604.533	x	x	x	x	460.225	545.15	580.925	459.567	544.229	495.967	487.471	501.067	543.057	
-16181	None	Trait_2_GENEX_CB_BXD	Blood alcohol concentration at 2hr [mg/dl]	x	353.4	365.1	365.567	383.933	424.44	x	437.86	x	x	x	449.114	x	x	x	619.76	x	x	452.8	x	x	x	x	x	x	x	x	x	x	385.917	530.3	x	478.133	x	412.933	x	363.8	463.533	395.467	x	340.5	471.267	573.822	399.733	x	x	496.8	524.533	464.533	414.8	x	x	x	476.88	360.933	x	x	x	543.267	455.5	297.9	403.017	561.767	426.92	424.833	365.0	441.486	500.067	452.5	459.3	x	420.367	433.933	451.433	x	608.933	x	334.733	376.433	387.444	x	402.4	448.425	397.1	388.0	414.467	x	321.167	285.9	x	x	x	x	372.12	371.525	612.25	412.033	467.433	429.067	500.9	382.8	499.257	
-16182	None	Trait_3_GENEX_CB_BXD	Pharmacology, toxicology: Alcohol response (6 mg/kg ip), blood alcohol concentration (BAC) 3 hr after injection of [mg/dl]	x	253.433	318.467	355.7	304.5	345.171	x	364.25	x	x	x	347.714	x	x	x	574.367	x	x	366.1	x	x	x	x	x	x	x	x	x	x	318.267	450.567	x	436.533	x	267.85	x	294.683	435.911	315.3	x	273.862	403.033	451.622	335.2	x	x	382.8	417.833	389.867	304.667	x	x	x	274.556	221.7	x	x	x	496.633	398.5	355.633	315.714	426.567	330.733	297.9	279.2	355.686	455.433	374.667	346.914	x	367.8	362.267	362.267	x	469.567	x	249.533	301.967	294.067	x	320.6	365.375	334.5	410.2	324.6	x	333.033	194.8	x	x	x	x	317.675	290.6	485.971	339.0	387.114	346.433	382.814	417.933	384.933	
-16183	None	Trait_4_GENEX_CB_BXD	Blood alcohol concentration at 7hr [mg/dl]	x	93.5667	94.7667	74.9333	36.5667	48.2	x	88.1667	x	x	x	76.2286	x	x	x	39.1333	x	x	65.4	x	x	x	x	x	x	x	x	x	x	29.2833	102.5	x	202.533	x	9.91667	x	70.7	156.489	49.7667	x	13.9625	169.767	81.3333	83.5333	x	x	38.0	59.6667	48.0667	83.4	x	x	x	34.72	64.0333	x	x	x	223.567	105.6	71.1	41.7429	89.6667	36.9667	50.2333	72.1667	77.1714	231.067	126.467	66.4571	x	66.0333	92.4667	43.5667	x	150.0	x	75.7	49.4	43.3778	x	67.8	58.35	22.9667	105.767	59.5	x	42.1	36.6	x	x	x	x	34.95	43.725	139.457	65.4333	15.3333	137.2	79.4667	151.267	75.8	
-16184	None	Trait_5_GENEX_CB_BXD	Blood alcohol concentration maximum [mg/dl]	x	507.92	423.133	442.267	435.167	477.914	x	507.533	x	x	x	535.971	x	x	x	619.76	x	x	502.9	x	x	x	x	x	x	x	x	x	x	432.867	594.967	x	539.033	x	473.933	x	417.35	610.733	460.733	x	400.425	531.833	573.822	490.8	x	x	528.0	577.467	538.967	476.667	x	x	x	616.625	491.633	x	x	x	594.067	515.233	409.767	444.814	561.767	469.167	491.467	484.3	583.2	571.267	513.367	525.0	x	502.467	479.4	528.333	x	608.933	x	451.033	473.7	631.733	x	472.933	496.486	478.08	506.3	478.833	x	430.233	604.533	x	x	x	x	460.225	545.15	612.25	459.567	544.229	495.967	500.9	501.067	543.057	
-16185	Original post publication description: Infectious disease, immune system: Herpes simplex virus Type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality] Original pre publication description: Infectious disease, immune system: Herpes simplex virus Type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality]	Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality]	Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality]	x	x	0.0	100.0	x	x	x	x	x	x	x	31.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	100.0	x	70.0	x	x	x	x	x	x	x	x	x	x	x	x	x	100.0	13.0	x	10.0	x	x	x	0.0	19.0	x	x	x	x	7.0	0.0	x	90.0	x	89.0	x	x	0.0	0.0	20.0	x	75.0	x	0.0	70.0	x	x	x	x	49.0	x	0.0	44.0	x	72.0	46.0	x	0.0	20.0	x	x	x	x	0.0	65.0	x	12.0	25.0	36.0	26.0	0.0	94.0	
-16186	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions]	Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions]	Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions]	x	x	0.01	4.0	x	x	x	x	x	x	x	4.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.25	x	4.5	x	x	x	x	x	x	x	x	x	x	x	x	x	4.5	2.9	x	3.75	x	x	x	3.6	4.35	x	x	x	x	2.05	0.5	x	x	x	x	x	x	0.95	0.1	x	x	x	x	1.75	x	x	x	x	x	x	x	1.8	2.75	x	4.0	4.5	x	0.01	2.65	x	x	x	x	2.6	4.75	2.5	3.25	4.2	3.05	x	4.0	4.4	
-16187	Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells] Original pre publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells]	Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells]	Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells]	x	x	x	x	12.45	3.9	x	40.7	56.06	31.02	1.88	x	15.41	27.39	32.26	38.39	25.4	61.32	12.48	13.48	x	x	x	9.26	x	29.56	27.17	48.18	x	35.01	8.57	25.43	21.41	x	x	x	8.47	30.26	21.2	x	27.97	20.87	30.17	20.07	x	x	24.79	x	-1.05	5.63	x	x	x	12.64	19.26	x	x	x	21.84	18.69	25.74	31.58	x	43.75	26.81	15.36	46.06	x	x	44.6	x	18.14	x	22.65	x	47.93	x	x	34.17	x	x	13.2	30.81	26.9	25.21	21.58	x	13.66	43.12	x	40.6	x	x	x	13.74	24.32	26.82	31.5	1.97	x	x	x	
-16188	Original post publication description: Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio]	x	10.16	9.55	x	x	12.57	8.93	11.49	x	9.49	9.9	11.36	x	10.69	x	x	9.98	x	12.0	x	10.36	x	x	x	x	x	10.43	x	x	8.6	x	x	10.88	x	x	x	x	10.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16189	Original post publication description: Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	x	6.91	7.45	x	x	6.56	5.44	8.05	x	6.48	7.67	7.76	x	7.39	x	x	7.38	x	7.94	x	7.05	x	x	x	x	x	8.31	x	x	6.25	x	x	7.75	x	x	x	x	7.46	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16190	Original post publication description: Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]	x	0.01	0.009	x	x	0.0138	0.01	0.011	x	0.01	0.009	0.011	x	0.01	x	x	0.009	x	0.011	x	0.01	x	x	x	x	x	0.008	x	x	0.008	x	x	0.01	x	x	x	x	0.009	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16191	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult female Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult female	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g]	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g]	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.095	x	0.102	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.243	x	0.148	x	x	x	x	0.142	x	x	x	x	x	0.064	x	x	x	x	x	x	0.084	0.124	x	x	x	x	0.082	x	0.201	x	x	x	x	x	x	0.14	x	x	0.9	x	0.107	0.115	x	x	x	x	0.118	x	0.096	0.134	x	0.18	0.138	0.127	x	
-16192	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult Male.	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g]	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g]	x	x	x	x	x	x	x	x	x	x	x	0.099	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.188	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.188	x	0.111	x	x	x	x	0.129	x	x	x	x	x	0.079	x	x	x	x	x	x	0.068	0.143	x	x	0.102	x	0.076	x	0.286	x	x	x	0.124	x	x	0.197	x	x	0.064	x	0.09	0.13	x	x	x	x	0.099	x	0.103	0.105	x	0.138	0.109	0.132	x	
-16193	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male and female combined. Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male and female combined.	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g]	Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g]	x	x	x	x	x	x	x	x	x	x	x	0.099	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	0.142	x	x	0.102	x	x	x	x	x	x	x	x	x	x	x	x	x	0.215	x	0.13	x	x	x	x	0.136	x	x	x	x	x	0.071	x	x	x	x	x	x	0.076	0.133	x	x	0.102	x	0.079	x	0.243	x	x	x	0.124	x	x	0.169	x	x	0.482	x	0.099	0.122	x	x	x	x	0.108	x	0.099	0.12	x	0.159	0.124	0.13	x	
-16194	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [percent maximum weight loss] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [percent maximum weight loss]	Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %]	Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %]	x	x	x	x	x	x	x	x	x	x	x	23.37	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.06	x	26.78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	19.67	x	19.38	x	x	x	11.17	15.55	x	x	x	x	3.57	5.54	x	36.32	x	39.31	x	x	6.63	14.34	31.52	x	28.87	x	10.2	x	33.68	x	x	x	x	x	10.32	x	x	x	17.7	x	30.27	x	x	x	x	x	14.78	30.56	18.94	20.51	16.79	22.29	14.5	25.48	32.57	
-16195	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male [percent maximum weight loss] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male [percent maximum weight loss]	Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %]	Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %]	x	x	x	x	x	x	x	x	x	x	x	26.35	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	33.85	x	25.22	x	x	x	x	x	x	x	x	x	x	x	x	x	31.91	9.3	x	28.14	x	x	x	24.26	26.39	x	x	x	x	9.39	8.05	x	34.51	x	38.04	x	x	14.12	18.65	28.2	x	28.85	x	20.81	x	36.37	x	x	x	16.12	x	5.05	x	x	x	30.71	x	27.31	x	x	x	x	x	x	33.07	19.18	9.84	24.53	21.27	15.24	24.8	30.51	
-16196	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [percent maximum weight loss combined] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [percent maximum weight loss combined]	Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %]	Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %]	x	x	6.4	32.2	x	x	x	x	x	x	x	25.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	34.21	x	26.0	x	x	x	x	x	x	x	x	x	x	x	x	x	25.79	9.3	x	23.76	x	x	x	17.72	20.97	x	x	x	x	6.48	6.7	x	35.42	x	38.74	x	x	9.96	16.57	29.86	x	28.9	x	13.74	x	34.87	x	x	x	16.12	x	7.68	x	x	x	23.48	x	28.96	x	x	x	x	x	14.78	31.74	19.13	14.86	20.66	21.47	14.83	25.13	31.54	
-16197	Original post publication description: Central nervous system, pharmacology, behavior: Difference in nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4) and saline response (0.9%, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec] Original pre publication description: Nic-Sal Pref	Nic-Sal Pref	Central nervous system, pharmacology, behavior: Difference in nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4) and saline response (0.9%, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec]	x	x	49.57	-120.05	25.77	-25.3	33.17	x	-81.39	-66.36	-58.16	29.39	x	16.39	6.47	90.65	51.2	x	-56.87	-22.66	x	x	x	x	x	88.3	21.59	x	x	-105.38	-237.41	1.59	-50.2	x	-50.62	x	-22.64	11.29	x	x	16.2	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16198	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in untreated brainstem at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in untreated brainstem at E9 (TUNEL+ cells/mm2)	x	x	533.355	x	x	1799.3	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	898.985	x	x	x	x	x	x	713.637	x	x	x	x	x	x	x	x	x	x	x	1214.31	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	222.913	x	188.897	x	x	x	x	x	x	549.402	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1178.27	x	x	x	x	x	x	299.504	
-16199	Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in untreated forebrain at E9 (TUNEL+ cells/mm2)	None	Central nervous system; embryonic neurogenesis; Cell death in untreated forebrain at E9 (TUNEL+ cells/mm2)	x	x	498.093	x	x	1308.47	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	659.24	x	x	x	x	x	x	400.988	x	x	x	x	x	x	x	x	x	x	x	1420.07	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1134.83	x	763.449	x	x	x	x	x	x	1106.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	743.16	x	x	x	x	x	x	380.748	
-16200	Central nervous system, behavior: Touchscreen, discrimination, habituation [sessions]	Central nervous system, behavior: Touchscreen, discrimination, habituation [sessions]	None	x	x	1.0	1.0	x	x	x	x	x	1.0	x	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	2.0	x	1.0	x	x	1.0	x	1.0	x	x	x	x	1.0	2.0	x	x	1.0	x	x	x	x	1.0	x	x	x	x	x	x	1.0	x	x	x	x	1.0	1.0	1.0	x	x	x	x	x	x	1.0	x	x	x	1.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	1.0	x	x	x	x	x	x	x	1.0	1.0	x	x	x	1.0	x	1.0	x	
-16201	Central nervous system, behavior: Touchscreen, discrimination, pavlovian autoshaping [sessions]	Central nervous system, behavior: Touchscreen, discrimination, pavlovian autoshaping [sessions]	None	x	x	1.0	1.0	x	x	x	x	x	1.0	x	2.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	10.0	x	2.0	x	x	1.0	x	1.0	x	x	x	x	1.0	1.0	x	x	1.0	x	x	x	x	1.0	x	x	x	x	x	x	1.0	x	x	x	x	1.0	2.0	1.0	x	x	x	x	x	x	2.0	x	x	x	2.0	1.0	x	x	x	x	x	x	x	x	x	x	x	x	1.0	x	x	x	x	x	x	x	1.0	1.0	x	x	x	1.0	x	1.0	x	
-16202	Central nervous system, behavior: Touchscreen, discrimination, touch [sessions]	Central nervous system, behavior: Touchscreen, discrimination, touch [sessions]	None	x	x	4.0	3.0	x	x	x	x	x	3.0	x	8.0	2.0	x	x	x	x	x	x	x	x	x	x	x	x	14.0	x	4.0	x	x	4.0	x	5.0	x	x	x	x	3.0	3.0	x	x	6.0	x	x	x	x	2.0	x	x	x	x	x	x	3.0	x	x	x	x	5.0	3.0	4.0	x	x	x	x	x	x	7.0	x	x	x	4.0	6.0	x	x	x	x	x	x	x	x	x	x	x	x	3.0	x	x	x	x	x	x	x	3.0	9.0	x	x	x	4.0	x	6.0	x	
-16203	Central nervous system, behavior: Touchscreen, discrimination, punish [sessions]	Central nervous system, behavior: Touchscreen, discrimination, punish [sessions]	None	x	x	5.0	4.0	x	x	x	x	x	2.0	x	11.0	5.0	x	x	x	x	x	x	x	x	x	x	x	x	20.0	x	5.0	x	x	15.0	x	7.0	x	x	x	x	4.0	1.0	x	x	14.0	x	x	x	x	2.0	x	x	x	x	x	x	7.0	x	x	x	x	12.0	1.0	3.0	x	x	x	x	x	x	7.0	x	x	x	5.0	13.0	x	x	x	x	x	x	x	x	x	x	x	x	3.0	x	x	x	x	x	x	x	1.0	7.0	x	x	x	7.0	x	5.0	x	
-16204	Central nervous system, behavior: Touchscreen, discrimination, discrimination sessions [sessions]	Central nervous system, behavior: Touchscreen, discrimination, discrimination sessions [sessions]	None	x	x	12.0	7.0	x	x	x	x	x	10.0	x	31.0	24.0	x	x	x	x	x	x	x	x	x	x	x	x	18.0	x	8.0	x	x	60.0	x	11.0	x	x	x	x	16.0	12.0	x	x	38.0	x	x	x	x	12.0	x	x	x	x	x	x	9.0	x	x	x	x	16.0	10.0	8.0	x	x	x	x	x	x	16.0	x	x	x	16.0	51.0	x	x	x	x	x	x	x	x	x	x	x	x	9.0	x	x	x	x	x	x	x	15.0	10.0	x	x	x	15.0	x	6.0	x	
-16205	Central nervous system, behavior: Touchscreen, discrimination, reversal sessions [sessions]	Central nervous system, behavior: Touchscreen, discrimination, reversal sessions [sessions]	None	x	x	23.0	9.0	x	x	x	x	x	9.0	x	38.0	26.0	x	x	x	x	x	x	x	x	x	x	x	x	42.0	x	16.0	x	x	x	x	18.0	x	x	x	x	22.0	15.0	x	x	24.0	x	x	x	x	20.0	x	x	x	x	x	x	12.0	x	x	x	x	24.0	14.0	16.0	x	x	x	x	x	x	22.0	x	x	x	27.0	60.0	x	x	x	x	x	x	x	x	x	x	x	x	14.0	x	x	x	x	x	x	x	48.0	21.0	x	x	x	32.0	x	7.0	x	
-16206	Central nervous system, behavior: Touchscreen, discrimination, extinction sessions [sessions]	Central nervous system, behavior, learning and memory: Extinction learning, mean number of sessions to extinguish a learned response using touchscreen assay (Figure S5 of Graybeal et al, 2014) [n sessions]	Central nervous system, behavior, learning and memory: Extinction learning, sessions to extinguish a well learned instrumental response using a touchscreen assay (low value = fast to extinguish unrewarded response, Figure S5 of Graybeal et al, 2014) in 3-month-old male mice [n sessions]	x	x	27.0	30.0	x	x	x	x	x	30.0	x	28.0	9.0	x	x	x	x	x	x	x	x	x	x	x	x	30.0	x	25.0	x	x	x	x	22.0	x	x	x	x	28.0	23.0	x	x	13.0	x	x	x	x	25.0	x	x	x	x	x	x	30.0	x	x	x	x	25.0	7.0	27.0	x	x	x	x	x	x	26.0	x	x	x	26.0	x	x	x	x	x	x	x	x	x	x	x	x	x	25.0	x	x	x	x	x	x	x	30.0	21.0	x	x	x	16.0	x	27.0	x	
-16207	Central nervous system, behavior: Touchscreen, discrimination correct responses [responses]	Central nervous system, behavior: Touchscreen, discrimination correct responses [responses]	None	x	x	240.75	151.5	x	x	x	x	x	239.22	x	517.0	501.0	x	x	x	x	x	x	x	x	x	x	x	x	312.0	x	162.0	x	x	825.0	x	223.0	x	x	x	x	321.0	248.4	x	x	814.5	x	x	x	x	244.0	x	x	x	x	x	x	152.17	x	x	x	x	329.3	167.0	160.4	x	x	x	x	x	x	329.3	x	x	x	276.17	853.5	x	x	x	x	x	x	x	x	x	x	x	x	173.56	x	x	x	x	x	x	x	279.5	203.71	x	x	x	214.17	x	126.71	x	
-16208	Central nervous system, behavior: Touchscreen, discrimination errors [responses]	Central nervous system, behavior: Touchscreen, discrimination errors [responses]	None	x	x	98.67	43.25	x	x	x	x	x	62.11	x	321.25	208.0	x	x	x	x	x	x	x	x	x	x	x	x	183.0	x	56.44	x	x	735.0	x	88.64	x	x	x	x	135.25	90.2	x	x	298.5	x	x	x	x	98.2	x	x	x	x	x	x	52.0	x	x	x	x	128.3	71.5	54.6	x	x	x	x	x	x	124.5	x	x	x	133.17	460.0	x	x	x	x	x	x	x	x	x	x	x	x	63.44	x	x	x	x	x	x	x	136.0	79.71	x	x	x	106.83	x	43.14	x	
-16209	Central nervous system, behavior: Touchscreen, discrimination correction errors [errors]	Central nervous system, behavior: Touchscreen, discrimination correction errors [errors]	None	x	x	237.58	84.75	x	x	x	x	x	108.78	x	843.25	464.0	x	x	x	x	x	x	x	x	x	x	x	x	491.0	x	131.67	x	x	1752.0	x	193.14	x	x	x	x	274.25	183.4	x	x	492.0	x	x	x	x	219.4	x	x	x	x	x	x	204.0	x	x	x	x	244.2	217.0	135.8	x	x	x	x	x	x	242.5	x	x	x	284.83	1000.0	x	x	x	x	x	x	x	x	x	x	x	x	193.78	x	x	x	x	x	x	x	297.5	175.14	x	x	x	216.67	x	87.57	x	
-16210	Central nervous system, behavior: Touchscreen, discrimination reaction time [time]	Central nervous system, behavior: Touchscreen, discrimination reaction time [time]	None	x	x	7.39	7.57	x	x	x	x	x	11.37	x	10.14	6.95	x	x	x	x	x	x	x	x	x	x	x	x	5.74	x	8.15	x	x	20.64	x	6.22	x	x	x	x	7.18	8.74	x	x	8.41	x	x	x	x	7.36	x	x	x	x	x	x	11.37	x	x	x	x	8.11	8.85	6.67	x	x	x	x	x	x	6.16	x	x	x	7.96	9.66	x	x	x	x	x	x	x	x	x	x	x	x	5.86	x	x	x	x	x	x	x	5.31	7.73	x	x	x	12.78	x	5.31	x	
-16211	Central nervous system, behavior: Touchscreen, discrimination magazine latency [time]	Central nervous system, behavior: Touchscreen, discrimination magazine latency [time]	None	x	x	2.07	1.74	x	x	x	x	x	3.13	x	2.19	3.21	x	x	x	x	x	x	x	x	x	x	x	x	2.25	x	2.76	x	x	2.6	x	2.01	x	x	x	x	2.66	2.46	x	x	2.15	x	x	x	x	5.72	x	x	x	x	x	x	1.99	x	x	x	x	2.66	2.1	1.76	x	x	x	x	x	x	4.01	x	x	x	3.73	18.78	x	x	x	x	x	x	x	x	x	x	x	x	2.01	x	x	x	x	x	x	x	1.6	3.89	x	x	x	2.18	x	1.74	x	
-16212	Central nervous system, behavior: Touchscreen, reversal correct responses [responses]	Central nervous system, behavior: Touchscreen, reversal correct responses [responses]	None	x	x	389.0	159.25	x	x	x	x	x	162.89	x	641.67	462.0	x	x	x	x	x	x	x	x	x	x	x	x	411.0	x	250.44	x	x	x	x	323.64	x	x	x	x	328.75	235.2	x	x	453.0	x	x	x	x	298.5	x	x	x	x	x	x	194.0	x	x	x	x	393.1	262.5	294.4	x	x	x	x	x	x	344.8	x	x	x	464.6	840.0	x	x	x	x	x	x	x	x	x	x	x	x	234.44	x	x	x	x	x	x	x	945.0	298.14	x	x	x	631.8	x	119.43	x	
-16213	Central nervous system, behavior: Touchscreen, reversal correct responses <50% [responses]	Central nervous system, behavior: Touchscreen, reversal correct responses <50% [responses]	None	x	x	60.33	17.5	x	x	x	x	x	16.89	x	76.0	53.0	x	x	x	x	x	x	x	x	x	x	x	x	102.0	x	39.78	x	x	x	x	40.93	x	x	x	x	87.75	55.0	x	x	42.0	x	x	x	x	44.5	x	x	x	x	x	x	25.33	x	x	x	x	83.2	17.5	36.2	x	x	x	x	x	x	75.7	x	x	x	113.0	421.0	x	x	x	x	x	x	x	x	x	x	x	x	33.78	x	x	x	x	x	x	x	66.5	57.86	x	x	x	221.2	x	16.57	x	
-16214	Central nervous system, behavior: Touchscreen, reversal correct responses >50% [responses]	Central nervous system, behavior: Touchscreen, reversal correct responses >50% [responses]	None	x	x	328.67	141.75	x	x	x	x	x	146.0	x	565.67	409.0	x	x	x	x	x	x	x	x	x	x	x	x	309.0	x	210.67	x	x	x	x	282.71	x	x	x	x	241.0	180.2	x	x	411.0	x	x	x	x	254.0	x	x	x	x	x	x	168.67	x	x	x	x	309.9	245.0	258.2	x	x	x	x	x	x	269.1	x	x	x	351.6	419.0	x	x	x	x	x	x	x	x	x	x	x	x	200.67	x	x	x	x	x	x	x	878.5	240.29	x	x	x	410.6	x	102.86	x	
-16215	Central nervous system, behavior: Touchscreen, reversal errors [errors]	Central nervous system, behavior: Touchscreen, reversal errors [errors]	None	x	x	233.0	84.0	x	x	x	x	x	79.44	x	394.67	309.0	x	x	x	x	x	x	x	x	x	x	x	x	266.0	x	149.22	x	x	x	x	168.29	x	x	x	x	215.13	156.6	x	x	219.0	x	x	x	x	162.1	x	x	x	x	x	x	110.33	x	x	x	x	264.8	123.0	153.6	x	x	x	x	x	x	219.9	x	x	x	322.2	898.0	x	x	x	x	x	x	x	x	x	x	x	x	133.11	x	x	x	x	x	x	x	433.0	198.57	x	x	x	350.6	x	58.57	x	
-16216	Central nervous system, behavior: Touchscreen, reversal errors <50% [errors]	Central nervous system, behavior: Touchscreen, reversal errors <50% [errors]	None	x	x	99.42	33.0	x	x	x	x	x	35.44	x	117.67	118.0	x	x	x	x	x	x	x	x	x	x	x	x	125.0	x	73.22	x	x	x	x	63.36	x	x	x	x	122.63	90.8	x	x	59.0	x	x	x	x	74.0	x	x	x	x	x	x	54.0	x	x	x	x	135.3	38.0	63.8	x	x	x	x	x	x	111.9	x	x	x	173.2	627.0	x	x	x	x	x	x	x	x	x	x	x	x	63.78	x	x	x	x	x	x	x	96.5	93.14	x	x	x	203.8	x	32.86	x	
-16217	Central nervous system, behavior: Touchscreen, reversal errors >50% [errors]	Central nervous system, behavior: Touchscreen, reversal errors >50% [errors]	None	x	x	133.58	51.0	x	x	x	x	x	44.0	x	277.0	191.0	x	x	x	x	x	x	x	x	x	x	x	x	141.0	x	76.0	x	x	x	x	104.93	x	x	x	x	92.5	65.8	x	x	160.0	x	x	x	x	88.1	x	x	x	x	x	x	56.33	x	x	x	x	129.5	85.0	89.8	x	x	x	x	x	x	108.0	x	x	x	149.0	271.0	x	x	x	x	x	x	x	x	x	x	x	x	69.33	x	x	x	x	x	x	x	336.5	106.14	x	x	x	146.8	x	25.71	x	
-16218	Central nervous system, behavior: Touchscreen, reversal correction errors [errors]	Central nervous system, behavior: Touchscreen, reversal correction errors [errors]	None	x	x	679.0	280.75	x	x	x	x	x	220.0	x	909.67	759.0	x	x	x	x	x	x	x	x	x	x	x	x	1096.0	x	469.67	x	x	x	x	428.93	x	x	x	x	565.0	500.8	x	x	469.0	x	x	x	x	530.3	x	x	x	x	x	x	333.17	x	x	x	x	667.9	321.0	287.0	x	x	x	x	x	x	619.9	x	x	x	751.8	2484.0	x	x	x	x	x	x	x	x	x	x	x	x	449.11	x	x	x	x	x	x	x	858.5	605.14	x	x	x	921.6	x	219.43	x	
-16219	Central nervous system, behavior: Touchscreen, reversal correction errors <50% [errors]	Central nervous system, behavior: Touchscreen, reversal correction errors <50% [errors]	None	x	x	440.75	179.5	x	x	x	x	x	147.11	x	458.67	437.0	x	x	x	x	x	x	x	x	x	x	x	x	752.0	x	342.11	x	x	x	x	250.71	x	x	x	x	407.0	381.0	x	x	207.0	x	x	x	x	371.9	x	x	x	x	x	x	236.83	x	x	x	x	448.0	176.0	189.8	x	x	x	x	x	x	412.1	x	x	x	483.8	1810.0	x	x	x	x	x	x	x	x	x	x	x	x	320.0	x	x	x	x	x	x	x	315.5	389.71	x	x	x	640.6	x	173.29	x	
-16220	Central nervous system, behavior: Touchscreen, reversal correction errors >50% [errors]	Central nervous system, behavior: Touchscreen, reversal correction errors >50% [errors]	None	x	x	238.25	101.25	x	x	x	x	x	72.89	x	451.0	322.0	x	x	x	x	x	x	x	x	x	x	x	x	344.0	x	127.56	x	x	x	x	178.21	x	x	x	x	158.0	119.8	x	x	262.0	x	x	x	x	158.4	x	x	x	x	x	x	96.33	x	x	x	x	219.9	145.0	97.2	x	x	x	x	x	x	207.8	x	x	x	268.0	674.0	x	x	x	x	x	x	x	x	x	x	x	x	129.11	x	x	x	x	x	x	x	543.0	215.43	x	x	x	294.8	x	46.14	x	
-16221	Central nervous system, behavior: Touchscreen, reversal reaction time [time]	Central nervous system, behavior: Touchscreen, reversal reaction time [time]	None	x	x	5.83	5.37	x	x	x	x	x	8.56	x	7.44	4.97	x	x	x	x	x	x	x	x	x	x	x	x	25.12	x	11.67	x	x	x	x	7.46	x	x	x	x	8.67	6.31	x	x	5.54	x	x	x	x	6.08	x	x	x	x	x	x	8.18	x	x	x	x	7.42	5.62	5.64	x	x	x	x	x	x	6.5	x	x	x	6.29	13.21	x	x	x	x	x	x	x	x	x	x	x	x	5.38	x	x	x	x	x	x	x	4.73	6.88	x	x	x	10.19	x	6.52	x	
-16222	Central nervous system, behavior: Touchscreen, reversal magazine latency [time]	Central nervous system, behavior: Touchscreen, reversal magazine latency [time]	None	x	x	2.57	1.86	x	x	x	x	x	2.03	x	5.2	1.52	x	x	x	x	x	x	x	x	x	x	x	x	2.3	x	2.52	x	x	x	x	3.47	x	x	x	x	2.66	2.09	x	x	2.14	x	x	x	x	2.6	x	x	x	x	x	x	2.0	x	x	x	x	3.44	1.96	1.81	x	x	x	x	x	x	5.32	x	x	x	1.92	3.98	x	x	x	x	x	x	x	x	x	x	x	x	1.69	x	x	x	x	x	x	x	1.88	2.63	x	x	x	2.46	x	1.85	x	
-16223	Central nervous system, behavior: Touchscreen, extinction correct responses[responses]	Central nervous system, behavior: Andrew Holmes laboratory unpublished trait	Central nervous system, behavior: Extinction, number of correct responses using a touchscreen paradigm [n]	x	x	201.0	345.25	x	x	x	x	x	276.11	x	197.5	95.0	x	x	x	x	x	x	x	x	x	x	x	x	118.0	x	212.11	x	x	x	x	157.71	x	x	x	x	255.71	228.6	x	x	104.0	x	x	x	x	167.2	x	x	x	x	x	x	265.67	x	x	x	x	194.78	63.0	205.6	x	x	x	x	x	x	215.22	x	x	x	211.25	x	x	x	x	x	x	x	x	x	x	x	x	x	240.56	x	x	x	x	x	x	x	149.0	203.29	x	x	x	124.33	x	189.71	x	
-16224	Central nervous system, behavior: Touchscreen, discrimination extinction errors [errors]	Central nervous system, behavior: Touchscreen, discrimination extinction errors [errors]	Central nervous system, behavior: Holmes leaning trait	x	x	107.83	169.25	x	x	x	x	x	194.0	x	107.0	34.0	x	x	x	x	x	x	x	x	x	x	x	x	90.0	x	123.33	x	x	x	x	78.71	x	x	x	x	126.71	114.6	x	x	37.0	x	x	x	x	103.1	x	x	x	x	x	x	142.0	x	x	x	x	99.67	13.0	124.4	x	x	x	x	x	x	115.0	x	x	x	131.75	x	x	x	x	x	x	x	x	x	x	x	x	x	103.0	x	x	x	x	x	x	x	102.0	61.0	x	x	x	51.67	x	127.57	x	
-16225	Central nervous system, behavior: Touchscreen, extinction correction errors [errors]	Central nervous system, behavior: Touchscreen, extinction correction errors [errors]	None	x	x	236.42	365.0	x	x	x	x	x	450.56	x	175.5	45.0	x	x	x	x	x	x	x	x	x	x	x	x	291.0	x	357.22	x	x	x	x	130.29	x	x	x	x	228.86	229.2	x	x	45.0	x	x	x	x	223.6	x	x	x	x	x	x	440.83	x	x	x	x	253.0	16.0	320.6	x	x	x	x	x	x	251.78	x	x	x	357.25	x	x	x	x	x	x	x	x	x	x	x	x	x	234.11	x	x	x	x	x	x	x	178.0	109.0	x	x	x	113.0	x	281.43	x	
-16226	Central nervous system, behavior: Touchscreen, extinction reaction time [time]	Central nervous system, behavior: Touchscreen, extinction reaction time [time]	None	x	x	120.94	17.24	x	x	x	x	x	66.58	x	58.51	148.97	x	x	x	x	x	x	x	x	x	x	x	x	46.99	x	90.09	x	x	x	x	100.48	x	x	x	x	79.97	40.3	x	x	75.22	x	x	x	x	94.99	x	x	x	x	x	x	64.62	x	x	x	x	66.73	289.64	119.92	x	x	x	x	x	x	64.92	x	x	x	32.37	x	x	x	x	x	x	x	x	x	x	x	x	x	93.38	x	x	x	x	x	x	x	49.83	93.29	x	x	x	45.86	x	51.7	x	
-16227	Central nervous system, behavior: Touchscreen, extinction magazine latency [time]	Central nervous system, behavior: Touchscreen, extinction magazine latency [time]	None	x	x	64.5	57.33	x	x	x	x	x	26.08	x	102.77	145.01	x	x	x	x	x	x	x	x	x	x	x	x	99.21	x	50.32	x	x	x	x	81.78	x	x	x	x	54.75	65.33	x	x	94.16	x	x	x	x	88.91	x	x	x	x	x	x	45.32	x	x	x	x	73.49	101.74	52.78	x	x	x	x	x	x	81.43	x	x	x	45.44	x	x	x	x	x	x	x	x	x	x	x	x	x	58.03	x	x	x	x	x	x	x	103.72	65.45	x	x	x	28.63	x	69.72	x	
-16228	Original post publication description: un-named trait Original pre publication description: RLT NMS F1	RLT NMS F1	un-named trait	x	x	x	x	x	x	x	x	x	x	x	300.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	700.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	125.0	x	x	x	x	x	x	x	x	x	x	x	500.0	x	175.0	150.0	x	x	x	x	x	x	x	x	x	x	x	x	x	300.0	x	x	550.0	x	300.0	425.0	x	x	x	x	x	800.0	x	600.0	x	300.0	350.0	x	500.0	
-16229	Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH]	Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH]	Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH]	x	x	10.99	11.6	13.41	11.54	x	8.525	x	x	14.765	10.17	31.29	14.9	16.12	x	x	9.665	x	x	x	x	7.72	x	x	x	x	x	x	x	10.56	13.98	x	x	x	x	x	13.305	9.73	x	x	8.985	x	x	x	x	x	x	x	11.84	x	x	x	15.435	x	x	x	x	x	19.18	x	x	x	x	x	x	x	x	x	x	x	11.41	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	9.67	x	11.655	x	x	x	x	x	
-16230	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males and females [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males and females [% LDH increase vs. untreated cells]	None	x	x	9.485	12.67	3.66	0.6	x	3.465	x	x	4.255	8.745	6.15	9.11	7.96	x	x	-2.62	x	x	x	x	5.51	x	x	x	x	x	x	x	21.45	1.59	x	x	x	x	x	4.41	20.62	x	x	10.145	x	x	x	x	x	x	x	24.62	x	x	x	3.21	x	x	x	x	x	12.35	x	x	x	x	x	x	x	x	x	x	x	5.735	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	12.34	x	7.81	x	x	x	x	x	
-16231	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in males and females [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in males and females [% LDH increase vs. untreated cells]	None	x	x	51.19	39.5	19.01	58.64	x	25.44	x	x	12.99	40.855	-15.55	14.12	20.75	x	x	50.835	x	x	x	x	10.26	x	x	x	x	x	x	x	35.59	15.71	x	x	x	x	x	6.625	31.04	x	x	1.64	x	x	x	x	x	x	x	5.24	x	x	x	38.42	x	x	x	x	x	18.98	x	x	x	x	x	x	x	x	x	x	x	-0.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.22	x	10.22	x	x	x	x	x	
-16232	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males and females [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males and females [% LDH increase vs. untreated cells]	None	x	x	39.375	60.28	41.17	74.735	x	32.745	x	x	31.01	51.17	-18.69	43.78	19.7	x	x	84.435	x	x	x	x	35.78	x	x	x	x	x	x	x	63.06	29.47	x	x	x	x	x	16.38	44.1	x	x	28.58	x	x	x	x	x	x	x	20.0	x	x	x	46.215	x	x	x	x	x	34.76	x	x	x	x	x	x	x	x	x	x	x	2.82	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	13.57	x	21.16	x	x	x	x	x	
-16233	Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males [% LDH supernatant of total LDH]	Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males [% LDH supernatant of total LDH]	None	x	x	10.99	20.08	14.83	14.425	x	8.63	x	x	17.15	15.23	35.0	18.27	17.44	x	x	12.505	x	x	x	x	9.915	x	x	x	x	x	x	x	11.06	15.285	x	x	x	x	x	15.29	9.73	x	x	7.98	x	x	x	x	x	x	x	11.09	x	x	x	16.6	x	x	x	x	x	19.365	x	x	x	x	x	x	x	x	x	x	x	13.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	10.205	x	13.32	x	x	x	x	x	
-16234	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males [% LDH increase vs. untreated cells]	None	x	x	9.485	0.91	2.665	2.15	x	-4.79	x	x	-5.675	3.765	3.2	5.93	6.595	x	x	-12.475	x	x	x	x	-6.19	x	x	x	x	x	x	x	21.45	1.615	x	x	x	x	x	9.97	17.5	x	x	10.64	x	x	x	x	x	x	x	27.54	x	x	x	-3.385	x	x	x	x	x	9.185	x	x	x	x	x	x	x	x	x	x	x	6.32	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	1.255	x	2.78	x	x	x	x	x	
-16235	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta medianin males [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta medianin males [% LDH increase vs. untreated cells]	None	x	x	42.63	158.03	18.18	76.7	x	26.085	x	x	12.99	48.74	-29.98	45.84	14.675	x	x	57.205	x	x	x	x	19.11	x	x	x	x	x	x	x	39.64	29.655	x	x	x	x	x	-3.67	31.04	x	x	7.99	x	x	x	x	x	x	x	31.39	x	x	x	39.56	x	x	x	x	x	18.88	x	x	x	x	x	x	x	x	x	x	x	0.46	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	2.08	x	2.75	x	x	x	x	x	
-16236	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males [% LDH increase vs. untreated cells]	None	x	x	35.23	165.56	24.77	93.34	x	34.105	x	x	18.52	30.245	-25.81	115.21	10.435	x	x	71.855	x	x	x	x	18.05	x	x	x	x	x	x	x	63.06	34.34	x	x	x	x	x	19.96	44.1	x	x	27.71	x	x	x	x	x	x	x	36.53	x	x	x	45.55	x	x	x	x	x	35.36	x	x	x	x	x	x	x	x	x	x	x	0.14	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	10.47	x	8.66	x	x	x	x	x	
-16237	Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in females [% LDH supernatant of total LDH]	Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in females [% LDH supernatant of total LDH]	None	x	x	10.57	10.625	9.98	9.85	x	8.525	x	x	11.745	7.475	11.55	12.79	13.73	x	x	7.88	x	x	x	x	7.6	x	x	x	x	x	x	x	10.17	9.69	x	x	x	x	x	11.11	10.79	x	x	9.44	x	x	x	x	x	x	x	12.88	x	x	x	11.005	x	x	x	x	x	14.4	x	x	x	x	x	x	x	x	x	x	x	10.65	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	8.98	x	9.2	x	x	x	x	x	
-16238	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in females [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in females [% LDH increase vs. untreated cells]	None	x	x	12.1	13.145	9.19	0.225	x	19.505	x	x	5.245	17.56	13.59	13.905	20.315	x	x	-0.57	x	x	x	x	10.59	x	x	x	x	x	x	x	22.18	1.59	x	x	x	x	x	-0.02	20.65	x	x	9.65	x	x	x	x	x	x	x	3.695	x	x	x	8.93	x	x	x	x	x	13.78	x	x	x	x	x	x	x	x	x	x	x	5.15	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	26.29	x	15.21	x	x	x	x	x	
-16239	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in females [% LDH increase vs. untreated cells]	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in females [% LDH increase vs. untreated cells]	None	x	x	81.875	35.725	24.85	42.865	x	25.44	x	x	13.935	39.295	21.695	10.6	26.1	x	x	50.835	x	x	x	x	10.26	x	x	x	x	x	x	x	28.48	6.06	x	x	x	x	x	9.58	32.61	x	x	-3.44	x	x	x	x	x	x	x	2.27	x	x	x	38.42	x	x	x	x	x	28.18	x	x	x	x	x	x	x	x	x	x	x	-10.53	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	15.24	x	58.8	x	x	x	x	x	
-16240	Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells]	Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells]	Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells]	x	x	50.95	59.435	60.15	50.12	x	32.745	x	x	38.64	79.87	29.175	26.63	22.185	x	x	86.505	x	x	x	x	58.08	x	x	x	x	x	x	x	57.995	19.76	x	x	x	x	x	12.8	35.575	x	x	29.45	x	x	x	x	x	x	x	4.445	x	x	x	62.84	x	x	x	x	x	27.12	x	x	x	x	x	x	x	x	x	x	x	5.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	20.95	x	63.64	x	x	x	x	x	
-16241	Original post publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	3.126	-0.084	-1.771	-1.351	-0.889	-2.188	-1.93	1.963	2.904	1.596	1.806	-2.717	2.289	-2.401	2.005	0.231	-0.21	0.394	2.92	-6.76	-1.822	-2.268	x	1.135	0.163	0.168	1.275	1.654	x	-1.354	1.792	-2.741	-0.183	x	-0.934	x	-4.823	-0.702	-2.257	x	-3.355	0.021	x	1.077	x	x	2.511	x	-0.906	1.437	x	x	x	-2.625	x	x	x	x	0.524	-2.662	-3.385	2.089	4.526	-2.003	3.441	2.854	-0.766	5.21	4.853	x	x	2.484	-5.394	-4.37	-3.185	1.393	x	-2.403	2.727	x	x	-6.726	2.599	3.26	2.088	6.108	x	-0.862	0.015	x	0.333	-3.201	-2.397	x	0.778	0.236	1.828	3.814	x	x	x	x	
-16242	Original post publication description: un-named trait Original pre publication description: Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)]	Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)]	Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)]	x	x	4.538	3.265	x	x	x	-4.145	x	x	x	x	x	x	x	-1.82	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-0.468	x	0.041	x	x	x	x	x	-0.336	x	-1.251	x	x	1.624	x	x	-2.957	-5.793	x	-0.72	x	x	x	x	0.33	x	x	x	1.858	3.475	1.254	x	x	x	x	x	x	6.157	-4.161	-1.538	x	3.084	-3.563	1.533	x	0.956	x	-2.906	-0.826	x	x	-1.328	2.17	x	x	x	x	1.838	-0.822	x	x	x	x	x	x	-2.088	1.716	0.761	0.122	x	x	x	
-16243	Original post publication description: Central nervous system, aging: Age at death (average) of hippocampal samples [days] Original pre publication description: Central nervous system, aging: Age at death (average) of hippocampal samples [days]	Metadata, cofactor: Age at death (average) of hippocampal samples (use only with UTHSC BXD Aged Hippocampus Affy expression data sets) [days]	Metadata, cofactor: Age at death (average) of hippocampal samples (use only with UTHSC BXD Aged Hippocampus Affy expression data sets) [days]	430.0	x	566.0	622.0	794.0	483.0	x	530.0	454.0	442.0	464.0	506.0	x	561.0	605.0	605.0	536.0	500.5	432.0	415.0	502.0	456.0	493.0	399.0	536.5	652.0	454.0	462.0	x	x	464.0	478.0	549.0	x	x	x	499.0	x	451.0	x	463.0	446.0	415.0	524.0	x	x	438.0	x	528.0	498.0	x	x	x	526.0	501.0	x	x	x	587.0	425.0	572.0	463.0	747.0	475.0	421.0	415.0	470.0	485.0	471.0	464.0	x	459.0	431.0	515.0	631.0	579.0	x	618.0	614.0	651.0	x	512.0	458.0	425.0	523.0	506.0	x	488.0	651.0	x	526.0	912.0	x	467.0	420.0	715.0	697.0	440.0	772.0	693.0	x	x	
-16244	Original post publication description: Cardiovascular system, morphology: Heart weight raw [mg]	Cardiovascular system, morphology: Heart weight, young adult males and females, unadjusted (BXD19 winsorized from 101.4 to 118) [mg]	Cardiovascular system, morphology: Heart weight, young adult males and females, unadjusted (BXD19 winsorized from 101.4 to 118) [mg]	118.9	x	122.4	193.2	148.5	165.7	x	131.4	151.5	129.5	156.7	154.3	x	135.0	x	x	x	118.0	x	169.2	142.5	141.8	x	155.4	x	132.3	x	x	x	119.4	121.8	156.5	166.5	x	144.0	x	157.2	150.1	170.4	x	x	127.5	122.0	127.1	x	x	134.6	x	158.9	138.6	x	x	x	151.1	x	x	x	x	146.2	136.5	128.6	146.7	148.7	151.1	152.9	125.7	140.8	146.8	149.9	175.3	x	149.3	124.0	139.7	138.4	185.6	125.3	161.3	154.8	x	x	135.4	146.8	132.8	181.3	151.3	x	142.9	164.6	142.9	150.6	x	x	148.9	134.1	149.0	155.5	150.9	x	x	x	x	
-16245	Original post publication description: Cardiovascular system, morphology: Heart weight adjusted by age, sex and body weight [mg]	Cardiovascular system, morphology: Heart weight, young adult males and females, adjusted by age, sex, and body weight (BXD19 winsorized from 80.7 to 118) [mg]	Cardiovascular system, morphology: Heart weight, young adult males and females, adjusted by age, sex, and body weight (BXD19 winsorized from 80.7 to 118) [mg]	134.9	x	129.8	181.5	142.4	165.0	x	146.0	141.4	125.9	149.1	143.5	x	140.6	x	x	x	118.0	x	159.0	134.6	154.1	x	139.9	x	143.8	x	x	x	129.6	134.2	171.6	158.5	x	147.0	x	166.7	158.7	165.9	x	x	130.6	124.2	142.3	x	x	133.4	x	146.8	139.0	x	x	x	151.3	x	x	x	x	131.8	132.5	130.7	156.3	143.4	146.7	155.7	129.5	136.3	146.4	151.6	146.5	x	159.9	134.6	139.1	144.2	164.4	123.6	144.2	147.3	x	x	132.5	139.5	133.8	178.8	152.5	x	146.3	163.3	155.2	140.5	x	x	118.8	135.9	148.4	146.4	143.7	x	x	x	x	
-16246	Original post publication description: Cortex L2/3 apoptosis	None	Central nervous system; post-natal neurogenesis; Apoptosis in cortex L2/3 (% caspase 3+ cells)	x	x	1.289	19.988	x	6.691	x	x	x	x	x	x	x	x	x	x	x	x	5.804	x	x	x	x	x	x	x	x	x	x	x	5.111	x	x	x	x	x	x	4.328	x	x	x	x	x	x	x	x	x	x	x	3.283	x	x	x	x	x	x	x	x	7.775	x	x	x	x	x	x	x	x	x	x	14.938	x	13.842	x	x	x	x	x	x	18.688	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	11.218	x	x	x	15.786	x	x	12.968	
-16247	Metagenome, gastrointestinal system: Microbiome, Actinobacteria (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Actinobacteria (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.518831	x	-0.156824	0.31448	x	x	x	x	x	x	-0.689001	0.724981	x	x	x	x	x	x	x	x	x	x	-0.0653891	x	x	x	x	x	x	x	-0.387328	x	x	x	x	x	x	x	x	x	x	x	-0.180422	0.0812122	x	x	-0.0508463	x	0.0557928	0.44173	x	x	x	x	-0.203314	x	x	x	-0.364487	-0.0144792	0.068776	x	x	-0.298034	0.528846	x	-0.201443	-0.0057032	-0.0126551	-0.0714455	x	x	x	0.518153	x	0.36181	x	x	x	x	x	0.19999	0.23894	-0.0342155	x	-0.113823	x	0.712927	0.107623	x	x	x	x	x	-0.637051	x	x	x	-0.675143	x	0.325173	x	
-16248	Metagenome, gastrointestinal system: Microbiome, Actinobacteria (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Actinobacteria (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.518831	x	-0.156824	0.31448	x	x	x	x	x	x	-0.689001	0.724981	x	x	x	x	x	x	x	x	x	x	-0.0653891	x	x	x	x	x	x	x	-0.387328	x	x	x	x	x	x	x	x	x	x	x	-0.180422	0.0812122	x	x	-0.0508463	x	0.0557928	0.44173	x	x	x	x	-0.203314	x	x	x	-0.364487	-0.0144792	0.068776	x	x	-0.298034	0.528846	x	-0.201443	-0.0057032	-0.0126551	-0.0714455	x	x	x	0.518153	x	0.36181	x	x	x	x	x	0.19999	0.23894	-0.0342155	x	-0.113823	x	0.712927	0.107623	x	x	x	x	x	-0.637051	x	x	x	-0.675143	x	0.325173	x	
-16249	Metagenome, gastrointestinal system: Microbiome, Actinobacteridae (subclass) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Actinobacteridae (subclass) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.493655	x	-0.575807	1.07654	x	x	x	x	x	x	-0.131479	-0.298258	x	x	x	x	x	x	x	x	x	x	-0.29357	x	x	x	x	x	x	x	-0.663642	x	x	x	x	x	x	x	x	x	x	x	-0.772682	-0.0520093	x	x	-0.291292	x	0.182453	0.616944	x	x	x	x	-0.407057	x	x	x	-0.280671	-0.0437554	-0.256199	x	x	-0.367829	-0.0698029	x	-0.255752	-0.129114	-0.159195	-0.0621979	x	x	x	0.0656433	x	0.942902	x	x	x	x	x	-0.202483	0.112618	-0.0431452	x	0.802235	x	0.988803	0.696573	x	x	x	x	x	-0.372203	x	x	x	-0.147797	x	0.884888	x	
-16250	Metagenome, gastrointestinal system: Microbiome, Actinomycetales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Actinomycetales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.491175	x	-0.573327	1.06929	x	x	x	x	x	x	-0.128999	-0.295778	x	x	x	x	x	x	x	x	x	x	-0.29109	x	x	x	x	x	x	x	-0.661162	x	x	x	x	x	x	x	x	x	x	x	-0.770202	-0.0515699	x	x	-0.291292	x	0.21274	0.616944	x	x	x	x	-0.376769	x	x	x	-0.280452	-0.028392	-0.25576	x	x	-0.337541	-0.0693634	x	-0.255313	-0.128675	-0.158755	-0.0617584	x	x	x	0.0660828	x	0.939736	x	x	x	x	x	-0.187339	0.112618	-0.0429255	x	0.797181	x	0.999498	0.56028	x	x	x	x	x	-0.370963	x	x	x	-0.147357	x	0.881593	x	
-16251	Metagenome, gastrointestinal system: Microbiome, Aerococcaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Aerococcaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.227958	x	-0.311711	0.0205206	x	x	x	x	x	x	-0.0165501	-0.422635	x	x	x	x	x	x	x	x	x	x	-0.503894	x	x	x	x	x	x	x	-0.398006	x	x	x	x	x	x	x	x	x	x	x	-0.356322	0.0010337	x	x	-0.225797	x	-0.017287	-0.126996	x	x	x	x	-0.0676221	x	x	x	-0.175983	0.121586	-0.112208	x	x	-0.0283943	0.0719612	x	0.0365271	0.013946	-0.166762	-0.0715648	x	x	x	-0.143623	x	0.668961	x	x	x	x	x	-0.0759333	-0.210009	-0.0254375	x	0.758159	x	1.36763	0.0103836	x	x	x	x	x	0.58762	x	x	x	-0.15473	x	0.181095	x	
-16252	Metagenome, gastrointestinal system: Microbiome, Aerococcus (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Aerococcus (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.227915	x	-0.311667	0.0205641	x	x	x	x	x	x	-0.0165065	-0.422592	x	x	x	x	x	x	x	x	x	x	-0.503851	x	x	x	x	x	x	x	-0.397962	x	x	x	x	x	x	x	x	x	x	x	-0.356279	0.0010337	x	x	-0.225797	x	-0.017287	-0.126996	x	x	x	x	-0.0676221	x	x	x	-0.175983	0.121586	-0.112208	x	x	-0.0283943	0.0719612	x	0.0365271	0.013946	-0.166762	-0.0715648	x	x	x	-0.143623	x	0.668983	x	x	x	x	x	-0.0759333	-0.210009	-0.0254375	x	0.758159	x	1.36722	0.0103836	x	x	x	x	x	0.587642	x	x	x	-0.15473	x	0.181116	x	
-16253	Metagenome, gastrointestinal system: Microbiome, Alistipes (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Alistipes (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.544218	x	-0.801056	-0.383372	x	x	x	x	x	x	-0.958986	1.30263	x	x	x	x	x	x	x	x	x	x	-1.1453	x	x	x	x	x	x	x	-0.0220506	x	x	x	x	x	x	x	x	x	x	x	1.03731	-0.144791	x	x	-1.17637	x	-0.0419391	0.640827	x	x	x	x	-0.350808	x	x	x	0.561449	0.264502	-0.440862	x	x	0.0332929	0.220489	x	0.238043	-0.241245	0.365953	0.484774	x	x	x	0.304317	x	-0.0268954	x	x	x	x	x	0.319757	0.269607	0.657682	x	-0.159915	x	0.0095781	0.296614	x	x	x	x	x	-1.16534	x	x	x	-0.662211	x	0.170111	x	
-16254	Metagenome, gastrointestinal system: Microbiome, Bacilli (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacilli (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.175631	x	0.0643576	0.0828972	x	x	x	x	x	x	-0.314874	-0.327173	x	x	x	x	x	x	x	x	x	x	0.102037	x	x	x	x	x	x	x	0.137568	x	x	x	x	x	x	x	x	x	x	x	-0.0310169	0.0888305	x	x	-0.177407	x	-0.025221	-0.0405718	x	x	x	x	0.100843	x	x	x	-0.0458157	-0.239702	0.0611031	x	x	0.0770017	-0.0478189	x	-0.186117	0.0353056	0.0912961	-0.049865	x	x	x	-0.0579127	x	0.150464	x	x	x	x	x	-0.0171508	0.0779871	0.0522646	x	0.078666	x	-0.0307228	-0.010306	x	x	x	x	x	0.105267	x	x	x	0.0865452	x	0.0336109	x	
-16255	Metagenome, gastrointestinal system: Microbiome, Bacteroidales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacteroidales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.0446889	x	-1.21738	-0.115595	x	x	x	x	x	x	0.186051	0.573394	x	x	x	x	x	x	x	x	x	x	0.331771	x	x	x	x	x	x	x	0.0509353	x	x	x	x	x	x	x	x	x	x	x	0.262439	-0.802288	x	x	-0.319515	x	0.0355208	-0.150273	x	x	x	x	-0.362807	x	x	x	0.446252	0.146154	0.171167	x	x	-0.106644	0.274185	x	0.421208	0.0962919	-0.202544	0.569655	x	x	x	0.357818	x	-0.711256	x	x	x	x	x	0.141332	0.233103	0.490095	x	-0.0752507	x	0.347905	0.234137	x	x	x	x	x	-1.07516	x	x	x	-0.604454	x	0.329057	x	
-16256	Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.0446889	x	-1.21738	-0.115595	x	x	x	x	x	x	0.186051	0.573394	x	x	x	x	x	x	x	x	x	x	0.331771	x	x	x	x	x	x	x	0.0509353	x	x	x	x	x	x	x	x	x	x	x	0.262439	-0.802288	x	x	-0.319515	x	0.0355208	-0.150273	x	x	x	x	-0.362807	x	x	x	0.446252	0.146154	0.171167	x	x	-0.106644	0.274185	x	0.421208	0.0962919	-0.202544	0.569655	x	x	x	0.357818	x	-0.711256	x	x	x	x	x	0.141332	0.233103	0.490095	x	-0.0752507	x	0.347905	0.234137	x	x	x	x	x	-1.07516	x	x	x	-0.604454	x	0.329057	x	
-16257	Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.052787	x	-0.811083	-0.192092	x	x	x	x	x	x	0.151683	0.522894	x	x	x	x	x	x	x	x	x	x	0.235884	x	x	x	x	x	x	x	-0.035648	x	x	x	x	x	x	x	x	x	x	x	0.176051	-0.815211	x	x	-0.171261	x	0.0275689	-0.240795	x	x	x	x	-0.31525	x	x	x	0.295878	0.137622	0.11389	x	x	-0.107427	0.282148	x	0.424369	0.099047	-0.145649	0.494136	x	x	x	0.314976	x	-0.720422	x	x	x	x	x	0.0640031	0.0478076	0.378928	x	-0.15851	x	0.295805	0.17925	x	x	x	x	x	-0.352205	x	x	x	-0.298157	x	0.174558	x	
-16258	Metagenome, gastrointestinal system: Microbiome, Clostridia (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Clostridia (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.426698	x	0.118477	0.120741	x	x	x	x	x	x	0.499147	0.226502	x	x	x	x	x	x	x	x	x	x	-0.452471	x	x	x	x	x	x	x	-0.134977	x	x	x	x	x	x	x	x	x	x	x	0.117907	0.0783203	x	x	0.28546	x	-0.056438	0.0613142	x	x	x	x	0.162186	x	x	x	0.214995	0.420538	-0.033524	x	x	-0.0420715	0.00078636	x	0.216338	-0.321217	-0.144049	-0.0742876	x	x	x	0.0208625	x	-0.474452	x	x	x	x	x	0.180638	-0.0173998	-0.299829	x	0.100176	x	-0.129281	-0.470697	x	x	x	x	x	0.0991319	x	x	x	0.0777258	x	0.0761444	x	
-16259	Metagenome, gastrointestinal system: Microbiome, Clostridiales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Clostridiales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.425997	x	0.117165	0.120251	x	x	x	x	x	x	0.498538	0.227792	x	x	x	x	x	x	x	x	x	x	-0.453562	x	x	x	x	x	x	x	-0.13328	x	x	x	x	x	x	x	x	x	x	x	0.118188	0.078881	x	x	0.285915	x	-0.0553559	0.0608066	x	x	x	x	0.162515	x	x	x	0.215089	0.419817	-0.0324586	x	x	-0.0436538	0.00086857	x	0.217339	-0.320542	-0.142937	-0.0756874	x	x	x	0.0214288	x	-0.472332	x	x	x	x	x	0.179997	-0.0171946	-0.301286	x	0.0980756	x	-0.127413	-0.47025	x	x	x	x	x	0.0963469	x	x	x	0.0770432	x	0.0758936	x	
-16260	Metagenome, gastrointestinal system: Microbiome, Coriobacteriaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Coriobacteriaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.298915	x	0.112491	-0.321125	x	x	x	x	x	x	-0.596804	1.02431	x	x	x	x	x	x	x	x	x	x	0.164162	x	x	x	x	x	x	x	-0.168559	x	x	x	x	x	x	x	x	x	x	x	0.102804	0.0949202	x	x	-0.0372589	x	0.0375579	0.433102	x	x	x	x	-0.151018	x	x	x	-0.329621	0.0135206	0.108685	x	x	-0.237843	0.561269	x	-0.167234	0.0480445	0.0271857	-0.0424244	x	x	x	0.549646	x	-0.309732	x	x	x	x	x	0.232147	0.243174	-0.0313238	x	-0.351518	x	0.288784	-0.0406591	x	x	x	x	x	-0.511369	x	x	x	-0.774942	x	0.328547	x	
-16261	Metagenome, gastrointestinal system: Microbiome, Coriobacteriales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Coriobacteriales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.298915	x	0.112491	-0.321125	x	x	x	x	x	x	-0.596804	1.02431	x	x	x	x	x	x	x	x	x	x	0.164162	x	x	x	x	x	x	x	-0.168559	x	x	x	x	x	x	x	x	x	x	x	0.102804	0.0949202	x	x	-0.0372589	x	0.0375579	0.433102	x	x	x	x	-0.151018	x	x	x	-0.329621	0.0135206	0.108685	x	x	-0.237843	0.561269	x	-0.167234	0.0480445	0.0271857	-0.0424244	x	x	x	0.549646	x	-0.309732	x	x	x	x	x	0.232147	0.243174	-0.0313238	x	-0.351518	x	0.288784	-0.0406591	x	x	x	x	x	-0.511369	x	x	x	-0.774942	x	0.328547	x	
-16262	Metagenome, gastrointestinal system: Microbiome, Coriobacteridaesub (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Coriobacteridaesub (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.298915	x	0.112491	-0.321125	x	x	x	x	x	x	-0.596804	1.02431	x	x	x	x	x	x	x	x	x	x	0.164162	x	x	x	x	x	x	x	-0.168559	x	x	x	x	x	x	x	x	x	x	x	0.102804	0.0949202	x	x	-0.0372589	x	0.0375579	0.433102	x	x	x	x	-0.151018	x	x	x	-0.329621	0.0135206	0.108685	x	x	-0.237843	0.561269	x	-0.167234	0.0480445	0.0271857	-0.0424244	x	x	x	0.549646	x	-0.309732	x	x	x	x	x	0.232147	0.243174	-0.0313238	x	-0.351518	x	0.288784	-0.0406591	x	x	x	x	x	-0.511369	x	x	x	-0.774942	x	0.328547	x	
-16263	Metagenome, gastrointestinal system: Microbiome, Coriobacterineae (suborder) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Coriobacterineae (suborder) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.298915	x	0.112491	-0.321125	x	x	x	x	x	x	-0.596804	1.02431	x	x	x	x	x	x	x	x	x	x	0.164162	x	x	x	x	x	x	x	-0.168559	x	x	x	x	x	x	x	x	x	x	x	0.102804	0.0949202	x	x	-0.0372589	x	0.0375579	0.433102	x	x	x	x	-0.151018	x	x	x	-0.329621	0.0135206	0.108685	x	x	-0.237843	0.561269	x	-0.167234	0.0480445	0.0271857	-0.0424244	x	x	x	0.549646	x	-0.309732	x	x	x	x	x	0.232147	0.243174	-0.0313238	x	-0.351518	x	0.288784	-0.0406591	x	x	x	x	x	-0.511369	x	x	x	-0.774942	x	0.328547	x	
-16264	Metagenome, gastrointestinal system: Microbiome, Corynebacteriaceae (family) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Corynebacteriaceae (family) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.244724	x	-0.326875	0.8252	x	x	x	x	x	x	-0.0323169	-0.588917	x	x	x	x	x	x	x	x	x	x	-0.672274	x	x	x	x	x	x	x	-0.714803	x	x	x	x	x	x	x	x	x	x	x	-0.673119	-0.212555	x	x	-0.250729	x	0.198623	0.236489	x	x	x	x	-0.302632	x	x	x	-0.220995	-0.180725	-0.0290138	x	x	-0.263404	0.00686757	x	-0.0285666	-0.0511476	-0.231856	-0.136658	x	x	x	-0.208717	x	1.00014	x	x	x	x	x	-0.205904	0.218348	-0.0715149	x	0.86199	x	0.907302	0.617009	x	x	x	x	x	-0.151139	x	x	x	-0.0711263	x	0.997745	x	
-16265	Metagenome, gastrointestinal system: Microbiome, Corynebacterineae (suborder) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Corynebacterineae (suborder) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.276183	x	-0.358335	1.05865	x	x	x	x	x	x	-0.0637763	-0.620376	x	x	x	x	x	x	x	x	x	x	-0.703734	x	x	x	x	x	x	x	-0.746262	x	x	x	x	x	x	x	x	x	x	x	-0.704579	-0.0764024	x	x	-0.311146	x	0.198623	0.238459	x	x	x	x	-0.302632	x	x	x	-0.257375	-0.186896	-0.0413563	x	x	-0.263404	-0.00547495	x	-0.040909	-0.0634901	-0.244198	-0.149001	x	x	x	-0.221059	x	0.98714	x	x	x	x	x	-0.083881	0.245397	-0.107895	x	0.855433	x	0.925484	0.617009	x	x	x	x	x	-0.197077	x	x	x	-0.0834688	x	0.982713	x	
-16266	Metagenome, gastrointestinal system: Microbiome, Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.244724	x	-0.326875	0.8252	x	x	x	x	x	x	-0.0323169	-0.588917	x	x	x	x	x	x	x	x	x	x	-0.672274	x	x	x	x	x	x	x	-0.714803	x	x	x	x	x	x	x	x	x	x	x	-0.673119	-0.212555	x	x	-0.250729	x	0.198623	0.236489	x	x	x	x	-0.302632	x	x	x	-0.220995	-0.180725	-0.0290138	x	x	-0.263404	0.00686757	x	-0.0285666	-0.0511476	-0.231856	-0.136658	x	x	x	-0.208717	x	1.00014	x	x	x	x	x	-0.205904	0.218348	-0.0715149	x	0.86199	x	0.907302	0.617009	x	x	x	x	x	-0.151139	x	x	x	-0.0711263	x	0.997745	x	
-16267	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.666374	x	1.28778	0.587961	x	x	x	x	x	x	0.153322	0.331	x	x	x	x	x	x	x	x	x	x	0.519012	x	x	x	x	x	x	x	0.0777729	x	x	x	x	x	x	x	x	x	x	x	-1.0343	0.415382	x	x	0.469347	x	-0.00773274	-0.160974	x	x	x	x	-0.241509	x	x	x	-0.445406	-0.0953455	-0.288817	x	x	-0.0910713	-0.404969	x	-0.289848	0.996801	0.359467	0.0475529	x	x	x	0.219512	x	0.701748	x	x	x	x	x	0.560564	-0.932489	-0.657249	x	-0.87568	x	-0.362342	-0.161732	x	x	x	x	x	0.594353	x	x	x	0.599039	x	-1.20478	x	
-16268	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.666374	x	1.28778	0.587961	x	x	x	x	x	x	0.153322	0.331	x	x	x	x	x	x	x	x	x	x	0.519012	x	x	x	x	x	x	x	0.0777729	x	x	x	x	x	x	x	x	x	x	x	-1.0343	0.415382	x	x	0.469347	x	-0.00773274	-0.160974	x	x	x	x	-0.241509	x	x	x	-0.445406	-0.0953455	-0.288817	x	x	-0.0910713	-0.404969	x	-0.289848	0.996801	0.359467	0.0475529	x	x	x	0.219512	x	0.701748	x	x	x	x	x	0.560564	-0.932489	-0.657249	x	-0.87568	x	-0.362342	-0.161732	x	x	x	x	x	0.594353	x	x	x	0.599039	x	-1.20478	x	
-16269	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichi (class) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Erysipelotrichi (class) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.666374	x	1.28778	0.587961	x	x	x	x	x	x	0.153322	0.331	x	x	x	x	x	x	x	x	x	x	0.519012	x	x	x	x	x	x	x	0.0777729	x	x	x	x	x	x	x	x	x	x	x	-1.0343	0.415382	x	x	0.469347	x	-0.00773274	-0.160974	x	x	x	x	-0.241509	x	x	x	-0.445406	-0.0953455	-0.288817	x	x	-0.0910713	-0.404969	x	-0.289848	0.996801	0.359467	0.0475529	x	x	x	0.219512	x	0.701748	x	x	x	x	x	0.560564	-0.932489	-0.657249	x	-0.87568	x	-0.362342	-0.161732	x	x	x	x	x	0.594353	x	x	x	0.599039	x	-1.20478	x	
-16270	Metagenome, gastrointestinal system: Microbiome, Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.0296774	x	0.0815978	0.0553438	x	x	x	x	x	x	0.0153972	-0.161755	x	x	x	x	x	x	x	x	x	x	-0.0137528	x	x	x	x	x	x	x	0.0283285	x	x	x	x	x	x	x	x	x	x	x	-0.00885991	0.0634745	x	x	0.0204117	x	-0.0292455	0.0133247	x	x	x	x	0.0943384	x	x	x	-0.0172929	-0.0177875	0.0161917	x	x	0.0577529	-0.0650127	x	-0.0762745	0.00402869	0.0300363	-0.0728906	x	x	x	-0.0503368	x	0.0487216	x	x	x	x	x	-0.0169733	0.00625448	-0.0516014	x	0.0481878	x	-0.093757	-0.0483435	x	x	x	x	x	0.0669109	x	x	x	0.0528318	x	-0.00892617	x	
-16271	Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae Incertae Sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae Incertae Sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.291713	x	-0.161637	-0.104141	x	x	x	x	x	x	0.476806	0.86281	x	x	x	x	x	x	x	x	x	x	-0.23363	x	x	x	x	x	x	x	0.40317	x	x	x	x	x	x	x	x	x	x	x	-0.219648	0.457722	x	x	0.594979	x	0.591208	0.401855	x	x	x	x	-0.173797	x	x	x	0.172929	0.309742	0.171417	x	x	-0.338134	-0.386662	x	0.496834	-0.364225	-0.520103	-0.0857305	x	x	x	-0.463669	x	-1.48526	x	x	x	x	x	-0.236941	-0.400222	-0.499692	x	0.419061	x	-0.16794	-0.482566	x	x	x	x	x	-0.0916087	x	x	x	0.367598	x	0.39776	x	
-16272	Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.428522	x	0.0810765	0.116844	x	x	x	x	x	x	0.455007	0.31158	x	x	x	x	x	x	x	x	x	x	-0.410224	x	x	x	x	x	x	x	-0.0995122	x	x	x	x	x	x	x	x	x	x	x	0.0605468	0.0671499	x	x	0.228891	x	-0.0218005	0.0912356	x	x	x	x	0.171946	x	x	x	0.211844	0.364129	0.0129055	x	x	-0.102911	0.030296	x	0.196323	-0.319809	-0.10675	-0.157542	x	x	x	0.0179584	x	-0.420778	x	x	x	x	x	0.209992	-0.0261196	-0.269106	x	0.0837835	x	-0.0849984	-0.473175	x	x	x	x	x	0.0260585	x	x	x	0.113566	x	0.0701148	x	
-16273	Metagenome, gastrointestinal system: Microbiome, Lactobacillaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.166769	x	-0.0335204	-0.188119	x	x	x	x	x	x	-0.292566	-0.245628	x	x	x	x	x	x	x	x	x	x	0.197213	x	x	x	x	x	x	x	0.234125	x	x	x	x	x	x	x	x	x	x	x	0.0627403	0.0812679	x	x	-0.153935	x	-0.0188299	-0.0221787	x	x	x	x	0.100631	x	x	x	-0.0402408	-0.259882	0.0755088	x	x	0.0810103	-0.0458573	x	-0.1782	0.0461477	0.108648	-0.0562578	x	x	x	-0.0626443	x	0.177345	x	x	x	x	x	-0.0194291	0.0193415	0.0692351	x	0.0911389	x	-0.0677089	-0.0057351	x	x	x	x	x	0.136946	x	x	x	0.0927899	x	-0.050126	x	
-16274	Metagenome, gastrointestinal system: Microbiome, Lactobacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.163324	x	-0.0414604	-0.186893	x	x	x	x	x	x	-0.291532	-0.243622	x	x	x	x	x	x	x	x	x	x	0.187369	x	x	x	x	x	x	x	0.225347	x	x	x	x	x	x	x	x	x	x	x	0.0569694	0.0784068	x	x	-0.15547	x	-0.0225379	-0.0219444	x	x	x	x	0.104223	x	x	x	-0.0398604	-0.251663	0.0721055	x	x	0.0827533	-0.038353	x	-0.179005	0.044831	0.102554	-0.0585214	x	x	x	-0.0480389	x	0.174505	x	x	x	x	x	-0.0196597	0.0203909	0.0681611	x	0.0876842	x	-0.0306362	-0.00948277	x	x	x	x	x	0.130958	x	x	x	0.0877733	x	-0.048675	x	
-16275	Metagenome, gastrointestinal system: Microbiome, Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.166257	x	-0.0344694	-0.188403	x	x	x	x	x	x	-0.293797	-0.242885	x	x	x	x	x	x	x	x	x	x	0.197666	x	x	x	x	x	x	x	0.234947	x	x	x	x	x	x	x	x	x	x	x	0.0620364	0.0811225	x	x	-0.15617	x	-0.019465	-0.0220185	x	x	x	x	0.101186	x	x	x	-0.0400069	-0.258527	0.0749236	x	x	0.0819602	-0.0441376	x	-0.17922	0.0443007	0.108643	-0.0563982	x	x	x	-0.0609753	x	0.177551	x	x	x	x	x	-0.020274	0.0199332	0.0700996	x	0.09102	x	-0.0676415	-0.00611784	x	x	x	x	x	0.136874	x	x	x	0.0926035	x	-0.0506184	x	
-16276	Metagenome, gastrointestinal system: Microbiome, Marinilabilia (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Marinilabilia (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.993771	x	-0.863711	-0.833092	x	x	x	x	x	x	-0.569295	-0.52309	x	x	x	x	x	x	x	x	x	x	-1.05589	x	x	x	x	x	x	x	0.987624	x	x	x	x	x	x	x	x	x	x	x	0.965482	-0.457954	x	x	-0.664574	x	-0.561936	-0.0652021	x	x	x	x	0.177632	x	x	x	0.195705	-0.910036	0.754849	x	x	0.0306079	-0.540057	x	0.412223	0.515941	-1.23032	1.29029	x	x	x	-0.605254	x	-1.09546	x	x	x	x	x	0.199433	1.46076	0.312049	x	0.818112	x	0.967787	0.539845	x	x	x	x	x	-0.864739	x	x	x	-1.21829	x	1.4368	x	
-16277	Metagenome, gastrointestinal system: Microbiome, Prevotellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Prevotellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.721831	x	-1.44635	0.372893	x	x	x	x	x	x	-1.06364	1.38996	x	x	x	x	x	x	x	x	x	x	-0.595141	x	x	x	x	x	x	x	0.577361	x	x	x	x	x	x	x	x	x	x	x	-0.174255	-1.3251	x	x	-0.958788	x	0.38873	-0.558501	x	x	x	x	-0.0725758	x	x	x	0.528854	0.352648	0.659431	x	x	-0.159085	0.393057	x	0.726732	0.023064	-0.526339	0.852699	x	x	x	0.292428	x	-0.542555	x	x	x	x	x	0.89849	0.933052	0.00708122	x	0.113571	x	0.634882	-0.915458	x	x	x	x	x	-1.45368	x	x	x	-0.6826	x	0.607313	x	
-16278	Metagenome, gastrointestinal system: Microbiome, Rikenellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Rikenellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.8277	x	-1.46379	-0.355714	x	x	x	x	x	x	-1.0204	1.02282	x	x	x	x	x	x	x	x	x	x	-1.80803	x	x	x	x	x	x	x	0.643781	x	x	x	x	x	x	x	x	x	x	x	0.899423	-0.641259	x	x	-1.36778	x	-0.00549038	0.3247	x	x	x	x	-0.223113	x	x	x	0.536495	0.0170183	0.314471	x	x	-0.173168	-0.122023	x	0.366687	0.218054	-0.255001	0.916512	x	x	x	0.0963906	x	-0.674298	x	x	x	x	x	0.310403	0.99694	0.759679	x	0.338541	x	0.793746	0.320277	x	x	x	x	x	-1.3553	x	x	x	-1.31313	x	1.07487	x	
-16279	Metagenome, gastrointestinal system: Microbiome, Ruminococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Ruminococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.414616	x	0.176192	0.225687	x	x	x	x	x	x	0.375886	0.265788	x	x	x	x	x	x	x	x	x	x	-0.462219	x	x	x	x	x	x	x	-0.513273	x	x	x	x	x	x	x	x	x	x	x	0.155383	0.0130721	x	x	0.320702	x	-0.210747	0.118105	x	x	x	x	0.13548	x	x	x	-0.00559473	0.581611	-0.212829	x	x	0.0542575	0.173474	x	0.250021	-0.306303	-0.150723	0.0776548	x	x	x	-0.00223868	x	-0.491184	x	x	x	x	x	0.150336	0.106015	-0.336554	x	0.128256	x	-0.173121	-0.298541	x	x	x	x	x	0.160177	x	x	x	-0.0856468	x	0.195492	x	
-16280	Metagenome, gastrointestinal system: Microbiome, TM7 genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, TM7 genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	1.05725	x	-0.944007	0.686322	x	x	x	x	x	x	-0.949877	-1.05493	x	x	x	x	x	x	x	x	x	x	-0.337048	x	x	x	x	x	x	x	-0.72779	x	x	x	x	x	x	x	x	x	x	x	1.01681	0.0639868	x	x	-1.45837	x	-0.830352	0.933026	x	x	x	x	0.379405	x	x	x	0.135504	0.626344	-0.54558	x	x	-0.585176	0.746883	x	0.507109	0.193912	-0.296364	0.162131	x	x	x	-0.428067	x	0.122313	x	x	x	x	x	0.722149	0.719246	0.23496	x	-0.0839088	x	1.08359	-0.0551184	x	x	x	x	x	-1.3781	x	x	x	-0.811472	x	1.09523	x	
-16281	Metagenome, gastrointestinal system: Microbiome, TM7 (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, TM7 (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	1.05725	x	-0.944007	0.686322	x	x	x	x	x	x	-0.949877	-1.05493	x	x	x	x	x	x	x	x	x	x	-0.337048	x	x	x	x	x	x	x	-0.72779	x	x	x	x	x	x	x	x	x	x	x	1.01681	0.0639868	x	x	-1.45837	x	-0.830352	0.933026	x	x	x	x	0.379405	x	x	x	0.135504	0.626344	-0.54558	x	x	-0.585176	0.746883	x	0.507109	0.193912	-0.296364	0.162131	x	x	x	-0.428067	x	0.122313	x	x	x	x	x	0.722149	0.719246	0.23496	x	-0.0839088	x	1.08359	-0.0551184	x	x	x	x	x	-1.3781	x	x	x	-0.811472	x	1.09523	x	
-16282	Metagenome, gastrointestinal system: Microbiome, Turicibacter (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Turicibacter (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.837607	x	1.77119	0.525424	x	x	x	x	x	x	-0.927229	-0.0978546	x	x	x	x	x	x	x	x	x	x	1.03085	x	x	x	x	x	x	x	-0.119392	x	x	x	x	x	x	x	x	x	x	x	-0.965971	-0.372315	x	x	-0.164168	x	-0.0995034	-0.366396	x	x	x	x	-0.149839	x	x	x	-0.182337	-0.184208	-0.337061	x	x	-0.110611	-0.00237705	x	-0.188326	1.63795	-0.391615	0.53696	x	x	x	-0.368476	x	1.26997	x	x	x	x	x	0.141262	-0.298895	-0.331461	x	-0.385042	x	-0.476425	0.229842	x	x	x	x	x	1.21808	x	x	x	-0.379584	x	-0.624843	x	
-16283	Metagenome, gastrointestinal system: Microbiome, Bacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.509227	x	1.34562	0.781456	x	x	x	x	x	x	0.255585	-0.52288	x	x	x	x	x	x	x	x	x	x	-0.159732	x	x	x	x	x	x	x	-1.65041	x	x	x	x	x	x	x	x	x	x	x	-1.38555	0.979671	x	x	-0.164978	x	-0.155753	0.394321	x	x	x	x	-0.264295	x	x	x	-0.0911772	0.165594	-0.863361	x	x	-0.274703	-0.183023	x	-0.612316	-0.436189	-0.35259	0.411867	x	x	x	-0.730184	x	-0.202938	x	x	x	x	x	0.126256	0.358318	-0.151305	x	0.0784648	x	0.564508	0.299649	x	x	x	x	x	0.347337	x	x	x	0.524417	x	1.05909	x	
-16284	Metagenome, gastrointestinal system: Microbiome, Staphylococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Staphylococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.515558	x	1.351	0.769464	x	x	x	x	x	x	0.258365	-0.541316	x	x	x	x	x	x	x	x	x	x	-0.153281	x	x	x	x	x	x	x	-1.64257	x	x	x	x	x	x	x	x	x	x	x	-1.37848	0.98483	x	x	-0.27297	x	-0.194812	0.456249	x	x	x	x	-0.260157	x	x	x	-0.20223	0.173208	-0.847674	x	x	-0.258979	-0.229813	x	-0.596808	-0.421394	-0.352209	0.40805	x	x	x	-0.753018	x	-0.237714	x	x	x	x	x	0.164327	0.42348	-0.110376	x	0.0907167	x	0.567059	0.304335	x	x	x	x	x	0.382058	x	x	x	0.536762	x	1.06834	x	
-16285	Metagenome, gastrointestinal system: Microbiome, Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.53052	x	1.38484	0.735944	x	x	x	x	x	x	0.242675	-0.50985	x	x	x	x	x	x	x	x	x	x	-0.18338	x	x	x	x	x	x	x	-1.60456	x	x	x	x	x	x	x	x	x	x	x	-1.34788	0.999303	x	x	-0.23702	x	-0.147351	0.480623	x	x	x	x	-0.321241	x	x	x	-0.174319	0.159347	-0.857457	x	x	-0.318658	-0.209337	x	-0.581701	-0.406593	-0.360293	0.427809	x	x	x	-0.719009	x	-0.317094	x	x	x	x	x	0.207293	0.280525	-0.0937761	x	0.0432627	x	0.550392	0.341859	x	x	x	x	x	0.412962	x	x	x	0.501139	x	1.09102	x	
-16286	Metagenome, gastrointestinal system: Microbiome, Jeotgalicoccus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Jeotgalicoccus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.39998	x	-0.726933	1.17051	x	x	x	x	x	x	0.397771	-0.834406	x	x	x	x	x	x	x	x	x	x	0.113036	x	x	x	x	x	x	x	-1.06839	x	x	x	x	x	x	x	x	x	x	x	-0.733612	0.108686	x	x	-0.373887	x	-0.327538	0.135225	x	x	x	x	0.310783	x	x	x	-0.15975	0.447092	-0.320143	x	x	0.148086	-0.163575	x	-0.101514	0.00254179	-0.270905	-0.0378914	x	x	x	-0.913629	x	0.239595	x	x	x	x	x	-0.258034	0.909799	-0.118824	x	0.481649	x	0.86244	-0.218316	x	x	x	x	x	0.0535525	x	x	x	0.0422198	x	0.804388	x	
-16287	Metagenome, gastrointestinal system: Microbiome, Bacteroidaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacteroidaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.454638	x	-1.06418	0.814548	x	x	x	x	x	x	-1.46221	1.26315	x	x	x	x	x	x	x	x	x	x	-0.230965	x	x	x	x	x	x	x	-1.01865	x	x	x	x	x	x	x	x	x	x	x	0.950246	-0.829507	x	x	-1.42975	x	-0.258696	0.39728	x	x	x	x	-0.500254	x	x	x	0.782929	0.3355	-0.00611854	x	x	0.480543	0.413909	x	0.177243	0.0746275	-0.141143	0.505859	x	x	x	0.913007	x	-0.86488	x	x	x	x	x	0.246317	0.148124	0.907988	x	-0.174652	x	-0.133395	0.198971	x	x	x	x	x	-0.932641	x	x	x	-0.454647	x	0.436818	x	
-16288	Metagenome, gastrointestinal system: Microbiome, Bacteroides (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Bacteroides (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.454619	x	-1.06418	0.814547	x	x	x	x	x	x	-1.46223	1.26318	x	x	x	x	x	x	x	x	x	x	-0.230937	x	x	x	x	x	x	x	-1.01867	x	x	x	x	x	x	x	x	x	x	x	0.95022	-0.829509	x	x	-1.42968	x	-0.258571	0.39736	x	x	x	x	-0.500147	x	x	x	0.782945	0.335544	-0.00610765	x	x	0.480129	0.41392	x	0.177242	0.0746193	-0.141126	0.505851	x	x	x	0.913006	x	-0.864893	x	x	x	x	x	0.24641	0.148229	0.907645	x	-0.174666	x	-0.133356	0.199048	x	x	x	x	x	-0.932585	x	x	x	-0.454655	x	0.436798	x	
-16289	Metagenome, gastrointestinal system: Microbiome, Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.110449	x	-0.256438	0.0125445	x	x	x	x	x	x	-0.0442753	0.910501	x	x	x	x	x	x	x	x	x	x	-0.107983	x	x	x	x	x	x	x	-0.474307	x	x	x	x	x	x	x	x	x	x	x	0.0783774	0.265936	x	x	-0.255395	x	0.360211	0.438629	x	x	x	x	-0.384531	x	x	x	-0.000326915	0.0699349	0.13694	x	x	0.0716448	0.745071	x	0.224942	0.307481	-0.789893	-0.0254416	x	x	x	0.182263	x	-0.597315	x	x	x	x	x	0.0785046	-0.0701852	0.0968717	x	-0.373935	x	0.34468	-0.315172	x	x	x	x	x	-0.717894	x	x	x	-0.286223	x	0.264334	x	
-16290	Metagenome, gastrointestinal system: Microbiome, Lactobacillus johnsonii (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillus johnsonii (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.440476	x	0.511281	0.0547226	x	x	x	x	x	x	0.244005	-2.47521	x	x	x	x	x	x	x	x	x	x	0.60437	x	x	x	x	x	x	x	0.635076	x	x	x	x	x	x	x	x	x	x	x	0.407482	0.479303	x	x	1.2792	x	0.831303	1.07773	x	x	x	x	0.182013	x	x	x	-0.254376	-3.15311	0.556686	x	x	0.446942	-0.13064	x	0.33951	0.704264	0.514822	0.379683	x	x	x	-4.57336	x	0.39439	x	x	x	x	x	0.949019	-0.365074	-2.57964	x	0.574613	x	-0.78529	0.84578	x	x	x	x	x	1.01271	x	x	x	0.573006	x	0.278322	x	
-16291	Metagenome, gastrointestinal system: Microbiome, Lactobacillus murinus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillus murinus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	1.50579	x	-2.4381	0.960542	x	x	x	x	x	x	-0.338603	1.82928	x	x	x	x	x	x	x	x	x	x	-5.24033	x	x	x	x	x	x	x	1.3068	x	x	x	x	x	x	x	x	x	x	x	0.931507	-0.0424446	x	x	-3.01301	x	-0.335567	1.44443	x	x	x	x	0.288892	x	x	x	1.03771	0.242734	-0.319416	x	x	0.325059	0.778031	x	0.0946134	0.0233313	0.20098	0.18155	x	x	x	0.505762	x	0.673257	x	x	x	x	x	0.672227	1.42131	1.27604	x	-0.401894	x	0.60146	-0.453527	x	x	x	x	x	-3.02855	x	x	x	-1.30083	x	0.610973	x	
-16292	Metagenome, gastrointestinal system: Microbiome, Lactobacillus intestinalis (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Lactobacillus intestinalis (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	1.81682	x	-0.367112	-2.68621	x	x	x	x	x	x	-0.542551	-2.85254	x	x	x	x	x	x	x	x	x	x	-3.09628	x	x	x	x	x	x	x	-0.567343	x	x	x	x	x	x	x	x	x	x	x	3.74495	0.755631	x	x	-3.11009	x	0.272371	0.175533	x	x	x	x	0.225425	x	x	x	-1.38146	-0.647724	0.962051	x	x	0.323943	0.472265	x	0.375084	0.739413	0.700516	0.764339	x	x	x	-3.8941	x	2.54968	x	x	x	x	x	1.65471	3.74254	-1.29901	x	0.780717	x	1.34902	0.513291	x	x	x	x	x	-0.83864	x	x	x	-2.54795	x	1.91271	x	
-16293	Metagenome, gastrointestinal system: Microbiome, Staphylococcus xylosus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Staphylococcus xylosus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.934974	x	1.8781	1.12797	x	x	x	x	x	x	0.710625	-0.104845	x	x	x	x	x	x	x	x	x	x	-0.257789	x	x	x	x	x	x	x	-4.99798	x	x	x	x	x	x	x	x	x	x	x	-0.753829	1.31617	x	x	-1.39833	x	-0.398366	1.5167	x	x	x	x	-0.263134	x	x	x	-0.693281	0.647897	-1.53654	x	x	-0.424516	-1.02842	x	-0.820257	-3.41658	-1.41836	1.76161	x	x	x	1.10594	x	0.499455	x	x	x	x	x	0.812163	-0.360838	1.15982	x	0.966136	x	0.972458	0.359042	x	x	x	x	x	0.887055	x	x	x	-0.754912	x	1.97186	x	
-16294	Metagenome, gastrointestinal system: Microbiome, Staphylococcus lentus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Staphylococcus lentus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	-0.912678	x	-2.52861	2.79972	x	x	x	x	x	x	2.56917	-2.36757	x	x	x	x	x	x	x	x	x	x	0.272821	x	x	x	x	x	x	x	-2.99654	x	x	x	x	x	x	x	x	x	x	x	-2.11249	0.21923	x	x	-1.6836	x	0.33462	0.923161	x	x	x	x	0.283263	x	x	x	0.0818799	-0.62505	-2.77466	x	x	0.145681	-2.15993	x	-0.12598	-1.79644	-0.381589	2.15396	x	x	x	-3.84856	x	1.10337	x	x	x	x	x	0.487053	2.61348	-0.0509118	x	2.46408	x	2.57232	-1.98981	x	x	x	x	x	2.55709	x	x	x	2.33023	x	2.44328	x	
-16295	Metagenome, gastrointestinal system: Microbiome, Barnsiella (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	None	Metagenome, gastrointestinal system: Microbiome, Barnsiella (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]	0.00304035	x	-2.64151	0.300188	x	x	x	x	x	x	0.840267	0.420511	x	x	x	x	x	x	x	x	x	x	-0.0688201	x	x	x	x	x	x	x	0.504685	x	x	x	x	x	x	x	x	x	x	x	0.923472	-2.66217	x	x	0.351238	x	0.17233	0.249233	x	x	x	x	-0.978736	x	x	x	0.518873	0.642998	0.149715	x	x	-0.626442	1.00393	x	0.610731	0.780141	-0.0834485	0.834213	x	x	x	0.951121	x	-0.310491	x	x	x	x	x	0.566277	0.174957	1.27112	x	0.0354868	x	0.453424	0.532845	x	x	x	x	x	-3.13209	x	x	x	-2.25496	x	0.467885	x	
-16296	Original post publication description: Delprato_Crusio_1 Original pre publication description: Delprato_Crusio_1	Delprato_Crusio_1	Unpublished	x	x	4.111	1.894	1.815	2.462	x	1.966	3.171	x	2.378	x	2.071	2.075	1.334	2.129	2.685	1.731	x	2.506	x	x	x	x	x	2.497	2.88	x	x	2.268	1.678	3.061	2.196	x	x	x	x	2.518	2.573	x	1.831	2.403	2.354	x	x	x	1.659	2.595	2.548	3.363	x	x	x	x	x	x	x	x	x	3.816	4.201	x	x	2.567	2.578	x	1.899	3.774	3.218	2.829	x	2.167	x	2.643	x	1.434	x	x	2.308	1.623	x	x	1.832	1.774	1.417	2.35	x	2.601	2.871	x	1.376	x	x	x	2.16	2.188	2.05	x	2.441	2.139	2.675	x	
-16297	Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD97, BXD92, and BXD65 have been merged together.) [cells/mm^3]	None	Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged) [cells/mm^3]	532285.0	496127.0	454220.0	476437.0	457598.0	x	430738.0	446377.0	495641.0	420529.0	430495.0	450736.0	466350.0	414452.0	446295.0	x	x	x	x	x	x	433777.0	x	x	x	440170.0	x	x	x	412741.0	201980.0	417369.0	459468.0	x	453167.0	x	483159.0	444788.0	425391.0	x	x	447714.0	391360.0	476600.0	x	x	425658.0	x	464332.0	463797.0	x	x	x	424639.0	481688.0	x	x	x	430323.0	496734.0	487072.0	435697.0	465094.0	478381.0	470057.0	417661.0	x	438878.0	439927.0	514277.0	x	465223.0	483608.0	472325.0	x	507147.0	x	x	x	489766.0	x	x	426039.0	466512.0	465378.0	409347.0	x	471576.0	447365.0	x	x	x	x	x	x	x	451449.0	x	x	x	x	x	
-16298	Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD97, BXD92, and BXD65 have been merged together. BXD96 and BXD48 have been merged together. BXD80 and BXD73 have been merged together.) [n x10^6]	None	Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged ) [n x10^6]	8415350.0	8330980.0	7947670.0	9018000.0	8242460.0	x	7029650.0	7539990.0	7841040.0	6142620.0	7959680.0	7301560.0	7484060.0	6285550.0	8225400.0	x	x	x	x	x	x	7957070.0	x	x	x	7126990.0	x	x	x	7008420.0	3507350.0	6066040.0	7376060.0	x	8656460.0	x	7898080.0	7498950.0	6637860.0	x	x	7896080.0	5969000.0	7419700.0	x	x	6678710.0	x	7355900.0	7282700.0	x	x	x	6925380.0	8706560.0	x	x	x	7406900.0	8189850.0	7637950.0	7291650.0	7827120.0	7936540.0	7283880.0	7051910.0	x	7067820.0	6100370.0	8228570.0	x	7569900.0	7277860.0	7143290.0	x	8119760.0	x	x	x	7704030.0	x	x	6637680.0	7419100.0	7167640.0	6332600.0	x	7440620.0	7315010.0	x	x	x	x	x	x	x	6783890.0	x	x	x	x	x	
-16310	Original post publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]	2.197	-1.227	-2.041	-1.217	0.81	-0.779	-2.989	0.976	-0.059	0.337	-3.842	-2.248	1.573	-3.876	0.963	0.429	-1.55	1.31	-1.58	-4.528	0.926	-1.357	x	2.605	2.237	0.704	4.621	0.472	x	-6.725	4.665	1.626	0.17	x	-0.793	x	-9.0	1.081	-2.872	x	-2.402	4.062	x	2.161	x	x	5.478	x	2.01	1.428	x	x	x	-3.818	x	x	x	x	2.662	0.127	-3.348	0.728	2.767	-0.909	-0.551	-0.059	3.334	8.203	1.584	x	x	2.13	-5.027	-4.22	-5.99	2.084	x	-3.466	2.186	x	x	-0.236	5.29	-2.253	3.875	7.865	x	0.928	0.218	x	0.899	-4.638	-1.507	x	-0.423	-0.508	-1.64	2.742	x	x	x	x	
-16300	Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) without strain merge, unilateral per retina in young adults of both sexes [cells/mm^3]	None	Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones), unilateral per retina in young adults of both sexes [cells/mm^3]	532285.0	496127.0	454220.0	476437.0	457598.0	x	430738.0	446377.0	495641.0	420529.0	430495.0	450736.0	466350.0	414452.0	446295.0	x	x	x	x	x	x	433777.0	x	x	x	440170.0	x	x	x	412741.0	201980.0	417369.0	459468.0	x	453167.0	x	483159.0	444788.0	425391.0	x	x	447714.0	391360.0	476600.0	x	x	429863.0	x	464332.0	463797.0	x	x	x	424639.0	481688.0	x	x	x	430323.0	496734.0	487072.0	435697.0	465094.0	473354.0	470057.0	417661.0	x	438878.0	439927.0	514277.0	x	454852.0	483608.0	472325.0	x	507147.0	x	x	475595.0	489766.0	x	x	426039.0	466512.0	465378.0	409347.0	x	471576.0	447365.0	x	506701.0	x	x	x	421453.0	459746.0	451449.0	x	x	x	x	x	
-16301	Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones) without strain mergence, unilateral per retina in young adults of both sexes [n x10^6]	None	Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes [n x10^6]	8415350.0	8330980.0	7947670.0	9018000.0	8242460.0	x	7029650.0	7539990.0	7841040.0	6142620.0	7959680.0	7301560.0	7484060.0	6285550.0	8225400.0	x	x	x	x	x	x	7957070.0	x	x	x	7126990.0	x	x	x	7008420.0	3507350.0	6066040.0	7376060.0	x	8656460.0	x	7898080.0	7498950.0	6637860.0	x	x	7896080.0	5969000.0	7419700.0	x	x	6577300.0	x	7355900.0	7282700.0	x	x	x	6925380.0	8706560.0	x	x	x	7406900.0	8189850.0	7637950.0	7291650.0	7827120.0	7941770.0	7283880.0	7051910.0	x	7067820.0	6100370.0	8228570.0	x	7244620.0	7277860.0	7143290.0	x	8119760.0	x	x	7895190.0	7704030.0	x	x	6637680.0	7419100.0	7167640.0	6332600.0	x	7440620.0	7315010.0	x	8309400.0	x	x	x	6780120.0	7634070.0	6783890.0	x	x	x	x	x	
-16302	Original post publication description: AVG Baseline TST Immobility (sec) entered at August/28 16:21:00 from IP 172.21.162.34	None	AVG Baseline TST Immobility (sec) entered at August/28 16:21:00 from IP 172.21.162.34	x	81.514	110.583	85.0	16.467	x	x	x	x	55.9	x	x	x	x	x	x	x	x	x	x	x	x	x	48.4	x	x	x	108.8	x	x	58.133	x	130.033	x	x	x	x	104.443	102.4	x	x	x	x	x	x	x	139.4	x	x	59.763	x	x	x	x	x	x	x	x	62.237	x	79.471	66.74	70.0	104.36	151.3	x	73.033	61.975	x	x	x	37.48	136.914	x	x	72.167	x	104.3	x	x	x	x	126.167	x	83.287	124.587	x	46.871	80.267	x	x	x	x	149.457	x	x	x	x	113.933	129.617	142.917	x	
-16303	Original post publication description: Central nervous system; post-natal neurogenesis; Apoptosis in cortex L5 (% caspase 3+ cells)	None	Central nervous system; post-natal neurogenesis; Apoptosis in cortex L5 (% caspase 3+ cells)	x	x	6.674	12.887	x	4.349	x	x	x	x	x	x	x	x	x	x	x	x	5.287	x	x	x	x	x	x	x	x	x	x	x	1.029	x	x	x	x	x	x	7.112	x	x	x	x	x	x	x	x	x	x	x	3.234	x	x	x	x	x	x	x	x	2.806	x	x	x	x	x	x	x	x	x	x	2.119	x	6.731	x	x	x	x	x	x	7.279	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	7.733	x	x	x	7.615	x	x	5.96	
-16304	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in males Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in males	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit]	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit]	x	x	x	x	x	x	x	x	x	x	x	250.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	500.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	275.0	x	x	x	x	x	225.0	250.0	x	x	x	x	x	x	175.0	400.0	425.0	x	x	x	175.0	x	x	x	x	x	x	x	350.0	300.0	x	x	x	x	x	250.0	x	x	x	x	350.0	300.0	x	375.0	80.0	200.0	225.0	400.0	x	
-16305	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in females Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in females	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit]	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit]	x	x	x	x	x	x	x	x	x	x	x	300.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	700.0	x	x	x	x	x	x	x	x	x	600.0	x	x	x	x	x	x	x	x	x	x	125.0	x	x	x	x	x	150.0	500.0	x	x	x	x	x	x	175.0	150.0	400.0	x	x	x	x	x	x	x	x	x	x	x	225.0	300.0	x	x	550.0	x	300.0	425.0	x	x	x	x	x	800.0	x	600.0	90.0	300.0	350.0	x	500.0	
-16306	Original post publication description: Jamboree: 2013 Birthdays Original pre publication description: Jamboree2013 secret trait	Jamboree2013 secret trait	Jamboree: 2013 Birthdays	x	x	11.0	21.0	1.0	27.0	3.0	20.0	7.0	10.0	21.0	21.0	30.0	12.0	10.0	16.0	23.0	28.0	8.0	29.0	11.0	13.0	28.0	5.0	23.0	20.0	27.0	32.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16307	Original post publication description: I entered at September/15 10:11:36 from IP 109.43.26.119	Delprato A, Crusio W Trait 1	Unpublished	x	x	4.111	1.894	1.815	2.462	x	1.966	3.171	x	2.378	x	2.071	2.075	1.334	2.129	2.685	1.731	x	2.506	x	x	x	x	x	2.497	2.88	x	x	2.268	1.678	3.061	2.196	x	x	x	x	2.518	2.573	x	1.831	2.403	2.354	x	x	x	1.659	2.595	2.548	3.363	x	x	x	x	x	x	x	x	x	3.816	4.201	x	x	2.567	2.578	x	1.899	3.774	3.218	2.829	x	2.167	x	2.643	x	1.434	x	x	2.308	1.623	x	x	1.832	1.774	1.417	2.35	x	2.601	2.871	x	1.376	x	x	x	2.16	2.188	2.05	x	2.441	2.139	2.675	x	
-16308	Original post publication description: H entered at September/15 10:11:36 from IP 109.43.26.119	None	H entered at September/15 10:11:36 from IP 109.43.26.119	x	x	12.76	8.497	9.941	8.418	x	10.851	9.239	x	9.083	x	12.083	9.854	8.103	8.918	8.724	10.399	x	9.156	x	x	x	x	x	10.217	9.832	x	x	11.175	9.093	9.499	7.485	x	x	x	x	9.573	11.156	x	10.404	7.597	9.43	x	x	x	9.346	10.712	10.367	8.53	x	x	x	x	x	x	x	x	x	11.026	10.652	x	x	10.392	9.34	x	9.457	10.361	10.162	8.185	x	9.334	x	8.637	x	8.039	x	x	9.64	9.987	x	x	9.499	9.51	8.946	8.789	x	8.425	9.167	x	11.03	x	x	x	8.945	8.448	9.317	x	7.761	9.564	10.817	x	
-16309	Original post publication description: Neurogenesis entered at September/16 10:24:03 from IP 77.24.242.160 Original pre publication description: New neurons in the dentate gyrus corrected for number of proliferating precursors. Derived from RecordIDs 10797 and 10795. Meta-trait from the Neuroinformatics Jamboree 2013.	Central nervous system: New neurons in the dentate gyrus corrected for number of proliferating precursors (data derived from Record IDs 10797 and 10795) [z score]	Central nervous system: New neurons in the dentate gyrus corrected for number of proliferating precursors (data derived from Record IDs 10797 and 10795) [z score]	x	x	x	x	-0.393	-0.461	0.921	0.588	x	-0.078	-0.83	0.197	x	0.005	0.273	-0.407	-0.173	0.277	x	0.387	-0.34	x	x	0.296	-0.534	0.115	-0.327	-0.75	0.017	0.316	-0.301	-0.039	0.19	0.282	x	x	0.324	-0.46	0.879	x	0.025	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16311	Original post publication description: Central nervous system, behavior: Impulsivity measured by 5-choice serial reaction time task [n] Original pre publication description: SD1_PremPokesTotalPokes entered at September/19 04:49:47 from IP 77.24.69.98	spijker001	spijker001	4.278	5.791	8.772	14.759	9.184	5.787	x	8.833	x	9.546	8.936	x	11.081	8.996	11.911	31.855	x	8.006	x	11.051	x	6.582	11.701	x	x	12.597	6.045	5.065	x	5.073	12.507	11.423	5.388	x	x	x	11.295	2.087	13.135	x	10.415	14.759	x	x	x	x	x	x	x	13.221	x	x	x	5.685	x	x	x	x	x	5.456	3.926	x	x	12.435	x	x	21.456	17.901	x	x	x	7.274	x	7.709	x	x	x	x	x	x	x	x	x	x	5.354	5.275	x	x	9.33	x	x	x	x	x	10.178	7.337	x	x	x	x	x	x	
-16312	Original post publication description: Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time] Original pre publication description: Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time]	Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time]	Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time]	x	x	26.0	12.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	18.0	x	37.0	x	x	x	x	30.0	x	x	x	x	x	x	x	x	10.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16.0	x	x	6.0	x	x	x	13.0	x	x	x	8.0	x	x	x	x	x	x	x	x	x	22.0	x	4.0	x	x	x	x	x	11.0	22.0	x	x	x	13.0	x	x	25.0	
-16313	Original post publication description: Pre-immunization weight (grams) Original pre publication description: Response of BXD female mice to immunization with TSHR A-subunit (human) adenovirus	Morphology, cofactor : Body weight of young adult females before immunization with TSHR A-subunit (human) adenovirus (see Traits 16314-16323 by McLachlan and colleagues) [g]	Morphology, cofactor : Body weight of young adult females before immunization with TSHR A-subunit (human) adenovirus (see Traits 16314 by McLachlan and colleagues) [g]	x	x	x	x	18.5	19.3	19.5	17.8	17.9	24.3	18.0	16.4	24.4	24.8	19.8	16.9	20.4	20.5	x	17.7	16.9	x	x	17.3	x	16.7	19.2	18.6	x	16.7	18.0	14.8	20.3	x	18.5	x	21.9	17.1	18.5	x	17.8	17.4	16.9	17.7	x	x	22.8	22.5	16.5	20.4	x	x	x	17.3	21.4	x	x	x	17.4	18.3	17.3	x	21.3	x	19.7	19.5	17.0	15.9	17.0	18.5	x	14.3	16.7	19.1	x	28.3	x	20.5	19.9	15.7	x	19.7	x	22.7	18.3	15.3	x	16.8	18.9	x	x	x	x	x	18.7	20.1	16.9	x	18.9	19.5	18.1	15.0	
-16314	Original post publication description: TBI-0x Original pre publication description: TBI-0x: Immune system: TBI-0x:serum inhibition of TSH binding to the TSHR before immunization (% inhibition)	Immune system: TBI-0x, pre-immunization serum inhibition of TSH binding to the TSHR [% inhibition]	Immune system, endocrinology: serum inhibition of TSH binding to the TSHR before immunization [% inhibition]	x	x	x	x	-0.1	6.2	9.6	5.1	6.9	11.2	12.0	21.8	5.6	3.7	13.9	6.4	14.8	7.4	x	5.6	-0.5	x	x	4.9	x	8.8	1.7	1.0	x	3.7	10.2	3.4	8.8	x	1.5	x	4.83	3.0	4.8	x	3.4	3.3	0.5	11.8	x	x	0.0	0.71	7.5	6.5	x	x	x	1.0	-0.1	x	x	x	5.1	2.7	23.1	x	0.7	x	4.9	4.8	1.8	7.0	3.2	6.5	x	1.9	-1.4	10.6	x	5.3	x	9.7	7.1	0.7	x	20.8	x	5.9	10.8	-1.2	x	9.9	2.5	x	x	x	x	x	6.2	8.1	-1.3	x	3.9	1.6	8.36	4.9	
-16315	Original post publication description: TBI-2x Original pre publication description: Immune system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus	Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition]	Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition]	x	x	x	x	51.7	67.6	39.5	42.8	69.0	32.5	27.9	57.6	84.8	79.2	55.1	19.3	49.2	58.7	x	46.2	77.0	x	x	50.3	x	38.0	21.2	53.2	x	18.2	31.1	26.9	x	x	58.4	x	53.5	56.4	43.4	x	75.3	72.7	44.8	59.0	x	x	39.9	76.3	30.6	x	x	x	x	79.1	x	x	x	x	56.1	58.3	37.1	x	53.1	x	44.8	68.5	64.7	44.3	31.0	34.5	x	37.6	60.8	67.1	x	62.7	x	10.8	35.9	77.7	x	82.0	x	39.8	57.4	32.6	x	65.7	45.4	x	x	x	x	x	59.0	54.3	59.8	x	75.9	63.0	72.2	21.2	
-16316	Original post publication description: TBI-3x Original pre publication description: # TBI-3x: Immune system, serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus (% inhibition)	Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females [% inhibition]	Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females [% inhibition]	x	x	x	x	46.0	87.1	39.9	52.2	62.4	36.8	21.7	33.6	83.6	82.5	55.6	20.8	34.6	59.6	x	39.6	69.0	x	x	58.1	x	43.4	24.5	67.3	x	21.8	41.5	24.9	45.7	x	60.0	x	48.8	51.3	32.6	x	71.9	73.5	37.0	67.1	x	x	53.1	66.0	33.1	54.8	x	x	x	82.5	27.0	x	x	x	47.2	64.9	43.4	x	65.2	x	47.2	83.1	65.7	35.7	25.6	29.8	x	39.7	74.3	83.2	x	52.8	x	8.7	40.0	74.7	x	82.1	x	72.7	56.7	33.4	x	75.2	57.2	x	x	x	x	x	56.6	58.5	62.9	x	79.0	77.0	64.3	38.0	
-16317	Original post publication description: T4 -0x Original pre publication description: Endocrine system: T4-0x, serum thyroxine (T4) at base-line (micrograms/dL)	Endocrine system, thyroid: T4-0x, serum thyroxine (T4) before immunization with TSHR A-subunit adenovirus [micrograms/dL]	Endocrine system, thyroid: T4-0x, serum thyroxine (T4) before immunization with TSHR A-subunit adenovirus [micrograms/dL]	x	x	x	x	2.9	4.0	4.6	2.5	3.8	2.7	3.4	3.1	2.5	3.5	2.8	2.2	2.6	1.9	x	3.8	2.0	x	x	3.7	x	2.7	5.2	4.4	x	3.0	2.8	2.6	3.5	x	3.3	x	3.02	3.4	4.1	x	3.7	3.9	4.3	5.2	x	x	2.7	3.33	5.1	4.2	x	x	x	6.4	4.1	x	x	x	3.7	3.2	2.3	x	2.7	x	5.7	6.5	3.4	2.4	5.2	3.2	x	2.8	3.2	1.8	x	3.5	x	3.4	2.5	3.2	x	4.66	x	3.0	5.1	3.5	x	4.3	3.8	x	x	x	x	x	2.4	4.5	x	x	4.1	4.02	3.25	2.6	
-16318	Original post publication description: T4 -2x Original pre publication description: Endocrine system: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus (micrograms/dL)	Endocrine system, thyroid: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus [micrograms/dL]	Endocrine system, thyroid: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus [micrograms/dL]	x	x	x	x	2.6	3.2	3.4	2.4	3.1	2.6	3.1	3.0	3.5	4.9	3.4	2.8	4.2	2.4	x	5.0	2.4	x	x	2.7	x	3.5	4.3	3.3	x	3.1	2.1	2.4	x	x	4.7	x	2.8	3.2	2.2	x	4.3	4.7	3.0	4.8	x	x	3.5	5.1	3.3	x	x	x	x	10.4	x	x	x	x	4.5	2.8	2.3	x	2.1	x	4.1	8.4	3.3	2.7	3.6	3.2	x	3.0	1.7	2.3	x	3.6	x	3.9	2.1	7.5	x	4.7	x	3.6	3.9	3.7	x	3.7	4.3	x	x	x	x	x	3.2	4.2	x	x	6.5	6.0	4.2	2.0	
-16319	Original post publication description: T4 -3x Original pre publication description: Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL]	Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL]	Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL]	x	x	x	x	1.9	1.4	2.8	1.9	3.5	3.4	1.8	2.8	3.2	3.9	2.4	1.9	2.7	2.5	x	2.6	2.4	x	x	2.1	x	3.1	2.8	4.4	x	1.9	2.0	2.3	2.7	x	4.8	x	3.0	2.5	1.5	x	3.5	2.0	3.6	3.3	x	x	3.1	2.4	2.8	3.5	x	x	x	5.4	3.3	x	x	x	2.6	2.0	2.0	x	3.3	x	4.3	5.1	2.7	2.7	4.7	2.5	x	2.5	1.4	2.3	x	3.7	x	2.8	1.9	4.6	x	3.82	x	2.0	2.4	3.3	x	3.9	3.1	x	x	x	x	x	2.6	2.5	x	x	6.0	3.6	3.0	1.9	
-16320	Original post publication description: ELISA-2x Original pre publication description: Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm]	Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm]	Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm]	x	x	x	x	1.53	1.17	1.69	0.9	1.48	1.35	0.74	1.3	1.04	1.03	1.23	0.79	1.1	1.55	x	1.41	1.41	x	x	1.47	x	0.73	1.81	0.9	x	1.23	0.92	1.12	x	x	1.19	x	1.28	1.2	1.37	x	1.46	1.3	2.13	1.62	x	x	1.52	1.01	1.84	x	x	x	x	1.53	x	x	x	x	1.32	1.69	1.42	x	1.97	x	1.4	1.52	1.05	1.43	1.38	1.79	x	0.9	1.43	1.57	x	1.63	x	0.85	1.15	1.57	x	1.61	x	1.25	1.56	1.5	x	1.57	1.26	x	x	x	x	x	1.38	1.25	1.65	x	1.54	1.42	1.25	0.8	
-16321	Original post publication description: ELISA-3x Original pre publication description: ELISA-3x: Immune system, ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm]	Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm]	Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm]	x	x	x	x	1.22	0.75	1.62	0.68	1.11	1.12	0.56	0.64	0.79	0.37	1.01	0.45	0.44	0.51	x	0.91	0.69	x	x	1.33	x	0.63	1.0	1.34	x	0.58	0.38	0.76	0.98	x	0.63	x	0.99	0.854	0.6	x	0.77	1.23	1.08	0.29	x	x	1.49	0.48	0.86	1.3	x	x	x	1.21	1.22	x	x	x	1.38	1.39	0.99	x	1.06	x	1.16	1.2	0.6	0.77	0.29	1.38	x	0.57	1.35	0.7	x	1.1	x	0.27	0.69	0.87	x	1.06	x	1.12	1.43	1.42	x	1.09	0.92	x	x	x	x	x	1.22	1.21	1.27	x	1.2	0.87	1.15	0.29	
-16322	Original post publication description: Serum thyroxine (T4) 1 week after 2 immunization of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Original pre publication description: Endocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunization of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	Endocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	Enodocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	x	x	x	x	-0.3	-0.8	-1.3	-0.1	-0.7	-0.1	-0.3	-0.1	1.1	1.4	0.6	0.7	1.7	0.5	x	1.2	0.4	x	x	-1.0	x	0.8	-0.9	-1.2	x	0.1	-0.7	-0.2	x	x	1.4	x	-0.2	-0.2	-1.8	x	0.6	0.9	-1.3	-0.4	x	x	0.8	1.8	-1.7	x	x	x	x	4.1	x	x	x	x	0.8	-0.4	0.0	x	-0.5	x	-1.6	1.9	-0.1	0.3	-1.6	-0.1	x	0.1	-1.5	0.5	x	0.1	x	0.5	-0.3	4.3	x	0.1	x	0.6	-1.2	0.2	x	-0.6	0.5	x	x	x	x	x	0.8	-0.3	x	x	2.4	2.0	1.0	-0.6	
-16323	Original post publication description: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Original pre publication description: Endocrine system, thyroid: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	Endocrine system, thyroid: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]	x	x	x	x	-1.1	-2.6	-1.8	-0.6	-0.3	0.7	-1.6	-0.3	0.7	0.4	-0.4	-0.3	0.2	0.6	x	-1.2	0.4	x	x	-1.6	x	0.4	-2.4	-0.1	x	-1.2	-0.9	-0.4	-0.8	x	1.5	x	0.0	-0.9	-2.6	x	-0.2	-1.8	-0.7	-1.9	x	x	0.3	-1.0	-2.2	-0.6	x	x	x	-1.0	-0.9	x	x	x	-1.1	-1.2	-0.3	x	0.6	x	-1.4	-1.4	-0.7	0.3	-0.5	-0.8	x	-0.4	-1.8	0.6	x	0.2	x	-0.6	-0.6	1.5	x	-0.8	x	-1.0	-2.7	-0.2	x	-0.4	-0.7	x	x	x	x	x	0.3	-2.0	x	x	1.9	-0.5	-0.2	-0.7	
-16341	None	Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	x	x	13.0909	12.5	14.6	15.75	x	12.5	17.75	21.0	15.5	10.3	13.25	x	13.8	14.5	14.1429	12.5	8.25	x	16.3333	x	12.6667	18.0	13.8	18.75	18.25	14.75	x	13.75	14.0	19.125	18.6875	x	x	x	12.75	13.375	11.85	x	10.25	12.25	13.2143	14.25	x	x	10.9791	x	9.7	21.8333	x	x	x	18.25	18.1	x	x	x	10.6	15.7083	14.3636	16.25	x	13.3637	12.5	17.0	11.5833	13.5294	14.1667	12.9444	x	16.5641	x	13.6667	x	10.6875	x	x	x	x	x	11.5	13.5	11.9286	16.9	21.7174	x	12.2222	14.5	x	13.9167	x	x	16.0	x	x	14.1	14.375	16.4375	9.5	10.6	x	
-16342	None	Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	16.6053	17.8125	14.7273	17.0385	17.1364	14.4444	16.8214	14.9231	17.9375	16.8958	15.4634	15.6346	14.1552	18.4348	15.9355	16.4231	16.4423	15.3942	14.2931	19.0	16.4	x	16.1562	18.05	13.8	18.7763	18.5833	16.1167	x	14.0323	14.8333	16.25	16.9891	16.25	15.175	x	12.2581	13.5857	13.1429	x	13.0435	15.4574	16.4322	13.5755	x	x	14.6202	x	13.7959	15.6667	x	x	x	16.0175	15.9091	x	x	x	15.1885	17.2154	15.8148	18.0	x	14.0887	19.32	15.9583	16.2727	15.8857	15.8559	13.9118	x	17.3621	x	13.91	x	14.8302	x	x	x	x	x	15.3516	14.6228	15.1449	17.3824	19.35	x	14.9135	15.119	x	15.0	x	x	17.1047	x	x	13.6444	18.5167	15.4925	11.1724	16.3298	x	
-16338	None	Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	17.375	18.0	15.6667	17.1833	18.5	x	17.5909	17.75	x	17.5625	16.8636	18.375	13.7222	18.0	18.3	17.0	17.3	14.2059	16.9545	21.75	x	x	16.9286	x	x	17.8	x	18.125	x	15.75	15.5714	15.4	13.625	16.25	18.0	x	12.5	13.6667	12.6	x	14.9375	14.5455	14.875	11.75	x	x	16.1875	x	15.0	14.1538	x	x	x	15.587	13.8333	x	x	x	16.45	17.5	16.4545	19.1154	x	14.2882	20.0833	14.0625	15.1786	16.8611	17.2353	15.0714	x	17.9961	x	12.7143	x	15.4167	x	x	x	x	x	14.875	14.9615	15.8235	18.3214	17.5556	x	16.25	14.95	x	14.4	x	x	18.0	x	x	13.5	21.3	14.8889	8.75	16.9688	x	
-16339	None	Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	16.5	20.15	15.1	19.1731	17.25	16.125	20.0833	16.0	18.9286	17.375	15.6	17.0	16.3	18.5833	16.5	14.875	17.75	17.9643	13.5	13.5	16.5	x	18.625	19.125	x	22.125	18.75	15.0833	x	15.1667	16.25	17.0	17.3571	x	14.5833	x	13.3182	12.6111	13.4	x	12.0	15.8571	16.6667	13.4211	x	x	13.0104	x	13.15	14.8182	x	x	x	17.2	14.0	x	x	x	17.3611	18.1667	14.8846	19.125	x	14.373	22.5	17.0833	18.7059	16.8636	17.7083	14.75	x	18.0268	x	15.3636	x	15.8214	x	x	x	x	x	15.7059	15.1429	16.7368	18.1875	21.0385	x	17.3636	17.8125	x	19.0	x	x	19.9375	x	x	12.1667	18.3333	14.1538	12.7	18.6875	x	
-16330	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive]	x	x	1.0	0.0	0.0	x	x	x	x	0.0	x	1.0	0.0	x	x	x	x	x	x	x	1.0	x	x	x	x	0.0	x	x	x	x	x	x	x	x	x	x	1.0	x	x	x	x	0.182	x	1.0	x	x	x	1.0	1.0	x	x	x	x	1.0	x	x	x	x	x	x	0.188	0.0	0.211	1.0	0.75	0.25	0.0	0.0	x	x	x	0.1	0.875	0.5	x	x	x	x	1.0	0.0	x	x	x	x	0.2	1.0	x	x	1.0	x	x	x	x	0.5	0.167	x	x	x	x	1.0	x	0.667	
-16331	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days]	x	x	11.0	3.13	3.5	x	x	x	x	3.333	x	11.0	3.25	x	x	x	x	x	x	x	11.0	x	x	x	x	7.0	x	x	x	x	x	x	x	x	x	x	11.0	x	x	x	x	5.182	x	11.0	x	x	x	11.0	11.0	x	x	x	x	11.0	x	x	x	x	x	x	5.188	3.25	5.737	11.0	9.5	5.625	3.25	4.0	x	x	x	4.5	10.75	8.0	x	x	x	x	11.0	3.5	x	x	x	x	5.0	11.0	x	x	11.0	x	x	x	x	7.5	5.083	x	x	x	x	11.0	x	8.917	
-16332	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight]	x	x	1.592	1.979	4.069	x	x	x	x	1.706	x	3.409	3.314	x	x	x	x	x	x	x	-0.108	x	x	x	x	-0.434	x	x	x	x	x	x	x	x	x	x	x	9.0	x	x	x	3.458	x	1.936	x	x	x	0.12	1.95	x	x	x	x	-0.02	x	x	x	x	x	x	4.14	2.015	2.794	2.418	5.44	2.644	6.311	4.442	x	x	x	0.897	2.453	1.949	x	x	x	x	2.583	0.649	x	x	x	x	2.982	1.008	x	x	-0.067	x	x	x	x	1.048	2.445	x	x	x	x	2.179	x	1.674	
-16333	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight]	x	x	10.166	13.025	9.853	x	x	x	x	6.585	x	16.265	13.28	x	x	x	x	x	x	x	12.475	x	x	x	x	5.552	x	x	x	x	x	x	x	x	x	x	x	17.111	x	x	x	11.925	x	15.282	x	x	x	6.782	5.397	x	x	x	x	14.422	x	x	x	x	x	x	12.432	14.068	9.305	4.264	14.804	10.54	14.991	13.547	x	x	x	11.679	11.22	13.759	x	x	x	x	12.309	6.706	x	x	x	x	14.666	12.792	x	x	7.724	x	x	x	x	11.585	9.973	x	x	x	x	10.105	x	11.767	
-16334	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight]	x	x	7.48	18.326	15.653	x	x	x	x	7.812	x	13.072	19.757	x	x	x	x	x	x	x	12.511	x	x	x	x	16.31	x	x	x	x	x	x	x	x	x	x	x	13.278	x	x	x	15.697	x	13.443	x	x	x	6.935	5.622	x	x	x	x	12.509	x	x	x	x	x	x	16.745	17.76	14.635	1.275	20.809	15.154	22.142	18.774	x	x	x	16.508	11.225	16.47	x	x	x	x	14.169	10.152	x	x	x	x	20.882	10.459	x	x	2.508	x	x	x	x	15.408	15.236	x	x	x	x	15.778	x	14.525	
-16335	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight]	x	x	6.79	21.15	16.168	x	x	x	x	9.673	x	11.176	24.646	x	x	x	x	x	x	x	7.121	x	x	x	x	20.995	x	x	x	x	x	x	x	x	x	x	x	10.722	x	x	x	18.125	x	11.889	x	x	x	3.649	4.242	x	x	x	x	9.274	x	x	x	x	x	x	20.053	27.717	18.033	-0.835	20.633	19.317	23.614	21.695	x	x	x	19.114	8.841	17.347	x	x	x	x	14.132	15.123	x	x	x	x	22.493	8.221	x	x	0.827	x	x	x	x	17.895	16.672	x	x	x	x	18.069	x	11.51	
-16340	None	Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	x	17.625	15.2273	16.8438	18.2	11.3333	13.1667	12.5	17.0	14.25	14.75	14.375	13.375	19.375	16.3333	16.75	18.125	14.1667	11.0	x	x	x	x	17.0	x	18.375	x	14.6667	x	12.625	13.9	18.0	18.9545	x	14.8333	x	9.58333	13.2143	13.75	x	11.75	17.875	21.8182	16.5	x	x	11.9	x	12.5	17.8889	x	x	x	15.0	18.875	x	x	x	14.4545	18.2368	14.6111	17.3333	x	13.4523	18.5	17.5	16.8333	17.0385	16.4583	12.5	x	17.9354	x	14.85	x	17.6429	x	x	x	x	x	16.2083	13.75	16.0714	16.6667	16.5	x	14.5417	15.3	x	14.0	x	x	17.75	x	x	18.6875	18.25	16.5455	13.25	15.2778	x	
-16337	None	Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes. Merged.	Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg]	15.6667	15.1111	15.375	16.7143	17.5	x	15.6	x	x	16.0833	14.4167	17.4286	13.9444	18.25	16.875	18.0714	16.4167	15.625	15.25	x	x	x	13.75	x	x	16.75	x	16.8333	x	12.5	14.8333	12.6667	14.3	x	13.75	x	12.5	15.5	15.5	x	16.7	17.25	14.4091	13.125	x	x	16.5359	x	14.8846	12.5556	x	x	x	15.3	15.5	x	x	x	15.375	16.1923	19.0	16.0714	x	14.35	17.6111	16.0	16.1667	15.5909	11.6667	13.0556	x	14.1463	x	13.1111	x	14.2083	x	x	x	x	x	17.3636	15.0	12.4583	16.2778	16.6875	x	14.1667	13.375	x	15.1667	x	x	15.0	x	x	11.6429	17.0	17.3125	12.9167	17.3333	x	
-16355	Original post publication description: Duration of call-day-7	Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 7 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec]	29.883	29.587	16.434	35.289	33.61	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	35.27	x	x	x	50.252	x	x	26.533	x	32.328	x	x	x	x	x	x	x	x	x	43.761	x	x	x	29.2	43.65	x	x	x	x	x	30.743	x	x	x	x	25.488	x	x	x	x	x	x	x	47.668	27.353	x	x	x	26.948	23.413	x	x	38.97	x	x	x	x	x	x	30.92	x	46.088	x	x	x	x	x	x	x	x	x	x	x	x	27.95	34.85	x	24.88	x	
-16336	Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time = 30 min of XX-week old males after inject of XX mg 2DG (2-deoxyglucose) [mg/dl] Original pre publication description: Metabolism: Thorens Trait 1	Metabolism: Thorens Trait 1 (demo only)	Metabolism: Demo data, Blood glucose level (intraperitoneal glucose tolerance test) at time = 30 min of XX-week old males after inject of XX mg 2DG (2-deoxyglucose) [mg/dl]	5.0	6.0	10.0	x	x	x	x	x	x	x	x	x	x	15.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16343	Original post publication description: Infectious disease, immune system, add other information Original pre publication description: Schughart trait RNASeq BWL	BWL for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), body weight loss day 3 after infection in 9-14 week-old females [%] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	86.35	81.71	x	x	x	85.48	x	x	x	x	x	x	x	x	x	x	x	x	76.5	x	x	x	x	x	x	91.0	x	x	x	x	x	x	x	x	x	x	97.25	x	x	x	x	80.8	x	x	85.71	86.57	81.77	x	x	x	x	x	x	x	x	x	x	x	74.25	x	81.76	x	92.42	x	x	x	x	x	x	80.41	80.4	x	x	x	x	x	x	x	x	81.05	x	x	83.46	x	x	x	x	x	x	x	x	x	x	90.29	89.59	82.53	x	x	x	85.09	
-16344	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu HA expression [RPKM plus 1, log2] - individual mice from RNAseq experiment [HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM] Original pre publication description: RPKM flu HA expression for RNAseq mice	RPKM flu HA expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu HA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	9.4	10.62	x	x	x	10.71	x	x	x	x	x	x	x	x	x	x	x	x	11.33	x	x	x	x	x	x	10.39	x	x	x	x	x	x	x	x	x	x	10.64	x	x	x	x	10.63	x	x	10.08	10.19	10.87	x	x	x	x	x	x	x	x	x	x	x	10.9	x	10.75	x	10.56	x	x	x	x	x	x	10.96	10.88	x	x	x	x	x	x	x	x	10.7	x	x	10.51	x	x	x	x	x	x	x	x	x	x	11.05	10.56	10.8	x	x	x	10.86	
-16345	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB1 expression [RPKM plus 1, log2] - individual mice from RNAseq experiment [HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM] Original pre publication description: RPKM flu PB1 expression for RNAseq mice	RPKM flu PB1 expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB1 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	8.37	10.98	x	x	x	10.44	x	x	x	x	x	x	x	x	x	x	x	x	11.77	x	x	x	x	x	x	9.65	x	x	x	x	x	x	x	x	x	x	9.68	x	x	x	x	9.84	x	x	9.24	9.23	10.52	x	x	x	x	x	x	x	x	x	x	x	10.88	x	10.2	x	9.82	x	x	x	x	x	x	10.3	x	x	x	x	x	x	x	x	x	10.27	x	x	9.25	x	x	x	x	x	x	x	x	x	x	10.04	9.69	10.43	x	x	x	10.22	
-16346	Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titers following corneal infection, young adult male and female (combined) Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titers following corneal infection, young adult male and female (combined)	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit]	Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit]	x	x	x	x	x	x	x	x	x	x	x	275.0	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	600.0	x	x	x	x	x	x	x	x	x	600.0	x	x	x	x	x	x	x	x	x	x	200.0	x	x	x	x	x	162.0	375.0	x	x	x	x	x	x	175.0	275.0	412.0	x	x	x	x	x	x	x	x	x	x	x	287.0	300.0	x	x	550.0	x	300.0	337.0	x	x	x	x	x	550.0	x	487.0	85.0	250.0	287.0	x	400.0	
-16347	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu M expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu M expression for RNAseq mice	RPKM flu M expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu M expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	7.31	9.17	x	x	x	8.59	x	x	x	x	x	x	x	x	x	x	x	x	9.57	x	x	x	x	x	x	8.43	x	x	x	x	x	x	x	x	x	x	8.66	x	x	x	x	8.61	x	x	8.08	8.28	9.18	x	x	x	x	x	x	x	x	x	x	x	9.17	x	8.77	x	8.61	x	x	x	x	x	x	8.89	9.66	x	x	x	x	x	x	x	x	8.83	x	x	8.63	x	x	x	x	x	x	x	x	x	x	8.99	8.56	8.82	x	x	x	8.84	
-16348	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NA expression for RNAseq mice	RPKM flu NA expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	4.63	6.15	x	x	x	5.51	x	x	x	x	x	x	x	x	x	x	x	x	6.88	x	x	x	x	x	x	5.44	x	x	x	x	x	x	x	x	x	x	5.64	x	x	x	x	5.72	x	x	5.24	5.24	6.27	x	x	x	x	x	x	x	x	x	x	x	6.49	x	6.17	x	5.83	x	x	x	x	x	x	6.13	6.85	x	x	x	x	x	x	x	x	5.69	x	x	5.51	x	x	x	x	x	x	x	x	x	x	5.72	5.2	5.89	x	x	x	6.06	
-16349	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NA expression for RNAseq mice	RPKM flu NS expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NS expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	8.24	9.93	x	x	x	9.66	x	x	x	x	x	x	x	x	x	x	x	x	10.18	x	x	x	x	x	x	9.28	x	x	x	x	x	x	x	x	x	x	9.48	x	x	x	x	9.38	x	x	9.13	9.13	10.09	x	x	x	x	x	x	x	x	x	x	x	10.03	x	9.59	x	9.66	x	x	x	x	x	x	9.96	10.43	x	x	x	x	x	x	x	x	9.85	x	x	9.43	x	x	x	x	x	x	x	x	x	x	10.03	9.56	9.86	x	x	x	9.81	
-16350	Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight]	Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight]	x	x	-1.649	1.164	0.448	x	x	x	x	-1.9	x	0.587	1.897	x	x	x	x	x	x	x	-1.05	x	x	x	x	-0.669	x	x	x	x	x	x	x	x	x	x	x	1.842	x	x	x	0.777	x	0.238	x	x	x	-2.741	-2.679	x	x	x	x	-0.588	x	x	x	x	x	x	1.254	1.744	0.127	-3.628	2.38	0.433	2.96	1.835	x	x	x	0.385	-0.734	0.77	x	x	x	x	0.183	-1.425	x	x	x	x	2.005	-0.933	x	x	-3.362	x	x	x	x	0.185	0.123	x	x	x	x	0.254	x	-0.234	
-16351	Original post publication description: Hab Activity entered at November/25 14:32:55 from IP 128.125.179.203	None	Hab Activity entered at November/25 14:32:55 from IP 128.125.179.203	x	x	1.0	0.0	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16352	Original post publication description: Central nervous system, neurotoxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults (mostly females) Original pre publication description: Central nervous system, neurotoxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu)	Central nervous system, neurotoxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu)	Central nervous system, neurotoxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults (mostly females)	x	x	1.0	0.0	0.5	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	
-16353	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB2 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu PB2 expression for RNAseq mice	RPKM flu PB2 expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB2 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	7.02	9.42	x	x	x	8.7	x	x	x	x	x	x	x	x	x	x	x	x	10.32	x	x	x	x	x	x	8.1	x	x	x	x	x	x	x	x	x	x	8.48	x	x	x	x	8.74	x	x	8.0	7.93	9.03	x	x	x	x	x	x	x	x	x	x	x	9.55	x	9.09	x	8.59	x	x	x	x	x	x	9.06	9.81	x	x	x	x	x	x	x	x	8.71	x	x	8.54	x	x	x	x	x	x	x	x	x	x	8.37	8.35	8.67	x	x	x	8.86	
-16354	Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NP expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NP expression for RNAseq mice	RPKM flu NP expression for RNAseq mice	Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NP expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM)	x	x	9.55	10.94	x	x	x	11.02	x	x	x	x	x	x	x	x	x	x	x	x	11.51	x	x	x	x	x	x	10.28	x	x	x	x	x	x	x	x	x	x	10.88	x	x	x	x	11.02	x	x	10.38	10.3	11.02	x	x	x	x	x	x	x	x	x	x	x	11.1	x	10.83	x	10.73	x	x	x	x	x	x	11.05	11.37	x	x	x	x	x	x	x	x	10.8	x	x	10.69	x	x	x	x	x	x	x	x	x	x	11.43	11.15	10.96	x	x	x	10.93	
-16356	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 8 [msec] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 8 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec]	32.117	32.846	16.289	33.503	36.36	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	39.32	x	x	x	51.45	x	x	27.98	x	38.35	x	x	x	x	x	x	x	x	x	46.603	x	x	x	31.99	43.783	x	x	x	x	x	27.74	x	x	x	x	22.715	x	x	x	x	x	x	x	41.76	26.458	x	x	x	24.3	26.335	x	x	37.47	x	x	x	x	x	x	30.41	x	41.5	x	x	x	x	x	x	x	x	x	x	x	x	33.35	31.0	x	26.07	x	
-16357	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day7 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 7 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB]	-40.27	-44.07	-34.57	-22.23	-40.62	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-29.06	x	x	x	-19.48	x	x	-36.317	x	-30.736	x	x	x	x	x	x	x	x	x	-29.546	x	x	x	-33.09	-32.349	x	x	x	x	x	-28.418	x	x	x	x	-33.145	x	x	x	x	x	x	x	-20.977	-40.186	x	x	x	-35.75	-34.157	x	x	-28.55	x	x	x	x	x	x	-37.99	x	-33.53	x	x	x	x	x	x	x	x	x	x	x	x	-27.871	-35.51	x	-29.53	x	
-16358	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, amplitude of call on day8, mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB]	-35.79	-41.067	-35.777	-15.95	-41.101	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-24.998	x	x	x	-20.278	x	x	-36.752	x	-22.12	x	x	x	x	x	x	x	x	x	-27.931	x	x	x	-25.929	-33.673	x	x	x	x	x	-30.997	x	x	x	x	-38.36	x	x	x	x	x	x	x	-19.16	-38.79	x	x	x	-39.327	-37.502	x	x	-30.402	x	x	x	x	x	x	-35.953	x	-37.019	x	x	x	x	x	x	x	x	x	x	x	x	-24.299	-31.028	x	-24.994	x	
-16359	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 7, mixed sexes from 2 to 5 litters [kHz] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 7, mixed sexes from 2 to 5 litters [kHz]	64.61	65.36	73.12	63.74	65.428	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	65.061	x	x	x	69.613	x	x	70.57	x	66.719	x	x	x	x	x	x	x	x	x	67.815	x	x	x	56.193	67.291	x	x	x	x	x	70.201	x	x	x	x	87.298	x	x	x	x	x	x	x	64.908	61.116	x	x	x	70.822	73.331	x	x	66.258	x	x	x	x	x	x	70.348	x	55.419	x	x	x	x	x	x	x	x	x	x	x	x	74.453	67.347	x	66.629	x	
-16360	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [kHz] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, Roy1	Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [kHz]	67.78	66.87	67.04	61.38	64.552	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	65.018	x	x	x	69.999	x	x	70.841	x	62.317	x	x	x	x	x	x	x	x	x	67.115	x	x	x	73.214	68.636	x	x	x	x	x	71.434	x	x	x	x	83.701	x	x	x	x	x	x	x	61.365	67.736	x	x	x	76.232	70.379	x	x	66.085	x	x	x	x	x	x	70.926	x	59.413	x	x	x	x	x	x	x	x	x	x	x	x	64.151	74.582	x	74.972	x	
-16361	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 9 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 9 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec]	29.067	25.485	15.526	33.654	35.89	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	31.06	x	x	x	45.533	x	x	26.767	x	36.273	x	x	x	x	x	x	x	x	x	44.913	x	x	x	30.15	45.615	x	x	x	x	x	32.225	x	x	x	x	20.485	x	x	x	x	x	x	x	32.43	26.06	x	x	x	26.51	21.292	x	x	34.6	x	x	x	x	x	x	30.425	x	41.32	x	x	x	x	x	x	x	x	x	x	x	x	33.657	30.5	x	27.45	x	
-16362	Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, amplitude of call on day 9, mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, Roy 1	Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 9 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB]	-36.73	-43.44	-36.22	-22.75	-41.448	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	-27.323	x	x	x	-20.642	x	x	-41.986	x	-25.05	x	x	x	x	x	x	x	x	x	-25.456	x	x	x	-32.062	-34.865	x	x	x	x	x	-25.044	x	x	x	x	-33.45	x	x	x	x	x	x	x	-25.46	-38.86	x	x	x	-37.829	-42.014	x	x	-34.394	x	x	x	x	x	x	-35.796	x	-38.927	x	x	x	x	x	x	x	x	x	x	x	x	-26.064	-29.513	x	-29.78	x	
-16363	Original post publication description: Uterine Weight entered at January/07 11:58:18 from IP 172.23.146.243 Original pre publication description: Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg]	Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg]	Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg]	84.918	109.317	61.714	98.693	62.152	x	62.247	x	x	85.894	68.812	62.88	98.831	x	x	48.141	x	72.035	x	x	73.579	x	x	59.126	x	35.501	x	64.377	x	72.837	89.12	x	85.482	x	92.271	x	x	81.025	77.517	x	57.807	75.819	50.241	89.667	x	x	63.615	x	84.743	89.833	x	x	x	102.647	104.061	x	x	x	86.815	67.38	73.811	93.228	88.368	87.168	82.685	52.414	73.693	67.398	x	69.365	x	75.26	93.96	103.049	x	86.626	x	58.284	63.909	66.743	x	80.206	73.374	113.495	61.452	87.994	x	92.682	85.052	x	77.527	x	x	87.431	82.589	76.075	69.69	89.329	90.177	104.606	84.339	73.351	
-16364	Original post publication description: Ovarian Weight Original pre publication description: Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg]	Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg]	Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg]	4.039	4.322	2.813	9.627	3.404	x	3.3	x	x	3.446	5.36	4.61	3.851	7.35	x	3.896	x	3.36	x	x	3.566	x	x	3.46	x	3.044	x	3.908	x	4.029	6.769	x	2.243	x	3.844	x	x	3.626	3.179	x	2.647	4.571	3.518	7.121	x	x	4.907	4.257	4.409	6.001	x	x	x	4.845	7.5	x	x	x	2.422	4.412	5.345	2.552	5.462	2.89	3.978	3.262	4.035	2.893	3.56	3.465	x	3.991	4.593	3.761	x	5.756	x	2.623	3.755	2.404	x	4.431	4.224	4.348	2.841	4.205	x	3.942	5.252	x	3.247	x	x	3.331	5.356	2.636	4.247	3.852	5.992	4.693	4.244	2.972	
-16365	Original post publication description: Uterine Body Length Original pre publication description: Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]	Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]	Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]	0.296	0.422	0.298	0.416	0.377	x	0.327	x	x	0.334	0.389	0.409	0.384	0.412	x	0.453	x	0.366	x	x	0.407	x	x	0.41	x	0.375	x	0.35	x	0.36	0.474	x	0.385	x	0.422	x	x	0.368	0.374	x	0.348	0.417	0.368	0.404	x	x	0.402	0.415	0.377	0.438	x	x	x	0.442	0.332	x	x	x	0.438	0.412	0.419	0.352	0.438	0.344	0.432	0.338	0.346	0.379	0.432	0.383	x	0.397	0.382	0.329	x	0.393	x	0.431	0.368	0.532	x	0.424	0.361	0.385	0.333	0.373	x	0.426	0.385	x	0.388	x	x	0.474	0.393	0.363	0.35	0.461	0.356	0.432	0.332	0.362	
-16366	Original post publication description: Uterine Body Weight Original pre publication description: Reproduction, urogenital system, morphology: uterine body weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg]	Reproduction, urogenital system, morphology: uterine body width at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]	Reproduction, urogenital system, morphology: uterine body width at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]	0.28	0.3	0.262	0.3	0.268	x	0.198	x	x	0.256	0.258	0.279	0.286	0.348	x	0.239	x	0.326	x	x	0.243	x	x	0.284	x	0.245	x	0.277	x	0.303	0.304	x	0.282	x	0.375	x	x	0.265	0.319	x	0.275	0.283	0.249	0.312	x	x	0.277	0.308	0.297	0.286	x	x	x	0.349	0.364	x	x	x	0.282	0.26	0.267	0.281	0.3	0.311	0.291	0.253	0.249	0.276	0.312	0.223	x	0.266	0.311	0.322	x	0.29	x	0.294	0.258	0.226	x	0.273	0.274	0.327	0.274	0.326	x	0.305	0.303	x	0.27	x	x	0.289	0.328	0.294	0.283	0.314	0.29	0.284	0.282	0.25	
-16367	Original post publication description: Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm] Original pre publication description: Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm]	Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm]	Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm]	1.778	1.887	1.619	1.602	1.487	x	1.487	x	x	2.031	1.388	1.348	1.63	1.61	x	1.426	x	1.655	x	x	1.516	x	x	1.581	x	1.587	x	1.486	x	1.569	1.695	x	1.459	x	1.42	x	x	1.563	1.441	x	1.699	1.809	1.569	1.619	x	x	1.778	1.652	1.793	1.538	x	x	x	1.644	1.586	x	x	x	1.545	1.69	1.522	1.86	1.575	1.715	1.595	1.58	1.83	1.737	1.831	1.664	x	1.663	1.812	1.912	x	1.846	x	1.295	1.657	1.856	x	1.884	1.786	1.653	1.681	1.573	x	1.821	1.631	x	1.598	x	x	1.961	1.648	1.602	1.592	1.743	1.725	1.876	2.037	1.691	
diff --git a/wqflask/maintenance/dataset/phenotypes.py b/wqflask/maintenance/dataset/phenotypes.py
index ae1e82cc..af2ba7b7 100644
--- a/wqflask/maintenance/dataset/phenotypes.py
+++ b/wqflask/maintenance/dataset/phenotypes.py
@@ -13,7 +13,7 @@ def fetch():
     inbredsetid = 1
     phenotypesfile = open('bxdphenotypes.txt', 'w+')
     #
-    phenotypesfile.write("id\tOriginal_description\tPre_publication_description\tPost_publication_description\t")
+    phenotypesfile.write("ID\tAuthors\tOriginal_description\tPre_publication_description\tPost_publication_description\t")
     # open db
     cursor = utilities.get_cursor()
     # get strain list
@@ -52,7 +52,7 @@ def fetch():
         original_description = clearspaces(phenotyperow[2])
         pre_publication_description = clearspaces(phenotyperow[3])
         post_publication_description = clearspaces(phenotyperow[4])
-        phenotypesfile.write("%s\t%s\t%s\t%s\t" % (publishxrefid, authors, original_description, pre_publication_description, post_publication_description))
+        phenotypesfile.write("%s\t%s\t%s\t%s\t%s\t" % (publishxrefid, authors, original_description, pre_publication_description, post_publication_description))
         sql = """
             SELECT Strain.Name, PublishData.value
             FROM (PublishXRef, PublishData, Strain)